<SEC-DOCUMENT>0000313143-23-000014.txt : 20230522
<SEC-HEADER>0000313143-23-000014.hdr.sgml : 20230522
<ACCEPTANCE-DATETIME>20230522160423
ACCESSION NUMBER:		0000313143-23-000014
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		107
CONFORMED PERIOD OF REPORT:	20230401
FILED AS OF DATE:		20230522
DATE AS OF CHANGE:		20230522

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HAEMONETICS CORP
		CENTRAL INDEX KEY:			0000313143
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042882273
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0401

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14041
		FILM NUMBER:		23944372

	BUSINESS ADDRESS:	
		STREET 1:		125 SUMMER STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		7818487100

	MAIL ADDRESS:	
		STREET 1:		125 SUMMER STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>hae-20230401.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:d8e9c074-6bb3-481a-a40c-b4f91e1c5276,g:f0cc1f72-36f0-46b0-9a43-9e0dba51bc09,d:a9c9dcfe45534d5b96005ebe816d5e7b--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:hae="http://www.haemonetics.com/20230401" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hae-20230401</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl80L2ZyYWc6ZDUwMDlkZDk3ZmM4NGQ4Y2JhMjhjZTkzZWU3NWJkZjEvdGFibGU6YWZmNDM3M2QzY2M4NDQwYzljY2I5ZWJkOWQ1NDg0NDAvdGFibGVyYW5nZTphZmY0MzczZDNjYzg0NDBjOWNjYjllYmQ5ZDU0ODQ0MF8wLTEtMS0xLTcwMzM0_e03e3178-babf-4e38-8521-498ac065c249">0000313143</ix:nonNumeric><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl80L2ZyYWc6ZDUwMDlkZDk3ZmM4NGQ4Y2JhMjhjZTkzZWU3NWJkZjEvdGFibGU6YWZmNDM3M2QzY2M4NDQwYzljY2I5ZWJkOWQ1NDg0NDAvdGFibGVyYW5nZTphZmY0MzczZDNjYzg0NDBjOWNjYjllYmQ5ZDU0ODQ0MF8xLTEtMS0xLTcwMzM0_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl80L2ZyYWc6ZDUwMDlkZDk3ZmM4NGQ4Y2JhMjhjZTkzZWU3NWJkZjEvdGFibGU6YWZmNDM3M2QzY2M4NDQwYzljY2I5ZWJkOWQ1NDg0NDAvdGFibGVyYW5nZTphZmY0MzczZDNjYzg0NDBjOWNjYjllYmQ5ZDU0ODQ0MF8yLTEtMS0xLTcwMzM0_1c6a4386-e46f-4a2c-bcd2-32d53fcedf70">FY</ix:nonNumeric><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl80L2ZyYWc6ZDUwMDlkZDk3ZmM4NGQ4Y2JhMjhjZTkzZWU3NWJkZjEvdGFibGU6YWZmNDM3M2QzY2M4NDQwYzljY2I5ZWJkOWQ1NDg0NDAvdGFibGVyYW5nZTphZmY0MzczZDNjYzg0NDBjOWNjYjllYmQ5ZDU0ODQ0MF8zLTEtMS0xLTcwMzM0_3b91239e-a37d-44a2-b81b-19a4a07f2aa4">false</ix:nonNumeric><ix:nonNumeric contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMC0xLTEtNzAzMzQ_34cb8f69-e36e-4863-9363-93e365f18a37">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMC0xLTEtNzAzMzQ_4c4b5b40-680d-44df-9a35-0e7bc64d7233">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMC0xLTEtNzAzMzQ_71a2b58f-3dab-4c09-b137-6558f9c15c80">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMC0xLTEtNzAzMzQ_993d52dc-b21b-4c73-bea1-865c14747532">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMC0xLTEtNzAzMzQ_64ce6304-0097-4fab-b514-f225878a9f4b">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMC0xLTEtNzAzMzQ_aece9495-28e3-4cad-8c7d-78640888fb76">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i760c632c599245f5913431ba3dca78dd_I20220402" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzAvZnJhZzpmMjY0MjFjYmMwYzc0ZWVjOTQyM2FmMDY1MjMzNzQwZi90ZXh0cmVnaW9uOmYyNjQyMWNiYzBjNzRlZWM5NDIzYWYwNjUyMzM3NDBmXzc_79441a6f-c39a-4b83-8324-195651c66585">15 years, 6 months, 30 days</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hae-20230401.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82f00f58456d4ce9b4e8c3e6f30b1b13_I20221001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ice2c089f520648328aa2b345444e9e2d_I20230518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-05-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff466f709be0458d96d07670e8506c93_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i0ca40b48f3114d14bf1271d7751fa199_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c45fa2cfd044c32806ebad955872fa5_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica07a6a12db04420a640cda640d48dcd_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb2d524b6a72478a8ce2435530d7cbc4_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42ee76458100485abe569121bb8658a3_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52763a808517454786578412ff4262d9_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60812e5a52b74920a9ce77100e55369d_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2752e169c88b4ff2a289838d456aec0d_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37f5873c934c4f319a70ed61b214fb3f_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id668923a47bf4311bb983f1280642d51_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i697ca53aa7594d49b0f5f0ea4adc78fc_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8a40e6978d54c79bf15a000c4fe1242_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a75725e0d6e42c5b75f249d0fd73f03_I20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18bd16d259fa4608b4077e65accd3342_I20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5fe2762223141c79cda70db2a2e1be5_I20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a31987923a94e60800afa0e777b9b45_I20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5148af9ebc54cf1b637aaff64021039_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dfd4364e8c24bc4b8394dd292c16b8c_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida4469bc869a466b9e701b962dc524a8_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2250e1e0cab44768927b6683d1fa68a_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99c9262cec6b4dda9414dc17ce49c2c4_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a826461f49548eeaa6114591f43ea92_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i529b729b5858426a8917c2a33f2e400c_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i642712cd53f84556a5ccf4b37238b593_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83ac7a16fc574ea38c5d4d9bbfa9d783_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f76d034fa45484ea27ccefad26663e6_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie18371e832794ec985b640a184d0d733_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54f0ad46abac454891cfccff72983699_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafa9b4b7857b47e3ba345fec50c6803f_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e354d29beb04828b88b6371c1870695_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3cf28e5ca804729899b65c631cd302c_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib38708d3cbd24fe78b4b34a0adf8f366_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7db70ed758f45088a07ed84e94c60aa_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="unit"><xbrli:measure>hae:unit</xbrli:measure></xbrli:unit><xbrli:context id="ia734649bb2e94aaaba0ee38844e22e8d_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cb751cf6eb5433f9a53896b439e745e_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b1bc73a7c434d8e9c1c7ea1d43cb121_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d19f87949e24b99a793aca6577b9df5_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c33fc42a5f5449fa7494bc0c090d585_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib49d6de2075749128f193bc5cdce0870_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd32c41156c94b0589e00e52da019550_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:OfficeEquipmentAndInformationTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03fe4b852d714a1aa9e19e12fe06664b_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:OfficeEquipmentAndInformationTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6edb3ee4a05545b48465b7b748a5455b_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:HaemoneticsEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40bfcce1095940b7b5d05d79a9a16330_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:HaemoneticsEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3acb260a76164a64b8af93dcc2faa623_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecd0cd60e86c45669800594f2197741d_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib118e4be0869418993e5e01e0a05c3d3_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hae:TenLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ica5c1f5ccf23408886c2ccf29b825567_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hae:TenLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic27d4ecc7a734888b526104ed27669d7_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hae:TenLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04ed8db1084a467599f50150cbd6f746_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hae:PlasmaCustomerCSLLimitedCSLMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i916dfcb35225444db2be37fbccd76378_I20210404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie55a1738904642cd8ecd0cbc158879ef_I20210404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fbc64b8be934aaba7b7e05bf27bf2df_I20210404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic28c109153f44c518dc27cd58f174f92_I20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia169b122e4e748a2bbfec2d666095114_I20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6982a32b8c784f13bc9963f00302b541_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ca6348e2ac24a4195142c309fc7a641_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifea5055cceb64d2faa7c2c933a01dfc9_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a75e1df66c146d8bc21150965eea19b_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id761fa129e9b4c9b8c14ce258bfb5327_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:PriorRestructuringProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4177f085a6164014b652e8ba2cbc96bc_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:PriorRestructuringProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i823363dc6c2c4b3ea41d483a51719275_I20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fbf2c91e0d14fe299efc100a438a840_I20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:PriorRestructuringProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i687b01b80c934827b2cb6b312b9524ad_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:PriorRestructuringProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8589d7325ec74adabcdb6aef0a20354d_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i002292f589b9486bbc885d8889b15b7b_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:PriorRestructuringProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i407111b2df044b2d85cd23b1b5025a83_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:PriorRestructuringProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62b2b847dc034a3db085e75ba45fed2e_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i984a455da961408f925ca49751e6ddef_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:PriorRestructuringProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie757a5b3c6874d30b0632b13796f7765_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35a58bb523b34502b7e9328f05462202_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54605da039714724a8b332c1eadca994_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e94fc8a563c41dbb911f86eebd74fb4_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60c21727b1644983b67286f3ff83bf6f_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if570127cbc674472bddd6c920a6680a6_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic03bd40350ab47b59e94e0eb9a16722d_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44318b6edd204f9bb959e54aa88e533c_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i202912003ea5483c8e977d2876231a84_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceda53e10aa943db9898cb8ab8dac15a_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic069cd0eb4c94953be95e2deb98ea5e5_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia79a8918d94541fbb215b791d3bc0308_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3ffef01c50b40dcbbc6f463d67d82a6_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b364431a43245b7a9f05a60dc7416df_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6794b0b382b4fb7886de74ba621481b_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i753483fb84d94062bdc30420838c80cf_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c4e22f5dd7d46aab1223c60d287905f_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e8e2ad8db6d4f6c859bc3263d7c9235_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i206a029467f0420ab5932b24faf54368_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f56f2e6daa64033b788180008d0fb12_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf36ce0a0ea1444d88b791a90bbfdf76_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6fc9e356f064785861fafa202778d12_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7405bd2190704f40b0b1839ce85522b7_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id878234d30d043a1869cefb375fae586_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f85a675d779468d9d4dbca1c8a1df77_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ff998f127d34759a4f6f4837bf4c1c2_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a4624f506734e78b0c21280a438461f_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9823c17774ed4746ae030a36d0b5328b_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95ab359c02104ffb9f744088a78d1303_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6dd8c04e15e409a938cebbc415144b4_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5dc66016da24927b10302bc7adc1138_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfb28cdda17d4216bac7c9d5cc1183fe_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcb82f284dea477ea7ca024b9ae58bae_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc62548e17174a3eaf8c1c8435fb16e5_D20210301-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4651aa24e89d4f19b23ca9c1b848272a_I20210113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:HASIntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4e2ba32e7d846df811c490e96dfc2db_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">hae:HASIntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86f7e1c8849a4449adccae1f6aa3a753_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">hae:HASIntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied3f33df8d1c44b78b90db973a88aed4_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0252aa2fd7447a48396f27529ad8ce1_D20230401-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id62c57cefd2b41e5a3798110a7fa7e0a_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e1cd971bed141ee9e1ec7750e91d3fd_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6277c2898c846d3b4349c549833daf4_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i616e2c0925064b749fa614ff59dd7499_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd18f7423eb842dca4250857300a60d4_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i203dfbcae1dd44178cef12e0b4685fe4_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if633c82b96c64c7e994ccb564cfd6ca7_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5038a81c8b424af199422b8a9d70bc1c_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">hae:VivasureMedicalLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="ia4acc494c5054244829743f91b7e2da7_D20200629-20200629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:FajardoPuertoRicoManufacturingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2752501b70f24fe681ec2c0d0d6e1c32_D20220703-20221001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:FajardoPuertoRicoManufacturingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-03</xbrli:startDate><xbrli:endDate>2022-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3207d32bf765482d974e19e8a1ba412c_I20200629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:FajardoPuertoRicoManufacturingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44250ce6b1a74481b968a4be5acfd176_D20200701-20200701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:USBloodDonorManagementSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6966c90880e42ea87ed7bdf600844e5_I20200701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:USBloodDonorManagementSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f15ab7ccf5a4506a8affa0b65b6006a_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:USBloodDonorManagementSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2b9fa2b5f664127b8fdc362bbb48a1e_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:USBloodDonorManagementSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i415a9f8fdf8b4219856aecb281c27444_D20200918-20200918"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:InlogHoldingsFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-18</xbrli:startDate><xbrli:endDate>2020-09-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ed16aebc739402e9a2e33283c09034b_I20200918"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:InlogHoldingsFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9b6d677fac64743add841031ac4146a_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:InlogHoldingsFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb9a6ef65b5a4fbda10aff17313ea7f0_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb2d1cef790a43cc813e187423890c9d_I20210117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibec6ab6de3e844179c838dce47275e1a_I20210117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66bfdbf0893842978853fb1777820b01_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4314f040e25a485baf6b4975aeefb581_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2625054aca6d4672ac4dfe103e5f3018_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0c1ae0e5e35463eabd3c1bdbdae5618_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if001c425b20b415582a047fc50a913ad_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i284b8cd4b4544ab58be9c3a7b5aef631_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hae:A2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e9d4875df194dab89de359ddb229826_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hae:A2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i911fdad529ca44e49f9d2e6eb98bf48e_I20220816"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hae:A2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fc032744cf14e5b8712fe75bf23387a_D20220816-20221104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hae:A2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-16</xbrli:startDate><xbrli:endDate>2022-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i474dead76fa741a1b6b0fcf117803177_D20221104-20221104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hae:A2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-04</xbrli:startDate><xbrli:endDate>2022-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8cb16fc7fbd4a119a8e39abd06c3f48_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hae:A2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46b375b6b4f542949b51fd68eaa34739_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-04-03</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ba643cdd69040399b37d76690fc345d_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72965c4a62614d3290bfa903e33eced7_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07ed489541e746a8b9deae1198e9c1c1_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b12e4fae98b451180b4184af64d8b88_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i004e8ca241ac4e4ca56b1a2a8a573d30_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42ce0fe93a644396931110078249d049_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e34ec5fd8bd4a428a2c86c1f65a1c72_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:OfficeEquipmentAndInformationTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie45ed624179b44a9aa90e98cbf443cd3_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:OfficeEquipmentAndInformationTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia49c226af761477286c878a9c01a26a8_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:HaemoneticsEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaf174529292432b93ffce203a8852e0_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:HaemoneticsEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9462d8afba8e42f1bdf6538fdf313e40_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b7e9feaba63462fb4d7c25051b882b9_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b2e53451fe5414ab6223fd9340d04f2_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">hae:AssetImpairmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66e23e49fe97425b9d4a7409908fbe9f_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">hae:AssetImpairmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee98836794a841af872ac5d2c262b2e1_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">hae:AssetImpairmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d967115487d4000bb10ef11e17c5ee3_I20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6471edc0acff4583a5b44bae2caf6812_I20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c0b4a3a52234ebca2c87d023a372f0d_I20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida4846630e6b4fe9abc8b036a5b0f2ca_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0134e8414f8c42618080f11b9286ca14_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5193ad1e9e4b4c359e874dfa2c7b2e29_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i890c831316434ae1b18be3b1ae53a567_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida09061210f544b39381b92caca71c36_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i728903670b674bc8867059c6c7f26220_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia69c0d5a250d4229b959398b479ddfa4_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2604f664a0d54bf69c814bdee8df438e_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc6430777b2d43ea89991090017c9b5a_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hae:OtherTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd9d2b7da12a4869876ddf3bd5cb0cd3_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e460218ba5d4a98bb1ebba94551faa3_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1c1d8f7dde943afbae8276595f08b9e_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">hae:InProcessSoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic30962d93d8542679db996ff09021707_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25a58336b11a40d2bc0242ec0ddcdf16_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">hae:InProcessPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfa652c38c114d559e869e8c58458b18_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iface21e4b3d043d29b088f04c24bece5_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23809cd4e75445928f37404062b1dd03_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hae:OtherTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92a64ff94d044686be5f9c39a18d0fd1_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i108b71d6b3c24623a40275dbf161561d_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85451529d01a46ff987455865e8cc517_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">hae:InProcessSoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9cc62c7a26a4855a7c2bde8ac969d41_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d4a14f19c3740fa8ef8bb4e38b7b19e_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">hae:InProcessPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4373220213f242c8b26e3d18d69d2ca7_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4f1d2dfba3142c997fbce5f50dfa603_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia88c59c423ec44039b63736f7e925910_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fb24bdd79a74f0eb39e5b0eecfbdaf6_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4cf1b883fd6484c9800097c24c1d893_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:ManufacturingSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i178b7f39a47e48ccbbd4fb779775b3cf_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:ManufacturingSpaceSecondRenewalTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i523638b9b7c54c378edd933028123e1e_I20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:ManufacturingSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85fa50a491e746dbbe80adc41c28821c_I20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:ManufacturingSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i760c632c599245f5913431ba3dca78dd_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:ManufacturingSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ef7fed91302418381fe9c7f81fce03e_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">hae:TermLoanNetofFinancingFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5206cff195784c31b27c9fddad5c6b59_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">hae:TermLoanNetofFinancingFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i925003616419483dae22f32ba1685a31_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25e28000700d43b485d92326bbc4bfb7_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i903c8d9492d64dafb77bbdf28e97066f_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">hae:BankLoansandOtherBorrowingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a29f8010b0f483eb7647596726afd6d_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">hae:BankLoansandOtherBorrowingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2c47b417de24ec0a72dcccb7db3cbe4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab86433186af40dcb319110ff6d19da1_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11f3eed068e24237b4a649f0058c65a2_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb6b31fbfdc24cad84abad0853c2b26c_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81bf02c0713c4e65b37b37c4baf36474_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8998d1b0b6314a3c9cc6e3cf409ae0e8_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib996e7dc8ee44cd2ad33f983f5f21944_I20180615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3967cacf6e894b93b61883e912ba1fe6_I20180615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb54cb0a2108432db260e72c7a6d4079_D20180615-20180615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-15</xbrli:startDate><xbrli:endDate>2018-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee47837acab14fbdac774a769db72497_D20180615-20180615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-15</xbrli:startDate><xbrli:endDate>2018-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2be5f41c5e2b4e1c8302bd6e01bebdfa_I20220726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a9006835c4148deb219670605797d8d_I20220726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id657b251abdc4abebff797dc16703707_I20220726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fd10418194d4183846d9bb8e0212b5d_I20220726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fce0a136f5a44868f4e4a7f2e21a61a_D20220726-20220726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-26</xbrli:startDate><xbrli:endDate>2022-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29c8a067458945ffa8f7969389dce91f_D20220726-20220726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-26</xbrli:startDate><xbrli:endDate>2022-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a709732686240949bc3efe71990d70e_D20220726-20220726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-26</xbrli:startDate><xbrli:endDate>2022-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i973bd797eb414599820e9d35565eeede_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a1b40a602a74e26bef73bbaf259f41c_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if339c602382f4eaf8286ac7302f32991_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0d3e0503f2e47369182add4c536c0b0_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0373e5b59bde4b20931153fa64e29e2b_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica4fb645f2a44680b45401f71819ac02_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8896432b873649499c520736535daf9b_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia304a8f1861445a888815c4e3fe5f060_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f25693c211040ecb83adb263cfb9f7f_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">hae:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c2e06723032498cae382b252778126a_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4174f7cffc824248a65ba67bdeea5ccf_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaea3475e1f9349fe82f8c3d1a089214d_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i764ec41ce0424c3da439a7f3192b0337_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i203893fd11e847cf96e92a3382d9cf3e_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40bb49f3669047d78a200b57b5089b10_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic098477b86064390ab0ce23b1ab8e887_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="swap"><xbrli:measure>hae:swap</xbrli:measure></xbrli:unit><xbrli:context id="i1fd6349491de4fe18e35a4e8da7c6adb_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide370a9836b84207b26c4ba915b66f5e_D20220726-20220726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">hae:SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-26</xbrli:startDate><xbrli:endDate>2022-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97fd6203f93c48a497546a24430f37f5_I20220726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">hae:SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5594635815ba48028990d42040a8998c_I20220726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">hae:SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7aae77517ed42c7b472d781ea7f2fd5_D20220901-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e00c74476ee4f559c6f5da509474dc8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17c4195f41c04cd69212868e1ecf674f_I20230615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc4d6f8cfb4043299d632162cf4b2dd3_D20230615-20230615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-15</xbrli:startDate><xbrli:endDate>2023-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68eff29e4ad24dbbbb27184442823054_I20180928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap267FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7000a797e0454253afd12b28826cf4c1_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap267FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ebfc574daa0449aa36b42ccd3735fb8_I20180928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap276FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fd5a33d65ce4c719c8ef554f98fd1b3_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap276FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee0aef522d1c43b297cb87bd0a1062c5_I20220923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap444FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc20bf01217b405abe467d85031aa1d8_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap444FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i929893b4a65b42a99d8cd2ed3e4ad16f_I20220923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap446FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95d4787e8ccb4c79bb1a2ae21210589b_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap446FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a2bff04bb124b3cb9565ede568309e3_I20220923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap408FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a0016d855bc4eae89b59f2528f0aac5_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap408FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia88f4a493fba4a00b9f4326a9f0089c9_I20220923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap415FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i143f09af5d36486a95b6a2443695e880_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap415FixedInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40cd2d153ec649379e2713e53825581e_I20220923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38a3ef0a8b5c416391e812e3c975190b_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a086617625d4770aa1177f5b215bdfe_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice83d5f54d3b4d1591f7e898bf73fe94_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34427df65a3f408681e89de77f0bcba5_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i496992eb4e324c4d93a9779270bd0d95_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if57d6790a07844cc9da693a20bd4bffe_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i926351f2cdb64cfca4fca48cd71ce175_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf952df669d84ad79ebbd6961839ffa5_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bd4348fb37642cb9d19c854b0b98777_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82d640169aec444b861eade7d445b02e_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib905d6d3d68e4f13963e09cdca04d335_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d438a36d1f445b99fa95273454cd16f_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc5fe4fd66044c45abd2da237f5b01bf_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if685fcb31a604071a3aea04895ad5ca2_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1ef3242c33f4d14968403e733c74eb4_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i745bbb354f3c49e4acff9d758a7db139_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2d5c4548b37436eade14b50d116e37c_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d0667d1ab6e437eb9e2cccfe3114e71_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc84f5e642914bcd8c36ff54535f264b_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i228a035c89694077beb4571a980c3787_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b7cc66dd3cd45aebc86f3ccac3daccb_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib78abe8a21bb47f6b491e1e88a0c022a_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21efcb597c134d47a7cdd7695ada55c7_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40d487570854407eae1cd91197412837_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b34b4bf50694564a2bdc0ddefcf34d0_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5d605e3bfc94e56bc0743876ebc5034_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie12da83b81b74a6f8c251cbd3104102c_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71f5eeccac2e405cbde81dd345b9a918_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if45b2edcb0a34394bcc87dce4e55afb6_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7652e23f4d9749d58d9f74cc7d60f8f7_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i943bf7094e994bad85fe8de21c1cb0da_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc297a9a523d452588c49f61b90fe397_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie449786761b5459d81987ca7b30f976f_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic114d1ef99f7486e882e676e604e60d4_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i192129d9183945dfb1fa96a6e3f72823_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79baee9eabb44eaea4f2911723087bce_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ed4fde198f34c0e96958ff15ac93475_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide6dff6dae06426caaac4bd1fc9ef699_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3dfaa9406244d52a985e71d364da711_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id872bc48d1694456accfff526b09b5e0_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7949d38eb6ed4baaa1e5b677d09753c9_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bba1f3bac8247d9a7bf0303421a3e7c_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65e664ee98504b0b8f8186d1d3cedbee_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6760b9812af24258ad4ca438476747d4_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d7138fbdd0d40408d7f37574315a72b_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb5872f4ce6d4a36ae9ff072fc3da7c5_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa8b08aa795f429987456bca970a1829_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic93412d801134bd49e320c00ae5f3f41_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0515c0920ac74a3fa99ec66f590742fa_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if632bd50d393422b8036fdeb475158dc_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0efe65c8e6a44ca28515bf3a0446df60_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4247054189a43a1a0450606d3475abb_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffb2d6495cab432aa90ea55629e7a34e_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:RevenueBasedPayments2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4f3c2f8402c490aa5ec976019d2d592_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e0e0c2a238340e5af49c732b3425472_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21aee3c1b74747239031c9b963f5fe6a_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">hae:SavingsPlusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb0b69d83b20498cb8aca63402b766a0_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">hae:SavingsPlusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6925d4ec697647ffa368e97ca8e3c332_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">hae:SavingsPlusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd7616c964054c72a3769144d3c72c21_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">hae:A401kPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3185e1665d8d4e5ab9844e5e3ff0d869_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">hae:A401kPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a0a0ee071214f54bd0d353709289c03_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">hae:A401kPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i460ae7aa48544e75825ca977d4447d2b_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4050db15299d4a36bbab78482cb7fb2f_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4da492c5e554b3890ff74a7a13fd058_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied4aca325d3e42f794837acb9bf1c5c7_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hae:A2019EquityPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31435e1c79be48e7b4ba1de17ba323da_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hae:A2019EquityPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51dd2ace410143febe089bb6d634e842_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hae:IncentiveCompensationPlan2005Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1fc79184fba4faa8a07007a4d564998_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hae:IncentiveCompensationPlan2005Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3ff55824d064fbd859089a1dce11fcb_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hae:EmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98eb603c686a4dcfaabd4aeab4b77a27_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44a4bfb9e6ff4d9b876946af45bf3409_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i717dd0e3550541a19cb91afee06fa0c1_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83a9bb7c454d4256b50d1b2a36133ef0_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie01f5826ba434059bfbcca75ed1388fb_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hae:EmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied103559dd2b43a4b0de550c083ea67f_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffbadda382114e1eb91a79d7e988c700_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6792b00ca8b4378bcb06b91412550eb_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd48961a67cf47bcaa9d15e8932acecb_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b0d0e4e19f34194b2cc3d61739b6ec8_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1366c0d1a26f4ae99257fc0a3af5b117_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">hae:Fiscal2016AwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia22139de2bdb42ccaa1b42693e6081e1_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a025b99984c40c8aa80efd44bf08d80_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13ad711590264a0292e2f60317f18a68_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07c8760c6cc84cf3b9856e00588d1d24_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59b37d77f2e14639a7e9f54a0a50c9ef_D20190331-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55c8b8347e1243739c1e1fac07b7a6c0_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1524cac1b104c79b7706146b0a9bdc2_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78a954ba53b547c2bed2e4234f13c99d_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">hae:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="period"><xbrli:measure>hae:period</xbrli:measure></xbrli:unit><xbrli:context id="i1aa3abbe789d42b1bb931051619eea7c_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">hae:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib47a041d2f4a41c580a5732760d4464d_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">hae:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">hae:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8876ecaa10546b49f1574bdf9545726_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">hae:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b7c9d1af64d4d1ba8bf38b9460a37f9_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">hae:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f9b935310f84ea0a50db4a3f1516c09_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f4398aaa87e4aeca6c11c93436c50e9_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d1e74dd6311434089cd6836e717625c_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57226d1153c648e282451a752c136567_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7892776f995348be9cb282d7d7c17651_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62ca9ec732184b39b11517312a810c90_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e5300fbf53a4887a95a3edcae203e9f_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i399cf413d8244296bc74b84fb599fdfd_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5feb3720fec44a2b9a7ac2e43eebe25a_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if49e6050da52421980ac8d48fb39b261_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia94875fad58e496e88688163402cab14_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f932dedc3e84a1fbcde03eaf16d4ba2_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c9dc15838804a3bb4198e9625eab973_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaff6cca2e524da7a844b31893ea255f_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i576a32257e5e4be9bdce60172bdce930_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icadc8db134484aaa9370b59b63b8a1be_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6464f6090754fc397d2bc24da66f3a5_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if321e27503a64a269742b2fad027648e_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i273ad073c5694d79aed7c48a2228305a_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b623f3420d9458a8f791677dd437cb4_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if43262ae4db34a16abb1b00f16706fe0_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie84ef4886d9b46769afc2d9cb8935627_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91c825bc7a7b400ea37266ab846efd90_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7897fa4a6b84510a657a7bf9ba065f2_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94645cd7c7cb469aa8da2ab698ba7ca3_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b81c17ea1be415d9752a1ec535c0262_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f37dbe4585f4c288f1e4f7cbbe8a03e_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7b45150004748bb969ff69c5cac6d6d_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i658880d6f36c48ed97500e003792583f_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c3f7ebdb8d149b1991a542469a17c70_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebc032eb54984b4da6020c485a1829e9_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib37801b66fa64a738f993541669fe76b_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied904893cdab40ac8e4ecf4261b0392c_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54c7a18fd41c4b87addd14329d3b8eb3_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f6c260335fd4fb6951eb3d58718e908_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i437233f16d55490f81474cc61bd50d53_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied7abd5a64d44ec8be1482592153b618_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0ea7f7a83854a4fb04976b762a1d6b4_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44db282af41942a9bc8bf049fea7b13c_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3065d0c1ee844421ae0cb9af4f53bd46_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8760c4c6918543eabfca879c50151fc5_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ad75f10bcaa44d3870719c7728eee20_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2ca668eb57a4e6ea2aa6d35644cb889_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77e56895100346f8967a4f2f2f7478e9_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:PlasmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbcb5690ee9e4cf58369fb43962e39d7_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:PlasmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie082775b703647d2a596091af2b69615_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:PlasmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie54d9c04734f4a3ca440be55cadea86d_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8b3574a63ea41058d11dde501f4dd4b_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57d49f4f72de40b6b6dcbc6a662b5afe_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i831da503c99a4196bacf1bd7aaa8e97c_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:HospitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba74e960f8174b6eb6f8237d8ec75488_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:HospitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibadbeb7294884727ba79dd447d78e637_D20200329-20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:HospitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2021-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d9aaac5c08240e7ac639d3d9318182d_I20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20163d468f534459b8f5e133c39e76bc_I20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i258a2ee961ae4548a116f4702808d630_I20210403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9661b76a961497bbfd87ed0b21aa594_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe8f263a99854b0f83abe062df3af1a2_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e8bc4e14d294ed18a1106b9bfecc30d_D20210404-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-04</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie871fb22a3cf4c40ae275a678c22a4c6_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i212720196aab4e27b97320442307e199_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f4e6fa1de00426ba9dc50efcffee0dd_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8ff71c228644456aa078f7b405de97b_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4888ce624cf2491996b6ac5702a159b1_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie331660e8b3c4a1d855c3ea8e8032707_D20220403-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-03</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93a31928c3f04bbe9786669a94886e63_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31840d7f9a0f42fb8999b7022a505464_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7b16ebd9bdb4cd58a89613d51ab905e_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"> SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington,&#160;D.C. 20549</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Form&#160;<ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQ4_7530065b-f45f-4b5d-8524-d7148bd8681d">10-K</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQz_3ca9654e-a549-46d3-a7a0-6293ac6fbf14">&#9745;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8yMDI_0ea9c83d-1481-46ed-9f98-94c1855879db"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8yMDI_bf6577ec-0395-4023-af52-1c15bf5ddf02">April 1</ix:nonNumeric>, 2023</ix:nonNumeric> </span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQ1_15bd5467-930f-4e00-a1fa-f3dc811f26a9">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from        to         </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQ5_f3eaa656-8257-4d7d-a765-b046ed80087f">001-14041</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTUw_4124ec12-1e57-4f0a-8fcb-61c93b7f43e9">HAEMONETICS CORPORATION</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"><tr><td style="width:1.0%"></td><td style="width:9.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.068%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV8wLTAtMS0xLTcwMzM0_4001148d-1236-4f5d-8def-5d1715eeeeac">Massachusetts</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV8wLTQtMS0xLTcwMzM0_cf403e96-021d-46ca-8b79-f2b90871b69e">04-2882273</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV8yLTAtMS0xLTcwMzM0_f2076f61-7617-4832-8ab7-7342c4574b72">125 Summer Street,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV8yLTQtMS0xLTcwMzM0_343a6a84-2d1e-4b3b-85f7-74b4e2666297">02110</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV8zLTAtMS0xLTcwMzM0_7037b1d4-fa53-4924-9e0b-5c8f8fdf61a4">Boston,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV8zLTItMS0xLTcwMzM0_f673e35e-a4a9-4f5e-a36a-447aef91c533">Massachusetts</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Zip Code)</span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Address of principal executive offices)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV81LTAtMS0xLTcwMzM0_711a779a-d372-48d3-9231-738391c92757">(781)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV81LTItMS0xLTcwMzM0_3e1a95ab-ca5b-4aca-80d8-fc2e8830dfbb">848-7100</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Registrant's telephone number, including area code)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.898%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6NTBjZTA1NzJhOGQ4NDMyZGFhNDljZWZiOWU2OGVlNmIvdGFibGVyYW5nZTo1MGNlMDU3MmE4ZDg0MzJkYWE0OWNlZmI5ZTY4ZWU2Yl8xLTAtMS0xLTcwMzM0_6cb1d059-ce9d-40cd-8972-79171bf9bf95">Common stock, $.01&#160;par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6NTBjZTA1NzJhOGQ4NDMyZGFhNDljZWZiOWU2OGVlNmIvdGFibGVyYW5nZTo1MGNlMDU3MmE4ZDg0MzJkYWE0OWNlZmI5ZTY4ZWU2Yl8xLTItMS0xLTcwMzM0_14f084fe-7e4a-4187-8181-ea3b46ecbeae">HAE</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6NTBjZTA1NzJhOGQ4NDMyZGFhNDljZWZiOWU2OGVlNmIvdGFibGVyYW5nZTo1MGNlMDU3MmE4ZDg0MzJkYWE0OWNlZmI5ZTY4ZWU2Yl8xLTQtMS0xLTcwMzM0_7536fc5d-146a-49c0-8080-19dcba70e45a">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">None</span></div><div style="margin-top:0.5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities</span></div><div style="margin-top:0.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Act.                                                                                                                                                                                                <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQw_e0b4f638-3bad-41dd-8fc9-5ab325cd19e0">Yes</ix:nonNumeric>&#160;&#9745;&#160;&#160;&#160;&#160;No&#160;&#9744;</span></div><div style="margin-top:0.5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act.&#160;&#160;Yes&#160;&#9744;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQ0_1ce69b89-9987-44f9-b2bd-8f522b9add8a">No</ix:nonNumeric>&#160;&#9745;</span></div><div style="margin-top:0.5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at least the past 90&#160;days.&#160;&#160;                                                                                 <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQ2_8bf983b7-c259-45b7-936a-c65391f781d6">Yes</ix:nonNumeric>&#160;&#9745;&#160;&#160;&#160;&#160;No&#160;&#9744;</span></div><div style="margin-top:0.5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;&#160;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;                                                                                                                                                     <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQ3_f1485a29-210d-46a3-941e-a03b3967c898">Yes</ix:nonNumeric>&#160;&#9745;&#160;&#160;&#160;&#160;No&#160;&#9744;</span></div><div style="margin-top:0.5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.847%"><tr><td style="width:1.0%"></td><td style="width:24.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.482%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.316%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZWNjZGU2ZjU2YmI2NGFhOWI1YzI2M2QwZDQ5NDQ3NTEvdGFibGVyYW5nZTplY2NkZTZmNTZiYjY0YWE5YjVjMjYzZDBkNDk0NDc1MV8wLTAtMS0xLTcwMzM0_07a8c11f-d39e-40df-91bb-55b09559f982">Large Accelerated Filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZWNjZGU2ZjU2YmI2NGFhOWI1YzI2M2QwZDQ5NDQ3NTEvdGFibGVyYW5nZTplY2NkZTZmNTZiYjY0YWE5YjVjMjYzZDBkNDk0NDc1MV8xLTYtMS0xLTcwMzM0_8fb79e3b-f0ae-4f9b-b248-9e14c013ad90">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZWNjZGU2ZjU2YmI2NGFhOWI1YzI2M2QwZDQ5NDQ3NTEvdGFibGVyYW5nZTplY2NkZTZmNTZiYjY0YWE5YjVjMjYzZDBkNDk0NDc1MV8yLTYtMS0xLTcwMzM0_8a222bc3-059b-4f1c-9b29-f5d8ac413ff6">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:0.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">       If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                      &#9744;</span></div><div style="margin-top:0.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">       Indicate by check mark whether the registrant has filed a report on and attestation to its management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.                                                                                                                                    <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTUx_cb92bc9e-bff6-4ef2-8f75-f2081325050d">&#9745;</ix:nonNumeric> </span></div><div style="margin-top:0.5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;            &#9744;</span></div><div style="margin-top:0.5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).           &#9744;</span></div><div style="margin-top:0.5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;      Yes&#160;<ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQx_17cd12f5-d667-4a98-8f82-4dcac8d4b82a">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160; No&#160;&#9745; </span></div><div style="margin-top:0.5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant (assuming for these purposes that all executive officers and directors are &#8220;affiliates&#8221; of the registrant) as of October&#160;1, 2022, the last business day of the registrant&#8217;s most recently completed second fiscal quarter was $<ix:nonFraction unitRef="usd" contextRef="i82f00f58456d4ce9b4e8c3e6f30b1b13_I20221001" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zNTQz_5459c92c-d050-453f-ba6a-e9e965ecb5f0">3,725,273,032</ix:nonFraction> (based on the closing sale price of the registrant&#8217;s common stock on that date as reported on the New York Stock Exchange).</span></div><div style="margin-top:1pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The number of shares of $0.01&#160;par value common stock outstanding as of May&#160;18, 2023 was</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="shares" contextRef="ice2c089f520648328aa2b345444e9e2d_I20230518" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zNzQ1_3039ff19-1fda-4aac-955b-243bf8e115ae">50,540,770</ix:nonFraction>.</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Documents Incorporated By Reference</span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQy_e0bb93ad-05da-4451-949d-f7999f0115bb" escape="true">Portions of the definitive proxy statement for our Annual Meeting of Shareholders to be held on August&#160;4, 2023 are incorporated by reference in Part&#160;III of this report.</ix:nonNumeric></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_7"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:3pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page<br/>Number</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_13">Business</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_28">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_28">17</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_31">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_31">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_34">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_34">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_37">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_37">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_40">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_40">30</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_46">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_46">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_49">Reserved</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_49">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_52">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_52">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_67">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_67">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_73">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_73">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_154">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_154">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_157">Control and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_157">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_160">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_160">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_163">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_163">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_169">Directors and Executive Officers of the Registrant and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_169">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_172">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_172">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_175">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_175">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_178">Certain Relationships and Related Transactions and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_178">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_181">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_181">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_187">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_187">99</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_10"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. BUSINESS</span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_16"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Company Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Haemonetics is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. When used in this report, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Haemonetics&#8221; and the &#8220;Company&#8221; mean Haemonetics Corporation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blood is essential to a modern healthcare system. Blood and its components (plasma, red cells and platelets) have many vital and frequently life-saving clinical applications. Plasma is used for patients with major blood loss and is manufactured into biopharmaceuticals to treat a variety of illnesses, including immune diseases and coagulation disorders. Red cells treat trauma patients or patients undergoing surgery with high blood loss, such as open heart surgery or organ transplant. Platelets have many uses in patient care, including supporting cancer patients undergoing chemotherapy. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We view our operations and manage our business in three principal reporting segments: Plasma, Blood Center and Hospital. For that purpose, &#8220;Plasma&#8221; includes plasma collection devices and disposables, plasma donor management software, and anticoagulant and saline sold to plasma customers. &#8220;Blood Center&#8221; includes blood collection and processing devices and disposables for red cells, platelets and whole blood. &#8220;Hospital&#8221;, which is comprised of Hemostasis Management, Vascular Closure, Cell Salvage and Transfusion Management products, includes devices and methodologies for measuring coagulation characteristics of blood, vascular closure devices, specialized blood cell processing systems and disposables, surgical blood salvage systems and blood transfusion management software. Financial information concerning these segments is provided in Note 18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Enterprise-Wide Information,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Plasma and Hospital have growth potential, while Blood Center competes in challenging markets that require us to manage the business differently, including reducing costs, shrinking the scope of the current product line, and evaluating opportunities to exit unfavorable customer contracts.</span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Market and Products</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Product Lines</span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_22"></div><div><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following describes our principal products in each of our segments. Availability of products may vary from one country or region to another as a result of specific local regulatory approval or clearance requirements. Applicable laws may restrict the sale, distribution or use of these products to, by, or on the order of a licensed healthcare practitioner.</span></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt;text-decoration:underline">Plasma</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Plasma business offers automated plasma collection systems, donor management software and supporting software solutions that improve the yield, efficiency, quality, safety and overall donor experience at plasma collection centers. We continue to invest in technology that lowers the overall cost to collect plasma while maintaining high standards of quality and safety.</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plasma Collection Market for Fractionation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Human plasma is collected for two purposes. First, it is used for transfusions in patients, such as trauma victims who need to compensate for extreme blood loss. Second, it is processed into pharmaceuticals that aid in the treatment of a broad range of immune system diseases and blood-related disorders. </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plasma for transfusion is almost exclusively collected by blood centers as part of their broader mission to supply blood components. Plasma that is fractionated and manufactured into pharmaceuticals - frequently referred to as &#8220;source plasma&#8221; - is mainly collected by vertically integrated biopharmaceutical companies that operate their own collection centers and recruit donors specifically for source plasma donation. The markets for transfusion plasma and source plasma have different participants, product requirements and growth profiles. We serve the market for plasma that is processed into pharmaceuticals through our Plasma business, and we serve the market for transfusion plasma through our Blood Center business.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of the distinguishing features of the source plasma market is the method of collection. There are three primary ways to collect plasma. The first is to collect it from whole blood donations. When whole blood is processed, plasma can be separated at the same time as red cells and platelets and stored for future use. The second is as part of an apheresis procedure that also collects another blood component. These two methods are mainly used by blood centers to collect plasma for transfusions. The third method is a dedicated apheresis procedure that only collects plasma and returns the other blood components to the donor. This third method is almost exclusively used for source plasma collection. </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Plasma business unit focuses on the collection of source plasma for pharmaceutical manufacturers using apheresis devices that only collect plasma and software solutions that support the efficient operation of dedicated source plasma collection centers. Our Blood Center business supports the collection of plasma for blood collectors, such as the American Red Cross, using both whole blood collections sets and multi-component apheresis collection devices.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the last 20 years, the collection of source plasma has increasingly been performed by vertically integrated biopharmaceutical companies such as CSL Limited (together with its affiliates, &#8220;CSL&#8221;), Grifols S.A. (together with its affiliates, &#8220;Grifols&#8221;), Octapharma AG and Takeda&#8217;s BioLife Plasma subsidiary. With their global operations and management expertise, these companies are focused on efficient plasma supply chain management and leveraging information technology to manage operations from the point of plasma donation through fractionation to the production of the final pharmaceutical product.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demand for source plasma has continued to grow because of an expanding end user market for plasma-derived biopharmaceuticals. In particular, therapies that require a significant quantity of plasma to create have fueled an increase in the number of donations and dedicated source plasma collection centers. A significant portion of this collection growth has occurred in the United States with U.S. produced plasma now meeting an increasing percentage of plasma volume demand worldwide. U.S. regulations are more favorable relative to other markets for plasma collectors. The frequency an individual may donate, the volume of plasma that may be donated each time and the ability to remunerate donors are all more favorable to efficient operations and output, leading to approximately 70% of worldwide source plasma collections occurring in the United States. Plasma collectors have long sought revisions to plasma collection regulations outside of the U.S. to allow for greater frequency, volume per donation, and remuneration, but updates have been limited and no significant short-term changes are foreseen in the prevalence of U.S. collections.</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plasma Products </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Our automated plasma collection devices, related disposables, software and services are designed to support multiple facets of plasma collector operations. We have a long-standing commitment to understanding our customers&#8217; collection and manufacturing processes. As a result, we aim to design equipment that is durable, dependable, and easy to use and to provide comprehensive training and support to help our customers optimize their plasma collections. </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Today, nearly all source plasma collections worldwide are performed using automated collection technology at dedicated facilities. We offer multiple products to support these dedicated source plasma operations, including our NexSys PCS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and PCS2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plasmapheresis equipment, related disposables and solutions. We also offer a portfolio of integrated information technology platforms for plasma customers to manage their donors, operations and supply chain. Our software products, including our latest NexLynk DMS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> donor management system and Donor360</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">app, automate the donor interview and qualification process, streamline the workflow process in the plasma center, provide the controls necessary to evaluate donor suitability, determine the ability to release units collected and manage unit distribution. With our software solutions, plasma collectors can manage processes across the plasma supply chain, ensure high quality and compliance process support, react quickly to business changes and implement opportunities to reduce costs.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With our PCS brand, we have provided an automated platform dedicated to the collection of plasma for over 30 years. In fiscal 2018, we began transitioning customers from our PCS2 equipment to NexSys PCS.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NexSys PCS is designed to enable higher plasma yield collections, improve productivity in our customers&#8217; centers, enhance the overall donor experience and provide safe and reliable collections that will become life-changing medicines for patients. NexSys PCS includes bi-directional connectivity to the NexLynk DMS donor management system to improve operational efficiency within plasma centers, through automated programming of donation procedures and automated data capture of procedure data. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our NexSys PCS with YES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Technology is a yield-enhancing solution that enables increases in plasma yield per collection by an additional 18-26 mL per donation, on average. In fiscal 2021, we received FDA 510(k) clearance for our NexSys PCS with proprietary Persona</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Technology. NexSys PCS with Persona Technology uses a percent plasma nomogram that customizes plasma collection based on an individual donor&#8217;s body composition, and enables a 9% to 12% average increase in plasma volume per donation, based on our PCS2 baseline device, software configuration and donor population. The new, proprietary Persona Technology strengthens the NexSys PCS value proposition and reinforces our commitment to supporting our Plasma customers. We expect to pursue further regulatory clearances for additional enhancements to the overall product offering.</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into agreements with all major U.S. customers to adopt NexSys PCS somewhere in their global collection network and we provide ongoing support of NexSys PCS devices and NexLynk DMS donor management software for these Plasma customers.</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Plasma business unit represen</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ted 42.5%, 35.4% and 38.2% of our to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tal revenue in fiscal 2023, 2022 and 2021, respectively. </span></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt;text-decoration:underline">Blood Center</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Blood Center business offers a range of solutions that improve donor collection centers&#8217; ability to collect and separate blood components for transfusions. We continue to look for solutions to help our customers improve donor safety, enhance yields and control costs through the existing product portfolio. Our products and technologies help donor collection centers optimize blood collection capabilities and donor processing management.</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blood Center Market</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; There are over 100 million blood donations around the world each year that produce blood products for transfusion to surgical, trauma or chronically ill patients. Patients typically receive only the blood components necessary to treat a particular clinical condition. Platelet therapy is frequently used to alleviate the effects of chemotherapy and to help patients with bleeding disorders. Red cells are often transfused to patients to replace blood lost during surgery and transfused to patients with blood disorders, such as sickle cell anemia or aplastic anemia. Plasma, in addition to its role in creating life-saving pharmaceuticals, is frequently transfused to replace blood volume in trauma victims and surgical patients.</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When collecting blood components there are two primary collection methods, manual whole blood donations and automated component blood collections. While most donations are manual whole blood, the benefit of automated component blood collections is the ability to collect more than one unit of the targeted blood component. Manual whole blood donations are collected from the donor and then transported to a laboratory where the blood is separated into its components. Automated component blood collections separate the blood component real-time while a person is donating. In this method, only the specific target blood component is collected and the remaining components are returned to the blood donor.</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While overall we expect total demand for blood to remain stable to slightly declining, demand in individual markets and for individual components can vary greatly. The development in mature markets of more minimally invasive procedures with lower associated blood loss, as well as hospitals&#8217; improved blood management techniques and protocols have more than offset the increasing demand for blood from aging populations. Emerging markets are seeing demand growth with expanded healthcare coverage and greater access to more advanced medical treatments.</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blood Center Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer automated blood component and manual whole blood collection systems to blood collection centers to collect blood products efficiently and cost effectively. </span></div><div style="margin-top:7pt;padding-left:72pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">We market the MCS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand apheresis equipment which is designed to collect specific blood components from the donor. Utilizing the MCS automated platelet collection protocols, blood centers collect one or more therapeutic &#8220;doses&#8221; of platelets during a single donation.</span></div><div style="margin-top:7pt;padding-left:72pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Our portfolio of disposable whole blood collection and component storage sets offer flexibility in collecting a unit of whole blood and the subsequent production and storage of blood components, including options for in-line or dockable filters for leukoreduction.</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Blood Center business unit represen</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ted 24.0%, 30.1% and 35.3% of ou</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r total revenue in fiscal 2023, 2022 and 2021, respectively.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt;text-decoration:underline">Hospital</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hospitals are called upon to provide the highest standard of patient care while at the same time to reduce operating costs. Haemonetics&#8217; Hospital business has four product lines: Hemostasis Management, Vascular Closure, Cell Salvage and Transfusion Management. Vascular Closure became a product line during fiscal 2021 as a result of the March 2021 acquisition of Cardiva Medical, Inc. (&#8220;Cardiva&#8221;), a market leader in vascular closure devices. Each product line has a leading market position and a mission of helping hospitals and clinicians provide the highest standard of patient care while at the same time reducing operating and procedural costs and helping decision makers in hospitals optimize blood acquisition, storage and usage in critical settings.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Hemostasis Management</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hemostasis Management Market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Hemostasis refers to a patient&#8217;s ability to form and maintain blood clots. The clinical management of hemostasis requires that physicians have the most complete information to make decisions on how to best maintain a patient&#8217;s coagulation equilibrium between hemorrhage (bleeding) and thrombosis (clotting). Hemostasis is a critical challenge in various medical procedures, including cardiovascular surgery, organ transplantation, trauma, post-partum hemorrhage and percutaneous coronary intervention. By understanding a patient&#8217;s hemostasis status, clinicians can better plan for the patient&#8217;s care pathway. For example, they may decide whether to start or discontinue the use of certain drugs or determine the need for a transfusion and which specific blood components would be most effective in minimizing blood loss and reducing clotting risk. Such planning supports better care, which can lead to lower hospital costs through a reduction in unnecessary blood product transfusions, reduced adverse transfusion reactions and shorter intensive care unit and hospital stays.</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hemostasis Management Products </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Our portfolio of hemostasis diagnostic systems enables clinicians to assess holistically the coagulation status of a patient at the point-of-care or laboratory setting. We have four viscoelastic testing systems that we market to hospitals and laboratories as an alternative to routine blood tests:&#160;the TEG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 5000 hemostasis analyzer system, the TEG 6s hemostasis analyzer system, the ClotPro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hemostasis analyzer system and the HAS-100 hemostasis analyzer system. While the TEG and HAS platforms utilize thromboelastography and the ClotPro system utilizes thromboelastometry, all of the platforms provide a method of testing the efficiency of blood coagulation using whole blood samples.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each hemostasis diagnostic system consists of an analyzer that is used with single-use reagents and disposables. In addition, TEG Manager</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> software connects multiple TEG 5000 and TEG 6S analyzers throughout the hospital, providing clinicians with remote access to both active and historical test results that inform treatment decisions.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The TEG 5000 system is approved for a broad set of indications in all of our markets. The TEG 6s system is approved for the same set of indications as the TEG 5000 in Europe, Australia and Japan. We continue to pursue a broader set of indications for TEG 6s in the U.S. In 2019, we received FDA clearance for the use of TEG 6s in adult trauma settings. This clearance builds on the previous indication for the TEG 6s system in cardiovascular surgery and cardiology procedures, making it the first cartridge-based system available in the U.S. to evaluate the hemostasis condition in adult trauma patients. The ClotPro system is CE marked and is currently available in select European and&#160;Asia Pacific&#160;markets. The HAS-100 device is currently commercialized in China.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Vascular Closure</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vascular Closure Market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Catheter-based, minimally invasive alternatives to open surgery have transformed cardiovascular medicine. The majority of these procedures gain access to the vascular system through the femoral artery or vein. These access sites in the vessel require closure post procedure. Even with the major advances in technology over the last 40 years, the most common complications in coronary and peripheral procedures are still related to the access site. Manual compression, the traditional standard of care, involves the application of pressure in order to facilitate the formation of a blood clot at the access site. Vascular closure devices improve upon manual compression by rapidly closing the access site and facilitating more efficient workflow.</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vascular Closure Products </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The VASCADE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology platform was developed to address the limitations of manual compression and existing vascular closure devices. Our VASCADE family of products consists of two devices, VASCADE and VASCADE MVP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which share a common, innovative technology that features a simple, catheter-based delivery system and leverages the natural clot-inducing properties of collagen. This novel design significantly reduces access site complications, increases patient satisfaction and improves hospital workflow metrics that, in turn, drive economic benefits and cost savings. Our Vascular Closure devices address the growing number of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">catheter-based coronary, peripheral and electrophysiology procedures that require vascular access site closure each year.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designed around an easy to use, catheter-based delivery system and the natural clot-inducing properties of collagen, our VASCADE product is the only marketed vascular closure device clinically proven to both increase workflow efficiency and reduce access site complications relative to manual compression for coronary and peripheral procedures. Similarly, our VASCADE MVP device is the only marketed vascular closure device clinically proven and labeled to improve workflow relative to manual compression for electrophysiology procedures. Importantly, these improvements drive meaningful cost savings for hospitals, ambulatory surgery centers and other treatment facilities. VASCADE MVP is the first and only vascular closure device to receive a U.S. Food and Drug Administration (&#8220;FDA&#8221;) indication for same-day discharge following atrial fibrillation ablation. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Cell Salvage</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cell Salvage Market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The Cell Salvage market is mainly comprised of devices designed to collect, wash and prepare a patient&#8217;s own blood for reinfusion during or after surgery. Loss of blood is common in many surgical procedures, including open heart, trauma, transplant, vascular and orthopedic procedures, and the need for transfusion of oxygen-carrying red cells to make up for lost blood volume is routine. Patients commonly receive donor (or allogeneic) blood which carries various risks for transfusion reactions including chills, fevers or other side effects that can prolong a patient&#8217;s recovery.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An alternative to allogeneic blood is surgical cell salvage, also known as autotransfusion, which reduces or eliminates a patient&#8217;s need for blood donated from others and ensures that the patient receives the freshest and safest blood possible - his or her own. Surgical cell salvage involves the collection of a patient&#8217;s own blood during or after surgery with the intent of reinfusion of red cells to that patient. Blood is suctioned from the surgical site or collected from a wound or chest drain, processed and washed through a centrifuge-based system that yields concentrated red cells, available in a reinfusion bag, for transfusion back to the patient at the physician&#8217;s discretion. This process occurs in a sterile, closed-circuit, single-use consumable set that is fitted into an electromechanical device. We market our surgical blood salvage products to surgical specialists, primarily cardiovascular, orthopedic and trauma surgeons, OB-GYN and to anesthesiologists and surgical suite service providers.</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cell Salvage Products </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Our Cell Saver</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Elite</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+ autologous blood recovery system is a surgical blood salvage system targeted to medium to high blood loss procedures, such as cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical and gynecological surgeries. The Cell Saver Elite + is designed to minimize allogeneic blood use and reliably recover and prepare a patient&#8217;s own high-quality blood for reinfusion.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Transfusion Management</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transfusion Management Market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Hospital transfusion services professionals and clinicians are facing cost restraints in addition to the pressure to enhance patient safety, compliance and operational efficiency.&#160;Managing the safety and traceability of the blood supply chain and comprehensive management of patients, orders, specimens, blood products, derivatives and accessories across the hospital network is challenging.&#160;In addition, providing clinicians with the vital access to blood when needed most while maintaining traceability is a key priority. Frequently when blood products leave the blood bank, the transfusion management staff loses control and visibility of the blood components. They often do not know if the blood was handled, stored or transfused properly, which may lead to negative effects on patient safety, product quality, inventory availability and staff efficiency as well as increased waste.</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transfusion Management Products </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Our Transfusion Management solutions are designed to help provide safety, traceability and compliance from the hospital blood bank to the patient bedside and enable consistent care across the hospital network.&#160;Our SafeTrace Tx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> transfusion management software is considered the system of record for all hospital blood bank and transfusion service information.&#160;BloodTrack</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> blood management software is a modular suite of blood management and bedside transfusion solutions that combines software with hardware components and acts as an extension of the hospital&#8217;s blood bank information system. The software is designed to work with blood storage devices, including the BloodTrack HaemoBank</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Hospital business unit repr</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">esented 31.8%, 32.5% and 24.2% of our t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">otal revenue in fiscal 2023, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has revenue associated with certain services, maintenance and parts, representing approximately 1.7%, 2.0% and 2.3% of our total revenue in fiscal 2023, 2022 and 2021, respectively.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketing/Sales/Distribution</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market and sell our products in approximately 90 countries through our own direct sales force (including full-time sales representatives and clinical specialists) as well as independent distributors. Our customers include biopharmaceutical companies, blood collection groups and independent blood centers, hospitals and hospital service providers, group purchasing organizations and national health organizations. Sales representatives target the primary decision-makers within each of those organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development centers in the U.S. ensure that protocol variations are incorporated to closely match local customer requirements. In addition, Haemonetics maintains software development operations in Canada. Customer collaborations are also an important part of our technical strength and competitive advantage. These collaborations with customers and transfusion experts provide us with ideas for new products and applications, enhanced protocols and potential test sites as well as objective evaluations and expert opinions regarding technical and performance issues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development of blood component separation products, hemostasis analyzers and software has required us to maintain technical expertise in various engineering disciplines, including mechanical, electrical, software, biomedical engineering and chemistry. Innovations resulting from these various engineering efforts enable us to develop systems that are faster, smaller and more user-friendly, or that incorporate additional features important to our customer base.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2023, research and development resources were allocated to support innovation across our product portfolio. In fiscal 2023, the VASCADE and VASCADE MVP systems received CE mark clearance, providing a pathway for country-specific introduction of these products in the European Union (&#8220;EU&#8221;). We also received 510(k) clearance from the FDA on Intelligent Control, the next-generation software for the Cell Saver Elite+ Autotransfusion System, which offers customers key enhancements to help simplify operations, supporting enhanced efficiency and an improved user experience. Additionally, we have continued to make investments related to our next generation plasma collection and software systems, the European Medical Device Regulation and In Vitro Diagnostic Regulation and our Hemostasis Management product line.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Manufacturing</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We endeavor to supply products that are both high quality and cost competitive for our customers by leveraging continuous improvement methodologies, focusing on our core competencies and partnering with strategic suppliers that complement our capabilities. In general, we design our equipment and consumables and use contract manufacturers to build the devices, while the majority of consumables are manufactured by us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our production activities occur in controlled settings or &#8220;clean room&#8221; environments and have built-in quality checks throughout the manufacturing processes. Our manufacturing teams are focused on continuously improving our productivity, product cost and product quality through change control procedures, validations and strong supplier management programs. We regularly review our logistics capabilities, inventory and safety stock levels and maintain business continuity plans to address supply disruptions that may occur. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary consumable manufacturing operations are located in North America and Malaysia.&#160;Contract manufacturers also supply component sets and liquid solutions according to our specifications, with component sets manufactured in Japan, Singapore, Thailand, Indonesia and the Philippines and liquid solutions manufactured in Europe.&#160;Our capital equipment is principally manufactured in Malaysia, Australia and the U.S.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced increased levels of unpredictability in the supply of certain raw materials and components used in the manufacturing of our products. While we continue to believe we will have access to the raw materials and components that we need, these supply chain dynamics could result in increased costs to us or an inability to fully meet customer demand for certain of our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider our intellectual property rights to be important to our business. We rely on a combination of patent, trademark, copyright and trade secret laws, as well as provisions in our agreements with third parties, to protect our intellectual property rights.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold numerous patents in the United States and have applied for numerous additional U.S. patents relating to our products and related technologies. We also own or have applied for corresponding patents in selected foreign countries. These patents cover certain elements of our products and processes, including protocols employed in our equipment and aspects of certain of our disposables. Our patents may cover current products, products in markets we plan to enter, or products in markets we plan to license to others. Certain patents may also be defensive in that they are directed to technologies not currently embodied in our current products. We also may license patent rights from third parties that cover technologies that we use or plan to use in our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own various trademarks that have been registered in the United States and certain other countries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our policy is to obtain patent and trademark rights in the U.S. and foreign countries where such rights are available and we believe it is commercially advantageous to do so. However, the standards for international protection of intellectual property vary widely. We cannot assure that pending patent and trademark applications will result in issued patents and registered trademarks, that patents issued to or licensed by us will not be challenged or circumvented by competitors, or that our patents will not be determined invalid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To maintain our competitive position, we also rely on the technical expertise and know-how of our personnel. We believe that unpatented know-how and trade secrets relied upon in connection with our business and products are generally as important as patent protection in establishing and maintaining a competitive advantage.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Competition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To remain competitive, we must continue to develop and acquire new cost-effective products, information technology platforms and business services. We believe that our ability to maintain a competitive advantage will continue to depend on a combination of factors. Some factors are largely within our control such as: (i) maintenance of a positive reputation among our customers, (ii) development of new products that meet our customer&#8217;s needs, (iii) obtaining regulatory approvals for our products in key markets, (iv) obtaining patents that protect our innovations, (v) development and protection of proprietary know-how in important technological areas, (vi) product quality, safety and cost effectiveness and (vii) continual and rigorous documentation of clinical performance. Other factors are outside of our control. We could see changes in regulatory standards or clinical practice that favor a competitor&#8217;s technology or reduce revenues in key areas of our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technical staff is highly skilled, but certain competitors have substantially greater financial resources and larger technical staff at their disposal. There can be no assurance that competitors will not direct substantial efforts and resources toward the development and marketing of products competitive with those of Haemonetics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we face competition from several large, global companies with product offerings similar to ours. Terumo Blood and Cell Technologies (&#8220;Terumo BCT&#8221;) and Fresenius SE &amp; Co. KGaA, in particular, have significant financial and other resources and are strong competitors in a number of our businesses. The following provides an overview of the key competitors in each of our three global product enterprises.</span></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Plasma</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the automated plasma collection market, we principally compete with Fresenius&#8217; Fenwal Aurora and Aurora Xi device product lines a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nd Terumo BCT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s Rika device on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the basis of procedure and enabled door-to-door time duration, plasma yield per donation, product quality and reliability, ease of use, services and technical features of the collection systems, supply chain reliability and on the long-term cost-effectiveness of equipment and disposables. In China, the market is populated by local producers, including Nigale and Haier Medical, which offer plasmapheresis device products that are intended to be similar to ours. In recent years, Nigale has expanded to markets beyond China, competing in European and South American countries. Scinomed competes in select European countries as well. In the field of plasma related software, we principally compete with applications developed internally by certain of our customers as well as MAK Systems.</span></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Blood Center</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most donations worldwide are traditional manual whole blood collections and approximate</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ly 30% of th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e Blood Center portfolio competes in this space. We face intense competition in our whole blood business on the basis of quality and price. Our main competitors are Fresenius, MacoPharma and Terumo BCT.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MCS automated component blood collections, which represents approx</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">imately 60% of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Blood Center portfolio, not only compete against the traditional manual whole blood collection market (particularly in red cells) but also </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compete with products from Terumo BCT and Fresenius. Technology is the key differentiator in automated component blood collections, with speed, as measured by the time to collect more than one unit of a specific targeted blood component, quality, reliability, ease of use, service and other technical features being key factors. In markets with a significant number of people eligible to donate more than one unit in a single donation, the processing speed can be a significant competitive differentiator. This is particularly relevant in platelet donations and can drive market share shifts in certain markets.</span></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hospital</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Hemostasis Management</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our hemostasis analyzer systems are used primarily in surgical applications. Competition includes routine coagulation tests, such as prothrombin time, partial thromboplastin time and platelet count marketed by various manufacturers, such as Instrumentation Laboratory, Diagnostica Stago SAS and Sysmex. The TEG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> analyzer competes with these routine laboratory tests based on its ability to provide a more complete picture of a patient&#8217;s hemostasis at a single point in time and to measure the clinically relevant platelet function for an individual patient.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, TEG and ClotPro systems compete more directly with other viscoelastic testing systems, including ROTEM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> analyzers, the VerifyNow&#8482; System and HemoSonics Quantra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ROTEM and VerifyNow instruments are marketed by Instrumentation Laboratory, a subsidiary of Werfen. HemoSonics is owned and offered by Diagnostica Stago. There are also additional technologies being explored to assess viscoelasticity and other characteristics that can provide insights into the coagulation status of a patient. In the advanced viscoelastic testing segment, Haemonetics is the global market leader.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vascular Closure</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vascular closure industry is highly competitive and has been evolving rapidly with the introduction of new products, technologies, regulations and activities of industry participants. Our VASCADE family of products serves as an alternative to existing methods of femoral vascular access site closure in interventional procedures, including manual compression and other femoral access closure devices. Our main competitors in femoral access closure for coronary and peripheral procedures include Terumo BCT, Abbott Laboratories and Cardinal Health. There are not currently any competing vascular access site closure devices that are labeled for electrophysiology procedures that require multiple access sites.</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete primarily on the basis that our products are optimized for the requirements of coronary, peripheral and electrophysiology procedures, including procedures that require multiple access sites. In addition, our value proposition is supported by robust clinical trial evidence and study data, which demonstrate reduced access site complication rates as well as workflow improvements compared to manual compression that lead to cost savings.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cell Salvage</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the intraoperative autotransfusion market, competition is based on reliability, ease of use, service, support and price. For high-volume platforms, each manufacturer's technology is similar and our Cell Saver</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology competes principally with products offered by LivaNova PLC, Medtronic and Fresenius.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Transfusion Management</span></div><div style="margin-top:7pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SafeTrace Tx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and BloodTrack</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compete in the transfusion management software market within the broader category of hospital information systems.&#160;SafeTrace Tx is an FDA regulated blood bank information system (&#8220;BBIS&#8221;) that integrates and communicates with other healthcare information systems such as the electronic health record and laboratory information system within the hospital. The BloodTrack software, also FDA regulated, is an extension of the BBIS and provides secure, traceable blood units at the point-of-care, including trauma, surgery, outpatient and critical care settings. Growth drivers for these markets include patient safety, operational efficiencies and compliance. </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SafeTrace Tx competition primarily consists of stand-alone BBIS including WellSky and some electronic health record software that includes a built-in transfusion management solution including Cerner.&#160;Global competition for BloodTrack varies by country including MSoft in Europe and established blood practices in the U.S. such as using standard refrigerators and manual movement of blood products. BloodTrack integrates with the hospital&#8217;s existing lab or blood bank system allowing for greater market acceptance.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Customers</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2023, 2022 and 2021, our ten largest customers accounted for approximately 48%, 45% and 49% of our net revenues, respectively. In fiscal 2023, one Plasma customer, CSL, was greater than 10% of total net revenues and in total accounted for approximately 14% of net revenues. In addition to CSL, two customers also accounted for greater than 10% of the Plasma segment&#8217;s net revenues and one customer accounted for greater than 10% of the Blood Center segment's net revenues, but did not exceed 10% of total net revenues, in fiscal 2023.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Government Regulation</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the variety of products that we manufacture, we and our products are subject to a wide range of regulations from numerous government agencies, including the FDA, and similar agencies outside the U.S. To varying degrees, each of these agencies requires us to comply with laws and regulations governing the development, testing, manufacturing, labeling, marketing and distribution of our products.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, medical devices, drugs and biological products are subject to extensive regulation by FDA under the Federal Food, Drug, and Cosmetic Act, or FDCA, and other federal and state statutes and regulations. The failure to comply with applicable U.S. requirements may subject a company to a variety of administrative or judicial sanctions, such as FDA refusal to clear or approve applications, warning or untitled letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, civil penalties and criminal prosecution.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Medical Device Regulation</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premarket Requirements - U.S.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless an exemption applies, all medical devices introduced to the U.S. market are required by the FDA, as a condition of marketing, to secure clearance of a 510(k) premarket notification, grant of a request for de novo classification, or approval of a premarket approval application, or PMA. The FDA classifies medical devices into one of three classes based on risk.&#160;Devices deemed to pose a low or moderate risk are placed in Class I or II. Manufacturers of most Class II devices, and a few Class I devices, must submit to the FDA a 510(k) premarket notification requesting clearance for commercial distribution.&#160;Devices deemed by the FDA to pose the greatest risk or devices deemed not substantially equivalent to a previously cleared 510(k) device are placed in Class III, requiring submission and approval of a PMA or risk-based classification through the de novo process.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To obtain 510(k) clearance, we must submit a premarket notification demonstrating that the proposed device is &#8220;substantially equivalent&#8221; to a previously 510(k)-cleared device or a device that was in commercial distribution before May 28, 1976 for which the FDA has not yet called for the submission of PMAs, or a device that has been the subject of a de novo classification.&#160;The FDA&#8217;s 510(k) clearance pathway usually takes from three to 12 months from the date the notification is submitted, but it can take longer, depending on the extent of the FDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s requests for additional information and the amount of time a sponsor takes to fulfill them.&#160;We may need to first obtain an investigational device exemption (for significant risk devices), known as an IDE, in order to conduct extensive clinical testing of the device to obtain the necessary clinical data for submission to the FDA. After a device receives 510(k) clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, will require a new 510(k) clearance or could require premarket approval.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A device that cannot demonstrate substantial equivalence to a previously marketed predicate is automatically deemed Class III. The de novo process provides a pathway to classify novel medical devices for which general controls alone, or general and special controls, provide reasonable assurance of safety and effectiveness for the intended use, but for which there is no legally marketed predicate device. Once a request for de novo classification is granted by the FDA, the newly classified device may be used as a predicate by the applicant or a competitor in a future 510(k) notification submission, if the FDA determines that new devices of the same type require 510(k) clearance.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Devices deemed by the FDA to pose the greatest risk are placed in Class III. A PMA is required for most Class III devices. The PMA process is generally more detailed, lengthier and more expensive than the 510(k) and de novo processes. Prior to the acquisition of Cardiva in March 2021, we had not been required to obtain a PMA for any of our products and did not have any Class III products in our product pipeline. Our VASCADE and VASCADE MVP products are both Class III products for which PMAs were previously obtained. The 510(k) clearance, de novo classification, and PMA processes can be resource intensive, expensive, lengthy and require payment of significant user fees.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Postmarket Requirements - U.S.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the FDA permits a device to enter commercial distribution, numerous regulatory requirements continue to apply. Generally, establishments that design and/or manufacture devices are required to register with the FDA. They also must provide the FDA with a list of the devices that they design and/or manufacture at their facilities. Other postmarket requirements include compliance with:</span></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Quality System Regulation, or QSR, which sets forth current good manufacturing practice, or cGMP, requirements for medical devices. The QSR applies to manufacturers, including contract manufacturers, of finished medical devices, and governs methods, facilities, and controls used in designing, manufacturing, packaging, labeling, storing, installing and servicing such devices. Among other requirements, manufacturers of medical devices must establish a quality system appropriate for the devices they manufacture.</span></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Labeling regulations, including unique device identification;</span></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical device reporting, or MDR, regulations, which require that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction were to recur; and</span></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical device correction and removal (recall) regulations with their associated reporting obligations.</span></div><div style="margin-top:7pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we and the manufacturing facilities of some of our suppliers are subject to unannounced inspections by the FDA to determine our compliance with the QSR and other applicable regulations described above. The FDA can issue Form 483 Notices of Observation, warning letters or untitled letters, seek a court order detaining or seizing certain devices, seek an injunction, suspend regulatory clearance or approvals, ban certain medical devices, order repair, replacement or refund of those devices and require notification of health professionals and others with regard to medical devices that present risks of substantial harm to the public health. The FDA may also initiate action for criminal prosecution of violations.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA also may require post market testing, surveillance, or other measures to monitor the effects of an approved or cleared product. The FDA may place conditions on a PMA-approved device that could restrict the distribution or use of the product. In addition, quality control, manufacture, cybersecurity, packaging and labeling procedures must continue to conform to QSRs after approval and clearance, and manufacturers are subject to periodic inspections by the FDA. Accordingly, manufacturers must continue to expend time, money, and effort in the areas of production and quality control to maintain compliance with QSRs. The FDA may withdraw product approvals or recommend or require product recalls if a company fails to comply with regulatory requirements.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising, marketing and promotional activities for devices are also subject to FDA oversight. The failure to comply with the requirements applicable to these activities can result in FDA enforcement action.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturers of medical devices are permitted to promote products solely for the uses and indications set forth in the approved or cleared product labeling. Promotion of products for uses not described in the approved or cleared labeling (&#8220;off-label&#8221; uses) has resulted in enforcement actions against manufacturers, including actions alleging violation of the Federal False Claims Act, federal and state healthcare fraud and abuse laws, and state consumer protection laws. The failure to comply with prohibitions on &#8220;off-label&#8221; promotion can result in significant monetary penalties, suspension of sales of certain products, product recalls, civil or criminal sanctions, exclusion from participating in federal healthcare programs, or other enforcement actions. In the United States, allegations of such wrongful conduct could also result in a corporate integrity agreement with the U.S. government that imposes significant administrative obligations and costs.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Requirements Outside the U.S.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory review process varies from country to country and may in some cases require the submission of clinical data. Our international sales are subject to regulatory requirements in the countries in which our products are sold. For example, the EU has adopted the EU Medical Device Regulation (the &#8220;EU MDR&#8221;) and the EU In Vitro Diagnostic Regulation (the &#8220;EU IVDR&#8221;), each of which impose stricter requirements for the marketing and sale of medical devices, including in the area of clinical evaluation requirements, quality systems and postmarket surveillance, than the medical device directives they replace. The EU MDR became fully applicable as of May 26, 2021 and the EU IVDR became fully applicable as of May 26, 2022. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a conditional transition period after the date of full application, the duration of which is dependent on the classification of the device. A new EU certificate under the applicable regulations must be obtained prior to the end of the transition period if there is to be no interruption in manufacturing and supply of devices to the market. There are nevertheless a number of provisions that need to be complied with from the date of application, including updating the postmarket surveillance process, appointing an importer for the EU, appointing a person responsible for regulatory compliance, and updating economic operator agreements. Complying with the requirements of these regulations has and will continue to require us to incur significant expenditures. Failure to meet these requirements could adversely impact our business in the EU and other regions that tie their product registrations to the EU requirements. Similarly, the separation of states from participation in the EU, such as through the cessation of the UK&#8217;s membership in the EU (commonly known as &#8220;Brexit&#8221;) and the separation of the Swiss and EU medical product markets with the adoption of the EU MDR (commonly referred to as &#8220;Swexit&#8221;), may result in further regulatory risk and complexity as the former EU member or participant state establishes separate laws and regulations governing medical products. Regulatory requirements in other jurisdictions also continue to become more stringent, increasing regulatory requirements to register and maintain products in these markets.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Drug Regulation</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Development and Approval</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the FDCA, FDA approval of a new drug application, or NDA, is generally required before any new drug can be marketed in the U.S. NDAs require extensive studies and submission of a large amount of data by the applicant.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A generic version of an approved drug is approved by means of an abbreviated new drug application, or ANDA, by which the sponsor demonstrates that the proposed product is the same as the approved, brand-name drug, which is referred to as the &#8220;reference listed drug,&#8221; or RLD. Generally, an ANDA must contain data and information showing that the proposed generic product and RLD have the same active ingredient, in the same strength and dosage form, to be delivered via the same route of administration, are intended for the same uses and are bioequivalent. This more limited data set is in lieu of independently demonstrating the proposed product&#8217;s safety and effectiveness, which are inferred from the fact that the product is the same as the RLD, which the FDA previously found to be safe and effective.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently hold NDAs and ANDAs for liquid solutions (including anticoagulants, intravenous saline and a red blood cell storage solution), which we sell with our blood component and whole blood collection systems.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-Approval Regulations</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the FDA permits a drug to enter commercial distribution, numerous regulatory requirements continue to apply. These include the FDA's current cGMPs, which include a series of requirements relating to organization and training of personnel, buildings and facilities, equipment, control of components and drug product containers and closures, production and process controls, quality control and quality assurance, packaging and labeling controls, holding and distribution, and laboratory controls and records and reports. The FDA has also established labeling regulations, advertising and promotion requirements and restrictions, regulations regarding conducting recalls of product and requirements relating to the reporting of adverse events.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with applicable FDA requirements and restrictions in this area may subject a company to adverse publicity, such as warning letters, and enforcement action by the FDA, the Department of Justice, or the Office of the Inspector General of the Department of Health and Human Services, as well as state authorities. This could subject a company to a range of penalties that could have a significant commercial impact, including civil and criminal fines and entering into agreements with the government that materially restrict the manner in which a company promotes or distributes drug or biological products.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Requirements Outside the U.S.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must obtain the requisite marketing authorizations from regulatory authorities in foreign countries prior to marketing of a product in those countries. The requirements and process governing product licensing vary from country to country. If we fail to comply with applicable foreign regulatory requirements, we may be subject to, among other things, warning letters or untitled letters, injunctions, civil, administrative, or criminal penalties, monetary fines or imprisonment, suspension or withdrawal of regulatory approvals, suspension of ongoing clinical studies, refusal to approve pending applications or supplements to applications filed by us, suspension or the imposition of restrictions on operations, product recalls, the refusal to permit the import or export of our products or the seizure or detention of products.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Conflict Minerals</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Dodd-Frank Wall Street Reform and Consumer Protection Act imposes disclosure requirements regarding the use of &#8220;Conflict Minerals&#8221; mined from the Democratic Republic of Congo and adjoining countries in products, whether or not these products are manufactured by third parties. The conflict minerals include tin, tantalum, tungsten and gold and their derivatives. These requirements could affect the pricing, sourcing and availability of minerals used in the manufacture of our products. There may be material additional costs associated with complying with the disclosure requirements, such as costs related to determining the source of any conflict minerals used in our products. Our supply chain is complex and we may be unable to verify the origins for all metals used in our products as well as costs of possible changes to products processes, or sources of supply as a consequence of such verification activities. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fraud and Abuse Laws</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to fraud and abuse and other healthcare laws and regulations that constrain the business or financial arrangements and relationships through which we market, sell and distribute our products. In addition, we are subject to transparency laws and patient privacy regulation by U.S. federal and state governments and by governments in foreign jurisdictions in which we conduct our business. We have described below some of the key federal, state and foreign healthcare laws and regulations that apply to our business.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal healthcare program Anti-Kickback Statute prohibits, among other things, knowingly and willfully offering, paying, soliciting or receiving remuneration, directly or indirectly, in cash or in kind, to induce or in return for purchasing, leasing, ordering or arranging for or recommending the purchase, lease or order of any healthcare item or service reimbursable, in whole or in part, under Medicare, Medicaid or other federally financed healthcare programs. This statute has been interpreted to apply to arrangements between manufacturers of federally reimbursed products on one hand and prescribers, purchasers and others in a position to recommend, refer, or order federally reimbursed products on the other. Although there are a number of statutory exemptions and regulatory safe harbors protecting certain common activities from prosecution, the exemptions and safe harbors are drawn narrowly and practices that involve remuneration to those who prescribe, purchase, or recommend medical devices or pharmaceutical and biological products, including certain discounts, or engaging consultants as speakers or consultants, may be subject to scrutiny if they do not fit squarely within the exemption or safe harbor. Our practices may not in all cases meet all of the criteria for safe harbor protection from anti-kickback liability. Moreover, there are no safe harbors for many common practices, such as educational and research grants. Liability may be established without a person or entity having actual knowledge of the federal Anti-Kickback Statute or specific intent to violate it. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal civil False Claims Act prohibits, among other things, any person from knowingly presenting, or causing to be presented, a false, fraudulent or materially incomplete claim for payment of government funds, or knowingly making, using, or causing to be made or used, a false record or statement material to an obligation to pay money to the government or knowingly concealing or knowingly and improperly avoiding, decreasing, or concealing an obligation to pay money to the federal government. In recent years, companies in the healthcare industry have faced enforcement actions under the federal False Claims Act for, among other things, allegedly providing free product to customers with the expectation that the customers would bill federal programs for the product or causing false claims to be submitted because of the company&#8217;s marketing the product for unapproved and thus non-reimbursable, uses. False Claims Act liability is potentially significant in the healthcare industry because the statute provides for treble damages and mandatory penalties of tens of thousands of dollars per false claim or statement. Healthcare companies also are subject to other federal false claims laws, including, among others, federal criminal healthcare fraud and false statement statutes that extend to non-government health benefit programs.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, among other things, imposes criminal and civil liability for knowingly and willfully executing a scheme to defraud any healthcare benefit program, including private third party payers and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Physician Payment Sunshine Act, implemented as the Open Payments program, requires manufacturers of certain products reimbursed by Medicare, Medicaid, or the Children&#8217;s Health Insurance Program to track and report information to the federal government on certain payments or transfers of value that they make to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Manufacturers are also required to collect information regarding payments and other transfers of value to physician assistants, nurse practitioners, clinical nurse specialists, anesthesiologist assistants, certified registered nurse anesthetists and certified nurse-midwives for reporting. The reported data is made available in searchable form on a public website on an annual basis. Failure to submit required information may result in civil monetary penalties.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many states have adopted analogous laws and regulations, including state anti-kickback and false claims laws, which may apply to items or services reimbursed under Medicaid and other state programs or, in several states, regardless of the payer. Several states have enacted legislation requiring pharmaceutical and medical device companies to, among other things, establish marketing compliance programs; file periodic reports with the state, including reports on gifts and payments to individual health care providers; make periodic public disclosures on sales, marketing, pricing, clinical trials and other activities; and/or register their sales representatives. Some states prohibit specified sales and marketing practices, including the provision of gifts, meals, or other items to certain health care providers and/or offering co-pay support to patients for certain prescription drugs.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other countries, including a number of EU Member States, have laws of similar application.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with international, federal and local environmental protection laws or regulations could have an adverse impact on our business or could require material capital expenditures. We continue to monitor changes in U.S. and international environmental regulations and emerging industry expectations that may present a significant risk to the business, including laws or regulations relating to the manufacture or sale of products using plastics and evolving customer expectations with respect to environmental stewardship.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Human Capital</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to building a collaborative, performance-driven culture that attracts and retains top talent. As of April&#160;1, 2023, we employed the full-time equivalent of 3,034&#160;persons. Approximately 79% of our employees are located in North America and the remaining 21% are located across 19 other countries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our industry, there is substantial competition for key personnel in the regions in which we operate. Recruiting, developing, engaging and retaining talented employees is critical to both our strategy and our ability to compete effectively in the markets we serve. Our human capital strategy focuses on a complementary set of initiatives designed to support our corporate strategy and secure top talent, including the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">We dedicate meaningful time and resources to employee development, training and succession planning.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pursuant to our Principles of Corporate Governance, our Board of Directors plans for succession to the position of Chief Executive Officer as well as other senior leadership positions and reviews potential successors to these roles at least annually. We maintain a robust performance management review process for our permanent employees below the senior leadership level to help develop talent and ensure alignment of performance goals at every level of the organization throughout the fiscal year. Additionally, we offer a variety of programs and resources designed to facilitate our employees&#8217; career development, training and networking, including:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Individual development planning by employees, in consultation with their managers, to help define individual development goals and facilitate manager coaching and feedback;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Manager development sessions focused on developing core leadership competencies, including performance management training, coaching and feedback and building trust;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Continuous improvement training for employees, including through our internal learning management platform, to promote individual development, strengthen our culture and drive compliance and quality across our organization;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Tuition reimbursement programs that provide eligible U.S. and Canadian employees with the opportunity to be reimbursed (up to a set dollar limit) for tuition and certain other expenses associated with degree programs, certifications and continuing education courses that relate to their work at the Company; and</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Regular recognition of employees across the organization who personify our core values.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:14.5pt">We engage regularly with our employees. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our senior leadership team participates in scheduled meetings with our employees throughout the fiscal year &#8211; including quarterly Town Halls with our global workforce &#8211; to reiterate strategic priorities, provide business updates, recognize employee contributions and answer employee questions. We also conduct an annual employee engagement survey, with at least 90% global participation since 2018. Feedback from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">these surveys is shared across the organization and informs both Company-sponsored initiatives and shared action plans between managers and direct reports.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">We seek to foster a diverse workforce and an inclusive culture. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize that the diversity of our teams and their ideas helps build our collaborative, performance-driven culture, and we are committed to providing an inclusive environment where every individual has the opportunity to thrive. Accordingly, we focus attention and purposeful investments on developing our diversity, equity and inclusion programs and practices and take steps to ensure consistent and fair pay practices. We also require that employees complete annual training on our Code of Conduct (which includes specific modules on how to promote an inclusive culture and help identify and prevent unlawful discrimination) as well as standalone anti-harassment and anti-discrimination training. Additionally, we maintain company-sponsored Colleague Resource Groups designed to provide a forum for employees with shared affinities to connect, advance business priorities and drive talent strategies with an inclusive focus.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.15pt">We offer market-competitive compensation opportunities and benefits that are designed to attract, retain and motivate exceptional employees and drive both individual and company performance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition to base salary, most of our employees have variable components to their compensation that are tied to achievement of corporate and individual performance goals, the fluctuations of our stock price, or a combination of both. We also offer a comprehensive package of global benefits to support the health and well-being of our employees and their families and continually introduce new and enhanced benefit offerings to meet the evolving needs of our workforce and to remain competitive in local markets, including a hybrid work offering for our corporate offices in the U.S. and certain other jurisdictions.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">We maintain policies and practices to promote employee health and safety</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a Company, we are committed to making our workplaces safe and secure. This includes eliminating unsafe work practices and workplace injuries and illnesses and promoting the health, safety and well-being of all employees, contractors and visitors. Important objectives in achieving our vision include: creating a positive safety culture, maintaining an effective safety management system and reducing risk in the workplace. Among other things, we utilize a third-party enterprise compliance and risk management solution at all of our locations to track incidents. We also require tailored health and safety compliance training for all site employees as well as annual training for all employees on our Code of Conduct, which includes a specific module on health and safety.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Availability of Reports and Other Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Principles of Corporate Governance, Code of Conduct and the charters of the Audit, Compensation, Governance and Compliance and Technology Committees of our Board of Directors are published on the Investor Relations section of our website at </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.haemonetics.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On this website the public can also access, free of charge, our annual, quarterly and current reports and other documents filed or furnished to the Securities and Exchange Commission, or SEC, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The SEC maintains an internet site (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">http://www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that contains reports, proxy and information statements and other information regarding issuers that file documents electronically.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_25"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Statement Regarding Forward-Looking Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements that we make from time to time, including statements contained in this Annual Report on Form 10-K and incorporated by reference into this report, constitute &#8220;forward looking-statements&#8221; within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.</span><span style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements do not relate strictly to historical or current facts and reflect management&#8217;s assumptions, views, plans, objectives and projections about the future. Forward-looking statements may be identified by the use of words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;predicts,&#8221; &#8220;foresees,&#8221; &#8220;potential&#8221; and other words of similar meaning in conjunction with, among other things: discussions of future operations; expected operating results and financial performance; the Company&#8217;s strategy for growth; product development, commercialization and anticipated performance and benefits; regulatory approvals; impacts of acquisitions or dispositions; and market position and expenditures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because forward-looking statements are based on current beliefs, expectations and assumptions regarding future events, they are subject to uncertainties, risks and changes that are difficult to predict and many of which are outside of the Company&#8217;s control. Investors should realize that if underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, the Company&#8217;s actual results and financial condition could vary materially from expectations and projections expressed or implied in its forward-looking statements. Investors are therefore cautioned not to rely on these forward-looking statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are some important factors that could cause our actual results to differ from our expectations in any forward-looking statements. For further discussion of these and other factors, see Item 1A. Risk Factors in this report.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to achieve our long-term strategic and financial-improvement goals;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Demand for and market acceptance risks for new and existing products, including material reductions in purchasing from or loss of a significant customer;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to develop, manufacture and market new products and technologies successfully and in a timely manner and the ability of our competitors and other third parties to develop products or technologies that render our products or technologies noncompetitive or obsolete;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product quality or safety concerns, leading to product recalls, withdrawals, regulatory action by the FDA (or similar non-U.S. regulatory agencies), reputational damage, declining sales or litigation;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Security breaches of our information technology systems or our products, which could impair our ability to conduct business or compromise sensitive information of the Company or its customers, suppliers and other business partners, or of customers&#8217; patients;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pricing pressures resulting from trends toward healthcare cost containment, including the continued consolidation among healthcare providers and other market participants;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The continuity, availability and pricing of plastic and other raw materials, finished goods and components used in the manufacturing of our products (including those purchased from sole-source suppliers) and the related continuity of our manufacturing, sterilization, supply and distribution;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to obtain the anticipated benefits of restructuring programs that we have or may undertake, including the Operational Excellence Program;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">The potential that the expected strategic benefits and opportunities from completed or planned acquisitions, divestitures or other strategic investments by the Company may not be realized or may take longer to realize than expected;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of enhanced requirements to obtain regulatory approval in the U.S. and around the world and the associated timing and cost of product approval;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to comply with established and developing U.S. and foreign legal and regulatory requirements, including FCPA, EU MDR/EU IVDR and similar laws in other jurisdictions, as well as U.S. and foreign export and import restrictions and tariffs;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to meet our debt obligations and raise additional capital when desired on terms reasonably acceptable to us;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential impact of our convertible senior notes and related capped call transactions;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Geopolitical and economic conditions in China, Russia and other foreign jurisdictions where we do business;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to execute and realize anticipated benefits from our investments in emerging economies;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential effect of foreign currency fluctuations and interest rate fluctuations on our net sales, expenses and resulting margins;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of changes in U.S. and international tax laws;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to protect intellectual property and the outcome of patent litigation;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Costs and risks associated with product liability and other litigation claims we may be subject to now or in the future;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">The impact of actual or threatened public health emergencies;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Our ability to retain and attract key personnel;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market conditions impacting our stock price and/or our share repurchase program, and the possibility that such share repurchase program may be delayed, suspended or discontinued; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to achieve against our corporate responsibility initiatives and meet evolving stakeholder expectations concerning corporate responsibility matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investors should understand that it is not possible to predict or identify all such factors and should not consider the risks described above and in Item 1A. Risk Factors to be a complete statement of all potential risks and uncertainties. The Company does not undertake to publicly update any forward-looking statement that may be made from time to time, whether as a result of new information or future events or developments.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_28"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the other information contained in this Annual Report on Form 10-K and the exhibits hereto, the following risk factors should be considered carefully in evaluating our business. Our business, financial condition, cash flows or results of operations could be materially adversely affected by any of these risks. This section contains forward-looking statements. Please refer to the cautionary statements made under the heading &#8220;Cautionary Statement Regarding Forward-Looking Information&#8221; at the end of Item&#160;1 of this Annual Report on Form 10-K for more information on the qualifications and limitations on forward-looking statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Business and Industry</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our business strategy does not yield the expected results or we fail to implement the necessary changes to our operations, we could see material adverse effects on our business, financial condition or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We view our operations and manage our business in three principal reporting segments: Plasma, Blood Center and Hospital. We believe that Plasma and Hospital have growth potential, while Blood Center competes in challenging markets that require us to manage the business differently, including reducing costs, shrinking the scope of the current product line and evaluating opportunities to exit unfavorable customer contracts. If we have not correctly identified the product categories with greatest growth potential, we will not allocate our resources appropriately which could have a material adverse effect on our business, financial condition or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material reductions in purchasing from or loss of a significant customer could adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2023, our ten largest customers accounted for approximately 48% of our net reve</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nues. As previously disclosed, our largest Plasma customer, CSL, informed us in April 2021 of its intent not to renew its supply agreement for the use of PCS2 plasma collection system devices and the purchase of disposable plasmapheresis kits in the U.S. following the expiration of the then current term of its contract, which was subsequently extended on a non-exclusive basis through December 2025. Any non-renewal, termination or material reduction in purchasing by any of our largest customers for any reason, includin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g material decreases in demand for plasma or development of alternative processes, could have a material adverse effect on our business, financial condition or results or operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face intense competition, and if we are unable to successfully expand our product lines through internal research and new product development or keep pace with rapid technological changes in the healthcare industry, our business may be materially and adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant element of our strategy is to increase revenue growth by focusing on innovation and new product development. The medical device markets in which we participate, however, are highly competitive. We encounter significant competition across our product lines and in each market in which our products are sold from various medical device companies, some of whom have greater financial and marketing resources than we do. In addition, the medical device markets in which we participate and healthcare industry generally are characterized by extensive research and development and rapid technological change.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New product development requires significant investment in research and development, clinical trials and regulatory approvals. The results of our product development efforts may be affected by a number of factors, including our ability to anticipate customer needs, innovate and develop new products and technologies, successfully complete clinical trials, obtain regulatory approvals in the United States and abroad, manufacture products in a cost-effective manner, obtain appropriate intellectual property protection for our products, and gain and maintain market acceptance of our products. In addition, patents attained by others could preclude or delay our commercialization of a product. There can be no assurance that any products now in development or that we may seek to develop in the future will achieve technological feasibility, obtain regulatory approval or gain market acceptance. If we fail to develop new products or enhance existing products, or if competitive technologies or therapeutic alternatives to plasma-derived pharmaceuticals in development, such as FcRn-targeted therapies, emerge and gain market acceptance, such events could have a material adverse effect on our business, financial condition or results of operations. In addition, a delay in the timing of the launch of next-generation products and the overall performance of, and continued customer confidence in, those products may result in declines in our market share and have an adverse impact on our business, financial condition or results of operations.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defects or quality issues associated with our products could adversely affect the results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quality is extremely important to us and our customers due to the serious and costly consequences of product failure. Manufacturing or design defects, component failures, unapproved or improper use of our products, or inadequate disclosure of risks or other information relating to the use of our products can lead to injury or other serious adverse events. These events could lead to recalls or safety alerts relating to our products (either voluntary or as required by the FDA or similar governmental authorities in other countries), and could result, in certain cases, in the removal of a product from the market. A recall could result in significant costs and lost sales and customers, enforcement actions and/or investigations by state and federal governments or other enforcement bodies, as well as negative publicity and damage to our reputation that could reduce future demand for our products. Personal injuries relating to the use of our products can also result in significant product liability claims being brought against us. In some circumstances, such adverse events could also cause delays in regulatory approval of new products or the imposition of post-market approval requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are increasingly dependent on information technology systems and subject to privacy and security laws and a cyber-attack or other breach of these systems could have a material adverse effect on our business, financial condition or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We increasingly rely on information technology systems, including cloud-based computing, to process, transmit and store electronic information for our day-to-day operations and for our customers, including sensitive personal information and proprietary or confidential information. Additionally, certain of our products collect data regarding patients and donors and connect to our systems for maintenance and other purposes or are actively managed by Haemonetics on behalf of specific customers. Similar to other large multi-national companies, the size and complexity of our information technology systems makes them vulnerable to a cyber-attack, malicious intrusion, breakdown, destruction, loss of data privacy, or other significant disruption. We also outsource certain elements of our information technology systems to third parties that, as a result of this outsourcing, could have access to certain confidential information and whose systems may also be vulnerable to these types of attacks or disruptions. Security threats, including cyber and other attacks are becoming increasingly sophisticated, frequent, and adaptive and, like other large multi-national companies, we have experienced cyber incidents in the past and may experience them in the future. Accordingly, our information systems require an ongoing commitment of significant resources to maintain, protect and enhance existing systems and develop new systems to keep pace with continuing changes in information processing technology, evolving systems and regulatory standards, the increasing need to protect patient and customer information and changing customer patterns. Although prior cyber incidents have not had a material effect on our business and we have invested and continue to invest in the protection of personal information and proprietary or confidential information, there can be no assurance that our efforts will prevent cyber-attacks, intrusions, breakdowns or other incidents or ensure compliance with all applicable securities and privacy laws, regulations, standard standards. In addition, third parties may attempt to hack into our products to obtain data relating to patients with our products or our proprietary information. Any failure by us or third parties we work with to maintain or protect our respective information technology systems and data integrity, including from cyber-attacks, intrusions or other breaches, could result in the unauthorized access to patient data and personally identifiable information, theft of intellectual property or other misappropriation of assets, or otherwise compromise our confidential or proprietary information and disrupt our operations. Any of these events, in turn, may cause us to lose existing customers, have difficulty preventing, detecting and controlling fraud, have disputes with customers, physicians and other healthcare professionals, be subject to legal claims and liability, have regulatory sanctions or penalties imposed, have increases in operating expenses, incur expenses or lose revenues as a result of a data privacy breach or theft of intellectual property, or suffer other adverse consequences, any of which could have a material adverse effect on our business, financial condition or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the legal and regulatory environment surrounding information security and privacy is increasingly demanding, with the imposition of new and changing requirements across businesses. We are required to comply with increasingly complex and changing legal and regulatory requirements that govern the collection, use, storage, security, transfer, disclosure and other processing of personal data in the United States and in other countries, including, but not limited to, HIPAA, HITECH, the California Consumer Privacy Act, or CCPA, the California Privacy Rights Act, and the EU&#8217;s General Data Protection Regulation, or GDPR. The GDPR imposes stringent EU data protection requirements and provides for significant penalties for noncompliance. HIPAA also imposes stringent data privacy and security requirements and the regulatory authority has imposed significant fines and penalties on organizations found to be out of compliance. CCPA provides consumers with a private right of action against companies who have a security breach due to lack of appropriate security measures, and several other U.S. states have introduced or proposed similar privacy laws which may apply to us directly or indirectly through our customers, manufacturers, suppliers or other third-party partners. In addition, new information security and privacy laws have also come into effect in China and other countries where we conduct business. We or our third-party providers and business partners may also be subjected to audits or investigations by one or more domestic or foreign government agencies relating to compliance </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with information security and privacy laws and regulations, and noncompliance with the laws and regulations could results in material fines or litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We outsource certain aspects of our business to a single third-party vendor that subjects us to risks, including disruptions in business and increased costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, we rely on a single vendor to support several of our business processes, including customer service and support and elements of enterprise technology, procurement, accounting and human resources. We make diligent efforts to ensure that the provider of these outsourced services is observing proper internal control practices. However, there are no guarantees that failures will not occur. Accordingly, we are subject to the risks associated with the vendor&#8217;s ability to successfully provide the necessary services to meet our needs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our vendor is unable to adequately protect our data or information is lost, if our ability to deliver our services is interrupted (including as a result of significant outbreaks of disease, natural disasters, extreme weather and other conditions caused by or related to climate change, strikes, terrorism attacks or other adverse events in the countries in which the vendor operates), if our vendor's fees are higher than expected, if our vendor makes mistakes in the execution of operations support, or if the vendor terminates our relationship, then our business and operating results may be negatively affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A significant portion of our revenue derives from the sale of blood collection supplies. Declines in the number of blood collection procedures have adversely impacted our business and future declines may have an adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The demand for whole blood disposable products in the U.S. continues to decrease due to sustained declines in transfusion rates caused by hospitals&#8217; improved blood management techniques and protocols. In response to this trend, U.S. blood center collection groups are primarily focused on obtaining the lowest average selling prices for their whole blood collection products. We expect to see continued declines in transfusion rates and the market to remain price-focused and highly competitive for the foreseeable future. Continued declines in this market could have a material adverse effect on our liquidity and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidation of healthcare providers and blood collectors, healthcare cost containment pressures, government payment and delivery system reforms and changes in private payer policies could decrease demand for our products, the prices which customers are willing to pay for those products and/or the number of procedures performed using our devices, which could have an adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Political, economic and policy influences are causing the healthcare and blood collection industries to make substantial structural and financial changes that affect our results of operations. Government and private sector initiatives limiting the growth of healthcare costs are causing structural reforms in healthcare delivery, including the reduction in blood use and reduced payments for care. These trends have placed greater pricing pressure on suppliers and, in some cases, decreased average selling prices and increased the number of sole source relationships. This pressure impacts our Hospital and Blood Center businesses. Our Vascular Closure devices, for example, are often perceived as physician preference devices with a relatively higher price point compared to certain vascular closure alternatives such as sutures or manual compression, and purchases are commonly made by a hospital only after approval by its value analysis committee. If a hospital value analysis committee does not approve or revokes prior approval for any of the reasons set forth above, the demand for our vascular closure devices may decrease and we could experience an adverse effect on our results of operations or financial condition. Additionally, while Hospital capital purchase patterns have increased from initially depressed levels earlier in the COVID-19 pandemic, it is difficult to predict the long-term impact of the pandemic on hospital spending patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The influence of integrated delivery networks, group purchasing organizations and large single accounts has the potential to put price pressure on our Hospital business. It also puts price pressure on our U.S. Blood Center customers who are also facing reduced demand for red cells. Our Blood Center customers have responded to this pressure by creating their own group purchasing organizations and resorting to single source tenders to create incentives for suppliers, including us, to significantly reduce prices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that market demand, government regulation, third-party reimbursement policies, government contracting requirements and societal pressures will continue to change the worldwide healthcare industry, resulting in further business consolidations and alliances among our customers and competitors. This may exert further downward pressure on the prices of our products and adversely impact our business, financial condition or results of operations.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An interruption in our ability to manufacture our products, obtain key components or raw materials, or the failure of a sole source supplier or sterilization service provider may adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a complex global supply chain that involves integrating key suppliers and our manufacturing capacity into a global movement of components and finished goods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture certain key disposables and devices at single locations with limited alternate facilities. If natural disasters, extreme weather and other conditions caused by or related to climate change, strikes, terrorism attacks or other adverse events occur that result in the closure of or damage to one or more of these facilities, we may be unable to supply the relevant products at previous levels or at all for some period. Additionally, for reasons of quality assurance or cost effectiveness, we purchase certain finished goods, components and raw materials from sole suppliers who have their own complex supply chains. We have experienced increased levels of unpredictability in the supply of certain raw materials and components, including semiconductor chips, used in the manufacturing of our products. While we continue to believe we will have access to the raw materials and components that we need, any disruption to one or more of our suppliers&#8217; production or delivery of sufficient volumes of raw materials and components conforming to our specifications could disrupt or delay our ability to deliver finished products to our customers. For example, we purchase components in Asia for use in manufacturing in the U.S. and Mexico. We source all of our apheresis equipment from Asia and regularly ship finished goods from the U.S. and Mexico to the rest of the world.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our products also require sterilization prior to sale or distribution and we utilize a mix of internal resources and contract sterilizers to perform this service. To the extent we or our contract sterilizers are unable to sterilize our products, whether due to capacity, availability of materials for sterilization, regulatory or other constraints, including federal and state regulations on the use of ethylene oxide, we may be unable to transition to alternative internal or external resources or methods in a timely or cost effective manner, or at all, which could have a material impact on our results of operations and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we manufacture our vascular closure devices under a shelter plan service agreement with Offshore International Incorporated (d/b/a Tetakawi) pursuant to which we lease our manufacturing facility in Guaymas, Mexico. Tetakawi is responsible for a number of ongoing services related to the facility, including provision of external security and maintenance, manufacturing personnel related human resource matters, recruiting support, government compliance, workforce transportation and cross-border shipping of raw components. We are reliant on Tetakawi to provide these services and any disruption in these services or our failure to maintain our contractual relationship with Tetakawi could significantly harm our ability to manufacture our vascular closure devices and maintain sufficient quality standards, which would negatively impact our business and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the high standards and stringent requirements of the FDA and other similar non-U.S. regulatory agencies applicable to manufacturing our products, such as the FDA&#8217;s QSR and cGMP regulations, we also may not be able to quickly establish additional or replacement sources for certain raw materials, components or finished goods. A reduction or interruption in manufacturing, or an inability to secure alternative sources of raw materials, components or finished goods on commercially reasonable terms or in a timely manner, could compromise our ability to manufacture our products on a timely and cost-competitive basis, which may have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in the cost, composition or availability of the plastics and resins we purchase, or of other raw materials and components used in our products, could adversely affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face risks related to the price, composition and availability of plastic raw materials used in our disposable products, which represent a substantial portion of our revenues. Material or sustained increases in the price of petroleum or petroleum derivatives could have an adverse impact on the costs to procure plastic raw materials. Additionally, our results of operations could be neg</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">atively impacted by volatility in the cost or availability of these and other raw materials and components used in our products that, in turn, increase the costs of producing and distributing our products. In recent years, we have experienced inflationary pressures that have significantly increased the cost of raw materials, transportation, construction, services and energy necessary for the production and distribution of our products. Continued uncertainty around inflationary pressures, rising interest rates and macroeconomic conditions have increased the risk of creating new, or exacerbating existing, economic challenges we face. Wh</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ile we have implemented cost containment measures, selective price increases and taken other actions to offset these inflationary pressures in our global supply chain, we may not be able to completely offset all the increases in our operational costs. Additionally, climate change (including laws or regulations passed in response thereto) could increase our supply costs, including energy and transportation/freight-related expenses, or reduce the availability of raw materials.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of the plastic we purchase is also important. Today, we purchase plastics that contain DEHP and other phthalates, which are used to make plastic malleable. Due to regulatory changes and evolving customer expectations, we may be required to remove materials such as phthalates from our devices, find alternative materials which then need to be validated or obtain regulatory approvals from the regulatory authorities for a number of products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have not experienced significant shortages in the past, any interruption in the supply for certain plastics could have a material impact on our business by limiting our ability to manufacture and sell the products that represent a significant portion of our revenues. These outcomes may in turn result in customers transitioning to available competitive products, loss of market share, negative publicity, reputational damage, loss of customer confidence or other negative consequences (including a decline in stock price).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not realize the benefits we expect from our Operational Excellence Program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, our Board of Directors approv</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ed a new Operational Excellence Program, also referred to in this report as the 2020 Program, and delegated authority to management to determine the detail of the initiatives that will comprise the program. While cost savings from the 2020 Program to date have been consistent with our expectations, it is possible that events and circumstances, such as rising interest rates, macroeconomic uncertainty and the related impacts on us, our customers and suppliers could result in our not realizing all of the anticipated benefits or our not realizing the anticipated benefits on our expected timetable. Additionally, any material reduction in purchases by significant customers and any actions we take in response to such anticipated reduction could result in a decrease in benefits we realize under the 2020 Program. Our inability to realize all of the anticipated benefits from the 2020 Pro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">gram could have a material adverse effect on our business, results of operations, cash flows and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our business development activities are unsuccessful, we may not realize the intended benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have sought and in the future may seek to supplement our organic growth through strategic acquisitions, investments and alliances. We have also sought and in the future may seek to divest certain assets deemed non-core to our long-term strategic objectives. Such transactions are inherently risky and require significant effort and management attention. The success of any acquisition, investment or alliance, or of any divestiture, may be affected by a number of factors, including our ability to properly assess and value the potential business opportunity or to successfully integrate any business we may acquire into our existing business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Promising partnerships and acquisitions may also not be completed for reasons such as competition among prospective partners or buyers, the inability to reach satisfactory terms, the need for regulatory approvals or the existence of economic conditions affecting our access to capital for acquisitions and other capital investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our business development activities are unsuccessful, we may not realize the intended benefits of such activities, including that acquisition and integration costs may be greater than expected or the possibility that expected return on investment synergies and accretion, or on new growth opportunities funded in whole or part by divestitures, will not be realized or will not be realized within the expected timeframe.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Government Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As a medical device and drug manufacturer, we operate in a highly regulated industry, and non-compliance with applicable laws or regulations could adversely affect our financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacture, distribution and marketing of our products are subject to extensive regulation by the FDA and other state and non-U.S. regulatory bodies. Our operations are also subject to review and monitoring by the FDA and other regulatory authorities. Government regulation of medical devices is meant to assure their safety and effectiveness, and includes regulation of, among other things, the product&#8217;s development, testing, premarket clearance and approval, manufacture, marketing, labeling, post-market surveillance, reporting, and imports and exports. Before a new medical device, or a new use of an existing product can be marketed in the United States, it must first receive either premarket clearance under Section 510(k) of the U.S. Federal Food, Drug, and Cosmetic Act, or FDCA, a grant of a request for de novo classification or a Premarket Approval, or PMA, from the FDA, unless an exemption applies. The process of obtaining regulatory clearances or approvals to market a medical device can be costly and time-consuming, and we may not be able to obtain these clearances or approvals on a timely basis, if at all.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Many of our currently commercialized products have received 510(k) clearance. In the future, the FDA may determine that our products will require more costly, lengthy and uncertain de novo or PMA processes. Modifications to Class III devices, like our Vascular Closure products, may require additional clinical studies or supplemental PMA submissions. If the FDA requires us to go through a lengthier, more rigorous process for future products or modifications to existing products, our product introductions or modifications could be delayed or canceled, which could adversely affect our revenue. In particular, the FDA has recently placed increased scrutiny on cybersecurity for medical devices which may necessitate additional time and cost for product development, submission and approval or clearance. In addition, even if we do obtain clearance or approval, the FDA may not approve or clear these products for the indications that we requested. Any delay in, or failure to receive or maintain, clearances or approvals for our products under development could prevent us from generating revenue from these products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to substantially comply with applicable regulations could subject our products to recall or seizure of our products by government authorities, or an order to suspend manufacturing and distribution activities. If our products were determined to have design or manufacturing flaws, this could also result in their recall or seizure. Either of these situations could also result in the imposition of fines, administrative actions like untitled or warning letters, and other penalties or sanctions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are also subject to approval and regulation by foreign regulatory and safety agencies. For example, the EU has adopted the EU Medical Device Regulation, or EU MDR, and EU In Vitro Diagnostic Regulation, or EU IVDR, each of which impose stricter requirements for the marketing and sale of medical devices beyond those of the current medical device directives they replace, including in the area of clinical evaluation requirements, quality systems and post-market surveillance. Complying with the requirements of these regulations may require us to incur significant expenditures and we may experience delays that negatively impact the ability to sell our full suite of products in certain jurisdictions. Similarly, the separation of states from participation in the EU, such as through the cessation of the UK&#8217;s membership in the EU (commonly known as &#8220;Brexit&#8221;) and the separation of the Swiss and EU medical product markets with the adoption of the EU MDR (commonly referred to as &#8220;Swexit&#8221;), may result in further regulatory risk and complexity as the former EU member or participant state establishes separate laws and regulations governing medical products. More stringent regulations have also been introduced in many countries outside of Europe that previously did not have medical device regulations, had minimal regulations or relied on reciprocal recognition of approval in other markets. Failure to meet these requirements could adversely impact our business in the EU and other applicable regions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or our suppliers fail to comply with laws and regulations governing the manufacture and production of our products, our products could be subject to restrictions or withdrawal from the market.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any product for which we obtain clearance or approval, and the manufacturing processes, reporting requirements, post-approval clinical data and promotional activities for such product, will be subject to continued regulatory review, oversight and periodic inspection (both routine and unannounced) by the FDA and other domestic and foreign regulatory bodies. In particular, we and our third-party suppliers must comply with the FDA&#8217;s QSR or cGMP requirements (depending on the products at issue), which address, among other things, the methods of documentation of the design, testing, production, control, quality assurance, labeling, packaging, sterilization, storage and shipping of our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any future failure by us or one of our suppliers to comply with applicable statutes and regulations administered by the FDA or other regulatory authority could result in administrative actions, field actions, or civil or criminal enforcement actions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, our key component suppliers may not currently be or may not continue to be in compliance with all applicable regulatory requirements, which could result in our failure to produce our products on a timely basis and in the required quantities, if at all. Any sanctions by the FDA or other regulatory authority could have a material adverse effect on our reputation, business, results of operations and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to environmental laws, which are becoming more stringent throughout the world. For example, the U.S. Environmental Protection Agency regulates the use of ethylene oxide for sterilization of medical devices, and is increasingly focused on reducing emissions from the ethylene oxide sterilization process, which could increase our costs of operations and necessitate changes to our manufacturing plants and processes. Other environmental laws may have similar consequences to us or our suppliers, or result in liability to us. Additionally, increased environmental regulation, including the enactment of laws and regulations to address climate change, may increase our compliance costs or restrict certain aspects of our activities.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our products cause or contribute to a death or serious injury, or malfunction in certain ways, we will be subject to medical device reporting requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the FDA&#8217;s medical device reporting regulations, medical device manufacturers are required to report to the FDA information of which they become aware that a device has or may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction of the device or one of our similar devices were to recur. Similar reporting requirements exist in some of the other jurisdictions in which we operate. Failure to report these events to the FDA or other applicable regulatory authorities within the required timeframes, or at all, could lead to enforcement actions, fines and criminal sanctions against us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our relationships with customers and third-party payers are subject to applicable anti-kickback, fraud and abuse, transparency and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, exclusion, contractual damages, reputational harm and diminished profits and future earnings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to fraud and abuse and other healthcare laws and regulations that constrain the business or financial arrangements and relationships through which we market, sell and distribute our products. In addition, we are subject to transparency laws and patient privacy regulation by U.S. federal and state governments and by governments in foreign jurisdictions in which we conduct our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shifting commercial compliance environment and the need to build and maintain robust and expandable systems to comply with different compliance or reporting requirements in multiple jurisdictions increase the possibility that a healthcare or pharmaceutical company may fail to comply fully with one or more of these requirements. Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations may involve substantial costs. It is possible that governmental authorities will conclude that our business practices do not comply with applicable fraud and abuse or other healthcare laws and regulations or guidance, or anti-bribery laws such as the Foreign Corrupt Practices Act of 1977, or equivalent laws in other jurisdictions. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, exclusion from government funded healthcare programs, such as Medicare and Medicaid, and the curtailment or restructuring of our operations. If any of the physicians or other providers or entities with whom we expect to do business are found not to be in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs. Even if we are not determined to have violated these laws, government investigations into these issues typically require the expenditure of significant resources and generate negative publicity, which could harm our financial condition and divert resources and the attention of our management from operating our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws or exposure to additional income tax liabilities could have a material impact on our financial condition, results of operations and/or liquidity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes, non-income based taxes and tax audits in the U.S. and various foreign jurisdictions. Tax authorities may disagree with certain positions we have taken and assess additional taxes. We regularly assess the likely outcomes of these audits in order to determine the appropriateness of our tax provision and have established contingency reserves for material, known tax exposures. However, the calculation of such tax exposures involves the application of complex tax laws and regulations in many jurisdictions, as well as interpretations as to the legality under various rules in certain jurisdictions. Therefore, there can be no assurance that we will accurately predict the outcomes of these disputes or other tax audits or that issues raised by tax authorities will be resolved at a financial cost that does not exceed our related reserves and the actual outcomes of these disputes and other tax audits could have a material impact on our results of operations or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax regimes we are subject to or operate under are unsettled and may be subject to significant change. For example, in August 2022, the United States enacted the Inflation Reduction Act that imposes a 15% minimum tax for large corporations on global adjusted financial statement income for tax years beginning after December 31, 2022, and a 1% excise tax on certain share repurchases occurring after December 31, 2022. We do not currently expect that the Inflation Reduction Act will have a material impact on our income tax liability, but we will continue to monitor this change in future periods. We are unable to predict what changes to the tax laws of the U.S. and other jurisdictions may be proposed or enacted in the future or what effect such changes would have on our business. Any significant increase in our future effective tax rate could have a material adverse impact on our business, financial condition, results of operations, or cash flows.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is also a high level of uncertainty in the current tax environment stemming from both global initiatives put forth by the Organization for Economic Co-operation and Development (the &#8220;OECD&#8221;) and unilateral measures being implemented by various countries due to a lack of consensus on these global initiatives. Further, unilateral measures in response to such measures are creating additional uncertainty.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we expand the scale of our international business activities, any changes in the U.S. or foreign taxation of such activities may increase our worldwide effective tax rate and harm our business, financial condition and results of operations. Such changes may also apply retroactively to our historical operations and result in taxes greater than the amounts estimated and recorded in our financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Financial Obligations and Indebtedness</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have a significant amount of debt that may decrease our business flexibility, access to capital, and/or increase our borrowing costs, and we may still incur additional debt in the future, which may adversely affect our operations and financial results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the Company entered into an amended and restated credit agreement with certain lenders to refinance the existing term loan and revolving loan and extend their maturity date through June 2025. The amended and restated credit agreement provides for a $280.0&#160;million term loan and access to a $420.0&#160;million revolving loan (together, the &#8220;Revised Credit Facilities&#8221;). As of April&#160;1, 2023, in addition to our $500.0 million aggregate principal amount of indebtedness under our convertible senior notes due 2026 (the &#8220;2026 Notes&#8221;), the Company had&#160;$274.7 million&#160;of debt outstanding under the term loan and no borrowings were ou</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tstanding under the revolving credit facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Revised Credit Facilities contain financial covenants that require us to maintain specified financial ratios that may limit our ability to borrow additional funds and that require us to make interest and principal payments. As of April&#160;1, 2023, we were in compliance with the covenants pursuant to our Revised Credit Facilities, and we currently forecast that we will be in compliance with these covenants through the period ending March 30, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The conditional conversion feature of the 2026 Notes, if triggered, may adversely affect our financial condition and operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under certain circumstances, the noteholders may convert their 2026 Notes at their option prior to the scheduled maturities. If one or more noteholders elect to convert their 2026 Notes, we would be required to settle a portion or all of our conversion obligation through the payment of cash, which could adversely affect our liquidity. In addition, holders of our 2026 Notes will have the right to require us to repurchase their 2026 Notes upon the occurrence of a fundamental change (as defined in the indenture, dated as of March 5, 2021, between U.S. Bank National Association, as trustee (the &#8220;Trustee&#8221;) and us (the &#8220;Indenture&#8221;)), at a repurchase price equal to the principal amount of the 2026 Notes to be repurchased, plus accrued and unpaid special interest, if any, to but not including, the fundamental change repurchase date. We may not have enough available cash or be able to obtain financing at the time we are required to repurchase the 2026 Notes or pay the cash amounts due upon conversion. In addition, applicable law, regulatory authorities and the agreements governing our other indebtedness may restrict our ability to repurchase the 2026 Notes or pay the cash amounts due upon conversion. Our failure to repurchase the 2026 Notes or to pay the cash amounts due upon conversion when required will constitute a default under the Indenture. A default under the Indenture or the fundamental change itself could also lead to a default under agreements governing our other indebtedness, including our Revised Credit Facilities, which may result in that other indebtedness becoming immediately payable in full. We may not have sufficient funds to satisfy all amounts due under the other indebtedness and the Notes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if holders do not elect to convert their 2026 Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the 2026 Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Capped Call Transactions may affect the value of the 2026 Notes and our common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2026 Notes issuance, we entered into privately negotiated capped call transactions (the &#8220;Capped Call Transactions&#8221;) with certain financial institutions (the &#8220;Option Counterparties&#8221;). The Capped Call Transactions are expected generally to reduce the potential dilution to our common stock upon any conversion of the 2026 Notes and/or offset any potential cash payments we are required to make in excess of the principal amount of converted Notes, as the case may be, with such reduction and/or offset subject to a cap.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Option Counterparties and/or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock or other securities of ours in secondary market transactions prior to the maturity of the 2026 Notes. This activity could also cause or avoid an increase or a decrease in the market price of our common stock or the 2026 Notes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to counterparty risk with respect to the Capped Call Transactions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Option Counterparties are financial institutions, and we are subject to the risk that one or more of the Option Counterparties may default or otherwise fail to perform, or may exercise certain rights to terminate, their obligations under the Capped Call Transactions. Our exposure to the credit risk of the option counterparties is not secured by any collateral. Past global economic conditions have from time to time resulted in the actual or perceived failure or financial difficulties of many financial institutions. If an Option Counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings with a claim equal to our exposure at the time under such transactions with such Option Counterparty. Our exposure depends on many factors, but our exposure will generally increase if the market price or the volatility of our common stock increases. In addition, upon default by an Option Counterparty, we may suffer more dilution than we currently anticipate with respect to our common stock. We can provide no assurances as to the financial stability or viability of the Option Counterparties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Capped Call Transactions are complex, and they may not operate as planned. For example, the terms of the Capped Call Transactions may be subject to adjustment, modification or, in some cases, renegotiation if certain corporate or other transactions occur. Accordingly, these transactions may not operate as we intend if we are required to adjust their terms as a result of transactions in the future or upon unanticipated developments that may adversely affect the functioning of the Capped Call Transactions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions in the Indenture could delay or prevent an otherwise beneficial takeover of us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain provisions in the 2026 Notes and the Indenture could make a third party attempt to acquire us more difficult or expensive. For example, if a takeover constitutes a fundamental change, then noteholders will have the right to require us to repurchase their 2026 Notes for cash. In addition, if a takeover constitutes a make-whole fundamental change, then we may be required to temporarily increase the conversion rate. In either case, and in other cases, our obligations under the 2026 Notes and the Indenture could increase the cost of acquiring us or otherwise discourage a third party from acquiring us or removing incumbent management, including in a transaction that noteholders or holders of our common stock may view as favorable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion of the 2026</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notes may dilute the ownership interest of existing stockholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion of some or all of the Notes will dilute the ownership interests of existing stockholders to the extent we deliver shares of our common stock upon conversion of any of the 2026 Notes. Any sales in the public market of the common stock issuable upon such conversion could adversely affect our common stock&#8217;s prevailing market prices. In addition, the existence of the 2026 Notes may encourage short selling by market participants because the conversion of the 2026 Notes could be used to satisfy short positions, or anticipated conversion of the 2026 Notes into shares of our common stock could depress the price of our common stock.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Operating Internationally</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As a substantial amount of our revenue comes from outside the U.S., we are subject to geopolitical events, economic volatility, violations of anti-corruption laws, export and import restrictions and tariffs, decisions by local regulatory authorities and the laws and medical practices in foreign jurisdictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do business in over 90 countries and have distributors in approximately 80 of these countries. This exposes us to currency fluctuation, geopolitical risk, economic volatility, anti-corruption laws, export and import restrictions, local regulatory authorities and the laws and medical practices in foreign jurisdictions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. legislation aimed at boosting competitiveness of U.S. businesses may have unintended effects on our business. Tariffs and other protectionist measures directed at China and other markets, as well as prolonged uncertainty regarding such measures as administrations change, may have adverse effects on our ability to source, manufacture and distribute products, or receive payments, in a timely and cost effective manner, thereby adversely affecting our business. Additionally, the military conflict between Russia and Ukraine has resulted in the implementation of sanctions by the U.S. and other governments against Russia and has caused significant volatility and disruptions to the global markets. It is not possible to predict the short- and long-term implications of this conflict, which could include but are not limited to further sanctions, uncertainty about economic and political stability, increases in inflation rate and energy prices, cyber-attacks, supply chain challenges and adverse effects on currency exchange rates and financial markets. We are continuing to monitor the situation in Ukraine and globally as well as assess its potential impact on our business. Although our business in Russia accounted for only about 1% of fiscal 2023 net revenues, a significant escalation or further expansion of the conflict&#8217;s current scope or related disruptions to the global markets could have a material adverse effect on our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international operations are governed by the U.S. Foreign Corrupt Practices Act, or FCPA, and other similar anti-corruption laws in other countries. Generally, these laws prohibit companies and their business partners or other intermediaries from making improper payments to foreign governments and government officials in order to obtain or retain business.&#160;Global enforcement of such anti-corruption laws has increased in recent years, including aggressive investigations and enforcement proceedings.&#160;While we have an active compliance program and various other safeguards to discourage impermissible practices, we have distributors in approximately 80 countries, several of which are considered high risk for corruption. As a result, our global operations carry some risk of unauthorized impermissible activity on the part of one of our distributors, employees, agents or consultants.&#160;Any alleged or actual violation could subject us to government scrutiny, severe criminal or civil fines, or sanctions on our ability to export product outside the U.S., which could adversely affect our reputation and financial condition.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Export of U.S.&#160;technology or goods manufactured in the U.S. to some jurisdictions requires special U.S.&#160;export authorization or local market controls that may be influenced by factors, including political dynamics, outside our control.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, any other significant changes in the competitive, legal, regulatory, reimbursement or economic environments of the jurisdictions in which we conduct our international business could have a material impact on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We sell our products in certain emerging economies which exposes us to less mature regulatory systems, more volatile markets for our products and greater credit risks. A loss of funding for our products or changes to the regulatory regime could lead to lost revenue or account receivables.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are risks with doing business in emerging economies, such as Brazil, Russia, India and China. These economies tend to have less mature product regulatory systems and more volatile financial markets. In addition, the government controlled healthcare system&#8217;s ability to invest in our products and systems may abruptly shift due to changing government priorities, geopolitical events or funding capacity. Our ability to sell products in these economies is dependent upon, among other factors, our ability to hire qualified employees or agents to represent our products locally and our ability to obtain and maintain the necessary regulatory approvals in a less mature regulatory environment. If we are unable to retain qualified representatives or maintain the necessary regulatory approvals, we will not be able to continue to sell products in these markets. We are also exposed to a higher degree of financial risk if we extend credit to customers in these economies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In many of the international markets in which we do business, including certain parts of Europe, South America, the Middle East and Asia, our employees, agents or distributors offer to sell our products in response to public tenders issued by various governmental agencies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is additional risk in selling our products through agents or distributors, particularly in public tenders. If they misrepresent our products, do not provide appropriate service and delivery, or commit a violation of local or U.S.&#160;law, our reputation could be harmed and we could be subject to fines, sanctions or both.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are exposed to fluctuations in currency exchange rates, which could adversely affect our cash flows and results of operations.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues and expenses account for a substantial portion of our operations. In fiscal&#160;2023, our international revenues accounted for&#160;27.9%&#160;of our total revenues. The exposure to fluctuations in currency exchange rates takes different forms. Reported revenues, as well as manufacturing and operational costs denominated in foreign currencies by our international businesses, fluctuate due to exchange rate movement when translated into U.S.&#160;dollars for financial reporting purposes. Fluctuations in exchange rates could adversely affect our profitability in U.S.&#160;dollars of products and services sold by us into international markets, where payment for our products and services and related manufacturing and operational costs is made in local currencies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our effective tax rate may fluctuate and we may incur obligations in tax jurisdictions in excess of amounts that have been accrued.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxation in numerous countries, states and other jurisdictions. In preparing our financial statements, we record the amount of tax payable in each of the jurisdictions in which we operate. Our future effective tax rate, however, may be lower or higher than prior years due to numerous factors, including a change in our geographic earnings mix, changes in the measurement of our deferred taxes and recently enacted and future tax law changes in jurisdictions in which we operate. Changes in our operations, including headcount in Switzerland or Malaysia, could adversely affect our tax rate due to favorable tax rulings in these jurisdictions. We are also subject to tax audits in various jurisdictions and tax authorities may disagree with certain positions we have taken and assess additional taxes. Any of these factors could cause us to experience an effective tax rate significantly different from previous periods or our current expectations, which could adversely affect our business, results of operations and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property and Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There is a risk that our intellectual property may be subject to misappropriation in some countries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain countries, particularly China and Russia, do not enforce compliance with laws that protect intellectual property rights with the same degree of vigor as is available under the U.S. and European systems of justice. In order to aggressively protect our intellectual property throughout the world, we have a program of patent disclosures and filings in markets where we conduct significant business. While we believe this program is reasonable and adequate, the risk of loss is inherent in litigation as different legal systems offer different levels of protection to intellectual property and it is still possible that even patented technologies may not be protected absolutely from infringement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending and future intellectual property litigation could be costly and disruptive to us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in an industry that is susceptible to significant intellectual property litigation. This type of litigation is expensive, complex and lengthy and its outcome is difficult to predict. Patent litigation may result in adverse outcomes and could significantly divert the attention of our technical and management personnel.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products may be determined to infringe another party&#8217;s patent, which could lead to financial losses or adversely affect our ability to market our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a risk that one or more of our products may be determined to infringe a patent held by another party. If this were to occur, we may be subject to an injunction or to payment of royalties, or both, which may adversely affect our ability to market the affected product or otherwise have an adverse effect on our results of operations. In addition, competitors may patent technological advances that may give them a competitive advantage or create barriers to entry.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to guard against the risk of infringement of intellectual property rights held by third parties we conduct freedom to operate studies through qualified counsel on all newly developed or acquired technologies. While we believe this practice is reasonable and adequate, there is risk that third party patents or trademarks were not identified in such studies or that litigation outcomes regarding infringement or validity may be contrary to our understanding of the facts or the established law.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We operate in an industry susceptible to significant product liability claims. Pending and future product liability claims and other litigation may adversely affect our financial condition and results of operations or liquidity, and they also have the potential to damage our reputation, impair our ability to market our products and impact our ability to maintain applicable insurance coverage on reasonable terms or at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are relied upon by medical personnel in connection with the treatment of patients and the collection of blood or blood components from donors. In the event that patients or donors sustain injury or death in connection with their condition or treatment, we, along with others, may be sued and whether or not we are ultimately determined to be liable, we may incur significant legal expenses. These claims may be brought by individuals seeking relief on their own behalf or purporting to represent a class. In addition, we may be subject to claims against us even if the apparent injury is due to the actions of others or the pre-existing health of the patient. For example, we rely on physicians and healthcare providers to properly and correctly use our products on patients. If these physicians or healthcare providers are not properly trained, are negligent in using our products or use our products &#8220;off-label,&#8221; the capabilities of our products may be diminished or the patient may suffer critical injury. We cannot prevent a physician from using our products for off-label applications. In addition, we cannot guarantee that physicians are trained by us or their peers prior to utilizing our products. Complications resulting from the use of our products off-label or use by physicians who have not been trained appropriately, or at all, may expose us to product liability claims and harm our reputation. Any such complications or adverse safety outcomes following use of VASCADE or VASCADE MVP may result in higher payments to our customers under a Performance Guarantee program applicable to those products, which would harm our business and results of operations. In addition, product liability claims may be asserted against us in the future based on events we are not aware of at the present time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we cannot successfully defend ourselves against pending or future product liability claims and other litigation (including class actions and stockholder derivative actions), we may incur substantial liabilities or be required to limit or halt commercialization of our products. Even successful defenses require significant financial and management resources. Regardless of the merits or eventual outcome, such litigation could have a material adverse effect on our financial condition, results of operations or liquidity and further could damage our reputation and, therefore, impair our ability to market our products and make applicable insurance coverage more costly or difficult to obtain. While we believe that our current product liability insurance coverage is sufficient, there is no assurance that such coverage will be adequate to cover incurred liabilities or that we will be able to obtain acceptable product and professional liability coverage in the future. Additionally, we do not maintain third-party insurance coverage for all categories of potential liability, which increases our exposure to unanticipated claims and adverse decisions and these losses could have a material adverse effect on our financial condition, results of operations or liquidity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Actual or threatened public health emergencies could harm our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and operations could be adversely affected by health epidemics that impact the markets and communities in which we, our partners and our clients operate. The COVID-19 pandemic caused significant disruption to the business and financial markets. We continue to monitor the potential effects of future health epidemics on our business and operations. While the spread and impact of COVID-19 has stabilized, there is no guarantee that a future outbreak of this or any other widespread epidemics will not occur, which could have the effect of decreasing demand and/or increasing volatility in demand for our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success depends on our ability to attract and retain key personnel needed to successfully operate the business and to plan for future executive transitions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to compete effectively depends on our ability to attract and retain key employees, including people in senior management, sales, marketing and R&amp;D positions, and to facilitate seamless leadership transitions for key positions. Our ability to recruit and retain key talent will depend on a number of factors, including hiring practices of our competitors, compensation and benefits, work location, work environment, hybrid work environment policies and industry economic conditions. If we fail to attract and retain key personnel in senior management and other positions, or if our succession planning efforts are not effective, it could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our share price has been volatile and may fluctuate, and accordingly, the value of an investment in our common stock may also fluctuate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock markets in general and our common stock in particular have experienced significant price and trading volume volatility over recent years. The market price and trading volume of our common stock may continue to be subject to significant fluctuations due to factors described under this&#160;Item 1A. Risk Factors, as well as economic and geopolitical conditions in general and to variability in the prevailing sentiment regarding our operations or business prospects, as well as, among other things, changing investment priorities of our shareholders. Because the market price of our common stock fluctuates significantly, shareholders may not be able sell their shares at attractive prices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share repurchase programs, including under our existing share repurchase authorization, could affect the price of our common stock and increase volatility and may be suspended or terminated at any time, which may result in a decrease in the trading price of our common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, we announced that our Board of Director</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s had approved a new three-year share repurchase program authorizing the repurchase of up to $300.0&#160;million of outstanding shares of our common stock through August 2025. Under the share repurchase program, we are authorized to repurchase, from time to time, outstanding shares of common stock in accordance with applicable laws both on the open market, including under trading plans established pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended and in privately negotiated transactions. The actual timing, number and value of shares repurchased is determined by us and depends on a number of factors, including market conditions, applicable legal requirements and compliance with the terms of loan covenants. The share repurchase program may b</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e suspended, modified or discontinued at any time and we have no obligation to repurchase any amount of our common stock under the programs. Repurchases pursuant to our share repurchase program could affect our stock price and increase its volatility. The existence of a share repurchase program could also cause our stock price to be higher than it would be in the absence of such a program and could potentially reduce the market liquidity for our common stock. There can be no assurance that any share repurchases will enhance shareholder value because the market price of our common stock may decline below the levels at which we repurchased our common stock. Although our share repurchase program is intended to enhance long-term shareholder value, short-term stock price fluctuations could reduce the program&#8217;s effectiveness. Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be negatively impacted by corporate responsibility matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been increased focus from certain regulatory bodies, investors, customers, employees and other stakeholders concerning corporate responsibility matters, including topics identified under the framework of Environmental, Social and Governance (&#8220;ESG&#8221;). For example, customer preferences or requirements may be influenced by company progress across various ESG topics related to, among other things, human capital and environmental impact matters. From time to time, we may announce certain initiatives, including goals, regarding corporate responsibility focus areas for our company. We may not achieve, or may be perceived as not achieving, against such initiatives, including as a result of changes in our business. Moreover, the standards by which corporate responsibility efforts and related matters are measured are developing and evolving, and certain areas are subject to assumptions that could change over time. Any failure, or perceived failure, to achieve against our corporate responsibility initiatives or to establish goals that align with stakeholder expectations could result in declines in our market share and have an adverse impact on our business, financial condition or results of operations.</span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B. UNRESOLVED STAFF COMMENTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_34"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. PROPERTIES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, our global headquarters are located in Boston, Massachusetts and our principal manufacturing centers are located in Pennsylvania and California within the U.S., as well as internationally in Mexico and Malaysia. Our products are distributed worldwide from primary distribution centers in Tennessee, Utah and Switzerland, as well as smaller locations globally. We believe all of these facilities are well-maintained and suitable for the operations conducted in them. These facilities produce and manufacture products for more than one of our business segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our facilities as of April&#160;1, 2023 (in approximate square feet):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Owned</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leased</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543,385&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885,398&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428,783&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. LEGAL PROCEEDINGS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to this Item may be found in Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments &amp; Contingencies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K, which is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.  MINE SAFETY DISCLOSURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_43"></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="margin-top:7pt;text-align:center"><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. MARKET FOR THE REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Market Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common sto</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ck is quoted on the New York Stock Exchange under the symbol &#8220;HAE.&#8221; As of April&#160;1, 2023, we had 106 stockholders of record. We have not historically paid cash dividends and do not currently anticipate paying cash dividends in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Issuer Purchases of Equity Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company&#8217;s Board of Directors approved a new three-year share repurchase program authorizing the repurchase of up to $300.0 million of the Company&#8217;s common stock from time to time, based on market conditions, through August 2025. Under the Company&#8217;s share repurchase program, shares may be repurchased in accordance with applicable laws both on the open market, including under trading plans established pursuant to Rule 10b5-1 under the Exchange Act, and in privately negotiated transactions. In November 2022, the Company completed a $75.0 million repurchase of its common stock pursuant to an accelerated share repurchase agreement (&#8220;ASR&#8221;) entered into with Citibank N.A. in August 2022. As of April&#160;1, 2023, the total remaining authorization for repurchases of the Company&#8217;s common stock under the share repurchase program was $225.0 million.</span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_49"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. RESERVED</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_52"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_55"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Haemonetics is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We view our operations and manage our business in three principal reporting segments: Plasma, Blood Center and Hospital. For that purpose, &#8220;Plasma&#8221; includes plasma collection devices and disposables, plasma donor management software and anticoagulant and saline sold to plasma customers. &#8220;Blood Center&#8221; includes blood collection and processing devices and disposables for red cells, platelets and whole blood. &#8220;Hospital&#8221;, which is comprised of Hemostasis Management, Vascular Closure, Cell Salvage and Transfusion Management products, includes devices and methodologies for measuring coagulation characteristics of blood, vascular closure devices, specialized blood cell processing systems and disposables, surgical blood salvage systems and blood transfusion management software.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Plasma and Hospital have growth potential, while Blood Center competes in challenging markets that require us to manage the business differently, including reducing costs, shrinking the scope of the current product line, and evaluating opportunities to exit unfavorable customer contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2022, we announced that our Board of Directors had approved a new three-year share repurchase program authorizing the repurchase of up to $300.0&#160;million of Haemonetics common stock from time to time, based on market conditions, through August 2025. In November 2022, the Company completed a $75.0&#160;million repurchase of its common stock pursuant to an accelerated share repurchase agreement (&#8220;ASR&#8221;) entered into with Citibank N.A. in August 2022. The total number of shares repurchased under the ASR was 1.0&#160;million at an average price per share upon final settlement of $75.20.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of April&#160;1, 2023, the total remaining authorization for repurchase of the Company&#8217;s common stock was $225.0&#160;million.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Debt Issuance and Repayment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 26, 2022, we entered into an amended and restated credit agreement with certain lenders to refinance the credit facilities under our 2018 credit agreement (as amended from time to time) and extend the applicable maturity date through June 2025. Our Revised Credit Facilities include a $280.0&#160;million senior unsecured term loan, the proceeds of which have been used to retire the balance of the term loan under our 2018 credit agreement, and a $420.0&#160;million senior unsecured revolving credit facility. In September 2022, we amended two prior interest rate swap agreements and entered into certain supplemental interest rate swap agreements to effectively convert between 70% to 80% of borrowings under our Revised Credit Facilities from a variable Term Secured Overnight Financing Rate (&#8220;SOFR&#8221;) rate to a fixed rate of interest through June 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Trends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plasma Market</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are two key aspects to the market for our plasma products - the growth in demand for plasma-derived biopharmaceuticals and the limited number of significant biopharmaceutical companies in this market. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in demand for plasma-derived biopharmaceuticals, particularly immunoglobulin, are the key driver of plasma collection volumes in the biopharmaceutical market. Various factors related to the supply of plasma and the production of plasma-derived biopharmaceuticals also affect collection volume, including the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Biopharmaceutical companies are seeking more yield from each plasma collection to meet growing demand for biopharmaceuticals without requiring an equivalent increase in plasma donations. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Newly approved indications for auto-immune diseases treated with plasma-derived therapies, the growing understanding and diagnosis of these diseases, longer lifespans and a growing aging patient population increase the demand for plasma. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Geographical expansion of biopharmaceuticals also increases demand for plasma.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the overall growth in the market, the number of biopharmaceutical companies that collect and fractionate source plasma is low and industry consolidation is ongoing. Significant barriers to entry exist for new entrants due to high capital outlay requirements for fractionation, long regulatory pathways to the licensing of collection centers and fractionation facilities and approval of plasma-derived biopharmaceuticals. As a result, there are relatively few customers for our Plasma products, especially in the U.S. where approximately 70% of the world&#8217;s source plasma is collected and only a few customers provide the majority of our Plasma re</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">venue. However, certain jurisdictions such as Egypt and the United Kingdom have begun to collect or are considering collection of plasma for fractionation for their local needs, which could expand the Plasma market.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Blood Center Market</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Blood Center market, we sell automated blood component and manual whole blood collection systems. While we sell products around the world, a significant portion of our sales are to a limited number of customers due to relatively limited number of blood collectors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the Blood Center market, we have seen three trends that have negatively impacted growth of the overall marketplace despite the overall increase in aging populations. Overall, we expect a flat to low single-digit decline in this business.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Declining transfusion rates in mature markets due to the development of more minimally invasive procedures with lower associated blood loss, as well as better blood management.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competition in multi-unit collection technology for automated blood component collection systems has intensified and has negatively impacted our sales in markets where these collections are prevalent. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Industry consolidation through group purchasing organizations has intensified pricing competition particularly in the manual whole blood collection systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hospital Markets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hemostasis Management Market - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of routine coagulation testing is well established throughout the world in various medical procedures, including cardiovascular surgery, organ transplantation, trauma, post-partum hemorrhage and percutaneous coronary intervention. While standard tests like prothrombin time, partial thromboplastin time and platelet count have limited ability to reveal a patient&#8217;s risk for bleeding, they do not provide information on the patient&#8217;s risk for thrombosis. In addition, these routine tests do not provide specific data about clot quality or stability. As a result of these limitations, clinicians are increasingly utilizing advanced hemostasis testing to provide more information about a patient&#8217;s hemostasis status, resulting in improved clinical decision-making. In addition, advanced hemostasis testing supports hospital efforts to reduce the risks, complications and costs associated with unnecessary blood component transfusions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Haemonetics&#8217; TEG, ClotPro and HAS hemostasis analyzer systems are advanced diagnostic tools that provide a comprehensive assessment of a patient&#8217;s overall hemostasis. This information enables clinicians to decide the most appropriate clinical treatment for the patient to minimize blood loss and reduce clotting risk. For example, TEG analyzers have been used to support clinical decision making in open cardiovascular surgery and organ transplantation, becoming the standard of care in liver transplants. In more recent years, interest has grown into the utilization of TEG in trauma and other procedures in which the risk of hemorrhage and thrombosis are high.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Geographically, TEG systems have achieved the highest market penetration in North America, Europe and China. However, there are considerable growth opportunities in these as well as other markets, as TEG systems become more established as the standard of care around the world. Our ClotPro system is currently available in select European and Asian markets and is not available for use or sale in the U.S. The HAS-100 is currently commercialized in China.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vascular Closure Market - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The target markets for our Vascular Closure products, coronary and peripheral procedures and electrophysiology procedures, are highly concentrated in the U.S. The mature market of coronary and peripheral procedures consists of interventions to diagnose and treat vascular diseases. Electrophysiology procedures consist of catheter-based </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interventions to diagnose and treat cardiac arrhythmias. This procedure category is expected to grow based on the increasing incidence and prevalence of cardiac arrhythmias, mainly in the U.S. Additionally, our VASCADE and VASCADE MVP vascular closure systems received CE mark clearance in fiscal 2023, providing a pathway for country-specific introduction of these products in the EU.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cell Salvage Market</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In recent years, more efficient blood use and less invasive surgeries have reduced demand for autotransfusion in these procedures and contributed to intense competition in mature markets, while increased access to healthcare in emerging economies has provided new markets and sources of growth. Orthopedic procedures have seen similar changes with improved blood management practices, including the use of tranexamic acid to treat and prevent postoperative bleeding, significantly reducing the number of transfusions and autotransfusion. Geographically, the Cell Saver has achieved the highest market penetration in North America, Europe and Japan. However, there are considerable growth opportunities in certain Asia Pacific and other emerging markets as addressable procedure volumes grow and the use of autotransfusion is becoming accepted as a standard of care.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfusion Management Market - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from BloodTrack have increased in the U.S. and Europe in recent years as hospitals seek means to improve efficiencies and meet compliance guidelines for tracking and dispositioning blood components to patients.&#160;SafeTrace Tx&#8217;s leading market share in the U.S. remains steady and in fiscal 2021 launched in the United Kingdom. We continue to explore opportunities to expand the portfolio internationally.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Summary</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Increase/(Decrease) </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,630)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before provision for income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">122.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of pre-tax income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">166.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">167.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share - diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">166.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on the Saturday closest to the last day of March. Fiscal years 2023 and 2022 included 52 weeks with each quarter having 13 weeks. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues for fiscal 2023 increased 17.7% compared with fiscal 2022. Without the effects of foreign exchange, net revenues increased 20.3% compared with fiscal 2022. Revenue increases in our Plasma and Hospital businesses, primarily related to volume and price, drove the overall increase in revenue during the fiscal year ended April 1, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income increased 93.2% during fiscal 2023 as compared with fiscal 2022, primarily due to increased revenues in Plasma and Hospital, savings from the Operational Excellence Program (&#8220;2020 Program&#8221;), decreased spending on acquisitions in fiscal 2023 and decreased amortization of acquired intangible assets, partially offset by higher performance-based compensation, lower revenues in Blood Center, increased freight costs in our global supply chain and increased sales and marketing expense.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management's Use of Non-GAAP Measures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management uses non-GAAP financial measures, in addition to financial measures in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;), to monitor the financial performance of the business, make informed business decisions, establish budgets and forecast future results. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with U.S. GAAP. Constant currency growth, a non-GAAP financial measure, measures the change in revenue between the current and prior year periods using a constant currency conversion rate. We have provided this non-GAAP financial measure because we believe it provides meaningful information regarding our results on a consistent and comparable basis for the periods presented.</span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Revenues by Geography</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.702%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported Growth</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency impact</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant currency growth </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168,660&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993,196&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="30" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Constant currency growth, a non-GAAP financial measure, measures the change in revenue between the current and prior year periods using a constant currency. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Management's Use of Non-GAAP Measures.&#8221;</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Operations and the Impact of Foreign Exchange</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal operations are in the United States, Europe, Japan and other parts of Asia. Our products are marketed in approximately 90 countries around the world through a combination of our direct sales force and independent distributors and agents.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The percentage of revenue generated in our principal operating regions is summarized below:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International sales are generally conducted in local currencies, primarily Japanese Yen, Euro and Chinese Yuan. Our results of operations are impacted by changes in foreign exchange rates, particularly in the value of the Yen and Euro, relative to the U.S.&#160;Dollar. We have placed foreign currency hedges to mitigate our exposure to foreign currency fluctuations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see the section entitled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Foreign Exchange&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in this discussion for a more complete explanation of how foreign currency affects our business and our strategy for managing this exposure.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Revenues by Business Unit</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.557%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported Growth</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency impact</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant currency growth</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,923&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,347&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168,660&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993,196&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Constant currency growth, a non-GAAP financial measure, measures the change in revenue between the current and prior year periods using a constant currency. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Management's Use of Non-GAAP Measures.&#8221;</span></div></td></tr><tr><td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Hospital revenue includes Hemostasis Management revenue of $138.9 million and $127.4 million for fiscal years 2023 and 2022, respectively. Hemostasis Management revenue increased 9.0% during fiscal 2023 as compared with fiscal 2022. Without the effect of foreign exchange, Hemostasis Management revenue increased 11.3% as compared with fiscal 2022. Vascular Closure revenue increased 35.1% during fiscal 2023 as compared with fiscal 2022.</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plasma</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plasma revenue increased 41.4% during fiscal 2023 as compared with fiscal 2022. Without the effect of foreign exchange, Plasma revenue increased 42.2% during fiscal 2023 as compared with fiscal 2022. This revenue increase was primarily driven by volume and price.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal 2022, we amended our supply agreement with CSL, which CSL had previously notified us of its intent not to renew and was initially set to expire in June 2022, to allow CSL to continue to use our PCS2 plasma collection system devices and purchase disposable plasmapheresis kits on a non-exclusive basis through December 2023. During the third quarter of fiscal 2023, we further amended our supply agreement with CSL to extend the term through December 2025. CSL has a minimum purchase commitment under the non-exclusive supply agreement that slightly exceeds $100.0 million in fiscal 2024, and we expect that CSL will continue to provide a meaningful contribution to our Plasma business revenue in fiscal 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Blood Center</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blood Center revenue decreased 6.2% during fiscal 2023 as compared with fiscal 2022. Without the effect of foreign exchange, Blood Center revenue decreased 1.8% during fiscal 2023. The decrease was primarily driven by declines in the volume of apheresis disposables, partially offset by an increase in whole blood disposables.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hospital</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hospital revenue increased 15.2% during fiscal 2023 as compared with fiscal 2022. Without the effect of foreign exchange, Hospital revenue increased 17.6% during fiscal 2023.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase was primarily attributable to Vascular Closure revenue, as well as increases in Hemostasis Management disposables revenue and Transfusion Management revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Increase/(Decrease)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit increased 21.7% during fiscal 2023 as compared with fiscal 2022. Without the effects of foreign exchange, gross profit increased 26.1% during fiscal 2023. The increase was primarily driven by volume, price, decreased spend on both restructuring and restructuring related costs and integration and transaction costs, as well as productivity savings from the 2020 Program. These drivers were partially offset by inflationary pressures in our global manufacturing and supply chain and increased depreciation expense.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Increase/(Decrease) </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,801&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(31.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on divestiture</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,603)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(96.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">42.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Research and development expenses increased 7.1% during fiscal 2023 as compared with fiscal 2022. Without the effects of foreign exchange, research and development expenses increased 7.4% during fiscal 2023. The increase in fiscal 2023 was primarily due to increased investments into product innovation, partially offset by decreased spend on MDR and IVDR.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased 10.7% during fiscal 2023 as compared with fiscal 2022. Without the effects of foreign exchange, selling, general and administrative expenses increased 12.6% during fiscal 2023. The increase in fiscal 2023 was primarily driven by higher performance-based compensation, inflationary pressures and higher freight costs in our global supply chain and increased investments in sales and marketing, partially offset by cost savings related to the 2020 Program and decreased acquisition costs and restructuring and restructuring related costs in fiscal 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization of Acquired Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized amortization expense related to our acquired intangible assets of $32.6 million and $47.4 million during fiscal 2023 and fiscal 2022, respectively. The decrease in fiscal 2023 is primarily the result of intangible assets that became fully amortized during fiscal 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gains on Divestitures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized gains on divestitures of $0.4 million and $9.6 million during fiscal 2023 and fiscal 2022, respectively. Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K for additional information.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest and Other Expense, Net</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other expenses de</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">creased</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 14.5% during fiscal 2023 as compared with fiscal 2022. Without the effects of foreign exchange, interest and other expenses de</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">creased</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 15.9% during fiscal 2023.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease was primarily driven by increased interest income on investments due to higher interest rates, lower interest paid on interest rate swaps due to market and rate volatility, partially offset by higher interest incurred on our term loan.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Increase/(Decrease)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reported Tax Rate</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business globally and report our results of operations in a number of foreign jurisdictions in addition to the U.S. Our reported tax rate is impacted by the jurisdictional mix of earnings in any given period as the foreign jurisdictions in which we operate have tax rates that differ from the U.S. statutory tax rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have assessed, on a jurisdictional basis, the available means of recovering deferred tax assets, including the ability to carry-back net operating losses, the existence of reversing temporary differences, the availability of tax planning strategies and available sources of future taxable income. As of April&#160;1, 2023, we maintain a valuation allowance against certain U.S. state and foreign tax credit carryforwards that are not more-likely-than-not realizable as well as a valuation allowance against the net deferred tax assets of certain foreign subsidiaries. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended April&#160;1, 2023, we recorded income tax expense of $26.0&#160;million on our worldwide pre-tax income of $141.4&#160;million, resulting in a reported tax rate of 18.4%. Our effective tax rate for the year ended April&#160;1, 2023 is lower than our effective tax rate of 31.8% for fiscal 2022, primarily due to the release of valuation allowance related to U.S. state deferred tax assets, the absence of provisions related to contingent consideration and decreased disallowed stock compensation expense, partially offset by jurisdictional mix of earnings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Effective beginning in fiscal 2023, the Tax Cuts and Jobs Act of 2017 requires the Company to capitalize, and subsequently amortize research and development expenses over five years for research activities conducted in the U.S. and over fifteen years for research activities conducted outside of the U.S. There was not a material impact on our effective tax rate in fiscal 2023 as a result of this requirement.</span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table contains certain key performance indicators we believe depict our liquidity and cash flow position:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash&#160;and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net debt position</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(481,420)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(514,093)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Days sales outstanding (DSO)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory turnover</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net debt position is the sum of cash and cash equivalents less total debt.</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary sources of liquidity are cash and cash equivalents, internally generated cash flow from operations and our revolving credit facility. We believe these sources are sufficient to fund our cash requirements over at least the next twelve months. Our expected cash outlays relate primarily to acquisitions, investments, capital expenditures, including enhancements to our North American manufacturing facilities, share repurchases and cash principal and interest payments under our revised credit agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company issued $500.0 million aggregate principal amount of 0% convertible senior notes due 2026, or the 2026 Notes. The 2026 Notes are governed by the terms of the Indenture between the Company and U.S. Bank National Association, as trustee. The total net proceeds from the sale of the 2026 Notes, after deducting the initial purchasers&#8217; discounts and debt issuance costs, were approximately $486.7 million. The 2026 Notes will mature on March 1, 2026, unless earlier converted, redeemed or repurchased. The 2026 Notes have an effective interest rate of 0.5% as of April&#160;1, 2023.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, we had $284.5 million in cash and cash equivalents, the majority of which is held in the U.S. or in countries from which it can be repatriated to the U.S. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 26, 2022, we entered into an amended and restated credit agreement with certain lenders to refinance our prior credit agreement entered into on June 15, 2018, which consisted of a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$350.0 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> term loan and a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$350.0 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> revolving loan (together, as amended from time to time, the &#8220;2018 Credit Facilities&#8221;), and extend the maturity date through June 2025. Our Revised Credit Facilities include a $280.0&#160;million senior unsecured term loan, the proceeds of which have been used to retire the balance of the term loan under the 2018 Credit Facilities, and a $420.0&#160;million senior unsecured revolving credit facility. Loans under the Revised Credit Facilities bear interest at an annual rate equal to the Adjusted Term SOFR Rate (as specified in the amended and restated credit agreement), which is subject to a floor of 0%, plus an applicable rate ranging from 1.125% to 1.750% based on the Company&#8217;s consolidated net leverage ratio (as specified in the amended and restated credit agreement) at the applicable measurement date. Adjusted Term SOFR Rate loans are also subject to a credit spread adjustment of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.10%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> per annum. The revolving credit facility carries an unused fee that ranges from 0.125% to 0.250% annually based on the Company&#8217;s consolidated net leverage ratio at the applicable measurement date. Under the Revised Credit Facilities, the Company is required to maintain certain leverage and interest coverage ratios specified in the amended and restated credit agreement as well as other customary non-financial affirmative and negative covenants. The Revised Credit Facilities mature on June 15, 2025. The principal amount of the term loan under the Revised Credit Facilities is repayable quarterly through the maturity date at a rate of 2.5% for the first year and 5% thereafter, with the unpaid balance due at maturity. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of April&#160;1, 2023, $274.7 million was outstanding under the term loan with an effective interest rate of 6.3%. Th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ere were no borrowings outstanding on the revolving loan. We also had $21.3 million of uncommitted operating lines of credit to fund our global operations under which there were no outstanding borrowings as of April&#160;1, 2023. Additionally, the Company was in compliance with the leverage and interest coverage ratios specified in the credit agreement as well as all other bank covenants as of April&#160;1, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has scheduled principal payments of $12.3 million required during fiscal 2024. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, our Board of Directors approved a revised 2020 Program. We now estimate that we will incur aggregate charges between $95&#160;million and $105&#160;million in connection with the 2020 Program. These charges, the majority of which will result in cash outlays, including severance and other employee costs, will be incurred as the specific actions required to execute these initiatives are identified and approved and are expected to be substantially completed by the end of fiscal 2025. During the fiscal years ended April&#160;1, 2023 and April&#160;2, 2022, the Company incurr</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$11.5 million and</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$28.7 million,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> respectively, of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> restructuring and restructuring related costs under this program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143,788)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100,364)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,749)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,936)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,978)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,970&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,191&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The balance sheet is affected by spot exchange rates used to translate local currency amounts into U.S.&#160;dollars. In accordance with U.S. GAAP, we have eliminated the effect of foreign currency throughout our cash flow statement, except for its effect on our cash and cash equivalents.</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net ca</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">sh provided by </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">operating activities was $273.1 million during fiscal 2023, an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">increase o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">f $100.8 million as compared with fiscal 2022. The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> increase in cash provided by operating activities was primarily the result of higher net income, decreased inventory driven by NexSys PCS device placements and increased accrued performance-based compensation, partially offset by increases in accounts receivable during fiscal 2023.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">used in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investing activities was $143.8 million during fiscal 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an increase </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $57.4 million as compared with fiscal 2022. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in cash used in investing activities was primarily the result of an increase in capital expenditures, driven by NexSys PCS device placements, and other investments made in fiscal 2023, partially offset by lower proceeds received from divestitures in fiscal 2023.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h used in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financing activities was $100.4 million during fiscal 2023, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an increase </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $84.6 million as compared with fiscal 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The increase in cash used in financing activities during fiscal 2023 was primarily due to share repurchases and acquisition-related contingent consideration payments made in fiscal 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our contractual and commercial commitments as of April&#160;1, 2023 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payments Due by Period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 1&#160;year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1-3&#160;years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3-5&#160;years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than 5&#160;years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,813</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected retirement plan benefit payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contractual obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,984&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest payments reflect the contractual interest payments on our outstanding debt and exclude the impact of interest rate swap agreements. Interest payments are projected using interest rates in effect as of April 1, 2023. Certain of these projected interest payments may differ in the future based on changes in market interest rates.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Includes amounts we are committed to spend on purchase orders entered in the normal course of business for capital equipment as well as commitments with contractors for the manufacture of certain disposable products and equipment. The majority of our operating expense spending does not require any advance commitment. </span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above table does not reflect our long-term liabilities associated with unrecognized tax benefits of $3.0 million recorded in accordance with ASC Topic 740, Income Taxes. We cannot reasonably make a reliable estimate of the period in which we expect to settle these long-term liabilities due to factors outside of our control, such as tax examinations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While approximately 48% of our revenue during fiscal 2023 was generated by our ten largest customers, concentrations of credit risk with respect to trade accounts receivable are generally limited due to our large number of customers and their diversity across many geographic areas. Certain markets and industries, however, can expose us to concentrations of credit risk. For example, in the Plasma business unit, sales are concentrated with several large customers. As a result, accounts receivable extended to any one of these biopharmaceutical customers can be significant at any point in time. In addition, a portion of our trade accounts receivable outside the U.S. include sales to government-owned or supported healthcare systems in several countries, which are subject to payment delays and local economic conditions. Payment is dependent upon the financial stability and creditworthiness of those countries&#8217; national economies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not incurred significant losses on trade accounts or other receivables. We continually evaluate all receivables for potential collection risks associated with the availability of government funding and reimbursement practices. If the financial condition of customers or the countries&#8217; healthcare systems deteriorate such that their ability to make payments is uncertain, allowances may be required in future periods.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with U.S. GAAP, we record a liability in our consolidated financial statements for legal matters when a loss is known or considered probable and the amount may be reasonably estimated. Actual settlements may be different than estimated and could have a material impact on our consolidated earnings, financial position and/or cash flows. For a discussion of our material legal proceedings refer to Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments &amp; Contingencies, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inflation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continued to experience rising inflationary pressures in our global supply chain that had an impact on our results of operations during fiscal 2023. We continue to monitor inflationary pressures generally and raw materials indices that may affect our procurement and produ</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ction costs. Increases in the price of petroleum derivatives could result in corresponding increases in our costs to procure plastic raw materials. Historically, we have been able to limit the impact of the effects of inflation by improving our manufacturing and purchasing efficiencies, by increasing employee productivity and by adjusting the selling prices of products, but we may not be able to fully mitigate these increases in our operational costs in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Exchange</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2023, 27.9% of our sales were generated outside the U.S., generally in foreign currencies, yet our reporting currency is the U.S. Dollar. We also incur certain manufacturing, marketing and selling costs in international markets in local currency. Our primary foreign currency exposures relate to sales denominated in Japanese Yen, Euro and Chinese Yuan. We also have foreign currency exposure related to manufacturing and other operational costs denominated in Swiss Francs, Canadian Dollars, Mexican Pesos and Malaysian Ringgit. The Yen, Euro and Yuan sales exposure is partially mitigated by costs and expenses for foreign operations and sourcing products denominated in foreign currencies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our foreign currency denominated Yen, Euro and Yuan sales exceed the foreign currency denominated costs, whenever the U.S. Dollar strengthens relative to the Yen, Euro or Yuan, there is an adverse effect on our results of operations and, conversely, whenever the U.S. Dollar weakens relative to the Yen, Euro or Yuan, there is a positive effect on our results of operations. For Swiss Francs, Canadian Dollars, Mexican Pesos and Malaysian Ringgit, our primary cash flows relate to product costs or costs and expenses of local operations. Whenever the U.S. Dollar strengthens relative to these foreign currencies, there is a positive effect on our results of operations. Conversely, whenever the U.S. Dollar weakens relative to these currencies, there is an adverse effect on our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a program in place that is designed to mitigate our exposure to changes in foreign currency exchange rates. That program includes the use of derivative financial instruments to minimize, for a period of time, the unforeseen impact on our financial results from changes in foreign exchange rates. We utilize forward foreign currency contracts to hedge the anticipated cash flows from transactions denominated in foreign currencies, primarily Japanese Yen and Euro, and to a lesser extent Swiss Franc and Mexican Peso. This does not eliminate the volatility of foreign exchange rates, but because we generally enter into forward contracts one year out, rates are fixed for a one-year period, thereby facilitating financial planning and resource allocation. These contracts are designated as cash flow hedges. The final impact of currency fluctuations on the results of operations is dependent on the local currency amounts hedged and the actual local currency results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are currently no recent accounting pronouncements that we expect to have a material impact on our financial position and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant accounting policies are summarized in Note&#160;2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K. While all of these significant accounting policies impact our financial condition and results of operations, we view certain of these policies as critical. Policies determined to be critical are those policies that have the most significant impact on our financial statements and require management to use a greater degree of judgment and/or estimates. Actual results may differ from those estimates. We consider an estimate to be a &#8220;critical accounting estimate&#8221; when (i) the nature of the estimate is material due to the level of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change; and (ii) the impact of the estimate on </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial condition or operating performance is material. The accounting policies and estimates identified as critical are as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price, which includes estimates of variable consideration related to rebates, product returns and volume discounts. These reserves, which are based on estimates of the amounts earned or to be claimed on the related sales, are recorded as a reduction of revenue and a current liability. Our estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reflect our best estimates of the amount of consideration to which we are entitled based on the terms of the contract. The amount of variable consideration included in the net sales price is limited to the amount that is probable not to result in a significant reversal in the amount of the cumulative revenue recognized in a future period. Revenue recognized in the current period related to performance obligations satisfied in prior periods was not material. If we are unable to estimate the expected rebates reasonably, we record a liability for the maximum potential rebate or discount that could be earned. In circumstances where we provide upfront rebate payments to customers, we capitalize the rebate payments and amortize the resulting asset as a reduction of revenue using a systematic method over the life of the contract. Refer to Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K for further information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we use consistent methodologies in developing the assumptions and estimates underlying the fair value calculations used in our impairment tests, these estimates are uncertain by nature and can vary from actual results. The use of alternative valuation assumptions, including estimated revenue projections, growth rates, cash flows and discount rates could result in different fair value estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future events that could have a negative impact on the levels of excess fair value over carrying value of our reporting units include, but are not limited to, the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Decreases in estimated market sizes or market growth rates due to greater-than-expected declines in procedural volumes, pricing pressures, product actions and/or competitive technology developments,</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Declines in our market share and penetration assumptions due to increased competition, an inability to develop or launch new and next-generation products and technology features in line with our commercialization strategies and market and/or regulatory conditions that may cause significant launch delays or product recalls,</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Decreases in our forecasted profitability due to an inability to implement successfully and achieve timely and sustainable cost improvement measures consistent with our expectations,</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in our reporting units or in the structure of our business as a result of future reorganizations, acquisitions or divestitures of assets or businesses and</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increases in our market-participant risk-adjusted weighted average cost of capital and increases in our market-participant tax rate and/or changes in tax laws or macroeconomic conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Negative changes in one or more of these factors, among others, could result in future impairment charges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review intangible assets subject to amortization for impairment at least annually or more frequently if certain conditions arise to determine if any adverse conditions exist that would indicate that the carrying value of an asset or asset group may not be recoverable, or that a change in the remaining useful life is required. Conditions indicating that an impairment exists include but are not limited to a change in the competitive landscape, internal decisions to pursue new or different technology strategies, a loss of a significant customer or a significant change in the marketplace including prices paid for our products or the size of the market for our products. Refer Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill &amp; Intangible Assets,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K for additional information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventory Provisions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base our provisions for excess, expired and obsolete inventory primarily on our estimates of forecasted net sales. A significant change in the timing or level of demand for our products as compared with forecasted amounts may result in recording additional provisions for excess, expired and obsolete inventory in the future. Additionally, uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to excess, expired and obsolete inventory.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision is calculated for all jurisdictions in which we operate. The income tax provision process involves calculating current taxes due and assessing temporary differences arising from items that are taxable or deductible in different periods for tax and accounting purposes and are recorded as deferred tax assets and liabilities. Deferred tax assets are evaluated for realizability and a valuation allowance is maintained for the portion of our deferred tax assets that are not more-likely-than-not realizable. All available evidence, both positive and negative, has been considered to determine whether, based on the weight of that evidence, a valuation allowance is needed against the deferred tax assets. Refer to Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K for further information and discussion of our income tax provision and balances.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file income tax returns in all jurisdictions in which we operate. We record a liability for uncertain tax positions taken or expected to be taken in income tax returns. Our financial statements reflect expected future tax consequences of such positions presuming the taxing authorities&#8217; full knowledge of the position and all relevant facts. We record a liability for the portion of unrecognized tax benefits claimed that we have determined are not more-likely-than-not realizable. These tax reserves have been established based on management&#8217;s assessment as to the potential exposure attributable to our uncertain tax positions as well as interest and penalties attributable to these uncertain tax positions. All tax reserves are analyzed quarterly and adjustments are made as events occur that result in changes in judgment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may become involved in various legal proceedings that arise in the ordinary course of business, including, without limitation, patent infringement, product liability and environmental matters. Accruals recorded for various contingencies including legal proceedings, employee related litigation, self-insurance and other claims are based on judgment, the probability of losses and, where applicable, the consideration of opinions of internal and/or external legal counsel and actuarially determined estimates. When a loss is probable and a range of loss is established but a best estimate cannot be made, we record the minimum loss contingency amount. These estimates are often initially developed substantially earlier than the ultimate loss is known and the estimates are reevaluated each accounting period, as additional information is available. When we are initially unable to develop a best estimate of loss, we record the minimum amount of loss, which could be zero. As information becomes known, an additional loss provision is recorded when either a best estimate can be made or the minimum loss amount is increased. When events result in an expectation of a more favorable outcome than previously expected, our best estimate is changed to a lower amount. With respect to the specific legal proceedings and claims described below, unless otherwise noted, the amount or range of possible losses is not reasonably estimable. There can be no assurance that the settlement, resolution, or other outcome of one or more matters, including the matters set forth below, during any subsequent reporting period will not have a material adverse effect on the Company&#8217;s results of operations or cash flows for that period or on the Company&#8217;s financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record tangible and intangible assets acquired and liabilities assumed in business combinations under the purchase method of accounting. Amounts paid for each acquisition are allocated to the assets acquired and liabilities assumed based on their fair values at the dates of acquisition. The fair value of identifiable intangible assets is based on detailed valuations that use information and assumptions including forecasted cash flows, revenues attributable to existing technology and existing customer attrition. When estimating the significant assumptions to be used in the valuation we included a consideration of current industry information, market and economic trends, historical results of the acquired business and other relevant factors. These significant assumptions are forward-looking and could be affected by future economic and market conditions. We allocate any excess purchase price over the fair value of the net tangible and intangible assets acquired and liabilities assumed to goodwill.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration is recorded at fair value as measured on the date of acquisition using an appropriate valuation model, such as the Monte Carlo simulation model. The value recorded is based on estimates of future financial projections under various potential scenarios, in which the model runs many simulations based on comparable companies&#8217; growth rates and their implied volatility. Our estimates of forecasted revenues in the earn out period include a consideration of current industry information, market and economic trends, historical results of the acquired business and other relevant factors. These cash flow projections are discounted with a risk adjusted rate. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and given the inherent uncertainties in making these estimates, actual results are likely to differ from the amounts originally recorded and could be materially different.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_67"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our exposures relative to market risk are due to foreign exchange risk and interest rate risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Exchange Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the section above entitled Foreign Exchange for a discussion of how foreign currency affects our business. It is our policy to minimize, for a period of time, the unforeseen impact on our financial results of fluctuations in foreign exchange rates by using derivative financial instruments known as forward contracts to hedge anticipated cash flows from forecasted foreign currency denominated sales and costs. We do not use the financial instruments for speculative or trading activities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the change in the fair value of all forward contracts assuming both a 10% strengthening and weakening of the U.S.&#160;Dollar relative to all other major currencies. As of April&#160;1, 2023, in the event of a 10% strengthening of the U.S.&#160;Dollar, the change in fair value of all forward contracts would result in a $4.2 million increase in the fair value of the forward contracts, whereas a 10% weakening of the U.S. Dollar would result in a $4.5 million decrease in the fair value of the forward contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our exposure to changes in interest rates is associated with borrowings under our credit facilities, all of which is variable rate debt. Total outstanding debt under our Revised Credit Facilities as of April&#160;1, 2023 was $274.7&#160;million with an interest rate of 6.3% based on prevailing Term SOFR rates. An increase of 100 basis points in Term SOFR rates would result in additional annual interest expense of $0.8 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In September 2022, we modified our two existing interest rate swaps to align to Term SOFR rather than LIBOR and entered into four additional interest rate swaps to effectively convert $194.8 million of borrowings under our Revised Credit Facilities from a variable rate to a fixed rate. These interest rate swaps are intended to mitigate the exposure to fluctuations in interest rates and qualify for hedge accounting treatment as cash flow hedges.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_70"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and Board of Directors of Haemonetics Corporation</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Haemonetics Corporation and subsidiaries (the Company) as of April 1, 2023 and April 2, 2022, the related consolidated statements of income, comprehensive income, stockholders' equity and cash flows for each of the three years in the period ended April 1, 2023, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at April 1, 2023 and April 2, 2022, and the results of its operations and its cash flows for each of the three years in the period ended April 1, 2023, in conformity with U.S. generally accepted accounting principles. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of April 1, 2023, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated May 22, 2023 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.626%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Valuation of goodwill</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 11 to the consolidated financial statements, the Company had approximately $466 million of goodwill allocated among its reporting units as of April 1, 2023. The Company performs its annual quantitative impairment analysis as of the first day of the fourth quarter, and more frequently if the Company believes indicators of impairment exist, utilizing a discounted cash flow income approach in order to value reporting units for the test. </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Auditing the annual goodwill impairment test was especially complex and judgmental due to the significant estimation required in determining the fair values of certain reporting units.  In particular, the fair value estimates involve judgmental assumptions including the amount and timing of expected future cash flows from revenue growth rates, which are affected by expectations about future market or economic conditions and reporting unit specific risk factors.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls over the Company&#8217;s goodwill impairment review process. For example, we tested controls over management's review of the significant inputs and assumptions used in determining the reporting unit fair values.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To test the estimated fair value of the Company&#8217;s reporting units, we performed audit procedures that included, among others, assessing fair value estimation methodologies, testing the significant assumptions discussed above and the completeness and accuracy of the underlying data used by the Company in its analysis. We compared the significant assumptions used by management to historical financial results of the reporting unit and information generated by external parties. We considered the historical accuracy of management&#8217;s estimates and performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value of the reporting unit that would result from changes in the assumptions. In addition, we involved our valuation professionals to assist in our evaluation of the significant assumptions used to develop the fair value estimates. We also evaluated the reconciliation of the estimated aggregate fair value of the reporting units to the market capitalization of the Company.</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83MC9mcmFnOjliNTE2NTZmNzY5ZjQ1Yjc5MWMzOTExZDM0NGRiNjNjL3RleHRyZWdpb246OWI1MTY1NmY3NjlmNDViNzkxYzM5MTFkMzQ0ZGI2M2NfMzk5MA_c5b7cce4-a63a-4a3e-a63e-a7cd65a839b7">Ernst &amp; Young LLP</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2002.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83MC9mcmFnOjliNTE2NTZmNzY5ZjQ1Yjc5MWMzOTExZDM0NGRiNjNjL3RleHRyZWdpb246OWI1MTY1NmY3NjlmNDViNzkxYzM5MTFkMzQ0ZGI2M2NfMzk5MQ_31ebefa0-7674-4ef0-aed9-37658b17d1a6">Boston, Massachusetts</ix:nonNumeric></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;22, 2023</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_73"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_76"></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except per share data)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 3,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMy0xLTEtMS03MDMzNA_eaf5e460-8173-4bb9-9f15-c3d2e179a56d">1,168,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMy0zLTEtMS03MDMzNA_542d5bb6-7c86-418a-b443-1fe17b3a9f19">993,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMy01LTEtMS03MDMzNA_7f745772-ee68-4897-be2a-398c8c1eba99">870,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNC0xLTEtMS03MDMzNA_8384fb9c-6d7d-4e66-b6c4-b64e9d362a57">553,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNC0zLTEtMS03MDMzNA_55375f4e-1867-47d2-a192-b866c6e83e86">487,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNC01LTEtMS03MDMzNA_87a862c7-2b2f-45b4-bfb7-9027d575e0bf">472,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNS0xLTEtMS03MDMzNA_ac2f5822-d0ae-4bad-9738-cc0f54c55510">615,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNS0zLTEtMS03MDMzNA_136444ed-7f1c-4f6e-8c05-b97591e5510f">505,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNS01LTEtMS03MDMzNA_c4bbb651-4f66-4846-9191-190b2edb5742">397,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNy0xLTEtMS03MDMzNA_114e3c45-1ec2-46b2-942e-3b43af2626a3">50,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNy0zLTEtMS03MDMzNA_851918b2-8028-4b57-bea9-15686841e7fc">46,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNy01LTEtMS03MDMzNA_9d76ffc6-9054-4bde-8b01-6d31ceaacf8e">32,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfOC0xLTEtMS03MDMzNA_2f974bfb-89d2-41db-b0ad-df6ae0fce807">376,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfOC0zLTEtMS03MDMzNA_4025683f-bbda-4ae9-95bc-24735b4df9c2">340,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfOC01LTEtMS03MDMzNA_535f421f-eda6-4453-a09d-701cb68ef0cc">275,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:AmortizationOfAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfOS0xLTEtMS03MDMzNA_84419a76-a1ab-4b94-a598-2dd4d8cacdc5">32,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:AmortizationOfAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfOS0zLTEtMS03MDMzNA_6f27446e-1610-4463-8038-0dda6516c078">47,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:AmortizationOfAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfOS01LTEtMS03MDMzNA_301612dc-98e5-465a-bed6-efaecaaa2ab2">32,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on divestitures and sale of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTEtMS0xLTEtNzAzMzQ_7e496ed2-fdb5-4f41-bb31-46cf90491220">382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTEtMy0xLTEtNzAzMzQ_371b43c7-4e96-4555-8cbc-f61269da888b">9,603</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTEtNS0xLTEtNzAzMzQ_564b8536-15c9-4530-bc29-05c1b25dac05">32,812</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTItMS0xLTEtNzAzMzQ_a9c4caf7-7dbe-49d8-b543-aaedbc9ae652">459,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTItMy0xLTEtNzAzMzQ_d7c4e2c7-1e78-4f75-8d8f-0841c4f26006">424,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTItNS0xLTEtNzAzMzQ_b076c31f-54bd-4bf4-acb0-059d0ba068c6">308,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTMtMS0xLTEtNzAzMzQ_3a7ce93b-54be-4a28-812e-564693fbb81c">156,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTMtMy0xLTEtNzAzMzQ_277a71ba-aa53-480e-ae3d-1197a5d61f06">80,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTMtNS0xLTEtNzAzMzQ_999fbe18-a285-4d08-9bc1-bb7bc52363ee">89,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTQtMS0xLTEtNzAzMzQ_37b7b96d-c749-493e-9ef0-949177f69119">14,630</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTQtMy0xLTEtNzAzMzQ_57ac7432-eedc-4663-8e8a-88a3255388d1">17,121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTQtNS0xLTEtNzAzMzQ_549666c7-ba49-4c35-b093-7619342c900e">16,834</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before provision (benefit) for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTUtMS0xLTEtNzAzMzQ_d256a525-b9bf-4168-836b-f9c3ff0114b3">141,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTUtMy0xLTEtNzAzMzQ_526c4679-1817-4d41-87f6-06cf88990c33">63,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTUtNS0xLTEtNzAzMzQ_9319090f-d7e0-4e11-a262-40fe22c4443e">72,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTYtMS0xLTEtNzAzMzQ_4a8093ca-955d-4d9c-94f5-8ba3b6ff7315">26,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTYtMy0xLTEtNzAzMzQ_a08f175e-6a4e-4eff-b0fc-4d3d0292933b">20,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTYtNS0xLTEtNzAzMzQ_0a3bf612-a54f-40a6-9ab7-747c4d9cb8cb">6,556</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTctMS0xLTEtNzAzMzQ_818ae1b9-2843-415a-ab42-e876a1170ca8">115,401</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTctMy0xLTEtNzAzMzQ_3230b122-f2f4-4a59-8f15-e9323a791978">43,375</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTctNS0xLTEtNzAzMzQ_bb658622-d311-413d-a287-33ab1f7460ed">79,469</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share &#8211; basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTktMS0xLTEtNzAzMzQ_6022b2ca-9f45-4e21-8bb7-1a576edd866f">2.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTktMy0xLTEtNzAzMzQ_058bdf63-ab5d-48bf-95ea-bacd7f3e5794">0.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTktNS0xLTEtNzAzMzQ_86e354ac-3703-46e4-918e-27d2a2a1bf9f">1.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share &#8211; diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjAtMS0xLTEtNzAzMzQ_34539a32-7ae7-47db-9087-43204c290eb2">2.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjAtMy0xLTEtNzAzMzQ_5c342655-9e49-4d20-b376-fab8db03c8a6">0.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjAtNS0xLTEtNzAzMzQ_f7314aa2-5e85-41be-8180-1086f63154de">1.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjMtMS0xLTEtNzAzMzQ_84dfc82e-9696-47c7-ab93-dc4457d38d2c">50,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjMtMy0xLTEtNzAzMzQ_5e3d4a7d-41b1-47a1-a6a2-7e5d087264e8">51,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjMtNS0xLTEtNzAzMzQ_18a89bc3-0dec-400c-93da-38d35bc179b2">50,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjQtMS0xLTEtNzAzMzQ_87e8a700-fe68-417f-b936-25f0eacdc808">51,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjQtMy0xLTEtNzAzMzQ_f7c4d74c-5cde-4d81-989f-ee46d9cd815b">51,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjQtNS0xLTEtNzAzMzQ_6d66ddba-e58e-476b-ba90-ff69ed80b108">51,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_79"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:60.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.237%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 3,<br/>2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMy0xLTEtMS03MDMzNA_5edd5a89-a154-4d3c-9a9f-d92b3533224f"><ix:nonFraction unitRef="usd" contextRef="i0ca40b48f3114d14bf1271d7751fa199_D20220403-20230401" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMy0xLTEtMS03MDMzNA_fc54bcfb-a261-4c75-a8f1-6e33b32cb391">115,401</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMy0zLTEtMS03MDMzNA_47457ec8-9427-480a-acaf-9836c8b7f318">43,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMy01LTEtMS03MDMzNA_05ab8e59-50d9-4d35-86b3-1bf38ddb5427">79,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of defined benefit plans, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfNi0xLTEtMS03MDMzNA_d06f3dff-48e5-4170-8538-06c3e4111a74">2,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfNi0zLTEtMS03MDMzNA_243ceec2-6ec8-4fc5-9468-69985099e5b4">2,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfNi01LTEtMS03MDMzNA_852ee6a6-089f-4c1c-bb9f-87466ca2198f">351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfNy0xLTEtMS03MDMzNA_b7883c4c-d546-4a18-a9b3-319caee191f6">6,016</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfNy0zLTEtMS03MDMzNA_4103a197-ac01-44af-93f1-f36e37579654">6,391</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfNy01LTEtMS03MDMzNA_29e14710-f25c-49b8-8fa3-c0e746749a1c">9,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on cash flow hedges, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfOC0xLTEtMS03MDMzNA_6fffe657-a2f7-4ec6-9c8e-59b46af726b1">4,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfOC0zLTEtMS03MDMzNA_b437ef1a-7443-48a7-80d5-e3049e6ad53b">5,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfOC01LTEtMS03MDMzNA_6f02d821-a533-4d19-989f-b4e4c827ebbc">489</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications into earnings of cash flow hedge (gains) losses, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfOS0xLTEtMS03MDMzNA_c5c95d13-4599-4602-9ca5-a5fad4630009">5,136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfOS0zLTEtMS03MDMzNA_ee8a75b8-18d5-4413-a84e-facb67ba2393">2,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfOS01LTEtMS03MDMzNA_215be425-92e9-4831-bb0e-ad1bd15231f1">6,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMTAtMS0xLTEtNzAzMzQ_33b763ba-fc4d-48ff-af40-a9d46f2327e6">4,427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMTAtMy0xLTEtNzAzMzQ_c807dd30-d533-428f-88f7-f6a85644c21a">3,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMTAtNS0xLTEtNzAzMzQ_7852006e-e4a8-4c37-a623-b78aaffc73fc">15,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMTEtMS0xLTEtNzAzMzQ_db90342a-b95b-49f2-83eb-7c1592a76b10">110,974</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMTEtMy0xLTEtNzAzMzQ_7a895131-a123-4b44-ac17-800f536aa908">46,968</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMTEtNS0xLTEtNzAzMzQ_9e89da07-8e91-4820-81d4-ecc987dfe405">95,057</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_82"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share data)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td></tr><tr style="height:14pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNC0xLTEtMS03MDMzNA_f1768fc8-01b5-4f0e-a078-1a17a05ba007">284,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNC0zLTEtMS03MDMzNA_ba6f631b-08c3-4eca-82aa-2176dba13ba4">259,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, less allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNS0wLTEtMS03MDMzNC90ZXh0cmVnaW9uOjE0MjcxNDhjZmI1MjRmMDQ5ZDg5MTcwNzhjM2RkM2Y3XzQz_9b6ebaa1-ace3-430d-9cbd-d537fdeb2c43">4,932</ix:nonFraction> at April 1, 2023 and $<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNS0wLTEtMS03MDMzNC90ZXh0cmVnaW9uOjE0MjcxNDhjZmI1MjRmMDQ5ZDg5MTcwNzhjM2RkM2Y3XzY3_a3abc4df-3430-474d-bfcc-bbf00f09ccb7">2,475</ix:nonFraction> at April 2, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNS0xLTEtMS03MDMzNA_f8db3251-6c0f-4a85-a2ef-3dde3a3a1809">179,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNS0zLTEtMS03MDMzNA_5ceb633b-fea3-41ff-a02e-04726006e8a6">159,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNi0xLTEtMS03MDMzNA_b003f5a6-ba3f-4b3d-b90a-9bb86af8eca3">259,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNi0zLTEtMS03MDMzNA_642ee430-2824-47df-957a-470834736c6c">293,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfOC0xLTEtMS03MDMzNA_2e0138b4-e1c1-4f87-81c7-fe02bdbd0204">46,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfOC0zLTEtMS03MDMzNA_81e956af-4ce0-42cc-acbb-c55ecc96dbc5">44,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfOS0xLTEtMS03MDMzNA_8f25ce81-288c-489f-aa39-c518ae14c4c7">769,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfOS0zLTEtMS03MDMzNA_9d40c1d8-cceb-45b4-b1bf-701a18c4e982">756,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTAtMS0xLTEtNzAzMzQ_a8fc986e-5b51-4f02-9356-015ee7a733bc">310,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTAtMy0xLTEtNzAzMzQ_f85e7b77-39dd-4a37-91db-627ef6de4087">258,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, less accumulated amortization of $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTEtMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjo2NTFiODZjOWU3NWE0NjJjYTEzYzI5MDM5YjdlMzdmOF81Ng_45b34273-7549-4f02-bd28-5e131285417e">417,422</ix:nonFraction> at April 1, 2023 and $<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTEtMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjo2NTFiODZjOWU3NWE0NjJjYTEzYzI5MDM5YjdlMzdmOF84MA_aca5e001-461d-4acd-a4b0-8c37d613cef6">376,552</ix:nonFraction> at April 2, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTEtMS0xLTEtNzAzMzQ_f5170388-dd79-4248-9243-88029905d116">275,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTEtMy0xLTEtNzAzMzQ_8a46b839-f7e3-4035-84c5-410163b17db6">310,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTItMS0xLTEtNzAzMzQ_5cab51ee-0145-4daf-a606-6829774bdaba">466,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTItMy0xLTEtNzAzMzQ_ef337b73-fc59-485b-90dc-937a46ac1c7a">467,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTMtMS0xLTEtNzAzMzQ_70d14603-172f-4a6b-bdb3-2d75d0055d95">5,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTMtMy0xLTEtNzAzMzQ_2d642095-6bab-4a0a-a0bd-385ba43cff50">4,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTQtMS0xLTEtNzAzMzQ_be775653-0111-4c99-b407-0ddc0ce9b2ad">106,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTQtMy0xLTEtNzAzMzQ_c723e598-90f2-4c13-a157-3d5c549bdf41">63,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTUtMS0xLTEtNzAzMzQ_1eb3f1de-056f-41d9-83b4-04b1dd4636fa">1,934,825</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTUtMy0xLTEtNzAzMzQ_1d9e0053-19da-48c7-a0f4-45beb75861a7">1,859,734</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes payable and current maturities of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTgtMS0xLTEtNzAzMzQ_0f34eede-d560-40b1-a9cd-536f09702704">11,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTgtMy0xLTEtNzAzMzQ_45c8e119-f98d-431a-a195-6e49511d6612">214,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTktMS0xLTEtNzAzMzQ_df90d110-3afc-44d9-98fa-440988af26a2">63,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTktMy0xLTEtNzAzMzQ_062b5696-6664-4ea6-ad75-2fd09cfefbb8">58,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued payroll and related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjAtMS0xLTEtNzAzMzQ_2ba7f85b-f3e8-460b-831d-470d4e47f440">64,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjAtMy0xLTEtNzAzMzQ_3ab7138d-8be6-43e9-83c5-fe9912d35ee0">48,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjEtMS0xLTEtNzAzMzQ_3d8042ae-4fb2-42a9-8fa8-297b12c3e9d0">111,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjEtMy0xLTEtNzAzMzQ_72b299a2-cade-4baf-b1bd-7848e8d0cbd6">121,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjItMS0xLTEtNzAzMzQ_77e3dcc1-b5ec-4364-a1ff-284b9eff2044">251,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjItMy0xLTEtNzAzMzQ_bee3eaf3-d0ff-4aa1-8872-301a62b29813">442,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, net of current maturities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjMtMS0xLTEtNzAzMzQ_767062ab-41a5-47a6-8857-ac79f5917ca9">754,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjMtMy0xLTEtNzAzMzQ_e604693c-fbe3-469f-ba1f-a8ad35fe6caa">559,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjQtMS0xLTEtNzAzMzQ_2163c873-76b9-4595-851b-cedd45e1180c">36,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjQtMy0xLTEtNzAzMzQ_3fca16f2-e8cc-469d-84a7-8e0203f9425f">28,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjUtMS0xLTEtNzAzMzQ_ea0c8dd4-d3bd-4d84-8962-132678b360b6">74,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjUtMy0xLTEtNzAzMzQ_6ccfb6c7-7cd8-427a-ae63-fcc3c5fb8b8f">79,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N18xOA_e2c9579c-ccb4-4dc5-9a26-b55b5280345d"><ix:nonFraction unitRef="usdPerShare" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N18xOA_f0f2d02a-e166-4fbd-8201-94dedf9a94f8">0.01</ix:nonFraction></ix:nonFraction>&#160;par value; Authorized&#160;&#8212; <ix:nonFraction unitRef="shares" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N180NQ_c8f4f426-11a9-4b85-85c0-0269185ad83a"><ix:nonFraction unitRef="shares" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N180NQ_f1810447-bb4a-4f7c-ac5e-f70cf69336cc">150,000,000</ix:nonFraction></ix:nonFraction>&#160;shares; Issued and outstanding&#160;&#8212; <ix:nonFraction unitRef="shares" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N184MQ_dcda904d-429e-4a1e-a6a5-9d13d9c6bb7c"><ix:nonFraction unitRef="shares" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N184MQ_e309f461-5ecc-4d88-a457-1146ed31d8b4">50,448,519</ix:nonFraction></ix:nonFraction>&#160;shares at April 1, 2023 and <ix:nonFraction unitRef="shares" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N18xMTI_2bfbf2cc-8bae-457e-9441-2543166122c4"><ix:nonFraction unitRef="shares" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N18xMTI_ef5e337a-876b-474b-b373-2efceb85f855">51,124,240</ix:nonFraction></ix:nonFraction>&#160;shares at April 2, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMS0xLTEtNzAzMzQ_a6cd1591-94e8-4c3a-9458-6b9010fb81ca">504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMy0xLTEtNzAzMzQ_f671d9a4-efae-4363-ad50-83874facc8fc">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjgtMS0xLTEtNzAzMzQ_72227dd2-7ace-4e60-af0b-8e421e8897b8">594,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjgtMy0xLTEtNzAzMzQ_3f4d6154-c4d5-4902-a615-a92bbfdec6c1">572,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjktMS0xLTEtNzAzMzQ_03fad37d-bdec-488a-9570-55ce3b01b299">253,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjktMy0xLTEtNzAzMzQ_99dee86a-6e96-4c45-a6a6-79c1d62e8367">202,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMzAtMS0xLTEtNzAzMzQ_a45de49e-1dbb-448f-8c84-949d122a1eb1">30,381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMzAtMy0xLTEtNzAzMzQ_0bdbd894-5ab1-4061-84ce-4a89b2751e2e">25,954</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMzEtMS0xLTEtNzAzMzQ_99bfd95d-6f59-4c60-a6cd-0cb87b18cf06">817,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMzEtMy0xLTEtNzAzMzQ_7e155d31-92be-4825-a993-ed322d5654c2">749,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMzItMS0xLTEtNzAzMzQ_52b8574a-e3f1-4c61-952d-555f28f33763">1,934,825</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMzItMy0xLTEtNzAzMzQ_c5cf5aa9-ecfc-44d2-98bb-2b3e5b76115c">1,859,734</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_85"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share data)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.214%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.743%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Income/(Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 28, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb2d524b6a72478a8ce2435530d7cbc4_I20200328" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMi0xLTEtMS03MDMzNA_4c3a9840-b7b3-42c1-9e27-7cc6e39b447a">50,323</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb2d524b6a72478a8ce2435530d7cbc4_I20200328" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMi0zLTEtMS03MDMzNA_9015b582-70cc-4ff4-8e53-2fe000cbc07c">503</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42ee76458100485abe569121bb8658a3_I20200328" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMi01LTEtMS03MDMzNA_31f5af0f-331d-4b42-b0d1-ad1eaa64f36a">553,229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52763a808517454786578412ff4262d9_I20200328" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMi03LTEtMS03MDMzNA_282fdf73-bbd8-4bfc-ad7c-b3189c661491">78,512</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60812e5a52b74920a9ce77100e55369d_I20200328" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMi05LTEtMS03MDMzNA_97e60cb8-9afc-4954-ad20-1a58c5163bf1">45,135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2752e169c88b4ff2a289838d456aec0d_I20200328" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMi0xMS0xLTEtNzAzMzQ_26530d0d-0cdd-4f42-a2bb-1790ed08a335">587,109</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37f5873c934c4f319a70ed61b214fb3f_D20200329-20210403" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMy0xLTEtMS03MDMzNA_b7a486f0-ca38-47fc-9234-ebc3324e4a16">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f5873c934c4f319a70ed61b214fb3f_D20200329-20210403" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMy0zLTEtMS03MDMzNA_a502c720-ea4f-461f-9679-d4260cf83717">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id668923a47bf4311bb983f1280642d51_D20200329-20210403" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMy01LTEtMS03MDMzNA_ad149d85-e83d-4cc3-ab7c-70981258f408">4,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMy0xMS0xLTEtNzAzMzQ_ed78348a-cc92-4df8-8721-4e9f05b08a87">4,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37f5873c934c4f319a70ed61b214fb3f_D20200329-20210403" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNC0xLTEtMS03MDMzNA_8a15b319-98e3-4267-b912-d120b1e7c281">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f5873c934c4f319a70ed61b214fb3f_D20200329-20210403" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNC0zLTEtMS03MDMzNA_ae81ad41-36ed-4b04-85f1-ab4d3af7cbdc">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id668923a47bf4311bb983f1280642d51_D20200329-20210403" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNC01LTEtMS03MDMzNA_f62d0236-1ac0-4d60-94fc-ef34e89a1c7f">6,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNC0xMS0xLTEtNzAzMzQ_3f1bbe16-1b5c-43fe-b15a-a0887a71d8cb">6,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of cancellations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37f5873c934c4f319a70ed61b214fb3f_D20200329-20210403" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNy0xLTEtMS03MDMzNA_2b450eaf-37ff-4f9e-aaf9-4589d32c79ab">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f5873c934c4f319a70ed61b214fb3f_D20200329-20210403" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNy0zLTEtMS03MDMzNA_6ffe80ea-a450-443a-8bbc-04ff68421f1b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id668923a47bf4311bb983f1280642d51_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNy01LTEtMS03MDMzNA_b0fd11ba-8c1e-4d27-9fbe-25613f88ea21">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNy0xMS0xLTEtNzAzMzQ_bca67e8e-0f80-45e8-a33d-05e5b2e21d17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id668923a47bf4311bb983f1280642d51_D20200329-20210403" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfOC01LTEtMS03MDMzNA_92b1a31c-2025-4235-a22b-8538d2583798">25,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfOC0xMS0xLTEtNzAzMzQ_e998ea4f-531f-405b-a332-776e6246749c">25,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity component of convertible notes, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id668923a47bf4311bb983f1280642d51_D20200329-20210403" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfOS01LTEtMS03MTMyNg_70a3aee9-8b49-4eb6-b365-b6a9056d4422">61,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfOS0xMS0xLTEtNzEzMjY_af30fd8c-ed30-49a8-90e9-3f06eebd6cef">61,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of capped call related to convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id668923a47bf4311bb983f1280642d51_D20200329-20210403" decimals="-3" name="hae:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTAtNS0xLTEtNzEzMjY_40da6c14-b584-41d3-9cef-cd7f540b5643">47,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTAtMTEtMS0xLTcxMzI2_6f49712f-ec77-429c-97de-61c49e916bf4">47,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i697ca53aa7594d49b0f5f0ea4adc78fc_D20200329-20210403" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfOS03LTEtMS03MDMzNA_b5035786-661d-4c4b-9e43-41d4590ad5e9">79,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfOS0xMS0xLTEtNzAzMzQ_b8209525-dd26-40bc-9d44-b85c58d9b1b7">79,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8a40e6978d54c79bf15a000c4fe1242_D20200329-20210403" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTAtOS0xLTEtNzAzMzQ_32c8b6bb-c331-4dfd-9399-834b4da76698">15,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTAtMTEtMS0xLTcwMzM0_35503c56-ee54-46db-bb55-036205860a2a">15,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, April 3, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a75725e0d6e42c5b75f249d0fd73f03_I20210403" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTEtMS0xLTEtNzAzMzQ_7d59cd15-2b79-4646-bf98-0b8b77c78ca5">50,869</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75725e0d6e42c5b75f249d0fd73f03_I20210403" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTEtMy0xLTEtNzAzMzQ_4e25a582-68ad-40ed-8dff-99d57b212917">509</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18bd16d259fa4608b4077e65accd3342_I20210403" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTEtNS0xLTEtNzAzMzQ_d209418d-0cee-46c6-99b4-d1ff900301b3">602,727</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5fe2762223141c79cda70db2a2e1be5_I20210403" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTEtNy0xLTEtNzAzMzQ_70e620c7-db7f-45ef-990a-5f2b0f9744a1">157,981</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a31987923a94e60800afa0e777b9b45_I20210403" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTEtOS0xLTEtNzAzMzQ_010c2788-63ff-4ffd-b4ac-05aadf0c712a">29,547</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTEtMTEtMS0xLTcwMzM0_da7706e2-ff3b-40fe-a0cb-dbfe2fc9c68c">731,670</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie5148af9ebc54cf1b637aaff64021039_D20210404-20220402" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTItMS0xLTEtNzAzMzQ_514be53f-ce73-44fc-a6e3-6b0775b23744">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5148af9ebc54cf1b637aaff64021039_D20210404-20220402" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTItMy0xLTEtNzAzMzQ_9bf81e04-ada0-46ac-960a-3c5b19a05519">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dfd4364e8c24bc4b8394dd292c16b8c_D20210404-20220402" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTItNS0xLTEtNzAzMzQ_f0c3c0aa-cad0-486a-9ac2-9f7b971342bd">4,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTItMTEtMS0xLTcwMzM0_645344eb-345f-456e-a694-0c0cf0120434">4,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie5148af9ebc54cf1b637aaff64021039_D20210404-20220402" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTMtMS0xLTEtNzAzMzQ_291fca50-0057-49fc-904a-50a1c7053e29">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5148af9ebc54cf1b637aaff64021039_D20210404-20220402" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTMtMy0xLTEtNzAzMzQ_3640e6c5-0fee-48c5-b5f2-a88a58d53be6">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dfd4364e8c24bc4b8394dd292c16b8c_D20210404-20220402" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTMtNS0xLTEtNzAzMzQ_ceb54abe-6215-4c34-9ac1-359a4d156cb6">2,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTMtMTEtMS0xLTcwMzM0_6e967825-57ba-4abb-ba01-304d2975b226">2,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of cancellations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie5148af9ebc54cf1b637aaff64021039_D20210404-20220402" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTUtMS0xLTEtNzAzMzQ_2d3105dc-a84a-417a-abef-df86c46f5068">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5148af9ebc54cf1b637aaff64021039_D20210404-20220402" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTUtMy0xLTEtNzAzMzQ_afcd073a-73c4-490f-beaa-942d7e74183a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dfd4364e8c24bc4b8394dd292c16b8c_D20210404-20220402" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTUtNS0xLTEtNzAzMzQ_3365a73f-e153-4671-aed0-42b134ca94d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTUtMTEtMS0xLTcwMzM0_4ef2e506-42eb-4d44-8105-34a1d7fb3cd2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dfd4364e8c24bc4b8394dd292c16b8c_D20210404-20220402" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTYtNS0xLTEtNzAzMzQ_571c3d45-e70a-4aee-9d14-27848e6f7b8e">24,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTYtMTEtMS0xLTcwMzM0_e0d14a90-2dbe-43a7-a864-7960f9a6673d">24,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative effect of change in accounting standards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida4469bc869a466b9e701b962dc524a8_I20220402" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtNS0xLTEtNzEzNjI_a772fde3-a869-4a0e-93d9-c78a1ddcad6e">61,156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2250e1e0cab44768927b6683d1fa68a_I20220402" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtNy0xLTEtNzEzNjI_d021210d-1eb2-4a6a-b32b-a131c5c2ab0a">1,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99c9262cec6b4dda9414dc17ce49c2c4_I20220402" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtMTEtMS0xLTcxMzYy_1d13659d-7589-4663-82b3-bb03910efee5">60,121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a826461f49548eeaa6114591f43ea92_D20210404-20220402" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTktNy0xLTEtNzAzMzQ_580b460d-5eec-4e6d-ae6c-62afa48bb758">43,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTktMTEtMS0xLTcwMzM0_971e6a84-0cc2-4617-9ea9-8f7f3053043e">43,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i529b729b5858426a8917c2a33f2e400c_D20210404-20220402" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjAtOS0xLTEtNzAzMzQ_e8571828-19f5-43eb-8b58-01d50ed0aa7d">3,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjAtMTEtMS0xLTcwMzM0_c2ab2b61-a522-4924-acf8-6b47f0687e53">3,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, April 2, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i642712cd53f84556a5ccf4b37238b593_I20220402" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtMS0xLTEtNzAzMzQ_93a8971c-30ce-456a-8b3d-1321c6e79390">51,124</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i642712cd53f84556a5ccf4b37238b593_I20220402" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtMy0xLTEtNzAzMzQ_dfe35026-55d8-44de-a61c-df72fbf3fc38">511</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ac7a16fc574ea38c5d4d9bbfa9d783_I20220402" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtNS0xLTEtNzAzMzQ_1078e112-1438-4e60-9efa-f6b53b6528c6">572,476</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f76d034fa45484ea27ccefad26663e6_I20220402" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtNy0xLTEtNzAzMzQ_d53b92e8-3fc1-44a7-8c0a-36a12e2e39ae">202,391</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie18371e832794ec985b640a184d0d733_I20220402" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtOS0xLTEtNzAzMzQ_a08b3b85-690d-48da-8bad-36b51dab1eaf">25,954</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtMTEtMS0xLTcwMzM0_bcd671aa-64f2-4e4a-8f7f-56576f862df8">749,424</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjItMS0xLTEtNzAzMzQ_9efa9b15-d5f2-4927-aa57-868a60f2a429">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjItMy0xLTEtNzAzMzQ_fa3d43ca-ddb1-4dad-8b82-1c4d91677d96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54f0ad46abac454891cfccff72983699_D20220403-20230401" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjItNS0xLTEtNzAzMzQ_19b28db4-3118-4c17-8e25-5c1d34b87f15">4,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjItMTEtMS0xLTcwMzM0_8bacc67e-8769-4850-b0e6-da63e22f1071">4,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjMtMS0xLTEtNzAzMzQ_ac72ac79-f542-4436-8763-a42d79c71d21">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjMtMy0xLTEtNzAzMzQ_42cfda62-2a1f-4f97-8738-8154cd642460">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54f0ad46abac454891cfccff72983699_D20220403-20230401" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjMtNS0xLTEtNzAzMzQ_04e8eb62-4fbe-4f39-999e-086b0776cbf1">2,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjMtMTEtMS0xLTcwMzM0_bc956dd8-2ed9-4368-96f2-fd769770a315">2,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtMS0xLTEtODUyNTU_9a0f40bc-5028-4f09-a5ba-6d741c87f942">997</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtMy0xLTEtODUyNTU_743e15c0-d269-4ce5-ab45-7e4655f2f076">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54f0ad46abac454891cfccff72983699_D20220403-20230401" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtNS0xLTEtODUyNTU_0a14e92a-d08a-4a30-99d9-d2246cddf1d6">10,366</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ca40b48f3114d14bf1271d7751fa199_D20220403-20230401" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtNy0xLTEtODUyNTU_9d0c3b7e-d1d4-4601-8c2f-b9bc4283c48d">64,624</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtMTEtMS0xLTg1MjU1_088842cf-1c0c-4350-842e-babe7067ce83">75,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of cancellations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjUtMS0xLTEtNzAzMzQ_70b73518-851c-4f92-b90e-f159aaa68015">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjUtMy0xLTEtNzAzMzQ_37be65cc-1a1e-444c-a960-a23d60563841">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54f0ad46abac454891cfccff72983699_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjUtNS0xLTEtNzAzMzQ_eb7adcca-1d03-4321-924c-106813a18264">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjUtMTEtMS0xLTcwMzM0_c407c02b-3f51-4a40-a140-12cd29cf1682">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54f0ad46abac454891cfccff72983699_D20220403-20230401" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjYtNS0xLTEtNzAzMzQ_77917d6e-71e2-4d29-8e29-4699dd902e52">25,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjYtMTEtMS0xLTcwMzM0_e3be77ec-9384-4b3e-859c-f4c77d213a6f">25,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtNy0xLTEtNzAzMzQ_5edd5a89-a154-4d3c-9a9f-d92b3533224f"><ix:nonFraction unitRef="usd" contextRef="i0ca40b48f3114d14bf1271d7751fa199_D20220403-20230401" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtNy0xLTEtNzAzMzQ_fc54bcfb-a261-4c75-a8f1-6e33b32cb391">115,401</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtMTEtMS0xLTcwMzM0_1e8cb236-bf2a-47e7-ad26-1bbf11a130d5">115,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa9b4b7857b47e3ba345fec50c6803f_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjktOS0xLTEtNzAzMzQ_eb7893ef-a7a0-45c6-83a4-519775770ec0">4,427</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjktMTEtMS0xLTcwMzM0_f6acf489-b74d-4b0b-94fc-f78e875c3f40">4,427</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, April 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e354d29beb04828b88b6371c1870695_I20230401" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMzAtMS0xLTEtNzAzMzQ_fc6a6269-67f0-459e-a731-eee4fcfc87fa">50,449</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e354d29beb04828b88b6371c1870695_I20230401" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMzAtMy0xLTEtNzAzMzQ_17a04647-8590-4de7-a5c9-ec8d6c92d496">504</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3cf28e5ca804729899b65c631cd302c_I20230401" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMzAtNS0xLTEtNzAzMzQ_7a9d5107-a567-41ed-83a3-bb45a48e0873">594,706</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib38708d3cbd24fe78b4b34a0adf8f366_I20230401" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMzAtNy0xLTEtNzAzMzQ_04da522c-07f6-4898-834f-d6d766c43c67">253,168</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7db70ed758f45088a07ed84e94c60aa_I20230401" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMzAtOS0xLTEtNzAzMzQ_2a9b2fab-13b7-4e01-96a6-4442aa636a5c">30,381</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMzAtMTEtMS0xLTcwMzM0_aed79006-f0ef-4eed-bbe3-23f9cfa86c46">817,997</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 3,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flows from Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMy0xLTEtMS03MDMzNA_5edd5a89-a154-4d3c-9a9f-d92b3533224f"><ix:nonFraction unitRef="usd" contextRef="i0ca40b48f3114d14bf1271d7751fa199_D20220403-20230401" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMy0xLTEtMS03MDMzNA_fc54bcfb-a261-4c75-a8f1-6e33b32cb391">115,401</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMy0zLTEtMS03MDMzNA_47457ec8-9427-480a-acaf-9836c8b7f318">43,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMy01LTEtMS03MDMzNA_05ab8e59-50d9-4d35-86b3-1bf38ddb5427">79,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-cash items:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNi0xLTEtMS03MDMzNA_b56b48f4-2f59-480b-aa6a-4f41a09df6cb">93,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNi0zLTEtMS03MDMzNA_52f78b39-c861-4b1b-a37f-998bc6a3def7">97,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNi01LTEtMS03MDMzNA_09187305-b482-4580-8db5-2fd5064f0490">84,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNy0xLTEtMS03MDMzNA_7509e6fa-3ad6-4f1a-be5a-2c3dbf179c30">607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNy0zLTEtMS03MDMzNA_68d69743-68f6-457a-8717-badb0b1186f6">7,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNy01LTEtMS03MDMzNA_836e348c-80d6-4970-9cef-7c9e78832739">21,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfOC0xLTEtMS03MDMzNA_ec749ed1-674c-4110-a89c-c72f6e56ab4b">25,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfOC0zLTEtMS03MDMzNA_83c72504-28d2-4ec3-a5b0-edaac0a85b2b">24,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfOC01LTEtMS03MDMzNA_6ac403ec-84af-4745-9a65-47d1400e5ded">25,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on divestitures and sale of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfOS0xLTEtMS03MDMzNA_838768d0-c294-4cd5-8d00-b9d795ae4e40">382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfOS0zLTEtMS03MDMzNA_c9aed119-e353-43ee-b79d-b4aa07271181">9,603</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfOS01LTEtMS03MDMzNA_07a5a211-96c5-47e8-8f5f-6a958b3461c1">32,812</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTAtMS0xLTEtNzAzMzQ_32d230c4-5afd-49cd-a475-c7f9dcdfd83a">504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTAtMy0xLTEtNzAzMzQ_dcd24994-c989-4e58-8596-18e59856d744">10,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTAtNS0xLTEtNzAzMzQ_9cb51749-acfe-4a6f-bdd6-3d6c414dea54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DeferredOtherTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTItMS0xLTEtNzAzMzQ_be721edf-fc48-4091-8109-c71d4a50d77b">4,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DeferredOtherTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTItMy0xLTEtNzAzMzQ_d87901ae-f292-4823-ab92-9b9336617c5e">5,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:DeferredOtherTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTItNS0xLTEtNzAzMzQ_e4b09c38-abd4-4266-ab69-821a7d1ef2ef">19,866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTQtMS0xLTEtNzAzMzQ_5dce4074-4c01-4e01-afa6-bda70e7d30c6">1,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTQtMy0xLTEtNzAzMzQ_45a285e6-30c6-4a0e-9cd7-126b118c3c25">3,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTQtNS0xLTEtNzAzMzQ_e1d42618-1c8f-4509-870f-119accc5ea22">564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision (benefit) for losses on inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:InventoryLossesProvisionBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTUtMS0xLTEtNzAzMzQ_2fb06603-9edb-47c0-bd75-96333e5bde30">664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="hae:InventoryLossesProvisionBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTUtMy0xLTEtNzAzMzQ_4dcedc81-75af-423e-ab8c-beed29e4a897">861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:InventoryLossesProvisionBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTUtNS0xLTEtNzAzMzQ_315b8aea-ef58-4825-a203-2df3ae201d51">7,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-cash operating activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTYtMS0xLTEtNzAzMzQ_186ab4d7-e9b2-4d03-9444-6db52f92a0c8">6,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTYtMy0xLTEtNzAzMzQ_b2e3835a-6d4b-40a5-b545-9cef48316857">5,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTYtNS0xLTEtNzAzMzQ_25114c25-a969-456a-a63a-a40a3bb89610">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTgtMS0xLTEtNzAzMzQ_137f2452-2b0f-4776-a1d5-aca23e8f166d">24,421</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTgtMy0xLTEtNzAzMzQ_cd426017-e82f-460f-a84f-c2124a1828e3">34,974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTgtNS0xLTEtNzAzMzQ_2d1abf7a-f001-48e7-89da-8a4f898c128f">44,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTktMS0xLTEtNzAzMzQ_ed0e3dc6-8898-4abf-b044-b50167f78e74">30,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTktMy0xLTEtNzAzMzQ_2aeb4f71-c446-4b58-bed6-397315938e98">24,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTktNS0xLTEtNzAzMzQ_3dea24f9-839b-457c-a655-1d777f6660b8">38,909</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjAtMS0xLTEtNzAzMzQ_c06ccbec-3936-4f83-aff6-54e684e12c22">1,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjAtMy0xLTEtNzAzMzQ_033f4f66-6569-4302-8d2f-3c461d358130">2,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjAtNS0xLTEtNzAzMzQ_5004118c-9e1f-41f1-87bc-cc07f079e49c">3,822</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in other assets and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjEtMS0xLTEtNzAzMzQ_61f4f716-68b8-418f-b536-703379cb1c47">22,334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjEtMy0xLTEtNzAzMzQ_66e17274-d9dc-471c-90ee-a727c5a5defa">15,022</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjEtNS0xLTEtNzAzMzQ_23e62c66-73ec-4097-8554-05bb9389c99a">4,650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjMtMS0xLTEtNzAzMzQ_4e3c185f-2149-41b4-be12-487a1ec1192b">39,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjMtMy0xLTEtNzAzMzQ_c616adb0-3106-4dad-8940-38cea30170d5">7,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjMtNS0xLTEtNzAzMzQ_60e6b993-65fc-4255-81f1-a6e2ebec192a">56,422</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjQtMS0xLTEtNzAzMzQ_60bd63cc-b899-40ae-bd83-418c453d5469">273,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjQtMy0xLTEtNzAzMzQ_c99ded54-8bc2-41df-aaa5-269a1d5ecfaf">172,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjQtNS0xLTEtNzAzMzQ_1add179e-7f34-4da2-99a2-aa38b0d2dffb">108,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flows from Investing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjYtMS0xLTEtNzAzMzQ_3f717d49-376c-457c-bead-fc9524e62bf1">110,191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjYtMy0xLTEtNzAzMzQ_85824cc6-1ade-4b74-969a-0cf7b7f554a5">96,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjYtNS0xLTEtNzAzMzQ_3c41d40b-eafb-4dd1-80d4-7f3a0b740c3e">37,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjctMS0xLTEtNzAzMzQ_73f4637d-4fdb-4a8e-a939-57e23f6bd7e7">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjctMy0xLTEtNzAzMzQ_94926e71-d036-4f54-96c0-4fdd6a9cbc50">10,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjctNS0xLTEtNzAzMzQ_dd54e299-aa73-482b-9c0b-f71d4de922c9">44,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjgtMS0xLTEtNzAzMzQ_aed06ebc-166d-4101-9581-52cdd5453a83">1,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjgtMy0xLTEtNzAzMzQ_d59da98c-02bd-48c8-8bfa-3e84bf2fe025">2,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjgtNS0xLTEtNzAzMzQ_85e39f53-75d1-4bb6-94c1-d67dc70da9aa">1,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzAtMS0xLTEtNzAzMzQ_2cd1cc82-361b-4e29-aa41-9161bce84c15">2,850</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzAtMy0xLTEtNzAzMzQ_7720f3bf-4dfa-4b5d-90e3-dee025b6deab">2,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzAtNS0xLTEtNzAzMzQ_17576968-f585-4b5a-a9ad-ec68c2547ccd">434,804</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:PaymentsToAcquireOtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzEtMS0xLTEtNzAzMzQ_1ef6fe16-fc63-4154-8dee-dd86b236dca5">33,205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:PaymentsToAcquireOtherInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzEtMy0xLTEtNzAzMzQ_ff5fbbe2-942d-4028-9d91-d0392632fcdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:PaymentsToAcquireOtherInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzEtNS0xLTEtNzAzMzQ_f510c552-3ed3-45ad-9a57-a506e925673b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzItMS0xLTEtNzAzMzQ_9425ae14-eb9a-45ac-8526-b758a101ce46">143,788</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzItMy0xLTEtNzAzMzQ_f772abc1-14c1-45e7-a616-5c07d2077766">86,345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzItNS0xLTEtNzAzMzQ_3fbdc76b-abca-4332-8d7f-9a0c4ba6f3e7">425,442</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flows from Financing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Term loan borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzQtMS0xLTEtNzAzMzQ_7150ef33-e3c0-4cdc-ae28-e813f15db395">280,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzQtMy0xLTEtNzAzMzQ_f967b1b9-ee57-4023-8b43-003d52199212">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzQtNS0xLTEtNzAzMzQ_fb399cdb-8673-4fd7-976c-61ba5567ad7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Term loan redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:DecreaseForRedemptionOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzUtMS0xLTEtNzQ4MzU_af38a743-fdc0-43ec-859f-03380f8d9a47">280,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:DecreaseForRedemptionOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzUtMy0xLTEtNzQ4MzU_8586ce52-2898-4ec6-98ea-59e2874e3355">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:DecreaseForRedemptionOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzUtNS0xLTEtNzQ4MzU_c38704f0-318e-4b0e-9489-bcef20b67772">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of term loan borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzUtMS0xLTEtNzAzMzQ_77152dab-3cba-477c-ab5f-e5ff033152b5">9,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzUtMy0xLTEtNzAzMzQ_aa5d862d-15a9-41fd-b6f9-5d97ac8f40ee">17,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzUtNS0xLTEtNzAzMzQ_4e5ed7eb-340a-41dc-91e1-c51620dd1166">21,875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from revolving facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzctMS0xLTEtNzQ4ODc_75bb71e3-4f86-4d29-a92b-a669f8ec496f">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzctMy0xLTEtNzQ4ODc_9fc07df0-25c2-48c4-9783-7e5db320588d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzctNS0xLTEtNzQ4ODc_e25697a6-3908-4578-9adb-4035f0d7c2d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on revolving facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzgtMS0xLTEtNzQ4ODc_921b37fc-caab-4a9b-9ce3-50faceb13a7d">50,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzgtMy0xLTEtNzQ4ODc_5b58406b-5284-4a1b-b2fe-cddc06a56d70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzgtNS0xLTEtNzQ4ODc_4d90e702-238f-4e1e-aab7-5e777be771e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzktMS0xLTEtNzQ4ODc_b0848465-e5cb-473a-8ab2-61bd4e2158d5">1,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzktMy0xLTEtNzQ4ODc_ad74c947-e0d5-4a06-b10f-4f9f9ddcfb83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzktNS0xLTEtNzQ4ODc_783407c9-c29c-4533-9dd4-201f187c3c5f">13,457</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net decrease in short-term loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzYtMS0xLTEtNzAzMzQ_6dcebaaf-8f95-46bc-8607-617beb89432d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzYtMy0xLTEtNzAzMzQ_cb4cccf6-7dfa-4071-8809-d1a11613a02a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzYtNS0xLTEtNzAzMzQ_9a181e0e-2000-4678-955b-65aeb6251d24">60,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzctMS0xLTEtNzAzMzQ_fe22c3c4-8ee8-4941-9be4-47f7e478ee75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzctMy0xLTEtNzAzMzQ_00b45773-f362-4a4f-bdfb-17c7c1e5fb99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzctNS0xLTEtNzAzMzQ_b6bd373a-e8e2-4b15-a116-4ed18a402ddf">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of capped call related to convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzgtMS0xLTEtNzAzMzQ_290df380-cfc3-4d38-a043-8fdf60808b99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzgtMy0xLTEtNzAzMzQ_151955cf-34dc-4911-b438-f7e854d49dac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzgtNS0xLTEtNzAzMzQ_cf074d20-1b51-4240-bc41-d68f34f383ff">47,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDAtMS0xLTEtNzAzMzQ_55422f53-8db4-4912-acf5-f748d962b715">21,593</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDAtMy0xLTEtNzAzMzQ_d6313c17-61c1-4440-869d-b26576f13448">4,791</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDAtNS0xLTEtNzAzMzQ_192fb5e0-7cb3-4695-a37d-fb329f96eff3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDEtMS0xLTEtNzAzMzQ_64147c33-4a72-4cfd-be85-fe167e576cc4">4,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDEtMy0xLTEtNzAzMzQ_48de1baf-438d-472f-b4fb-7b682cb23f29">4,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDEtNS0xLTEtNzAzMzQ_bf69a225-9ef3-4b4a-ae70-22b04835b064">4,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDItMS0xLTEtNzAzMzQ_b258fe99-0aec-4e87-92d6-e2aa8edbe3e8">2,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDItMy0xLTEtNzAzMzQ_d6a8719b-2caf-4f91-bcab-e182633e226a">2,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDItNS0xLTEtNzAzMzQ_4199f53a-3d90-4df5-a0c6-ccd7e53f78d1">6,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDMtMS0xLTEtNzAzMzQ_8a80041e-5df2-4ebf-9742-5a3ef84c6506">75,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDMtMy0xLTEtNzAzMzQ_223cfb8d-5e00-4389-8c8e-2ae8acf9edaf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDMtNS0xLTEtNzAzMzQ_9e632ff4-1456-46a3-9987-5e5173b69acf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDQtMS0xLTEtNzAzMzQ_3d5a8ea8-a740-4aae-b3dc-20876acd8ae7">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDQtMy0xLTEtNzAzMzQ_b6d4f8e4-7abc-4dbe-8cfc-598b11738215">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDQtNS0xLTEtNzAzMzQ_e0b21ac3-f5b7-435f-8cf4-18e8e5681968">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDUtMS0xLTEtNzAzMzQ_99b6e4f5-f3cb-497d-a331-f5ba14dcfecc">100,364</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDUtMy0xLTEtNzAzMzQ_b02971a6-5251-465e-9390-edb46af3f74c">15,749</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDUtNS0xLTEtNzAzMzQ_b5f8a2f8-fb60-4a80-991f-26206b00e1ce">367,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rates on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDYtMS0xLTEtNzAzMzQ_8f50e090-2911-4fcc-a8a0-90a61517630f">3,936</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDYtMy0xLTEtNzAzMzQ_ab7894c3-658d-46ea-aee0-d8075038e9e4">2,978</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDYtNS0xLTEtNzAzMzQ_3ae5bd9a-ecf1-4110-8df4-d0e74603248c">4,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net Change in Cash and Cash Equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDctMS0xLTEtNzAzMzQ_bcf0d325-8be3-4ec1-ad38-18e75e0afe65">24,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDctMy0xLTEtNzAzMzQ_c25fd66b-74cc-490d-a4c0-29a1275d4301">67,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDctNS0xLTEtNzAzMzQ_7570e834-d52c-435a-9c94-eb57ef1334af">54,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and Cash Equivalents at Beginning of Year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDgtMS0xLTEtNzAzMzQ_fbc82fdd-11cd-412a-8dfb-d83d01829fe8">259,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDgtMy0xLTEtNzAzMzQ_876182fa-478f-4124-9728-d3169a789c43">192,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2752e169c88b4ff2a289838d456aec0d_I20200328" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDgtNS0xLTEtNzAzMzQ_2de97dfc-b7db-4db0-a67f-0f3e4061a097">137,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and Cash Equivalents at End of Year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDktMS0xLTEtNzAzMzQ_45c0e852-a6b2-4b22-a881-d02b8f785bc0">284,466</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDktMy0xLTEtNzAzMzQ_44fef604-67ce-42b9-befd-1d34d3e2619f">259,496</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDktNS0xLTEtNzAzMzQ_1ce6c73f-4fe3-49c2-8ffe-03dbebe81891">192,305</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental Disclosures of Cash Flow Information:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTEtMS0xLTEtNzAzMzQ_32008deb-a706-4e3c-aef6-4a5b34b40a28">13,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTEtMy0xLTEtNzAzMzQ_314da785-8564-4545-b46e-3d678ffff756">6,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTEtNS0xLTEtNzAzMzQ_660fd792-197b-473b-9768-4ea30f7c597e">7,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTItMS0xLTEtNzAzMzQ_20ba15cb-ce47-480a-934b-b20dc6fd549c">17,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTItMy0xLTEtNzAzMzQ_cac86991-b816-4645-98a2-1b716a6ae11d">24,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTItNS0xLTEtNzAzMzQ_ea37fbb8-eeb0-4243-90c1-b170766f1b36">12,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Investing and Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transfers from inventory to fixed assets for placement of Haemonetics equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:TransfersFromInventoryToFixedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTQtMS0xLTEtNzAzMzQ_21eb4b69-e78d-41e5-8b54-b26c9517f1ec">81,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:TransfersFromInventoryToFixedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTQtMy0xLTEtNzAzMzQ_568fc833-7712-4bef-945b-414056a47a94">51,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:TransfersFromInventoryToFixedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTQtNS0xLTEtNzAzMzQ_9728b389-b102-4fc5-b2ab-11bae8abd0dc">9,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_91"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:7pt;text-align:center"><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 1. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85NC9mcmFnOjdhZTU4NTRiZDkzYTRmNGZiZjE1YmU4NGIxMzA5NDdlL3RleHRyZWdpb246N2FlNTg1NGJkOTNhNGY0ZmJmMTViZTg0YjEzMDk0N2VfMjYwOA_dfc68c53-d03a-4d89-bac5-873ebfaeb99e" continuedAt="i0c1727fd8fe748b5a8669ece7a1a4618" escape="true">DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0c1727fd8fe748b5a8669ece7a1a4618"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Haemonetics is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. When used in this report, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Haemonetics&#8221; and the &#8220;Company&#8221; mean Haemonetics Corporation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blood is essential to a modern healthcare system. Blood and its components (plasma, red cells and platelets) have many vital and frequently life-saving clinical applications. Plasma is used for patients with major blood loss and is manufactured into biopharmaceuticals to treat a variety of illnesses, including immune diseases and coagulation disorders. Red cells treat trauma patients or patients undergoing surgery with high blood loss, such as open heart surgery or organ transplant. Platelets have many uses in patient care, including supporting cancer patients undergoing chemotherapy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Haemonetics manages its business in <ix:nonFraction unitRef="unit" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85NC9mcmFnOjdhZTU4NTRiZDkzYTRmNGZiZjE1YmU4NGIxMzA5NDdlL3RleHRyZWdpb246N2FlNTg1NGJkOTNhNGY0ZmJmMTViZTg0YjEzMDk0N2VfMTY0OTI2NzQ0NDQzNA_287febe9-4bf5-4a4e-8d6a-1fb6ecb2ce5a">three</ix:nonFraction> principal reporting segments: Plasma, Blood Center and Hospital. For that purpose, &#8220;Plasma&#8221; includes plasma collection devices and disposables, plasma donor management software, and anticoagulant and saline sold to plasma customers. &#8220;Blood Center&#8221; includes blood collection and processing devices and disposables for red cells, platelets and whole blood. &#8220;Hospital&#8221;, which is comprised of Hemostasis Management, Vascular Closure, Cell Salvage and Transfusion Management products, includes devices and methodologies for measuring coagulation characteristics of blood, vascular closure devices, specialized blood cell processing systems and disposables, surgical blood salvage systems and blood transfusion management software.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements present separately the Company&#8217;s consolidated financial position, results of operations, cash flows and changes in shareholders&#8217; equity. The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). All amounts presented, except per share amounts, are stated in thousands of U.S. dollars, unless otherwise indicated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events.</span></div></ix:continuation><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE2NzI_2c6fac7b-4a14-447a-9fb8-df4811eb9e7c" continuedAt="ie1ab88275c294d058cb1a9bdc22907fe" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie1ab88275c294d058cb1a9bdc22907fe" continuedAt="i7efe9c1361bc41e7b35185a50bed3c4c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:FiscalPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3NDk_33a4ed01-44f3-4f51-b4c1-6b2c1903c5b1" continuedAt="i0dfec356e56149e79c72d304d45474ae" escape="true">Fiscal Year</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0dfec356e56149e79c72d304d45474ae">Haemonetics&#8217; fiscal year ends on the Saturday closest to the last day of March. Fiscal years <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjc1_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric> and 2022 included 52 weeks with each quarter having 13 weeks. Fiscal 2021 included 53 weeks with each of the first three quarters having 13 weeks and the fourth quarter having 14 weeks.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE2NzM_8406d651-1068-4b71-a7bc-8a3f6f41634d" continuedAt="i81d6ad0d9830435bad57962929b4b0ef" escape="true">Principles of Consolidation</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i81d6ad0d9830435bad57962929b4b0ef">The accompanying consolidated financial statements include all accounts including those of its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. In addition, we assess our strategic investments to determine whether they meet the definition of a variable interest entity (&#8220;VIE&#8221;), and if so, whether the Company has controlling financial interest. Controlling financial interest occurs if the Company has both the power to direct activities of the VIE that most significantly impact the VIE&#8217;s economic performance and an obligation to absorb losses of or the right to receive benefits from the VIE that could potentially be significant to the VIE. The Company&#8217;s strategic investments did not meet the controlling financial interest criteria, as such no VIEs were consolidated during fiscal 2023, 2022 or 2021.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE2NTM_3fc39ea4-b0e0-4bb1-978a-a2d3e1f70040" continuedAt="i960ed080c9354003919ac6a60888431a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i7efe9c1361bc41e7b35185a50bed3c4c" continuedAt="i2a5bba5cd32445d2b22485e7fe84fc54"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i960ed080c9354003919ac6a60888431a">could vary from the amounts derived from its estimates and assumptions. The Company considers estimates to be critical if they are required to make assumptions about material matters that are uncertain at the time of estimation or if materially different estimates could have been made or it is reasonably likely that the accounting estimate will change from period to period. The following are areas considered to be critical and require management&#8217;s judgment: revenue recognition, inventory provisions, intangible asset and goodwill valuation, legal and other judgmental accruals and income taxes.</ix:continuation></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4MDg_64497716-a48a-4849-8ba8-a2ba08f8b518" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may become involved in various legal proceedings that arise in the ordinary course of business, including, without limitation, patent infringement, product liability and environmental matters. Accruals recorded for various contingencies including legal proceedings, employee related litigation, self-insurance and other claims are based on judgment, the probability of losses and, where applicable, the consideration of opinions of internal and/or external legal counsel and actuarially determined estimates. When a loss is probable and a range of loss is established but a best estimate cannot be made, the Company records the minimum loss contingency amount, which could be zero. These estimates are often initially developed substantially earlier than the ultimate loss is known and the estimates are reevaluated each accounting period, as additional information is available. As information becomes known, an additional loss provision is recorded when either a best estimate can be made or the minimum loss amount is increased. When events result in an expectation of a more favorable outcome than previously expected, the best estimate is changed to a lower amount.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4MTg_7cb66d79-3330-46c7-bf19-287ea489ebb1" continuedAt="i00f3e76120c6412c9cb5ff1379cb51f5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenue recognition policy is to recognize revenues from product sales, software and services in accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Codification (&#8220;ASC&#8221;) Update No. 2014-19, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers (Topic 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; this occurs with the transfer of control of the Company&#8217;s goods or services. The Company considers revenue to be earned when all of the following criteria are met: it has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the consideration the Company expects to receive for transferring goods or providing services, is determinable and it has transferred control of the promised items to the customer. A promise in a contract to transfer a distinct good or service to the customer is identified as a performance obligation. A contract&#8217;s transaction price is allocated to each performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of the Company&#8217;s contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the contract&#8217;s transaction price to each performance obligation based on the estimated standalone selling prices of the good or service in the contract. For goods or services for which observable standalone selling prices are not available, the Company uses an expected cost plus a margin approach to estimate the standalone selling price of each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Revenues</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company&#8217;s performance obligations related to product sales are satisfied at a point in time. Product revenue consists of the sale of its disposable blood component collection and processing sets and the related equipment. The Company&#8217;s performance obligation related to product sales is satisfied upon shipment or delivery to the customer based on the specified terms set forth in the customer contract. Shipping and handling activities performed after a customer obtains control of the good are treated as fulfillment activities and are not considered to be a separate performance obligation. Revenue is recognized over time for maintenance plans provided to customers that provide services beyond the Company&#8217;s standard warranty period. Payment terms between customers related to product sales vary by the type of customer, country of sale, and the products or services offered and could result in an unbilled receivable or deferred revenue balance depending on whether the performance obligation has been satisfied (or partially satisfied). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For product sales to distributors, the Company recognizes revenue for both equipment and disposables upon shipment to distributors, which is when its performance obligations are complete. The Company's standard contracts with its distributors state that title to the equipment passes to the distributors at point of shipment to a distributor&#8217;s location. The distributors are responsible for shipment to the end customer along with any installation, training and acceptance of the equipment by the end customer. Payments from distributors are not contingent upon resale of the product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also places equipment at customer sites. While the Company retains ownership of this equipment, the customer has the right to use it for a period of time provided they meet certain agreed to conditions. The Company recovers the cost of providing the equipment from the sale of its disposables.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i2a5bba5cd32445d2b22485e7fe84fc54" continuedAt="i99ef9de740934c669776353d864bea93"><ix:continuation id="i00f3e76120c6412c9cb5ff1379cb51f5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Software and Other Revenues</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To a lesser extent, the Company enters into other types of contracts including certain software licensing arrangements to provide software solutions to support its plasma, blood collection and hospital customers. A portion of its software sales are perpetual licenses typically accompanied by significant implementation services related to software customization as well as other professional and technical services. The Company generally recognizes revenue from the sale of perpetual licenses and related customization services over time (the Company is creating or enhancing an asset that the customer controls) using an input method which requires it to make estimates of the extent of progress toward completion of the contract. When the Company provides other services, including in some instances hosting, technical support and maintenance, it recognizes these fees and charges over time (the customer simultaneously receives and consumes benefits), as performance obligations for these services are satisfied during the contract period. Certain of the Company&#8217;s software licensing arrangements are term-based licenses that include a per-collection or a usage-based fee related to the use of the license and the related technical support and hosting services. For these usage-based arrangements, the Company applies the revenue recognition exception resulting in revenue recognition occurring upon the later of actual usage or satisfaction of the related performance obligations. The payment terms for software licensing arrangements vary by customer pursuant to the terms set forth in the customer contract and result in an unbilled receivable or deferred revenue balance depending on whether the performance obligation has been satisfied (or partially satisfied). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Significant Judgments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price, which includes estimates of variable consideration related to rebates, product returns and volume discounts. These reserves, which are based on estimates of the amounts earned or to be claimed on the related sales, are recorded as a reduction of revenue and a current liability. The Company&#8217;s estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#8217;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract. The amount of variable consideration included in the net sales price is limited to the amount that is probable not to result in a significant reversal in the amount of the cumulative revenue recognized in a future period. Revenue recognized in the current period related to performance obligations satisfied in prior periods was not material. If the Company is unable to estimate the expected rebates reasonably, it records a liability for the maximum potential rebate or discount that could be earned. In circumstances where the Company provides upfront rebate payments to customers, it capitalizes the rebate payments and amortizes the resulting asset as a reduction of revenue using a systematic method over the life of the contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Balances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables and contract assets, as well as customer advances, customer deposits and deferred revenue (contract liabilities) on the consolidated balance sheets. The difference in timing between billing and revenue recognition primarily occurs in software licensing arrangements, resulting in contract assets and contract liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Practical Expedients</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected not to disclose the value of transaction price allocated to unsatisfied performance obligations for contracts with an original expected length of <ix:nonNumeric contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" name="us-gaap:RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTAzNTc_66892351-0fde-48b6-8599-e89a8c440d9e">one year</ix:nonNumeric> or less. When applicable, the Company has also elected to use the practical expedient to not adjust the promised amount of consideration for the effects of a significant financing component if it is expected, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service, will be <ix:nonNumeric contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" name="us-gaap:RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTA3NDU_66892351-0fde-48b6-8599-e89a8c440d9e">one year</ix:nonNumeric> or less.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE2ODI_a527e76f-b654-451b-9fda-182dba25a99c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Translation of Foreign Currencies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All assets and liabilities of foreign subsidiaries are translated at the rate of exchange at year-end while sales and expenses are translated at an average rate in effect during the year. The net effect of these translation adjustments is shown in the accompanying financial statements as a component of stockholders&#8217; equity. Foreign currency transaction gains and losses, including those resulting from intercompany transactions, are charged directly to earnings and included in other expense, net on the consolidated statements of income. The impact of foreign exchange on long-term intercompany loans, for which repayment has not been scheduled or planned, are recorded in accumulated other comprehensive loss on the consolidated balance sheet.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i99ef9de740934c669776353d864bea93" continuedAt="i511e905d26474694bebb2141f8dce847"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3MzE_535437c9-3ac3-4fcb-93ec-190d7c3218a7" continuedAt="i321266e22a1a4c56b71352d2f3d1319a" escape="true">Cash and Cash Equivalents</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i321266e22a1a4c56b71352d2f3d1319a">Cash equivalents include various instruments such as money market funds, U.S. government obligations and commercial paper with maturities of <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="hae:MaximumTermOfMaturitiesForCashAndCashEquivalents" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTE3MTA_2cce708b-8eb0-481d-9f84-27bfedddae3d">three months</ix:nonNumeric> or less at date of acquisition. Cash and cash equivalents are recorded at cost, which approximates fair market value. As of April&#160;1, 2023, cash and cash equivalents consisted primarily of investments in United States Government Agency and institutional money market funds.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4MTA_d806b00a-e3ce-488a-8cd6-94620141bd90" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Credit Losses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes a specific allowance for customers when it is probable that they will not be able to meet their financial obligations. Customer accounts are reviewed individually on a regular basis and reserves are established as deemed appropriate. The Company also maintains a general reserve using a percentage that is established based upon the age of its receivables and its collection history. The Company establishes allowances for balances not yet due and past due accounts based on past experience.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3MDA_24168525-d39a-462d-8ed9-f42ce0bcc9b5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value and include the cost of material, labor and manufacturing overhead. Cost is determined with the first-in, first-out method. The Company has based its provisions for excess, expired and obsolete inventory primarily on its estimates of forecasted net sales. Significant changes in the timing or level of demand for the Company&#8217;s products result in recording additional provisions for excess, expired and obsolete inventory. Additionally, uncertain timing of next-generation product approvals, variability in product launch strategies, non-cancelable purchase commitments, product recalls and variation in product utilization all affect the Company&#8217;s estimates related to excess, expired and obsolete inventory.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4MjA_9bb4545c-8e9d-43b8-8054-9d7860a50c77" continuedAt="i1b6415c4480c4f36888f460fe44f8eb5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="hae:ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3NTE_34f2c7f2-1857-4f97-aef1-d35b6431300f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment is recorded at historical cost. The Company provides for depreciation and amortization by charges to operations using the straight-line method in amounts estimated to recover the cost of the building and improvements, equipment and furniture and fixtures over their estimated useful lives as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:86.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Classification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia734649bb2e94aaaba0ee38844e22e8d_D20220403-20230401" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfMS0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOmQ3MTZiNDRjYmEyMjRlYmY4NGNlZmE5YjQ1Mjk4NjhiXzQ_aa8b30fe-3fb6-4af0-972f-fd3a83669e34">30</ix:nonNumeric>-<ix:nonNumeric contextRef="i4cb751cf6eb5433f9a53896b439e745e_D20220403-20230401" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfMS0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOmQ3MTZiNDRjYmEyMjRlYmY4NGNlZmE5YjQ1Mjk4NjhiXzc_88ef2860-b690-48de-b270-ff782c4bde1e">40</ix:nonNumeric> Years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b1bc73a7c434d8e9c1c7ea1d43cb121_D20220403-20230401" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfMi0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjQxM2MwOTNkMGUxOTQ1YjE4OTgxNTMxNDM4ZGQxMTBkXzQ_845b8a4c-d6c0-4bdd-afcf-5737294e2423">5</ix:nonNumeric>-<ix:nonNumeric contextRef="i8d19f87949e24b99a793aca6577b9df5_D20220403-20230401" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfMi0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjQxM2MwOTNkMGUxOTQ1YjE4OTgxNTMxNDM4ZGQxMTBkXzc_beb65f29-e0f9-4f85-be69-eec2f065bb65">20</ix:nonNumeric> Years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant equipment and machinery</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c33fc42a5f5449fa7494bc0c090d585_D20220403-20230401" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfMy0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjZkNTdkMTk5NTAxZDRiMGFiYTEzYTZhOWViNjIyZTYwXzQ_7f713eb4-34df-4dd1-bc65-1739a04c2fbe">3</ix:nonNumeric>-<ix:nonNumeric contextRef="ib49d6de2075749128f193bc5cdce0870_D20220403-20230401" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfMy0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjZkNTdkMTk5NTAxZDRiMGFiYTEzYTZhOWViNjIyZTYwXzc_9ffe3e1f-c701-4fba-b7da-430f920193ee">15</ix:nonNumeric> Years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and information technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibd32c41156c94b0589e00e52da019550_D20220403-20230401" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfNC0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjg4Y2RkMzVkZDMyNzRkZjg4MDdlNDk5MjMzZmZiMjRhXzQ_06fad584-c0f1-42c1-9ab1-7287ffd69fbe">3</ix:nonNumeric>-<ix:nonNumeric contextRef="i03fe4b852d714a1aa9e19e12fe06664b_D20220403-20230401" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfNC0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjg4Y2RkMzVkZDMyNzRkZjg4MDdlNDk5MjMzZmZiMjRhXzc_8f77ea71-3658-464f-abd9-687f185af2fd">10</ix:nonNumeric> Years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Haemonetics equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6edb3ee4a05545b48465b7b748a5455b_D20220403-20230401" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfNS0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjRlNjA3NmM4Y2QyNjQ1MDk4OWVlN2NjMjNkNTliZmU0XzQ_c2c6a65f-d619-4546-af07-fd3de6245bf1">3</ix:nonNumeric>-<ix:nonNumeric contextRef="i40bfcce1095940b7b5d05d79a9a16330_D20220403-20230401" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfNS0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjRlNjA3NmM4Y2QyNjQ1MDk4OWVlN2NjMjNkNTliZmU0Xzc_346e4e92-be95-4965-91fa-fce35c7d904c">7</ix:nonNumeric> Years</span></div></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the depreciation periods of property, plant and equipment to determine whether events or circumstances warrant revised estimates of useful lives. All property, plant and equipment are also tested for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s installed base of devices includes devices owned by the Company and devices sold to the customer. The asset on its balance sheet classified as Haemonetics equipment consists of medical devices installed at customer sites but owned by Haemonetics. Generally, the customer has the right to use it for a period of time as long as they meet the conditions the Company has established, which among other things, generally include one or more of the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Purchase and consumption of a certain level of disposable products</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Payment of monthly rental fees </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An asset utilization performance metric, such as performing a minimum level of procedures per month per device</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the impairment tests noted below for other intangible assets subject to amortization, the Company reviews Haemonetics equipment and the related useful lives of such equipment at least once a year, or more frequently if certain conditions arise, to determine if any adverse conditions exist that would indicate the carrying value of these assets may not be recoverable. To conduct these reviews, the Company estimates the future amount and timing of demand for disposables used </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i511e905d26474694bebb2141f8dce847" continuedAt="i88ef40fb0e5e4f609c0fa06fc4169ffb"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1b6415c4480c4f36888f460fe44f8eb5" continuedAt="iaf749a788a4b4072aca9d0b0dec1a494">with these devices, from which it generates revenues. The Company also considers product life cycle in its evaluation of useful life and recoverability. Changes in expected demand can result in additional depreciation expense, which is classified as cost of goods sold. Any significant unanticipated changes in demand could impact the value of the Company&#8217;s devices and its reported operating results.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaf749a788a4b4072aca9d0b0dec1a494">Leasehold improvements are depreciated over the lesser of their useful lives or the term of the lease. Maintenance and repairs are generally expensed to operations as incurred. When the repair or maintenance costs significantly extend the life of the asset, these costs may be capitalized. When equipment and improvements are sold or otherwise disposed of, the asset cost and accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is included in the consolidated statements of income.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3Mzk_fd846c70-8bd2-46a1-9426-38b977348849" continuedAt="i55c2f55f3dd8431abc6a9bf6d9576c17" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess purchase price over the fair value of the net tangible and other identifiable intangible assets acquired. Goodwill is not amortized and is instead reviewed for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying value. The Company performs its annual impairment test on the first day of the fiscal fourth quarter for each of its reporting units. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC Update No. 2017-04,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">entities perform their goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit&#8217;s fair value. A reporting unit is defined as an operating segment or one level below an operating segment, referred to as a component. The Company determines its reporting units by first identifying its operating segments and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. The Company aggregates components within an operating segment that have similar economic characteristics. The Company&#8217;s reportable segments and reporting units are as follows: Plasma, Blood Center and Hospital.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When allocating goodwill from business combinations to its reporting units, the Company assigns goodwill to the reporting units that it expects to benefit from the respective business combination at the time of acquisition. In addition, for purposes of performing its goodwill impairment tests, assets and liabilities, including corporate assets, which relate to a reporting unit&#8217;s operations and would be considered in determining its fair value, are allocated to the individual reporting units. The Company allocates assets and liabilities not directly related to a specific reporting unit, but from which the reporting unit benefits, based primarily on the respective revenue contribution of each reporting unit. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the income approach, specifically the discounted cash flow method, to derive the fair value of each of its reporting units in preparing its goodwill impairment assessments. This approach calculates fair value by estimating the after-tax cash flows attributable to a reporting unit and then discounting these after-tax cash flows to a present value using a risk-adjusted discount rate. The Company selected this method as being the most meaningful in preparing its goodwill assessments because the use of the income approach typically generates a more precise measurement of fair value than the market approach.&#160;In applying the income approach to its accounting for goodwill, the Company makes assumptions about the amount and timing of future expected cash flows, terminal value growth rates and appropriate discount rates. The amount and timing of future cash flows within the Company&#8217;s discounted cash flow analysis is based on its most recent operational budgets, long range strategic plans and other estimates. The terminal value growth rate is used to calculate the value of cash flows beyond the last projected period in the Company&#8217;s discounted cash flow analysis and reflects the Company&#8217;s best estimates for stable, perpetual growth of its reporting units. The Company uses estimates of market-participant risk adjusted weighted average cost of capital as a basis for determining the discount rates to apply to its reporting units&#8217; future expected cash flows. The Company corroborated the valuations that arose from the discounted cash flow approach by performing both a market multiple valuation and by reconciling the aggregate fair value of its reporting units to its market capitalization at the time of the test.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2023, 2022 and 2021, the Company performed its annual goodwill impairment test. The results of the goodwill impairment test performed indicated that the estimated fair value of all of its reporting units exceeded their respective carrying values. There were no reporting units at risk of impairment as of the fiscal 2023, 2022 and 2021 annual test date. </span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i88ef40fb0e5e4f609c0fa06fc4169ffb" continuedAt="i6bf4b523d8304b258ecf1cff1f03f14d"><ix:continuation id="i55c2f55f3dd8431abc6a9bf6d9576c17"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews intangible assets subject to amortization for impairment at least annually or more frequently if certain conditions arise to determine if any adverse conditions exist that would indicate that the carrying value of an asset or asset group may not be recoverable, or that a change in the remaining useful life is required. Conditions indicating that an impairment exists include, but are not limited to, a change in the competitive landscape, internal decisions to pursue new or different technology strategies, a loss of a significant customer or a significant change in the marketplace including prices paid for its products or the size of the market for its products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When an impairment indicator exists, the Company tests the intangible asset for recoverability. For purposes of the recoverability test, the Company groups its amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset (asset group) exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset (asset group), the Company will write the carrying value down to the fair value in the period identified. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally calculates the fair value of its intangible assets as the present value of estimated future cash flows it expects to generate from the asset using a risk-adjusted discount rate. In determining its estimated future cash flows associated with its intangible assets, the Company uses estimates and assumptions about future revenue contributions, cost structures and remaining useful lives of the asset (asset group).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company determines the estimate of an intangible asset&#8217;s remaining useful life should be reduced based on its expected use of the asset, the remaining carrying amount of the asset is amortized prospectively over the revised estimated useful life. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has in-process research and development (&#8220;IPR&amp;D&#8221;) intangible assets with indefinite lives. IPR&amp;D assets are not amortized. The Company reviews these assets for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of the asset is less than its carrying value. The Company performs its annual impairment test on the first day of the fiscal fourth quarter for its IPR&amp;D assets. The Company makes assumptions about future cash flows, terminal value growth, costs for completion and appropriate discount rates. The Company elected qualitative assessments in fiscal 2023 and 2022.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4MzQ_627271f4-b965-4c63-b7e0-41b8ff5ecbea" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for the Costs of Computer Software to be Sold, Leased, or Otherwise Marketed</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 985-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software - Costs of Software to be Sold, Leased or Marketed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, specifies that costs incurred internally in researching and developing a computer software product should be charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs should be capitalized until the product is available for general release to customers, at which point capitalized costs are amortized over their estimated useful life of <ix:nonNumeric contextRef="i3acb260a76164a64b8af93dcc2faa623_D20220403-20230401" name="hae:SoftwareCapitalizationTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjQwMTc_d0e47447-e6f1-4afb-be2b-4555bba5cb13">5</ix:nonNumeric> to <ix:nonNumeric contextRef="iecd0cd60e86c45669800594f2197741d_D20220403-20230401" name="hae:SoftwareCapitalizationTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjQwMjM_30a0d7a3-95ff-4f9e-9bee-38a89ae3746d">10</ix:nonNumeric> years. Technological feasibility is established when it has a detailed design of the software and when research and development activities on the underlying device, if applicable, are completed. The Company capitalizes costs associated with both software that it sells as a separate product and software that is embedded in a device.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the net realizable value of capitalized assets periodically to assess the recoverability of amounts capitalized. There were <ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="INF" name="us-gaap:CapitalizedComputerSoftwareImpairments1" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjQ0OTk_150c3d39-af54-456a-932a-c544ab6fe701"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="INF" name="us-gaap:CapitalizedComputerSoftwareImpairments1" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjQ0OTk_67b8c789-b38a-49a0-b8a1-d5bf76e0e386"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="INF" name="us-gaap:CapitalizedComputerSoftwareImpairments1" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjQ0OTk_dd9bcd8a-33b7-4601-a16c-7301c7266c5b">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment charges recorded during fiscal <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjQ1NDQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric>, 2022 and 2021. In the future, the net realizable value may be adversely affected by the loss of a significant customer or a significant change in the market place, which could result in an impairment being recorded.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3ODE_215e0a59-4298-4879-9d1b-4f2224e9f1c6" continuedAt="i8d8164d3e8594889a56dbfce08b84cdc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities represent items payable or expected to settle within the next twelve months. The items included in the fiscal year end balances were:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfMy0xLTEtMS03MDMzNA_383d1582-03da-44c2-82b1-6edb8f5ca27f">30,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfMy0zLTEtMS03MDMzNA_0d642e47-fb9e-4222-8466-a81a2f945a6c">26,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfNy0xLTEtMS03MDMzNA_b3ff5c99-4ec8-412f-a0fe-9c1e84f03457">863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfNy0zLTEtMS03MDMzNA_6776d9c9-6b80-4e80-b71d-80b125c4bbd1">31,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfOC0xLTEtMS03MDMzNA_b291fe6c-3e53-4c73-bb2d-a67d39826b74">80,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfOC0zLTEtMS03MDMzNA_dba932ab-f7d5-4b42-8018-aab206214a96">63,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfOS0xLTEtMS03MDMzNA_ce88a954-18e9-49d8-a289-58388ec3b1f1">111,628</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfOS0zLTEtMS03MDMzNA_4ff75efc-31c6-4c58-b67f-d14d6706a574">121,207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i6bf4b523d8304b258ecf1cff1f03f14d" continuedAt="i41f1c06e8823478aad6d079a156ffd89"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i8d8164d3e8594889a56dbfce08b84cdc" continuedAt="i3f5ba35fa2c443b3acd1c6d549e083b1">Other Long-Term Liabilities</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3f5ba35fa2c443b3acd1c6d549e083b1">Other long-term liabilities represent items that are not payable or expected to settle within the next twelve months.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4NDE_427ea4ff-9379-4546-9f71-a118d16613b2" continuedAt="if897d7ce1a4a4bc4aac3cb9a96637fbf" escape="true">Research and Development Expenses</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if897d7ce1a4a4bc4aac3cb9a96637fbf">All research and development costs are expensed as incurred.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4MjU_407225dd-b77b-46a5-978e-5affd577f592" continuedAt="i0c563001b3fd43cdbc335b254f71f610" escape="true">Advertising Costs</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0c563001b3fd43cdbc335b254f71f610">All advertising costs are expensed as incurred and are included in selling, general and administrative expenses in the consolidated statements of income.</ix:continuation> Advertising expenses were $<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjUzOTc_63691334-a4f4-4db3-b769-37c76eb292b7">7.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjU0MDE_2c3a7d52-f368-4ffc-8075-7d3c99f2c49c">4.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjU0MDg_44070206-c477-4e21-b014-6b1f81698686">2.7</ix:nonFraction> million in fiscal <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjU0MjE_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric>, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3NjI_76998b31-0989-4425-9821-1428e271df3a" continuedAt="i40c54f767bad427cba459e2000163882" escape="true">Shipping and Handling Costs</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i40c54f767bad427cba459e2000163882">Shipping and handling costs are included in selling, general and administrative expenses.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3NDA_aa0f4818-5cf0-4b88-b216-961d3be142c3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision is calculated for all jurisdictions in which the Company operates. The income tax provision process involves calculating current taxes due and assessing temporary differences arising from items that are taxable or deductible in different periods for tax and accounting purposes and are recorded as deferred tax assets and liabilities. Deferred tax assets are evaluated for realizability and a valuation allowance is maintained for the portion of the Company&#8217;s deferred tax assets that are not more-likely-than-not realizable. All available evidence, both positive and negative, has been considered to determine whether, based on the weight of that evidence, a valuation allowance is needed against the deferred tax assets. Refer to Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information and discussion of the Company&#8217;s income tax provision and balances.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in all jurisdictions in which it operates. The Company records a liability for uncertain tax positions taken or expected to be taken in income tax returns. The Company&#8217;s financial statements reflect expected future tax consequences of such positions presuming the taxing authorities&#8217; full knowledge of the position and all relevant facts. The Company records a liability for the portion of unrecognized tax benefits claimed that it has determined are not more-likely-than-not realizable. These tax reserves have been established based on management&#8217;s assessment as to the potential exposure attributable to the Company&#8217;s uncertain tax positions as well as interest and penalties attributable to these uncertain tax positions. All tax reserves are analyzed quarterly and adjustments are made as events occur that result in changes in judgment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates at the end of each reporting period whether some or all of the undistributed earnings of its foreign subsidiaries are permanently reinvested. The Company recognizes deferred income tax liabilities to the extent that management asserts that undistributed earnings of its foreign subsidiaries are not permanently reinvested or will not be permanently reinvested in the future. The Company&#8217;s position is based upon several factors including management&#8217;s evaluation of the Haemonetics and its subsidiaries&#8217; financial requirements, the short-term and long-term operational and fiscal objectives of the Company and the tax consequences associated with the repatriation of earnings.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:DebtPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ4ODExOA_0e05bf70-0308-4959-b92b-59e0d44429c2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to April 4, 2021, the Company accounted for convertible senior notes as separate liability and equity components, determining the fair value of the respective liability components based on an estimate of the fair value of a similar liability without a conversion option and assigning the residual value to the equity component.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective April 4, 2021, the Company accounted for convertible senior notes as a single liability measured at its amortized cost. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. At issuance, the carrying amount is calculated as the proceeds, net of initial debt issuance costs. The difference between the principal amount and carrying value is amortized to interest expense over the term of the convertible senior notes using the effective interest rate method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A detailed analysis of the terms of the convertible senior notes transactions is required to determine existence of any derivatives that may require separate mark-to-market accounting under applicable accounting guidance.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i41f1c06e8823478aad6d079a156ffd89" continuedAt="id3371cb9595349208cdd771c10214846"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4NDA_b22411a5-7c60-4d5c-938b-d0077bcec887" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its derivative financial instruments in accordance with ASC Topic 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 815&#8221;) and ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 820&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for the change in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative as a hedging instrument for accounting purposes and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. In addition, ASC 815 provides that, for derivative instruments that qualify for hedge accounting, changes in the fair value are either (a)&#160;offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings or (b)&#160;recognized in equity until the hedged item is recognized in earnings, depending on whether the derivative is being used to hedge changes in fair value or cash flows. The ineffective portion of a derivative&#8217;s change in fair value is immediately recognized in earnings. The Company does not use derivative financial instruments for trading or speculation purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the underlying hedged transaction affects earnings, the gains or losses on the forward foreign exchange rate contracts designated as hedges are recorded in net revenues, cost of goods sold, operating expenses and other expense, net in the Company&#8217;s consolidated statements of income, depending on the nature of the underlying hedged transactions. The cash flows related to the gains and losses are classified in the consolidated statements of cash flows as part of cash flows from operating activities. For those derivative instruments that are not designated as part of a hedging relationship the Company records the gains or losses in earnings currently. These gains and losses are intended to offset the gains and losses recorded on net monetary assets or liabilities that are denominated in foreign currencies. The Company recorded foreign currency losses of $<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMzEyMDY_f927ebee-def8-400b-8a22-703678913375">1.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMzEyMTA_e64ae4f6-1b32-4ea8-a325-26edec703052">1.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMzEyMTc_51971b52-f8dc-4828-8092-b41033b6c513">0.7</ix:nonFraction> million in fiscal <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMzEyMzA_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric>, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a quarterly basis, the Company assesses whether the cash flow hedges are highly effective in offsetting changes in the cash flow of the hedged item. The Company manages the credit risk of its counterparties by dealing only with institutions that it considers financially sound and considers the risk of non-performance to be remote. Additionally, the Company&#8217;s interest rate risk management strategy includes the use of interest rate swaps to mitigate its exposure to changes in variable interest rates. The Company&#8217;s objective in using interest rate swaps is to add stability to interest expense and to manage and reduce the risk inherent in interest rate fluctuations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s derivative instruments do not subject its earnings or cash flows to material risk, as gains and losses on these derivatives are intended to offset losses and gains on the item being hedged. The Company does not enter into derivative transactions for speculative purposes and it does not have any non-derivative instruments that are designated as hedging instruments pursuant to ASC 815.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3NTI_ccb15765-a275-49bb-9f87-da1741a563e7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expenses the fair value of share-based awards granted to employees, board members and others, net of estimated forfeitures. To calculate the grant-date fair value of its stock options the Company uses the Black-Scholes option-pricing model and for performance share units it uses Monte Carlo simulation models.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3NDc_0ca7c02f-b4f3-4f76-9947-84ad40afa807" continuedAt="i7a9bd2400fc642b6aa5cf3021ed5fd61" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Costs Associated with Exit Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records employee termination costs in accordance with ASC Topic 712</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Compensation - Nonretirement and Postemployment Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if it pays the benefits as part of an on-going benefit arrangement, which includes benefits provided as part of its established severance policies or that it provides in accordance with international statutory requirements. The Company accrues employee termination costs associated with an on-going benefit arrangement if the obligation is attributable to prior services rendered, the rights to the benefits have vested, the payment is probable and the liability can be reasonably estimated. The Company accounts for employee termination benefits that represent a one-time benefit in accordance with ASC Topic 420</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Exit or Disposal Cost Obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. It records such costs into expense over the employee&#8217;s future service period, if any.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other costs associated with exit activities may include contract termination costs, including costs related to leased facilities to be abandoned or subleased, consultant fees and impairments of long-lived assets. The costs are expensed in accordance with ASC Topic 420 and ASC Topic 360</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Property, Plant and Equipment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and are included primarily in selling, general and administrative costs in its consolidated statement of income. Additionally, costs directly related to the Company&#8217;s active restructuring initiatives, including program management costs, accelerated depreciation and costs to transfer product lines </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="id3371cb9595349208cdd771c10214846" continuedAt="ie98ba96f4e8d4d7da19233c681bbb514"><div><ix:continuation id="i7a9bd2400fc642b6aa5cf3021ed5fd61"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">among facilities are included within costs of goods sold and selling, general and administrative costs in its consolidated statement of income. Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information and discussion of its restructuring plans.</span></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3NzY_f8159a8b-b23e-4c8b-8f03-36fd232f327d" continuedAt="ifa03e843aac94c40b689d9341319d8bc" escape="true">Valuation of Acquisitions</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifa03e843aac94c40b689d9341319d8bc">The Company allocates the amounts it pays for each acquisition to the assets acquired and liabilities assumed based on their estimated fair values at the dates of acquisition, including acquired identifiable intangible assets. The Company bases the estimated fair value of identifiable intangible assets on detailed valuations that use significant assumptions including forecasted cash flows, revenues attributable to existing technology and existing customer attrition. When estimating the significant assumptions to be used in the valuation, the Company includes a consideration of current industry information, market and economic trends, historical results of the acquired business, and other relevant factors. These significant assumptions are forward-looking and could be affected by future economic and market conditions. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ4NTM2NA_51d93681-104a-4af5-b6cd-4280879a8220" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds strategic investments, including preferred stock and a special share, in a privately held entity. The special share allows the Company to acquire the entity in accordance with an agreement between the parties. As these equity instruments do not have readily determinable fair values, they have been measured using the measurement alternative, at cost less impairment. The carrying amount for these instruments would be subsequently adjusted for observable price changes, or prices in orderly transactions for an identical investment or similar investment of the same issuer. In addition, these investments are periodically evaluated for impairment. The investments are classified as other long-term assets on the Company&#8217;s Consolidated Balance Sheets and the Company has <ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ4ODc5Ng_d2e6d671-c348-4763-b6c5-57ec8655a846">not</ix:nonFraction> recorded any adjustments to the carrying value of strategic investments in fiscal 2023.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE2OTg_311a9075-1d2c-449a-aabb-5bedca98b5b4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Significant Customers</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents and accounts receivable. In fiscal 2023, 2022 and 2021, the Company&#8217;s ten largest customers accounted for approximately <ix:nonFraction unitRef="number" contextRef="ib118e4be0869418993e5e01e0a05c3d3_D20220403-20230401" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMzU3MzY_226b0829-0ab0-4cb3-afa4-5a51f286a86a">48</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ica5c1f5ccf23408886c2ccf29b825567_D20210404-20220402" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ4ODgxOA_e14e4aac-2703-44f4-b5a4-d860afef16ae">45</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ic27d4ecc7a734888b526104ed27669d7_D20200329-20210403" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ4ODgyMg_8dee7c0c-f861-4956-9f7d-94bada969438">49</ix:nonFraction>% of net revenues, respectively. In fiscal 2023, one Plasma customer, CSL Limited (together with its affiliates, &#8220;CSL&#8221;) was greater than 10% of total net revenues and in total accounted for approximately <ix:nonFraction unitRef="number" contextRef="i04ed8db1084a467599f50150cbd6f746_D20220403-20230401" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMzU5NzE_9d1fb7ec-9263-4f23-a2d6-7f8de11a77a6">14</ix:nonFraction>% of net revenues. In addition to CSL, two customers also accounted for greater than 10% of the Plasma segment&#8217;s net revenues and one customer also accounted for greater than 10% of the Blood Center segment&#8217;s net revenues, but did not exceed 10% of total net revenues, in fiscal 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain other markets and industries can expose the Company to concentrations of credit risk. For example, in the Plasma business unit, sales are concentrated with several large customers. As a result, accounts receivable extended to any one of these biopharmaceutical customers can be significant at any point in time. Also, a portion of the Company&#8217;s trade accounts receivable outside the U.S. include sales to government-owned or supported healthcare systems in several countries, which are subject to payment delays. Payment is dependent upon the financial stability and creditworthiness of those countries&#8217; national economies. The Company has not incurred significant losses on government receivables. The Company continually evaluates all government receivables for potential collection risks associated with the availability of government funding and reimbursement practices. If the financial condition of customers or the countries&#8217; healthcare systems deteriorate such that their ability to make payments is uncertain, allowances may be required in future periods.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE2NjA_40d28ebe-ddb3-477d-b941-9cb89a875f79" continuedAt="i81474b50502d44388c604fde626c0ad5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Standards Implemented</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Codification (&#8220;ASC&#8221;) Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326). ASC Update No. 2016-13 is intended to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information, including forecasted information, to develop credit loss estimates. The Company adopted ASC Update No. 2016-13 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company&#8217;s consolidated financial statements. </span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ie98ba96f4e8d4d7da19233c681bbb514"><ix:continuation id="i81474b50502d44388c604fde626c0ad5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASC Update No. 2018-15, Intangibles, Goodwill and Other - Internal-Use Software (Subtopic 350-40). The new guidance aligns the accounting implementation costs incurred in a cloud computing arrangement that is a service contract with the accounting for internal-use software licenses. The Company adopted ASC Update No. 2018-15 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Securities and Exchange Commission (&#8220;SEC&#8221;) issued a final rule that amends the financial statement requirements for acquisitions and dispositions of businesses. The amendments primarily relate to disclosures required by Rule 3-05 and Article 11 of Regulation S-X and modifies the tests provided in Rule 1-02(w) of Regulation S-X used to determine whether a subsidiary or an acquired or disposed business is significant and modifies the number of years of audited financial statements required for acquisitions with significance levels greater than specified percentages. The Company early adopted these amendments during the fourth quarter of fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Codification (&#8220;ASC&#8221;) Update No. 2019-12 &#8212; Income Taxes (Topic 740). The new guidance improves consistent application of and simplifies the accounting for income taxes by removing certain exceptions to the general principals in Topic 740. The Company adopted ASC Update No. 2019-12 effective April 4, 2021. The adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASC ASU Update No. 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). The amendments simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company early adopted ASC Update No. 2020-06 effective April 4, 2021 using the modified retrospective method, which resulted in a decrease of $<ix:nonFraction unitRef="usd" contextRef="i916dfcb35225444db2be37fbccd76378_I20210404" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ5NjY2Nw_a9199d05-d9f0-4e93-81cb-ce1c4851319e">61.2</ix:nonFraction>&#160;million to additional paid-in capital, a decrease to non-current deferred tax liabilities of $<ix:nonFraction unitRef="usd" contextRef="ie55a1738904642cd8ecd0cbc158879ef_I20210404" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ5NjY5OA_ee48642b-6e9a-4e58-9aec-bb3744e31f5a">20.0</ix:nonFraction>&#160;million, and an increase of $<ix:nonFraction unitRef="usd" contextRef="ie55a1738904642cd8ecd0cbc158879ef_I20210404" decimals="-5" name="us-gaap:ConvertibleLongTermNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ5NjcyNw_21402c4e-490a-4471-8298-7a4342cc4218">80.3</ix:nonFraction>&#160;million to non-current convertible notes, net, on the consolidated balance sheets. Additionally, retained earnings was adjusted to remove amortization expense recognized in prior periods related to the debt discount and the convertible notes no longer have a debt discount that will be amortized, net of taxes. The impact to retained earnings on the consolidated balance sheets as of April 4, 2021 is an increase of $<ix:nonFraction unitRef="usd" contextRef="i8fbc64b8be934aaba7b7e05bf27bf2df_I20210404" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ5Njc1Ng_86a0ef42-9f5e-4a8b-bd3b-790072e6f149">1.0</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the FASB issued ASC Update No. 2021-05 &#8212; Leases (Topic 842). The new guidance requires a lessor to classify a lease with variable lease payments that do not depend on an index or rate as an operating lease at lease commencement if the lease would have been classified as a sales-type lease or a direct financing lease in accordance with the classification criteria of ASC 842 and the lessor would have otherwise recognized a day-one loss. The Company prospectively adopted ASC Update No. 2021-05 effective in the second quarter of fiscal year 2022. The adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzI5MDE_a7f215c1-f3df-4967-b220-2c37a53f25d2" continuedAt="ibf5fbf3e47f7417c9b28cb3c30e9f619" escape="true">RESTRUCTURING</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibf5fbf3e47f7417c9b28cb3c30e9f619" continuedAt="i7ce68da72ff243b29e030b2788332f36"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, the Company reviews the global economy, the healthcare industry, and the markets in which it competes to identify opportunities for efficiencies, enhance commercial capabilities, align its resources and offer its customers better solutions. In order to realize these opportunities, the Company undertakes restructuring-type activities to transform its business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Board of Directors of the Company approved the Operational Excellence Program (the &#8220;2020 Program&#8221;) and delegated authority to the Company&#8217;s management to determine the detail of the initiatives that will comprise the program. During fiscal 2022, the Company revised the program to improve product and service quality, reduce cost principally in its manufacturing and supply chain operations and ensure sustainability while helping to offset impacts from a previously announced customer loss, rising inflationary pressures and effects of the COVID-19 pandemic. The Company expects to incur aggregate charges between $<ix:nonFraction unitRef="usd" contextRef="ic28c109153f44c518dc27cd58f174f92_I20190731" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzEwNjY_ddf02f97-a9ab-43ab-bfe5-91acf38325a6">95</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ia169b122e4e748a2bbfec2d666095114_I20190731" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzEwNzM_b599e4c9-df74-4259-aa19-679d971acd34">105</ix:nonFraction>&#160;million by the end of fiscal 2025 under the program. The majority of charges will result in cash outlays, including severance and other employee costs, and will be incurred as the specific actions required to execute these initiatives are identified and approved. During fiscal <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzEzMjg_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric>, 2022 and 2021, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="i6982a32b8c784f13bc9963f00302b541_D20220403-20230401" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzEzNjQ_d66bf2b3-357d-41e8-b4f2-3bf291cfd831">11.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i5ca6348e2ac24a4195142c309fc7a641_D20210404-20220402" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzEzNjg_d7bead0f-bb5b-418f-b3c0-a7730259993c">28.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifea5055cceb64d2faa7c2c933a01dfc9_D20200329-20210403" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzEzNzU_7f131477-e2df-473f-92b7-666d06403970">15.1</ix:nonFraction>&#160;million of restructuring and restructuring related costs under this program, respectively. Total cumulative charges under this program are $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzE1MDk_269919f4-25b1-4bfa-9fdd-cb0067e00706">67.2</ix:nonFraction> million as of April&#160;1, 2023.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i7ce68da72ff243b29e030b2788332f36" continuedAt="ie365efa98e344eec84881e5a0dca45f3"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzI5MTQ_255a1683-6f43-472e-b7ac-543c347e3f6a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for restructuring reserves related to the 2020 Program and prior programs for the fiscal years ended April&#160;1, 2023, April&#160;2, 2022 and April&#160;3, 2021, substantially all of which relates to employee severance and other employee costs:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 Program</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 28, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75e1df66c146d8bc21150965eea19b_I20200328" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEtMS0xLTEtNzAzMzQ_09a79dd4-b033-452b-8b86-8c2ea046a38c">1,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id761fa129e9b4c9b8c14ce258bfb5327_I20200328" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEtMy0xLTEtNzAzMzQ_091f0533-93d7-4796-9a5e-28304b0c1f57">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2752e169c88b4ff2a289838d456aec0d_I20200328" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEtNS0xLTEtNzAzMzQ_81a172d2-622c-42d9-8f2b-5ee27d385479">2,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred, net of reversals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifea5055cceb64d2faa7c2c933a01dfc9_D20200329-20210403" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzItMS0xLTEtNzAzMzQ_f965087a-293b-4a36-b63f-260c2a79c7eb">1,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4177f085a6164014b652e8ba2cbc96bc_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzItMy0xLTEtNzAzMzQ_b8cc0941-b6b8-4439-8668-945437334adb">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzItNS0xLTEtNzAzMzQ_697ad85d-0efa-443a-b4d5-9d38b90fec64">1,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifea5055cceb64d2faa7c2c933a01dfc9_D20200329-20210403" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzMtMS0xLTEtNzAzMzQ_235c5f40-a8fe-4e75-bdca-e08b2e010d98">2,062</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4177f085a6164014b652e8ba2cbc96bc_D20200329-20210403" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzMtMy0xLTEtNzAzMzQ_95456e40-5ad6-430b-9ffb-40fe7700655a">1,018</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzMtNS0xLTEtNzAzMzQ_c38b5693-cf42-4896-9925-34c65d484c1d">3,080</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 3, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i823363dc6c2c4b3ea41d483a51719275_I20210403" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzUtMS0xLTEtNzAzMzQ_884e3233-4c40-4c4e-9125-ae3ad2fbb960">575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fbf2c91e0d14fe299efc100a438a840_I20210403" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzUtMy0xLTEtNzAzMzQ_78953fed-b783-4ec4-b8b6-e67de9c60812">437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzUtNS0xLTEtNzAzMzQ_0502a823-ce15-4805-a889-85d4eae94285">1,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred, net of reversals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ca6348e2ac24a4195142c309fc7a641_D20210404-20220402" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzYtMS0xLTEtNzAzMzQ_208984d9-1f48-4744-aec1-eb018bf87242">4,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i687b01b80c934827b2cb6b312b9524ad_D20210404-20220402" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzYtMy0xLTEtNzAzMzQ_75724522-3f88-4009-987f-95eed11b026c">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzYtNS0xLTEtNzAzMzQ_e9db3fff-1e35-401e-80cf-35b118280902">4,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ca6348e2ac24a4195142c309fc7a641_D20210404-20220402" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzctMS0xLTEtNzAzMzQ_84b7de53-ad69-4def-b62e-c1509497da85">2,317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i687b01b80c934827b2cb6b312b9524ad_D20210404-20220402" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzctMy0xLTEtNzAzMzQ_aadd1b97-3ee4-4a19-a314-c432cb666fbb">120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzctNS0xLTEtNzAzMzQ_6f940334-d60f-4d64-afa2-6041d8dd7166">2,437</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 2, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8589d7325ec74adabcdb6aef0a20354d_I20220402" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzktMS0xLTEtNzAzMzQ_20aa38ec-cc5c-46a7-ab10-7065fb746de6">2,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i002292f589b9486bbc885d8889b15b7b_I20220402" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzktMy0xLTEtNzAzMzQ_e09e337f-fbcb-451a-93ef-63ce36c8bf53">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzktNS0xLTEtNzAzMzQ_7e6acff8-1f72-4385-85f3-c2e4d30c30df">2,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred, net of reversals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6982a32b8c784f13bc9963f00302b541_D20220403-20230401" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEwLTEtMS0xLTcwMzM0_f681a99b-9d13-4bb5-a00b-d121a0b17130">576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i407111b2df044b2d85cd23b1b5025a83_D20220403-20230401" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEwLTMtMS0xLTcwMzM0_97fda0aa-47aa-4838-b0ff-1efd59b8a56c">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEwLTUtMS0xLTcwMzM0_ec6ff2c5-564b-4025-8804-8ff9c8acb50f">657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6982a32b8c784f13bc9963f00302b541_D20220403-20230401" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzExLTEtMS0xLTcwMzM0_26273253-ab58-4e40-a8a9-a7a85be78456">1,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i407111b2df044b2d85cd23b1b5025a83_D20220403-20230401" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzExLTMtMS0xLTcwMzM0_a1db4dec-7bff-493c-be40-193ae49fa061">86</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzExLTUtMS0xLTcwMzM0_d48920b0-29a5-42f5-92b7-e6925b04353b">1,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 1, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b2b847dc034a3db085e75ba45fed2e_I20230401" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEyLTEtMS0xLTcwMzM0_49d1d244-5998-4f7b-a00c-ef556647450a">1,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i984a455da961408f925ca49751e6ddef_I20230401" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEyLTMtMS0xLTcwMzM0_833c8e75-5c33-42f6-b7a8-7cbf839ed3b7">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEyLTUtMS0xLTcwMzM0_48dcd7bc-0048-46a4-ac96-b1e7f38e49d5">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the restructuring costs by line item during fiscal <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzE4NDM_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric>, 2022 and 2021 within our accompanying consolidated statements of income and comprehensive income: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie757a5b3c6874d30b0632b13796f7765_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzEtMS0xLTEtNzAzMzQ_a2805209-d5a5-4045-b7b1-e33d912d8970">215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a58bb523b34502b7e9328f05462202_D20210404-20220402" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzEtMy0xLTEtNzAzMzQ_fd25d962-d09b-401c-bc3d-3dfbdf4a4b9d">2,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54605da039714724a8b332c1eadca994_D20200329-20210403" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzEtNS0xLTEtNzAzMzQ_58c83ebc-b2e1-41b0-8090-8dc0e91ab9bb">390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e94fc8a563c41dbb911f86eebd74fb4_D20220403-20230401" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzItMS0xLTEtNzAzMzQ_57f50d2b-d13e-4045-86bf-1406fc2bd6e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c21727b1644983b67286f3ff83bf6f_D20210404-20220402" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzItMy0xLTEtNzAzMzQ_16d8aec3-457e-44c3-b942-2c7996750c09">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if570127cbc674472bddd6c920a6680a6_D20200329-20210403" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzItNS0xLTEtNzAzMzQ_ab9e5dad-2fd4-4efc-9ec7-e7e8a246c753">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03bd40350ab47b59e94e0eb9a16722d_D20220403-20230401" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzMtMS0xLTEtNzAzMzQ_9ee21837-48dd-490c-991b-5d753490d476">872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44318b6edd204f9bb959e54aa88e533c_D20210404-20220402" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzMtMy0xLTEtNzAzMzQ_0c0874de-0cde-44dd-b753-414004bdb120">1,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i202912003ea5483c8e977d2876231a84_D20200329-20210403" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzMtNS0xLTEtNzAzMzQ_c0c9e9ed-3fcd-4d36-b7f9-28d67b52c694">912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzQtMS0xLTEtNzAzMzQ_127d0c3c-4f35-444a-8f28-90deceb9ee0a">657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzQtMy0xLTEtNzAzMzQ_576e74cd-0ddf-417b-8f11-ab693746346e">4,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzQtNS0xLTEtNzAzMzQ_300138e4-2914-43cb-a22f-6506dd75f9bd">1,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company had a restructuring liability of $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzIwMDA_d784f7fe-e00d-4ce5-a56e-ea34fb8a0cbb">2.2</ix:nonFraction> million, of which approximately $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="hae:RestructuringChargesPayableInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzIwMjc_e988de08-381e-49db-a676-5485a18288d2">1.8</ix:nonFraction> million is payable within the next twelve months. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the restructuring expenses included in the table above, the Company also incurred costs of $<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-5" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzIxODA_35251ed3-9fce-428c-bb52-a50dd480189b">10.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-5" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzIxODQ_1c839f59-b66d-4d39-aec0-a7a50e724b6d">24.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-5" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzIxOTE_82f46e83-a24b-4531-9061-5da85fd5806f">14.2</ix:nonFraction> million in fiscal 2023, 2022 and 2021, respectively, that do not constitute restructuring costs under ASC 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit and Disposal Cost Obligations,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and which the Company instead refers to as restructuring related costs. These costs consist primarily of expenditures directly related to the restructuring actions.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzI5MTY_424e1b58-4069-491a-b9af-850b3c54dd27" continuedAt="icb5fa6234d0a492bb9532b87e077d74c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the restructuring related costs by line item during fiscal <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzI2OTk_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric>, 2022 and 2021 within our accompanying consolidated statements of income and comprehensive income: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie757a5b3c6874d30b0632b13796f7765_D20220403-20230401" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzEtMS0xLTEtNzAzMzQ_4f2288e4-7f2d-428b-ba42-2b1dcda08f21">7,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a58bb523b34502b7e9328f05462202_D20210404-20220402" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzEtMy0xLTEtNzAzMzQ_108bca00-12f3-4f54-b342-9958307a0b3d">17,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54605da039714724a8b332c1eadca994_D20200329-20210403" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzEtNS0xLTEtNzAzMzQ_c1b44bd3-ed4d-46b8-91f0-aedcb296c8f3">9,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e94fc8a563c41dbb911f86eebd74fb4_D20220403-20230401" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzItMS0xLTEtNzAzMzQ_d12766ce-9c76-457b-83c8-bcf0c734b39c">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c21727b1644983b67286f3ff83bf6f_D20210404-20220402" decimals="-3" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzItMy0xLTEtNzAzMzQ_05753f63-a912-4393-b624-baa37837d0f9">714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if570127cbc674472bddd6c920a6680a6_D20200329-20210403" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzItNS0xLTEtNzAzMzQ_b4a31b96-2b39-439e-b567-e30cf1438bef">1,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03bd40350ab47b59e94e0eb9a16722d_D20220403-20230401" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzMtMS0xLTEtNzAzMzQ_720ec2e4-9f89-4ec1-8a2f-35834d1243f9">1,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44318b6edd204f9bb959e54aa88e533c_D20210404-20220402" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzMtMy0xLTEtNzAzMzQ_0716cae0-a11e-4c25-8d63-51c4386e7a35">6,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i202912003ea5483c8e977d2876231a84_D20200329-20210403" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzMtNS0xLTEtNzAzMzQ_458d5105-4f50-49f6-8be8-f4ea19bde1df">3,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzQtMS0xLTEtNzAzMzQ_fa6e71ff-691e-4dce-bdfa-0cc2aec01b5e">10,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzQtMy0xLTEtNzAzMzQ_ec8a77d6-a83b-4a69-adc9-e00f804000bd">24,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzQtNS0xLTEtNzAzMzQ_71c0fb45-6641-428e-9223-eaad5c58a256">14,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ie365efa98e344eec84881e5a0dca45f3"><ix:continuation id="icb5fa6234d0a492bb9532b87e077d74c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present restructuring and restructuring related costs by reportable segment:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iceda53e10aa943db9898cb8ab8dac15a_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzItMS0xLTEtNzAzMzQ_ccc71b1f-387b-424f-8822-ff0cc8bed29f">48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic069cd0eb4c94953be95e2deb98ea5e5_D20210404-20220402" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzItMy0xLTEtNzAzMzQ_1c15a79d-135f-4d92-ba30-657c7776f73f">2,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia79a8918d94541fbb215b791d3bc0308_D20200329-20210403" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzItNS0xLTEtNzAzMzQ_c479dd7a-e1c9-485e-943a-c423d7918abc">454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ffef01c50b40dcbbc6f463d67d82a6_D20220403-20230401" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzMtMS0xLTEtNzAzMzQ_069f7a3a-fe40-42da-b330-bff2677c65af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b364431a43245b7a9f05a60dc7416df_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzMtMy0xLTEtNzAzMzQ_90a248ad-1d75-4a5d-8c9f-13af379d7b39">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6794b0b382b4fb7886de74ba621481b_D20200329-20210403" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzMtNS0xLTEtNzAzMzQ_d5198805-40fa-47af-9d14-22aef0a5c0f6">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i753483fb84d94062bdc30420838c80cf_D20220403-20230401" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzQtMS0xLTEtNzAzMzQ_d60bdf7d-9ce1-4440-9e2b-0ce351efca25">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c4e22f5dd7d46aab1223c60d287905f_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzQtMy0xLTEtNzAzMzQ_aa0e65a3-946a-4b50-9891-bc5e1689e0cc">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e8e2ad8db6d4f6c859bc3263d7c9235_D20200329-20210403" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzQtNS0xLTEtNzAzMzQ_7157b0ab-9b6c-4663-af37-eb90a8909816">322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i206a029467f0420ab5932b24faf54368_D20220403-20230401" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzUtMS0xLTEtNzAzMzQ_8daa1b37-2389-4feb-a303-1ff99bead2f6">540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f56f2e6daa64033b788180008d0fb12_D20210404-20220402" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzUtMy0xLTEtNzAzMzQ_547d9434-1bfe-4c32-aea8-7c9fa98fd756">1,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf36ce0a0ea1444d88b791a90bbfdf76_D20200329-20210403" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzUtNS0xLTEtNzAzMzQ_1a9bf8b5-549b-418a-a08f-4026ce0e53ad">467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzYtMS0xLTEtNzAzMzQ_17a6d82a-2446-4d4f-b717-a4050482fe8b">657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzYtMy0xLTEtNzAzMzQ_5706051f-15d2-4880-ba94-a5b5af7d3899">4,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzYtNS0xLTEtNzAzMzQ_61278da0-09d7-4949-8d5c-b3de23e0e548">1,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring related costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzktMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceda53e10aa943db9898cb8ab8dac15a_D20220403-20230401" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEwLTEtMS0xLTcwMzM0_861d0bed-001a-48fe-8e6c-b087c255e7fe">1,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic069cd0eb4c94953be95e2deb98ea5e5_D20210404-20220402" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEwLTMtMS0xLTcwMzM0_f46da577-8d54-4f82-ae74-340d77edbae6">7,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia79a8918d94541fbb215b791d3bc0308_D20200329-20210403" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEwLTUtMS0xLTcwMzM0_887e830e-4953-4d3d-8d7d-31774b1e59f6">1,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ffef01c50b40dcbbc6f463d67d82a6_D20220403-20230401" decimals="-3" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzExLTEtMS0xLTcwMzM0_2a4f8534-6271-48df-a337-65bb8ff9de10">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b364431a43245b7a9f05a60dc7416df_D20210404-20220402" decimals="-3" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzExLTMtMS0xLTcwMzM0_0a627843-dbdb-41b7-b4e0-99b76e7e079a">556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6794b0b382b4fb7886de74ba621481b_D20200329-20210403" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzExLTUtMS0xLTcwMzM0_6e7a9269-bb05-43a3-b55d-86dcc88cbc49">1,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i753483fb84d94062bdc30420838c80cf_D20220403-20230401" decimals="-3" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEyLTEtMS0xLTcwMzM0_dce08647-9629-4308-9b4c-db266828fb9a">546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4e22f5dd7d46aab1223c60d287905f_D20210404-20220402" decimals="-3" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEyLTMtMS0xLTcwMzM0_d3638df1-affc-4ee8-9d9c-4fedef6dbac6">379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e8e2ad8db6d4f6c859bc3263d7c9235_D20200329-20210403" decimals="-3" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEyLTUtMS0xLTcwMzM0_23148394-3ea0-44dd-944d-c9b275b9b473">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i206a029467f0420ab5932b24faf54368_D20220403-20230401" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEzLTEtMS0xLTcwMzM0_61c9be52-ef94-4d9f-a23f-787412a925a3">8,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f56f2e6daa64033b788180008d0fb12_D20210404-20220402" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEzLTMtMS0xLTcwMzM0_f2a1b053-9a53-413d-b11b-40f4df3cc4c8">15,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf36ce0a0ea1444d88b791a90bbfdf76_D20200329-20210403" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEzLTUtMS0xLTcwMzM0_8d210529-44a6-46b7-86f8-7162a5a9566c">10,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzE0LTEtMS0xLTcwMzM0_186d8233-d8cc-4eb9-919e-2a689b71bf8a">10,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzE0LTMtMS0xLTcwMzM0_e7807e98-5e3c-4a6e-b25a-ebfc3bacee50">24,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:RestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzE0LTUtMS0xLTcwMzM0_dd7d1911-3cf4-4a07-8429-410abb441a6f">14,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total restructuring and restructuring related costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:RestructuringandRestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzE2LTEtMS0xLTcwMzM0_362a5a11-7a47-4c7a-b599-d9c41dcbc9fd">11,549</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:RestructuringandRestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzE2LTMtMS0xLTcwMzM0_b6b78b39-2000-4014-9ec6-b56a3a51cf5f">28,824</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:RestructuringandRestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzE2LTUtMS0xLTcwMzM0_51cd8109-b52f-4330-8ee6-0306b6ff8480">15,661</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_103"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzk5NTc_8256db22-efbb-431c-82c0-815583ba3426" continuedAt="i6214ea8b7c2f433884cdae754d2603e4" escape="true">ACQUISITIONS AND STRATEGIC INVESTMENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6214ea8b7c2f433884cdae754d2603e4" continuedAt="i4854804ec1b8424eb2b75f121eebbb78"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiva Medical, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 17, 2021, the Company entered into an Agreement and Plan of Merger with Cardiva Medical, Inc. (&#8220;Cardiva&#8221;), an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. In connection with this acquisition, which closed on March 1, 2021, the Company acquired <ix:nonFraction unitRef="number" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzM0OA_9c982a9b-e51a-4740-894f-1e5123171a21">100</ix:nonFraction>% of the issued and outstanding shares of capital stock of Cardiva for total consideration of $<ix:nonFraction unitRef="usd" contextRef="i7405bd2190704f40b0b1839ce85522b7_D20210301-20210301" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzQ0Mw_2df1d5c3-45bd-4f70-8c28-5be23d4cb230">489.8</ix:nonFraction>&#160;million, which consisted of upfront payments in the aggregate of $<ix:nonFraction unitRef="usd" contextRef="i7405bd2190704f40b0b1839ce85522b7_D20210301-20210301" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzUwMw_edcd6cb6-5a75-40d0-8a41-3ea7368dd015">465.5</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i7405bd2190704f40b0b1839ce85522b7_D20210301-20210301" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzUwNw_35ac4eca-8be4-49f3-8cf5-cefd1d9cef3a">418.2</ix:nonFraction>&#160;million net of cash acquired) and the fair value of contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzU4Mg_736f836f-b406-4437-8726-19671c5841d5">24.3</ix:nonFraction>&#160;million.  Cardiva achieved the contingent consideration maximum payout of $<ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzY0Nw_570a1482-0df2-48e7-a4d6-0642eb2db742">35.0</ix:nonFraction>&#160;million, of which the final payment was made in fiscal 2023. The Company financed the acquisition through a combination of cash, borrowings under its revolving credit facility and an additional $<ix:nonFraction unitRef="usd" contextRef="i7405bd2190704f40b0b1839ce85522b7_D20210301-20210301" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzg0MQ_9d845974-be38-44de-a9f3-a9ba23ae5770">150.0</ix:nonFraction>&#160;million term loan under its existing credit facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiva&#8217;s portfolio includes two catheter-based vascular access site closure devices. The VASCADE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vascular closure system is designed for &#8220;small-bore&#8221; femoral arterial and venous closure, generally used in interventional cardiology and peripheral vascular procedures. The VASCADE MVP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vascular closure system is designed for &#8220;mid-bore&#8221; multi-access femoral venous closure, generally used in electrophysiology procedures, and is the only U.S. Food and Drug Administration (&#8220;FDA&#8221;) approved closure device for use following cardiac ablation procedures requiring two or more access sites within the same vessel. The addition of the VASCADE portfolio to the Hospital business unit includes products with demonstrated benefits and enhances penetration into the large and growing interventional cardiology and electrophysiology markets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the acquisition of Cardiva as a business combination, and in accordance with FASB ASC Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Topic 805</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzk5NjE_fa134f42-ae41-43f4-956a-fc2adbb53847" continuedAt="ib0ddfacff154479db51540957f4c82d8" escape="true"></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i4854804ec1b8424eb2b75f121eebbb78" continuedAt="i5d9f50d966094f23833ef297310ba842"><ix:continuation id="ib0ddfacff154479db51540957f4c82d8" continuedAt="i76afcf3525ad4e36a71bfefc78a53f22"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts represent the fair value of the identifiable assets acquired and liabilities assumed for Cardiva:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzEtMS0xLTEtNzAzMzQ_0b27fd6f-dff8-40dd-86b6-4a604e125349">7,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzItMS0xLTEtNzAzMzQ_c37292cb-42ba-4054-932e-a3b4514b5d72">18,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzMtMS0xLTEtNzAzMzQ_819848b9-9807-492b-9237-9d5fe8a8cf52">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzQtMS0xLTEtNzAzMzQ_0bf5ca8a-7b4e-47bd-9c52-49e9e8af0520">1,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzUtMS0xLTEtNzAzMzQ_e5ca28be-0d22-4d38-8813-a4df930d9dbe">250,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzYtMS0xLTEtNzAzMzQ_645128f2-cba4-4f99-bf2d-cee43091e34b">253,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzctMS0xLTEtNzAzMzQ_16da6268-6ba4-439e-bd6a-e2515c67c242">1,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzgtMS0xLTEtNzAzMzQ_7dd88dde-ad58-482f-bd36-4963f82fec91">534,240</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzktMS0xLTEtNzAzMzQ_d180f008-6e64-41cd-9a1b-137ff76413d3">3,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="hae:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzEwLTEtMS0xLTcwMzM0_5399fcb9-6ae5-44bb-84ef-4771852c6c45">58,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzExLTEtMS0xLTcwMzM0_ac524582-cdd6-4d30-ba1f-23cc49b9d7dc">1,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzEyLTEtMS0xLTcwMzM0_bc562094-cad8-43ab-a0b7-8a8239345bce">26,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzEzLTEtMS0xLTcwMzM0_e070a6fc-1511-4126-998f-ba0dcd09b7ea">1,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzE0LTEtMS0xLTcwMzM0_afaf3d47-485d-408c-8acd-62fdfa3f88dc">91,971</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzE1LTEtMS0xLTcwMzM0_e118a86a-8713-4608-aee3-56cb513b66dc">442,269</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the identifiable intangible assets were completed technology, customer relationships, trademarks and in-process research and development (&#8220;IPR&amp;D&#8221;). The fair values of intangible assets were based on valuation techniques with estimates and assumptions developed by the Company. Completed technology and IPR&amp;D were valued using the excess earnings method. Customer relationships were valued using the distributor method. Trademarks were valued using the relief from royalty method. The cash flows used in the valuation of the intangible assets were based on estimates used to price the transaction. In developing the discount rates applied to the cash flow projections, the discount rates were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital and then adjusted to reflect the relative risk of the asset.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the purchase price over the tangible assets, identifiable intangible assets and assumed liabilities was recorded as goodwill. As a result of the acquisition of Cardiva, the Company recognized goodwill of $<ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzMyNjU_86e94fb2-11d9-427b-8f1c-1ba138b49b27">253.7</ix:nonFraction>&#160;million, which is attributable to the revenue and cash flow projections associated with completed technologies and the development of future technology that does not exist in the current IPR&amp;D pipeline. The goodwill is not deductible for tax purposes and relates entirely to the Hospital reportable segment.</span></div><div><span><br/></span></div><ix:continuation id="i76afcf3525ad4e36a71bfefc78a53f22" continuedAt="i968a8928803347748dc34da7c2b5ce77"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets acquired consist of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk-Adjusted Discount<br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id878234d30d043a1869cefb375fae586_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzEtMS0xLTEtNzAzMzQ_ad1290eb-db7a-4b79-ad20-7e41d0e0b6c4">213,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5f85a675d779468d9d4dbca1c8a1df77_D20210301-20210301" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzEtMi0xLTEtNzAzMzQ_d0790a4b-c4cd-499d-89d3-6985610d3eff">13</ix:nonNumeric> years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id878234d30d043a1869cefb375fae586_I20210301" decimals="INF" name="hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzEtMy0xLTEtNzAzMzQ_89360467-427f-4e08-aaf5-f43e7fadad40">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff998f127d34759a4f6f4837bf4c1c2_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzItMS0xLTEtNzAzMzQ_7280b746-60ac-4ee1-8277-ca7ea1da41c9">18,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1a4624f506734e78b0c21280a438461f_D20210301-20210301" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzItMi0xLTEtNzAzMzQ_9ba4a62c-6d32-4fba-a05b-16d4a44578a2">12</ix:nonNumeric> years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8ff998f127d34759a4f6f4837bf4c1c2_I20210301" decimals="INF" name="hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzItMy0xLTEtNzAzMzQ_1bdfd129-2aa1-432e-806c-a1f652a5d38b">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9823c17774ed4746ae030a36d0b5328b_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzMtMS0xLTEtNzAzMzQ_6454e04e-cf5e-4ab0-b493-99ed08f6db00">5,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i95ab359c02104ffb9f744088a78d1303_D20210301-20210301" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzMtMi0xLTEtNzAzMzQ_55a3bc13-ac78-4efe-91b6-8a30fa384fc7">13</ix:nonNumeric> years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9823c17774ed4746ae030a36d0b5328b_I20210301" decimals="INF" name="hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzMtMy0xLTEtNzAzMzQ_fc536274-a183-4d27-8a9a-0a8c3d325fd9">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dd8c04e15e409a938cebbc415144b4_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzQtMS0xLTEtNzAzMzQ_a36c3ea2-6eaa-4722-a363-fa74f25752df">13,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if6dd8c04e15e409a938cebbc415144b4_I20210301" decimals="INF" name="hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzQtMy0xLTEtNzAzMzQ_0631ebde-8991-4af5-9c61-4730c22dfd0f">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzUtMS0xLTEtNzAzMzQ_3453da50-901e-454b-ba8f-c1fc394414a0">250,560</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a long-term deferred tax liability, net, of $<ix:nonFraction unitRef="usd" contextRef="id6fc9e356f064785861fafa202778d12_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzM2OTA_ef8904e6-1f73-43da-b847-b8a859ec78c9">26.8</ix:nonFraction>&#160;million primarily related to acquired intangible assets which cannot be deducted for tax purposes, partially offset by deferred tax assets primarily related to net operating losses acquired.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i5d9f50d966094f23833ef297310ba842" continuedAt="i6bb772af87a3410db287d80a8db2706b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of acquisition-related costs incurred associated with the acquisition was $<ix:nonFraction unitRef="usd" contextRef="id5dc66016da24927b10302bc7adc1138_D20200329-20210403" decimals="-5" name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzM5ODk_ec90e896-2470-453f-8994-8b59ab901604">9.6</ix:nonFraction>&#160;million for the fiscal year ending April 3, 2021. The Company incurred acquisition costs related to legal and other professional fees in the amount of $<ix:nonFraction unitRef="usd" contextRef="idfb28cdda17d4216bac7c9d5cc1183fe_D20200329-20210403" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzQxMzU_6d864e8f-8dc9-448a-86ab-ed7da034144e">6.6</ix:nonFraction>&#160;million and an additional $<ix:nonFraction unitRef="usd" contextRef="idcb82f284dea477ea7ca024b9ae58bae_D20200329-20210403" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzQxNTY_8968948b-500b-4dc2-80e9-228d8e84d758">3.0</ix:nonFraction>&#160;million of debt financing costs and lender fees which were recognized in selling, general and administrative and as interest expense on the consolidated statements of income, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Financial Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiva contributed revenues of $<ix:nonFraction unitRef="usd" contextRef="idc62548e17174a3eaf8c1c8435fb16e5_D20210301-20210403" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzQ0MTY_ac22dcac-761e-4889-b568-da179f8da773">7.7</ix:nonFraction>&#160;million to net revenues and losses of $<ix:nonFraction unitRef="usd" contextRef="idc62548e17174a3eaf8c1c8435fb16e5_D20210301-20210403" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzQ0NDk_c03e2a87-c58a-41d5-aa30-6dd2a8d642dd">7.6</ix:nonFraction>&#160;million to net income for the period post acquisition through April 3, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited estimated pro forma results presented below include the effects of the acquisition of Cardiva as if it was consummated on March 31, 2019. In fiscal 2021, the Company incurred nonrecurring charges attributed to the acquisition of Cardiva, which are presented in the consolidated statements of income for this period. These charges include acquisition-related costs, retention bonuses and severance payments, adjusted for the related tax effects. These nonrecurring charges are reflected as adjustments to the pro forma earnings presented below for fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, these pro forma amounts have been calculated, net of tax, after adjusting the results of Cardiva to reflect the additional costs associated with fair value adjustments relating to inventories, leases and intangible assets as if the acquisition had occurred on March 31, 2019 and adjusting interest amounts related to long-term debt assumptions. There was no significant impact to the pro forma amounts after applying the Company&#8217;s accounting policies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The supplemental pro forma information presented below is for informational purposes only and should be read in conjunction with our historical financial statements. The pro forma results do not include any anticipated synergies or other expected benefits of the acquisition. Accordingly, the unaudited estimated pro forma financial information below is not necessarily indicative of what the actual results of operations of the combined companies would have been had the acquisition of Cardiva occurred as of March 31, 2019, nor are they indicative of future results of operations. The pro forma assumptions and adjustments are reasonable and appropriate under the circumstances and are factually supported based on information currently available.</span></div><div><span><br/></span></div><div style="text-align:center"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzk5NTk_e9e235a1-a542-4f76-8f25-72e7be8f2101" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:86.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) (Unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5dc66016da24927b10302bc7adc1138_D20200329-20210403" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo3MWNiOGY2Nzc1MTk0M2E1OWRjNmYwNGRkNDU5NjBmZC90YWJsZXJhbmdlOjcxY2I4ZjY3NzUxOTQzYTU5ZGM2ZjA0ZGQ0NTk2MGZkXzEtMS0xLTEtNzAzMzQ_317270dc-b733-4ef0-babc-873a098113bb">916,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5dc66016da24927b10302bc7adc1138_D20200329-20210403" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo3MWNiOGY2Nzc1MTk0M2E1OWRjNmYwNGRkNDU5NjBmZC90YWJsZXJhbmdlOjcxY2I4ZjY3NzUxOTQzYTU5ZGM2ZjA0ZGQ0NTk2MGZkXzItMS0xLTEtNzAzMzQ_f3923cb1-a2eb-4439-af92-b53ead29e62a">53,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HAS Intellectual Property</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company entered into an agreement to acquire certain intellectual property owned by HemoAssay Science and Technology (Suzhou) Co. Ltd., a China-incorporated company, and its affiliates (collectively, &#8220;HemoAssay&#8221;) underlying their HAS viscoelastic diagnostic devices, related assays and disposables. The Company previously entered into exclusive manufacturing and distribution agreements with HemoAssay pursuant to which it has exclusive rights to commercialize HemoAssay&#8217;s HAS devices in China. In connection with the transaction, the Company has agreed to pay up to $<ix:nonFraction unitRef="usd" contextRef="i4651aa24e89d4f19b23ca9c1b848272a_I20210113" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzY5NDk_df51e019-11ce-4531-ad30-59fc730474a1">15.0</ix:nonFraction>&#160;million to HemoAssay in contingent consideration based on certain developmental and manufacturing based milestones. In fiscal years 2023 and 2022, the Company made milestone payments of $<ix:nonFraction unitRef="usd" contextRef="id4e2ba32e7d846df811c490e96dfc2db_D20220403-20230401" decimals="-5" name="hae:AssetAcquisitionMilestonePayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzE2NDkyNjc0NjAzMDc_a57d0267-117b-402b-9bd7-f916a6f50e89">2.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i86f7e1c8849a4449adccae1f6aa3a753_D20210404-20220402" decimals="-5" name="hae:AssetAcquisitionMilestonePayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzcwOTM_97036dcd-8fa7-443f-ab85-82b3c16cccdc">2.5</ix:nonFraction>&#160;million, respectively, which were recorded within intangible assets on the consolidated balance sheets. These products augment the Company&#8217;s portfolio of hemostasis analyzers within the Hospital business unit.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enicor GmbH</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2020, the Company acquired all of the outstanding equity of enicor GmbH (&#8220;enicor&#8221;), the manufacturer of ClotPro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a new generation whole blood coagulation testing system that is currently available in select European and Asia Pacific markets, for total consideration of $<ix:nonFraction unitRef="usd" contextRef="ied3f33df8d1c44b78b90db973a88aed4_D20200401-20200401" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzc2MDE_b9af0544-6646-40cf-b5dc-4f6a2124186c">20.5</ix:nonFraction>&#160;million, which consisted of upfront payments of $<ix:nonFraction unitRef="usd" contextRef="ied3f33df8d1c44b78b90db973a88aed4_D20200401-20200401" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzc2NDQ_ed881b90-4d3a-4bb5-9308-74a5ffb38f22">16.6</ix:nonFraction>&#160;million and the fair value of contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzc2OTc_a24fb686-97d4-4c5c-842f-94be5dc8e3ba">3.9</ix:nonFraction>&#160;million. The contingent consideration, which could total a maximum of $<ix:nonFraction unitRef="usd" contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzc3NjI_9ecdf4c6-5b1f-4414-9a60-dafb1be27296">4.5</ix:nonFraction>&#160;million, consists of payments related to the achievement of certain revenue and regulatory milestones. As of April 1, 2023, the Company has made $<ix:nonFraction unitRef="usd" contextRef="ic0252aa2fd7447a48396f27529ad8ce1_D20230401-20230401" decimals="-5" name="hae:AssetAcquisitionMilestonePayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzE2NDkyNjc0NTk5MzY_16539082-d6c9-4d58-91cc-d2fac3a91815">2.3</ix:nonFraction>&#160;million of milestone payments. The acquisition of this viscoelastic diagnostic device augments the Company&#8217;s portfolio of hemostasis analyzers within the Hospital business unit.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i6bb772af87a3410db287d80a8db2706b" continuedAt="i6e4e20bdde334f6cbc9939518dc2d682"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the acquisition of enicor as a business combination, and in accordance with FASB ASC Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Topic 805</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date.</span></div><div><span><br/></span></div><ix:continuation id="i968a8928803347748dc34da7c2b5ce77" continuedAt="i6fbc77e6e4d84eb9bb42c7c5d5a63744"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts represent the fair value of the identifiable assets acquired and liabilities assumed for enicor completed during fiscal 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.182%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 1, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzEtMi0xLTEtNzAzMzQ_5ce910a1-5eb9-4636-9798-29a3d6b8514f">634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzItMi0xLTEtNzAzMzQ_4ea38ff3-bcf3-47b8-a0a4-61a623f3a381">685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzMtMi0xLTEtNzAzMzQ_772e4fbf-5a78-4f66-9dd4-963757eeb905">289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzQtMi0xLTEtNzAzMzQ_b9c24561-03d6-44e9-84c3-f88c82c41845">14,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzUtMi0xLTEtNzAzMzQ_9bd76d06-dc46-48d1-ad46-d993620721d6">8,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzYtMi0xLTEtNzAzMzQ_71da7f0e-b1b3-45c1-b126-ba9160502c5b">23,851</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzctMi0xLTEtNzAzMzQ_6f1e700f-0dd2-4af4-ae77-d8d170584932">289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzgtMi0xLTEtNzAzMzQ_1640bed1-45f6-4b8c-b333-8f857b5aaa63">3,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzktMi0xLTEtNzAzMzQ_bc65ceed-7b73-4c5a-a9e0-a92c75c6170b">3,325</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzEwLTItMS0xLTcwMzM0_89faff4e-d1e3-42fb-91b2-9aafc4315c74">20,526</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the identifiable intangible assets were completed technology, customer relationships and a trademark. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a rate of <ix:nonFraction unitRef="number" contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401" decimals="INF" name="hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzg3MjU_62d57413-8241-41ab-b9e2-2dc289ea8d29">20</ix:nonFraction>%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The benefits of adding a viscoelastic diagnostic device to the Company&#8217;s portfolio of hemostasis analyzers within the Hospital business unit contributed to an acquisition price in excess of the fair value of net assets acquired for enicor, which resulted in the establishment of goodwill. In addition, the benefits of lower cost manufacturing and complementary sales channels also contributed to the establishment of goodwill for this acquisition. The goodwill is not deductible for income tax purposes.</span></div><div><span><br/></span></div><ix:continuation id="i6fbc77e6e4d84eb9bb42c7c5d5a63744"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets acquired consist of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk-Adjusted Discount<br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id62c57cefd2b41e5a3798110a7fa7e0a_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzEtMi0xLTEtNzAzMzQ_6a5eb860-0277-4383-88f5-233e38e56ec4">13,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3e1cd971bed141ee9e1ec7750e91d3fd_D20200401-20200401" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzEtNC0xLTEtNzAzMzQ_c5612929-eee9-40ea-862f-681b9f3e61f3">10</ix:nonNumeric> Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id62c57cefd2b41e5a3798110a7fa7e0a_I20200401" decimals="INF" name="hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzEtNi0xLTEtNzAzMzQ_af5793e4-56f7-4d40-ba23-c09439542b5e">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6277c2898c846d3b4349c549833daf4_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzItMi0xLTEtNzAzMzQ_ba2a5f02-a2a2-4fc7-b73c-5151aeb117a0">347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i616e2c0925064b749fa614ff59dd7499_D20200401-20200401" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzItNC0xLTEtNzAzMzQ_e835d199-7220-4a79-ae79-45fe03cd43a8">10</ix:nonNumeric> Years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic6277c2898c846d3b4349c549833daf4_I20200401" decimals="INF" name="hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzItNi0xLTEtNzAzMzQ_8b5f913e-8135-4dc1-a08f-0cbe2d94ce44">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd18f7423eb842dca4250857300a60d4_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzMtMi0xLTEtNzAzMzQ_e00e841e-41a9-4e43-950f-ef9cac6a58d8">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i203dfbcae1dd44178cef12e0b4685fe4_D20200401-20200401" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzMtNC0xLTEtNzAzMzQ_cf03b485-e2e0-495b-96ce-b831c04b3129">10</ix:nonNumeric> Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd18f7423eb842dca4250857300a60d4_I20200401" decimals="INF" name="hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzMtNi0xLTEtNzAzMzQ_abed81a6-80de-4d9e-861d-8135bb9ac7a9">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzQtMi0xLTEtNzAzMzQ_d8451b7e-b963-4a7e-ad05-f1d7d8354f53">14,090</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="if633c82b96c64c7e994ccb564cfd6ca7_D20200329-20210403" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzk2MDk_c24ca3e7-3352-4079-87f5-596b2817a7c8">0.2</ix:nonFraction>&#160;million of acquisition-related costs associated with the acquisition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Financial Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enicor had an immaterial impact to the Company&#8217;s net revenues and net income for fiscal 2021. The unaudited estimated pro forma impact of the results of the acquisition of enicor as if it was consummated on April 1, 2019 are immaterial. </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i6e4e20bdde334f6cbc9939518dc2d682"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2023, the Company made investments in Vivasure Medical LTD (&#8220;Vivasure&#8221;), totaling &#8364;<ix:nonFraction unitRef="eur" contextRef="i5038a81c8b424af199422b8a9d70bc1c_I20230401" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzIxOTkwMjMyNzMwMTc_d35cc9f9-b9e4-4912-aad0-2be7e5df7252">30</ix:nonFraction>&#160;million. The investments include both preferred stock and a special share that allows the Company to acquire Vivasure in accordance with an agreement between the parties. The investments are classified as other long-term assets on the consolidated balance sheets and the Company has <ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzE2NDkyNjc0NTgzNTY_a87539fc-cc4a-43ba-968f-c031344f3d07">not</ix:nonFraction> recorded any adjustments to the carrying value of our strategic investments in fiscal 2023.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzQ4MjA_76af0308-f429-436e-a441-1cf01b6ec249" continuedAt="i30ca458962464d48b0f5d49da9f8a06e" escape="true">DIVESTITURES </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i30ca458962464d48b0f5d49da9f8a06e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fajardo, Puerto Rico Manufacturing Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 29, 2020, the Company sold its Fajardo, Puerto Rico, manufacturing operations to GVS, S.p.A (&#8220;GVS&#8221;), a leading provider of advanced filtration solutions for critical applications for $<ix:nonFraction unitRef="usd" contextRef="ia4acc494c5054244829743f91b7e2da7_D20200629-20200629" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI2Mg_9d72f1a0-feb6-4c91-b211-b53d9fcf38bd">15.1</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="ia4acc494c5054244829743f91b7e2da7_D20200629-20200629" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI2Ng_2d97d32a-d1e9-433a-9e16-0ae5e0abfa2e">7.8</ix:nonFraction>&#160;million, net of cash transferred). Under the terms of the agreement, Haemonetics retained all intellectual property rights to its proprietary blood filters currently manufactured at its Fajardo facility and GVS acquired certain assets consisting primarily of property, plant and equipment, inventory and cash and has assumed certain related liabilities. In connection with this transaction, the Company and GVS also entered into a long-term supply and development agreement that, among other things, grants GVS exclusive rights to manufacture and supply the blood filters currently produced at the Fajardo facility for Haemonetics. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this transaction, Haemonetics recognized a pre-tax impairment charge in its Blood Center business unit of $<ix:nonFraction unitRef="usd" contextRef="ia4acc494c5054244829743f91b7e2da7_D20200629-20200629" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzEwMTY_d8b737b9-79f7-43ea-aa03-4d170c335362">1.0</ix:nonFraction>&#160;million in the first quarter of fiscal 2021 and an incremental loss of $<ix:nonFraction unitRef="usd" contextRef="i2752501b70f24fe681ec2c0d0d6e1c32_D20220703-20221001" decimals="-5" name="hae:DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzEwODI_b60838db-7738-4973-8b85-ca8f06ce3eee">0.4</ix:nonFraction>&#160;million based on closing adjustments during the third quarter of fiscal 2021, as the carrying value of the assets and liabilities in the asset transfer exceeded the net of the $<ix:nonFraction unitRef="usd" contextRef="ia4acc494c5054244829743f91b7e2da7_D20200629-20200629" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzEyNTM_4c2f719a-1cbb-481d-8475-2b55526068b9">15.1</ix:nonFraction>&#160;million of cash proceeds and an additional contingent liability of $<ix:nonFraction unitRef="usd" contextRef="ia4acc494c5054244829743f91b7e2da7_D20200629-20200629" decimals="-5" name="hae:DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzEzMTU_ea024c9b-1200-4c32-be8b-60bdeb518d1e">1.5</ix:nonFraction>&#160;million. The disposal group consisted of $<ix:nonFraction unitRef="usd" contextRef="i3207d32bf765482d974e19e8a1ba412c_I20200629" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzEzNTE_b5426a08-fd27-4114-adc5-53e691853a35">3.3</ix:nonFraction>&#160;million of inventory, $<ix:nonFraction unitRef="usd" contextRef="i3207d32bf765482d974e19e8a1ba412c_I20200629" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzEzNjg_080b821c-83eb-4309-87b6-ebc5a74d3869">7.2</ix:nonFraction>&#160;million of fixed assets, $<ix:nonFraction unitRef="usd" contextRef="i3207d32bf765482d974e19e8a1ba412c_I20200629" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzEzODg_088efaa8-04fe-4e5a-8a63-bcb818d764f4">3.2</ix:nonFraction>&#160;million of other liabilities, and $<ix:nonFraction unitRef="usd" contextRef="i3207d32bf765482d974e19e8a1ba412c_I20200629" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzE0MTc_99d6ac96-b21a-4c19-994b-7b228f158c05">0.4</ix:nonFraction>&#160;million of goodwill allocated based on fair value to the business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Blood Donor Management Software</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2020, the Company sold certain U.S. blood donor management software solution assets within its Blood Center business unit to the GPI Group (&#8220;GPI&#8221;) for an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i44250ce6b1a74481b968a4be5acfd176_D20200701-20200701" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzE3MDc_415747ed-555e-431d-a280-d52887201c98">14.0</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="id6966c90880e42ea87ed7bdf600844e5_I20200701" decimals="-5" name="hae:ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzE3MTE_8897860e-1775-4ab8-aa58-528ee7fb862c">13.6</ix:nonFraction>&#160;million, net of working capital adjustments) and up to $<ix:nonFraction unitRef="usd" contextRef="i44250ce6b1a74481b968a4be5acfd176_D20200701-20200701" decimals="-5" name="hae:ProceedsFromDivestureOfBusinessContingentConsiderationReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzE3NjE_f4a823e7-d2cc-4144-a0e7-b2f49db77d48">14.0</ix:nonFraction>&#160;million in additional consideration contingent on the achievement of commercial milestones over the twelve month period immediately following the closing of the transaction. The disposal group consisted of $<ix:nonFraction unitRef="usd" contextRef="id6966c90880e42ea87ed7bdf600844e5_I20200701" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzE5NjI_da50245e-5052-4d23-a0cb-757ab946d8b8">1.4</ix:nonFraction>&#160;million of accounts receivable, $<ix:nonFraction unitRef="usd" contextRef="id6966c90880e42ea87ed7bdf600844e5_I20200701" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzE5ODk_1c170ca5-6e9c-4581-8a33-0c76acac0c6e">0.9</ix:nonFraction>&#160;million of intangible assets, other liabilities of $<ix:nonFraction unitRef="usd" contextRef="id6966c90880e42ea87ed7bdf600844e5_I20200701" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzIwMzU_a4d49894-36a9-478e-af46-33ee87519bb4">1.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="id6966c90880e42ea87ed7bdf600844e5_I20200701" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzIwNDI_ce7b3e16-a31b-4f51-9ad8-a9a2f17ee09e">1.4</ix:nonFraction>&#160;million of goodwill allocated based on fair value to the business. The Company recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="i44250ce6b1a74481b968a4be5acfd176_D20200701-20200701" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzIxMzc_c71684fc-70e7-494f-875e-2ade719e2955">13.2</ix:nonFraction>&#160;million associated with the transaction in fiscal 2021. In fiscal years 2023 and 2022, the Company recognized additional gains of $<ix:nonFraction unitRef="usd" contextRef="i0f15ab7ccf5a4506a8affa0b65b6006a_D20220403-20230401" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzIxOTkwMjMyNjQwODQ_da2e189c-0580-49c1-b0ff-d0f9c7004f0a">0.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib2b9fa2b5f664127b8fdc362bbb48a1e_D20210404-20220402" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzIyNTQ_ac5cdf58-7ac9-4842-851e-d41ac8551c01">9.6</ix:nonFraction>&#160;million, respectively, for contingent consideration earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inlog Holdings France</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 18, 2020, the Company sold its wholly-owned subsidiary Inlog Holdings France SAS to Ab&#233;nex Capital (&#8220;Ab&#233;nex&#8221;), a private equity firm based in France for $<ix:nonFraction unitRef="usd" contextRef="i415a9f8fdf8b4219856aecb281c27444_D20200918-20200918" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI0ODQ_dba07136-552e-4e8e-a309-5857fe06c3d0">30.5</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i415a9f8fdf8b4219856aecb281c27444_D20200918-20200918" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI0ODg_025e3bf9-e0da-4c70-a65b-0040b5de8368">24.5</ix:nonFraction>&#160;million, net of cash transferred). Inlog Holdings France SAS, through its subsidiary In Log SAS, develops and sells blood bank and hospital software solutions used predominantly in France and in several other countries outside of the U.S. The disposal group included $<ix:nonFraction unitRef="usd" contextRef="i1ed16aebc739402e9a2e33283c09034b_I20200918" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI3NTE_bb768554-faea-4403-baea-80e20417968f">2.2</ix:nonFraction>&#160;million of intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i1ed16aebc739402e9a2e33283c09034b_I20200918" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI3NzY_14b33d41-daa2-4717-8f82-5e26b9e631ce">2.2</ix:nonFraction>&#160;million of accounts receivable, $<ix:nonFraction unitRef="usd" contextRef="i1ed16aebc739402e9a2e33283c09034b_I20200918" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI4MDM_edc6e6ff-b328-4cb3-a1aa-0b34dafdf925">0.3</ix:nonFraction>&#160;million of other assets, $<ix:nonFraction unitRef="usd" contextRef="i1ed16aebc739402e9a2e33283c09034b_I20200918" decimals="-5" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI4MjM_d0dae1a6-a325-4830-b69c-e0f5ea7a2cec">3.3</ix:nonFraction>&#160;million of liabilities and $<ix:nonFraction unitRef="usd" contextRef="i1ed16aebc739402e9a2e33283c09034b_I20200918" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI4NDU_21493e10-0c5d-465e-9d1d-f75a787adc36">3.3</ix:nonFraction>&#160;million of goodwill allocated based on the fair value of the business which impacted both the Blood Center and Hospital business units. The Company recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="if9b6d677fac64743add841031ac4146a_D20200329-20210403" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzMwMDk_76ed7725-3c60-4add-a4db-405cf6e8c3e3">20.0</ix:nonFraction>&#160;million associated with the transaction in fiscal 2021.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_109"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzg3OTA_b3fca83d-9c44-4cea-ad53-fb7a060db7ef" continuedAt="i48b9a5d5c36047299c52eb439d41ce00" escape="true">INCOME TAXES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i48b9a5d5c36047299c52eb439d41ce00" continuedAt="i874a17efc1794761b7bdbbda68f42346"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzg4MDc_f6945a9a-aff1-4cb2-ae82-77f03b6efbf5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Domestic and foreign income before provision (benefit) for income tax is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzEtMS0xLTEtNzAzMzQ_49f808ed-2437-47b2-a918-a9ac21ba198e">85,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzEtMy0xLTEtNzAzMzQ_166eaf98-d169-459f-bf1a-01b64811fa13">5,219</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzEtNS0xLTEtNzAzMzQ_369db891-21ac-446c-968e-34aaea8e947f">5,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzItMS0xLTEtNzAzMzQ_c69671d7-8434-40f6-8df4-50c7303081e8">55,746</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzItMy0xLTEtNzAzMzQ_0cd78b7c-8944-4538-901a-a7170bb8bd93">68,848</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzItNS0xLTEtNzAzMzQ_530950a3-aeb2-4ce1-b0c8-ffca62b663db">67,387</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzMtMS0xLTEtNzAzMzQ_5961314c-8b6c-441a-8551-dc2963b134ef">141,403</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzMtMy0xLTEtNzAzMzQ_efc2dee6-8994-4df9-8084-d157a54735e3">63,629</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzMtNS0xLTEtNzAzMzQ_23289a65-ef41-4d5d-b910-49d72b463f34">72,913</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzg4MTc_c0a22b91-7a90-4b91-bece-a51802f7898b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision (benefit) from continuing operations contains the following components:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzItMS0xLTEtNzAzMzQ_d5d4677e-6fee-4db1-b424-fbc99c0b7ba5">6,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzItMy0xLTEtNzAzMzQ_697ad329-1897-4e67-80c9-e7695eebedbc">3,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzItNS0xLTEtNzAzMzQ_d81848d0-e3ca-45d7-9bf3-cfc7ed793c95">289</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzMtMS0xLTEtNzAzMzQ_506ed584-680a-4594-ab9e-c062a45dfc8a">4,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzMtMy0xLTEtNzAzMzQ_796e40df-5514-4b5a-8e5f-ff0b37bd047a">1,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzMtNS0xLTEtNzAzMzQ_fd54f11e-ab93-4d87-b7c9-6de154d8e303">1,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzQtMS0xLTEtNzAzMzQ_2760d1b5-4f90-480b-94d8-09735a72d4ec">8,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzQtMy0xLTEtNzAzMzQ_918d6518-46b0-4c99-a9b3-173d59226ae6">9,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzQtNS0xLTEtNzAzMzQ_a7566126-30ea-48bd-91f6-dff191c47955">13,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzUtMS0xLTEtNzAzMzQ_611715ac-4bca-4fb7-9265-24dfac713475">20,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzUtMy0xLTEtNzAzMzQ_35193b34-9fb8-4653-96b0-72ff43d9b027">15,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzUtNS0xLTEtNzAzMzQ_731e1144-62b5-45bf-b8e3-65f53220c5e2">14,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzctMS0xLTEtNzAzMzQ_93dc5671-75df-4215-872b-a60cce36c9f3">14,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzctMy0xLTEtNzAzMzQ_c52c2c51-fbb6-4eb7-b507-6bfdd9311514">3,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzctNS0xLTEtNzAzMzQ_50bdba77-3654-48b2-bda4-5973d972c26a">12,906</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzgtMS0xLTEtNzAzMzQ_194254a6-c801-4d04-91ae-821e149e866a">7,678</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzgtMy0xLTEtNzAzMzQ_adb1c734-fc2f-4f35-8352-b16633c510f9">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzgtNS0xLTEtNzAzMzQ_88893f27-6c5b-4f13-b0c0-72ad0de55e8c">2,436</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzktMS0xLTEtNzAzMzQ_876f7cb3-8c80-45ec-9b65-597772d902dd">843</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzktMy0xLTEtNzAzMzQ_fd2c5813-12b7-4d93-9e31-874b17c66ce2">1,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzktNS0xLTEtNzAzMzQ_7f6bce3a-4b5a-4663-8cfc-7310cdc978c2">5,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzEwLTEtMS0xLTcwMzM0_bcf7f4ea-c3f0-4c48-bd37-0e445106e787">5,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzEwLTMtMS0xLTcwMzM0_8d6cdb66-bb4f-45b3-907c-3e767c5cabff">5,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzEwLTUtMS0xLTcwMzM0_865ebebc-b0f4-4c65-862a-fba639b7cc0b">20,842</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzExLTEtMS0xLTcwMzM0_6c7f2b50-2b53-4800-aad7-4ba017880093">26,002</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzExLTMtMS0xLTcwMzM0_de9f3179-d92b-42ed-a173-aab1b533daf5">20,254</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzExLTUtMS0xLTcwMzM0_d3f6f1a4-b7f4-47dc-ac14-a62157f9b76b">6,556</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business globally and reports its results of operations in a number of foreign jurisdictions in addition to the United States. The Company&#8217;s reported tax rate is impacted by the jurisdictional mix of earnings in any given period as the foreign jurisdictions in which it operates have tax rates that differ from the U.S. statutory tax rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s subsidiary in Malaysia has been granted a full income tax exemption to manufacture whole blood and apheresis devices that could be in effect for up to <ix:nonNumeric contextRef="ifb9a6ef65b5a4fbda10aff17313ea7f0_D20220403-20230401" name="hae:TaxHolidayTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzc0NQ_f5e323c6-012d-4388-ac3d-50934fc2191e">ten years</ix:nonNumeric>, provided certain conditions are satisfied. The income tax exemption was in effect beginning June 1, 2016.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i874a17efc1794761b7bdbbda68f42346" continuedAt="iaa54cbc133ea461b958429b5c35958bb"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzg4MDI_4162b950-4879-466a-865f-cc41f0f7466b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax effected, significant temporary differences comprising the net deferred tax liability are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="hae:DeferredTaxAssetsDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzItMS0xLTEtNzAzMzQ_f1e87993-fcee-4d00-aa64-5dc701996de5">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="hae:DeferredTaxAssetsDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzItMy0xLTEtNzAzMzQ_6d7dc193-7750-40d2-9570-771f67b1df03">623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="hae:DeferredTaxAssetsAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzMtMS0xLTEtNzAzMzQ_2198ac0f-7288-4c29-95b3-674dcc147d9e">1,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="hae:DeferredTaxAssetsAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzMtMy0xLTEtNzAzMzQ_5c6ba3bf-6e96-4622-880a-ca5d75d7a756">1,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzQtMS0xLTEtNzAzMzQ_14bd85df-1159-43af-b7bb-cddd8b68db42">7,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzQtMy0xLTEtNzAzMzQ_eda131b2-ee13-47f5-acc0-7c398a875021">6,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals, reserves and other deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzYtMS0xLTEtNzAzMzQ_6412a131-2ec3-4a60-b364-5598c89c430f">15,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzYtMy0xLTEtNzAzMzQ_be5bebe1-2b42-4ad8-8e58-c34b21bba75f">13,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carry-forward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzctMS0xLTEtNzAzMzQ_ffd63f1c-3db8-4650-8344-e38ec1468601">20,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzctMy0xLTEtNzAzMzQ_b4b44f67-62f1-413d-bf77-3c9f4d633e95">30,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzgtMS0xLTEtNzAzMzQ_0b034f83-65d7-46d2-bc54-7a222b87b9ee">4,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzgtMy0xLTEtNzAzMzQ_7437dafa-2e15-4c7f-bc7c-8de4d6eb74cb">4,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="hae:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzktMS0xLTEtNzAzMzQ_2951d4bb-3fa0-4ac1-b611-9ef5f4252149">15,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="hae:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzktMy0xLTEtNzAzMzQ_6800c306-8638-4280-9554-54404e3e76d6">15,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carry-forward, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzEwLTEtMS0xLTcwMzM0_422d9836-ad35-41b3-8760-e908f49d9633">5,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzEwLTMtMS0xLTcwMzM0_6bd1d66b-8e7f-4b33-b319-b1808eadcdca">6,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized research expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="hae:DeferredTaxAssetsResearchExpensesCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzExLTEtMS0xLTcwMzM0_05230e45-321f-4050-9755-8126480f75f5">19,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="hae:DeferredTaxAssetsResearchExpensesCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzExLTMtMS0xLTcwMzM0_fea848cb-db94-47da-9443-47953d346423">6,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzEyLTEtMS0xLTcwMzM0_a5bb4198-507c-4686-a463-7bfc70b4cdbe">90,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzEyLTMtMS0xLTcwMzM0_acac8954-e9d1-4b01-827d-060896e83311">85,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzEzLTEtMS0xLTcwMzM0_5aecb010-1fab-4601-bdc4-d1e98f98372f">8,838</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzEzLTMtMS0xLTcwMzM0_a217ebbb-8053-44cc-92ed-be66f4829cef">14,077</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets (after valuation allowance)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE0LTEtMS0xLTcwMzM0_76d6659b-b758-4ea8-b641-84444d674d87">81,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE0LTMtMS0xLTcwMzM0_54e9909c-f143-42c4-9d38-1bd82899e7fd">71,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="hae:DeferredTaxLiabilitiesDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE2LTEtMS0xLTcwMzM0_aaa41495-0f1f-4dff-acbb-1095a0918ce9">37,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="hae:DeferredTaxLiabilitiesDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE2LTMtMS0xLTcwMzM0_1c0f32cf-ec68-44d5-ac29-920a47d0af3e">15,727</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of goodwill and intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="hae:DeferredTaxLiabilitiesAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE3LTEtMS0xLTcwMzM0_91f2b2e8-2aa3-44ef-9693-df6e3c28c947">57,752</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="hae:DeferredTaxLiabilitiesAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE3LTMtMS0xLTcwMzM0_46970053-1bc5-426c-af5c-15e1b1213a44">63,004</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unremitted earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE4LTEtMS0xLTcwMzM0_2671667e-5d18-49f7-9c2c-cf28300e18dc">1,163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE4LTMtMS0xLTcwMzM0_2d98e613-cce5-49cd-92ee-6e274b46b826">1,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="hae:DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE5LTEtMS0xLTcwMzM0_ecf610fb-9dae-4997-a92f-d85dd32ddecb">13,220</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="hae:DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE5LTMtMS0xLTcwMzM0_e0783e1d-5553-494a-9fd2-bd9ddab7ca1e">12,877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzIxLTEtMS0xLTcwMzM0_8e7190b3-1aeb-486c-b7cb-ae79cbae1c38">2,942</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzIxLTMtMS0xLTcwMzM0_95d6b018-c251-4541-997a-258cceb30abe">2,643</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzIyLTEtMS0xLTcwMzM0_d2194295-91a6-4695-a10d-fd34ca4e6356">112,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzIyLTMtMS0xLTcwMzM0_c0f500a0-fb54-4184-b49d-2da98391eb84">95,505</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzIzLTEtMS0xLTcwMzM0_9a097d56-55b8-466a-8887-3d8cbf359586">30,954</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzIzLTMtMS0xLTcwMzM0_67464c16-c8ce-45d9-a5c7-98dada862582">24,259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The increase in the worldwide net deferred tax liability is primarily due to tax depreciation deductions in excess of book depreciation expense during fiscal 2023 and utilization of net operating loss carryforwards, partially offset by research expenditures capitalized for tax purposes and impact of the release of valuation allowance previously maintained against certain U.S. state and foreign deferred tax assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The valuation allowance decrease of $<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzIxOTkwMjMyNzQ3MjU_85224ee3-c958-4fcf-8b10-3914da02d846">5.2</ix:nonFraction>&#160;million during fiscal 2023 is primarily due to the release of valuation allowance related to certain U.S. state and foreign deferred tax assets and changes in the valuation allowance in other jurisdictions based on current year operating results.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has assessed, on a jurisdictional basis, the available means of recovering deferred tax assets, including the ability to carry-back net operating losses, the existence of reversing temporary differences, the availability of tax planning strategies and available sources of future taxable income. It has also considered the ability to implement certain strategies that would, if necessary, be implemented to accelerate taxable income and use expiring deferred tax assets. Based upon cumulative profitability in the U.S. and Malaysia, and increases in future taxable income projections, management has determined there is sufficient positive evidence to release a portion of the valuation allowance previously provided against certain U.S. state and foreign deferred tax assets. The Company has concluded future taxable income can be considered a source of income to realize a benefit for deferred tax assets in certain jurisdictions. The Company believes it is able to support the deferred tax assets recognized as of the end of the year based on all of the available evidence. The worldwide net deferred tax liability as of April&#160;1, 2023 includes deferred tax liabilities related to amortizable tax basis in goodwill and other indefinite lived assets, which can only be used as a source of income to benefit other indefinite lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company maintains a valuation allowance against certain U.S. tax credit carryforwards that are not more-likely-than-not realizable as well as a valuation allowance against the net deferred tax assets of certain foreign subsidiaries. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the March 2021 acquisition of Cardiva, the Company acquired federal and state net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ieb2d1cef790a43cc813e187423890c9d_I20210117" decimals="-5" name="hae:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzMyNDY_f9719545-ef88-4845-806e-fe8f11b1c273">150.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ibec6ab6de3e844179c838dce47275e1a_I20210117" decimals="-5" name="hae:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzMyNTM_f11c6969-da5d-44da-bb10-360b30319477">93.3</ix:nonFraction>&#160;million, respectively. The Company also acquired federal and state tax research credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ieb2d1cef790a43cc813e187423890c9d_I20210117" decimals="-5" name="hae:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzMzNTI_52dd0741-1522-4d43-b4fe-2622b5da7dc1">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ibec6ab6de3e844179c838dce47275e1a_I20210117" decimals="-5" name="hae:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzMzNTk_09ee9e1f-51b9-4b51-bcfd-d5b51ceaf14c">0.4</ix:nonFraction>&#160;million, respectively. These net operating loss and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="iaa54cbc133ea461b958429b5c35958bb" continuedAt="i7e0c3d2922ea4394867f71df84dcdd0a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shareholders over a three-year period in excess of 50 percent as defined under Section 382 and 383 of the U.S. Internal Revenue Code of 1986, respectively, as well as similar state provisions. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. The Company conducted a Section 382 study covering the period of inception (July 2002) through March 1, 2021. The study concluded that ownership changes occurred during that period which limit the amount of the Company&#8217;s net operating losses and tax credit carryforwards that can be utilized before expiring. The carryforwards disclosed represent the amount of attributes that can be utilized based on the results of the study. The Company does not believe it has had an ownership change through April 1, 2023. Subsequent ownership changes may further affect the limitation in future years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company has U.S. federal net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i66bfdbf0893842978853fb1777820b01_I20230401" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQzODI_cdf3a9cb-8c12-4ab6-8f0b-8bc66bb2ff16">64.4</ix:nonFraction>&#160;million of which $<ix:nonFraction unitRef="usd" contextRef="i66bfdbf0893842978853fb1777820b01_I20230401" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQzOTQ_b2fc15f6-4bac-4814-b5ab-bbe3f3872f5c">8.4</ix:nonFraction>&#160;million will begin to expire in fiscal 2024 and $<ix:nonFraction unitRef="usd" contextRef="i66bfdbf0893842978853fb1777820b01_I20230401" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ0Mzc_f12c0c49-8ff4-4b4a-8b92-2a75e1dbf736">56.0</ix:nonFraction>&#160;million can be carried forward indefinitely. The Company has U.S. state net operating losses of $<ix:nonFraction unitRef="usd" contextRef="i4314f040e25a485baf6b4975aeefb581_I20230401" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ1Mjg_bcb676b5-6cbc-4c69-b15b-5429c87d4faa">75.7</ix:nonFraction>&#160;million of which $<ix:nonFraction unitRef="usd" contextRef="i4314f040e25a485baf6b4975aeefb581_I20230401" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ1NDA_50d85187-bbca-40c5-a4e2-d8769311a22d">62.3</ix:nonFraction>&#160;million will expire at various times between fiscal 2024 and fiscal 2040 and $<ix:nonFraction unitRef="usd" contextRef="i4314f040e25a485baf6b4975aeefb581_I20230401" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ1ODM_2267f24e-4f35-466a-8944-4b3d78ca7488">13.4</ix:nonFraction>&#160;million can be carried forward indefinitely. The Company has federal and state tax credits of $<ix:nonFraction unitRef="usd" contextRef="i2625054aca6d4672ac4dfe103e5f3018_D20220403-20230401" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ2NzI_e9c86ab1-2be8-4f67-9334-385ec92b2598">0.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if0c1ae0e5e35463eabd3c1bdbdae5618_D20220403-20230401" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ2Nzk_06653023-e6a8-4c13-b5af-93a7c1c428b4">5.4</ix:nonFraction>&#160;million, respectively, which will begin to expire in fiscal 2029 and fiscal 2028, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company has foreign net operating losses of approximately $<ix:nonFraction unitRef="usd" contextRef="if001c425b20b415582a047fc50a913ad_I20230401" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ4NDQ_11598f34-aefa-40be-9fa2-f8170d3bf07e">10.5</ix:nonFraction>&#160;million that are available to reduce future income of which $<ix:nonFraction unitRef="usd" contextRef="if001c425b20b415582a047fc50a913ad_I20230401" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ4OTk_9235fbc2-ea3d-4031-8646-81a8b23f0d92">6.9</ix:nonFraction> million will begin to expire in fiscal 2034 and $<ix:nonFraction unitRef="usd" contextRef="if001c425b20b415582a047fc50a913ad_I20230401" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ5NDI_178f7be0-2342-45bd-95fd-f98e9e6a3218">3.6</ix:nonFraction>&#160;million can be carried forward indefinitely. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, substantially all of the unremitted earnings of the Company have been taxed in the U.S. The Company has not provided U.S. deferred income taxes or foreign withholding taxes on unremitted earnings of foreign subsidiaries of approximately $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzUzODU_8fba698c-4708-4744-893f-fdd75199a250">72.0</ix:nonFraction>&#160;million as such amounts are considered to be indefinitely reinvested in the business. The accumulated earnings in the foreign subsidiaries are primarily utilized to fund working capital requirements as its subsidiaries continue to expand their operations and to fund future foreign acquisitions. The Company does not believe it is practicable to estimate the amount of income taxes payable on the earnings that are indefinitely reinvested in foreign operations, however a significant portion of the unremitted earnings could be remitted without a future tax cost.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision (benefit) from continuing operations differs from the tax provision (benefit) computed at the U.S.&#160;federal statutory income tax rate due to the following:</span></div><div style="margin-top:7pt"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzg4MjM_d268c694-9c87-42c0-8f64-72af70fee07c" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:41.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.102%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEtMS0xLTEtNzAzMzQ_9729ecf7-cabe-4181-86f7-9ebe7176a2f7">29,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEtMy0xLTEtNzAzMzQ_cdba3166-69da-4775-9129-47734a3a40ca">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEtNS0xLTEtNzAzMzQ_930606a9-ed6e-4791-b8e0-0bc900066799">13,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEtNy0xLTEtNzAzMzQ_92781814-c523-415a-844d-fa7bf112d05f">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEtOS0xLTEtNzAzMzQ_59d9f9db-1193-431e-ac9b-ea89467bf093">15,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEtMTEtMS0xLTcwMzM0_c5f9cf2c-127c-4e5e-9e1f-139673c5f58c">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzMtMS0xLTEtNzAzMzQ_97624218-e509-4305-b7f9-e66f71afb493">2,408</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzMtMy0xLTEtNzAzMzQ_50d96e24-ebc5-4fb9-8c65-1046436ee334">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzMtNS0xLTEtNzAzMzQ_71d394f4-4e25-46d4-8d88-a9965e5e7eec">3,799</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzMtNy0xLTEtNzAzMzQ_c6781eaa-4762-494d-b764-82ef74b2bfc4">6.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzMtOS0xLTEtNzAzMzQ_3d73872b-1962-4d55-916a-324ae15ea1d5">7,049</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzMtMTEtMS0xLTcwMzM0_757baf29-986b-4dbb-96e3-3d677d1011fa">9.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes net of federal benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzQtMS0xLTEtNzAzMzQ_b7272bd3-4b79-44e4-a478-3737bc185d10">2,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzQtMy0xLTEtNzAzMzQ_02362605-3dd6-42ec-ac2d-9952a84c5aa1">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzQtNS0xLTEtNzAzMzQ_4bac72e9-237b-4c47-81f0-d245e9ba711c">1,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzQtNy0xLTEtNzAzMzQ_9bc4fa05-ea6b-43ab-a962-39564cae503b">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzQtOS0xLTEtNzAzMzQ_5ca28a6f-fd0b-4e6a-96e7-c426289193f2">924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzQtMTEtMS0xLTcwMzM0_639bfd64-7fc7-43ef-9c88-38dcd3675679">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:IncomeTaxReconciliationChangeinUncertainTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzUtMS0xLTEtNzAzMzQ_e56ff44b-c8ce-4369-9a80-347ccbfc1a8d">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" name="hae:EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzUtMy0xLTEtNzAzMzQ_6342261c-4d01-4abe-a9ce-a53f491b13f6">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="hae:IncomeTaxReconciliationChangeinUncertainTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzUtNS0xLTEtNzAzMzQ_7fdaf997-5364-4d97-977c-21986dcb7a5e">777</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="3" sign="-" name="hae:EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzUtNy0xLTEtNzAzMzQ_4b3b6cc9-c11b-4c18-910c-aaaa6ebabfbd">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:IncomeTaxReconciliationChangeinUncertainTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzUtOS0xLTEtNzAzMzQ_6ee95701-1c71-4188-b30b-8602519116ef">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" name="hae:EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzUtMTEtMS0xLTcwMzM0_d6ec0544-15f4-490c-9e2d-0df141a1ba0b">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low taxed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzctMS0xLTEtNzAzMzQ_35c98512-aa22-4040-9245-12f4c0922233">828</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" sign="-" name="hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzctMy0xLTEtNzAzMzQ_af90dbb6-d924-4328-8718-4ba0e56ae9c0">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzctNS0xLTEtNzAzMzQ_e9af8917-2d0e-4625-8060-09110a347c96">3,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="3" name="hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzctNy0xLTEtNzAzMzQ_9f1a9289-5e78-42bd-86a4-7ba202cd0a86">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzctOS0xLTEtNzAzMzQ_1484c297-4aaf-424a-8bf1-99b74ca6806f">758</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" sign="-" name="hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzctMTEtMS0xLTcwMzM0_f5a348bf-0d47-4a12-9006-c01e9ab44c0b">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unremitted earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzgtMS0xLTEtNzAzMzQ_e4f7f32e-631c-4d66-a116-4eec5c379157">91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" sign="-" name="hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzgtMy0xLTEtNzAzMzQ_a8528916-adfa-4e73-abfc-ec6246f99376">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzgtNS0xLTEtNzAzMzQ_c90a0b7f-10e5-4539-b99c-6451437d9742">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="3" name="hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzgtNy0xLTEtNzAzMzQ_171028ad-f133-4d9c-ab41-02043c1616d9">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzgtOS0xLTEtNzAzMzQ_1609fc27-7baa-4dcd-b9c6-1471d7c3c9b5">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" name="hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzgtMTEtMS0xLTcwMzM0_1b25e6b3-f2a8-466c-b0e7-915248347d33">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred statutory rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzktMS0xLTEtNzAzMzQ_5436bc77-15e9-443e-87ca-8d95bf89314d">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzktMy0xLTEtNzAzMzQ_5cb3bc7c-c03c-4fca-97c1-d17c3933831d">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzktNS0xLTEtNzAzMzQ_28df5052-df2c-4ec0-ae11-a448a39c5e6b">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzktNy0xLTEtNzAzMzQ_e1575b18-6c50-4970-9794-ade4cd02b4a0">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzktOS0xLTEtNzAzMzQ_7fdf1856-21b5-4b78-98a1-570eb5567053">243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzktMTEtMS0xLTcwMzM0_51649405-ea41-4256-a9cd-0226388eea77">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzExLTEtMS0xLTcwMzM0_a93e7888-1359-465b-b6e2-cb9494dafa5e">1,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzExLTMtMS0xLTcwMzM0_4e27939f-fe09-4052-8ce6-81fd2e11373c">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzExLTUtMS0xLTcwMzM0_f681016d-66ac-487a-8b8b-14b7d7896cda">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzExLTctMS0xLTcwMzM0_a7c02a95-2ed5-4ef6-a77f-dbd62decde79">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzExLTktMS0xLTcwMzM0_e2d2406f-c466-4c42-92b8-ba9e6415ea4b">2,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzExLTExLTEtMS03MDMzNA_11283491-7042-45d0-a3b6-e1a46aef2c3c">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEyLTEtMS0xLTcwMzM0_6201c499-d7d5-4cfa-9403-f9df9471fd67">827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEyLTMtMS0xLTcwMzM0_76714084-4ff7-4df4-b3c9-4f28e4690994">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEyLTUtMS0xLTcwMzM0_27b07778-2478-4a3f-ae3a-cad599703edf">741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEyLTctMS0xLTcwMzM0_21d3bf43-9060-4d76-9291-ba036f7f47b5">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEyLTktMS0xLTcwMzM0_28dedaa6-5a12-4256-847b-bc39f05d19c5">2,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEyLTExLTEtMS03MDMzNA_95b8e042-6b81-4244-8417-186c5320fab6">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation shortfalls (benefits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEzLTEtMS0xLTcwMzM0_b0d53fac-359b-447e-b3cd-bfb49737eb3b">1,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEzLTMtMS0xLTcwMzM0_c3ccd4ee-6e84-4686-8f27-d57c4cc0e585">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEzLTUtMS0xLTcwMzM0_71ad1c35-7aa0-45e2-a2eb-04ddaca8db85">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEzLTctMS0xLTcwMzM0_4a1518e1-34c8-49a6-adf9-c7ae4c459e70">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEzLTktMS0xLTcwMzM0_ee73b446-a860-44c9-b69f-ea9ffefbef81">5,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEzLTExLTEtMS03MDMzNA_0afd5dff-b8c7-44c0-a8a6-df57e0f7be0e">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE0LTEtMS0xLTcwMzM0_c9ac17a6-1646-4538-bcc0-fa4ad175e16a">2,073</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE0LTMtMS0xLTcwMzM0_23d7c3cd-28d6-47c7-bfdc-1a33b0ed2037">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE0LTUtMS0xLTcwMzM0_17cb7566-acfe-4595-b4e3-ea3304b97983">1,496</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE0LTctMS0xLTcwMzM0_b4fa62ec-ae09-4f38-936f-6a7e14fe945a">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE0LTktMS0xLTcwMzM0_f48ee20a-4c1b-4672-aa68-b763551b0376">1,230</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE0LTExLTEtMS03MDMzNA_250c3711-9685-475e-961e-339b309913ae">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE1LTEtMS0xLTcwMzM0_3ca34ad2-9166-4394-a96d-aa5bba739d3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" name="hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE1LTMtMS0xLTcwMzM0_6bd26d1b-78ba-447d-8d23-24960d13d56e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE1LTUtMS0xLTcwMzM0_da79a305-3cec-41b6-a210-4e3dd315591c">1,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="3" name="hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE1LTctMS0xLTcwMzM0_6f8a9856-9c82-4fc9-af84-00b215162832">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE1LTktMS0xLTcwMzM0_2cc206e9-1c3f-4673-9b5e-f1a9f7a1cf7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" name="hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE1LTExLTEtMS03MDMzNA_1f0ebfef-bd4b-461e-91b9-15af2164b159">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany sale of intellectual property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE2LTEtMS0xLTcwMzM0_06ee9659-e072-46f9-a80d-ade6c5f07d46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" name="hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE2LTMtMS0xLTcwMzM0_e4c880cb-21d7-4885-bf17-45f6ae3bee43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE2LTUtMS0xLTcwMzM0_5ff8a6d2-68cb-4dd3-9c21-969469cec148">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="3" name="hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE2LTctMS0xLTcwMzM0_ca1e8d3e-b6b0-461d-835a-00bbfcb0cb15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE2LTktMS0xLTcwMzM0_32d942f1-c79a-403b-99ed-c474736ef8d3">7,550</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" name="hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE2LTExLTEtMS03MDMzNA_7e6b32c4-7e50-48f8-bb49-af83e45e572f">10.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE5LTEtMS0xLTcwMzM0_962256e6-bfbc-4289-995c-32aa90b949d7">5,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE5LTMtMS0xLTcwMzM0_694a4b05-2b9b-42c1-93bf-555a2a279e91">3.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE5LTUtMS0xLTcwMzM0_cbcdfb12-6fcd-4936-a7c5-300472df2ca3">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE5LTctMS0xLTcwMzM0_01563903-b5fb-4a1b-94b0-7f16f6fadff0">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE5LTktMS0xLTcwMzM0_bc629995-1bdc-444a-a253-ffa7e2659c51">3,144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE5LTExLTEtMS03MDMzNA_51a1f9c8-9be4-4852-a464-371fb5f2e320">4.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIwLTEtMS0xLTcwMzM0_c045b0f5-702c-433f-8fc0-11ed83385c7c">409</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIwLTMtMS0xLTcwMzM0_58566b7e-067f-4ab3-aed1-37dae995b079">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIwLTUtMS0xLTcwMzM0_584cfb40-d4b4-47a7-b5b7-f5dfea966a8f">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIwLTctMS0xLTcwMzM0_b6fb4bfb-0917-42cc-89c6-40f60c5e6258">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIwLTktMS0xLTcwMzM0_59eb02b8-e4bb-4a6c-bbc7-62396d14acc6">1,171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIwLTExLTEtMS03MDMzNA_993d3453-5e8d-45c3-b72e-a068e1c490c5">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax provision (benefit)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIxLTEtMS0xLTcwMzM0_46d6ea48-5105-486d-b036-90cd78ecd5d5">26,002</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIxLTMtMS0xLTcwMzM0_fd88efff-71b9-4bb5-b00f-9774fe1878fd">18.4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIxLTUtMS0xLTcwMzM0_215b718b-8121-4d4d-8f75-0e99814b30de">20,254</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIxLTctMS0xLTcwMzM0_7fb213f6-2efd-4269-ac7c-f2d95bca7b74">31.8</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIxLTktMS0xLTcwMzM0_7494c4da-b78c-4837-a970-0c13f8a57b00">6,556</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIxLTExLTEtMS03MDMzNA_2f4cec27-847d-4bd5-9eab-85eba9ce1b6a">9.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company recorded an income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzE2NDkyNjc0NzA5NDE_93831c6c-d21d-434d-9320-6f09479dafa7">26.0</ix:nonFraction>&#160;million, representing an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzYyNTQ_fd88efff-71b9-4bb5-b00f-9774fe1878fd">18.4</ix:nonFraction>%. The effective tax rate is lower than the U.S. statutory rate of <ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzYzMjM_cdba3166-69da-4775-9129-47734a3a40ca">21.0</ix:nonFraction>%, primarily due to jurisdictional mix of earnings, research credits generated and the change in valuation allowance, partially offset by state taxes, non-deductible executive compensation and disallowed stock compensation expense. The Company has recorded an immaterial tax expense related to unremitted foreign earnings that are not considered permanently reinvested.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i7e0c3d2922ea4394867f71df84dcdd0a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unrecognized Tax Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized tax benefits represent uncertain tax positions for which reserves have been established. As of April&#160;1, 2023, the Company had $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzY4OTY_0257c4d9-d518-48f0-8ad7-d429fc44755f">3.9</ix:nonFraction> million of unrecognized tax benefits, of which $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzY5Mzg_f83764a0-fa17-4399-a1f6-bd907c061b8e">3.2</ix:nonFraction> million would impact the effective tax rate, if recognized. As of April&#160;2, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzcwMTk_1421f889-042f-4a85-bcf1-bac33a5ec80f">3.9</ix:nonFraction> million of unrecognized tax benefits, of which $<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzcwNjE_3368c638-9806-41a1-a85f-e1e89b4e81b4">3.1</ix:nonFraction> million would impact the effective tax rate, if recognized. At April&#160;3, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzcxMzk_71c55829-022a-47b5-b621-be5f8395b364">6.1</ix:nonFraction> million of unrecognized tax benefits, of which $<ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzcxODE_040b16c4-b7b6-4b39-9566-984d17d50b5c">5.3</ix:nonFraction> million would impact the effective tax rate, if recognized.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzg4MTM_9f08c4e0-af89-468e-b1b3-c7744d3a5f6b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to its gross unrecognized tax benefits for the fiscal years ended April&#160;1, 2023, April&#160;2, 2022 and April&#160;3, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 3,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzEtMS0xLTEtNzAzMzQ_f825f277-6090-44a0-9def-3c4c4c92d66a">3,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzEtMy0xLTEtNzAzMzQ_11d61f7c-c8e2-4b5a-b4b7-3e7247c7474d">6,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2752e169c88b4ff2a289838d456aec0d_I20200328" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzEtNS0xLTEtNzAzMzQ_e67461b4-00c5-44df-8b2f-9465f093ff40">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzItMS0xLTEtNzAzMzQ_7e3bbd7a-2200-4a06-9186-f371eb8d79b1">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzItMy0xLTEtNzAzMzQ_81a282d8-bbfe-4e62-b8a8-913f09b27434">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzItNS0xLTEtNzAzMzQ_e33e9020-1879-4889-b81c-31c9fb3eb72a">335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzMtMS0xLTEtNzAzMzQ_b2e872e1-61cc-447e-89f3-d2a2cb4073a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzMtMy0xLTEtNzAzMzQ_e7e5a533-b5a9-4324-aa6a-860954ca4d97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzMtNS0xLTEtNzAzMzQ_07396d2e-6f5b-413b-a3ac-4502e27e1a00">1,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions of tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzQtMS0xLTEtNzAzMzQ_8ab661d0-d147-4837-87bc-55c1278a43bd">290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzQtMy0xLTEtNzAzMzQ_751fc3d6-df22-4a48-9089-a4ccf0055ac1">808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzQtNS0xLTEtNzAzMzQ_392e0c65-9a35-4235-af73-9bd7d01684c7">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements of tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzUtMS0xLTEtNzAzMzQ_a720bbeb-4f0b-4a58-93ab-7ea2d2bc2d67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzUtMy0xLTEtNzAzMzQ_a2b8af20-7e5e-485c-98a8-1386e2a05665">1,579</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzUtNS0xLTEtNzAzMzQ_fbb20597-30df-431d-8e88-7e84a89ea577">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzctMS0xLTEtNzAzMzQ_ae7596f8-cc2d-4f27-b76f-75dca5b9d6ad">3,941</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzctMy0xLTEtNzAzMzQ_16ffa965-d2f4-4983-9609-60c949a93f12">3,939</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzctNS0xLTEtNzAzMzQ_c02034a3-7fb6-4330-8cd9-b8882352fd91">6,107</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company anticipates that the liability for unrecognized tax benefits for uncertain tax positions could change by up to $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzc1MDg_73d7467e-7f06-46df-b9e5-a33049c57da9">0.2</ix:nonFraction> million in the next twelve months, as a result of closure of various statutes of limitations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s historical practice has been and continues to be to recognize interest and penalties related to federal, state and foreign income tax matters in income tax expense. Approximately $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzc3OTE_456d396e-4276-4340-820c-4e327fb755a7">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzc3OTg_ccec2b11-2b1d-4125-946f-5ebef02f8aaa">0.1</ix:nonFraction> million of gross interest and penalties were accrued at April&#160;1, 2023 and April&#160;2, 2022, respectively, and are not included in the amounts above. Additionally, $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="hae:IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzc5MzE_e22bfd87-7ef4-4a52-a983-618e71d502ac">0.1</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-5" name="hae:IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzc5MzU_46d8c07b-feb7-4429-9368-f8b98bb10e63">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-5" name="hae:IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzc5NDI_8d10cd5e-30d4-4833-ab2f-e2c8ef109cea">0.9</ix:nonFraction>&#160;million of accrued interest and penalties was included in income tax provision (benefit) for the years ended April&#160;1, 2023, April&#160;2, 2022 and April&#160;3, 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business globally and, as a result, files federal, state and foreign income tax returns in multiple jurisdictions. In the normal course of business, it is subject to examination by taxing authorities throughout the world. With a few exceptions, the Company is no longer subject to U.S. federal, state, or local income tax examinations for years before fiscal 2020 and foreign income tax examinations for years before fiscal 2018. To the extent that the Company has tax attribute carry-forwards, the tax years in which the attribute was generated may still be adjusted upon examination by the Internal Revenue Service, state, or foreign tax authorities to the extent utilized in a future period.</span></div></ix:continuation><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzEyOTM_1fc44953-62c2-4b49-a031-62044582a33e" continuedAt="i89aab02060f84c65bd2d74a131d6c235" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i89aab02060f84c65bd2d74a131d6c235" continuedAt="iffbbbf5b69184b47a2a2a5ea9e726dcd"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzEzMDk_17e43664-bdf5-4a65-aebf-c5b459906f4a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:58.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzItMS0xLTEtNzAzMzQ_5edd5a89-a154-4d3c-9a9f-d92b3533224f"><ix:nonFraction unitRef="usd" contextRef="i0ca40b48f3114d14bf1271d7751fa199_D20220403-20230401" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzItMS0xLTEtNzAzMzQ_fc54bcfb-a261-4c75-a8f1-6e33b32cb391">115,401</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzItMy0xLTEtNzAzMzQ_47457ec8-9427-480a-acaf-9836c8b7f318">43,375</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzItNS0xLTEtNzAzMzQ_05ab8e59-50d9-4d35-86b3-1bf38ddb5427">79,469</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzMtMS0xLTEtNzAzMzQ_84dfc82e-9696-47c7-ab93-dc4457d38d2c">50,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzMtMy0xLTEtNzAzMzQ_5e3d4a7d-41b1-47a1-a6a2-7e5d087264e8">51,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzMtNS0xLTEtNzAzMzQ_18a89bc3-0dec-400c-93da-38d35bc179b2">50,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic income per share</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzQtMS0xLTEtNzAzMzQ_6022b2ca-9f45-4e21-8bb7-1a576edd866f">2.27</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzQtMy0xLTEtNzAzMzQ_058bdf63-ab5d-48bf-95ea-bacd7f3e5794">0.85</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzQtNS0xLTEtNzAzMzQ_86e354ac-3703-46e4-918e-27d2a2a1bf9f">1.57</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzYtMS0xLTEtNzAzMzQ_5edd5a89-a154-4d3c-9a9f-d92b3533224f"><ix:nonFraction unitRef="usd" contextRef="i0ca40b48f3114d14bf1271d7751fa199_D20220403-20230401" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzYtMS0xLTEtNzAzMzQ_fc54bcfb-a261-4c75-a8f1-6e33b32cb391">115,401</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzYtMy0xLTEtNzAzMzQ_47457ec8-9427-480a-acaf-9836c8b7f318">43,375</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzYtNS0xLTEtNzAzMzQ_05ab8e59-50d9-4d35-86b3-1bf38ddb5427">79,469</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzctMS0xLTEtNzAzMzQ_84dfc82e-9696-47c7-ab93-dc4457d38d2c">50,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzctMy0xLTEtNzAzMzQ_5e3d4a7d-41b1-47a1-a6a2-7e5d087264e8">51,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzctNS0xLTEtNzAzMzQ_18a89bc3-0dec-400c-93da-38d35bc179b2">50,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzgtMS0xLTEtNzAzMzQ_57c8f0d8-9660-4fc3-b4d0-9821079be7ff">637</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzgtMy0xLTEtNzAzMzQ_95647693-e522-492e-9e9f-d8d69f1d873c">306</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzgtNS0xLTEtNzAzMzQ_c3edb022-7aa8-4c17-ab59-16dddafacc6f">604</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzktMS0xLTEtNzAzMzQ_87e8a700-fe68-417f-b936-25f0eacdc808">51,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzktMy0xLTEtNzAzMzQ_f7c4d74c-5cde-4d81-989f-ee46d9cd815b">51,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzktNS0xLTEtNzAzMzQ_6d66ddba-e58e-476b-ba90-ff69ed80b108">51,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted income per share</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzEwLTEtMS0xLTcwMzM0_34539a32-7ae7-47db-9087-43204c290eb2">2.24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzEwLTMtMS0xLTcwMzM0_5c342655-9e49-4d20-b376-fab8db03c8a6">0.84</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzEwLTUtMS0xLTcwMzM0_f7314aa2-5e85-41be-8180-1086f63154de">1.55</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="iffbbbf5b69184b47a2a2a5ea9e726dcd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated using the Company&#8217;s weighted-average outstanding common shares. Diluted earnings per share is calculated using its weighted-average outstanding common shares including the dilutive effect of stock awards as determined under the treasury stock method and the convertible senior notes as determined under the net share settlement method. From the time of the issuance of the convertible senior notes, the average market price of the Company&#8217;s common shares has been less than the initial conversion price, and consequently no shares have been included in diluted earnings per share for the conversion value of the convertible senior notes. For fiscal 2023, 2022 and 2021, weighted average shares outstanding, assuming dilution, excludes the impact of <ix:nonFraction unitRef="shares" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzk0Ng_26db6737-1bc8-490b-bf00-97b94428870e">0.6</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzk1MA_aba4c874-dfc1-4568-9eb1-77049380e168">0.9</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzk1Nw_e71a2dab-4275-465a-b72d-d618c359fa78">0.5</ix:nonFraction> million anti-dilutive shares, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company announced that its Board of Directors had approved a new <ix:nonNumeric contextRef="i284b8cd4b4544ab58be9c3a7b5aef631_D20220403-20230401" name="us-gaap:StockRepurchaseProgramPeriodInForce1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzQzOTgwNDY1MTUzMDk_93160487-0cfc-4d8c-8c44-292301acb243">three-year</ix:nonNumeric> share repurchase program authorizing the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="i1e9d4875df194dab89de359ddb229826_I20220831" decimals="-3" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzE2NDkyNjc0NDQ0NDc_0b545ebb-f03c-4aa2-9a2a-91a14b0d4707">300.0</ix:nonFraction>&#160;million of Haemonetics common stock, based on market conditions, through August 2025. Under the share repurchase program, the Company is authorized to repurchase, from time to time, outstanding shares of common stock in accordance with applicable laws on the open market, including under trading plans established pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, and in privately negotiated transactions. The actual timing, number and value of shares repurchased will be determined by the Company at its discretion and will depend on a number of factors, including market conditions, applicable legal requirements and compliance with the terms of loan covenants. The share repurchase program may be suspended, modified or discontinued at any time, and the Company has no obligation to repurchase any amount of its common stock under the program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2022, the Company completed a $<ix:nonFraction unitRef="usd" contextRef="i911fdad529ca44e49f9d2e6eb98bf48e_I20220816" decimals="-3" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzE2NDkyNjc0NDQ0NjI_66e0fc50-7d79-432b-8aec-1ae75edce1d6">75.0</ix:nonFraction>&#160;million repurchase of its common stock pursuant to an accelerated share repurchase agreement (&#8220;ASR&#8221;) entered into with Citibank N.A. in August 2022. The total number of shares repurchased under the ASR was <ix:nonFraction unitRef="shares" contextRef="i6fc032744cf14e5b8712fe75bf23387a_D20220816-20221104" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzE2NDkyNjc0NDQ0ODU_a0d1c333-19b9-4c24-8763-b2629b1261b1">1.0</ix:nonFraction>&#160;million at an average price per share upon final settlement of $<ix:nonFraction unitRef="usdPerShare" contextRef="i474dead76fa741a1b6b0fcf117803177_D20221104-20221104" decimals="2" name="us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzE2NDkyNjc0NDQ0Nzc_385f92b0-8ca1-4ab4-9f7e-1a8bbbed3fbf">75.20</ix:nonFraction>.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the total remaining authorization for repurchases of the Company&#8217;s common stock under the share repurchase program was $<ix:nonFraction unitRef="usd" contextRef="ic8cb16fc7fbd4a119a8e39abd06c3f48_I20230401" decimals="-3" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzE2NDkyNjc0NDQ0OTg_edbfb78d-2330-40d1-8cff-6f49166423f5">225.0</ix:nonFraction>&#160;million.</span></div></ix:continuation><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_115"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzI5MjY_2d6af812-9d12-4a53-a1a7-485a8926217c" continuedAt="i36fece97e96a4675adfce354e07dd669" escape="true">REVENUE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i36fece97e96a4675adfce354e07dd669" continuedAt="icaab4eaa7cd349468078a88bad0c9886"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenue recognition policy is to recognize revenues from product sales, software and services in accordance with ASC Topic 606,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; this occurs with the transfer of control of the Company&#8217;s goods or services. The Company considers revenue to be earned when all of the following criteria are met: it has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the consideration it expects to receive for transferring goods or providing services, is determinable and it has transferred control of the promised items to the customer. A promise in a contract to transfer a distinct good or service to the customer is identified as a performance obligation. A contract&#8217;s transaction price is allocated to each performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of the Company&#8217;s contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the contract&#8217;s transaction price to each performance obligation based on the estimated standalone selling prices of the good or service in the contract. For goods or services for which observable standalone selling prices are not available, the Company uses an expected cost plus a margin approach to estimate the standalone selling price of each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company had $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzE2MTE_246e7fbf-db73-431d-8766-f9479c4d8f8f">24.0</ix:nonFraction> million of transaction price allocated to remaining performance obligations related to executed contracts with an original duration of <ix:nonNumeric contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" name="us-gaap:RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzE3NDE_66892351-0fde-48b6-8599-e89a8c440d9e">one year</ix:nonNumeric> or more. The Company expects to recognize approximately <ix:nonFraction unitRef="number" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzE4MDA_ed112e7e-e20c-4a58-a5a8-012880e9d02b">77</ix:nonFraction>% of this amount as revenue within the next <ix:nonNumeric contextRef="i46b375b6b4f542949b51fd68eaa34739_I20230401" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzE4NDU_d81de252-36b5-4b41-a272-9cd5250ca4ac">twelve months</ix:nonNumeric> and the remaining balance thereafter.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables and contract assets, as well as customer advances, customer deposits and deferred revenue (contract liabilities) on the consolidated balance sheets. The difference in timing between billing and revenue recognition primarily occurs in software licensing arrangements, resulting in contract assets and contract liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023 and April&#160;2, 2022, the Company had contract liabilities of $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzE2NDkyNjc0NDUwODY_d68d1a28-6215-4d76-a591-8bc21117b521">30.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzE2NDkyNjc0NDUwOTM_e5148fc4-5c18-41de-b678-648f562572c8">26.8</ix:nonFraction>&#160;million, respectively. During fiscal 2023, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzI3MTg_ee050ec3-e775-464c-af4d-d0b055a678a9">24.3</ix:nonFraction> million of revenue that was included in the above April&#160;2, 2022 contract </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icaab4eaa7cd349468078a88bad0c9886">liability balance. Contract liabilities are classified as other current liabilities on the consolidated balance sheet. As of April&#160;1, 2023 and April&#160;2, 2022, the Company&#8217;s contract assets were immaterial.</ix:continuation></span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_118"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90ZXh0cmVnaW9uOjI4NGVlY2FiMThhNjRhZjk5NjJlM2I4ZWQwZmQ5N2NhXzIxNg_7c848416-ca6d-42e1-aa80-e61ab189e30b" continuedAt="i500fe063c44948909f125dfbf24fc52a" escape="true">INVENTORIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i500fe063c44948909f125dfbf24fc52a"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90ZXh0cmVnaW9uOjI4NGVlY2FiMThhNjRhZjk5NjJlM2I4ZWQwZmQ5N2NhXzIyNw_90ff4e64-a40b-4e2f-a8e5-4ef0c2fb1e6a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value and include the cost of material, labor and manufacturing overhead. Cost is determined with the first-in, first-out method. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzEtMS0xLTEtNzAzMzQ_be87c6b9-a489-4af8-a3ab-386a87056041">115,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzEtMy0xLTEtNzAzMzQ_c80d4ff7-df53-475a-bc1e-e91e0afda4a1">77,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:InventoryWorkInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzItMS0xLTEtNzAzMzQ_47c32c95-fc27-475d-968f-8839a6b87953">12,572</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:InventoryWorkInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzItMy0xLTEtNzAzMzQ_1f2e0a08-11bd-4ffc-87fe-dd7eed70a041">17,187</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzMtMS0xLTEtNzAzMzQ_bbc3a90c-10b9-4adc-996e-3282e40f7acc">131,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzMtMy0xLTEtNzAzMzQ_7d6b5ffd-2e8d-41e2-a6dc-0dbc6a246e82">197,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzQtMS0xLTEtNzAzMzQ_bfbaa99d-f29f-4878-938a-6c2bfb866bfc">259,379</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzQtMy0xLTEtNzAzMzQ_10254462-7c1f-42a2-ac50-e53c02948c77">293,027</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Prior year raw materials and finished goods balances have been adjusted to conform with current year presentation.</span></div></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzMwMTk_3d4349bd-0f44-4dc4-958c-e89b3740ea2f" continuedAt="ifb5947db75ac4820921ec64f1611d527" escape="true">PROPERTY, PLANT AND EQUIPMENT</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ifb5947db75ac4820921ec64f1611d527"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzMwMzQ_41bb3662-c0d3-4859-b59d-4c4c98baf8de" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consisted of the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba643cdd69040399b37d76690fc345d_I20230401" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzEtMi0xLTEtNzAzMzQ_cad3728e-83d4-4272-8042-9b28cf129763">5,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72965c4a62614d3290bfa903e33eced7_I20220402" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzEtNC0xLTEtNzAzMzQ_01e3263c-9547-4f37-9ee7-89ac8ee30a26">5,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and building improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07ed489541e746a8b9deae1198e9c1c1_I20230401" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzItMi0xLTEtNzAzMzQ_60d3f655-384c-4756-a3d7-8b83d18e0eb2">127,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b12e4fae98b451180b4184af64d8b88_I20220402" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzItNC0xLTEtNzAzMzQ_c5246ad8-b272-4084-ae19-0b2a802038fd">104,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant equipment and machinery</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i004e8ca241ac4e4ca56b1a2a8a573d30_I20230401" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzMtMi0xLTEtNzAzMzQ_30343c38-5d22-4ff0-a152-8eacff1082c4">194,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42ce0fe93a644396931110078249d049_I20220402" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzMtNC0xLTEtNzAzMzQ_bdc1da0a-0284-4def-8890-4244bc251ac8">180,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and information technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e34ec5fd8bd4a428a2c86c1f65a1c72_I20230401" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzQtMi0xLTEtNzAzMzQ_345c2962-6e80-47d0-9daf-ff373afd64cf">123,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie45ed624179b44a9aa90e98cbf443cd3_I20220402" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzQtNC0xLTEtNzAzMzQ_1aaa036f-eac4-4a9f-b65c-b91ed7b98bd0">120,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Haemonetics equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia49c226af761477286c878a9c01a26a8_I20230401" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzUtMi0xLTEtNzAzMzQ_8d042ea4-d194-463b-9887-9091339d1454">463,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaf174529292432b93ffce203a8852e0_I20220402" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzUtNC0xLTEtNzAzMzQ_a00ef515-2563-4cc8-ac56-6bcf683f10bb">405,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9462d8afba8e42f1bdf6538fdf313e40_I20230401" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzYtMi0xLTEtNzg3Mzk_cc920700-821d-4bce-8f76-4b54bdf032fb">29,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b7e9feaba63462fb4d7c25051b882b9_I20220402" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzYtNC0xLTEtNzg3Mzk_17e4b187-ec72-4d1a-abe6-1fdb26b5018b">53,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzYtMi0xLTEtNzAzMzQ_470444e2-68e9-4c98-9de6-12dfd2c3457d">944,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzYtNC0xLTEtNzAzMzQ_bc225fbd-c7cf-40c2-8f37-de70f1a76ab2">869,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzctMi0xLTEtNzAzMzQ_dae30650-f47c-48f4-9030-7e334e254498">633,330</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzctNC0xLTEtNzAzMzQ_a70118db-28f8-4711-a45d-cf0b20ce1aa0">610,665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzgtMi0xLTEtNzAzMzQ_391f7732-6882-40e9-b9e5-9d68074b014b">310,885</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzgtNC0xLTEtNzAzMzQ_7442ca52-6844-4bcc-805e-d8c56e97e4ae">258,482</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzEyMA_5bd8ef47-c62f-44c4-9c3d-70396c00d767">51.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzEyNA_48887638-d37c-4ac9-88f8-e0e059a5a9f5">44.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzEzMQ_21989799-8d11-4f58-84d6-d305253d1d92">43.1</ix:nonFraction> million in fiscal <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzE0NA_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric>, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, the Company incurred an impairment of property, plant and equipment of $<ix:nonFraction unitRef="usd" contextRef="i3b2e53451fe5414ab6223fd9340d04f2_D20210404-20220402" decimals="-5" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzIxOTkwMjMyNjk2NTM_86b4376a-d403-4232-9d39-82339474b553">5.2</ix:nonFraction>&#160;million in connection with the 2020 Program, refer to Note 3 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details on the 2020 Program, and $<ix:nonFraction unitRef="usd" contextRef="i66e23e49fe97425b9d4a7409908fbe9f_D20210404-20220402" decimals="-5" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzIxNQ_83516229-7a57-4a50-a5f5-019cfa96271b">2.8</ix:nonFraction>&#160;million of accelerated depreciation costs related to disposables manufacturing equipment that was no longer in use. In fiscal 2021, the Company incurred a one-time impairment charge of $<ix:nonFraction unitRef="usd" contextRef="iee98836794a841af872ac5d2c262b2e1_D20200329-20210403" decimals="-5" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzEwNzI_0de5a8f9-9159-4286-b8a9-708919120d5c">20.9</ix:nonFraction>&#160;million related to in-process disposables manufacturing equipment that would not be placed in service. These impairment charges were included in cost of goods sold on the consolidated statements of income and impacted the Plasma reporting segment in the respective periods.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzI1Nzg_aecd76f1-131d-49a6-814d-198928b6ca64" continuedAt="i5f2c09fe2d8e4066882c75dbf627e458" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5f2c09fe2d8e4066882c75dbf627e458" continuedAt="if0b2bd48d30d48cfbf5e36a48196acf1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill by operating segment for fiscal 2023 and 2022 are as follows:</span></div><div style="margin-top:5pt"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzI1NTk_23189da2-1fa1-4880-b7c2-60c9c65eb7f4" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Plasma</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Blood Center</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hospital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount as of April 3, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d967115487d4000bb10ef11e17c5ee3_I20210403" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEtMS0xLTEtNzAzMzQ_400ea227-4c11-4b83-a2fa-d5dc89607823">29,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6471edc0acff4583a5b44bae2caf6812_I20210403" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEtMy0xLTEtNzAzMzQ_fbe00fa8-a74f-4191-b285-c2e963b89ab6">34,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b4a3a52234ebca2c87d023a372f0d_I20210403" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEtNS0xLTEtNzAzMzQ_ed0a63d8-9463-4564-8117-e004a2b4c31d">402,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEtNy0xLTEtNzAzMzQ_37dae78a-c4e5-4a28-8d24-f6cfbb009a5a">466,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic069cd0eb4c94953be95e2deb98ea5e5_D20210404-20220402" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzQtMS0xLTEtNzYxODA_7ff5feda-1fba-4a69-8c9d-1f60891c329b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b364431a43245b7a9f05a60dc7416df_D20210404-20220402" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzQtMy0xLTEtNzYxODA_ba468f48-10ab-44b8-a770-caa950e0a14a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4e22f5dd7d46aab1223c60d287905f_D20210404-20220402" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzQtNS0xLTEtNzYxODA_59313b10-72ec-40c5-9b23-68eef1f283e2">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzQtNy0xLTEtNzYxODA_694f942e-6335-444e-bbd1-2ae0f6d7ac99">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic069cd0eb4c94953be95e2deb98ea5e5_D20210404-20220402" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzUtMS0xLTEtNzAzMzQ_f1b85c63-3aef-4e4e-8c81-37886585d1cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b364431a43245b7a9f05a60dc7416df_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzUtMy0xLTEtNzAzMzQ_e95a3c57-cb88-4671-9820-a0be35e9cc46">362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c4e22f5dd7d46aab1223c60d287905f_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzUtNS0xLTEtNzAzMzQ_cd3e79c1-f10e-45f4-8c72-11a880a222e2">865</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzUtNy0xLTEtNzAzMzQ_e4202401-63a1-43f4-a21d-985c886683ab">1,227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount as of April 2, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida4846630e6b4fe9abc8b036a5b0f2ca_I20220402" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzYtMS0xLTEtNzAzMzQ_e8bac8c8-539c-4467-82b7-7b917b21fb4d">29,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0134e8414f8c42618080f11b9286ca14_I20220402" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzYtMy0xLTEtNzAzMzQ_734294d3-1e52-4904-8f1a-93fce4bf0cdd">34,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5193ad1e9e4b4c359e874dfa2c7b2e29_I20220402" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzYtNS0xLTEtNzAzMzQ_11f5c239-6fa2-4198-abc7-16a220cfefbd">404,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzYtNy0xLTEtNzAzMzQ_648dfedd-dc9b-4e34-9734-b2900ebc8ddd">467,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceda53e10aa943db9898cb8ab8dac15a_D20220403-20230401" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEwLTEtMS0xLTcwMzM0_ff18c0e0-f218-480b-be50-564ae4aaa9bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ffef01c50b40dcbbc6f463d67d82a6_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEwLTMtMS0xLTcwMzM0_24f2bce0-78d8-4ac5-9244-a8d95a71599f">311</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i753483fb84d94062bdc30420838c80cf_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEwLTUtMS0xLTcwMzM0_72ed49ea-5715-4f71-84b5-bcfc71beda80">745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEwLTctMS0xLTcwMzM0_27159bf1-b40b-4136-9add-7bf500cd955e">1,056</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying amount as of April 1, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890c831316434ae1b18be3b1ae53a567_I20230401" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzExLTEtMS0xLTcwMzM0_74d776e6-3960-4eec-be57-17d2250b166f">29,043</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida09061210f544b39381b92caca71c36_I20230401" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzExLTMtMS0xLTcwMzM0_1876541d-111e-4442-95fa-3316390096fa">33,855</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728903670b674bc8867059c6c7f26220_I20230401" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzExLTUtMS0xLTcwMzM0_3a9598cb-449c-4cb0-b327-1c08dfd5cdbf">403,333</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzExLTctMS0xLTcwMzM0_c12fb540-f5eb-48d8-a6f4-1738c3f6b038">466,231</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="if0b2bd48d30d48cfbf5e36a48196acf1" continuedAt="ie51c221689b54f77b215d5872cb889cb"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of the Company&#8217;s goodwill impairment test performed in the fourth quarter of fiscal 2023, 2022 and 2021 indicated that the estimated fair value of all reporting units exceeded their respective carrying values. There were no reporting units at risk of impairment as of the fiscal <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzQyMA_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric>, 2022 and 2021 annual test dates. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzI1NTI_f5a349bf-ee21-4583-9675-670329e0fe45" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of intangible assets and the related accumulated amortization as of April&#160;1, 2023 and April&#160;2, 2022 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of April 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69c0d5a250d4229b959398b479ddfa4_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzQtMS0xLTEtNzAzMzQ_5df1c751-fb34-42f0-b5aa-d776b74710db">18,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69c0d5a250d4229b959398b479ddfa4_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzQtMy0xLTEtNzAzMzQ_552782c4-301f-4eba-beb5-b9b51a40c58e">10,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69c0d5a250d4229b959398b479ddfa4_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzQtNS0xLTEtNzAzMzQ_f38cf39e-6018-4ad2-a531-85f8a96ee9f9">7,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2604f664a0d54bf69c814bdee8df438e_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzUtMS0xLTEtNzAzMzQ_af3af2dd-319c-4d02-8e94-af32625e29cb">78,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2604f664a0d54bf69c814bdee8df438e_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzUtMy0xLTEtNzAzMzQ_6d6dcdd3-ae7f-4aff-8cf8-68823a8baf1c">60,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2604f664a0d54bf69c814bdee8df438e_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzUtNS0xLTEtNzAzMzQ_25341857-4c3c-4c2c-bea1-98c6a4d89999">18,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc6430777b2d43ea89991090017c9b5a_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzYtMS0xLTEtNzAzMzQ_878a27f0-a8b6-49c6-8671-930d7f540c04">362,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc6430777b2d43ea89991090017c9b5a_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzYtMy0xLTEtNzAzMzQ_a735b635-2497-45b6-9557-fc48e89aecc3">153,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc6430777b2d43ea89991090017c9b5a_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzYtNS0xLTEtNzAzMzQ_e4cedaea-d788-4126-b5f7-8486d1dc1555">209,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts and related relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9d2b7da12a4869876ddf3bd5cb0cd3_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzctMS0xLTEtNzAzMzQ_ce6fc6ba-de37-47da-94c0-139c20cf4ac7">203,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9d2b7da12a4869876ddf3bd5cb0cd3_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzctMy0xLTEtNzAzMzQ_03826f7a-f11b-46b2-80b9-18afbde69c9b">187,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9d2b7da12a4869876ddf3bd5cb0cd3_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzctNS0xLTEtNzAzMzQ_2ebbb0c2-8b31-4432-9bb1-1987a6931682">15,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e460218ba5d4a98bb1ebba94551faa3_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzgtMS0xLTEtNzAzMzQ_e9961664-a423-43b1-9484-29d5194fe888">9,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e460218ba5d4a98bb1ebba94551faa3_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzgtMy0xLTEtNzAzMzQ_a7e54d0a-04f1-4ef4-88d0-fef3583644d2">4,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e460218ba5d4a98bb1ebba94551faa3_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzgtNS0xLTEtNzAzMzQ_7dd8330d-6c6d-4473-8c81-2adf9b40a858">4,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzktMS0xLTEtNzAzMzQ_88fe18db-448d-4e82-b13e-cf6ab47ac693">672,720</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzktMy0xLTEtNzAzMzQ_e53515a8-a021-4b04-b120-bd352a5bd9ed">417,422</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzktNS0xLTEtNzAzMzQ_701b93fc-4ebc-4856-b5b8-2428f149c89c">255,298</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-amortizable:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process software development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c1d8f7dde943afbae8276595f08b9e_I20230401" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzExLTEtMS0xLTcwMzM0_26704565-bf8d-4c4e-abf0-35474f3896ef">3,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic30962d93d8542679db996ff09021707_I20230401" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzEyLTEtMS0xLTcwMzM0_4a9b93d9-a33a-41e8-8375-bbfdc00c8a1d">13,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a58336b11a40d2bc0242ec0ddcdf16_I20230401" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzEzLTEtMS0xLTcwMzM0_483ac653-5592-4c0e-987e-5ccf3bf9dd5b">2,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzE0LTEtMS0xLTcwMzM0_9b8cf1ad-e7c2-418d-b3db-b60ccd80fc52">20,473</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of April 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfa652c38c114d559e869e8c58458b18_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzQtMS0xLTEtNzAzMzQ_6d3acf9b-201c-4ff3-a5b6-f49bc5a10c52">14,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfa652c38c114d559e869e8c58458b18_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzQtMy0xLTEtNzAzMzQ_5b96e964-8426-4fd4-aaf5-b57d6412d7f0">9,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfa652c38c114d559e869e8c58458b18_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzQtNS0xLTEtNzAzMzQ_328dbe5a-3b4c-4b39-8fe6-112f3ad8a7af">4,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iface21e4b3d043d29b088f04c24bece5_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzUtMS0xLTEtNzAzMzQ_d9ee51ce-7aab-4043-86d6-ba94003fbe38">76,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iface21e4b3d043d29b088f04c24bece5_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzUtMy0xLTEtNzAzMzQ_dbcbcee8-a677-4c93-bffe-f9c6ac58a03c">52,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iface21e4b3d043d29b088f04c24bece5_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzUtNS0xLTEtNzAzMzQ_a6de78a7-2b4c-482a-9f0f-832d20b0d756">24,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23809cd4e75445928f37404062b1dd03_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzYtMS0xLTEtNzAzMzQ_9046ed3a-615c-43f4-a202-7b64d3a148d7">362,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23809cd4e75445928f37404062b1dd03_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzYtMy0xLTEtNzAzMzQ_1009273b-1d02-44c6-b435-ca560e96d94d">124,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23809cd4e75445928f37404062b1dd03_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzYtNS0xLTEtNzAzMzQ_d99875fd-387d-4436-8bbe-23958c14b037">237,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts and related relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a64ff94d044686be5f9c39a18d0fd1_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzctMS0xLTEtNzAzMzQ_7ef0f8b0-f693-4287-819a-4a8f44d75477">204,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a64ff94d044686be5f9c39a18d0fd1_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzctMy0xLTEtNzAzMzQ_67652c20-799d-41bd-b11c-dcb552fdc29f">185,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a64ff94d044686be5f9c39a18d0fd1_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzctNS0xLTEtNzAzMzQ_48a6ddee-1120-43ae-b6c6-8dcc934855bc">19,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108b71d6b3c24623a40275dbf161561d_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzgtMS0xLTEtNzAzMzQ_96345e5b-018a-4091-82b5-6d08109fd776">9,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108b71d6b3c24623a40275dbf161561d_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzgtMy0xLTEtNzAzMzQ_aa706bff-826d-4e9c-bcde-037973399e02">4,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108b71d6b3c24623a40275dbf161561d_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzgtNS0xLTEtNzAzMzQ_7489a9e5-068c-45bc-b7cb-365524b1beab">4,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzktMS0xLTEtNzAzMzQ_d74e10c8-0b9f-4754-8dde-3a33d1826e2c">667,603</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzktMy0xLTEtNzAzMzQ_99ae96c2-2c7e-4fb2-bbad-e3d673ae3071">376,552</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzktNS0xLTEtNzAzMzQ_d9bcad06-0a38-45ff-bd3b-35495b3225ae">291,051</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-amortizable:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process software development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85451529d01a46ff987455865e8cc517_I20220402" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzExLTEtMS0xLTcwMzM0_8d5f5a59-7447-4e19-934d-f11868213206">2,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9cc62c7a26a4855a7c2bde8ac969d41_I20220402" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzEyLTEtMS0xLTc2MjM0_82254bdf-cc77-458f-8080-1510b04f2568">13,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4a14f19c3740fa8ef8bb4e38b7b19e_I20220402" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzEyLTEtMS0xLTcwMzM0_c7ab3782-1bc5-4051-b682-d8408611f6f1">2,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzEzLTEtMS0xLTcwMzM0_5a86d845-a52f-41be-af1f-146b043ac464">19,210</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Strategic Investments,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding acquisitions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets include the value assigned to license rights and other developed technology, patents, customer contracts and relationships and trade names. The estimated useful lives for all of these intangible assets are approximately <ix:nonNumeric contextRef="i3acb260a76164a64b8af93dcc2faa623_D20220403-20230401" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzkwMA_2f847cf9-c347-4784-81a5-e9e6e598acef">5</ix:nonNumeric> to <ix:nonNumeric contextRef="iecd0cd60e86c45669800594f2197741d_D20220403-20230401" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzkwNg_7ecad5bd-165b-468f-bf62-3ee7da8fed4d">15</ix:nonNumeric>&#160;years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate amortization expense for amortized intangible assets for fiscal 2023, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzEwMDM_26b33add-6599-4135-b602-1f3b2fc63683">42.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzEwMDc_1b8f275c-e915-455d-a3e2-e7840ef07cf8">56.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzEwMTQ_d81d014b-d7bc-4d5d-8d48-c4bcb51824b7">41.2</ix:nonFraction> million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ie51c221689b54f77b215d5872cb889cb"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzI1NTM_f8413760-f8f9-4499-bde5-5d31e3e19d93" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future annual amortization expense on intangible assets is estimated to be as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:83.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.563%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTpkOWQ5YWI0MDJiMmM0NjA0YWU3ZDg2N2Y2NGFmMjQyNi90YWJsZXJhbmdlOmQ5ZDlhYjQwMmIyYzQ2MDRhZTdkODY3ZjY0YWYyNDI2XzEtMi0xLTEtNzAzMzQ_17cddae6-910a-4197-9cfa-2a40d24fa51b">35,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTpkOWQ5YWI0MDJiMmM0NjA0YWU3ZDg2N2Y2NGFmMjQyNi90YWJsZXJhbmdlOmQ5ZDlhYjQwMmIyYzQ2MDRhZTdkODY3ZjY0YWYyNDI2XzItMi0xLTEtNzAzMzQ_c07c121b-53c4-4253-ad66-dfde932ea966">28,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTpkOWQ5YWI0MDJiMmM0NjA0YWU3ZDg2N2Y2NGFmMjQyNi90YWJsZXJhbmdlOmQ5ZDlhYjQwMmIyYzQ2MDRhZTdkODY3ZjY0YWYyNDI2XzMtMi0xLTEtNzAzMzQ_88f05a20-252f-491f-8643-ddb1c216f765">22,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTpkOWQ5YWI0MDJiMmM0NjA0YWU3ZDg2N2Y2NGFmMjQyNi90YWJsZXJhbmdlOmQ5ZDlhYjQwMmIyYzQ2MDRhZTdkODY3ZjY0YWYyNDI2XzQtMi0xLTEtNzAzMzQ_38ed83cb-182d-4a85-9529-f499b054712f">20,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTpkOWQ5YWI0MDJiMmM0NjA0YWU3ZDg2N2Y2NGFmMjQyNi90YWJsZXJhbmdlOmQ5ZDlhYjQwMmIyYzQ2MDRhZTdkODY3ZjY0YWYyNDI2XzUtMi0xLTEtNzAzMzQ_935b704b-4881-4238-b41a-53acdb76bb6b">19,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For costs incurred related to the development of software to be sold, leased, or otherwise marketed, the Company applies the provisions of ASC Topic 985-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software - Costs of Software to be Sold, Leased or Marketed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which specifies that costs incurred internally in researching and developing a computer software product should be charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs should be capitalized until the product is available for general release to customers. The costs capitalized for each project are included in intangible assets in the consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized $<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-5" name="us-gaap:PaymentsToDevelopSoftware" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzIwMzc_b23e4813-cd19-4b15-9852-c5b2845c5a00">3.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-5" name="us-gaap:PaymentsToDevelopSoftware" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzIwNDQ_49f593dd-da16-43e8-885e-605d29420257">3.4</ix:nonFraction>&#160;million in software development costs for ongoing initiatives during fiscal <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzIxMTU_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric> and 2022, respectively. At April&#160;1, 2023 and April&#160;2, 2022, the Company had a total of $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzIxOTkwMjMyNTgxODU_26c53dfe-635b-438a-b9d9-73f934856d19">82.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-5" name="us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzIxOTkwMjMyNTgxNzY_12f41500-0848-4f5d-9d93-ac6f6fd4e09f">79.0</ix:nonFraction>&#160;million of software costs capitalized, of which $<ix:nonFraction unitRef="usd" contextRef="i4373220213f242c8b26e3d18d69d2ca7_I20230401" decimals="-5" name="us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzIyMzE_175b188c-9ed4-4aa1-9ed7-663e97a075a2">3.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic4f1d2dfba3142c997fbce5f50dfa603_I20220402" decimals="-5" name="us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzIyMzg_10dd3a4b-13ed-47d0-99d1-a21442c821a7">5.0</ix:nonFraction>&#160;million are related to in process software development initiatives, respectively, and the remaining balance represents in-service assets that are being amortized over their useful lives. Amortization expense for capitalized software was $<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzI0NzA_ecff8500-68df-4208-8ab4-5d749b3e57d9">8.5</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzI0NzQ_f53f6eec-ec48-440d-b04d-7d274348da8b">8.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzI0ODI_b3c9d287-c220-46c9-9655-2efe4142d442">7.8</ix:nonFraction>&#160;million for fiscal <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzE2NDkyNjc0NDU1MjI_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric>, 2022 and 2021, respectively.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQwOTA_a63d53bc-3ae0-4787-abab-1744d272e862" continuedAt="ic678b96833494b57898d0560c3e647df" escape="true">LEASES </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic678b96833494b57898d0560c3e647df" continuedAt="i0ac7faf8b3284998a07c35824f83872b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee Activity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for office space, land, warehouse and manufacturing space, R&amp;D laboratories, vehicles and certain equipment. Finance leases are not significant. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company&#8217;s leases have remaining lease terms of&#160;<ix:nonNumeric contextRef="ia88c59c423ec44039b63736f7e925910_I20230401" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzYwMA_dc52fc53-cdad-40bc-b99c-bb4885a6db36">1</ix:nonNumeric> year&#160;to approximately&#160;<ix:nonNumeric contextRef="i6fb24bdd79a74f0eb39e5b0eecfbdaf6_I20230401" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzYyNQ_ebc0de79-ef66-4881-bdef-376e98be4f58">30</ix:nonNumeric> years, some of which may include options to extend the leases for up to&#160;<ix:nonNumeric contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzcwMA_ee46fd26-9a00-4bc1-96d7-88405cc80883">10</ix:nonNumeric> years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the appropriate incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, the Company entered into a lease for manufacturing space in Clinton, PA. In fiscal 2023, the Company&#8217;s manufacturing operations in Leetsdale, PA were relocated to the Clinton, PA facility. The lease term associated with the new manufacturing facility is 15 years and 7 months and includes two <ix:nonNumeric contextRef="ie4cf1b883fd6484c9800097c24c1d893_I20230401" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQzOTgwNDY1MTYzNDQ_ff7d0f1e-a2bc-4976-85c5-a91ce804e087">five year</ix:nonNumeric> renewal options followed by one <ix:nonNumeric contextRef="i178b7f39a47e48ccbbd4fb779775b3cf_I20230401" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQzOTgwNDY1MTYzNDU_e73b6e81-aaed-4b44-9848-f35db46504ac">four year</ix:nonNumeric> renewal option. During fiscal 2021, the Company recorded a right-of-use asset of $<ix:nonFraction unitRef="usd" contextRef="i523638b9b7c54c378edd933028123e1e_I20210403" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzE2NDkyNjc0NDY5MzM_87243dca-0bc0-46b2-a113-0787000c16fa">11.3</ix:nonFraction>&#160;million and corresponding liabilities of $<ix:nonFraction unitRef="usd" contextRef="i523638b9b7c54c378edd933028123e1e_I20210403" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzE2NDkyNjc0NDY5NjI_61a52910-486d-4488-958e-4fdeccb570ea">15.4</ix:nonFraction>&#160;million upon commencement of the lease term in May 2020. In addition, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i85fa50a491e746dbbe80adc41c28821c_I20220101" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzE2NDkyNjc0NDY5OTA_e241f0d2-54a7-4075-a28e-f36365bf8ece">4.1</ix:nonFraction>&#160;million lease incentive receivable associated with this lease agreement which was received during fiscal 2021.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i0ac7faf8b3284998a07c35824f83872b"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="hae:AssetsandLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQwOTE_2046fd9b-6589-45bb-9b5c-3896ace269df" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental balance sheet information related to the Company&#8217;s operating leases:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.806%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMC0xLTEtNzAzMzQ_34cb8f69-e36e-4863-9363-93e365f18a37"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMC0xLTEtNzAzMzQ_4c4b5b40-680d-44df-9a35-0e7bc64d7233"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMi0xLTEtNzAzMzQ_fe04e14b-3462-4114-ae2e-7f76a692cc41">53,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMy0xLTEtNzAzMzQ_d90b0b82-3283-4fa7-8087-a81cd9fdc9ac">52,749</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMC0xLTEtNzAzMzQ_71a2b58f-3dab-4c09-b137-6558f9c15c80"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMC0xLTEtNzAzMzQ_993d52dc-b21b-4c73-bea1-865c14747532"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current liabilities</span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMi0xLTEtNzAzMzQ_35f5d72b-aa33-4e49-b4e5-2bcf08b5b4a3">7,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMy0xLTEtNzAzMzQ_cfc0e7d0-3ae1-4668-987f-d48bb610e949">7,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMC0xLTEtNzAzMzQ_64ce6304-0097-4fab-b514-f225878a9f4b"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMC0xLTEtNzAzMzQ_aece9495-28e3-4cad-8c7d-78640888fb76"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term liabilities</span></span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMi0xLTEtNzAzMzQ_5b6876e2-1fa2-4075-ba10-41a15668440d">55,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMy0xLTEtNzAzMzQ_8db663ce-daa4-4859-957c-79538716b89c">55,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="hae:LesseeOperatingLeasesOtherInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQwODc_68753f96-8c5d-445d-ad1f-ebc7f41b9235" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and discount rate information related to our operating leases:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.806%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTphZDA5NjU1MTFkY2M0NWZkYWFhOTNmZDA4MDMyZWJkNC90YWJsZXJhbmdlOmFkMDk2NTUxMWRjYzQ1ZmRhYWE5M2ZkMDgwMzJlYmQ0XzEtMi0xLTEtNzAzMzQ_0d36ef59-67f1-4ee1-bdc7-d174c219ef40">9.0</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTphZDA5NjU1MTFkY2M0NWZkYWFhOTNmZDA4MDMyZWJkNC90YWJsZXJhbmdlOmFkMDk2NTUxMWRjYzQ1ZmRhYWE5M2ZkMDgwMzJlYmQ0XzEtMy0xLTEtNzAzMzQ_96d3927c-2f32-42b3-ad83-17bd178465a1">10.0</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTphZDA5NjU1MTFkY2M0NWZkYWFhOTNmZDA4MDMyZWJkNC90YWJsZXJhbmdlOmFkMDk2NTUxMWRjYzQ1ZmRhYWE5M2ZkMDgwMzJlYmQ0XzItMi0xLTEtNzAzMzQ_5240586e-09a5-4b1f-9442-1a3c2549e1ef">4.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTphZDA5NjU1MTFkY2M0NWZkYWFhOTNmZDA4MDMyZWJkNC90YWJsZXJhbmdlOmFkMDk2NTUxMWRjYzQ1ZmRhYWE5M2ZkMDgwMzJlYmQ0XzItMy0xLTEtNzAzMzQ_87f938c0-a4dc-4d91-a462-d79263065179">4.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating lease costs were&#160;$<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-5" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzI5MDY_29544f38-aad0-40cd-ab64-e043e406584a">10.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-5" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzI5MTA_a187c54d-3a2d-4c6b-a3bd-1f80a4af52cd">11.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-5" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzI5MTc_12d9a454-5ba4-4eda-a5c3-f2be77aed72e">11.7</ix:nonFraction>&#160;million during fiscal 2023, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQwODg_97153239-6ddd-4cfd-8633-c608e2a6a764" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information related to our operating leases:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:69.739%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.328%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 3, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used for operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo4NTdjZTM0YTgwNmI0YjQwYjczYTEzMzBhNGFhNDE4Yy90YWJsZXJhbmdlOjg1N2NlMzRhODA2YjRiNDBiNzNhMTMzMGE0YWE0MThjXzItMi0xLTEtNzAzMzQ_5610ccf9-2597-4002-bd5c-d0e39b9a2688">11,450</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo4NTdjZTM0YTgwNmI0YjQwYjczYTEzMzBhNGFhNDE4Yy90YWJsZXJhbmdlOjg1N2NlMzRhODA2YjRiNDBiNzNhMTMzMGE0YWE0MThjXzItMy0xLTEtNzAzMzQ_2714c710-11f5-4941-96f2-487443ddbf00">11,014</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo4NTdjZTM0YTgwNmI0YjQwYjczYTEzMzBhNGFhNDE4Yy90YWJsZXJhbmdlOjg1N2NlMzRhODA2YjRiNDBiNzNhMTMzMGE0YWE0MThjXzItNC0xLTEtNzAzMzQ_96b125a3-5ede-4bd1-8258-f1f643162972">10,456</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo4NTdjZTM0YTgwNmI0YjQwYjczYTEzMzBhNGFhNDE4Yy90YWJsZXJhbmdlOjg1N2NlMzRhODA2YjRiNDBiNzNhMTMzMGE0YWE0MThjXzMtMi0xLTEtNzAzMzQ_0cf0acc6-f3bf-4101-9d93-c88f7b0f74d2">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo4NTdjZTM0YTgwNmI0YjQwYjczYTEzMzBhNGFhNDE4Yy90YWJsZXJhbmdlOjg1N2NlMzRhODA2YjRiNDBiNzNhMTMzMGE0YWE0MThjXzMtMy0xLTEtNzAzMzQ_50b18828-3f6a-4252-bd8e-8f03bb1489f8">587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo4NTdjZTM0YTgwNmI0YjQwYjczYTEzMzBhNGFhNDE4Yy90YWJsZXJhbmdlOjg1N2NlMzRhODA2YjRiNDBiNzNhMTMzMGE0YWE0MThjXzMtNC0xLTEtNzAzMzQ_9071d224-3c8e-4f41-85d9-af3873b0ea46">29,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQwODk_fec46fa9-ecc5-4bb2-834a-9ae00b16b10e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturities of our operating lease liabilities as of&#160;April&#160;1, 2023:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:83.877%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzEtMi0xLTEtNzAzMzQ_d27559c9-fad2-4e9b-bd53-696077b5062e">9,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzItMi0xLTEtNzAzMzQ_cf3cb52c-10df-4ce4-9011-44dc8d1d48d0">9,007</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzMtMi0xLTEtNzAzMzQ_5e3d54eb-6d84-4e57-a3a2-3199162b29c2">8,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzQtMi0xLTEtNzAzMzQ_dc312afe-3e08-4520-9749-f2b4bc8a401d">9,073</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzUtMi0xLTEtNzAzMzQ_03adfc06-958d-41a2-9fc1-98ed4e6122ef">7,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzYtMi0xLTEtNzAzMzQ_41631c00-73cd-448a-bb98-fd591d351521">33,646</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum operating lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzctMi0xLTEtNzAzMzQ_b6ca3472-dff7-47c6-b488-dcb27d2bf167">77,630</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzgtMi0xLTEtNzAzMzQ_dca8dc70-6969-44d2-bf1d-fea25e43f1f6">14,565</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzktMi0xLTEtNzAzMzQ_8020f012-a95f-4275-9531-8e60231dad63">63,065</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Activity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets on the Company&#8217;s balance sheet classified as Haemonetics equipment primarily consists of medical devices installed at customer sites but owned by Haemonetics. These devices are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as the purchase and consumption of a certain level of disposable products. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where devices are provided under operating lease arrangements, a substantial majority of the entire lease revenue is variable and subject to subsequent non-lease component (disposable products) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Operating lease revenue represents approximately <ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="2" name="hae:OperatingLeaseRevenueAsAPercentageOfTotalNetSales" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQwNTE_9c998482-78fd-4d9a-b48f-3df06e241565">3</ix:nonFraction> percent of the Company&#8217;s total net sales.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_133"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzExMzcy_66d2ce48-2b68-40ac-b932-eff627b70f80" continuedAt="i2ccba4f033df49359df85d4a94139d57" escape="true">NOTES&#160;PAYABLE AND LONG-TERM DEBT</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2ccba4f033df49359df85d4a94139d57" continuedAt="i79278ed8b5c44df8983afc1cc3fad5dd"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzExMzc3_698452bb-7bb8-4f63-9178-9d5abaaf3c19" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes payable and long-term debt consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.468%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, net of financing fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef7fed91302418381fe9c7f81fce03e_I20230401" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzEtMS0xLTEtNzAzMzQ_774d8512-6fd8-4d31-abf3-66cabef9a946">273,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5206cff195784c31b27c9fddad5c6b59_I20220402" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzEtMy0xLTEtNzAzMzQ_00c694da-3d75-4fae-b122-9f14208cf306">284,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925003616419483dae22f32ba1685a31_I20230401" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzItMS0xLTEtNzAzMzQ_67929f7a-96fb-4a55-bfa7-e17e4782b288">492,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25e28000700d43b485d92326bbc4bfb7_I20220402" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzItMy0xLTEtNzAzMzQ_b8295453-78f7-4795-b833-2b55389b9931">489,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i903c8d9492d64dafb77bbdf28e97066f_I20230401" decimals="-3" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzMtMS0xLTEtNzAzMzQ_3e8683a2-52bf-4888-aa17-65f06f5bf216">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a29f8010b0f483eb7647596726afd6d_I20220402" decimals="-3" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzMtMy0xLTEtNzAzMzQ_6a1380a1-653f-45cf-a183-282e302b4575">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzQtMS0xLTEtNzAzMzQ_98f3c40b-f644-41a0-9b9f-68296aecda60">11,784</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzQtMy0xLTEtNzAzMzQ_59b4a1e3-e766-4317-9ac5-da5febd6585a">214,148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzUtMS0xLTEtNzAzMzQ_654e6084-ada9-4e7b-bc38-1ed36f723cb0">754,102</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzUtMy0xLTEtNzAzMzQ_d9b131ea-e994-41ed-b7d2-75e2c7f22dcf">559,441</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company issued $<ix:nonFraction unitRef="usd" contextRef="ib2c47b417de24ec0a72dcccb7db3cbe4_I20210331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2Nw_bcdec7eb-0960-4b06-a584-3abbccb9c3ad">500.0</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ib2c47b417de24ec0a72dcccb7db3cbe4_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzIwMA_83774249-729b-40e3-8472-f0ac543c9629">0</ix:nonFraction>% convertible senior notes due 2026 (the &#8220;2026 Notes&#8221;). The 2026 Notes are governed by the terms of the Indenture between the Company and U.S. Bank National Association, as trustee (the &#8220;Indenture&#8221;). The total net proceeds from the sale of the 2026 Notes, after deducting the initial purchasers&#8217; discounts and debt issuance costs, were approximately $<ix:nonFraction unitRef="usd" contextRef="iab86433186af40dcb319110ff6d19da1_D20210301-20210331" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzU1MQ_d2760821-80fc-410d-8815-1792e9d77597">486.7</ix:nonFraction>&#160;million. The 2026 Notes will mature on March 1, 2026, unless earlier converted, redeemed or repurchased.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their notes at their option at any time prior to the close of business on the business day immediately preceding September 1, 2025 only under the following circumstances:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During any calendar quarter (and only during such calendar quarter) beginning after June 30, 2021, if, the last reported sale price per share of the Company&#8217;s common stock exceeds <ix:nonFraction unitRef="number" contextRef="iab86433186af40dcb319110ff6d19da1_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwMjQ_6dde60fe-c6bd-4353-a37f-3109b1ad5f77">130</ix:nonFraction>% of the applicable conversion price on each applicable trading day for at least 20 trading days (whether or not consecutive) in the period of the 30 consecutive trading day period ending on, and including, the last trading day of the immediately preceding calendar quarter;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the five business day period after any five consecutive trading day period in which, for each day of that period, the trading price per $1,000 principal amount of the 2026 Notes for such trading day was less than <ix:nonFraction unitRef="number" contextRef="iab86433186af40dcb319110ff6d19da1_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE1MjE_e9a24f7e-d21e-429f-9767-af12706de59c">98</ix:nonFraction>% of the product of the last reported sale price of the Company&#8217;s common stock and the applicable conversion rate on such trading day;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company issues to common stockholders any rights, options, or warrants, entitling them, for a period of not more than 60 days, to purchase shares of common stock at a price per share less than the average closing sale price of 10 consecutive trading days, or the Company&#8217;s election to make a distribution to common stockholders exceeding <ix:nonFraction unitRef="number" contextRef="iab86433186af40dcb319110ff6d19da1_D20210301-20210331" decimals="INF" name="hae:DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzIwMDA_4fc75ce8-9059-4630-b8fd-9e4268d540e7">10</ix:nonFraction>% of the previous day&#8217;s closing sale price;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Upon the occurrence of specified corporate events, as set forth in the indenture governing the 2026 Notes; or</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the related redemption date if the Company calls the 2026 Notes for redemption</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after September 1, 2025, until the close of business on the scheduled trading day immediately preceding the maturity date, holders may convert all or a portion of their 2026 Notes, in multiples of $1,000 principal amount, at any time, regardless of the foregoing circumstances. The conversion rate for the 2026 Notes is <ix:nonFraction unitRef="number" contextRef="iab86433186af40dcb319110ff6d19da1_D20210301-20210331" decimals="INF" name="hae:DebtInstrumentConvertibleComponentConversionPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzI1NzI_779087ee-64a3-479e-8c96-43fb9e280ee2">5.7033</ix:nonFraction> shares of common stock per $1,000 principal amount of notes (which is equal to an initial conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="ib2c47b417de24ec0a72dcccb7db3cbe4_I20210331" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzI2OTk_58863f5f-f5d4-4535-b964-786c928ec775">175.34</ix:nonFraction> per share of the Company&#8217;s common stock), subject to adjustment as set forth in the Indenture. Upon conversion, the Company will pay cash up to the aggregate principal amount of the notes to be converted and pay or deliver, as the case may be, cash, common stock or a combination of cash and common stock, at the Company&#8217;s election, in respect of the remainder, if any, of the Company&#8217;s conversion obligation in excess of the aggregate principal amount of the notes being converted. If a make-whole adjustment event, as described in the Indenture, occurs and a holder elects to convert its 2026 Notes in connection with such make-whole adjustment event, such holder may be entitled to an increase in the conversion rate as described in the Indenture.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2023, the conditions allowing holders of the 2026 Notes to convert have not been met. The 2026 Notes were therefore not convertible as of April&#160;1, 2023 and were classified as long-term debt on the Company&#8217;s consolidated balance sheets.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i79278ed8b5c44df8983afc1cc3fad5dd" continuedAt="ia4290ec820114e86b659809352fe9a12"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2026 Notes will be redeemable, in whole or in part, at the Company&#8217;s option at any time, and from time to time, on or after March 5, 2024 and on or before the 40th scheduled trading day immediately before the maturity date, if the last reported sale price per share of the Company&#8217;s common stock exceeds <ix:nonFraction unitRef="number" contextRef="i11f3eed068e24237b4a649f0058c65a2_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzQwMTM_e65eea26-59fd-4796-a54c-5ff45cd8f420">130</ix:nonFraction>% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately before the date the Company sends the related redemption notice at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="ibb6b31fbfdc24cad84abad0853c2b26c_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzQ0MTc_76024192-6795-44cb-9326-ec70f9a4ed4d">100</ix:nonFraction>% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. Upon the occurrence of certain fundamental changes involving the Company, holders of the 2026 Notes may require the Company to repurchase for cash all or part of their 2026 Notes at a repurchase price equal to <ix:nonFraction unitRef="number" contextRef="ibb6b31fbfdc24cad84abad0853c2b26c_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzQ3NjA_d782e963-b678-4992-8285-07a41d2271b3">100</ix:nonFraction>% of the principal amount of the 2026 Notes to be repurchased, plus</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accrued and unpaid interest.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2021, the Company adopted ASC Update No. 2020-06 using the modified retrospective method, which resulted in a decrease of $<ix:nonFraction unitRef="usd" contextRef="i916dfcb35225444db2be37fbccd76378_I20210404" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTg3NTI_a9199d05-d9f0-4e93-81cb-ce1c4851319e">61.2</ix:nonFraction>&#160;million to additional paid-in capital, a decrease to non-current deferred tax liabilities of $<ix:nonFraction unitRef="usd" contextRef="ie55a1738904642cd8ecd0cbc158879ef_I20210404" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTg3NTY_ee48642b-6e9a-4e58-9aec-bb3744e31f5a">20.0</ix:nonFraction>&#160;million, and an increase of $<ix:nonFraction unitRef="usd" contextRef="ie55a1738904642cd8ecd0cbc158879ef_I20210404" decimals="-5" name="us-gaap:ConvertibleLongTermNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTg3NjA_21402c4e-490a-4471-8298-7a4342cc4218">80.3</ix:nonFraction>&#160;million to non-current convertible notes, net, on the consolidated balance sheets. Additionally, retained earnings was adjusted to remove amortization expense recognized in prior periods related to the debt discount and the convertible notes no longer have a debt discount that will be amortized, net of taxes. The impact to retained earnings on the consolidated balance sheets as of April 4, 2021 is an increase of $<ix:nonFraction unitRef="usd" contextRef="i8fbc64b8be934aaba7b7e05bf27bf2df_I20210404" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTg3NjQ_86a0ef42-9f5e-4a8b-bd3b-790072e6f149">1.0</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the $<ix:nonFraction unitRef="usd" contextRef="ib2c47b417de24ec0a72dcccb7db3cbe4_I20210331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzU1NDU_1c6c7807-b75e-4a13-811a-bdced1f69832">500.0</ix:nonFraction>&#160;million principal balance was netted down by the $<ix:nonFraction unitRef="usd" contextRef="i81bf02c0713c4e65b37b37c4baf36474_D20220403-20230401" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzU1ODk_46ce1feb-0ee4-428a-b9cf-af0410cfd745">7.9</ix:nonFraction>&#160;million of remaining debt issuance costs, resulting in a net convertible note payable of $<ix:nonFraction unitRef="usd" contextRef="i925003616419483dae22f32ba1685a31_I20230401" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzU2NzM_6b25b93f-43f6-4675-9073-eb223869d759">492.1</ix:nonFraction>&#160;million. Interest expense related to the 2026 Notes was $<ix:nonFraction unitRef="usd" contextRef="i81bf02c0713c4e65b37b37c4baf36474_D20220403-20230401" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzU3MjQ_feea3a41-1d27-4684-8101-421961e137d4">2.7</ix:nonFraction>&#160;million for the fiscal year ended April 1, 2023, which is entirely attributable to the amortization of the debt issuance costs. The debt issuance costs are amortized at an effective interest rate of <ix:nonFraction unitRef="number" contextRef="i925003616419483dae22f32ba1685a31_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzU4Nzg_7b976a9a-538b-4aea-b44d-104b12266d32">0.5</ix:nonFraction>%. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capped Calls</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the 2026 Notes, the Company entered into capped call transactions with certain counterparties (&#8220;Capped Calls&#8221;). The Capped Calls each have an initial strike price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i8998d1b0b6314a3c9cc6e3cf409ae0e8_D20210301-20210331" decimals="2" name="hae:DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzYxMTU_b7263f13-1f08-4cfb-a0e6-98cec42d5580">175.34</ix:nonFraction> per share, subject to certain adjustments, which corresponds to the initial conversion price of the 2026 Notes. The Capped Calls have initial cap prices of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8998d1b0b6314a3c9cc6e3cf409ae0e8_D20210301-20210331" decimals="2" name="hae:DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzYyNzQ_dcb4f6c5-0962-4643-9845-9ce36c81513f">250.48</ix:nonFraction> per share, subject to certain adjustments. The Capped Calls are expected to partially offset the potential dilution to the Company&#8217;s common stock upon any conversion of the 2026 Notes, with such offset subject to a cap based on the cap price. The Capped Calls cover, subject to anti-dilution adjustments, approximately <ix:nonFraction unitRef="shares" contextRef="i8998d1b0b6314a3c9cc6e3cf409ae0e8_D20210301-20210331" decimals="-4" name="hae:DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzY1OTY_3eb3a0bb-aebb-418d-b160-2e336b3bd51f">2.85</ix:nonFraction>&#160;million shares of the Company&#8217;s common stock. For accounting purposes, the Capped Calls are separate transactions, and not part of the 2026 Notes. As these transactions meet certain accounting criteria, the Capped Calls are recorded in stockholders&#8217; equity and are not accounted for as derivatives. The cost of $<ix:nonFraction unitRef="usd" contextRef="i8998d1b0b6314a3c9cc6e3cf409ae0e8_D20210301-20210331" decimals="-5" name="hae:DebtInstrumentConvertibleCappedCallTransactionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzY5MDI_a27e2598-7c7d-4d5f-b588-e180e1e66356">47.4</ix:nonFraction>&#160;million incurred to purchase the Capped Calls was recorded as a reduction to additional paid-in capital in fiscal 2021 and will not be remeasured.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2018, the Company entered into a credit agreement with certain lenders that provided for a $<ix:nonFraction unitRef="usd" contextRef="ib996e7dc8ee44cd2ad33f983f5f21944_I20180615" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzcxNTM_4c7d2bb8-1257-4f2b-942d-37e9c5cef93f">350.0</ix:nonFraction> million term loan and a $<ix:nonFraction unitRef="usd" contextRef="i3967cacf6e894b93b61883e912ba1fe6_I20180615" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzcxOTA_b5d6b381-79c3-4bb9-a7da-517fd11ad256">350.0</ix:nonFraction> million revolving loan (together with the term loan, as amended from time to time, the &#8220;2018 Credit Facilities&#8221;) that were each scheduled to mature on June 15, 2023 with applicable interest rates during the period established using LIBOR plus <ix:nonFraction unitRef="number" contextRef="ibb54cb0a2108432db260e72c7a6d4079_D20180615-20180615" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc0MTM_4bdb1704-ba99-4f7e-bbdd-ddff0288efa9">1.13</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="iee47837acab14fbdac774a769db72497_D20180615-20180615" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc0MTg_c50aac50-9c40-4aa5-b0df-4b002396ac7f">1.75</ix:nonFraction>%, depending on the Company's leverage ratio. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 26, 2022, the Company entered into an amended and restated credit agreement with certain lenders to refinance the 2018 Credit Facilities and extend their maturity date through June 2025. The amended and restated credit agreement provides for a $<ix:nonFraction unitRef="usd" contextRef="i2be5f41c5e2b4e1c8302bd6e01bebdfa_I20220726" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU3Njg_61e672be-5248-4e56-92d0-7b90dd922cad">280.0</ix:nonFraction>&#160;million&#160;senior unsecured term loan, the proceeds of which have been used to settle the balance of the term loan under the 2018 Credit Facilities, and a $<ix:nonFraction unitRef="usd" contextRef="i2a9006835c4148deb219670605797d8d_I20220726" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU3ODg_d1b84563-bcaa-40dc-a8c8-2eced74e8415">420.0</ix:nonFraction>&#160;million&#160;senior unsecured revolving credit facility (together, the &#8220;Revised Credit Facilities&#8221;). Loans under the Revised Credit Facilities bear interest at an annual rate equal to the Adjusted Term SOFR Rate (as specified in the amended and restated credit agreement), which is subject to a floor of <ix:nonFraction unitRef="number" contextRef="id657b251abdc4abebff797dc16703707_I20220726" decimals="INF" name="hae:DebtInstrumentInterestRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4MDc_b3794fb0-a55e-43cb-a747-4cf6da3c19a0">0</ix:nonFraction>%, plus an applicable rate ranging from <ix:nonFraction unitRef="number" contextRef="id657b251abdc4abebff797dc16703707_I20220726" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4MTM_f7024950-999c-45f1-88be-622ce8f227e1">1.125</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i1fd10418194d4183846d9bb8e0212b5d_I20220726" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4MjE_eefba645-2e38-4afc-aad9-739160963f85">1.750</ix:nonFraction>% based on the Company&#8217;s consolidated net leverage ratio (as specified in the amended and restated credit agreement) at the applicable measurement date. Adjusted Term SOFR Rate loans are also subject to a credit spread adjustment of <ix:nonFraction unitRef="number" contextRef="i5fce0a136f5a44868f4e4a7f2e21a61a_D20220726-20220726" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4Mjk_11dbbcd0-c389-4d72-af43-439983c286ff">0.10</ix:nonFraction>% per annum. The revolving credit facility carries an unused fee that ranges from <ix:nonFraction unitRef="number" contextRef="i29c8a067458945ffa8f7969389dce91f_D20220726-20220726" decimals="5" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4MzY_8a7a4e6d-169b-4863-b9e8-b9c1f00ddc06">0.125</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i7a709732686240949bc3efe71990d70e_D20220726-20220726" decimals="5" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4NDQ_95cd310c-d195-4cbd-8a72-421e17cfd449">0.250</ix:nonFraction>% annually based on the Company&#8217;s consolidated net leverage ratio at the applicable measurement date. Under the Revised Credit Facilities, the Company is required to maintain certain leverage and interest coverage ratios specified in the amended and restated credit agreement as well as other customary non-financial affirmative and negative covenants. The Revised Credit Facilities mature on June 15, 2025. The principal amount of the term loan under the Revised Credit Facilities is repayable quarterly through the maturity date at a rate of <ix:nonFraction unitRef="number" contextRef="i2be5f41c5e2b4e1c8302bd6e01bebdfa_I20220726" decimals="3" name="hae:DebtInstrumentPercentOfPrincipalAmountDueInYearOne" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4NTI_35212e9a-b658-44b7-9567-ec518516c0f3">2.5</ix:nonFraction>% for the first year and <ix:nonFraction unitRef="number" contextRef="i2be5f41c5e2b4e1c8302bd6e01bebdfa_I20220726" decimals="2" name="hae:DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4NTg_ff980c6b-6ecf-4aa1-b5e6-fc891bffc936">5</ix:nonFraction>% thereafter, with the unpaid balance due at maturity.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ia4290ec820114e86b659809352fe9a12" continuedAt="ib3731b0da33048cfbe71ff78866abe72"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company applied modification accounting for the credit facility refinancing. For the term loan under the Revised Credit Facilities, for fiscal 2023, the Company recognized interest expense of $<ix:nonFraction unitRef="usd" contextRef="i973bd797eb414599820e9d35565eeede_D20220403-20230401" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU5NTE_ee9a9ce6-762f-40bf-b6c1-f0809b946243">0.5</ix:nonFraction>&#160;million for third party fees incurred and capitalized $<ix:nonFraction unitRef="usd" contextRef="i973bd797eb414599820e9d35565eeede_D20220403-20230401" decimals="-5" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU5NzA_d308e9ef-02b3-4fd1-9135-37bff69b9759">0.2</ix:nonFraction>&#160;million of lender fees related to the term loan. For fiscal 2023, the Company capitalized $<ix:nonFraction unitRef="usd" contextRef="i9a1b40a602a74e26bef73bbaf259f41c_D20220403-20230401" decimals="-5" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTYwMjk_83253ff2-4b4b-4c62-93eb-43035f94e942">1.1</ix:nonFraction>&#160;million of lender fees and third-party costs incurred in the refinancing related to the revolving credit facility under the Revised Credit Facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;1, 2023, $<ix:nonFraction unitRef="usd" contextRef="if339c602382f4eaf8286ac7302f32991_I20230401" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc0NzI_f7ceb09a-c5c7-450d-aa3e-d9903b67e847">274.7</ix:nonFraction> million was outstanding under the term loan with an effective interest rate of <ix:nonFraction unitRef="number" contextRef="if339c602382f4eaf8286ac7302f32991_I20230401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc1NDY_542a4ae7-d5da-45bf-b809-4b272b618847">6.3</ix:nonFraction>%. There were <ix:nonFraction unitRef="usd" contextRef="id0d3e0503f2e47369182add4c536c0b0_I20230401" decimals="INF" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTYwNTI_91bbd2fb-dffa-4813-ba50-b14248264272">no</ix:nonFraction> outstanding borrowings under the revolving credit facility at April&#160;1, 2023. The Company also had $<ix:nonFraction unitRef="usd" contextRef="i0373e5b59bde4b20931153fa64e29e2b_I20230401" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc2NDQ_eb90c6d3-05bd-4c90-b90c-0123fc04a02a">21.3</ix:nonFraction> million of uncommitted operating lines of credit to fund its global operations under which there were <ix:nonFraction unitRef="usd" contextRef="i0373e5b59bde4b20931153fa64e29e2b_I20230401" decimals="INF" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc3NDE_ece7059a-fb10-4f56-8b30-d3e42725e5bf">no</ix:nonFraction> outstanding borrowings as of April&#160;1, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Revised Credit Facilities, the Company is required to maintain a consolidated leverage ratio not to exceed <ix:nonFraction unitRef="number" contextRef="id0d3e0503f2e47369182add4c536c0b0_I20230401" decimals="INF" name="hae:ConsolidatedTotalLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc4ODc_216278f5-534b-4415-b042-ee7b9146b084">3.5</ix:nonFraction>:1.0 and a consolidated interest coverage ratio not to be less than <ix:nonFraction unitRef="number" contextRef="id0d3e0503f2e47369182add4c536c0b0_I20230401" decimals="INF" name="hae:ConsolidatedInterestCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc5NTc_dca514d3-18e5-4a8c-838a-60aaa44e02e0">4.0</ix:nonFraction>:1.0 during periods when the Revised Credit Facilities are outstanding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company is required to satisfy these covenants, on a pro forma basis, in connection with any new borrowings (including any letter of credit issuances) on the revolving credit facility as of the time of such borrowings. The Consolidated Interest Coverage Ratio is calculated as the consolidated EBITDA divided by consolidated interest expense while the Consolidated Net Leverage ratio is calculated as consolidated total debt minus liquidity, divided by consolidated EBITDA. Consolidated EBITDA includes EBITDA adjusted by non-recurring and unusual transactions specifically as defined in the Revised Credit Facilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revised Credit Facilities also contain usual and customary non-financial affirmative and negative covenants that include certain restrictions with respect to subsequent indebtedness, liens, loans and investments (including acquisitions), financial reporting obligations, mergers, consolidations, dispositions, dissolutions or liquidation, asset sales, affiliate transactions, change of its business, capital expenditures, share repurchase and other restricted payments. These covenants are subject to exceptions and qualifications set forth in the credit agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure to comply with the financial and operating covenants of the Revised Credit Facilities would prevent the Company from being able to borrow additional funds and would constitute a default, which could result in, among other things, the amounts outstanding including all accrued interest and unpaid fees, becoming immediately due and payable. In addition, the Revised Credit Facilities include customary events of default, in certain cases subject to customary cure periods. As of April&#160;1, 2023, the Company was in compliance with the covenants. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commitment Fee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Revised Credit Facilities, the Company is required to pay, on the last day of each calendar quarter, a commitment fee on the unused portion of the revolving credit facility. The commitment fee is subject to a pricing grid based on the Company&#8217;s consolidated leverage ratio. The commitment fee ranges from <ix:nonFraction unitRef="number" contextRef="ica4fb645f2a44680b45401f71819ac02_D20220403-20230401" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwNDcw_326acbfb-c90f-4412-bfe1-cc94993eb9f9">0.125</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i8896432b873649499c520736535daf9b_D20220403-20230401" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwNDc2_9e321d74-c5a2-4955-b0c7-87b90fce3019">0.250</ix:nonFraction>%. The current commitment fee on the undrawn portion of the revolving credit facility is <ix:nonFraction unitRef="number" contextRef="ia304a8f1861445a888815c4e3fe5f060_D20220403-20230401" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwNTY2_a1df1cc5-5b8b-457d-b2cc-effee0201bde">0.175</ix:nonFraction>%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Issuance Costs and Interest </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses associated with the issuance of the term loan were capitalized and are amortized to interest expense over the life of the term loan using the effective interest method. As of April&#160;1, 2023, the $<ix:nonFraction unitRef="usd" contextRef="if339c602382f4eaf8286ac7302f32991_I20230401" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwNzk4_f7ceb09a-c5c7-450d-aa3e-d9903b67e847">274.7</ix:nonFraction> million term loan balance was netted down by the $<ix:nonFraction unitRef="usd" contextRef="i7f25693c211040ecb83adb263cfb9f7f_D20220403-20230401" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwODQy_b8a281ae-116e-4319-964b-6b9306e23c59">1.0</ix:nonFraction> million of remaining debt discount, resulting in a net note payable of $<ix:nonFraction unitRef="usd" contextRef="i6ef7fed91302418381fe9c7f81fce03e_I20230401" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwOTA4_65827cd6-e648-49b7-9410-cd3a48e8f483">273.7</ix:nonFraction> million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwOTM1_d1cffaec-6954-4f3a-8ca4-90d7b433b4b1">13.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwOTM5_6ce7d6f3-e6d2-4e5b-b4f0-f17bc5f3d37b">5.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwOTQ2_018ff355-cff2-42d1-b028-ed23b45d0fc7">9.4</ix:nonFraction> million for fiscal 2023, 2022 and 2021, respectively. Accrued interest associated with the outstanding debt is included as a component of other current liabilities in the accompanying consolidated balance sheets. As of both April&#160;1, 2023 and April&#160;2, 2022, the Company had an insignificant amount of accrued interest associated with the outstanding debt.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ib3731b0da33048cfbe71ff78866abe72"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzExMzU2_6f14117e-3465-4cce-8d09-4935199d0f38" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate amount of debt maturing during the next five fiscal years are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:88.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal year</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTpjMDNhZmI3ZmMyMWY0NmVkODQ1NGQ3MThhMmZiZWJkMS90YWJsZXJhbmdlOmMwM2FmYjdmYzIxZjQ2ZWQ4NDU0ZDcxOGEyZmJlYmQxXzEtMS0xLTEtNzAzMzQ_1bc4c6ba-8555-49aa-8245-a862dc86a062">12,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTpjMDNhZmI3ZmMyMWY0NmVkODQ1NGQ3MThhMmZiZWJkMS90YWJsZXJhbmdlOmMwM2FmYjdmYzIxZjQ2ZWQ4NDU0ZDcxOGEyZmJlYmQxXzItMS0xLTEtNzAzMzQ_c4d0f67a-bb50-4fb4-9006-eb3dcf41777d">10,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTpjMDNhZmI3ZmMyMWY0NmVkODQ1NGQ3MThhMmZiZWJkMS90YWJsZXJhbmdlOmMwM2FmYjdmYzIxZjQ2ZWQ4NDU0ZDcxOGEyZmJlYmQxXzMtMS0xLTEtNzAzMzQ_7cbf2e57-cd7d-46f2-8e09-7d298a15e6d4">752,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTpjMDNhZmI3ZmMyMWY0NmVkODQ1NGQ3MThhMmZiZWJkMS90YWJsZXJhbmdlOmMwM2FmYjdmYzIxZjQ2ZWQ4NDU0ZDcxOGEyZmJlYmQxXzQtMS0xLTEtNzAzMzQ_f3922f80-f434-41de-bff4-3eb6160e8fa2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTpjMDNhZmI3ZmMyMWY0NmVkODQ1NGQ3MThhMmZiZWJkMS90YWJsZXJhbmdlOmMwM2FmYjdmYzIxZjQ2ZWQ4NDU0ZDcxOGEyZmJlYmQxXzUtMS0xLTEtNzAzMzQ_858083fa-2f4c-498c-9b83-0268a4a7ff86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:DerivativesAndFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzEyMzA5_751e8b14-4914-40db-bcdc-68ec0f19ccc2" continuedAt="i17b43e0315a84618a23fb815491d4aee" escape="true">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i17b43e0315a84618a23fb815491d4aee" continuedAt="i0aee9e84d4434fcd83fdcfd440ec0bf3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manufactures, markets and sells its products globally. For the fiscal year ended April&#160;1, 2023, <ix:nonFraction unitRef="number" contextRef="i0c2e06723032498cae382b252778126a_D20220403-20230401" decimals="3" name="hae:PercentageOfNetSalesGeneratedOutsideOfUs" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE1Nw_05ffb6de-9cdd-4d63-92d4-ea4e73d65870">27.9</ix:nonFraction>% of the Company&#8217;s sales were generated outside the U.S.&#160;in local currencies. The Company also incurs certain manufacturing, marketing and selling costs in international markets in local currency.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, earnings and cash flows are exposed to market risk from changes in foreign currency exchange rates relative to the U.S. Dollar, the Company&#8217;s reporting currency. The Company has a program in place that is designed to mitigate the exposure to changes in foreign currency exchange rates. That program includes the use of derivative financial instruments to minimize, for a period of time, the impact on its financial results from changes in foreign exchange rates. The Company utilizes foreign currency forward contracts to hedge the anticipated cash flows from transactions denominated in foreign currencies, primarily Japanese Yen and Euro, and to a lesser extent Swiss Franc and Mexican Peso. This does not eliminate the impact of the volatility of foreign exchange rates. However, because the Company generally enters into forward contracts one year out, rates are fixed for a <ix:nonNumeric contextRef="i0c2e06723032498cae382b252778126a_D20220403-20230401" name="us-gaap:AverageRemainingMaturityOfForeignCurrencyDerivatives1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzEyMzE0_46e5f746-32bf-451a-b135-11c90cba9be4">one-year</ix:nonNumeric> period, thereby facilitating financial planning and resource allocation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Designated Foreign Currency Hedge Contracts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s designated foreign currency hedge contracts as of April&#160;1, 2023 and April&#160;2, 2022 were cash flow hedges under ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 815&#8221;). The Company records the effective portion of any change in the fair value of designated foreign currency hedge contracts in other comprehensive income until the related third-party transaction occurs. Once the related third-party transaction occurs, the Company reclassifies the effective portion of any related gain or loss on the designated foreign currency hedge contracts to earnings. In the event the hedged forecasted transaction does not occur, or it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. The Company had designated foreign currency hedge contracts outstanding in the contract amount of $<ix:nonFraction unitRef="usd" contextRef="i4174f7cffc824248a65ba67bdeea5ccf_I20230401" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzIyOTM_ae338821-aa33-404b-acbd-cbfa7fed6c61">51.8</ix:nonFraction> million as of April&#160;1, 2023 and $<ix:nonFraction unitRef="usd" contextRef="iaea3475e1f9349fe82f8c3d1a089214d_I20220402" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzIzMDk_34e43af2-8630-4ea8-b906-90ea97d28e32">67.3</ix:nonFraction> million as of April&#160;2, 2022. At April&#160;1, 2023, a gain of $<ix:nonFraction unitRef="usd" contextRef="i764ec41ce0424c3da439a7f3192b0337_D20220403-20230401" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzIzMzk_893c95f2-9dbd-49ff-9737-e923718a4615">2.8</ix:nonFraction> million, net of tax, will be reclassified to earnings within the next twelve months. Substantially all currency cash flow hedges outstanding as of April&#160;1, 2023 mature within twelve months. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Designated Foreign Currency Contracts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its exposure to changes in foreign currency on a consolidated basis to take advantage of offsetting transactions and balances. It uses foreign currency forward contracts as a part of its strategy to manage exposure related to foreign currency denominated monetary assets and liabilities. These foreign currency forward contracts are entered into for periods consistent with currency transaction exposures, generally one month. They are not designated as cash flow or fair value hedges under ASC 815. These forward contracts are marked-to-market with changes in fair value recorded to earnings. The Company had non-designated foreign currency hedge contracts under ASC 815 outstanding in the contract amount of $<ix:nonFraction unitRef="usd" contextRef="i203893fd11e847cf96e92a3382d9cf3e_I20230401" decimals="-5" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzMyODg_5af9d361-c15a-4226-a048-97184ba12f4e">44.7</ix:nonFraction> million as of April&#160;1, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i40bb49f3669047d78a200b57b5089b10_I20220402" decimals="-5" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzMzMDQ_88007d4f-1878-41d0-9187-79a22ee710f4">39.5</ix:nonFraction> million as of April&#160;2, 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i0aee9e84d4434fcd83fdcfd440ec0bf3" continuedAt="ie29418426784404eb71cc70feb7b9871"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swaps</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Part of the Company&#8217;s interest rate risk management strategy includes the use of interest rate swaps to mitigate its exposure to changes in variable interest rates. The Company&#8217;s objective in using interest rate swaps is to add stability to interest expense and to manage and reduce the risk inherent in interest rate fluctuations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2018, the Company entered into the 2018 Credit Facilities which provided for a $<ix:nonFraction unitRef="usd" contextRef="ib996e7dc8ee44cd2ad33f983f5f21944_I20180615" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzM0MjE_3dbc2835-9e6d-41a2-89a8-24297f95328f">350.0</ix:nonFraction> million term loan and a $<ix:nonFraction unitRef="usd" contextRef="i3967cacf6e894b93b61883e912ba1fe6_I20180615" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzM0NDA_610c73e3-0f02-4df1-a61d-db0a84fc32e3">350.0</ix:nonFraction> million revolving credit facility. Under the terms of the 2018 Credit Facilities, interest was established using LIBOR plus the applicable rate ranging from <ix:nonFraction unitRef="number" contextRef="ibb54cb0a2108432db260e72c7a6d4079_D20180615-20180615" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzM1NTM_4a1754a9-e50a-4ad8-8edf-00194a4f7914">1.13</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="iee47837acab14fbdac774a769db72497_D20180615-20180615" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzM1NTg_baa77c87-6de0-44b4-a076-9140dadbaec8">1.75</ix:nonFraction>% based on the Company&#8217;s leverage ratio. In August 2018, the Company entered into <ix:nonFraction unitRef="swap" contextRef="ic098477b86064390ab0ce23b1ab8e887_I20180831" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzQwNDQ_1f4c4191-cb6a-4bd8-9379-3ab79b0ab1a0">two</ix:nonFraction> interest rate swap agreements to pay an average fixed rate of <ix:nonFraction unitRef="number" contextRef="ic098477b86064390ab0ce23b1ab8e887_I20180831" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzQxMjM_66444f18-64e4-417a-9549-33b714e917f9">2.80</ix:nonFraction>% plus the applicable rate on a total notional value of $<ix:nonFraction unitRef="usd" contextRef="ic098477b86064390ab0ce23b1ab8e887_I20180831" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzQxNTU_1c8f50ab-de53-45d8-97e9-06c8661b61c3">241.9</ix:nonFraction> million of debt, or <ix:nonFraction unitRef="number" contextRef="i1fd6349491de4fe18e35a4e8da7c6adb_I20180831" decimals="INF" name="hae:DerivativePercentofDebtExposed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzQyMDc_12306153-4b6a-47df-9e71-70760a205718">70</ix:nonFraction>% of the notional value of the unsecured term loan. The 2018 interest rate swaps mature on June 15, 2023. As a result of the Company&#8217;s refinancing of the 2018 Credit Facilities in July 2022, as discussed below, the 2018 interest rate swaps were amended in September 2022 to align with the Term Secured Overnight Financing Rate (&#8220;SOFR&#8221;) rate rather than LIBOR (the &#8220;Amended Swaps&#8221;). In order to avoid dedesignation, the Company elected certain practical expedients under ASC 848.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, the Company&#8217;s earnings and cash flows are exposed to interest rate risk from changes to SOFR. The Company concluded that the Amended Swaps were still effective such that hedge accounting was continued on these swaps.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 26, 2022, the Company entered into an amended and restated credit agreement to refinance the 2018 Credit Facilities and extend their maturity date through June 2025. The Revised Credit Facilities include a $<ix:nonFraction unitRef="usd" contextRef="i2be5f41c5e2b4e1c8302bd6e01bebdfa_I20220726" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NTk5ODY_61e672be-5248-4e56-92d0-7b90dd922cad">280.0</ix:nonFraction>&#160;million senior unsecured term loan and a $<ix:nonFraction unitRef="usd" contextRef="i2a9006835c4148deb219670605797d8d_I20220726" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NTk5OTM_d1b84563-bcaa-40dc-a8c8-2eced74e8415">420.0</ix:nonFraction>&#160;million&#160;senior unsecured revolving credit facility. Loans under the Revised Credit Facilities bear interest at an annual rate equal to the 1-month USD Term SOFR plus <ix:nonFraction unitRef="number" contextRef="ide370a9836b84207b26c4ba915b66f5e_D20220726-20220726" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwNTc_b8c45a98-2ce1-41e8-83e7-f9f6a8db11fe">0.10</ix:nonFraction>% and an applicable rate ranging from <ix:nonFraction unitRef="number" contextRef="i97fd6203f93c48a497546a24430f37f5_I20220726" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwMDY_3f0bddfc-421f-42f8-bc09-4d7841672330">1.125</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i5594635815ba48028990d42040a8998c_I20220726" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwMTQ_139639d4-32bf-4678-a885-5d926f9ba3e7">1.750</ix:nonFraction>% based on the Company&#8217;s consolidated net leverage ratio. In September 2022, the Company entered into <ix:nonFraction unitRef="unit" contextRef="ic7aae77517ed42c7b472d781ea7f2fd5_D20220901-20220930" decimals="INF" name="hae:NumberOfInterestRateSwapsEntered" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwMjE_bb7dc13c-df6a-4a07-a461-55f742d4a277">four</ix:nonFraction> additional interest rate swaps, which when combined with the Amended Swaps, result in an average blended fixed interest rate of <ix:nonFraction unitRef="number" contextRef="i7e00c74476ee4f559c6f5da509474dc8_I20220930" decimals="4" name="hae:DerivativeBlendedFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwMjM_303fd90b-6a50-41e9-ab0e-07c97d3f74dc">3.57</ix:nonFraction>% plus the applicable rate on <ix:nonFraction unitRef="number" contextRef="ic7aae77517ed42c7b472d781ea7f2fd5_D20220901-20220930" decimals="2" name="hae:DerivativePercentageOfNotionalValueOfDebt" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwMzA_57bf0edb-3b6a-47b7-b662-6de76ffac7c7">70</ix:nonFraction>% of the notional value of the unsecured term loan until mid-June 2023 and <ix:nonFraction unitRef="number" contextRef="i17c4195f41c04cd69212868e1ecf674f_I20230615" decimals="4" name="hae:DerivativeBlendedFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwMzU_3a8455b5-aa71-4918-b745-142920e48ed4">4.12</ix:nonFraction>% plus the applicable rate thereafter on <ix:nonFraction unitRef="number" contextRef="ibc4d6f8cfb4043299d632162cf4b2dd3_D20230615-20230615" decimals="2" name="hae:DerivativePercentageOfNotionalValueOfDebt" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwNDI_b259e80d-2de6-4ef8-80c4-60531995439c">80</ix:nonFraction>% of the notional until the maturity date in June 2025. The Company has concluded that each of these <ix:nonFraction unitRef="unit" contextRef="ic7aae77517ed42c7b472d781ea7f2fd5_D20220901-20220930" decimals="INF" name="hae:NumberOfInterestRateSwapsEntered" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjI1MjY_c6a7f93c-6576-482c-a895-e40dd3b0ca50">four</ix:nonFraction> additional interest rate swaps are effective and qualify for hedge accounting treatment.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjA4Mjg_d55f9816-8198-4864-bb59-fe04c27f5cc9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company held the following interest rate swaps as of April&#160;1, 2023:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:21.634%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.643%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Original Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount as of April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value Assets (Liabilities)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68eff29e4ad24dbbbb27184442823054_I20180928" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzItMi0xLTEtNzQ2NDA_ee3d21a4-18dc-443e-a56b-88bfded9300c">140,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7000a797e0454253afd12b28826cf4c1_I20230401" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzItNC0xLTEtNzQ2NDM_86219476-97e8-4b9b-8a39-ba9594c91fb9">28,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/28/2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/30/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7000a797e0454253afd12b28826cf4c1_I20230401" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzItMTItMS0xLTc0NjQ1_7d0b8279-03cf-4c5f-99ec-ac50b06e8b51">2.67</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7000a797e0454253afd12b28826cf4c1_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzItMTQtMS0xLTc0NjQ3_52d3bc16-f6db-48b7-b03f-e9e22e6e44a4">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ebfc574daa0449aa36b42ccd3735fb8_I20180928" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzMtMi0xLTEtNzQ2NTE_063ccb90-a6ed-43a1-820a-5794e24d13a8">101,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5a33d65ce4c719c8ef554f98fd1b3_I20230401" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzMtNC0xLTEtNzQ2NTE_2515deb1-266f-447c-96be-9428c27e2f12">20,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/28/2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/30/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2fd5a33d65ce4c719c8ef554f98fd1b3_I20230401" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzMtMTItMS0xLTc0NjYy_205fc945-9b4c-4bb5-998c-1379657eed74">2.76</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd5a33d65ce4c719c8ef554f98fd1b3_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzMtMTQtMS0xLTc0NjYy_cd639928-f4e3-43d1-8a4c-631a2d4a70d7">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee0aef522d1c43b297cb87bd0a1062c5_I20220923" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzQtMi0xLTEtNzQ2NTE_6ff551a6-569e-48ec-a6e3-bbeecdfc8f21">23,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc20bf01217b405abe467d85031aa1d8_I20230401" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzQtNC0xLTEtNzQ2NTE_4d984ee9-7710-46dd-989c-5f6bc08dc28f">71,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/23/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/30/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc20bf01217b405abe467d85031aa1d8_I20230401" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzQtMTItMS0xLTc0NjYy_b0100f1c-66d2-4c7c-9dce-43151bfd7a3d">4.44</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc20bf01217b405abe467d85031aa1d8_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzQtMTQtMS0xLTc0NjYy_28fddab4-cafc-4668-8d89-1f9c01eadac2">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i929893b4a65b42a99d8cd2ed3e4ad16f_I20220923" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzUtMi0xLTEtNzQ2NTE_0394ab36-c538-4b6c-88ce-c5e93edbe543">23,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95d4787e8ccb4c79bb1a2ae21210589b_I20230401" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzUtNC0xLTEtNzQ2NTE_aebd6f9b-b128-4c2e-be93-29fe58032c2a">71,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/23/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/30/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95d4787e8ccb4c79bb1a2ae21210589b_I20230401" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzUtMTItMS0xLTc0NjYy_43af0143-1c31-4c27-a501-d235d46adec9">4.46</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95d4787e8ccb4c79bb1a2ae21210589b_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzUtMTQtMS0xLTc0NjYy_17493047-7fd0-4abc-abbc-585db352636e">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2bff04bb124b3cb9565ede568309e3_I20220923" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzYtMi0xLTEtNzQ2NTE_15ce28fb-da75-429a-92b9-9cfcf7013d40">109,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0016d855bc4eae89b59f2528f0aac5_I20230401" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzYtNC0xLTEtNzQ2NTE_101982e4-5e77-4f33-8d59-6b42897f4ab1">109,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/23/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a0016d855bc4eae89b59f2528f0aac5_I20230401" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzYtMTItMS0xLTc0NjYy_ccbc864c-cf95-4b9f-94bf-509cd38d2371">4.08</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0016d855bc4eae89b59f2528f0aac5_I20230401" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzYtMTQtMS0xLTc0NjYy_7bfb1593-ee13-41bd-80f5-f8f3b522294f">464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88f4a493fba4a00b9f4326a9f0089c9_I20220923" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzctMi0xLTEtNzQ2NTE_82be1c11-2a86-418e-b9f8-e519c4553b34">109,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143f09af5d36486a95b6a2443695e880_I20230401" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzctNC0xLTEtNzQ2NTE_c7381224-d71d-4e26-b453-bd1c2bf9fdda">109,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/23/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i143f09af5d36486a95b6a2443695e880_I20230401" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzctMTItMS0xLTc0NjYy_214d410d-613f-4f76-9501-cd9cb31985fd">4.15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i143f09af5d36486a95b6a2443695e880_I20230401" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzctMTQtMS0xLTc0NjYy_3aff2e66-f1c0-4d2c-beb0-cc7e7a4d4658">585</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40cd2d153ec649379e2713e53825581e_I20220923" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzgtMi0xLTEtNzQ3MjE_08c9eb1e-2508-445c-a1fd-1603fb7991d1">509,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38a3ef0a8b5c416391e812e3c975190b_I20230401" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzgtNC0xLTEtNzQ3MjM_0e19cbfd-6d08-4e41-b391-c62c730e75f8">412,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38a3ef0a8b5c416391e812e3c975190b_I20230401" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzgtMTQtMS0xLTc0NzI1_18f3d9db-abd1-4a2f-a992-995040a5a3a6">696</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For fiscal 2023, the Company recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="i0a086617625d4770aa1177f5b215bdfe_D20220403-20230401" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzQ1Mzc_f8dc7989-e16b-4f27-a7da-ec8464e8d739">2.6</ix:nonFraction> million, net of tax, in accumulated other comprehensive loss to recognize the effective portion of the fair value of the swaps that qualify as cash flow hedges. </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ie29418426784404eb71cc70feb7b9871" continuedAt="id55088b7ce914549b4e33c0a00b30256"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trade Receivables</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company grants trade credit to its customers on normal credit terms. In an effort to reduce its credit risk, the Company (i) establishes credit limits for all customers, (ii) performs ongoing credit evaluations of customers&#8217; financial condition, (iii) monitors the payment history and aging of customers&#8217; receivables and (iv) monitors open orders against an individual customer&#8217;s outstanding receivable balance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses is maintained for trade accounts receivable based on the expected collectability, the historical collection experience, the length of time an account is outstanding, the financial position of the customer and information provided by credit rating services. Effective March 29, 2020, the Company adopted Update No. 2016-13,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses&#160;(Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which requires consideration of events or circumstances indicating historic collection rates may not be indicative of future collectability. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzEyMzE4_d9a5bce6-4b19-4f5e-bd2f-cb9ecfadbb2c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of the allowance for credit losses:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.231%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.231%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 3, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzItMi0xLTEtNzAzMzQ_42bf1d16-9b9d-4f13-9bc1-e8ed9d46fe35">2,475</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzItNC0xLTEtNzAzMzQ_230804dc-4140-4333-ac27-3efd06e1f008">2,226</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2752e169c88b4ff2a289838d456aec0d_I20200328" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzItNi0xLTEtNzAzMzQ_e276a9c1-1f11-4906-b529-3841f13f6f6b">3,824</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Credit (gain) loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzMtMi0xLTEtNzAzMzQ_ddb38c46-1009-49b5-84a7-0dbe9cbbc8cc">2,623</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzMtNC0xLTEtNzAzMzQ_cee67d4b-c71e-4800-b1f8-fea8c8549cec">359</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzMtNi0xLTEtNzAzMzQ_231ade7e-ddf6-4f81-b2b4-273569e1abba">991</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Write-offs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzQtMi0xLTEtNzAzMzQ_6c3db267-c1b6-462e-a23b-a07481ffb489">166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzQtNC0xLTEtNzAzMzQ_f35a531d-d81e-44c2-87dd-85e9a3050018">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzQtNi0xLTEtNzAzMzQ_2afcdd2f-5142-457d-aaee-53ab30f27602">607</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzUtMi0xLTEtNzAzMzQ_a0758c77-0179-48ad-81ce-daea929ee0f4">4,932</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzUtNC0xLTEtNzAzMzQ_1724a678-2c1d-45fd-becb-6da47e2677c9">2,475</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzUtNi0xLTEtNzAzMzQ_50287ca8-6588-4408-ae46-de70446d3538">2,226</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Derivative Instruments</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzEyMzIw_194d2242-ff8c-48e7-99e6-aee1441317e3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of the Company&#8217;s derivative instruments designated as cash flow hedges and those not designated as hedging instruments under ASC 815 in its consolidated statements of income and comprehensive income for the fiscal year ended April 1, 2023.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.055%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Instruments  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain Recognized in Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Consolidated Statements of Income and Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain Excluded from<br/>Effectiveness<br/>Testing</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Consolidated Statements of Income and Comprehensive Income</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i764ec41ce0424c3da439a7f3192b0337_D20220403-20230401" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzItMi0xLTEtNzAzMzQ_6bef7336-5597-4145-9337-605b0d74fb18">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i764ec41ce0424c3da439a7f3192b0337_D20220403-20230401" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzItNC0xLTEtNzAzMzQ_b2151598-d676-4bef-919a-5ca3704a9ab4">6,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues, COGS and SG&amp;A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice83d5f54d3b4d1591f7e898bf73fe94_D20220403-20230401" decimals="-3" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzItOC0xLTEtNzAzMzQ_00828cba-56c1-463a-a941-1633e2efe587">983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34427df65a3f408681e89de77f0bcba5_D20220403-20230401" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzMtMi0xLTEtNzAzMzQ_ade24dd6-e5c4-4d2c-b59b-109ada2b3cff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34427df65a3f408681e89de77f0bcba5_D20220403-20230401" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzMtNC0xLTEtNzAzMzQ_fe957a24-fcfe-48a7-b889-9a7af5f28c1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i496992eb4e324c4d93a9779270bd0d95_D20220403-20230401" decimals="-3" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzMtOC0xLTEtNzAzMzQ_6320ec3b-4f5e-4326-be6a-aae65861cea7">923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if57d6790a07844cc9da693a20bd4bffe_D20220403-20230401" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzQtMi0xLTEtNzAzMzQ_d73a7111-df32-4242-8059-272d7c95be7b">1,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if57d6790a07844cc9da693a20bd4bffe_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzQtNC0xLTEtNzAzMzQ_608e26fe-d178-4d80-8813-1e4ce46efa24">1,119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i926351f2cdb64cfca4fca48cd71ce175_D20220403-20230401" xsi:nil="true" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzQtOC0xLTEtNzAzMzQ_458ffc84-585d-4616-aa6b-c02c09db7d95"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have fair value hedges or net investment hedges outstanding as of April&#160;1, 2023 or April&#160;2, 2022. As of April&#160;1, 2023, no material deferred taxes were recognized for designated foreign currency hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 815 requires all derivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, by considering the estimated amount it would receive or pay to sell or transfer these instruments at the reporting date and by taking into account current interest rates, currency exchange rates, current interest rate curves, interest rate volatilities, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company may utilize financial models to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="id55088b7ce914549b4e33c0a00b30256" continuedAt="i8552cd8403bb4c579d08d7408920319a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in markets that are not active; other observable inputs for the asset or liability; and inputs derived principally from, or corroborated by, observable market data by correlation or other means. As of April&#160;1, 2023, the Company has classified its derivative assets and liabilities within Level 2 of the fair value hierarchy prescribed by ASC 815, as discussed below, because these observable inputs are available for substantially the full term of its derivative instruments.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzEyMzE5_fad79a71-b83d-436f-b29a-8a87911791ac" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of the Company&#8217;s derivative instruments as they appear in its consolidated balance sheets as of April&#160;1, 2023 and April&#160;2, 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.680%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location in<br/>Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf952df669d84ad79ebbd6961839ffa5_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzItMy0xLTEtNzAzMzQ_0b9cf66c-6dcd-41d7-84f0-073919348511">1,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bd4348fb37642cb9d19c854b0b98777_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzItNS0xLTEtNzAzMzQ_fe535085-0bc6-4c0e-95aa-f864d2288151">3,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82d640169aec444b861eade7d445b02e_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzMtMy0xLTEtNzAzMzQ_fec1e323-76fc-4f1e-a000-b6f5b6dbf04c">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib905d6d3d68e4f13963e09cdca04d335_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzMtNS0xLTEtNzAzMzQ_674dc0bb-30ad-4ef5-a901-c027bc9538f8">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d438a36d1f445b99fa95273454cd16f_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzQtMy0xLTEtNzU3Njc_fd1338ef-c9c0-41fc-8a69-bcb53f39bff1">1,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc5fe4fd66044c45abd2da237f5b01bf_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzQtNS0xLTEtNzU3Njc_73f2683d-24ce-4f6f-98c4-d2d03a69dfd6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if685fcb31a604071a3aea04895ad5ca2_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzQtMy0xLTEtNzAzMzQ_df149aba-2742-4f2c-b275-1a2046139d15">2,813</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1ef3242c33f4d14968403e733c74eb4_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzQtNS0xLTEtNzAzMzQ_8ad45843-d8ef-4137-94f3-73fd2a9c53ef">3,232</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745bbb354f3c49e4acff9d758a7db139_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzYtMy0xLTEtNzAzMzQ_86c1b59f-2d0a-4a7b-a8da-5ca097a73559">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2d5c4548b37436eade14b50d116e37c_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzYtNS0xLTEtNzAzMzQ_1d315c63-3780-4f46-af62-6027b1712e48">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d0667d1ab6e437eb9e2cccfe3114e71_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzctMy0xLTEtNzAzMzQ_8d3b9213-a3c2-47fd-926e-544b410ecc92">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc84f5e642914bcd8c36ff54535f264b_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzctNS0xLTEtNzAzMzQ_b66a525c-fb40-4d6a-a6ec-9feaa286cdb0">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228a035c89694077beb4571a980c3787_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzgtMy0xLTEtNzAzMzQ_3aef6364-f414-4c21-8b7f-dff454222f91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b7cc66dd3cd45aebc86f3ccac3daccb_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzgtNS0xLTEtNzAzMzQ_1072f530-6ecd-414f-b594-1b21f40af416">1,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib78abe8a21bb47f6b491e1e88a0c022a_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzktMy0xLTEtNzAzMzQ_5be4106e-0d87-4feb-82e4-ca39d3190fad">1,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21efcb597c134d47a7cdd7695ada55c7_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzktNS0xLTEtNzAzMzQ_9831dcd1-52b7-4ad5-902d-c90e68409b19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if685fcb31a604071a3aea04895ad5ca2_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzEwLTMtMS0xLTcwMzM0_23ac12bc-7f02-4b73-b3a7-3f5d33143410">1,889</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1ef3242c33f4d14968403e733c74eb4_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzEwLTUtMS0xLTcwMzM0_246e950b-8745-48ec-bf60-8a48250aa86f">1,894</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Fair Value Measurements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exit price that would be received from the sale of an asset or paid to transfer a liability, using assumptions that market participants would use in pricing an asset or liability. The fair value guidance establishes the following three-level hierarchy used for measuring fair value:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8212; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8212; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8212; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s money market funds carried at fair value are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i8552cd8403bb4c579d08d7408920319a" continuedAt="ib496ad0a26ee4c45a8758631a4ea24c7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measured on a Recurring Basis</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzEyMjkx_83701310-ae0e-4a79-a3ae-84841430e619" continuedAt="id140437f28fb467cbfc03bfa46bee455" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and financial liabilities measured at fair value on a recurring basis consist of the following as of April&#160;1, 2023 and April&#160;2, 2022.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.601%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 1, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d487570854407eae1cd91197412837_I20230401" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzMtMi0xLTEtNzAzMzQ_b6cfc301-b509-49a7-b3e8-cbec10b9f87e">132,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b34b4bf50694564a2bdc0ddefcf34d0_I20230401" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzMtNC0xLTEtNzAzMzQ_1dea39ca-4d6f-4cee-b180-f4500a367d2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5d605e3bfc94e56bc0743876ebc5034_I20230401" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzMtOC0xLTEtNzAzMzQ_2db7d6b4-eca4-481d-8f94-9c93509521a3">132,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie12da83b81b74a6f8c251cbd3104102c_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzQtMi0xLTEtNzAzMzQ_5dd1fe02-120f-4058-96d5-c7c7ef85b197">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf952df669d84ad79ebbd6961839ffa5_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzQtNC0xLTEtNzAzMzQ_0b9cf66c-6dcd-41d7-84f0-073919348511">1,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71f5eeccac2e405cbde81dd345b9a918_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzQtOC0xLTEtNzAzMzQ_defe66da-c5ff-4f4f-805f-17759b92d31b">1,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45b2edcb0a34394bcc87dce4e55afb6_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzUtMi0xLTEtNzAzMzQ_69ccaae2-3857-4b3a-8aa5-f14455345047">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82d640169aec444b861eade7d445b02e_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzUtNC0xLTEtNzAzMzQ_fec1e323-76fc-4f1e-a000-b6f5b6dbf04c">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7652e23f4d9749d58d9f74cc7d60f8f7_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzUtOC0xLTEtNzAzMzQ_e58d19eb-88ad-4bdc-9dc3-c16017a1e88d">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943bf7094e994bad85fe8de21c1cb0da_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzctMi0xLTEtNzU3ODE_02ba920b-ab12-45ee-9204-b847d52c1b9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d438a36d1f445b99fa95273454cd16f_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzctNC0xLTEtNzU3ODE_fd1338ef-c9c0-41fc-8a69-bcb53f39bff1">1,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc297a9a523d452588c49f61b90fe397_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzctOC0xLTEtNzU3ODk_eec9eb0a-a5d8-4f90-94f8-e052b97c0526">1,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d487570854407eae1cd91197412837_I20230401" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzctMi0xLTEtNzAzMzQ_1ce70cb0-7db1-408d-b952-32eee985350a">132,341</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b34b4bf50694564a2bdc0ddefcf34d0_I20230401" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzctNC0xLTEtNzAzMzQ_f0a02f10-f015-4f1a-9af2-9b96a9ceb04a">2,813</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5d605e3bfc94e56bc0743876ebc5034_I20230401" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzctOC0xLTEtNzAzMzQ_6b898060-0f57-4d5e-bc53-f3af8d15d20c">135,154</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie12da83b81b74a6f8c251cbd3104102c_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzktMi0xLTEtNzAzMzQ_c55c0b3f-8cf0-460a-8a1b-3180a4e51fe1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745bbb354f3c49e4acff9d758a7db139_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzktNC0xLTEtNzAzMzQ_86c1b59f-2d0a-4a7b-a8da-5ca097a73559">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71f5eeccac2e405cbde81dd345b9a918_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzktOC0xLTEtNzAzMzQ_de64bd5c-f73f-411f-b6d8-1938e1f89f19">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45b2edcb0a34394bcc87dce4e55afb6_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEwLTItMS0xLTcwMzM0_a9d0320a-dc5f-4774-9dc7-3e20c452d113">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d0667d1ab6e437eb9e2cccfe3114e71_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEwLTQtMS0xLTcwMzM0_8d3b9213-a3c2-47fd-926e-544b410ecc92">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7652e23f4d9749d58d9f74cc7d60f8f7_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEwLTgtMS0xLTcwMzM0_9e526ebc-fac6-448c-a50e-1b219a0594c2">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943bf7094e994bad85fe8de21c1cb0da_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzExLTItMS0xLTcwMzM0_30fbd189-b9dd-4c14-a0b1-27454eea1abe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib78abe8a21bb47f6b491e1e88a0c022a_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzExLTQtMS0xLTcwMzM0_5be4106e-0d87-4feb-82e4-ca39d3190fad">1,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc297a9a523d452588c49f61b90fe397_I20230401" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzExLTgtMS0xLTcwMzM0_31bc7acf-919a-4dfe-830a-5a905650b8f8">1,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie449786761b5459d81987ca7b30f976f_I20230401" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEyLTYtMS0xLTcwMzM0_be2c09e0-439c-455c-9e0b-aa2dd1537b78">863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic114d1ef99f7486e882e676e604e60d4_I20230401" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEyLTgtMS0xLTcwMzM0_0a5a2607-94f1-4814-88bf-86e67b97f353">863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d487570854407eae1cd91197412837_I20230401" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEzLTItMS0xLTcwMzM0_0952cbbf-cedc-444f-baea-7040c9633812">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b34b4bf50694564a2bdc0ddefcf34d0_I20230401" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEzLTQtMS0xLTcwMzM0_cef76656-7c2a-4f9c-97eb-4379ee165165">1,889</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192129d9183945dfb1fa96a6e3f72823_I20230401" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEzLTYtMS0xLTcwMzM0_4e5d401a-3523-46cb-9b8d-5cc900397c78">863</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5d605e3bfc94e56bc0743876ebc5034_I20230401" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEzLTgtMS0xLTcwMzM0_dd38f37d-8ea9-4f5a-8c38-110c798fe0b1">2,752</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79baee9eabb44eaea4f2911723087bce_I20220402" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzE4LTItMS0xLTcwMzM0_b0b60cfe-ea02-4980-a808-d003e293f230">97,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed4fde198f34c0e96958ff15ac93475_I20220402" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzE4LTQtMS0xLTcwMzM0_c00f237e-63dd-41c6-b45e-f9eddb4e0dbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide6dff6dae06426caaac4bd1fc9ef699_I20220402" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzE4LTgtMS0xLTcwMzM0_447d8e69-098e-4a63-af13-ebe0861440a5">97,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3dfaa9406244d52a985e71d364da711_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzE5LTItMS0xLTcwMzM0_1532b3d0-067a-494f-99cd-5d14920491ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id872bc48d1694456accfff526b09b5e0_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzE5LTQtMS0xLTcwMzM0_2698cdc4-0487-4caf-8567-5213ca9c80c4">3,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7949d38eb6ed4baaa1e5b677d09753c9_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzE5LTgtMS0xLTcwMzM0_cde5fa2c-5520-4842-8851-ff73f99ba5e1">3,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bba1f3bac8247d9a7bf0303421a3e7c_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzIwLTItMS0xLTcwMzM0_6140ce0e-d5a4-4d23-bee2-7c3d6a4e57a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e664ee98504b0b8f8186d1d3cedbee_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzIwLTQtMS0xLTcwMzM0_5abbf08e-3b89-47de-8208-4f0ff59a66b5">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6760b9812af24258ad4ca438476747d4_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzIwLTgtMS0xLTcwMzM0_8e62c452-377e-4f6b-b0c3-da7678c84ac0">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79baee9eabb44eaea4f2911723087bce_I20220402" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzIyLTItMS0xLTcwMzM0_b95ad33f-fde4-4a69-b46f-dffc874521ad">97,425</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed4fde198f34c0e96958ff15ac93475_I20220402" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzIyLTQtMS0xLTcwMzM0_005e30be-f47c-412f-a87f-7d296897403b">3,232</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide6dff6dae06426caaac4bd1fc9ef699_I20220402" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzIyLTgtMS0xLTcwMzM0_dd111768-ba39-44ae-87c0-419fab92f404">100,657</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3dfaa9406244d52a985e71d364da711_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI0LTItMS0xLTcwMzM0_1911e68b-0794-4646-8095-450fba70d19b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d7138fbdd0d40408d7f37574315a72b_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI0LTQtMS0xLTcwMzM0_36df5da5-c3ab-4911-b2cb-fd86c669a1ea">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7949d38eb6ed4baaa1e5b677d09753c9_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI0LTgtMS0xLTcwMzM0_77ca4f66-8efe-4320-aec8-974899c2da13">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bba1f3bac8247d9a7bf0303421a3e7c_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI1LTItMS0xLTcwMzM0_62ac0c9f-8093-4c88-9632-2b5c2da5e911">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb5872f4ce6d4a36ae9ff072fc3da7c5_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI1LTQtMS0xLTcwMzM0_e09c67bc-4bc5-4092-a163-0cbc5f1a5e95">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6760b9812af24258ad4ca438476747d4_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI1LTgtMS0xLTcwMzM0_55d12866-c57c-47a4-8765-d169da18f86c">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa8b08aa795f429987456bca970a1829_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI2LTItMS0xLTcwMzM0_ad73195e-f928-4390-96b1-86c681d534c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic93412d801134bd49e320c00ae5f3f41_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI2LTQtMS0xLTcwMzM0_8b946fb2-7b18-48bf-92ef-76a5ee8a4a08">1,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0515c0920ac74a3fa99ec66f590742fa_I20220402" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI2LTgtMS0xLTcwMzM0_32db77cd-f5d2-41dd-9328-8233293cb801">1,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if632bd50d393422b8036fdeb475158dc_I20220402" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI3LTYtMS0xLTcwMzM0_f4883978-efb1-4848-821f-e62f1a9680da">33,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0efe65c8e6a44ca28515bf3a0446df60_I20220402" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI3LTgtMS0xLTcwMzM0_b41b092a-ea47-44cf-82cc-927132cc8fcc">33,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79baee9eabb44eaea4f2911723087bce_I20220402" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI4LTItMS0xLTcwMzM0_3e11b4a3-44c4-4f31-8c06-ebdf663c7862">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed4fde198f34c0e96958ff15ac93475_I20220402" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI4LTQtMS0xLTcwMzM0_58892467-5997-449d-b731-f5ede7ce871e">1,894</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4247054189a43a1a0450606d3475abb_I20220402" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI4LTYtMS0xLTcwMzM0_57059b65-f360-4fa2-b2b1-a64ec6c205aa">33,675</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide6dff6dae06426caaac4bd1fc9ef699_I20220402" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI4LTgtMS0xLTcwMzM0_23298b58-5e41-47e7-8791-0fa6300c6f7d">35,569</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency hedge contracts - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of foreign currency hedge contracts was measured using significant other observable inputs and valued by reference to over-the-counter quoted market prices for similar instruments. The Company does not believe that the fair value of these derivative instruments differs significantly from the amount that could be realized upon settlement or maturity, or that the changes in fair value will have a significant effect on its results of operations, financial condition or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate swaps - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of interest rate swaps are measured using the present value of expected future cash flows using market-based observable inputs, including credit risk and interest rate yield curves. The Company does not believe that the fair values of these derivative instruments differ significantly from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a significant effect on its results of operations, financial condition or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent consideration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The fair value of contingent consideration liabilities is based on significant unobservable inputs, including management estimates and assumptions, and is measured based on the probability-weighted present value of the payments expected to be made. Accordingly, the fair value of contingent consideration has been classified as level 3 within the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ib496ad0a26ee4c45a8758631a4ea24c7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fair value hierarchy. <ix:continuation id="id140437f28fb467cbfc03bfa46bee455" continuedAt="ic143a660388c4786b703c314f3f3ec56">The recurring level 3 fair value measurements of contingent consideration liabilities include the following significant unobservable inputs:</ix:continuation></span></div><div><span><br/></span></div><div><ix:continuation id="ic143a660388c4786b703c314f3f3ec56" continuedAt="i76d47000a0a749d8bd852f7f422818f3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:21.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.550%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technique</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue-based payments</span></td><td colspan="3" style="padding:0 1pt"></td><td rowspan="2" style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb2d6495cab432aa90ea55629e7a34e_I20230401" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpiYmRjMjdlNGYyZGM0ODIwYjBiMGQ1NGI0Nzk0MDdiNS90YWJsZXJhbmdlOmJiZGMyN2U0ZjJkYzQ4MjBiMGIwZDU0YjQ3OTQwN2I1XzQtMi0xLTEtNzAzMzQ_5f10c737-295d-4e90-b71f-08feca6a92a7">863</ix:nonFraction>&#160;</span></td><td rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iffb2d6495cab432aa90ea55629e7a34e_I20230401" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpiYmRjMjdlNGYyZGM0ODIwYjBiMGQ1NGI0Nzk0MDdiNS90YWJsZXJhbmdlOmJiZGMyN2U0ZjJkYzQ4MjBiMGIwZDU0YjQ3OTQwN2I1XzQtOC0xLTEtNzAzMzQ_958a0756-9d60-4106-b036-752bcdec37e5">8.5</ix:nonFraction>%</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of contingent consideration associated with acquisitions was $<ix:nonFraction unitRef="usd" contextRef="ic114d1ef99f7486e882e676e604e60d4_I20230401" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjQzNjI_871c7238-a321-4429-93ec-4aba69a1ed21">0.9</ix:nonFraction>&#160;million at April&#160;1, 2023 and was included in other current liabilities. <ix:continuation id="i76d47000a0a749d8bd852f7f422818f3" continuedAt="i5ae07e683bbb468297d99e4d49e54735">A reconciliation of the change in the fair value of contingent consideration is included in the following table:</ix:continuation></span></div><div><ix:continuation id="i5ae07e683bbb468297d99e4d49e54735"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0efe65c8e6a44ca28515bf3a0446df60_I20220402" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2ODc1MmUwY2U0YzQ0MjVhYTk1NWY5NTlkM2VkZDAxYy90YWJsZXJhbmdlOjY4NzUyZTBjZTRjNDQyNWFhOTU1Zjk1OWQzZWRkMDFjXzEtMi0xLTEtNzAzMzQ_13f1ea5b-77de-4022-905c-d36f4c7ca9a8">33,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f3c2f8402c490aa5ec976019d2d592_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2ODc1MmUwY2U0YzQ0MjVhYTk1NWY5NTlkM2VkZDAxYy90YWJsZXJhbmdlOjY4NzUyZTBjZTRjNDQyNWFhOTU1Zjk1OWQzZWRkMDFjXzItMi0xLTEtNzAzMzQ_a2e7ccb7-eee9-4fdd-9b5b-2a2fd4a8b700">504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f3c2f8402c490aa5ec976019d2d592_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2ODc1MmUwY2U0YzQ0MjVhYTk1NWY5NTlkM2VkZDAxYy90YWJsZXJhbmdlOjY4NzUyZTBjZTRjNDQyNWFhOTU1Zjk1OWQzZWRkMDFjXzMtMi0xLTEtNzAzMzQ_bce8cce3-4fbb-4e14-b2c1-a4a04f1311eb">32,293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f3c2f8402c490aa5ec976019d2d592_D20220403-20230401" decimals="-3" sign="-" name="hae:ContingentConsiderationForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2ODc1MmUwY2U0YzQ0MjVhYTk1NWY5NTlkM2VkZDAxYy90YWJsZXJhbmdlOjY4NzUyZTBjZTRjNDQyNWFhOTU1Zjk1OWQzZWRkMDFjXzQtMi0xLTEtNzAzMzQ_0247b397-badf-42cb-9e38-3c38363545cc">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic114d1ef99f7486e882e676e604e60d4_I20230401" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2ODc1MmUwY2U0YzQ0MjVhYTk1NWY5NTlkM2VkZDAxYy90YWJsZXJhbmdlOjY4NzUyZTBjZTRjNDQyNWFhOTU1Zjk1OWQzZWRkMDFjXzUtMi0xLTEtNzAzMzQ_6c8cb760-d6fa-4cb8-8727-dc71a3093ad2">863</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Fair Value Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the 2026 Notes as of April&#160;1, 2023 was $<ix:nonFraction unitRef="usd" contextRef="i9e0e0c2a238340e5af49c732b3425472_I20230401" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzExNTY1_a7cebfd3-f029-49b7-9866-240aa4333593">425.7</ix:nonFraction>&#160;million, which was determined based on the quoted price for the 2026 Notes in an inactive market on the last trading day of the reporting period and is considered as level 2 in the fair value hierarchy. In estimating the risk adjusted yield, the Company utilized both an income and market approach. For the income approach, the Company used a convertible bond pricing model, which included several assumptions including volatility and the risk-free rate. For the market approach, the Company performed an evaluation of issuances of debt securities issued by other comparable companies and broader market indices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term loan (which is carried at amortized cost), accounts receivable and accounts payable approximate fair value.</span></div></ix:continuation><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_139"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUwNjg_0024e006-cf66-4443-897c-cb4279525062" continuedAt="icd624ec6bf2842bab6f272b56a4cf9ba" escape="true">RETIREMENT PLANS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="icd624ec6bf2842bab6f272b56a4cf9ba" continuedAt="i034629a4b3564dc3bd01bc5cf3f2ff60"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Savings Plus Plan (the &#8220;401k Plan&#8221;) that allows its U.S.&#160;employees to accumulate savings on a pre-tax basis. In addition, matching contributions are made to the 401k Plan based upon pre-established rates. The Company&#8217;s matching contributions amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i21aee3c1b74747239031c9b963f5fe6a_D20220403-20230401" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzM2Mw_9b75f6e8-04b2-42fb-aaf1-96bc96ca3951">6.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="icb0b69d83b20498cb8aca63402b766a0_D20210404-20220402" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzM2Nw_370506cd-c496-4bed-bdbd-f71ad29669c7">6.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6925d4ec697647ffa368e97ca8e3c332_D20200329-20210403" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzM3NA_89395369-112c-4676-aa6a-0d0da8dafb07">4.9</ix:nonFraction> million in fiscal <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzM4Nw_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric>, 2022 and 2021, respectively. Upon the Company&#8217;s Board of Directors&#8217; approval, additional discretionary contributions can also be made. <ix:nonFraction unitRef="usd" contextRef="ifd7616c964054c72a3769144d3c72c21_D20210404-20220402" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUyMg_4408acaa-0d1e-4f9d-8928-d907238ae48c"><ix:nonFraction unitRef="usd" contextRef="i3185e1665d8d4e5ab9844e5e3ff0d869_D20220403-20230401" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUyMg_5f4fd392-6302-4276-941c-c939a96f1565"><ix:nonFraction unitRef="usd" contextRef="i6a0a0ee071214f54bd0d353709289c03_D20200329-20210403" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUyMg_c0c606dd-491a-4c63-9b00-0133f6c5ec40">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> discretionary contributions were made for the 401k Plan in fiscal <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzU5MQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric>, 2022, or 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s subsidiaries also have defined contribution plans, to which both the employee and the employer make contributions. The employer contributions to these plans totaled $<ix:nonFraction unitRef="usd" contextRef="i460ae7aa48544e75825ca977d4447d2b_D20220403-20230401" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzc5NA_7fa642dc-0791-44cd-9dfe-b87141ec4152">0.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4050db15299d4a36bbab78482cb7fb2f_D20210404-20220402" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzc5OA_9d09e905-0ac5-47b1-96cb-b24f92814642">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if4da492c5e554b3890ff74a7a13fd058_D20200329-20210403" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzgwNQ_c19e2074-8dc8-40f7-b508-fdbd4acc68f2">0.7</ix:nonFraction> million in fiscal <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzgxOA_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric>, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 715, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation&#160;&#8212; Retirement Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, requires an employer to: (a)&#160;recognize in its statement of financial position an asset for a plan&#8217;s over-funded status or a liability for a plan&#8217;s under-funded status; (b)&#160;measure a plan&#8217;s assets and its obligations that determine its funded status as of the end of the employer&#8217;s fiscal year (with limited exceptions); and (c)&#160;recognize changes in the funded status of a defined benefit post retirement plan in the year in which the changes occur. Accordingly, the Company is required to report changes in its funded status in comprehensive loss on its consolidated statement of stockholders&#8217; equity and consolidated statement of comprehensive income.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i034629a4b3564dc3bd01bc5cf3f2ff60" continuedAt="i25ad3b42e3bf430eb33b2a95c048b1e8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefits under these plans are generally based on either career average or final average salaries and creditable years of service as defined in the plans. The annual cost for these plans is determined using the projected unit credit actuarial cost method that includes actuarial assumptions and estimates that are subject to change.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUwNzU_3957efa1-1924-4943-b926-cce5d6d62e48" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s foreign subsidiaries have defined benefit pension plans covering substantially all full time employees at those subsidiaries. Net periodic benefit costs for the plans in the aggregate include the following components:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzEtMS0xLTEtNzAzMzQ_2d7205c2-a8cd-424d-b7bd-1801a49556ac">1,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzEtMy0xLTEtNzAzMzQ_61fd8fe4-3ee3-42b5-b6ea-8e7f9fca3ccc">1,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzEtNS0xLTEtNzAzMzQ_1042feca-da0d-4d01-a7f2-e3323a8dd49d">1,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" name="hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzItMC0xLTEtNzAzMzQ_187d8f0f-fe1e-4c11-97bd-50e2ebb5ef34"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzItMC0xLTEtNzAzMzQ_88e5742b-a426-4d10-948e-e8b8721513af"><ix:nonNumeric contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" name="hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzItMC0xLTEtNzAzMzQ_ff05df60-541f-416e-9c77-c039000f6b4d">Interest cost on benefit obligation</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzItMS0xLTEtNzAzMzQ_84395802-6240-4ca7-be44-daf4a41fe802">409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzItMy0xLTEtNzAzMzQ_e2cc3178-81ff-484b-8b1e-d7f48a4dcdc4">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzItNS0xLTEtNzAzMzQ_0eccbf80-3346-4a0f-9c01-fa5786345d20">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzMtMC0xLTEtNzAzMzQ_410a90f4-a4ce-4cb6-840f-d38b2cc33cd8"><ix:nonNumeric contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" name="hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzMtMC0xLTEtNzAzMzQ_76264dd2-73ed-4769-bbe4-fbf74170ce19"><ix:nonNumeric contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" name="hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzMtMC0xLTEtNzAzMzQ_d7c4e939-1801-40fb-a48c-aa212c390d19">Expected return on plan assets</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzMtMS0xLTEtNzAzMzQ_284d29b5-7d8c-4d6a-950a-056da261c7c5">180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzMtMy0xLTEtNzAzMzQ_1c44060d-b10e-4a49-be05-bce52f3bf3e3">88</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzMtNS0xLTEtNzAzMzQ_4ec5f8bf-42b5-4eb5-9fd4-59087dd6eddd">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" name="hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzQtMC0xLTEtNzAzMzQ_1cfdc20e-be01-4d62-887b-f07df4734030"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzQtMC0xLTEtNzAzMzQ_64d9ddef-da2d-432a-9202-392d7d1894e0"><ix:nonNumeric contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" name="hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzQtMC0xLTEtNzAzMzQ_db134473-6bce-4e8a-8dd9-abae9338a85d">Actuarial loss</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzQtMS0xLTEtNzAzMzQ_c7c2bf9a-9a67-4154-abd8-b05ecbec660b">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzQtMy0xLTEtNzAzMzQ_eb6fbc6a-0d25-40e6-9158-6e904ce2f98f">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzQtNS0xLTEtNzAzMzQ_26c2fcf3-0177-48ca-89f1-4394011d20b9">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" name="hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzUtMC0xLTEtNzAzMzQ_07e5e158-7276-4e99-bfd0-01f1f673f727"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzUtMC0xLTEtNzAzMzQ_327c3c05-bdcb-4d94-bd08-a40f3578f479"><ix:nonNumeric contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" name="hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzUtMC0xLTEtNzAzMzQ_9f7bc171-91cd-47dc-9402-90f6e61e7579">Amortization of unrecognized prior service cost</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzUtMS0xLTEtNzAzMzQ_f9963927-ab5b-463b-b23b-d6e8918fadb7">180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzUtMy0xLTEtNzAzMzQ_0f3d93e1-fe9e-4ca5-affc-123f56b4460c">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzUtNS0xLTEtNzAzMzQ_4f9c56a8-a50f-478f-9cfa-f8be95367021">123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" name="hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzctMC0xLTEtNzAzMzQ_145800d4-5aae-4f18-ae25-6d007756aaac"><ix:nonNumeric contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" name="hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzctMC0xLTEtNzAzMzQ_a927d1a0-67b4-4758-b243-b16defbbc948"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzctMC0xLTEtNzAzMzQ_d32db4cc-a58c-48fe-9111-d1b313f3e38b">Plan settlements</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzctMS0xLTEtNzAzMzQ_0feeb835-a57d-457b-a6cf-f1f00cc18232">330</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzctMy0xLTEtNzAzMzQ_01313c26-1624-4239-afca-d82569667167">184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzctNS0xLTEtNzAzMzQ_55a634fc-0acb-4fd3-bfe2-d0640731ce87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzgtMS0xLTEtNzAzMzQ_f8a49316-a4bc-4125-aedd-b04b13a1ab43">1,191</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzgtMy0xLTEtNzAzMzQ_56279ccd-9c27-433d-85d4-882c6057192b">1,698</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzgtNS0xLTEtNzAzMzQ_d84c30cd-5d4c-4609-bc5a-069d52fa2b09">2,070</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfNetFundedStatusTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUwNDk_dd0eed20-41a4-42f8-a880-0039fea07886" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity under those defined benefit plans are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in Benefit Obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzItMS0xLTEtNzAzMzQ_0f223973-b1fa-47fb-be93-61617f7937bb">30,410</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzItMy0xLTEtNzAzMzQ_43a74eef-db69-4578-9e5c-c8146636a780">31,891</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzMtMS0xLTEtNzAzMzQ_1f7f2ece-73f5-4d2b-be59-256bcac2c007">1,453</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzMtMy0xLTEtNzAzMzQ_66f12be2-3713-433d-ab00-8b098412466e">1,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzQtMS0xLTEtNzAzMzQ_81ff6893-c349-4220-8be2-170d4b1928cd">409</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzQtMy0xLTEtNzAzMzQ_7ba092f9-bc6b-455a-b911-cefe302b8751">242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzUtMS0xLTEtNzAzMzQ_f3bc0489-875f-4748-9453-c1b611a229fc">748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzUtMy0xLTEtNzAzMzQ_e909fb32-ce2c-4c24-ad74-283d5d1b09ca">928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzYtMS0xLTEtNzAzMzQ_72798c47-8fa3-4806-a7c3-38da8d1e0f47">3,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzYtMy0xLTEtNzAzMzQ_afd0f1cf-d2bf-4ac0-92d6-b8cc67b493a0">3,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee and plan participants contribution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzctMS0xLTEtNzAzMzQ_441cd33a-b6a3-4acf-94f0-dfc1822021c2">1,599</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzctMy0xLTEtNzAzMzQ_489ec027-a0c0-4b94-8417-839dd3bc502a">2,093</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzgtMS0xLTEtNzAzMzQ_e067ae4e-8c84-41b1-821a-1576787090b1">1,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzgtMy0xLTEtNzAzMzQ_dbd8b653-d3b0-4adf-8ff6-0117b11ac5c9">1,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzktMS0xLTEtNzAzMzQ_19063d10-a491-4389-a3d7-d3f37127a8f8">2,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzktMy0xLTEtNzAzMzQ_602548c4-d8d9-465a-a1f8-650e5e011657">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit obligation, end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzEwLTEtMS0xLTcwMzM0_66fea61a-2843-4b32-a0d6-5f9a87573c88">25,465</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzEwLTMtMS0xLTcwMzM0_c2672a44-d91d-4e04-b329-3fa549eef5fb">30,410</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in Plan Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzEyLTEtMS0xLTcwMzM0_ad1bbc74-20c3-424d-ac06-22e3311d68de">17,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzEyLTMtMS0xLTcwMzM0_c4575a3d-af78-433a-8222-161ee8ca7b85">16,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzEzLTEtMS0xLTcwMzM0_8844a983-eff4-4cca-9670-b2795b2221d1">1,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzEzLTMtMS0xLTcwMzM0_9385a02e-0278-4f60-adcd-3e0b32e3b1a0">1,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE0LTEtMS0xLTcwMzM0_c7d29ce9-d59c-47f5-9f1b-1b63d29c2acc">593</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE0LTMtMS0xLTcwMzM0_f9b473b1-0f93-487c-93d5-28ef24c0c307">719</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE1LTEtMS0xLTcwMzM0_9505af20-c31d-4324-99ac-4fdfbe200edb">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE1LTMtMS0xLTcwMzM0_efbb1747-6f6d-4cb5-ac57-6be5742997b4">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee and plan participants contribution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE2LTEtMS0xLTcwMzM0_3b69c352-5a66-45b4-9ef9-753541e9e3d6">1,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE2LTMtMS0xLTcwMzM0_3cd7e973-edf3-49a1-b0b9-4b002df0feec">2,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE3LTEtMS0xLTcwMzM0_75517b30-eb5e-477b-aa24-5e75e6fdec59">1,647</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE3LTMtMS0xLTcwMzM0_80ad9e40-b045-4663-b390-a8a677d82675">1,356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE4LTEtMS0xLTcwMzM0_68e51bca-ce9c-47d1-a726-191dfd56fd16">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE4LTMtMS0xLTcwMzM0_9d63be66-ebc4-4c50-be67-d32a51e16695">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of plan assets, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE5LTEtMS0xLTcwMzM0_2b307c25-6761-45a0-99d0-c3ab6bdba875">18,463</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE5LTMtMS0xLTcwMzM0_b4acac21-7d0d-45c8-9932-c8357431ec58">17,447</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded Status</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIwLTEtMS0xLTcwMzM0_214727bc-ea7e-4025-807d-fcbf23b5d316">7,002</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIwLTMtMS0xLTcwMzM0_157ac174-07c9-4084-a30d-8dbce727a6f3">12,963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized net actuarial gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" sign="-" name="hae:UnrecognizedNetActuarialLossGain" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIxLTEtMS0xLTcwMzM0_0080e7e2-ff66-4979-b7b5-c43cac9524a5">3,757</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" sign="-" name="hae:UnrecognizedNetActuarialLossGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIxLTMtMS0xLTcwMzM0_60fba306-2bcf-4bcd-9a1d-3f4cc85ce463">236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="hae:UnrecognizedPriorServiceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIyLTEtMS0xLTcwMzM0_a058104c-fdda-4927-b0d4-9efcbb3ce644">1,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="hae:UnrecognizedPriorServiceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIyLTMtMS0xLTcwMzM0_5ced7967-7b33-4b53-8e94-fbe5dfea623c">1,099</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net amount recognized</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIzLTEtMS0xLTcwMzM0_7498f493-38fc-4475-bd19-7d3fd4135940">11,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIzLTMtMS0xLTcwMzM0_cfe7073c-3ba8-42b1-8b16-9c6947319f36">14,298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Substantially all of the unfunded status is non-current</span></div></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of the benefit plans is funded by benefit payments made by the Company through the purchase of reinsurance contracts that do not qualify as plan assets under ASC Topic 715. Accordingly, that plan has no assets included in the information presented above. The total asset value associated with the reinsurance contracts was $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="hae:DefinedBenefitPlanReinsuranceContractsAssetValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzI1NDY_6b8f11ad-e086-4013-948e-2b3cf6d54906">7.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-5" name="hae:DefinedBenefitPlanReinsuranceContractsAssetValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzI1NTM_9aa9f87c-4262-41df-b9d6-8caa669793d9">6.8</ix:nonFraction> million at April&#160;1, 2023 and April&#160;2, 2022, respectively. The total liability for this plan, which is included in the table above, was $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="hae:DefinedBenefitPlanBenefitObligationPlanFundedbyCompany" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzI2NjE_53ab6c77-1bc3-4080-8444-c08c8ea4491e">7.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-5" name="hae:DefinedBenefitPlanBenefitObligationPlanFundedbyCompany" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzI2Njg_77177251-a9ae-4c84-8fa2-7ff60c954ab7">9.6</ix:nonFraction> million as of April&#160;1, 2023 and April&#160;2, 2022, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i25ad3b42e3bf430eb33b2a95c048b1e8" continuedAt="i6d45e5ebd39c4142b3224692ae842783"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated benefit obligation for all plans was $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzI3NTY_60bcecd2-85f1-4e35-a71f-67812f3b168d">25.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzI3NjM_3d51cc63-ece8-4086-992f-8371326d1ac3">28.4</ix:nonFraction> million for fiscal 2023 and 2022, respectively. There were no plans where the plan assets were greater than the accumulated benefit obligation as of April&#160;1, 2023 and April&#160;2, 2022. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUwNTk_c5fa37b1-553f-42f6-933a-5be83cf3157e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the change recorded in the Company&#8217;s accumulated other comprehensive loss related to its defined benefit plans, net of tax, are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 28, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2752e169c88b4ff2a289838d456aec0d_I20200328" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzAtMS0xLTEtNzAzMzQ_33fd3742-61fd-49d3-8999-ddb4ab184086">209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzItMS0xLTEtNzAzMzQ_f81cfc62-b864-4901-9aac-63c77d148227">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzMtMS0xLTEtNzAzMzQ_d8075d8f-0b3e-43b2-b5bd-bf36f663e827">130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of April 3, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzUtMS0xLTEtNzAzMzQ_eef945c7-5506-45dc-9620-853e6d1ce83e">560</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzYtMS0xLTEtNzAzMzQ_7ab1e34b-7721-4e28-89d6-914aa3374217">2,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzctMS0xLTEtNzAzMzQ_560a17bd-2aa1-499d-9b9d-a17e8988a883">194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzgtMS0xLTEtNzAzMzQ_bf186e88-f38a-4ec6-bb17-88f769f95e08">159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of April 2, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzktMS0xLTEtNzAzMzQ_078dfcb8-3d02-4231-a02f-4e24a55857e2">1,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzEwLTEtMS0xLTcwMzM0_9228ffb8-047b-4a08-bed6-705a9c9828d4">2,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzExLTEtMS0xLTcwMzM0_816837e3-0168-4ac0-9356-798b4617caea">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzEyLTEtMS0xLTcwMzM0_a8f1bc8e-f647-45a4-b08b-0c58bd256e11">285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of April 1, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzEzLTEtMS0xLTcwMzM0_0e228b8d-18ab-45ec-8917-82da5ba88f48">4,075</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to amortize $<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedAmortizationNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzMxMTc_c2e4fb5d-0fe7-4348-a837-d9223fc463fe">0.4</ix:nonFraction> million from accumulated other comprehensive loss to net periodic benefit cost during fiscal 2024.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUwMjY_b59990b8-ecda-441b-91b2-2b7a1e5b16a5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average rates used to determine the net periodic benefit costs and projected benefit obligations were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzEtMS0xLTEtNzAzMzQ_95ce9e0a-0e9a-4c80-be2b-26e32876f12e">2.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzEtMy0xLTEtNzAzMzQ_59064117-8472-4d7b-987a-bb248f777170">1.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzEtNS0xLTEtNzAzMzQ_d52a1ff8-850b-400b-940c-04ca3cf10ada">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increased salary levels</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzItMS0xLTEtNzAzMzQ_9e59e724-8106-4494-ac4e-48e8f680a3e3">1.94</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzItMy0xLTEtNzAzMzQ_0b9eaeaa-4515-43a2-aaed-a65c1ac08348">1.81</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzItNS0xLTEtNzAzMzQ_d4fac23a-ceca-4e38-82c7-694b49394b9c">1.64</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzMtMS0xLTEtNzAzMzQ_c27b15ff-965a-4818-81f6-b3ebd08a56d4">0.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzMtMy0xLTEtNzAzMzQ_a07f5a53-2aa6-42d3-86d3-c61dc1b5dc0e">0.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzMtNS0xLTEtNzAzMzQ_9c0947a9-134f-474b-b905-6f40593d481c">0.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions for expected long-term rate of return on plan assets are based upon actual historical returns, future expectations of returns for each asset class and the effect of periodic target asset allocation rebalancing. The results are adjusted for the payment of reasonable expenses of the plan from plan assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has no other material obligation for post-retirement or post-employment benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment policy for pension plans is to balance risk and return through a diversified portfolio to reduce interest rate and market risk. Maturities are managed so that sufficient liquidity exists to meet immediate and future benefit payment requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, provides guidance for reporting and measuring the plan assets of the Company&#8217;s defined benefit pension plan at fair value as of April&#160;1, 2023. Using the same three-level valuation hierarchy for disclosure of fair value measurements as described in Note&#160;14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, all of the assets of the Company&#8217;s plan are classified within Level&#160;2 of the fair value hierarchy because the plan assets are primarily insurance contracts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected benefit payments for both plans are estimated using the same assumptions used in determining the Company&#8217;s benefit obligation at April&#160;1, 2023. Benefit payments will depend on future employment and compensation levels, average years employed and average life spans, among other factors, and changes in any of these factors could significantly affect these estimated future benefit payments. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUwNTI_83eb8d29-5f79-4c74-a8d4-c70d1a3baad9" continuedAt="ibf5341efb450440a957c2cb96212e037" escape="true">Estimated future benefit payments are as follows:</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><div><ix:continuation id="i6d45e5ebd39c4142b3224692ae842783" continuedAt="icefbed2abcee471a86fc763c55ddfc45"><ix:continuation id="ibf5341efb450440a957c2cb96212e037"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo4NjU5ZDZlOTYyZDU0N2E5OThmYzFiZjZmNzkyOGRiNS90YWJsZXJhbmdlOjg2NTlkNmU5NjJkNTQ3YTk5OGZjMWJmNmY3OTI4ZGI1XzEtMS0xLTEtNzAzMzQ_ab241b5a-2c2c-477b-99ea-2bfb0aefac07">1,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo4NjU5ZDZlOTYyZDU0N2E5OThmYzFiZjZmNzkyOGRiNS90YWJsZXJhbmdlOjg2NTlkNmU5NjJkNTQ3YTk5OGZjMWJmNmY3OTI4ZGI1XzItMS0xLTEtNzAzMzQ_6124ea3d-d0dc-45ed-b7a2-212563a4ff8d">1,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo4NjU5ZDZlOTYyZDU0N2E5OThmYzFiZjZmNzkyOGRiNS90YWJsZXJhbmdlOjg2NTlkNmU5NjJkNTQ3YTk5OGZjMWJmNmY3OTI4ZGI1XzMtMS0xLTEtNzAzMzQ_0242b5bc-f5c8-4dbf-b6e1-9af88ea5d47d">1,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo4NjU5ZDZlOTYyZDU0N2E5OThmYzFiZjZmNzkyOGRiNS90YWJsZXJhbmdlOjg2NTlkNmU5NjJkNTQ3YTk5OGZjMWJmNmY3OTI4ZGI1XzQtMS0xLTEtNzAzMzQ_e593f2b5-c767-41e6-b1e2-8959f185d56a">1,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo4NjU5ZDZlOTYyZDU0N2E5OThmYzFiZjZmNzkyOGRiNS90YWJsZXJhbmdlOjg2NTlkNmU5NjJkNTQ3YTk5OGZjMWJmNmY3OTI4ZGI1XzUtMS0xLTEtNzAzMzQ_34e7f5ae-17ae-4d6e-896a-3266ff970e44">1,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2029-2033</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo4NjU5ZDZlOTYyZDU0N2E5OThmYzFiZjZmNzkyOGRiNS90YWJsZXJhbmdlOjg2NTlkNmU5NjJkNTQ3YTk5OGZjMWJmNmY3OTI4ZGI1XzYtMS0xLTEtNzAzMzQ_d0ec9bc5-02ad-4fc0-8989-50b6dc805581">11,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icefbed2abcee471a86fc763c55ddfc45">The Company&#8217;s contributions for fiscal 2024 are expected to be consistent with the current year.</ix:continuation> </span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_142"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDIvZnJhZzpjZmIwZTZkYjhkNDI0YWE4YmUxMGU5NWVhMmNlNjNlMC90ZXh0cmVnaW9uOmNmYjBlNmRiOGQ0MjRhYThiZTEwZTk1ZWEyY2U2M2UwXzI2MjY_0c591b69-689f-4c3f-b2b2-dfc2da95ac28" continuedAt="i89adfab7746c469283a4690b7857210b" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i89adfab7746c469283a4690b7857210b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described below, there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. At each reporting period, management evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for all matters. Legal costs are expensed as incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal 2021, the Company received a subpoena from the U.S. Attorney&#8217;s Office for the District of Massachusetts. The subpoena requested certain documents regarding the Company&#8217;s apheresis and autotransfusion devices and disposables, including documents relating to product complaints and adverse event reporting, regulatory clearances and product design changes, among other matters. The Company has fully cooperated with this inquiry. On August 16, 2022, the U.S. Department of Justice (&#8220;DOJ&#8221;) filed a motion on behalf of the United States and 31 states reflecting their decision to not intervene in the underlying </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> action captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Berthelot et al. v. Haemonetics Corp.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 1:20-cv-11062-ADB, pending in the U.S. District Court for the District of Massachusetts, indicating that the DOJ had completed its investigative activity based on then available information. The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case was unsealed by order dated August 18, 2022. During the fourth fiscal quarter of 2023, the Company recorded a loss contingency related to this matter, which did not have a material impact on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of fiscal 2021, a putative class action complaint was filed against the Company in the Circuit Court of Cook County, Illinois by Mary Crumpton, on behalf of herself and similarly situated individuals. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mary Crumpton v. Haemonetics Corporation, Case No. 1:21-cv-1402</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In her complaint, the plaintiff asserts that between June 2017 and August 2018 she donated plasma at a center operated by one of the Company&#8217;s customers, that the center required her to scan her finger print in a scanner that stored her finger print to identify her prior to plasma donation, and that the Company&#8217;s eQue donor management software sent her biometric information to a Company-owned server to be collected and stored in a manner that violated her rights under the Illinois Biometric Information Privacy Act (&#8220;BIPA&#8221;). The plaintiff seeks statutory damages, attorneys&#8217; fees, and injunctive and equitable relief. In March 2021, the Company moved to dismiss the complaint for lack of personal jurisdiction and concurrently filed a motion to dismiss for failure to state a claim and a motion to stay. In March 2022, the court denied the Company&#8217;s motion to dismiss for lack of personal jurisdiction but did not address the merits of the Company&#8217;s other positions. In March 2023, the Company filed a second motion to dismiss the complaint, which is pending before the court. The Company believes it has valid and meritorious defenses to the complaint. During the fourth fiscal quarter of 2023, the Company recorded a loss contingency related to this matter, which did not have a material impact on its consolidated financial statements.</span></div></ix:continuation><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_145"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0NjU_e6fd9709-5059-4718-80bb-e6eb08b8041f" continuedAt="ib06e3e53f0504d7f9d8f15c534958569" escape="true">CAPITAL STOCK</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib06e3e53f0504d7f9d8f15c534958569" continuedAt="i970cba65e41a4fd78661c1b36b051492"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 25, 2019 (the &#8220;Effective Date&#8221;), the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan (the &#8220;2019 Equity Plan&#8221;) was approved and became effective. The 2019 Equity Plan permits the award of incentive stock options, non-qualified stock options, stock appreciation rights (&#8220;SARs&#8221;), restricted stock, restricted stock units (including performance-based restricted stock units) and other awards to the Company&#8217;s key employees, non-employee directors and certain consultants and advisors of the Company and its subsidiaries. The 2019 Equity Plan is administered by the Compensation Committee of the Board of Directors (the &#8220;Committee&#8221;), which consists of four independent members of the Company&#8217;s Board of Directors, and </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i970cba65e41a4fd78661c1b36b051492" continuedAt="ibe1e175450b34e8c83373323e5f67c41"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is the successor to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan, as amended (the &#8220;2005 Equity Plan&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the Effective Date, no further awards were granted under the 2005 Equity Plan; however, each outstanding award under the 2005 Equity Plan will remain outstanding under that plan and continue to be governed under its terms and any applicable award agreement. The maximum number of shares available for award under 2019 Equity Plan is <ix:nonFraction unitRef="shares" contextRef="ied4aca325d3e42f794837acb9bf1c5c7_I20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzEyNDY_9f46d160-1412-46d1-8131-6968a2b2747c">5,759,433</ix:nonFraction>, which consists of <ix:nonFraction unitRef="shares" contextRef="i31435e1c79be48e7b4ba1de17ba323da_I20230401" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzEyNjg_a7f3ae31-0a43-4cb3-b19d-0a16762d3a78">2,700,000</ix:nonFraction> shares of common stock authorized for issuance under the 2019 Equity Plan plus <ix:nonFraction unitRef="shares" contextRef="i51dd2ace410143febe089bb6d634e842_I20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzEzNTA_96d09d82-a09d-49ac-9156-62bbaca3602f">3,059,433</ix:nonFraction> shares of common stock reserved for issuance under the 2005 Equity Plan that remained available for grant under the 2005 Plan as of the Effective Date. Under the 2019 Equity Plan, any shares that are subject to the award of stock options or SARs will be counted against the authorized share reserve as one share for every one&#160;share issued and any shares that are subject to awards other than stock options, SARs or cash awards will be counted against the authorized share reserve as <ix:nonFraction unitRef="shares" contextRef="ib1fc79184fba4faa8a07007a4d564998_D20220403-20230401" decimals="2" name="hae:NumberofOptionsCountedAgainstMaximumNumberofAwardShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzE4MzY_8182fe2c-af24-42c6-85bb-55d5045fd33c">2.76</ix:nonFraction>&#160;shares for every one&#160;share granted. Shares of common stock subject to outstanding grants under the 2005 Equity Plan as of the Effective Date that terminate, expire, or are otherwise canceled without having been exercised will be added to the share reserve at the applicable 2019 Equity Plan ratios. The total shares available for future grant as of April&#160;1, 2023 were <ix:nonFraction unitRef="shares" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzIxOTY_f7984bab-a0b7-4f3b-9691-d33ee563e032">3,118,602</ix:nonFraction>.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0NDM_221bbc99-8374-4b42-8d84-d9e067193694" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation cost related to share-based transactions is recognized in the consolidated financial statements based on fair</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">value. The total amount of share-based compensation expense, which is recorded on a straight line basis, is as follows:</span></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:58.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic03bd40350ab47b59e94e0eb9a16722d_D20220403-20230401" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzEtMS0xLTEtNzAzMzQ_009e2094-a450-46ec-b4b2-a45ded538420">21,903</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i44318b6edd204f9bb959e54aa88e533c_D20210404-20220402" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzEtMy0xLTEtNzAzMzQ_cc5dae38-f5ef-4287-94ef-67777664e1bc">20,694</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i202912003ea5483c8e977d2876231a84_D20200329-20210403" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzEtNS0xLTEtNzAzMzQ_dbbef7aa-f8f7-4ea8-935f-9ee62014e9a3">22,888</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e94fc8a563c41dbb911f86eebd74fb4_D20220403-20230401" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzItMS0xLTEtNzAzMzQ_6686b4b5-36a9-4bb8-9253-679e86792a5e">2,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c21727b1644983b67286f3ff83bf6f_D20210404-20220402" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzItMy0xLTEtNzAzMzQ_9f2b7270-30d9-4e1a-af8c-41e6bacdf4fd">2,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if570127cbc674472bddd6c920a6680a6_D20200329-20210403" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzItNS0xLTEtNzAzMzQ_8b9a8b6f-e8b8-45eb-969c-c6eedb1be0ba">1,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie757a5b3c6874d30b0632b13796f7765_D20220403-20230401" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzMtMS0xLTEtNzAzMzQ_f5e5373f-ce42-49ad-95f6-08afbd467396">1,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a58bb523b34502b7e9328f05462202_D20210404-20220402" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzMtMy0xLTEtNzAzMzQ_247b9d76-4a0d-486d-a20f-6b88ad2fd28a">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54605da039714724a8b332c1eadca994_D20200329-20210403" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzMtNS0xLTEtNzAzMzQ_bf0f33d6-9222-4f9b-8e51-c976f1d30ce2">754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzQtMS0xLTEtNzAzMzQ_fbb2aa40-d729-449c-b11d-846b2c322886">25,583</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzQtMy0xLTEtNzAzMzQ_ff2f6a18-54c1-4fe4-9a6c-9b781c88cd29">24,359</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzQtNS0xLTEtNzAzMzQ_409accc2-36cf-4b50-ab7f-1399ebafe2a8">25,516</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options are granted to purchase common stock at prices as determined by the Committee, but in no event shall such exercise price be less than the fair market value of the common stock at the time of the grant. Options generally vest in equal installments over a <ix:nonNumeric contextRef="ib3ff55824d064fbd859089a1dce11fcb_D20220403-20230401" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzQzOTgwNDY1MTk2MjM_ba6830ed-2868-4d86-a371-e348f178dea1">four year</ix:nonNumeric> period for employees and <ix:nonNumeric contextRef="i98eb603c686a4dcfaabd4aeab4b77a27_D20220403-20230401" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzI3ODM_b3920458-614e-4b42-8915-12c8eeed29aa">one year</ix:nonNumeric> from grant for non-employee directors. Options expire not more than <ix:nonNumeric contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzI4NTQ_82614829-44fb-4e49-8860-ee9e3dcd576d">7</ix:nonNumeric> years from the date of the grant. The grant-date fair value of options, adjusted for estimated forfeitures, is recognized as expense on a straight line basis over the requisite service period, which is generally the vesting period. Forfeitures are estimated based on historical experience. </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ibe1e175450b34e8c83373323e5f67c41" continuedAt="iaa142b6f5cbe4b44a2a1f7609c8f1048"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0ODU_30eb7f8c-6cce-4a2e-a31b-e661509dcbf7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity for the fiscal year ended April&#160;1, 2023 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:45.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.805%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price<br/>per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Life (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>($000&#8217;s)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at April 2, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i44a4bfb9e6ff4d9b876946af45bf3409_I20220402" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzEtMS0xLTEtNzAzMzQ_4fe8ee2f-c86b-40cf-b27e-a823d2c5a0af">1,056,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i44a4bfb9e6ff4d9b876946af45bf3409_I20220402" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzEtMy0xLTEtNzAzMzQ_1c2e5fd3-b735-4d36-b110-ae33685d0400">66.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzEtNS0xLTEtNzAzMzQ_e169e529-59a5-4f58-8ff7-48949585e600">3.79</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a4bfb9e6ff4d9b876946af45bf3409_I20220402" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzEtNy0xLTEtNzAzMzQ_77f57005-9c79-4018-a499-789ebfdbc991">12,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzItMS0xLTEtNzAzMzQ_cd7c2a26-ba6c-4f87-994b-3d2ba433892d">276,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzItMy0xLTEtNzAzMzQ_ccdce404-1c4d-4936-8bd7-936e0f7d1263">58.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzMtMS0xLTEtNzAzMzQ_86c60f30-8a7e-45cd-8905-dde9b1d0c454">59,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzMtMy0xLTEtNzAzMzQ_478e979e-0266-49da-b876-6d61b1115ee1">44.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzQtMS0xLTEtNzAzMzQ_ee23c037-e5eb-4bcd-8199-ef2acffe92ed">123,972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzQtMy0xLTEtNzAzMzQ_7a3329ef-1060-4a40-982a-b8c7a76df72f">82.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzUtMS0xLTEtNzAzMzQ_9fa39dee-bad7-403b-b02d-c6d7a11a2c1e">1,150,194</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzUtMy0xLTEtNzAzMzQ_d9f0c0e7-ec17-4a17-b02c-0e98741ba3b3">64.21</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzUtNS0xLTEtNzAzMzQ_78ca479b-4fea-48d3-88bf-4c7bef2f650f">3.55</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzUtNy0xLTEtNzAzMzQ_21b723af-f023-4fab-8bd2-2103c7b9a0b5">27,481</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzctMS0xLTEtNzAzMzQ_06bd6f52-5125-4083-a35d-c2afda206eb7">618,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzctMy0xLTEtNzAzMzQ_09f66ed6-f7c0-4b68-a515-1a2931b5413b">62.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzctNS0xLTEtNzAzMzQ_339ae186-ece9-4dff-a58e-aeda906be01d">1.97</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzctNy0xLTEtNzAzMzQ_f72d7240-6427-4de9-92de-8652af8238c5">16,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested or expected to vest at April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzktMS0xLTEtNzAzMzQ_add3a4c5-f7db-4214-92aa-25fd280af61f">1,054,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzktMy0xLTEtNzAzMzQ_f63dca84-8aae-4c68-ace5-8cd557b7ccf1">64.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzktNS0xLTEtNzAzMzQ_02490518-2ceb-4289-b8fa-fbceb19e2b97">3.12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzktNy0xLTEtNzAzMzQ_2d452dc3-a377-49ba-8b14-9ecb3192106a">25,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of options exercised was $<ix:nonFraction unitRef="usd" contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzMyNzY_6cfb279e-c2c2-4047-b19f-c69b054efc77">1.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzMyODA_a9de8188-f697-4cef-ad79-2e9fc1fa3755">1.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i83a9bb7c454d4256b50d1b2a36133ef0_D20200329-20210403" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzMyODc_38de8bb6-8d11-4d78-83e8-fe52b80712c9">8.2</ix:nonFraction> million during fiscal <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzMzMDQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric>, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, there was $<ix:nonFraction unitRef="usd" contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzMzNTQ_90717b51-30f4-4a0d-9e45-30f9a13bf929">9.1</ix:nonFraction> million of total unrecognized compensation cost related to non-vested stock options. This cost is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzM1MDc_a135592d-73d6-4984-b266-55764a3af98f">2.6</ix:nonNumeric>&#160;years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value was estimated using the Black-Scholes option-pricing model based on the closing stock price at the grant date and the weighted average assumptions specific to the underlying options. Expected volatility assumptions are based on the historical volatility of the Company&#8217;s common stock over the expected term of the option. The risk-free interest rate was selected based upon yields of U.S.&#160;Treasury issues with a term equal to the expected life of the option being valued. The expected life of the option was estimated with reference to historical exercise patterns, the contractual term of the option and the vesting period. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0OTM_9041bd71-e791-41a6-a7b3-5b2a56638a4d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions utilized for option grants during the periods presented are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzEtMS0xLTEtNzAzMzQ_9a51250a-30c4-4de6-b7e1-648901bc769d">45.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzEtMy0xLTEtNzAzMzQ_4936d184-c12e-4316-acb2-9356f12485ef">41.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83a9bb7c454d4256b50d1b2a36133ef0_D20200329-20210403" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzEtNS0xLTEtNzAzMzQ_a69e8fe4-8636-4df2-b2e4-510fe5286efb">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzItMS0xLTEtNzAzMzQ_a02890da-3c36-455c-8e4e-cb6ca8f384d9">5.0</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzItMy0xLTEtNzAzMzQ_aaf38bcb-90bd-4f97-a95f-956c365174ed">4.9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i83a9bb7c454d4256b50d1b2a36133ef0_D20200329-20210403" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzItNS0xLTEtNzAzMzQ_3e21b13c-3525-46a9-b7c1-ce561e432b61">4.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzMtMS0xLTEtNzAzMzQ_16b96a71-2f4f-448f-8cac-e1d539e53542">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzMtMy0xLTEtNzAzMzQ_502e021e-cde8-4236-b5ed-1c560a1cb32e">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83a9bb7c454d4256b50d1b2a36133ef0_D20200329-20210403" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzMtNS0xLTEtNzAzMzQ_43ad23fd-bf38-4867-8bd6-a180a2f95b8f">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzQtMS0xLTEtNzAzMzQ_c0f29ced-a0da-4ccd-a81c-54f61425e360">0.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzQtMy0xLTEtNzAzMzQ_ca624f65-8ba2-40b0-8e48-f541d818d566">0.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83a9bb7c454d4256b50d1b2a36133ef0_D20200329-20210403" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzQtNS0xLTEtNzAzMzQ_d2ad2583-da59-4e95-a844-39db1555cc38">0.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value per Option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzUtMS0xLTEtNzAzMzQ_95e7148f-984e-4aac-9688-d153a024c116">24.86</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzUtMy0xLTEtNzAzMzQ_2bb33b5b-1984-41bd-999e-f882a5f0b081">20.97</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i83a9bb7c454d4256b50d1b2a36133ef0_D20200329-20210403" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzUtNS0xLTEtNzAzMzQ_086d6e1f-3553-4aae-ae22-f142dfbd7692">30.53</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted Stock Units (&#8220;RSUs&#8221;) generally vest in equal installments over a <ix:nonNumeric contextRef="ie01f5826ba434059bfbcca75ed1388fb_D20220403-20230401" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzQzOTgwNDY1MTk2MjA_98f700b6-e712-4a84-84cc-6154ad530b85">four year</ix:nonNumeric> period for employees and <ix:nonNumeric contextRef="ied103559dd2b43a4b0de550c083ea67f_D20220403-20230401" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzQzODU_847cc1e3-ca30-4651-9365-b260084625fb">one year</ix:nonNumeric> from grant for non-employee directors. The grant-date fair value of RSUs, adjusted for estimated forfeitures, is recognized as expense on a straight-line basis over the requisite service period, which is generally the vesting period. The fair market value of RSUs is determined based on the market value of the Company&#8217;s shares on the date of grant.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="iaa142b6f5cbe4b44a2a1f7609c8f1048" continuedAt="i7a446ebcc54c458589c62045ca19f56f"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0NTg_2ff65413-6f5c-46fd-a20b-c7c932241ff8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU activity for the fiscal year ended April&#160;1, 2023 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at April 2, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iffbadda382114e1eb91a79d7e988c700_I20220402" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzEtMS0xLTEtNzAzMzQ_a934dc00-045b-4cdb-ba3c-55bd6beb0f68">386,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iffbadda382114e1eb91a79d7e988c700_I20220402" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzEtMy0xLTEtNzAzMzQ_b13fa9e4-aba8-4362-a78a-19b095802612">69.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzItMS0xLTEtNzAzMzQ_fd9f25d0-72e9-4061-95a9-d10af2729be0">207,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzItMy0xLTEtNzAzMzQ_2bae6684-3bc9-49bc-8828-a959159498f9">59.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzMtMS0xLTEtNzAzMzQ_447ae432-02d8-4191-a21c-e30ec4a46bae">161,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzMtMy0xLTEtNzAzMzQ_8c8ee717-e859-40aa-9e35-be4fd11ddb71">70.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzQtMS0xLTEtNzAzMzQ_d873a5b5-b20f-424b-a3dc-d7b9299ad9c5">51,360</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzQtMy0xLTEtNzAzMzQ_4e941d8b-d7f0-466b-b8ff-df338226fabb">65.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6792b00ca8b4378bcb06b91412550eb_I20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzUtMS0xLTEtNzAzMzQ_7a7828cb-24c3-4dfe-a6b4-a340477e89e7">381,308</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if6792b00ca8b4378bcb06b91412550eb_I20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzUtMy0xLTEtNzAzMzQ_df637b98-1dfc-498b-9730-b29dde14eb75">63.94</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of RSUs granted and total fair value of RSUs vested are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTozMDVkMjZlMzBkYjE0N2I1ODZlZjU0YWE2NjAzYzBkYS90YWJsZXJhbmdlOjMwNWQyNmUzMGRiMTQ3YjU4NmVmNTRhYTY2MDNjMGRhXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value per RSU</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTozMDVkMjZlMzBkYjE0N2I1ODZlZjU0YWE2NjAzYzBkYS90YWJsZXJhbmdlOjMwNWQyNmUzMGRiMTQ3YjU4NmVmNTRhYTY2MDNjMGRhXzEtMS0xLTEtNzAzMzQ_03600c63-1785-4a30-887e-ffc5d3cb7bf1">59.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibd48961a67cf47bcaa9d15e8932acecb_D20210404-20220402" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTozMDVkMjZlMzBkYjE0N2I1ODZlZjU0YWE2NjAzYzBkYS90YWJsZXJhbmdlOjMwNWQyNmUzMGRiMTQ3YjU4NmVmNTRhYTY2MDNjMGRhXzEtMy0xLTEtNzAzMzQ_b26907a0-a83a-4b8e-a508-d88edf9bd662">56.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0b0d0e4e19f34194b2cc3d61739b6ec8_D20200329-20210403" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTozMDVkMjZlMzBkYjE0N2I1ODZlZjU0YWE2NjAzYzBkYS90YWJsZXJhbmdlOjMwNWQyNmUzMGRiMTQ3YjU4NmVmNTRhYTY2MDNjMGRhXzEtNS0xLTEtNzAzMzQ_da02f836-e366-4ac6-b630-520d00a7d09e">102.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of RSUs vested</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTozMDVkMjZlMzBkYjE0N2I1ODZlZjU0YWE2NjAzYzBkYS90YWJsZXJhbmdlOjMwNWQyNmUzMGRiMTQ3YjU4NmVmNTRhYTY2MDNjMGRhXzItMS0xLTEtNzAzMzQ_add8c16b-4cca-4e0a-8c7b-8bcf55a2605a">70.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibd48961a67cf47bcaa9d15e8932acecb_D20210404-20220402" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTozMDVkMjZlMzBkYjE0N2I1ODZlZjU0YWE2NjAzYzBkYS90YWJsZXJhbmdlOjMwNWQyNmUzMGRiMTQ3YjU4NmVmNTRhYTY2MDNjMGRhXzItMy0xLTEtNzAzMzQ_6ec28d5a-7f87-4b40-8d8f-2a1ee206fb7f">79.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0b0d0e4e19f34194b2cc3d61739b6ec8_D20200329-20210403" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTozMDVkMjZlMzBkYjE0N2I1ODZlZjU0YWE2NjAzYzBkYS90YWJsZXJhbmdlOjMwNWQyNmUzMGRiMTQ3YjU4NmVmNTRhYTY2MDNjMGRhXzItNS0xLTEtNzAzMzQ_395ddf15-965b-492d-898c-af23d2525cfc">66.87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, there was $<ix:nonFraction unitRef="usd" contextRef="if6792b00ca8b4378bcb06b91412550eb_I20230401" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzQ5NDY_70b4fe13-c108-491b-ad7c-f964f4fd9f23">15.4</ix:nonFraction> million of total unrecognized compensation cost related to non-vested restricted stock units. This cost is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzUxMDg_8d267b02-0279-4664-9e2b-f89506fd83b5">2.5</ix:nonNumeric>&#160;years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Share Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant date fair value of Performance Share Units (&#8220;PSUs&#8221;), adjusted for estimated forfeitures, is recognized as expense on a straight line basis from the grant date through the end of the performance period. The value of these PSUs is generally based on relative total shareholder return which equals total shareholder return for the Company as compared with total shareholder return of the PSU comparison group, measured over a <ix:nonNumeric contextRef="i1366c0d1a26f4ae99257fc0a3af5b117_D20220403-20230401" name="hae:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzQzOTgwNDY1MTk2MjE_7d0d9164-fc8e-48c0-bbd2-0c24704f73fe">three year</ix:nonNumeric> performance period. The PSUs comparison group consists of the Standard and Poor's (&#8220;S&amp;P&#8221;) MidCap 400 Index. Depending on the Company&#8217;s relative performance during the performance period, a recipient of the award is entitled to receive a number of ordinary shares equal to a percentage, ranging from <ix:nonFraction unitRef="number" contextRef="ia22139de2bdb42ccaa1b42693e6081e1_I20230401" decimals="INF" name="hae:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzU4ODQ_9aeceba8-5174-4ce0-83e8-37434a1eea91">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i1a025b99984c40c8aa80efd44bf08d80_I20230401" decimals="INF" name="hae:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzU4OTA_efd12769-43ce-4998-8acd-b245b356a8c2">200</ix:nonFraction>%, of the award granted. If the Company&#8217;s total shareholder return for the performance period is negative, then any share payout will be capped at <ix:nonFraction unitRef="number" contextRef="i13ad711590264a0292e2f60317f18a68_I20230401" decimals="INF" name="hae:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzYwMzg_5a1d7c6e-48bc-43fd-aade-bfc27a7a46f5">100</ix:nonFraction>% of the target award, regardless of the Company&#8217;s performance relative to the its comparison group. As a result, the Company may issue up to <ix:nonFraction unitRef="shares" contextRef="i13ad711590264a0292e2f60317f18a68_I20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzYxODE_4651428c-1e89-48c7-8abd-d2d8bacce99a">647,974</ix:nonFraction> shares related to outstanding performance-based awards.</span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0NDc_5fff49a2-c3fe-4c3e-8dd2-1b83ffc6d7b7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of PSU activity for the fiscal year ended April&#160;1, 2023 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at April 2, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07c8760c6cc84cf3b9856e00588d1d24_I20220402" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzEtMS0xLTEtNzAzMzQ_bd71e28d-3e69-451a-b1fa-615399aa6614">282,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i07c8760c6cc84cf3b9856e00588d1d24_I20220402" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzEtMy0xLTEtNzAzMzQ_f069f96a-c79e-41a9-a635-99afdfda8ed8">102.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzItMS0xLTEtNzAzMzQ_13082a4f-4a03-4b15-a243-bbb6ec778626">88,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzItMy0xLTEtNzAzMzQ_6e96eea0-c6be-4098-810a-f7d4e9655fe1">84.96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzMtMS0xLTEtNzAzMzQ_311ec1e2-0c62-4444-bf8f-7f8169b89f82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzMtMy0xLTEtNzAzMzQ_7f4af61b-821c-454f-8f6a-fc4ab00960b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzQtMS0xLTEtNzAzMzQ_46f07347-d4bf-48c1-936a-4282f987895c">47,810</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzQtMy0xLTEtNzAzMzQ_03b69d2b-abb2-4dd9-bc62-bd0f16f2adbf">89.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i13ad711590264a0292e2f60317f18a68_I20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzUtMS0xLTEtNzAzMzQ_5a46972c-e759-44dc-869c-60afc58c8125">323,987</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i13ad711590264a0292e2f60317f18a68_I20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzUtMy0xLTEtNzAzMzQ_71c9b765-02b1-4bd7-945f-5b6627b74bdc">87.35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Includes the adjustment of <ix:nonFraction unitRef="shares" contextRef="i59b37d77f2e14639a7e9f54a0a50c9ef_D20190331-20200328" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzYtMC0xLTEtOTQ2NDUvdGV4dHJlZ2lvbjowMDUxM2IzNmUxODk0MjAxYmRlZWFkNGU0OGVkMjA2MF8xNjQ5MjY3NDQxODI4_34afbec8-a029-4203-a342-5505b291cfe5">62,577</ix:nonFraction> shares for awards granted in fiscal 2020, based on actual relative total shareholder return of 0%</span></div></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Monte Carlo model to estimate the probability of satisfying the performance criteria and the resulting fair value of PSU awards with market conditions. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="hae:ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0NjE_8a964ff9-a8eb-4fb8-8ac1-faf90cf3695b" continuedAt="i73e2394dc613482ba0c97b406dfc5123" escape="true">The assumptions used in the Monte Carlo model for PSUs granted during each fiscal year were as follows: </ix:nonNumeric></span></div><div><ix:continuation id="i73e2394dc613482ba0c97b406dfc5123" continuedAt="i03fb90f39c884c239ea1a73281497e94"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzEtMS0xLTEtNzAzMzQ_81c13f43-2e30-4c06-8e17-e762fab9fd0e">52.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55c8b8347e1243739c1e1fac07b7a6c0_D20210404-20220402" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzEtMy0xLTEtNzAzMzQ_ef0d2dee-010d-4c7c-b47d-3da041c73741">49.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id1524cac1b104c79b7706146b0a9bdc2_D20200329-20210403" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzEtNS0xLTEtNzAzMzQ_19fbcf0c-c4b8-4cf1-8600-73e9e248ba51">36.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peer group stock price volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401" decimals="4" name="hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzItMS0xLTEtNzAzMzQ_6c2cbff5-6e16-46bb-a9be-0e18b5b0c215">47.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55c8b8347e1243739c1e1fac07b7a6c0_D20210404-20220402" decimals="4" name="hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzItMy0xLTEtNzAzMzQ_11311be8-817d-40bd-9e0b-5665e8a90e33">45.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id1524cac1b104c79b7706146b0a9bdc2_D20200329-20210403" decimals="4" name="hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzItNS0xLTEtNzAzMzQ_d22e4707-c377-449e-88e7-8c5a5a814052">42.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Correlation of returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401" decimals="4" name="hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzMtMS0xLTEtNzAzMzQ_961cf7d5-41dc-4c8e-b5bc-2ce35f479061">65.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55c8b8347e1243739c1e1fac07b7a6c0_D20210404-20220402" decimals="4" name="hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzMtMy0xLTEtNzAzMzQ_9f87a7c8-2c76-4785-a82d-5b30f24df801">65.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id1524cac1b104c79b7706146b0a9bdc2_D20200329-20210403" decimals="4" name="hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzMtNS0xLTEtNzAzMzQ_6c7c7e3f-650e-4be4-851e-e35d79611131">65.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i7a446ebcc54c458589c62045ca19f56f"><ix:continuation id="i03fb90f39c884c239ea1a73281497e94"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of PSUs granted and total fair value of PSUs vested are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:59.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1Y2NmMDk5MWUyZTM0NzFlOTA5MmUwYzY2NjQyZGQ0Mi90YWJsZXJhbmdlOjVjY2YwOTkxZTJlMzQ3MWU5MDkyZTBjNjY2NDJkZDQyXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value per PSU</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1Y2NmMDk5MWUyZTM0NzFlOTA5MmUwYzY2NjQyZGQ0Mi90YWJsZXJhbmdlOjVjY2YwOTkxZTJlMzQ3MWU5MDkyZTBjNjY2NDJkZDQyXzEtMS0xLTEtNzAzMzQ_c405e0e4-a2ba-49f8-8fbd-f8fda35d6af8">84.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i55c8b8347e1243739c1e1fac07b7a6c0_D20210404-20220402" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1Y2NmMDk5MWUyZTM0NzFlOTA5MmUwYzY2NjQyZGQ0Mi90YWJsZXJhbmdlOjVjY2YwOTkxZTJlMzQ3MWU5MDkyZTBjNjY2NDJkZDQyXzEtMy0xLTEtNzAzMzQ_d1b58336-d492-44d4-8a1f-f538827aa01f">72.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id1524cac1b104c79b7706146b0a9bdc2_D20200329-20210403" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1Y2NmMDk5MWUyZTM0NzFlOTA5MmUwYzY2NjQyZGQ0Mi90YWJsZXJhbmdlOjVjY2YwOTkxZTJlMzQ3MWU5MDkyZTBjNjY2NDJkZDQyXzEtNS0xLTEtNzAzMzQ_00527b11-2ff8-4f56-8e4a-02c0554c9091">123.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of PSUs vested</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1Y2NmMDk5MWUyZTM0NzFlOTA5MmUwYzY2NjQyZGQ0Mi90YWJsZXJhbmdlOjVjY2YwOTkxZTJlMzQ3MWU5MDkyZTBjNjY2NDJkZDQyXzItMS0xLTEtNzAzMzQ_b5c06477-8ead-4d52-8401-064143ea1058">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i55c8b8347e1243739c1e1fac07b7a6c0_D20210404-20220402" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1Y2NmMDk5MWUyZTM0NzFlOTA5MmUwYzY2NjQyZGQ0Mi90YWJsZXJhbmdlOjVjY2YwOTkxZTJlMzQ3MWU5MDkyZTBjNjY2NDJkZDQyXzItMy0xLTEtNzAzMzQ_70888391-85b6-45b3-8005-fa7498fe9382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id1524cac1b104c79b7706146b0a9bdc2_D20200329-20210403" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1Y2NmMDk5MWUyZTM0NzFlOTA5MmUwYzY2NjQyZGQ0Mi90YWJsZXJhbmdlOjVjY2YwOTkxZTJlMzQ3MWU5MDkyZTBjNjY2NDJkZDQyXzItNS0xLTEtNzAzMzQ_77cc71a8-3758-4608-8ea9-52738432cb21">47.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, there was $<ix:nonFraction unitRef="usd" contextRef="i13ad711590264a0292e2f60317f18a68_I20230401" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzY3Mjg_796e56dc-aa44-4856-91f5-5c605b315aaf">14.5</ix:nonFraction> million of total unrecognized compensation cost related to non-vested performance share units. This cost is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzY4OTE_4ad0ece3-ea93-4b85-9699-887c87a48b8a">1.8</ix:nonNumeric>&#160;years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an Employee Stock Purchase Plan (the &#8220;Purchase Plan&#8221;) under which a maximum of <ix:nonFraction unitRef="shares" contextRef="i78a954ba53b547c2bed2e4234f13c99d_I20230401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzcwMjc_f71cad6d-6cad-4102-856a-773cbcf75dbc">3,200,000</ix:nonFraction>&#160;shares (subject to adjustment for stock splits and similar changes) of common stock may be purchased by eligible employees. Substantially all of its full-time employees are eligible to participate in the Purchase Plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Purchase Plan provides for <ix:nonFraction unitRef="period" contextRef="i78a954ba53b547c2bed2e4234f13c99d_I20230401" decimals="INF" name="hae:NumberOfPurchasePeriods" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzcyODE_a09e8bf5-3935-4134-ab5d-94f810dc8b72">two</ix:nonFraction> &#8220;purchase periods&#8221; within each of its fiscal years, the first commencing on November 1 of each year and continuing through April 30 of the next calendar year, and the second commencing on May 1 of each year and continuing through October 31 of such year. Shares are purchased through an accumulation of payroll deductions (of not less than <ix:nonFraction unitRef="number" contextRef="i1aa3abbe789d42b1bb931051619eea7c_D20220403-20230401" decimals="INF" name="hae:PercentageOfSharesPurchasedThroughPayrollDeductions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzc2MjQ_4c7ca643-4f82-4aee-b095-f3ea7b90f304">2</ix:nonFraction>% or more than <ix:nonFraction unitRef="number" contextRef="ib47a041d2f4a41c580a5732760d4464d_D20220403-20230401" decimals="INF" name="hae:PercentageOfSharesPurchasedThroughPayrollDeductions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzc2NDA_9eed1733-b4fc-4640-93de-d5482f65676b">15</ix:nonFraction>% of compensation, as defined) for the number of whole shares determined by dividing the balance in the employee&#8217;s account on the last day of the purchase period by the purchase price per share for the stock determined under the Purchase Plan. The purchase price for shares is the lower of <ix:nonFraction unitRef="number" contextRef="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401" decimals="INF" name="hae:PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzc5MzE_72854ec4-5b52-4a0f-9e43-23c392993866">85</ix:nonFraction>% of the fair market value of the common stock at the beginning of the purchase period, or <ix:nonFraction unitRef="number" contextRef="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401" decimals="INF" name="hae:PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzgwMjM_72854ec4-5b52-4a0f-9e43-23c392993866">85</ix:nonFraction>% of such value at the end of the purchase period.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0ODA_186867e7-9d64-4b45-a89a-3b2b381d9b23" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of shares purchased under the Employee Stock Purchase Plan are estimated using the Black-Scholes single option-pricing model with the following weighted average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzEtMS0xLTEtNzAzMzQ_9edd60e3-3db5-403f-abd2-ff6d0d68ab4a">44.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id8876ecaa10546b49f1574bdf9545726_D20210404-20220402" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzEtMy0xLTEtNzAzMzQ_8e07c44d-91c1-4cad-a976-bb85d35468dc">55.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5b7c9d1af64d4d1ba8bf38b9460a37f9_D20200329-20210403" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzEtNS0xLTEtNzAzMzQ_87ba7108-f6d4-46d4-ad60-54c27a085524">49.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (months)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzItMS0xLTEtNzAzMzQ_dfebc439-eb60-454b-b5fb-8fd5121c317a">6</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id8876ecaa10546b49f1574bdf9545726_D20210404-20220402" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzItMy0xLTEtNzAzMzQ_706fde32-79de-4ae0-a9c6-88781b25c987">6</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5b7c9d1af64d4d1ba8bf38b9460a37f9_D20200329-20210403" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzItNS0xLTEtNzAzMzQ_d3784db3-93a6-481a-ac0f-cfaf61b4e078">6</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzMtMS0xLTEtNzAzMzQ_5fc8fae3-24fb-4fb3-8ebd-967b720b1951">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id8876ecaa10546b49f1574bdf9545726_D20210404-20220402" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzMtMy0xLTEtNzAzMzQ_ad0c5bbb-f07a-4e09-bd4d-c89b2c2ca4fc">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5b7c9d1af64d4d1ba8bf38b9460a37f9_D20200329-20210403" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzMtNS0xLTEtNzAzMzQ_28a8fc99-b061-4cbf-9d80-90ffc7b4d966">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend Yield</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzQtMS0xLTEtNzAzMzQ_6c5400a6-52ac-441b-82b3-a4567abdf9e3">0.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id8876ecaa10546b49f1574bdf9545726_D20210404-20220402" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzQtMy0xLTEtNzAzMzQ_21a7c27b-64b7-4fe5-bdc8-f114569ebd4f">0.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5b7c9d1af64d4d1ba8bf38b9460a37f9_D20200329-20210403" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzQtNS0xLTEtNzAzMzQ_0f3616bc-3590-4653-8e76-754b3caeb1c1">0.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of the <ix:nonNumeric contextRef="id8876ecaa10546b49f1574bdf9545726_D20210404-20220402" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzQzOTgwNDY1MTk2MjI_f95cea89-3910-4918-99ad-3aa024cb8741">six-month</ix:nonNumeric> option inherent in the Purchase Plan was approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401" decimals="2" name="hae:WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzgzODM_99481ae4-2a62-4d55-9c8d-80b17aa120d9">18.10</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="id8876ecaa10546b49f1574bdf9545726_D20210404-20220402" decimals="2" name="hae:WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzgzODc_89d5b261-a947-4dd8-8a8b-3dde172efe4f">20.77</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i5b7c9d1af64d4d1ba8bf38b9460a37f9_D20200329-20210403" decimals="2" name="hae:WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzgzOTQ_8dfe25e0-f569-4c8f-a755-bb5d4053ff43">30.77</ix:nonFraction> during fiscal <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0MTE_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric>, 2022 and 2021, respectively.</span></div></ix:continuation><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_148"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90ZXh0cmVnaW9uOjFmMmM0MTU1Y2YwMzQ4ZTE5YmJlMzBhM2Y1ODI3NmI1XzI1OTA_7d76547b-c8d0-4e36-89d1-e77b95a07845" continuedAt="i4d2268e549ef48f9b01e1b639083c733" escape="true">SEGMENT AND ENTERPRISE-WIDE INFORMATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4d2268e549ef48f9b01e1b639083c733" continuedAt="i6a1cbce888ba462da8f3a24a9b5b5986"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines its reportable segments by first identifying its operating segments, and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. The Company&#8217;s reporting structure aligns with its operating structure of <ix:nonFraction unitRef="unit" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90ZXh0cmVnaW9uOjFmMmM0MTU1Y2YwMzQ4ZTE5YmJlMzBhM2Y1ODI3NmI1XzQ0Mg_25b5380f-c61d-442c-8b39-d49b585ae6a2">three</ix:nonFraction> global business units and the information that is regularly reviewed by the Company&#8217;s chief operating decision maker.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable and operating segments are as follows:</span></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Plasma</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Blood Center</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Hospital</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management measures and evaluates the operating segments based on operating income. Management excludes certain corporate expenses from segment operating income. In addition, certain amounts that management considers to be non-recurring or non-operational are excluded from segment operating income because management evaluates the operating results of the segments excluding such items. These items include integration and transaction costs, amortization of acquired intangible assets, restructuring and restructuring related costs, digital transformation costs related to the upgrade of our enterprise resource planning system, impairments, accelerated device depreciation and related costs, costs related to compliance with the European Union Medical Device Regulation (&#8220;MDR&#8221;) and In Vitro Diagnostic Regulation (&#8220;IVDR&#8221;), unusual or infrequent and material litigation-related charges and gains and losses on dispositions and sale of assets. Although these amounts are excluded from </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i6a1cbce888ba462da8f3a24a9b5b5986" continuedAt="i84d1621154b048549d5d759bbec796ed"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">segment operating income, as applicable, they are included in the reconciliations that follow. Management measures and evaluates the Company&#8217;s net revenues and operating income using internally derived standard currency exchange rates that remain constant from year to year; therefore, segment information is presented on this basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected information by reportable segment is presented below:</span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90ZXh0cmVnaW9uOjFmMmM0MTU1Y2YwMzQ4ZTE5YmJlMzBhM2Y1ODI3NmI1XzI1ODY_839b333f-9076-4830-9f47-efff1db85721" continuedAt="i8b41c9c406c446559168d0ecdfb110aa" escape="true"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceda53e10aa943db9898cb8ab8dac15a_D20220403-20230401" decimals="-3" name="hae:NetRevenuesBeforeForeignExchangeImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzItMS0xLTEtNzAzMzQ_aff9a251-b060-4845-b315-c994cfefcaee">500,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic069cd0eb4c94953be95e2deb98ea5e5_D20210404-20220402" decimals="-3" name="hae:NetRevenuesBeforeForeignExchangeImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzItMy0xLTEtNzAzMzQ_1a2bcca6-afab-440c-9a6a-6ed2d23e9ac3">351,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia79a8918d94541fbb215b791d3bc0308_D20200329-20210403" decimals="-3" name="hae:NetRevenuesBeforeForeignExchangeImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzItNS0xLTEtNzAzMzQ_24cf999f-d505-45b4-8677-1c541c985e14">333,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ffef01c50b40dcbbc6f463d67d82a6_D20220403-20230401" decimals="-3" name="hae:NetRevenuesBeforeForeignExchangeImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzMtMS0xLTEtNzAzMzQ_fb2ce0b7-cec2-479a-a0f9-d12e9cace11c">289,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b364431a43245b7a9f05a60dc7416df_D20210404-20220402" decimals="-3" name="hae:NetRevenuesBeforeForeignExchangeImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzMtMy0xLTEtNzAzMzQ_ab7aa5ac-c1d8-43a8-b38a-f01f0542a32b">294,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6794b0b382b4fb7886de74ba621481b_D20200329-20210403" decimals="-3" name="hae:NetRevenuesBeforeForeignExchangeImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzMtNS0xLTEtNzAzMzQ_230052c8-e1a2-4c31-86f4-e71705229fa2">307,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i753483fb84d94062bdc30420838c80cf_D20220403-20230401" decimals="-3" name="hae:NetRevenuesBeforeForeignExchangeImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzQtMS0xLTEtNzAzMzQ_30ba3f64-c6ec-4b60-8c52-0d43c3d03511">378,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4e22f5dd7d46aab1223c60d287905f_D20210404-20220402" decimals="-3" name="hae:NetRevenuesBeforeForeignExchangeImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzQtMy0xLTEtNzAzMzQ_8ad32bb2-42ef-4a87-b30a-617cb6a33574">321,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e8e2ad8db6d4f6c859bc3263d7c9235_D20200329-20210403" decimals="-3" name="hae:NetRevenuesBeforeForeignExchangeImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzQtNS0xLTEtNzAzMzQ_259c5f38-f2c8-4a28-be3c-188737515045">210,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues by business unit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:NetRevenuesBeforeForeignExchangeImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzUtMS0xLTEtNzAzMzQ_608264c8-6116-4c48-8395-21c11f40fe8b">1,168,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:NetRevenuesBeforeForeignExchangeImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzUtMy0xLTEtNzAzMzQ_4f9c9329-a4c4-4b38-9f0c-03b432db167f">968,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:NetRevenuesBeforeForeignExchangeImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzUtNS0xLTEtNzAzMzQ_e8409a31-c976-405d-b049-5c77bb178c12">851,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f9b935310f84ea0a50db4a3f1516c09_D20220403-20230401" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzYtMS0xLTEtNzAzMzQ_d87ce59d-48ee-4bd6-a936-0b55a937895c">21,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f4398aaa87e4aeca6c11c93436c50e9_D20210404-20220402" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzYtMy0xLTEtNzAzMzQ_f51f9185-a0e1-48e4-b80b-a4e5bcfa5248">20,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d1e74dd6311434089cd6836e717625c_D20200329-20210403" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzYtNS0xLTEtNzAzMzQ_f3146322-7a6a-4b90-842d-8af1ba4d8bdc">20,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="hae:EffectofExchangeRateonRevenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzctMS0xLTEtNzAzMzQ_fd35ce1b-1efb-405c-a0a1-17ff7e8ee0d9">20,824</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:EffectofExchangeRateonRevenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzctMy0xLTEtNzAzMzQ_a4ca1c08-ea83-4cdd-b31f-6fbad4623060">4,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="hae:EffectofExchangeRateonRevenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzctNS0xLTEtNzAzMzQ_a92d68c8-8599-40e4-8366-680ffcedbc7c">1,605</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzgtMS0xLTEtNzAzMzQ_159abb41-2b1d-4a38-a27a-1b9d63fcb18a">1,168,660</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzgtMy0xLTEtNzAzMzQ_c0b9d488-ae83-4e44-ac81-0ac681a87748">993,196</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzgtNS0xLTEtNzAzMzQ_fb33f552-20e7-43c1-b61f-64d3ff2466fc">870,463</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Reflects revenue for service, maintenance and parts.</span></div></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57226d1153c648e282451a752c136567_D20220403-20230401" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzItMS0xLTEtNzAzMzQ_b8b91d8b-b664-46f2-8d21-88de9353af2d">278,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7892776f995348be9cb282d7d7c17651_D20210404-20220402" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzItMy0xLTEtNzAzMzQ_0b8067e9-8d8d-4103-a41e-ecaba7c37752">183,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62ca9ec732184b39b11517312a810c90_D20200329-20210403" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzItNS0xLTEtNzAzMzQ_14b27694-0e1b-4e04-91cd-bd581eee4a3b">172,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5300fbf53a4887a95a3edcae203e9f_D20220403-20230401" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzMtMS0xLTEtNzAzMzQ_cde84e17-9ac0-406b-8147-331fa3e71d68">132,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i399cf413d8244296bc74b84fb599fdfd_D20210404-20220402" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzMtMy0xLTEtNzAzMzQ_20fb563a-3bd2-4185-8f9e-a5ba796cd893">136,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5feb3720fec44a2b9a7ac2e43eebe25a_D20200329-20210403" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzMtNS0xLTEtNzAzMzQ_c85d8422-d6a3-42e9-9c0c-512ef57cbf2b">141,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49e6050da52421980ac8d48fb39b261_D20220403-20230401" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzQtMS0xLTEtNzAzMzQ_70305a9e-38ae-42a1-9310-13d397fa8195">154,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94875fad58e496e88688163402cab14_D20210404-20220402" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzQtMy0xLTEtNzAzMzQ_ef25fca0-cae9-4b62-a82f-04c268ae18f1">129,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f932dedc3e84a1fbcde03eaf16d4ba2_D20200329-20210403" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzQtNS0xLTEtNzAzMzQ_ab431ffd-16e9-4848-a6d5-50b984005e70">84,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c9dc15838804a3bb4198e9625eab973_D20220403-20230401" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzUtMS0xLTEtNzAzMzQ_e89139ee-f697-4490-876d-df7f788d131d">565,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaff6cca2e524da7a844b31893ea255f_D20210404-20220402" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzUtMy0xLTEtNzAzMzQ_600b47f0-1d41-4df6-a182-62bf556a862f">449,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i576a32257e5e4be9bdce60172bdce930_D20200329-20210403" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzUtNS0xLTEtNzAzMzQ_f8a89ca8-f299-43ab-a246-d837104a1cd2">398,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Corporate expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icadc8db134484aaa9370b59b63b8a1be_D20220403-20230401" decimals="-3" name="us-gaap:OtherExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzYtMS0xLTEtNzAzMzQ_a0104c39-b0f3-4765-a7ab-f4f6953ee3a2">355,089</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6464f6090754fc397d2bc24da66f3a5_D20210404-20220402" decimals="-3" name="us-gaap:OtherExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzYtMy0xLTEtNzAzMzQ_ee72116e-d242-427a-a484-d9cdc9875bea">281,476</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if321e27503a64a269742b2fad027648e_D20200329-20210403" decimals="-3" name="us-gaap:OtherExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzYtNS0xLTEtNzAzMzQ_d743db83-7fca-4448-848e-2b3bff11ea8b">256,751</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Effect of exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:EffectofExchangeRatesonOperatingIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzctMS0xLTEtNzAzMzQ_de1ba7dc-b6da-4471-acce-eb80ef45b383">8,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:EffectofExchangeRatesonOperatingIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzctMy0xLTEtNzAzMzQ_678f0a3b-93c1-4b70-a6cc-119e562fd18d">18,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:EffectofExchangeRatesonOperatingIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzctNS0xLTEtNzAzMzQ_d3d9072a-6ae9-44a8-aeb9-5e4abd2a67c8">12,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:AmortizationOfAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzgtMS0xLTEtNzAzMzQ_1cd7cac7-90a8-499b-b8ca-a2abcdcf043b">32,640</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:AmortizationOfAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzgtMy0xLTEtNzAzMzQ_42165b22-46e4-442b-a134-8ac1e4e5ae5c">47,414</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:AmortizationOfAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzgtNS0xLTEtNzAzMzQ_b5ad6c7d-5dd4-486f-893e-5641bc98b3c1">32,830</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of assets and PCS2 related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="hae:ImpairmentOfAssetsAndRelatedCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzktMS0xLTEtNzAzMzQ_a00f183b-dbeb-4c17-b594-952132930fce">616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:ImpairmentOfAssetsAndRelatedCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzktMy0xLTEtNzAzMzQ_d9047c48-72a7-479d-b0d6-769a7abe89d3">5,732</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:ImpairmentOfAssetsAndRelatedCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzktNS0xLTEtNzAzMzQ_e98f7afb-8785-46ac-8084-40b76eda22c5">25,696</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration and transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="hae:OperatingExpensesTransactionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEwLTEtMS0xLTcwMzM0_fbcb1e45-28bc-468c-a691-12aa9a512551">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:OperatingExpensesTransactionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEwLTMtMS0xLTcwMzM0_44a892f5-fce4-49f4-a6cd-11ce4f6bb046">21,604</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:OperatingExpensesTransactionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEwLTUtMS0xLTcwMzM0_cf9aa0ac-abb3-4450-966a-aefd3cd1466b">18,421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and restructuring related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:RestructuringandRestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzExLTEtMS0xLTcwMzM0_e39f96ef-883e-453a-9ffb-47c25a45f48b">11,549</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:RestructuringandRestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzExLTMtMS0xLTcwMzM0_17333a14-905a-46d0-b06a-738969e7ac3e">28,824</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:RestructuringandRestructuringRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzExLTUtMS0xLTcwMzM0_6db5d9d2-5674-4c6b-84eb-2f601d4ded42">15,661</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digital transformation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:DigitalTransformationCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEyLTEtMS0xLTg5ODEx_f17aee80-a657-4919-9b82-e279ba5fb6f5">4,536</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:DigitalTransformationCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEyLTMtMS0xLTg5ODEx_30d21d34-4b8f-410e-92ba-c62dff108b61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:DigitalTransformationCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEyLTUtMS0xLTg5ODEx_97860d49-1749-4aba-9d3d-77e4794c9841">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDR and IVDR costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="hae:EuropeanMedicalDeviceRegulationCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEyLTEtMS0xLTcwMzM0_5b27d4ed-0470-48ec-b41b-1e532012a9cd">9,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="hae:EuropeanMedicalDeviceRegulationCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEyLTMtMS0xLTcwMzM0_9a318ece-a3d0-4a6a-b508-bbe6814fdfdc">11,033</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="hae:EuropeanMedicalDeviceRegulationCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEyLTUtMS0xLTcwMzM0_9e5f41d4-42aa-416e-bf69-1c197ad59e2f">4,130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEzLTEtMS0xLTcwMzM0_29fb1eeb-9ebb-45e4-8787-f171ca651e08">5,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEzLTMtMS0xLTcwMzM0_5770462b-5e27-47b2-badb-037d4086f597">1,368</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEzLTUtMS0xLTcwMzM0_99cc1b31-144f-4646-a35f-3bb87c83800b">897</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on divestitures and sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzE0LTEtMS0xLTcwMzM0_a708ef69-b9b7-43e9-870f-df078861595f">382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzE0LTMtMS0xLTcwMzM0_f9b30e6e-afa7-4ba2-973a-b1c4af23755e">9,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzE0LTUtMS0xLTcwMzM0_1dd90ce4-0a13-4704-8f04-e2e04c05a60c">32,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzE1LTEtMS0xLTcwMzM0_e49bce7c-30a0-4b26-a017-80f9445f0eb2">156,033</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzE1LTMtMS0xLTcwMzM0_56c7faa5-c513-40e8-842f-f4bb9cafba32">80,750</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzE1LTUtMS0xLTcwMzM0_08c97689-e974-4534-ba94-68ec8d1693d0">89,747</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.</span></div></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:59.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceda53e10aa943db9898cb8ab8dac15a_D20220403-20230401" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzItMS0xLTEtNzAzMzQ_9f194e72-39e2-4723-a4a3-ae5e6c6ac392">41,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic069cd0eb4c94953be95e2deb98ea5e5_D20210404-20220402" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzItMy0xLTEtNzAzMzQ_6efb55dc-a614-450e-b341-68a89830832c">28,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia79a8918d94541fbb215b791d3bc0308_D20200329-20210403" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzItNS0xLTEtNzAzMzQ_11cd9516-6917-4f02-8026-fc7fdc8f8388">24,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ffef01c50b40dcbbc6f463d67d82a6_D20220403-20230401" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzMtMS0xLTEtNzAzMzQ_0b703f93-fe1e-4ca0-b3fe-03e879e03317">13,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b364431a43245b7a9f05a60dc7416df_D20210404-20220402" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzMtMy0xLTEtNzAzMzQ_8898945c-6717-4b55-bbc9-120b24de8c18">32,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6794b0b382b4fb7886de74ba621481b_D20200329-20210403" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzMtNS0xLTEtNzAzMzQ_e8af99ff-da91-411c-b519-67439ce6b930">39,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i753483fb84d94062bdc30420838c80cf_D20220403-20230401" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzQtMS0xLTEtNzAzMzQ_890aada6-d65f-4f4a-8074-57b85d2657a4">37,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4e22f5dd7d46aab1223c60d287905f_D20210404-20220402" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzQtMy0xLTEtNzAzMzQ_4fbc9e99-766d-4617-93f9-b21c65ca2635">36,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e8e2ad8db6d4f6c859bc3263d7c9235_D20200329-20210403" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzQtNS0xLTEtNzAzMzQ_37bd1175-c76b-423e-941d-07aeb9ab0e74">20,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total depreciation and amortization (excluding impairment charges)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzUtMS0xLTEtNzAzMzQ_fa11d9bc-8020-4e62-ac0e-72ca1524ce23">93,307</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzUtMy0xLTEtNzAzMzQ_d8f99966-3e8d-4a0c-9ced-df33487b8103">97,747</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzUtNS0xLTEtNzAzMzQ_3de582a6-f8a5-4821-a8bf-9d8f90890804">84,287</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i84d1621154b048549d5d759bbec796ed"><ix:continuation id="i8b41c9c406c446559168d0ecdfb110aa"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890c831316434ae1b18be3b1ae53a567_I20230401" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzItMS0xLTEtNzAzMzQ_0c557ac9-83d1-42ae-96b8-ee38bcd91c42">202,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida4846630e6b4fe9abc8b036a5b0f2ca_I20220402" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzItMy0xLTEtNzAzMzQ_93940ffc-5742-4347-a61d-70d25f611ba7">129,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida09061210f544b39381b92caca71c36_I20230401" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzMtMS0xLTEtNzAzMzQ_0eb11922-4f29-46c9-a967-f6fc803dd760">68,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0134e8414f8c42618080f11b9286ca14_I20220402" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzMtMy0xLTEtNzAzMzQ_30480b97-d682-48b3-b8be-b408a33f3742">82,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728903670b674bc8867059c6c7f26220_I20230401" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzQtMS0xLTEtNzAzMzQ_a8b08589-3cf7-407a-ac13-3ea6eb1fa027">40,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5193ad1e9e4b4c359e874dfa2c7b2e29_I20220402" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzQtMy0xLTEtNzAzMzQ_c74cde99-4d46-450e-a763-57edc30f0c7d">46,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzUtMS0xLTEtNzAzMzQ_3fb9d4bd-e65c-4b80-bb79-31c4a8ecdd67">310,885</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzUtMy0xLTEtNzAzMzQ_c8562517-0941-485b-aaf8-d16bfe2df516">258,482</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Long-lived assets are comprised of property, plant and equipment.</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected information by operating regions is presented below:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273ad073c5694d79aed7c48a2228305a_I20230401" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzItMS0xLTEtNzAzMzQ_836661cb-bcbe-4a96-a95a-bf6c7335dc13">251,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b623f3420d9458a8f791677dd437cb4_I20220402" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzItMy0xLTEtNzAzMzQ_d971440f-4672-4677-be7c-01d3fb2199e9">200,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if43262ae4db34a16abb1b00f16706fe0_I20230401" decimals="-3" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzMtMS0xLTEtNzAzMzQ_f9e4579e-88fa-42dd-8810-d10e407f1fd2">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84ef4886d9b46769afc2d9cb8935627_I20220402" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzMtMy0xLTEtNzAzMzQ_6fe36737-1ed3-4f84-80e6-274b7a649211">1,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c825bc7a7b400ea37266ab846efd90_I20230401" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzQtMS0xLTEtNzAzMzQ_15ae29cc-2aa1-424b-aa74-d159a3636421">14,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7897fa4a6b84510a657a7bf9ba065f2_I20220402" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzQtMy0xLTEtNzAzMzQ_ac479eec-5085-4bbc-8941-f44d33acbf46">11,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94645cd7c7cb469aa8da2ab698ba7ca3_I20230401" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzUtMS0xLTEtNzAzMzQ_5de83a81-421b-48a4-8973-396c116be6a4">26,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b81c17ea1be415d9752a1ec535c0262_I20220402" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzUtMy0xLTEtNzAzMzQ_f75f8d37-2507-4b0c-b1a9-98f7998b7dbd">28,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f37dbe4585f4c288f1e4f7cbbe8a03e_I20230401" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzYtMS0xLTEtNzAzMzQ_faa438d2-2f06-4855-bba0-6c2608098140">17,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7b45150004748bb969ff69c5cac6d6d_I20220402" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzYtMy0xLTEtNzAzMzQ_1b85ab57-a219-49e6-8947-5e725941676d">16,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzctMS0xLTEtNzAzMzQ_c677ad82-56c8-4257-b467-7051800e74ec">310,885</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzctMy0xLTEtNzAzMzQ_76eb8520-c54a-4876-a273-388eeeed8723">258,482</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Long-lived assets are comprised of property, plant and equipment.</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658880d6f36c48ed97500e003792583f_D20220403-20230401" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzEtMS0xLTEtNzAzMzQ_80b83d0b-98b9-4f52-9566-0b7f9c47f421">842,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c3f7ebdb8d149b1991a542469a17c70_D20210404-20220402" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzEtMy0xLTEtNzAzMzQ_684d762e-ef60-4bca-999b-31915c3fb58a">639,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebc032eb54984b4da6020c485a1829e9_D20200329-20210403" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzEtNS0xLTEtNzAzMzQ_24548fdc-6b90-42dd-94db-24543dd5b88c">522,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib37801b66fa64a738f993541669fe76b_D20220403-20230401" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzItMS0xLTEtNzAzMzQ_b07d806d-c5ed-483c-8eb4-337cbd3d89a9">61,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied904893cdab40ac8e4ecf4261b0392c_D20210404-20220402" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzItMy0xLTEtNzAzMzQ_623d6f07-d899-4946-b50b-734f3c50ba81">75,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54c7a18fd41c4b87addd14329d3b8eb3_D20200329-20210403" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzItNS0xLTEtNzAzMzQ_95c8f740-3fe1-4cf7-92a6-2f950310cd1e">77,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6c260335fd4fb6951eb3d58718e908_D20220403-20230401" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzMtMS0xLTEtNzAzMzQ_8b2e011e-15b9-47d6-a60c-dedd7deb20b1">156,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437233f16d55490f81474cc61bd50d53_D20210404-20220402" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzMtMy0xLTEtNzAzMzQ_8a36f604-b6cf-4e82-b782-af1029e15767">163,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7abd5a64d44ec8be1482592153b618_D20200329-20210403" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzMtNS0xLTEtNzAzMzQ_18dfae70-aec2-4e1a-950d-4017afd84bfe">159,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0ea7f7a83854a4fb04976b762a1d6b4_D20220403-20230401" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzQtMS0xLTEtNzAzMzQ_c96aebd7-1ece-4a47-b6b9-e9da1022f1fd">104,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44db282af41942a9bc8bf049fea7b13c_D20210404-20220402" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzQtMy0xLTEtNzAzMzQ_0dcfb2ff-3dbc-4784-bbc4-72c347b2ee63">110,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3065d0c1ee844421ae0cb9af4f53bd46_D20200329-20210403" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzQtNS0xLTEtNzAzMzQ_7e1b9b1d-c2a2-4f26-8380-7152698f685c">105,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8760c4c6918543eabfca879c50151fc5_D20220403-20230401" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzUtMS0xLTEtNzAzMzQ_2fd785d3-e699-44a3-9084-c1bb54cb7ef3">3,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad75f10bcaa44d3870719c7728eee20_D20210404-20220402" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzUtMy0xLTEtNzAzMzQ_6ed90a67-b9be-4f3f-92cd-72dc117dc8c5">3,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2ca668eb57a4e6ea2aa6d35644cb889_D20200329-20210403" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzUtNS0xLTEtNzAzMzQ_9cabe911-1a95-4f1e-8008-0d124ef82275">5,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzYtMS0xLTEtNzAzMzQ_dc9bc66b-dbb4-4e5f-bab2-acb1dfc9c8ec">1,168,660</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzYtMy0xLTEtNzAzMzQ_238ada8d-2220-48c6-b425-8d0219138030">993,196</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzYtNS0xLTEtNzAzMzQ_0f8b7b73-5af9-49af-a78d-969f2302eb95">870,463</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews revenue based on the reportable segments noted above.&#160;Although these reportable segments are primarily product-based, they differ from the Company&#8217;s product line revenues for Plasma products and services and Blood Center products and services.&#160;Specifically, the Blood Center reportable segment includes plasma products utilized for collection in blood centers primarily for transfusion purposes.&#160;Additionally, product line revenues also include service revenues which are excluded from the reportable segments.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90ZXh0cmVnaW9uOjFmMmM0MTU1Y2YwMzQ4ZTE5YmJlMzBhM2Y1ODI3NmI1XzI1Nzg_1fa65f7d-dfff-441c-ac12-fa0012206eb0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues by product line are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:61.972%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.716%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.716%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.720%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma products and services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77e56895100346f8967a4f2f2f7478e9_D20220403-20230401" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzEtMS0xLTEtNzAzMzQ_4ae0aa75-8618-49a5-b937-d5ed3a5633e7">563,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbcb5690ee9e4cf58369fb43962e39d7_D20210404-20220402" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzEtMy0xLTEtNzAzMzQ_1bba2fb8-be1a-42e8-88fa-1c6a796ceda7">427,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie082775b703647d2a596091af2b69615_D20200329-20210403" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzEtNS0xLTEtNzAzMzQ_0747a6c4-45db-4cb6-b048-5918868cfe1a">414,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center products and services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie54d9c04734f4a3ca440be55cadea86d_D20220403-20230401" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzItMS0xLTEtNzAzMzQ_08fcc5f8-3a67-47ce-8e94-5685c965b1e2">226,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8b3574a63ea41058d11dde501f4dd4b_D20210404-20220402" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzItMy0xLTEtNzAzMzQ_382c84d0-3e30-4954-abc1-ed19758a1707">236,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57d49f4f72de40b6b6dcbc6a662b5afe_D20200329-20210403" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzItNS0xLTEtNzAzMzQ_5e89630b-bc7c-4220-87e9-d419bd83a310">239,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital products and services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i831da503c99a4196bacf1bd7aaa8e97c_D20220403-20230401" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzMtMS0xLTEtNzAzMzQ_26ce98c7-0acb-48f0-845c-b8de5fbc28b8">378,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba74e960f8174b6eb6f8237d8ec75488_D20210404-20220402" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzMtMy0xLTEtNzAzMzQ_6d097f31-8298-4a1f-8b69-9b10045da37e">329,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibadbeb7294884727ba79dd447d78e637_D20200329-20210403" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzMtNS0xLTEtNzAzMzQ_749d324a-e468-4b49-90ff-bee533eca234">216,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzQtMS0xLTEtNzAzMzQ_7fa9a88f-5119-4653-99c8-b753dda4f37a">1,168,660</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzQtMy0xLTEtNzAzMzQ_e62961c5-d66c-43d0-9964-b4bcd9abebad">993,196</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzQtNS0xLTEtNzAzMzQ_d0e60f58-55cb-48ad-865d-0b9791b7b88b">870,463</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_151"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS&#160;&#8212;&#160;(Continued)</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19. <ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90ZXh0cmVnaW9uOjQ5Mzk5NGMwMDU3YzRiYTY5NzY5NjY3Yzk4YWVlOGQ1XzE4Nw_20c207d2-f486-4bcc-85f1-af707a927965" continuedAt="id34f3146a406405ea840f357dc68ba49" escape="true">ACCUMULATED OTHER COMPREHENSIVE LOSS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id34f3146a406405ea840f357dc68ba49"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90ZXh0cmVnaW9uOjQ5Mzk5NGMwMDU3YzRiYTY5NzY5NjY3Yzk4YWVlOGQ1XzE4NQ_1d540fee-6bd9-4d39-9ade-89324fc38685" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll-forward of the components of accumulated other comprehensive loss, net of tax, for the years ended April&#160;1, 2023 and April&#160;2, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:46.623%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined benefit plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Unrealized Gain (Loss) on Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, April 3, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d9aaac5c08240e7ac639d3d9318182d_I20210403" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzEtMi0xLTEtNzAzMzQ_dfd29e12-4e73-474e-974f-0935d711829e">21,528</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20163d468f534459b8f5e133c39e76bc_I20210403" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzEtNC0xLTEtNzAzMzQ_41b385fb-a6cb-47cb-a5ff-d18626d68556">560</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i258a2ee961ae4548a116f4702808d630_I20210403" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzEtNi0xLTEtNzAzMzQ_982befb9-dcb6-47ef-b071-ba8ae643a985">7,459</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzEtOC0xLTEtNzAzMzQ_7c028e5b-f7b3-45f8-9f91-898eb2fa0ba9">29,547</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9661b76a961497bbfd87ed0b21aa594_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzItMi0xLTEtNzAzMzQ_2a14fd48-6e04-4f7c-be99-5750a65e158c">6,391</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8f263a99854b0f83abe062df3af1a2_D20210404-20220402" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzItNC0xLTEtNzAzMzQ_73ccf0af-f433-4a9f-b04e-549369e1a602">2,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e8bc4e14d294ed18a1106b9bfecc30d_D20210404-20220402" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzItNi0xLTEtNzAzMzQ_a45c5398-4b02-4825-a468-a2b7be012c2d">5,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzItOC0xLTEtNzAzMzQ_b7884643-abfe-4f10-af1e-0cb09ba09057">1,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive gain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9661b76a961497bbfd87ed0b21aa594_D20210404-20220402" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzMtMi0xLTEtNzAzMzQ_704dd97b-5686-4dff-b2d2-2aef5dfe362d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8f263a99854b0f83abe062df3af1a2_D20210404-20220402" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzMtNC0xLTEtNzAzMzQ_703ec232-2d65-4634-95b9-b5527fa6bf96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e8bc4e14d294ed18a1106b9bfecc30d_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzMtNi0xLTEtNzAzMzQ_bd16f397-2250-43ad-a896-d43041c69cef">2,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzMtOC0xLTEtNzAzMzQ_82968885-d495-4aa2-9c6a-f8e9b737326c">2,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9661b76a961497bbfd87ed0b21aa594_D20210404-20220402" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzQtMi0xLTEtNzAzMzQ_d3d6c12e-47d7-4f0e-8b6a-b78b60a9566a">6,391</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8f263a99854b0f83abe062df3af1a2_D20210404-20220402" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzQtNC0xLTEtNzAzMzQ_f684093c-aad7-4cf5-b591-5ae9d3dd1d7d">2,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e8bc4e14d294ed18a1106b9bfecc30d_D20210404-20220402" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzQtNi0xLTEtNzAzMzQ_5d326671-6dfd-4e19-a64c-065740203fbc">7,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzQtOC0xLTEtNzAzMzQ_317cf17b-68bd-4829-b568-b1b131afbb96">3,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, April 2, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie871fb22a3cf4c40ae275a678c22a4c6_I20220402" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzUtMi0xLTEtNzAzMzQ_cc7d8c90-f84f-4e99-a0a0-00dae6764841">27,919</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i212720196aab4e27b97320442307e199_I20220402" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzUtNC0xLTEtNzAzMzQ_7cbbe36a-e9f4-49cd-9cce-c9a5dc2d8a14">1,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f4e6fa1de00426ba9dc50efcffee0dd_I20220402" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzUtNi0xLTEtNzAzMzQ_762a3cda-9a62-4bc8-bc09-fe18f4bf9ccd">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzUtOC0xLTEtNzAzMzQ_53419278-8ed4-4684-8515-5c7bf1a594de">25,954</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8ff71c228644456aa078f7b405de97b_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzYtMi0xLTEtNzAzMzQ_24c2fb64-3011-4e7f-b1ed-d34e35dcf8f1">6,016</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4888ce624cf2491996b6ac5702a159b1_D20220403-20230401" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzYtNC0xLTEtNzAzMzQ_a13c8bd3-aa1c-4dfd-8365-2e4e3091f244">2,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie331660e8b3c4a1d855c3ea8e8032707_D20220403-20230401" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzYtNi0xLTEtNzAzMzQ_94759783-c5ad-4ca6-9f38-939a7f7a56ac">4,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzYtOC0xLTEtNzAzMzQ_3b3a2cbe-935f-4e32-a1ee-d9925f7d88b8">709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive gain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ff71c228644456aa078f7b405de97b_D20220403-20230401" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzctMi0xLTEtNzAzMzQ_78591574-3982-450b-a666-0673b39cf595">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4888ce624cf2491996b6ac5702a159b1_D20220403-20230401" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzctNC0xLTEtNzAzMzQ_9f7e6c48-a756-4261-8f29-0030beddf93e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie331660e8b3c4a1d855c3ea8e8032707_D20220403-20230401" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzctNi0xLTEtNzAzMzQ_84535cc0-2dda-4baf-b8a0-c4213e77429c">5,136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzctOC0xLTEtNzAzMzQ_4ebf390b-21ae-4295-84b9-8c42ceb624f4">5,136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8ff71c228644456aa078f7b405de97b_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzgtMi0xLTEtNzAzMzQ_53652ffb-dac3-4cc0-a0d8-75f6ed5b3aa4">6,016</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4888ce624cf2491996b6ac5702a159b1_D20220403-20230401" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzgtNC0xLTEtNzAzMzQ_da151c6b-2412-485f-827a-535fedf0eced">2,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie331660e8b3c4a1d855c3ea8e8032707_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzgtNi0xLTEtNzAzMzQ_61df5411-d37f-4501-858e-20a120cef5a8">867</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzgtOC0xLTEtNzAzMzQ_44f38c40-23b3-4b2b-b2f5-1ab91e3d80c6">4,427</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93a31928c3f04bbe9786669a94886e63_I20230401" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzktMi0xLTEtNzAzMzQ_44983278-a943-4097-bc4d-018a27b6c41f">33,935</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31840d7f9a0f42fb8999b7022a505464_I20230401" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzktNC0xLTEtNzAzMzQ_84cb6e7f-64ef-4bb9-b9c3-df959ec7bff2">4,075</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7b16ebd9bdb4cd58a89613d51ab905e_I20230401" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzktNi0xLTEtNzAzMzQ_15fda8b3-f96e-4ad6-a457-13e7a395172c">521</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzktOC0xLTEtNzAzMzQ_d76ac699-81e7-4240-9a77-6a789e1db715">30,381</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Presented net of income taxes, the amounts of which are insignificant.</span></div></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_154"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_157"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A. CONTROLS AND PROCEDURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the end of the period covered by this report, we conducted an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer (our principal executive officer and principal financial officer, respectively) regarding the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule&#160;13a-15 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;). Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of that date, our disclosure controls and procedures were effective.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reports on Internal Control</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Management&#8217;s Annual Report on Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f). The Company&#8217;s internal control system was designed to provide reasonable assurance to the Company&#8217;s management and Board of Directors regarding the preparation and fair presentation of published financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management assessed the effectiveness of its internal control over financial reporting as of April&#160;1, 2023. In making this assessment, the management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework (2013 framework). Based on our assessment, the Company&#8217;s management believes that its internal controls over financial reporting were effective as of April&#160;1, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst&#160;&amp; Young, LLP, an independent registered public accounting firm, has issued an attestation report on the effectiveness of our internal control over financial reporting. This report, in which they expressed an unqualified opinion, is included below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Controls</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting during the quarter ended April&#160;1, 2023 that have materially affected, or are likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and Board of Directors of Haemonetics Corporation</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Haemonetics Corporation and subsidiaries&#8217; internal control over financial reporting as of April 1, 2023, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Haemonetics Corporation and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of April 1, 2023, based on</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the COSO criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the 2023 consolidated financial statements of the Company and our report dated May 22, 2023 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;22, 2023</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_160"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B. OTHER INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_163"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_166"></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;III</span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_169"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a Code of Ethics that applies to our Chief Executive Officer, Chief Financial Officer and senior financial officers. The Code of Ethics is incorporated into the Company&#8217;s Code of Conduct located on the Company&#8217;s website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.haemonetics.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under the &#8220;Investor Relations&#8221; caption and under the &#8220;Corporate Governance&#8221; sub-caption. A copy of the Code of Conduct will be provided free of charge by making a written request and mailing it to our corporate headquarters offices to the attention of our Investor Relations Department. Any amendments to, or waivers from, a provision of our Code of Ethics that applies to our Chief Executive Officer, Chief Financial Officer or senior financial officers will be disclosed on the Company&#8217;s website promptly following the date of such amendment or waiver.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The additional information required by this item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of shareholders to be filed with the Securities and Exchange Commission within 120 days after the close of our fiscal year.</span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_172"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11. EXECUTIVE COMPENSATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of shareholders to be filed with the Securities and Exchange Commission within 120 days after the close of our fiscal year. Notwithstanding the foregoing, the Compensation Committee Report included within the Proxy Statement is only being &#8220;furnished&#8221; hereunder and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934.</span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_175"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of shareholders to be filed with the Securities and Exchange Commission within 120 days after the close of our fiscal year.</span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_178"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of shareholders to be filed with the Securities and Exchange Commission within 120 days after the close of our fiscal year.</span></div><div><span><br/></span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_181"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of shareholders to be filed with the Securities and Exchange Commission within 120 days after the close of our fiscal year.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_184"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;IV</span></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_187"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed as a part of this report:</span></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.45pt">Financial Statements are included in Part&#160;II of this report</span></div><div style="margin-top:7pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statements required by Item&#160;8 of this Form</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_70">Report of Independent Registered Public Accounting Firm (PCAOB ID </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xODcvZnJhZzo1OTZjODBkMWJkZmY0YjVhYTFkNDQ0N2NjNDI2YTczZS90YWJsZTo0MTJkYjQ4NjFhNTg0ZDA5OGQwZjc3M2M3YjE3ZmM1MC90YWJsZXJhbmdlOjQxMmRiNDg2MWE1ODRkMDk4ZDBmNzczYzdiMTdmYzUwXzEtMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjo4NDY5Nzk4YmRmZWE0ZjVkODllZDllMTA1M2RkZDlkY183MA_b73c1d8b-2060-4269-b47b-6314a7e06d44">42</ix:nonNumeric></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_70">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_70">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_76">Consolidated Statements of Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_76">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_79">Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_79">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_82">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_82">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_85">Consolidated Statements of Stockholders&#8217; Equ</a>ity</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_85">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_88">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_88">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_91">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_91">52</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other schedules have been omitted because they are not applicable or not required.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt">Exhibits required by Item&#160;601 of Regulation&#160;S-K are listed in the Exhibit&#160;Index beginning at page&#160;100, which is incorporated herein by reference.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_190"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:13pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBITS&#160;FILED WITH SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number and Description of Exhibit</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.&#160;&#160;Articles of Organization</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314319000035/exhibit31-restatedarticles.htm">3A</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restated Articles of Organization of Haemonetics Corporation, reflecting Articles of Amendment dated August 23, 1993, August 21, 2006, July 26, 2018 and July 25, 2019 (filed as Exhibit 3.1 to the Company&#8217;s Form 8-K dated July 29, 2019 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314320000052/by-lawsasamended62920.htm">3B</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By-Laws of the Company, as amended through June 29, 2020 (filed as Exhibit 3.1 to the Company&#8217;s Form 8-K dated June 30, 2020 and incorporated herein by reference).</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.&#160;&#160;Instruments Defining the Rights of Security Holders</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specimen certificate for shares of common stock (filed as Exhibit&#160;4B to the Company&#8217;s Amendment No.&#160;1 to Form&#160;S-1 No.&#160;33-39490 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314320000028/fy2020exh4b.htm">4B</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description of Common Stock (filed as Exhibit 4B to the Company&#8217;s Form 10-K for the fiscal year ended March 28, 2020 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000110465921032760/tm218226d4_ex4-1.htm">4C</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated as of March 5, 2021, between Haemonetics Corporation and U.S. Bank National Association, as trustee (filed as Exhibit 4.1 to the Company&#8217;s Form 8-K dated March 5, 2021 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000110465921032760/tm218226d4_ex4-1.htm">4D</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of certificate representing the 0.00% Convertible Senior Notes due 2026 (included as Exhibit A to Exhibit 4D) (filed as Exhibit 4.2 to the Company&#8217;s Form 8-K dated March 5, 2021 and incorporated herein by reference).</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.&#160;&#160;Material Contracts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314314000086/a2005long-termincentivepla.htm">10A</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan, reflecting amendments dated July 31, 2008, July 29, 2009, July 21, 2011, November 30, 2012, July 24, 2013, January 21, 2014, and July 23, 2014 (filed as Exhibit 10.1 to the Company&#8217;s Form 8-K dated July 25, 2014 and incorporated herein by reference) (1).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314319000035/exhibit101-2019plan.htm">10B</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan (filed as Exhibit 10.1 to the Company&#8217;s Form 8-K dated July 29, 2019 and incorporated herein by reference) (1).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000095012310054652/b80592exv10ws.htm">10C</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Form of Non-Qualified Stock Option Award Agreement under 2005 Long-Term Incentive Compensation Plan for Employees (filed as Exhibit 10S to the Company&#8217;s Form 10-K for the fiscal year ended March 30, 2010 and incorporated herein by reference) (1).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314318000052/haeq1jun2019ex102.htm">10D</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Form of Non-Qualified Stock Option Award Agreement under 2005 Long-Term Incentive Compensation Plan for Employees (adopted fiscal 2019) (filed as Exhibit 10.2 to the Company&#8217;s Form 10-Q for the quarter ended June 30, 2018 and incorporated herein by reference) (1).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314319000053/haeq2sep2020ex104.htm">10E</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Form of Non-Qualified Stock Option Award Agreement under 2019 Long-Term Incentive Compensation Plan (adopted fiscal 2020) (filed as Exhibit 10.4 to the Company&#8217;s Form 10-Q for the quarter ended September 28, 2019 and incorporated herein by reference) (1).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314319000053/haeq2sep2020ex102.htm">10F</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Form of Restricted Stock Unit Award Agreement with Non-Employee Directors under 2019 Long-Term Incentive Compensation Plan (fiscal 2020) (filed as Exhibit&#160;10.2 to the Company&#8217;s Form&#160;10-Q for the quarter ended September 28, 2019 and incorporated herein by reference) (1).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314319000053/haeq2sep2020ex103.htm">10G</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Form of Restricted Stock Unit Award Agreement with Employees under 2019 Long-Term Incentive Compensation Plan (adopted fiscal 2020) (filed as Exhibit&#160;10.3 to the Company&#8217;s Form&#160;10-Q for the quarter ended September 28, 2019 and incorporated herein by reference) (1).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314319000053/haeq2sep2020ex105.htm">10H</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Form of Performance Share Unit Award Agreement Under 2019 Long-Term Incentive Compensation Plan (rTSR Metrics, adopted fiscal 2020) (filed herewith as Exhibit 10.5 to the Company&#8217;s Form 10-Q for the quarter ended September 28, 2019 and incorporated herein by reference) (1).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314316000143/haeq1jun2017ex102.htm">10I</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Amended and Restated 2007 Employee Stock Purchase Plan (as amended and restated on July 21, 2016 incorporated as Exhibit 10.2 to the Company&#8217;s Form 10-Q, for the quarter ended July 2, 2016 and incorporated herein by reference) (1).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314316000123/exhibit101haemonetics-simo.htm">10J</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Employment Agreement effective as of May 16, 2016 between the Company and Christopher A. Simon (filed as Exhibit 10.1 to the Company&#8217;s Form 8-K dated May 10, 2016 and incorporated herein by reference) (1).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314317000044/haeq2sep2018ex104.htm">10K</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Executive Severance Agreement between the Company and Christopher A. Simon dated as of November 7, 2017 (filed as Exhibit 10.4 to the Company&#8217;s Form 10-Q dated for the quarter ended September 30, 2017 and incorporated herein by reference) (1).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314317000044/haeq2sep2018ex105.htm">10L</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Change in Control Agreement between the Company and Christopher A. Simon dated as of November 7, 2017 (filed as Exhibit 10.5 to the Company&#8217;s Form 10-Q dated for the quarter ended September 30, 2017 and incorporated herein by reference) (1).</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314317000044/haeq2sep2018ex102.htm">10M</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Form of Executive Severance Agreement between the Company and executive officers other than Christopher A. Simon (filed as Exhibit 10.2 to the Company&#8217;s Form 10-Q for the quarter ended September 30, 2017 and incorporated herein by reference) (1).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314317000044/haeq2sep2018ex103.htm">10N</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Form of Change in Control Agreement between the Company and executive officers other than Christopher A. Simon (filed as Exhibit 10.3 to the Company&#8217;s Form 10-Q for the quarter ended September 30, 2017 and incorporated herein by reference) (1).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314319000010/exhibit101.htm">10O</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Haemonetics Corporation Worldwide Employee Bonus Plan (as amended and restated effective April 23, 2019) (filed as Exhibit 10.1 to the Company&#8217;s Form 8-K dated April 29, 2019 and incorporated herein by reference) (1).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314322000008/exhibit102-cfotransitionag.htm">10P</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">CFO Retention and Transition Agreement, dated as of November 8, 2021, by and between the Company and William P. Burke (filed as Exhibit 10.2 to the Company&#8217;s Form 10-Q for the quarter ended January 1, 2022 and incorporated herein by reference) (1).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314318000058/haeq2sep2019ex101.htm">10Q</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Indemnification Agreement (as executed with each director and executive officer of the Company) (filed as Exhibit 10.1 to the Company&#8217;s Form 10-Q for the quarter ended September 29, 2018 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314319000007/haeq3dec2019ex101.htm">10R</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office Lease Agreement, dated as of December 18, 2018, by and between OPG 125 Summer Owner (DE) LLC and the Company (filed as Exhibit 10.1 to the Company&#8217;s Form 10-Q for the quarter ended December 29, 2018 and incorporated herein by reference) (2).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314320000065/ex101toform10-qq1offis.htm">10S</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrial Lease Agreement, dated as of May 22, 2020, by and between Clinton Commerce III, LLC and the Company (filed as Exhibit 10.1 to the Company&#8217;s Form 10-Q for the quarter ended June 27, 2020 and incorporated herein by reference) (3).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314321000010/ex101-firstamendmenttoclin.htm">10T</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment to Industrial Lease Agreement, dated as of October 1, 2020, by and between Clinton Commerce III, LLC and the Company (filed as Exhibit 10.1 to the Company&#8217;s Form 10-Q for the quarter ended December 26, 2020 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314313000085/a10jleasebbva_ensatec2x21x.htm">10U</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease dated February 21, 2000 between BBVA Bancomer Servicios, S.A., as Trustee of the &#8220;Submetropoli de Tijuana&#8221; Trust and Haemonetics Mexico Manufacturing, S. de R.L. de C.V., as successor in interest to Ensatec, S.A. de C.V. with authorization of El Florido California, S.A. de C.V., for property located in Tijuana, Mexico (filed as Exhibit 10J to the Company&#8217;s Form 10-K for the year ended March 30, 2013 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314313000085/a10kbbvaensatec11730tijuan.htm">10V</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Lease dated February 21, 2000 made as of July 25, 2008 between BBVA Bancomer Servicios, S.A., as Trustee of the &#8220;Submetropoli de Tijuana&#8221; Trust Haemonetics Mexico Manufacturing, S. de R.L. de C.V., as successor in interest to Ensatec, S.A. de C.V., for property located in Tijuana, Mexico (filed as Exhibit 10K to the Company&#8217;s Form 10-K for the year ended March 30, 2013 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314313000085/a10lextleasefeb212000ensat.htm">10W</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extension to Lease dated February 21, 2000, made as of August 14, 2011 between PROCADEF 1, S.A.P.I. de C.V. and Haemonetics Mexico Manufacturing, S. de R.L. de C.V., as successor in interest to Ensatec, S.A. de C.V., for property located in Tijuana, Mexico (Spanish to English translation filed as Exhibit 10L to the Company&#8217;s Form 10-K for the year ended March 30, 2013 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314313000085/a10mbbvaletteragreeaug1420.htm">10X</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment Letter to Lease dated February 21, 2000, made as of August 14, 2011 between BBVA Bancomer Servicios, S.A., as Trustee of the &#8220;Submetropoli de Tijuana&#8221; Trust and Haemonetics Mexico Manufacturing, S. de R.L. de C.V., as successor in interest to Ensatec, S.A. de C.V., for property located in Tijuana, Mexico (filed as Exhibit 10M to the Company&#8217;s Form 10-K for the year ended March 30, 2013 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314313000085/a10n11730tijuianaletterfeb.htm">10Y</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notice of Assignment to Lease dated February 21, 2000, made as of February 23, 2012 between BBVA Bancomer Servicios, S.A., as Trustee of the &#8220;Submetropoli de Tijuana&#8221; Trust and Haemonetics Mexico Manufacturing, S. de R.L. de C.V., as successor in interest to Ensatec, S.A. de C.V. for property located in Tijuana, Mexico (Spanish to English translation filed as Exhibit 10N to the Company&#8217;s Form 10-K for the year ended March 30, 2013 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314318000020/fy2018exh10r.htm">10Z</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Lease dated February 21, 2000 made as of January 1, 2018 between MEGA2013, S.A.P.I. de CV (as successor in interest to BBVA Bancomer Servicios, S.A., as Trustee of the &#8220;Submetropoli de Tijuana&#8221; Trust) and Haemonetics Mexico Manufacturing, S. de R.L. de C.V., as successor in interest to Ensatec, S.A. de C.V., for property located in Tijuana, Mexico (filed as Exhibit 10R to the Company&#8217;s Form 10-K for the year ended March 31, 2018 and incorporated herein by reference).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314313000085/a10wcolungaleaseagreedec32.htm">10AA</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease Agreement effective December 3, 2007 between Mrs. Blanca Estela Colunga Santelices, by her own right, and Pall Life Sciences Mexico, S.de R.L. de C.V. for the property located in Tijuana, Mexico (Spanish to English translation filed as Exhibit&#160;10W to the Company&#8217;s Form&#160;10-K for the year ended March&#160;30, 2013 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314313000085/a10xcolungaassignleasedec2.htm">10AB</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assignment to Lease Agreement effective December 3, 2007, made as of December 2, 2011 between Mrs. Blanca Estela Colunga Santelices, by her own right, Pall Life Sciences Mexico, S.de R.L. de C.V., (&#8220;Assignor&#8221;) and Haemonetics Mexico Manufacturing, S. de R.L. de C.V.as successor in interest to Pall Mexico Manufacturing S. de R.L. de C.V., (&#8220;Assignee&#8221;) assigned in favor of the property located in Tijuana, Mexico (filed as Exhibit&#160;10X to the Company&#8217;s Form&#160;10-K for the year ended March&#160;30, 2013 and incorporated herein by reference).</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314318000020/fy2018exh10u.htm">10AC</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Lease Agreement effective December 3, 2007, made in 2017 between Mrs. Blanca Estela Colunga Santelices, by her own right, Pall Life Sciences Mexico, S.de R.L. de C.V. (&#8220;Assignor&#8221;) and Haemonetics Mexico Manufacturing, S. de R.L. de C.V. as successor in interest to Pall Mexico Manufacturing S. de R.L. de C.V., (&#8220;Assignee&#8221;) assigned in favor of the property located in Tijuana, Mexico  (filed as Exhibit 10U to the Company&#8217;s Form 10-K for the year ended March 31, 2018 and incorporated herein by reference).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314322000052/haeq1june2022ex101.htm">10AD</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Amendment to Lease Agreement effective December 3, 2007, made as of June 17, 2022 between Mrs. Blanca Estela Colunga Santelices and Haemonetics Mexico Manufacturing, S. de R.L. de C.V. (filed as Exhibit 10.1 to the Company&#8217;s Form 10-Q for the quarter ended July 2, 2022 and incorporated herein by reference) (3).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314314000097/haeq1june2015exhibit10dpen.htm">10AE</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease dated September 19, 2013 between the Penang Development Corporation and Haemonetics Malaysia Sdn Bhd of the property located in Penang, Malaysia (filed as Exhibit 10D to the Company&#8217;s 10-Q for the quarter ended June 28, 2014 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001520325/000119312521001047/d833938dex1023.htm">10AF</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shelter Plan Service Agreement, dated June 10, 2014, by and between Cardiva Medical, Inc. and Offshore International, Incorporated (filed as Exhibit 10.23 to Cardiva Medical, Inc.&#8217;s Form S-1 (File No. 333-251885) dated January 4, 2021 and incorporated herein by reference) (3).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1520325/000119312521001047/d833938dex1023.htm">10AG</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 1 to Shelter Plan Service Agreement dated June 10, 2014, by and between Cardiva Medical, Inc. and Offshore International, Incorporated, dated as of October 30, 2019 (filed as Exhibit 10.23 to Cardiva Medical, Inc.&#8217;s Form S-1 (File No. 333-251885) dated January 4, 2021 and incorporated herein by reference) (3).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314322000061/haefy23q2ex102.htm">10AH</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 2 to Shelter Plan Service Agreement dated June 10, 2014, by and between Cardiva Medical, Inc. and Offshore International, Incorporated, dated as of August 3, 2022 (filed as Exhibit 10.2 to the Company&#8217;s Form 10-Q for the quarter ended October 1, 2022 and incorporated herein by reference) (3).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314322000042/ex1012022arcreditagreement.htm">10AI</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Credit Agreement, dated as of July 26, 2022, by and among the Company, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent (filed as Exhibit 10.1 to the Company&#8217;s Form 8-K dated August 1, 2022 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000110465921032760/tm218226d4_ex10-1.htm">10AJ</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Confirmation of Call Option Transaction (filed as Exhibit 10.1 to the Company&#8217;s Form 8-K dated as of March 5, 2021 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000110465921037152/tm219747d1_ex10-1.htm">10AK</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Confirmation of Additional Call Option Transaction (filed as Exhibit 10.1 to the Company&#8217;s Form 8-K dated as of March 16, 2021 and incorporated herein by reference).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/313143/000031314321000010/ex104-agreementandplanofme.htm">10AL</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated as of January 17, 2021, by and among the Company, Concordia Merger Sub, Inc., Cardiva Medical, Inc. and Fortis Advisors LLC, as the Seller Representative (filed as Exhibit 10.4 to the Company&#8217;s 10-Q for the quarter ended December 26, 2020 and incorporated herein by reference) (3).</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4. Subsidiaries Certifications and Consents</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy2023ex211.htm">21.1*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsidiaries of the Company.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy2023ex231.htm">23.1*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of the Independent Registered Public Accounting Firm.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy2023ex311.htm">31.1*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification pursuant to Section&#160;302 of Sarbanes-Oxley Act of 2002, of Christopher A. Simon, President and Chief Executive Officer of the Company.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy2023ex312.htm">31.2*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification pursuant to Section&#160;302 of Sarbanes-Oxley of 2002 of James D'Arecca, Executive Vice President, Chief Financial Officer of the Company.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy2023ex321.htm">32.1**</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification Pursuant to 18 United States Code Section&#160;1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of Christopher A. Simon, President and Chief Executive Officer of the Company.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy2023ex322.htm">32.2**</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification Pursuant to 18 United States Code Section&#160;1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of James D'Arecca, Executive Vice President, Chief Financial Officer of the Company.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from Haemonetics Corporation on Form&#160;10-K for the year ended April 1, 2023, formatted in inline Extensible Business Reporting Language (XBRL) includes: (i)&#160;Consolidated Statements of Income, (ii)&#160;Consolidated Statements of Comprehensive Income, (iii) Consolidated Balance Sheets, (iv)&#160;Consolidated Statement of Stockholders' Equity, (v) Consolidated Statements of Cash Flows, and (vi)&#160;Notes to Consolidated Financial Statements.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Document filed with this report.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Document furnished with this report.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agreement, plan, or arrangement related to the compensation of officers or directors.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidential treatment has been requested as to portions of the exhibit. Confidential materials omitted and filed separately with the Securities and Exchange Commission.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain portions of this exhibit are considered confidential and have been omitted as permitted under Securities and Exchange Commission rules and regulations.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><div id="ia9c9dcfe45534d5b96005ebe816d5e7b_193"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia9c9dcfe45534d5b96005ebe816d5e7b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:48.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HAEMONETICS CORPORATION</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christopher A. Simon</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher A. Simon</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, Chief Executive Officer and a Director</span></td></tr></table></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: May 22, 2023</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.</span></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.75pt"><tr><td style="width:1.0pt"></td><td style="width:154.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:274.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:69.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christopher A. Simon</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, Chief Executive Officer and a Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 22, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher A. Simon</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James C. D&#8217;Arecca</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 22, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James C. D&#8217;Arecca</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Maryanne E. Farris</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Chief Accounting Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 22, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryanne E. Farris</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Robert E. Abernathy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 22, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert E. Abernathy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Catherine M. Burzik</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 22, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catherine M. Burzik</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael J. Coyle</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 22, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. Coyle</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Charles J. Dockendorff</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 22, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles J. Dockendorff</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Lloyd E. Johnson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 22, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lloyd E. Johnson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mark W. Kroll</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 22, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark W. Kroll</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Claire Pomeroy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 22, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claire Pomeroy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ellen M. Zane</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 22, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ellen M. Zane</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>fy2023ex211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iecaeb023ee6244d5ac5a247a69a14003_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 21.1 - Subsidiaries of the Company</font></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.935%"><tr><td style="width:1.0%"></td><td style="width:52.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.328%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Subsidiary of Haemonetics Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Jurisdiction of Incorporation or Organization</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5D Information Management, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Arryx, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cardiva Medical, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Enicor GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Global Med Technologies, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Colorado</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics (Hong Kong) Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Asia Incorporated</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Asia UK Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Australia PTY Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Victoria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics BV</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Canada Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">British Columbia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics CZ, spol. s.r.o.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Czech Republic</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics France S.a.r.l</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Handelsgesellschaft m.b.H.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Healthcare India Private Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Hospitalar EIRELI</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics International Finance S.a.r.l.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics International Holdings GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Italia s.r.l.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Japan GK</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Korea, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Seoul, Korea</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Malaysia Sdn. Bhd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Malaysia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Manufacturing, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics (Shanghai) Management Co. Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Shanghai,China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Mexico Manufacturing, S.de R.L. de C.V.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics New Zealand Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">New Zealand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics S.A.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Scandinavia AB</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemonetics Singapore Pte. Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Haemoscope Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr></table></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>fy2023ex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i288a787743aa4ff5875621915e8722c8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)  Registration Statement (Form S-8 No. 333-232899), pertaining to the 2019 Long-Term Incentive Compensation Plan of Haemonetics Corporation&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)  Registration Statement (Form S-8 No. 333-222877), pertaining to the 2007 Employee Stock Purchase Plan of Haemonetics Corporation&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)  Registration Statement (Form S-8 No. 333-200226), pertaining to the 2005 Long-Term Incentive Compensation Plan of Haemonetics Corporation, as amended by that certain Post-Effective Amendment No. 1 to the Registration Statement (No. 333-200226)&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)  Registration Statement (Form S-8 No. 333-181847), pertaining to the 2005 Long-Term Incentive Compensation Plan of Haemonetics Corporation&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)  Registration Statement (Form S-8 No. 333-159434), pertaining to the 2005 Long-Term Incentive Compensation Plan of Haemonetics Corporation&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)  Registration Statement (Form S-8 No. 333-149205), pertaining to the 2007 Employee Stock Purchase Plan of Haemonetics Corporation&#59; and </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)  Registration Statement (Form S-8 No. 333-136839), pertaining to the 2005 Long-Term Incentive Compensation Plan of Haemonetics Corporation&#59;</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our reports dated May&#160;22, 2023, with respect to the consolidated financial statements of Haemonetics Corporation and the effectiveness of internal control over financial reporting of Haemonetics Corporation included in this Annual Report (Form 10-K) of Haemonetics Corporation for the fiscal year ended April&#160;1, 2023.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;22, 2023</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>fy2023ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i0443ca4322de4d55ba1fe6e2ebbca875_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.1</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christopher A. Simon, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of Haemonetics Corporation&#59; </font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt"> Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May 22, 2023 </font></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:39.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher A. Simon</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher A. Simon, President and Chief Executive Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>fy2023ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ifa75802b206841849d8a8acc44f0cb6a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.2</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, James D'Arecca, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of Haemonetics Corporation&#59; </font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt"> Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May 22, 2023 </font></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; James D'Arecca</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James D'Arecca, Executive Vice President, Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>fy2023ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id2caccd39923442cb09fe8fd2f4ff061_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification Pursuant To</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 USC. Section&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As Adopted Pursuant To</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;906 of the Sarbanes&#47;Oxley Act of 2002</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of Haemonetics Corporation (the &#8220;Company&#8221;) on Form 10-K for the period ended April&#160;1, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Christopher A. Simon, President and Chief Executive Officer of the Company, certify, pursuant to Section&#160;1350 of Chapter&#160;63 of Title 18, United States Code, that this Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May 22, 2023 </font></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.477%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.297%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher A. Simon</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher A. Simon,&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer<br>(Principal Executive Officer)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-top:1pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section&#160;906, has been provided to Haemonetics and will be retained by Haemonetics and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>fy2023ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i820686509529468eb034078b78746eb1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.2</font></div><div style="margin-top:12pt;text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification Pursuant To</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 USC. Section&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As Adopted Pursuant To</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;906 of the Sarbanes&#47;Oxley Act of 2002</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of Haemonetics Corporation (the &#8220;Company&#8221;) on Form 10-K for the period ended April&#160;1, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, James D'Arecca, Chief Financial Officer and Executive Vice President of the Company, certify, pursuant to Section&#160;1350 of Chapter&#160;63 of Title 18, United States Code, that this Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May 22, 2023 </font></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.759%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; James D'Arecca</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James D'Arecca, Executive Vice President, Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-top:1pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section&#160;906, has been provided to Haemonetics and will be retained by Haemonetics and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>hae-20230401.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d8e9c074-6bb3-481a-a40c-b4f91e1c5276,g:f0cc1f72-36f0-46b0-9a43-9e0dba51bc09-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hae="http://www.haemonetics.com/20230401" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.haemonetics.com/20230401">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hae-20230401_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hae-20230401_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hae-20230401_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hae-20230401_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DOCUMENTANDENTITYINFORMATION" roleURI="http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION">
        <link:definition>0000001 - Document - DOCUMENT AND ENTITY INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AUDITINFORMATION" roleURI="http://www.haemonetics.com/role/AUDITINFORMATION">
        <link:definition>0000002 - Document - AUDIT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOME" roleURI="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME">
        <link:definition>0000003 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>0000004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000005 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSPARENTHETICAL" roleURI="http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETSPARENTHETICAL">
        <link:definition>0000006 - Statement - CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" roleURI="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFTHEBUSINESSANDBASISOFPRESENTATION" roleURI="http://www.haemonetics.com/role/DESCRIPTIONOFTHEBUSINESSANDBASISOFPRESENTATION">
        <link:definition>0000009 - Disclosure - DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURING" roleURI="http://www.haemonetics.com/role/RESTRUCTURING">
        <link:definition>0000011 - Disclosure - RESTRUCTURING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDSTRATEGICINVESTMENTS" roleURI="http://www.haemonetics.com/role/ACQUISITIONSANDSTRATEGICINVESTMENTS">
        <link:definition>0000012 - Disclosure - ACQUISITIONS AND STRATEGIC INVESTMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURE" roleURI="http://www.haemonetics.com/role/DIVESTITURE">
        <link:definition>0000013 - Disclosure - DIVESTITURE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.haemonetics.com/role/INCOMETAXES">
        <link:definition>0000014 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.haemonetics.com/role/EARNINGSPERSHARE">
        <link:definition>0000015 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUE" roleURI="http://www.haemonetics.com/role/REVENUE">
        <link:definition>0000016 - Disclosure - REVENUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIES" roleURI="http://www.haemonetics.com/role/INVENTORIES">
        <link:definition>0000017 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENT" roleURI="http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENT">
        <link:definition>0000018 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>0000019 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.haemonetics.com/role/LEASES">
        <link:definition>0000020 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NOTESPAYABLEANDLONGTERMDEBT" roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT">
        <link:definition>0000021 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS">
        <link:definition>0000022 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANS" roleURI="http://www.haemonetics.com/role/RETIREMENTPLANS">
        <link:definition>0000023 - Disclosure - RETIREMENT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>0000024 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CAPITALSTOCK" roleURI="http://www.haemonetics.com/role/CAPITALSTOCK">
        <link:definition>0000025 - Disclosure - CAPITAL STOCK</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDENTERPRISEWIDEINFORMATION" roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION">
        <link:definition>0000026 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSS" roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS">
        <link:definition>0000027 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>0000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGTables" roleURI="http://www.haemonetics.com/role/RESTRUCTURINGTables">
        <link:definition>0000030 - Disclosure - RESTRUCTURING (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSTables" roleURI="http://www.haemonetics.com/role/ACQUISITIONSTables">
        <link:definition>0000031 - Disclosure - ACQUISITIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.haemonetics.com/role/INCOMETAXESTables">
        <link:definition>0000032 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.haemonetics.com/role/EARNINGSPERSHARETables">
        <link:definition>0000033 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESTables" roleURI="http://www.haemonetics.com/role/INVENTORIESTables">
        <link:definition>0000034 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTTables" roleURI="http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTTables">
        <link:definition>0000035 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>0000036 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.haemonetics.com/role/LEASESTables">
        <link:definition>0000037 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NOTESPAYABLEANDLONGTERMDEBTTables" roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTTables">
        <link:definition>0000038 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables">
        <link:definition>0000039 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSTables" roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSTables">
        <link:definition>0000040 - Disclosure - RETIREMENT PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CAPITALSTOCKTables" roleURI="http://www.haemonetics.com/role/CAPITALSTOCKTables">
        <link:definition>0000041 - Disclosure - CAPITAL STOCK (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDENTERPRISEWIDEINFORMATIONTables" roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables">
        <link:definition>0000042 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables">
        <link:definition>0000043 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
        <link:definition>0000044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGNarrativeDetails" roleURI="http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails">
        <link:definition>0000045 - Disclosure - RESTRUCTURING (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" roleURI="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails">
        <link:definition>0000046 - Disclosure - RESTRUCTURING (Schedule of Restructuring Reserve by Type of Cost) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSDetails" roleURI="http://www.haemonetics.com/role/ACQUISITIONSDetails">
        <link:definition>0000047 - Disclosure - ACQUISITIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSPurchasePriceAllocationDetails" roleURI="http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails">
        <link:definition>0000048 - Disclosure - ACQUISITIONS - Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSIntangibleAssetsAcquiredDetails" roleURI="http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails">
        <link:definition>0000049 - Disclosure - ACQUISITIONS - Intangible Assets Acquired (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STRATEGICINVESTMENTSDetails" roleURI="http://www.haemonetics.com/role/STRATEGICINVESTMENTSDetails">
        <link:definition>0000050 - Disclosure - STRATEGIC INVESTMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITUREDetails" roleURI="http://www.haemonetics.com/role/DIVESTITUREDetails">
        <link:definition>0000051 - Disclosure - DIVESTITURE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails">
        <link:definition>0000052 - Disclosure - INCOME TAXES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails" roleURI="http://www.haemonetics.com/role/INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails">
        <link:definition>0000053 - Disclosure - INCOME TAXES (Schedule Domestic and Foreign Income Before Provision for Income Tax) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails" roleURI="http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails">
        <link:definition>0000054 - Disclosure - INCOME TAXES (Schedule of Income Tax Provision Components) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofNetDeferredTaxAssetDetails" roleURI="http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails">
        <link:definition>0000055 - Disclosure - INCOME TAXES (Schedule of Net Deferred Tax Asset) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails">
        <link:definition>0000056 - Disclosure - INCOME TAXES (Schedule of Effective Income Tax Rate Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESSummaryofGrossUnrecognizedTaxBenefitsDetails" roleURI="http://www.haemonetics.com/role/INCOMETAXESSummaryofGrossUnrecognizedTaxBenefitsDetails">
        <link:definition>0000057 - Disclosure - INCOME TAXES (Summary of Gross Unrecognized Tax Benefits) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails" roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails">
        <link:definition>0000058 - Disclosure - EARNINGS PER SHARE (Schedule of Earnings Per Share Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREShareRepurchasePlanDetails" roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails">
        <link:definition>0000059 - Disclosure - EARNINGS PER SHARE (Share Repurchase Plan) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEDetails" roleURI="http://www.haemonetics.com/role/REVENUEDetails">
        <link:definition>0000060 - Disclosure - REVENUE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEPerformanceObligationsDetails" roleURI="http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails">
        <link:definition>0000061 - Disclosure - REVENUE Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEPerformanceObligationsDetails_1" roleURI="http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails_1">
        <link:definition>0000061 - Disclosure - REVENUE Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESScheduleofInventoriesDetails" roleURI="http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails">
        <link:definition>0000062 - Disclosure - INVENTORIES (Schedule of Inventories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTDetails" roleURI="http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails">
        <link:definition>0000063 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSNarrativeDetails" roleURI="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails">
        <link:definition>0000064 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails" roleURI="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails">
        <link:definition>0000065 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" roleURI="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails">
        <link:definition>0000066 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetails" roleURI="http://www.haemonetics.com/role/LEASESDetails">
        <link:definition>0000067 - Disclosure - LEASES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails" roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails">
        <link:definition>0000068 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Schedule of Notes Payable and Long-Term Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails" roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails">
        <link:definition>0000069 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtMaturitiesDetails" roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtMaturitiesDetails">
        <link:definition>0000070 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Schedule of Notes Payable and Long-Term Debt Maturities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>0000071 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails" roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails">
        <link:definition>0000072 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Interest Rate Swaps) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails" roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails">
        <link:definition>0000073 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Allowance for credit losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails" roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails">
        <link:definition>0000074 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails" roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails">
        <link:definition>0000075 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedules of Derivatives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSNarrativeDetails" roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails">
        <link:definition>0000076 - Disclosure - RETIREMENT PLANS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails" roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails">
        <link:definition>0000077 - Disclosure - RETIREMENT PLANS (Schedule of Components of Net Periodic Benefit Costs of Defined Benefit Pension Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails" roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails">
        <link:definition>0000078 - Disclosure - RETIREMENT PLANS (Schedule of Activity Under Defined Benefit Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSScheduleofComponentsofChangeRecordedinAccumulatedOtherComprehensiveIncomeRelatedtoDefinedBenefitPlansNetofTaxDetails" roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofChangeRecordedinAccumulatedOtherComprehensiveIncomeRelatedtoDefinedBenefitPlansNetofTaxDetails">
        <link:definition>0000079 - Disclosure - RETIREMENT PLANS (Schedule of Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSScheduleofWeightedAverageRatesUsedtoDetermineNetPeriodicBenefitCostsDetails" roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofWeightedAverageRatesUsedtoDetermineNetPeriodicBenefitCostsDetails">
        <link:definition>0000080 - Disclosure - RETIREMENT PLANS (Schedule of Weighted Average Rates Used to Determine Net Periodic Benefit Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSScheduleofEstimatedFutureBenefitPaymentsDetails" roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofEstimatedFutureBenefitPaymentsDetails">
        <link:definition>0000081 - Disclosure - RETIREMENT PLANS (Schedule of Estimated Future Benefit Payments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CAPITALSTOCKNarrativeDetails" roleURI="http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails">
        <link:definition>0000082 - Disclosure - CAPITAL STOCK (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CAPITALSTOCKScheduleofShareBasedCompensationDetails" roleURI="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofShareBasedCompensationDetails">
        <link:definition>0000083 - Disclosure - CAPITAL STOCK (Schedule of Share-Based Compensation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails" roleURI="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails">
        <link:definition>0000084 - Disclosure - CAPITAL STOCK (Schedule of Summary of Stock Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails" roleURI="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails">
        <link:definition>0000085 - Disclosure - CAPITAL STOCK (Schedule of Assumptions Used to Estimate Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails" roleURI="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails">
        <link:definition>0000086 - Disclosure - CAPITAL STOCK (Schedule of Summary of Equity Awards other than Options Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDENTERPRISEWIDEINFORMATIONDetails" roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails">
        <link:definition>0000087 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1" roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1">
        <link:definition>0000088 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="hae_Fiscal2016AwardsMember" abstract="true" name="Fiscal2016AwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_HaemoneticsEquipmentMember" abstract="true" name="HaemoneticsEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_SummaryOfSignificantAccountingPronouncementsLineItems" abstract="true" name="SummaryOfSignificantAccountingPronouncementsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_AssetImpairmentsMember" abstract="true" name="AssetImpairmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_UnrecognizedPriorServiceCost" abstract="false" name="UnrecognizedPriorServiceCost" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_RestructuringRelatedCosts" abstract="false" name="RestructuringRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DeferredTaxLiabilitiesDepreciation" abstract="false" name="DeferredTaxLiabilitiesDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DeferredTaxAssetsOperatingLeaseLiability" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales" abstract="false" name="OperatingLeaseRevenueAsAPercentageOfTotalNetSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" abstract="false" name="DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hae_NumberOfPurchasePeriods" abstract="false" name="NumberOfPurchasePeriods" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DerivativePercentofDebtExposed" abstract="false" name="DerivativePercentofDebtExposed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_AssetAcquisitionMilestonePayment" abstract="false" name="AssetAcquisitionMilestonePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_IncomeTaxReconciliationChangeinUncertainTaxPositions" abstract="false" name="IncomeTaxReconciliationChangeinUncertainTaxPositions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice" abstract="false" name="DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="hae_ManufacturingSpaceMember" abstract="true" name="ManufacturingSpaceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_RestructuringChargesPayableInNextTwelveMonths" abstract="false" name="RestructuringChargesPayableInNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice" abstract="false" name="DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" abstract="true" name="NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_TermLoanNetofFinancingFeesMember" abstract="true" name="TermLoanNetofFinancingFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_RevisedCreditAgreementMember" abstract="true" name="RevisedCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_InterestRateSwap267FixedInterestRateMember" abstract="true" name="InterestRateSwap267FixedInterestRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" abstract="false" name="DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hae_MaximumTermOfMaturitiesForCashAndCashEquivalents" abstract="false" name="MaximumTermOfMaturitiesForCashAndCashEquivalents" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hae_DeferredTaxLiabilitiesAmortization" abstract="false" name="DeferredTaxLiabilitiesAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_OtherCountryorRegionMember" abstract="true" name="OtherCountryorRegionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_DebtInstrumentConvertibleComponentConversionPrice" abstract="false" name="DebtInstrumentConvertibleComponentConversionPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes" abstract="false" name="PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DecreaseForRedemptionOfLongTermDebt" abstract="false" name="DecreaseForRedemptionOfLongTermDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DebtInstrumentInterestRateFloor" abstract="false" name="DebtInstrumentInterestRateFloor" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_RevenueBasedPayments2Member" abstract="true" name="RevenueBasedPayments2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_CardivaMedicalIncMember" abstract="true" name="CardivaMedicalIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_VivasureMedicalLTDMember" abstract="true" name="VivasureMedicalLTDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty" abstract="false" name="EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense" abstract="false" name="IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_InProcessSoftwareDevelopmentMember" abstract="true" name="InProcessSoftwareDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_DerivativePercentageOfNotionalValueOfDebt" abstract="false" name="DerivativePercentageOfNotionalValueOfDebt" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_OperatingExpensesTransactionCosts" abstract="false" name="OperatingExpensesTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" abstract="false" name="DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_IncomeTaxesLineItems" abstract="true" name="IncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hae_ImpairmentOfAssetsAndRelatedCharges" abstract="false" name="ImpairmentOfAssetsAndRelatedCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_InventoryLossesProvisionBenefit" abstract="false" name="InventoryLossesProvisionBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hae_HospitalMember" abstract="true" name="HospitalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_EuropeanMedicalDeviceRegulationCosts" abstract="false" name="EuropeanMedicalDeviceRegulationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_A2019EquityPlanMember" abstract="true" name="A2019EquityPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_InProcessPatentsMember" abstract="true" name="InProcessPatentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_ContingentConsiderationForeignCurrencyTranslationAdjustment" abstract="false" name="ContingentConsiderationForeignCurrencyTranslationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_ManufacturingSpaceSecondRenewalTermMember" abstract="true" name="ManufacturingSpaceSecondRenewalTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares" abstract="false" name="NumberofOptionsCountedAgainstMaximumNumberofAwardShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hae_EffectofExchangeRatesonOperatingIncome" abstract="false" name="EffectofExchangeRatesonOperatingIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_InterestRateSwap446FixedInterestRateMember" abstract="true" name="InterestRateSwap446FixedInterestRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_InterestRateSwap276FixedInterestRateMember" abstract="true" name="InterestRateSwap276FixedInterestRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_OtherTechnologyMember" abstract="true" name="OtherTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_NumberOfInterestRateSwapsEntered" abstract="false" name="NumberOfInterestRateSwapsEntered" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hae_DerivativeBlendedFixedInterestRate" abstract="false" name="DerivativeBlendedFixedInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_EnicorMember" abstract="true" name="EnicorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock" abstract="false" name="ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hae_UnrecognizedNetActuarialLossGain" abstract="false" name="UnrecognizedNetActuarialLossGain" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_A401kPlanMember" abstract="true" name="A401kPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_LesseeOperatingLeasesOtherInformationTableTextBlock" abstract="false" name="LesseeOperatingLeasesOtherInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue" abstract="false" name="PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" abstract="false" name="ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hae_TaxHolidayTerm" abstract="false" name="TaxHolidayTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hae_DefinedBenefitPlanReinsuranceContractsAssetValue" abstract="false" name="DefinedBenefitPlanReinsuranceContractsAssetValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_HASIntellectualPropertyMember" abstract="true" name="HASIntellectualPropertyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_PlasmaMember" abstract="true" name="PlasmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_AmortizationOfAcquiredIntangibleAssets" abstract="false" name="AmortizationOfAcquiredIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity" abstract="false" name="DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_AssetsandLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsandLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember" abstract="true" name="SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_DeferredTaxAssetsResearchExpensesCapitalized" abstract="false" name="DeferredTaxAssetsResearchExpensesCapitalized" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DebtInstrumentConvertibleCappedCallTransactionAmount" abstract="false" name="DebtInstrumentConvertibleCappedCallTransactionAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" abstract="false" name="DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hae_EffectofExchangeRateonRevenues" abstract="false" name="EffectofExchangeRateonRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_InlogHoldingsFranceMember" abstract="true" name="InlogHoldingsFranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany" abstract="false" name="DefinedBenefitPlanBenefitObligationPlanFundedbyCompany" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_OtherIncomeExpenseNetMember" abstract="true" name="OtherIncomeExpenseNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset" abstract="false" name="DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_USBloodDonorManagementSoftwareMember" abstract="true" name="USBloodDonorManagementSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_BankLoansandOtherBorrowingMember" abstract="true" name="BankLoansandOtherBorrowingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_OfficeEquipmentAndInformationTechnologyMember" abstract="true" name="OfficeEquipmentAndInformationTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_TenLargestCustomersMember" abstract="true" name="TenLargestCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" abstract="false" name="DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hae_InterestRateSwap408FixedInterestRateMember" abstract="true" name="InterestRateSwap408FixedInterestRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_ConsolidatedInterestCoverageRatio" abstract="false" name="ConsolidatedInterestCoverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="hae_PriorRestructuringProgramsMember" abstract="true" name="PriorRestructuringProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne" abstract="false" name="DebtInstrumentPercentOfPrincipalAmountDueInYearOne" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_FajardoPuertoRicoManufacturingOperationsMember" abstract="true" name="FajardoPuertoRicoManufacturingOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_SummaryOfSignificantAccountingPronouncementsTable" abstract="true" name="SummaryOfSignificantAccountingPronouncementsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="hae_EmployeesMember" abstract="true" name="EmployeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_TransfersFromInventoryToFixedAssets" abstract="false" name="TransfersFromInventoryToFixedAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_A2020ProgramMember" abstract="true" name="A2020ProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived" abstract="false" name="ProceedsFromDivestureOfBusinessContingentConsiderationReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" abstract="false" name="DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_SoftwareCapitalizationTerm" abstract="false" name="SoftwareCapitalizationTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hae_PercentageOfSharesPurchasedThroughPayrollDeductions" abstract="false" name="PercentageOfSharesPurchasedThroughPayrollDeductions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice" abstract="false" name="DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_PlasmaCustomerCSLLimitedCSLMember" abstract="true" name="PlasmaCustomerCSLLimitedCSLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_NetRevenuesBeforeForeignExchangeImpact" abstract="false" name="NetRevenuesBeforeForeignExchangeImpact" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_PercentageOfNetSalesGeneratedOutsideOfUs" abstract="false" name="PercentageOfNetSalesGeneratedOutsideOfUs" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_IncentiveCompensationPlan2005Member" abstract="true" name="IncentiveCompensationPlan2005Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" abstract="false" name="DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares" abstract="false" name="DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hae_InterestRateSwap444FixedInterestRateMember" abstract="true" name="InterestRateSwap444FixedInterestRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_DigitalTransformationCosts" abstract="false" name="DigitalTransformationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_SavingsPlusPlanMember" abstract="true" name="SavingsPlusPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments" abstract="false" name="ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_InterestRateSwap415FixedInterestRateMember" abstract="true" name="InterestRateSwap415FixedInterestRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward" abstract="true" name="ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hae_BloodCenterMember" abstract="true" name="BloodCenterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DeferredTaxAssetsAmortization" abstract="false" name="DeferredTaxAssetsAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_RestructuringandRestructuringRelatedCosts" abstract="false" name="RestructuringandRestructuringRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DocumentAndEntityInformationAbstract" abstract="true" name="DocumentAndEntityInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hae_A2022AcceleratedShareRepurchaseProgramMember" abstract="true" name="A2022AcceleratedShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_ConsolidatedTotalLeverageRatio" abstract="false" name="ConsolidatedTotalLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan" abstract="false" name="WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="hae_DeferredTaxAssetsDepreciation" abstract="false" name="DeferredTaxAssetsDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hae_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate" abstract="false" name="AcquiredIntangibleAssetsRiskAdjustedDiscountRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>hae-20230401_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d8e9c074-6bb3-481a-a40c-b4f91e1c5276,g:f0cc1f72-36f0-46b0-9a43-9e0dba51bc09-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="hae-20230401.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_69446278-1d31-4a63-a429-a990ddbecb49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_1a25bafa-2e91-43cc-85f6-e50df6579616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_69446278-1d31-4a63-a429-a990ddbecb49" xlink:to="loc_us-gaap_GrossProfit_1a25bafa-2e91-43cc-85f6-e50df6579616" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e0817acb-665d-40aa-a81b-52836a761dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_69446278-1d31-4a63-a429-a990ddbecb49" xlink:to="loc_us-gaap_OperatingExpenses_e0817acb-665d-40aa-a81b-52836a761dc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3cff6aa3-81b1-45f7-a34f-e8f96a2b5435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_007d56ef-faa4-4aa6-9a81-0be267c9dd80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3cff6aa3-81b1-45f7-a34f-e8f96a2b5435" xlink:to="loc_us-gaap_OperatingIncomeLoss_007d56ef-faa4-4aa6-9a81-0be267c9dd80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_83110a79-0419-49fc-88ef-5c21f96e115e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3cff6aa3-81b1-45f7-a34f-e8f96a2b5435" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_83110a79-0419-49fc-88ef-5c21f96e115e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ea17f147-1873-41a3-8be8-4c22fb660838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_721f94d4-54dc-4c06-b9f7-a5e617231419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ea17f147-1873-41a3-8be8-4c22fb660838" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_721f94d4-54dc-4c06-b9f7-a5e617231419" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_280e9f46-7427-4ccc-89d7-26b5c67581a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ea17f147-1873-41a3-8be8-4c22fb660838" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_280e9f46-7427-4ccc-89d7-26b5c67581a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_13bbc729-7eb6-4e4c-b75a-9a036ef42f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_61e612a0-6cce-4ebc-acd1-44cabe70e999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_13bbc729-7eb6-4e4c-b75a-9a036ef42f6b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_61e612a0-6cce-4ebc-acd1-44cabe70e999" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a2bb3606-f86f-4f62-8b5f-89dc7ae2b3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_13bbc729-7eb6-4e4c-b75a-9a036ef42f6b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a2bb3606-f86f-4f62-8b5f-89dc7ae2b3b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AmortizationOfAcquiredIntangibleAssets_634d0c70-31e6-49cd-93b3-9d8b70941b0a" xlink:href="hae-20230401.xsd#hae_AmortizationOfAcquiredIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_13bbc729-7eb6-4e4c-b75a-9a036ef42f6b" xlink:to="loc_hae_AmortizationOfAcquiredIntangibleAssets_634d0c70-31e6-49cd-93b3-9d8b70941b0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_1983bc85-e47e-4a32-a786-e04905aceda9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_13bbc729-7eb6-4e4c-b75a-9a036ef42f6b" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_1983bc85-e47e-4a32-a786-e04905aceda9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a7ccf0c5-9e9f-4556-b4e5-28104977fa5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_73296d7f-2ad8-4cdb-8f79-807e13c51959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_a7ccf0c5-9e9f-4556-b4e5-28104977fa5f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_73296d7f-2ad8-4cdb-8f79-807e13c51959" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_e8313cc5-e92e-48ef-8f0d-d10bb6a820d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_a7ccf0c5-9e9f-4556-b4e5-28104977fa5f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_e8313cc5-e92e-48ef-8f0d-d10bb6a820d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="hae-20230401.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4585d840-66d8-4619-a663-8bcafa71c798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_149fc05a-1508-477f-864c-d3d2aa029ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4585d840-66d8-4619-a663-8bcafa71c798" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_149fc05a-1508-477f-864c-d3d2aa029ff1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1394f87f-5bda-42f9-b9d9-eae2b8a5c968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4585d840-66d8-4619-a663-8bcafa71c798" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1394f87f-5bda-42f9-b9d9-eae2b8a5c968" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_4c419faa-6555-47c3-b1b3-4a49fba2dee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4585d840-66d8-4619-a663-8bcafa71c798" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_4c419faa-6555-47c3-b1b3-4a49fba2dee5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1b219fcc-c7db-4b6f-8395-701e88aa16a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4585d840-66d8-4619-a663-8bcafa71c798" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1b219fcc-c7db-4b6f-8395-701e88aa16a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a01f0bc4-12f0-4eab-ab5d-c5c41b2e2577" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cf5aed11-09a6-49bf-9118-e7f0eb9329b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a01f0bc4-12f0-4eab-ab5d-c5c41b2e2577" xlink:to="loc_us-gaap_NetIncomeLoss_cf5aed11-09a6-49bf-9118-e7f0eb9329b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_280b85fb-f59e-463d-b3e9-75b4930c3d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a01f0bc4-12f0-4eab-ab5d-c5c41b2e2577" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_280b85fb-f59e-463d-b3e9-75b4930c3d8e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="hae-20230401.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8f2fefda-2154-4c53-82e8-98b0a9011ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2d94047a-1f98-47a9-959f-fa95a69a639b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8f2fefda-2154-4c53-82e8-98b0a9011ce8" xlink:to="loc_us-gaap_LiabilitiesCurrent_2d94047a-1f98-47a9-959f-fa95a69a639b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ad0c9abb-51a4-4faf-a51e-89ce0bf9489b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8f2fefda-2154-4c53-82e8-98b0a9011ce8" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ad0c9abb-51a4-4faf-a51e-89ce0bf9489b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_786c379f-1f89-4f3f-9b6c-b0c4c01e9263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8f2fefda-2154-4c53-82e8-98b0a9011ce8" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_786c379f-1f89-4f3f-9b6c-b0c4c01e9263" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5066419e-a2ae-4c28-ad73-789f0b9304a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8f2fefda-2154-4c53-82e8-98b0a9011ce8" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5066419e-a2ae-4c28-ad73-789f0b9304a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9c392383-3c51-4e2b-ad41-6fc999cda4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8f2fefda-2154-4c53-82e8-98b0a9011ce8" xlink:to="loc_us-gaap_StockholdersEquity_9c392383-3c51-4e2b-ad41-6fc999cda4fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_35850e6d-b3c4-47d2-88e7-ee86918316dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_46884f76-bac7-4831-b6f8-d4742d432a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_35850e6d-b3c4-47d2-88e7-ee86918316dc" xlink:to="loc_us-gaap_LongTermDebtCurrent_46884f76-bac7-4831-b6f8-d4742d432a7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_83ab5432-b6cf-4fcd-b89d-4918ef79f02a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_35850e6d-b3c4-47d2-88e7-ee86918316dc" xlink:to="loc_us-gaap_AccountsPayableCurrent_83ab5432-b6cf-4fcd-b89d-4918ef79f02a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_34892f98-d7a6-475d-a35a-c3f5c0675b54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_35850e6d-b3c4-47d2-88e7-ee86918316dc" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_34892f98-d7a6-475d-a35a-c3f5c0675b54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_ee622e17-b222-455b-8790-eb1212fd00da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_35850e6d-b3c4-47d2-88e7-ee86918316dc" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_ee622e17-b222-455b-8790-eb1212fd00da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_dc3a2e02-9478-4dc9-8466-0e4d3852e311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3ff42dda-e071-4e6e-9af0-920fc85f6b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_dc3a2e02-9478-4dc9-8466-0e4d3852e311" xlink:to="loc_us-gaap_CommonStockValue_3ff42dda-e071-4e6e-9af0-920fc85f6b9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d5634674-2c20-4d73-83e3-aa22cdc7cbbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_dc3a2e02-9478-4dc9-8466-0e4d3852e311" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d5634674-2c20-4d73-83e3-aa22cdc7cbbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f191294d-8a83-44f8-b58c-d902caa08214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_dc3a2e02-9478-4dc9-8466-0e4d3852e311" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f191294d-8a83-44f8-b58c-d902caa08214" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5e9683a1-b280-47d4-baca-a396b10c1d46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_dc3a2e02-9478-4dc9-8466-0e4d3852e311" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5e9683a1-b280-47d4-baca-a396b10c1d46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8963f07f-5905-4532-a82b-49e3238dad34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_586848a2-52b2-4ad4-a307-12efd44f20ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8963f07f-5905-4532-a82b-49e3238dad34" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_586848a2-52b2-4ad4-a307-12efd44f20ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_5d202b65-141c-4342-84cc-67b43faab56e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8963f07f-5905-4532-a82b-49e3238dad34" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_5d202b65-141c-4342-84cc-67b43faab56e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9199a61e-216a-409a-876b-5eff6482dffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8963f07f-5905-4532-a82b-49e3238dad34" xlink:to="loc_us-gaap_InventoryNet_9199a61e-216a-409a-876b-5eff6482dffc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5589717c-ac11-4cee-b2d1-f284aba9cee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8963f07f-5905-4532-a82b-49e3238dad34" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5589717c-ac11-4cee-b2d1-f284aba9cee7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ed0001e1-3fc3-426b-92a3-fb2087ee7355" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_becb9474-4b90-4cd9-aa15-9faf5ca73998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ed0001e1-3fc3-426b-92a3-fb2087ee7355" xlink:to="loc_us-gaap_AssetsCurrent_becb9474-4b90-4cd9-aa15-9faf5ca73998" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_47577d45-f66a-4cbb-ac0d-0a0a5c9e738f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ed0001e1-3fc3-426b-92a3-fb2087ee7355" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_47577d45-f66a-4cbb-ac0d-0a0a5c9e738f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2a99a257-af95-4d55-8557-3d57e7ece033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ed0001e1-3fc3-426b-92a3-fb2087ee7355" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2a99a257-af95-4d55-8557-3d57e7ece033" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f910c8b1-4754-44dd-8498-9c105eb60349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ed0001e1-3fc3-426b-92a3-fb2087ee7355" xlink:to="loc_us-gaap_Goodwill_f910c8b1-4754-44dd-8498-9c105eb60349" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_3bd33967-7237-48bd-9204-8d3eea12d24c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ed0001e1-3fc3-426b-92a3-fb2087ee7355" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_3bd33967-7237-48bd-9204-8d3eea12d24c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_cfd2befe-a084-4906-a178-d1fb40c2e547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ed0001e1-3fc3-426b-92a3-fb2087ee7355" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_cfd2befe-a084-4906-a178-d1fb40c2e547" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="hae-20230401.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bdaf01d3-f3af-46d1-a796-a545b8fac03c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975139b4-5627-4d76-8f54-ddfca473b05d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bdaf01d3-f3af-46d1-a796-a545b8fac03c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975139b4-5627-4d76-8f54-ddfca473b05d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_004097ab-2eb5-41f2-a6b5-90dda34e0447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bdaf01d3-f3af-46d1-a796-a545b8fac03c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_004097ab-2eb5-41f2-a6b5-90dda34e0447" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_65d58d27-593c-4ad7-bc5b-991e2ae8d1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bdaf01d3-f3af-46d1-a796-a545b8fac03c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_65d58d27-593c-4ad7-bc5b-991e2ae8d1a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7078f878-f518-4cca-9f97-fc2de6108864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bdaf01d3-f3af-46d1-a796-a545b8fac03c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7078f878-f518-4cca-9f97-fc2de6108864" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ea1d57b9-fa5c-4e0a-a907-b42449c508b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:to="loc_us-gaap_NetIncomeLoss_ea1d57b9-fa5c-4e0a-a907-b42449c508b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOtherTaxExpenseBenefit_26b4e187-b739-4fae-b234-702ac317b4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOtherTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:to="loc_us-gaap_DeferredOtherTaxExpenseBenefit_26b4e187-b739-4fae-b234-702ac317b4e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_f7f51359-5143-45c2-bc6d-62d37eee4584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:to="loc_us-gaap_DepreciationAndAmortization_f7f51359-5143-45c2-bc6d-62d37eee4584" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InventoryLossesProvisionBenefit_3266668f-a538-4227-b204-d02dcbfb86a7" xlink:href="hae-20230401.xsd#hae_InventoryLossesProvisionBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:to="loc_hae_InventoryLossesProvisionBenefit_3266668f-a538-4227-b204-d02dcbfb86a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_7f658f41-6736-4a27-8816-b53b2bca0e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_7f658f41-6736-4a27-8816-b53b2bca0e7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_5df22846-85fb-43c2-9c5e-fdc8f5f2f4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_5df22846-85fb-43c2-9c5e-fdc8f5f2f4ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_75960db3-3682-4f90-adc9-e7855177a5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:to="loc_us-gaap_ShareBasedCompensation_75960db3-3682-4f90-adc9-e7855177a5fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_37d7aef8-93e9-4e68-97d3-079f83740c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_37d7aef8-93e9-4e68-97d3-079f83740c45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d676a36b-f059-4c1a-ba89-4b3e5da79085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d676a36b-f059-4c1a-ba89-4b3e5da79085" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_24010e4f-d7d5-49a5-902d-7c3840668188" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:to="loc_us-gaap_AssetImpairmentCharges_24010e4f-d7d5-49a5-902d-7c3840668188" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_5bcc7224-fa19-47d8-8d2e-fe98f567ae03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_5bcc7224-fa19-47d8-8d2e-fe98f567ae03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_ac3d9c3f-a12f-4d72-a814-be154df1f0af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_ac3d9c3f-a12f-4d72-a814-be154df1f0af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_d07b5387-dd19-4015-a5a4-67698bffb0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_d07b5387-dd19-4015-a5a4-67698bffb0ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f357f33e-5f13-40ef-ae55-6c8afd833c04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f357f33e-5f13-40ef-ae55-6c8afd833c04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ed1ce5cf-e913-4889-ba9a-29fb0cf175bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bc57997-50e3-4e57-8231-a821111c8939" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ed1ce5cf-e913-4889-ba9a-29fb0cf175bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26457407-3532-404b-80eb-fb06b363c0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_f68d762c-2f9a-4eda-aace-092a0591f923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26457407-3532-404b-80eb-fb06b363c0c8" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_f68d762c-2f9a-4eda-aace-092a0591f923" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_09ed5889-2e7b-45fe-9230-7b614a775a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26457407-3532-404b-80eb-fb06b363c0c8" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_09ed5889-2e7b-45fe-9230-7b614a775a04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_631dbac3-eca7-4e0a-8c7a-ddebc40d0bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26457407-3532-404b-80eb-fb06b363c0c8" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_631dbac3-eca7-4e0a-8c7a-ddebc40d0bd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_3db8beb4-2c2e-493c-8d4b-27b02580f49b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26457407-3532-404b-80eb-fb06b363c0c8" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_3db8beb4-2c2e-493c-8d4b-27b02580f49b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ff7ba9bc-805b-4df5-9322-adf6f3699046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26457407-3532-404b-80eb-fb06b363c0c8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ff7ba9bc-805b-4df5-9322-adf6f3699046" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_16296e40-327a-43af-acc2-a94d70818b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26457407-3532-404b-80eb-fb06b363c0c8" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_16296e40-327a-43af-acc2-a94d70818b60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_bd98d1af-e5dd-428f-a447-fefdb8f74cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26457407-3532-404b-80eb-fb06b363c0c8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_bd98d1af-e5dd-428f-a447-fefdb8f74cf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DecreaseForRedemptionOfLongTermDebt_36559447-7501-4ddf-9709-e82809f277ad" xlink:href="hae-20230401.xsd#hae_DecreaseForRedemptionOfLongTermDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26457407-3532-404b-80eb-fb06b363c0c8" xlink:to="loc_hae_DecreaseForRedemptionOfLongTermDebt_36559447-7501-4ddf-9709-e82809f277ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_e3b00cee-2418-4a87-bcf5-523bf4a5c3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26457407-3532-404b-80eb-fb06b363c0c8" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_e3b00cee-2418-4a87-bcf5-523bf4a5c3f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_d28cda06-da83-4a68-b520-6564977fd98b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26457407-3532-404b-80eb-fb06b363c0c8" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_d28cda06-da83-4a68-b520-6564977fd98b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes_cb6279c7-31fa-4eaa-80dd-f718043152f6" xlink:href="hae-20230401.xsd#hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26457407-3532-404b-80eb-fb06b363c0c8" xlink:to="loc_hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes_cb6279c7-31fa-4eaa-80dd-f718043152f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9a3db5d0-801a-4b27-9993-4c8bdfe39e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26457407-3532-404b-80eb-fb06b363c0c8" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9a3db5d0-801a-4b27-9993-4c8bdfe39e1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_354f5ea7-039c-4e85-85f4-c0954b286c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26457407-3532-404b-80eb-fb06b363c0c8" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_354f5ea7-039c-4e85-85f4-c0954b286c93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_573867d9-afca-410e-b87b-c71b3848713a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26457407-3532-404b-80eb-fb06b363c0c8" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_573867d9-afca-410e-b87b-c71b3848713a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_63c8c5cc-3210-47ea-bc8e-78330bae6ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_da5161c5-c764-44b3-9360-167f7931e47c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_63c8c5cc-3210-47ea-bc8e-78330bae6ab9" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_da5161c5-c764-44b3-9360-167f7931e47c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_512ba60c-b975-49ed-8e6b-298728e38be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_63c8c5cc-3210-47ea-bc8e-78330bae6ab9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_512ba60c-b975-49ed-8e6b-298728e38be1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_86346516-07ce-4194-82a9-dfd81c1ef20d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_63c8c5cc-3210-47ea-bc8e-78330bae6ab9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_86346516-07ce-4194-82a9-dfd81c1ef20d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d52dc67e-86dd-471c-bb06-47b32500e1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_63c8c5cc-3210-47ea-bc8e-78330bae6ab9" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d52dc67e-86dd-471c-bb06-47b32500e1f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_2c62192e-e02a-4361-9e66-315cfc040888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_63c8c5cc-3210-47ea-bc8e-78330bae6ab9" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_2c62192e-e02a-4361-9e66-315cfc040888" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1f8654c1-ad8e-4399-998f-26028bff74ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_174ee585-9c3c-423d-9fc1-09e6630c268d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1f8654c1-ad8e-4399-998f-26028bff74ac" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_174ee585-9c3c-423d-9fc1-09e6630c268d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_843fc3ff-38f2-465e-853a-5ddd9b1fbe9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1f8654c1-ad8e-4399-998f-26028bff74ac" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_843fc3ff-38f2-465e-853a-5ddd9b1fbe9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_0de2df66-1712-41cf-9330-562f6b95d3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1f8654c1-ad8e-4399-998f-26028bff74ac" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_0de2df66-1712-41cf-9330-562f6b95d3e5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#ACQUISITIONSPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_654a0f63-3327-4888-a4e9-80eba3b9af9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_5db2ed29-3552-4c71-8055-3a3bc319cd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_654a0f63-3327-4888-a4e9-80eba3b9af9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_5db2ed29-3552-4c71-8055-3a3bc319cd1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts_58a5b979-5871-4579-8194-45a6aafda5a5" xlink:href="hae-20230401.xsd#hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_654a0f63-3327-4888-a4e9-80eba3b9af9c" xlink:to="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts_58a5b979-5871-4579-8194-45a6aafda5a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_77c8b5af-1032-47a8-b599-9feb19d40057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_654a0f63-3327-4888-a4e9-80eba3b9af9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_77c8b5af-1032-47a8-b599-9feb19d40057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_41cb39e8-10b1-4a17-becc-64beecdb874c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_654a0f63-3327-4888-a4e9-80eba3b9af9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_41cb39e8-10b1-4a17-becc-64beecdb874c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_16e3d949-34a6-4ec1-a189-c0fe2af2d62c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_654a0f63-3327-4888-a4e9-80eba3b9af9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_16e3d949-34a6-4ec1-a189-c0fe2af2d62c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1ec2fb65-f52a-4000-baa5-597b0df4b522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_60422d6b-e635-4f12-8225-3e239f432a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1ec2fb65-f52a-4000-baa5-597b0df4b522" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_60422d6b-e635-4f12-8225-3e239f432a46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_bbc76cf7-b70f-4639-9bec-003f8cf4cbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1ec2fb65-f52a-4000-baa5-597b0df4b522" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_bbc76cf7-b70f-4639-9bec-003f8cf4cbaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1a34b324-9a0b-44a5-8be1-c11d63382b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1ec2fb65-f52a-4000-baa5-597b0df4b522" xlink:to="loc_us-gaap_Goodwill_1a34b324-9a0b-44a5-8be1-c11d63382b8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_fa2a588c-940f-44b6-98c1-41434e8284d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1ec2fb65-f52a-4000-baa5-597b0df4b522" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_fa2a588c-940f-44b6-98c1-41434e8284d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_1726c4a4-41e2-437b-918a-0cd17db5bf52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1ec2fb65-f52a-4000-baa5-597b0df4b522" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_1726c4a4-41e2-437b-918a-0cd17db5bf52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_be7e34c8-33c3-49be-bcc7-529f0b5d19b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1ec2fb65-f52a-4000-baa5-597b0df4b522" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_be7e34c8-33c3-49be-bcc7-529f0b5d19b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_97fa3bf2-3f47-4dab-9a49-435d14a2eca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1ec2fb65-f52a-4000-baa5-597b0df4b522" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_97fa3bf2-3f47-4dab-9a49-435d14a2eca9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cde3fb85-de13-4e6f-ab9e-0fdbc019abd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_b6477900-0127-453a-b5bf-31195f84ce9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cde3fb85-de13-4e6f-ab9e-0fdbc019abd4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_b6477900-0127-453a-b5bf-31195f84ce9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_bcdfe867-bf81-4c47-8c14-906c52deade7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cde3fb85-de13-4e6f-ab9e-0fdbc019abd4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_bcdfe867-bf81-4c47-8c14-906c52deade7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2c564e87-4f7a-4ddd-9c53-fe48336664e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_79351bd7-1631-4020-b2fb-9a7930202cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_2c564e87-4f7a-4ddd-9c53-fe48336664e1" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_79351bd7-1631-4020-b2fb-9a7930202cf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7e187174-fe59-444a-ac3c-ec31509fb04f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_2c564e87-4f7a-4ddd-9c53-fe48336664e1" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7e187174-fe59-444a-ac3c-ec31509fb04f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_331678c1-e9fc-4a6c-893a-3bcda29ca66d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_ae382e68-0b35-4046-9f55-a4ade78cb1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_331678c1-e9fc-4a6c-893a-3bcda29ca66d" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_ae382e68-0b35-4046-9f55-a4ade78cb1fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_cfb4ee00-83f9-48a2-8bb9-d9481502ad1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_331678c1-e9fc-4a6c-893a-3bcda29ca66d" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_cfb4ee00-83f9-48a2-8bb9-d9481502ad1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4e4a1813-8cb5-412a-9436-9acba90ae0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_331678c1-e9fc-4a6c-893a-3bcda29ca66d" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4e4a1813-8cb5-412a-9436-9acba90ae0f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_914cca8f-724d-4f7d-946f-da74aa17956e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_c7ed73b5-c8c4-4afa-aeab-2f03fa5abef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_914cca8f-724d-4f7d-946f-da74aa17956e" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_c7ed73b5-c8c4-4afa-aeab-2f03fa5abef9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_e14892bf-4865-437e-9a98-af43d8066058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_914cca8f-724d-4f7d-946f-da74aa17956e" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_e14892bf-4865-437e-9a98-af43d8066058" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_596ba7c5-7bd7-4054-8497-a8bb301fa65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_914cca8f-724d-4f7d-946f-da74aa17956e" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_596ba7c5-7bd7-4054-8497-a8bb301fa65a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#INCOMETAXESScheduleofNetDeferredTaxAssetDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_83193202-8d21-48cc-a538-ab486badef4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxLiabilitiesDepreciation_271a2504-5406-4910-864a-2fe1c940e603" xlink:href="hae-20230401.xsd#hae_DeferredTaxLiabilitiesDepreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_83193202-8d21-48cc-a538-ab486badef4a" xlink:to="loc_hae_DeferredTaxLiabilitiesDepreciation_271a2504-5406-4910-864a-2fe1c940e603" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxLiabilitiesAmortization_6c49e012-518a-4572-b58d-1cedd289355a" xlink:href="hae-20230401.xsd#hae_DeferredTaxLiabilitiesAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_83193202-8d21-48cc-a538-ab486badef4a" xlink:to="loc_hae_DeferredTaxLiabilitiesAmortization_6c49e012-518a-4572-b58d-1cedd289355a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_a734badb-e9ec-4caa-8698-d1281857f39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_83193202-8d21-48cc-a538-ab486badef4a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_a734badb-e9ec-4caa-8698-d1281857f39d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_ab3a1365-9378-4d4e-825a-231d3a36bbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_83193202-8d21-48cc-a538-ab486badef4a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_ab3a1365-9378-4d4e-825a-231d3a36bbdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset_8f5c3cc2-e843-486e-bf8d-9d7b4757c731" xlink:href="hae-20230401.xsd#hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_83193202-8d21-48cc-a538-ab486badef4a" xlink:to="loc_hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset_8f5c3cc2-e843-486e-bf8d-9d7b4757c731" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_3395d09d-1814-4056-b022-80bcf03aea06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxAssetsDepreciation_15ba245c-69fd-49e2-a384-8498f1197927" xlink:href="hae-20230401.xsd#hae_DeferredTaxAssetsDepreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3395d09d-1814-4056-b022-80bcf03aea06" xlink:to="loc_hae_DeferredTaxAssetsDepreciation_15ba245c-69fd-49e2-a384-8498f1197927" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxAssetsAmortization_99bff93e-d04d-4f3f-82b6-cb8c340bd4f4" xlink:href="hae-20230401.xsd#hae_DeferredTaxAssetsAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3395d09d-1814-4056-b022-80bcf03aea06" xlink:to="loc_hae_DeferredTaxAssetsAmortization_99bff93e-d04d-4f3f-82b6-cb8c340bd4f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_ddde240d-8ac4-4b52-84fc-b1c29509930c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3395d09d-1814-4056-b022-80bcf03aea06" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_ddde240d-8ac4-4b52-84fc-b1c29509930c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_9e4ca2dc-0f42-4fa1-858b-85fd32c2c0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3395d09d-1814-4056-b022-80bcf03aea06" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_9e4ca2dc-0f42-4fa1-858b-85fd32c2c0ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b214b57b-825c-4476-a35b-696f375fe80a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3395d09d-1814-4056-b022-80bcf03aea06" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b214b57b-825c-4476-a35b-696f375fe80a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_222b4d0a-210d-44a3-964b-050f0eca6586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3395d09d-1814-4056-b022-80bcf03aea06" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_222b4d0a-210d-44a3-964b-050f0eca6586" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_61e08576-dd84-4e18-83e8-7935ffe42918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3395d09d-1814-4056-b022-80bcf03aea06" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_61e08576-dd84-4e18-83e8-7935ffe42918" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxAssetsOperatingLeaseLiability_f0395680-e9e1-41da-b67c-94470f6a2012" xlink:href="hae-20230401.xsd#hae_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3395d09d-1814-4056-b022-80bcf03aea06" xlink:to="loc_hae_DeferredTaxAssetsOperatingLeaseLiability_f0395680-e9e1-41da-b67c-94470f6a2012" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxAssetsResearchExpensesCapitalized_06334cb2-744e-4c91-b4c2-408bc45b6b70" xlink:href="hae-20230401.xsd#hae_DeferredTaxAssetsResearchExpensesCapitalized"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3395d09d-1814-4056-b022-80bcf03aea06" xlink:to="loc_hae_DeferredTaxAssetsResearchExpensesCapitalized_06334cb2-744e-4c91-b4c2-408bc45b6b70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_f1c1f997-f166-47b1-8d5b-bbd5b29150d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_a2a119cc-d012-4529-9353-2bff56f0f223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f1c1f997-f166-47b1-8d5b-bbd5b29150d6" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_a2a119cc-d012-4529-9353-2bff56f0f223" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_ef796c79-b849-4f7a-b593-3e8cc5a6135a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f1c1f997-f166-47b1-8d5b-bbd5b29150d6" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_ef796c79-b849-4f7a-b593-3e8cc5a6135a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_5f63fa3f-9fbf-4b88-a05b-53bfb2d05296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_b3d10fbe-b7fa-4b5f-9297-1f64b9bcd207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_5f63fa3f-9fbf-4b88-a05b-53bfb2d05296" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_b3d10fbe-b7fa-4b5f-9297-1f64b9bcd207" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f8e49965-4405-4741-b80e-fbbf9899d81f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_5f63fa3f-9fbf-4b88-a05b-53bfb2d05296" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f8e49965-4405-4741-b80e-fbbf9899d81f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1e817330-7ed0-4ef9-a076-da6c05db8461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1e817330-7ed0-4ef9-a076-da6c05db8461" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_aff4550d-4728-411e-abae-21f120d62df3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_aff4550d-4728-411e-abae-21f120d62df3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_3cccb47e-2ef1-4ac6-b023-058d1617c783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_3cccb47e-2ef1-4ac6-b023-058d1617c783" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_26cae135-e344-4f12-a13f-1bc6a5efe250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_26cae135-e344-4f12-a13f-1bc6a5efe250" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_c415d83b-f2bd-4b89-bd55-2da0af34f5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_c415d83b-f2bd-4b89-bd55-2da0af34f5a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_IncomeTaxReconciliationChangeinUncertainTaxPositions_57d7de27-3212-472f-b321-e686b39f75b6" xlink:href="hae-20230401.xsd#hae_IncomeTaxReconciliationChangeinUncertainTaxPositions"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:to="loc_hae_IncomeTaxReconciliationChangeinUncertainTaxPositions_57d7de27-3212-472f-b321-e686b39f75b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_5344424d-ae3e-45ce-b2ef-3940ca4b62ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_5344424d-ae3e-45ce-b2ef-3940ca4b62ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_548e6cf3-089e-49bf-9eb7-4f35fb8f1855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_548e6cf3-089e-49bf-9eb7-4f35fb8f1855" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount_6137ecf8-1471-4b77-92c3-261f2aca9f38" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount_6137ecf8-1471-4b77-92c3-261f2aca9f38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_a1b7598a-bb2c-45cc-838b-39f4f2c02eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_a1b7598a-bb2c-45cc-838b-39f4f2c02eb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2ac41736-1096-4762-b44d-959da4f045bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2ac41736-1096-4762-b44d-959da4f045bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_7b324044-23e4-4816-a8cd-832e43d647d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_7b324044-23e4-4816-a8cd-832e43d647d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount_51209106-6fc1-44a2-a754-a18e90f3c0a8" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount_51209106-6fc1-44a2-a754-a18e90f3c0a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty_3d67c641-bff2-4a22-ae38-d6c137538eb9" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty_3d67c641-bff2-4a22-ae38-d6c137538eb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount_d5d4ffaf-889d-4851-8a63-7c901a582832" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_774110ed-51b5-42ae-bcde-f015b6095628" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount_d5d4ffaf-889d-4851-8a63-7c901a582832" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_de25e0e9-e6ff-4290-aa19-ef13d8bfc13e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_de25e0e9-e6ff-4290-aa19-ef13d8bfc13e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_bebdd3b6-7cae-4070-8277-e081625be2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_bebdd3b6-7cae-4070-8277-e081625be2b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f2a57831-f1f7-4cff-b8ae-93384f62adcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f2a57831-f1f7-4cff-b8ae-93384f62adcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_9db4abb6-4604-4567-b9c8-8c52b9e0a3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_9db4abb6-4604-4567-b9c8-8c52b9e0a3fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_22642d9a-6ab4-473f-8340-3fdd9fd92691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_22642d9a-6ab4-473f-8340-3fdd9fd92691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions_6e76d98b-f4b3-4f35-bbe6-a1b1799a4b2b" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions_6e76d98b-f4b3-4f35-bbe6-a1b1799a4b2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_62f05abb-0c84-4211-9a97-9ae9f9d4c0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_62f05abb-0c84-4211-9a97-9ae9f9d4c0d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_8926ae9b-473b-4744-8f7f-cfddccc3c841" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_8926ae9b-473b-4744-8f7f-cfddccc3c841" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent_1c3a90f4-effa-457d-9989-986a751d3a1a" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent_1c3a90f4-effa-457d-9989-986a751d3a1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_dd4a7c22-5931-4355-94d4-0be91b0e91da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_dd4a7c22-5931-4355-94d4-0be91b0e91da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_84425fe6-b183-45bf-a47b-5ddeeba67443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_84425fe6-b183-45bf-a47b-5ddeeba67443" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent_2915fe5e-29f8-4eba-a5d3-bcaa7deea9a6" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent_2915fe5e-29f8-4eba-a5d3-bcaa7deea9a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_770966c4-e272-49fb-8faf-cb6591e79cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_770966c4-e272-49fb-8faf-cb6591e79cd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent_7d24d608-b83f-46e7-ad09-d6160279b617" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent_7d24d608-b83f-46e7-ad09-d6160279b617" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent_6e1ab9aa-86cc-45bb-a068-4f72cdf96cd9" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8b8c5495-f7a0-4784-9224-6a5f7b6aec2a" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent_6e1ab9aa-86cc-45bb-a068-4f72cdf96cd9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_38e99078-091d-407f-a074-6e157c77ba1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_80d6af09-194d-4197-9176-bdd8c2afc5cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_38e99078-091d-407f-a074-6e157c77ba1a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_80d6af09-194d-4197-9176-bdd8c2afc5cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3cadca79-860d-4b0c-8971-baf4c0521dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_38e99078-091d-407f-a074-6e157c77ba1a" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3cadca79-860d-4b0c-8971-baf4c0521dbf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#INVENTORIESScheduleofInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_fb6324a6-d4f1-4b31-bb3b-f53e1869e585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_fb54de3f-c3cd-41ff-8f57-6c1eaf97cfdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_fb6324a6-d4f1-4b31-bb3b-f53e1869e585" xlink:to="loc_us-gaap_InventoryRawMaterials_fb54de3f-c3cd-41ff-8f57-6c1eaf97cfdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_f3702a27-dd9e-430b-8e56-ad11231e212b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_fb6324a6-d4f1-4b31-bb3b-f53e1869e585" xlink:to="loc_us-gaap_InventoryWorkInProcess_f3702a27-dd9e-430b-8e56-ad11231e212b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_f1ec7829-0714-4ad5-a3a2-77f9dbbd9f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_fb6324a6-d4f1-4b31-bb3b-f53e1869e585" xlink:to="loc_us-gaap_InventoryFinishedGoods_f1ec7829-0714-4ad5-a3a2-77f9dbbd9f1b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6dcdbaa7-df70-4433-9129-938b96a6c91c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_42832ec5-a95f-45db-ac17-8164044e21ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_6dcdbaa7-df70-4433-9129-938b96a6c91c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_42832ec5-a95f-45db-ac17-8164044e21ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_61ba4b49-f46e-40fa-ad0d-4139560663b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_6dcdbaa7-df70-4433-9129-938b96a6c91c" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_61ba4b49-f46e-40fa-ad0d-4139560663b0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d650f785-6300-43b7-9614-81622c93cc96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5dade481-cd8e-422a-a606-6ff196d27ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d650f785-6300-43b7-9614-81622c93cc96" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5dade481-cd8e-422a-a606-6ff196d27ab8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c39f6be8-0e2a-4eb2-8833-41c8d684d02f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d650f785-6300-43b7-9614-81622c93cc96" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c39f6be8-0e2a-4eb2-8833-41c8d684d02f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2c9ccef6-e858-4a28-9194-a86fef34c556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_d7c39450-bfde-422b-936e-5af9ff81118f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2c9ccef6-e858-4a28-9194-a86fef34c556" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_d7c39450-bfde-422b-936e-5af9ff81118f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_a9a37123-9990-4b05-825a-608dafd90b25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2c9ccef6-e858-4a28-9194-a86fef34c556" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_a9a37123-9990-4b05-825a-608dafd90b25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_c95d7352-f775-469f-ba69-35d0245bf5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2c9ccef6-e858-4a28-9194-a86fef34c556" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_c95d7352-f775-469f-ba69-35d0245bf5f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_fe98d9a1-7954-4b9a-b38b-4d945ed33729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2c9ccef6-e858-4a28-9194-a86fef34c556" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_fe98d9a1-7954-4b9a-b38b-4d945ed33729" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_ff5afc49-15db-439c-81c0-5e3b5ff1a56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2c9ccef6-e858-4a28-9194-a86fef34c556" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_ff5afc49-15db-439c-81c0-5e3b5ff1a56f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_e57978e1-f404-47f3-b669-b2bf62fca9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2c9ccef6-e858-4a28-9194-a86fef34c556" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_e57978e1-f404-47f3-b669-b2bf62fca9fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_136cb8c4-82b9-4ff8-b492-1540172f8259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7c01b91a-c88a-4897-98f7-2b94f0644ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_136cb8c4-82b9-4ff8-b492-1540172f8259" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7c01b91a-c88a-4897-98f7-2b94f0644ac9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8a919d0e-55b4-48cb-ac57-2c721e033310" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_136cb8c4-82b9-4ff8-b492-1540172f8259" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8a919d0e-55b4-48cb-ac57-2c721e033310" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_7cdfb272-ff5c-493f-8b09-8da9a6f5af41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_5548fad6-fd77-45df-bae9-ec76b918798c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_7cdfb272-ff5c-493f-8b09-8da9a6f5af41" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_5548fad6-fd77-45df-bae9-ec76b918798c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_UnrecognizedNetActuarialLossGain_31a06e54-59fa-4a0d-b097-f7684f80e82a" xlink:href="hae-20230401.xsd#hae_UnrecognizedNetActuarialLossGain"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_7cdfb272-ff5c-493f-8b09-8da9a6f5af41" xlink:to="loc_hae_UnrecognizedNetActuarialLossGain_31a06e54-59fa-4a0d-b097-f7684f80e82a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_UnrecognizedPriorServiceCost_384b539a-bbb5-48e1-bdcf-5edcc1ad8428" xlink:href="hae-20230401.xsd#hae_UnrecognizedPriorServiceCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_7cdfb272-ff5c-493f-8b09-8da9a6f5af41" xlink:to="loc_hae_UnrecognizedPriorServiceCost_384b539a-bbb5-48e1-bdcf-5edcc1ad8428" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1" xlink:type="simple" xlink:href="hae-20230401.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bac182f7-45a8-44f2-acf3-7ae8245d89bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_089badfe-6bd7-4a8d-8e84-d352afee6aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bac182f7-45a8-44f2-acf3-7ae8245d89bb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_089badfe-6bd7-4a8d-8e84-d352afee6aad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ba8bb527-90f7-4a01-90e6-08de8b5d03c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bac182f7-45a8-44f2-acf3-7ae8245d89bb" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ba8bb527-90f7-4a01-90e6-08de8b5d03c1" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>hae-20230401_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d8e9c074-6bb3-481a-a40c-b4f91e1c5276,g:f0cc1f72-36f0-46b0-9a43-9e0dba51bc09-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="hae-20230401.xsd#CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="icea809b4da0b4b12bd72077a6f16e104_CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_24758221-3987-4387-8f4a-97dbd88b7b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_24758221-3987-4387-8f4a-97dbd88b7b5a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_a4fdff23-e956-4e81-9808-5f7c7574c0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_SharesIssued_a4fdff23-e956-4e81-9808-5f7c7574c0e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7839177d-06c7-4bef-aabe-b4a8651987c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockholdersEquity_7839177d-06c7-4bef-aabe-b4a8651987c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c779547b-77f4-436c-851c-817004c1277b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c779547b-77f4-436c-851c-817004c1277b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_8a28272e-bdad-4d7c-9167-5986f0fc0d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_8a28272e-bdad-4d7c-9167-5986f0fc0d31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_89047b07-7396-430f-b026-99c3a57e9ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_89047b07-7396-430f-b026-99c3a57e9ef1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ec4d63e8-1f11-48e8-869e-e434b37f0444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ec4d63e8-1f11-48e8-869e-e434b37f0444" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_d7f2b1b4-e54c-4ba3-b1e8-9ed6cbbaaae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_d7f2b1b4-e54c-4ba3-b1e8-9ed6cbbaaae1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_e627d6c6-a534-4c7d-bd20-88655742b2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_e627d6c6-a534-4c7d-bd20-88655742b2d8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_4a71552b-476a-441e-9ea9-27bc4fa10f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_4a71552b-476a-441e-9ea9-27bc4fa10f58" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_945e82c4-3423-4d45-b091-297a69728c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_945e82c4-3423-4d45-b091-297a69728c12" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_67b3d0f0-2457-4e57-bb67-22bcd073b025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_67b3d0f0-2457-4e57-bb67-22bcd073b025" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_740c6e44-01f4-44b8-a80c-b564554c06b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_740c6e44-01f4-44b8-a80c-b564554c06b1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases_06bb2c3d-b7e8-444c-8d18-da26d5ff4607" xlink:href="hae-20230401.xsd#hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases_06bb2c3d-b7e8-444c-8d18-da26d5ff4607" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6f3095e1-c5f8-4fdd-9cc7-2771bc38331b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_NetIncomeLoss_6f3095e1-c5f8-4fdd-9cc7-2771bc38331b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_87690360-fbec-493b-b33e-eeebf2921346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_87690360-fbec-493b-b33e-eeebf2921346" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_60fbfa41-09ff-4992-a5ce-3369d28da6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cf64cf54-a7de-461b-bc18-de657c693f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_21271963-b3bb-4b4e-bb82-53d9a886ea11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_24758221-3987-4387-8f4a-97dbd88b7b5a" xlink:to="loc_us-gaap_StatementTable_21271963-b3bb-4b4e-bb82-53d9a886ea11" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_74e55ef7-9f45-4c20-8c17-659f133371ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_21271963-b3bb-4b4e-bb82-53d9a886ea11" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_74e55ef7-9f45-4c20-8c17-659f133371ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_74e55ef7-9f45-4c20-8c17-659f133371ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_74e55ef7-9f45-4c20-8c17-659f133371ee" xlink:to="loc_us-gaap_EquityComponentDomain_74e55ef7-9f45-4c20-8c17-659f133371ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_01ebead3-afa0-48d9-bd04-137d25eda533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_74e55ef7-9f45-4c20-8c17-659f133371ee" xlink:to="loc_us-gaap_EquityComponentDomain_01ebead3-afa0-48d9-bd04-137d25eda533" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_516af9ce-c4f9-4c3d-8ac0-e7d8a845832c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_01ebead3-afa0-48d9-bd04-137d25eda533" xlink:to="loc_us-gaap_CommonStockMember_516af9ce-c4f9-4c3d-8ac0-e7d8a845832c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9b7db65f-cb8c-47b5-be7f-3d5c22556973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_01ebead3-afa0-48d9-bd04-137d25eda533" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9b7db65f-cb8c-47b5-be7f-3d5c22556973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_21ae9651-bc38-491e-b001-68fffda4ae00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_01ebead3-afa0-48d9-bd04-137d25eda533" xlink:to="loc_us-gaap_RetainedEarningsMember_21ae9651-bc38-491e-b001-68fffda4ae00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_10344649-cf38-43be-a07c-fff4966989de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_01ebead3-afa0-48d9-bd04-137d25eda533" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_10344649-cf38-43be-a07c-fff4966989de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_de511c6a-8388-4480-8bab-488eaeded70d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_21271963-b3bb-4b4e-bb82-53d9a886ea11" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_de511c6a-8388-4480-8bab-488eaeded70d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_de511c6a-8388-4480-8bab-488eaeded70d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_de511c6a-8388-4480-8bab-488eaeded70d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_de511c6a-8388-4480-8bab-488eaeded70d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_83ebca3e-9bf7-4220-9252-4814829069aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_de511c6a-8388-4480-8bab-488eaeded70d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_83ebca3e-9bf7-4220-9252-4814829069aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2e0dbd58-f27f-4c28-9598-73e23cea1341" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_83ebca3e-9bf7-4220-9252-4814829069aa" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2e0dbd58-f27f-4c28-9598-73e23cea1341" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended" id="ic20a45253aa446c3a4d639826167cd15_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:href="hae-20230401.xsd#hae_SummaryOfSignificantAccountingPronouncementsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration_a8c8d9e9-f26f-427c-94ec-6184ff5aba3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration_a8c8d9e9-f26f-427c-94ec-6184ff5aba3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_MaximumTermOfMaturitiesForCashAndCashEquivalents_b7a8453f-3e12-4a55-a072-2b306464ff27" xlink:href="hae-20230401.xsd#hae_MaximumTermOfMaturitiesForCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_hae_MaximumTermOfMaturitiesForCashAndCashEquivalents_b7a8453f-3e12-4a55-a072-2b306464ff27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a7855cc5-1bfe-43ff-ac48-be6b7024b75d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a7855cc5-1bfe-43ff-ac48-be6b7024b75d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SoftwareCapitalizationTerm_1cfbe209-d835-4dcd-bede-57646aea8344" xlink:href="hae-20230401.xsd#hae_SoftwareCapitalizationTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_hae_SoftwareCapitalizationTerm_1cfbe209-d835-4dcd-bede-57646aea8344" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareImpairments1_4927e8e6-5681-44d7-9aaf-4f31cf38b79a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareImpairments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareImpairments1_4927e8e6-5681-44d7-9aaf-4f31cf38b79a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_405e3b95-c162-4f49-bdad-7ff3c758d605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_405e3b95-c162-4f49-bdad-7ff3c758d605" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_06b740ae-cf5b-4cab-9534-461e15ce4bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_06b740ae-cf5b-4cab-9534-461e15ce4bcd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d5db76aa-0e3e-4bce-ab76-440e2c915326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_06b740ae-cf5b-4cab-9534-461e15ce4bcd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d5db76aa-0e3e-4bce-ab76-440e2c915326" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_4821c64f-7760-4467-97e8-d86515a8c24a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_06b740ae-cf5b-4cab-9534-461e15ce4bcd" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_4821c64f-7760-4467-97e8-d86515a8c24a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2bc5cdc4-ca4a-48c6-bd04-2437facd6607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_06b740ae-cf5b-4cab-9534-461e15ce4bcd" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2bc5cdc4-ca4a-48c6-bd04-2437facd6607" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_68f453f6-9295-4e44-92ad-4b787b1ead17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_06b740ae-cf5b-4cab-9534-461e15ce4bcd" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_68f453f6-9295-4e44-92ad-4b787b1ead17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_c799f019-3de9-40ba-ba59-5c3f456f2142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_AdvertisingExpense_c799f019-3de9-40ba-ba59-5c3f456f2142" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_d709742a-863d-43be-8712-8b843b6afdae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_d709742a-863d-43be-8712-8b843b6afdae" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_d2a4d7f5-aeac-4214-993e-0825ca4099ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_GainLossOnInvestments_d2a4d7f5-aeac-4214-993e-0825ca4099ac" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5944e2c0-e7c7-42c9-9f8e-1633c70831eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_StockholdersEquity_5944e2c0-e7c7-42c9-9f8e-1633c70831eb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_adee80ed-a6e5-48d4-966c-76383cbac30a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_adee80ed-a6e5-48d4-966c-76383cbac30a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_bdc870c0-5fdf-42a5-b74a-1027c46bfb65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_bdc870c0-5fdf-42a5-b74a-1027c46bfb65" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:href="hae-20230401.xsd#hae_SummaryOfSignificantAccountingPronouncementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9c001d1a-c566-48d1-8692-ae7676daa7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9c001d1a-c566-48d1-8692-ae7676daa7b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_9c001d1a-c566-48d1-8692-ae7676daa7b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9c001d1a-c566-48d1-8692-ae7676daa7b4" xlink:to="loc_us-gaap_TypeOfAdoptionMember_9c001d1a-c566-48d1-8692-ae7676daa7b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_a65e28bb-14b6-4522-8623-13c540b57270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9c001d1a-c566-48d1-8692-ae7676daa7b4" xlink:to="loc_us-gaap_TypeOfAdoptionMember_a65e28bb-14b6-4522-8623-13c540b57270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_cc90ff67-2cf1-4fb6-9e00-d5c3e26d4467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_a65e28bb-14b6-4522-8623-13c540b57270" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_cc90ff67-2cf1-4fb6-9e00-d5c3e26d4467" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_537c3a04-4d29-4879-949f-acbbb5b8cc31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_537c3a04-4d29-4879-949f-acbbb5b8cc31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_537c3a04-4d29-4879-949f-acbbb5b8cc31_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_537c3a04-4d29-4879-949f-acbbb5b8cc31" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_537c3a04-4d29-4879-949f-acbbb5b8cc31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1fb124f3-818f-44ad-a07d-820a03fdb968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_537c3a04-4d29-4879-949f-acbbb5b8cc31" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1fb124f3-818f-44ad-a07d-820a03fdb968" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_14e1ea55-5088-4805-a937-decd6445fbf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1fb124f3-818f-44ad-a07d-820a03fdb968" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_14e1ea55-5088-4805-a937-decd6445fbf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1721e50c-e56a-4c36-9a9e-3b2f61e5afe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1721e50c-e56a-4c36-9a9e-3b2f61e5afe6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1721e50c-e56a-4c36-9a9e-3b2f61e5afe6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1721e50c-e56a-4c36-9a9e-3b2f61e5afe6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1721e50c-e56a-4c36-9a9e-3b2f61e5afe6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3c3d091b-f14b-477e-a206-39080133aa62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1721e50c-e56a-4c36-9a9e-3b2f61e5afe6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3c3d091b-f14b-477e-a206-39080133aa62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_3a176256-943d-48f7-a204-294e42154c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_3c3d091b-f14b-477e-a206-39080133aa62" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_3a176256-943d-48f7-a204-294e42154c7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_664d791e-2911-48c4-98d1-991a3e764214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_664d791e-2911-48c4-98d1-991a3e764214" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_664d791e-2911-48c4-98d1-991a3e764214_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_664d791e-2911-48c4-98d1-991a3e764214" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_664d791e-2911-48c4-98d1-991a3e764214_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f78afb6-28d0-4921-853b-0442acb68181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_664d791e-2911-48c4-98d1-991a3e764214" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f78afb6-28d0-4921-853b-0442acb68181" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_7d1f7df9-1dc9-4861-8156-c26f7a33c497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f78afb6-28d0-4921-853b-0442acb68181" xlink:to="loc_us-gaap_BuildingMember_7d1f7df9-1dc9-4861-8156-c26f7a33c497" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_258dc4bc-2de0-43c6-91b9-9f81b24debf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f78afb6-28d0-4921-853b-0442acb68181" xlink:to="loc_us-gaap_BuildingImprovementsMember_258dc4bc-2de0-43c6-91b9-9f81b24debf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_fd696877-a1be-4501-8a56-ca63968175b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f78afb6-28d0-4921-853b-0442acb68181" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_fd696877-a1be-4501-8a56-ca63968175b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OfficeEquipmentAndInformationTechnologyMember_77e11b80-718c-48da-a644-3f1938d90ea9" xlink:href="hae-20230401.xsd#hae_OfficeEquipmentAndInformationTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f78afb6-28d0-4921-853b-0442acb68181" xlink:to="loc_hae_OfficeEquipmentAndInformationTechnologyMember_77e11b80-718c-48da-a644-3f1938d90ea9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HaemoneticsEquipmentMember_fc0b08f6-44fa-4310-8912-7da75715441f" xlink:href="hae-20230401.xsd#hae_HaemoneticsEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f78afb6-28d0-4921-853b-0442acb68181" xlink:to="loc_hae_HaemoneticsEquipmentMember_fc0b08f6-44fa-4310-8912-7da75715441f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_59d95b85-0ee4-4589-9732-c05b1f7c7b37" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:to="loc_srt_RangeAxis_59d95b85-0ee4-4589-9732-c05b1f7c7b37" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_59d95b85-0ee4-4589-9732-c05b1f7c7b37_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_59d95b85-0ee4-4589-9732-c05b1f7c7b37" xlink:to="loc_srt_RangeMember_59d95b85-0ee4-4589-9732-c05b1f7c7b37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5fc5ba7d-f650-47d4-bae7-979b34a8a610" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_59d95b85-0ee4-4589-9732-c05b1f7c7b37" xlink:to="loc_srt_RangeMember_5fc5ba7d-f650-47d4-bae7-979b34a8a610" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ab809fa0-943d-4a46-bdb0-f6390fb623a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5fc5ba7d-f650-47d4-bae7-979b34a8a610" xlink:to="loc_srt_MinimumMember_ab809fa0-943d-4a46-bdb0-f6390fb623a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a6bc0ada-953d-45f6-866a-8add1b54a8e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5fc5ba7d-f650-47d4-bae7-979b34a8a610" xlink:to="loc_srt_MaximumMember_a6bc0ada-953d-45f6-866a-8add1b54a8e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_8f281cb3-01d9-4e4d-a547-123d70bb017a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:to="loc_srt_MajorCustomersAxis_8f281cb3-01d9-4e4d-a547-123d70bb017a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8f281cb3-01d9-4e4d-a547-123d70bb017a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_8f281cb3-01d9-4e4d-a547-123d70bb017a" xlink:to="loc_srt_NameOfMajorCustomerDomain_8f281cb3-01d9-4e4d-a547-123d70bb017a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_7ad84341-e80b-4834-8b21-454c65c03f2f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_8f281cb3-01d9-4e4d-a547-123d70bb017a" xlink:to="loc_srt_NameOfMajorCustomerDomain_7ad84341-e80b-4834-8b21-454c65c03f2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TenLargestCustomersMember_cc9701e8-aec2-4abe-9392-0d34c7c47d3d" xlink:href="hae-20230401.xsd#hae_TenLargestCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_7ad84341-e80b-4834-8b21-454c65c03f2f" xlink:to="loc_hae_TenLargestCustomersMember_cc9701e8-aec2-4abe-9392-0d34c7c47d3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaCustomerCSLLimitedCSLMember_a5bd5cfa-92ef-426c-8b58-e576c1e51a4a" xlink:href="hae-20230401.xsd#hae_PlasmaCustomerCSLLimitedCSLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_7ad84341-e80b-4834-8b21-454c65c03f2f" xlink:to="loc_hae_PlasmaCustomerCSLLimitedCSLMember_a5bd5cfa-92ef-426c-8b58-e576c1e51a4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a316a98b-8648-477e-b99c-ea376f0412a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a316a98b-8648-477e-b99c-ea376f0412a9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a316a98b-8648-477e-b99c-ea376f0412a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a316a98b-8648-477e-b99c-ea376f0412a9" xlink:to="loc_us-gaap_EquityComponentDomain_a316a98b-8648-477e-b99c-ea376f0412a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9648b9a1-4720-4630-986c-1edc5eee43d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a316a98b-8648-477e-b99c-ea376f0412a9" xlink:to="loc_us-gaap_EquityComponentDomain_9648b9a1-4720-4630-986c-1edc5eee43d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6539d0aa-397a-4961-be68-84fd2ce26091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9648b9a1-4720-4630-986c-1edc5eee43d7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6539d0aa-397a-4961-be68-84fd2ce26091" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_13052a52-e8ca-4000-92a1-4e6b020e44a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9648b9a1-4720-4630-986c-1edc5eee43d7" xlink:to="loc_us-gaap_RetainedEarningsMember_13052a52-e8ca-4000-92a1-4e6b020e44a9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#RESTRUCTURINGNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails" xlink:type="extended" id="ifcd2f77a856444ae98c94e1300cd31b3_RESTRUCTURINGNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_ec683e0f-db61-499b-a876-440716c3015f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_ec683e0f-db61-499b-a876-440716c3015f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandRestructuringRelatedCosts_5b0c34d3-c366-4caa-b597-a71c9a97bc06" xlink:href="hae-20230401.xsd#hae_RestructuringandRestructuringRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:to="loc_hae_RestructuringandRestructuringRelatedCosts_5b0c34d3-c366-4caa-b597-a71c9a97bc06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_5ff0ae04-5cbe-4120-ba39-2aa4f6dce8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_5ff0ae04-5cbe-4120-ba39-2aa4f6dce8cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_a9ab48ca-2a2b-4a38-b8db-f6f4a039952e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:to="loc_us-gaap_RestructuringReserve_a9ab48ca-2a2b-4a38-b8db-f6f4a039952e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringChargesPayableInNextTwelveMonths_1079848b-b98a-4161-ba21-daebd85f6e89" xlink:href="hae-20230401.xsd#hae_RestructuringChargesPayableInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:to="loc_hae_RestructuringChargesPayableInNextTwelveMonths_1079848b-b98a-4161-ba21-daebd85f6e89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringRelatedCosts_7d957f7d-fde2-4d7c-a195-aa216706c8bf" xlink:href="hae-20230401.xsd#hae_RestructuringRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:to="loc_hae_RestructuringRelatedCosts_7d957f7d-fde2-4d7c-a195-aa216706c8bf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_614d08f5-533b-4548-a51d-7d4b61f1db8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_614d08f5-533b-4548-a51d-7d4b61f1db8d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_65a3f1ce-b6b6-424e-a81a-ff0e3b6a08b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_65a3f1ce-b6b6-424e-a81a-ff0e3b6a08b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cb1d2315-602a-44ee-a9fb-ff3e52183162" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_65a3f1ce-b6b6-424e-a81a-ff0e3b6a08b4" xlink:to="loc_srt_RangeAxis_cb1d2315-602a-44ee-a9fb-ff3e52183162" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cb1d2315-602a-44ee-a9fb-ff3e52183162_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cb1d2315-602a-44ee-a9fb-ff3e52183162" xlink:to="loc_srt_RangeMember_cb1d2315-602a-44ee-a9fb-ff3e52183162_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a7b9115a-6016-477c-8ca8-98f636c1d0b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cb1d2315-602a-44ee-a9fb-ff3e52183162" xlink:to="loc_srt_RangeMember_a7b9115a-6016-477c-8ca8-98f636c1d0b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cda76fbe-edfe-4acd-9174-ad4f778a700c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a7b9115a-6016-477c-8ca8-98f636c1d0b7" xlink:to="loc_srt_MinimumMember_cda76fbe-edfe-4acd-9174-ad4f778a700c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_afa5bde8-85fa-4738-8505-0b5e0c9ea00e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a7b9115a-6016-477c-8ca8-98f636c1d0b7" xlink:to="loc_srt_MaximumMember_afa5bde8-85fa-4738-8505-0b5e0c9ea00e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_38a7c84b-cacf-424e-ade5-f0b696b760de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_65a3f1ce-b6b6-424e-a81a-ff0e3b6a08b4" xlink:to="loc_us-gaap_RestructuringPlanAxis_38a7c84b-cacf-424e-ade5-f0b696b760de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_38a7c84b-cacf-424e-ade5-f0b696b760de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_38a7c84b-cacf-424e-ade5-f0b696b760de" xlink:to="loc_us-gaap_RestructuringPlanDomain_38a7c84b-cacf-424e-ade5-f0b696b760de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_cb7b0642-15b4-462e-b613-de9b169ea27a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_38a7c84b-cacf-424e-ade5-f0b696b760de" xlink:to="loc_us-gaap_RestructuringPlanDomain_cb7b0642-15b4-462e-b613-de9b169ea27a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2020ProgramMember_3d280ff4-bc4f-42c0-b65f-7f81ebb6bcd0" xlink:href="hae-20230401.xsd#hae_A2020ProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_cb7b0642-15b4-462e-b613-de9b169ea27a" xlink:to="loc_hae_A2020ProgramMember_3d280ff4-bc4f-42c0-b65f-7f81ebb6bcd0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="extended" id="i6d2458b26a314812962b16f0b9f51a4a_RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1e6f5691-b2a6-4425-84b7-bf425ce0a235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_1687c747-29d7-4d41-b888-d517f153af4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e6f5691-b2a6-4425-84b7-bf425ce0a235" xlink:to="loc_us-gaap_RestructuringReserveRollForward_1687c747-29d7-4d41-b888-d517f153af4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_098cb700-b2a8-411a-b2ee-ab325a9c8f51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1687c747-29d7-4d41-b888-d517f153af4f" xlink:to="loc_us-gaap_RestructuringReserve_098cb700-b2a8-411a-b2ee-ab325a9c8f51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_019afb00-6b9f-406c-b349-aae4bea97c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1687c747-29d7-4d41-b888-d517f153af4f" xlink:to="loc_us-gaap_RestructuringCharges_019afb00-6b9f-406c-b349-aae4bea97c3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_5ef67e51-16a0-4249-a0c8-facfb6ce6b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1687c747-29d7-4d41-b888-d517f153af4f" xlink:to="loc_us-gaap_PaymentsForRestructuring_5ef67e51-16a0-4249-a0c8-facfb6ce6b63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_d343db45-fec1-44b9-82d2-37d07d054128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringRelatedCosts_9279dbfd-da42-4ea6-8f7b-81204e2643c8" xlink:href="hae-20230401.xsd#hae_RestructuringRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e6f5691-b2a6-4425-84b7-bf425ce0a235" xlink:to="loc_hae_RestructuringRelatedCosts_9279dbfd-da42-4ea6-8f7b-81204e2643c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandRestructuringRelatedCosts_9ece9c44-402e-48c7-b0b2-39233f28057a" xlink:href="hae-20230401.xsd#hae_RestructuringandRestructuringRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e6f5691-b2a6-4425-84b7-bf425ce0a235" xlink:to="loc_hae_RestructuringandRestructuringRelatedCosts_9ece9c44-402e-48c7-b0b2-39233f28057a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9cae0ac5-89f8-4fc3-b4cf-cd0352bee0af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e6f5691-b2a6-4425-84b7-bf425ce0a235" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9cae0ac5-89f8-4fc3-b4cf-cd0352bee0af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e8ae6e2e-83ab-47bf-ba90-dd4b46a5825a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9cae0ac5-89f8-4fc3-b4cf-cd0352bee0af" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e8ae6e2e-83ab-47bf-ba90-dd4b46a5825a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e8ae6e2e-83ab-47bf-ba90-dd4b46a5825a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e8ae6e2e-83ab-47bf-ba90-dd4b46a5825a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e8ae6e2e-83ab-47bf-ba90-dd4b46a5825a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f544320f-115a-404c-8556-f9110536a6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e8ae6e2e-83ab-47bf-ba90-dd4b46a5825a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f544320f-115a-404c-8556-f9110536a6ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_499fff36-9225-4489-b2a5-b80068a4c65d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f544320f-115a-404c-8556-f9110536a6ea" xlink:to="loc_us-gaap_CostOfSalesMember_499fff36-9225-4489-b2a5-b80068a4c65d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_b100c09e-9eac-4779-b7b5-6a5fea570083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f544320f-115a-404c-8556-f9110536a6ea" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_b100c09e-9eac-4779-b7b5-6a5fea570083" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_53b1dffd-dc04-465c-a92a-75f6d14b6f55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f544320f-115a-404c-8556-f9110536a6ea" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_53b1dffd-dc04-465c-a92a-75f6d14b6f55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_ecd9933e-e4f3-4a7d-b368-a21901f0365f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9cae0ac5-89f8-4fc3-b4cf-cd0352bee0af" xlink:to="loc_us-gaap_RestructuringPlanAxis_ecd9933e-e4f3-4a7d-b368-a21901f0365f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_ecd9933e-e4f3-4a7d-b368-a21901f0365f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_ecd9933e-e4f3-4a7d-b368-a21901f0365f" xlink:to="loc_us-gaap_RestructuringPlanDomain_ecd9933e-e4f3-4a7d-b368-a21901f0365f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_7c597d7f-e6d2-4c47-8236-09abd4b91ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_ecd9933e-e4f3-4a7d-b368-a21901f0365f" xlink:to="loc_us-gaap_RestructuringPlanDomain_7c597d7f-e6d2-4c47-8236-09abd4b91ecd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2020ProgramMember_1da2c77c-6c6c-4bd3-8d48-eeb67672957c" xlink:href="hae-20230401.xsd#hae_A2020ProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_7c597d7f-e6d2-4c47-8236-09abd4b91ecd" xlink:to="loc_hae_A2020ProgramMember_1da2c77c-6c6c-4bd3-8d48-eeb67672957c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PriorRestructuringProgramsMember_6691c102-7685-4c73-8dec-d97daedec56b" xlink:href="hae-20230401.xsd#hae_PriorRestructuringProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_7c597d7f-e6d2-4c47-8236-09abd4b91ecd" xlink:to="loc_hae_PriorRestructuringProgramsMember_6691c102-7685-4c73-8dec-d97daedec56b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c8315f61-29bf-47d6-88b7-0a5b5a038662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9cae0ac5-89f8-4fc3-b4cf-cd0352bee0af" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c8315f61-29bf-47d6-88b7-0a5b5a038662" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c8315f61-29bf-47d6-88b7-0a5b5a038662_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c8315f61-29bf-47d6-88b7-0a5b5a038662" xlink:to="loc_us-gaap_SegmentDomain_c8315f61-29bf-47d6-88b7-0a5b5a038662_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a7e5eaee-0bb7-4718-88ea-6d4417ce2b48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c8315f61-29bf-47d6-88b7-0a5b5a038662" xlink:to="loc_us-gaap_SegmentDomain_a7e5eaee-0bb7-4718-88ea-6d4417ce2b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaMember_17ce0d62-f0c8-4d66-9ce7-ea1c0e29dd68" xlink:href="hae-20230401.xsd#hae_PlasmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a7e5eaee-0bb7-4718-88ea-6d4417ce2b48" xlink:to="loc_hae_PlasmaMember_17ce0d62-f0c8-4d66-9ce7-ea1c0e29dd68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterMember_6d9802c8-98e9-4c6f-bd90-deeec8603a74" xlink:href="hae-20230401.xsd#hae_BloodCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a7e5eaee-0bb7-4718-88ea-6d4417ce2b48" xlink:to="loc_hae_BloodCenterMember_6d9802c8-98e9-4c6f-bd90-deeec8603a74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalMember_4c7188fb-11b7-405a-9172-d58c55847729" xlink:href="hae-20230401.xsd#hae_HospitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a7e5eaee-0bb7-4718-88ea-6d4417ce2b48" xlink:to="loc_hae_HospitalMember_4c7188fb-11b7-405a-9172-d58c55847729" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_3d3af7f0-1a73-4170-bd5b-c43b251dd254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a7e5eaee-0bb7-4718-88ea-6d4417ce2b48" xlink:to="loc_us-gaap_AllOtherSegmentsMember_3d3af7f0-1a73-4170-bd5b-c43b251dd254" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITIONSDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#ACQUISITIONSDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/ACQUISITIONSDetails" xlink:type="extended" id="icdc8cb1ac3464dceaa472ab0db888f80_ACQUISITIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b259181a-f6f7-441b-8292-bf21cbceeb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b259181a-f6f7-441b-8292-bf21cbceeb4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7e4a585b-7ec8-447a-9da8-2ceaf7335d07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7e4a585b-7ec8-447a-9da8-2ceaf7335d07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_fd250f14-f2e3-4af4-8c8b-cd73791e7da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_fd250f14-f2e3-4af4-8c8b-cd73791e7da3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3d843af0-2f29-40e4-83ce-eaa8fb6c8ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3d843af0-2f29-40e4-83ce-eaa8fb6c8ba2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_760b11ef-e25f-42e0-a553-64952a7c716c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_760b11ef-e25f-42e0-a553-64952a7c716c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_12052229-e1dd-49cb-96f4-f0edffa874a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_12052229-e1dd-49cb-96f4-f0edffa874a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_3e8a25b2-6cca-4f83-ad71-8482e33c486a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_3e8a25b2-6cca-4f83-ad71-8482e33c486a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7e21a9f9-4598-46a2-bd1f-c61d91a2d94e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_Goodwill_7e21a9f9-4598-46a2-bd1f-c61d91a2d94e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_9f25111b-3561-4fc9-bb4f-c5a17d420004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_9f25111b-3561-4fc9-bb4f-c5a17d420004" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_7d0f4243-19ed-4493-862b-4ee6483c8f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_7d0f4243-19ed-4493-862b-4ee6483c8f05" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_a93f3492-4866-43a6-b201-e1d77a044570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_a93f3492-4866-43a6-b201-e1d77a044570" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_37080219-4dd2-4007-9c36-6f80c3b35cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_37080219-4dd2-4007-9c36-6f80c3b35cb8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetAcquisitionMilestonePayment_d30900e2-dce8-47b1-ad84-9ed69c8bb31f" xlink:href="hae-20230401.xsd#hae_AssetAcquisitionMilestonePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_hae_AssetAcquisitionMilestonePayment_d30900e2-dce8-47b1-ad84-9ed69c8bb31f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate_89991d63-2724-4055-a096-9a0e72ad08d7" xlink:href="hae-20230401.xsd#hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate_89991d63-2724-4055-a096-9a0e72ad08d7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_c0b4acee-f230-40aa-be0a-abb66eff65b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_c0b4acee-f230-40aa-be0a-abb66eff65b3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21ac2fb2-4fb5-4335-b61c-fd50bf1aa479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21ac2fb2-4fb5-4335-b61c-fd50bf1aa479" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cc4df385-0687-4a3d-9e31-8aa04c829e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21ac2fb2-4fb5-4335-b61c-fd50bf1aa479" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cc4df385-0687-4a3d-9e31-8aa04c829e63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc4df385-0687-4a3d-9e31-8aa04c829e63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cc4df385-0687-4a3d-9e31-8aa04c829e63" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc4df385-0687-4a3d-9e31-8aa04c829e63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37f0bdb6-7f85-440f-b5a8-4523b3016620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cc4df385-0687-4a3d-9e31-8aa04c829e63" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37f0bdb6-7f85-440f-b5a8-4523b3016620" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CardivaMedicalIncMember_18f73c66-9ba8-4f30-8575-7db121eefaf4" xlink:href="hae-20230401.xsd#hae_CardivaMedicalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37f0bdb6-7f85-440f-b5a8-4523b3016620" xlink:to="loc_hae_CardivaMedicalIncMember_18f73c66-9ba8-4f30-8575-7db121eefaf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember_9c345aaf-1ee7-4772-9f28-803ddece7495" xlink:href="hae-20230401.xsd#hae_EnicorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37f0bdb6-7f85-440f-b5a8-4523b3016620" xlink:to="loc_hae_EnicorMember_9c345aaf-1ee7-4772-9f28-803ddece7495" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HASIntellectualPropertyMember_ad5aefae-d97f-460e-92f5-d92e6d9a440f" xlink:href="hae-20230401.xsd#hae_HASIntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37f0bdb6-7f85-440f-b5a8-4523b3016620" xlink:to="loc_hae_HASIntellectualPropertyMember_ad5aefae-d97f-460e-92f5-d92e6d9a440f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_d5231507-28d8-4f19-b941-cbd98078a1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21ac2fb2-4fb5-4335-b61c-fd50bf1aa479" xlink:to="loc_us-gaap_AssetAcquisitionAxis_d5231507-28d8-4f19-b941-cbd98078a1c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_d5231507-28d8-4f19-b941-cbd98078a1c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_d5231507-28d8-4f19-b941-cbd98078a1c6" xlink:to="loc_us-gaap_AssetAcquisitionDomain_d5231507-28d8-4f19-b941-cbd98078a1c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_a5f68f63-6919-4183-a6ee-b9a4016ea095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_d5231507-28d8-4f19-b941-cbd98078a1c6" xlink:to="loc_us-gaap_AssetAcquisitionDomain_a5f68f63-6919-4183-a6ee-b9a4016ea095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HASIntellectualPropertyMember_807531f8-be4b-48d5-8788-cd589f3ff692" xlink:href="hae-20230401.xsd#hae_HASIntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_a5f68f63-6919-4183-a6ee-b9a4016ea095" xlink:to="loc_hae_HASIntellectualPropertyMember_807531f8-be4b-48d5-8788-cd589f3ff692" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember_36086036-516f-4a10-aeb2-dce510dcc234" xlink:href="hae-20230401.xsd#hae_EnicorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_a5f68f63-6919-4183-a6ee-b9a4016ea095" xlink:to="loc_hae_EnicorMember_36086036-516f-4a10-aeb2-dce510dcc234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5da7f8c7-f842-4bf9-ac93-485e2e0257f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21ac2fb2-4fb5-4335-b61c-fd50bf1aa479" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5da7f8c7-f842-4bf9-ac93-485e2e0257f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5da7f8c7-f842-4bf9-ac93-485e2e0257f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5da7f8c7-f842-4bf9-ac93-485e2e0257f7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5da7f8c7-f842-4bf9-ac93-485e2e0257f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0050e69e-3786-405e-9e2e-958d7e8ed697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5da7f8c7-f842-4bf9-ac93-485e2e0257f7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0050e69e-3786-405e-9e2e-958d7e8ed697" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2355e409-7397-4fef-b03e-2918e41a9441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0050e69e-3786-405e-9e2e-958d7e8ed697" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2355e409-7397-4fef-b03e-2918e41a9441" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_8fabdbbe-67e5-46eb-8e40-f7f886c6dcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0050e69e-3786-405e-9e2e-958d7e8ed697" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_8fabdbbe-67e5-46eb-8e40-f7f886c6dcdd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#ACQUISITIONSPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails" xlink:type="extended" id="i33a5268a4349405e93ba24ab40344dc8_ACQUISITIONSPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_27f2bbb1-2255-4003-839c-770817605f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_27f2bbb1-2255-4003-839c-770817605f41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_09dff74d-55db-4393-9aea-5bed556a7469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_09dff74d-55db-4393-9aea-5bed556a7469" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_4372f840-c595-4c56-8b20-a785a0de1e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_4372f840-c595-4c56-8b20-a785a0de1e5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_42821fa0-7499-41fb-a86e-6f200991cc91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_42821fa0-7499-41fb-a86e-6f200991cc91" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a3fc7979-9287-4545-a985-ee117c0e8a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a3fc7979-9287-4545-a985-ee117c0e8a68" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1fc7414f-272e-42f2-be76-005ae9cea8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1fc7414f-272e-42f2-be76-005ae9cea8b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f73f57ce-6956-401a-bd31-321584eedf95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_Goodwill_f73f57ce-6956-401a-bd31-321584eedf95" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_75e444db-76cc-4937-b6b8-1f26e5bd3fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_75e444db-76cc-4937-b6b8-1f26e5bd3fb9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_e6a8cb63-d57c-4667-aa6f-ca06cc4d2f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_e6a8cb63-d57c-4667-aa6f-ca06cc4d2f4c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_673496b3-2153-43a2-b286-3a5212d1f720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_673496b3-2153-43a2-b286-3a5212d1f720" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts_1e2c5125-3f2b-427f-b7d5-cb62823c7636" xlink:href="hae-20230401.xsd#hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts_1e2c5125-3f2b-427f-b7d5-cb62823c7636" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_619bcf1e-a51a-4891-8bdd-20016cecbaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_619bcf1e-a51a-4891-8bdd-20016cecbaf3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d123f9c2-7115-4d32-9c5a-5f4a903f4415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d123f9c2-7115-4d32-9c5a-5f4a903f4415" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_5f40bdca-95bf-4957-b4ed-e5c98fe5eba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_5f40bdca-95bf-4957-b4ed-e5c98fe5eba4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7a375d27-b07a-4776-a714-1f6bbc34e7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7a375d27-b07a-4776-a714-1f6bbc34e7cd" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0119adde-b0ae-4b2b-b671-fe6f51442685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0119adde-b0ae-4b2b-b671-fe6f51442685" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d20290d5-326d-4f5f-9b4e-fb5550f8643a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d20290d5-326d-4f5f-9b4e-fb5550f8643a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_00d083a0-4f3d-4437-8ae3-d849f2e9cdb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d20290d5-326d-4f5f-9b4e-fb5550f8643a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_00d083a0-4f3d-4437-8ae3-d849f2e9cdb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00d083a0-4f3d-4437-8ae3-d849f2e9cdb9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_00d083a0-4f3d-4437-8ae3-d849f2e9cdb9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00d083a0-4f3d-4437-8ae3-d849f2e9cdb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b854ec2-c1c3-43f6-b9ce-73f0622a43ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_00d083a0-4f3d-4437-8ae3-d849f2e9cdb9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b854ec2-c1c3-43f6-b9ce-73f0622a43ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CardivaMedicalIncMember_10aef90e-b2cb-4f1d-8680-f1213f411198" xlink:href="hae-20230401.xsd#hae_CardivaMedicalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b854ec2-c1c3-43f6-b9ce-73f0622a43ac" xlink:to="loc_hae_CardivaMedicalIncMember_10aef90e-b2cb-4f1d-8680-f1213f411198" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember_ffa8b544-180c-4365-b4e2-d9f3f4e6f833" xlink:href="hae-20230401.xsd#hae_EnicorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b854ec2-c1c3-43f6-b9ce-73f0622a43ac" xlink:to="loc_hae_EnicorMember_ffa8b544-180c-4365-b4e2-d9f3f4e6f833" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#ACQUISITIONSIntangibleAssetsAcquiredDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails" xlink:type="extended" id="i334d8e274cad454c91af84bebe264a6e_ACQUISITIONSIntangibleAssetsAcquiredDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_42fcd39d-57ad-40ca-9f48-91bb35eb0e76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_87fa61e6-1be0-431d-8f95-53590c63f52e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_42fcd39d-57ad-40ca-9f48-91bb35eb0e76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_87fa61e6-1be0-431d-8f95-53590c63f52e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_f50a1452-21a2-4d73-bc7c-24fe27c06f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_42fcd39d-57ad-40ca-9f48-91bb35eb0e76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_f50a1452-21a2-4d73-bc7c-24fe27c06f0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_b90fd7b3-6355-4c04-b258-dae85080640a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_42fcd39d-57ad-40ca-9f48-91bb35eb0e76" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_b90fd7b3-6355-4c04-b258-dae85080640a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate_7ed43641-778f-448b-a6b0-c7633187e1e3" xlink:href="hae-20230401.xsd#hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_42fcd39d-57ad-40ca-9f48-91bb35eb0e76" xlink:to="loc_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate_7ed43641-778f-448b-a6b0-c7633187e1e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b9d5ed33-f6af-46e0-9fcb-96f8ec0093a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_42fcd39d-57ad-40ca-9f48-91bb35eb0e76" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b9d5ed33-f6af-46e0-9fcb-96f8ec0093a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4562cc77-804d-453f-b69e-5b4b956aa5cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b9d5ed33-f6af-46e0-9fcb-96f8ec0093a8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4562cc77-804d-453f-b69e-5b4b956aa5cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4562cc77-804d-453f-b69e-5b4b956aa5cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4562cc77-804d-453f-b69e-5b4b956aa5cf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4562cc77-804d-453f-b69e-5b4b956aa5cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c63878d3-3144-42e3-b404-750cfee05b68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4562cc77-804d-453f-b69e-5b4b956aa5cf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c63878d3-3144-42e3-b404-750cfee05b68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CardivaMedicalIncMember_45c39c52-a590-483f-97d3-83cd3dcd9350" xlink:href="hae-20230401.xsd#hae_CardivaMedicalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c63878d3-3144-42e3-b404-750cfee05b68" xlink:to="loc_hae_CardivaMedicalIncMember_45c39c52-a590-483f-97d3-83cd3dcd9350" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember_05e622d9-3822-4dbd-a824-08613deb0401" xlink:href="hae-20230401.xsd#hae_EnicorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c63878d3-3144-42e3-b404-750cfee05b68" xlink:to="loc_hae_EnicorMember_05e622d9-3822-4dbd-a824-08613deb0401" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e8f9ab90-f218-4a08-ad96-7a5b0037c432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b9d5ed33-f6af-46e0-9fcb-96f8ec0093a8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e8f9ab90-f218-4a08-ad96-7a5b0037c432" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8f9ab90-f218-4a08-ad96-7a5b0037c432_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e8f9ab90-f218-4a08-ad96-7a5b0037c432" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8f9ab90-f218-4a08-ad96-7a5b0037c432_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f7b19aec-230c-4408-a065-5d38195d6551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e8f9ab90-f218-4a08-ad96-7a5b0037c432" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f7b19aec-230c-4408-a065-5d38195d6551" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dcac282b-3dc1-4fa1-acc8-7ab4d751731e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f7b19aec-230c-4408-a065-5d38195d6551" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dcac282b-3dc1-4fa1-acc8-7ab4d751731e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_0eda566c-cb59-4555-ad1d-c55008f35b44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f7b19aec-230c-4408-a065-5d38195d6551" xlink:to="loc_us-gaap_CustomerRelationshipsMember_0eda566c-cb59-4555-ad1d-c55008f35b44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_622b88f9-a5de-400a-a7b3-f9d1d01d2404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f7b19aec-230c-4408-a065-5d38195d6551" xlink:to="loc_us-gaap_TrademarksMember_622b88f9-a5de-400a-a7b3-f9d1d01d2404" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fff4f4a4-3dc0-4bad-9b76-88c4be5ae2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b9d5ed33-f6af-46e0-9fcb-96f8ec0093a8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fff4f4a4-3dc0-4bad-9b76-88c4be5ae2fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fff4f4a4-3dc0-4bad-9b76-88c4be5ae2fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fff4f4a4-3dc0-4bad-9b76-88c4be5ae2fb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fff4f4a4-3dc0-4bad-9b76-88c4be5ae2fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f955a69c-eaf3-4516-a3e4-6d02b3b45736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fff4f4a4-3dc0-4bad-9b76-88c4be5ae2fb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f955a69c-eaf3-4516-a3e4-6d02b3b45736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_5b2eee2b-1368-4496-83cc-5682af6df038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f955a69c-eaf3-4516-a3e4-6d02b3b45736" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_5b2eee2b-1368-4496-83cc-5682af6df038" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/STRATEGICINVESTMENTSDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#STRATEGICINVESTMENTSDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/STRATEGICINVESTMENTSDetails" xlink:type="extended" id="i8684bf7004b841aeafb9c67ee93e2420_STRATEGICINVESTMENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_b0d94d0c-9b1a-42b8-93f5-e9e56f0320f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_3a57d1d1-d337-46be-9e4a-84a612f5af92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b0d94d0c-9b1a-42b8-93f5-e9e56f0320f0" xlink:to="loc_us-gaap_GainLossOnInvestments_3a57d1d1-d337-46be-9e4a-84a612f5af92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_98cc9850-8a77-4667-a03d-7b67bdc779c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b0d94d0c-9b1a-42b8-93f5-e9e56f0320f0" xlink:to="loc_us-gaap_Investments_98cc9850-8a77-4667-a03d-7b67bdc779c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_d14e12cd-b883-4d0b-9bfd-2e277157dc55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b0d94d0c-9b1a-42b8-93f5-e9e56f0320f0" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_d14e12cd-b883-4d0b-9bfd-2e277157dc55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c5f017a4-a8a4-4074-bc04-253258c5269d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_d14e12cd-b883-4d0b-9bfd-2e277157dc55" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c5f017a4-a8a4-4074-bc04-253258c5269d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c5f017a4-a8a4-4074-bc04-253258c5269d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c5f017a4-a8a4-4074-bc04-253258c5269d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c5f017a4-a8a4-4074-bc04-253258c5269d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d7b6b09b-b499-42e2-8492-1e5fc990d939" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c5f017a4-a8a4-4074-bc04-253258c5269d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d7b6b09b-b499-42e2-8492-1e5fc990d939" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_VivasureMedicalLTDMember_30d10ea4-bc88-4ba8-8d04-bc994ef78aa9" xlink:href="hae-20230401.xsd#hae_VivasureMedicalLTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d7b6b09b-b499-42e2-8492-1e5fc990d939" xlink:to="loc_hae_VivasureMedicalLTDMember_30d10ea4-bc88-4ba8-8d04-bc994ef78aa9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/DIVESTITUREDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#DIVESTITUREDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/DIVESTITUREDetails" xlink:type="extended" id="i9eed7e13fb954753a9e863901130a920_DIVESTITUREDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ac358292-cda7-4cf8-a711-8f1bb9451542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ac358292-cda7-4cf8-a711-8f1bb9451542" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_d87d8de3-cd8e-4b60-9dd5-2e16f604e3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_d87d8de3-cd8e-4b60-9dd5-2e16f604e3e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_35e937f8-ef3f-42e8-9261-3e765d0e2ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_AssetImpairmentCharges_35e937f8-ef3f-42e8-9261-3e765d0e2ad5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments_f399beb2-8854-4c34-b707-09ee7ea29f2c" xlink:href="hae-20230401.xsd#hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments_f399beb2-8854-4c34-b707-09ee7ea29f2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell_d5118378-4e21-4eda-afa0-30e0555bb1b7" xlink:href="hae-20230401.xsd#hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell_d5118378-4e21-4eda-afa0-30e0555bb1b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_b5b7d99a-d524-4215-9cc0-9abe7b436f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_b5b7d99a-d524-4215-9cc0-9abe7b436f18" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_4e056d30-0d05-4544-a002-acdf883eac9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_4e056d30-0d05-4544-a002-acdf883eac9a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_58e7492c-d2ae-4092-8c29-f374f20dc99d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_58e7492c-d2ae-4092-8c29-f374f20dc99d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5278cd85-8bac-463d-981d-7b88481c3218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_Goodwill_5278cd85-8bac-463d-981d-7b88481c3218" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments_fc1958c8-a94b-4d98-8108-d16620f899b0" xlink:href="hae-20230401.xsd#hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments_fc1958c8-a94b-4d98-8108-d16620f899b0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_91d96877-512e-4244-a17c-2aa577010081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_91d96877-512e-4244-a17c-2aa577010081" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_8a903621-1605-4935-900d-323812bb4bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_8a903621-1605-4935-900d-323812bb4bf1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_34fa2f8f-31ce-42cc-b21a-6c1f74b25cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_34fa2f8f-31ce-42cc-b21a-6c1f74b25cdc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_416addd8-8f94-46fb-a214-a53416f7faf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_416addd8-8f94-46fb-a214-a53416f7faf8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_54e758cc-58f2-4b59-b2a1-e49b8c782a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_54e758cc-58f2-4b59-b2a1-e49b8c782a12" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_9f33c748-4a7f-426b-b419-fb35d65b3269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_9f33c748-4a7f-426b-b419-fb35d65b3269" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived_d1de3a40-e1fd-41a0-b9e2-e4378f62e7cc" xlink:href="hae-20230401.xsd#hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived_d1de3a40-e1fd-41a0-b9e2-e4378f62e7cc" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0ba5dde9-10d8-49d8-9b31-2a24ede563c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0ba5dde9-10d8-49d8-9b31-2a24ede563c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0213c51b-9717-4ec1-bdc8-4c72d3ea09e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0ba5dde9-10d8-49d8-9b31-2a24ede563c7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0213c51b-9717-4ec1-bdc8-4c72d3ea09e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0213c51b-9717-4ec1-bdc8-4c72d3ea09e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0213c51b-9717-4ec1-bdc8-4c72d3ea09e3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0213c51b-9717-4ec1-bdc8-4c72d3ea09e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9502eda1-f202-40f2-8244-7ec530119f77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0213c51b-9717-4ec1-bdc8-4c72d3ea09e3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9502eda1-f202-40f2-8244-7ec530119f77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_FajardoPuertoRicoManufacturingOperationsMember_4d97997b-c69a-427c-b4fc-4bf89f965293" xlink:href="hae-20230401.xsd#hae_FajardoPuertoRicoManufacturingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9502eda1-f202-40f2-8244-7ec530119f77" xlink:to="loc_hae_FajardoPuertoRicoManufacturingOperationsMember_4d97997b-c69a-427c-b4fc-4bf89f965293" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_USBloodDonorManagementSoftwareMember_f072927b-042b-48f7-92b3-5c3a5627287c" xlink:href="hae-20230401.xsd#hae_USBloodDonorManagementSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9502eda1-f202-40f2-8244-7ec530119f77" xlink:to="loc_hae_USBloodDonorManagementSoftwareMember_f072927b-042b-48f7-92b3-5c3a5627287c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InlogHoldingsFranceMember_800cc058-4c3a-4ccc-9d70-5aff99382a0c" xlink:href="hae-20230401.xsd#hae_InlogHoldingsFranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9502eda1-f202-40f2-8244-7ec530119f77" xlink:to="loc_hae_InlogHoldingsFranceMember_800cc058-4c3a-4ccc-9d70-5aff99382a0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_05de7116-682e-4845-9e46-69bb78233e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0ba5dde9-10d8-49d8-9b31-2a24ede563c7" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_05de7116-682e-4845-9e46-69bb78233e7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_05de7116-682e-4845-9e46-69bb78233e7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_05de7116-682e-4845-9e46-69bb78233e7d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_05de7116-682e-4845-9e46-69bb78233e7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1d2b2738-0a03-444d-b686-ad2fb9119499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_05de7116-682e-4845-9e46-69bb78233e7d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1d2b2738-0a03-444d-b686-ad2fb9119499" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_3695ce17-d796-4c1a-bf3e-22ffc230627d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_1d2b2738-0a03-444d-b686-ad2fb9119499" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_3695ce17-d796-4c1a-bf3e-22ffc230627d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#INCOMETAXESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended" id="icdea417e3c2f4c1ea54854c0d7bfc93c_INCOMETAXESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:href="hae-20230401.xsd#hae_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TaxHolidayTerm_cefec14d-362f-48e2-84e3-7c94673ee6ae" xlink:href="hae-20230401.xsd#hae_TaxHolidayTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_hae_TaxHolidayTerm_cefec14d-362f-48e2-84e3-7c94673ee6ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_83af404f-6b23-4e30-aa74-fd6bea295542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_83af404f-6b23-4e30-aa74-fd6bea295542" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_9550d03e-59cf-40d9-a76b-b7322317b3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_9550d03e-59cf-40d9-a76b-b7322317b3ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_7d429ee2-cece-4098-9f7d-71b22db9a0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_OperatingLossCarryforwards_7d429ee2-cece-4098-9f7d-71b22db9a0f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_cd41da7d-a4b8-4dd6-90e0-af6b481fed02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_cd41da7d-a4b8-4dd6-90e0-af6b481fed02" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_776a6458-0cc9-416d-bf95-f6f09e636054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_776a6458-0cc9-416d-bf95-f6f09e636054" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_d38dd315-4fa1-4074-a940-b77f6ed799b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_d38dd315-4fa1-4074-a940-b77f6ed799b9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_81cc0cde-7d3f-4ecb-907c-c6aeb53882d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_81cc0cde-7d3f-4ecb-907c-c6aeb53882d2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_1a99c7b2-7975-4f8e-96ce-21ee873927a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_1a99c7b2-7975-4f8e-96ce-21ee873927a0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_8b3ef9f1-a12e-47ec-b665-95ac0472c360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_8b3ef9f1-a12e-47ec-b665-95ac0472c360" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3c35e831-df94-4b7f-8119-6b42caccc638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3c35e831-df94-4b7f-8119-6b42caccc638" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount_c5f90877-490a-4af9-8aeb-9f452176c37c" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount_c5f90877-490a-4af9-8aeb-9f452176c37c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7de1f4fb-20d9-4da3-941a-c7011f5c2af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7de1f4fb-20d9-4da3-941a-c7011f5c2af2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8e81bf6c-c20d-48d6-bb6d-721789070bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8e81bf6c-c20d-48d6-bb6d-721789070bbb" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_e09b7ea0-2557-49f2-986a-65ed40872940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_e09b7ea0-2557-49f2-986a-65ed40872940" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_c75ced09-ecf3-4d63-90dc-718f04cec90f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_c75ced09-ecf3-4d63-90dc-718f04cec90f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_9563ec15-184f-4258-89ba-001342b5c019" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_9563ec15-184f-4258-89ba-001342b5c019" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_0fdd427f-61f0-44a0-8d65-9ec32d67f78b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_0fdd427f-61f0-44a0-8d65-9ec32d67f78b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense_9acd73c0-7822-49eb-a111-212b167205cc" xlink:href="hae-20230401.xsd#hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense_9acd73c0-7822-49eb-a111-212b167205cc" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards_b9a1cf2e-5bd9-4b0d-8f68-d55f1927cac3" xlink:href="hae-20230401.xsd#hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards_b9a1cf2e-5bd9-4b0d-8f68-d55f1927cac3" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch_dfb43921-d46d-465a-80ed-9db53cf98cf9" xlink:href="hae-20230401.xsd#hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch_dfb43921-d46d-465a-80ed-9db53cf98cf9" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_401f570c-bf17-415a-8529-c5ae91ebd551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_401f570c-bf17-415a-8529-c5ae91ebd551" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_e9121c8c-a0bb-4ed4-9f62-457ee7b1b915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_e9121c8c-a0bb-4ed4-9f62-457ee7b1b915" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c5326104-9763-40f8-8914-9d35e92b583f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_e9121c8c-a0bb-4ed4-9f62-457ee7b1b915" xlink:to="loc_srt_StatementGeographicalAxis_c5326104-9763-40f8-8914-9d35e92b583f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c5326104-9763-40f8-8914-9d35e92b583f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c5326104-9763-40f8-8914-9d35e92b583f" xlink:to="loc_srt_SegmentGeographicalDomain_c5326104-9763-40f8-8914-9d35e92b583f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e9c82cc9-0176-46f4-975c-36669a343778" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c5326104-9763-40f8-8914-9d35e92b583f" xlink:to="loc_srt_SegmentGeographicalDomain_e9c82cc9-0176-46f4-975c-36669a343778" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_MY_fda7886f-bccc-4ce3-b895-d4324dad3c61" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e9c82cc9-0176-46f4-975c-36669a343778" xlink:to="loc_country_MY_fda7886f-bccc-4ce3-b895-d4324dad3c61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b1eeda1a-5a8b-42d8-9fdf-ba7b3b6e74e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_e9121c8c-a0bb-4ed4-9f62-457ee7b1b915" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b1eeda1a-5a8b-42d8-9fdf-ba7b3b6e74e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b1eeda1a-5a8b-42d8-9fdf-ba7b3b6e74e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b1eeda1a-5a8b-42d8-9fdf-ba7b3b6e74e3" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b1eeda1a-5a8b-42d8-9fdf-ba7b3b6e74e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_a6dba364-29b3-4d30-8714-b4659394f21e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b1eeda1a-5a8b-42d8-9fdf-ba7b3b6e74e3" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_a6dba364-29b3-4d30-8714-b4659394f21e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_a2e909a8-e86a-4192-bd02-681bd38b2ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_a6dba364-29b3-4d30-8714-b4659394f21e" xlink:to="loc_us-gaap_DomesticCountryMember_a2e909a8-e86a-4192-bd02-681bd38b2ac9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_c41e4795-e27e-43f5-b6d2-a7686b64985e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_a6dba364-29b3-4d30-8714-b4659394f21e" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_c41e4795-e27e-43f5-b6d2-a7686b64985e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_d2faf1a1-93aa-4a8b-ae56-42d9fd6aa22a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_a6dba364-29b3-4d30-8714-b4659394f21e" xlink:to="loc_us-gaap_ForeignCountryMember_d2faf1a1-93aa-4a8b-ae56-42d9fd6aa22a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0a0ec683-8705-4b3f-b1cc-f8df399dcebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_e9121c8c-a0bb-4ed4-9f62-457ee7b1b915" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0a0ec683-8705-4b3f-b1cc-f8df399dcebb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0a0ec683-8705-4b3f-b1cc-f8df399dcebb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0a0ec683-8705-4b3f-b1cc-f8df399dcebb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0a0ec683-8705-4b3f-b1cc-f8df399dcebb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_59b32a9f-2b0c-47e3-bc4c-5b1de55177eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0a0ec683-8705-4b3f-b1cc-f8df399dcebb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_59b32a9f-2b0c-47e3-bc4c-5b1de55177eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CardivaMedicalIncMember_e4b23da0-a636-49b9-8879-ed1f4157ce93" xlink:href="hae-20230401.xsd#hae_CardivaMedicalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_59b32a9f-2b0c-47e3-bc4c-5b1de55177eb" xlink:to="loc_hae_CardivaMedicalIncMember_e4b23da0-a636-49b9-8879-ed1f4157ce93" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#EARNINGSPERSHAREShareRepurchasePlanDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails" xlink:type="extended" id="i97bd78869f254e46b1f8835ae618c376_EARNINGSPERSHAREShareRepurchasePlanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_78f9ba2a-2a0d-4be4-85b7-11a08c0301a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_78f9ba2a-2a0d-4be4-85b7-11a08c0301a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_8d0b05a0-48ef-4597-9d74-44430950cb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_8d0b05a0-48ef-4597-9d74-44430950cb48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_40dcfa99-db09-40f3-9940-0e1d74fc56d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_40dcfa99-db09-40f3-9940-0e1d74fc56d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_187c9aec-c109-4a76-a55d-f37f93fa5950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_187c9aec-c109-4a76-a55d-f37f93fa5950" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_19f84815-85db-4ae3-a57b-9f14a188078b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_19f84815-85db-4ae3-a57b-9f14a188078b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_8a1a4c87-7bd3-4e69-b1b8-bbacdc409890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_8a1a4c87-7bd3-4e69-b1b8-bbacdc409890" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_70fdf9f0-7e86-4335-a719-4b5be11c9826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_70fdf9f0-7e86-4335-a719-4b5be11c9826" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_af9ccece-45b2-4405-8ecd-b0430105f2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_70fdf9f0-7e86-4335-a719-4b5be11c9826" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_af9ccece-45b2-4405-8ecd-b0430105f2d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_af9ccece-45b2-4405-8ecd-b0430105f2d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_af9ccece-45b2-4405-8ecd-b0430105f2d2" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_af9ccece-45b2-4405-8ecd-b0430105f2d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_abc33ed0-4081-407c-a6bc-5eb1d90ca961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_af9ccece-45b2-4405-8ecd-b0430105f2d2" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_abc33ed0-4081-407c-a6bc-5eb1d90ca961" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2022AcceleratedShareRepurchaseProgramMember_21b33ef5-ab50-4263-8852-7b915213fa5a" xlink:href="hae-20230401.xsd#hae_A2022AcceleratedShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_abc33ed0-4081-407c-a6bc-5eb1d90ca961" xlink:to="loc_hae_A2022AcceleratedShareRepurchaseProgramMember_21b33ef5-ab50-4263-8852-7b915213fa5a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#REVENUEPerformanceObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails" xlink:type="extended" id="if4a0d47501f943e7aecdb47428c7d79c_REVENUEPerformanceObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_bed912fd-f24a-4dcf-ba26-8ff07d4d7560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5ab0db45-7e83-4bbc-abe1-2b5c42880c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_bed912fd-f24a-4dcf-ba26-8ff07d4d7560" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5ab0db45-7e83-4bbc-abe1-2b5c42880c4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_f9ec3c4e-7acd-45da-8e08-5c6d71cdcec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_bed912fd-f24a-4dcf-ba26-8ff07d4d7560" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_f9ec3c4e-7acd-45da-8e08-5c6d71cdcec2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_a2526d2d-7289-4672-810f-779759059610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_f9ec3c4e-7acd-45da-8e08-5c6d71cdcec2" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_a2526d2d-7289-4672-810f-779759059610" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="hae-20230401.xsd#REVENUEPerformanceObligationsDetails_1"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails_1" xlink:type="extended" id="ibba016f52fb24721b12db5f31849afc3_REVENUEPerformanceObligationsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_bed912fd-f24a-4dcf-ba26-8ff07d4d7560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5ab0db45-7e83-4bbc-abe1-2b5c42880c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_bed912fd-f24a-4dcf-ba26-8ff07d4d7560" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5ab0db45-7e83-4bbc-abe1-2b5c42880c4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_f9ec3c4e-7acd-45da-8e08-5c6d71cdcec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_bed912fd-f24a-4dcf-ba26-8ff07d4d7560" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_f9ec3c4e-7acd-45da-8e08-5c6d71cdcec2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended" id="i369ccec43d4643e986cd95d89443f9f6_PROPERTYPLANTANDEQUIPMENTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8ca693e0-ed9c-480b-8dcd-a61e3dcf461b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_b6a87271-53d5-4d91-8e4c-02a6006c0592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8ca693e0-ed9c-480b-8dcd-a61e3dcf461b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_b6a87271-53d5-4d91-8e4c-02a6006c0592" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_aa592594-ee64-4314-9a2a-80fe3550b130" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8ca693e0-ed9c-480b-8dcd-a61e3dcf461b" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_aa592594-ee64-4314-9a2a-80fe3550b130" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_636a0025-6438-4ee0-b4b2-45e694f8f160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8ca693e0-ed9c-480b-8dcd-a61e3dcf461b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_636a0025-6438-4ee0-b4b2-45e694f8f160" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_d345f216-dc6b-4f43-a326-373dab8cc323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8ca693e0-ed9c-480b-8dcd-a61e3dcf461b" xlink:to="loc_us-gaap_Depreciation_d345f216-dc6b-4f43-a326-373dab8cc323" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_f4f5c2ad-e33e-44b2-b242-5e6e09511ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8ca693e0-ed9c-480b-8dcd-a61e3dcf461b" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_f4f5c2ad-e33e-44b2-b242-5e6e09511ea4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33c1ea47-2cf9-4289-9189-8019f5edad45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8ca693e0-ed9c-480b-8dcd-a61e3dcf461b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33c1ea47-2cf9-4289-9189-8019f5edad45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_85588970-70fc-4be8-8f95-fb8125664cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33c1ea47-2cf9-4289-9189-8019f5edad45" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_85588970-70fc-4be8-8f95-fb8125664cc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_85588970-70fc-4be8-8f95-fb8125664cc5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_85588970-70fc-4be8-8f95-fb8125664cc5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_85588970-70fc-4be8-8f95-fb8125664cc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_85588970-70fc-4be8-8f95-fb8125664cc5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_fb7e760a-bb4e-4a31-88ff-ffc1ece275b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:to="loc_us-gaap_LandMember_fb7e760a-bb4e-4a31-88ff-ffc1ece275b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_bee6c929-599b-4fac-a15d-a0a98255b894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_bee6c929-599b-4fac-a15d-a0a98255b894" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_209e30a3-65a7-4e81-98c8-cbd67c850e05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_209e30a3-65a7-4e81-98c8-cbd67c850e05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OfficeEquipmentAndInformationTechnologyMember_4dd5d7ac-d3ad-4d47-906d-843c7c92ddb4" xlink:href="hae-20230401.xsd#hae_OfficeEquipmentAndInformationTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:to="loc_hae_OfficeEquipmentAndInformationTechnologyMember_4dd5d7ac-d3ad-4d47-906d-843c7c92ddb4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HaemoneticsEquipmentMember_8bb209b2-1987-4c66-89ab-0f1a249d6fb2" xlink:href="hae-20230401.xsd#hae_HaemoneticsEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:to="loc_hae_HaemoneticsEquipmentMember_8bb209b2-1987-4c66-89ab-0f1a249d6fb2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_faa8ea95-eabb-44d0-9438-c906b2651a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:to="loc_us-gaap_ConstructionInProgressMember_faa8ea95-eabb-44d0-9438-c906b2651a63" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_a6c9952b-4bca-46e2-9aa6-a54edb06e82e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33c1ea47-2cf9-4289-9189-8019f5edad45" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_a6c9952b-4bca-46e2-9aa6-a54edb06e82e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_a6c9952b-4bca-46e2-9aa6-a54edb06e82e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_a6c9952b-4bca-46e2-9aa6-a54edb06e82e" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_a6c9952b-4bca-46e2-9aa6-a54edb06e82e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_ee52de54-dc96-4dda-aeff-0b6faa03c78b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_a6c9952b-4bca-46e2-9aa6-a54edb06e82e" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_ee52de54-dc96-4dda-aeff-0b6faa03c78b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetImpairmentsMember_11b99bfe-1d9d-4d79-ae11-d266ec4f6aa2" xlink:href="hae-20230401.xsd#hae_AssetImpairmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_ee52de54-dc96-4dda-aeff-0b6faa03c78b" xlink:to="loc_hae_AssetImpairmentsMember_11b99bfe-1d9d-4d79-ae11-d266ec4f6aa2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_f928a32f-b1ba-44fa-be4d-e7c1bfd122e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33c1ea47-2cf9-4289-9189-8019f5edad45" xlink:to="loc_us-gaap_RestructuringPlanAxis_f928a32f-b1ba-44fa-be4d-e7c1bfd122e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_f928a32f-b1ba-44fa-be4d-e7c1bfd122e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_f928a32f-b1ba-44fa-be4d-e7c1bfd122e6" xlink:to="loc_us-gaap_RestructuringPlanDomain_f928a32f-b1ba-44fa-be4d-e7c1bfd122e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_74430352-b916-447a-858c-aae86d6d4411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_f928a32f-b1ba-44fa-be4d-e7c1bfd122e6" xlink:to="loc_us-gaap_RestructuringPlanDomain_74430352-b916-447a-858c-aae86d6d4411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2020ProgramMember_567e416b-ad5e-4a5d-8a88-444d03556bfe" xlink:href="hae-20230401.xsd#hae_A2020ProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_74430352-b916-447a-858c-aae86d6d4411" xlink:to="loc_hae_A2020ProgramMember_567e416b-ad5e-4a5d-8a88-444d03556bfe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#GOODWILLANDINTANGIBLEASSETSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" xlink:type="extended" id="i063008b822464ebc88715fb95f7e7e7e_GOODWILLANDINTANGIBLEASSETSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7504cb08-f56a-4450-bd4e-43c934e51163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_5303b030-4244-48f3-a294-560329b0bbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7504cb08-f56a-4450-bd4e-43c934e51163" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_5303b030-4244-48f3-a294-560329b0bbf9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3f21e4c8-4919-45cd-ac6e-e808ecc5464b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7504cb08-f56a-4450-bd4e-43c934e51163" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3f21e4c8-4919-45cd-ac6e-e808ecc5464b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_9114068d-1b4c-4078-806e-bdb3203e57e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7504cb08-f56a-4450-bd4e-43c934e51163" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_9114068d-1b4c-4078-806e-bdb3203e57e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_715b69bf-2c6d-4555-a829-32a65c8aff38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7504cb08-f56a-4450-bd4e-43c934e51163" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_715b69bf-2c6d-4555-a829-32a65c8aff38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5bd7e01c-36ba-4e98-a74f-03130b724875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7504cb08-f56a-4450-bd4e-43c934e51163" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5bd7e01c-36ba-4e98-a74f-03130b724875" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4c7d72ae-2ac0-4ada-97c4-5e206e017d00" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5bd7e01c-36ba-4e98-a74f-03130b724875" xlink:to="loc_srt_RangeAxis_4c7d72ae-2ac0-4ada-97c4-5e206e017d00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4c7d72ae-2ac0-4ada-97c4-5e206e017d00_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4c7d72ae-2ac0-4ada-97c4-5e206e017d00" xlink:to="loc_srt_RangeMember_4c7d72ae-2ac0-4ada-97c4-5e206e017d00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_73101dec-b44e-4a42-81d8-aa68208cbc9f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4c7d72ae-2ac0-4ada-97c4-5e206e017d00" xlink:to="loc_srt_RangeMember_73101dec-b44e-4a42-81d8-aa68208cbc9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ad0b4d9e-e07e-4009-ad90-c7a9a0cefa01" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_73101dec-b44e-4a42-81d8-aa68208cbc9f" xlink:to="loc_srt_MinimumMember_ad0b4d9e-e07e-4009-ad90-c7a9a0cefa01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_86ff032b-c44c-42d4-8bd2-b215eb1f75ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_73101dec-b44e-4a42-81d8-aa68208cbc9f" xlink:to="loc_srt_MaximumMember_86ff032b-c44c-42d4-8bd2-b215eb1f75ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_4e6b9575-c7d0-4fd3-8807-6cb144093a60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers_774fb3c8-23d6-41a7-8d22-78d5ae353b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_4e6b9575-c7d0-4fd3-8807-6cb144093a60" xlink:to="loc_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers_774fb3c8-23d6-41a7-8d22-78d5ae353b8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2af48eab-bf57-42d8-8843-dfa47bd09eae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_4e6b9575-c7d0-4fd3-8807-6cb144093a60" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2af48eab-bf57-42d8-8843-dfa47bd09eae" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7b179fa5-31a2-42d1-aa7a-b538f32f9af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2af48eab-bf57-42d8-8843-dfa47bd09eae" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7b179fa5-31a2-42d1-aa7a-b538f32f9af3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7b179fa5-31a2-42d1-aa7a-b538f32f9af3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7b179fa5-31a2-42d1-aa7a-b538f32f9af3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7b179fa5-31a2-42d1-aa7a-b538f32f9af3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_631a4960-ddee-4f90-ad54-49a3e1203808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7b179fa5-31a2-42d1-aa7a-b538f32f9af3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_631a4960-ddee-4f90-ad54-49a3e1203808" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_867e745d-3054-4118-8486-a53d0e13aba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_631a4960-ddee-4f90-ad54-49a3e1203808" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_867e745d-3054-4118-8486-a53d0e13aba4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="extended" id="iac1a1f6cde6c4d7689b680898fc47c17_GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_94ef27ca-88cb-4cad-b165-fd97074b5aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_ddede7a2-55e0-40a8-8705-73525da12cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_94ef27ca-88cb-4cad-b165-fd97074b5aa3" xlink:to="loc_us-gaap_GoodwillRollForward_ddede7a2-55e0-40a8-8705-73525da12cf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_23a68163-e132-4c95-9529-31b4166d28d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ddede7a2-55e0-40a8-8705-73525da12cf3" xlink:to="loc_us-gaap_Goodwill_23a68163-e132-4c95-9529-31b4166d28d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_dd26c5c3-04c2-4ab7-92f4-186e45a283f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ddede7a2-55e0-40a8-8705-73525da12cf3" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_dd26c5c3-04c2-4ab7-92f4-186e45a283f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_cdc74cfa-18fc-408d-90a9-ce828d37b89c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ddede7a2-55e0-40a8-8705-73525da12cf3" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_cdc74cfa-18fc-408d-90a9-ce828d37b89c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_44d96637-07e7-4760-870c-e664a25aa8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6c378615-11fb-4be7-9a99-a772f85140fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_94ef27ca-88cb-4cad-b165-fd97074b5aa3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6c378615-11fb-4be7-9a99-a772f85140fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1b704570-6982-462c-bce6-8f5eb7fa5760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_94ef27ca-88cb-4cad-b165-fd97074b5aa3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1b704570-6982-462c-bce6-8f5eb7fa5760" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a86d8cb2-275c-43fc-8a2b-764b70745702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_94ef27ca-88cb-4cad-b165-fd97074b5aa3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a86d8cb2-275c-43fc-8a2b-764b70745702" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8349c9a7-b3ef-4636-8bbc-7e9aa4383ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_94ef27ca-88cb-4cad-b165-fd97074b5aa3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8349c9a7-b3ef-4636-8bbc-7e9aa4383ed6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5a26475e-c41c-4d58-90c3-11aa99aa77e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_94ef27ca-88cb-4cad-b165-fd97074b5aa3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5a26475e-c41c-4d58-90c3-11aa99aa77e2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d6e35f42-c73e-4830-8dd7-c63d9c9f4e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5a26475e-c41c-4d58-90c3-11aa99aa77e2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d6e35f42-c73e-4830-8dd7-c63d9c9f4e5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d6e35f42-c73e-4830-8dd7-c63d9c9f4e5e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d6e35f42-c73e-4830-8dd7-c63d9c9f4e5e" xlink:to="loc_us-gaap_SegmentDomain_d6e35f42-c73e-4830-8dd7-c63d9c9f4e5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_da863e82-de36-45d5-83a3-7f38a9779f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d6e35f42-c73e-4830-8dd7-c63d9c9f4e5e" xlink:to="loc_us-gaap_SegmentDomain_da863e82-de36-45d5-83a3-7f38a9779f2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaMember_c0575a48-b45b-45d3-b862-c774c5fcaa0e" xlink:href="hae-20230401.xsd#hae_PlasmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_da863e82-de36-45d5-83a3-7f38a9779f2e" xlink:to="loc_hae_PlasmaMember_c0575a48-b45b-45d3-b862-c774c5fcaa0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterMember_0ced6d97-de7a-43b1-9f9f-a4447492a6bc" xlink:href="hae-20230401.xsd#hae_BloodCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_da863e82-de36-45d5-83a3-7f38a9779f2e" xlink:to="loc_hae_BloodCenterMember_0ced6d97-de7a-43b1-9f9f-a4447492a6bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalMember_0ac4bdb5-1407-4a09-a632-8775581cab58" xlink:href="hae-20230401.xsd#hae_HospitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_da863e82-de36-45d5-83a3-7f38a9779f2e" xlink:to="loc_hae_HospitalMember_0ac4bdb5-1407-4a09-a632-8775581cab58" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="extended" id="ibe9ffcc64cc44d04a2e8b7f54dbfa5fd_GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_d1dc1803-de9b-46ca-baf5-294c377e7755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_49cca7e7-d51f-432d-bd98-3a0be801a6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_d1dc1803-de9b-46ca-baf5-294c377e7755" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_49cca7e7-d51f-432d-bd98-3a0be801a6ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_aa0eec78-234b-4d04-92a5-180e811f3981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_49cca7e7-d51f-432d-bd98-3a0be801a6ef" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_aa0eec78-234b-4d04-92a5-180e811f3981" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_f66e837e-3fcb-4510-bbe7-fc2f07ba1de5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_d1dc1803-de9b-46ca-baf5-294c377e7755" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_f66e837e-3fcb-4510-bbe7-fc2f07ba1de5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_aa7fef94-8d91-4ed3-a1c9-2b8880554cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_f66e837e-3fcb-4510-bbe7-fc2f07ba1de5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_aa7fef94-8d91-4ed3-a1c9-2b8880554cba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_aa7fef94-8d91-4ed3-a1c9-2b8880554cba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_aa7fef94-8d91-4ed3-a1c9-2b8880554cba" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_aa7fef94-8d91-4ed3-a1c9-2b8880554cba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5d7efe3e-90a4-4d9d-bcc4-433d17aee286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_aa7fef94-8d91-4ed3-a1c9-2b8880554cba" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5d7efe3e-90a4-4d9d-bcc4-433d17aee286" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InProcessSoftwareDevelopmentMember_86fb1e39-5654-4e67-8b60-195c7d2a78f2" xlink:href="hae-20230401.xsd#hae_InProcessSoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5d7efe3e-90a4-4d9d-bcc4-433d17aee286" xlink:to="loc_hae_InProcessSoftwareDevelopmentMember_86fb1e39-5654-4e67-8b60-195c7d2a78f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_3dc81981-0326-4f2e-925e-d7ca44d91604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5d7efe3e-90a4-4d9d-bcc4-433d17aee286" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_3dc81981-0326-4f2e-925e-d7ca44d91604" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InProcessPatentsMember_0edf70bb-b0cd-4ed8-a512-4e49c910839b" xlink:href="hae-20230401.xsd#hae_InProcessPatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5d7efe3e-90a4-4d9d-bcc4-433d17aee286" xlink:to="loc_hae_InProcessPatentsMember_0edf70bb-b0cd-4ed8-a512-4e49c910839b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_353c69ce-e376-42e2-9493-a9293ae43c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_353c69ce-e376-42e2-9493-a9293ae43c20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c4ee2a82-d03e-4789-b8e8-58ec20271f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_353c69ce-e376-42e2-9493-a9293ae43c20" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c4ee2a82-d03e-4789-b8e8-58ec20271f84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_27a0f3f8-b927-412f-aba2-8be30d55903e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_353c69ce-e376-42e2-9493-a9293ae43c20" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_27a0f3f8-b927-412f-aba2-8be30d55903e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1f0d4197-478b-4db6-acf6-71c3378cfc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_353c69ce-e376-42e2-9493-a9293ae43c20" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1f0d4197-478b-4db6-acf6-71c3378cfc9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c3fe28e5-c496-4758-a539-0d2263635dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c3fe28e5-c496-4758-a539-0d2263635dac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_973bff57-e955-4a45-8f47-817f5b201d40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_973bff57-e955-4a45-8f47-817f5b201d40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3a59e7d1-6a6a-4fdb-938f-034b75ff6862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3a59e7d1-6a6a-4fdb-938f-034b75ff6862" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_48dc82dd-4258-4d9c-8c43-d176ced13343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_48dc82dd-4258-4d9c-8c43-d176ced13343" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_fd5f360b-2396-4ebe-8866-b1abf2fabb49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_fd5f360b-2396-4ebe-8866-b1abf2fabb49" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_75f23442-3b08-45b9-a383-507390af510f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_75f23442-3b08-45b9-a383-507390af510f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_50551928-bf3d-4e7a-8441-f2aaea8d3b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_50551928-bf3d-4e7a-8441-f2aaea8d3b84" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_663cb842-79b8-4aac-aca7-ab81df7771af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_663cb842-79b8-4aac-aca7-ab81df7771af" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1dbae9d4-7e35-44f6-93b3-c1f32b3fbf2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_663cb842-79b8-4aac-aca7-ab81df7771af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1dbae9d4-7e35-44f6-93b3-c1f32b3fbf2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1dbae9d4-7e35-44f6-93b3-c1f32b3fbf2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1dbae9d4-7e35-44f6-93b3-c1f32b3fbf2b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1dbae9d4-7e35-44f6-93b3-c1f32b3fbf2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f3a4cba-b84d-48d1-80ce-e917cca04e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1dbae9d4-7e35-44f6-93b3-c1f32b3fbf2b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f3a4cba-b84d-48d1-80ce-e917cca04e7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_c99d17ec-52ac-48fa-a6d9-55513fca2042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f3a4cba-b84d-48d1-80ce-e917cca04e7e" xlink:to="loc_us-gaap_PatentsMember_c99d17ec-52ac-48fa-a6d9-55513fca2042" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_0cfd3a2e-c72d-49fa-a332-710d022247a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f3a4cba-b84d-48d1-80ce-e917cca04e7e" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_0cfd3a2e-c72d-49fa-a332-710d022247a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherTechnologyMember_cfb97af6-4cb4-45a4-b404-1fd3c1df7c85" xlink:href="hae-20230401.xsd#hae_OtherTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f3a4cba-b84d-48d1-80ce-e917cca04e7e" xlink:to="loc_hae_OtherTechnologyMember_cfb97af6-4cb4-45a4-b404-1fd3c1df7c85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_b29d11cb-e62b-4136-8e87-c274e32823a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f3a4cba-b84d-48d1-80ce-e917cca04e7e" xlink:to="loc_us-gaap_CustomerContractsMember_b29d11cb-e62b-4136-8e87-c274e32823a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a93d6389-8118-4230-a0ee-31110add437c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f3a4cba-b84d-48d1-80ce-e917cca04e7e" xlink:to="loc_us-gaap_TradeNamesMember_a93d6389-8118-4230-a0ee-31110add437c" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/LEASESDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#LEASESDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/LEASESDetails" xlink:type="extended" id="i0e388a36939a4d1daa47354aa835b3d2_LEASESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_02e1a854-c917-4276-b8ee-84febfa578ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_02e1a854-c917-4276-b8ee-84febfa578ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_c8f880ce-1453-4d8e-ad21-a014bb1041ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_c8f880ce-1453-4d8e-ad21-a014bb1041ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fcf6c95d-980d-4c7d-a116-d55151fc762e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_fcf6c95d-980d-4c7d-a116-d55151fc762e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7654026e-6fd1-48a2-a2aa-44cc0d984cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseLiability_7654026e-6fd1-48a2-a2aa-44cc0d984cad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_556ba897-bc44-451a-9978-c4ac95c68f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_556ba897-bc44-451a-9978-c4ac95c68f14" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f2cd6f0a-1c8e-4298-929d-cd9222357645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f2cd6f0a-1c8e-4298-929d-cd9222357645" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7ea5f34f-4dc2-4500-b514-c8c306aff7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7ea5f34f-4dc2-4500-b514-c8c306aff7e8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_18c703f1-7958-4be8-8f8b-17f7eef70750" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_18c703f1-7958-4be8-8f8b-17f7eef70750" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_d09e5b9a-d878-45d3-8534-53fcdec8d1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseCost_d09e5b9a-d878-45d3-8534-53fcdec8d1c5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_f0532689-9b61-4c0a-b0b6-e4636be85081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeasePayments_f0532689-9b61-4c0a-b0b6-e4636be85081" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3e663af8-a6d2-40ea-a411-92d617a528a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3e663af8-a6d2-40ea-a411-92d617a528a9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d95d11b8-4613-429d-a5d3-3f30550ba79f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d95d11b8-4613-429d-a5d3-3f30550ba79f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_cddca0e3-f9e5-4ff2-8b7a-37859e0ee707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_cddca0e3-f9e5-4ff2-8b7a-37859e0ee707" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_368c08fd-1e4e-4ab8-90dd-46c83c90b68f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_368c08fd-1e4e-4ab8-90dd-46c83c90b68f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_23759018-9751-44f2-9dbc-c1aaf4361f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_23759018-9751-44f2-9dbc-c1aaf4361f64" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7c871ace-7d30-454c-91a2-03aea39266f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7c871ace-7d30-454c-91a2-03aea39266f9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c9625752-a057-4328-804e-94599f64c713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c9625752-a057-4328-804e-94599f64c713" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_26eddf38-d597-4f10-8069-d2305ae336a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_26eddf38-d597-4f10-8069-d2305ae336a8" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_918b7a76-f866-4394-831f-cfdcd315f702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_918b7a76-f866-4394-831f-cfdcd315f702" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_df3f2002-dd15-4540-ad75-6b6a106819de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_df3f2002-dd15-4540-ad75-6b6a106819de" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_fa7af953-efe4-4a63-8429-0457ac7f0f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_fa7af953-efe4-4a63-8429-0457ac7f0f7e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_744ac772-5b3a-4b42-b7ae-9cd3d747b92f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_744ac772-5b3a-4b42-b7ae-9cd3d747b92f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_6eebf2ab-cdff-48f8-a933-373518500bff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_6eebf2ab-cdff-48f8-a933-373518500bff" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales_7461f0a9-5d51-416e-a668-fbcfae6ce017" xlink:href="hae-20230401.xsd#hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales_7461f0a9-5d51-416e-a668-fbcfae6ce017" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_47033d89-b48c-4416-a18b-825b31836267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_47033d89-b48c-4416-a18b-825b31836267" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_33c3ed9f-fe3a-48e8-b18b-5e73d49e075e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_47033d89-b48c-4416-a18b-825b31836267" xlink:to="loc_srt_RangeAxis_33c3ed9f-fe3a-48e8-b18b-5e73d49e075e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_33c3ed9f-fe3a-48e8-b18b-5e73d49e075e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_33c3ed9f-fe3a-48e8-b18b-5e73d49e075e" xlink:to="loc_srt_RangeMember_33c3ed9f-fe3a-48e8-b18b-5e73d49e075e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3de0b6a6-8f8c-4c81-9b89-0545fb5362d4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_33c3ed9f-fe3a-48e8-b18b-5e73d49e075e" xlink:to="loc_srt_RangeMember_3de0b6a6-8f8c-4c81-9b89-0545fb5362d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8afa4705-cd6f-4de9-b1a4-5470a5945003" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3de0b6a6-8f8c-4c81-9b89-0545fb5362d4" xlink:to="loc_srt_MinimumMember_8afa4705-cd6f-4de9-b1a4-5470a5945003" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9bfa2c04-41a5-4dd4-bb78-6d0ae93808c5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3de0b6a6-8f8c-4c81-9b89-0545fb5362d4" xlink:to="loc_srt_MaximumMember_9bfa2c04-41a5-4dd4-bb78-6d0ae93808c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0bfa01c9-b71a-4112-8d28-6af46d9ea6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_47033d89-b48c-4416-a18b-825b31836267" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0bfa01c9-b71a-4112-8d28-6af46d9ea6f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0bfa01c9-b71a-4112-8d28-6af46d9ea6f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0bfa01c9-b71a-4112-8d28-6af46d9ea6f0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0bfa01c9-b71a-4112-8d28-6af46d9ea6f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c75f25ed-4267-4e30-9cf4-c980a7b2e0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0bfa01c9-b71a-4112-8d28-6af46d9ea6f0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c75f25ed-4267-4e30-9cf4-c980a7b2e0b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ManufacturingSpaceMember_6dc4c7bf-5aab-4e6a-b481-750ae0202eed" xlink:href="hae-20230401.xsd#hae_ManufacturingSpaceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c75f25ed-4267-4e30-9cf4-c980a7b2e0b0" xlink:to="loc_hae_ManufacturingSpaceMember_6dc4c7bf-5aab-4e6a-b481-750ae0202eed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ManufacturingSpaceSecondRenewalTermMember_35b902b0-26b9-4d8b-bafb-dc64ef5ff47e" xlink:href="hae-20230401.xsd#hae_ManufacturingSpaceSecondRenewalTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c75f25ed-4267-4e30-9cf4-c980a7b2e0b0" xlink:to="loc_hae_ManufacturingSpaceSecondRenewalTermMember_35b902b0-26b9-4d8b-bafb-dc64ef5ff47e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails" xlink:type="extended" id="i418c494f0998425d818d62aed86f0764_NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f15e89e2-81cb-4e32-afaf-a7a12c9a3dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_LongTermDebt_f15e89e2-81cb-4e32-afaf-a7a12c9a3dde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_c6f3c2b2-afb9-47db-a05d-1e71e0031044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_LongTermDebtCurrent_c6f3c2b2-afb9-47db-a05d-1e71e0031044" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_bc7d0216-d8d9-462b-8fa4-fa760433e489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_bc7d0216-d8d9-462b-8fa4-fa760433e489" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6039f30f-0cd6-4e07-a3a1-5149e8ba8496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6039f30f-0cd6-4e07-a3a1-5149e8ba8496" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentInterestRateFloor_18279887-09b7-4b68-b7de-bc1f6f442b0f" xlink:href="hae-20230401.xsd#hae_DebtInstrumentInterestRateFloor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_hae_DebtInstrumentInterestRateFloor_18279887-09b7-4b68-b7de-bc1f6f442b0f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_853006c5-c556-48f7-9895-2a962372a17f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_853006c5-c556-48f7-9895-2a962372a17f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_be597e4a-e355-46ba-8221-c6a175a7f504" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_be597e4a-e355-46ba-8221-c6a175a7f504" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_3dc17c26-2425-40e0-a7da-b4ce6917e1da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_3dc17c26-2425-40e0-a7da-b4ce6917e1da" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne_b747a3df-fdd1-4f77-8284-357b50c85b49" xlink:href="hae-20230401.xsd#hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne_b747a3df-fdd1-4f77-8284-357b50c85b49" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity_acf80b59-1309-4439-aa77-51a14921c036" xlink:href="hae-20230401.xsd#hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity_acf80b59-1309-4439-aa77-51a14921c036" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_9edc4448-6487-4d46-add5-c1a030bcaa52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_InterestExpense_9edc4448-6487-4d46-add5-c1a030bcaa52" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_4b7eb14a-4722-4906-96db-929d4c4d5642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_InterestCostsCapitalized_4b7eb14a-4722-4906-96db-929d4c4d5642" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_6715395c-986e-4894-a153-250c07c823e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_6715395c-986e-4894-a153-250c07c823e6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c768f511-25b7-471d-8801-90f251ec12b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_DebtInstrumentTable_c768f511-25b7-471d-8801-90f251ec12b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d4e71777-e2d0-40f0-8be9-62537ca7cff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c768f511-25b7-471d-8801-90f251ec12b1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d4e71777-e2d0-40f0-8be9-62537ca7cff9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d4e71777-e2d0-40f0-8be9-62537ca7cff9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d4e71777-e2d0-40f0-8be9-62537ca7cff9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d4e71777-e2d0-40f0-8be9-62537ca7cff9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d4e71777-e2d0-40f0-8be9-62537ca7cff9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TermLoanNetofFinancingFeesMember_7d8eb164-c386-497d-8c85-36669ccdb26f" xlink:href="hae-20230401.xsd#hae_TermLoanNetofFinancingFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:to="loc_hae_TermLoanNetofFinancingFeesMember_7d8eb164-c386-497d-8c85-36669ccdb26f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BankLoansandOtherBorrowingMember_a11591b7-fb8b-4110-92de-0212d392aef5" xlink:href="hae-20230401.xsd#hae_BankLoansandOtherBorrowingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:to="loc_hae_BankLoansandOtherBorrowingMember_a11591b7-fb8b-4110-92de-0212d392aef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_7b46bbd9-3a3f-4817-8f2b-dcb07f1e5a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:to="loc_us-gaap_ConvertibleDebtMember_7b46bbd9-3a3f-4817-8f2b-dcb07f1e5a44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_c79d3235-2de0-4d47-9f4d-56984a687340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:to="loc_us-gaap_UnsecuredDebtMember_c79d3235-2de0-4d47-9f4d-56984a687340" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_72bd1476-bdc2-4033-b088-f3cee64581f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:to="loc_us-gaap_LineOfCreditMember_72bd1476-bdc2-4033-b088-f3cee64581f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_2737aed3-0b82-45a7-84e5-15c1f8f82b68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_2737aed3-0b82-45a7-84e5-15c1f8f82b68" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0e80b260-a282-4784-a5e0-7ac68eb6526a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c768f511-25b7-471d-8801-90f251ec12b1" xlink:to="loc_us-gaap_DebtInstrumentAxis_0e80b260-a282-4784-a5e0-7ac68eb6526a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0e80b260-a282-4784-a5e0-7ac68eb6526a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0e80b260-a282-4784-a5e0-7ac68eb6526a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0e80b260-a282-4784-a5e0-7ac68eb6526a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_70fa8f64-eb5d-4942-b35b-504f18bc023b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0e80b260-a282-4784-a5e0-7ac68eb6526a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_70fa8f64-eb5d-4942-b35b-504f18bc023b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RevisedCreditAgreementMember_cc6510d3-f0d8-40a4-9266-18247fdc8892" xlink:href="hae-20230401.xsd#hae_RevisedCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_70fa8f64-eb5d-4942-b35b-504f18bc023b" xlink:to="loc_hae_RevisedCreditAgreementMember_cc6510d3-f0d8-40a4-9266-18247fdc8892" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_34fa8c52-e01e-4418-892f-12d12a6590c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c768f511-25b7-471d-8801-90f251ec12b1" xlink:to="loc_us-gaap_CreditFacilityAxis_34fa8c52-e01e-4418-892f-12d12a6590c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_34fa8c52-e01e-4418-892f-12d12a6590c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_34fa8c52-e01e-4418-892f-12d12a6590c2" xlink:to="loc_us-gaap_CreditFacilityDomain_34fa8c52-e01e-4418-892f-12d12a6590c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2315648c-4a14-497c-99ec-1f6fcd53542d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_34fa8c52-e01e-4418-892f-12d12a6590c2" xlink:to="loc_us-gaap_CreditFacilityDomain_2315648c-4a14-497c-99ec-1f6fcd53542d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_36c75110-c5c7-4114-8f30-9604c19007c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2315648c-4a14-497c-99ec-1f6fcd53542d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_36c75110-c5c7-4114-8f30-9604c19007c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_245eda33-7758-4641-a576-c7cd26881fd4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c768f511-25b7-471d-8801-90f251ec12b1" xlink:to="loc_srt_RangeAxis_245eda33-7758-4641-a576-c7cd26881fd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_245eda33-7758-4641-a576-c7cd26881fd4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_245eda33-7758-4641-a576-c7cd26881fd4" xlink:to="loc_srt_RangeMember_245eda33-7758-4641-a576-c7cd26881fd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_392c1716-f5e1-4a6f-b2cd-6d5bdca19244" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_245eda33-7758-4641-a576-c7cd26881fd4" xlink:to="loc_srt_RangeMember_392c1716-f5e1-4a6f-b2cd-6d5bdca19244" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2d13fc11-532f-438d-a937-263d73dcb683" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_392c1716-f5e1-4a6f-b2cd-6d5bdca19244" xlink:to="loc_srt_MinimumMember_2d13fc11-532f-438d-a937-263d73dcb683" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cc880f75-6795-4161-91fd-ff1b0355030a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_392c1716-f5e1-4a6f-b2cd-6d5bdca19244" xlink:to="loc_srt_MaximumMember_cc880f75-6795-4161-91fd-ff1b0355030a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_bee97c51-9376-4ff7-8414-f3000fc68e15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c768f511-25b7-471d-8801-90f251ec12b1" xlink:to="loc_us-gaap_VariableRateAxis_bee97c51-9376-4ff7-8414-f3000fc68e15" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_bee97c51-9376-4ff7-8414-f3000fc68e15_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_bee97c51-9376-4ff7-8414-f3000fc68e15" xlink:to="loc_us-gaap_VariableRateDomain_bee97c51-9376-4ff7-8414-f3000fc68e15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b7adfb44-e887-48df-b97c-3d22331b39f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_bee97c51-9376-4ff7-8414-f3000fc68e15" xlink:to="loc_us-gaap_VariableRateDomain_b7adfb44-e887-48df-b97c-3d22331b39f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_80595b77-6bce-48b9-bbbc-9d14c29eaeab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b7adfb44-e887-48df-b97c-3d22331b39f5" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_80595b77-6bce-48b9-bbbc-9d14c29eaeab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails" xlink:type="extended" id="i52aefb902205494f8fdcb78c7c72ea98_NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_3c6cf5f1-acaa-419a-8084-b336e9c86589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_3c6cf5f1-acaa-419a-8084-b336e9c86589" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_707d6356-2f4e-43f6-8cb8-9872a13764e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_707d6356-2f4e-43f6-8cb8-9872a13764e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_4df14043-f74a-4577-96e0-246ea36b110f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_4df14043-f74a-4577-96e0-246ea36b110f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_d207986f-af89-45cd-962c-237bfca757e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_d207986f-af89-45cd-962c-237bfca757e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_d8567352-3666-4656-936b-2e66da2d95d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_d8567352-3666-4656-936b-2e66da2d95d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice_aec06623-b3de-4dee-94b6-4490fa9b2e66" xlink:href="hae-20230401.xsd#hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice_aec06623-b3de-4dee-94b6-4490fa9b2e66" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentConvertibleComponentConversionPrice_3ddb60d4-c5e1-4a30-bbf7-d9845d1af2b8" xlink:href="hae-20230401.xsd#hae_DebtInstrumentConvertibleComponentConversionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_DebtInstrumentConvertibleComponentConversionPrice_3ddb60d4-c5e1-4a30-bbf7-d9845d1af2b8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e29d1e19-cd08-463c-bb23-11b4fb75fa8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e29d1e19-cd08-463c-bb23-11b4fb75fa8d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ConsolidatedTotalLeverageRatio_51b209e5-2337-46b1-8619-1a7e0f885d6e" xlink:href="hae-20230401.xsd#hae_ConsolidatedTotalLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_ConsolidatedTotalLeverageRatio_51b209e5-2337-46b1-8619-1a7e0f885d6e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_83611f08-4397-4db6-9206-05730255fc84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_83611f08-4397-4db6-9206-05730255fc84" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ConsolidatedInterestCoverageRatio_152a8181-de10-49d0-9627-49c392acd7c5" xlink:href="hae-20230401.xsd#hae_ConsolidatedInterestCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_ConsolidatedInterestCoverageRatio_152a8181-de10-49d0-9627-49c392acd7c5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_74b3f0be-eb50-4306-b810-9ab178eed175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_74b3f0be-eb50-4306-b810-9ab178eed175" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_e049bd3b-8d21-4e4b-b3bd-1cd6daee0240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_e049bd3b-8d21-4e4b-b3bd-1cd6daee0240" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_900cd404-60fe-4abf-91fd-ac7468d45210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_LongTermDebt_900cd404-60fe-4abf-91fd-ac7468d45210" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_eb09bc48-0b9d-46e3-900b-9b11d0f11e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_InterestExpenseDebt_eb09bc48-0b9d-46e3-900b-9b11d0f11e5b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_acba9a2f-1e1c-424f-bb52-ffef28741829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_acba9a2f-1e1c-424f-bb52-ffef28741829" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice_43db076e-296e-48b8-8860-16e1c7ce37f2" xlink:href="hae-20230401.xsd#hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice_43db076e-296e-48b8-8860-16e1c7ce37f2" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice_01178093-f7fd-40ff-b15a-90b813edcb21" xlink:href="hae-20230401.xsd#hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice_01178093-f7fd-40ff-b15a-90b813edcb21" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares_f978ee55-62d2-46c1-a5d5-23ad850881c5" xlink:href="hae-20230401.xsd#hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares_f978ee55-62d2-46c1-a5d5-23ad850881c5" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentConvertibleCappedCallTransactionAmount_d8ee2af7-7ffd-4d70-a3c6-387da63519fb" xlink:href="hae-20230401.xsd#hae_DebtInstrumentConvertibleCappedCallTransactionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_DebtInstrumentConvertibleCappedCallTransactionAmount_d8ee2af7-7ffd-4d70-a3c6-387da63519fb" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b57f228a-1e70-4914-8af0-be0d49cdc3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b57f228a-1e70-4914-8af0-be0d49cdc3eb" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2c3fbb95-c1af-410d-85ff-75f04d4dff3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2c3fbb95-c1af-410d-85ff-75f04d4dff3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2c3fbb95-c1af-410d-85ff-75f04d4dff3d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2c3fbb95-c1af-410d-85ff-75f04d4dff3d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2c3fbb95-c1af-410d-85ff-75f04d4dff3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2c3fbb95-c1af-410d-85ff-75f04d4dff3d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_9a6c30b4-4427-40c1-9b5d-4a712058b45f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:to="loc_us-gaap_ConvertibleDebtMember_9a6c30b4-4427-40c1-9b5d-4a712058b45f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_d2a3aa5d-2b81-4e97-912e-2a5eba4f5507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:to="loc_us-gaap_MediumTermNotesMember_d2a3aa5d-2b81-4e97-912e-2a5eba4f5507" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_65ba0842-3a55-404e-8dce-860f8fb5d25f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:to="loc_us-gaap_LineOfCreditMember_65ba0842-3a55-404e-8dce-860f8fb5d25f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TermLoanMember_226db209-8a5c-4fc6-91b5-b3508b09b91c" xlink:href="hae-20230401.xsd#hae_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:to="loc_hae_TermLoanMember_226db209-8a5c-4fc6-91b5-b3508b09b91c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3cb39d40-4084-48c6-9ecd-a0fe0e7d5679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3cb39d40-4084-48c6-9ecd-a0fe0e7d5679" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TermLoanNetofFinancingFeesMember_45fd9bad-1419-400b-a191-da46e57285b3" xlink:href="hae-20230401.xsd#hae_TermLoanNetofFinancingFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:to="loc_hae_TermLoanNetofFinancingFeesMember_45fd9bad-1419-400b-a191-da46e57285b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e32448a5-49a0-4404-a170-2665ac8559be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:to="loc_us-gaap_VariableRateAxis_e32448a5-49a0-4404-a170-2665ac8559be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e32448a5-49a0-4404-a170-2665ac8559be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_e32448a5-49a0-4404-a170-2665ac8559be" xlink:to="loc_us-gaap_VariableRateDomain_e32448a5-49a0-4404-a170-2665ac8559be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3489e3e5-e52a-4165-a529-7e4030e08701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_e32448a5-49a0-4404-a170-2665ac8559be" xlink:to="loc_us-gaap_VariableRateDomain_3489e3e5-e52a-4165-a529-7e4030e08701" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2675ddde-265d-49d5-9cbc-04d05006b6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_3489e3e5-e52a-4165-a529-7e4030e08701" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2675ddde-265d-49d5-9cbc-04d05006b6c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b8739a99-c9eb-4dd4-96d6-42daed70a697" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:to="loc_srt_RangeAxis_b8739a99-c9eb-4dd4-96d6-42daed70a697" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b8739a99-c9eb-4dd4-96d6-42daed70a697_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b8739a99-c9eb-4dd4-96d6-42daed70a697" xlink:to="loc_srt_RangeMember_b8739a99-c9eb-4dd4-96d6-42daed70a697_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_42ae8be4-0e93-4413-9f3c-caa43517cda7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b8739a99-c9eb-4dd4-96d6-42daed70a697" xlink:to="loc_srt_RangeMember_42ae8be4-0e93-4413-9f3c-caa43517cda7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3ce94873-4c39-4fe0-917c-f5c8146d78a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_42ae8be4-0e93-4413-9f3c-caa43517cda7" xlink:to="loc_srt_MinimumMember_3ce94873-4c39-4fe0-917c-f5c8146d78a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3264bd25-178c-4041-ba0b-b69e2a3bea99" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_42ae8be4-0e93-4413-9f3c-caa43517cda7" xlink:to="loc_srt_MaximumMember_3264bd25-178c-4041-ba0b-b69e2a3bea99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9ae0ddd0-278a-4be7-bb0e-1c1167fb0e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9ae0ddd0-278a-4be7-bb0e-1c1167fb0e6a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9ae0ddd0-278a-4be7-bb0e-1c1167fb0e6a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9ae0ddd0-278a-4be7-bb0e-1c1167fb0e6a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9ae0ddd0-278a-4be7-bb0e-1c1167fb0e6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_92297c14-674c-45de-8050-ddbd9844a7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9ae0ddd0-278a-4be7-bb0e-1c1167fb0e6a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_92297c14-674c-45de-8050-ddbd9844a7f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_d6083c08-d5ec-4b0e-8e17-4710f6371d52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_92297c14-674c-45de-8050-ddbd9844a7f6" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_d6083c08-d5ec-4b0e-8e17-4710f6371d52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_0758023c-f940-44c6-855c-2ff4f50d7143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_92297c14-674c-45de-8050-ddbd9844a7f6" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_0758023c-f940-44c6-855c-2ff4f50d7143" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c2e1a38f-c11a-4834-afd8-0f02ca15a509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c2e1a38f-c11a-4834-afd8-0f02ca15a509" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c2e1a38f-c11a-4834-afd8-0f02ca15a509_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c2e1a38f-c11a-4834-afd8-0f02ca15a509" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c2e1a38f-c11a-4834-afd8-0f02ca15a509_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3377607c-e4fa-43f4-90e5-d504a003d71d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c2e1a38f-c11a-4834-afd8-0f02ca15a509" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3377607c-e4fa-43f4-90e5-d504a003d71d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CardivaMedicalIncMember_ef4df8ac-3ebc-48fd-a3b7-376fdaa4a6e9" xlink:href="hae-20230401.xsd#hae_CardivaMedicalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3377607c-e4fa-43f4-90e5-d504a003d71d" xlink:to="loc_hae_CardivaMedicalIncMember_ef4df8ac-3ebc-48fd-a3b7-376fdaa4a6e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c11f0121-7b7f-413e-ad0f-e87d5060c686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:to="loc_us-gaap_DebtInstrumentAxis_c11f0121-7b7f-413e-ad0f-e87d5060c686" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c11f0121-7b7f-413e-ad0f-e87d5060c686_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c11f0121-7b7f-413e-ad0f-e87d5060c686" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c11f0121-7b7f-413e-ad0f-e87d5060c686_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dcbb9120-dab6-4271-9c64-249c023c5e17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c11f0121-7b7f-413e-ad0f-e87d5060c686" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dcbb9120-dab6-4271-9c64-249c023c5e17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RevisedCreditAgreementMember_ceac82e4-4ddd-4914-9f89-e1ea8e698199" xlink:href="hae-20230401.xsd#hae_RevisedCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dcbb9120-dab6-4271-9c64-249c023c5e17" xlink:to="loc_hae_RevisedCreditAgreementMember_ceac82e4-4ddd-4914-9f89-e1ea8e698199" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_07a28375-ab65-4f32-aaf6-949c76197c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_07a28375-ab65-4f32-aaf6-949c76197c4a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_07a28375-ab65-4f32-aaf6-949c76197c4a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_07a28375-ab65-4f32-aaf6-949c76197c4a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_07a28375-ab65-4f32-aaf6-949c76197c4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_92023405-5433-4890-947d-395c9a3cb59a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_07a28375-ab65-4f32-aaf6-949c76197c4a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_92023405-5433-4890-947d-395c9a3cb59a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_586223c5-a13f-4ca9-9641-69e7c8283873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_92023405-5433-4890-947d-395c9a3cb59a" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_586223c5-a13f-4ca9-9641-69e7c8283873" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended" id="id6534565c5d14eb3bb6c22528248ec56_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PercentageOfNetSalesGeneratedOutsideOfUs_d809ab8c-3e37-4536-b8fe-137eaa5b6d04" xlink:href="hae-20230401.xsd#hae_PercentageOfNetSalesGeneratedOutsideOfUs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_hae_PercentageOfNetSalesGeneratedOutsideOfUs_d809ab8c-3e37-4536-b8fe-137eaa5b6d04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1_0f16b94f-aa4a-4d43-bb2f-225225eade5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1_0f16b94f-aa4a-4d43-bb2f-225225eade5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet_5908d5a0-abaf-4c81-b738-b32c69b1cede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet_5908d5a0-abaf-4c81-b738-b32c69b1cede" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet_20d6e145-e9d0-4565-9c44-f1c4ee5d172a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet_20d6e145-e9d0-4565-9c44-f1c4ee5d172a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f66735fe-44a6-490f-9177-c910f047c009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f66735fe-44a6-490f-9177-c910f047c009" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ff149c1b-17df-49e3-962d-2f015615f515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ff149c1b-17df-49e3-962d-2f015615f515" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_31ddfb34-9d4f-4906-9956-cd956798e5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_31ddfb34-9d4f-4906-9956-cd956798e5dd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_580de1c6-b046-423a-bd22-d1e1a8be5a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_580de1c6-b046-423a-bd22-d1e1a8be5a8c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DerivativePercentofDebtExposed_7c6fa889-f033-4b89-a22b-2a5f0c199bbf" xlink:href="hae-20230401.xsd#hae_DerivativePercentofDebtExposed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_hae_DerivativePercentofDebtExposed_7c6fa889-f033-4b89-a22b-2a5f0c199bbf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_c57855ad-6416-4726-9eb5-cdaf467eb5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_c57855ad-6416-4726-9eb5-cdaf467eb5e8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_ea8ec5aa-b78b-4ef9-b556-b9c658ee0cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_DerivativeNotionalAmount_ea8ec5aa-b78b-4ef9-b556-b9c658ee0cc9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_423e27b3-5808-4475-9cd2-348615e63517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_LongTermDebt_423e27b3-5808-4475-9cd2-348615e63517" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_d9345c11-8b83-4862-907f-296b85e407a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_d9345c11-8b83-4862-907f-296b85e407a8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_ad223bb7-5160-4a59-a3e7-d25f3fe97e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_ad223bb7-5160-4a59-a3e7-d25f3fe97e97" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_fba65707-4fa9-444a-b6fc-4f161bf5708e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_fba65707-4fa9-444a-b6fc-4f161bf5708e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b21155d4-e8ec-425c-b5a3-9da1ca12f2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b21155d4-e8ec-425c-b5a3-9da1ca12f2d9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_3a36d7d2-99d5-48ef-a2a7-eebd9bfaa32b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_3a36d7d2-99d5-48ef-a2a7-eebd9bfaa32b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationForeignCurrencyTranslationAdjustment_f8b36a8e-4da9-498c-9a5c-379c4b369477" xlink:href="hae-20230401.xsd#hae_ContingentConsiderationForeignCurrencyTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_hae_ContingentConsiderationForeignCurrencyTranslationAdjustment_f8b36a8e-4da9-498c-9a5c-379c4b369477" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_26a0ff8d-38ff-4ec5-bda7-917bd67c822a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_26a0ff8d-38ff-4ec5-bda7-917bd67c822a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_f3efe404-3351-44b5-a66d-067d7ccd86ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_LongTermDebtFairValue_f3efe404-3351-44b5-a66d-067d7ccd86ef" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ae51076d-f2cd-41c3-9874-187ab3fbc86c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ae51076d-f2cd-41c3-9874-187ab3fbc86c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NumberOfInterestRateSwapsEntered_fbeeed67-1db0-4754-9c12-e08f0943d028" xlink:href="hae-20230401.xsd#hae_NumberOfInterestRateSwapsEntered"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_hae_NumberOfInterestRateSwapsEntered_fbeeed67-1db0-4754-9c12-e08f0943d028" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DerivativeBlendedFixedInterestRate_bdbd056c-3cd2-4a5f-a5ce-c3cd923e6a2b" xlink:href="hae-20230401.xsd#hae_DerivativeBlendedFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_hae_DerivativeBlendedFixedInterestRate_bdbd056c-3cd2-4a5f-a5ce-c3cd923e6a2b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DerivativePercentageOfNotionalValueOfDebt_8cbc87be-419e-4cca-92c0-1323d1d7e6ec" xlink:href="hae-20230401.xsd#hae_DerivativePercentageOfNotionalValueOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_hae_DerivativePercentageOfNotionalValueOfDebt_8cbc87be-419e-4cca-92c0-1323d1d7e6ec" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e9fa8373-1e4f-4d3f-b9e5-0f64373bed0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e9fa8373-1e4f-4d3f-b9e5-0f64373bed0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e9fa8373-1e4f-4d3f-b9e5-0f64373bed0c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e9fa8373-1e4f-4d3f-b9e5-0f64373bed0c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e9fa8373-1e4f-4d3f-b9e5-0f64373bed0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fb1d8625-d5c8-4353-81d5-68fbd941c14e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e9fa8373-1e4f-4d3f-b9e5-0f64373bed0c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fb1d8625-d5c8-4353-81d5-68fbd941c14e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_e09ef945-ccde-4088-b2d8-cc53795c9941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_fb1d8625-d5c8-4353-81d5-68fbd941c14e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_e09ef945-ccde-4088-b2d8-cc53795c9941" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d76ad53-a415-484a-9e9d-b8add504006a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d76ad53-a415-484a-9e9d-b8add504006a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d76ad53-a415-484a-9e9d-b8add504006a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d76ad53-a415-484a-9e9d-b8add504006a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d76ad53-a415-484a-9e9d-b8add504006a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f966112-7a99-4178-ac02-34af8c11d7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d76ad53-a415-484a-9e9d-b8add504006a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f966112-7a99-4178-ac02-34af8c11d7f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d745ba1e-eda5-48e8-b078-d09f01ae297c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f966112-7a99-4178-ac02-34af8c11d7f4" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d745ba1e-eda5-48e8-b078-d09f01ae297c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f2011de7-7a5f-419a-98e3-09c3d818d501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_HedgingDesignationAxis_f2011de7-7a5f-419a-98e3-09c3d818d501" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f2011de7-7a5f-419a-98e3-09c3d818d501_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_f2011de7-7a5f-419a-98e3-09c3d818d501" xlink:to="loc_us-gaap_HedgingDesignationDomain_f2011de7-7a5f-419a-98e3-09c3d818d501_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b53e41c0-d393-47b0-89fe-eb96f19757e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_f2011de7-7a5f-419a-98e3-09c3d818d501" xlink:to="loc_us-gaap_HedgingDesignationDomain_b53e41c0-d393-47b0-89fe-eb96f19757e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c5f97899-12a1-4386-b85f-432dd9633d59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b53e41c0-d393-47b0-89fe-eb96f19757e6" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c5f97899-12a1-4386-b85f-432dd9633d59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_26f6423e-7794-4dc8-a3df-2f9ac35a3594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b53e41c0-d393-47b0-89fe-eb96f19757e6" xlink:to="loc_us-gaap_NondesignatedMember_26f6423e-7794-4dc8-a3df-2f9ac35a3594" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5c50e9e0-bbee-4e79-a054-310844d1adec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5c50e9e0-bbee-4e79-a054-310844d1adec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5c50e9e0-bbee-4e79-a054-310844d1adec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5c50e9e0-bbee-4e79-a054-310844d1adec" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5c50e9e0-bbee-4e79-a054-310844d1adec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_72c3bdb3-a5ed-4972-b81a-ef8288d68d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5c50e9e0-bbee-4e79-a054-310844d1adec" xlink:to="loc_us-gaap_HedgingRelationshipDomain_72c3bdb3-a5ed-4972-b81a-ef8288d68d09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_da63beea-d237-4156-88a2-7db7ce910060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_72c3bdb3-a5ed-4972-b81a-ef8288d68d09" xlink:to="loc_us-gaap_ForeignExchangeContractMember_da63beea-d237-4156-88a2-7db7ce910060" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_eb6d8d55-7f21-45a9-b04d-853d49e4ec09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_72c3bdb3-a5ed-4972-b81a-ef8288d68d09" xlink:to="loc_us-gaap_CashFlowHedgingMember_eb6d8d55-7f21-45a9-b04d-853d49e4ec09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5b236829-01b2-4f87-8826-7de5550c9ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_72c3bdb3-a5ed-4972-b81a-ef8288d68d09" xlink:to="loc_us-gaap_InterestRateSwapMember_5b236829-01b2-4f87-8826-7de5550c9ccc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_289bed70-e42f-4421-9fff-687e93e4d1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_289bed70-e42f-4421-9fff-687e93e4d1e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_289bed70-e42f-4421-9fff-687e93e4d1e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_289bed70-e42f-4421-9fff-687e93e4d1e8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_289bed70-e42f-4421-9fff-687e93e4d1e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cfeac5a9-5fb4-44ed-b9a5-0b7337428020" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_289bed70-e42f-4421-9fff-687e93e4d1e8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cfeac5a9-5fb4-44ed-b9a5-0b7337428020" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_594f5a4d-0e16-4c5d-abb5-3ff117ee6ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cfeac5a9-5fb4-44ed-b9a5-0b7337428020" xlink:to="loc_us-gaap_ForeignExchangeContractMember_594f5a4d-0e16-4c5d-abb5-3ff117ee6ecf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1fd4cc30-ccac-4845-bb15-c3af0081478d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cfeac5a9-5fb4-44ed-b9a5-0b7337428020" xlink:to="loc_us-gaap_InterestRateSwapMember_1fd4cc30-ccac-4845-bb15-c3af0081478d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationMember_d4fbc440-1fed-46f1-a2a7-1b8d5d53dcba" xlink:href="hae-20230401.xsd#hae_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cfeac5a9-5fb4-44ed-b9a5-0b7337428020" xlink:to="loc_hae_ContingentConsiderationMember_d4fbc440-1fed-46f1-a2a7-1b8d5d53dcba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f983bec5-d422-44be-b520-1d60ce49fa2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f983bec5-d422-44be-b520-1d60ce49fa2e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f983bec5-d422-44be-b520-1d60ce49fa2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f983bec5-d422-44be-b520-1d60ce49fa2e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f983bec5-d422-44be-b520-1d60ce49fa2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bd1a2c02-0106-450a-9554-4101322eda49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f983bec5-d422-44be-b520-1d60ce49fa2e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bd1a2c02-0106-450a-9554-4101322eda49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_048cccd8-6589-4c67-91bd-100b92b69d8b" xlink:href="hae-20230401.xsd#hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bd1a2c02-0106-450a-9554-4101322eda49" xlink:to="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_048cccd8-6589-4c67-91bd-100b92b69d8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherIncomeExpenseNetMember_cd08f9d7-8f22-4963-a405-237b6660a053" xlink:href="hae-20230401.xsd#hae_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bd1a2c02-0106-450a-9554-4101322eda49" xlink:to="loc_hae_OtherIncomeExpenseNetMember_cd08f9d7-8f22-4963-a405-237b6660a053" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_741becd3-bb04-405a-b44e-eeceb169f781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_741becd3-bb04-405a-b44e-eeceb169f781" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_741becd3-bb04-405a-b44e-eeceb169f781_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_741becd3-bb04-405a-b44e-eeceb169f781" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_741becd3-bb04-405a-b44e-eeceb169f781_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_95fadcd6-dd8d-4096-8a08-9f8f64e2fa9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_741becd3-bb04-405a-b44e-eeceb169f781" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_95fadcd6-dd8d-4096-8a08-9f8f64e2fa9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_83c3344e-3ea7-4062-9d57-80f622cecc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95fadcd6-dd8d-4096-8a08-9f8f64e2fa9b" xlink:to="loc_us-gaap_MediumTermNotesMember_83c3344e-3ea7-4062-9d57-80f622cecc9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_76f0ee76-ceb4-44b0-9552-fb5f5b0bc19c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95fadcd6-dd8d-4096-8a08-9f8f64e2fa9b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_76f0ee76-ceb4-44b0-9552-fb5f5b0bc19c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_b7ab2941-c109-49dd-9dff-35d0f8156c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_VariableRateAxis_b7ab2941-c109-49dd-9dff-35d0f8156c28" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b7ab2941-c109-49dd-9dff-35d0f8156c28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_b7ab2941-c109-49dd-9dff-35d0f8156c28" xlink:to="loc_us-gaap_VariableRateDomain_b7ab2941-c109-49dd-9dff-35d0f8156c28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a1d62f13-de8d-40d0-bdbc-401b6feae330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_b7ab2941-c109-49dd-9dff-35d0f8156c28" xlink:to="loc_us-gaap_VariableRateDomain_a1d62f13-de8d-40d0-bdbc-401b6feae330" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d4c0d89c-7d99-4c10-9321-faffaca0045f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_a1d62f13-de8d-40d0-bdbc-401b6feae330" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d4c0d89c-7d99-4c10-9321-faffaca0045f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember_6d8d8086-b8a0-4cca-9538-be651c77827d" xlink:href="hae-20230401.xsd#hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_a1d62f13-de8d-40d0-bdbc-401b6feae330" xlink:to="loc_hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember_6d8d8086-b8a0-4cca-9538-be651c77827d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_323ee015-0c32-47d5-9cbe-6e41bfa07907" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_srt_RangeAxis_323ee015-0c32-47d5-9cbe-6e41bfa07907" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_323ee015-0c32-47d5-9cbe-6e41bfa07907_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_323ee015-0c32-47d5-9cbe-6e41bfa07907" xlink:to="loc_srt_RangeMember_323ee015-0c32-47d5-9cbe-6e41bfa07907_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c320d2db-0ac2-4273-a05f-5a4ee2faf539" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_323ee015-0c32-47d5-9cbe-6e41bfa07907" xlink:to="loc_srt_RangeMember_c320d2db-0ac2-4273-a05f-5a4ee2faf539" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_92fde71c-4157-425b-8de6-9758d610fc9e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c320d2db-0ac2-4273-a05f-5a4ee2faf539" xlink:to="loc_srt_MinimumMember_92fde71c-4157-425b-8de6-9758d610fc9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9255413c-f752-443c-b86f-0ae0e8a63541" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c320d2db-0ac2-4273-a05f-5a4ee2faf539" xlink:to="loc_srt_MaximumMember_9255413c-f752-443c-b86f-0ae0e8a63541" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bd51092a-9a85-4550-8fc3-335d0a0679ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bd51092a-9a85-4550-8fc3-335d0a0679ef" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bd51092a-9a85-4550-8fc3-335d0a0679ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bd51092a-9a85-4550-8fc3-335d0a0679ef" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bd51092a-9a85-4550-8fc3-335d0a0679ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_df250c59-a918-49a9-a165-d327fbf6da5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bd51092a-9a85-4550-8fc3-335d0a0679ef" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_df250c59-a918-49a9-a165-d327fbf6da5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember_1ac5adf6-3386-4c04-ac87-ab4d69e9f957" xlink:href="hae-20230401.xsd#hae_EnicorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_df250c59-a918-49a9-a165-d327fbf6da5c" xlink:to="loc_hae_EnicorMember_1ac5adf6-3386-4c04-ac87-ab4d69e9f957" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_586e8b1e-c71e-422c-84e8-a5a399c57350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_586e8b1e-c71e-422c-84e8-a5a399c57350" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_586e8b1e-c71e-422c-84e8-a5a399c57350_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_586e8b1e-c71e-422c-84e8-a5a399c57350" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_586e8b1e-c71e-422c-84e8-a5a399c57350_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b97a7519-996c-4c9c-aab0-1415a8c81615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_586e8b1e-c71e-422c-84e8-a5a399c57350" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b97a7519-996c-4c9c-aab0-1415a8c81615" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_58ec2b19-97c8-45c5-8b70-81b6fe3ecc21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b97a7519-996c-4c9c-aab0-1415a8c81615" xlink:to="loc_us-gaap_SubsequentEventMember_58ec2b19-97c8-45c5-8b70-81b6fe3ecc21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1a787c05-7ae6-455d-8880-ef251c01d9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1a787c05-7ae6-455d-8880-ef251c01d9ad" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_1a787c05-7ae6-455d-8880-ef251c01d9ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1a787c05-7ae6-455d-8880-ef251c01d9ad" xlink:to="loc_us-gaap_TypeOfAdoptionMember_1a787c05-7ae6-455d-8880-ef251c01d9ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_5240d7d9-8bb6-4f48-8458-3030b4489726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1a787c05-7ae6-455d-8880-ef251c01d9ad" xlink:to="loc_us-gaap_TypeOfAdoptionMember_5240d7d9-8bb6-4f48-8458-3030b4489726" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_bf0e8321-17d1-4291-a5ff-6dab49d2975b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_5240d7d9-8bb6-4f48-8458-3030b4489726" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_bf0e8321-17d1-4291-a5ff-6dab49d2975b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails" xlink:type="extended" id="i385fd8f04633404b8f969db17a3c5daf_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4ae7390d-2acb-45d0-bb5c-e7bba3fb6688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e2c54528-6467-436a-961c-85ccbe64c04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4ae7390d-2acb-45d0-bb5c-e7bba3fb6688" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e2c54528-6467-436a-961c-85ccbe64c04b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_42cc9fc1-c13f-44e2-a7b1-5fee4aeabb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4ae7390d-2acb-45d0-bb5c-e7bba3fb6688" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_42cc9fc1-c13f-44e2-a7b1-5fee4aeabb1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_2acd11bb-7053-4c60-89af-b6c073af4c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4ae7390d-2acb-45d0-bb5c-e7bba3fb6688" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_2acd11bb-7053-4c60-89af-b6c073af4c5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NumberOfInterestRateSwapsEntered_ea567a20-9f8c-4a36-81a3-403ffe400850" xlink:href="hae-20230401.xsd#hae_NumberOfInterestRateSwapsEntered"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4ae7390d-2acb-45d0-bb5c-e7bba3fb6688" xlink:to="loc_hae_NumberOfInterestRateSwapsEntered_ea567a20-9f8c-4a36-81a3-403ffe400850" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_b2e67be4-070f-4f58-8161-723c96ef0e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_4ae7390d-2acb-45d0-bb5c-e7bba3fb6688" xlink:to="loc_us-gaap_DerivativeTable_b2e67be4-070f-4f58-8161-723c96ef0e89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyAxis_b130395b-51d3-4ce0-9a15-ee1a175793ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EnergyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b2e67be4-070f-4f58-8161-723c96ef0e89" xlink:to="loc_srt_EnergyAxis_b130395b-51d3-4ce0-9a15-ee1a175793ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyDomain_b130395b-51d3-4ce0-9a15-ee1a175793ed_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EnergyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_EnergyAxis_b130395b-51d3-4ce0-9a15-ee1a175793ed" xlink:to="loc_srt_EnergyDomain_b130395b-51d3-4ce0-9a15-ee1a175793ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyDomain_da178a7c-187e-4766-9b2d-8c7aef23ef4b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EnergyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_EnergyAxis_b130395b-51d3-4ce0-9a15-ee1a175793ed" xlink:to="loc_srt_EnergyDomain_da178a7c-187e-4766-9b2d-8c7aef23ef4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ea3c66ce-d148-46f9-9af5-57acb6f2e26b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b2e67be4-070f-4f58-8161-723c96ef0e89" xlink:to="loc_us-gaap_VariableRateAxis_ea3c66ce-d148-46f9-9af5-57acb6f2e26b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ea3c66ce-d148-46f9-9af5-57acb6f2e26b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_ea3c66ce-d148-46f9-9af5-57acb6f2e26b" xlink:to="loc_us-gaap_VariableRateDomain_ea3c66ce-d148-46f9-9af5-57acb6f2e26b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_789d0f9f-e0eb-408b-9191-8b2a7eaccd67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_ea3c66ce-d148-46f9-9af5-57acb6f2e26b" xlink:to="loc_us-gaap_VariableRateDomain_789d0f9f-e0eb-408b-9191-8b2a7eaccd67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_55582e41-0841-45c0-ab12-df8c1ba0bcf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b2e67be4-070f-4f58-8161-723c96ef0e89" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_55582e41-0841-45c0-ab12-df8c1ba0bcf0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_55582e41-0841-45c0-ab12-df8c1ba0bcf0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_55582e41-0841-45c0-ab12-df8c1ba0bcf0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_55582e41-0841-45c0-ab12-df8c1ba0bcf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_55582e41-0841-45c0-ab12-df8c1ba0bcf0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap267FixedInterestRateMember_17e3066c-1bd6-4bfe-ad57-be667583af47" xlink:href="hae-20230401.xsd#hae_InterestRateSwap267FixedInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:to="loc_hae_InterestRateSwap267FixedInterestRateMember_17e3066c-1bd6-4bfe-ad57-be667583af47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap276FixedInterestRateMember_d7da539f-4683-4343-8c14-2f4041b72bfb" xlink:href="hae-20230401.xsd#hae_InterestRateSwap276FixedInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:to="loc_hae_InterestRateSwap276FixedInterestRateMember_d7da539f-4683-4343-8c14-2f4041b72bfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap444FixedInterestRateMember_d39986fe-0666-4318-9847-b9afd5f4b65d" xlink:href="hae-20230401.xsd#hae_InterestRateSwap444FixedInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:to="loc_hae_InterestRateSwap444FixedInterestRateMember_d39986fe-0666-4318-9847-b9afd5f4b65d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap446FixedInterestRateMember_e9987f00-6729-4385-a77b-76c1787d1276" xlink:href="hae-20230401.xsd#hae_InterestRateSwap446FixedInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:to="loc_hae_InterestRateSwap446FixedInterestRateMember_e9987f00-6729-4385-a77b-76c1787d1276" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap408FixedInterestRateMember_a91e3f08-4b7d-40c1-8d3f-b0520b82bb12" xlink:href="hae-20230401.xsd#hae_InterestRateSwap408FixedInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:to="loc_hae_InterestRateSwap408FixedInterestRateMember_a91e3f08-4b7d-40c1-8d3f-b0520b82bb12" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap415FixedInterestRateMember_96242ca2-db91-4b46-93d3-8aa05891b2a0" xlink:href="hae-20230401.xsd#hae_InterestRateSwap415FixedInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:to="loc_hae_InterestRateSwap415FixedInterestRateMember_96242ca2-db91-4b46-93d3-8aa05891b2a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1fa712e5-42ad-424f-8f29-977a94e88c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:to="loc_us-gaap_InterestRateSwapMember_1fa712e5-42ad-424f-8f29-977a94e88c2f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_51e8ea20-af85-4183-8c30-acb667b37f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b2e67be4-070f-4f58-8161-723c96ef0e89" xlink:to="loc_us-gaap_PositionAxis_51e8ea20-af85-4183-8c30-acb667b37f2a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_51e8ea20-af85-4183-8c30-acb667b37f2a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_51e8ea20-af85-4183-8c30-acb667b37f2a" xlink:to="loc_us-gaap_PositionDomain_51e8ea20-af85-4183-8c30-acb667b37f2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_b09473b5-76db-4ed8-b626-8a2a983acf74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_51e8ea20-af85-4183-8c30-acb667b37f2a" xlink:to="loc_us-gaap_PositionDomain_b09473b5-76db-4ed8-b626-8a2a983acf74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_134d69c1-f74a-46f1-8223-c923a30c704b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b2e67be4-070f-4f58-8161-723c96ef0e89" xlink:to="loc_srt_RangeAxis_134d69c1-f74a-46f1-8223-c923a30c704b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_134d69c1-f74a-46f1-8223-c923a30c704b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_134d69c1-f74a-46f1-8223-c923a30c704b" xlink:to="loc_srt_RangeMember_134d69c1-f74a-46f1-8223-c923a30c704b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3d150bdf-2dbf-4276-ab28-fb879217cac5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_134d69c1-f74a-46f1-8223-c923a30c704b" xlink:to="loc_srt_RangeMember_3d150bdf-2dbf-4276-ab28-fb879217cac5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="i56909a532c0a41529573bdbbaacf5353_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_79be51a2-feb7-4dfb-accb-04e46153c702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_11b6fcf4-8255-4fff-a25e-fa31aa20eaf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_79be51a2-feb7-4dfb-accb-04e46153c702" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_11b6fcf4-8255-4fff-a25e-fa31aa20eaf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_83b4682c-ba76-4a46-a9e3-c788c868b0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_79be51a2-feb7-4dfb-accb-04e46153c702" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_83b4682c-ba76-4a46-a9e3-c788c868b0e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_624fbc79-f579-4d2d-a0b0-03e860458ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_79be51a2-feb7-4dfb-accb-04e46153c702" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_624fbc79-f579-4d2d-a0b0-03e860458ee7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f8847eb-5caa-4004-8eee-0add84ebc42e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_79be51a2-feb7-4dfb-accb-04e46153c702" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f8847eb-5caa-4004-8eee-0add84ebc42e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f0a0182e-2285-4938-8f35-5cb6d265c44e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f8847eb-5caa-4004-8eee-0add84ebc42e" xlink:to="loc_us-gaap_HedgingDesignationAxis_f0a0182e-2285-4938-8f35-5cb6d265c44e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f0a0182e-2285-4938-8f35-5cb6d265c44e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_f0a0182e-2285-4938-8f35-5cb6d265c44e" xlink:to="loc_us-gaap_HedgingDesignationDomain_f0a0182e-2285-4938-8f35-5cb6d265c44e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_290c7a5e-b9a2-4453-8e47-3bd2ea28d254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_f0a0182e-2285-4938-8f35-5cb6d265c44e" xlink:to="loc_us-gaap_HedgingDesignationDomain_290c7a5e-b9a2-4453-8e47-3bd2ea28d254" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_87db050e-b0fb-47b6-8038-b39d9a0139e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_290c7a5e-b9a2-4453-8e47-3bd2ea28d254" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_87db050e-b0fb-47b6-8038-b39d9a0139e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_fa85748b-5bda-4e40-a6fc-eb84d5f5a33d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_290c7a5e-b9a2-4453-8e47-3bd2ea28d254" xlink:to="loc_us-gaap_NondesignatedMember_fa85748b-5bda-4e40-a6fc-eb84d5f5a33d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b700f787-6f5f-499d-aedf-d5df0e50b690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f8847eb-5caa-4004-8eee-0add84ebc42e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b700f787-6f5f-499d-aedf-d5df0e50b690" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b700f787-6f5f-499d-aedf-d5df0e50b690_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b700f787-6f5f-499d-aedf-d5df0e50b690" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b700f787-6f5f-499d-aedf-d5df0e50b690_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a6a3ddf1-b323-46a4-bf6b-7c74dcd97e59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b700f787-6f5f-499d-aedf-d5df0e50b690" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a6a3ddf1-b323-46a4-bf6b-7c74dcd97e59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_ef0d8edc-374c-4c58-bd3d-194f9e74e0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a6a3ddf1-b323-46a4-bf6b-7c74dcd97e59" xlink:to="loc_us-gaap_CashFlowHedgingMember_ef0d8edc-374c-4c58-bd3d-194f9e74e0f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_718b9b42-42f7-410b-96dc-1d96ae24fc49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a6a3ddf1-b323-46a4-bf6b-7c74dcd97e59" xlink:to="loc_us-gaap_InterestRateSwapMember_718b9b42-42f7-410b-96dc-1d96ae24fc49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ac550a4d-a3b6-48d4-9b38-f217d31638b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f8847eb-5caa-4004-8eee-0add84ebc42e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ac550a4d-a3b6-48d4-9b38-f217d31638b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ac550a4d-a3b6-48d4-9b38-f217d31638b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ac550a4d-a3b6-48d4-9b38-f217d31638b8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ac550a4d-a3b6-48d4-9b38-f217d31638b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1d80d5aa-0228-4f38-a64d-7477e70e8139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ac550a4d-a3b6-48d4-9b38-f217d31638b8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1d80d5aa-0228-4f38-a64d-7477e70e8139" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a3003a27-b28f-43df-93d6-4645c40828b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1d80d5aa-0228-4f38-a64d-7477e70e8139" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a3003a27-b28f-43df-93d6-4645c40828b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3be08b58-97be-40e2-8853-ba9e54e61637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f8847eb-5caa-4004-8eee-0add84ebc42e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3be08b58-97be-40e2-8853-ba9e54e61637" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3be08b58-97be-40e2-8853-ba9e54e61637_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3be08b58-97be-40e2-8853-ba9e54e61637" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3be08b58-97be-40e2-8853-ba9e54e61637_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d5444236-d698-4772-bd06-93e4f090afa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3be08b58-97be-40e2-8853-ba9e54e61637" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d5444236-d698-4772-bd06-93e4f090afa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_5c67bb93-fa4f-49db-84e1-fcb2a3ed11fa" xlink:href="hae-20230401.xsd#hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d5444236-d698-4772-bd06-93e4f090afa6" xlink:to="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_5c67bb93-fa4f-49db-84e1-fcb2a3ed11fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherIncomeExpenseNetMember_8fb64202-4bfe-45d3-a3f8-27419cf39f9c" xlink:href="hae-20230401.xsd#hae_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d5444236-d698-4772-bd06-93e4f090afa6" xlink:to="loc_hae_OtherIncomeExpenseNetMember_8fb64202-4bfe-45d3-a3f8-27419cf39f9c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails" xlink:type="extended" id="ic1df7e298c064279965c68468d45a0b2_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acfc6f5f-46a2-4e67-9927-45b79be130a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_44b64ed3-86d7-4a67-b183-ff06b9563294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acfc6f5f-46a2-4e67-9927-45b79be130a8" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_44b64ed3-86d7-4a67-b183-ff06b9563294" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_7e3f88a0-03ec-43a9-a614-7c5661910ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_44b64ed3-86d7-4a67-b183-ff06b9563294" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_7e3f88a0-03ec-43a9-a614-7c5661910ff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_afc3b9c5-d5c2-4df6-8897-9d46db999e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_44b64ed3-86d7-4a67-b183-ff06b9563294" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_afc3b9c5-d5c2-4df6-8897-9d46db999e3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_590904d6-9fb9-4d30-9bd4-60b712a9db3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_44b64ed3-86d7-4a67-b183-ff06b9563294" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_590904d6-9fb9-4d30-9bd4-60b712a9db3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1c556d79-0fc3-4c74-8356-d6c8dbf2315d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acfc6f5f-46a2-4e67-9927-45b79be130a8" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1c556d79-0fc3-4c74-8356-d6c8dbf2315d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_3fe8f96b-8064-4434-bf63-3356314cb26c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1c556d79-0fc3-4c74-8356-d6c8dbf2315d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_3fe8f96b-8064-4434-bf63-3356314cb26c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_deea5698-6150-4e9e-8d3b-03de9b7daa63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1c556d79-0fc3-4c74-8356-d6c8dbf2315d" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_deea5698-6150-4e9e-8d3b-03de9b7daa63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_f8bd647c-8063-4354-9c1e-9b1ac3dc1494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acfc6f5f-46a2-4e67-9927-45b79be130a8" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_f8bd647c-8063-4354-9c1e-9b1ac3dc1494" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acfc6f5f-46a2-4e67-9927-45b79be130a8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9eee14b6-ef67-4fb4-868c-0fc47ab9f345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9eee14b6-ef67-4fb4-868c-0fc47ab9f345" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9eee14b6-ef67-4fb4-868c-0fc47ab9f345_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9eee14b6-ef67-4fb4-868c-0fc47ab9f345" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9eee14b6-ef67-4fb4-868c-0fc47ab9f345_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5209ce93-4be0-4e9a-8d64-4936e5eceaa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9eee14b6-ef67-4fb4-868c-0fc47ab9f345" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5209ce93-4be0-4e9a-8d64-4936e5eceaa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f4df7546-459e-4e5a-ba8b-7c1847090c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5209ce93-4be0-4e9a-8d64-4936e5eceaa1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f4df7546-459e-4e5a-ba8b-7c1847090c24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_df7ccc53-3b1b-4054-8ec1-fe0295e76a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_df7ccc53-3b1b-4054-8ec1-fe0295e76a3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_df7ccc53-3b1b-4054-8ec1-fe0295e76a3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_df7ccc53-3b1b-4054-8ec1-fe0295e76a3c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_df7ccc53-3b1b-4054-8ec1-fe0295e76a3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3eca0565-0197-4fb4-8281-ba54dd999dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_df7ccc53-3b1b-4054-8ec1-fe0295e76a3c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3eca0565-0197-4fb4-8281-ba54dd999dbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6fd4f12a-5d44-4327-8ec8-9882a5e81822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3eca0565-0197-4fb4-8281-ba54dd999dbb" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6fd4f12a-5d44-4327-8ec8-9882a5e81822" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_28fed7eb-4e3c-474e-b168-0a638e6987ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3eca0565-0197-4fb4-8281-ba54dd999dbb" xlink:to="loc_us-gaap_InterestRateSwapMember_28fed7eb-4e3c-474e-b168-0a638e6987ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationMember_4d13d79b-7d27-4715-8b41-9438ce177b4f" xlink:href="hae-20230401.xsd#hae_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3eca0565-0197-4fb4-8281-ba54dd999dbb" xlink:to="loc_hae_ContingentConsiderationMember_4d13d79b-7d27-4715-8b41-9438ce177b4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5562d267-2c73-4238-9f53-eca273803582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5562d267-2c73-4238-9f53-eca273803582" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5562d267-2c73-4238-9f53-eca273803582_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5562d267-2c73-4238-9f53-eca273803582" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5562d267-2c73-4238-9f53-eca273803582_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_564c84df-f776-4f55-b8fd-5f5fe2a0fef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5562d267-2c73-4238-9f53-eca273803582" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_564c84df-f776-4f55-b8fd-5f5fe2a0fef6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_313e5e4c-68a4-4b92-a2e4-45278cc86e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_564c84df-f776-4f55-b8fd-5f5fe2a0fef6" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_313e5e4c-68a4-4b92-a2e4-45278cc86e27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_f1e1e008-a334-41e8-976b-ee08ffde6589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_564c84df-f776-4f55-b8fd-5f5fe2a0fef6" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_f1e1e008-a334-41e8-976b-ee08ffde6589" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f909639e-15ca-486e-aa40-3a1bc7d8b072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_564c84df-f776-4f55-b8fd-5f5fe2a0fef6" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f909639e-15ca-486e-aa40-3a1bc7d8b072" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e8dc3cde-9034-45ed-abb7-4ee83d4d0301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:to="loc_us-gaap_HedgingDesignationAxis_e8dc3cde-9034-45ed-abb7-4ee83d4d0301" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e8dc3cde-9034-45ed-abb7-4ee83d4d0301_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_e8dc3cde-9034-45ed-abb7-4ee83d4d0301" xlink:to="loc_us-gaap_HedgingDesignationDomain_e8dc3cde-9034-45ed-abb7-4ee83d4d0301_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4190aaac-507e-48fa-bcd4-6080585bba0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_e8dc3cde-9034-45ed-abb7-4ee83d4d0301" xlink:to="loc_us-gaap_HedgingDesignationDomain_4190aaac-507e-48fa-bcd4-6080585bba0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f285a62a-5446-45d2-a578-d76af94a9b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_4190aaac-507e-48fa-bcd4-6080585bba0b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f285a62a-5446-45d2-a578-d76af94a9b6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_b60cce12-e29e-485b-bbab-ffad726a4e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_4190aaac-507e-48fa-bcd4-6080585bba0b" xlink:to="loc_us-gaap_NondesignatedMember_b60cce12-e29e-485b-bbab-ffad726a4e2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_89078af2-b730-4e02-a8f0-5612b4db15ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_89078af2-b730-4e02-a8f0-5612b4db15ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_89078af2-b730-4e02-a8f0-5612b4db15ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_89078af2-b730-4e02-a8f0-5612b4db15ab" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_89078af2-b730-4e02-a8f0-5612b4db15ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_acda421a-b2fc-4973-abb2-e81c42b0d39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_89078af2-b730-4e02-a8f0-5612b4db15ab" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_acda421a-b2fc-4973-abb2-e81c42b0d39e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_cf10bb39-aff3-4e3a-a1b5-22788b573b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_acda421a-b2fc-4973-abb2-e81c42b0d39e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_cf10bb39-aff3-4e3a-a1b5-22788b573b6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_cf147947-fcf5-4b3d-ae39-fbd882bfcfd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_acda421a-b2fc-4973-abb2-e81c42b0d39e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_cf147947-fcf5-4b3d-ae39-fbd882bfcfd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ce6d1301-9cf3-4f2f-ac09-d8a837128041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_acda421a-b2fc-4973-abb2-e81c42b0d39e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ce6d1301-9cf3-4f2f-ac09-d8a837128041" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_75513ecc-f83d-4087-ae26-888abb171c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_75513ecc-f83d-4087-ae26-888abb171c43" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_75513ecc-f83d-4087-ae26-888abb171c43_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_75513ecc-f83d-4087-ae26-888abb171c43" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_75513ecc-f83d-4087-ae26-888abb171c43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4e62a653-cb79-42bc-8fc3-304dac8c12af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_75513ecc-f83d-4087-ae26-888abb171c43" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4e62a653-cb79-42bc-8fc3-304dac8c12af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RevenueBasedPayments2Member_d9586530-1d9a-4b37-a24c-830ad02a8c3a" xlink:href="hae-20230401.xsd#hae_RevenueBasedPayments2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4e62a653-cb79-42bc-8fc3-304dac8c12af" xlink:to="loc_hae_RevenueBasedPayments2Member_d9586530-1d9a-4b37-a24c-830ad02a8c3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_3743e735-7d24-4e06-b424-bbbe7d0f8b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:to="loc_us-gaap_ValuationTechniqueAxis_3743e735-7d24-4e06-b424-bbbe7d0f8b32" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_3743e735-7d24-4e06-b424-bbbe7d0f8b32_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_3743e735-7d24-4e06-b424-bbbe7d0f8b32" xlink:to="loc_us-gaap_ValuationTechniqueDomain_3743e735-7d24-4e06-b424-bbbe7d0f8b32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_414453ad-d469-44b3-bd39-f64254fccf33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_3743e735-7d24-4e06-b424-bbbe7d0f8b32" xlink:to="loc_us-gaap_ValuationTechniqueDomain_414453ad-d469-44b3-bd39-f64254fccf33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_b61b8236-6345-467f-aac2-bbccb52548d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_414453ad-d469-44b3-bd39-f64254fccf33" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_b61b8236-6345-467f-aac2-bbccb52548d0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#RETIREMENTPLANSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails" xlink:type="extended" id="i7dd05d42274e49b280297046b12dd79b_RETIREMENTPLANSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9fc2b3b3-4c90-4b88-9959-73282405f863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_527ec927-fe1a-4744-8c5c-227a9ede0c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9fc2b3b3-4c90-4b88-9959-73282405f863" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_527ec927-fe1a-4744-8c5c-227a9ede0c9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany_718ebfd9-0d9e-4a3b-94c0-1662cab4faf5" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9fc2b3b3-4c90-4b88-9959-73282405f863" xlink:to="loc_hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany_718ebfd9-0d9e-4a3b-94c0-1662cab4faf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanReinsuranceContractsAssetValue_8679ddb8-18bc-4c9a-976c-b95f2706f5e7" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanReinsuranceContractsAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9fc2b3b3-4c90-4b88-9959-73282405f863" xlink:to="loc_hae_DefinedBenefitPlanReinsuranceContractsAssetValue_8679ddb8-18bc-4c9a-976c-b95f2706f5e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_771492ae-60f5-45b1-9dc8-b50275a6dd19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9fc2b3b3-4c90-4b88-9959-73282405f863" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_771492ae-60f5-45b1-9dc8-b50275a6dd19" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear_624510a7-2e0e-4539-a2a8-3c9f9e2178f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9fc2b3b3-4c90-4b88-9959-73282405f863" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear_624510a7-2e0e-4539-a2a8-3c9f9e2178f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ee1b402a-9a3c-4944-a538-c09ce50ebd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9fc2b3b3-4c90-4b88-9959-73282405f863" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ee1b402a-9a3c-4944-a538-c09ce50ebd5e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_5ad1d9ae-b2b4-45ad-8463-29d0be74bcd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ee1b402a-9a3c-4944-a538-c09ce50ebd5e" xlink:to="loc_us-gaap_RetirementPlanNameAxis_5ad1d9ae-b2b4-45ad-8463-29d0be74bcd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_5ad1d9ae-b2b4-45ad-8463-29d0be74bcd9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_5ad1d9ae-b2b4-45ad-8463-29d0be74bcd9" xlink:to="loc_us-gaap_RetirementPlanNameDomain_5ad1d9ae-b2b4-45ad-8463-29d0be74bcd9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_72129b83-c34c-4976-9d21-4bea8fbc7d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_5ad1d9ae-b2b4-45ad-8463-29d0be74bcd9" xlink:to="loc_us-gaap_RetirementPlanNameDomain_72129b83-c34c-4976-9d21-4bea8fbc7d44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SavingsPlusPlanMember_fac6579a-4374-4c16-88ef-20b77799238f" xlink:href="hae-20230401.xsd#hae_SavingsPlusPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_72129b83-c34c-4976-9d21-4bea8fbc7d44" xlink:to="loc_hae_SavingsPlusPlanMember_fac6579a-4374-4c16-88ef-20b77799238f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A401kPlanMember_ba80415c-a285-48a8-8324-d22b6cda10ef" xlink:href="hae-20230401.xsd#hae_A401kPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_72129b83-c34c-4976-9d21-4bea8fbc7d44" xlink:to="loc_hae_A401kPlanMember_ba80415c-a285-48a8-8324-d22b6cda10ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_05f55446-1ea4-4ff7-8be5-bba214ff9016" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ee1b402a-9a3c-4944-a538-c09ce50ebd5e" xlink:to="loc_srt_ConsolidatedEntitiesAxis_05f55446-1ea4-4ff7-8be5-bba214ff9016" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_05f55446-1ea4-4ff7-8be5-bba214ff9016_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_05f55446-1ea4-4ff7-8be5-bba214ff9016" xlink:to="loc_srt_ConsolidatedEntitiesDomain_05f55446-1ea4-4ff7-8be5-bba214ff9016_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ef324fc3-6e2d-4467-b919-4ae13b461d75" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_05f55446-1ea4-4ff7-8be5-bba214ff9016" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ef324fc3-6e2d-4467-b919-4ae13b461d75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_b0807bad-8e33-41dd-91de-075c0275e9f3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_ef324fc3-6e2d-4467-b919-4ae13b461d75" xlink:to="loc_srt_SubsidiariesMember_b0807bad-8e33-41dd-91de-075c0275e9f3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#CAPITALSTOCKNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails" xlink:type="extended" id="i5c79ac3ee099454190255ac3b70951d1_CAPITALSTOCKNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5f34572a-c605-463b-90f4-d09b76c3bea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5f34572a-c605-463b-90f4-d09b76c3bea4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares_51a31f19-a008-4efe-be59-664fabbc8b24" xlink:href="hae-20230401.xsd#hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares_51a31f19-a008-4efe-be59-664fabbc8b24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_163213c6-cfb0-429a-a98f-ab85aa6c38d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_163213c6-cfb0-429a-a98f-ab85aa6c38d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a9267e67-2c1a-42f6-bacd-5df0c90f94c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a9267e67-2c1a-42f6-bacd-5df0c90f94c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_582371dd-9f6a-4104-995b-0a723e53456b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_582371dd-9f6a-4104-995b-0a723e53456b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bf1c931c-edd0-4f6c-b921-56ab987f519b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bf1c931c-edd0-4f6c-b921-56ab987f519b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_da8cf99b-7149-4ae4-ae3d-c13c4b6af52f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_da8cf99b-7149-4ae4-ae3d-c13c4b6af52f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NumberOfPurchasePeriods_0bceed12-64c9-42cf-8b07-8ed94e18bcb1" xlink:href="hae-20230401.xsd#hae_NumberOfPurchasePeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_hae_NumberOfPurchasePeriods_0bceed12-64c9-42cf-8b07-8ed94e18bcb1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PercentageOfSharesPurchasedThroughPayrollDeductions_506f8e3e-f570-49f4-bc4f-f0839a799b61" xlink:href="hae-20230401.xsd#hae_PercentageOfSharesPurchasedThroughPayrollDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_hae_PercentageOfSharesPurchasedThroughPayrollDeductions_506f8e3e-f570-49f4-bc4f-f0839a799b61" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue_d1dd41fa-6393-47d5-bed6-bcb9bcb08458" xlink:href="hae-20230401.xsd#hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue_d1dd41fa-6393-47d5-bed6-bcb9bcb08458" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1bee2987-465d-40e8-9195-461799e58e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1bee2987-465d-40e8-9195-461799e58e02" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fcc80ad8-ef0f-47c8-aa4c-97904bbc742c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fcc80ad8-ef0f-47c8-aa4c-97904bbc742c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e8ea60dd-c1cf-4cee-843c-d4270c3bba39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e8ea60dd-c1cf-4cee-843c-d4270c3bba39" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan_a5eb3cd8-91e7-4d7a-a79f-da4a321600df" xlink:href="hae-20230401.xsd#hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan_a5eb3cd8-91e7-4d7a-a79f-da4a321600df" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44dc38c2-7bb0-44d9-8034-3065cbdd4c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44dc38c2-7bb0-44d9-8034-3065cbdd4c6b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7647823c-8480-43ac-9c12-c45dcfcbe734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7647823c-8480-43ac-9c12-c45dcfcbe734" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod_716f40b7-ca25-4f94-862d-768dfcfe95b2" xlink:href="hae-20230401.xsd#hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod_716f40b7-ca25-4f94-862d-768dfcfe95b2" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget_b07062e0-3df9-4929-a653-d026b4248557" xlink:href="hae-20230401.xsd#hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget_b07062e0-3df9-4929-a653-d026b4248557" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e1538886-12f7-4fe2-849b-e2e230029045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e1538886-12f7-4fe2-849b-e2e230029045" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_863f8091-7b26-430f-bc92-890cace60c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:to="loc_us-gaap_PlanNameAxis_863f8091-7b26-430f-bc92-890cace60c5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_863f8091-7b26-430f-bc92-890cace60c5f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_863f8091-7b26-430f-bc92-890cace60c5f" xlink:to="loc_us-gaap_PlanNameDomain_863f8091-7b26-430f-bc92-890cace60c5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0f45b7f0-1d03-4412-b9d0-f74806a44121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_863f8091-7b26-430f-bc92-890cace60c5f" xlink:to="loc_us-gaap_PlanNameDomain_0f45b7f0-1d03-4412-b9d0-f74806a44121" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2019EquityPlanMember_d36a5502-9faa-4c20-ba64-0a84e57eda1e" xlink:href="hae-20230401.xsd#hae_A2019EquityPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_0f45b7f0-1d03-4412-b9d0-f74806a44121" xlink:to="loc_hae_A2019EquityPlanMember_d36a5502-9faa-4c20-ba64-0a84e57eda1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_IncentiveCompensationPlan2005Member_ac9258f0-0ccc-4eb0-aae0-2ac7786f9f4f" xlink:href="hae-20230401.xsd#hae_IncentiveCompensationPlan2005Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_0f45b7f0-1d03-4412-b9d0-f74806a44121" xlink:to="loc_hae_IncentiveCompensationPlan2005Member_ac9258f0-0ccc-4eb0-aae0-2ac7786f9f4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_eb6c4c22-524b-4040-8734-1275b84e79a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:to="loc_us-gaap_AwardTypeAxis_eb6c4c22-524b-4040-8734-1275b84e79a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eb6c4c22-524b-4040-8734-1275b84e79a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_eb6c4c22-524b-4040-8734-1275b84e79a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eb6c4c22-524b-4040-8734-1275b84e79a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6aab928c-bbd6-43e5-bb49-ccec24cd27f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_eb6c4c22-524b-4040-8734-1275b84e79a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6aab928c-bbd6-43e5-bb49-ccec24cd27f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4e52f869-c9eb-4c2f-96ab-4b68d963c29d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6aab928c-bbd6-43e5-bb49-ccec24cd27f0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4e52f869-c9eb-4c2f-96ab-4b68d963c29d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d7bc2541-c0ba-45fa-b886-b319a7cbd672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6aab928c-bbd6-43e5-bb49-ccec24cd27f0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d7bc2541-c0ba-45fa-b886-b319a7cbd672" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_17876e7e-20bd-4c77-83d1-2eb56765a44a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6aab928c-bbd6-43e5-bb49-ccec24cd27f0" xlink:to="loc_us-gaap_PerformanceSharesMember_17876e7e-20bd-4c77-83d1-2eb56765a44a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_e6bb2af1-2224-4b95-94d2-500863554d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6aab928c-bbd6-43e5-bb49-ccec24cd27f0" xlink:to="loc_us-gaap_StockCompensationPlanMember_e6bb2af1-2224-4b95-94d2-500863554d26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_32dfc469-9951-49b5-a397-b4cb2efe7a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:to="loc_us-gaap_VestingAxis_32dfc469-9951-49b5-a397-b4cb2efe7a59" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_32dfc469-9951-49b5-a397-b4cb2efe7a59_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_32dfc469-9951-49b5-a397-b4cb2efe7a59" xlink:to="loc_us-gaap_VestingDomain_32dfc469-9951-49b5-a397-b4cb2efe7a59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_0549e961-c28d-4c21-897a-529b8d7dd09f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_32dfc469-9951-49b5-a397-b4cb2efe7a59" xlink:to="loc_us-gaap_VestingDomain_0549e961-c28d-4c21-897a-529b8d7dd09f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_Fiscal2016AwardsMember_25e7c008-9bc3-4955-9bb0-fb31ef66d934" xlink:href="hae-20230401.xsd#hae_Fiscal2016AwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_0549e961-c28d-4c21-897a-529b8d7dd09f" xlink:to="loc_hae_Fiscal2016AwardsMember_25e7c008-9bc3-4955-9bb0-fb31ef66d934" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_41f9a2a7-cfac-4457-beda-070c3e1ddea3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:to="loc_srt_TitleOfIndividualAxis_41f9a2a7-cfac-4457-beda-070c3e1ddea3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_41f9a2a7-cfac-4457-beda-070c3e1ddea3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_41f9a2a7-cfac-4457-beda-070c3e1ddea3" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_41f9a2a7-cfac-4457-beda-070c3e1ddea3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32e4d787-ed11-430e-ac52-adac6c2a52cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_41f9a2a7-cfac-4457-beda-070c3e1ddea3" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32e4d787-ed11-430e-ac52-adac6c2a52cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EmployeesMember_eb508a30-0b5a-4c1b-912f-ecebe4d39cfb" xlink:href="hae-20230401.xsd#hae_EmployeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32e4d787-ed11-430e-ac52-adac6c2a52cb" xlink:to="loc_hae_EmployeesMember_eb508a30-0b5a-4c1b-912f-ecebe4d39cfb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_217614c8-760f-49b1-88cb-ff662394214c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32e4d787-ed11-430e-ac52-adac6c2a52cb" xlink:to="loc_srt_DirectorMember_217614c8-760f-49b1-88cb-ff662394214c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_10a2cb80-3d50-48a4-b3f2-bf2afd534cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_10a2cb80-3d50-48a4-b3f2-bf2afd534cfb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_10a2cb80-3d50-48a4-b3f2-bf2afd534cfb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_10a2cb80-3d50-48a4-b3f2-bf2afd534cfb" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_10a2cb80-3d50-48a4-b3f2-bf2afd534cfb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_01bfa33c-c6c0-4884-89c7-02841a37e54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_10a2cb80-3d50-48a4-b3f2-bf2afd534cfb" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_01bfa33c-c6c0-4884-89c7-02841a37e54d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EmployeeStockPurchasePlanMember_fad5f36f-c5b2-421e-a6ed-7198928768d8" xlink:href="hae-20230401.xsd#hae_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_01bfa33c-c6c0-4884-89c7-02841a37e54d" xlink:to="loc_hae_EmployeeStockPurchasePlanMember_fad5f36f-c5b2-421e-a6ed-7198928768d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_58bbdbb8-304c-4cbb-94ca-ed697e2791d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:to="loc_srt_RangeAxis_58bbdbb8-304c-4cbb-94ca-ed697e2791d9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_58bbdbb8-304c-4cbb-94ca-ed697e2791d9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_58bbdbb8-304c-4cbb-94ca-ed697e2791d9" xlink:to="loc_srt_RangeMember_58bbdbb8-304c-4cbb-94ca-ed697e2791d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f9e96f55-9c3a-45e7-a481-794e8a819d7c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_58bbdbb8-304c-4cbb-94ca-ed697e2791d9" xlink:to="loc_srt_RangeMember_f9e96f55-9c3a-45e7-a481-794e8a819d7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_25c7756d-fff6-40e1-8ab9-a023dd8b33fc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f9e96f55-9c3a-45e7-a481-794e8a819d7c" xlink:to="loc_srt_MinimumMember_25c7756d-fff6-40e1-8ab9-a023dd8b33fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4f4a31b2-ca8f-43ba-a7fb-62376dff8f97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f9e96f55-9c3a-45e7-a481-794e8a819d7c" xlink:to="loc_srt_MaximumMember_4f4a31b2-ca8f-43ba-a7fb-62376dff8f97" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofShareBasedCompensationDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#CAPITALSTOCKScheduleofShareBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofShareBasedCompensationDetails" xlink:type="extended" id="idf8da5f68ece4af3893cb7d4148acff4_CAPITALSTOCKScheduleofShareBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_117abcc1-e72f-4374-993d-7d74e09ee1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_31739fbf-40ea-4de6-8df0-8530e2ba0065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_117abcc1-e72f-4374-993d-7d74e09ee1c3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_31739fbf-40ea-4de6-8df0-8530e2ba0065" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2d45df26-e64e-4e94-b6d5-9a6f87a87ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_117abcc1-e72f-4374-993d-7d74e09ee1c3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2d45df26-e64e-4e94-b6d5-9a6f87a87ebc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c54a5066-b536-4c5e-879c-056bb5ff6fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2d45df26-e64e-4e94-b6d5-9a6f87a87ebc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c54a5066-b536-4c5e-879c-056bb5ff6fff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c54a5066-b536-4c5e-879c-056bb5ff6fff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c54a5066-b536-4c5e-879c-056bb5ff6fff" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c54a5066-b536-4c5e-879c-056bb5ff6fff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7b1022d8-1ad2-416c-ba53-003a9f119842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c54a5066-b536-4c5e-879c-056bb5ff6fff" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7b1022d8-1ad2-416c-ba53-003a9f119842" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_77c928a9-b050-496d-af19-d96c231e65d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7b1022d8-1ad2-416c-ba53-003a9f119842" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_77c928a9-b050-496d-af19-d96c231e65d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_dad0a3e9-d05c-4872-8644-21da51bbfb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7b1022d8-1ad2-416c-ba53-003a9f119842" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_dad0a3e9-d05c-4872-8644-21da51bbfb8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_a6043e09-0b68-4e0f-9e59-1345b08d9a08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7b1022d8-1ad2-416c-ba53-003a9f119842" xlink:to="loc_us-gaap_CostOfSalesMember_a6043e09-0b68-4e0f-9e59-1345b08d9a08" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails" xlink:type="extended" id="i2446cde27a574253a75c04edf5eb8a7d_CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855710a2-0805-4627-ab9e-8a554ec67916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e515b3ad-a77f-4ac0-b4a7-24ed0f207d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855710a2-0805-4627-ab9e-8a554ec67916" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e515b3ad-a77f-4ac0-b4a7-24ed0f207d87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2b9214be-5037-4728-87ce-cd97b74dd082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e515b3ad-a77f-4ac0-b4a7-24ed0f207d87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2b9214be-5037-4728-87ce-cd97b74dd082" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_fbf2e9f0-63a8-48ab-a2a8-36d4ecb8934e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e515b3ad-a77f-4ac0-b4a7-24ed0f207d87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_fbf2e9f0-63a8-48ab-a2a8-36d4ecb8934e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_32d1757f-f817-4003-830f-086e10e494b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e515b3ad-a77f-4ac0-b4a7-24ed0f207d87" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_32d1757f-f817-4003-830f-086e10e494b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3ff9fa52-e742-4df1-a61a-c725069896fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e515b3ad-a77f-4ac0-b4a7-24ed0f207d87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3ff9fa52-e742-4df1-a61a-c725069896fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_543db4a5-9144-4944-bb71-20496e14a377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2283aca7-11cc-480d-a4a2-0891a05847f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855710a2-0805-4627-ab9e-8a554ec67916" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2283aca7-11cc-480d-a4a2-0891a05847f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_968d05a1-d168-41de-9cd2-4b7ecd1dfd24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2283aca7-11cc-480d-a4a2-0891a05847f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_968d05a1-d168-41de-9cd2-4b7ecd1dfd24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a59f5abb-c150-4f59-9435-a96fc0ae1d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2283aca7-11cc-480d-a4a2-0891a05847f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a59f5abb-c150-4f59-9435-a96fc0ae1d26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4915ed22-643f-4f8a-a75c-c5ca176496d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2283aca7-11cc-480d-a4a2-0891a05847f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4915ed22-643f-4f8a-a75c-c5ca176496d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c96cd9d1-3ee6-4292-978c-251148180445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2283aca7-11cc-480d-a4a2-0891a05847f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c96cd9d1-3ee6-4292-978c-251148180445" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3adbf6e5-d98d-4542-ae7c-19ee13483459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855710a2-0805-4627-ab9e-8a554ec67916" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8edc5319-cebe-4101-8390-ad378a2e463f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8edc5319-cebe-4101-8390-ad378a2e463f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_631834bb-0b44-4da6-bb16-249055529d28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_631834bb-0b44-4da6-bb16-249055529d28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_713a6847-a0a6-4e3f-99de-5dbedc2d92d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_713a6847-a0a6-4e3f-99de-5dbedc2d92d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_54b9585f-2d80-4e42-b3fc-1ff6c25bcba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_54b9585f-2d80-4e42-b3fc-1ff6c25bcba6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_25377f16-4875-4400-ac07-8b64a3217bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_25377f16-4875-4400-ac07-8b64a3217bc1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_a599544f-de88-4ba5-8795-f4f80ec02d90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_a599544f-de88-4ba5-8795-f4f80ec02d90" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_6f7d5719-8a67-4f21-8141-d5620c7c9726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_6f7d5719-8a67-4f21-8141-d5620c7c9726" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_30836774-c34d-46b5-b123-ba896f17dc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_30836774-c34d-46b5-b123-ba896f17dc1f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_bea967d1-070f-4805-82c1-200855266b28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_bea967d1-070f-4805-82c1-200855266b28" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_7cf235ec-492d-46ad-b594-c276c13c99da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_7cf235ec-492d-46ad-b594-c276c13c99da" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b4bdd9-cac8-4967-bdf0-f3d396174629" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855710a2-0805-4627-ab9e-8a554ec67916" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b4bdd9-cac8-4967-bdf0-f3d396174629" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6caf9b85-c505-4a32-af40-e542127dd2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b4bdd9-cac8-4967-bdf0-f3d396174629" xlink:to="loc_us-gaap_AwardTypeAxis_6caf9b85-c505-4a32-af40-e542127dd2ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6caf9b85-c505-4a32-af40-e542127dd2ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6caf9b85-c505-4a32-af40-e542127dd2ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6caf9b85-c505-4a32-af40-e542127dd2ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8be5cf36-8aa2-474f-98e3-cf3a4f916cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6caf9b85-c505-4a32-af40-e542127dd2ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8be5cf36-8aa2-474f-98e3-cf3a4f916cb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a6a7ef7e-2634-4eb5-a157-24329e9f796b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8be5cf36-8aa2-474f-98e3-cf3a4f916cb8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a6a7ef7e-2634-4eb5-a157-24329e9f796b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails" xlink:type="extended" id="i7343c14b3f11466ebe17d0ad5c085706_CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b91b0255-7f73-46b8-9724-1a94ff286e15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b91b0255-7f73-46b8-9724-1a94ff286e15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility_d49d5d30-6481-4ad7-8a09-f8f1b338dc85" xlink:href="hae-20230401.xsd#hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility_d49d5d30-6481-4ad7-8a09-f8f1b338dc85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns_03cdee06-49de-4673-9785-d2044c14509a" xlink:href="hae-20230401.xsd#hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns_03cdee06-49de-4673-9785-d2044c14509a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6f09f672-e5d5-4108-8126-68069a88c842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6f09f672-e5d5-4108-8126-68069a88c842" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3f42d264-6e85-44cd-8913-31f0914d3744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3f42d264-6e85-44cd-8913-31f0914d3744" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6d41930b-b721-4c37-a506-7811d3898e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6d41930b-b721-4c37-a506-7811d3898e0d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7215acc2-1f19-4f28-9b77-34a12e2a84c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7215acc2-1f19-4f28-9b77-34a12e2a84c7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8fe4a97e-609f-46c4-82fe-c584b9442669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8fe4a97e-609f-46c4-82fe-c584b9442669" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fb07fb39-4426-4f0b-a809-0c00c29fd444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fb07fb39-4426-4f0b-a809-0c00c29fd444" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cfe3a299-da3b-4273-a2da-fce33d0169ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cfe3a299-da3b-4273-a2da-fce33d0169ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_01adcb78-ac68-4c84-8b7b-e423808f6b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cfe3a299-da3b-4273-a2da-fce33d0169ce" xlink:to="loc_us-gaap_AwardTypeAxis_01adcb78-ac68-4c84-8b7b-e423808f6b17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01adcb78-ac68-4c84-8b7b-e423808f6b17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_01adcb78-ac68-4c84-8b7b-e423808f6b17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01adcb78-ac68-4c84-8b7b-e423808f6b17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_564eaa05-780a-4c6f-acd6-b188bae17d34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_01adcb78-ac68-4c84-8b7b-e423808f6b17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_564eaa05-780a-4c6f-acd6-b188bae17d34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d3885e07-a4e9-46de-a6da-344ff0a2312c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_564eaa05-780a-4c6f-acd6-b188bae17d34" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d3885e07-a4e9-46de-a6da-344ff0a2312c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_47a92adc-076d-479b-a744-9562e45adff3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_564eaa05-780a-4c6f-acd6-b188bae17d34" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_47a92adc-076d-479b-a744-9562e45adff3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_8790580e-1a03-458e-9663-0b54d21f28f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_564eaa05-780a-4c6f-acd6-b188bae17d34" xlink:to="loc_us-gaap_PerformanceSharesMember_8790580e-1a03-458e-9663-0b54d21f28f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_737cbf10-bf27-484b-845f-606ff4d96036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cfe3a299-da3b-4273-a2da-fce33d0169ce" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_737cbf10-bf27-484b-845f-606ff4d96036" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_737cbf10-bf27-484b-845f-606ff4d96036_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_737cbf10-bf27-484b-845f-606ff4d96036" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_737cbf10-bf27-484b-845f-606ff4d96036_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_3b220861-c09e-4036-b0af-f31ca53c8574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_737cbf10-bf27-484b-845f-606ff4d96036" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_3b220861-c09e-4036-b0af-f31ca53c8574" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EmployeeStockPurchasePlanMember_bd7a2ffc-e5a8-4b10-9c78-e9e1ff970867" xlink:href="hae-20230401.xsd#hae_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_3b220861-c09e-4036-b0af-f31ca53c8574" xlink:to="loc_hae_EmployeeStockPurchasePlanMember_bd7a2ffc-e5a8-4b10-9c78-e9e1ff970867" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails" xlink:type="extended" id="i7bc670de533742389ec28f31f3f9c44f_CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489f353-48b4-420e-b467-19145a33bce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_efad8319-a8ce-4bd5-85ac-0c26659e890d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489f353-48b4-420e-b467-19145a33bce8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_efad8319-a8ce-4bd5-85ac-0c26659e890d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bd7bd862-3f04-490e-a4af-33525480f9c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_efad8319-a8ce-4bd5-85ac-0c26659e890d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bd7bd862-3f04-490e-a4af-33525480f9c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6aeea3c7-f190-4f3c-b43f-6f39cd727406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_efad8319-a8ce-4bd5-85ac-0c26659e890d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6aeea3c7-f190-4f3c-b43f-6f39cd727406" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_03bb2ebc-c2d8-4ad9-9f04-c4ccdf61db39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_efad8319-a8ce-4bd5-85ac-0c26659e890d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_03bb2ebc-c2d8-4ad9-9f04-c4ccdf61db39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3a8b0327-fa13-4285-8e4c-6c83ec7e9895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_efad8319-a8ce-4bd5-85ac-0c26659e890d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3a8b0327-fa13-4285-8e4c-6c83ec7e9895" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5f3ae0d2-3721-4649-aea2-4793b9a354ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7d215aa9-45aa-4ec8-bae4-9af506a607f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489f353-48b4-420e-b467-19145a33bce8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7d215aa9-45aa-4ec8-bae4-9af506a607f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c5ac18f4-f1a6-4e74-b172-2c4ba8441c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7d215aa9-45aa-4ec8-bae4-9af506a607f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c5ac18f4-f1a6-4e74-b172-2c4ba8441c11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c2255a01-e116-4dd9-b94e-36f36faeb844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7d215aa9-45aa-4ec8-bae4-9af506a607f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c2255a01-e116-4dd9-b94e-36f36faeb844" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a8bdac20-e631-4172-8f68-1782b4b19354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7d215aa9-45aa-4ec8-bae4-9af506a607f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a8bdac20-e631-4172-8f68-1782b4b19354" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_222f45f5-555f-4b4e-b74d-fa3c3043cd07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7d215aa9-45aa-4ec8-bae4-9af506a607f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_222f45f5-555f-4b4e-b74d-fa3c3043cd07" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0dea0985-75e9-4d88-b542-d047bbba965c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f33d9f19-d52d-480f-907e-f08c2a3ebdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489f353-48b4-420e-b467-19145a33bce8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f33d9f19-d52d-480f-907e-f08c2a3ebdcd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_48cdacf7-0602-4fe7-987e-c9bf5e871c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f33d9f19-d52d-480f-907e-f08c2a3ebdcd" xlink:to="loc_us-gaap_AwardTypeAxis_48cdacf7-0602-4fe7-987e-c9bf5e871c4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48cdacf7-0602-4fe7-987e-c9bf5e871c4d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_48cdacf7-0602-4fe7-987e-c9bf5e871c4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48cdacf7-0602-4fe7-987e-c9bf5e871c4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_867c5fd6-6020-403c-b058-cfad5856fa3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_48cdacf7-0602-4fe7-987e-c9bf5e871c4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_867c5fd6-6020-403c-b058-cfad5856fa3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_208e8164-b6ed-44bc-a413-3bfe98eae235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_867c5fd6-6020-403c-b058-cfad5856fa3d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_208e8164-b6ed-44bc-a413-3bfe98eae235" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_201a959e-0e08-4ffc-a5fb-51b66504c617" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_867c5fd6-6020-403c-b058-cfad5856fa3d" xlink:to="loc_us-gaap_PerformanceSharesMember_201a959e-0e08-4ffc-a5fb-51b66504c617" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails" xlink:type="extended" id="ibcc78762c77747a9a3d05d8e43667c00_SEGMENTANDENTERPRISEWIDEINFORMATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_0b9bced7-b059-4e3c-8078-f74f493b5cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_NumberOfReportingUnits_0b9bced7-b059-4e3c-8078-f74f493b5cec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NetRevenuesBeforeForeignExchangeImpact_aa65c828-0415-44f4-89b7-344e7d50ae8a" xlink:href="hae-20230401.xsd#hae_NetRevenuesBeforeForeignExchangeImpact"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_NetRevenuesBeforeForeignExchangeImpact_aa65c828-0415-44f4-89b7-344e7d50ae8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectofExchangeRateonRevenues_be0bcb9e-5702-4bf6-b876-963d153dd5a0" xlink:href="hae-20230401.xsd#hae_EffectofExchangeRateonRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_EffectofExchangeRateonRevenues_be0bcb9e-5702-4bf6-b876-963d153dd5a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_57ce3026-caad-4390-917a-e488fee6f657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_57ce3026-caad-4390-917a-e488fee6f657" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c01d646f-f369-499e-ae5e-a4e9d4a1bcba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_OperatingIncomeLoss_c01d646f-f369-499e-ae5e-a4e9d4a1bcba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_f723b643-854a-4beb-9626-c77301bfa516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_OtherExpenses_f723b643-854a-4beb-9626-c77301bfa516" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectofExchangeRatesonOperatingIncome_29844ece-a684-42c5-ab9a-e9a6518d34d0" xlink:href="hae-20230401.xsd#hae_EffectofExchangeRatesonOperatingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_EffectofExchangeRatesonOperatingIncome_29844ece-a684-42c5-ab9a-e9a6518d34d0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AmortizationOfAcquiredIntangibleAssets_c52f98b4-bf1a-4141-bf6d-128754361a1f" xlink:href="hae-20230401.xsd#hae_AmortizationOfAcquiredIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_AmortizationOfAcquiredIntangibleAssets_c52f98b4-bf1a-4141-bf6d-128754361a1f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ImpairmentOfAssetsAndRelatedCharges_58f50a1b-bbd8-49e9-bc92-094536be1695" xlink:href="hae-20230401.xsd#hae_ImpairmentOfAssetsAndRelatedCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_ImpairmentOfAssetsAndRelatedCharges_58f50a1b-bbd8-49e9-bc92-094536be1695" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OperatingExpensesTransactionCosts_44a90637-f3b2-4a8b-8b05-23a627a598ac" xlink:href="hae-20230401.xsd#hae_OperatingExpensesTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_OperatingExpensesTransactionCosts_44a90637-f3b2-4a8b-8b05-23a627a598ac" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandRestructuringRelatedCosts_dd5d1092-2579-4fe3-801f-fb3321f6146e" xlink:href="hae-20230401.xsd#hae_RestructuringandRestructuringRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_RestructuringandRestructuringRelatedCosts_dd5d1092-2579-4fe3-801f-fb3321f6146e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DigitalTransformationCosts_d86de4af-6ab8-4276-8914-038d6a1918d8" xlink:href="hae-20230401.xsd#hae_DigitalTransformationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_DigitalTransformationCosts_d86de4af-6ab8-4276-8914-038d6a1918d8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EuropeanMedicalDeviceRegulationCosts_4d157901-1f26-437a-8f23-1746c19ee197" xlink:href="hae-20230401.xsd#hae_EuropeanMedicalDeviceRegulationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_EuropeanMedicalDeviceRegulationCosts_4d157901-1f26-437a-8f23-1746c19ee197" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_b0263758-5871-481d-bf13-abe17a04577c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_b0263758-5871-481d-bf13-abe17a04577c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_bd7d731b-8e79-4a07-8a8b-74159336fa94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_bd7d731b-8e79-4a07-8a8b-74159336fa94" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_71bc73e6-d33e-492d-95bb-abba66530f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_DepreciationAndAmortization_71bc73e6-d33e-492d-95bb-abba66530f4f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_caea0830-ff3c-4b9d-955d-40062dcd2c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_NoncurrentAssets_caea0830-ff3c-4b9d-955d-40062dcd2c1a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_38555166-018a-4791-a9fa-11e3d3476842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_NumberOfReportableSegments_38555166-018a-4791-a9fa-11e3d3476842" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_68018d95-b9e1-4beb-8642-8d500f3d26f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_68018d95-b9e1-4beb-8642-8d500f3d26f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ccf926ce-efb2-4864-8c80-e65540285605" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_68018d95-b9e1-4beb-8642-8d500f3d26f1" xlink:to="loc_srt_ConsolidationItemsAxis_ccf926ce-efb2-4864-8c80-e65540285605" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ccf926ce-efb2-4864-8c80-e65540285605_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_ccf926ce-efb2-4864-8c80-e65540285605" xlink:to="loc_srt_ConsolidationItemsDomain_ccf926ce-efb2-4864-8c80-e65540285605_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0ff43e95-1c13-4d4a-85dc-b3ed66355010" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_ccf926ce-efb2-4864-8c80-e65540285605" xlink:to="loc_srt_ConsolidationItemsDomain_0ff43e95-1c13-4d4a-85dc-b3ed66355010" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9fd95627-f3e0-4460-a4ef-3beec8703e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_0ff43e95-1c13-4d4a-85dc-b3ed66355010" xlink:to="loc_us-gaap_OperatingSegmentsMember_9fd95627-f3e0-4460-a4ef-3beec8703e5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b6db9489-2724-4d10-bc87-8e8282e89315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_0ff43e95-1c13-4d4a-85dc-b3ed66355010" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b6db9489-2724-4d10-bc87-8e8282e89315" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_55d2d9a2-7a76-4293-900b-24a8e82c53f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_68018d95-b9e1-4beb-8642-8d500f3d26f1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_55d2d9a2-7a76-4293-900b-24a8e82c53f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_55d2d9a2-7a76-4293-900b-24a8e82c53f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_55d2d9a2-7a76-4293-900b-24a8e82c53f3" xlink:to="loc_us-gaap_SegmentDomain_55d2d9a2-7a76-4293-900b-24a8e82c53f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_04839fcd-37f6-446b-8c9c-777bf72bd6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_55d2d9a2-7a76-4293-900b-24a8e82c53f3" xlink:to="loc_us-gaap_SegmentDomain_04839fcd-37f6-446b-8c9c-777bf72bd6ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaMember_13c4f583-bf50-4cc6-95dc-f3df8cbcb8bd" xlink:href="hae-20230401.xsd#hae_PlasmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_04839fcd-37f6-446b-8c9c-777bf72bd6ee" xlink:to="loc_hae_PlasmaMember_13c4f583-bf50-4cc6-95dc-f3df8cbcb8bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterMember_865a87f7-07f8-43ea-b561-ed205ebbce7e" xlink:href="hae-20230401.xsd#hae_BloodCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_04839fcd-37f6-446b-8c9c-777bf72bd6ee" xlink:to="loc_hae_BloodCenterMember_865a87f7-07f8-43ea-b561-ed205ebbce7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalMember_42129451-7ca5-4143-be8b-8a1294f2c1a8" xlink:href="hae-20230401.xsd#hae_HospitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_04839fcd-37f6-446b-8c9c-777bf72bd6ee" xlink:to="loc_hae_HospitalMember_42129451-7ca5-4143-be8b-8a1294f2c1a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a2cd78bd-9019-4c54-be25-d11cb193b849" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_68018d95-b9e1-4beb-8642-8d500f3d26f1" xlink:to="loc_srt_StatementGeographicalAxis_a2cd78bd-9019-4c54-be25-d11cb193b849" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a2cd78bd-9019-4c54-be25-d11cb193b849_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a2cd78bd-9019-4c54-be25-d11cb193b849" xlink:to="loc_srt_SegmentGeographicalDomain_a2cd78bd-9019-4c54-be25-d11cb193b849_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_01e5e346-4246-4f56-a182-692db39187f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a2cd78bd-9019-4c54-be25-d11cb193b849" xlink:to="loc_srt_SegmentGeographicalDomain_01e5e346-4246-4f56-a182-692db39187f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a221d57b-47da-4099-ac9b-3902cbdee9ea" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_01e5e346-4246-4f56-a182-692db39187f6" xlink:to="loc_country_US_a221d57b-47da-4099-ac9b-3902cbdee9ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_7e21a53f-80a8-409f-bc9d-2169aefb5de9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_01e5e346-4246-4f56-a182-692db39187f6" xlink:to="loc_country_JP_7e21a53f-80a8-409f-bc9d-2169aefb5de9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_b17338a5-8ebb-469f-9ed5-46461fdca5cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_01e5e346-4246-4f56-a182-692db39187f6" xlink:to="loc_srt_EuropeMember_b17338a5-8ebb-469f-9ed5-46461fdca5cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_e9663d27-e169-44ad-988a-06263b28b5a2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_01e5e346-4246-4f56-a182-692db39187f6" xlink:to="loc_srt_AsiaMember_e9663d27-e169-44ad-988a-06263b28b5a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherCountryorRegionMember_8985a904-cdcf-4a68-8699-8e99e1eaf097" xlink:href="hae-20230401.xsd#hae_OtherCountryorRegionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_01e5e346-4246-4f56-a182-692db39187f6" xlink:to="loc_hae_OtherCountryorRegionMember_8985a904-cdcf-4a68-8699-8e99e1eaf097" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1b2cbc86-4f7d-47c5-b0d7-b8156e5f15b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_68018d95-b9e1-4beb-8642-8d500f3d26f1" xlink:to="loc_srt_ProductOrServiceAxis_1b2cbc86-4f7d-47c5-b0d7-b8156e5f15b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1b2cbc86-4f7d-47c5-b0d7-b8156e5f15b2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1b2cbc86-4f7d-47c5-b0d7-b8156e5f15b2" xlink:to="loc_srt_ProductsAndServicesDomain_1b2cbc86-4f7d-47c5-b0d7-b8156e5f15b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_edcc7cc8-089a-4282-8363-d2984ea82111" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1b2cbc86-4f7d-47c5-b0d7-b8156e5f15b2" xlink:to="loc_srt_ProductsAndServicesDomain_edcc7cc8-089a-4282-8363-d2984ea82111" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_59ac6291-d519-4c03-a1c4-2dc71d68b1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_edcc7cc8-089a-4282-8363-d2984ea82111" xlink:to="loc_us-gaap_ServiceMember_59ac6291-d519-4c03-a1c4-2dc71d68b1cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaMember_15d0a7b0-fce2-4e90-b076-1dddab5458cf" xlink:href="hae-20230401.xsd#hae_PlasmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_edcc7cc8-089a-4282-8363-d2984ea82111" xlink:to="loc_hae_PlasmaMember_15d0a7b0-fce2-4e90-b076-1dddab5458cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterMember_042363d6-c59d-4762-8516-799a1dbdbbaa" xlink:href="hae-20230401.xsd#hae_BloodCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_edcc7cc8-089a-4282-8363-d2984ea82111" xlink:to="loc_hae_BloodCenterMember_042363d6-c59d-4762-8516-799a1dbdbbaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalMember_6f61e96a-bc67-4e52-a48f-f0ff40e303de" xlink:href="hae-20230401.xsd#hae_HospitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_edcc7cc8-089a-4282-8363-d2984ea82111" xlink:to="loc_hae_HospitalMember_6f61e96a-bc67-4e52-a48f-f0ff40e303de" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1" xlink:type="simple" xlink:href="hae-20230401.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1" xlink:type="extended" id="ic1f6eb39397442529c7d835ff538cb91_ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ed2cbc51-6dee-4a14-9ad7-9ea1adaff947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9424e328-dff8-4dcc-924b-0ae49aca93e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ed2cbc51-6dee-4a14-9ad7-9ea1adaff947" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9424e328-dff8-4dcc-924b-0ae49aca93e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b64d7ba0-6e05-40bb-9da1-cb0778326e44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ed2cbc51-6dee-4a14-9ad7-9ea1adaff947" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b64d7ba0-6e05-40bb-9da1-cb0778326e44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f31eb340-5718-44e3-9ddf-777982970449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ed2cbc51-6dee-4a14-9ad7-9ea1adaff947" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f31eb340-5718-44e3-9ddf-777982970449" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b4eba650-f62b-47bb-ae6c-d094e0a80891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ed2cbc51-6dee-4a14-9ad7-9ea1adaff947" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b4eba650-f62b-47bb-ae6c-d094e0a80891" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a451c3c1-340c-47a7-948f-b3385329ce22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_49fa75a1-adf1-4368-a0f5-4fbc12399d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ed2cbc51-6dee-4a14-9ad7-9ea1adaff947" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_49fa75a1-adf1-4368-a0f5-4fbc12399d20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9d89e110-0a29-4d66-a246-2e6fc6138565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_49fa75a1-adf1-4368-a0f5-4fbc12399d20" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9d89e110-0a29-4d66-a246-2e6fc6138565" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9d89e110-0a29-4d66-a246-2e6fc6138565_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9d89e110-0a29-4d66-a246-2e6fc6138565" xlink:to="loc_us-gaap_EquityComponentDomain_9d89e110-0a29-4d66-a246-2e6fc6138565_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_945d147b-c099-4612-8ddb-ce791e238b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9d89e110-0a29-4d66-a246-2e6fc6138565" xlink:to="loc_us-gaap_EquityComponentDomain_945d147b-c099-4612-8ddb-ce791e238b84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_38dd6c52-cc4b-4a9e-9176-2808a3ea91d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_945d147b-c099-4612-8ddb-ce791e238b84" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_38dd6c52-cc4b-4a9e-9176-2808a3ea91d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0d4d74ed-6df9-4db8-97b3-5ad153b8f5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_945d147b-c099-4612-8ddb-ce791e238b84" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0d4d74ed-6df9-4db8-97b3-5ad153b8f5ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_ffc48f43-ceea-4265-994c-7faaa6a5036b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_945d147b-c099-4612-8ddb-ce791e238b84" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_ffc48f43-ceea-4265-994c-7faaa6a5036b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>hae-20230401_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d8e9c074-6bb3-481a-a40c-b4f91e1c5276,g:f0cc1f72-36f0-46b0-9a43-9e0dba51bc09-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_f5552612-45c6-48ba-a496-778190711646_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosures of Cash Flow Information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_8306201d-aaf6-4dc2-b011-b23db40fe763_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_3ba25a56-bd8f-4d78-9ef7-0388efa94a18_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9fc8f577-5b91-45a9-9420-9b6b6dc73dc5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_86e7e8ce-4396-47dc-97a0-6ab5cdf0cf39_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_949db287-17ff-436c-96ea-70b9812cbb39_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_60e649eb-5efc-4cdd-9c47-4adad54a12a7_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_c350523f-5efd-4534-b55f-3093cc70ca2e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_TransfersFromInventoryToFixedAssets_231d0beb-7f59-4109-a109-1a947bc4a0a7_terseLabel_en-US" xlink:label="lab_hae_TransfersFromInventoryToFixedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers from inventory to fixed assets for placement of Haemonetics equipment</link:label>
    <link:label id="lab_hae_TransfersFromInventoryToFixedAssets_label_en-US" xlink:label="lab_hae_TransfersFromInventoryToFixedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers from Inventory to Fixed Assets</link:label>
    <link:label id="lab_hae_TransfersFromInventoryToFixedAssets_documentation_en-US" xlink:label="lab_hae_TransfersFromInventoryToFixedAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers from inventory to fixed assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TransfersFromInventoryToFixedAssets" xlink:href="hae-20230401.xsd#hae_TransfersFromInventoryToFixedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_TransfersFromInventoryToFixedAssets" xlink:to="lab_hae_TransfersFromInventoryToFixedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_b0622855-24fa-45d2-ad1e-ef940df5d36f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_9a50d755-d140-492b-9c6d-13ea8cd02112_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_e6873952-af0f-4043-a421-a96186915576_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_da25b284-99a6-41ba-81e4-1f5c096da142_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value (in dollars per share), Forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_23c6874a-f070-4bad-9d1d-21e8a5aebefe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payments</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_df63c4cf-aa46-414e-9d69-b07d88e6ae02_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_df8de7a2-1eb8-4a3e-8252-9f26d6d970a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding, (in shares), Forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d2afb81f-926a-4e05-ba7a-a065ab50b2e5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_d7f720d5-f1e0-4089-b54b-bcb61fb0e73c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation of Foreign Currencies</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_368245d2-4163-4862-8f51-4ec9cc2a9f11_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_82c074fd-fccc-4c5e-bec9-67420edb3966_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_814605a0-234f-49fc-9646-c700c26882d5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8622c931-dd97-4ddc-806d-ff3f7e7fa87d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e31fc15c-7f82-4abb-8a66-08c9a20d48b3_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Change in Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_NetRevenuesBeforeForeignExchangeImpact_d42f727d-0e1a-4e26-9bd7-e395b7bfffcd_terseLabel_en-US" xlink:label="lab_hae_NetRevenuesBeforeForeignExchangeImpact" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues by business unit</link:label>
    <link:label id="lab_hae_NetRevenuesBeforeForeignExchangeImpact_label_en-US" xlink:label="lab_hae_NetRevenuesBeforeForeignExchangeImpact" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Before Foreign Exchange Impact</link:label>
    <link:label id="lab_hae_NetRevenuesBeforeForeignExchangeImpact_documentation_en-US" xlink:label="lab_hae_NetRevenuesBeforeForeignExchangeImpact" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Before Foreign Exchange Impact</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NetRevenuesBeforeForeignExchangeImpact" xlink:href="hae-20230401.xsd#hae_NetRevenuesBeforeForeignExchangeImpact"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_NetRevenuesBeforeForeignExchangeImpact" xlink:to="lab_hae_NetRevenuesBeforeForeignExchangeImpact" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_20aebf62-7a82-4b49-98d2-7fc38b99f0e6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected stock price volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_e647e969-735b-41d4-b748-724bf747d657_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0e184948-0b15-4794-8d2b-4cae528f4129_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1c889f23-c7f3-4082-ae63-0f2db4302241_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Acquisition Date Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_c2127022-4007-4c3f-8744-bcad82415751_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase accounting adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DeferredTaxLiabilitiesAmortization_2b44a965-ad28-4c42-9187-5c13ab297466_negatedTerseLabel_en-US" xlink:label="lab_hae_DeferredTaxLiabilitiesAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of goodwill and intangibles</link:label>
    <link:label id="lab_hae_DeferredTaxLiabilitiesAmortization_label_en-US" xlink:label="lab_hae_DeferredTaxLiabilitiesAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Amortization</link:label>
    <link:label id="lab_hae_DeferredTaxLiabilitiesAmortization_documentation_en-US" xlink:label="lab_hae_DeferredTaxLiabilitiesAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxLiabilitiesAmortization" xlink:href="hae-20230401.xsd#hae_DeferredTaxLiabilitiesAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DeferredTaxLiabilitiesAmortization" xlink:to="lab_hae_DeferredTaxLiabilitiesAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount_b068696f-c0d2-4a1d-9a64-81a897a8e275_terseLabel_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global intangible low taxed income</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount_label_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Global Intangible Low Taxed Income, Amount</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount_documentation_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Global Intangible Low Taxed Income, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount" xlink:to="lab_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_31f1d0bf-fb21-47f6-8c68-fb6d3fdd218a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on divestitures and sale of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_TermLoanNetofFinancingFeesMember_3c0cc6b5-f249-49fd-b9d0-e7e90fb7dfb4_terseLabel_en-US" xlink:label="lab_hae_TermLoanNetofFinancingFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan, net of financing fees</link:label>
    <link:label id="lab_hae_TermLoanNetofFinancingFeesMember_label_en-US" xlink:label="lab_hae_TermLoanNetofFinancingFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan, Net of Financing Fees [Member]</link:label>
    <link:label id="lab_hae_TermLoanNetofFinancingFeesMember_documentation_en-US" xlink:label="lab_hae_TermLoanNetofFinancingFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan, Net of Financing Fees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TermLoanNetofFinancingFeesMember" xlink:href="hae-20230401.xsd#hae_TermLoanNetofFinancingFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_TermLoanNetofFinancingFeesMember" xlink:to="lab_hae_TermLoanNetofFinancingFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget_9e4d1ae3-d457-4f2c-b51b-40d91a027650_terseLabel_en-US" xlink:label="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance shares target, percentage</link:label>
    <link:label id="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget_label_en-US" xlink:label="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Performance Target</link:label>
    <link:label id="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget_documentation_en-US" xlink:label="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Performance Target</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget" xlink:href="hae-20230401.xsd#hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget" xlink:to="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_22a2b9e4-dcd8-492c-ba93-f67c2fb9d46c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_81855275-7f25-4178-87d8-524d46b89a57_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d40d607e-75ad-45a0-9e82-c33b3fbb90e3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_e35cbfdc-1fe7-41aa-bc68-d619eac279e2_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_394381b6-3894-4be4-8057-0e39c43b2ecb_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7f511fe8-ebff-4fb0-8b93-575992abfe9f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_beb37922-bc60-42e7-a7d7-0ece4536ff8c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Transformation Costs by Type of Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_993ba683-e45a-45b6-a790-b4c0e0b30f75_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Amortization Period</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_afb016ad-3744-431f-ac5c-14f3c8716238_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_3b243111-440a-4aac-b081-b2e20cade65b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_bb7bf5d4-886e-4560-898c-15241bd69a3d_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets (after valuation allowance)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_bec9b847-8ad1-4e88-a06d-36747672366c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7e5eaacd-4628-456a-9b30-3d4eba7f006f_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive shares (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7f4c5f91-0a5d-40c2-ae93-58eef408a1ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_1129f679-88c5-4976-a3bd-b1fa1ad6489e_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_c32286b0-85cc-42c0-badf-a500204fb563_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_FajardoPuertoRicoManufacturingOperationsMember_c17b85f0-8880-42b5-ab07-33d64334c813_terseLabel_en-US" xlink:label="lab_hae_FajardoPuertoRicoManufacturingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fajardo, Puerto Rico Manufacturing Operations</link:label>
    <link:label id="lab_hae_FajardoPuertoRicoManufacturingOperationsMember_label_en-US" xlink:label="lab_hae_FajardoPuertoRicoManufacturingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fajardo, Puerto Rico Manufacturing Operations [Member]</link:label>
    <link:label id="lab_hae_FajardoPuertoRicoManufacturingOperationsMember_documentation_en-US" xlink:label="lab_hae_FajardoPuertoRicoManufacturingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fajardo, Puerto Rico Manufacturing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_FajardoPuertoRicoManufacturingOperationsMember" xlink:href="hae-20230401.xsd#hae_FajardoPuertoRicoManufacturingOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_FajardoPuertoRicoManufacturingOperationsMember" xlink:to="lab_hae_FajardoPuertoRicoManufacturingOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_d1372bd8-7d16-4ce6-b8ac-73ec47735c28_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_6aec2105-f23c-4e84-b754-e512cb32891f_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d34d73a-82bb-4e4b-8864-02ff71524364_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_a173da24-fd7d-4249-99de-f0a6d78de634_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_bc4de5a0-b55e-496e-bb7c-8d5c6986ec8d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4e0fe3cf-3cd5-4c81-a31d-8c3adf4b3ec6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding, (in shares), Exercisable and End of Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_7abcc9dc-2954-4b42-aaae-f16e59164ad6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_e79a128c-97c8-491e-b2fa-a519149b862e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_57043ee7-94c1-43ba-8d62-08a7fa337b3c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_Fiscal2016AwardsMember_5c825705-dd35-451c-9d91-295119e9a346_terseLabel_en-US" xlink:label="lab_hae_Fiscal2016AwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2016 Awards [Member]</link:label>
    <link:label id="lab_hae_Fiscal2016AwardsMember_label_en-US" xlink:label="lab_hae_Fiscal2016AwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2016 Awards [Member]</link:label>
    <link:label id="lab_hae_Fiscal2016AwardsMember_documentation_en-US" xlink:label="lab_hae_Fiscal2016AwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2016 Awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_Fiscal2016AwardsMember" xlink:href="hae-20230401.xsd#hae_Fiscal2016AwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_Fiscal2016AwardsMember" xlink:to="lab_hae_Fiscal2016AwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_PercentageOfSharesPurchasedThroughPayrollDeductions_83a79ac2-c795-474e-b21c-95717e8a6796_terseLabel_en-US" xlink:label="lab_hae_PercentageOfSharesPurchasedThroughPayrollDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of shares purchased through payroll deductions (as a percent)</link:label>
    <link:label id="lab_hae_PercentageOfSharesPurchasedThroughPayrollDeductions_label_en-US" xlink:label="lab_hae_PercentageOfSharesPurchasedThroughPayrollDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Shares Purchased Through Payroll Deductions</link:label>
    <link:label id="lab_hae_PercentageOfSharesPurchasedThroughPayrollDeductions_documentation_en-US" xlink:label="lab_hae_PercentageOfSharesPurchasedThroughPayrollDeductions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Shares Purchased Through Payroll Deductions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PercentageOfSharesPurchasedThroughPayrollDeductions" xlink:href="hae-20230401.xsd#hae_PercentageOfSharesPurchasedThroughPayrollDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_PercentageOfSharesPurchasedThroughPayrollDeductions" xlink:to="lab_hae_PercentageOfSharesPurchasedThroughPayrollDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_954bb863-614f-4250-84f8-a2985cc27d6c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_3658a54b-3a8c-4107-9dda-8e26ed255719_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_5249bd95-6f9b-4669-be2b-70c202d7b4db_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives and Fair Value [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:to="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_TermLoanMember_68189f55-2683-4bf1-843b-4ff97c9d3ac6_terseLabel_en-US" xlink:label="lab_hae_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_hae_TermLoanMember_label_en-US" xlink:label="lab_hae_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_hae_TermLoanMember_documentation_en-US" xlink:label="lab_hae_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TermLoanMember" xlink:href="hae-20230401.xsd#hae_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_TermLoanMember" xlink:to="lab_hae_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_f1ff1d17-dbbf-4240-83c5-0b130e6a4a15_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_A2019EquityPlanMember_92bdfff8-9177-49e5-a380-e06ccbb489f5_terseLabel_en-US" xlink:label="lab_hae_A2019EquityPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Equity Plan [Member]</link:label>
    <link:label id="lab_hae_A2019EquityPlanMember_label_en-US" xlink:label="lab_hae_A2019EquityPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Equity Plan [Member]</link:label>
    <link:label id="lab_hae_A2019EquityPlanMember_documentation_en-US" xlink:label="lab_hae_A2019EquityPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Equity Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2019EquityPlanMember" xlink:href="hae-20230401.xsd#hae_A2019EquityPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_A2019EquityPlanMember" xlink:to="lab_hae_A2019EquityPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_11f894e2-f34b-4c8b-a401-fcf6a0db22ae_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_33acc30d-fb71-413a-998d-ba3f17647aa4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_97346f28-5126-4602-b5e3-f29e14a21f8b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_b637c826-08e3-4531-a789-c322ac0f43d0_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy_5175e19a-baa2-4d6d-8984-9eb411bb93fd_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable, Allowance for Doubtful Accounts, Estimation Methodology, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy" xlink:to="lab_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_0e88cd62-4c44-4516-8db0-86ba0bb354ac_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward_a6fee1a8-f98e-4b9b-9e3e-489ed1dfb03c_terseLabel_en-US" xlink:label="lab_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward_label_en-US" xlink:label="lab_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward_documentation_en-US" xlink:label="lab_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward" xlink:href="hae-20230401.xsd#hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward" xlink:to="lab_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_719dbaca-338b-4dbf-b5ed-cb053b65f805_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative fixed interest rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_00041568-7d13-4587-83d7-836b1210b7a4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_9565c79f-0b8b-4da4-a379-c4395d73c543_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_9ab4917b-ceed-4f30-9df6-9514b2eba8b6_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic income per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_e1f926b7-0b71-49d6-9982-cf33aec592a8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carry-forwards subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_6ef6b61e-e4f9-4366-b760-f32d9ffa117a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_5bf57997-ac32-4387-bc64-9b4c1d585212_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:to="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0f0e6cbd-5494-4011-bcb4-3404a5c38fdd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity instruments other than options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2498cc46-0d17-40ba-83db-7133e3c50d8a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_fc9bd4d4-5d3d-4e4e-abc7-48da949a7103_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0e44933f-81ef-4e86-a8c9-545935661814_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_0a5edd27-19c9-4421-aacb-6e7cd4b7878c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_70cf659b-8122-4921-ad84-c9cae70cf307_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_906a0a4c-4317-43b5-9edd-e7164a820e2e_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted EPS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_80814f6c-7b71-4212-a3bf-0e59936795a3_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_40dce46a-920e-4c0e-83e3-766341de2d36_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plant equipment and machinery</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_bcc6e1ca-51b8-442d-827a-a4e5965f4b56_verboseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plant equipment and machinery</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_581afa76-1b39-41b1-91db-61dab305c0db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_a96253f2-45fa-4f06-8d87-5a7a3e1305cf_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_2db46b48-c3d4-4e5f-809d-91ec0261f2cc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet_ebd5ed5b-a44b-4245-89b5-53db65d8d4ef_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-designated foreign currency hedge contracts outstanding</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet" xlink:to="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_1c7b515c-6bde-4632-bec3-0daf059ae8f1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected Information by Business Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_3b6877a1-de90-4fb7-a62f-5d7071966742_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_968484e8-f4af-4fd8-92e3-1c1638442c4d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_a7d14c46-3d4d-44ef-889a-b12aaed91a2d_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_4239b6bd-c921-4939-8f61-120f9d108254_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_29f25808-b128-4104-a3cf-3702c4a3066a_terseLabel_en-US" xlink:label="lab_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues, COGS and SG&amp;A</link:label>
    <link:label id="lab_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues Cost Of Goods Sold And Selling General And Administrative Expense [Member]</link:label>
    <link:label id="lab_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_documentation_en-US" xlink:label="lab_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues Cost Of Goods Sold And Selling General And Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" xlink:href="hae-20230401.xsd#hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" xlink:to="lab_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_a04c1ab7-acc1-41af-ac7c-b74393c4574d_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_27594227-3268-4213-8bb0-953287861c71_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_2d175b6f-b6f3-4854-a681-5810d5f4da1e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_4b4e6f92-7702-400b-9f69-e83dda1d3b74_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fb209074-7a16-4344-a03d-decb0597c37c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_6c7b1e6b-6827-4286-8e3e-da3efc189712_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_da4b252b-250b-42c3-871c-47d1d54c7dcf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_3bb3905a-1eef-4e79-bd59-43e8827d8cce_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_AuditInformationAbstract_label_en-US" xlink:label="lab_hae_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_hae_AuditInformationAbstract_documentation_en-US" xlink:label="lab_hae_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AuditInformationAbstract" xlink:href="hae-20230401.xsd#hae_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_AuditInformationAbstract" xlink:to="lab_hae_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_4ed006d9-4de0-4be0-98c1-0a1bdb62985b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits increases</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_135cdb8a-4945-4ec9-bed6-a88671cfe33a_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions of current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_d0bdb93d-31c3-499f-81c7-91b8ab389aa5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate_c66160d9-d8cf-4219-a8eb-59555c0c846a_terseLabel_en-US" xlink:label="lab_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-Adjusted Discount Rates used in Purchase Price Allocation</link:label>
    <link:label id="lab_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate_label_en-US" xlink:label="lab_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Intangible Assets, Risk-Adjusted Discount Rate</link:label>
    <link:label id="lab_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate_documentation_en-US" xlink:label="lab_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Intangible Assets, Risk-Adjusted Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate" xlink:href="hae-20230401.xsd#hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate" xlink:to="lab_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ContingentConsiderationForeignCurrencyTranslationAdjustment_1b79094d-89c7-49d2-ae45-5f8f82ba3b24_terseLabel_en-US" xlink:label="lab_hae_ContingentConsiderationForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_hae_ContingentConsiderationForeignCurrencyTranslationAdjustment_label_en-US" xlink:label="lab_hae_ContingentConsiderationForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_hae_ContingentConsiderationForeignCurrencyTranslationAdjustment_documentation_en-US" xlink:label="lab_hae_ContingentConsiderationForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Foreign Currency Translation Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationForeignCurrencyTranslationAdjustment" xlink:href="hae-20230401.xsd#hae_ContingentConsiderationForeignCurrencyTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ContingentConsiderationForeignCurrencyTranslationAdjustment" xlink:to="lab_hae_ContingentConsiderationForeignCurrencyTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_baff7076-3306-4224-851e-fa5b47a3b2ba_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_f0513895-16b1-4e62-857e-b871613ee22b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that will impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_1c570a12-c0d1-43bd-9585-74562738ad74_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_e37ea5ff-a132-4714-a944-09f7eedc3647_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_A2022AcceleratedShareRepurchaseProgramMember_60f8e574-ab14-4ec5-89ea-f15bbd349f5f_terseLabel_en-US" xlink:label="lab_hae_A2022AcceleratedShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Share Repurchase Program</link:label>
    <link:label id="lab_hae_A2022AcceleratedShareRepurchaseProgramMember_label_en-US" xlink:label="lab_hae_A2022AcceleratedShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Accelerated Share Repurchase Program [Member]</link:label>
    <link:label id="lab_hae_A2022AcceleratedShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_hae_A2022AcceleratedShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Accelerated Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2022AcceleratedShareRepurchaseProgramMember" xlink:href="hae-20230401.xsd#hae_A2022AcceleratedShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_A2022AcceleratedShareRepurchaseProgramMember" xlink:to="lab_hae_A2022AcceleratedShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_e94b1fb5-001d-4c4c-994b-1a81d76be334_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ac9de080-9ef7-489a-bf46-6b924f4f1db0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_0797df2b-203d-4c5a-b795-9d6f0e400adc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_efed5559-0f44-4e68-ab53-122ec343acc1_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_TaxHolidayTerm_7168c723-e7ec-4086-9a76-8d10d807ff64_terseLabel_en-US" xlink:label="lab_hae_TaxHolidayTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax grant or holiday term</link:label>
    <link:label id="lab_hae_TaxHolidayTerm_label_en-US" xlink:label="lab_hae_TaxHolidayTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Holiday Term</link:label>
    <link:label id="lab_hae_TaxHolidayTerm_documentation_en-US" xlink:label="lab_hae_TaxHolidayTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Holiday Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TaxHolidayTerm" xlink:href="hae-20230401.xsd#hae_TaxHolidayTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_TaxHolidayTerm" xlink:to="lab_hae_TaxHolidayTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_692b6c00-5149-448f-98a5-95963c990550_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_3c173e83-f3b4-48cd-94bf-16f289e61122_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3cc13239-7d20-4fc0-857d-f4882b12a296_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DeferredTaxAssetsOperatingLeaseLiability_76eef628-b44f-4585-8d08-1b411b6fd6f4_terseLabel_en-US" xlink:label="lab_hae_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_hae_DeferredTaxAssetsOperatingLeaseLiability_label_en-US" xlink:label="lab_hae_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:label id="lab_hae_DeferredTaxAssetsOperatingLeaseLiability_documentation_en-US" xlink:label="lab_hae_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxAssetsOperatingLeaseLiability" xlink:href="hae-20230401.xsd#hae_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DeferredTaxAssetsOperatingLeaseLiability" xlink:to="lab_hae_DeferredTaxAssetsOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_ea0d750f-b704-4076-a7d7-6be71457f809_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameAxis" xlink:to="lab_us-gaap_RetirementPlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ae570393-e30a-4b68-aa23-51a1d76a96df_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_3b81467b-8190-4ab7-a643-e489beab2542_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_cc115472-7a10-473f-b3dc-77bc9573cdd9_terseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_ad4eb076-8762-4f82-a67a-01e203cc3068_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_66d1aadf-1c20-49d3-ac11-4b91f554ad11_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_b07a5ec9-097d-45e5-9378-2444d78d968a_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_304d6af3-82c7-44cf-b718-271b95a99e6c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_511705a4-bc10-41c5-8569-c68f5d1b3e83_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EnicorMember_7f2f9da5-904f-43cd-95b0-5c767ca0b94e_terseLabel_en-US" xlink:label="lab_hae_EnicorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enicor</link:label>
    <link:label id="lab_hae_EnicorMember_label_en-US" xlink:label="lab_hae_EnicorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enicor [Member]</link:label>
    <link:label id="lab_hae_EnicorMember_documentation_en-US" xlink:label="lab_hae_EnicorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enicor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember" xlink:href="hae-20230401.xsd#hae_EnicorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EnicorMember" xlink:to="lab_hae_EnicorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_21ea6ff2-90ef-47d9-99dd-3495dc0d0675_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ImpairmentOfAssetsAndRelatedCharges_d68921bd-d3b7-4415-88dc-a3684b4b35ce_negatedTerseLabel_en-US" xlink:label="lab_hae_ImpairmentOfAssetsAndRelatedCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of assets and PCS2 related charges</link:label>
    <link:label id="lab_hae_ImpairmentOfAssetsAndRelatedCharges_label_en-US" xlink:label="lab_hae_ImpairmentOfAssetsAndRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Of Assets And Related Charges</link:label>
    <link:label id="lab_hae_ImpairmentOfAssetsAndRelatedCharges_documentation_en-US" xlink:label="lab_hae_ImpairmentOfAssetsAndRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Of Assets And Related Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ImpairmentOfAssetsAndRelatedCharges" xlink:href="hae-20230401.xsd#hae_ImpairmentOfAssetsAndRelatedCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ImpairmentOfAssetsAndRelatedCharges" xlink:to="lab_hae_ImpairmentOfAssetsAndRelatedCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_AssetAcquisitionMilestonePayment_26ac46fe-7435-4763-ae2f-62638b9384d6_terseLabel_en-US" xlink:label="lab_hae_AssetAcquisitionMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Milestone Payment</link:label>
    <link:label id="lab_hae_AssetAcquisitionMilestonePayment_label_en-US" xlink:label="lab_hae_AssetAcquisitionMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Milestone Payment</link:label>
    <link:label id="lab_hae_AssetAcquisitionMilestonePayment_documentation_en-US" xlink:label="lab_hae_AssetAcquisitionMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Milestone Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetAcquisitionMilestonePayment" xlink:href="hae-20230401.xsd#hae_AssetAcquisitionMilestonePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_AssetAcquisitionMilestonePayment" xlink:to="lab_hae_AssetAcquisitionMilestonePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_d75b3164-b519-4b93-8132-08df15f1b7ba_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_A2020ProgramMember_30492933-7169-4591-85fa-104582ebce23_terseLabel_en-US" xlink:label="lab_hae_A2020ProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Program</link:label>
    <link:label id="lab_hae_A2020ProgramMember_label_en-US" xlink:label="lab_hae_A2020ProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Program [Member]</link:label>
    <link:label id="lab_hae_A2020ProgramMember_documentation_en-US" xlink:label="lab_hae_A2020ProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2020ProgramMember" xlink:href="hae-20230401.xsd#hae_A2020ProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_A2020ProgramMember" xlink:to="lab_hae_A2020ProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_4af4d2bb-55e9-43eb-ad9d-138cef595d16_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring liability</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_ac4ed799-dd5d-4469-b717-e0a73be56087_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_c9425f86-e614-45f7-a376-6362a848458d_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_a3d2bf23-04e3-4c3f-805e-320d689911fd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_5f472551-9185-4dac-8aaf-90b6dc594728_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_HospitalMember_f850c167-66a1-40fe-a0c2-5db8201f448c_terseLabel_en-US" xlink:label="lab_hae_HospitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospital products and services</link:label>
    <link:label id="lab_hae_HospitalMember_label_en-US" xlink:label="lab_hae_HospitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospital [Member]</link:label>
    <link:label id="lab_hae_HospitalMember_documentation_en-US" xlink:label="lab_hae_HospitalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalMember" xlink:href="hae-20230401.xsd#hae_HospitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_HospitalMember" xlink:to="lab_hae_HospitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_fac3d621-4b84-41c8-8a39-ba89f71cbbbb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_9620d0d9-081c-4249-ba7f-88fd576e282a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORIES</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_f82a6379-b70b-43e6-876d-3eff11275737_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1ae33ecb-bea2-4933-9842-7b1076c88f05_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Life, Balance</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_85f238b7-b1fd-48a1-87d2-aa363ddb5a61_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_PlasmaCustomerCSLLimitedCSLMember_2b87a1f1-f53a-4594-857c-e2fda0e5ee8b_terseLabel_en-US" xlink:label="lab_hae_PlasmaCustomerCSLLimitedCSLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plasma Customer, CSL Limited (CSL) [Member]</link:label>
    <link:label id="lab_hae_PlasmaCustomerCSLLimitedCSLMember_label_en-US" xlink:label="lab_hae_PlasmaCustomerCSLLimitedCSLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plasma Customer, CSL Limited (CSL) [Member]</link:label>
    <link:label id="lab_hae_PlasmaCustomerCSLLimitedCSLMember_documentation_en-US" xlink:label="lab_hae_PlasmaCustomerCSLLimitedCSLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Plasma Customer, CSL Limited (CSL)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaCustomerCSLLimitedCSLMember" xlink:href="hae-20230401.xsd#hae_PlasmaCustomerCSLLimitedCSLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_PlasmaCustomerCSLLimitedCSLMember" xlink:to="lab_hae_PlasmaCustomerCSLLimitedCSLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8b4fde3b-a93a-440b-b130-36817053787b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_7f76ea2a-046a-4fb4-8de1-0db07dd75dca_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_05345d7b-d735-476e-9644-8fc94aa0742c_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_5335ef07-250d-4fe2-9676-fcf26f7ffa2a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ba558790-bc1c-4226-ae53-379a8fd0c1f9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01&#160;par value; Authorized&#160;&#8212; 150,000,000&#160;shares; Issued and outstanding&#160;&#8212; 50,448,519&#160;shares at April 1, 2023 and 51,124,240&#160;shares at April 2, 2022</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6fa83611-32b6-4848-9bd1-203a9d8fd7b5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_65c3483f-581a-4284-8408-fdec3c1cf948_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation cost related to non vested stock options, weighted average period of recognition (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_bc851c2c-3ab5-47bc-b4c6-54a1ffb7e44f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value (in dollars per share), Beginning Balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c04db46c-3341-4416-b7c8-5ac63ae1f36d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value (in dollars per share), Ending Balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell_a730f008-e2df-435c-9067-604775a5c257_terseLabel_en-US" xlink:label="lab_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operations, Expected Cost To Sell</link:label>
    <link:label id="lab_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell_label_en-US" xlink:label="lab_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operations, Expected Cost To Sell</link:label>
    <link:label id="lab_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell_documentation_en-US" xlink:label="lab_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operations, Expected Cost To Sell</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" xlink:href="hae-20230401.xsd#hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" xlink:to="lab_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_0292b97e-7198-4f54-a924-c89141c1717a_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_748767f1-a07a-426f-9dbb-12cde29dfc28_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_ea7754f4-8b2d-4006-b09c-c290a4691139_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_04e0ac23-5516-4441-8112-7e3ae5bbbd9e_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded Status*</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_8ac90863-6193-463b-b2a1-45fe4c421bcd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Strategic Investments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DecreaseForRedemptionOfLongTermDebt_b0776346-28e6-4d74-84c5-5ddf9c2a867d_negatedTerseLabel_en-US" xlink:label="lab_hae_DecreaseForRedemptionOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan redemption</link:label>
    <link:label id="lab_hae_DecreaseForRedemptionOfLongTermDebt_label_en-US" xlink:label="lab_hae_DecreaseForRedemptionOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease For Redemption Of Long-Term Debt</link:label>
    <link:label id="lab_hae_DecreaseForRedemptionOfLongTermDebt_documentation_en-US" xlink:label="lab_hae_DecreaseForRedemptionOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease For Redemption Of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DecreaseForRedemptionOfLongTermDebt" xlink:href="hae-20230401.xsd#hae_DecreaseForRedemptionOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DecreaseForRedemptionOfLongTermDebt" xlink:to="lab_hae_DecreaseForRedemptionOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_10637758-db3f-4340-b30c-b4204ead4d8d_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_22fc2b24-0bc6-483f-9ab5-a9ca0f46d921_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assumptions Utilized for Estimating Fair Value of Option Grants</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_a712eab1-c5a5-4ade-b3b0-2c0db1d314c3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_27b8ecf5-a9c8-4057-ac21-970e105ecb99_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4db3fec8-e613-484c-a78a-72b2321e4d85_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1_35fe277f-4fea-47ea-94c0-b27d1a3874d4_terseLabel_en-US" xlink:label="lab_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity period for foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1_label_en-US" xlink:label="lab_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Remaining Maturity of Foreign Currency Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1" xlink:to="lab_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EuropeanMedicalDeviceRegulationCosts_89bf0ea5-f383-4cfb-a1a5-d2647d64c988_terseLabel_en-US" xlink:label="lab_hae_EuropeanMedicalDeviceRegulationCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Medical Device Regulation Costs</link:label>
    <link:label id="lab_hae_EuropeanMedicalDeviceRegulationCosts_label_en-US" xlink:label="lab_hae_EuropeanMedicalDeviceRegulationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Medical Device Regulation Costs</link:label>
    <link:label id="lab_hae_EuropeanMedicalDeviceRegulationCosts_documentation_en-US" xlink:label="lab_hae_EuropeanMedicalDeviceRegulationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Medical Device Regulation Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EuropeanMedicalDeviceRegulationCosts" xlink:href="hae-20230401.xsd#hae_EuropeanMedicalDeviceRegulationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EuropeanMedicalDeviceRegulationCosts" xlink:to="lab_hae_EuropeanMedicalDeviceRegulationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_c10e85f1-48d9-4ecd-a2de-55e5cfce59a7_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Gross Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_199958ee-51bd-47ff-8ed4-6627913ab6c9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1d0414f6-2f8e-42cd-b551-85fb6a4e5a33_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_OtherIncomeExpenseNetMember_ee06fa57-7727-4994-875b-5fc8f6fc9405_terseLabel_en-US" xlink:label="lab_hae_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other expense, net</link:label>
    <link:label id="lab_hae_OtherIncomeExpenseNetMember_label_en-US" xlink:label="lab_hae_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense), Net [Member]</link:label>
    <link:label id="lab_hae_OtherIncomeExpenseNetMember_documentation_en-US" xlink:label="lab_hae_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense), Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherIncomeExpenseNetMember" xlink:href="hae-20230401.xsd#hae_OtherIncomeExpenseNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_OtherIncomeExpenseNetMember" xlink:to="lab_hae_OtherIncomeExpenseNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_4a2ed199-0980-4d8e-91c2-727ec644b875_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_VivasureMedicalLTDMember_29e4ffa1-6aaf-4ace-8203-b693be491ff5_terseLabel_en-US" xlink:label="lab_hae_VivasureMedicalLTDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vivasure Medical LTD</link:label>
    <link:label id="lab_hae_VivasureMedicalLTDMember_label_en-US" xlink:label="lab_hae_VivasureMedicalLTDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vivasure Medical LTD [Member]</link:label>
    <link:label id="lab_hae_VivasureMedicalLTDMember_documentation_en-US" xlink:label="lab_hae_VivasureMedicalLTDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vivasure Medical LTD</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_VivasureMedicalLTDMember" xlink:href="hae-20230401.xsd#hae_VivasureMedicalLTDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_VivasureMedicalLTDMember" xlink:to="lab_hae_VivasureMedicalLTDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_69a8f89d-f948-42ac-9697-2f2a58c41b94_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_c7281db0-0f9c-4a60-ab4b-9d1be65d1cad_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax positions possible change in the next twelve months</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_43d007a6-900c-4e51-9304-0a6b8726ddf5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_383a4d7c-25de-4d74-96fa-2d2f61513e49_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_0d925642-4b2b-4b6e-8459-cfa312a92284_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_666dad7c-6c2a-433d-8973-bb796da7c99a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DefinedBenefitPlanReinsuranceContractsAssetValue_82380b6a-0eef-4e26-af64-cfb135ba6c2d_terseLabel_en-US" xlink:label="lab_hae_DefinedBenefitPlanReinsuranceContractsAssetValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance contracts asset value</link:label>
    <link:label id="lab_hae_DefinedBenefitPlanReinsuranceContractsAssetValue_label_en-US" xlink:label="lab_hae_DefinedBenefitPlanReinsuranceContractsAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Reinsurance Contracts Asset Value</link:label>
    <link:label id="lab_hae_DefinedBenefitPlanReinsuranceContractsAssetValue_documentation_en-US" xlink:label="lab_hae_DefinedBenefitPlanReinsuranceContractsAssetValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Reinsurance Contracts Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanReinsuranceContractsAssetValue" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanReinsuranceContractsAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DefinedBenefitPlanReinsuranceContractsAssetValue" xlink:to="lab_hae_DefinedBenefitPlanReinsuranceContractsAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_3fbc96d5-e23a-43ef-95a9-7d8a7d61620b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carry-forwards not subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_6133ca5c-d49f-4348-a860-be1850314aba_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments_402050f1-806d-45c3-baea-5abd7cb90259_terseLabel_en-US" xlink:label="lab_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operations, Incremental Loss On Closing Adjustments</link:label>
    <link:label id="lab_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments_label_en-US" xlink:label="lab_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operations, Incremental Loss On Closing Adjustments</link:label>
    <link:label id="lab_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments_documentation_en-US" xlink:label="lab_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operations, Incremental Loss On Closing Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" xlink:href="hae-20230401.xsd#hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" xlink:to="lab_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_40ea3cbe-09ac-43ca-b7a6-1d11435856f5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT AND ENTERPRISE-WIDE INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_dbe29e34-abda-4324-8db1-d35425f4a3a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efc399a4-5fcd-42dc-ab18-7b892508b4e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_737f2569-b9b2-426f-946b-345809d3bb05_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerContractsMember_75f276bf-05b2-4585-a067-d5ffcc75bace_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer contracts and related relationships</link:label>
    <link:label id="lab_us-gaap_CustomerContractsMember_label_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerContractsMember" xlink:to="lab_us-gaap_CustomerContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_0f92bcf1-68eb-409b-b274-0e4bee2f32bf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_e3ca4ee8-e193-43bb-a320-d904c9607fdf_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_a2b9e99a-e6ac-4026-afa4-8816c15a0491_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_a49c8b61-f948-464f-bc1a-640c361da94e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DocumentAndEntityInformationAbstract_399cdfad-70c9-4121-a188-33e1c71fcb80_terseLabel_en-US" xlink:label="lab_hae_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:label id="lab_hae_DocumentAndEntityInformationAbstract_label_en-US" xlink:label="lab_hae_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:label id="lab_hae_DocumentAndEntityInformationAbstract_documentation_en-US" xlink:label="lab_hae_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DocumentAndEntityInformationAbstract" xlink:href="hae-20230401.xsd#hae_DocumentAndEntityInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DocumentAndEntityInformationAbstract" xlink:to="lab_hae_DocumentAndEntityInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_8109283b-7336-4a7d-ac85-65f991c24d1b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2029-2033</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_8a922a9d-83ab-4691-9d38-8a51b91ce615_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_d8ffeaca-690c-4f36-bdc0-3f93c934701f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation shortfalls (benefits)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_491b1f23-8751-496d-846f-2b42acd8542e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_821cc07a-d8a0-4be5-a8f3-1ac5e55bd15e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of notes</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_BankLoansandOtherBorrowingMember_a0db2ba7-70e1-4a80-ba2a-794e34dc1f33_verboseLabel_en-US" xlink:label="lab_hae_BankLoansandOtherBorrowingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank loans and other borrowings</link:label>
    <link:label id="lab_hae_BankLoansandOtherBorrowingMember_label_en-US" xlink:label="lab_hae_BankLoansandOtherBorrowingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Loans and Other Borrowing [Member]</link:label>
    <link:label id="lab_hae_BankLoansandOtherBorrowingMember_documentation_en-US" xlink:label="lab_hae_BankLoansandOtherBorrowingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Loans and Other Borrowing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BankLoansandOtherBorrowingMember" xlink:href="hae-20230401.xsd#hae_BankLoansandOtherBorrowingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_BankLoansandOtherBorrowingMember" xlink:to="lab_hae_BankLoansandOtherBorrowingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_eaf268ff-a3bc-42ca-8b07-cf21e9a3e96f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_28a32003-8a6e-4769-911f-a87ee056dee7_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used, Asset Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used, Asset Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b90cfb8f-eb26-4af7-99bb-e058858bb635_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_e6d0655b-2d14-4c41-a1dd-3e6b1a54c65f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_50feb20c-63ed-48da-862d-4367b456f190_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c7faef7f-6be3-4734-a75c-84036801960a_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_22fcefac-031d-4494-9315-fafb791213ea_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:to="lab_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_country_JP_3aff7505-bd17-4794-893e-897da8c0ebed_verboseLabel_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan</link:label>
    <link:label id="lab_country_JP_label_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JAPAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_JP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_JP" xlink:to="lab_country_JP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_35f11ada-5e5f-494d-b512-9cf124d2b8ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_07214a78-bede-49b5-8921-7d73fa8ff3b1_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c665dddc-6357-41d1-a551-2d9218d58fef_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4c168df2-041d-4e1e-8f7c-f7de5b131627_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_14f46030-c244-4f2a-8b21-0ddca2445e35_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_8f497a51-378a-4359-9594-adfb306408a6_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_9a1a23d7-a1a2-4971-a816-b86d7c34496b_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_29de6fec-369b-4912-aec0-fca5aed098f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers_1848e821-eb90-4eb1-b4f7-7218d1a95dfc_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs capitalized related to in process software development initiatives</link:label>
    <link:label id="lab_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers_label_en-US" xlink:label="lab_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Software Development Costs for Software Sold to Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xlink:to="lab_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8b66d09e-2505-48c6-a964-229963c3f6f8_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9e05d9d5-c73c-4cf5-8d3b-e9ed3e4c7245_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense_e287b72d-f7d6-4f0a-b340-d1452f9d63af_terseLabel_en-US" xlink:label="lab_hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Included in Income Tax Expense</link:label>
    <link:label id="lab_hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense_label_en-US" xlink:label="lab_hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Included in Income Tax Expense</link:label>
    <link:label id="lab_hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense_documentation_en-US" xlink:label="lab_hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Included in Income Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense" xlink:href="hae-20230401.xsd#hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense" xlink:to="lab_hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_4e4bceb3-0a95-4718-81af-ed00bfc445f3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_2467da77-afc9-41b7-be2a-f6c95fe9e2b8_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2a2b8b24-b7d4-4039-8215-d8658e8300e5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards_cec8ab85-ec89-4995-83ef-5e4ad2adcc87_terseLabel_en-US" xlink:label="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Operating Carryforwards</link:label>
    <link:label id="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards_label_en-US" xlink:label="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Operating Carryforwards</link:label>
    <link:label id="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards_documentation_en-US" xlink:label="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Operating Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards" xlink:href="hae-20230401.xsd#hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards" xlink:to="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_fcab5cc4-7c98-4057-8d21-a4f14d185f29_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_e1466195-f068-4e77-b583-41ebb4acab83_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_e3909eec-32b3-4228-9c8c-493ebdc5715d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_0a2f32c0-cb5f-4a3a-a8af-2af662faf91c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on divestitures and sale of assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_99585bf2-ad3a-42c1-89ce-f4bd6ccc3301_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on divestitures and sale of assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_224f8cd3-c915-464a-ac49-74dc9e72e61d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk and Significant Customers</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_e494fff3-8fbf-42db-87dc-bc8a72f69cd7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7782ca1c-57ba-4578-8f2a-a178df22154f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_76fb5da5-1771-4247-bc12-00565dd9d07f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_0c62b9d1-f45f-4cb1-a42c-43f2105a57d9_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts_d7f83324-daba-403d-a63f-5bbe31ad797f_terseLabel_en-US" xlink:label="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and related costs</link:label>
    <link:label id="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts_label_en-US" xlink:label="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Payroll and Related Costs</link:label>
    <link:label id="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts_documentation_en-US" xlink:label="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Payroll and Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts" xlink:href="hae-20230401.xsd#hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts" xlink:to="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a9fa7be4-f4e8-42fb-9f4d-0b21e68a6cb5_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Totals</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_87e731c2-a900-49a6-b5f2-2513031ab213_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of defined benefit plans, net of tax, balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_4d3bd035-9778-4171-9b94-585abeab5ab5_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of defined benefit plans, net of tax, balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_A401kPlanMember_c15221f8-4614-48da-b0c9-79560634084a_terseLabel_en-US" xlink:label="lab_hae_A401kPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401k Plan</link:label>
    <link:label id="lab_hae_A401kPlanMember_label_en-US" xlink:label="lab_hae_A401kPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401k Plan [Member]</link:label>
    <link:label id="lab_hae_A401kPlanMember_documentation_en-US" xlink:label="lab_hae_A401kPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401k Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A401kPlanMember" xlink:href="hae-20230401.xsd#hae_A401kPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_A401kPlanMember" xlink:to="lab_hae_A401kPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_95fde824-92df-4101-ac2d-c37ee91d39cc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_072634fe-6217-4cb4-a0fa-8cbc4d980962_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DebtInstrumentConvertibleComponentConversionPrice_8b07739b-d85a-480a-be02-33d44a53ddf2_terseLabel_en-US" xlink:label="lab_hae_DebtInstrumentConvertibleComponentConversionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:label id="lab_hae_DebtInstrumentConvertibleComponentConversionPrice_label_en-US" xlink:label="lab_hae_DebtInstrumentConvertibleComponentConversionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible Component, Conversion Price</link:label>
    <link:label id="lab_hae_DebtInstrumentConvertibleComponentConversionPrice_documentation_en-US" xlink:label="lab_hae_DebtInstrumentConvertibleComponentConversionPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible Component, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentConvertibleComponentConversionPrice" xlink:href="hae-20230401.xsd#hae_DebtInstrumentConvertibleComponentConversionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DebtInstrumentConvertibleComponentConversionPrice" xlink:to="lab_hae_DebtInstrumentConvertibleComponentConversionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_1049342f-6aa1-4054-ad6d-2adb1dc0785c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_0845bd86-1f33-41d2-bfab-b6b49e07bdcb_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_de79600d-a8c8-4654-b71e-69835dab27f2_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_a58ac732-1ad3-43ae-997b-e05df74ab3d5_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_5d5eb923-7ccf-4200-b13d-a4ba3c65b6ab_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_72be074a-265a-41e7-accf-6c4613361fb4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_ffcb23c1-39c5-43a0-8433-f89c0d374afb_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_f3a2e9e6-cfdd-4888-954a-58b242e97e00_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_OfficeEquipmentAndInformationTechnologyMember_3655f493-7411-43f5-91ee-138cb8c9f345_terseLabel_en-US" xlink:label="lab_hae_OfficeEquipmentAndInformationTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office equipment and information technology</link:label>
    <link:label id="lab_hae_OfficeEquipmentAndInformationTechnologyMember_36fa9ecd-db35-4f55-9107-30f9413563d1_verboseLabel_en-US" xlink:label="lab_hae_OfficeEquipmentAndInformationTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office equipment and information technology</link:label>
    <link:label id="lab_hae_OfficeEquipmentAndInformationTechnologyMember_label_en-US" xlink:label="lab_hae_OfficeEquipmentAndInformationTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment and Information Technology [Member]</link:label>
    <link:label id="lab_hae_OfficeEquipmentAndInformationTechnologyMember_documentation_en-US" xlink:label="lab_hae_OfficeEquipmentAndInformationTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment and Information Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OfficeEquipmentAndInformationTechnologyMember" xlink:href="hae-20230401.xsd#hae_OfficeEquipmentAndInformationTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_OfficeEquipmentAndInformationTechnologyMember" xlink:to="lab_hae_OfficeEquipmentAndInformationTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_b817c6d6-3fa7-4d73-a2e8-ca90249ede55_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ConsolidatedInterestCoverageRatio_8c3c1aff-63cf-40c4-9945-d73b927d1f8a_terseLabel_en-US" xlink:label="lab_hae_ConsolidatedInterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated interest coverage ratio</link:label>
    <link:label id="lab_hae_ConsolidatedInterestCoverageRatio_label_en-US" xlink:label="lab_hae_ConsolidatedInterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Interest Coverage Ratio</link:label>
    <link:label id="lab_hae_ConsolidatedInterestCoverageRatio_documentation_en-US" xlink:label="lab_hae_ConsolidatedInterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Interest Coverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ConsolidatedInterestCoverageRatio" xlink:href="hae-20230401.xsd#hae_ConsolidatedInterestCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ConsolidatedInterestCoverageRatio" xlink:to="lab_hae_ConsolidatedInterestCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_e8ec48eb-26ee-497f-ba30-065cf73a8822_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_fd76644f-5371-449c-baff-9108d0f47bd6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee and plan participants contribution</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_9595191c-7867-4a5c-80bd-bb87d9d28fc3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price (in dollars per share), Forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b485dbe7-6796-4ffb-a860-caf487348d8e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_79ebc22c-5bb4-4e96-b8aa-623d2a4fc721_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_5cc03eca-838f-486e-94be-28f1f41a366d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_958ebfa2-b14c-43f7-a861-1be7a83fcc7b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, less allowance for credit losses of $4,932 at April 1, 2023 and $2,475 at April 2, 2022</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_beece8f0-74fb-47d2-b3c4-ab9ea06c28d0_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_92e51b09-5f93-4623-83af-367c7ec3e48f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_91131395-0d76-4a05-95db-7e8847250fa3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3fa89827-d066-426b-8003-287bb615519a_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_8556361b-a1b0-49f2-b0b8-011d415d013f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Plan Assets:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_44bbedfe-1044-4cea-a6bc-c30979b27b69_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_6c9d6c51-5405-4aaa-a8ee-f05b1e13084b_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a52d3c16-72d6-4c47-a7c9-41d0b6dd0deb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9b1d46f8-5751-4ea0-a297-e3cacb4ac04d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_bbc41469-262e-4d51-9008-8f21b9c249ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_country_MY_1787b3bb-c703-4093-ac04-a771c0be0a24_terseLabel_en-US" xlink:label="lab_country_MY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malaysia</link:label>
    <link:label id="lab_country_MY_label_en-US" xlink:label="lab_country_MY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MALAYSIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_MY" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_MY" xlink:to="lab_country_MY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_71a401cc-8499-4810-a57e-ede7de50f385_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications into earnings of cash flow hedge (gains) losses, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_9b51f459-c335-4a5f-b0ce-6f250b0979a0_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4cab5f1c-3d7b-4bb7-bc6d-76e2bda0b720_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_cac00acf-e11d-4b5a-a74b-f6719a5646b0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_a4c861ec-c0d5-4b2f-8029-d02e81f8ad02_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_cdf9ac1c-16f8-4dfc-840e-3311043f67f4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_cecaa5ac-03d7-432d-bb4b-7ad34fefc543_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_b1848d71-0853-46be-92a3-45b86f1ce88e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable and current maturities of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_12c845fc-28f2-4eba-9438-0d6eb4ce3589_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_7b36ba4c-042b-474c-a27d-17981e964d65_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_9edb64e5-5e98-4944-a93e-a0f3f6b2f14b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_2d89e903-3bc4-4b95-ad2e-86f2e51af2df_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_ce896cda-3e42-4465-aeb1-6af8f29da796_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_5e06a090-5843-415d-b82d-798b14397ad9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation shortfalls (benefits)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_249df20e-b64e-4955-8fe5-adb559b6ba44_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value per option (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_2e27ff72-6bc6-4173-aa7c-874d16e155f6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent_bcab47f2-b19d-4b25-afbe-0aee1335a8ca_terseLabel_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent_label_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Contingent Consideration Liability, Percent</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent_documentation_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Contingent Consideration Liability, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent" xlink:to="lab_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_56988c43-557c-401c-91f3-5b4f6af75caa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5f83f1e8-1036-4e00-8a5d-99e64b063006_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_caa3bf27-ef24-4d24-9fe0-7fece09b5f5e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet_be92f6cb-6f94-4799-b586-54fa8eaedbf1_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated foreign currency hedge contracts outstanding</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Derivative at Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_OperatingExpensesTransactionCosts_ae1f7e3a-88f7-4f15-857d-c6a19c7febe7_terseLabel_en-US" xlink:label="lab_hae_OperatingExpensesTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration and transaction costs</link:label>
    <link:label id="lab_hae_OperatingExpensesTransactionCosts_label_en-US" xlink:label="lab_hae_OperatingExpensesTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OperatingExpensesTransactionCosts</link:label>
    <link:label id="lab_hae_OperatingExpensesTransactionCosts_documentation_en-US" xlink:label="lab_hae_OperatingExpensesTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OperatingExpensesTransactionCosts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OperatingExpensesTransactionCosts" xlink:href="hae-20230401.xsd#hae_OperatingExpensesTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_OperatingExpensesTransactionCosts" xlink:to="lab_hae_OperatingExpensesTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_772c9736-b1b3-4220-9084-2a9fc67aeaab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on cash flow hedges, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_acc520d7-e4cb-4116-a1fc-ec278d486fbd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligation amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_HASIntellectualPropertyMember_e36e3ff4-62e8-4006-85f1-18ee831d58d9_terseLabel_en-US" xlink:label="lab_hae_HASIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HAS Intellectual Property</link:label>
    <link:label id="lab_hae_HASIntellectualPropertyMember_label_en-US" xlink:label="lab_hae_HASIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HAS Intellectual Property [Member]</link:label>
    <link:label id="lab_hae_HASIntellectualPropertyMember_documentation_en-US" xlink:label="lab_hae_HASIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HAS Intellectual Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HASIntellectualPropertyMember" xlink:href="hae-20230401.xsd#hae_HASIntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_HASIntellectualPropertyMember" xlink:to="lab_hae_HASIntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_e357e9e8-ad9c-4bf6-ba76-c2c2342087b3_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_InlogHoldingsFranceMember_0c073c34-0935-4560-9f69-c35ec5c122c2_terseLabel_en-US" xlink:label="lab_hae_InlogHoldingsFranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inlog Holdings France</link:label>
    <link:label id="lab_hae_InlogHoldingsFranceMember_label_en-US" xlink:label="lab_hae_InlogHoldingsFranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inlog Holdings France [Member]</link:label>
    <link:label id="lab_hae_InlogHoldingsFranceMember_documentation_en-US" xlink:label="lab_hae_InlogHoldingsFranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inlog Holdings France</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InlogHoldingsFranceMember" xlink:href="hae-20230401.xsd#hae_InlogHoldingsFranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_InlogHoldingsFranceMember" xlink:to="lab_hae_InlogHoldingsFranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_0e27ed79-43c5-4d28-ac3c-0fef6091a583_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock, net of cancellations</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_a231c747-2175-4a41-92e8-bf807d27a975_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_507d2335-730b-4272-a671-d18765e2ae62_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c2d1cb53-bde9-4e0d-a35d-45b311bb928d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_038cb338-471b-44fc-9821-9107483aba2f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_0350e3d5-af09-452b-9149-549fca095d5e_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_4b37bf5f-10b2-4f3c-bd6b-ad03beea1169_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_e89db2d0-9eb8-4559-a550-51f9b96942a2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_f8589808-f113-491a-9237-6df6235b6fca_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_039a45ca-93e5-432f-95e4-5a9f6f4eaa12_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4d99162d-dc3d-4e14-8b55-f5e95d026bb4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_087d01f0-18cd-4300-945e-39cb2d74fea8_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1f3115a2-3b51-4226-a891-e2f4bd2c543c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_bea445d0-b8e6-4fe3-bc4d-ba60d1b83003_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_InterestRateSwap444FixedInterestRateMember_4c64968d-c6eb-4bf4-9287-f2296b377020_terseLabel_en-US" xlink:label="lab_hae_InterestRateSwap444FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.44% Fixed Interest Rate</link:label>
    <link:label id="lab_hae_InterestRateSwap444FixedInterestRateMember_label_en-US" xlink:label="lab_hae_InterestRateSwap444FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.44% Fixed Interest Rate [Member]</link:label>
    <link:label id="lab_hae_InterestRateSwap444FixedInterestRateMember_documentation_en-US" xlink:label="lab_hae_InterestRateSwap444FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.44% Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap444FixedInterestRateMember" xlink:href="hae-20230401.xsd#hae_InterestRateSwap444FixedInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_InterestRateSwap444FixedInterestRateMember" xlink:to="lab_hae_InterestRateSwap444FixedInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_713c3925-ce2d-416f-8239-cf40f184719f_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_a9a7d6f8-d7a3-4e61-8b25-aea67492d11b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_c36f84bd-8c64-4a9c-af5e-ecf540af729a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Life, Exercisable at End of Period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_6c9d7703-69c6-46cd-b531-b39ae4dc9071_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount_a665df9a-9d09-4204-a54a-814797cd6f42_terseLabel_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unremitted earnings</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount_label_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Unremitted Earnings, Amount</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount_documentation_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Unremitted Earnings, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount" xlink:to="lab_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ec2f4a3e-f81b-4b6d-9842-d434f3c230b1_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_e6659551-6d63-4365-bc80-863df54afa98_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_94c7c822-51e9-40e2-9f90-3bcf0f63881b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_bfe9e1e5-8124-4fd6-aca6-c99b2add1224_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_63ae9310-a3ab-4e01-9506-951319e65c8f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02a00460-e48f-4580-a534-53ff7f2799b7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_SummaryOfSignificantAccountingPronouncementsTable_f19ff2df-3c88-4882-bff0-898a250f2229_terseLabel_en-US" xlink:label="lab_hae_SummaryOfSignificantAccountingPronouncementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Pronouncements [Table]</link:label>
    <link:label id="lab_hae_SummaryOfSignificantAccountingPronouncementsTable_label_en-US" xlink:label="lab_hae_SummaryOfSignificantAccountingPronouncementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Pronouncements [Table]</link:label>
    <link:label id="lab_hae_SummaryOfSignificantAccountingPronouncementsTable_documentation_en-US" xlink:label="lab_hae_SummaryOfSignificantAccountingPronouncementsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Pronouncements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SummaryOfSignificantAccountingPronouncementsTable" xlink:href="hae-20230401.xsd#hae_SummaryOfSignificantAccountingPronouncementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable" xlink:to="lab_hae_SummaryOfSignificantAccountingPronouncementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_1177db38-6e07-49b0-aed7-c2f0f6bef9b5_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_51c8db42-988b-4258-8aa0-0ed63a836cd1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unremitted earnings</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_e3ee3d32-525e-428e-91ac-d0754c269916_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unremitted earnings</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_d21c393f-7c7d-4331-bf24-9c85e592071c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_762c4ec4-a56c-4912-aa04-2ca262e42d42_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_8489a07e-b7d9-4a90-81f8-d82240718547_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_adcda00e-d8c4-4b05-b391-5ecc40e940d7_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_760cc431-374b-48d6-ac8f-ee214da8fb4e_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_9d2f03dc-243d-49d6-b3f4-9aaefe2f50fd_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DebtInstrumentConvertibleCappedCallTransactionAmount_4ac7e4a9-a656-4388-97bf-2083a81e780d_terseLabel_en-US" xlink:label="lab_hae_DebtInstrumentConvertibleCappedCallTransactionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Call Transaction, Amount</link:label>
    <link:label id="lab_hae_DebtInstrumentConvertibleCappedCallTransactionAmount_label_en-US" xlink:label="lab_hae_DebtInstrumentConvertibleCappedCallTransactionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Call Transaction, Amount</link:label>
    <link:label id="lab_hae_DebtInstrumentConvertibleCappedCallTransactionAmount_documentation_en-US" xlink:label="lab_hae_DebtInstrumentConvertibleCappedCallTransactionAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Call Transaction, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentConvertibleCappedCallTransactionAmount" xlink:href="hae-20230401.xsd#hae_DebtInstrumentConvertibleCappedCallTransactionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DebtInstrumentConvertibleCappedCallTransactionAmount" xlink:to="lab_hae_DebtInstrumentConvertibleCappedCallTransactionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0ecb243f-5bdd-4844-b94e-cadaf1812245_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4d678e54-72d7-4530-88e6-f282f25d06ed_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_31497901-59d7-41df-91da-6e5830eec65c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of foreign operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_IncomeTaxReconciliationChangeinUncertainTaxPositions_252ce363-c52c-42f4-8821-76bb16a7f50a_terseLabel_en-US" xlink:label="lab_hae_IncomeTaxReconciliationChangeinUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in uncertain tax positions</link:label>
    <link:label id="lab_hae_IncomeTaxReconciliationChangeinUncertainTaxPositions_label_en-US" xlink:label="lab_hae_IncomeTaxReconciliationChangeinUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation, Change in Uncertain Tax Positions</link:label>
    <link:label id="lab_hae_IncomeTaxReconciliationChangeinUncertainTaxPositions_documentation_en-US" xlink:label="lab_hae_IncomeTaxReconciliationChangeinUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation, Change in Uncertain Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_IncomeTaxReconciliationChangeinUncertainTaxPositions" xlink:href="hae-20230401.xsd#hae_IncomeTaxReconciliationChangeinUncertainTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_IncomeTaxReconciliationChangeinUncertainTaxPositions" xlink:to="lab_hae_IncomeTaxReconciliationChangeinUncertainTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_b13b1b94-ddc5-4519-9e1e-be29538da56c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_09316f99-eca3-46a3-8b35-1e9f43cc8db1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan_841cbf78-1b5e-4b30-998a-a933f4e89d8d_terseLabel_en-US" xlink:label="lab_hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value of the six-month option inherent in the Purchase Plan (in dollars per share)</link:label>
    <link:label id="lab_hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan_label_en-US" xlink:label="lab_hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value of Six-Month Option Inherent in Purchase Plan</link:label>
    <link:label id="lab_hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan_documentation_en-US" xlink:label="lab_hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value of Six-Month Option Inherent in Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan" xlink:href="hae-20230401.xsd#hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan" xlink:to="lab_hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_96232322-fd49-48cd-a0e9-d6d9e8e441dc_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f33c5f0e-1e58-4a48-b170-cff4a9d4b6f8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember_d54acb74-dcab-4931-a06d-914ec302d506_terseLabel_en-US" xlink:label="lab_hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) One-Month USD Term Rate</link:label>
    <link:label id="lab_hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember_label_en-US" xlink:label="lab_hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) One-Month USD Term Rate [Member]</link:label>
    <link:label id="lab_hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember_documentation_en-US" xlink:label="lab_hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) One-Month USD Term Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember" xlink:href="hae-20230401.xsd#hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember" xlink:to="lab_hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent_389bf2e7-a7fb-48da-aaf6-dea0e442ef70_terseLabel_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unremitted earnings</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent_label_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Unremitted Earnings, Percent</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent_documentation_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Unremitted Earnings, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent" xlink:to="lab_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_19994efd-a0e4-4076-af52-df3ede3b39c2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Incurred</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_4eb99b95-42ee-4236-a9ab-4581d32541d3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Benefit Payments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_899dbf14-a7ba-4810-ae20-291c2f3db5c1_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_dcd55145-4929-4c6d-ad60-1fb066559410_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_414eac85-950d-460b-8cf5-2ab2509f87fb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_f33659ee-102d-4221-b979-260ca629fe55_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock_1ffef9cd-da4c-4097-a812-63e14b0abdea_terseLabel_en-US" xlink:label="lab_hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Equity Other Than Options, Valuation Assumptions</link:label>
    <link:label id="lab_hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Equity Other Than Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Equity Other Than Options, Valuation Assumptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:href="hae-20230401.xsd#hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments_8cdb8cb1-5099-4517-8e6b-394737c7acc2_terseLabel_en-US" xlink:label="lab_hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Divesture Of Business Net Of Working Capital Adjustments</link:label>
    <link:label id="lab_hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments_label_en-US" xlink:label="lab_hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Divesture Of Business Net Of Working Capital Adjustments</link:label>
    <link:label id="lab_hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments_documentation_en-US" xlink:label="lab_hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Divesture Of Business Net Of Working Capital Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments" xlink:href="hae-20230401.xsd#hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments" xlink:to="lab_hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_c0f00545-b3dc-4037-8def-f1f55466c7f0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation of Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_845997b4-4cf7-45cc-9b89-6f23ec604def_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of convertible notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_UnrecognizedNetActuarialLossGain_8b711456-d00c-4201-a1fb-ff12d15b769c_terseLabel_en-US" xlink:label="lab_hae_UnrecognizedNetActuarialLossGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized net actuarial gain</link:label>
    <link:label id="lab_hae_UnrecognizedNetActuarialLossGain_label_en-US" xlink:label="lab_hae_UnrecognizedNetActuarialLossGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Net Actuarial Loss / (Gain)</link:label>
    <link:label id="lab_hae_UnrecognizedNetActuarialLossGain_documentation_en-US" xlink:label="lab_hae_UnrecognizedNetActuarialLossGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Net Actuarial Loss/(Gain)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_UnrecognizedNetActuarialLossGain" xlink:href="hae-20230401.xsd#hae_UnrecognizedNetActuarialLossGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_UnrecognizedNetActuarialLossGain" xlink:to="lab_hae_UnrecognizedNetActuarialLossGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c3e12389-b5ce-471a-b8a5-5bb7f4cd4483_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_141930e8-20dc-48e6-8202-259e66e60231_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_35e1d29f-8524-441b-b52d-ff6e10a120f0_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_71e8f518-ed6c-4401-a11d-7f3d34b8113f_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_InterestRateSwap267FixedInterestRateMember_a708966a-19d5-4679-acb4-3a20468e536b_terseLabel_en-US" xlink:label="lab_hae_InterestRateSwap267FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2.67% Fixed Interest Rate</link:label>
    <link:label id="lab_hae_InterestRateSwap267FixedInterestRateMember_label_en-US" xlink:label="lab_hae_InterestRateSwap267FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2.67% Fixed Interest Rate [Member]</link:label>
    <link:label id="lab_hae_InterestRateSwap267FixedInterestRateMember_documentation_en-US" xlink:label="lab_hae_InterestRateSwap267FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2.67% Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap267FixedInterestRateMember" xlink:href="hae-20230401.xsd#hae_InterestRateSwap267FixedInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_InterestRateSwap267FixedInterestRateMember" xlink:to="lab_hae_InterestRateSwap267FixedInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_45e35d51-59c9-4666-92e8-628932526a1a_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_e7aa3bad-3e7b-4c38-875e-fa819d973853_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0f22a2a7-2ddb-422c-9bef-395cd9693620_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_bc1a69b2-bfe0-4f6e-8014-cc166efebe13_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_dc6bae20-4cf9-44e9-a091-3d21fef394f7_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1fccb01d-f321-4241-9cd6-c3f4ac2c7c97_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_87bb49b5-1284-4746-88ec-7bfc9769d8f4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_c0a6bed5-2a7e-47e4-9fa8-928ff23d22e7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_f7f15a5d-2da4-45b9-890f-2a06d07c55ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_56e96c62-775a-4c70-9d27-76eddc7b9e3a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_ab624af9-5388-42c9-9736-47d8ace89752_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_61de05a6-f2c1-4b17-9665-61056a767406_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_4fcbdc40-fb97-47f9-87e6-fcf8b80d8168_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod_9fdf6636-8cd4-4854-8300-612f691feaeb_terseLabel_en-US" xlink:label="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award performance period</link:label>
    <link:label id="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod_label_en-US" xlink:label="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Performance Period</link:label>
    <link:label id="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod_documentation_en-US" xlink:label="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod" xlink:href="hae-20230401.xsd#hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod" xlink:to="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_44d2b317-0c93-48da-bc1c-384407c027f3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DigitalTransformationCosts_2f16673c-7cee-4786-b2c2-13889bff2113_terseLabel_en-US" xlink:label="lab_hae_DigitalTransformationCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digital transformation costs</link:label>
    <link:label id="lab_hae_DigitalTransformationCosts_label_en-US" xlink:label="lab_hae_DigitalTransformationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digital transformation costs</link:label>
    <link:label id="lab_hae_DigitalTransformationCosts_documentation_en-US" xlink:label="lab_hae_DigitalTransformationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digital transformation costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DigitalTransformationCosts" xlink:href="hae-20230401.xsd#hae_DigitalTransformationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DigitalTransformationCosts" xlink:to="lab_hae_DigitalTransformationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_6d296e26-caf5-4b28-a33b-bc28819a543a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_792907ab-52c4-4eb9-9718-7e2d582fff77_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Year</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_d77cb6d5-3baa-45ad-b859-39acc3ae3a87_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loan borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_17f4b6c2-26cb-4875-a06b-bb07e1f9b22d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_IncentiveCompensationPlan2005Member_d098b098-7fdc-4546-ae92-9d3c85502ec7_terseLabel_en-US" xlink:label="lab_hae_IncentiveCompensationPlan2005Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Compensation Plan 2005</link:label>
    <link:label id="lab_hae_IncentiveCompensationPlan2005Member_label_en-US" xlink:label="lab_hae_IncentiveCompensationPlan2005Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Compensation Plan 2005 [Member]</link:label>
    <link:label id="lab_hae_IncentiveCompensationPlan2005Member_documentation_en-US" xlink:label="lab_hae_IncentiveCompensationPlan2005Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Compensation Plan 2005 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_IncentiveCompensationPlan2005Member" xlink:href="hae-20230401.xsd#hae_IncentiveCompensationPlan2005Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_IncentiveCompensationPlan2005Member" xlink:to="lab_hae_IncentiveCompensationPlan2005Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_9bcce542-4c4b-4e4d-bd28-c8403c791763_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_46469f0c-5ea4-4865-8936-01b6ea3f2a3f_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_58501e56-ac4c-431f-b1bd-023019f49713_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions_6fe8e186-3447-49a9-9e46-a084f3a5ab8e_terseLabel_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in uncertain tax positions</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions_label_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Uncertain Tax Positions</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions_documentation_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Uncertain Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions" xlink:to="lab_hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_60ab4656-f359-4804-bdbd-f769674a8a61_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_265faca6-7d24-4c9e-b0d5-53d0841b0cf7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligation percent</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_59b524a6-d93c-40d2-875f-79348cd8b24c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_d5d9b6e7-c475-4c73-8171-cf3e227816f4_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_2c832732-7ab0-4edd-a0b9-a43979bdb44a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_fbc3e9ed-9f75-4fd8-845e-cc3b36a30fcf_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty_99a00935-95bd-4d0a-9c08-e68e8802e25d_negatedTerseLabel_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany sale of intellectual property</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty_label_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intercompany Sale of Intellectual Property</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty_documentation_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intercompany Sale of Intellectual Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty" xlink:to="lab_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_47f00ea9-a909-4fce-a449-791ce6bc316f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price (in dollars per share), Beginning Balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_aa6eb6dc-fdfd-4468-be99-920b4e8dc4f1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price (in dollars per share), Ending Balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_645f2297-8a1e-4fe3-98f4-86aeebc76650_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_AmortizationOfAcquiredIntangibleAssets_2472e792-13bc-43c2-b694-219a8a25c70f_terseLabel_en-US" xlink:label="lab_hae_AmortizationOfAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_hae_AmortizationOfAcquiredIntangibleAssets_label_en-US" xlink:label="lab_hae_AmortizationOfAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Acquired Intangible Assets</link:label>
    <link:label id="lab_hae_AmortizationOfAcquiredIntangibleAssets_documentation_en-US" xlink:label="lab_hae_AmortizationOfAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Acquired Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AmortizationOfAcquiredIntangibleAssets" xlink:href="hae-20230401.xsd#hae_AmortizationOfAcquiredIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_AmortizationOfAcquiredIntangibleAssets" xlink:to="lab_hae_AmortizationOfAcquiredIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_bae8b503-f472-453e-abf3-66e8ec69f166_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_901462a0-1cd1-4ce2-9e74-ec11aed5c8bb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_f5ab9bcc-dd46-4311-92bf-5587ce23126a_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_53f596ce-b86d-4873-b2e5-ef2a9b3ab0ba_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dbbe8237-d22c-4232-9754-52040c593c90_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9f3abd7e-5a84-4957-895e-f06b0fb9b138_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_da7eb14d-468a-4355-8fb1-04669404b281_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e22cd59a-60c0-4c2e-a669-45a730adb955_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_f3ccb351-1bf0-4286-bda9-ad7874b17c98_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_f68dca4c-32ea-416b-8842-dd1e5705f7b6_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Settlement (Payment) or Receipt</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Settlement (Payment) or Receipt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_deb791e5-cd90-4c79-8264-6b601543b8c7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable at End of Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_b3ec46f3-a1c6-47af-9ed2-7057d812f7ef_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_3cf046cf-c822-47bc-bc12-ec7051f0137a_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease_449ee544-3fdd-47e6-bc46-0534cba334e2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_bfc8e002-26fa-4942-9b8c-4086fd785041_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_22c08d8c-1d37-44a6-90ea-ecaa819113ca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_38f272d5-02e7-46fa-bbbd-1a47aeef1367_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_ebda0816-a105-44cb-9d48-e00fd3b6aabf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_37827289-828f-4dc8-8420-240ecae9573e_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a5b3eb49-85db-4ae7-a46c-7dce29a20fa0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales_8c7f1a9d-01a1-4410-9643-a14aacf7a534_terseLabel_en-US" xlink:label="lab_hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease revenue as a percentage of net sales (as a percent)</link:label>
    <link:label id="lab_hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales_label_en-US" xlink:label="lab_hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Revenue, As A Percentage Of Total Net Sales</link:label>
    <link:label id="lab_hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales_documentation_en-US" xlink:label="lab_hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Revenue, As A Percentage Of Total Net Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales" xlink:href="hae-20230401.xsd#hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales" xlink:to="lab_hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_22d2d61a-4b1f-4ea0-81a2-f04a4ea49dbd_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_e528e5e4-07f0-42c9-ba54-c9a761ca916e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_f6e42a5d-5110-45a4-9b7f-791ac84aa74e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2729a29f-fe35-4eaa-b242-4e89b2d579f6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9df5b3d8-e56b-46fb-96dc-67d620cce8aa_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_d42a7166-bd32-4949-8911-b48f4316e310_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DeferredTaxLiabilitiesDepreciation_18f5c60b-660a-40f3-b689-832bb1b5689a_negatedTerseLabel_en-US" xlink:label="lab_hae_DeferredTaxLiabilitiesDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_hae_DeferredTaxLiabilitiesDepreciation_label_en-US" xlink:label="lab_hae_DeferredTaxLiabilitiesDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Depreciation</link:label>
    <link:label id="lab_hae_DeferredTaxLiabilitiesDepreciation_documentation_en-US" xlink:label="lab_hae_DeferredTaxLiabilitiesDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxLiabilitiesDepreciation" xlink:href="hae-20230401.xsd#hae_DeferredTaxLiabilitiesDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DeferredTaxLiabilitiesDepreciation" xlink:to="lab_hae_DeferredTaxLiabilitiesDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_21801dd2-e0ac-4961-bd9e-e209274cac1c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_8f2ab223-933d-4a75-9e7f-f205981403f1_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_a9bb3c71-705f-421f-ac8d-918721717ec2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Summary of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3dbe2afc-027d-4bb2-ac22-d6500a16fffc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_e3ada8b7-dd07-4ddc-8503-d65f2cd3c597_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Net Periodic Benefit Costs of Defined Benefit Pension Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_2e6b4c94-c51e-4fcd-abd1-bfda890c273b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity component of convertible notes, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_3a316e05-eabd-44e5-91fa-099b95690759_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_6808c80c-cd7c-4462-91a4-df5f769232fe_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_64180bae-6ea4-4785-99e6-dcba428a5710_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_43ffb87a-9517-41e1-86e3-4048cee79fd2_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6e53a1be-9742-4ab5-b2d3-4ddc6ef838d0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1dec00b3-9913-4cf0-aa7c-b9e2a9309239_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ea25d5fb-db69-422b-b866-c2a6b99cb5e2_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_9ed89b64-572c-4c28-b025-9c37a24b1022_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_e6090abc-e16b-437d-a9fe-eba662692e43_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8b303b55-2b33-4fcb-9cd5-c7091b2ddcf7_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_d30ad77f-5af8-47fc-b95d-a5d1ae9cebef_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_0d391d23-9718-4de2-b235-cd5373f86fe4_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e4c42e47-9831-4bb2-a5bf-f5a247093728_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_8ad9b419-5602-41d3-b58e-8eef10749b34_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived_4b50f382-5245-4324-9892-32f4c7ebc4d0_terseLabel_en-US" xlink:label="lab_hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Divesture of Business, Contingent Consideration Received</link:label>
    <link:label id="lab_hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived_label_en-US" xlink:label="lab_hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Divesture of Business, Contingent Consideration Received</link:label>
    <link:label id="lab_hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived_documentation_en-US" xlink:label="lab_hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Divesture of Business, Contingent Consideration Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived" xlink:href="hae-20230401.xsd#hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived" xlink:to="lab_hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_0e1d2322-2729-4680-b21b-1e2bc4e6b9bb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaMember_dd1b6dce-144b-4916-8009-b176aa85537b_terseLabel_en-US" xlink:label="lab_srt_AsiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia</link:label>
    <link:label id="lab_srt_AsiaMember_label_en-US" xlink:label="lab_srt_AsiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaMember" xlink:to="lab_srt_AsiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_ab31526e-6fcd-4c06-963c-af6bf024fe70_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Vested and Expected to Vest at End of Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_7f43872a-843d-4c32-be47-a00d4e3b43b8_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_53e336a0-2d94-4d91-a68d-bd03c7db60ca_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy_9a24d08c-931d-4516-ab43-0e83a976152a_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for the Costs of Computer Software to be Sold, Leased, or Otherwise Marketed</link:label>
    <link:label id="lab_us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy_label_en-US" xlink:label="lab_us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software to be Sold, Leased, or Otherwise Marketed, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy" xlink:to="lab_us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DerivativePercentageOfNotionalValueOfDebt_1fa4ee23-4246-4c7d-9888-c7e1d4f35d29_terseLabel_en-US" xlink:label="lab_hae_DerivativePercentageOfNotionalValueOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Percentage Of Notional Value Of Debt</link:label>
    <link:label id="lab_hae_DerivativePercentageOfNotionalValueOfDebt_label_en-US" xlink:label="lab_hae_DerivativePercentageOfNotionalValueOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Percentage Of Notional Value Of Debt</link:label>
    <link:label id="lab_hae_DerivativePercentageOfNotionalValueOfDebt_documentation_en-US" xlink:label="lab_hae_DerivativePercentageOfNotionalValueOfDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Percentage Of Notional Value Of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DerivativePercentageOfNotionalValueOfDebt" xlink:href="hae-20230401.xsd#hae_DerivativePercentageOfNotionalValueOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DerivativePercentageOfNotionalValueOfDebt" xlink:to="lab_hae_DerivativePercentageOfNotionalValueOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_6e5086d7-3b99-4b28-b5f9-ab1a424a569f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:to="lab_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EffectofExchangeRateonRevenues_b7d880e0-0131-4a7c-b741-7587f275595d_terseLabel_en-US" xlink:label="lab_hae_EffectofExchangeRateonRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rates</link:label>
    <link:label id="lab_hae_EffectofExchangeRateonRevenues_label_en-US" xlink:label="lab_hae_EffectofExchangeRateonRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Revenues</link:label>
    <link:label id="lab_hae_EffectofExchangeRateonRevenues_documentation_en-US" xlink:label="lab_hae_EffectofExchangeRateonRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectofExchangeRateonRevenues" xlink:href="hae-20230401.xsd#hae_EffectofExchangeRateonRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EffectofExchangeRateonRevenues" xlink:to="lab_hae_EffectofExchangeRateonRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_10702d34-f46a-48cb-8880-10d70cda17c7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_095942a4-9fac-406a-9a01-70d611ca91e4_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amount recognized</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ba4fd066-3143-40fa-88c0-11a1c8494dc5_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_b60058d0-ea71-4d0a-b6b4-bc9e3294bbba_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2028</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_RestructuringRelatedCosts_9bd2c98d-146c-48c3-8dcd-89590b553f7f_terseLabel_en-US" xlink:label="lab_hae_RestructuringRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring related costs</link:label>
    <link:label id="lab_hae_RestructuringRelatedCosts_label_en-US" xlink:label="lab_hae_RestructuringRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Costs</link:label>
    <link:label id="lab_hae_RestructuringRelatedCosts_documentation_en-US" xlink:label="lab_hae_RestructuringRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringRelatedCosts" xlink:href="hae-20230401.xsd#hae_RestructuringRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_RestructuringRelatedCosts" xlink:to="lab_hae_RestructuringRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_75efa1c2-9d62-4779-b331-7cda0c34e6a5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation cost related to non vested awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_01768c76-104c-474e-a298-ad0fd0c3687a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_c3624019-21c1-4f46-8e96-d260b5112965_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_a7e9415d-dc59-47b0-a4c6-3564d1455576_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_683b3299-341e-46d0-81ad-a97795dcbf6e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_80c924e8-6134-4087-b7b1-032cf2d7b1d5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_370e5c54-9151-4e8e-9c59-a4ade3f2263c_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_d7cce48d-b2d8-4a0c-bc97-8e764df3b230_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_0f10398c-6e94-4e14-8ea1-b823c150579d_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, carrying amount</link:label>
    <link:label id="lab_us-gaap_Goodwill_c237600d-82e1-42b6-93f3-01b206160936_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, carrying amount</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_1a845228-71a3-4d26-ba7a-52337fcc4cdb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_0a9ef676-f670-447c-a93b-3010234334d6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of foreign operations</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_ec936922-1054-4e7a-917a-219e2ec33930_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_601344ab-6b2d-407f-9b99-7ed5ff6c11cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d94da3b4-0cb0-48cc-bb53-c91d12c13891_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_4e98de78-0a29-4e0b-ad8c-d41617015eaa_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_d05b3c82-5e8f-483f-be72-834c514274ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Derivative Instruments as They Appear in Consolidated Balance Sheets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_79416f5e-cb29-4f3b-b1b4-d4e4355276ae_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_4dc46d7d-609f-4584-80d3-08dcfb9071dd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice_6dd307f8-43c1-4683-97c7-f4f22dc032a9_terseLabel_en-US" xlink:label="lab_hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Call Transaction, Initial Strike Price</link:label>
    <link:label id="lab_hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice_label_en-US" xlink:label="lab_hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Call Transaction, Initial Strike Price</link:label>
    <link:label id="lab_hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice_documentation_en-US" xlink:label="lab_hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Call Transaction, Initial Strike Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice" xlink:href="hae-20230401.xsd#hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice" xlink:to="lab_hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_18d77d36-95fa-4d0d-a752-0e3390e097fc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_ce068bc1-8f8e-4fbe-93e4-97907764e432_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DebtInstrumentInterestRateFloor_96ce7292-b5c1-44d2-82cc-e98464f2dd2b_terseLabel_en-US" xlink:label="lab_hae_DebtInstrumentInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Floor</link:label>
    <link:label id="lab_hae_DebtInstrumentInterestRateFloor_label_en-US" xlink:label="lab_hae_DebtInstrumentInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Floor</link:label>
    <link:label id="lab_hae_DebtInstrumentInterestRateFloor_documentation_en-US" xlink:label="lab_hae_DebtInstrumentInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Floor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentInterestRateFloor" xlink:href="hae-20230401.xsd#hae_DebtInstrumentInterestRateFloor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DebtInstrumentInterestRateFloor" xlink:to="lab_hae_DebtInstrumentInterestRateFloor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_a03062f5-5265-4889-aaf0-edeb7b2d3314_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Life, Vested or Expected to Vest at End of Period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionAxis_e4a5e849-f55d-4d36-862c-c6bf34a062be_terseLabel_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:label id="lab_us-gaap_PositionAxis_label_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionAxis" xlink:to="lab_us-gaap_PositionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_a80d7e7f-e6ac-4d9f-89ee-e3b946819dc3_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_02f98e50-1d7b-4f8b-96d4-4d4ba52db165_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_2b189b11-0d13-4bce-92c3-029d9e3ca851_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns_96b93a8a-cc43-4364-a835-bfe9d687b836_terseLabel_en-US" xlink:label="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Correlation of returns</link:label>
    <link:label id="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns_label_en-US" xlink:label="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Correlation of Returns</link:label>
    <link:label id="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns_documentation_en-US" xlink:label="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Correlation of Returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns" xlink:href="hae-20230401.xsd#hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns" xlink:to="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_b9079949-d8f6-4dd4-bbd1-24a2bd202b1f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_03a8b0cb-0e0a-4fe3-8137-8737bab5a7c4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c7edf889-0242-405a-b464-e6ca55ef3d80_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal statutory income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b951f444-0032-45d7-a664-70d2730389dd_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_5e0a7a8f-09c5-4229-bcab-900fa8745162_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_361b0d47-d9e7-4c17-8985-0d7d002d3df1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d519fe28-b6b0-46a8-9c17-bb549f1b1cda_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_adf19961-ab7e-413f-b5c1-f99d9c8b7b0d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_6b3a6987-66e8-422c-b111-96518e52ef62_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_f21124b2-251c-42d8-b326-4cbe2780afa0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_264e4ed2-28db-4a1f-bfbc-195b20a0774d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carry-forward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_a8f4d4bd-0abb-4949-91f7-2a547a54072a_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit Activities</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_ad46e513-2c65-411f-88fe-50655fac944e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost on benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_6a71ca44-27fb-4b14-be82-67b0a606b103_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DerivativeBlendedFixedInterestRate_edca4e6f-c569-4cdb-97a8-a01e79a18420_terseLabel_en-US" xlink:label="lab_hae_DerivativeBlendedFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Blended Fixed Interest Rate</link:label>
    <link:label id="lab_hae_DerivativeBlendedFixedInterestRate_label_en-US" xlink:label="lab_hae_DerivativeBlendedFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Blended Fixed Interest Rate</link:label>
    <link:label id="lab_hae_DerivativeBlendedFixedInterestRate_documentation_en-US" xlink:label="lab_hae_DerivativeBlendedFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Blended Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DerivativeBlendedFixedInterestRate" xlink:href="hae-20230401.xsd#hae_DerivativeBlendedFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DerivativeBlendedFixedInterestRate" xlink:to="lab_hae_DerivativeBlendedFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_c1c876d4-50db-4e6c-8c16-2345ffe79902_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and related costs</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_07d834f0-7e13-41fc-bd15-fc1a6a16b3ba_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_f3ec75f3-7ecc-45f2-bfc0-03bf50404e52_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ca15d578-f133-4c13-b684-a29bc52904ba_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bd1d2ee6-a99e-409b-9b36-45379c569574_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_7c96a366-d8ca-470d-b015-9dee76f07cc6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notes Payable and Long-Term Debt Maturities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_96b012cd-6f8f-4586-a2f3-5dfc91b998a5_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_bd10c18b-4de3-4d2e-99e8-7fa25042da4b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_26a85f6b-5e86-4734-97c0-0d298520cd2a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_b0d98f93-13f3-47ac-95f2-abdb522b4450_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_a510a9f0-d0bd-43e4-91cc-47d7d7157406_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_bc17db0e-b2f3-4fed-a25e-37d99611a177_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ae442872-48c8-4740-93dd-8e1cb9bcf692_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_7c5ef66f-8429-45c7-9545-83de2012233b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_85f6d670-7564-4665-846c-8fe90093d6ce_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DeferredTaxAssetsAmortization_12d9d185-de4a-48d4-842c-06386998225c_terseLabel_en-US" xlink:label="lab_hae_DeferredTaxAssetsAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_hae_DeferredTaxAssetsAmortization_label_en-US" xlink:label="lab_hae_DeferredTaxAssetsAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Amortization</link:label>
    <link:label id="lab_hae_DeferredTaxAssetsAmortization_documentation_en-US" xlink:label="lab_hae_DeferredTaxAssetsAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxAssetsAmortization" xlink:href="hae-20230401.xsd#hae_DeferredTaxAssetsAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DeferredTaxAssetsAmortization" xlink:to="lab_hae_DeferredTaxAssetsAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_bd0a06f1-0c45-45a7-9221-cfd240608e11_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_629b6d05-e21a-4407-9e39-feb41902a912_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c70a5937-5f6b-49a7-aff8-3d72752e870e_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_03770324-85e4-437e-ae35-de8bece6a5d9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EnergyDomain_e6051871-edb0-4b56-bce5-c0f532f7038c_terseLabel_en-US" xlink:label="lab_srt_EnergyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy [Domain]</link:label>
    <link:label id="lab_srt_EnergyDomain_label_en-US" xlink:label="lab_srt_EnergyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EnergyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EnergyDomain" xlink:to="lab_srt_EnergyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3ce144ea-b219-4313-a916-b4d2e6a75e5c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice_22984b1d-8a09-4ecc-87b5-d36a850eaf55_terseLabel_en-US" xlink:label="lab_hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Previous Closing Price</link:label>
    <link:label id="lab_hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice_label_en-US" xlink:label="lab_hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Previous Closing Price</link:label>
    <link:label id="lab_hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice_documentation_en-US" xlink:label="lab_hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Previous Closing Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice" xlink:href="hae-20230401.xsd#hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice" xlink:to="lab_hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_28e872bb-7466-43f0-9c1b-4fc720011c78_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DIVESTITURE</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_2ed6c620-4cbd-4d91-9797-cd198643c4d2_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameDomain" xlink:to="lab_us-gaap_RetirementPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_02b76cd8-4694-4a57-bc16-3e1cf0ccb922_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_2bf67c35-7485-480b-b90d-064847102b90_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_915b095c-44df-4541-b1a7-0e8b14112350_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_64a21309-643d-4030-af36-3066e5f40b6b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_10d33948-f261-4d14-8232-743118042cae_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e831e1d0-c717-4852-9daf-a365f5339dee_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value (in dollars per share), Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_204cfba3-8285-4d13-b346-18326b617471_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_a080e049-bb3b-48eb-940d-158df573a330_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3273a337-892c-4765-bfcf-c0351fc11c2f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_SummaryOfSignificantAccountingPronouncementsLineItems_fa90be27-9c8f-4650-85a9-432972acf47c_terseLabel_en-US" xlink:label="lab_hae_SummaryOfSignificantAccountingPronouncementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Pronouncements [Line Items]</link:label>
    <link:label id="lab_hae_SummaryOfSignificantAccountingPronouncementsLineItems_label_en-US" xlink:label="lab_hae_SummaryOfSignificantAccountingPronouncementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Pronouncements [Line Items]</link:label>
    <link:label id="lab_hae_SummaryOfSignificantAccountingPronouncementsLineItems_documentation_en-US" xlink:label="lab_hae_SummaryOfSignificantAccountingPronouncementsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Pronouncements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems" xlink:href="hae-20230401.xsd#hae_SummaryOfSignificantAccountingPronouncementsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems" xlink:to="lab_hae_SummaryOfSignificantAccountingPronouncementsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_3c5e72fa-61bf-4b04-b39e-d12da6e43701_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_e6e0a0d1-445c-412f-870e-e24e26c4abad_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_22f5fb77-8ae4-459e-b640-f50d40a8108c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_78c8d987-99b0-43c7-bd2c-96a6400b3440_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_label_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:to="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_507fa543-c1f8-4475-8d2b-4ca2469a8811_terseLabel_en-US" xlink:label="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_988809fa-814f-4fe2-9dd0-42fbd69d016a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_8b241bb4-8690-4404-ae41-d4e5381bd493_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_09ca4df7-a7d5-44c4-8396-8b1ca4fa1521_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price (in dollars per share), Vested or Expected to Vest at End of Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b3e48380-4c0f-499b-a2bf-3409978bce0f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_PriorRestructuringProgramsMember_7fd638b0-d3e2-46f1-a55f-2a39686cd198_terseLabel_en-US" xlink:label="lab_hae_PriorRestructuringProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Programs</link:label>
    <link:label id="lab_hae_PriorRestructuringProgramsMember_label_en-US" xlink:label="lab_hae_PriorRestructuringProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Restructuring Programs [Member]</link:label>
    <link:label id="lab_hae_PriorRestructuringProgramsMember_documentation_en-US" xlink:label="lab_hae_PriorRestructuringProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Restructuring Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PriorRestructuringProgramsMember" xlink:href="hae-20230401.xsd#hae_PriorRestructuringProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_PriorRestructuringProgramsMember" xlink:to="lab_hae_PriorRestructuringProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EmployeeStockPurchasePlanMember_85207adb-50ca-4c75-baa4-2139c4f49ec4_terseLabel_en-US" xlink:label="lab_hae_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_hae_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_hae_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_hae_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_hae_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EmployeeStockPurchasePlanMember" xlink:href="hae-20230401.xsd#hae_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EmployeeStockPurchasePlanMember" xlink:to="lab_hae_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_fa246181-2e9f-48af-9faa-a1ee4dcbffce_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_3f98750e-efc7-46f0-870c-1d7ff3ce8d2e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a52b3edc-0c3a-4255-a353-53e0ea04e835_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_d3e28ef6-1593-4915-ab33-a75bb093b928_terseLabel_en-US" xlink:label="lab_hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment Estimated Useful Lives</link:label>
    <link:label id="lab_hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_label_en-US" xlink:label="lab_hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment, Estimated Useful Lives [Table Text Block]</link:label>
    <link:label id="lab_hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_documentation_en-US" xlink:label="lab_hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment, Estimated Useful Lives [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:href="hae-20230401.xsd#hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:to="lab_hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7794a461-975f-448d-9854-64c547db7cba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_50973f39-b688-42d7-8f1e-5e61454c02cd_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding, (in shares), Beginning Balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_471bbfcf-297b-449a-93ab-1f75468f2a56_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding, (in shares), Ending Balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_6d50910f-c86d-43bc-8033-99fbf2c4e2d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Performance Share Unit awards</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_ebacbf04-7c7b-4eca-b4c8-c9e832ca1beb_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_55cf2ceb-2489-4ad8-b80e-900e1d0fd800_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_2a702287-d91c-4ae5-abcf-396183ee73f9_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_227c9314-8cc0-480e-97dd-f34bc9f1bdcc_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_e4b7f080-b846-4133-aa92-4535ebfea235_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of unrecognized prior service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1fb19cc1-f95c-4ea4-b207-8c9782ce154a_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9b90a586-563f-4990-b5de-eb8e4925a50f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_c71342db-ea7a-43d3-aa29-50f805e87030_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_CardivaMedicalIncMember_0658f94a-bf69-4db5-b4b1-1dd2d150b399_terseLabel_en-US" xlink:label="lab_hae_CardivaMedicalIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiva Medical, Inc.</link:label>
    <link:label id="lab_hae_CardivaMedicalIncMember_label_en-US" xlink:label="lab_hae_CardivaMedicalIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiva Medical, Inc. [Member]</link:label>
    <link:label id="lab_hae_CardivaMedicalIncMember_documentation_en-US" xlink:label="lab_hae_CardivaMedicalIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiva Medical, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CardivaMedicalIncMember" xlink:href="hae-20230401.xsd#hae_CardivaMedicalIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_CardivaMedicalIncMember" xlink:to="lab_hae_CardivaMedicalIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5dd5f053-bcf0-474d-85b8-e51e68fb7302_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Deferred Tax Asset</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_23065f5b-faa6-4afa-96c4-6ba0929d4a9a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible expenses</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration_26a95d44-de57-4b76-baff-7433623eb4db_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optional exemption term</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Optional Exemption, Remaining Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7371016e-8d95-4567-96e1-09728409b16a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5a83f442-3178-4ab6-8ecc-20b812f8ab0b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany_4538e19f-7d2c-4c60-9468-92202a4881de_terseLabel_en-US" xlink:label="lab_hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation, plan funded by company</link:label>
    <link:label id="lab_hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany_label_en-US" xlink:label="lab_hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Plan Funded by Company</link:label>
    <link:label id="lab_hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany_documentation_en-US" xlink:label="lab_hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Plan Funded by Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany" xlink:to="lab_hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_2a78b563-efe8-4e8b-a34a-e5d2b052c0b6_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_f435b67c-e815-46a7-9fb7-009762803f5c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_52d8cbee-90f0-4b60-a363-1862e161bcca_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_79fac6de-9bac-497e-b783-54a224980e4e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of defined benefit plans, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c3fae429-f05f-40dc-aa7a-770b9c994590_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent_0aae6565-12c0-4c75-9787-0c941928b6f8_negatedTerseLabel_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany sale of intellectual property</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent_label_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intercompany Sale of Intellectual Property, Percent</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent_documentation_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intercompany Sale of Intellectual Property, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent" xlink:to="lab_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_23a3f044-14b2-48a2-8cea-133037bd33c4_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases_f64b64fd-5bd5-45b2-b059-2a568c7ec0bb_negatedTerseLabel_en-US" xlink:label="lab_hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of capped call related to convertible notes</link:label>
    <link:label id="lab_hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases_label_en-US" xlink:label="lab_hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Convertible Debt, Capped Call Purchases</link:label>
    <link:label id="lab_hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases_documentation_en-US" xlink:label="lab_hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Convertible Debt, Capped Call Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases" xlink:href="hae-20230401.xsd#hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases" xlink:to="lab_hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_84b3f55a-4329-4390-929f-6316bb83a984_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_89e38c46-7238-4ad6-9aee-ff0dd7d0c50c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1bdab68b-35b3-4fbf-9a92-f9295e16d17d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_f9c79eb9-b972-44ba-a6ff-765476fe5d3a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carry-forward, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e5da08a1-80db-482d-962a-45ad2193e713_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares available for award (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_bae1dc3f-283c-4bc2-b56a-aa8888bf9ce7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_LesseeOperatingLeasesOtherInformationTableTextBlock_b3875fd9-2fe7-4859-8050-26cb1d615e6d_terseLabel_en-US" xlink:label="lab_hae_LesseeOperatingLeasesOtherInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases, Other Information [Table Text Block]</link:label>
    <link:label id="lab_hae_LesseeOperatingLeasesOtherInformationTableTextBlock_label_en-US" xlink:label="lab_hae_LesseeOperatingLeasesOtherInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases, Other Information [Table Text Block]</link:label>
    <link:label id="lab_hae_LesseeOperatingLeasesOtherInformationTableTextBlock_documentation_en-US" xlink:label="lab_hae_LesseeOperatingLeasesOtherInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases, Other Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_LesseeOperatingLeasesOtherInformationTableTextBlock" xlink:href="hae-20230401.xsd#hae_LesseeOperatingLeasesOtherInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_LesseeOperatingLeasesOtherInformationTableTextBlock" xlink:to="lab_hae_LesseeOperatingLeasesOtherInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_33114e7c-a953-4d43-95ec-01d86308612a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in short-term loans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_e4684c3f-46e3-4f4f-a32b-dc924ded7ef6_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_e96b75c9-65fc-4870-811a-79026f79d7e6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_3d018112-1a7d-43be-821b-0f83de779256_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit (gain) loss</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_32c21e15-6ed8-4eee-b103-bd9505f7f2a7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_7757f1d1-dbc6-4e20-b77f-76480b8cc174_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DeferredTaxAssetsDepreciation_1a6b6174-8f99-4e21-94a8-657a84364566_terseLabel_en-US" xlink:label="lab_hae_DeferredTaxAssetsDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_hae_DeferredTaxAssetsDepreciation_label_en-US" xlink:label="lab_hae_DeferredTaxAssetsDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Depreciation</link:label>
    <link:label id="lab_hae_DeferredTaxAssetsDepreciation_documentation_en-US" xlink:label="lab_hae_DeferredTaxAssetsDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxAssetsDepreciation" xlink:href="hae-20230401.xsd#hae_DeferredTaxAssetsDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DeferredTaxAssetsDepreciation" xlink:to="lab_hae_DeferredTaxAssetsDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_214a7cc7-6c9e-46e0-89c3-477c0352397f_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_9064b669-7737-4b64-af83-295da212d7d1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash operating activities</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_4b40b1ce-fc1d-40db-b143-acb0d5478ef2_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ContingentConsiderationMember_a565a5fe-d50d-42c4-b482-4a5059c7ab21_terseLabel_en-US" xlink:label="lab_hae_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_hae_ContingentConsiderationMember_label_en-US" xlink:label="lab_hae_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_hae_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_hae_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationMember" xlink:href="hae-20230401.xsd#hae_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ContingentConsiderationMember" xlink:to="lab_hae_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_54d7b190-0eb8-438f-aedb-cc31e756184e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_d2804dce-b79e-44ad-9a61-0b8520ce6cd7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_6c47317a-ec83-4bc6-be2f-461eac964b0e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility_8fe09bba-8bd5-4a7f-8ee4-c496c5360c9e_terseLabel_en-US" xlink:label="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer group stock price volatility</link:label>
    <link:label id="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility_label_en-US" xlink:label="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Peer Group Stock Price Volatility</link:label>
    <link:label id="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility_documentation_en-US" xlink:label="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Peer Group Stock Price Volatility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility" xlink:href="hae-20230401.xsd#hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility" xlink:to="lab_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_a4dd902b-8273-4373-bc5b-6c23f056c026_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1cfeb86f-af18-4545-af15-70cef30d8636_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_fe32e57c-69ac-448d-9f20-e03d59d2c3be_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a0be83f9-d84a-4aa9-84d4-779720e06b8a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price (in dollars per share), Exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_acfc445f-2469-41d3-838c-63fd6320a6cb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_a904f021-eadd-4ffb-bb43-5d022331d3b8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EffectofExchangeRatesonOperatingIncome_46263fc9-dd4b-445c-b94a-ed710b4195e5_terseLabel_en-US" xlink:label="lab_hae_EffectofExchangeRatesonOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rates</link:label>
    <link:label id="lab_hae_EffectofExchangeRatesonOperatingIncome_label_en-US" xlink:label="lab_hae_EffectofExchangeRatesonOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rates on Operating Income</link:label>
    <link:label id="lab_hae_EffectofExchangeRatesonOperatingIncome_documentation_en-US" xlink:label="lab_hae_EffectofExchangeRatesonOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rates on Operating Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectofExchangeRatesonOperatingIncome" xlink:href="hae-20230401.xsd#hae_EffectofExchangeRatesonOperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EffectofExchangeRatesonOperatingIncome" xlink:to="lab_hae_EffectofExchangeRatesonOperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_7ae33227-521b-4df7-a13e-59765eabe666_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_652e8703-37f4-4462-af9e-e2fde06a6407_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_e7c5daaa-5d43-49e9-aab9-8532f96bb04c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_b96eefd4-d07a-49ba-a201-ed110fd414e4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_534d82cc-92c7-4905-899c-913ba5b6db9c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_InProcessSoftwareDevelopmentMember_76cd1854-16d3-42dc-b8d3-affdbd023d39_terseLabel_en-US" xlink:label="lab_hae_InProcessSoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process software development</link:label>
    <link:label id="lab_hae_InProcessSoftwareDevelopmentMember_label_en-US" xlink:label="lab_hae_InProcessSoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Software Development [Member]</link:label>
    <link:label id="lab_hae_InProcessSoftwareDevelopmentMember_documentation_en-US" xlink:label="lab_hae_InProcessSoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InProcessSoftwareDevelopmentMember" xlink:href="hae-20230401.xsd#hae_InProcessSoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_InProcessSoftwareDevelopmentMember" xlink:to="lab_hae_InProcessSoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_43c870f1-2c50-433e-80b0-d1e3caa96996_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_a22eded0-dcf0-46f7-a494-71fcad80b96f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_162fd6bd-81c4-4680-a7e3-36e63ebcd84b_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_ded34419-b5b5-4bad-bc87-fe919667ca33_terseLabel_en-US" xlink:label="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_71b337e5-3d63-4ccf-a981-948850eadfb4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in other assets and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_a7223dbe-ee80-4e19-892e-afc6a078663d_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_UnrecognizedPriorServiceCost_6b3cdb78-42c2-45da-b7e3-15e88dfd1511_negatedTerseLabel_en-US" xlink:label="lab_hae_UnrecognizedPriorServiceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized prior service cost</link:label>
    <link:label id="lab_hae_UnrecognizedPriorServiceCost_label_en-US" xlink:label="lab_hae_UnrecognizedPriorServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Prior Service Cost</link:label>
    <link:label id="lab_hae_UnrecognizedPriorServiceCost_documentation_en-US" xlink:label="lab_hae_UnrecognizedPriorServiceCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Prior Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_UnrecognizedPriorServiceCost" xlink:href="hae-20230401.xsd#hae_UnrecognizedPriorServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_UnrecognizedPriorServiceCost" xlink:to="lab_hae_UnrecognizedPriorServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d2f9a313-f454-4750-9abf-455694f94487_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4fe078d5-d4a9-4d99-8ee9-0d7acb82b6d6_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rates on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_IncomeTaxesLineItems_62ed035c-02ce-4502-801a-a2379433b0fd_terseLabel_en-US" xlink:label="lab_hae_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_hae_IncomeTaxesLineItems_label_en-US" xlink:label="lab_hae_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_hae_IncomeTaxesLineItems_documentation_en-US" xlink:label="lab_hae_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_IncomeTaxesLineItems" xlink:href="hae-20230401.xsd#hae_IncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_IncomeTaxesLineItems" xlink:to="lab_hae_IncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_55711d69-e0a4-422b-8a76-b032f6b606a5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_ea644262-3f49-4b34-9f40-a5d7ed438f4c_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_InterestRateSwap276FixedInterestRateMember_e97dd512-0b09-46c0-a5f9-839f70afd6e1_terseLabel_en-US" xlink:label="lab_hae_InterestRateSwap276FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2.76% Fixed Interest Rate</link:label>
    <link:label id="lab_hae_InterestRateSwap276FixedInterestRateMember_label_en-US" xlink:label="lab_hae_InterestRateSwap276FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2.76% Fixed Interest Rate [Member]</link:label>
    <link:label id="lab_hae_InterestRateSwap276FixedInterestRateMember_documentation_en-US" xlink:label="lab_hae_InterestRateSwap276FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2.76% Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap276FixedInterestRateMember" xlink:href="hae-20230401.xsd#hae_InterestRateSwap276FixedInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_InterestRateSwap276FixedInterestRateMember" xlink:to="lab_hae_InterestRateSwap276FixedInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b7fc6328-32fc-4316-bbb4-addf41620d1b_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_PlasmaMember_3892fa05-327e-4d80-a360-544907a1fe72_terseLabel_en-US" xlink:label="lab_hae_PlasmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plasma products and services</link:label>
    <link:label id="lab_hae_PlasmaMember_label_en-US" xlink:label="lab_hae_PlasmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plasma [Member]</link:label>
    <link:label id="lab_hae_PlasmaMember_documentation_en-US" xlink:label="lab_hae_PlasmaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plasma [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaMember" xlink:href="hae-20230401.xsd#hae_PlasmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_PlasmaMember" xlink:to="lab_hae_PlasmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares_6b41f1bc-0a98-47b9-98cf-5de0115f9e15_terseLabel_en-US" xlink:label="lab_hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Call Transaction, Anti-Dilution Adjustment, Shares</link:label>
    <link:label id="lab_hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares_label_en-US" xlink:label="lab_hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Call Transaction, Anti-Dilution Adjustment, Shares</link:label>
    <link:label id="lab_hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares_documentation_en-US" xlink:label="lab_hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Call Transaction, Anti-Dilution Adjustment, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares" xlink:href="hae-20230401.xsd#hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares" xlink:to="lab_hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_75ccd8d1-c529-4002-857c-8d5302174e5c_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain Excluded from Effectiveness Testing</link:label>
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_label_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:to="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_bb4267e7-74b5-41ce-8a28-7a39aa2334b3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount_6d2fca40-dd14-4011-a2d4-dad7f6490b81_terseLabel_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount_label_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Contingent Consideration Liability, Amount</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount_documentation_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Contingent Consideration Liability, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount" xlink:to="lab_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_3dc8c3ac-82ed-41fe-a048-a98dd26a1b8a_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_3a615c05-d713-43ee-8828-01203a2dcf22_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset_67f57e82-6454-4997-8dbc-b8d430ae4c08_negatedTerseLabel_en-US" xlink:label="lab_hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset_label_en-US" xlink:label="lab_hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease, Right of Use Asset</link:label>
    <link:label id="lab_hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset_documentation_en-US" xlink:label="lab_hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease, Right of Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset" xlink:href="hae-20230401.xsd#hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset" xlink:to="lab_hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToDevelopSoftware_bda45303-4481-4ff2-866f-8e6abbc46e24_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software development costs capitalized</link:label>
    <link:label id="lab_us-gaap_PaymentsToDevelopSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Develop Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToDevelopSoftware" xlink:to="lab_us-gaap_PaymentsToDevelopSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d7816fcc-91a8-43cb-94e4-090feefc79b4_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_db2eb3ee-d528-4a9f-83d1-378da3b56a9d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_6c8f7d3c-2270-4e37-95d3-c4cb155cdef4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_34f1cd22-f434-499d-9de8-6127fc63ad42_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NOTES&#160;PAYABLE AND LONG-TERM DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_07a47e12-5da0-44c0-9466-4a46922c93a2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Provision Components</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_22bb436a-ba94-4972-bc7d-476e7dfb4152_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f7e8ece5-a1c9-4774-89c9-c521d8c5e32e_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAPITAL STOCK</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_ebd41455-3ff5-4aa7-8b91-a8fc222a7685_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_4c39b3b0-e35a-43b6-a255-ebdac963a001_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_200903d5-87c9-4d26-809a-a4622bcded61_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency losses</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_SavingsPlusPlanMember_adc8a202-2912-4fa2-86ac-3142782f0ed7_terseLabel_en-US" xlink:label="lab_hae_SavingsPlusPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Savings Plus Plan</link:label>
    <link:label id="lab_hae_SavingsPlusPlanMember_label_en-US" xlink:label="lab_hae_SavingsPlusPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Savings Plus Plan [Member]</link:label>
    <link:label id="lab_hae_SavingsPlusPlanMember_documentation_en-US" xlink:label="lab_hae_SavingsPlusPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Savings Plus Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SavingsPlusPlanMember" xlink:href="hae-20230401.xsd#hae_SavingsPlusPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_SavingsPlusPlanMember" xlink:to="lab_hae_SavingsPlusPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_91b4651c-2f0e-40b7-985d-879ac29f2020_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Units (PSUs)</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DeferredTaxAssetsResearchExpensesCapitalized_45aed373-2771-421b-80c4-71d31c2926f3_terseLabel_en-US" xlink:label="lab_hae_DeferredTaxAssetsResearchExpensesCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Research Expenses Capitalized</link:label>
    <link:label id="lab_hae_DeferredTaxAssetsResearchExpensesCapitalized_label_en-US" xlink:label="lab_hae_DeferredTaxAssetsResearchExpensesCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Research Expenses Capitalized</link:label>
    <link:label id="lab_hae_DeferredTaxAssetsResearchExpensesCapitalized_documentation_en-US" xlink:label="lab_hae_DeferredTaxAssetsResearchExpensesCapitalized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Research Expenses Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxAssetsResearchExpensesCapitalized" xlink:href="hae-20230401.xsd#hae_DeferredTaxAssetsResearchExpensesCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DeferredTaxAssetsResearchExpensesCapitalized" xlink:to="lab_hae_DeferredTaxAssetsResearchExpensesCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_BloodCenterMember_0c909131-dcb5-4f82-ae97-e456a6e94df7_terseLabel_en-US" xlink:label="lab_hae_BloodCenterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Center products and services</link:label>
    <link:label id="lab_hae_BloodCenterMember_label_en-US" xlink:label="lab_hae_BloodCenterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Center [Member]</link:label>
    <link:label id="lab_hae_BloodCenterMember_documentation_en-US" xlink:label="lab_hae_BloodCenterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Center [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterMember" xlink:href="hae-20230401.xsd#hae_BloodCenterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_BloodCenterMember" xlink:to="lab_hae_BloodCenterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e87baac0-a7ea-4bbd-a22f-11f3a30aa769_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3070aa97-bfef-43e0-ac83-72953025fd00_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss), Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_580abf4d-8beb-470f-8768-96333f01d843_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss), Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c733ccda-e50f-42a5-baa1-acab888923c8_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_InventoryLossesProvisionBenefit_26c9fb9a-c2d7-4040-9620-50dbdf0220ac_terseLabel_en-US" xlink:label="lab_hae_InventoryLossesProvisionBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for losses on inventory</link:label>
    <link:label id="lab_hae_InventoryLossesProvisionBenefit_label_en-US" xlink:label="lab_hae_InventoryLossesProvisionBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Losses, Provision (Benefit)</link:label>
    <link:label id="lab_hae_InventoryLossesProvisionBenefit_documentation_en-US" xlink:label="lab_hae_InventoryLossesProvisionBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Losses, Provision (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InventoryLossesProvisionBenefit" xlink:href="hae-20230401.xsd#hae_InventoryLossesProvisionBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_InventoryLossesProvisionBenefit" xlink:to="lab_hae_InventoryLossesProvisionBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_715eea2b-d449-4ca5-8ea6-0dbbeacb50de_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_08c57ac6-aaae-4f39-8ebd-ef8757debdf3_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_68f68af8-2859-4c88-a8e6-8f2f1c5a3a14_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency changes</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_da5ee9ec-c7bd-4572-894a-604e2ddf8ee3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Rate Derivatives</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Rate Derivatives [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_b03c6645-f1ac-48d0-a7bf-75111977957f_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RETIREMENT PLANS</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_1056eefc-2d75-4674-944f-4c5fe506da2b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_bd79a0e0-0bc6-4168-b5cf-4f57ba23a4ce_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_73046b06-e768-42de-810f-c123d1e68fc7_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_35d15c31-c5e3-4757-a5ed-555311652b13_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_033d6d0d-b750-4094-a687-3464cce63e1f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_159ab473-6006-448b-a9df-b59235cbc58a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_825fa0b1-f39e-4944-94ec-5968c931f611_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_74ca2c1b-d4af-448c-8b56-80aad2d4b12e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP) Name [Axis]</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP) Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:to="lab_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_AssetsandLiabilitiesLesseeTableTextBlock_4559f497-ead8-4d91-8244-7997acd4559e_terseLabel_en-US" xlink:label="lab_hae_AssetsandLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Lessee [Table Text Block]</link:label>
    <link:label id="lab_hae_AssetsandLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_hae_AssetsandLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Lessee [Table Text Block]</link:label>
    <link:label id="lab_hae_AssetsandLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_hae_AssetsandLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetsandLiabilitiesLesseeTableTextBlock" xlink:href="hae-20230401.xsd#hae_AssetsandLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_AssetsandLiabilitiesLesseeTableTextBlock" xlink:to="lab_hae_AssetsandLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2139fb49-890b-4a66-a39e-ca5a786a1f79_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_458250e3-e9b0-45d3-ac08-c35e020cbce3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_da9483ac-6d4b-47f5-883c-e6a3c3816392_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_0f2985e6-f16a-456a-a4c9-28ecdf56ea72_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_88e99ca8-ef53-4c6a-a4d2-ab1909e42b72_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foregin source income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0b9692a1-9da6-48ef-ab16-33457dc0f767_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_da8dd323-12ec-4092-8305-ada374b33e27_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building improvements</link:label>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_a661b535-b762-4bee-9e06-f79c87f476b9_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_05915048-4aca-4af7-a162-83a54d349697_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_b93f52fc-4da8-4282-8855-defab82ca452_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_3fcaf5f3-ecf5-4cf3-8f1b-8021ace31dd6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_d6a9bfb1-48fd-4912-b57a-7e662670cca2_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_eea298b9-ee94-4eb6-8127-3c8343e928f8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_6780c17f-3b5e-46d1-ba74-2f112ee58737_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_f60d18fe-1740-4eb8-9f07-aded4b1a8f39_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_f94570cd-1d28-4822-aec6-5f519ade8493_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RESTRUCTURING</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3fb27328-3a15-4663-8a12-5ffc391b1933_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_b1ede571-fc5c-43b8-b96b-99d84f806517_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_86eebc4f-f86f-4581-9854-82872d96ebee_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_OtherCountryorRegionMember_fcc6773d-86fe-457d-a2a1-aa4c3dad74e5_verboseLabel_en-US" xlink:label="lab_hae_OtherCountryorRegionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_hae_OtherCountryorRegionMember_label_en-US" xlink:label="lab_hae_OtherCountryorRegionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Country or Region [Member]</link:label>
    <link:label id="lab_hae_OtherCountryorRegionMember_documentation_en-US" xlink:label="lab_hae_OtherCountryorRegionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Country or Region [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherCountryorRegionMember" xlink:href="hae-20230401.xsd#hae_OtherCountryorRegionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_OtherCountryorRegionMember" xlink:to="lab_hae_OtherCountryorRegionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_9c37e028-6e38-487f-b659-2ebd21b426ca_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_384a571b-b898-4b6e-8bab-97fe53de7fee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Summary of Restricted Stock Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_3ae30fe2-3d10-47de-ae2e-8cd768c5b1da_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_0dd9198b-262c-4fcb-996f-7fefcc674ebc_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of assets</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8acc44c7-f37e-4994-93f6-f86630796446_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_72ff7682-44bb-4d93-afec-ccb25e30d444_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_26b9d5b8-2123-4994-90d9-a94691204bd9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred statutory rate changes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_0fe5e7a3-46df-47cc-9c02-f0a2a0b829db_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_e3d7d45d-01be-4917-8a94-a8297b485f35_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency changes</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1940a950-4677-4636-a264-858e62ba0157_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_9984f8de-662c-4041-a5b5-751cbb70a486_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_d27f8281-e94f-4520-80f7-f12f4c692bbc_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_0b631b0d-c5f4-4aad-a4e7-a5ee1cee6578_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_a2eb9c64-5e17-48b9-beff-220c1412aa95_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_0fa80773-b36c-47ca-b146-6623833eb46d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_1339a120-7764-4e39-a953-21b832f1fcfe_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_MaximumTermOfMaturitiesForCashAndCashEquivalents_250c13e3-cc46-453c-b721-1d4bcb00e6b1_terseLabel_en-US" xlink:label="lab_hae_MaximumTermOfMaturitiesForCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents maximum maturity period</link:label>
    <link:label id="lab_hae_MaximumTermOfMaturitiesForCashAndCashEquivalents_label_en-US" xlink:label="lab_hae_MaximumTermOfMaturitiesForCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Term of Maturities for Cash and Cash Equivalents</link:label>
    <link:label id="lab_hae_MaximumTermOfMaturitiesForCashAndCashEquivalents_documentation_en-US" xlink:label="lab_hae_MaximumTermOfMaturitiesForCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Term of Maturities for Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_MaximumTermOfMaturitiesForCashAndCashEquivalents" xlink:href="hae-20230401.xsd#hae_MaximumTermOfMaturitiesForCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_MaximumTermOfMaturitiesForCashAndCashEquivalents" xlink:to="lab_hae_MaximumTermOfMaturitiesForCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_95df583a-0553-4fa3-8c08-1279d4b76fce_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_20d4f7fc-fa2b-4fa1-b920-3e2de4fbfbe2_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price (in dollars per share), Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_c6a0eb5b-1ea6-4a8f-9a60-81d6dfec9782_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price (in dollars per share), Exercisable at End of Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7a626e32-a7f9-4428-ad87-7f7d76ff11d7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_6e1dfec5-593d-4b28-a2f2-abe67ea7629b_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_NumberOfInterestRateSwapsEntered_e5e44ca3-5c11-4df9-99ba-41cc6827059b_terseLabel_en-US" xlink:label="lab_hae_NumberOfInterestRateSwapsEntered" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Interest Rate Swaps Entered</link:label>
    <link:label id="lab_hae_NumberOfInterestRateSwapsEntered_label_en-US" xlink:label="lab_hae_NumberOfInterestRateSwapsEntered" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Interest Rate Swaps Entered</link:label>
    <link:label id="lab_hae_NumberOfInterestRateSwapsEntered_documentation_en-US" xlink:label="lab_hae_NumberOfInterestRateSwapsEntered" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Interest Rate Swaps Entered</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NumberOfInterestRateSwapsEntered" xlink:href="hae-20230401.xsd#hae_NumberOfInterestRateSwapsEntered"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_NumberOfInterestRateSwapsEntered" xlink:to="lab_hae_NumberOfInterestRateSwapsEntered" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_9bf5b323-041f-4aa6-be63-9709ca8ca0ac_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carry-forwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_783459a6-9181-4dd0-b883-4c611a7444dc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_c5ad6dd8-93e6-4b2b-80d5-2cbfa4c6803a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Increase (Decrease) in Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice_cb90c412-ddf9-4045-ad31-7943c30ba58e_terseLabel_en-US" xlink:label="lab_hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Call Transaction, Initial Cap Price</link:label>
    <link:label id="lab_hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice_label_en-US" xlink:label="lab_hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Call Transaction, Initial Cap Price</link:label>
    <link:label id="lab_hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice_documentation_en-US" xlink:label="lab_hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Capped Call Transaction, Initial Cap Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice" xlink:href="hae-20230401.xsd#hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice" xlink:to="lab_hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_654877f3-d255-42ea-b622-54853a20f6b0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite lived intangibles acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_cfabd48b-3259-4088-b485-dc4fcd4a6e88_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Rates Used to Determine Net Periodic Benefit Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_c903699c-1737-4cbc-af91-e4f8c17d83e1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assumptions Used, Other than Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_60000e9b-d26f-4b29-b1ec-26b10578dc95_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_InterestRateSwap415FixedInterestRateMember_76be9b6e-85b0-423e-9dc1-9f939bdb38ba_terseLabel_en-US" xlink:label="lab_hae_InterestRateSwap415FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.15% Fixed Interest Rate</link:label>
    <link:label id="lab_hae_InterestRateSwap415FixedInterestRateMember_label_en-US" xlink:label="lab_hae_InterestRateSwap415FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.15% Fixed Interest Rate [Member]</link:label>
    <link:label id="lab_hae_InterestRateSwap415FixedInterestRateMember_documentation_en-US" xlink:label="lab_hae_InterestRateSwap415FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.15% Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap415FixedInterestRateMember" xlink:href="hae-20230401.xsd#hae_InterestRateSwap415FixedInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_InterestRateSwap415FixedInterestRateMember" xlink:to="lab_hae_InterestRateSwap415FixedInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_b5cacac2-b8af-4d35-a3b4-1cdfcc93e6d2_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest costs capitalized</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_1b8b74c5-ab4f-44be-a6f2-8c1495100ba6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Future Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3d1480d4-7d2b-46df-88a6-3110caabccde_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_76c9bb86-cca0-4c40-a595-76c49e79d5da_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_b980b8c8-7537-46fd-9c77-ba5be339741a_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares_e47cdb2c-e179-48e4-81a8-4c8ee759cf8e_terseLabel_en-US" xlink:label="lab_hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options counted against maximum number of award shares for every share option issued (in shares)</link:label>
    <link:label id="lab_hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares_label_en-US" xlink:label="lab_hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options Counted Against Maximum Number of Award Shares</link:label>
    <link:label id="lab_hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares_documentation_en-US" xlink:label="lab_hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options Counted Against Maximum Number of Award Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares" xlink:href="hae-20230401.xsd#hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares" xlink:to="lab_hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_7cc8751b-a83b-4d83-8c52-d2b53442ad54_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_f34f62e7-637d-436e-8a5d-b8bfb4daeafe_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_c1f33819-f7c4-4b27-84aa-6931c0a7b208_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected long-term rate of return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3b961a1d-fd36-4225-a088-286d19d226e0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_3da3f9ed-4e81-4ad8-ab23-e58ff60d5f80_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_eb4c1883-fc49-4017-bdf8-eeda7afe57b5_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_41f4c0ee-bfea-4ad8-9ed1-631e050aee81_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_f7ec6e6c-591e-49c1-9abe-a30326831670_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e0d301b0-e7cd-4c62-b31d-ef92a2745c78_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_RevenueBasedPayments2Member_9ed2839a-0ea9-4d65-818c-72e532a4f997_terseLabel_en-US" xlink:label="lab_hae_RevenueBasedPayments2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue-based payments</link:label>
    <link:label id="lab_hae_RevenueBasedPayments2Member_label_en-US" xlink:label="lab_hae_RevenueBasedPayments2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Based Payments 2 [Member]</link:label>
    <link:label id="lab_hae_RevenueBasedPayments2Member_documentation_en-US" xlink:label="lab_hae_RevenueBasedPayments2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Based Payments 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RevenueBasedPayments2Member" xlink:href="hae-20230401.xsd#hae_RevenueBasedPayments2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_RevenueBasedPayments2Member" xlink:to="lab_hae_RevenueBasedPayments2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_fbcc8cb4-ed3c-4d14-aacd-75e01f84a110_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_7f335552-7d10-4765-b8aa-5e827f1f44a0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_fb946499-503d-466e-94ca-d1f065a1e43e_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_8a99d793-2355-4bba-9190-8723fcf9778b_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_23729f10-1470-4098-b9b8-74a20cc94919_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Product Line</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_7b3f4c73-ff1c-4460-938f-12159fdaf475_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d3ccd314-37bb-441c-b576-4b08de0b72e0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_6d1a6af2-c1df-4666-883b-6a6b1df4be65_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_411c33d8-dcf3-44aa-bb35-996d3c038e2a_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_973f5ede-2845-43a7-b3e2-29ffeaad7069_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of instruments held</link:label>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_76df8e2b-0eec-4a7e-a203-11424be7358d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_4e3686dc-123c-4c97-af83-5694b87370d5_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-amortizable intangibles</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_4b868015-4f41-41b6-a440-84325bfe47bd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3a0a545c-52a5-4f51-995d-426f70031c57_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_TenLargestCustomersMember_ba65e842-a7ef-46af-b9c2-ca50cf9dc836_terseLabel_en-US" xlink:label="lab_hae_TenLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ten Largest Customers</link:label>
    <link:label id="lab_hae_TenLargestCustomersMember_label_en-US" xlink:label="lab_hae_TenLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ten Largest Customers [Member]</link:label>
    <link:label id="lab_hae_TenLargestCustomersMember_documentation_en-US" xlink:label="lab_hae_TenLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ten Largest Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TenLargestCustomersMember" xlink:href="hae-20230401.xsd#hae_TenLargestCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_TenLargestCustomersMember" xlink:to="lab_hae_TenLargestCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_9ccac8b4-0f5c-4919-8a30-cd5751c24cc1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a3ff0bdd-8896-4729-8e28-00f2c9a2d9a6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_c3be78aa-d1c0-43e5-bb2a-44823b3aa9b4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Unrealized Gain (Loss) on Derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_db26ed22-4895-455d-8f4c-2007bf4a2d37_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_0e9aece5-f408-45df-9224-c168a9ed9375_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_272c398f-3271-4f55-874b-51d5e2b66bd3_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_RevisedCreditAgreementMember_b65d1bd2-d36a-46c1-9e25-7e5ab716f611_terseLabel_en-US" xlink:label="lab_hae_RevisedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revised Credit Agreement</link:label>
    <link:label id="lab_hae_RevisedCreditAgreementMember_label_en-US" xlink:label="lab_hae_RevisedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revised Credit Agreement [Member]</link:label>
    <link:label id="lab_hae_RevisedCreditAgreementMember_documentation_en-US" xlink:label="lab_hae_RevisedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revised Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RevisedCreditAgreementMember" xlink:href="hae-20230401.xsd#hae_RevisedCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_RevisedCreditAgreementMember" xlink:to="lab_hae_RevisedCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_e6ceeb3c-9570-423c-8975-7ea88c2a20f6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding, (in shares), Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EmployeesMember_992f8389-ca5b-4bbd-935f-926b2d311e5d_terseLabel_en-US" xlink:label="lab_hae_EmployeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees</link:label>
    <link:label id="lab_hae_EmployeesMember_label_en-US" xlink:label="lab_hae_EmployeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees [Member]</link:label>
    <link:label id="lab_hae_EmployeesMember_documentation_en-US" xlink:label="lab_hae_EmployeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EmployeesMember" xlink:href="hae-20230401.xsd#hae_EmployeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EmployeesMember" xlink:to="lab_hae_EmployeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e1f5b13c-80a2-44e3-9117-7948242ab0a0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e7a7d755-49d5-4ea9-b50b-18d66138225a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_f256746d-7943-463a-a4d6-f57de54a0dd6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_628373d1-4fc7-4faf-861e-b855633fc9c8_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_097d1aa7-4e38-4eb0-8398-94ca742caaca_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c035ef99-812b-482c-b45c-80730799a452_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_c8805827-b5ec-4865-af14-54f99e04f259_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_d6194a16-3e3f-4895-951b-32fdff3120a9_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_244fb2b3-209f-4bae-beb5-672fe22806b9_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_9e6a3ed8-926b-48f9-ba7e-de9d2918a773_terseLabel_en-US" xlink:label="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_24a0fe03-904d-4ac5-adc2-400f82a477c0_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions of tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_36bf3218-bf99-4f47-9a30-1049cf76e3ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_aa97d23d-be2b-48ff-896c-85bc8c63fffe_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_34a437e0-25e0-40fe-8e54-43a2b5b0f48c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_3977fbbe-03e3-464e-ba5c-4a4ebb67c607_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity Under Defined Benefit Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Funded Status [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetFundedStatusTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ConsolidatedTotalLeverageRatio_684de6d1-f2eb-46f5-baa6-be79b18a3448_terseLabel_en-US" xlink:label="lab_hae_ConsolidatedTotalLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated total leverage ratio</link:label>
    <link:label id="lab_hae_ConsolidatedTotalLeverageRatio_label_en-US" xlink:label="lab_hae_ConsolidatedTotalLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Total Leverage Ratio</link:label>
    <link:label id="lab_hae_ConsolidatedTotalLeverageRatio_documentation_en-US" xlink:label="lab_hae_ConsolidatedTotalLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Total Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ConsolidatedTotalLeverageRatio" xlink:href="hae-20230401.xsd#hae_ConsolidatedTotalLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ConsolidatedTotalLeverageRatio" xlink:to="lab_hae_ConsolidatedTotalLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_ba700316-584d-4a38-b89b-540d34a05f3e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_e389116f-7cf1-4b31-b540-603d8dbc2192_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals, reserves and other deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue_ff4453eb-753f-40e5-ab5f-039b8349c931_terseLabel_en-US" xlink:label="lab_hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of purchase price for shares of common stock at fair market value (as a percent)</link:label>
    <link:label id="lab_hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue_label_en-US" xlink:label="lab_hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Purchase Price for Shares of Common Stock at Fair Market Value</link:label>
    <link:label id="lab_hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue_documentation_en-US" xlink:label="lab_hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Purchase Price for Shares of Common Stock at Fair Market Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue" xlink:href="hae-20230401.xsd#hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue" xlink:to="lab_hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_InProcessPatentsMember_7a9dfa8b-b929-4843-9ac9-6a9e4e8431b2_terseLabel_en-US" xlink:label="lab_hae_InProcessPatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process patents</link:label>
    <link:label id="lab_hae_InProcessPatentsMember_label_en-US" xlink:label="lab_hae_InProcessPatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Patents [Member]</link:label>
    <link:label id="lab_hae_InProcessPatentsMember_documentation_en-US" xlink:label="lab_hae_InProcessPatentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InProcessPatentsMember" xlink:href="hae-20230401.xsd#hae_InProcessPatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_InProcessPatentsMember" xlink:to="lab_hae_InProcessPatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e36125b-748b-4ec5-8a7d-d4c549b41685_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_a09db9dd-afca-4eec-9a03-73a00f32421c_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_InterestRateSwap408FixedInterestRateMember_936f2108-9f7c-4d6f-84d2-bf5c52ade6c6_terseLabel_en-US" xlink:label="lab_hae_InterestRateSwap408FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.08% Fixed Interest Rate</link:label>
    <link:label id="lab_hae_InterestRateSwap408FixedInterestRateMember_label_en-US" xlink:label="lab_hae_InterestRateSwap408FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.08% Fixed Interest Rate [Member]</link:label>
    <link:label id="lab_hae_InterestRateSwap408FixedInterestRateMember_documentation_en-US" xlink:label="lab_hae_InterestRateSwap408FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.08% Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap408FixedInterestRateMember" xlink:href="hae-20230401.xsd#hae_InterestRateSwap408FixedInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_InterestRateSwap408FixedInterestRateMember" xlink:to="lab_hae_InterestRateSwap408FixedInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_bd0fb8cb-abff-4774-a5b6-21d8e51b12a3_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_d1eed9f1-93e1-43c1-864d-d7516df14fdd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_0a79f64c-0090-41fe-8067-02b4074b3117_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_68591e99-722e-481f-94f8-d067c08c3960_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_ae56f24e-1431-4ddf-9420-cd396fff2d7a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_RestructuringChargesPayableInNextTwelveMonths_08d115b1-294d-4411-8d54-729746c5ce5e_terseLabel_en-US" xlink:label="lab_hae_RestructuringChargesPayableInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Payable In Next Twelve Months</link:label>
    <link:label id="lab_hae_RestructuringChargesPayableInNextTwelveMonths_label_en-US" xlink:label="lab_hae_RestructuringChargesPayableInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Payable In Next Twelve Months</link:label>
    <link:label id="lab_hae_RestructuringChargesPayableInNextTwelveMonths_documentation_en-US" xlink:label="lab_hae_RestructuringChargesPayableInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Payable In Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringChargesPayableInNextTwelveMonths" xlink:href="hae-20230401.xsd#hae_RestructuringChargesPayableInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_RestructuringChargesPayableInNextTwelveMonths" xlink:to="lab_hae_RestructuringChargesPayableInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_c97f138f-4876-4d05-9cee-8bbcf8851ec1_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_5df18e1a-27bd-4fd3-b8cb-7c9620bcc6c2_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_dbef0b4b-1b7d-4036-a6fb-1a381d5c1059_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1c0c91f0-6a60-48f8-bd8b-ab254461e82c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_d3b8531c-0157-4978-b893-50fe0232a365_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_e800f787-45e7-459a-b00e-6988cf72e619_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock-Based Compensation Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_b33da561-23f6-4ad0-82c4-2f64f29e3340_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4cec5211-5ea7-4cf0-87dd-10cf058a97b4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_830c6f64-2b0d-4a28-8067-9f9dfa5cc689_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_afe6afe8-eb6e-4b52-9ee4-2978cf207f94_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_26ef2817-6573-4821-b3c9-bad2ccd32914_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation-related charges</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes_937835ab-6e6c-4ada-bb48-90141161cb8d_negatedTerseLabel_en-US" xlink:label="lab_hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of capped call related to convertible notes</link:label>
    <link:label id="lab_hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes_label_en-US" xlink:label="lab_hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Purchase of Capped Call Related To Convertible Notes</link:label>
    <link:label id="lab_hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes_documentation_en-US" xlink:label="lab_hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Purchase of Capped Call Related To Convertible Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes" xlink:href="hae-20230401.xsd#hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes" xlink:to="lab_hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_08242380-b157-4a7f-b9fd-994dd98f3de6_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-employee director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_1dd8983d-9850-4279-bdc0-970d2457a16f_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_be435fe7-e39c-4945-a4f1-dd78fa0184be_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_5e5bc449-78a5-4f05-8e44-08e107e80e73_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_095b138e-4066-4d43-8ac6-7720eabe9708_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_e8f79c39-190f-4daf-9971-a8a800f85ee6_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_8038582c-15e9-4ebe-8983-8618acc838e2_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_c792c1ed-11c5-41ea-8cf7-b56104c000d6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_7f7dbc30-21aa-4323-bfed-aea448406fd5_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed foreign earnings of subsidiaries</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ManufacturingSpaceSecondRenewalTermMember_89f66631-e19a-4d8c-9d78-fb721f6d28ea_terseLabel_en-US" xlink:label="lab_hae_ManufacturingSpaceSecondRenewalTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Space, Second Renewal Term</link:label>
    <link:label id="lab_hae_ManufacturingSpaceSecondRenewalTermMember_label_en-US" xlink:label="lab_hae_ManufacturingSpaceSecondRenewalTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Space, Second Renewal Term [Member]</link:label>
    <link:label id="lab_hae_ManufacturingSpaceSecondRenewalTermMember_documentation_en-US" xlink:label="lab_hae_ManufacturingSpaceSecondRenewalTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Space, Second Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ManufacturingSpaceSecondRenewalTermMember" xlink:href="hae-20230401.xsd#hae_ManufacturingSpaceSecondRenewalTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ManufacturingSpaceSecondRenewalTermMember" xlink:to="lab_hae_ManufacturingSpaceSecondRenewalTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_fac5ea71-a87a-4f3b-bdd1-4289321d428e_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable, Noncurrent</link:label>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:to="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_d505b8ec-b576-4f86-a81e-169575377bcc_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_71e88111-a76d-4cda-830f-7bccd7255edc_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_51e0d400-aa85-4fad-a860-9b53be68c316_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of satisifaction</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_4b024a4d-85ea-4f7e-bfbe-399bdc613622_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_fb84e290-6ffe-44cb-a348-9c1fd9aa7489_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_2921f253-f34d-4af3-a7ac-ed9b463a99fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notes Payable and Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d813463e-3762-456a-ac63-fe172478daa5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_7ffe0765-4a0b-432d-968f-f82ebbf8903a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_33fe46ab-772b-490a-8eb3-8ee3e8e4a3f9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic EPS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_6ead95a6-1e50-4118-b02e-bb45af6f3066_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_e6de6c73-8f90-4bd6-8d87-f2336da83c17_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible executive compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_319a3956-d9bb-44ec-8462-92ee1106ad0c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_779a3ed0-15c7-4ad0-811e-8ef479433575_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_bd0b6e61-c679-4675-8458-03842f64fdaf_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_30aeb7c0-d15a-4b65-8ebd-5bf7f0464af0_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted income per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_932eba47-fb4a-4cd3-bdfd-a9320166d515_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_474fc62a-90af-4416-96ee-42a4849eaac8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on revolving facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7344fdea-9f9d-4b96-b8aa-17f1c524b29c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net effect of common stock equivalents (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_47121981-c095-4913-a807-c7d888db9fc3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_fa14d923-43f8-441a-aa0b-e5c2476e0dd3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_3914e6c8-8eb0-4429-9b94-da24cc97972d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_e701d78b-d222-4ee1-8a41-afeac6ab0604_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible executive compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_798d9186-eb37-48fa-8767-fc834939439b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_ccb32222-48e9-4b48-b706-fb33e3e723d4_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, less accumulated amortization of $417,422 at April 1, 2023 and $376,552 at April 2, 2022</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_0bb0fef9-80dc-447b-92e4-fa515ea378c7_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_2b27ca2e-05e5-4402-a8c3-dbfe95c03fe9_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8a520caf-5f9e-4471-9efa-ede8250b6ce6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_dcb3c9fa-19b2-4e36-bdfb-4afada040756_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-amortizable:</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_4f217fd9-18db-4597-8d86-3dccd6846efc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Policy</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock" xlink:to="lab_us-gaap_DebtPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_c76b4250-a9da-439c-8018-5afcc71d2565_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_cc217174-077f-42a4-b0d1-9b6efd58d074_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_d5f85527-5fd8-43d9-b472-3c4bc1ee182a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_ccc121f9-d3d3-4010-a989-b53d1ce9a18f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_99459b2e-6902-43de-910a-65ebb209dcc9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_e3061f47-27e9-48bc-8063-f5d9a9584916_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_35882d64-328f-42c3-8590-24997fc82276_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EnergyAxis_bea67015-d5f5-4ce7-b818-ce114c066a12_terseLabel_en-US" xlink:label="lab_srt_EnergyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy [Axis]</link:label>
    <link:label id="lab_srt_EnergyAxis_label_en-US" xlink:label="lab_srt_EnergyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EnergyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EnergyAxis" xlink:to="lab_srt_EnergyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_AssetImpairmentsMember_81db01b2-0ceb-4aba-8429-f858e02074ed_terseLabel_en-US" xlink:label="lab_hae_AssetImpairmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairments</link:label>
    <link:label id="lab_hae_AssetImpairmentsMember_label_en-US" xlink:label="lab_hae_AssetImpairmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairments [Member]</link:label>
    <link:label id="lab_hae_AssetImpairmentsMember_documentation_en-US" xlink:label="lab_hae_AssetImpairmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetImpairmentsMember" xlink:href="hae-20230401.xsd#hae_AssetImpairmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_AssetImpairmentsMember" xlink:to="lab_hae_AssetImpairmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_b52ad84d-7d7c-4acb-b7e1-543df73e9aa3_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Final Price Paid Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_OtherTechnologyMember_f31494f1-c05b-4a65-b821-f1dc2828de84_terseLabel_en-US" xlink:label="lab_hae_OtherTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other developed technology</link:label>
    <link:label id="lab_hae_OtherTechnologyMember_label_en-US" xlink:label="lab_hae_OtherTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Technology [Member]</link:label>
    <link:label id="lab_hae_OtherTechnologyMember_documentation_en-US" xlink:label="lab_hae_OtherTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherTechnologyMember" xlink:href="hae-20230401.xsd#hae_OtherTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_OtherTechnologyMember" xlink:to="lab_hae_OtherTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_54efcdf4-6204-460c-b742-eb574ab8b12f_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred statutory rate changes</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_ea33ee43-0d9f-4e57-a30d-4b71a8fecb85_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dce24b8c-0989-4bcc-ad11-9fc3b718843b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income/(Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_57b55c2b-a8e3-45ea-be50-3a99c8c784de_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_c3e64eb8-942b-4587-9d4a-9539abeba7f3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_594f5798-77b1-4d2b-ba6b-28e2cb753aa1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_a41b157b-c882-4830-b46b-fcad65ae04fb_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_PercentageOfNetSalesGeneratedOutsideOfUs_e0815cef-695c-4b12-9193-956e9a87e0d2_terseLabel_en-US" xlink:label="lab_hae_PercentageOfNetSalesGeneratedOutsideOfUs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of sales generated outside the US</link:label>
    <link:label id="lab_hae_PercentageOfNetSalesGeneratedOutsideOfUs_label_en-US" xlink:label="lab_hae_PercentageOfNetSalesGeneratedOutsideOfUs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Net Sales Generated Outside Of The US</link:label>
    <link:label id="lab_hae_PercentageOfNetSalesGeneratedOutsideOfUs_documentation_en-US" xlink:label="lab_hae_PercentageOfNetSalesGeneratedOutsideOfUs" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Net Sales Generated Outside Of The US</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PercentageOfNetSalesGeneratedOutsideOfUs" xlink:href="hae-20230401.xsd#hae_PercentageOfNetSalesGeneratedOutsideOfUs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_PercentageOfNetSalesGeneratedOutsideOfUs" xlink:to="lab_hae_PercentageOfNetSalesGeneratedOutsideOfUs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_29c1449d-8dab-4abd-af2f-c032e6c22eac_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_445527a7-277b-4f78-b5d0-ba3e9075ac01_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock, net of cancellations (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_66d370e9-7851-4f8f-9e3f-6e5db480c4bd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestitures</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_RestructuringandRestructuringRelatedCosts_abede10f-1d48-4b4f-ac2f-10178b976455_terseLabel_en-US" xlink:label="lab_hae_RestructuringandRestructuringRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring and restructuring related costs</link:label>
    <link:label id="lab_hae_RestructuringandRestructuringRelatedCosts_0a34173d-2f1e-443e-9906-b9d20d8f71ad_negatedTerseLabel_en-US" xlink:label="lab_hae_RestructuringandRestructuringRelatedCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Restructuring Related Costs</link:label>
    <link:label id="lab_hae_RestructuringandRestructuringRelatedCosts_label_en-US" xlink:label="lab_hae_RestructuringandRestructuringRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Restructuring Related Costs</link:label>
    <link:label id="lab_hae_RestructuringandRestructuringRelatedCosts_documentation_en-US" xlink:label="lab_hae_RestructuringandRestructuringRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Restructuring Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandRestructuringRelatedCosts" xlink:href="hae-20230401.xsd#hae_RestructuringandRestructuringRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_RestructuringandRestructuringRelatedCosts" xlink:to="lab_hae_RestructuringandRestructuringRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_aea9d418-1725-4122-885f-cd47fabf275e_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_7a26e9bc-bfff-4201-bdbe-d2b9aa69107d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_84ddf242-8ac9-415d-9243-e0eb389281ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ManufacturingSpaceMember_015b8a64-ea3a-4ca4-adac-ab7202f39f91_terseLabel_en-US" xlink:label="lab_hae_ManufacturingSpaceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Space</link:label>
    <link:label id="lab_hae_ManufacturingSpaceMember_label_en-US" xlink:label="lab_hae_ManufacturingSpaceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Space [Member]</link:label>
    <link:label id="lab_hae_ManufacturingSpaceMember_documentation_en-US" xlink:label="lab_hae_ManufacturingSpaceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Space</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ManufacturingSpaceMember" xlink:href="hae-20230401.xsd#hae_ManufacturingSpaceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ManufacturingSpaceMember" xlink:to="lab_hae_ManufacturingSpaceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_09844e2c-dfad-403a-b00b-c5d843f597a7_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_SoftwareCapitalizationTerm_240c2561-b91d-47be-bf4d-7bafe7de89c4_terseLabel_en-US" xlink:label="lab_hae_SoftwareCapitalizationTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software capitalization term</link:label>
    <link:label id="lab_hae_SoftwareCapitalizationTerm_label_en-US" xlink:label="lab_hae_SoftwareCapitalizationTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Capitalization Term</link:label>
    <link:label id="lab_hae_SoftwareCapitalizationTerm_documentation_en-US" xlink:label="lab_hae_SoftwareCapitalizationTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Capitalization Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SoftwareCapitalizationTerm" xlink:href="hae-20230401.xsd#hae_SoftwareCapitalizationTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_SoftwareCapitalizationTerm" xlink:to="lab_hae_SoftwareCapitalizationTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_834d77ec-dd30-4b5d-ab06-85e4a8a8ac85_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible expenses</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_c9b3c689-6b51-4b8d-abf5-31e3dc6912a9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_9cb29be8-e257-4687-bdfe-62796f3ccfff_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_b3f780dc-d804-4820-965d-a212c4dcae73_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Obligation, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_a5236e60-8e56-4615-b155-319bb94430f3_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_HaemoneticsEquipmentMember_6c475e54-2edd-4b3a-9c30-78043d015705_terseLabel_en-US" xlink:label="lab_hae_HaemoneticsEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Haemonetics equipment</link:label>
    <link:label id="lab_hae_HaemoneticsEquipmentMember_e4374bfb-2d08-484e-a638-99381cbcac7e_verboseLabel_en-US" xlink:label="lab_hae_HaemoneticsEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Haemonetics equipment</link:label>
    <link:label id="lab_hae_HaemoneticsEquipmentMember_label_en-US" xlink:label="lab_hae_HaemoneticsEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Haemonetics Equipment [Member]</link:label>
    <link:label id="lab_hae_HaemoneticsEquipmentMember_documentation_en-US" xlink:label="lab_hae_HaemoneticsEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Haemonetics Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HaemoneticsEquipmentMember" xlink:href="hae-20230401.xsd#hae_HaemoneticsEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_HaemoneticsEquipmentMember" xlink:to="lab_hae_HaemoneticsEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_f21190aa-937c-4fbc-9ba6-381b6956118a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_0734c65f-df3a-495c-ae8a-10b5d318b293_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear_88a3ef50-9585-4b9a-8cfd-fdbbda69c9e6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount expected to be amortized from accumulated other comprehensive loss in next fiscal year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_e9e2359c-66ae-4fab-86d3-40bc09500047_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_bd0a62f5-a3af-4fa4-a7fb-6b4c8c61b8d6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_80d7fe47-cdbf-4649-9971-799cce684e91_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding, (in shares), Vested and Expected to Vest at End of Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_3628b739-18bb-4f6a-b516-04640ff713f4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_f4b14960-1381-4e26-bbea-a1bd6611c5b1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_eb9e0f36-1996-4078-854f-9d195bea70f0_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_51a9dce8-e7b9-42d1-b104-873236f3032b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_b3143586-9726-4d4d-89e2-c1cbf38e77de_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_b1ef4d12-18ec-4f66-8bc3-0edb1b7a1313_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_15399e67-63ee-4923-8168-1ddcf910206a_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense recognized</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_ed6407b0-3a22-4ad4-a2c8-0b63a2d2f65e_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling Costs</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_2d68d877-c80b-4fd7-8c2d-2c6e4f81ca02_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_85d30c12-10a6-42b7-a58c-a2e82eb6de63_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_996adce9-b15e-4ea7-9db9-3e7b1386bbc5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Domestic and Foreign Income Before Provision for Income Tax</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_07375238-9e69-4bae-b986-5d0e60bb4dbd_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DerivativePercentofDebtExposed_ccc3596e-bb04-4893-addb-9ebf31114f17_terseLabel_en-US" xlink:label="lab_hae_DerivativePercentofDebtExposed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt exposed to interest rate risk</link:label>
    <link:label id="lab_hae_DerivativePercentofDebtExposed_label_en-US" xlink:label="lab_hae_DerivativePercentofDebtExposed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Percent of Debt Exposed</link:label>
    <link:label id="lab_hae_DerivativePercentofDebtExposed_documentation_en-US" xlink:label="lab_hae_DerivativePercentofDebtExposed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Percent of Debt Exposed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DerivativePercentofDebtExposed" xlink:href="hae-20230401.xsd#hae_DerivativePercentofDebtExposed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DerivativePercentofDebtExposed" xlink:to="lab_hae_DerivativePercentofDebtExposed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_274f51b7-a31d-4466-984e-557c3e21fab5_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents at Beginning of Year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fe7e31cf-d244-414e-9c61-0288b0df2cb2_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents at End of Year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_0d69de20-a38c-44ea-ac9e-402fbe3b2d07_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_2822e0d4-4133-4f39-be4c-a2c3f6ff7f82_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_eaf8ee8e-4584-487f-8c37-8b48a3cf092d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_004c6a08-d964-4b23-820e-18e0e9e377b5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_2c31f488-2c15-4de5-9a75-6e573808d2d1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_InterestRateSwap446FixedInterestRateMember_5ce42b27-828f-4ed6-a188-b54e1424a1d6_terseLabel_en-US" xlink:label="lab_hae_InterestRateSwap446FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.46% Fixed Interest Rate</link:label>
    <link:label id="lab_hae_InterestRateSwap446FixedInterestRateMember_label_en-US" xlink:label="lab_hae_InterestRateSwap446FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.46% Fixed Interest Rate [Member]</link:label>
    <link:label id="lab_hae_InterestRateSwap446FixedInterestRateMember_documentation_en-US" xlink:label="lab_hae_InterestRateSwap446FixedInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.46% Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap446FixedInterestRateMember" xlink:href="hae-20230401.xsd#hae_InterestRateSwap446FixedInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_InterestRateSwap446FixedInterestRateMember" xlink:to="lab_hae_InterestRateSwap446FixedInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_eb7169b1-def9-4239-a12e-98fd8add2b01_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable:</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2c8416f6-23c6-4911-8168-f05a05c3bf5f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amoritized Intangibles</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_64760164-63c8-4c17-8658-fb152fe1e8b5_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized costs amortized (placed into service)</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_ed960621-ff6d-4844-8b30-19e77552d5b3_terseLabel_en-US" xlink:label="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_623cf4ac-0680-4f62-ad42-996acf0df067_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b4901860-ffd5-47e4-8116-407d04116f17_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding, (in shares), Exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cbd5c1f1-73dc-4017-8e3c-0e4f51dcddf9_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0a5419f8-a7bd-45f4-932c-6506464072fc_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_5628fc70-9fbf-48ca-a802-201e2d7d5123_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity_3918f596-a6bd-4d18-b073-4f56ac797c1a_terseLabel_en-US" xlink:label="lab_hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Percent Of Principal Amount Due After Year One Per Year Until Maturity</link:label>
    <link:label id="lab_hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity_label_en-US" xlink:label="lab_hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Percent Of Principal Amount Due After Year One Per Year Until Maturity</link:label>
    <link:label id="lab_hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity_documentation_en-US" xlink:label="lab_hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Percent Of Principal Amount Due After Year One Per Year Until Maturity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity" xlink:href="hae-20230401.xsd#hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity" xlink:to="lab_hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne_d3f0f0cf-783c-436f-afc0-c0e0b18b7332_terseLabel_en-US" xlink:label="lab_hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Percent of Principal Amount Due In Year One</link:label>
    <link:label id="lab_hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne_label_en-US" xlink:label="lab_hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Percent of Principal Amount Due In Year One</link:label>
    <link:label id="lab_hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne_documentation_en-US" xlink:label="lab_hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Percent of Principal Amount Due In Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne" xlink:href="hae-20230401.xsd#hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne" xlink:to="lab_hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_3fe1341f-583a-48bf-8e68-781dda462b44_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2ea0fe00-3874-4cc8-b5bf-7d2d22b55bad_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE LOSS</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_883a0b3d-812a-4fe5-bc34-e4a88e144e2a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_bb7e073e-ed1a-42f9-b59c-357400584db0_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_7826b05b-5cf5-4bb9-a305-aff9378bba04_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_8081ccf0-66b9-4c57-a20f-f16e8b330253_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Benefit Obligation:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_54f88e8c-7f59-4d89-bcd9-a1d0f87c8056_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and building improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_986797df-afd2-41c5-8f56-39d81a3f093d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareImpairments1_f9ff48a7-775a-4ed8-a5fc-64eee04d24d9_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareImpairments1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges related to the discontinuance of certain capitalized software projects</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareImpairments1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareImpairments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Impairments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareImpairments1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareImpairments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareImpairments1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareImpairments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2fd171e6-ce29-45c0-a48d-7caa9e7b1b18_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value (in dollars per share), Vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredOtherTaxExpenseBenefit_ac297319-b3cc-41b4-9761-c6a565bc3848_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredOtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredOtherTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredOtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Other Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOtherTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOtherTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOtherTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredOtherTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_USBloodDonorManagementSoftwareMember_fd175678-92d8-445a-b03b-5b190ffb29fa_terseLabel_en-US" xlink:label="lab_hae_USBloodDonorManagementSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Blood Donor Management Software</link:label>
    <link:label id="lab_hae_USBloodDonorManagementSoftwareMember_label_en-US" xlink:label="lab_hae_USBloodDonorManagementSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Blood Donor Management Software [Member]</link:label>
    <link:label id="lab_hae_USBloodDonorManagementSoftwareMember_documentation_en-US" xlink:label="lab_hae_USBloodDonorManagementSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Blood Donor Management Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_USBloodDonorManagementSoftwareMember" xlink:href="hae-20230401.xsd#hae_USBloodDonorManagementSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_USBloodDonorManagementSoftwareMember" xlink:to="lab_hae_USBloodDonorManagementSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_NumberOfPurchasePeriods_9a5c5ecf-350d-4a14-bcb5-461374f8c8da_terseLabel_en-US" xlink:label="lab_hae_NumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of purchase periods (in purchase periods)</link:label>
    <link:label id="lab_hae_NumberOfPurchasePeriods_label_en-US" xlink:label="lab_hae_NumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Purchase Periods</link:label>
    <link:label id="lab_hae_NumberOfPurchasePeriods_documentation_en-US" xlink:label="lab_hae_NumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Purchase Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NumberOfPurchasePeriods" xlink:href="hae-20230401.xsd#hae_NumberOfPurchasePeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_NumberOfPurchasePeriods" xlink:to="lab_hae_NumberOfPurchasePeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_f6fb9853-ab70-4573-b6f8-2b29c5d88b88_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ba96a003-d5c6-4296-af0f-ca65b678d773_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_01640365-b590-4a7e-b625-8e88d75e697a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_3661e6c9-657b-423e-ad42-e20b7de27cfe_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch_c07a2842-5978-4286-8334-dcd32dea7601_terseLabel_en-US" xlink:label="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tax Credit, Research</link:label>
    <link:label id="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch_label_en-US" xlink:label="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tax Credit, Research</link:label>
    <link:label id="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch_documentation_en-US" xlink:label="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tax Credit, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch" xlink:href="hae-20230401.xsd#hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch" xlink:to="lab_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionDomain_6cfa815e-c4eb-41de-9a2f-3465ecb501aa_terseLabel_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:label id="lab_us-gaap_PositionDomain_label_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionDomain" xlink:to="lab_us-gaap_PositionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_2463eab7-12e8-406f-b183-9ef11326ea98_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_15febfc1-1f0a-467a-b7ec-5dfeb4424750_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_9b160e0a-8cf1-4808-b34d-488507ba609e_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent_658387c2-bd2c-47e2-bfa1-900732435189_terseLabel_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global intangible low taxed income</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent_label_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Global Intangible Low Taxes Income, Percent</link:label>
    <link:label id="lab_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent_documentation_en-US" xlink:label="lab_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Global Intangible Low Taxes Income, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent" xlink:to="lab_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_b9fe5ee0-d698-441e-9c15-484dac99eb0d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of increased salary levels</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_3bdf0b49-6a11-4c12-84ec-0ff8528484c1_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising expense</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_a16044f0-ab7f-4014-a919-8918cfc0a9f1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_2e28404a-89e5-4a76-a073-7137b83369d6_terseLabel_en-US" xlink:label="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:label id="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_8ce44fb7-0f6f-45f6-8ed7-6686d1932948_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_73588c6e-34f8-4a22-b7b9-840aa6e5c8f1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_f9bd0098-e1b8-4ee4-9bfc-0041201a262e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_3460d8e2-9dc0-48e4-88a7-3004f1cde34c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_6dc1082e-46ba-4d2f-9732-9219ca133a7b_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods Sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_3f1679c4-0a47-47a6-adde-2732f460b6af_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_00a9add1-5f67-4f9d-8d0d-f1f393e84ed3_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_b6fc3f7f-e700-448d-8e28-d839581c8ecb_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk by Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpenses_45a95800-62e0-4e05-80f1-f4b7afe2635b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expenses</link:label>
    <link:label id="lab_us-gaap_OtherExpenses_label_en-US" xlink:label="lab_us-gaap_OtherExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpenses" xlink:to="lab_us-gaap_OtherExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_672c46d9-5778-4d69-bf1d-787fb39c36ce_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9ab8c732-f4fd-48be-bd86-8baf5cbb319c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_5cb1d56b-db0c-4a92-b46e-ac9ea49059e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_efe8991b-329f-45fa-b2a9-e2193d6679d9_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash items:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>hae-20230401_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d8e9c074-6bb3-481a-a40c-b4f91e1c5276,g:f0cc1f72-36f0-46b0-9a43-9e0dba51bc09-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION" xlink:type="simple" xlink:href="hae-20230401.xsd#DOCUMENTANDENTITYINFORMATION"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:href="hae-20230401.xsd#hae_DocumentAndEntityInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_36239c75-b06e-4ee5-a4da-14d8c2588019" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_DocumentType_36239c75-b06e-4ee5-a4da-14d8c2588019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_8700e092-f78f-4175-b9d0-9f0fbb8c036e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_DocumentAnnualReport_8700e092-f78f-4175-b9d0-9f0fbb8c036e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0ceca035-4705-4c8c-98ba-c7d7217035c3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_DocumentPeriodEndDate_0ceca035-4705-4c8c-98ba-c7d7217035c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_00222b72-ab1e-4d20-9579-4c44e87b82bd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_CurrentFiscalYearEndDate_00222b72-ab1e-4d20-9579-4c44e87b82bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9aceae61-8a88-4092-8003-7f3aa694249b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_DocumentTransitionReport_9aceae61-8a88-4092-8003-7f3aa694249b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_19316e8e-8d13-44fb-8e5b-3ae82d32ad98" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityFileNumber_19316e8e-8d13-44fb-8e5b-3ae82d32ad98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_4bcbb6c9-b62f-4f41-9b07-b76a5794308c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityRegistrantName_4bcbb6c9-b62f-4f41-9b07-b76a5794308c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e5a45b31-250b-499d-890d-f8012d93ca7d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e5a45b31-250b-499d-890d-f8012d93ca7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b833895b-b38c-4128-ab09-aeeda5b5f899" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityTaxIdentificationNumber_b833895b-b38c-4128-ab09-aeeda5b5f899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_c97da068-ccf6-43a2-9d74-bb70b50bac57" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityAddressAddressLine1_c97da068-ccf6-43a2-9d74-bb70b50bac57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_630b3206-1642-4f35-8b66-09b08f140540" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityAddressCityOrTown_630b3206-1642-4f35-8b66-09b08f140540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_2acf139e-cd2d-454e-bf72-f737e8fd1aef" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityAddressStateOrProvince_2acf139e-cd2d-454e-bf72-f737e8fd1aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4fd5c076-1392-42a5-97a3-a722b4566754" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityAddressPostalZipCode_4fd5c076-1392-42a5-97a3-a722b4566754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_dab46e4a-9431-4f03-8eb6-db8b4f981197" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_CityAreaCode_dab46e4a-9431-4f03-8eb6-db8b4f981197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_8a653eb3-bf02-48e8-9b73-b835be688ce6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_LocalPhoneNumber_8a653eb3-bf02-48e8-9b73-b835be688ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_2c4099df-7008-4745-a479-740a05cb8bfe" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_Security12bTitle_2c4099df-7008-4745-a479-740a05cb8bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cb7724cf-23c3-4f68-ac22-c089525109f1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_TradingSymbol_cb7724cf-23c3-4f68-ac22-c089525109f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1b6f887c-3270-49b7-8865-e70424792479" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_SecurityExchangeName_1b6f887c-3270-49b7-8865-e70424792479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_b7ccff9e-462d-490c-a811-1400e7110f4f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_b7ccff9e-462d-490c-a811-1400e7110f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_bcbab599-d8c8-4baa-a5d9-89c1e1f88a2a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityVoluntaryFilers_bcbab599-d8c8-4baa-a5d9-89c1e1f88a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_aa0c337e-c57a-406b-b42a-544d2a1833c0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityCurrentReportingStatus_aa0c337e-c57a-406b-b42a-544d2a1833c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5d12d844-5d56-4b28-a2fe-746bb6a1b756" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityInteractiveDataCurrent_5d12d844-5d56-4b28-a2fe-746bb6a1b756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_3eca298b-1913-4cd7-a8f4-deb02c3bf614" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntitySmallBusiness_3eca298b-1913-4cd7-a8f4-deb02c3bf614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_bb3a8002-d2ae-445f-a325-824c099b7f53" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityFilerCategory_bb3a8002-d2ae-445f-a325-824c099b7f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8bc5605e-798c-4c89-83eb-9c53cf7a5149" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityEmergingGrowthCompany_8bc5605e-798c-4c89-83eb-9c53cf7a5149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_7ad345ee-9c99-450a-a449-885bd27528d1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityShellCompany_7ad345ee-9c99-450a-a449-885bd27528d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_96dbd353-7547-43e0-a18e-1a3554dd1e50" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_IcfrAuditorAttestationFlag_96dbd353-7547-43e0-a18e-1a3554dd1e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_5518db19-506a-4918-9639-d27ecaafb175" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityPublicFloat_5518db19-506a-4918-9639-d27ecaafb175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2961080a-11b6-4512-8041-60096916d57d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_2961080a-11b6-4512-8041-60096916d57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_0cd53468-ab6b-408f-baaf-73ebcd500ebf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_0cd53468-ab6b-408f-baaf-73ebcd500ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e03c1808-152c-47e1-9b61-52cb901db42f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_EntityCentralIndexKey_e03c1808-152c-47e1-9b61-52cb901db42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4ee4b898-a84c-46b8-82f9-36e2f2b85a43" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_DocumentFiscalYearFocus_4ee4b898-a84c-46b8-82f9-36e2f2b85a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_f97692ec-21ae-412c-8c4b-b38dac647df0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_DocumentFiscalPeriodFocus_f97692ec-21ae-412c-8c4b-b38dac647df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6fb36bc7-267e-46e2-b2bd-625b4a06268d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_DocumentAndEntityInformationAbstract_5b09bf19-e084-436e-89cb-f64d532f560a" xlink:to="loc_dei_AmendmentFlag_6fb36bc7-267e-46e2-b2bd-625b4a06268d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/AUDITINFORMATION" xlink:type="simple" xlink:href="hae-20230401.xsd#AUDITINFORMATION"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/AUDITINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hae_AuditInformationAbstract_587ca4ed-0773-44b0-a10f-9846e8213f6e" xlink:href="hae-20230401.xsd#hae_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_bced32d9-3c39-4b4b-969e-226226603d1b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_AuditInformationAbstract_587ca4ed-0773-44b0-a10f-9846e8213f6e" xlink:to="loc_dei_AuditorName_bced32d9-3c39-4b4b-969e-226226603d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_3873a332-5d44-4be3-b551-6a4c0bea6482" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_AuditInformationAbstract_587ca4ed-0773-44b0-a10f-9846e8213f6e" xlink:to="loc_dei_AuditorLocation_3873a332-5d44-4be3-b551-6a4c0bea6482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_965ca976-98af-4fc3-bca4-820e82f7fabe" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_AuditInformationAbstract_587ca4ed-0773-44b0-a10f-9846e8213f6e" xlink:to="loc_dei_AuditorFirmId_965ca976-98af-4fc3-bca4-820e82f7fabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="hae-20230401.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_b271e7a6-9b7b-400e-9261-8fae0a8120db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_23464ad9-a08e-4508-a2cb-46ad7ea18542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b271e7a6-9b7b-400e-9261-8fae0a8120db" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_23464ad9-a08e-4508-a2cb-46ad7ea18542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_742b2eb4-7efa-469b-b581-c151fdd72d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b271e7a6-9b7b-400e-9261-8fae0a8120db" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_742b2eb4-7efa-469b-b581-c151fdd72d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_b623a3f7-17d9-414a-8e2e-29882bef3c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b271e7a6-9b7b-400e-9261-8fae0a8120db" xlink:to="loc_us-gaap_GrossProfit_b623a3f7-17d9-414a-8e2e-29882bef3c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_5659ba0a-73ac-4d3c-9645-b6168fa86fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b271e7a6-9b7b-400e-9261-8fae0a8120db" xlink:to="loc_us-gaap_OperatingExpensesAbstract_5659ba0a-73ac-4d3c-9645-b6168fa86fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_027cfa70-d0c6-49aa-a058-028f8c115050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5659ba0a-73ac-4d3c-9645-b6168fa86fff" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_027cfa70-d0c6-49aa-a058-028f8c115050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e8b80540-32fa-4be5-8c55-7980f8e33791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5659ba0a-73ac-4d3c-9645-b6168fa86fff" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e8b80540-32fa-4be5-8c55-7980f8e33791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AmortizationOfAcquiredIntangibleAssets_5f0f157f-1516-4d92-8443-16220ef841b6" xlink:href="hae-20230401.xsd#hae_AmortizationOfAcquiredIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5659ba0a-73ac-4d3c-9645-b6168fa86fff" xlink:to="loc_hae_AmortizationOfAcquiredIntangibleAssets_5f0f157f-1516-4d92-8443-16220ef841b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_47cb567d-c24c-419d-a718-9a8f2d6067e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5659ba0a-73ac-4d3c-9645-b6168fa86fff" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_47cb567d-c24c-419d-a718-9a8f2d6067e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_df5d951d-6731-42ff-81e8-50ccfbf2efb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5659ba0a-73ac-4d3c-9645-b6168fa86fff" xlink:to="loc_us-gaap_OperatingExpenses_df5d951d-6731-42ff-81e8-50ccfbf2efb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_cef28c00-0e23-413a-94cd-8f5bc54a49b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b271e7a6-9b7b-400e-9261-8fae0a8120db" xlink:to="loc_us-gaap_OperatingIncomeLoss_cef28c00-0e23-413a-94cd-8f5bc54a49b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7a0d6041-f23d-4597-89cb-22d7926e4770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b271e7a6-9b7b-400e-9261-8fae0a8120db" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7a0d6041-f23d-4597-89cb-22d7926e4770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c874c9ac-cc8a-4216-bbed-5962fa5b2bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b271e7a6-9b7b-400e-9261-8fae0a8120db" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c874c9ac-cc8a-4216-bbed-5962fa5b2bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0bb246cb-b834-45fe-bcdb-f11aff5ff9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b271e7a6-9b7b-400e-9261-8fae0a8120db" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0bb246cb-b834-45fe-bcdb-f11aff5ff9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_92efd0f7-b14d-45b0-965d-6573cb977d45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b271e7a6-9b7b-400e-9261-8fae0a8120db" xlink:to="loc_us-gaap_NetIncomeLoss_92efd0f7-b14d-45b0-965d-6573cb977d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ad58f255-b3d2-4181-897b-f90a90dcacee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b271e7a6-9b7b-400e-9261-8fae0a8120db" xlink:to="loc_us-gaap_EarningsPerShareBasic_ad58f255-b3d2-4181-897b-f90a90dcacee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c4bb9b05-f0d0-4a40-b91e-4f60920154ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b271e7a6-9b7b-400e-9261-8fae0a8120db" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c4bb9b05-f0d0-4a40-b91e-4f60920154ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_14fbb2e8-249c-4ee4-86cd-1b4908c16f34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b271e7a6-9b7b-400e-9261-8fae0a8120db" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_14fbb2e8-249c-4ee4-86cd-1b4908c16f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8be895b7-3d92-462f-a17f-95a9a2bbe9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_14fbb2e8-249c-4ee4-86cd-1b4908c16f34" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8be895b7-3d92-462f-a17f-95a9a2bbe9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e161ce50-a857-4094-96a2-553302bcc767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_14fbb2e8-249c-4ee4-86cd-1b4908c16f34" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e161ce50-a857-4094-96a2-553302bcc767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="hae-20230401.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dd3add22-8214-4534-8de9-f98aacdb406c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_23287667-fb8d-4337-ac96-2b4e284c9b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dd3add22-8214-4534-8de9-f98aacdb406c" xlink:to="loc_us-gaap_NetIncomeLoss_23287667-fb8d-4337-ac96-2b4e284c9b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bfb68d98-9d06-46e5-8676-7b1d2f6a1cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dd3add22-8214-4534-8de9-f98aacdb406c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bfb68d98-9d06-46e5-8676-7b1d2f6a1cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3ed4b2ad-2dc2-48dc-a284-d543c0b34580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bfb68d98-9d06-46e5-8676-7b1d2f6a1cc2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3ed4b2ad-2dc2-48dc-a284-d543c0b34580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bd7695ab-1907-49d2-9bbb-87e7f1604269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bfb68d98-9d06-46e5-8676-7b1d2f6a1cc2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bd7695ab-1907-49d2-9bbb-87e7f1604269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b244b558-2c8f-4ce5-8748-137faa7402ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bfb68d98-9d06-46e5-8676-7b1d2f6a1cc2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b244b558-2c8f-4ce5-8748-137faa7402ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6b104a66-45e2-4c73-90d1-1e7ea2423719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bfb68d98-9d06-46e5-8676-7b1d2f6a1cc2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6b104a66-45e2-4c73-90d1-1e7ea2423719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6adc2f1b-69b0-44b0-89cb-1d6dc0471923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dd3add22-8214-4534-8de9-f98aacdb406c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6adc2f1b-69b0-44b0-89cb-1d6dc0471923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f22b4de3-ac47-4cfc-a1ad-e812a6736420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dd3add22-8214-4534-8de9-f98aacdb406c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_f22b4de3-ac47-4cfc-a1ad-e812a6736420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="hae-20230401.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6899f83f-1c02-440a-93ba-13725ff0e5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_2733512a-c4ee-40c0-851f-ce4c0bb90cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6899f83f-1c02-440a-93ba-13725ff0e5d1" xlink:to="loc_us-gaap_AssetsAbstract_2733512a-c4ee-40c0-851f-ce4c0bb90cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_dec2a6db-2444-4167-86f7-e77f7114ea4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2733512a-c4ee-40c0-851f-ce4c0bb90cf2" xlink:to="loc_us-gaap_AssetsCurrentAbstract_dec2a6db-2444-4167-86f7-e77f7114ea4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3dd4b60e-bb4d-494b-b3ad-e21b8ca2351e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dec2a6db-2444-4167-86f7-e77f7114ea4b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3dd4b60e-bb4d-494b-b3ad-e21b8ca2351e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0c413579-5aee-488e-a4b3-05ed2085946f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dec2a6db-2444-4167-86f7-e77f7114ea4b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0c413579-5aee-488e-a4b3-05ed2085946f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_142598cb-f071-45cd-9d57-8f8f5ae8deed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dec2a6db-2444-4167-86f7-e77f7114ea4b" xlink:to="loc_us-gaap_InventoryNet_142598cb-f071-45cd-9d57-8f8f5ae8deed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cf863163-4aa4-44a2-9312-423220014fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dec2a6db-2444-4167-86f7-e77f7114ea4b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cf863163-4aa4-44a2-9312-423220014fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_208c4171-a374-4245-9afd-1c6ac313d037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dec2a6db-2444-4167-86f7-e77f7114ea4b" xlink:to="loc_us-gaap_AssetsCurrent_208c4171-a374-4245-9afd-1c6ac313d037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_46ebb148-6339-43d9-8da2-e85477f16630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dec2a6db-2444-4167-86f7-e77f7114ea4b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_46ebb148-6339-43d9-8da2-e85477f16630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cbe46b43-e000-4129-86c7-9bf5b86afed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dec2a6db-2444-4167-86f7-e77f7114ea4b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cbe46b43-e000-4129-86c7-9bf5b86afed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f236d85d-f779-4b30-b471-fca5743a15a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dec2a6db-2444-4167-86f7-e77f7114ea4b" xlink:to="loc_us-gaap_Goodwill_f236d85d-f779-4b30-b471-fca5743a15a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_dcfaa24f-5733-4bfb-8e22-d77b2c81c935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dec2a6db-2444-4167-86f7-e77f7114ea4b" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_dcfaa24f-5733-4bfb-8e22-d77b2c81c935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_326725cc-a80e-4779-8938-e0667e5c7a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dec2a6db-2444-4167-86f7-e77f7114ea4b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_326725cc-a80e-4779-8938-e0667e5c7a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8f2d7af4-c374-40a3-be9b-a8956046f84c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_dec2a6db-2444-4167-86f7-e77f7114ea4b" xlink:to="loc_us-gaap_Assets_8f2d7af4-c374-40a3-be9b-a8956046f84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_84b3c3de-089e-47d3-b14a-1a4661390cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6899f83f-1c02-440a-93ba-13725ff0e5d1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_84b3c3de-089e-47d3-b14a-1a4661390cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_4267367d-5e46-44d6-a2a7-34a3a6cbfc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_84b3c3de-089e-47d3-b14a-1a4661390cc4" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_4267367d-5e46-44d6-a2a7-34a3a6cbfc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_b4dfa0ca-f85e-416b-bfe8-9e19f2588410" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4267367d-5e46-44d6-a2a7-34a3a6cbfc4a" xlink:to="loc_us-gaap_LongTermDebtCurrent_b4dfa0ca-f85e-416b-bfe8-9e19f2588410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7c5c0d83-e814-4bc7-b858-895ee7e02d11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4267367d-5e46-44d6-a2a7-34a3a6cbfc4a" xlink:to="loc_us-gaap_AccountsPayableCurrent_7c5c0d83-e814-4bc7-b858-895ee7e02d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d7817790-174f-4628-80ef-211580bc269d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4267367d-5e46-44d6-a2a7-34a3a6cbfc4a" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d7817790-174f-4628-80ef-211580bc269d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_ce29110f-cbb0-48d3-8b07-35b97215b9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4267367d-5e46-44d6-a2a7-34a3a6cbfc4a" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_ce29110f-cbb0-48d3-8b07-35b97215b9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f8a7d154-cd76-4fdb-9e21-a65ed3bc7210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4267367d-5e46-44d6-a2a7-34a3a6cbfc4a" xlink:to="loc_us-gaap_LiabilitiesCurrent_f8a7d154-cd76-4fdb-9e21-a65ed3bc7210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_acbe03ee-d4e6-49f0-9e48-c792280cb148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_84b3c3de-089e-47d3-b14a-1a4661390cc4" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_acbe03ee-d4e6-49f0-9e48-c792280cb148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0609d06d-5904-4ce4-9060-38e76513da13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_84b3c3de-089e-47d3-b14a-1a4661390cc4" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0609d06d-5904-4ce4-9060-38e76513da13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b330bb99-d748-4115-82c1-2cf1de856bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_84b3c3de-089e-47d3-b14a-1a4661390cc4" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b330bb99-d748-4115-82c1-2cf1de856bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_ef090485-eb81-40e4-95dc-ff09ef48cf0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_84b3c3de-089e-47d3-b14a-1a4661390cc4" xlink:to="loc_us-gaap_StockholdersEquityAbstract_ef090485-eb81-40e4-95dc-ff09ef48cf0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6ec9dc3a-8f2f-407c-9c86-09890bd4b537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ef090485-eb81-40e4-95dc-ff09ef48cf0d" xlink:to="loc_us-gaap_CommonStockValue_6ec9dc3a-8f2f-407c-9c86-09890bd4b537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7f484620-de89-4932-93b8-9a71755a3cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ef090485-eb81-40e4-95dc-ff09ef48cf0d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7f484620-de89-4932-93b8-9a71755a3cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ddc8b7b1-b243-40af-a9fa-e9795c6d7366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ef090485-eb81-40e4-95dc-ff09ef48cf0d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ddc8b7b1-b243-40af-a9fa-e9795c6d7366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f0ba332b-447d-460e-9226-21bd705b90f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ef090485-eb81-40e4-95dc-ff09ef48cf0d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f0ba332b-447d-460e-9226-21bd705b90f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b4e10b4e-5751-412e-8997-344175ed4821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ef090485-eb81-40e4-95dc-ff09ef48cf0d" xlink:to="loc_us-gaap_StockholdersEquity_b4e10b4e-5751-412e-8997-344175ed4821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4e1e28bd-8253-4af7-9f34-f41b5527779c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_84b3c3de-089e-47d3-b14a-1a4661390cc4" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_4e1e28bd-8253-4af7-9f34-f41b5527779c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETSPARENTHETICAL" xlink:type="simple" xlink:href="hae-20230401.xsd#CONSOLIDATEDBALANCESHEETSPARENTHETICAL"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETSPARENTHETICAL" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2a145c3b-30a5-4497-b45d-05f2bc310f79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_477691ac-7691-4634-a642-0b66be0f5d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2a145c3b-30a5-4497-b45d-05f2bc310f79" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_477691ac-7691-4634-a642-0b66be0f5d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_79003d8f-5cde-41f3-8c5c-8ff53000d8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2a145c3b-30a5-4497-b45d-05f2bc310f79" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_79003d8f-5cde-41f3-8c5c-8ff53000d8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5ed60768-cc3d-4b4c-99f0-f5d8eb46ba97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2a145c3b-30a5-4497-b45d-05f2bc310f79" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5ed60768-cc3d-4b4c-99f0-f5d8eb46ba97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_3014c024-a903-4a17-81f0-8c23c81f1732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2a145c3b-30a5-4497-b45d-05f2bc310f79" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_3014c024-a903-4a17-81f0-8c23c81f1732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ae79f10a-6666-4a91-aa72-074a05c057e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2a145c3b-30a5-4497-b45d-05f2bc310f79" xlink:to="loc_us-gaap_CommonStockSharesIssued_ae79f10a-6666-4a91-aa72-074a05c057e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a0f27bc6-4dca-47d6-86b9-ca1e37c319e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2a145c3b-30a5-4497-b45d-05f2bc310f79" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a0f27bc6-4dca-47d6-86b9-ca1e37c319e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="hae-20230401.xsd#CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_80eae58c-3190-4b6d-9b3b-2bcc917d28a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_21271963-b3bb-4b4e-bb82-53d9a886ea11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_80eae58c-3190-4b6d-9b3b-2bcc917d28a4" xlink:to="loc_us-gaap_StatementTable_21271963-b3bb-4b4e-bb82-53d9a886ea11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_74e55ef7-9f45-4c20-8c17-659f133371ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_21271963-b3bb-4b4e-bb82-53d9a886ea11" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_74e55ef7-9f45-4c20-8c17-659f133371ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_01ebead3-afa0-48d9-bd04-137d25eda533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_74e55ef7-9f45-4c20-8c17-659f133371ee" xlink:to="loc_us-gaap_EquityComponentDomain_01ebead3-afa0-48d9-bd04-137d25eda533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_516af9ce-c4f9-4c3d-8ac0-e7d8a845832c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_01ebead3-afa0-48d9-bd04-137d25eda533" xlink:to="loc_us-gaap_CommonStockMember_516af9ce-c4f9-4c3d-8ac0-e7d8a845832c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9b7db65f-cb8c-47b5-be7f-3d5c22556973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_01ebead3-afa0-48d9-bd04-137d25eda533" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9b7db65f-cb8c-47b5-be7f-3d5c22556973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_21ae9651-bc38-491e-b001-68fffda4ae00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_01ebead3-afa0-48d9-bd04-137d25eda533" xlink:to="loc_us-gaap_RetainedEarningsMember_21ae9651-bc38-491e-b001-68fffda4ae00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_10344649-cf38-43be-a07c-fff4966989de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_01ebead3-afa0-48d9-bd04-137d25eda533" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_10344649-cf38-43be-a07c-fff4966989de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_de511c6a-8388-4480-8bab-488eaeded70d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_21271963-b3bb-4b4e-bb82-53d9a886ea11" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_de511c6a-8388-4480-8bab-488eaeded70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_83ebca3e-9bf7-4220-9252-4814829069aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_de511c6a-8388-4480-8bab-488eaeded70d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_83ebca3e-9bf7-4220-9252-4814829069aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2e0dbd58-f27f-4c28-9598-73e23cea1341" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_83ebca3e-9bf7-4220-9252-4814829069aa" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2e0dbd58-f27f-4c28-9598-73e23cea1341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_24758221-3987-4387-8f4a-97dbd88b7b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_21271963-b3bb-4b4e-bb82-53d9a886ea11" xlink:to="loc_us-gaap_StatementLineItems_24758221-3987-4387-8f4a-97dbd88b7b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_24758221-3987-4387-8f4a-97dbd88b7b5a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_a4fdff23-e956-4e81-9808-5f7c7574c0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_SharesIssued_a4fdff23-e956-4e81-9808-5f7c7574c0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7839177d-06c7-4bef-aabe-b4a8651987c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockholdersEquity_7839177d-06c7-4bef-aabe-b4a8651987c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c779547b-77f4-436c-851c-817004c1277b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c779547b-77f4-436c-851c-817004c1277b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_8a28272e-bdad-4d7c-9167-5986f0fc0d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_8a28272e-bdad-4d7c-9167-5986f0fc0d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_89047b07-7396-430f-b026-99c3a57e9ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_89047b07-7396-430f-b026-99c3a57e9ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ec4d63e8-1f11-48e8-869e-e434b37f0444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ec4d63e8-1f11-48e8-869e-e434b37f0444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_d7f2b1b4-e54c-4ba3-b1e8-9ed6cbbaaae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_d7f2b1b4-e54c-4ba3-b1e8-9ed6cbbaaae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_e627d6c6-a534-4c7d-bd20-88655742b2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_e627d6c6-a534-4c7d-bd20-88655742b2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_4a71552b-476a-441e-9ea9-27bc4fa10f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_4a71552b-476a-441e-9ea9-27bc4fa10f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_945e82c4-3423-4d45-b091-297a69728c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_945e82c4-3423-4d45-b091-297a69728c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_67b3d0f0-2457-4e57-bb67-22bcd073b025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_67b3d0f0-2457-4e57-bb67-22bcd073b025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_740c6e44-01f4-44b8-a80c-b564554c06b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_740c6e44-01f4-44b8-a80c-b564554c06b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases_06bb2c3d-b7e8-444c-8d18-da26d5ff4607" xlink:href="hae-20230401.xsd#hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases_06bb2c3d-b7e8-444c-8d18-da26d5ff4607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6f3095e1-c5f8-4fdd-9cc7-2771bc38331b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_NetIncomeLoss_6f3095e1-c5f8-4fdd-9cc7-2771bc38331b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_87690360-fbec-493b-b33e-eeebf2921346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_87690360-fbec-493b-b33e-eeebf2921346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_60fbfa41-09ff-4992-a5ce-3369d28da6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_SharesIssued_60fbfa41-09ff-4992-a5ce-3369d28da6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cf64cf54-a7de-461b-bc18-de657c693f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0a2a396-4299-4e5d-b228-e07001ba891b" xlink:to="loc_us-gaap_StockholdersEquity_cf64cf54-a7de-461b-bc18-de657c693f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="hae-20230401.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_c29153a0-f88f-47f1-ae37-815e4abd7d78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_89bd9f84-53fa-457e-b4d5-f52e6b92bde9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c29153a0-f88f-47f1-ae37-815e4abd7d78" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_89bd9f84-53fa-457e-b4d5-f52e6b92bde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b9b02fa8-f58f-40df-b44b-4b5d314e4b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_89bd9f84-53fa-457e-b4d5-f52e6b92bde9" xlink:to="loc_us-gaap_NetIncomeLoss_b9b02fa8-f58f-40df-b44b-4b5d314e4b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_56e5bf46-1f29-4335-b2cb-f3e002e61a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_89bd9f84-53fa-457e-b4d5-f52e6b92bde9" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_56e5bf46-1f29-4335-b2cb-f3e002e61a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2495ad1-3f41-4bff-91e6-757ec13fee5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_56e5bf46-1f29-4335-b2cb-f3e002e61a8b" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2495ad1-3f41-4bff-91e6-757ec13fee5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_02928aa9-a6e0-4d76-a154-3b2001be1fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2495ad1-3f41-4bff-91e6-757ec13fee5e" xlink:to="loc_us-gaap_DepreciationAndAmortization_02928aa9-a6e0-4d76-a154-3b2001be1fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_51d28ff3-6e71-4ab4-84fe-7f8d9ba9bf97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2495ad1-3f41-4bff-91e6-757ec13fee5e" xlink:to="loc_us-gaap_AssetImpairmentCharges_51d28ff3-6e71-4ab4-84fe-7f8d9ba9bf97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c4201834-7324-4c16-99fb-404b32eec64b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2495ad1-3f41-4bff-91e6-757ec13fee5e" xlink:to="loc_us-gaap_ShareBasedCompensation_c4201834-7324-4c16-99fb-404b32eec64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_60e8e904-c19f-4690-91e5-58d8d1075c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2495ad1-3f41-4bff-91e6-757ec13fee5e" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_60e8e904-c19f-4690-91e5-58d8d1075c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f48379f3-511f-4a72-b674-7dcb42d01a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2495ad1-3f41-4bff-91e6-757ec13fee5e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f48379f3-511f-4a72-b674-7dcb42d01a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOtherTaxExpenseBenefit_74407b28-112f-4fb2-afc0-0b803e6e7762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOtherTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2495ad1-3f41-4bff-91e6-757ec13fee5e" xlink:to="loc_us-gaap_DeferredOtherTaxExpenseBenefit_74407b28-112f-4fb2-afc0-0b803e6e7762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_da2e1b40-4842-4637-bd61-4ad60bbba3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2495ad1-3f41-4bff-91e6-757ec13fee5e" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_da2e1b40-4842-4637-bd61-4ad60bbba3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InventoryLossesProvisionBenefit_35459b40-fdca-4933-bfdd-b36b24c88860" xlink:href="hae-20230401.xsd#hae_InventoryLossesProvisionBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2495ad1-3f41-4bff-91e6-757ec13fee5e" xlink:to="loc_hae_InventoryLossesProvisionBenefit_35459b40-fdca-4933-bfdd-b36b24c88860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_db1abd20-95e0-4ced-8db7-c9f128a1cba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2495ad1-3f41-4bff-91e6-757ec13fee5e" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_db1abd20-95e0-4ced-8db7-c9f128a1cba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fd3b5fc1-2783-4b08-ba3f-8d0efed5936f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_56e5bf46-1f29-4335-b2cb-f3e002e61a8b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fd3b5fc1-2783-4b08-ba3f-8d0efed5936f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_509f5da6-728a-4bf9-95b0-1a7338748ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fd3b5fc1-2783-4b08-ba3f-8d0efed5936f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_509f5da6-728a-4bf9-95b0-1a7338748ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a802374d-b03a-4928-acfd-33847d3a89da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fd3b5fc1-2783-4b08-ba3f-8d0efed5936f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a802374d-b03a-4928-acfd-33847d3a89da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_276f9174-a840-4b1a-8a39-f05ff1b7080c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fd3b5fc1-2783-4b08-ba3f-8d0efed5936f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_276f9174-a840-4b1a-8a39-f05ff1b7080c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_955dc81c-270d-4170-ab1b-f3a36b3081a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fd3b5fc1-2783-4b08-ba3f-8d0efed5936f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_955dc81c-270d-4170-ab1b-f3a36b3081a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_94624d17-1c5c-4011-b31d-5d32955ac64f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fd3b5fc1-2783-4b08-ba3f-8d0efed5936f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_94624d17-1c5c-4011-b31d-5d32955ac64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc347a98-6b74-475f-af96-966c15d90838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_89bd9f84-53fa-457e-b4d5-f52e6b92bde9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc347a98-6b74-475f-af96-966c15d90838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7458df35-8b5e-4c41-895d-d4d8a74614b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c29153a0-f88f-47f1-ae37-815e4abd7d78" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7458df35-8b5e-4c41-895d-d4d8a74614b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_351bf045-ebe2-42dd-b099-5eb1287eadfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7458df35-8b5e-4c41-895d-d4d8a74614b9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_351bf045-ebe2-42dd-b099-5eb1287eadfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_14cabc1e-cae0-422c-8415-acfbcd4ec1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7458df35-8b5e-4c41-895d-d4d8a74614b9" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_14cabc1e-cae0-422c-8415-acfbcd4ec1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_80d6598c-d4b1-4e6f-84a6-e8914108ef84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7458df35-8b5e-4c41-895d-d4d8a74614b9" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_80d6598c-d4b1-4e6f-84a6-e8914108ef84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_59314365-85e0-4a67-b325-e1c57cab4ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7458df35-8b5e-4c41-895d-d4d8a74614b9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_59314365-85e0-4a67-b325-e1c57cab4ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_8c0b32a7-a4e0-4508-a1ac-f443bcc4684a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7458df35-8b5e-4c41-895d-d4d8a74614b9" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_8c0b32a7-a4e0-4508-a1ac-f443bcc4684a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70c742db-85b8-4240-909f-f08128d344e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7458df35-8b5e-4c41-895d-d4d8a74614b9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70c742db-85b8-4240-909f-f08128d344e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c29153a0-f88f-47f1-ae37-815e4abd7d78" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_0ee235f8-4708-4424-b535-33db7067cc0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_0ee235f8-4708-4424-b535-33db7067cc0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DecreaseForRedemptionOfLongTermDebt_835a05d2-91be-4109-8a8f-28b6c5c28f22" xlink:href="hae-20230401.xsd#hae_DecreaseForRedemptionOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:to="loc_hae_DecreaseForRedemptionOfLongTermDebt_835a05d2-91be-4109-8a8f-28b6c5c28f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_711e2b03-f2c1-453c-883d-84f102e3b5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_711e2b03-f2c1-453c-883d-84f102e3b5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_4129c627-f00e-41b4-87c5-ffef8422eca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_4129c627-f00e-41b4-87c5-ffef8422eca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_488c5a9f-09fa-4e28-a3f0-df0d20e9e862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_488c5a9f-09fa-4e28-a3f0-df0d20e9e862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_6da7a2e1-876f-4247-badb-5dcec783b8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_6da7a2e1-876f-4247-badb-5dcec783b8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_a6687793-4009-496a-86a5-b346fdd479e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_a6687793-4009-496a-86a5-b346fdd479e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_5f4367c0-4ecd-4560-8d79-be1307535bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_5f4367c0-4ecd-4560-8d79-be1307535bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes_1e9e0c55-4033-42e9-a481-db5d7b3ef303" xlink:href="hae-20230401.xsd#hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:to="loc_hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes_1e9e0c55-4033-42e9-a481-db5d7b3ef303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_8736867f-6816-4e39-a254-06a7f5fa7bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_8736867f-6816-4e39-a254-06a7f5fa7bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_92ce68a3-9579-4d87-922d-b5d4d606bfe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_92ce68a3-9579-4d87-922d-b5d4d606bfe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_e23a6300-0519-458d-8430-f3d848a727ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_e23a6300-0519-458d-8430-f3d848a727ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_617db0f6-8408-472f-a5e3-9476f91f1a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_617db0f6-8408-472f-a5e3-9476f91f1a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c3c4bda6-0fb9-480e-989e-3c2f5fe49b44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c3c4bda6-0fb9-480e-989e-3c2f5fe49b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7ccb1ca2-ce03-44ed-bf7f-d3bc914a523a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_89e3753e-b356-4683-9f1f-27dd2cb9b178" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7ccb1ca2-ce03-44ed-bf7f-d3bc914a523a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_45fd1331-7067-486e-94b0-5410221c39ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c29153a0-f88f-47f1-ae37-815e4abd7d78" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_45fd1331-7067-486e-94b0-5410221c39ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_eed4d4f5-265c-4924-b4bf-3b2c39e5c708" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c29153a0-f88f-47f1-ae37-815e4abd7d78" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_eed4d4f5-265c-4924-b4bf-3b2c39e5c708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6cbad38d-cabd-4c18-89e1-a9e13af92fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c29153a0-f88f-47f1-ae37-815e4abd7d78" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6cbad38d-cabd-4c18-89e1-a9e13af92fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_19ba4f56-8783-4fee-875b-b94730214db9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c29153a0-f88f-47f1-ae37-815e4abd7d78" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_19ba4f56-8783-4fee-875b-b94730214db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_49d4ece4-694a-477e-98b8-538948820e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c29153a0-f88f-47f1-ae37-815e4abd7d78" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_49d4ece4-694a-477e-98b8-538948820e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_03457dc5-f8e7-4d9a-810b-3f14c3b991a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_49d4ece4-694a-477e-98b8-538948820e6f" xlink:to="loc_us-gaap_InterestPaidNet_03457dc5-f8e7-4d9a-810b-3f14c3b991a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_0b5f808d-99a9-4c9c-bd91-ded35a9cc6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_49d4ece4-694a-477e-98b8-538948820e6f" xlink:to="loc_us-gaap_IncomeTaxesPaid_0b5f808d-99a9-4c9c-bd91-ded35a9cc6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TransfersFromInventoryToFixedAssets_488dee31-51ae-4d6c-8b2c-66eec394ac0d" xlink:href="hae-20230401.xsd#hae_TransfersFromInventoryToFixedAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_49d4ece4-694a-477e-98b8-538948820e6f" xlink:to="loc_hae_TransfersFromInventoryToFixedAssets_488dee31-51ae-4d6c-8b2c-66eec394ac0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/DESCRIPTIONOFTHEBUSINESSANDBASISOFPRESENTATION" xlink:type="simple" xlink:href="hae-20230401.xsd#DESCRIPTIONOFTHEBUSINESSANDBASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/DESCRIPTIONOFTHEBUSINESSANDBASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5a128e2c-3695-4f53-9d34-e2dd51826e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7b5f2765-a83c-4f71-b4ca-e64750a05d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5a128e2c-3695-4f53-9d34-e2dd51826e20" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7b5f2765-a83c-4f71-b4ca-e64750a05d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="hae-20230401.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_7a0200b0-6504-4c2b-9d58-14127b8463ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_d858260a-b9fa-4b7a-aacd-03d1457edae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_7a0200b0-6504-4c2b-9d58-14127b8463ee" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_d858260a-b9fa-4b7a-aacd-03d1457edae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURING" xlink:type="simple" xlink:href="hae-20230401.xsd#RESTRUCTURING"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURING" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8e5b8d7c-9e7b-428d-a35e-d630d2cf6c53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_b292ae77-4b1a-4935-90ee-f838f03644c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8e5b8d7c-9e7b-428d-a35e-d630d2cf6c53" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_b292ae77-4b1a-4935-90ee-f838f03644c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITIONSANDSTRATEGICINVESTMENTS" xlink:type="simple" xlink:href="hae-20230401.xsd#ACQUISITIONSANDSTRATEGICINVESTMENTS"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/ACQUISITIONSANDSTRATEGICINVESTMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_fbdbeb44-66c9-40d6-8395-9271f00544d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_644e9f06-8825-46c6-87c9-af0bb34e11e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_fbdbeb44-66c9-40d6-8395-9271f00544d4" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_644e9f06-8825-46c6-87c9-af0bb34e11e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/DIVESTITURE" xlink:type="simple" xlink:href="hae-20230401.xsd#DIVESTITURE"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/DIVESTITURE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_504773de-7dca-4bcd-9068-1a24508bde41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_48419309-70be-4646-a632-f04223949045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_504773de-7dca-4bcd-9068-1a24508bde41" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_48419309-70be-4646-a632-f04223949045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXES" xlink:type="simple" xlink:href="hae-20230401.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_dba85671-a507-46f5-915b-bd7bea99475e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_e505ec56-e8fd-4da9-b84c-60cba124a90c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dba85671-a507-46f5-915b-bd7bea99475e" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_e505ec56-e8fd-4da9-b84c-60cba124a90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="hae-20230401.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7c6c1945-46b5-4c67-b766-68e511592233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_3d179add-ef4d-450e-8a34-20a5a0a0411c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7c6c1945-46b5-4c67-b766-68e511592233" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_3d179add-ef4d-450e-8a34-20a5a0a0411c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/REVENUE" xlink:type="simple" xlink:href="hae-20230401.xsd#REVENUE"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/REVENUE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_061bdd8f-e181-46af-a3ab-7de08441e61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_4c2dcb48-f5b8-48f1-adb5-2f645086e038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_061bdd8f-e181-46af-a3ab-7de08441e61c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_4c2dcb48-f5b8-48f1-adb5-2f645086e038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INVENTORIES" xlink:type="simple" xlink:href="hae-20230401.xsd#INVENTORIES"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INVENTORIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_400d1f93-e138-4ea6-bfeb-b5eb4f961585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_48c0da5c-c5ba-4499-8ec2-2fb210f2d332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_400d1f93-e138-4ea6-bfeb-b5eb4f961585" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_48c0da5c-c5ba-4499-8ec2-2fb210f2d332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="simple" xlink:href="hae-20230401.xsd#PROPERTYPLANTANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5eeacd8b-979f-47f3-9484-4e06e76e0e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_39605b0c-4d90-4968-bdda-0c00376c1b85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5eeacd8b-979f-47f3-9484-4e06e76e0e8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_39605b0c-4d90-4968-bdda-0c00376c1b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="hae-20230401.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6fb68e6b-a010-4c5c-862e-85f67f09620b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_a416613c-a300-46b7-9649-2183077eac5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6fb68e6b-a010-4c5c-862e-85f67f09620b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_a416613c-a300-46b7-9649-2183077eac5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/LEASES" xlink:type="simple" xlink:href="hae-20230401.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e99da608-bb14-4ce6-b6d7-f34ee82eb4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_adf00122-fce3-4282-b7d3-312e8cb81c05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e99da608-bb14-4ce6-b6d7-f34ee82eb4d4" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_adf00122-fce3-4282-b7d3-312e8cb81c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT" xlink:type="simple" xlink:href="hae-20230401.xsd#NOTESPAYABLEANDLONGTERMDEBT"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e146381a-6d84-4fd6-9244-534fae70e49d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_b66f9566-649c-4897-88ca-515a5636b641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e146381a-6d84-4fd6-9244-534fae70e49d" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_b66f9566-649c-4897-88ca-515a5636b641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="hae-20230401.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a6e1f43a-3dfd-4104-8d5f-2590098cd97e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_ba600dc7-0caf-4fdf-8cf2-9df1bef73620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a6e1f43a-3dfd-4104-8d5f-2590098cd97e" xlink:to="loc_us-gaap_DerivativesAndFairValueTextBlock_ba600dc7-0caf-4fdf-8cf2-9df1bef73620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RETIREMENTPLANS" xlink:type="simple" xlink:href="hae-20230401.xsd#RETIREMENTPLANS"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RETIREMENTPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ca578087-e972-40d6-b4b0-22140894f986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_5caf6d47-dc2f-464d-bacb-b246355d842f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ca578087-e972-40d6-b4b0-22140894f986" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_5caf6d47-dc2f-464d-bacb-b246355d842f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="hae-20230401.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a520bc37-688e-46f9-b3dc-89f0d6b5bba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fa31c8af-78f9-494b-ba99-1f308822d4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a520bc37-688e-46f9-b3dc-89f0d6b5bba7" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fa31c8af-78f9-494b-ba99-1f308822d4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CAPITALSTOCK" xlink:type="simple" xlink:href="hae-20230401.xsd#CAPITALSTOCK"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CAPITALSTOCK" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fd5a571f-1c05-47d7-afad-3625424eabc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0e721522-a173-4fcc-9c6c-2a4342c9f5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fd5a571f-1c05-47d7-afad-3625424eabc0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0e721522-a173-4fcc-9c6c-2a4342c9f5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION" xlink:type="simple" xlink:href="hae-20230401.xsd#SEGMENTANDENTERPRISEWIDEINFORMATION"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_da79a68d-a0a4-494b-9ab7-f6fb7c404a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_d0855232-3d1d-41a1-a4c6-b765f1fdc1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_da79a68d-a0a4-494b-9ab7-f6fb7c404a94" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_d0855232-3d1d-41a1-a4c6-b765f1fdc1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="hae-20230401.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_48bd51b7-3e80-4ee0-aefe-bce978aac97c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f5d1d058-2a8d-4cab-9c1c-d2a67360a945" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_48bd51b7-3e80-4ee0-aefe-bce978aac97c" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f5d1d058-2a8d-4cab-9c1c-d2a67360a945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="hae-20230401.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_b613f2fc-91f4-4cd0-a1ed-314fb8d3fc08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_FiscalPeriod_b613f2fc-91f4-4cd0-a1ed-314fb8d3fc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_7b8eaa1b-08df-4f23-8a09-a1da1c0ed6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_7b8eaa1b-08df-4f23-8a09-a1da1c0ed6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_e4e4e548-d6cf-4cb6-bbbc-dc23a71293d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_UseOfEstimates_e4e4e548-d6cf-4cb6-bbbc-dc23a71293d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_6c4d8452-d2af-4b77-97f1-1e6de3844932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_6c4d8452-d2af-4b77-97f1-1e6de3844932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_e0ef89cc-f3f5-4644-8bc5-7f04acd24f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_e0ef89cc-f3f5-4644-8bc5-7f04acd24f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_5639d499-a0de-4eb2-bdbc-1b9a4de069f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_5639d499-a0de-4eb2-bdbc-1b9a4de069f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c0100e2d-42e9-4992-b4b5-9917c70029ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c0100e2d-42e9-4992-b4b5-9917c70029ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy_d4318217-ab27-4b9b-b900-212e4b595be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy_d4318217-ab27-4b9b-b900-212e4b595be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_eed2859a-08ba-40fe-b98c-7999c3ef4b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_eed2859a-08ba-40fe-b98c-7999c3ef4b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0264dd2b-9134-4fea-a027-9bb44545e77e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0264dd2b-9134-4fea-a027-9bb44545e77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_f133fa8c-df4b-44a5-9131-87d12bd339f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_f133fa8c-df4b-44a5-9131-87d12bd339f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy_a60d5f33-3266-41e0-b0ee-42ea79932372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy_a60d5f33-3266-41e0-b0ee-42ea79932372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_b2b7fa80-0213-46a7-b6e2-b3fdff014359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_b2b7fa80-0213-46a7-b6e2-b3fdff014359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_2375118d-6019-4df7-a098-533f5bd81030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_2375118d-6019-4df7-a098-533f5bd81030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_df64a2cb-92a4-4568-a70e-5756bd41222c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_df64a2cb-92a4-4568-a70e-5756bd41222c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_01151e70-f6f7-4071-b601-10f93d001d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_01151e70-f6f7-4071-b601-10f93d001d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_8e8f1699-a023-4854-ac4d-e078cc1db59b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_DebtPolicyTextBlock_8e8f1699-a023-4854-ac4d-e078cc1db59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_9e231e9a-f88e-4469-87b6-ca4e8e3cb6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_9e231e9a-f88e-4469-87b6-ca4e8e3cb6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d5d47c18-5524-4b04-b1f8-fa11f3c175f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d5d47c18-5524-4b04-b1f8-fa11f3c175f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_bb4e3446-5dd4-4b11-87e0-7ac569040f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_bb4e3446-5dd4-4b11-87e0-7ac569040f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_742a7218-2272-4431-9f74-328580b04db0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_742a7218-2272-4431-9f74-328580b04db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_b0f85ac2-ee2c-40f8-843a-48d03767bacd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_b0f85ac2-ee2c-40f8-843a-48d03767bacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_ac2c547f-bd46-4d2a-92b2-65af2ab7d693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_ac2c547f-bd46-4d2a-92b2-65af2ab7d693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ea5ed9cb-27fa-40a1-813c-7f73d0d16078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_af11fe86-f18d-4af7-9c29-55e5222bb98e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ea5ed9cb-27fa-40a1-813c-7f73d0d16078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="hae-20230401.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_edea7cc9-b8d8-4870-96c8-304051846002" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_ed9558e4-2cd9-4ffd-9cf4-f4c0620a67ad" xlink:href="hae-20230401.xsd#hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_edea7cc9-b8d8-4870-96c8-304051846002" xlink:to="loc_hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_ed9558e4-2cd9-4ffd-9cf4-f4c0620a67ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_7cea8b8d-e3f8-43d8-9d2e-7724969cf2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_edea7cc9-b8d8-4870-96c8-304051846002" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_7cea8b8d-e3f8-43d8-9d2e-7724969cf2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGTables" xlink:type="simple" xlink:href="hae-20230401.xsd#RESTRUCTURINGTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d041b8aa-eee1-4995-b789-754fc9a7224c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_67af6c9f-2bd9-476f-aee4-c60fa788bd6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d041b8aa-eee1-4995-b789-754fc9a7224c" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_67af6c9f-2bd9-476f-aee4-c60fa788bd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_cc658386-2703-40b8-901b-f084fd1cafc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d041b8aa-eee1-4995-b789-754fc9a7224c" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_cc658386-2703-40b8-901b-f084fd1cafc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITIONSTables" xlink:type="simple" xlink:href="hae-20230401.xsd#ACQUISITIONSTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/ACQUISITIONSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_d5a113af-50e1-4ef4-817e-5009ce79f64e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_f6d4ced2-a0f1-4dbd-a8ce-2795c913c5da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d5a113af-50e1-4ef4-817e-5009ce79f64e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_f6d4ced2-a0f1-4dbd-a8ce-2795c913c5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_c974aebc-205d-43ec-baf2-d2b33e32975f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d5a113af-50e1-4ef4-817e-5009ce79f64e" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_c974aebc-205d-43ec-baf2-d2b33e32975f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="hae-20230401.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b801bc4e-fac0-4b9e-96cb-97d85291d001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b8403ead-af8c-40d4-8a64-a973d9e1604d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b801bc4e-fac0-4b9e-96cb-97d85291d001" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b8403ead-af8c-40d4-8a64-a973d9e1604d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_8df6224c-5472-45f4-b667-1381ec83961f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b801bc4e-fac0-4b9e-96cb-97d85291d001" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_8df6224c-5472-45f4-b667-1381ec83961f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0f6deada-53ed-4e48-92ac-ddd3f2172c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b801bc4e-fac0-4b9e-96cb-97d85291d001" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0f6deada-53ed-4e48-92ac-ddd3f2172c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_648c0f63-4e7d-443e-a211-429ccfae28cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b801bc4e-fac0-4b9e-96cb-97d85291d001" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_648c0f63-4e7d-443e-a211-429ccfae28cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_5ab087c6-aabe-4a4f-a7ac-be02f65ebf56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b801bc4e-fac0-4b9e-96cb-97d85291d001" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_5ab087c6-aabe-4a4f-a7ac-be02f65ebf56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="hae-20230401.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b323e037-83f4-4a86-b9bb-d50b15430450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8edada7e-a5fc-4086-bfeb-9570aa0761ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b323e037-83f4-4a86-b9bb-d50b15430450" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8edada7e-a5fc-4086-bfeb-9570aa0761ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="hae-20230401.xsd#INVENTORIESTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INVENTORIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_b96fc8c0-d28c-4049-8db4-29ad0243fd86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_496b2c6e-1abc-481b-9971-da2b08ee08e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_b96fc8c0-d28c-4049-8db4-29ad0243fd86" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_496b2c6e-1abc-481b-9971-da2b08ee08e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="simple" xlink:href="hae-20230401.xsd#PROPERTYPLANTANDEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d3ac6a38-cc8e-475a-87cf-44d4319fb36d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_f6b1a54a-387b-4ac3-8c3e-085bea13c79b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d3ac6a38-cc8e-475a-87cf-44d4319fb36d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_f6b1a54a-387b-4ac3-8c3e-085bea13c79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="hae-20230401.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_32b60162-eb10-46e7-882c-643d8435b49c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_e9740037-dc06-4f6c-a506-4e8ca25d22cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_32b60162-eb10-46e7-882c-643d8435b49c" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_e9740037-dc06-4f6c-a506-4e8ca25d22cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_7c1027d8-aba7-473c-a3cb-02a87a765771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_32b60162-eb10-46e7-882c-643d8435b49c" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_7c1027d8-aba7-473c-a3cb-02a87a765771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_2b41b215-ed35-40f6-8b96-eb14cd6e2769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_32b60162-eb10-46e7-882c-643d8435b49c" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_2b41b215-ed35-40f6-8b96-eb14cd6e2769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/LEASESTables" xlink:type="simple" xlink:href="hae-20230401.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c81becb0-8b11-4464-abcb-e988dc7831d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetsandLiabilitiesLesseeTableTextBlock_88088da8-b226-436a-b234-99883492e695" xlink:href="hae-20230401.xsd#hae_AssetsandLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c81becb0-8b11-4464-abcb-e988dc7831d2" xlink:to="loc_hae_AssetsandLiabilitiesLesseeTableTextBlock_88088da8-b226-436a-b234-99883492e695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_LesseeOperatingLeasesOtherInformationTableTextBlock_b4ca4304-207a-46b8-9962-eedce55d178e" xlink:href="hae-20230401.xsd#hae_LesseeOperatingLeasesOtherInformationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c81becb0-8b11-4464-abcb-e988dc7831d2" xlink:to="loc_hae_LesseeOperatingLeasesOtherInformationTableTextBlock_b4ca4304-207a-46b8-9962-eedce55d178e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_09ae2c78-fb37-46f6-8ca1-139fd69b9e92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c81becb0-8b11-4464-abcb-e988dc7831d2" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_09ae2c78-fb37-46f6-8ca1-139fd69b9e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_9aab868e-f8dc-44cd-b241-8411a1195e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c81becb0-8b11-4464-abcb-e988dc7831d2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_9aab868e-f8dc-44cd-b241-8411a1195e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTTables" xlink:type="simple" xlink:href="hae-20230401.xsd#NOTESPAYABLEANDLONGTERMDEBTTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_50f3743c-2b8f-4df7-9d29-9f909206da1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_9f77cf16-1934-4389-bc78-8b33b575cfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_50f3743c-2b8f-4df7-9d29-9f909206da1e" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_9f77cf16-1934-4389-bc78-8b33b575cfa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d425328a-2946-46b9-af2c-d48c9d4f671b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_50f3743c-2b8f-4df7-9d29-9f909206da1e" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d425328a-2946-46b9-af2c-d48c9d4f671b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="hae-20230401.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3cf85c39-ba6a-487e-8fb9-a2bb776c701f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_b11520a8-0c5e-4f74-899c-9948a68c6e93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3cf85c39-ba6a-487e-8fb9-a2bb776c701f" xlink:to="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_b11520a8-0c5e-4f74-899c-9948a68c6e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_b78568b1-b0ec-4072-98e4-2473fee74a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3cf85c39-ba6a-487e-8fb9-a2bb776c701f" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_b78568b1-b0ec-4072-98e4-2473fee74a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_e69cc79a-d001-4178-b8a0-8bd8215e3b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3cf85c39-ba6a-487e-8fb9-a2bb776c701f" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_e69cc79a-d001-4178-b8a0-8bd8215e3b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_e190c984-b889-4e3d-b0cc-3929bd04615d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3cf85c39-ba6a-487e-8fb9-a2bb776c701f" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_e190c984-b889-4e3d-b0cc-3929bd04615d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_7821452a-c734-4d4b-bbaf-c8d2d6204ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3cf85c39-ba6a-487e-8fb9-a2bb776c701f" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_7821452a-c734-4d4b-bbaf-c8d2d6204ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSTables" xlink:type="simple" xlink:href="hae-20230401.xsd#RETIREMENTPLANSTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RETIREMENTPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f64115ec-00f7-4b95-9246-83a1eae4e398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_05819955-d4a3-4e40-8fcc-a2676f8fb269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f64115ec-00f7-4b95-9246-83a1eae4e398" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_05819955-d4a3-4e40-8fcc-a2676f8fb269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_ed49c8b3-94e8-4455-994f-ad6fa24de10f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetFundedStatusTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f64115ec-00f7-4b95-9246-83a1eae4e398" xlink:to="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_ed49c8b3-94e8-4455-994f-ad6fa24de10f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_dca317fd-ee91-420f-96fb-147c2ed3f2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f64115ec-00f7-4b95-9246-83a1eae4e398" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_dca317fd-ee91-420f-96fb-147c2ed3f2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_f26fa252-4774-4ec6-85f1-c15e4ca8e42d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f64115ec-00f7-4b95-9246-83a1eae4e398" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_f26fa252-4774-4ec6-85f1-c15e4ca8e42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_19c53413-75d2-4b13-b3b4-2df21be159c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f64115ec-00f7-4b95-9246-83a1eae4e398" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_19c53413-75d2-4b13-b3b4-2df21be159c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CAPITALSTOCKTables" xlink:type="simple" xlink:href="hae-20230401.xsd#CAPITALSTOCKTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CAPITALSTOCKTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_509d3c25-a45a-46d4-a233-e61ffb5f1e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_069ca605-b4c3-494b-ae09-78a64ef69cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_509d3c25-a45a-46d4-a233-e61ffb5f1e66" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_069ca605-b4c3-494b-ae09-78a64ef69cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8c4bc9fd-d66e-4bc9-b080-a0a68a61d3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_509d3c25-a45a-46d4-a233-e61ffb5f1e66" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8c4bc9fd-d66e-4bc9-b080-a0a68a61d3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_7352309d-e279-4f09-8d96-d3ad765e5294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_509d3c25-a45a-46d4-a233-e61ffb5f1e66" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_7352309d-e279-4f09-8d96-d3ad765e5294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_c76956b9-e13c-4491-9a7d-e56788e4e2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_509d3c25-a45a-46d4-a233-e61ffb5f1e66" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_c76956b9-e13c-4491-9a7d-e56788e4e2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_ec209cca-bc85-4ed8-8c91-6d3d060799c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_509d3c25-a45a-46d4-a233-e61ffb5f1e66" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_ec209cca-bc85-4ed8-8c91-6d3d060799c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_f4542f60-72c1-43f9-98b2-4ae6b47f3a84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_509d3c25-a45a-46d4-a233-e61ffb5f1e66" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_f4542f60-72c1-43f9-98b2-4ae6b47f3a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_181467bc-7c3a-4fd3-862a-95226f0833bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_509d3c25-a45a-46d4-a233-e61ffb5f1e66" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_181467bc-7c3a-4fd3-862a-95226f0833bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock_615c000c-7dc2-4645-a880-584667629c79" xlink:href="hae-20230401.xsd#hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_509d3c25-a45a-46d4-a233-e61ffb5f1e66" xlink:to="loc_hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock_615c000c-7dc2-4645-a880-584667629c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables" xlink:type="simple" xlink:href="hae-20230401.xsd#SEGMENTANDENTERPRISEWIDEINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9d779acd-1ed4-4775-9f61-7f803f05b849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_178a6dc4-11cf-4049-9810-938df97fc9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9d779acd-1ed4-4775-9f61-7f803f05b849" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_178a6dc4-11cf-4049-9810-938df97fc9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_11ad675e-9eee-4d00-84ec-beb9ebe7ca90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9d779acd-1ed4-4775-9f61-7f803f05b849" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_11ad675e-9eee-4d00-84ec-beb9ebe7ca90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="simple" xlink:href="hae-20230401.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_945a90cd-d075-41f8-a758-c5edd1f7180a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5bc97d43-2930-42cb-95b1-a03793c7d571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_945a90cd-d075-41f8-a758-c5edd1f7180a" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5bc97d43-2930-42cb-95b1-a03793c7d571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_514d0ecf-42f2-4e19-a431-2ab4306a0152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:href="hae-20230401.xsd#hae_SummaryOfSignificantAccountingPronouncementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_514d0ecf-42f2-4e19-a431-2ab4306a0152" xlink:to="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9c001d1a-c566-48d1-8692-ae7676daa7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9c001d1a-c566-48d1-8692-ae7676daa7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_a65e28bb-14b6-4522-8623-13c540b57270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9c001d1a-c566-48d1-8692-ae7676daa7b4" xlink:to="loc_us-gaap_TypeOfAdoptionMember_a65e28bb-14b6-4522-8623-13c540b57270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_cc90ff67-2cf1-4fb6-9e00-d5c3e26d4467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_a65e28bb-14b6-4522-8623-13c540b57270" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_cc90ff67-2cf1-4fb6-9e00-d5c3e26d4467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_537c3a04-4d29-4879-949f-acbbb5b8cc31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_537c3a04-4d29-4879-949f-acbbb5b8cc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1fb124f3-818f-44ad-a07d-820a03fdb968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_537c3a04-4d29-4879-949f-acbbb5b8cc31" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1fb124f3-818f-44ad-a07d-820a03fdb968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_14e1ea55-5088-4805-a937-decd6445fbf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1fb124f3-818f-44ad-a07d-820a03fdb968" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_14e1ea55-5088-4805-a937-decd6445fbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1721e50c-e56a-4c36-9a9e-3b2f61e5afe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1721e50c-e56a-4c36-9a9e-3b2f61e5afe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3c3d091b-f14b-477e-a206-39080133aa62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1721e50c-e56a-4c36-9a9e-3b2f61e5afe6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3c3d091b-f14b-477e-a206-39080133aa62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_3a176256-943d-48f7-a204-294e42154c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_3c3d091b-f14b-477e-a206-39080133aa62" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_3a176256-943d-48f7-a204-294e42154c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_664d791e-2911-48c4-98d1-991a3e764214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_664d791e-2911-48c4-98d1-991a3e764214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f78afb6-28d0-4921-853b-0442acb68181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_664d791e-2911-48c4-98d1-991a3e764214" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f78afb6-28d0-4921-853b-0442acb68181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_7d1f7df9-1dc9-4861-8156-c26f7a33c497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f78afb6-28d0-4921-853b-0442acb68181" xlink:to="loc_us-gaap_BuildingMember_7d1f7df9-1dc9-4861-8156-c26f7a33c497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_258dc4bc-2de0-43c6-91b9-9f81b24debf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f78afb6-28d0-4921-853b-0442acb68181" xlink:to="loc_us-gaap_BuildingImprovementsMember_258dc4bc-2de0-43c6-91b9-9f81b24debf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_fd696877-a1be-4501-8a56-ca63968175b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f78afb6-28d0-4921-853b-0442acb68181" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_fd696877-a1be-4501-8a56-ca63968175b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OfficeEquipmentAndInformationTechnologyMember_77e11b80-718c-48da-a644-3f1938d90ea9" xlink:href="hae-20230401.xsd#hae_OfficeEquipmentAndInformationTechnologyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f78afb6-28d0-4921-853b-0442acb68181" xlink:to="loc_hae_OfficeEquipmentAndInformationTechnologyMember_77e11b80-718c-48da-a644-3f1938d90ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HaemoneticsEquipmentMember_fc0b08f6-44fa-4310-8912-7da75715441f" xlink:href="hae-20230401.xsd#hae_HaemoneticsEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f78afb6-28d0-4921-853b-0442acb68181" xlink:to="loc_hae_HaemoneticsEquipmentMember_fc0b08f6-44fa-4310-8912-7da75715441f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_59d95b85-0ee4-4589-9732-c05b1f7c7b37" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:to="loc_srt_RangeAxis_59d95b85-0ee4-4589-9732-c05b1f7c7b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5fc5ba7d-f650-47d4-bae7-979b34a8a610" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_59d95b85-0ee4-4589-9732-c05b1f7c7b37" xlink:to="loc_srt_RangeMember_5fc5ba7d-f650-47d4-bae7-979b34a8a610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ab809fa0-943d-4a46-bdb0-f6390fb623a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5fc5ba7d-f650-47d4-bae7-979b34a8a610" xlink:to="loc_srt_MinimumMember_ab809fa0-943d-4a46-bdb0-f6390fb623a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a6bc0ada-953d-45f6-866a-8add1b54a8e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5fc5ba7d-f650-47d4-bae7-979b34a8a610" xlink:to="loc_srt_MaximumMember_a6bc0ada-953d-45f6-866a-8add1b54a8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_8f281cb3-01d9-4e4d-a547-123d70bb017a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:to="loc_srt_MajorCustomersAxis_8f281cb3-01d9-4e4d-a547-123d70bb017a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_7ad84341-e80b-4834-8b21-454c65c03f2f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_8f281cb3-01d9-4e4d-a547-123d70bb017a" xlink:to="loc_srt_NameOfMajorCustomerDomain_7ad84341-e80b-4834-8b21-454c65c03f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TenLargestCustomersMember_cc9701e8-aec2-4abe-9392-0d34c7c47d3d" xlink:href="hae-20230401.xsd#hae_TenLargestCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7ad84341-e80b-4834-8b21-454c65c03f2f" xlink:to="loc_hae_TenLargestCustomersMember_cc9701e8-aec2-4abe-9392-0d34c7c47d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaCustomerCSLLimitedCSLMember_a5bd5cfa-92ef-426c-8b58-e576c1e51a4a" xlink:href="hae-20230401.xsd#hae_PlasmaCustomerCSLLimitedCSLMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7ad84341-e80b-4834-8b21-454c65c03f2f" xlink:to="loc_hae_PlasmaCustomerCSLLimitedCSLMember_a5bd5cfa-92ef-426c-8b58-e576c1e51a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a316a98b-8648-477e-b99c-ea376f0412a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a316a98b-8648-477e-b99c-ea376f0412a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9648b9a1-4720-4630-986c-1edc5eee43d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a316a98b-8648-477e-b99c-ea376f0412a9" xlink:to="loc_us-gaap_EquityComponentDomain_9648b9a1-4720-4630-986c-1edc5eee43d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6539d0aa-397a-4961-be68-84fd2ce26091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9648b9a1-4720-4630-986c-1edc5eee43d7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6539d0aa-397a-4961-be68-84fd2ce26091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_13052a52-e8ca-4000-92a1-4e6b020e44a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9648b9a1-4720-4630-986c-1edc5eee43d7" xlink:to="loc_us-gaap_RetainedEarningsMember_13052a52-e8ca-4000-92a1-4e6b020e44a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:href="hae-20230401.xsd#hae_SummaryOfSignificantAccountingPronouncementsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsTable_afe3383b-cb42-4767-8d66-ddd9a00776a3" xlink:to="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration_a8c8d9e9-f26f-427c-94ec-6184ff5aba3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration_a8c8d9e9-f26f-427c-94ec-6184ff5aba3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_MaximumTermOfMaturitiesForCashAndCashEquivalents_b7a8453f-3e12-4a55-a072-2b306464ff27" xlink:href="hae-20230401.xsd#hae_MaximumTermOfMaturitiesForCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_hae_MaximumTermOfMaturitiesForCashAndCashEquivalents_b7a8453f-3e12-4a55-a072-2b306464ff27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a7855cc5-1bfe-43ff-ac48-be6b7024b75d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a7855cc5-1bfe-43ff-ac48-be6b7024b75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SoftwareCapitalizationTerm_1cfbe209-d835-4dcd-bede-57646aea8344" xlink:href="hae-20230401.xsd#hae_SoftwareCapitalizationTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_hae_SoftwareCapitalizationTerm_1cfbe209-d835-4dcd-bede-57646aea8344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareImpairments1_4927e8e6-5681-44d7-9aaf-4f31cf38b79a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareImpairments1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareImpairments1_4927e8e6-5681-44d7-9aaf-4f31cf38b79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_405e3b95-c162-4f49-bdad-7ff3c758d605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_405e3b95-c162-4f49-bdad-7ff3c758d605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_06b740ae-cf5b-4cab-9534-461e15ce4bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_06b740ae-cf5b-4cab-9534-461e15ce4bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d5db76aa-0e3e-4bce-ab76-440e2c915326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_06b740ae-cf5b-4cab-9534-461e15ce4bcd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d5db76aa-0e3e-4bce-ab76-440e2c915326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_4821c64f-7760-4467-97e8-d86515a8c24a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_06b740ae-cf5b-4cab-9534-461e15ce4bcd" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_4821c64f-7760-4467-97e8-d86515a8c24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2bc5cdc4-ca4a-48c6-bd04-2437facd6607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_06b740ae-cf5b-4cab-9534-461e15ce4bcd" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2bc5cdc4-ca4a-48c6-bd04-2437facd6607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_68f453f6-9295-4e44-92ad-4b787b1ead17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_06b740ae-cf5b-4cab-9534-461e15ce4bcd" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_68f453f6-9295-4e44-92ad-4b787b1ead17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_c799f019-3de9-40ba-ba59-5c3f456f2142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_AdvertisingExpense_c799f019-3de9-40ba-ba59-5c3f456f2142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_d709742a-863d-43be-8712-8b843b6afdae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_d709742a-863d-43be-8712-8b843b6afdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_d2a4d7f5-aeac-4214-993e-0825ca4099ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_GainLossOnInvestments_d2a4d7f5-aeac-4214-993e-0825ca4099ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5944e2c0-e7c7-42c9-9f8e-1633c70831eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_StockholdersEquity_5944e2c0-e7c7-42c9-9f8e-1633c70831eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_adee80ed-a6e5-48d4-966c-76383cbac30a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_adee80ed-a6e5-48d4-966c-76383cbac30a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_bdc870c0-5fdf-42a5-b74a-1027c46bfb65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_SummaryOfSignificantAccountingPronouncementsLineItems_86292abe-bece-44f4-961f-580338d531bc" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_bdc870c0-5fdf-42a5-b74a-1027c46bfb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#RESTRUCTURINGNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4333ede9-b080-4c80-87cc-d47e7ceaf8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_65a3f1ce-b6b6-424e-a81a-ff0e3b6a08b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4333ede9-b080-4c80-87cc-d47e7ceaf8fa" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_65a3f1ce-b6b6-424e-a81a-ff0e3b6a08b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cb1d2315-602a-44ee-a9fb-ff3e52183162" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_65a3f1ce-b6b6-424e-a81a-ff0e3b6a08b4" xlink:to="loc_srt_RangeAxis_cb1d2315-602a-44ee-a9fb-ff3e52183162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a7b9115a-6016-477c-8ca8-98f636c1d0b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cb1d2315-602a-44ee-a9fb-ff3e52183162" xlink:to="loc_srt_RangeMember_a7b9115a-6016-477c-8ca8-98f636c1d0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cda76fbe-edfe-4acd-9174-ad4f778a700c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a7b9115a-6016-477c-8ca8-98f636c1d0b7" xlink:to="loc_srt_MinimumMember_cda76fbe-edfe-4acd-9174-ad4f778a700c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_afa5bde8-85fa-4738-8505-0b5e0c9ea00e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a7b9115a-6016-477c-8ca8-98f636c1d0b7" xlink:to="loc_srt_MaximumMember_afa5bde8-85fa-4738-8505-0b5e0c9ea00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_38a7c84b-cacf-424e-ade5-f0b696b760de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_65a3f1ce-b6b6-424e-a81a-ff0e3b6a08b4" xlink:to="loc_us-gaap_RestructuringPlanAxis_38a7c84b-cacf-424e-ade5-f0b696b760de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_cb7b0642-15b4-462e-b613-de9b169ea27a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_38a7c84b-cacf-424e-ade5-f0b696b760de" xlink:to="loc_us-gaap_RestructuringPlanDomain_cb7b0642-15b4-462e-b613-de9b169ea27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2020ProgramMember_3d280ff4-bc4f-42c0-b65f-7f81ebb6bcd0" xlink:href="hae-20230401.xsd#hae_A2020ProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_cb7b0642-15b4-462e-b613-de9b169ea27a" xlink:to="loc_hae_A2020ProgramMember_3d280ff4-bc4f-42c0-b65f-7f81ebb6bcd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_65a3f1ce-b6b6-424e-a81a-ff0e3b6a08b4" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_ec683e0f-db61-499b-a876-440716c3015f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_ec683e0f-db61-499b-a876-440716c3015f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandRestructuringRelatedCosts_5b0c34d3-c366-4caa-b597-a71c9a97bc06" xlink:href="hae-20230401.xsd#hae_RestructuringandRestructuringRelatedCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:to="loc_hae_RestructuringandRestructuringRelatedCosts_5b0c34d3-c366-4caa-b597-a71c9a97bc06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_5ff0ae04-5cbe-4120-ba39-2aa4f6dce8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_5ff0ae04-5cbe-4120-ba39-2aa4f6dce8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_a9ab48ca-2a2b-4a38-b8db-f6f4a039952e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:to="loc_us-gaap_RestructuringReserve_a9ab48ca-2a2b-4a38-b8db-f6f4a039952e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringChargesPayableInNextTwelveMonths_1079848b-b98a-4161-ba21-daebd85f6e89" xlink:href="hae-20230401.xsd#hae_RestructuringChargesPayableInNextTwelveMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:to="loc_hae_RestructuringChargesPayableInNextTwelveMonths_1079848b-b98a-4161-ba21-daebd85f6e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringRelatedCosts_7d957f7d-fde2-4d7c-a195-aa216706c8bf" xlink:href="hae-20230401.xsd#hae_RestructuringRelatedCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:to="loc_hae_RestructuringRelatedCosts_7d957f7d-fde2-4d7c-a195-aa216706c8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_614d08f5-533b-4548-a51d-7d4b61f1db8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_401152b9-ff78-4cbb-8968-167d1471d46d" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_614d08f5-533b-4548-a51d-7d4b61f1db8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9ee22ce1-18e7-4a34-b69b-e17b6f040725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9cae0ac5-89f8-4fc3-b4cf-cd0352bee0af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9ee22ce1-18e7-4a34-b69b-e17b6f040725" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9cae0ac5-89f8-4fc3-b4cf-cd0352bee0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e8ae6e2e-83ab-47bf-ba90-dd4b46a5825a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9cae0ac5-89f8-4fc3-b4cf-cd0352bee0af" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e8ae6e2e-83ab-47bf-ba90-dd4b46a5825a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f544320f-115a-404c-8556-f9110536a6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e8ae6e2e-83ab-47bf-ba90-dd4b46a5825a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f544320f-115a-404c-8556-f9110536a6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_499fff36-9225-4489-b2a5-b80068a4c65d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f544320f-115a-404c-8556-f9110536a6ea" xlink:to="loc_us-gaap_CostOfSalesMember_499fff36-9225-4489-b2a5-b80068a4c65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_b100c09e-9eac-4779-b7b5-6a5fea570083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f544320f-115a-404c-8556-f9110536a6ea" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_b100c09e-9eac-4779-b7b5-6a5fea570083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_53b1dffd-dc04-465c-a92a-75f6d14b6f55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f544320f-115a-404c-8556-f9110536a6ea" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_53b1dffd-dc04-465c-a92a-75f6d14b6f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_ecd9933e-e4f3-4a7d-b368-a21901f0365f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9cae0ac5-89f8-4fc3-b4cf-cd0352bee0af" xlink:to="loc_us-gaap_RestructuringPlanAxis_ecd9933e-e4f3-4a7d-b368-a21901f0365f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_7c597d7f-e6d2-4c47-8236-09abd4b91ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_ecd9933e-e4f3-4a7d-b368-a21901f0365f" xlink:to="loc_us-gaap_RestructuringPlanDomain_7c597d7f-e6d2-4c47-8236-09abd4b91ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2020ProgramMember_1da2c77c-6c6c-4bd3-8d48-eeb67672957c" xlink:href="hae-20230401.xsd#hae_A2020ProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_7c597d7f-e6d2-4c47-8236-09abd4b91ecd" xlink:to="loc_hae_A2020ProgramMember_1da2c77c-6c6c-4bd3-8d48-eeb67672957c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PriorRestructuringProgramsMember_6691c102-7685-4c73-8dec-d97daedec56b" xlink:href="hae-20230401.xsd#hae_PriorRestructuringProgramsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_7c597d7f-e6d2-4c47-8236-09abd4b91ecd" xlink:to="loc_hae_PriorRestructuringProgramsMember_6691c102-7685-4c73-8dec-d97daedec56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c8315f61-29bf-47d6-88b7-0a5b5a038662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9cae0ac5-89f8-4fc3-b4cf-cd0352bee0af" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c8315f61-29bf-47d6-88b7-0a5b5a038662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a7e5eaee-0bb7-4718-88ea-6d4417ce2b48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c8315f61-29bf-47d6-88b7-0a5b5a038662" xlink:to="loc_us-gaap_SegmentDomain_a7e5eaee-0bb7-4718-88ea-6d4417ce2b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaMember_17ce0d62-f0c8-4d66-9ce7-ea1c0e29dd68" xlink:href="hae-20230401.xsd#hae_PlasmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a7e5eaee-0bb7-4718-88ea-6d4417ce2b48" xlink:to="loc_hae_PlasmaMember_17ce0d62-f0c8-4d66-9ce7-ea1c0e29dd68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterMember_6d9802c8-98e9-4c6f-bd90-deeec8603a74" xlink:href="hae-20230401.xsd#hae_BloodCenterMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a7e5eaee-0bb7-4718-88ea-6d4417ce2b48" xlink:to="loc_hae_BloodCenterMember_6d9802c8-98e9-4c6f-bd90-deeec8603a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalMember_4c7188fb-11b7-405a-9172-d58c55847729" xlink:href="hae-20230401.xsd#hae_HospitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a7e5eaee-0bb7-4718-88ea-6d4417ce2b48" xlink:to="loc_hae_HospitalMember_4c7188fb-11b7-405a-9172-d58c55847729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_3d3af7f0-1a73-4170-bd5b-c43b251dd254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a7e5eaee-0bb7-4718-88ea-6d4417ce2b48" xlink:to="loc_us-gaap_AllOtherSegmentsMember_3d3af7f0-1a73-4170-bd5b-c43b251dd254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1e6f5691-b2a6-4425-84b7-bf425ce0a235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9cae0ac5-89f8-4fc3-b4cf-cd0352bee0af" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_1e6f5691-b2a6-4425-84b7-bf425ce0a235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_1687c747-29d7-4d41-b888-d517f153af4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e6f5691-b2a6-4425-84b7-bf425ce0a235" xlink:to="loc_us-gaap_RestructuringReserveRollForward_1687c747-29d7-4d41-b888-d517f153af4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_098cb700-b2a8-411a-b2ee-ab325a9c8f51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1687c747-29d7-4d41-b888-d517f153af4f" xlink:to="loc_us-gaap_RestructuringReserve_098cb700-b2a8-411a-b2ee-ab325a9c8f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_019afb00-6b9f-406c-b349-aae4bea97c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1687c747-29d7-4d41-b888-d517f153af4f" xlink:to="loc_us-gaap_RestructuringCharges_019afb00-6b9f-406c-b349-aae4bea97c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_5ef67e51-16a0-4249-a0c8-facfb6ce6b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1687c747-29d7-4d41-b888-d517f153af4f" xlink:to="loc_us-gaap_PaymentsForRestructuring_5ef67e51-16a0-4249-a0c8-facfb6ce6b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_d343db45-fec1-44b9-82d2-37d07d054128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_1687c747-29d7-4d41-b888-d517f153af4f" xlink:to="loc_us-gaap_RestructuringReserve_d343db45-fec1-44b9-82d2-37d07d054128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringRelatedCosts_9279dbfd-da42-4ea6-8f7b-81204e2643c8" xlink:href="hae-20230401.xsd#hae_RestructuringRelatedCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e6f5691-b2a6-4425-84b7-bf425ce0a235" xlink:to="loc_hae_RestructuringRelatedCosts_9279dbfd-da42-4ea6-8f7b-81204e2643c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandRestructuringRelatedCosts_9ece9c44-402e-48c7-b0b2-39233f28057a" xlink:href="hae-20230401.xsd#hae_RestructuringandRestructuringRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1e6f5691-b2a6-4425-84b7-bf425ce0a235" xlink:to="loc_hae_RestructuringandRestructuringRelatedCosts_9ece9c44-402e-48c7-b0b2-39233f28057a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITIONSDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#ACQUISITIONSDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/ACQUISITIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_cfb49b70-1f03-49d2-a735-7f8fe626212b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21ac2fb2-4fb5-4335-b61c-fd50bf1aa479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_cfb49b70-1f03-49d2-a735-7f8fe626212b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21ac2fb2-4fb5-4335-b61c-fd50bf1aa479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cc4df385-0687-4a3d-9e31-8aa04c829e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21ac2fb2-4fb5-4335-b61c-fd50bf1aa479" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cc4df385-0687-4a3d-9e31-8aa04c829e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37f0bdb6-7f85-440f-b5a8-4523b3016620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cc4df385-0687-4a3d-9e31-8aa04c829e63" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37f0bdb6-7f85-440f-b5a8-4523b3016620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CardivaMedicalIncMember_18f73c66-9ba8-4f30-8575-7db121eefaf4" xlink:href="hae-20230401.xsd#hae_CardivaMedicalIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37f0bdb6-7f85-440f-b5a8-4523b3016620" xlink:to="loc_hae_CardivaMedicalIncMember_18f73c66-9ba8-4f30-8575-7db121eefaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember_9c345aaf-1ee7-4772-9f28-803ddece7495" xlink:href="hae-20230401.xsd#hae_EnicorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37f0bdb6-7f85-440f-b5a8-4523b3016620" xlink:to="loc_hae_EnicorMember_9c345aaf-1ee7-4772-9f28-803ddece7495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HASIntellectualPropertyMember_ad5aefae-d97f-460e-92f5-d92e6d9a440f" xlink:href="hae-20230401.xsd#hae_HASIntellectualPropertyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37f0bdb6-7f85-440f-b5a8-4523b3016620" xlink:to="loc_hae_HASIntellectualPropertyMember_ad5aefae-d97f-460e-92f5-d92e6d9a440f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_d5231507-28d8-4f19-b941-cbd98078a1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21ac2fb2-4fb5-4335-b61c-fd50bf1aa479" xlink:to="loc_us-gaap_AssetAcquisitionAxis_d5231507-28d8-4f19-b941-cbd98078a1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_a5f68f63-6919-4183-a6ee-b9a4016ea095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_d5231507-28d8-4f19-b941-cbd98078a1c6" xlink:to="loc_us-gaap_AssetAcquisitionDomain_a5f68f63-6919-4183-a6ee-b9a4016ea095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HASIntellectualPropertyMember_807531f8-be4b-48d5-8788-cd589f3ff692" xlink:href="hae-20230401.xsd#hae_HASIntellectualPropertyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_a5f68f63-6919-4183-a6ee-b9a4016ea095" xlink:to="loc_hae_HASIntellectualPropertyMember_807531f8-be4b-48d5-8788-cd589f3ff692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember_36086036-516f-4a10-aeb2-dce510dcc234" xlink:href="hae-20230401.xsd#hae_EnicorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_a5f68f63-6919-4183-a6ee-b9a4016ea095" xlink:to="loc_hae_EnicorMember_36086036-516f-4a10-aeb2-dce510dcc234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5da7f8c7-f842-4bf9-ac93-485e2e0257f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21ac2fb2-4fb5-4335-b61c-fd50bf1aa479" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5da7f8c7-f842-4bf9-ac93-485e2e0257f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0050e69e-3786-405e-9e2e-958d7e8ed697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5da7f8c7-f842-4bf9-ac93-485e2e0257f7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0050e69e-3786-405e-9e2e-958d7e8ed697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2355e409-7397-4fef-b03e-2918e41a9441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0050e69e-3786-405e-9e2e-958d7e8ed697" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2355e409-7397-4fef-b03e-2918e41a9441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_8fabdbbe-67e5-46eb-8e40-f7f886c6dcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0050e69e-3786-405e-9e2e-958d7e8ed697" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_8fabdbbe-67e5-46eb-8e40-f7f886c6dcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_21ac2fb2-4fb5-4335-b61c-fd50bf1aa479" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b259181a-f6f7-441b-8292-bf21cbceeb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b259181a-f6f7-441b-8292-bf21cbceeb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7e4a585b-7ec8-447a-9da8-2ceaf7335d07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7e4a585b-7ec8-447a-9da8-2ceaf7335d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_fd250f14-f2e3-4af4-8c8b-cd73791e7da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_fd250f14-f2e3-4af4-8c8b-cd73791e7da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3d843af0-2f29-40e4-83ce-eaa8fb6c8ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3d843af0-2f29-40e4-83ce-eaa8fb6c8ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_760b11ef-e25f-42e0-a553-64952a7c716c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_760b11ef-e25f-42e0-a553-64952a7c716c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_12052229-e1dd-49cb-96f4-f0edffa874a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_12052229-e1dd-49cb-96f4-f0edffa874a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_3e8a25b2-6cca-4f83-ad71-8482e33c486a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_3e8a25b2-6cca-4f83-ad71-8482e33c486a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7e21a9f9-4598-46a2-bd1f-c61d91a2d94e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_Goodwill_7e21a9f9-4598-46a2-bd1f-c61d91a2d94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_9f25111b-3561-4fc9-bb4f-c5a17d420004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_9f25111b-3561-4fc9-bb4f-c5a17d420004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_7d0f4243-19ed-4493-862b-4ee6483c8f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_7d0f4243-19ed-4493-862b-4ee6483c8f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_a93f3492-4866-43a6-b201-e1d77a044570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_a93f3492-4866-43a6-b201-e1d77a044570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_37080219-4dd2-4007-9c36-6f80c3b35cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_37080219-4dd2-4007-9c36-6f80c3b35cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetAcquisitionMilestonePayment_d30900e2-dce8-47b1-ad84-9ed69c8bb31f" xlink:href="hae-20230401.xsd#hae_AssetAcquisitionMilestonePayment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_hae_AssetAcquisitionMilestonePayment_d30900e2-dce8-47b1-ad84-9ed69c8bb31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate_89991d63-2724-4055-a096-9a0e72ad08d7" xlink:href="hae-20230401.xsd#hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate_89991d63-2724-4055-a096-9a0e72ad08d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_c0b4acee-f230-40aa-be0a-abb66eff65b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9624e69e-4323-4636-9004-b4ae1806cb54" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_c0b4acee-f230-40aa-be0a-abb66eff65b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#ACQUISITIONSPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_ee33bd63-8e2f-49a0-a246-516832189169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d20290d5-326d-4f5f-9b4e-fb5550f8643a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_ee33bd63-8e2f-49a0-a246-516832189169" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d20290d5-326d-4f5f-9b4e-fb5550f8643a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_00d083a0-4f3d-4437-8ae3-d849f2e9cdb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d20290d5-326d-4f5f-9b4e-fb5550f8643a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_00d083a0-4f3d-4437-8ae3-d849f2e9cdb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b854ec2-c1c3-43f6-b9ce-73f0622a43ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_00d083a0-4f3d-4437-8ae3-d849f2e9cdb9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b854ec2-c1c3-43f6-b9ce-73f0622a43ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CardivaMedicalIncMember_10aef90e-b2cb-4f1d-8680-f1213f411198" xlink:href="hae-20230401.xsd#hae_CardivaMedicalIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b854ec2-c1c3-43f6-b9ce-73f0622a43ac" xlink:to="loc_hae_CardivaMedicalIncMember_10aef90e-b2cb-4f1d-8680-f1213f411198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember_ffa8b544-180c-4365-b4e2-d9f3f4e6f833" xlink:href="hae-20230401.xsd#hae_EnicorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b854ec2-c1c3-43f6-b9ce-73f0622a43ac" xlink:to="loc_hae_EnicorMember_ffa8b544-180c-4365-b4e2-d9f3f4e6f833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d20290d5-326d-4f5f-9b4e-fb5550f8643a" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_27f2bbb1-2255-4003-839c-770817605f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_27f2bbb1-2255-4003-839c-770817605f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_09dff74d-55db-4393-9aea-5bed556a7469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_09dff74d-55db-4393-9aea-5bed556a7469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_4372f840-c595-4c56-8b20-a785a0de1e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_4372f840-c595-4c56-8b20-a785a0de1e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_42821fa0-7499-41fb-a86e-6f200991cc91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_42821fa0-7499-41fb-a86e-6f200991cc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a3fc7979-9287-4545-a985-ee117c0e8a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a3fc7979-9287-4545-a985-ee117c0e8a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1fc7414f-272e-42f2-be76-005ae9cea8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1fc7414f-272e-42f2-be76-005ae9cea8b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f73f57ce-6956-401a-bd31-321584eedf95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_Goodwill_f73f57ce-6956-401a-bd31-321584eedf95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_75e444db-76cc-4937-b6b8-1f26e5bd3fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_75e444db-76cc-4937-b6b8-1f26e5bd3fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_e6a8cb63-d57c-4667-aa6f-ca06cc4d2f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_e6a8cb63-d57c-4667-aa6f-ca06cc4d2f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_673496b3-2153-43a2-b286-3a5212d1f720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_673496b3-2153-43a2-b286-3a5212d1f720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts_1e2c5125-3f2b-427f-b7d5-cb62823c7636" xlink:href="hae-20230401.xsd#hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts_1e2c5125-3f2b-427f-b7d5-cb62823c7636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_619bcf1e-a51a-4891-8bdd-20016cecbaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_619bcf1e-a51a-4891-8bdd-20016cecbaf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d123f9c2-7115-4d32-9c5a-5f4a903f4415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d123f9c2-7115-4d32-9c5a-5f4a903f4415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_5f40bdca-95bf-4957-b4ed-e5c98fe5eba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_5f40bdca-95bf-4957-b4ed-e5c98fe5eba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7a375d27-b07a-4776-a714-1f6bbc34e7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7a375d27-b07a-4776-a714-1f6bbc34e7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0119adde-b0ae-4b2b-b671-fe6f51442685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_da29023d-501c-4ca9-94b7-3186c5ec8f25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0119adde-b0ae-4b2b-b671-fe6f51442685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#ACQUISITIONSIntangibleAssetsAcquiredDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_52c64e14-a394-4f98-a8bd-a246fdc9c8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b9d5ed33-f6af-46e0-9fcb-96f8ec0093a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_52c64e14-a394-4f98-a8bd-a246fdc9c8a5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b9d5ed33-f6af-46e0-9fcb-96f8ec0093a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4562cc77-804d-453f-b69e-5b4b956aa5cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b9d5ed33-f6af-46e0-9fcb-96f8ec0093a8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4562cc77-804d-453f-b69e-5b4b956aa5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c63878d3-3144-42e3-b404-750cfee05b68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4562cc77-804d-453f-b69e-5b4b956aa5cf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c63878d3-3144-42e3-b404-750cfee05b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CardivaMedicalIncMember_45c39c52-a590-483f-97d3-83cd3dcd9350" xlink:href="hae-20230401.xsd#hae_CardivaMedicalIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c63878d3-3144-42e3-b404-750cfee05b68" xlink:to="loc_hae_CardivaMedicalIncMember_45c39c52-a590-483f-97d3-83cd3dcd9350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember_05e622d9-3822-4dbd-a824-08613deb0401" xlink:href="hae-20230401.xsd#hae_EnicorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c63878d3-3144-42e3-b404-750cfee05b68" xlink:to="loc_hae_EnicorMember_05e622d9-3822-4dbd-a824-08613deb0401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e8f9ab90-f218-4a08-ad96-7a5b0037c432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b9d5ed33-f6af-46e0-9fcb-96f8ec0093a8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e8f9ab90-f218-4a08-ad96-7a5b0037c432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f7b19aec-230c-4408-a065-5d38195d6551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e8f9ab90-f218-4a08-ad96-7a5b0037c432" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f7b19aec-230c-4408-a065-5d38195d6551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dcac282b-3dc1-4fa1-acc8-7ab4d751731e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f7b19aec-230c-4408-a065-5d38195d6551" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dcac282b-3dc1-4fa1-acc8-7ab4d751731e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_0eda566c-cb59-4555-ad1d-c55008f35b44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f7b19aec-230c-4408-a065-5d38195d6551" xlink:to="loc_us-gaap_CustomerRelationshipsMember_0eda566c-cb59-4555-ad1d-c55008f35b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_622b88f9-a5de-400a-a7b3-f9d1d01d2404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f7b19aec-230c-4408-a065-5d38195d6551" xlink:to="loc_us-gaap_TrademarksMember_622b88f9-a5de-400a-a7b3-f9d1d01d2404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fff4f4a4-3dc0-4bad-9b76-88c4be5ae2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b9d5ed33-f6af-46e0-9fcb-96f8ec0093a8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fff4f4a4-3dc0-4bad-9b76-88c4be5ae2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f955a69c-eaf3-4516-a3e4-6d02b3b45736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fff4f4a4-3dc0-4bad-9b76-88c4be5ae2fb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f955a69c-eaf3-4516-a3e4-6d02b3b45736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_5b2eee2b-1368-4496-83cc-5682af6df038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f955a69c-eaf3-4516-a3e4-6d02b3b45736" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_5b2eee2b-1368-4496-83cc-5682af6df038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_42fcd39d-57ad-40ca-9f48-91bb35eb0e76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b9d5ed33-f6af-46e0-9fcb-96f8ec0093a8" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_42fcd39d-57ad-40ca-9f48-91bb35eb0e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_87fa61e6-1be0-431d-8f95-53590c63f52e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_42fcd39d-57ad-40ca-9f48-91bb35eb0e76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_87fa61e6-1be0-431d-8f95-53590c63f52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_f50a1452-21a2-4d73-bc7c-24fe27c06f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_42fcd39d-57ad-40ca-9f48-91bb35eb0e76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_f50a1452-21a2-4d73-bc7c-24fe27c06f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_b90fd7b3-6355-4c04-b258-dae85080640a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_42fcd39d-57ad-40ca-9f48-91bb35eb0e76" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_b90fd7b3-6355-4c04-b258-dae85080640a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate_7ed43641-778f-448b-a6b0-c7633187e1e3" xlink:href="hae-20230401.xsd#hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_42fcd39d-57ad-40ca-9f48-91bb35eb0e76" xlink:to="loc_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate_7ed43641-778f-448b-a6b0-c7633187e1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/STRATEGICINVESTMENTSDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#STRATEGICINVESTMENTSDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/STRATEGICINVESTMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f8b4a786-72e9-46f6-83e1-16d7d455fb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_d14e12cd-b883-4d0b-9bfd-2e277157dc55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f8b4a786-72e9-46f6-83e1-16d7d455fb48" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_d14e12cd-b883-4d0b-9bfd-2e277157dc55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c5f017a4-a8a4-4074-bc04-253258c5269d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_d14e12cd-b883-4d0b-9bfd-2e277157dc55" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c5f017a4-a8a4-4074-bc04-253258c5269d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d7b6b09b-b499-42e2-8492-1e5fc990d939" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c5f017a4-a8a4-4074-bc04-253258c5269d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d7b6b09b-b499-42e2-8492-1e5fc990d939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_VivasureMedicalLTDMember_30d10ea4-bc88-4ba8-8d04-bc994ef78aa9" xlink:href="hae-20230401.xsd#hae_VivasureMedicalLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d7b6b09b-b499-42e2-8492-1e5fc990d939" xlink:to="loc_hae_VivasureMedicalLTDMember_30d10ea4-bc88-4ba8-8d04-bc994ef78aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_b0d94d0c-9b1a-42b8-93f5-e9e56f0320f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_d14e12cd-b883-4d0b-9bfd-2e277157dc55" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_b0d94d0c-9b1a-42b8-93f5-e9e56f0320f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_3a57d1d1-d337-46be-9e4a-84a612f5af92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b0d94d0c-9b1a-42b8-93f5-e9e56f0320f0" xlink:to="loc_us-gaap_GainLossOnInvestments_3a57d1d1-d337-46be-9e4a-84a612f5af92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_98cc9850-8a77-4667-a03d-7b67bdc779c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_b0d94d0c-9b1a-42b8-93f5-e9e56f0320f0" xlink:to="loc_us-gaap_Investments_98cc9850-8a77-4667-a03d-7b67bdc779c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/DIVESTITUREDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#DIVESTITUREDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/DIVESTITUREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4efd7687-fa0e-46cf-8ba0-08e873aca8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0ba5dde9-10d8-49d8-9b31-2a24ede563c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4efd7687-fa0e-46cf-8ba0-08e873aca8cc" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0ba5dde9-10d8-49d8-9b31-2a24ede563c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0213c51b-9717-4ec1-bdc8-4c72d3ea09e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0ba5dde9-10d8-49d8-9b31-2a24ede563c7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0213c51b-9717-4ec1-bdc8-4c72d3ea09e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9502eda1-f202-40f2-8244-7ec530119f77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0213c51b-9717-4ec1-bdc8-4c72d3ea09e3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9502eda1-f202-40f2-8244-7ec530119f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_FajardoPuertoRicoManufacturingOperationsMember_4d97997b-c69a-427c-b4fc-4bf89f965293" xlink:href="hae-20230401.xsd#hae_FajardoPuertoRicoManufacturingOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9502eda1-f202-40f2-8244-7ec530119f77" xlink:to="loc_hae_FajardoPuertoRicoManufacturingOperationsMember_4d97997b-c69a-427c-b4fc-4bf89f965293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_USBloodDonorManagementSoftwareMember_f072927b-042b-48f7-92b3-5c3a5627287c" xlink:href="hae-20230401.xsd#hae_USBloodDonorManagementSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9502eda1-f202-40f2-8244-7ec530119f77" xlink:to="loc_hae_USBloodDonorManagementSoftwareMember_f072927b-042b-48f7-92b3-5c3a5627287c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InlogHoldingsFranceMember_800cc058-4c3a-4ccc-9d70-5aff99382a0c" xlink:href="hae-20230401.xsd#hae_InlogHoldingsFranceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9502eda1-f202-40f2-8244-7ec530119f77" xlink:to="loc_hae_InlogHoldingsFranceMember_800cc058-4c3a-4ccc-9d70-5aff99382a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_05de7116-682e-4845-9e46-69bb78233e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0ba5dde9-10d8-49d8-9b31-2a24ede563c7" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_05de7116-682e-4845-9e46-69bb78233e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1d2b2738-0a03-444d-b686-ad2fb9119499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_05de7116-682e-4845-9e46-69bb78233e7d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1d2b2738-0a03-444d-b686-ad2fb9119499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_3695ce17-d796-4c1a-bf3e-22ffc230627d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_1d2b2738-0a03-444d-b686-ad2fb9119499" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_3695ce17-d796-4c1a-bf3e-22ffc230627d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0ba5dde9-10d8-49d8-9b31-2a24ede563c7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ac358292-cda7-4cf8-a711-8f1bb9451542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ac358292-cda7-4cf8-a711-8f1bb9451542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_d87d8de3-cd8e-4b60-9dd5-2e16f604e3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_d87d8de3-cd8e-4b60-9dd5-2e16f604e3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_35e937f8-ef3f-42e8-9261-3e765d0e2ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_AssetImpairmentCharges_35e937f8-ef3f-42e8-9261-3e765d0e2ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments_f399beb2-8854-4c34-b707-09ee7ea29f2c" xlink:href="hae-20230401.xsd#hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments_f399beb2-8854-4c34-b707-09ee7ea29f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell_d5118378-4e21-4eda-afa0-30e0555bb1b7" xlink:href="hae-20230401.xsd#hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell_d5118378-4e21-4eda-afa0-30e0555bb1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_b5b7d99a-d524-4215-9cc0-9abe7b436f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_b5b7d99a-d524-4215-9cc0-9abe7b436f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_4e056d30-0d05-4544-a002-acdf883eac9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_4e056d30-0d05-4544-a002-acdf883eac9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_58e7492c-d2ae-4092-8c29-f374f20dc99d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_58e7492c-d2ae-4092-8c29-f374f20dc99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5278cd85-8bac-463d-981d-7b88481c3218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_Goodwill_5278cd85-8bac-463d-981d-7b88481c3218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments_fc1958c8-a94b-4d98-8108-d16620f899b0" xlink:href="hae-20230401.xsd#hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments_fc1958c8-a94b-4d98-8108-d16620f899b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_91d96877-512e-4244-a17c-2aa577010081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_91d96877-512e-4244-a17c-2aa577010081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_8a903621-1605-4935-900d-323812bb4bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_8a903621-1605-4935-900d-323812bb4bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_34fa2f8f-31ce-42cc-b21a-6c1f74b25cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_34fa2f8f-31ce-42cc-b21a-6c1f74b25cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_416addd8-8f94-46fb-a214-a53416f7faf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_416addd8-8f94-46fb-a214-a53416f7faf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_54e758cc-58f2-4b59-b2a1-e49b8c782a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_54e758cc-58f2-4b59-b2a1-e49b8c782a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_9f33c748-4a7f-426b-b419-fb35d65b3269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_9f33c748-4a7f-426b-b419-fb35d65b3269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived_d1de3a40-e1fd-41a0-b9e2-e4378f62e7cc" xlink:href="hae-20230401.xsd#hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_de0e7268-3a72-4102-97e9-430ab56d7734" xlink:to="loc_hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived_d1de3a40-e1fd-41a0-b9e2-e4378f62e7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#INCOMETAXESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_15103017-3f7f-4463-a8d5-f70970349098" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_e9121c8c-a0bb-4ed4-9f62-457ee7b1b915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_15103017-3f7f-4463-a8d5-f70970349098" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_e9121c8c-a0bb-4ed4-9f62-457ee7b1b915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c5326104-9763-40f8-8914-9d35e92b583f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_e9121c8c-a0bb-4ed4-9f62-457ee7b1b915" xlink:to="loc_srt_StatementGeographicalAxis_c5326104-9763-40f8-8914-9d35e92b583f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e9c82cc9-0176-46f4-975c-36669a343778" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c5326104-9763-40f8-8914-9d35e92b583f" xlink:to="loc_srt_SegmentGeographicalDomain_e9c82cc9-0176-46f4-975c-36669a343778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_MY_fda7886f-bccc-4ce3-b895-d4324dad3c61" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MY"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e9c82cc9-0176-46f4-975c-36669a343778" xlink:to="loc_country_MY_fda7886f-bccc-4ce3-b895-d4324dad3c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b1eeda1a-5a8b-42d8-9fdf-ba7b3b6e74e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_e9121c8c-a0bb-4ed4-9f62-457ee7b1b915" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b1eeda1a-5a8b-42d8-9fdf-ba7b3b6e74e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_a6dba364-29b3-4d30-8714-b4659394f21e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b1eeda1a-5a8b-42d8-9fdf-ba7b3b6e74e3" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_a6dba364-29b3-4d30-8714-b4659394f21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_a2e909a8-e86a-4192-bd02-681bd38b2ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_a6dba364-29b3-4d30-8714-b4659394f21e" xlink:to="loc_us-gaap_DomesticCountryMember_a2e909a8-e86a-4192-bd02-681bd38b2ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_c41e4795-e27e-43f5-b6d2-a7686b64985e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_a6dba364-29b3-4d30-8714-b4659394f21e" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_c41e4795-e27e-43f5-b6d2-a7686b64985e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_d2faf1a1-93aa-4a8b-ae56-42d9fd6aa22a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_a6dba364-29b3-4d30-8714-b4659394f21e" xlink:to="loc_us-gaap_ForeignCountryMember_d2faf1a1-93aa-4a8b-ae56-42d9fd6aa22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0a0ec683-8705-4b3f-b1cc-f8df399dcebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_e9121c8c-a0bb-4ed4-9f62-457ee7b1b915" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0a0ec683-8705-4b3f-b1cc-f8df399dcebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_59b32a9f-2b0c-47e3-bc4c-5b1de55177eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0a0ec683-8705-4b3f-b1cc-f8df399dcebb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_59b32a9f-2b0c-47e3-bc4c-5b1de55177eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CardivaMedicalIncMember_e4b23da0-a636-49b9-8879-ed1f4157ce93" xlink:href="hae-20230401.xsd#hae_CardivaMedicalIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_59b32a9f-2b0c-47e3-bc4c-5b1de55177eb" xlink:to="loc_hae_CardivaMedicalIncMember_e4b23da0-a636-49b9-8879-ed1f4157ce93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:href="hae-20230401.xsd#hae_IncomeTaxesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_e9121c8c-a0bb-4ed4-9f62-457ee7b1b915" xlink:to="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TaxHolidayTerm_cefec14d-362f-48e2-84e3-7c94673ee6ae" xlink:href="hae-20230401.xsd#hae_TaxHolidayTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_hae_TaxHolidayTerm_cefec14d-362f-48e2-84e3-7c94673ee6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_83af404f-6b23-4e30-aa74-fd6bea295542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_83af404f-6b23-4e30-aa74-fd6bea295542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_9550d03e-59cf-40d9-a76b-b7322317b3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_9550d03e-59cf-40d9-a76b-b7322317b3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_7d429ee2-cece-4098-9f7d-71b22db9a0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_OperatingLossCarryforwards_7d429ee2-cece-4098-9f7d-71b22db9a0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_cd41da7d-a4b8-4dd6-90e0-af6b481fed02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_cd41da7d-a4b8-4dd6-90e0-af6b481fed02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_776a6458-0cc9-416d-bf95-f6f09e636054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_776a6458-0cc9-416d-bf95-f6f09e636054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_d38dd315-4fa1-4074-a940-b77f6ed799b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_d38dd315-4fa1-4074-a940-b77f6ed799b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_81cc0cde-7d3f-4ecb-907c-c6aeb53882d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_81cc0cde-7d3f-4ecb-907c-c6aeb53882d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_1a99c7b2-7975-4f8e-96ce-21ee873927a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_1a99c7b2-7975-4f8e-96ce-21ee873927a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_8b3ef9f1-a12e-47ec-b665-95ac0472c360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_8b3ef9f1-a12e-47ec-b665-95ac0472c360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3c35e831-df94-4b7f-8119-6b42caccc638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3c35e831-df94-4b7f-8119-6b42caccc638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount_c5f90877-490a-4af9-8aeb-9f452176c37c" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount_c5f90877-490a-4af9-8aeb-9f452176c37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7de1f4fb-20d9-4da3-941a-c7011f5c2af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7de1f4fb-20d9-4da3-941a-c7011f5c2af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8e81bf6c-c20d-48d6-bb6d-721789070bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8e81bf6c-c20d-48d6-bb6d-721789070bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_e09b7ea0-2557-49f2-986a-65ed40872940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_e09b7ea0-2557-49f2-986a-65ed40872940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_c75ced09-ecf3-4d63-90dc-718f04cec90f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_c75ced09-ecf3-4d63-90dc-718f04cec90f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_9563ec15-184f-4258-89ba-001342b5c019" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_9563ec15-184f-4258-89ba-001342b5c019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_0fdd427f-61f0-44a0-8d65-9ec32d67f78b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_0fdd427f-61f0-44a0-8d65-9ec32d67f78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense_9acd73c0-7822-49eb-a111-212b167205cc" xlink:href="hae-20230401.xsd#hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense_9acd73c0-7822-49eb-a111-212b167205cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards_b9a1cf2e-5bd9-4b0d-8f68-d55f1927cac3" xlink:href="hae-20230401.xsd#hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards_b9a1cf2e-5bd9-4b0d-8f68-d55f1927cac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch_dfb43921-d46d-465a-80ed-9db53cf98cf9" xlink:href="hae-20230401.xsd#hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch_dfb43921-d46d-465a-80ed-9db53cf98cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_401f570c-bf17-415a-8529-c5ae91ebd551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_IncomeTaxesLineItems_6388aad7-2493-4554-a664-2ee63eaee70d" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_401f570c-bf17-415a-8529-c5ae91ebd551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d05a89fc-7832-4ac8-8145-23e76692a30c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_257f2e3e-5428-423a-8c2b-452e5adeacf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d05a89fc-7832-4ac8-8145-23e76692a30c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_257f2e3e-5428-423a-8c2b-452e5adeacf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_62f6d978-26ed-4782-88a1-2a43bf224fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d05a89fc-7832-4ac8-8145-23e76692a30c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_62f6d978-26ed-4782-88a1-2a43bf224fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1f0fbce1-ffc7-437d-a9a1-58714f84d93b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d05a89fc-7832-4ac8-8145-23e76692a30c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1f0fbce1-ffc7-437d-a9a1-58714f84d93b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5959e736-3507-488f-ad51-321b73fdb846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1d5f011b-539d-40bc-88b1-4fed1a76b9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5959e736-3507-488f-ad51-321b73fdb846" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1d5f011b-539d-40bc-88b1-4fed1a76b9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_a5e3f421-4177-4a0b-9d52-893b032bb896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1d5f011b-539d-40bc-88b1-4fed1a76b9ad" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_a5e3f421-4177-4a0b-9d52-893b032bb896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_0d1df8c6-be9b-4a65-a4d4-e1de18227c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1d5f011b-539d-40bc-88b1-4fed1a76b9ad" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_0d1df8c6-be9b-4a65-a4d4-e1de18227c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_55485696-70e8-40c6-b4f2-0ba74d7c51a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1d5f011b-539d-40bc-88b1-4fed1a76b9ad" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_55485696-70e8-40c6-b4f2-0ba74d7c51a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6b207da6-beab-48d5-9c59-47f0d54dcda0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1d5f011b-539d-40bc-88b1-4fed1a76b9ad" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6b207da6-beab-48d5-9c59-47f0d54dcda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c04b74d6-1d9a-4037-854f-04a7fa43b12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5959e736-3507-488f-ad51-321b73fdb846" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c04b74d6-1d9a-4037-854f-04a7fa43b12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_836d6f51-ab34-4ca9-915e-3a9a925dc495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c04b74d6-1d9a-4037-854f-04a7fa43b12f" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_836d6f51-ab34-4ca9-915e-3a9a925dc495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_9d7b9ecc-5b80-43bb-980d-766e86e42112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c04b74d6-1d9a-4037-854f-04a7fa43b12f" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_9d7b9ecc-5b80-43bb-980d-766e86e42112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_86813825-8103-46ee-bad9-887ee51d2a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c04b74d6-1d9a-4037-854f-04a7fa43b12f" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_86813825-8103-46ee-bad9-887ee51d2a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7c5365a9-25e8-4a76-80d4-9313228f6bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c04b74d6-1d9a-4037-854f-04a7fa43b12f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7c5365a9-25e8-4a76-80d4-9313228f6bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_56646dee-c67b-436b-884a-a50e32a1d154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c04b74d6-1d9a-4037-854f-04a7fa43b12f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_56646dee-c67b-436b-884a-a50e32a1d154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#INCOMETAXESScheduleofNetDeferredTaxAssetDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxAssetsDepreciation_5647a5da-8ac3-4c5e-b3e0-1954919ec8fe" xlink:href="hae-20230401.xsd#hae_DeferredTaxAssetsDepreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_hae_DeferredTaxAssetsDepreciation_5647a5da-8ac3-4c5e-b3e0-1954919ec8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxAssetsAmortization_e34f0423-7e2c-46a3-866f-f7191ee81c75" xlink:href="hae-20230401.xsd#hae_DeferredTaxAssetsAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_hae_DeferredTaxAssetsAmortization_e34f0423-7e2c-46a3-866f-f7191ee81c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_bf177633-0021-4575-a296-c8eed64a3e76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_bf177633-0021-4575-a296-c8eed64a3e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_a3380258-b8f3-4c65-b206-3b0deb296a03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_a3380258-b8f3-4c65-b206-3b0deb296a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f83114e5-617e-49a3-bc93-240c35689787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f83114e5-617e-49a3-bc93-240c35689787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_78317561-48f6-4026-844c-fb19195ee8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_78317561-48f6-4026-844c-fb19195ee8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxAssetsOperatingLeaseLiability_39dab00e-f095-46b6-ba6f-2d335580ccd4" xlink:href="hae-20230401.xsd#hae_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_hae_DeferredTaxAssetsOperatingLeaseLiability_39dab00e-f095-46b6-ba6f-2d335580ccd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_2ecff357-45a8-431c-a116-30de554b59b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_2ecff357-45a8-431c-a116-30de554b59b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxAssetsResearchExpensesCapitalized_231ec6b4-bcb8-49b1-85f2-72fbfcdb8530" xlink:href="hae-20230401.xsd#hae_DeferredTaxAssetsResearchExpensesCapitalized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_hae_DeferredTaxAssetsResearchExpensesCapitalized_231ec6b4-bcb8-49b1-85f2-72fbfcdb8530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_b33917d4-7c51-4150-929d-22c6f5b40b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_b33917d4-7c51-4150-929d-22c6f5b40b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_49a9ea3d-b179-4e24-b2ba-c5f4438e28ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_49a9ea3d-b179-4e24-b2ba-c5f4438e28ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_d5955a38-f7f2-43dd-9fbe-94cb59b97725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_d5955a38-f7f2-43dd-9fbe-94cb59b97725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxLiabilitiesDepreciation_60b67fc4-ebc3-4699-a94d-4e13d4d60457" xlink:href="hae-20230401.xsd#hae_DeferredTaxLiabilitiesDepreciation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_hae_DeferredTaxLiabilitiesDepreciation_60b67fc4-ebc3-4699-a94d-4e13d4d60457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxLiabilitiesAmortization_460ca989-1aad-4257-9c75-e0535b4afce7" xlink:href="hae-20230401.xsd#hae_DeferredTaxLiabilitiesAmortization"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_hae_DeferredTaxLiabilitiesAmortization_460ca989-1aad-4257-9c75-e0535b4afce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_1e8ec2c9-9886-428d-a7e3-3db9d8877b29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_1e8ec2c9-9886-428d-a7e3-3db9d8877b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset_6202094a-69b6-4dba-b9c8-19ac9968fb0f" xlink:href="hae-20230401.xsd#hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset_6202094a-69b6-4dba-b9c8-19ac9968fb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_bf646225-fbda-405c-b79b-abff96f51251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_bf646225-fbda-405c-b79b-abff96f51251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_0f541330-c61c-4ea1-a87e-64dd4b4b5c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_0f541330-c61c-4ea1-a87e-64dd4b4b5c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_41906b88-bccb-453a-8542-da85d654a190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40e768d6-ab68-4c33-8d18-1c5bfe35bee3" xlink:to="loc_us-gaap_DeferredTaxLiabilities_41906b88-bccb-453a-8542-da85d654a190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3580b823-ba4e-4530-8a60-48fa02654235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3580b823-ba4e-4530-8a60-48fa02654235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_21c83dfc-9de7-4254-8d6f-7a5266dbb298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_21c83dfc-9de7-4254-8d6f-7a5266dbb298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_efbc04ac-b9d6-42fa-a4b5-86345ee1b476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_efbc04ac-b9d6-42fa-a4b5-86345ee1b476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_471c4f24-97fc-4379-af3f-461fdbe57cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_471c4f24-97fc-4379-af3f-461fdbe57cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_9564cef1-3733-44dc-af11-3e4708ad5893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_9564cef1-3733-44dc-af11-3e4708ad5893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_47323dc3-93b2-4ce9-9c06-a6cf8790730b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_47323dc3-93b2-4ce9-9c06-a6cf8790730b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_IncomeTaxReconciliationChangeinUncertainTaxPositions_75086e61-bf64-4b40-a27c-488e62401f9f" xlink:href="hae-20230401.xsd#hae_IncomeTaxReconciliationChangeinUncertainTaxPositions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_hae_IncomeTaxReconciliationChangeinUncertainTaxPositions_75086e61-bf64-4b40-a27c-488e62401f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions_7a49af9d-ca28-48bb-be2c-82dae0f12e84" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions_7a49af9d-ca28-48bb-be2c-82dae0f12e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount_9ab65e43-1d80-46cc-9362-fb15d17cb965" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount_9ab65e43-1d80-46cc-9362-fb15d17cb965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent_f6b43c81-0616-4a31-925e-fcd400e5d59e" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent_f6b43c81-0616-4a31-925e-fcd400e5d59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount_0dfabcb3-f00c-4614-b03c-f3285a587e6e" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount_0dfabcb3-f00c-4614-b03c-f3285a587e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent_c8ec1140-398a-4626-8424-f086b6537a62" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent_c8ec1140-398a-4626-8424-f086b6537a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_62dd9019-3140-4f3d-9828-b0987313406d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_62dd9019-3140-4f3d-9828-b0987313406d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_dceba207-3ae1-49ef-a382-6d922a3c8c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_dceba207-3ae1-49ef-a382-6d922a3c8c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_962af28e-7701-4325-ada1-6065a710c6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_962af28e-7701-4325-ada1-6065a710c6ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_28fa9f39-415b-4890-aa71-537b9ec628a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_28fa9f39-415b-4890-aa71-537b9ec628a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_a8a06522-2b8b-480d-90ee-dd5a9bce6554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_a8a06522-2b8b-480d-90ee-dd5a9bce6554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_0ad062a2-3425-4b14-89ff-30de34142b08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_0ad062a2-3425-4b14-89ff-30de34142b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_38d53d44-e2bf-4b39-98be-78daa4de5f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_38d53d44-e2bf-4b39-98be-78daa4de5f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_9da7bae0-795f-4d83-a819-13d71cae8bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_9da7bae0-795f-4d83-a819-13d71cae8bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_4120b642-a609-4270-ab3a-43ee816eddf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_4120b642-a609-4270-ab3a-43ee816eddf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_2e946758-7c13-4eb1-8d2c-0f875e5bace2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_2e946758-7c13-4eb1-8d2c-0f875e5bace2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount_a8047dd4-76a4-45ac-b794-32267db7d990" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount_a8047dd4-76a4-45ac-b794-32267db7d990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent_7d0496f7-9102-4cbb-a100-57af43bb2ea0" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent_7d0496f7-9102-4cbb-a100-57af43bb2ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty_29521858-96a3-47fb-92de-7fc2bf9aa995" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty_29521858-96a3-47fb-92de-7fc2bf9aa995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent_0f59de06-bac0-41d3-a8a8-5c613633a437" xlink:href="hae-20230401.xsd#hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent_0f59de06-bac0-41d3-a8a8-5c613633a437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_acbf1f48-e539-4880-9a44-efca8ac4a5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_acbf1f48-e539-4880-9a44-efca8ac4a5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_01813661-8985-4a49-8bbe-0f732f670e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_01813661-8985-4a49-8bbe-0f732f670e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_94f4c30f-3e94-490f-a654-927ceb56a424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_94f4c30f-3e94-490f-a654-927ceb56a424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_d5620a45-e9b7-45db-8c97-4c1753242d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_d5620a45-e9b7-45db-8c97-4c1753242d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_47487bc9-4945-454a-ab44-8509755059d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_47487bc9-4945-454a-ab44-8509755059d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_783504ce-48ce-41b3-b354-d4f018635f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba97acc7-7fc8-445f-afc2-e1d6d2a21a9c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_783504ce-48ce-41b3-b354-d4f018635f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXESSummaryofGrossUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#INCOMETAXESSummaryofGrossUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXESSummaryofGrossUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1b1acf0e-3a3f-411f-a7da-c854696ff791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_85a32bde-8cfa-45ff-8c37-a03264c88115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b1acf0e-3a3f-411f-a7da-c854696ff791" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_85a32bde-8cfa-45ff-8c37-a03264c88115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_35888537-02e4-4ba2-a3ec-d22dbac86024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_85a32bde-8cfa-45ff-8c37-a03264c88115" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_35888537-02e4-4ba2-a3ec-d22dbac86024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_504bef4c-d9ca-49cb-9c91-cf2661b13b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_85a32bde-8cfa-45ff-8c37-a03264c88115" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_504bef4c-d9ca-49cb-9c91-cf2661b13b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_87eac541-08bc-455f-a3a9-ab0326b111ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_85a32bde-8cfa-45ff-8c37-a03264c88115" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_87eac541-08bc-455f-a3a9-ab0326b111ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_51e1b7fa-df11-4a42-9cfb-603869072073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_85a32bde-8cfa-45ff-8c37-a03264c88115" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_51e1b7fa-df11-4a42-9cfb-603869072073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_a01bf16d-4016-496e-b05f-dec536e4c3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_85a32bde-8cfa-45ff-8c37-a03264c88115" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_a01bf16d-4016-496e-b05f-dec536e4c3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_54c74ad9-e3c4-4b27-a834-67b3fb5a1063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_85a32bde-8cfa-45ff-8c37-a03264c88115" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_54c74ad9-e3c4-4b27-a834-67b3fb5a1063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_75bc6f52-c0e0-40c0-b802-09cb13d7cb58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_64a4b6ba-3f27-4bfa-9856-a339c3c9681c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75bc6f52-c0e0-40c0-b802-09cb13d7cb58" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_64a4b6ba-3f27-4bfa-9856-a339c3c9681c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1a450782-9b94-4e2c-993a-17683cf8d5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_64a4b6ba-3f27-4bfa-9856-a339c3c9681c" xlink:to="loc_us-gaap_NetIncomeLoss_1a450782-9b94-4e2c-993a-17683cf8d5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b6a9ca2a-0bcd-40c7-a898-f0c3e8a1e33b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_64a4b6ba-3f27-4bfa-9856-a339c3c9681c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b6a9ca2a-0bcd-40c7-a898-f0c3e8a1e33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_80610e0d-ee8e-4465-93cd-a76cf4055a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_64a4b6ba-3f27-4bfa-9856-a339c3c9681c" xlink:to="loc_us-gaap_EarningsPerShareBasic_80610e0d-ee8e-4465-93cd-a76cf4055a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_bd94b12c-f076-4f69-98b1-49e25ec886a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75bc6f52-c0e0-40c0-b802-09cb13d7cb58" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_bd94b12c-f076-4f69-98b1-49e25ec886a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6a1ec0b4-44cf-4a2e-bfe8-fe2e7be5aa42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_bd94b12c-f076-4f69-98b1-49e25ec886a6" xlink:to="loc_us-gaap_NetIncomeLoss_6a1ec0b4-44cf-4a2e-bfe8-fe2e7be5aa42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_31584240-5f2e-42a8-ba8a-4c44fe63a033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_bd94b12c-f076-4f69-98b1-49e25ec886a6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_31584240-5f2e-42a8-ba8a-4c44fe63a033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_5cbebe30-c41c-4fea-bcc5-2e3a9eaf7ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_bd94b12c-f076-4f69-98b1-49e25ec886a6" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_5cbebe30-c41c-4fea-bcc5-2e3a9eaf7ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_586694fb-f848-4bf6-a75c-b789e4cbe35b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_bd94b12c-f076-4f69-98b1-49e25ec886a6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_586694fb-f848-4bf6-a75c-b789e4cbe35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2b330780-8fc7-4f04-beb0-017f947dcc58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_bd94b12c-f076-4f69-98b1-49e25ec886a6" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2b330780-8fc7-4f04-beb0-017f947dcc58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a6405df3-ea6c-448f-8f94-99ee02cf6882" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75bc6f52-c0e0-40c0-b802-09cb13d7cb58" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a6405df3-ea6c-448f-8f94-99ee02cf6882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#EARNINGSPERSHAREShareRepurchasePlanDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_aea02d04-e3b8-48bd-b947-fc10a8d82b24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_70fdf9f0-7e86-4335-a719-4b5be11c9826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_aea02d04-e3b8-48bd-b947-fc10a8d82b24" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_70fdf9f0-7e86-4335-a719-4b5be11c9826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_af9ccece-45b2-4405-8ecd-b0430105f2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_70fdf9f0-7e86-4335-a719-4b5be11c9826" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_af9ccece-45b2-4405-8ecd-b0430105f2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_abc33ed0-4081-407c-a6bc-5eb1d90ca961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_af9ccece-45b2-4405-8ecd-b0430105f2d2" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_abc33ed0-4081-407c-a6bc-5eb1d90ca961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2022AcceleratedShareRepurchaseProgramMember_21b33ef5-ab50-4263-8852-7b915213fa5a" xlink:href="hae-20230401.xsd#hae_A2022AcceleratedShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_abc33ed0-4081-407c-a6bc-5eb1d90ca961" xlink:to="loc_hae_A2022AcceleratedShareRepurchaseProgramMember_21b33ef5-ab50-4263-8852-7b915213fa5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_70fdf9f0-7e86-4335-a719-4b5be11c9826" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_78f9ba2a-2a0d-4be4-85b7-11a08c0301a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_78f9ba2a-2a0d-4be4-85b7-11a08c0301a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_8d0b05a0-48ef-4597-9d74-44430950cb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_8d0b05a0-48ef-4597-9d74-44430950cb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_40dcfa99-db09-40f3-9940-0e1d74fc56d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_40dcfa99-db09-40f3-9940-0e1d74fc56d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_187c9aec-c109-4a76-a55d-f37f93fa5950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_187c9aec-c109-4a76-a55d-f37f93fa5950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_19f84815-85db-4ae3-a57b-9f14a188078b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_19f84815-85db-4ae3-a57b-9f14a188078b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_8a1a4c87-7bd3-4e69-b1b8-bbacdc409890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_1a4ed77b-2cfc-488e-b2f8-942a53003b86" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_8a1a4c87-7bd3-4e69-b1b8-bbacdc409890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/REVENUEDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#REVENUEDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/REVENUEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_24fd566e-52af-4add-a461-f578125d87c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_ec07d352-bea6-4801-8396-3dd7eb5c5f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_24fd566e-52af-4add-a461-f578125d87c3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_ec07d352-bea6-4801-8396-3dd7eb5c5f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration_b86d0f19-ad9d-49d1-a218-b105c889a6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_24fd566e-52af-4add-a461-f578125d87c3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration_b86d0f19-ad9d-49d1-a218-b105c889a6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_4b5c8a19-dd23-4d65-af8c-4ef5f3db0673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_24fd566e-52af-4add-a461-f578125d87c3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_4b5c8a19-dd23-4d65-af8c-4ef5f3db0673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_5f11f44d-5ec0-41fc-8483-6f042e03232b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_24fd566e-52af-4add-a461-f578125d87c3" xlink:to="loc_us-gaap_ContractWithCustomerLiability_5f11f44d-5ec0-41fc-8483-6f042e03232b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_96ec26bb-9c0f-43c1-ac24-818f93d4ce8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_24fd566e-52af-4add-a461-f578125d87c3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_96ec26bb-9c0f-43c1-ac24-818f93d4ce8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#REVENUEPerformanceObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c2986b41-903f-4fcc-914e-a76ace0549eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_f9ec3c4e-7acd-45da-8e08-5c6d71cdcec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c2986b41-903f-4fcc-914e-a76ace0549eb" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_f9ec3c4e-7acd-45da-8e08-5c6d71cdcec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_a2526d2d-7289-4672-810f-779759059610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_f9ec3c4e-7acd-45da-8e08-5c6d71cdcec2" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_a2526d2d-7289-4672-810f-779759059610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_bed912fd-f24a-4dcf-ba26-8ff07d4d7560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_f9ec3c4e-7acd-45da-8e08-5c6d71cdcec2" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_bed912fd-f24a-4dcf-ba26-8ff07d4d7560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5ab0db45-7e83-4bbc-abe1-2b5c42880c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_bed912fd-f24a-4dcf-ba26-8ff07d4d7560" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5ab0db45-7e83-4bbc-abe1-2b5c42880c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="hae-20230401.xsd#REVENUEPerformanceObligationsDetails_1"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#INVENTORIESScheduleofInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_65093dc3-57a1-4b21-a928-ae65079df21b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_6afb52ff-800a-4155-8762-4e98f3c58e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_65093dc3-57a1-4b21-a928-ae65079df21b" xlink:to="loc_us-gaap_InventoryRawMaterials_6afb52ff-800a-4155-8762-4e98f3c58e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_c355112a-05b5-4c92-b259-750f177268d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_65093dc3-57a1-4b21-a928-ae65079df21b" xlink:to="loc_us-gaap_InventoryWorkInProcess_c355112a-05b5-4c92-b259-750f177268d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_83218428-65fc-4870-b1ad-43b9face9343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_65093dc3-57a1-4b21-a928-ae65079df21b" xlink:to="loc_us-gaap_InventoryFinishedGoods_83218428-65fc-4870-b1ad-43b9face9343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_bdb57219-8e4e-4c4f-842f-80909aed30d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_65093dc3-57a1-4b21-a928-ae65079df21b" xlink:to="loc_us-gaap_InventoryNet_bdb57219-8e4e-4c4f-842f-80909aed30d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2523bd35-66f8-47db-9a49-6cabd4b4f5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33c1ea47-2cf9-4289-9189-8019f5edad45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2523bd35-66f8-47db-9a49-6cabd4b4f5b8" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33c1ea47-2cf9-4289-9189-8019f5edad45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_85588970-70fc-4be8-8f95-fb8125664cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33c1ea47-2cf9-4289-9189-8019f5edad45" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_85588970-70fc-4be8-8f95-fb8125664cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_85588970-70fc-4be8-8f95-fb8125664cc5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_fb7e760a-bb4e-4a31-88ff-ffc1ece275b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:to="loc_us-gaap_LandMember_fb7e760a-bb4e-4a31-88ff-ffc1ece275b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_bee6c929-599b-4fac-a15d-a0a98255b894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_bee6c929-599b-4fac-a15d-a0a98255b894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_209e30a3-65a7-4e81-98c8-cbd67c850e05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_209e30a3-65a7-4e81-98c8-cbd67c850e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OfficeEquipmentAndInformationTechnologyMember_4dd5d7ac-d3ad-4d47-906d-843c7c92ddb4" xlink:href="hae-20230401.xsd#hae_OfficeEquipmentAndInformationTechnologyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:to="loc_hae_OfficeEquipmentAndInformationTechnologyMember_4dd5d7ac-d3ad-4d47-906d-843c7c92ddb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HaemoneticsEquipmentMember_8bb209b2-1987-4c66-89ab-0f1a249d6fb2" xlink:href="hae-20230401.xsd#hae_HaemoneticsEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:to="loc_hae_HaemoneticsEquipmentMember_8bb209b2-1987-4c66-89ab-0f1a249d6fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_faa8ea95-eabb-44d0-9438-c906b2651a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a22e38ab-20a0-4c8c-af2a-6794ffca33e7" xlink:to="loc_us-gaap_ConstructionInProgressMember_faa8ea95-eabb-44d0-9438-c906b2651a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_a6c9952b-4bca-46e2-9aa6-a54edb06e82e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33c1ea47-2cf9-4289-9189-8019f5edad45" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_a6c9952b-4bca-46e2-9aa6-a54edb06e82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_ee52de54-dc96-4dda-aeff-0b6faa03c78b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_a6c9952b-4bca-46e2-9aa6-a54edb06e82e" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_ee52de54-dc96-4dda-aeff-0b6faa03c78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetImpairmentsMember_11b99bfe-1d9d-4d79-ae11-d266ec4f6aa2" xlink:href="hae-20230401.xsd#hae_AssetImpairmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_ee52de54-dc96-4dda-aeff-0b6faa03c78b" xlink:to="loc_hae_AssetImpairmentsMember_11b99bfe-1d9d-4d79-ae11-d266ec4f6aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_f928a32f-b1ba-44fa-be4d-e7c1bfd122e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33c1ea47-2cf9-4289-9189-8019f5edad45" xlink:to="loc_us-gaap_RestructuringPlanAxis_f928a32f-b1ba-44fa-be4d-e7c1bfd122e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_74430352-b916-447a-858c-aae86d6d4411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_f928a32f-b1ba-44fa-be4d-e7c1bfd122e6" xlink:to="loc_us-gaap_RestructuringPlanDomain_74430352-b916-447a-858c-aae86d6d4411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2020ProgramMember_567e416b-ad5e-4a5d-8a88-444d03556bfe" xlink:href="hae-20230401.xsd#hae_A2020ProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_74430352-b916-447a-858c-aae86d6d4411" xlink:to="loc_hae_A2020ProgramMember_567e416b-ad5e-4a5d-8a88-444d03556bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8ca693e0-ed9c-480b-8dcd-a61e3dcf461b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33c1ea47-2cf9-4289-9189-8019f5edad45" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8ca693e0-ed9c-480b-8dcd-a61e3dcf461b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_b6a87271-53d5-4d91-8e4c-02a6006c0592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8ca693e0-ed9c-480b-8dcd-a61e3dcf461b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_b6a87271-53d5-4d91-8e4c-02a6006c0592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_aa592594-ee64-4314-9a2a-80fe3550b130" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8ca693e0-ed9c-480b-8dcd-a61e3dcf461b" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_aa592594-ee64-4314-9a2a-80fe3550b130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_636a0025-6438-4ee0-b4b2-45e694f8f160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8ca693e0-ed9c-480b-8dcd-a61e3dcf461b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_636a0025-6438-4ee0-b4b2-45e694f8f160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_d345f216-dc6b-4f43-a326-373dab8cc323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8ca693e0-ed9c-480b-8dcd-a61e3dcf461b" xlink:to="loc_us-gaap_Depreciation_d345f216-dc6b-4f43-a326-373dab8cc323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_f4f5c2ad-e33e-44b2-b242-5e6e09511ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8ca693e0-ed9c-480b-8dcd-a61e3dcf461b" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_f4f5c2ad-e33e-44b2-b242-5e6e09511ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#GOODWILLANDINTANGIBLEASSETSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b2d0e0e8-d3ce-4bcc-a001-b33da7af60ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5bd7e01c-36ba-4e98-a74f-03130b724875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b2d0e0e8-d3ce-4bcc-a001-b33da7af60ca" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5bd7e01c-36ba-4e98-a74f-03130b724875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4c7d72ae-2ac0-4ada-97c4-5e206e017d00" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5bd7e01c-36ba-4e98-a74f-03130b724875" xlink:to="loc_srt_RangeAxis_4c7d72ae-2ac0-4ada-97c4-5e206e017d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_73101dec-b44e-4a42-81d8-aa68208cbc9f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4c7d72ae-2ac0-4ada-97c4-5e206e017d00" xlink:to="loc_srt_RangeMember_73101dec-b44e-4a42-81d8-aa68208cbc9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ad0b4d9e-e07e-4009-ad90-c7a9a0cefa01" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_73101dec-b44e-4a42-81d8-aa68208cbc9f" xlink:to="loc_srt_MinimumMember_ad0b4d9e-e07e-4009-ad90-c7a9a0cefa01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_86ff032b-c44c-42d4-8bd2-b215eb1f75ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_73101dec-b44e-4a42-81d8-aa68208cbc9f" xlink:to="loc_srt_MaximumMember_86ff032b-c44c-42d4-8bd2-b215eb1f75ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7504cb08-f56a-4450-bd4e-43c934e51163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5bd7e01c-36ba-4e98-a74f-03130b724875" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7504cb08-f56a-4450-bd4e-43c934e51163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_5303b030-4244-48f3-a294-560329b0bbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7504cb08-f56a-4450-bd4e-43c934e51163" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_5303b030-4244-48f3-a294-560329b0bbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3f21e4c8-4919-45cd-ac6e-e808ecc5464b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7504cb08-f56a-4450-bd4e-43c934e51163" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3f21e4c8-4919-45cd-ac6e-e808ecc5464b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_9114068d-1b4c-4078-806e-bdb3203e57e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7504cb08-f56a-4450-bd4e-43c934e51163" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_9114068d-1b4c-4078-806e-bdb3203e57e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_715b69bf-2c6d-4555-a829-32a65c8aff38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7504cb08-f56a-4450-bd4e-43c934e51163" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_715b69bf-2c6d-4555-a829-32a65c8aff38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2af48eab-bf57-42d8-8843-dfa47bd09eae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b2d0e0e8-d3ce-4bcc-a001-b33da7af60ca" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2af48eab-bf57-42d8-8843-dfa47bd09eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7b179fa5-31a2-42d1-aa7a-b538f32f9af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2af48eab-bf57-42d8-8843-dfa47bd09eae" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7b179fa5-31a2-42d1-aa7a-b538f32f9af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_631a4960-ddee-4f90-ad54-49a3e1203808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7b179fa5-31a2-42d1-aa7a-b538f32f9af3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_631a4960-ddee-4f90-ad54-49a3e1203808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_867e745d-3054-4118-8486-a53d0e13aba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_631a4960-ddee-4f90-ad54-49a3e1203808" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_867e745d-3054-4118-8486-a53d0e13aba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_4e6b9575-c7d0-4fd3-8807-6cb144093a60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2af48eab-bf57-42d8-8843-dfa47bd09eae" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_4e6b9575-c7d0-4fd3-8807-6cb144093a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers_774fb3c8-23d6-41a7-8d22-78d5ae353b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_4e6b9575-c7d0-4fd3-8807-6cb144093a60" xlink:to="loc_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers_774fb3c8-23d6-41a7-8d22-78d5ae353b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5cd0f270-a1eb-427b-81be-83baab824f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5a26475e-c41c-4d58-90c3-11aa99aa77e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5cd0f270-a1eb-427b-81be-83baab824f6e" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5a26475e-c41c-4d58-90c3-11aa99aa77e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d6e35f42-c73e-4830-8dd7-c63d9c9f4e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5a26475e-c41c-4d58-90c3-11aa99aa77e2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d6e35f42-c73e-4830-8dd7-c63d9c9f4e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_da863e82-de36-45d5-83a3-7f38a9779f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d6e35f42-c73e-4830-8dd7-c63d9c9f4e5e" xlink:to="loc_us-gaap_SegmentDomain_da863e82-de36-45d5-83a3-7f38a9779f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaMember_c0575a48-b45b-45d3-b862-c774c5fcaa0e" xlink:href="hae-20230401.xsd#hae_PlasmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_da863e82-de36-45d5-83a3-7f38a9779f2e" xlink:to="loc_hae_PlasmaMember_c0575a48-b45b-45d3-b862-c774c5fcaa0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterMember_0ced6d97-de7a-43b1-9f9f-a4447492a6bc" xlink:href="hae-20230401.xsd#hae_BloodCenterMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_da863e82-de36-45d5-83a3-7f38a9779f2e" xlink:to="loc_hae_BloodCenterMember_0ced6d97-de7a-43b1-9f9f-a4447492a6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalMember_0ac4bdb5-1407-4a09-a632-8775581cab58" xlink:href="hae-20230401.xsd#hae_HospitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_da863e82-de36-45d5-83a3-7f38a9779f2e" xlink:to="loc_hae_HospitalMember_0ac4bdb5-1407-4a09-a632-8775581cab58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_94ef27ca-88cb-4cad-b165-fd97074b5aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5a26475e-c41c-4d58-90c3-11aa99aa77e2" xlink:to="loc_us-gaap_GoodwillLineItems_94ef27ca-88cb-4cad-b165-fd97074b5aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_ddede7a2-55e0-40a8-8705-73525da12cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_94ef27ca-88cb-4cad-b165-fd97074b5aa3" xlink:to="loc_us-gaap_GoodwillRollForward_ddede7a2-55e0-40a8-8705-73525da12cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_23a68163-e132-4c95-9529-31b4166d28d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ddede7a2-55e0-40a8-8705-73525da12cf3" xlink:to="loc_us-gaap_Goodwill_23a68163-e132-4c95-9529-31b4166d28d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_dd26c5c3-04c2-4ab7-92f4-186e45a283f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ddede7a2-55e0-40a8-8705-73525da12cf3" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_dd26c5c3-04c2-4ab7-92f4-186e45a283f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_cdc74cfa-18fc-408d-90a9-ce828d37b89c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ddede7a2-55e0-40a8-8705-73525da12cf3" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_cdc74cfa-18fc-408d-90a9-ce828d37b89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_44d96637-07e7-4760-870c-e664a25aa8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ddede7a2-55e0-40a8-8705-73525da12cf3" xlink:to="loc_us-gaap_Goodwill_44d96637-07e7-4760-870c-e664a25aa8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6c378615-11fb-4be7-9a99-a772f85140fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_94ef27ca-88cb-4cad-b165-fd97074b5aa3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6c378615-11fb-4be7-9a99-a772f85140fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1b704570-6982-462c-bce6-8f5eb7fa5760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_94ef27ca-88cb-4cad-b165-fd97074b5aa3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1b704570-6982-462c-bce6-8f5eb7fa5760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a86d8cb2-275c-43fc-8a2b-764b70745702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_94ef27ca-88cb-4cad-b165-fd97074b5aa3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a86d8cb2-275c-43fc-8a2b-764b70745702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8349c9a7-b3ef-4636-8bbc-7e9aa4383ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_94ef27ca-88cb-4cad-b165-fd97074b5aa3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8349c9a7-b3ef-4636-8bbc-7e9aa4383ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a601dc74-b4c8-479c-aada-26ceb243dc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_f66e837e-3fcb-4510-bbe7-fc2f07ba1de5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a601dc74-b4c8-479c-aada-26ceb243dc9c" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_f66e837e-3fcb-4510-bbe7-fc2f07ba1de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_aa7fef94-8d91-4ed3-a1c9-2b8880554cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_f66e837e-3fcb-4510-bbe7-fc2f07ba1de5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_aa7fef94-8d91-4ed3-a1c9-2b8880554cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5d7efe3e-90a4-4d9d-bcc4-433d17aee286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_aa7fef94-8d91-4ed3-a1c9-2b8880554cba" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5d7efe3e-90a4-4d9d-bcc4-433d17aee286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InProcessSoftwareDevelopmentMember_86fb1e39-5654-4e67-8b60-195c7d2a78f2" xlink:href="hae-20230401.xsd#hae_InProcessSoftwareDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5d7efe3e-90a4-4d9d-bcc4-433d17aee286" xlink:to="loc_hae_InProcessSoftwareDevelopmentMember_86fb1e39-5654-4e67-8b60-195c7d2a78f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_3dc81981-0326-4f2e-925e-d7ca44d91604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5d7efe3e-90a4-4d9d-bcc4-433d17aee286" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_3dc81981-0326-4f2e-925e-d7ca44d91604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InProcessPatentsMember_0edf70bb-b0cd-4ed8-a512-4e49c910839b" xlink:href="hae-20230401.xsd#hae_InProcessPatentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5d7efe3e-90a4-4d9d-bcc4-433d17aee286" xlink:to="loc_hae_InProcessPatentsMember_0edf70bb-b0cd-4ed8-a512-4e49c910839b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_d1dc1803-de9b-46ca-baf5-294c377e7755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_f66e837e-3fcb-4510-bbe7-fc2f07ba1de5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_d1dc1803-de9b-46ca-baf5-294c377e7755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_49cca7e7-d51f-432d-bd98-3a0be801a6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_d1dc1803-de9b-46ca-baf5-294c377e7755" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_49cca7e7-d51f-432d-bd98-3a0be801a6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_aa0eec78-234b-4d04-92a5-180e811f3981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_49cca7e7-d51f-432d-bd98-3a0be801a6ef" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_aa0eec78-234b-4d04-92a5-180e811f3981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_663cb842-79b8-4aac-aca7-ab81df7771af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a601dc74-b4c8-479c-aada-26ceb243dc9c" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_663cb842-79b8-4aac-aca7-ab81df7771af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1dbae9d4-7e35-44f6-93b3-c1f32b3fbf2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_663cb842-79b8-4aac-aca7-ab81df7771af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1dbae9d4-7e35-44f6-93b3-c1f32b3fbf2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f3a4cba-b84d-48d1-80ce-e917cca04e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1dbae9d4-7e35-44f6-93b3-c1f32b3fbf2b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f3a4cba-b84d-48d1-80ce-e917cca04e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_c99d17ec-52ac-48fa-a6d9-55513fca2042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f3a4cba-b84d-48d1-80ce-e917cca04e7e" xlink:to="loc_us-gaap_PatentsMember_c99d17ec-52ac-48fa-a6d9-55513fca2042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_0cfd3a2e-c72d-49fa-a332-710d022247a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f3a4cba-b84d-48d1-80ce-e917cca04e7e" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_0cfd3a2e-c72d-49fa-a332-710d022247a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherTechnologyMember_cfb97af6-4cb4-45a4-b404-1fd3c1df7c85" xlink:href="hae-20230401.xsd#hae_OtherTechnologyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f3a4cba-b84d-48d1-80ce-e917cca04e7e" xlink:to="loc_hae_OtherTechnologyMember_cfb97af6-4cb4-45a4-b404-1fd3c1df7c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_b29d11cb-e62b-4136-8e87-c274e32823a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f3a4cba-b84d-48d1-80ce-e917cca04e7e" xlink:to="loc_us-gaap_CustomerContractsMember_b29d11cb-e62b-4136-8e87-c274e32823a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a93d6389-8118-4230-a0ee-31110add437c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f3a4cba-b84d-48d1-80ce-e917cca04e7e" xlink:to="loc_us-gaap_TradeNamesMember_a93d6389-8118-4230-a0ee-31110add437c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_663cb842-79b8-4aac-aca7-ab81df7771af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_353c69ce-e376-42e2-9493-a9293ae43c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_353c69ce-e376-42e2-9493-a9293ae43c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c4ee2a82-d03e-4789-b8e8-58ec20271f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_353c69ce-e376-42e2-9493-a9293ae43c20" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c4ee2a82-d03e-4789-b8e8-58ec20271f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_27a0f3f8-b927-412f-aba2-8be30d55903e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_353c69ce-e376-42e2-9493-a9293ae43c20" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_27a0f3f8-b927-412f-aba2-8be30d55903e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1f0d4197-478b-4db6-acf6-71c3378cfc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_353c69ce-e376-42e2-9493-a9293ae43c20" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1f0d4197-478b-4db6-acf6-71c3378cfc9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c3fe28e5-c496-4758-a539-0d2263635dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c3fe28e5-c496-4758-a539-0d2263635dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_973bff57-e955-4a45-8f47-817f5b201d40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_973bff57-e955-4a45-8f47-817f5b201d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3a59e7d1-6a6a-4fdb-938f-034b75ff6862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3a59e7d1-6a6a-4fdb-938f-034b75ff6862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_48dc82dd-4258-4d9c-8c43-d176ced13343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_48dc82dd-4258-4d9c-8c43-d176ced13343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_fd5f360b-2396-4ebe-8866-b1abf2fabb49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_fd5f360b-2396-4ebe-8866-b1abf2fabb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_75f23442-3b08-45b9-a383-507390af510f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_75f23442-3b08-45b9-a383-507390af510f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_50551928-bf3d-4e7a-8441-f2aaea8d3b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d03eb20d-ad91-475b-bac4-d021dfab33e0" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_50551928-bf3d-4e7a-8441-f2aaea8d3b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/LEASESDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#LEASESDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/LEASESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2fded3c1-1b26-485d-986d-bf06dab2ba4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_47033d89-b48c-4416-a18b-825b31836267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2fded3c1-1b26-485d-986d-bf06dab2ba4a" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_47033d89-b48c-4416-a18b-825b31836267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_33c3ed9f-fe3a-48e8-b18b-5e73d49e075e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_47033d89-b48c-4416-a18b-825b31836267" xlink:to="loc_srt_RangeAxis_33c3ed9f-fe3a-48e8-b18b-5e73d49e075e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3de0b6a6-8f8c-4c81-9b89-0545fb5362d4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_33c3ed9f-fe3a-48e8-b18b-5e73d49e075e" xlink:to="loc_srt_RangeMember_3de0b6a6-8f8c-4c81-9b89-0545fb5362d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8afa4705-cd6f-4de9-b1a4-5470a5945003" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3de0b6a6-8f8c-4c81-9b89-0545fb5362d4" xlink:to="loc_srt_MinimumMember_8afa4705-cd6f-4de9-b1a4-5470a5945003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9bfa2c04-41a5-4dd4-bb78-6d0ae93808c5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3de0b6a6-8f8c-4c81-9b89-0545fb5362d4" xlink:to="loc_srt_MaximumMember_9bfa2c04-41a5-4dd4-bb78-6d0ae93808c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0bfa01c9-b71a-4112-8d28-6af46d9ea6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_47033d89-b48c-4416-a18b-825b31836267" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0bfa01c9-b71a-4112-8d28-6af46d9ea6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c75f25ed-4267-4e30-9cf4-c980a7b2e0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0bfa01c9-b71a-4112-8d28-6af46d9ea6f0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c75f25ed-4267-4e30-9cf4-c980a7b2e0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ManufacturingSpaceMember_6dc4c7bf-5aab-4e6a-b481-750ae0202eed" xlink:href="hae-20230401.xsd#hae_ManufacturingSpaceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c75f25ed-4267-4e30-9cf4-c980a7b2e0b0" xlink:to="loc_hae_ManufacturingSpaceMember_6dc4c7bf-5aab-4e6a-b481-750ae0202eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ManufacturingSpaceSecondRenewalTermMember_35b902b0-26b9-4d8b-bafb-dc64ef5ff47e" xlink:href="hae-20230401.xsd#hae_ManufacturingSpaceSecondRenewalTermMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c75f25ed-4267-4e30-9cf4-c980a7b2e0b0" xlink:to="loc_hae_ManufacturingSpaceSecondRenewalTermMember_35b902b0-26b9-4d8b-bafb-dc64ef5ff47e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_47033d89-b48c-4416-a18b-825b31836267" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_02e1a854-c917-4276-b8ee-84febfa578ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_02e1a854-c917-4276-b8ee-84febfa578ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_c8f880ce-1453-4d8e-ad21-a014bb1041ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_c8f880ce-1453-4d8e-ad21-a014bb1041ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fcf6c95d-980d-4c7d-a116-d55151fc762e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_fcf6c95d-980d-4c7d-a116-d55151fc762e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7654026e-6fd1-48a2-a2aa-44cc0d984cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseLiability_7654026e-6fd1-48a2-a2aa-44cc0d984cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_556ba897-bc44-451a-9978-c4ac95c68f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_556ba897-bc44-451a-9978-c4ac95c68f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f2cd6f0a-1c8e-4298-929d-cd9222357645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f2cd6f0a-1c8e-4298-929d-cd9222357645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7ea5f34f-4dc2-4500-b514-c8c306aff7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7ea5f34f-4dc2-4500-b514-c8c306aff7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_18c703f1-7958-4be8-8f8b-17f7eef70750" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_18c703f1-7958-4be8-8f8b-17f7eef70750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_d09e5b9a-d878-45d3-8534-53fcdec8d1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseCost_d09e5b9a-d878-45d3-8534-53fcdec8d1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_f0532689-9b61-4c0a-b0b6-e4636be85081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeasePayments_f0532689-9b61-4c0a-b0b6-e4636be85081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3e663af8-a6d2-40ea-a411-92d617a528a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3e663af8-a6d2-40ea-a411-92d617a528a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d95d11b8-4613-429d-a5d3-3f30550ba79f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d95d11b8-4613-429d-a5d3-3f30550ba79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_cddca0e3-f9e5-4ff2-8b7a-37859e0ee707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_cddca0e3-f9e5-4ff2-8b7a-37859e0ee707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_368c08fd-1e4e-4ab8-90dd-46c83c90b68f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_368c08fd-1e4e-4ab8-90dd-46c83c90b68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_23759018-9751-44f2-9dbc-c1aaf4361f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_23759018-9751-44f2-9dbc-c1aaf4361f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7c871ace-7d30-454c-91a2-03aea39266f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7c871ace-7d30-454c-91a2-03aea39266f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c9625752-a057-4328-804e-94599f64c713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c9625752-a057-4328-804e-94599f64c713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_26eddf38-d597-4f10-8069-d2305ae336a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_26eddf38-d597-4f10-8069-d2305ae336a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_918b7a76-f866-4394-831f-cfdcd315f702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_918b7a76-f866-4394-831f-cfdcd315f702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_df3f2002-dd15-4540-ad75-6b6a106819de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_df3f2002-dd15-4540-ad75-6b6a106819de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_fa7af953-efe4-4a63-8429-0457ac7f0f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_fa7af953-efe4-4a63-8429-0457ac7f0f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_744ac772-5b3a-4b42-b7ae-9cd3d747b92f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_744ac772-5b3a-4b42-b7ae-9cd3d747b92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_6eebf2ab-cdff-48f8-a933-373518500bff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_6eebf2ab-cdff-48f8-a933-373518500bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales_7461f0a9-5d51-416e-a668-fbcfae6ce017" xlink:href="hae-20230401.xsd#hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_36b22929-ef4d-4cbb-a764-bb0d1901047d" xlink:to="loc_hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales_7461f0a9-5d51-416e-a668-fbcfae6ce017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2b632c37-93f9-475f-8b4f-45d02cb8a116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c768f511-25b7-471d-8801-90f251ec12b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2b632c37-93f9-475f-8b4f-45d02cb8a116" xlink:to="loc_us-gaap_DebtInstrumentTable_c768f511-25b7-471d-8801-90f251ec12b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d4e71777-e2d0-40f0-8be9-62537ca7cff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c768f511-25b7-471d-8801-90f251ec12b1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d4e71777-e2d0-40f0-8be9-62537ca7cff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d4e71777-e2d0-40f0-8be9-62537ca7cff9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TermLoanNetofFinancingFeesMember_7d8eb164-c386-497d-8c85-36669ccdb26f" xlink:href="hae-20230401.xsd#hae_TermLoanNetofFinancingFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:to="loc_hae_TermLoanNetofFinancingFeesMember_7d8eb164-c386-497d-8c85-36669ccdb26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BankLoansandOtherBorrowingMember_a11591b7-fb8b-4110-92de-0212d392aef5" xlink:href="hae-20230401.xsd#hae_BankLoansandOtherBorrowingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:to="loc_hae_BankLoansandOtherBorrowingMember_a11591b7-fb8b-4110-92de-0212d392aef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_7b46bbd9-3a3f-4817-8f2b-dcb07f1e5a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:to="loc_us-gaap_ConvertibleDebtMember_7b46bbd9-3a3f-4817-8f2b-dcb07f1e5a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_c79d3235-2de0-4d47-9f4d-56984a687340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:to="loc_us-gaap_UnsecuredDebtMember_c79d3235-2de0-4d47-9f4d-56984a687340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_72bd1476-bdc2-4033-b088-f3cee64581f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:to="loc_us-gaap_LineOfCreditMember_72bd1476-bdc2-4033-b088-f3cee64581f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_2737aed3-0b82-45a7-84e5-15c1f8f82b68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99d4f521-1f30-4553-9129-e126d0fccbe9" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_2737aed3-0b82-45a7-84e5-15c1f8f82b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0e80b260-a282-4784-a5e0-7ac68eb6526a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c768f511-25b7-471d-8801-90f251ec12b1" xlink:to="loc_us-gaap_DebtInstrumentAxis_0e80b260-a282-4784-a5e0-7ac68eb6526a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_70fa8f64-eb5d-4942-b35b-504f18bc023b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0e80b260-a282-4784-a5e0-7ac68eb6526a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_70fa8f64-eb5d-4942-b35b-504f18bc023b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RevisedCreditAgreementMember_cc6510d3-f0d8-40a4-9266-18247fdc8892" xlink:href="hae-20230401.xsd#hae_RevisedCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_70fa8f64-eb5d-4942-b35b-504f18bc023b" xlink:to="loc_hae_RevisedCreditAgreementMember_cc6510d3-f0d8-40a4-9266-18247fdc8892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_34fa8c52-e01e-4418-892f-12d12a6590c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c768f511-25b7-471d-8801-90f251ec12b1" xlink:to="loc_us-gaap_CreditFacilityAxis_34fa8c52-e01e-4418-892f-12d12a6590c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2315648c-4a14-497c-99ec-1f6fcd53542d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_34fa8c52-e01e-4418-892f-12d12a6590c2" xlink:to="loc_us-gaap_CreditFacilityDomain_2315648c-4a14-497c-99ec-1f6fcd53542d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_36c75110-c5c7-4114-8f30-9604c19007c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2315648c-4a14-497c-99ec-1f6fcd53542d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_36c75110-c5c7-4114-8f30-9604c19007c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_245eda33-7758-4641-a576-c7cd26881fd4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c768f511-25b7-471d-8801-90f251ec12b1" xlink:to="loc_srt_RangeAxis_245eda33-7758-4641-a576-c7cd26881fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_392c1716-f5e1-4a6f-b2cd-6d5bdca19244" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_245eda33-7758-4641-a576-c7cd26881fd4" xlink:to="loc_srt_RangeMember_392c1716-f5e1-4a6f-b2cd-6d5bdca19244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2d13fc11-532f-438d-a937-263d73dcb683" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_392c1716-f5e1-4a6f-b2cd-6d5bdca19244" xlink:to="loc_srt_MinimumMember_2d13fc11-532f-438d-a937-263d73dcb683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cc880f75-6795-4161-91fd-ff1b0355030a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_392c1716-f5e1-4a6f-b2cd-6d5bdca19244" xlink:to="loc_srt_MaximumMember_cc880f75-6795-4161-91fd-ff1b0355030a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_bee97c51-9376-4ff7-8414-f3000fc68e15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c768f511-25b7-471d-8801-90f251ec12b1" xlink:to="loc_us-gaap_VariableRateAxis_bee97c51-9376-4ff7-8414-f3000fc68e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b7adfb44-e887-48df-b97c-3d22331b39f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_bee97c51-9376-4ff7-8414-f3000fc68e15" xlink:to="loc_us-gaap_VariableRateDomain_b7adfb44-e887-48df-b97c-3d22331b39f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_80595b77-6bce-48b9-bbbc-9d14c29eaeab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b7adfb44-e887-48df-b97c-3d22331b39f5" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_80595b77-6bce-48b9-bbbc-9d14c29eaeab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c768f511-25b7-471d-8801-90f251ec12b1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f15e89e2-81cb-4e32-afaf-a7a12c9a3dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_LongTermDebt_f15e89e2-81cb-4e32-afaf-a7a12c9a3dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_c6f3c2b2-afb9-47db-a05d-1e71e0031044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_LongTermDebtCurrent_c6f3c2b2-afb9-47db-a05d-1e71e0031044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_bc7d0216-d8d9-462b-8fa4-fa760433e489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_bc7d0216-d8d9-462b-8fa4-fa760433e489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6039f30f-0cd6-4e07-a3a1-5149e8ba8496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6039f30f-0cd6-4e07-a3a1-5149e8ba8496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentInterestRateFloor_18279887-09b7-4b68-b7de-bc1f6f442b0f" xlink:href="hae-20230401.xsd#hae_DebtInstrumentInterestRateFloor"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_hae_DebtInstrumentInterestRateFloor_18279887-09b7-4b68-b7de-bc1f6f442b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_853006c5-c556-48f7-9895-2a962372a17f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_853006c5-c556-48f7-9895-2a962372a17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_be597e4a-e355-46ba-8221-c6a175a7f504" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_be597e4a-e355-46ba-8221-c6a175a7f504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_3dc17c26-2425-40e0-a7da-b4ce6917e1da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_3dc17c26-2425-40e0-a7da-b4ce6917e1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne_b747a3df-fdd1-4f77-8284-357b50c85b49" xlink:href="hae-20230401.xsd#hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne_b747a3df-fdd1-4f77-8284-357b50c85b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity_acf80b59-1309-4439-aa77-51a14921c036" xlink:href="hae-20230401.xsd#hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity_acf80b59-1309-4439-aa77-51a14921c036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_9edc4448-6487-4d46-add5-c1a030bcaa52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_InterestExpense_9edc4448-6487-4d46-add5-c1a030bcaa52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_4b7eb14a-4722-4906-96db-929d4c4d5642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_InterestCostsCapitalized_4b7eb14a-4722-4906-96db-929d4c4d5642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_6715395c-986e-4894-a153-250c07c823e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b1fdeee2-350e-43d4-b30a-9376b0885491" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_6715395c-986e-4894-a153-250c07c823e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_49db100a-a6d6-4102-aefa-c4dce711dd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_49db100a-a6d6-4102-aefa-c4dce711dd0c" xlink:to="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2c3fbb95-c1af-410d-85ff-75f04d4dff3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2c3fbb95-c1af-410d-85ff-75f04d4dff3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2c3fbb95-c1af-410d-85ff-75f04d4dff3d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_9a6c30b4-4427-40c1-9b5d-4a712058b45f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:to="loc_us-gaap_ConvertibleDebtMember_9a6c30b4-4427-40c1-9b5d-4a712058b45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_d2a3aa5d-2b81-4e97-912e-2a5eba4f5507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:to="loc_us-gaap_MediumTermNotesMember_d2a3aa5d-2b81-4e97-912e-2a5eba4f5507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_65ba0842-3a55-404e-8dce-860f8fb5d25f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:to="loc_us-gaap_LineOfCreditMember_65ba0842-3a55-404e-8dce-860f8fb5d25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TermLoanMember_226db209-8a5c-4fc6-91b5-b3508b09b91c" xlink:href="hae-20230401.xsd#hae_TermLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:to="loc_hae_TermLoanMember_226db209-8a5c-4fc6-91b5-b3508b09b91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3cb39d40-4084-48c6-9ecd-a0fe0e7d5679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3cb39d40-4084-48c6-9ecd-a0fe0e7d5679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TermLoanNetofFinancingFeesMember_45fd9bad-1419-400b-a191-da46e57285b3" xlink:href="hae-20230401.xsd#hae_TermLoanNetofFinancingFeesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a009ab91-5d0b-4adc-b093-99bc805f1c13" xlink:to="loc_hae_TermLoanNetofFinancingFeesMember_45fd9bad-1419-400b-a191-da46e57285b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e32448a5-49a0-4404-a170-2665ac8559be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:to="loc_us-gaap_VariableRateAxis_e32448a5-49a0-4404-a170-2665ac8559be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3489e3e5-e52a-4165-a529-7e4030e08701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_e32448a5-49a0-4404-a170-2665ac8559be" xlink:to="loc_us-gaap_VariableRateDomain_3489e3e5-e52a-4165-a529-7e4030e08701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2675ddde-265d-49d5-9cbc-04d05006b6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_3489e3e5-e52a-4165-a529-7e4030e08701" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2675ddde-265d-49d5-9cbc-04d05006b6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b8739a99-c9eb-4dd4-96d6-42daed70a697" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:to="loc_srt_RangeAxis_b8739a99-c9eb-4dd4-96d6-42daed70a697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_42ae8be4-0e93-4413-9f3c-caa43517cda7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b8739a99-c9eb-4dd4-96d6-42daed70a697" xlink:to="loc_srt_RangeMember_42ae8be4-0e93-4413-9f3c-caa43517cda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3ce94873-4c39-4fe0-917c-f5c8146d78a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_42ae8be4-0e93-4413-9f3c-caa43517cda7" xlink:to="loc_srt_MinimumMember_3ce94873-4c39-4fe0-917c-f5c8146d78a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3264bd25-178c-4041-ba0b-b69e2a3bea99" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_42ae8be4-0e93-4413-9f3c-caa43517cda7" xlink:to="loc_srt_MaximumMember_3264bd25-178c-4041-ba0b-b69e2a3bea99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9ae0ddd0-278a-4be7-bb0e-1c1167fb0e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9ae0ddd0-278a-4be7-bb0e-1c1167fb0e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_92297c14-674c-45de-8050-ddbd9844a7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_9ae0ddd0-278a-4be7-bb0e-1c1167fb0e6a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_92297c14-674c-45de-8050-ddbd9844a7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_d6083c08-d5ec-4b0e-8e17-4710f6371d52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_92297c14-674c-45de-8050-ddbd9844a7f6" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_d6083c08-d5ec-4b0e-8e17-4710f6371d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_0758023c-f940-44c6-855c-2ff4f50d7143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_92297c14-674c-45de-8050-ddbd9844a7f6" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_0758023c-f940-44c6-855c-2ff4f50d7143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c2e1a38f-c11a-4834-afd8-0f02ca15a509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c2e1a38f-c11a-4834-afd8-0f02ca15a509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3377607c-e4fa-43f4-90e5-d504a003d71d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c2e1a38f-c11a-4834-afd8-0f02ca15a509" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3377607c-e4fa-43f4-90e5-d504a003d71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CardivaMedicalIncMember_ef4df8ac-3ebc-48fd-a3b7-376fdaa4a6e9" xlink:href="hae-20230401.xsd#hae_CardivaMedicalIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3377607c-e4fa-43f4-90e5-d504a003d71d" xlink:to="loc_hae_CardivaMedicalIncMember_ef4df8ac-3ebc-48fd-a3b7-376fdaa4a6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c11f0121-7b7f-413e-ad0f-e87d5060c686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:to="loc_us-gaap_DebtInstrumentAxis_c11f0121-7b7f-413e-ad0f-e87d5060c686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dcbb9120-dab6-4271-9c64-249c023c5e17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c11f0121-7b7f-413e-ad0f-e87d5060c686" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dcbb9120-dab6-4271-9c64-249c023c5e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RevisedCreditAgreementMember_ceac82e4-4ddd-4914-9f89-e1ea8e698199" xlink:href="hae-20230401.xsd#hae_RevisedCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dcbb9120-dab6-4271-9c64-249c023c5e17" xlink:to="loc_hae_RevisedCreditAgreementMember_ceac82e4-4ddd-4914-9f89-e1ea8e698199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_07a28375-ab65-4f32-aaf6-949c76197c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_07a28375-ab65-4f32-aaf6-949c76197c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_92023405-5433-4890-947d-395c9a3cb59a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_07a28375-ab65-4f32-aaf6-949c76197c4a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_92023405-5433-4890-947d-395c9a3cb59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_586223c5-a13f-4ca9-9641-69e7c8283873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_92023405-5433-4890-947d-395c9a3cb59a" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_586223c5-a13f-4ca9-9641-69e7c8283873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2884567b-12cc-4328-8714-347ebb5aa9b5" xlink:to="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_3c6cf5f1-acaa-419a-8084-b336e9c86589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_3c6cf5f1-acaa-419a-8084-b336e9c86589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_707d6356-2f4e-43f6-8cb8-9872a13764e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_707d6356-2f4e-43f6-8cb8-9872a13764e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_4df14043-f74a-4577-96e0-246ea36b110f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_4df14043-f74a-4577-96e0-246ea36b110f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_d207986f-af89-45cd-962c-237bfca757e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_d207986f-af89-45cd-962c-237bfca757e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_d8567352-3666-4656-936b-2e66da2d95d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_d8567352-3666-4656-936b-2e66da2d95d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice_aec06623-b3de-4dee-94b6-4490fa9b2e66" xlink:href="hae-20230401.xsd#hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice_aec06623-b3de-4dee-94b6-4490fa9b2e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentConvertibleComponentConversionPrice_3ddb60d4-c5e1-4a30-bbf7-d9845d1af2b8" xlink:href="hae-20230401.xsd#hae_DebtInstrumentConvertibleComponentConversionPrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_DebtInstrumentConvertibleComponentConversionPrice_3ddb60d4-c5e1-4a30-bbf7-d9845d1af2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e29d1e19-cd08-463c-bb23-11b4fb75fa8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e29d1e19-cd08-463c-bb23-11b4fb75fa8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ConsolidatedTotalLeverageRatio_51b209e5-2337-46b1-8619-1a7e0f885d6e" xlink:href="hae-20230401.xsd#hae_ConsolidatedTotalLeverageRatio"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_ConsolidatedTotalLeverageRatio_51b209e5-2337-46b1-8619-1a7e0f885d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_83611f08-4397-4db6-9206-05730255fc84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_83611f08-4397-4db6-9206-05730255fc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ConsolidatedInterestCoverageRatio_152a8181-de10-49d0-9627-49c392acd7c5" xlink:href="hae-20230401.xsd#hae_ConsolidatedInterestCoverageRatio"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_ConsolidatedInterestCoverageRatio_152a8181-de10-49d0-9627-49c392acd7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_74b3f0be-eb50-4306-b810-9ab178eed175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_74b3f0be-eb50-4306-b810-9ab178eed175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_e049bd3b-8d21-4e4b-b3bd-1cd6daee0240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_e049bd3b-8d21-4e4b-b3bd-1cd6daee0240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_900cd404-60fe-4abf-91fd-ac7468d45210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_LongTermDebt_900cd404-60fe-4abf-91fd-ac7468d45210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_eb09bc48-0b9d-46e3-900b-9b11d0f11e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_InterestExpenseDebt_eb09bc48-0b9d-46e3-900b-9b11d0f11e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_acba9a2f-1e1c-424f-bb52-ffef28741829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_acba9a2f-1e1c-424f-bb52-ffef28741829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice_43db076e-296e-48b8-8860-16e1c7ce37f2" xlink:href="hae-20230401.xsd#hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice_43db076e-296e-48b8-8860-16e1c7ce37f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice_01178093-f7fd-40ff-b15a-90b813edcb21" xlink:href="hae-20230401.xsd#hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice_01178093-f7fd-40ff-b15a-90b813edcb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares_f978ee55-62d2-46c1-a5d5-23ad850881c5" xlink:href="hae-20230401.xsd#hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares_f978ee55-62d2-46c1-a5d5-23ad850881c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DebtInstrumentConvertibleCappedCallTransactionAmount_d8ee2af7-7ffd-4d70-a3c6-387da63519fb" xlink:href="hae-20230401.xsd#hae_DebtInstrumentConvertibleCappedCallTransactionAmount"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_hae_DebtInstrumentConvertibleCappedCallTransactionAmount_d8ee2af7-7ffd-4d70-a3c6-387da63519fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b57f228a-1e70-4914-8af0-be0d49cdc3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db49057a-6416-4ae3-a2fe-23b11968b293" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_b57f228a-1e70-4914-8af0-be0d49cdc3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtMaturitiesDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2cb4a8cd-37df-419e-997c-50ca40bf73fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_094177e2-83a9-4f59-b84f-a2f1caff2223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2cb4a8cd-37df-419e-997c-50ca40bf73fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_094177e2-83a9-4f59-b84f-a2f1caff2223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0c333ab0-e1f3-42b1-8441-5884de957e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2cb4a8cd-37df-419e-997c-50ca40bf73fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0c333ab0-e1f3-42b1-8441-5884de957e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d6167b69-3c6a-45c5-bb48-f5b25c22d1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2cb4a8cd-37df-419e-997c-50ca40bf73fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d6167b69-3c6a-45c5-bb48-f5b25c22d1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_31439e09-c720-4851-a3ac-bb99d12334fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2cb4a8cd-37df-419e-997c-50ca40bf73fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_31439e09-c720-4851-a3ac-bb99d12334fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5b7c3c8e-fea4-40e1-88c6-09130d22a93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2cb4a8cd-37df-419e-997c-50ca40bf73fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5b7c3c8e-fea4-40e1-88c6-09130d22a93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_324d3daf-e4a3-4f71-836e-a13944d9e366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_324d3daf-e4a3-4f71-836e-a13944d9e366" xlink:to="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e9fa8373-1e4f-4d3f-b9e5-0f64373bed0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e9fa8373-1e4f-4d3f-b9e5-0f64373bed0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fb1d8625-d5c8-4353-81d5-68fbd941c14e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e9fa8373-1e4f-4d3f-b9e5-0f64373bed0c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fb1d8625-d5c8-4353-81d5-68fbd941c14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_e09ef945-ccde-4088-b2d8-cc53795c9941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_fb1d8625-d5c8-4353-81d5-68fbd941c14e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_e09ef945-ccde-4088-b2d8-cc53795c9941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d76ad53-a415-484a-9e9d-b8add504006a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d76ad53-a415-484a-9e9d-b8add504006a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f966112-7a99-4178-ac02-34af8c11d7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d76ad53-a415-484a-9e9d-b8add504006a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f966112-7a99-4178-ac02-34af8c11d7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d745ba1e-eda5-48e8-b078-d09f01ae297c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f966112-7a99-4178-ac02-34af8c11d7f4" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d745ba1e-eda5-48e8-b078-d09f01ae297c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f2011de7-7a5f-419a-98e3-09c3d818d501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_HedgingDesignationAxis_f2011de7-7a5f-419a-98e3-09c3d818d501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b53e41c0-d393-47b0-89fe-eb96f19757e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_f2011de7-7a5f-419a-98e3-09c3d818d501" xlink:to="loc_us-gaap_HedgingDesignationDomain_b53e41c0-d393-47b0-89fe-eb96f19757e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c5f97899-12a1-4386-b85f-432dd9633d59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b53e41c0-d393-47b0-89fe-eb96f19757e6" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c5f97899-12a1-4386-b85f-432dd9633d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_26f6423e-7794-4dc8-a3df-2f9ac35a3594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b53e41c0-d393-47b0-89fe-eb96f19757e6" xlink:to="loc_us-gaap_NondesignatedMember_26f6423e-7794-4dc8-a3df-2f9ac35a3594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5c50e9e0-bbee-4e79-a054-310844d1adec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5c50e9e0-bbee-4e79-a054-310844d1adec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_72c3bdb3-a5ed-4972-b81a-ef8288d68d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5c50e9e0-bbee-4e79-a054-310844d1adec" xlink:to="loc_us-gaap_HedgingRelationshipDomain_72c3bdb3-a5ed-4972-b81a-ef8288d68d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_da63beea-d237-4156-88a2-7db7ce910060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_72c3bdb3-a5ed-4972-b81a-ef8288d68d09" xlink:to="loc_us-gaap_ForeignExchangeContractMember_da63beea-d237-4156-88a2-7db7ce910060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_eb6d8d55-7f21-45a9-b04d-853d49e4ec09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_72c3bdb3-a5ed-4972-b81a-ef8288d68d09" xlink:to="loc_us-gaap_CashFlowHedgingMember_eb6d8d55-7f21-45a9-b04d-853d49e4ec09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5b236829-01b2-4f87-8826-7de5550c9ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_72c3bdb3-a5ed-4972-b81a-ef8288d68d09" xlink:to="loc_us-gaap_InterestRateSwapMember_5b236829-01b2-4f87-8826-7de5550c9ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_289bed70-e42f-4421-9fff-687e93e4d1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_289bed70-e42f-4421-9fff-687e93e4d1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cfeac5a9-5fb4-44ed-b9a5-0b7337428020" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_289bed70-e42f-4421-9fff-687e93e4d1e8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cfeac5a9-5fb4-44ed-b9a5-0b7337428020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_594f5a4d-0e16-4c5d-abb5-3ff117ee6ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cfeac5a9-5fb4-44ed-b9a5-0b7337428020" xlink:to="loc_us-gaap_ForeignExchangeContractMember_594f5a4d-0e16-4c5d-abb5-3ff117ee6ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1fd4cc30-ccac-4845-bb15-c3af0081478d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cfeac5a9-5fb4-44ed-b9a5-0b7337428020" xlink:to="loc_us-gaap_InterestRateSwapMember_1fd4cc30-ccac-4845-bb15-c3af0081478d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationMember_d4fbc440-1fed-46f1-a2a7-1b8d5d53dcba" xlink:href="hae-20230401.xsd#hae_ContingentConsiderationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cfeac5a9-5fb4-44ed-b9a5-0b7337428020" xlink:to="loc_hae_ContingentConsiderationMember_d4fbc440-1fed-46f1-a2a7-1b8d5d53dcba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f983bec5-d422-44be-b520-1d60ce49fa2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f983bec5-d422-44be-b520-1d60ce49fa2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bd1a2c02-0106-450a-9554-4101322eda49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f983bec5-d422-44be-b520-1d60ce49fa2e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bd1a2c02-0106-450a-9554-4101322eda49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_048cccd8-6589-4c67-91bd-100b92b69d8b" xlink:href="hae-20230401.xsd#hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bd1a2c02-0106-450a-9554-4101322eda49" xlink:to="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_048cccd8-6589-4c67-91bd-100b92b69d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherIncomeExpenseNetMember_cd08f9d7-8f22-4963-a405-237b6660a053" xlink:href="hae-20230401.xsd#hae_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bd1a2c02-0106-450a-9554-4101322eda49" xlink:to="loc_hae_OtherIncomeExpenseNetMember_cd08f9d7-8f22-4963-a405-237b6660a053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_741becd3-bb04-405a-b44e-eeceb169f781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_741becd3-bb04-405a-b44e-eeceb169f781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_95fadcd6-dd8d-4096-8a08-9f8f64e2fa9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_741becd3-bb04-405a-b44e-eeceb169f781" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_95fadcd6-dd8d-4096-8a08-9f8f64e2fa9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_83c3344e-3ea7-4062-9d57-80f622cecc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95fadcd6-dd8d-4096-8a08-9f8f64e2fa9b" xlink:to="loc_us-gaap_MediumTermNotesMember_83c3344e-3ea7-4062-9d57-80f622cecc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_76f0ee76-ceb4-44b0-9552-fb5f5b0bc19c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95fadcd6-dd8d-4096-8a08-9f8f64e2fa9b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_76f0ee76-ceb4-44b0-9552-fb5f5b0bc19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_b7ab2941-c109-49dd-9dff-35d0f8156c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_VariableRateAxis_b7ab2941-c109-49dd-9dff-35d0f8156c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a1d62f13-de8d-40d0-bdbc-401b6feae330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_b7ab2941-c109-49dd-9dff-35d0f8156c28" xlink:to="loc_us-gaap_VariableRateDomain_a1d62f13-de8d-40d0-bdbc-401b6feae330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d4c0d89c-7d99-4c10-9321-faffaca0045f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_a1d62f13-de8d-40d0-bdbc-401b6feae330" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d4c0d89c-7d99-4c10-9321-faffaca0045f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember_6d8d8086-b8a0-4cca-9538-be651c77827d" xlink:href="hae-20230401.xsd#hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_a1d62f13-de8d-40d0-bdbc-401b6feae330" xlink:to="loc_hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember_6d8d8086-b8a0-4cca-9538-be651c77827d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_323ee015-0c32-47d5-9cbe-6e41bfa07907" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_srt_RangeAxis_323ee015-0c32-47d5-9cbe-6e41bfa07907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c320d2db-0ac2-4273-a05f-5a4ee2faf539" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_323ee015-0c32-47d5-9cbe-6e41bfa07907" xlink:to="loc_srt_RangeMember_c320d2db-0ac2-4273-a05f-5a4ee2faf539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_92fde71c-4157-425b-8de6-9758d610fc9e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c320d2db-0ac2-4273-a05f-5a4ee2faf539" xlink:to="loc_srt_MinimumMember_92fde71c-4157-425b-8de6-9758d610fc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9255413c-f752-443c-b86f-0ae0e8a63541" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c320d2db-0ac2-4273-a05f-5a4ee2faf539" xlink:to="loc_srt_MaximumMember_9255413c-f752-443c-b86f-0ae0e8a63541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bd51092a-9a85-4550-8fc3-335d0a0679ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bd51092a-9a85-4550-8fc3-335d0a0679ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_df250c59-a918-49a9-a165-d327fbf6da5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bd51092a-9a85-4550-8fc3-335d0a0679ef" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_df250c59-a918-49a9-a165-d327fbf6da5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember_1ac5adf6-3386-4c04-ac87-ab4d69e9f957" xlink:href="hae-20230401.xsd#hae_EnicorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_df250c59-a918-49a9-a165-d327fbf6da5c" xlink:to="loc_hae_EnicorMember_1ac5adf6-3386-4c04-ac87-ab4d69e9f957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_586e8b1e-c71e-422c-84e8-a5a399c57350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_586e8b1e-c71e-422c-84e8-a5a399c57350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b97a7519-996c-4c9c-aab0-1415a8c81615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_586e8b1e-c71e-422c-84e8-a5a399c57350" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b97a7519-996c-4c9c-aab0-1415a8c81615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_58ec2b19-97c8-45c5-8b70-81b6fe3ecc21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b97a7519-996c-4c9c-aab0-1415a8c81615" xlink:to="loc_us-gaap_SubsequentEventMember_58ec2b19-97c8-45c5-8b70-81b6fe3ecc21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1a787c05-7ae6-455d-8880-ef251c01d9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1a787c05-7ae6-455d-8880-ef251c01d9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_5240d7d9-8bb6-4f48-8458-3030b4489726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1a787c05-7ae6-455d-8880-ef251c01d9ad" xlink:to="loc_us-gaap_TypeOfAdoptionMember_5240d7d9-8bb6-4f48-8458-3030b4489726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_bf0e8321-17d1-4291-a5ff-6dab49d2975b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_5240d7d9-8bb6-4f48-8458-3030b4489726" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_bf0e8321-17d1-4291-a5ff-6dab49d2975b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fb9cb654-5b05-4ffc-92c7-ccaa70604c03" xlink:to="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PercentageOfNetSalesGeneratedOutsideOfUs_d809ab8c-3e37-4536-b8fe-137eaa5b6d04" xlink:href="hae-20230401.xsd#hae_PercentageOfNetSalesGeneratedOutsideOfUs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_hae_PercentageOfNetSalesGeneratedOutsideOfUs_d809ab8c-3e37-4536-b8fe-137eaa5b6d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1_0f16b94f-aa4a-4d43-bb2f-225225eade5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1_0f16b94f-aa4a-4d43-bb2f-225225eade5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet_5908d5a0-abaf-4c81-b738-b32c69b1cede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet_5908d5a0-abaf-4c81-b738-b32c69b1cede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet_20d6e145-e9d0-4565-9c44-f1c4ee5d172a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet_20d6e145-e9d0-4565-9c44-f1c4ee5d172a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f66735fe-44a6-490f-9177-c910f047c009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f66735fe-44a6-490f-9177-c910f047c009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ff149c1b-17df-49e3-962d-2f015615f515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ff149c1b-17df-49e3-962d-2f015615f515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_31ddfb34-9d4f-4906-9956-cd956798e5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_31ddfb34-9d4f-4906-9956-cd956798e5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_580de1c6-b046-423a-bd22-d1e1a8be5a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_580de1c6-b046-423a-bd22-d1e1a8be5a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DerivativePercentofDebtExposed_7c6fa889-f033-4b89-a22b-2a5f0c199bbf" xlink:href="hae-20230401.xsd#hae_DerivativePercentofDebtExposed"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_hae_DerivativePercentofDebtExposed_7c6fa889-f033-4b89-a22b-2a5f0c199bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_c57855ad-6416-4726-9eb5-cdaf467eb5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_c57855ad-6416-4726-9eb5-cdaf467eb5e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_ea8ec5aa-b78b-4ef9-b556-b9c658ee0cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_DerivativeNotionalAmount_ea8ec5aa-b78b-4ef9-b556-b9c658ee0cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_423e27b3-5808-4475-9cd2-348615e63517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_LongTermDebt_423e27b3-5808-4475-9cd2-348615e63517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_d9345c11-8b83-4862-907f-296b85e407a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_d9345c11-8b83-4862-907f-296b85e407a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_ad223bb7-5160-4a59-a3e7-d25f3fe97e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_ad223bb7-5160-4a59-a3e7-d25f3fe97e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_fba65707-4fa9-444a-b6fc-4f161bf5708e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_fba65707-4fa9-444a-b6fc-4f161bf5708e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b21155d4-e8ec-425c-b5a3-9da1ca12f2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b21155d4-e8ec-425c-b5a3-9da1ca12f2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_3a36d7d2-99d5-48ef-a2a7-eebd9bfaa32b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_3a36d7d2-99d5-48ef-a2a7-eebd9bfaa32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationForeignCurrencyTranslationAdjustment_f8b36a8e-4da9-498c-9a5c-379c4b369477" xlink:href="hae-20230401.xsd#hae_ContingentConsiderationForeignCurrencyTranslationAdjustment"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_hae_ContingentConsiderationForeignCurrencyTranslationAdjustment_f8b36a8e-4da9-498c-9a5c-379c4b369477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_26a0ff8d-38ff-4ec5-bda7-917bd67c822a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_26a0ff8d-38ff-4ec5-bda7-917bd67c822a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_f3efe404-3351-44b5-a66d-067d7ccd86ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_LongTermDebtFairValue_f3efe404-3351-44b5-a66d-067d7ccd86ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ae51076d-f2cd-41c3-9874-187ab3fbc86c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ae51076d-f2cd-41c3-9874-187ab3fbc86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NumberOfInterestRateSwapsEntered_fbeeed67-1db0-4754-9c12-e08f0943d028" xlink:href="hae-20230401.xsd#hae_NumberOfInterestRateSwapsEntered"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_hae_NumberOfInterestRateSwapsEntered_fbeeed67-1db0-4754-9c12-e08f0943d028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DerivativeBlendedFixedInterestRate_bdbd056c-3cd2-4a5f-a5ce-c3cd923e6a2b" xlink:href="hae-20230401.xsd#hae_DerivativeBlendedFixedInterestRate"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_hae_DerivativeBlendedFixedInterestRate_bdbd056c-3cd2-4a5f-a5ce-c3cd923e6a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DerivativePercentageOfNotionalValueOfDebt_8cbc87be-419e-4cca-92c0-1323d1d7e6ec" xlink:href="hae-20230401.xsd#hae_DerivativePercentageOfNotionalValueOfDebt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1a60c3b4-f379-4b42-8185-057c84af56f6" xlink:to="loc_hae_DerivativePercentageOfNotionalValueOfDebt_8cbc87be-419e-4cca-92c0-1323d1d7e6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2937ed02-9d42-44af-a616-8a9aee5282bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_b2e67be4-070f-4f58-8161-723c96ef0e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2937ed02-9d42-44af-a616-8a9aee5282bf" xlink:to="loc_us-gaap_DerivativeTable_b2e67be4-070f-4f58-8161-723c96ef0e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyAxis_b130395b-51d3-4ce0-9a15-ee1a175793ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EnergyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2e67be4-070f-4f58-8161-723c96ef0e89" xlink:to="loc_srt_EnergyAxis_b130395b-51d3-4ce0-9a15-ee1a175793ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyDomain_da178a7c-187e-4766-9b2d-8c7aef23ef4b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EnergyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EnergyAxis_b130395b-51d3-4ce0-9a15-ee1a175793ed" xlink:to="loc_srt_EnergyDomain_da178a7c-187e-4766-9b2d-8c7aef23ef4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ea3c66ce-d148-46f9-9af5-57acb6f2e26b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2e67be4-070f-4f58-8161-723c96ef0e89" xlink:to="loc_us-gaap_VariableRateAxis_ea3c66ce-d148-46f9-9af5-57acb6f2e26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_789d0f9f-e0eb-408b-9191-8b2a7eaccd67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_ea3c66ce-d148-46f9-9af5-57acb6f2e26b" xlink:to="loc_us-gaap_VariableRateDomain_789d0f9f-e0eb-408b-9191-8b2a7eaccd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_55582e41-0841-45c0-ab12-df8c1ba0bcf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2e67be4-070f-4f58-8161-723c96ef0e89" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_55582e41-0841-45c0-ab12-df8c1ba0bcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_55582e41-0841-45c0-ab12-df8c1ba0bcf0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap267FixedInterestRateMember_17e3066c-1bd6-4bfe-ad57-be667583af47" xlink:href="hae-20230401.xsd#hae_InterestRateSwap267FixedInterestRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:to="loc_hae_InterestRateSwap267FixedInterestRateMember_17e3066c-1bd6-4bfe-ad57-be667583af47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap276FixedInterestRateMember_d7da539f-4683-4343-8c14-2f4041b72bfb" xlink:href="hae-20230401.xsd#hae_InterestRateSwap276FixedInterestRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:to="loc_hae_InterestRateSwap276FixedInterestRateMember_d7da539f-4683-4343-8c14-2f4041b72bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap444FixedInterestRateMember_d39986fe-0666-4318-9847-b9afd5f4b65d" xlink:href="hae-20230401.xsd#hae_InterestRateSwap444FixedInterestRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:to="loc_hae_InterestRateSwap444FixedInterestRateMember_d39986fe-0666-4318-9847-b9afd5f4b65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap446FixedInterestRateMember_e9987f00-6729-4385-a77b-76c1787d1276" xlink:href="hae-20230401.xsd#hae_InterestRateSwap446FixedInterestRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:to="loc_hae_InterestRateSwap446FixedInterestRateMember_e9987f00-6729-4385-a77b-76c1787d1276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap408FixedInterestRateMember_a91e3f08-4b7d-40c1-8d3f-b0520b82bb12" xlink:href="hae-20230401.xsd#hae_InterestRateSwap408FixedInterestRateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:to="loc_hae_InterestRateSwap408FixedInterestRateMember_a91e3f08-4b7d-40c1-8d3f-b0520b82bb12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InterestRateSwap415FixedInterestRateMember_96242ca2-db91-4b46-93d3-8aa05891b2a0" xlink:href="hae-20230401.xsd#hae_InterestRateSwap415FixedInterestRateMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:to="loc_hae_InterestRateSwap415FixedInterestRateMember_96242ca2-db91-4b46-93d3-8aa05891b2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1fa712e5-42ad-424f-8f29-977a94e88c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef47ff9c-c2d2-451e-9f9c-91fed841a052" xlink:to="loc_us-gaap_InterestRateSwapMember_1fa712e5-42ad-424f-8f29-977a94e88c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_51e8ea20-af85-4183-8c30-acb667b37f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2e67be4-070f-4f58-8161-723c96ef0e89" xlink:to="loc_us-gaap_PositionAxis_51e8ea20-af85-4183-8c30-acb667b37f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_b09473b5-76db-4ed8-b626-8a2a983acf74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_51e8ea20-af85-4183-8c30-acb667b37f2a" xlink:to="loc_us-gaap_PositionDomain_b09473b5-76db-4ed8-b626-8a2a983acf74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_134d69c1-f74a-46f1-8223-c923a30c704b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2e67be4-070f-4f58-8161-723c96ef0e89" xlink:to="loc_srt_RangeAxis_134d69c1-f74a-46f1-8223-c923a30c704b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3d150bdf-2dbf-4276-ab28-fb879217cac5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_134d69c1-f74a-46f1-8223-c923a30c704b" xlink:to="loc_srt_RangeMember_3d150bdf-2dbf-4276-ab28-fb879217cac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4ae7390d-2acb-45d0-bb5c-e7bba3fb6688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2e67be4-070f-4f58-8161-723c96ef0e89" xlink:to="loc_us-gaap_DerivativeLineItems_4ae7390d-2acb-45d0-bb5c-e7bba3fb6688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e2c54528-6467-436a-961c-85ccbe64c04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4ae7390d-2acb-45d0-bb5c-e7bba3fb6688" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e2c54528-6467-436a-961c-85ccbe64c04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_42cc9fc1-c13f-44e2-a7b1-5fee4aeabb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4ae7390d-2acb-45d0-bb5c-e7bba3fb6688" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_42cc9fc1-c13f-44e2-a7b1-5fee4aeabb1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_2acd11bb-7053-4c60-89af-b6c073af4c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4ae7390d-2acb-45d0-bb5c-e7bba3fb6688" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_2acd11bb-7053-4c60-89af-b6c073af4c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NumberOfInterestRateSwapsEntered_ea567a20-9f8c-4a36-81a3-403ffe400850" xlink:href="hae-20230401.xsd#hae_NumberOfInterestRateSwapsEntered"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4ae7390d-2acb-45d0-bb5c-e7bba3fb6688" xlink:to="loc_hae_NumberOfInterestRateSwapsEntered_ea567a20-9f8c-4a36-81a3-403ffe400850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_64de6bd2-2f7d-4a81-8db1-a44923458b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_62fef060-8807-4dcc-83d7-a81c6bd30931" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_64de6bd2-2f7d-4a81-8db1-a44923458b3e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_62fef060-8807-4dcc-83d7-a81c6bd30931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_04b857b9-5763-452b-8698-97b6b199ce02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_62fef060-8807-4dcc-83d7-a81c6bd30931" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_04b857b9-5763-452b-8698-97b6b199ce02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_97f7ecb4-081f-442f-a254-54f788035e51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_62fef060-8807-4dcc-83d7-a81c6bd30931" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_97f7ecb4-081f-442f-a254-54f788035e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_edd2e1d4-98b6-4873-ae44-5d099071f8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_62fef060-8807-4dcc-83d7-a81c6bd30931" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_edd2e1d4-98b6-4873-ae44-5d099071f8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_13eb3c7b-3461-4e17-85f5-1dcc176405ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_62fef060-8807-4dcc-83d7-a81c6bd30931" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_13eb3c7b-3461-4e17-85f5-1dcc176405ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c0fbd1be-d71a-410d-a279-8b811062cd0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f8847eb-5caa-4004-8eee-0add84ebc42e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c0fbd1be-d71a-410d-a279-8b811062cd0b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f8847eb-5caa-4004-8eee-0add84ebc42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f0a0182e-2285-4938-8f35-5cb6d265c44e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f8847eb-5caa-4004-8eee-0add84ebc42e" xlink:to="loc_us-gaap_HedgingDesignationAxis_f0a0182e-2285-4938-8f35-5cb6d265c44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_290c7a5e-b9a2-4453-8e47-3bd2ea28d254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_f0a0182e-2285-4938-8f35-5cb6d265c44e" xlink:to="loc_us-gaap_HedgingDesignationDomain_290c7a5e-b9a2-4453-8e47-3bd2ea28d254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_87db050e-b0fb-47b6-8038-b39d9a0139e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_290c7a5e-b9a2-4453-8e47-3bd2ea28d254" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_87db050e-b0fb-47b6-8038-b39d9a0139e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_fa85748b-5bda-4e40-a6fc-eb84d5f5a33d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_290c7a5e-b9a2-4453-8e47-3bd2ea28d254" xlink:to="loc_us-gaap_NondesignatedMember_fa85748b-5bda-4e40-a6fc-eb84d5f5a33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b700f787-6f5f-499d-aedf-d5df0e50b690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f8847eb-5caa-4004-8eee-0add84ebc42e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b700f787-6f5f-499d-aedf-d5df0e50b690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a6a3ddf1-b323-46a4-bf6b-7c74dcd97e59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b700f787-6f5f-499d-aedf-d5df0e50b690" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a6a3ddf1-b323-46a4-bf6b-7c74dcd97e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_ef0d8edc-374c-4c58-bd3d-194f9e74e0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a6a3ddf1-b323-46a4-bf6b-7c74dcd97e59" xlink:to="loc_us-gaap_CashFlowHedgingMember_ef0d8edc-374c-4c58-bd3d-194f9e74e0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_718b9b42-42f7-410b-96dc-1d96ae24fc49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a6a3ddf1-b323-46a4-bf6b-7c74dcd97e59" xlink:to="loc_us-gaap_InterestRateSwapMember_718b9b42-42f7-410b-96dc-1d96ae24fc49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ac550a4d-a3b6-48d4-9b38-f217d31638b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f8847eb-5caa-4004-8eee-0add84ebc42e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ac550a4d-a3b6-48d4-9b38-f217d31638b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1d80d5aa-0228-4f38-a64d-7477e70e8139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ac550a4d-a3b6-48d4-9b38-f217d31638b8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1d80d5aa-0228-4f38-a64d-7477e70e8139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a3003a27-b28f-43df-93d6-4645c40828b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1d80d5aa-0228-4f38-a64d-7477e70e8139" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a3003a27-b28f-43df-93d6-4645c40828b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3be08b58-97be-40e2-8853-ba9e54e61637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f8847eb-5caa-4004-8eee-0add84ebc42e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3be08b58-97be-40e2-8853-ba9e54e61637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d5444236-d698-4772-bd06-93e4f090afa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3be08b58-97be-40e2-8853-ba9e54e61637" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d5444236-d698-4772-bd06-93e4f090afa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_5c67bb93-fa4f-49db-84e1-fcb2a3ed11fa" xlink:href="hae-20230401.xsd#hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d5444236-d698-4772-bd06-93e4f090afa6" xlink:to="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_5c67bb93-fa4f-49db-84e1-fcb2a3ed11fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherIncomeExpenseNetMember_8fb64202-4bfe-45d3-a3f8-27419cf39f9c" xlink:href="hae-20230401.xsd#hae_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d5444236-d698-4772-bd06-93e4f090afa6" xlink:to="loc_hae_OtherIncomeExpenseNetMember_8fb64202-4bfe-45d3-a3f8-27419cf39f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_79be51a2-feb7-4dfb-accb-04e46153c702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_3f8847eb-5caa-4004-8eee-0add84ebc42e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_79be51a2-feb7-4dfb-accb-04e46153c702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_11b6fcf4-8255-4fff-a25e-fa31aa20eaf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_79be51a2-feb7-4dfb-accb-04e46153c702" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_11b6fcf4-8255-4fff-a25e-fa31aa20eaf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_83b4682c-ba76-4a46-a9e3-c788c868b0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_79be51a2-feb7-4dfb-accb-04e46153c702" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_83b4682c-ba76-4a46-a9e3-c788c868b0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_624fbc79-f579-4d2d-a0b0-03e860458ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_79be51a2-feb7-4dfb-accb-04e46153c702" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_624fbc79-f579-4d2d-a0b0-03e860458ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9d70d6df-99c1-4402-a7d6-7084b1631b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9d70d6df-99c1-4402-a7d6-7084b1631b06" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9eee14b6-ef67-4fb4-868c-0fc47ab9f345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9eee14b6-ef67-4fb4-868c-0fc47ab9f345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5209ce93-4be0-4e9a-8d64-4936e5eceaa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9eee14b6-ef67-4fb4-868c-0fc47ab9f345" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5209ce93-4be0-4e9a-8d64-4936e5eceaa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f4df7546-459e-4e5a-ba8b-7c1847090c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5209ce93-4be0-4e9a-8d64-4936e5eceaa1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f4df7546-459e-4e5a-ba8b-7c1847090c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_df7ccc53-3b1b-4054-8ec1-fe0295e76a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_df7ccc53-3b1b-4054-8ec1-fe0295e76a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3eca0565-0197-4fb4-8281-ba54dd999dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_df7ccc53-3b1b-4054-8ec1-fe0295e76a3c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3eca0565-0197-4fb4-8281-ba54dd999dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6fd4f12a-5d44-4327-8ec8-9882a5e81822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3eca0565-0197-4fb4-8281-ba54dd999dbb" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6fd4f12a-5d44-4327-8ec8-9882a5e81822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_28fed7eb-4e3c-474e-b168-0a638e6987ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3eca0565-0197-4fb4-8281-ba54dd999dbb" xlink:to="loc_us-gaap_InterestRateSwapMember_28fed7eb-4e3c-474e-b168-0a638e6987ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationMember_4d13d79b-7d27-4715-8b41-9438ce177b4f" xlink:href="hae-20230401.xsd#hae_ContingentConsiderationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3eca0565-0197-4fb4-8281-ba54dd999dbb" xlink:to="loc_hae_ContingentConsiderationMember_4d13d79b-7d27-4715-8b41-9438ce177b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5562d267-2c73-4238-9f53-eca273803582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5562d267-2c73-4238-9f53-eca273803582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_564c84df-f776-4f55-b8fd-5f5fe2a0fef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5562d267-2c73-4238-9f53-eca273803582" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_564c84df-f776-4f55-b8fd-5f5fe2a0fef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_313e5e4c-68a4-4b92-a2e4-45278cc86e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_564c84df-f776-4f55-b8fd-5f5fe2a0fef6" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_313e5e4c-68a4-4b92-a2e4-45278cc86e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_f1e1e008-a334-41e8-976b-ee08ffde6589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_564c84df-f776-4f55-b8fd-5f5fe2a0fef6" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_f1e1e008-a334-41e8-976b-ee08ffde6589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f909639e-15ca-486e-aa40-3a1bc7d8b072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_564c84df-f776-4f55-b8fd-5f5fe2a0fef6" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f909639e-15ca-486e-aa40-3a1bc7d8b072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e8dc3cde-9034-45ed-abb7-4ee83d4d0301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:to="loc_us-gaap_HedgingDesignationAxis_e8dc3cde-9034-45ed-abb7-4ee83d4d0301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4190aaac-507e-48fa-bcd4-6080585bba0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_e8dc3cde-9034-45ed-abb7-4ee83d4d0301" xlink:to="loc_us-gaap_HedgingDesignationDomain_4190aaac-507e-48fa-bcd4-6080585bba0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f285a62a-5446-45d2-a578-d76af94a9b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_4190aaac-507e-48fa-bcd4-6080585bba0b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f285a62a-5446-45d2-a578-d76af94a9b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_b60cce12-e29e-485b-bbab-ffad726a4e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_4190aaac-507e-48fa-bcd4-6080585bba0b" xlink:to="loc_us-gaap_NondesignatedMember_b60cce12-e29e-485b-bbab-ffad726a4e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_89078af2-b730-4e02-a8f0-5612b4db15ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_89078af2-b730-4e02-a8f0-5612b4db15ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_acda421a-b2fc-4973-abb2-e81c42b0d39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_89078af2-b730-4e02-a8f0-5612b4db15ab" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_acda421a-b2fc-4973-abb2-e81c42b0d39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_cf10bb39-aff3-4e3a-a1b5-22788b573b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_acda421a-b2fc-4973-abb2-e81c42b0d39e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_cf10bb39-aff3-4e3a-a1b5-22788b573b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_cf147947-fcf5-4b3d-ae39-fbd882bfcfd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_acda421a-b2fc-4973-abb2-e81c42b0d39e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_cf147947-fcf5-4b3d-ae39-fbd882bfcfd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ce6d1301-9cf3-4f2f-ac09-d8a837128041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_acda421a-b2fc-4973-abb2-e81c42b0d39e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ce6d1301-9cf3-4f2f-ac09-d8a837128041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_75513ecc-f83d-4087-ae26-888abb171c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_75513ecc-f83d-4087-ae26-888abb171c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4e62a653-cb79-42bc-8fc3-304dac8c12af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_75513ecc-f83d-4087-ae26-888abb171c43" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4e62a653-cb79-42bc-8fc3-304dac8c12af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RevenueBasedPayments2Member_d9586530-1d9a-4b37-a24c-830ad02a8c3a" xlink:href="hae-20230401.xsd#hae_RevenueBasedPayments2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4e62a653-cb79-42bc-8fc3-304dac8c12af" xlink:to="loc_hae_RevenueBasedPayments2Member_d9586530-1d9a-4b37-a24c-830ad02a8c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_3743e735-7d24-4e06-b424-bbbe7d0f8b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:to="loc_us-gaap_ValuationTechniqueAxis_3743e735-7d24-4e06-b424-bbbe7d0f8b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_414453ad-d469-44b3-bd39-f64254fccf33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_3743e735-7d24-4e06-b424-bbbe7d0f8b32" xlink:to="loc_us-gaap_ValuationTechniqueDomain_414453ad-d469-44b3-bd39-f64254fccf33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_b61b8236-6345-467f-aac2-bbccb52548d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_414453ad-d469-44b3-bd39-f64254fccf33" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_b61b8236-6345-467f-aac2-bbccb52548d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acfc6f5f-46a2-4e67-9927-45b79be130a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a485dbf-0d5b-4d13-a129-0478de99bb3a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acfc6f5f-46a2-4e67-9927-45b79be130a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_44b64ed3-86d7-4a67-b183-ff06b9563294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acfc6f5f-46a2-4e67-9927-45b79be130a8" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_44b64ed3-86d7-4a67-b183-ff06b9563294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_7e3f88a0-03ec-43a9-a614-7c5661910ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_44b64ed3-86d7-4a67-b183-ff06b9563294" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_7e3f88a0-03ec-43a9-a614-7c5661910ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_afc3b9c5-d5c2-4df6-8897-9d46db999e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_44b64ed3-86d7-4a67-b183-ff06b9563294" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_afc3b9c5-d5c2-4df6-8897-9d46db999e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_590904d6-9fb9-4d30-9bd4-60b712a9db3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_44b64ed3-86d7-4a67-b183-ff06b9563294" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_590904d6-9fb9-4d30-9bd4-60b712a9db3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1c556d79-0fc3-4c74-8356-d6c8dbf2315d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acfc6f5f-46a2-4e67-9927-45b79be130a8" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1c556d79-0fc3-4c74-8356-d6c8dbf2315d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_3fe8f96b-8064-4434-bf63-3356314cb26c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1c556d79-0fc3-4c74-8356-d6c8dbf2315d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_3fe8f96b-8064-4434-bf63-3356314cb26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_deea5698-6150-4e9e-8d3b-03de9b7daa63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1c556d79-0fc3-4c74-8356-d6c8dbf2315d" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_deea5698-6150-4e9e-8d3b-03de9b7daa63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_f8bd647c-8063-4354-9c1e-9b1ac3dc1494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acfc6f5f-46a2-4e67-9927-45b79be130a8" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_f8bd647c-8063-4354-9c1e-9b1ac3dc1494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#RETIREMENTPLANSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e03ada1a-fdee-4f27-b364-7a2f2e16efef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ee1b402a-9a3c-4944-a538-c09ce50ebd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e03ada1a-fdee-4f27-b364-7a2f2e16efef" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ee1b402a-9a3c-4944-a538-c09ce50ebd5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_5ad1d9ae-b2b4-45ad-8463-29d0be74bcd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ee1b402a-9a3c-4944-a538-c09ce50ebd5e" xlink:to="loc_us-gaap_RetirementPlanNameAxis_5ad1d9ae-b2b4-45ad-8463-29d0be74bcd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_72129b83-c34c-4976-9d21-4bea8fbc7d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_5ad1d9ae-b2b4-45ad-8463-29d0be74bcd9" xlink:to="loc_us-gaap_RetirementPlanNameDomain_72129b83-c34c-4976-9d21-4bea8fbc7d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SavingsPlusPlanMember_fac6579a-4374-4c16-88ef-20b77799238f" xlink:href="hae-20230401.xsd#hae_SavingsPlusPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_72129b83-c34c-4976-9d21-4bea8fbc7d44" xlink:to="loc_hae_SavingsPlusPlanMember_fac6579a-4374-4c16-88ef-20b77799238f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A401kPlanMember_ba80415c-a285-48a8-8324-d22b6cda10ef" xlink:href="hae-20230401.xsd#hae_A401kPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_72129b83-c34c-4976-9d21-4bea8fbc7d44" xlink:to="loc_hae_A401kPlanMember_ba80415c-a285-48a8-8324-d22b6cda10ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_05f55446-1ea4-4ff7-8be5-bba214ff9016" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ee1b402a-9a3c-4944-a538-c09ce50ebd5e" xlink:to="loc_srt_ConsolidatedEntitiesAxis_05f55446-1ea4-4ff7-8be5-bba214ff9016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ef324fc3-6e2d-4467-b919-4ae13b461d75" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_05f55446-1ea4-4ff7-8be5-bba214ff9016" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ef324fc3-6e2d-4467-b919-4ae13b461d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_b0807bad-8e33-41dd-91de-075c0275e9f3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_ef324fc3-6e2d-4467-b919-4ae13b461d75" xlink:to="loc_srt_SubsidiariesMember_b0807bad-8e33-41dd-91de-075c0275e9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9fc2b3b3-4c90-4b88-9959-73282405f863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ee1b402a-9a3c-4944-a538-c09ce50ebd5e" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9fc2b3b3-4c90-4b88-9959-73282405f863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_527ec927-fe1a-4744-8c5c-227a9ede0c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9fc2b3b3-4c90-4b88-9959-73282405f863" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_527ec927-fe1a-4744-8c5c-227a9ede0c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany_718ebfd9-0d9e-4a3b-94c0-1662cab4faf5" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9fc2b3b3-4c90-4b88-9959-73282405f863" xlink:to="loc_hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany_718ebfd9-0d9e-4a3b-94c0-1662cab4faf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanReinsuranceContractsAssetValue_8679ddb8-18bc-4c9a-976c-b95f2706f5e7" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanReinsuranceContractsAssetValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9fc2b3b3-4c90-4b88-9959-73282405f863" xlink:to="loc_hae_DefinedBenefitPlanReinsuranceContractsAssetValue_8679ddb8-18bc-4c9a-976c-b95f2706f5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_771492ae-60f5-45b1-9dc8-b50275a6dd19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9fc2b3b3-4c90-4b88-9959-73282405f863" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_771492ae-60f5-45b1-9dc8-b50275a6dd19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear_624510a7-2e0e-4539-a2a8-3c9f9e2178f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_9fc2b3b3-4c90-4b88-9959-73282405f863" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear_624510a7-2e0e-4539-a2a8-3c9f9e2178f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce6de609-e5df-43f9-a352-2e68f53d0616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_bad3636d-f2e5-457c-87b0-504928d74631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce6de609-e5df-43f9-a352-2e68f53d0616" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_bad3636d-f2e5-457c-87b0-504928d74631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_c2338f0a-15d7-4604-abcf-c46507e3837c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce6de609-e5df-43f9-a352-2e68f53d0616" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_c2338f0a-15d7-4604-abcf-c46507e3837c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_7d1dca96-9a6e-43bd-bf23-0bd2076d07fb" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce6de609-e5df-43f9-a352-2e68f53d0616" xlink:to="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_7d1dca96-9a6e-43bd-bf23-0bd2076d07fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_19a3fcb2-c81e-4c8c-b9b8-a6d66ba69749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce6de609-e5df-43f9-a352-2e68f53d0616" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_19a3fcb2-c81e-4c8c-b9b8-a6d66ba69749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_f9535944-3435-4474-bbc9-02ead34fbc2b" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce6de609-e5df-43f9-a352-2e68f53d0616" xlink:to="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_f9535944-3435-4474-bbc9-02ead34fbc2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_d07b13eb-62d0-456c-b248-7e099ac26972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce6de609-e5df-43f9-a352-2e68f53d0616" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_d07b13eb-62d0-456c-b248-7e099ac26972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_71cc157f-aa2a-43ae-a2e5-8ceaddb41453" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce6de609-e5df-43f9-a352-2e68f53d0616" xlink:to="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_71cc157f-aa2a-43ae-a2e5-8ceaddb41453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_2bcc00de-1d55-43a6-9bfd-63ba0d10fa4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce6de609-e5df-43f9-a352-2e68f53d0616" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_2bcc00de-1d55-43a6-9bfd-63ba0d10fa4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_38a06991-6368-48ca-b17a-db2625a82c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce6de609-e5df-43f9-a352-2e68f53d0616" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_38a06991-6368-48ca-b17a-db2625a82c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_73089f6e-bd71-4418-8f7c-bf31f76ba076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce6de609-e5df-43f9-a352-2e68f53d0616" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_73089f6e-bd71-4418-8f7c-bf31f76ba076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_e7146181-85e5-4138-bf72-a170626e69d8" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce6de609-e5df-43f9-a352-2e68f53d0616" xlink:to="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_e7146181-85e5-4138-bf72-a170626e69d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_545317c6-57e5-49df-a0a7-4faa05ca4856" xlink:href="hae-20230401.xsd#hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce6de609-e5df-43f9-a352-2e68f53d0616" xlink:to="loc_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag_545317c6-57e5-49df-a0a7-4faa05ca4856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_91d1b1ca-c00f-44b8-be7c-0f7bbf31fd97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_db70b9a4-5394-48df-91c0-b9e3eb551517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_91d1b1ca-c00f-44b8-be7c-0f7bbf31fd97" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_db70b9a4-5394-48df-91c0-b9e3eb551517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_4d60836c-a48a-417d-9977-679754565384" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_db70b9a4-5394-48df-91c0-b9e3eb551517" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_4d60836c-a48a-417d-9977-679754565384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_b3df9ca5-8952-453a-be87-1810c761c469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_db70b9a4-5394-48df-91c0-b9e3eb551517" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_b3df9ca5-8952-453a-be87-1810c761c469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_c72e09a0-0db2-4146-bf17-f9a9f6e7d040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_db70b9a4-5394-48df-91c0-b9e3eb551517" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_c72e09a0-0db2-4146-bf17-f9a9f6e7d040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_61050124-50a9-48b8-b38a-54afc176a533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_db70b9a4-5394-48df-91c0-b9e3eb551517" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_61050124-50a9-48b8-b38a-54afc176a533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_eb91b685-2896-486d-8fa2-3ea070fc2dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_db70b9a4-5394-48df-91c0-b9e3eb551517" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_eb91b685-2896-486d-8fa2-3ea070fc2dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_e2fc8e25-5936-4580-90cf-46695f3c90d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_db70b9a4-5394-48df-91c0-b9e3eb551517" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_e2fc8e25-5936-4580-90cf-46695f3c90d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_23c0b61d-cd62-423a-8bd1-8ccb3ddf5e48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_db70b9a4-5394-48df-91c0-b9e3eb551517" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_23c0b61d-cd62-423a-8bd1-8ccb3ddf5e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_82f9e81c-128a-403b-8569-0744df544fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_db70b9a4-5394-48df-91c0-b9e3eb551517" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_82f9e81c-128a-403b-8569-0744df544fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7b2cc290-40c1-46f8-8687-8367a29f8f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_db70b9a4-5394-48df-91c0-b9e3eb551517" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7b2cc290-40c1-46f8-8687-8367a29f8f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a46365d5-3c63-4178-a9bb-0131a50b170a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_91d1b1ca-c00f-44b8-be7c-0f7bbf31fd97" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a46365d5-3c63-4178-a9bb-0131a50b170a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4c8c5bd7-3ed5-42b1-bce9-39da441dc3a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a46365d5-3c63-4178-a9bb-0131a50b170a" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4c8c5bd7-3ed5-42b1-bce9-39da441dc3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_00fc168e-5b87-4d7a-a623-8538ff1ac546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a46365d5-3c63-4178-a9bb-0131a50b170a" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_00fc168e-5b87-4d7a-a623-8538ff1ac546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_2adec96d-2f7c-4cfd-8fe3-5e99455b8972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a46365d5-3c63-4178-a9bb-0131a50b170a" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_2adec96d-2f7c-4cfd-8fe3-5e99455b8972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease_9bce2801-523c-468c-a394-b85c7ffcf128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a46365d5-3c63-4178-a9bb-0131a50b170a" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease_9bce2801-523c-468c-a394-b85c7ffcf128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_c3adc756-c42c-48f2-8489-d9a8f9e61b15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a46365d5-3c63-4178-a9bb-0131a50b170a" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_c3adc756-c42c-48f2-8489-d9a8f9e61b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_00be9855-8e7c-43ba-8071-83e576dede99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a46365d5-3c63-4178-a9bb-0131a50b170a" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_00be9855-8e7c-43ba-8071-83e576dede99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_77cf02df-d86c-48a6-95d8-375c57157e46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a46365d5-3c63-4178-a9bb-0131a50b170a" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_77cf02df-d86c-48a6-95d8-375c57157e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5fc74563-175d-4216-ab2c-37499e0824ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a46365d5-3c63-4178-a9bb-0131a50b170a" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5fc74563-175d-4216-ab2c-37499e0824ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_65e80990-f45a-4dc5-8029-7be0960c81fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_91d1b1ca-c00f-44b8-be7c-0f7bbf31fd97" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_65e80990-f45a-4dc5-8029-7be0960c81fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_UnrecognizedNetActuarialLossGain_48334529-156e-4f61-a567-0c0ed3202d50" xlink:href="hae-20230401.xsd#hae_UnrecognizedNetActuarialLossGain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_91d1b1ca-c00f-44b8-be7c-0f7bbf31fd97" xlink:to="loc_hae_UnrecognizedNetActuarialLossGain_48334529-156e-4f61-a567-0c0ed3202d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_UnrecognizedPriorServiceCost_8c4479cd-2447-46ff-938f-c417ae19e19c" xlink:href="hae-20230401.xsd#hae_UnrecognizedPriorServiceCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_91d1b1ca-c00f-44b8-be7c-0f7bbf31fd97" xlink:to="loc_hae_UnrecognizedPriorServiceCost_8c4479cd-2447-46ff-938f-c417ae19e19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_f6de8090-8430-47a8-a198-97fc65493ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_91d1b1ca-c00f-44b8-be7c-0f7bbf31fd97" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_f6de8090-8430-47a8-a198-97fc65493ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofChangeRecordedinAccumulatedOtherComprehensiveIncomeRelatedtoDefinedBenefitPlansNetofTaxDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#RETIREMENTPLANSScheduleofComponentsofChangeRecordedinAccumulatedOtherComprehensiveIncomeRelatedtoDefinedBenefitPlansNetofTaxDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofChangeRecordedinAccumulatedOtherComprehensiveIncomeRelatedtoDefinedBenefitPlansNetofTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_da5384e1-10be-4d3f-8579-6492dfa32f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward_faa78b43-7452-4862-bd0a-00c393503063" xlink:href="hae-20230401.xsd#hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_da5384e1-10be-4d3f-8579-6492dfa32f05" xlink:to="loc_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward_faa78b43-7452-4862-bd0a-00c393503063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_52fb31db-c7c0-48f4-a3af-a8d94d2a66d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward_faa78b43-7452-4862-bd0a-00c393503063" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_52fb31db-c7c0-48f4-a3af-a8d94d2a66d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_f6e85dd3-3113-4d43-bc58-06e2fc7ffc64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward_faa78b43-7452-4862-bd0a-00c393503063" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_f6e85dd3-3113-4d43-bc58-06e2fc7ffc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_3372c261-f51d-4aec-a8d0-123ce15bc77d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward_faa78b43-7452-4862-bd0a-00c393503063" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_3372c261-f51d-4aec-a8d0-123ce15bc77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_233d5113-3fca-4855-b919-e84213454057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward_faa78b43-7452-4862-bd0a-00c393503063" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_233d5113-3fca-4855-b919-e84213454057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_43a508a8-1723-4626-8d44-f62ff6a96901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward_faa78b43-7452-4862-bd0a-00c393503063" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_43a508a8-1723-4626-8d44-f62ff6a96901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofWeightedAverageRatesUsedtoDetermineNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#RETIREMENTPLANSScheduleofWeightedAverageRatesUsedtoDetermineNetPeriodicBenefitCostsDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofWeightedAverageRatesUsedtoDetermineNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b432505-4fd3-4442-bd9e-5fca94d25518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_c3f9a058-f4d2-4922-b08e-2fae57780b08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b432505-4fd3-4442-bd9e-5fca94d25518" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_c3f9a058-f4d2-4922-b08e-2fae57780b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_c15d4150-a5c5-4990-95fc-0cc872a35975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b432505-4fd3-4442-bd9e-5fca94d25518" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_c15d4150-a5c5-4990-95fc-0cc872a35975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_2292d7a0-80a4-401a-8534-59c2ab2d953c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b432505-4fd3-4442-bd9e-5fca94d25518" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_2292d7a0-80a4-401a-8534-59c2ab2d953c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofEstimatedFutureBenefitPaymentsDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#RETIREMENTPLANSScheduleofEstimatedFutureBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofEstimatedFutureBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e44cbde9-ee64-44f7-954c-77b79c6f3258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_e2678816-6625-4905-a2d5-99275b22ca80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e44cbde9-ee64-44f7-954c-77b79c6f3258" xlink:to="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_e2678816-6625-4905-a2d5-99275b22ca80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_41883050-1aa3-4f8a-a453-3db4f89b352d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_e2678816-6625-4905-a2d5-99275b22ca80" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_41883050-1aa3-4f8a-a453-3db4f89b352d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_6cedb3b3-703d-4959-bfaa-12599f84d636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_e2678816-6625-4905-a2d5-99275b22ca80" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_6cedb3b3-703d-4959-bfaa-12599f84d636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_38d210a8-8a23-4de2-95ce-94238d2310d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_e2678816-6625-4905-a2d5-99275b22ca80" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_38d210a8-8a23-4de2-95ce-94238d2310d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_0858426f-9ce2-41a3-94bf-909c05de20e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_e2678816-6625-4905-a2d5-99275b22ca80" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_0858426f-9ce2-41a3-94bf-909c05de20e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_8f25157c-c166-4672-9e48-a6ff222dec1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_e2678816-6625-4905-a2d5-99275b22ca80" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_8f25157c-c166-4672-9e48-a6ff222dec1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_866d03b7-668d-41ff-a0ff-431b0cdbaaac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_e2678816-6625-4905-a2d5-99275b22ca80" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_866d03b7-668d-41ff-a0ff-431b0cdbaaac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#CAPITALSTOCKNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84e8119b-2720-4d18-b3e8-a4ceabc2d894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84e8119b-2720-4d18-b3e8-a4ceabc2d894" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_863f8091-7b26-430f-bc92-890cace60c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:to="loc_us-gaap_PlanNameAxis_863f8091-7b26-430f-bc92-890cace60c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0f45b7f0-1d03-4412-b9d0-f74806a44121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_863f8091-7b26-430f-bc92-890cace60c5f" xlink:to="loc_us-gaap_PlanNameDomain_0f45b7f0-1d03-4412-b9d0-f74806a44121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2019EquityPlanMember_d36a5502-9faa-4c20-ba64-0a84e57eda1e" xlink:href="hae-20230401.xsd#hae_A2019EquityPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_0f45b7f0-1d03-4412-b9d0-f74806a44121" xlink:to="loc_hae_A2019EquityPlanMember_d36a5502-9faa-4c20-ba64-0a84e57eda1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_IncentiveCompensationPlan2005Member_ac9258f0-0ccc-4eb0-aae0-2ac7786f9f4f" xlink:href="hae-20230401.xsd#hae_IncentiveCompensationPlan2005Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_0f45b7f0-1d03-4412-b9d0-f74806a44121" xlink:to="loc_hae_IncentiveCompensationPlan2005Member_ac9258f0-0ccc-4eb0-aae0-2ac7786f9f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_eb6c4c22-524b-4040-8734-1275b84e79a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:to="loc_us-gaap_AwardTypeAxis_eb6c4c22-524b-4040-8734-1275b84e79a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6aab928c-bbd6-43e5-bb49-ccec24cd27f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_eb6c4c22-524b-4040-8734-1275b84e79a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6aab928c-bbd6-43e5-bb49-ccec24cd27f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4e52f869-c9eb-4c2f-96ab-4b68d963c29d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6aab928c-bbd6-43e5-bb49-ccec24cd27f0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4e52f869-c9eb-4c2f-96ab-4b68d963c29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d7bc2541-c0ba-45fa-b886-b319a7cbd672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6aab928c-bbd6-43e5-bb49-ccec24cd27f0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d7bc2541-c0ba-45fa-b886-b319a7cbd672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_17876e7e-20bd-4c77-83d1-2eb56765a44a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6aab928c-bbd6-43e5-bb49-ccec24cd27f0" xlink:to="loc_us-gaap_PerformanceSharesMember_17876e7e-20bd-4c77-83d1-2eb56765a44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_e6bb2af1-2224-4b95-94d2-500863554d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6aab928c-bbd6-43e5-bb49-ccec24cd27f0" xlink:to="loc_us-gaap_StockCompensationPlanMember_e6bb2af1-2224-4b95-94d2-500863554d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_32dfc469-9951-49b5-a397-b4cb2efe7a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:to="loc_us-gaap_VestingAxis_32dfc469-9951-49b5-a397-b4cb2efe7a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_0549e961-c28d-4c21-897a-529b8d7dd09f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_32dfc469-9951-49b5-a397-b4cb2efe7a59" xlink:to="loc_us-gaap_VestingDomain_0549e961-c28d-4c21-897a-529b8d7dd09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_Fiscal2016AwardsMember_25e7c008-9bc3-4955-9bb0-fb31ef66d934" xlink:href="hae-20230401.xsd#hae_Fiscal2016AwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_0549e961-c28d-4c21-897a-529b8d7dd09f" xlink:to="loc_hae_Fiscal2016AwardsMember_25e7c008-9bc3-4955-9bb0-fb31ef66d934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_41f9a2a7-cfac-4457-beda-070c3e1ddea3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:to="loc_srt_TitleOfIndividualAxis_41f9a2a7-cfac-4457-beda-070c3e1ddea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32e4d787-ed11-430e-ac52-adac6c2a52cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_41f9a2a7-cfac-4457-beda-070c3e1ddea3" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32e4d787-ed11-430e-ac52-adac6c2a52cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EmployeesMember_eb508a30-0b5a-4c1b-912f-ecebe4d39cfb" xlink:href="hae-20230401.xsd#hae_EmployeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32e4d787-ed11-430e-ac52-adac6c2a52cb" xlink:to="loc_hae_EmployeesMember_eb508a30-0b5a-4c1b-912f-ecebe4d39cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_217614c8-760f-49b1-88cb-ff662394214c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_32e4d787-ed11-430e-ac52-adac6c2a52cb" xlink:to="loc_srt_DirectorMember_217614c8-760f-49b1-88cb-ff662394214c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_10a2cb80-3d50-48a4-b3f2-bf2afd534cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_10a2cb80-3d50-48a4-b3f2-bf2afd534cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_01bfa33c-c6c0-4884-89c7-02841a37e54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_10a2cb80-3d50-48a4-b3f2-bf2afd534cfb" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_01bfa33c-c6c0-4884-89c7-02841a37e54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EmployeeStockPurchasePlanMember_fad5f36f-c5b2-421e-a6ed-7198928768d8" xlink:href="hae-20230401.xsd#hae_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_01bfa33c-c6c0-4884-89c7-02841a37e54d" xlink:to="loc_hae_EmployeeStockPurchasePlanMember_fad5f36f-c5b2-421e-a6ed-7198928768d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_58bbdbb8-304c-4cbb-94ca-ed697e2791d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:to="loc_srt_RangeAxis_58bbdbb8-304c-4cbb-94ca-ed697e2791d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f9e96f55-9c3a-45e7-a481-794e8a819d7c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_58bbdbb8-304c-4cbb-94ca-ed697e2791d9" xlink:to="loc_srt_RangeMember_f9e96f55-9c3a-45e7-a481-794e8a819d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_25c7756d-fff6-40e1-8ab9-a023dd8b33fc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f9e96f55-9c3a-45e7-a481-794e8a819d7c" xlink:to="loc_srt_MinimumMember_25c7756d-fff6-40e1-8ab9-a023dd8b33fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4f4a31b2-ca8f-43ba-a7fb-62376dff8f97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f9e96f55-9c3a-45e7-a481-794e8a819d7c" xlink:to="loc_srt_MaximumMember_4f4a31b2-ca8f-43ba-a7fb-62376dff8f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fb1475a6-a0d3-40e2-a73d-7dcda976ec74" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5f34572a-c605-463b-90f4-d09b76c3bea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5f34572a-c605-463b-90f4-d09b76c3bea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares_51a31f19-a008-4efe-be59-664fabbc8b24" xlink:href="hae-20230401.xsd#hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares_51a31f19-a008-4efe-be59-664fabbc8b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_163213c6-cfb0-429a-a98f-ab85aa6c38d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_163213c6-cfb0-429a-a98f-ab85aa6c38d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a9267e67-2c1a-42f6-bacd-5df0c90f94c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a9267e67-2c1a-42f6-bacd-5df0c90f94c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_582371dd-9f6a-4104-995b-0a723e53456b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_582371dd-9f6a-4104-995b-0a723e53456b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bf1c931c-edd0-4f6c-b921-56ab987f519b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bf1c931c-edd0-4f6c-b921-56ab987f519b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_da8cf99b-7149-4ae4-ae3d-c13c4b6af52f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_da8cf99b-7149-4ae4-ae3d-c13c4b6af52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NumberOfPurchasePeriods_0bceed12-64c9-42cf-8b07-8ed94e18bcb1" xlink:href="hae-20230401.xsd#hae_NumberOfPurchasePeriods"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_hae_NumberOfPurchasePeriods_0bceed12-64c9-42cf-8b07-8ed94e18bcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PercentageOfSharesPurchasedThroughPayrollDeductions_506f8e3e-f570-49f4-bc4f-f0839a799b61" xlink:href="hae-20230401.xsd#hae_PercentageOfSharesPurchasedThroughPayrollDeductions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_hae_PercentageOfSharesPurchasedThroughPayrollDeductions_506f8e3e-f570-49f4-bc4f-f0839a799b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue_d1dd41fa-6393-47d5-bed6-bcb9bcb08458" xlink:href="hae-20230401.xsd#hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue_d1dd41fa-6393-47d5-bed6-bcb9bcb08458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1bee2987-465d-40e8-9195-461799e58e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1bee2987-465d-40e8-9195-461799e58e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fcc80ad8-ef0f-47c8-aa4c-97904bbc742c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fcc80ad8-ef0f-47c8-aa4c-97904bbc742c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e8ea60dd-c1cf-4cee-843c-d4270c3bba39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e8ea60dd-c1cf-4cee-843c-d4270c3bba39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan_a5eb3cd8-91e7-4d7a-a79f-da4a321600df" xlink:href="hae-20230401.xsd#hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan_a5eb3cd8-91e7-4d7a-a79f-da4a321600df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44dc38c2-7bb0-44d9-8034-3065cbdd4c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44dc38c2-7bb0-44d9-8034-3065cbdd4c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7647823c-8480-43ac-9c12-c45dcfcbe734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7647823c-8480-43ac-9c12-c45dcfcbe734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod_716f40b7-ca25-4f94-862d-768dfcfe95b2" xlink:href="hae-20230401.xsd#hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod_716f40b7-ca25-4f94-862d-768dfcfe95b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget_b07062e0-3df9-4929-a653-d026b4248557" xlink:href="hae-20230401.xsd#hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget_b07062e0-3df9-4929-a653-d026b4248557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e1538886-12f7-4fe2-849b-e2e230029045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_86a694e4-32a9-4146-b787-7d1f79b7d1f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e1538886-12f7-4fe2-849b-e2e230029045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofShareBasedCompensationDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#CAPITALSTOCKScheduleofShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fcd5afac-5b02-49ca-b296-7e152e9f91c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2d45df26-e64e-4e94-b6d5-9a6f87a87ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fcd5afac-5b02-49ca-b296-7e152e9f91c7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2d45df26-e64e-4e94-b6d5-9a6f87a87ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c54a5066-b536-4c5e-879c-056bb5ff6fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2d45df26-e64e-4e94-b6d5-9a6f87a87ebc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c54a5066-b536-4c5e-879c-056bb5ff6fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7b1022d8-1ad2-416c-ba53-003a9f119842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c54a5066-b536-4c5e-879c-056bb5ff6fff" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7b1022d8-1ad2-416c-ba53-003a9f119842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_77c928a9-b050-496d-af19-d96c231e65d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7b1022d8-1ad2-416c-ba53-003a9f119842" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_77c928a9-b050-496d-af19-d96c231e65d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_dad0a3e9-d05c-4872-8644-21da51bbfb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7b1022d8-1ad2-416c-ba53-003a9f119842" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_dad0a3e9-d05c-4872-8644-21da51bbfb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_a6043e09-0b68-4e0f-9e59-1345b08d9a08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7b1022d8-1ad2-416c-ba53-003a9f119842" xlink:to="loc_us-gaap_CostOfSalesMember_a6043e09-0b68-4e0f-9e59-1345b08d9a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_117abcc1-e72f-4374-993d-7d74e09ee1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2d45df26-e64e-4e94-b6d5-9a6f87a87ebc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_117abcc1-e72f-4374-993d-7d74e09ee1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_31739fbf-40ea-4de6-8df0-8530e2ba0065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_117abcc1-e72f-4374-993d-7d74e09ee1c3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_31739fbf-40ea-4de6-8df0-8530e2ba0065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_526e2473-ac18-4da8-86f8-3552f181b1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b4bdd9-cac8-4967-bdf0-f3d396174629" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_526e2473-ac18-4da8-86f8-3552f181b1d1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b4bdd9-cac8-4967-bdf0-f3d396174629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6caf9b85-c505-4a32-af40-e542127dd2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b4bdd9-cac8-4967-bdf0-f3d396174629" xlink:to="loc_us-gaap_AwardTypeAxis_6caf9b85-c505-4a32-af40-e542127dd2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8be5cf36-8aa2-474f-98e3-cf3a4f916cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6caf9b85-c505-4a32-af40-e542127dd2ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8be5cf36-8aa2-474f-98e3-cf3a4f916cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a6a7ef7e-2634-4eb5-a157-24329e9f796b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8be5cf36-8aa2-474f-98e3-cf3a4f916cb8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a6a7ef7e-2634-4eb5-a157-24329e9f796b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855710a2-0805-4627-ab9e-8a554ec67916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08b4bdd9-cac8-4967-bdf0-f3d396174629" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855710a2-0805-4627-ab9e-8a554ec67916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e515b3ad-a77f-4ac0-b4a7-24ed0f207d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855710a2-0805-4627-ab9e-8a554ec67916" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e515b3ad-a77f-4ac0-b4a7-24ed0f207d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2b9214be-5037-4728-87ce-cd97b74dd082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e515b3ad-a77f-4ac0-b4a7-24ed0f207d87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2b9214be-5037-4728-87ce-cd97b74dd082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_fbf2e9f0-63a8-48ab-a2a8-36d4ecb8934e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e515b3ad-a77f-4ac0-b4a7-24ed0f207d87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_fbf2e9f0-63a8-48ab-a2a8-36d4ecb8934e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_32d1757f-f817-4003-830f-086e10e494b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e515b3ad-a77f-4ac0-b4a7-24ed0f207d87" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_32d1757f-f817-4003-830f-086e10e494b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3ff9fa52-e742-4df1-a61a-c725069896fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e515b3ad-a77f-4ac0-b4a7-24ed0f207d87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3ff9fa52-e742-4df1-a61a-c725069896fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_543db4a5-9144-4944-bb71-20496e14a377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e515b3ad-a77f-4ac0-b4a7-24ed0f207d87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_543db4a5-9144-4944-bb71-20496e14a377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2283aca7-11cc-480d-a4a2-0891a05847f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855710a2-0805-4627-ab9e-8a554ec67916" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2283aca7-11cc-480d-a4a2-0891a05847f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_968d05a1-d168-41de-9cd2-4b7ecd1dfd24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2283aca7-11cc-480d-a4a2-0891a05847f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_968d05a1-d168-41de-9cd2-4b7ecd1dfd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a59f5abb-c150-4f59-9435-a96fc0ae1d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2283aca7-11cc-480d-a4a2-0891a05847f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a59f5abb-c150-4f59-9435-a96fc0ae1d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4915ed22-643f-4f8a-a75c-c5ca176496d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2283aca7-11cc-480d-a4a2-0891a05847f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4915ed22-643f-4f8a-a75c-c5ca176496d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c96cd9d1-3ee6-4292-978c-251148180445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2283aca7-11cc-480d-a4a2-0891a05847f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c96cd9d1-3ee6-4292-978c-251148180445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3adbf6e5-d98d-4542-ae7c-19ee13483459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2283aca7-11cc-480d-a4a2-0891a05847f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3adbf6e5-d98d-4542-ae7c-19ee13483459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855710a2-0805-4627-ab9e-8a554ec67916" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8edc5319-cebe-4101-8390-ad378a2e463f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8edc5319-cebe-4101-8390-ad378a2e463f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_631834bb-0b44-4da6-bb16-249055529d28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_631834bb-0b44-4da6-bb16-249055529d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_713a6847-a0a6-4e3f-99de-5dbedc2d92d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_713a6847-a0a6-4e3f-99de-5dbedc2d92d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_54b9585f-2d80-4e42-b3fc-1ff6c25bcba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_54b9585f-2d80-4e42-b3fc-1ff6c25bcba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_25377f16-4875-4400-ac07-8b64a3217bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_25377f16-4875-4400-ac07-8b64a3217bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_a599544f-de88-4ba5-8795-f4f80ec02d90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_a599544f-de88-4ba5-8795-f4f80ec02d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_6f7d5719-8a67-4f21-8141-d5620c7c9726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_6f7d5719-8a67-4f21-8141-d5620c7c9726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_30836774-c34d-46b5-b123-ba896f17dc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_30836774-c34d-46b5-b123-ba896f17dc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_bea967d1-070f-4805-82c1-200855266b28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_bea967d1-070f-4805-82c1-200855266b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_7cf235ec-492d-46ad-b594-c276c13c99da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e0c44bc-0e10-4be3-b979-78a4ccd9c5dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_7cf235ec-492d-46ad-b594-c276c13c99da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7a3b132b-5625-4329-8910-ef6b134ac774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cfe3a299-da3b-4273-a2da-fce33d0169ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7a3b132b-5625-4329-8910-ef6b134ac774" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cfe3a299-da3b-4273-a2da-fce33d0169ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_01adcb78-ac68-4c84-8b7b-e423808f6b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cfe3a299-da3b-4273-a2da-fce33d0169ce" xlink:to="loc_us-gaap_AwardTypeAxis_01adcb78-ac68-4c84-8b7b-e423808f6b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_564eaa05-780a-4c6f-acd6-b188bae17d34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_01adcb78-ac68-4c84-8b7b-e423808f6b17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_564eaa05-780a-4c6f-acd6-b188bae17d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d3885e07-a4e9-46de-a6da-344ff0a2312c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_564eaa05-780a-4c6f-acd6-b188bae17d34" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d3885e07-a4e9-46de-a6da-344ff0a2312c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_47a92adc-076d-479b-a744-9562e45adff3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_564eaa05-780a-4c6f-acd6-b188bae17d34" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_47a92adc-076d-479b-a744-9562e45adff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_8790580e-1a03-458e-9663-0b54d21f28f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_564eaa05-780a-4c6f-acd6-b188bae17d34" xlink:to="loc_us-gaap_PerformanceSharesMember_8790580e-1a03-458e-9663-0b54d21f28f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_737cbf10-bf27-484b-845f-606ff4d96036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cfe3a299-da3b-4273-a2da-fce33d0169ce" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_737cbf10-bf27-484b-845f-606ff4d96036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_3b220861-c09e-4036-b0af-f31ca53c8574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_737cbf10-bf27-484b-845f-606ff4d96036" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_3b220861-c09e-4036-b0af-f31ca53c8574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EmployeeStockPurchasePlanMember_bd7a2ffc-e5a8-4b10-9c78-e9e1ff970867" xlink:href="hae-20230401.xsd#hae_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_3b220861-c09e-4036-b0af-f31ca53c8574" xlink:to="loc_hae_EmployeeStockPurchasePlanMember_bd7a2ffc-e5a8-4b10-9c78-e9e1ff970867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cfe3a299-da3b-4273-a2da-fce33d0169ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b91b0255-7f73-46b8-9724-1a94ff286e15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b91b0255-7f73-46b8-9724-1a94ff286e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility_d49d5d30-6481-4ad7-8a09-f8f1b338dc85" xlink:href="hae-20230401.xsd#hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility_d49d5d30-6481-4ad7-8a09-f8f1b338dc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns_03cdee06-49de-4673-9785-d2044c14509a" xlink:href="hae-20230401.xsd#hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns_03cdee06-49de-4673-9785-d2044c14509a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6f09f672-e5d5-4108-8126-68069a88c842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6f09f672-e5d5-4108-8126-68069a88c842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3f42d264-6e85-44cd-8913-31f0914d3744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3f42d264-6e85-44cd-8913-31f0914d3744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6d41930b-b721-4c37-a506-7811d3898e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6d41930b-b721-4c37-a506-7811d3898e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7215acc2-1f19-4f28-9b77-34a12e2a84c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7215acc2-1f19-4f28-9b77-34a12e2a84c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8fe4a97e-609f-46c4-82fe-c584b9442669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8fe4a97e-609f-46c4-82fe-c584b9442669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fb07fb39-4426-4f0b-a809-0c00c29fd444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4d21fdcd-a74c-467a-91f4-711cac762f61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fb07fb39-4426-4f0b-a809-0c00c29fd444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6ea8a59d-36ad-4dfc-8c1b-d247dfda946b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f33d9f19-d52d-480f-907e-f08c2a3ebdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6ea8a59d-36ad-4dfc-8c1b-d247dfda946b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f33d9f19-d52d-480f-907e-f08c2a3ebdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_48cdacf7-0602-4fe7-987e-c9bf5e871c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f33d9f19-d52d-480f-907e-f08c2a3ebdcd" xlink:to="loc_us-gaap_AwardTypeAxis_48cdacf7-0602-4fe7-987e-c9bf5e871c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_867c5fd6-6020-403c-b058-cfad5856fa3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_48cdacf7-0602-4fe7-987e-c9bf5e871c4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_867c5fd6-6020-403c-b058-cfad5856fa3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_208e8164-b6ed-44bc-a413-3bfe98eae235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_867c5fd6-6020-403c-b058-cfad5856fa3d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_208e8164-b6ed-44bc-a413-3bfe98eae235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_201a959e-0e08-4ffc-a5fb-51b66504c617" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_867c5fd6-6020-403c-b058-cfad5856fa3d" xlink:to="loc_us-gaap_PerformanceSharesMember_201a959e-0e08-4ffc-a5fb-51b66504c617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489f353-48b4-420e-b467-19145a33bce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f33d9f19-d52d-480f-907e-f08c2a3ebdcd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489f353-48b4-420e-b467-19145a33bce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_efad8319-a8ce-4bd5-85ac-0c26659e890d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489f353-48b4-420e-b467-19145a33bce8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_efad8319-a8ce-4bd5-85ac-0c26659e890d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bd7bd862-3f04-490e-a4af-33525480f9c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_efad8319-a8ce-4bd5-85ac-0c26659e890d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bd7bd862-3f04-490e-a4af-33525480f9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6aeea3c7-f190-4f3c-b43f-6f39cd727406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_efad8319-a8ce-4bd5-85ac-0c26659e890d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6aeea3c7-f190-4f3c-b43f-6f39cd727406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_03bb2ebc-c2d8-4ad9-9f04-c4ccdf61db39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_efad8319-a8ce-4bd5-85ac-0c26659e890d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_03bb2ebc-c2d8-4ad9-9f04-c4ccdf61db39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3a8b0327-fa13-4285-8e4c-6c83ec7e9895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_efad8319-a8ce-4bd5-85ac-0c26659e890d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3a8b0327-fa13-4285-8e4c-6c83ec7e9895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5f3ae0d2-3721-4649-aea2-4793b9a354ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_efad8319-a8ce-4bd5-85ac-0c26659e890d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5f3ae0d2-3721-4649-aea2-4793b9a354ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7d215aa9-45aa-4ec8-bae4-9af506a607f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489f353-48b4-420e-b467-19145a33bce8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7d215aa9-45aa-4ec8-bae4-9af506a607f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c5ac18f4-f1a6-4e74-b172-2c4ba8441c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7d215aa9-45aa-4ec8-bae4-9af506a607f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c5ac18f4-f1a6-4e74-b172-2c4ba8441c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c2255a01-e116-4dd9-b94e-36f36faeb844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7d215aa9-45aa-4ec8-bae4-9af506a607f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c2255a01-e116-4dd9-b94e-36f36faeb844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a8bdac20-e631-4172-8f68-1782b4b19354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7d215aa9-45aa-4ec8-bae4-9af506a607f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a8bdac20-e631-4172-8f68-1782b4b19354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_222f45f5-555f-4b4e-b74d-fa3c3043cd07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7d215aa9-45aa-4ec8-bae4-9af506a607f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_222f45f5-555f-4b4e-b74d-fa3c3043cd07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0dea0985-75e9-4d88-b542-d047bbba965c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7d215aa9-45aa-4ec8-bae4-9af506a607f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0dea0985-75e9-4d88-b542-d047bbba965c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails" xlink:type="simple" xlink:href="hae-20230401.xsd#SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_74397e1a-9f89-4c5b-8e0c-d39a9ac57674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_68018d95-b9e1-4beb-8642-8d500f3d26f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_74397e1a-9f89-4c5b-8e0c-d39a9ac57674" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_68018d95-b9e1-4beb-8642-8d500f3d26f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ccf926ce-efb2-4864-8c80-e65540285605" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_68018d95-b9e1-4beb-8642-8d500f3d26f1" xlink:to="loc_srt_ConsolidationItemsAxis_ccf926ce-efb2-4864-8c80-e65540285605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0ff43e95-1c13-4d4a-85dc-b3ed66355010" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_ccf926ce-efb2-4864-8c80-e65540285605" xlink:to="loc_srt_ConsolidationItemsDomain_0ff43e95-1c13-4d4a-85dc-b3ed66355010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9fd95627-f3e0-4460-a4ef-3beec8703e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_0ff43e95-1c13-4d4a-85dc-b3ed66355010" xlink:to="loc_us-gaap_OperatingSegmentsMember_9fd95627-f3e0-4460-a4ef-3beec8703e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b6db9489-2724-4d10-bc87-8e8282e89315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_0ff43e95-1c13-4d4a-85dc-b3ed66355010" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b6db9489-2724-4d10-bc87-8e8282e89315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_55d2d9a2-7a76-4293-900b-24a8e82c53f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_68018d95-b9e1-4beb-8642-8d500f3d26f1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_55d2d9a2-7a76-4293-900b-24a8e82c53f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_04839fcd-37f6-446b-8c9c-777bf72bd6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_55d2d9a2-7a76-4293-900b-24a8e82c53f3" xlink:to="loc_us-gaap_SegmentDomain_04839fcd-37f6-446b-8c9c-777bf72bd6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaMember_13c4f583-bf50-4cc6-95dc-f3df8cbcb8bd" xlink:href="hae-20230401.xsd#hae_PlasmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_04839fcd-37f6-446b-8c9c-777bf72bd6ee" xlink:to="loc_hae_PlasmaMember_13c4f583-bf50-4cc6-95dc-f3df8cbcb8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterMember_865a87f7-07f8-43ea-b561-ed205ebbce7e" xlink:href="hae-20230401.xsd#hae_BloodCenterMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_04839fcd-37f6-446b-8c9c-777bf72bd6ee" xlink:to="loc_hae_BloodCenterMember_865a87f7-07f8-43ea-b561-ed205ebbce7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalMember_42129451-7ca5-4143-be8b-8a1294f2c1a8" xlink:href="hae-20230401.xsd#hae_HospitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_04839fcd-37f6-446b-8c9c-777bf72bd6ee" xlink:to="loc_hae_HospitalMember_42129451-7ca5-4143-be8b-8a1294f2c1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a2cd78bd-9019-4c54-be25-d11cb193b849" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_68018d95-b9e1-4beb-8642-8d500f3d26f1" xlink:to="loc_srt_StatementGeographicalAxis_a2cd78bd-9019-4c54-be25-d11cb193b849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_01e5e346-4246-4f56-a182-692db39187f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a2cd78bd-9019-4c54-be25-d11cb193b849" xlink:to="loc_srt_SegmentGeographicalDomain_01e5e346-4246-4f56-a182-692db39187f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a221d57b-47da-4099-ac9b-3902cbdee9ea" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_01e5e346-4246-4f56-a182-692db39187f6" xlink:to="loc_country_US_a221d57b-47da-4099-ac9b-3902cbdee9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_7e21a53f-80a8-409f-bc9d-2169aefb5de9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_JP"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_01e5e346-4246-4f56-a182-692db39187f6" xlink:to="loc_country_JP_7e21a53f-80a8-409f-bc9d-2169aefb5de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_b17338a5-8ebb-469f-9ed5-46461fdca5cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_01e5e346-4246-4f56-a182-692db39187f6" xlink:to="loc_srt_EuropeMember_b17338a5-8ebb-469f-9ed5-46461fdca5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_e9663d27-e169-44ad-988a-06263b28b5a2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_01e5e346-4246-4f56-a182-692db39187f6" xlink:to="loc_srt_AsiaMember_e9663d27-e169-44ad-988a-06263b28b5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherCountryorRegionMember_8985a904-cdcf-4a68-8699-8e99e1eaf097" xlink:href="hae-20230401.xsd#hae_OtherCountryorRegionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_01e5e346-4246-4f56-a182-692db39187f6" xlink:to="loc_hae_OtherCountryorRegionMember_8985a904-cdcf-4a68-8699-8e99e1eaf097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1b2cbc86-4f7d-47c5-b0d7-b8156e5f15b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_68018d95-b9e1-4beb-8642-8d500f3d26f1" xlink:to="loc_srt_ProductOrServiceAxis_1b2cbc86-4f7d-47c5-b0d7-b8156e5f15b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_edcc7cc8-089a-4282-8363-d2984ea82111" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1b2cbc86-4f7d-47c5-b0d7-b8156e5f15b2" xlink:to="loc_srt_ProductsAndServicesDomain_edcc7cc8-089a-4282-8363-d2984ea82111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_59ac6291-d519-4c03-a1c4-2dc71d68b1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_edcc7cc8-089a-4282-8363-d2984ea82111" xlink:to="loc_us-gaap_ServiceMember_59ac6291-d519-4c03-a1c4-2dc71d68b1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaMember_15d0a7b0-fce2-4e90-b076-1dddab5458cf" xlink:href="hae-20230401.xsd#hae_PlasmaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_edcc7cc8-089a-4282-8363-d2984ea82111" xlink:to="loc_hae_PlasmaMember_15d0a7b0-fce2-4e90-b076-1dddab5458cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterMember_042363d6-c59d-4762-8516-799a1dbdbbaa" xlink:href="hae-20230401.xsd#hae_BloodCenterMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_edcc7cc8-089a-4282-8363-d2984ea82111" xlink:to="loc_hae_BloodCenterMember_042363d6-c59d-4762-8516-799a1dbdbbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalMember_6f61e96a-bc67-4e52-a48f-f0ff40e303de" xlink:href="hae-20230401.xsd#hae_HospitalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_edcc7cc8-089a-4282-8363-d2984ea82111" xlink:to="loc_hae_HospitalMember_6f61e96a-bc67-4e52-a48f-f0ff40e303de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_68018d95-b9e1-4beb-8642-8d500f3d26f1" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_0b9bced7-b059-4e3c-8078-f74f493b5cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_NumberOfReportingUnits_0b9bced7-b059-4e3c-8078-f74f493b5cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NetRevenuesBeforeForeignExchangeImpact_aa65c828-0415-44f4-89b7-344e7d50ae8a" xlink:href="hae-20230401.xsd#hae_NetRevenuesBeforeForeignExchangeImpact"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_NetRevenuesBeforeForeignExchangeImpact_aa65c828-0415-44f4-89b7-344e7d50ae8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectofExchangeRateonRevenues_be0bcb9e-5702-4bf6-b876-963d153dd5a0" xlink:href="hae-20230401.xsd#hae_EffectofExchangeRateonRevenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_EffectofExchangeRateonRevenues_be0bcb9e-5702-4bf6-b876-963d153dd5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_57ce3026-caad-4390-917a-e488fee6f657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_57ce3026-caad-4390-917a-e488fee6f657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c01d646f-f369-499e-ae5e-a4e9d4a1bcba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_OperatingIncomeLoss_c01d646f-f369-499e-ae5e-a4e9d4a1bcba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_f723b643-854a-4beb-9626-c77301bfa516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_OtherExpenses_f723b643-854a-4beb-9626-c77301bfa516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectofExchangeRatesonOperatingIncome_29844ece-a684-42c5-ab9a-e9a6518d34d0" xlink:href="hae-20230401.xsd#hae_EffectofExchangeRatesonOperatingIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_EffectofExchangeRatesonOperatingIncome_29844ece-a684-42c5-ab9a-e9a6518d34d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AmortizationOfAcquiredIntangibleAssets_c52f98b4-bf1a-4141-bf6d-128754361a1f" xlink:href="hae-20230401.xsd#hae_AmortizationOfAcquiredIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_AmortizationOfAcquiredIntangibleAssets_c52f98b4-bf1a-4141-bf6d-128754361a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ImpairmentOfAssetsAndRelatedCharges_58f50a1b-bbd8-49e9-bc92-094536be1695" xlink:href="hae-20230401.xsd#hae_ImpairmentOfAssetsAndRelatedCharges"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_ImpairmentOfAssetsAndRelatedCharges_58f50a1b-bbd8-49e9-bc92-094536be1695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OperatingExpensesTransactionCosts_44a90637-f3b2-4a8b-8b05-23a627a598ac" xlink:href="hae-20230401.xsd#hae_OperatingExpensesTransactionCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_OperatingExpensesTransactionCosts_44a90637-f3b2-4a8b-8b05-23a627a598ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandRestructuringRelatedCosts_dd5d1092-2579-4fe3-801f-fb3321f6146e" xlink:href="hae-20230401.xsd#hae_RestructuringandRestructuringRelatedCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_RestructuringandRestructuringRelatedCosts_dd5d1092-2579-4fe3-801f-fb3321f6146e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DigitalTransformationCosts_d86de4af-6ab8-4276-8914-038d6a1918d8" xlink:href="hae-20230401.xsd#hae_DigitalTransformationCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_DigitalTransformationCosts_d86de4af-6ab8-4276-8914-038d6a1918d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EuropeanMedicalDeviceRegulationCosts_4d157901-1f26-437a-8f23-1746c19ee197" xlink:href="hae-20230401.xsd#hae_EuropeanMedicalDeviceRegulationCosts"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_hae_EuropeanMedicalDeviceRegulationCosts_4d157901-1f26-437a-8f23-1746c19ee197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_b0263758-5871-481d-bf13-abe17a04577c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_b0263758-5871-481d-bf13-abe17a04577c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_bd7d731b-8e79-4a07-8a8b-74159336fa94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_bd7d731b-8e79-4a07-8a8b-74159336fa94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_71bc73e6-d33e-492d-95bb-abba66530f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_DepreciationAndAmortization_71bc73e6-d33e-492d-95bb-abba66530f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_caea0830-ff3c-4b9d-955d-40062dcd2c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_NoncurrentAssets_caea0830-ff3c-4b9d-955d-40062dcd2c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_38555166-018a-4791-a9fa-11e3d3476842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1fce4fa-4760-423a-8e8e-2f7fa208cf3c" xlink:to="loc_us-gaap_NumberOfReportableSegments_38555166-018a-4791-a9fa-11e3d3476842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1" xlink:type="simple" xlink:href="hae-20230401.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_d58c83d6-ea2d-4233-ae74-e5483c0a9f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_49fa75a1-adf1-4368-a0f5-4fbc12399d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d58c83d6-ea2d-4233-ae74-e5483c0a9f18" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_49fa75a1-adf1-4368-a0f5-4fbc12399d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9d89e110-0a29-4d66-a246-2e6fc6138565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_49fa75a1-adf1-4368-a0f5-4fbc12399d20" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9d89e110-0a29-4d66-a246-2e6fc6138565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_945d147b-c099-4612-8ddb-ce791e238b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9d89e110-0a29-4d66-a246-2e6fc6138565" xlink:to="loc_us-gaap_EquityComponentDomain_945d147b-c099-4612-8ddb-ce791e238b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_38dd6c52-cc4b-4a9e-9176-2808a3ea91d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_945d147b-c099-4612-8ddb-ce791e238b84" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_38dd6c52-cc4b-4a9e-9176-2808a3ea91d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0d4d74ed-6df9-4db8-97b3-5ad153b8f5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_945d147b-c099-4612-8ddb-ce791e238b84" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0d4d74ed-6df9-4db8-97b3-5ad153b8f5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_ffc48f43-ceea-4265-994c-7faaa6a5036b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_945d147b-c099-4612-8ddb-ce791e238b84" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_ffc48f43-ceea-4265-994c-7faaa6a5036b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ed2cbc51-6dee-4a14-9ad7-9ea1adaff947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_49fa75a1-adf1-4368-a0f5-4fbc12399d20" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ed2cbc51-6dee-4a14-9ad7-9ea1adaff947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9424e328-dff8-4dcc-924b-0ae49aca93e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ed2cbc51-6dee-4a14-9ad7-9ea1adaff947" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9424e328-dff8-4dcc-924b-0ae49aca93e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b64d7ba0-6e05-40bb-9da1-cb0778326e44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ed2cbc51-6dee-4a14-9ad7-9ea1adaff947" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b64d7ba0-6e05-40bb-9da1-cb0778326e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f31eb340-5718-44e3-9ddf-777982970449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ed2cbc51-6dee-4a14-9ad7-9ea1adaff947" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f31eb340-5718-44e3-9ddf-777982970449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b4eba650-f62b-47bb-ae6c-d094e0a80891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ed2cbc51-6dee-4a14-9ad7-9ea1adaff947" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b4eba650-f62b-47bb-ae6c-d094e0a80891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a451c3c1-340c-47a7-948f-b3385329ce22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ed2cbc51-6dee-4a14-9ad7-9ea1adaff947" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a451c3c1-340c-47a7-948f-b3385329ce22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597100227376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DOCUMENT AND ENTITY INFORMATION - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>May 18, 2023</div></th>
<th class="th"><div>Oct. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--04-01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-14041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HAEMONETICS CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2882273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">125 Summer Street,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boston,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(781)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">848-7100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $.01&#160;par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HAE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,725,273,032<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,540,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the definitive proxy statement for our Annual Meeting of Shareholders to be held on August&#160;4, 2023 are incorporated by reference in Part&#160;III of this report.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000313143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Document and Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098918288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>AUDIT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Boston, Massachusetts<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098721296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 1,168,660<span></span>
</td>
<td class="nump">$ 993,196<span></span>
</td>
<td class="nump">$ 870,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">553,563<span></span>
</td>
<td class="nump">487,694<span></span>
</td>
<td class="nump">472,625<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">615,097<span></span>
</td>
<td class="nump">505,502<span></span>
</td>
<td class="nump">397,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">50,131<span></span>
</td>
<td class="nump">46,801<span></span>
</td>
<td class="nump">32,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">376,675<span></span>
</td>
<td class="nump">340,140<span></span>
</td>
<td class="nump">275,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AmortizationOfAcquiredIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">32,640<span></span>
</td>
<td class="nump">47,414<span></span>
</td>
<td class="nump">32,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Gains on divestitures and sale of assets</a></td>
<td class="num">(382)<span></span>
</td>
<td class="num">(9,603)<span></span>
</td>
<td class="num">(32,812)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">459,064<span></span>
</td>
<td class="nump">424,752<span></span>
</td>
<td class="nump">308,091<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">156,033<span></span>
</td>
<td class="nump">80,750<span></span>
</td>
<td class="nump">89,747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Interest and other expense, net</a></td>
<td class="num">(14,630)<span></span>
</td>
<td class="num">(17,121)<span></span>
</td>
<td class="num">(16,834)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision (benefit) for income taxes</a></td>
<td class="nump">141,403<span></span>
</td>
<td class="nump">63,629<span></span>
</td>
<td class="nump">72,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (benefit) for income taxes</a></td>
<td class="nump">26,002<span></span>
</td>
<td class="nump">20,254<span></span>
</td>
<td class="num">(6,556)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 115,401<span></span>
</td>
<td class="nump">$ 43,375<span></span>
</td>
<td class="nump">$ 79,469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share - basic (in dollars per share)</a></td>
<td class="nump">$ 2.27<span></span>
</td>
<td class="nump">$ 0.85<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share - diluted (in dollars per share)</a></td>
<td class="nump">$ 2.24<span></span>
</td>
<td class="nump">$ 0.84<span></span>
</td>
<td class="nump">$ 1.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">50,783<span></span>
</td>
<td class="nump">51,047<span></span>
</td>
<td class="nump">50,688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">51,420<span></span>
</td>
<td class="nump">51,353<span></span>
</td>
<td class="nump">51,292<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_AmortizationOfAcquiredIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Acquired Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_AmortizationOfAcquiredIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098901168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 115,401<span></span>
</td>
<td class="nump">$ 43,375<span></span>
</td>
<td class="nump">$ 79,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Impact of defined benefit plans, net of tax</a></td>
<td class="nump">2,456<span></span>
</td>
<td class="nump">2,179<span></span>
</td>
<td class="num">(351)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of tax</a></td>
<td class="num">(6,016)<span></span>
</td>
<td class="num">(6,391)<span></span>
</td>
<td class="nump">9,572<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on cash flow hedges, net of tax</a></td>
<td class="nump">4,269<span></span>
</td>
<td class="nump">5,785<span></span>
</td>
<td class="num">(489)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassifications into earnings of cash flow hedge (gains) losses, net of tax</a></td>
<td class="num">(5,136)<span></span>
</td>
<td class="nump">2,020<span></span>
</td>
<td class="nump">6,856<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(4,427)<span></span>
</td>
<td class="nump">3,593<span></span>
</td>
<td class="nump">15,588<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 110,974<span></span>
</td>
<td class="nump">$ 46,968<span></span>
</td>
<td class="nump">$ 95,057<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093912400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 284,466<span></span>
</td>
<td class="nump">$ 259,496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less allowance for credit losses of $4,932 at April 1, 2023 and $2,475 at April 2, 2022</a></td>
<td class="nump">179,142<span></span>
</td>
<td class="nump">159,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">259,379<span></span>
</td>
<td class="nump">293,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">46,735<span></span>
</td>
<td class="nump">44,132<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">769,722<span></span>
</td>
<td class="nump">756,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">310,885<span></span>
</td>
<td class="nump">258,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, less accumulated amortization of $417,422 at April 1, 2023 and $376,552 at April 2, 2022</a></td>
<td class="nump">275,771<span></span>
</td>
<td class="nump">310,261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">466,231<span></span>
</td>
<td class="nump">467,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax asset</a></td>
<td class="nump">5,241<span></span>
</td>
<td class="nump">4,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">106,975<span></span>
</td>
<td class="nump">63,205<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,934,825<span></span>
</td>
<td class="nump">1,859,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Notes payable and current maturities of long-term debt</a></td>
<td class="nump">11,784<span></span>
</td>
<td class="nump">214,148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">63,929<span></span>
</td>
<td class="nump">58,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and related costs</a></td>
<td class="nump">64,475<span></span>
</td>
<td class="nump">48,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">111,628<span></span>
</td>
<td class="nump">121,207<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">251,816<span></span>
</td>
<td class="nump">442,266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current maturities</a></td>
<td class="nump">754,102<span></span>
</td>
<td class="nump">559,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">36,195<span></span>
</td>
<td class="nump">28,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">74,715<span></span>
</td>
<td class="nump">79,876<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01&#160;par value; Authorized&#160;&#8212; 150,000,000&#160;shares; Issued and outstanding&#160;&#8212; 50,448,519&#160;shares at April 1, 2023 and 51,124,240&#160;shares at April 2, 2022</a></td>
<td class="nump">504<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">594,706<span></span>
</td>
<td class="nump">572,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">253,168<span></span>
</td>
<td class="nump">202,391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(30,381)<span></span>
</td>
<td class="num">(25,954)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">817,997<span></span>
</td>
<td class="nump">749,424<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 1,934,825<span></span>
</td>
<td class="nump">$ 1,859,734<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597100586960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance</a></td>
<td class="nump">$ 4,932<span></span>
</td>
<td class="nump">$ 2,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, accumulated amortization</a></td>
<td class="nump">$ 417,422<span></span>
</td>
<td class="nump">$ 376,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">50,448,519<span></span>
</td>
<td class="nump">51,124,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">50,448,519<span></span>
</td>
<td class="nump">51,124,240<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093121104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income/(Loss)</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares (in shares) at Mar. 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, value at Mar. 28, 2020</a></td>
<td class="nump">$ 587,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 503<span></span>
</td>
<td class="nump">$ 553,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (45,135)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">4,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">4,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">6,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">6,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">25,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible notes, net of issuance costs</a></td>
<td class="nump">61,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases', window );">Purchase of capped call related to convertible notes</a></td>
<td class="num">(47,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">79,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">15,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,588<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares (in shares) at Apr. 03, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, value at Apr. 03, 2021</a></td>
<td class="nump">731,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 509<span></span>
</td>
<td class="nump">602,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,547)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">4,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">4,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">2,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">2,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">24,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">43,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">3,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,593<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares (in shares) at Apr. 02, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, value at Apr. 02, 2022</a></td>
<td class="nump">749,424<span></span>
</td>
<td class="num">$ (60,121)<span></span>
</td>
<td class="nump">$ 511<span></span>
</td>
<td class="nump">572,476<span></span>
</td>
<td class="num">$ (61,156)<span></span>
</td>
<td class="nump">202,391<span></span>
</td>
<td class="nump">$ 1,035<span></span>
</td>
<td class="num">(25,954)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">4,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">4,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">2,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">2,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(997)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased</a></td>
<td class="num">(75,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
<td class="num">(10,366)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64,624)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">25,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">115,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(4,427)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,427)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares (in shares) at Apr. 01, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, value at Apr. 01, 2023</a></td>
<td class="nump">$ 817,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 504<span></span>
</td>
<td class="nump">$ 594,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 253,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (30,381)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Convertible Debt, Capped Call Purchases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093003152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 115,401<span></span>
</td>
<td class="nump">$ 43,375<span></span>
</td>
<td class="nump">$ 79,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Non-cash items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">93,307<span></span>
</td>
<td class="nump">97,747<span></span>
</td>
<td class="nump">84,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment of assets</a></td>
<td class="nump">607<span></span>
</td>
<td class="nump">7,953<span></span>
</td>
<td class="nump">21,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">25,583<span></span>
</td>
<td class="nump">24,359<span></span>
</td>
<td class="nump">25,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Gains on divestitures and sale of assets</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">9,603<span></span>
</td>
<td class="nump">32,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration</a></td>
<td class="num">(504)<span></span>
</td>
<td class="nump">10,461<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOtherTaxExpenseBenefit', window );">Deferred tax benefit</a></td>
<td class="nump">4,783<span></span>
</td>
<td class="nump">5,013<span></span>
</td>
<td class="num">(19,866)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs</a></td>
<td class="nump">1,970<span></span>
</td>
<td class="nump">3,404<span></span>
</td>
<td class="nump">564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_InventoryLossesProvisionBenefit', window );">Provision (benefit) for losses on inventory</a></td>
<td class="nump">664<span></span>
</td>
<td class="num">(861)<span></span>
</td>
<td class="nump">7,860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other non-cash operating activities</a></td>
<td class="nump">6,126<span></span>
</td>
<td class="nump">5,592<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Change in accounts receivable</a></td>
<td class="num">(24,421)<span></span>
</td>
<td class="num">(34,974)<span></span>
</td>
<td class="nump">44,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Change in inventories</a></td>
<td class="nump">30,754<span></span>
</td>
<td class="nump">24,307<span></span>
</td>
<td class="num">(38,909)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Change in prepaid income taxes</a></td>
<td class="nump">1,688<span></span>
</td>
<td class="nump">2,870<span></span>
</td>
<td class="num">(3,822)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Change in other assets and other liabilities</a></td>
<td class="num">(22,334)<span></span>
</td>
<td class="num">(15,022)<span></span>
</td>
<td class="num">(4,650)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Change in accounts payable and accrued expenses</a></td>
<td class="nump">39,816<span></span>
</td>
<td class="nump">7,642<span></span>
</td>
<td class="num">(56,422)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">273,058<span></span>
</td>
<td class="nump">172,263<span></span>
</td>
<td class="nump">108,805<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(110,191)<span></span>
</td>
<td class="num">(96,509)<span></span>
</td>
<td class="num">(37,040)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures</a></td>
<td class="nump">850<span></span>
</td>
<td class="nump">10,642<span></span>
</td>
<td class="nump">44,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property, plant and equipment</a></td>
<td class="nump">1,608<span></span>
</td>
<td class="nump">2,022<span></span>
</td>
<td class="nump">1,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="nump">2,850<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">434,804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Payments to Acquire Other Investments</a></td>
<td class="num">(33,205)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(143,788)<span></span>
</td>
<td class="num">(86,345)<span></span>
</td>
<td class="num">(425,442)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Term loan borrowings</a></td>
<td class="nump">280,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DecreaseForRedemptionOfLongTermDebt', window );">Term loan redemption</a></td>
<td class="num">(280,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of term loan borrowings</a></td>
<td class="num">(9,625)<span></span>
</td>
<td class="num">(17,500)<span></span>
</td>
<td class="num">(21,875)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from revolving facility</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Payments on revolving facility</a></td>
<td class="num">(50,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="num">(1,118)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(13,457)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Net decrease in short-term loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(60,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes', window );">Purchase of capped call related to convertible notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(47,400)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Contingent consideration payments</a></td>
<td class="num">(21,593)<span></span>
</td>
<td class="num">(4,791)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP', window );">Proceeds from employee stock purchase plan</a></td>
<td class="nump">4,378<span></span>
</td>
<td class="nump">4,209<span></span>
</td>
<td class="nump">4,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">2,638<span></span>
</td>
<td class="nump">2,338<span></span>
</td>
<td class="nump">6,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Share repurchases</a></td>
<td class="num">(75,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities</a></td>
<td class="num">(44)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(100,364)<span></span>
</td>
<td class="num">(15,749)<span></span>
</td>
<td class="nump">367,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rates on cash and cash equivalents</a></td>
<td class="num">(3,936)<span></span>
</td>
<td class="num">(2,978)<span></span>
</td>
<td class="nump">4,179<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net Change in Cash and Cash Equivalents</a></td>
<td class="nump">24,970<span></span>
</td>
<td class="nump">67,191<span></span>
</td>
<td class="nump">54,994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents at Beginning of Year</a></td>
<td class="nump">259,496<span></span>
</td>
<td class="nump">192,305<span></span>
</td>
<td class="nump">137,311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents at End of Year</a></td>
<td class="nump">284,466<span></span>
</td>
<td class="nump">259,496<span></span>
</td>
<td class="nump">192,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosures of Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">13,587<span></span>
</td>
<td class="nump">6,187<span></span>
</td>
<td class="nump">7,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">17,967<span></span>
</td>
<td class="nump">24,298<span></span>
</td>
<td class="nump">12,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_TransfersFromInventoryToFixedAssets', window );">Transfers from inventory to fixed assets for placement of Haemonetics equipment</a></td>
<td class="nump">$ 81,136<span></span>
</td>
<td class="nump">$ 51,800<span></span>
</td>
<td class="nump">$ 9,287<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DecreaseForRedemptionOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease For Redemption Of Long-Term Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DecreaseForRedemptionOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_InventoryLossesProvisionBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory Losses, Provision (Benefit)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_InventoryLossesProvisionBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Purchase of Capped Call Related To Convertible Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_TransfersFromInventoryToFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfers from inventory to fixed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_TransfersFromInventoryToFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the amount of cash contributions during the period made by the entity to the Employee Stock Ownership Plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109244661&amp;loc=d3e17540-113929<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597103466848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text">DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Haemonetics is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. When used in this report, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Haemonetics&#8221; and the &#8220;Company&#8221; mean Haemonetics Corporation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blood is essential to a modern healthcare system. Blood and its components (plasma, red cells and platelets) have many vital and frequently life-saving clinical applications. Plasma is used for patients with major blood loss and is manufactured into biopharmaceuticals to treat a variety of illnesses, including immune diseases and coagulation disorders. Red cells treat trauma patients or patients undergoing surgery with high blood loss, such as open heart surgery or organ transplant. Platelets have many uses in patient care, including supporting cancer patients undergoing chemotherapy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Haemonetics manages its business in three principal reporting segments: Plasma, Blood Center and Hospital. For that purpose, &#8220;Plasma&#8221; includes plasma collection devices and disposables, plasma donor management software, and anticoagulant and saline sold to plasma customers. &#8220;Blood Center&#8221; includes blood collection and processing devices and disposables for red cells, platelets and whole blood. &#8220;Hospital&#8221;, which is comprised of Hemostasis Management, Vascular Closure, Cell Salvage and Transfusion Management products, includes devices and methodologies for measuring coagulation characteristics of blood, vascular closure devices, specialized blood cell processing systems and disposables, surgical blood salvage systems and blood transfusion management software.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements present separately the Company&#8217;s consolidated financial position, results of operations, cash flows and changes in shareholders&#8217; equity. The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). All amounts presented, except per share amounts, are stated in thousands of U.S. dollars, unless otherwise indicated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098344240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 02, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Haemonetics&#8217; fiscal year ends on the Saturday closest to the last day of March. Fiscal years 2023 and 2022 included 52 weeks with each quarter having 13 weeks. Fiscal 2021 included 53 weeks with each of the first three quarters having 13 weeks and the fourth quarter having 14 weeks. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include all accounts including those of its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. In addition, we assess our strategic investments to determine whether they meet the definition of a variable interest entity (&#8220;VIE&#8221;), and if so, whether the Company has controlling financial interest. Controlling financial interest occurs if the Company has both the power to direct activities of the VIE that most significantly impact the VIE&#8217;s economic performance and an obligation to absorb losses of or the right to receive benefits from the VIE that could potentially be significant to the VIE. The Company&#8217;s strategic investments did not meet the controlling financial interest criteria, as such no VIEs were consolidated during fiscal 2023, 2022 or 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">could vary from the amounts derived from its estimates and assumptions. The Company considers estimates to be critical if they are required to make assumptions about material matters that are uncertain at the time of estimation or if materially different estimates could have been made or it is reasonably likely that the accounting estimate will change from period to period. The following are areas considered to be critical and require management&#8217;s judgment: revenue recognition, inventory provisions, intangible asset and goodwill valuation, legal and other judgmental accruals and income taxes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may become involved in various legal proceedings that arise in the ordinary course of business, including, without limitation, patent infringement, product liability and environmental matters. Accruals recorded for various contingencies including legal proceedings, employee related litigation, self-insurance and other claims are based on judgment, the probability of losses and, where applicable, the consideration of opinions of internal and/or external legal counsel and actuarially determined estimates. When a loss is probable and a range of loss is established but a best estimate cannot be made, the Company records the minimum loss contingency amount, which could be zero. These estimates are often initially developed substantially earlier than the ultimate loss is known and the estimates are reevaluated each accounting period, as additional information is available. As information becomes known, an additional loss provision is recorded when either a best estimate can be made or the minimum loss amount is increased. When events result in an expectation of a more favorable outcome than previously expected, the best estimate is changed to a lower amount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenue recognition policy is to recognize revenues from product sales, software and services in accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Codification (&#8220;ASC&#8221;) Update No. 2014-19, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers (Topic 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; this occurs with the transfer of control of the Company&#8217;s goods or services. The Company considers revenue to be earned when all of the following criteria are met: it has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the consideration the Company expects to receive for transferring goods or providing services, is determinable and it has transferred control of the promised items to the customer. A promise in a contract to transfer a distinct good or service to the customer is identified as a performance obligation. A contract&#8217;s transaction price is allocated to each performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of the Company&#8217;s contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the contract&#8217;s transaction price to each performance obligation based on the estimated standalone selling prices of the good or service in the contract. For goods or services for which observable standalone selling prices are not available, the Company uses an expected cost plus a margin approach to estimate the standalone selling price of each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Revenues</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company&#8217;s performance obligations related to product sales are satisfied at a point in time. Product revenue consists of the sale of its disposable blood component collection and processing sets and the related equipment. The Company&#8217;s performance obligation related to product sales is satisfied upon shipment or delivery to the customer based on the specified terms set forth in the customer contract. Shipping and handling activities performed after a customer obtains control of the good are treated as fulfillment activities and are not considered to be a separate performance obligation. Revenue is recognized over time for maintenance plans provided to customers that provide services beyond the Company&#8217;s standard warranty period. Payment terms between customers related to product sales vary by the type of customer, country of sale, and the products or services offered and could result in an unbilled receivable or deferred revenue balance depending on whether the performance obligation has been satisfied (or partially satisfied). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For product sales to distributors, the Company recognizes revenue for both equipment and disposables upon shipment to distributors, which is when its performance obligations are complete. The Company's standard contracts with its distributors state that title to the equipment passes to the distributors at point of shipment to a distributor&#8217;s location. The distributors are responsible for shipment to the end customer along with any installation, training and acceptance of the equipment by the end customer. Payments from distributors are not contingent upon resale of the product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also places equipment at customer sites. While the Company retains ownership of this equipment, the customer has the right to use it for a period of time provided they meet certain agreed to conditions. The Company recovers the cost of providing the equipment from the sale of its disposables.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Software and Other Revenues</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To a lesser extent, the Company enters into other types of contracts including certain software licensing arrangements to provide software solutions to support its plasma, blood collection and hospital customers. A portion of its software sales are perpetual licenses typically accompanied by significant implementation services related to software customization as well as other professional and technical services. The Company generally recognizes revenue from the sale of perpetual licenses and related customization services over time (the Company is creating or enhancing an asset that the customer controls) using an input method which requires it to make estimates of the extent of progress toward completion of the contract. When the Company provides other services, including in some instances hosting, technical support and maintenance, it recognizes these fees and charges over time (the customer simultaneously receives and consumes benefits), as performance obligations for these services are satisfied during the contract period. Certain of the Company&#8217;s software licensing arrangements are term-based licenses that include a per-collection or a usage-based fee related to the use of the license and the related technical support and hosting services. For these usage-based arrangements, the Company applies the revenue recognition exception resulting in revenue recognition occurring upon the later of actual usage or satisfaction of the related performance obligations. The payment terms for software licensing arrangements vary by customer pursuant to the terms set forth in the customer contract and result in an unbilled receivable or deferred revenue balance depending on whether the performance obligation has been satisfied (or partially satisfied). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Significant Judgments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price, which includes estimates of variable consideration related to rebates, product returns and volume discounts. These reserves, which are based on estimates of the amounts earned or to be claimed on the related sales, are recorded as a reduction of revenue and a current liability. The Company&#8217;s estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#8217;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract. The amount of variable consideration included in the net sales price is limited to the amount that is probable not to result in a significant reversal in the amount of the cumulative revenue recognized in a future period. Revenue recognized in the current period related to performance obligations satisfied in prior periods was not material. If the Company is unable to estimate the expected rebates reasonably, it records a liability for the maximum potential rebate or discount that could be earned. In circumstances where the Company provides upfront rebate payments to customers, it capitalizes the rebate payments and amortizes the resulting asset as a reduction of revenue using a systematic method over the life of the contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Balances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables and contract assets, as well as customer advances, customer deposits and deferred revenue (contract liabilities) on the consolidated balance sheets. The difference in timing between billing and revenue recognition primarily occurs in software licensing arrangements, resulting in contract assets and contract liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Practical Expedients</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected not to disclose the value of transaction price allocated to unsatisfied performance obligations for contracts with an original expected length of one year or less. When applicable, the Company has also elected to use the practical expedient to not adjust the promised amount of consideration for the effects of a significant financing component if it is expected, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service, will be one year or less.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Translation of Foreign Currencies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All assets and liabilities of foreign subsidiaries are translated at the rate of exchange at year-end while sales and expenses are translated at an average rate in effect during the year. The net effect of these translation adjustments is shown in the accompanying financial statements as a component of stockholders&#8217; equity. Foreign currency transaction gains and losses, including those resulting from intercompany transactions, are charged directly to earnings and included in other expense, net on the consolidated statements of income. The impact of foreign exchange on long-term intercompany loans, for which repayment has not been scheduled or planned, are recorded in accumulated other comprehensive loss on the consolidated balance sheet.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents include various instruments such as money market funds, U.S. government obligations and commercial paper with maturities of three months or less at date of acquisition. Cash and cash equivalents are recorded at cost, which approximates fair market value. As of April&#160;1, 2023, cash and cash equivalents consisted primarily of investments in United States Government Agency and institutional money market funds. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Credit Losses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes a specific allowance for customers when it is probable that they will not be able to meet their financial obligations. Customer accounts are reviewed individually on a regular basis and reserves are established as deemed appropriate. The Company also maintains a general reserve using a percentage that is established based upon the age of its receivables and its collection history. The Company establishes allowances for balances not yet due and past due accounts based on past experience.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value and include the cost of material, labor and manufacturing overhead. Cost is determined with the first-in, first-out method. The Company has based its provisions for excess, expired and obsolete inventory primarily on its estimates of forecasted net sales. Significant changes in the timing or level of demand for the Company&#8217;s products result in recording additional provisions for excess, expired and obsolete inventory. Additionally, uncertain timing of next-generation product approvals, variability in product launch strategies, non-cancelable purchase commitments, product recalls and variation in product utilization all affect the Company&#8217;s estimates related to excess, expired and obsolete inventory.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment is recorded at historical cost. The Company provides for depreciation and amortization by charges to operations using the straight-line method in amounts estimated to recover the cost of the building and improvements, equipment and furniture and fixtures over their estimated useful lives as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:86.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.191%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Classification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30-40 Years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-20 Years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant equipment and machinery</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-15 Years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and information technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-10 Years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Haemonetics equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-7 Years</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the depreciation periods of property, plant and equipment to determine whether events or circumstances warrant revised estimates of useful lives. All property, plant and equipment are also tested for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s installed base of devices includes devices owned by the Company and devices sold to the customer. The asset on its balance sheet classified as Haemonetics equipment consists of medical devices installed at customer sites but owned by Haemonetics. Generally, the customer has the right to use it for a period of time as long as they meet the conditions the Company has established, which among other things, generally include one or more of the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Purchase and consumption of a certain level of disposable products</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Payment of monthly rental fees </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An asset utilization performance metric, such as performing a minimum level of procedures per month per device</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the impairment tests noted below for other intangible assets subject to amortization, the Company reviews Haemonetics equipment and the related useful lives of such equipment at least once a year, or more frequently if certain conditions arise, to determine if any adverse conditions exist that would indicate the carrying value of these assets may not be recoverable. To conduct these reviews, the Company estimates the future amount and timing of demand for disposables used </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with these devices, from which it generates revenues. The Company also considers product life cycle in its evaluation of useful life and recoverability. Changes in expected demand can result in additional depreciation expense, which is classified as cost of goods sold. Any significant unanticipated changes in demand could impact the value of the Company&#8217;s devices and its reported operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are depreciated over the lesser of their useful lives or the term of the lease. Maintenance and repairs are generally expensed to operations as incurred. When the repair or maintenance costs significantly extend the life of the asset, these costs may be capitalized. When equipment and improvements are sold or otherwise disposed of, the asset cost and accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is included in the consolidated statements of income. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess purchase price over the fair value of the net tangible and other identifiable intangible assets acquired. Goodwill is not amortized and is instead reviewed for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying value. The Company performs its annual impairment test on the first day of the fiscal fourth quarter for each of its reporting units. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC Update No. 2017-04,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">entities perform their goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit&#8217;s fair value. A reporting unit is defined as an operating segment or one level below an operating segment, referred to as a component. The Company determines its reporting units by first identifying its operating segments and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. The Company aggregates components within an operating segment that have similar economic characteristics. The Company&#8217;s reportable segments and reporting units are as follows: Plasma, Blood Center and Hospital.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When allocating goodwill from business combinations to its reporting units, the Company assigns goodwill to the reporting units that it expects to benefit from the respective business combination at the time of acquisition. In addition, for purposes of performing its goodwill impairment tests, assets and liabilities, including corporate assets, which relate to a reporting unit&#8217;s operations and would be considered in determining its fair value, are allocated to the individual reporting units. The Company allocates assets and liabilities not directly related to a specific reporting unit, but from which the reporting unit benefits, based primarily on the respective revenue contribution of each reporting unit. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the income approach, specifically the discounted cash flow method, to derive the fair value of each of its reporting units in preparing its goodwill impairment assessments. This approach calculates fair value by estimating the after-tax cash flows attributable to a reporting unit and then discounting these after-tax cash flows to a present value using a risk-adjusted discount rate. The Company selected this method as being the most meaningful in preparing its goodwill assessments because the use of the income approach typically generates a more precise measurement of fair value than the market approach.&#160;In applying the income approach to its accounting for goodwill, the Company makes assumptions about the amount and timing of future expected cash flows, terminal value growth rates and appropriate discount rates. The amount and timing of future cash flows within the Company&#8217;s discounted cash flow analysis is based on its most recent operational budgets, long range strategic plans and other estimates. The terminal value growth rate is used to calculate the value of cash flows beyond the last projected period in the Company&#8217;s discounted cash flow analysis and reflects the Company&#8217;s best estimates for stable, perpetual growth of its reporting units. The Company uses estimates of market-participant risk adjusted weighted average cost of capital as a basis for determining the discount rates to apply to its reporting units&#8217; future expected cash flows. The Company corroborated the valuations that arose from the discounted cash flow approach by performing both a market multiple valuation and by reconciling the aggregate fair value of its reporting units to its market capitalization at the time of the test.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2023, 2022 and 2021, the Company performed its annual goodwill impairment test. The results of the goodwill impairment test performed indicated that the estimated fair value of all of its reporting units exceeded their respective carrying values. There were no reporting units at risk of impairment as of the fiscal 2023, 2022 and 2021 annual test date. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews intangible assets subject to amortization for impairment at least annually or more frequently if certain conditions arise to determine if any adverse conditions exist that would indicate that the carrying value of an asset or asset group may not be recoverable, or that a change in the remaining useful life is required. Conditions indicating that an impairment exists include, but are not limited to, a change in the competitive landscape, internal decisions to pursue new or different technology strategies, a loss of a significant customer or a significant change in the marketplace including prices paid for its products or the size of the market for its products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When an impairment indicator exists, the Company tests the intangible asset for recoverability. For purposes of the recoverability test, the Company groups its amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset (asset group) exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset (asset group), the Company will write the carrying value down to the fair value in the period identified. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally calculates the fair value of its intangible assets as the present value of estimated future cash flows it expects to generate from the asset using a risk-adjusted discount rate. In determining its estimated future cash flows associated with its intangible assets, the Company uses estimates and assumptions about future revenue contributions, cost structures and remaining useful lives of the asset (asset group).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company determines the estimate of an intangible asset&#8217;s remaining useful life should be reduced based on its expected use of the asset, the remaining carrying amount of the asset is amortized prospectively over the revised estimated useful life. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has in-process research and development (&#8220;IPR&amp;D&#8221;) intangible assets with indefinite lives. IPR&amp;D assets are not amortized. The Company reviews these assets for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of the asset is less than its carrying value. The Company performs its annual impairment test on the first day of the fiscal fourth quarter for its IPR&amp;D assets. The Company makes assumptions about future cash flows, terminal value growth, costs for completion and appropriate discount rates. The Company elected qualitative assessments in fiscal 2023 and 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for the Costs of Computer Software to be Sold, Leased, or Otherwise Marketed</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 985-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software - Costs of Software to be Sold, Leased or Marketed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, specifies that costs incurred internally in researching and developing a computer software product should be charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs should be capitalized until the product is available for general release to customers, at which point capitalized costs are amortized over their estimated useful life of 5 to 10 years. Technological feasibility is established when it has a detailed design of the software and when research and development activities on the underlying device, if applicable, are completed. The Company capitalizes costs associated with both software that it sells as a separate product and software that is embedded in a device.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the net realizable value of capitalized assets periodically to assess the recoverability of amounts capitalized. There were no impairment charges recorded during fiscal 2023, 2022 and 2021. In the future, the net realizable value may be adversely affected by the loss of a significant customer or a significant change in the market place, which could result in an impairment being recorded.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities represent items payable or expected to settle within the next twelve months. The items included in the fiscal year end balances were:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,809&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">111,628</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">121,207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Long-Term Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities represent items that are not payable or expected to settle within the next twelve months. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All research and development costs are expensed as incurred. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All advertising costs are expensed as incurred and are included in selling, general and administrative expenses in the consolidated statements of income. Advertising expenses were $7.2 million, $4.4 million and $2.7 million in fiscal 2023, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs are included in selling, general and administrative expenses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision is calculated for all jurisdictions in which the Company operates. The income tax provision process involves calculating current taxes due and assessing temporary differences arising from items that are taxable or deductible in different periods for tax and accounting purposes and are recorded as deferred tax assets and liabilities. Deferred tax assets are evaluated for realizability and a valuation allowance is maintained for the portion of the Company&#8217;s deferred tax assets that are not more-likely-than-not realizable. All available evidence, both positive and negative, has been considered to determine whether, based on the weight of that evidence, a valuation allowance is needed against the deferred tax assets. Refer to Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information and discussion of the Company&#8217;s income tax provision and balances.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in all jurisdictions in which it operates. The Company records a liability for uncertain tax positions taken or expected to be taken in income tax returns. The Company&#8217;s financial statements reflect expected future tax consequences of such positions presuming the taxing authorities&#8217; full knowledge of the position and all relevant facts. The Company records a liability for the portion of unrecognized tax benefits claimed that it has determined are not more-likely-than-not realizable. These tax reserves have been established based on management&#8217;s assessment as to the potential exposure attributable to the Company&#8217;s uncertain tax positions as well as interest and penalties attributable to these uncertain tax positions. All tax reserves are analyzed quarterly and adjustments are made as events occur that result in changes in judgment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates at the end of each reporting period whether some or all of the undistributed earnings of its foreign subsidiaries are permanently reinvested. The Company recognizes deferred income tax liabilities to the extent that management asserts that undistributed earnings of its foreign subsidiaries are not permanently reinvested or will not be permanently reinvested in the future. The Company&#8217;s position is based upon several factors including management&#8217;s evaluation of the Haemonetics and its subsidiaries&#8217; financial requirements, the short-term and long-term operational and fiscal objectives of the Company and the tax consequences associated with the repatriation of earnings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to April 4, 2021, the Company accounted for convertible senior notes as separate liability and equity components, determining the fair value of the respective liability components based on an estimate of the fair value of a similar liability without a conversion option and assigning the residual value to the equity component.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective April 4, 2021, the Company accounted for convertible senior notes as a single liability measured at its amortized cost. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. At issuance, the carrying amount is calculated as the proceeds, net of initial debt issuance costs. The difference between the principal amount and carrying value is amortized to interest expense over the term of the convertible senior notes using the effective interest rate method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A detailed analysis of the terms of the convertible senior notes transactions is required to determine existence of any derivatives that may require separate mark-to-market accounting under applicable accounting guidance.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its derivative financial instruments in accordance with ASC Topic 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 815&#8221;) and ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 820&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for the change in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative as a hedging instrument for accounting purposes and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. In addition, ASC 815 provides that, for derivative instruments that qualify for hedge accounting, changes in the fair value are either (a)&#160;offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings or (b)&#160;recognized in equity until the hedged item is recognized in earnings, depending on whether the derivative is being used to hedge changes in fair value or cash flows. The ineffective portion of a derivative&#8217;s change in fair value is immediately recognized in earnings. The Company does not use derivative financial instruments for trading or speculation purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the underlying hedged transaction affects earnings, the gains or losses on the forward foreign exchange rate contracts designated as hedges are recorded in net revenues, cost of goods sold, operating expenses and other expense, net in the Company&#8217;s consolidated statements of income, depending on the nature of the underlying hedged transactions. The cash flows related to the gains and losses are classified in the consolidated statements of cash flows as part of cash flows from operating activities. For those derivative instruments that are not designated as part of a hedging relationship the Company records the gains or losses in earnings currently. These gains and losses are intended to offset the gains and losses recorded on net monetary assets or liabilities that are denominated in foreign currencies. The Company recorded foreign currency losses of $1.0 million, $1.5 million and $0.7 million in fiscal 2023, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a quarterly basis, the Company assesses whether the cash flow hedges are highly effective in offsetting changes in the cash flow of the hedged item. The Company manages the credit risk of its counterparties by dealing only with institutions that it considers financially sound and considers the risk of non-performance to be remote. Additionally, the Company&#8217;s interest rate risk management strategy includes the use of interest rate swaps to mitigate its exposure to changes in variable interest rates. The Company&#8217;s objective in using interest rate swaps is to add stability to interest expense and to manage and reduce the risk inherent in interest rate fluctuations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s derivative instruments do not subject its earnings or cash flows to material risk, as gains and losses on these derivatives are intended to offset losses and gains on the item being hedged. The Company does not enter into derivative transactions for speculative purposes and it does not have any non-derivative instruments that are designated as hedging instruments pursuant to ASC 815.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expenses the fair value of share-based awards granted to employees, board members and others, net of estimated forfeitures. To calculate the grant-date fair value of its stock options the Company uses the Black-Scholes option-pricing model and for performance share units it uses Monte Carlo simulation models.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Costs Associated with Exit Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records employee termination costs in accordance with ASC Topic 712</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Compensation - Nonretirement and Postemployment Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if it pays the benefits as part of an on-going benefit arrangement, which includes benefits provided as part of its established severance policies or that it provides in accordance with international statutory requirements. The Company accrues employee termination costs associated with an on-going benefit arrangement if the obligation is attributable to prior services rendered, the rights to the benefits have vested, the payment is probable and the liability can be reasonably estimated. The Company accounts for employee termination benefits that represent a one-time benefit in accordance with ASC Topic 420</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Exit or Disposal Cost Obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. It records such costs into expense over the employee&#8217;s future service period, if any.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other costs associated with exit activities may include contract termination costs, including costs related to leased facilities to be abandoned or subleased, consultant fees and impairments of long-lived assets. The costs are expensed in accordance with ASC Topic 420 and ASC Topic 360</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Property, Plant and Equipment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and are included primarily in selling, general and administrative costs in its consolidated statement of income. Additionally, costs directly related to the Company&#8217;s active restructuring initiatives, including program management costs, accelerated depreciation and costs to transfer product lines </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">among facilities are included within costs of goods sold and selling, general and administrative costs in its consolidated statement of income. Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information and discussion of its restructuring plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Acquisitions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocates the amounts it pays for each acquisition to the assets acquired and liabilities assumed based on their estimated fair values at the dates of acquisition, including acquired identifiable intangible assets. The Company bases the estimated fair value of identifiable intangible assets on detailed valuations that use significant assumptions including forecasted cash flows, revenues attributable to existing technology and existing customer attrition. When estimating the significant assumptions to be used in the valuation, the Company includes a consideration of current industry information, market and economic trends, historical results of the acquired business, and other relevant factors. These significant assumptions are forward-looking and could be affected by future economic and market conditions. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds strategic investments, including preferred stock and a special share, in a privately held entity. The special share allows the Company to acquire the entity in accordance with an agreement between the parties. As these equity instruments do not have readily determinable fair values, they have been measured using the measurement alternative, at cost less impairment. The carrying amount for these instruments would be subsequently adjusted for observable price changes, or prices in orderly transactions for an identical investment or similar investment of the same issuer. In addition, these investments are periodically evaluated for impairment. The investments are classified as other long-term assets on the Company&#8217;s Consolidated Balance Sheets and the Company has not recorded any adjustments to the carrying value of strategic investments in fiscal 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Significant Customers</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents and accounts receivable. In fiscal 2023, 2022 and 2021, the Company&#8217;s ten largest customers accounted for approximately 48%, 45% and 49% of net revenues, respectively. In fiscal 2023, one Plasma customer, CSL Limited (together with its affiliates, &#8220;CSL&#8221;) was greater than 10% of total net revenues and in total accounted for approximately 14% of net revenues. In addition to CSL, two customers also accounted for greater than 10% of the Plasma segment&#8217;s net revenues and one customer also accounted for greater than 10% of the Blood Center segment&#8217;s net revenues, but did not exceed 10% of total net revenues, in fiscal 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain other markets and industries can expose the Company to concentrations of credit risk. For example, in the Plasma business unit, sales are concentrated with several large customers. As a result, accounts receivable extended to any one of these biopharmaceutical customers can be significant at any point in time. Also, a portion of the Company&#8217;s trade accounts receivable outside the U.S. include sales to government-owned or supported healthcare systems in several countries, which are subject to payment delays. Payment is dependent upon the financial stability and creditworthiness of those countries&#8217; national economies. The Company has not incurred significant losses on government receivables. The Company continually evaluates all government receivables for potential collection risks associated with the availability of government funding and reimbursement practices. If the financial condition of customers or the countries&#8217; healthcare systems deteriorate such that their ability to make payments is uncertain, allowances may be required in future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Standards Implemented</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Codification (&#8220;ASC&#8221;) Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326). ASC Update No. 2016-13 is intended to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information, including forecasted information, to develop credit loss estimates. The Company adopted ASC Update No. 2016-13 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company&#8217;s consolidated financial statements. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASC Update No. 2018-15, Intangibles, Goodwill and Other - Internal-Use Software (Subtopic 350-40). The new guidance aligns the accounting implementation costs incurred in a cloud computing arrangement that is a service contract with the accounting for internal-use software licenses. The Company adopted ASC Update No. 2018-15 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Securities and Exchange Commission (&#8220;SEC&#8221;) issued a final rule that amends the financial statement requirements for acquisitions and dispositions of businesses. The amendments primarily relate to disclosures required by Rule 3-05 and Article 11 of Regulation S-X and modifies the tests provided in Rule 1-02(w) of Regulation S-X used to determine whether a subsidiary or an acquired or disposed business is significant and modifies the number of years of audited financial statements required for acquisitions with significance levels greater than specified percentages. The Company early adopted these amendments during the fourth quarter of fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Codification (&#8220;ASC&#8221;) Update No. 2019-12 &#8212; Income Taxes (Topic 740). The new guidance improves consistent application of and simplifies the accounting for income taxes by removing certain exceptions to the general principals in Topic 740. The Company adopted ASC Update No. 2019-12 effective April 4, 2021. The adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASC ASU Update No. 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). The amendments simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company early adopted ASC Update No. 2020-06 effective April 4, 2021 using the modified retrospective method, which resulted in a decrease of $61.2&#160;million to additional paid-in capital, a decrease to non-current deferred tax liabilities of $20.0&#160;million, and an increase of $80.3&#160;million to non-current convertible notes, net, on the consolidated balance sheets. Additionally, retained earnings was adjusted to remove amortization expense recognized in prior periods related to the debt discount and the convertible notes no longer have a debt discount that will be amortized, net of taxes. The impact to retained earnings on the consolidated balance sheets as of April 4, 2021 is an increase of $1.0&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the FASB issued ASC Update No. 2021-05 &#8212; Leases (Topic 842). The new guidance requires a lessor to classify a lease with variable lease payments that do not depend on an index or rate as an operating lease at lease commencement if the lease would have been classified as a sales-type lease or a direct financing lease in accordance with the classification criteria of ASC 842 and the lessor would have otherwise recognized a day-one loss. The Company prospectively adopted ASC Update No. 2021-05 effective in the second quarter of fiscal year 2022. The adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098579776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">RESTRUCTURING</a></td>
<td class="text">RESTRUCTURING<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, the Company reviews the global economy, the healthcare industry, and the markets in which it competes to identify opportunities for efficiencies, enhance commercial capabilities, align its resources and offer its customers better solutions. In order to realize these opportunities, the Company undertakes restructuring-type activities to transform its business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Board of Directors of the Company approved the Operational Excellence Program (the &#8220;2020 Program&#8221;) and delegated authority to the Company&#8217;s management to determine the detail of the initiatives that will comprise the program. During fiscal 2022, the Company revised the program to improve product and service quality, reduce cost principally in its manufacturing and supply chain operations and ensure sustainability while helping to offset impacts from a previously announced customer loss, rising inflationary pressures and effects of the COVID-19 pandemic. The Company expects to incur aggregate charges between $95&#160;million and $105&#160;million by the end of fiscal 2025 under the program. The majority of charges will result in cash outlays, including severance and other employee costs, and will be incurred as the specific actions required to execute these initiatives are identified and approved. During fiscal 2023, 2022 and 2021, the Company incurred $11.5 million, $28.7 million and $15.1&#160;million of restructuring and restructuring related costs under this program, respectively. Total cumulative charges under this program are $67.2 million as of April&#160;1, 2023.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for restructuring reserves related to the 2020 Program and prior programs for the fiscal years ended April&#160;1, 2023, April&#160;2, 2022 and April&#160;3, 2021, substantially all of which relates to employee severance and other employee costs:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 Program</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior Programs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 28, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred, net of reversals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,062)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,018)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,080)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 3, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred, net of reversals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,317)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,437)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 2, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred, net of reversals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 1, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,810&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the restructuring costs by line item during fiscal 2023, 2022 and 2021 within our accompanying consolidated statements of income and comprehensive income: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company had a restructuring liability of $2.2 million, of which approximately $1.8 million is payable within the next twelve months. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the restructuring expenses included in the table above, the Company also incurred costs of $10.9 million, $24.6 million and $14.2 million in fiscal 2023, 2022 and 2021, respectively, that do not constitute restructuring costs under ASC 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit and Disposal Cost Obligations,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and which the Company instead refers to as restructuring related costs. These costs consist primarily of expenditures directly related to the restructuring actions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the restructuring related costs by line item during fiscal 2023, 2022 and 2021 within our accompanying consolidated statements of income and comprehensive income: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,991&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,892&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,594&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present restructuring and restructuring related costs by reportable segment:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring related costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,906&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,594&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total restructuring and restructuring related costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,549</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,824</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,661</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098705488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND STRATEGIC INVESTMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions and Strategic Investments</a></td>
<td class="text">ACQUISITIONS AND STRATEGIC INVESTMENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiva Medical, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 17, 2021, the Company entered into an Agreement and Plan of Merger with Cardiva Medical, Inc. (&#8220;Cardiva&#8221;), an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. In connection with this acquisition, which closed on March 1, 2021, the Company acquired 100% of the issued and outstanding shares of capital stock of Cardiva for total consideration of $489.8&#160;million, which consisted of upfront payments in the aggregate of $465.5&#160;million ($418.2&#160;million net of cash acquired) and the fair value of contingent consideration of $24.3&#160;million.  Cardiva achieved the contingent consideration maximum payout of $35.0&#160;million, of which the final payment was made in fiscal 2023. The Company financed the acquisition through a combination of cash, borrowings under its revolving credit facility and an additional $150.0&#160;million term loan under its existing credit facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiva&#8217;s portfolio includes two catheter-based vascular access site closure devices. The VASCADE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vascular closure system is designed for &#8220;small-bore&#8221; femoral arterial and venous closure, generally used in interventional cardiology and peripheral vascular procedures. The VASCADE MVP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vascular closure system is designed for &#8220;mid-bore&#8221; multi-access femoral venous closure, generally used in electrophysiology procedures, and is the only U.S. Food and Drug Administration (&#8220;FDA&#8221;) approved closure device for use following cardiac ablation procedures requiring two or more access sites within the same vessel. The addition of the VASCADE portfolio to the Hospital business unit includes products with demonstrated benefits and enhances penetration into the large and growing interventional cardiology and electrophysiology markets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the acquisition of Cardiva as a business combination, and in accordance with FASB ASC Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Topic 805</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts represent the fair value of the identifiable assets acquired and liabilities assumed for Cardiva:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">534,240</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91,971</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">442,269</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the identifiable intangible assets were completed technology, customer relationships, trademarks and in-process research and development (&#8220;IPR&amp;D&#8221;). The fair values of intangible assets were based on valuation techniques with estimates and assumptions developed by the Company. Completed technology and IPR&amp;D were valued using the excess earnings method. Customer relationships were valued using the distributor method. Trademarks were valued using the relief from royalty method. The cash flows used in the valuation of the intangible assets were based on estimates used to price the transaction. In developing the discount rates applied to the cash flow projections, the discount rates were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital and then adjusted to reflect the relative risk of the asset.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the purchase price over the tangible assets, identifiable intangible assets and assumed liabilities was recorded as goodwill. As a result of the acquisition of Cardiva, the Company recognized goodwill of $253.7&#160;million, which is attributable to the revenue and cash flow projections associated with completed technologies and the development of future technology that does not exist in the current IPR&amp;D pipeline. The goodwill is not deductible for tax purposes and relates entirely to the Hospital reportable segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets acquired consist of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk-Adjusted Discount<br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">250,560</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a long-term deferred tax liability, net, of $26.8&#160;million primarily related to acquired intangible assets which cannot be deducted for tax purposes, partially offset by deferred tax assets primarily related to net operating losses acquired.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of acquisition-related costs incurred associated with the acquisition was $9.6&#160;million for the fiscal year ending April 3, 2021. The Company incurred acquisition costs related to legal and other professional fees in the amount of $6.6&#160;million and an additional $3.0&#160;million of debt financing costs and lender fees which were recognized in selling, general and administrative and as interest expense on the consolidated statements of income, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Financial Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiva contributed revenues of $7.7&#160;million to net revenues and losses of $7.6&#160;million to net income for the period post acquisition through April 3, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited estimated pro forma results presented below include the effects of the acquisition of Cardiva as if it was consummated on March 31, 2019. In fiscal 2021, the Company incurred nonrecurring charges attributed to the acquisition of Cardiva, which are presented in the consolidated statements of income for this period. These charges include acquisition-related costs, retention bonuses and severance payments, adjusted for the related tax effects. These nonrecurring charges are reflected as adjustments to the pro forma earnings presented below for fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, these pro forma amounts have been calculated, net of tax, after adjusting the results of Cardiva to reflect the additional costs associated with fair value adjustments relating to inventories, leases and intangible assets as if the acquisition had occurred on March 31, 2019 and adjusting interest amounts related to long-term debt assumptions. There was no significant impact to the pro forma amounts after applying the Company&#8217;s accounting policies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The supplemental pro forma information presented below is for informational purposes only and should be read in conjunction with our historical financial statements. The pro forma results do not include any anticipated synergies or other expected benefits of the acquisition. Accordingly, the unaudited estimated pro forma financial information below is not necessarily indicative of what the actual results of operations of the combined companies would have been had the acquisition of Cardiva occurred as of March 31, 2019, nor are they indicative of future results of operations. The pro forma assumptions and adjustments are reasonable and appropriate under the circumstances and are factually supported based on information currently available.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:86.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) (Unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916,601&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HAS Intellectual Property</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company entered into an agreement to acquire certain intellectual property owned by HemoAssay Science and Technology (Suzhou) Co. Ltd., a China-incorporated company, and its affiliates (collectively, &#8220;HemoAssay&#8221;) underlying their HAS viscoelastic diagnostic devices, related assays and disposables. The Company previously entered into exclusive manufacturing and distribution agreements with HemoAssay pursuant to which it has exclusive rights to commercialize HemoAssay&#8217;s HAS devices in China. In connection with the transaction, the Company has agreed to pay up to $15.0&#160;million to HemoAssay in contingent consideration based on certain developmental and manufacturing based milestones. In fiscal years 2023 and 2022, the Company made milestone payments of $2.9&#160;million and $2.5&#160;million, respectively, which were recorded within intangible assets on the consolidated balance sheets. These products augment the Company&#8217;s portfolio of hemostasis analyzers within the Hospital business unit.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enicor GmbH</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2020, the Company acquired all of the outstanding equity of enicor GmbH (&#8220;enicor&#8221;), the manufacturer of ClotPro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a new generation whole blood coagulation testing system that is currently available in select European and Asia Pacific markets, for total consideration of $20.5&#160;million, which consisted of upfront payments of $16.6&#160;million and the fair value of contingent consideration of $3.9&#160;million. The contingent consideration, which could total a maximum of $4.5&#160;million, consists of payments related to the achievement of certain revenue and regulatory milestones. As of April 1, 2023, the Company has made $2.3&#160;million of milestone payments. The acquisition of this viscoelastic diagnostic device augments the Company&#8217;s portfolio of hemostasis analyzers within the Hospital business unit.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the acquisition of enicor as a business combination, and in accordance with FASB ASC Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Topic 805</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts represent the fair value of the identifiable assets acquired and liabilities assumed for enicor completed during fiscal 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.182%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 1, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,851</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,325</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,526</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the identifiable intangible assets were completed technology, customer relationships and a trademark. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a rate of 20%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The benefits of adding a viscoelastic diagnostic device to the Company&#8217;s portfolio of hemostasis analyzers within the Hospital business unit contributed to an acquisition price in excess of the fair value of net assets acquired for enicor, which resulted in the establishment of goodwill. In addition, the benefits of lower cost manufacturing and complementary sales channels also contributed to the establishment of goodwill for this acquisition. The goodwill is not deductible for income tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets acquired consist of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.063%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk-Adjusted Discount<br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 Years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,090</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, the Company incurred $0.2&#160;million of acquisition-related costs associated with the acquisition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Financial Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enicor had an immaterial impact to the Company&#8217;s net revenues and net income for fiscal 2021. The unaudited estimated pro forma impact of the results of the acquisition of enicor as if it was consummated on April 1, 2019 are immaterial. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2023, the Company made investments in Vivasure Medical LTD (&#8220;Vivasure&#8221;), totaling &#8364;30&#160;million. The investments include both preferred stock and a special share that allows the Company to acquire Vivasure in accordance with an agreement between the parties. The investments are classified as other long-term assets on the consolidated balance sheets and the Company has not recorded any adjustments to the carrying value of our strategic investments in fiscal 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597103944320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 02, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">DIVESTITURE</a></td>
<td class="text">DIVESTITURES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fajardo, Puerto Rico Manufacturing Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 29, 2020, the Company sold its Fajardo, Puerto Rico, manufacturing operations to GVS, S.p.A (&#8220;GVS&#8221;), a leading provider of advanced filtration solutions for critical applications for $15.1&#160;million ($7.8&#160;million, net of cash transferred). Under the terms of the agreement, Haemonetics retained all intellectual property rights to its proprietary blood filters currently manufactured at its Fajardo facility and GVS acquired certain assets consisting primarily of property, plant and equipment, inventory and cash and has assumed certain related liabilities. In connection with this transaction, the Company and GVS also entered into a long-term supply and development agreement that, among other things, grants GVS exclusive rights to manufacture and supply the blood filters currently produced at the Fajardo facility for Haemonetics. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this transaction, Haemonetics recognized a pre-tax impairment charge in its Blood Center business unit of $1.0&#160;million in the first quarter of fiscal 2021 and an incremental loss of $0.4&#160;million based on closing adjustments during the third quarter of fiscal 2021, as the carrying value of the assets and liabilities in the asset transfer exceeded the net of the $15.1&#160;million of cash proceeds and an additional contingent liability of $1.5&#160;million. The disposal group consisted of $3.3&#160;million of inventory, $7.2&#160;million of fixed assets, $3.2&#160;million of other liabilities, and $0.4&#160;million of goodwill allocated based on fair value to the business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Blood Donor Management Software</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2020, the Company sold certain U.S. blood donor management software solution assets within its Blood Center business unit to the GPI Group (&#8220;GPI&#8221;) for an upfront cash payment of $14.0&#160;million ($13.6&#160;million, net of working capital adjustments) and up to $14.0&#160;million in additional consideration contingent on the achievement of commercial milestones over the twelve month period immediately following the closing of the transaction. The disposal group consisted of $1.4&#160;million of accounts receivable, $0.9&#160;million of intangible assets, other liabilities of $1.8&#160;million and $1.4&#160;million of goodwill allocated based on fair value to the business. The Company recognized a gain of $13.2&#160;million associated with the transaction in fiscal 2021. In fiscal years 2023 and 2022, the Company recognized additional gains of $0.4&#160;million and $9.6&#160;million, respectively, for contingent consideration earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inlog Holdings France</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 18, 2020, the Company sold its wholly-owned subsidiary Inlog Holdings France SAS to Ab&#233;nex Capital (&#8220;Ab&#233;nex&#8221;), a private equity firm based in France for $30.5&#160;million ($24.5&#160;million, net of cash transferred). Inlog Holdings France SAS, through its subsidiary In Log SAS, develops and sells blood bank and hospital software solutions used predominantly in France and in several other countries outside of the U.S. The disposal group included $2.2&#160;million of intangible assets, $2.2&#160;million of accounts receivable, $0.3&#160;million of other assets, $3.3&#160;million of liabilities and $3.3&#160;million of goodwill allocated based on the fair value of the business which impacted both the Blood Center and Hospital business units. The Company recognized a gain of $20.0&#160;million associated with the transaction in fiscal 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597210232448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Domestic and foreign income before provision (benefit) for income tax is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,657&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,219)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,746&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,848&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,387&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">141,403</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63,629</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision (benefit) from continuing operations contains the following components:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,906)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,678)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,436)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(843)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,777&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,842)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,002</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,556)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business globally and reports its results of operations in a number of foreign jurisdictions in addition to the United States. The Company&#8217;s reported tax rate is impacted by the jurisdictional mix of earnings in any given period as the foreign jurisdictions in which it operates have tax rates that differ from the U.S. statutory tax rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s subsidiary in Malaysia has been granted a full income tax exemption to manufacture whole blood and apheresis devices that could be in effect for up to ten years, provided certain conditions are satisfied. The income tax exemption was in effect beginning June 1, 2016.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax effected, significant temporary differences comprising the net deferred tax liability are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals, reserves and other deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carry-forward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carry-forward, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized research expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,838)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,077)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets (after valuation allowance)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of goodwill and intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,752)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,004)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unremitted earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,877)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,942)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,477)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,505)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30,954)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24,259)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The increase in the worldwide net deferred tax liability is primarily due to tax depreciation deductions in excess of book depreciation expense during fiscal 2023 and utilization of net operating loss carryforwards, partially offset by research expenditures capitalized for tax purposes and impact of the release of valuation allowance previously maintained against certain U.S. state and foreign deferred tax assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The valuation allowance decrease of $5.2&#160;million during fiscal 2023 is primarily due to the release of valuation allowance related to certain U.S. state and foreign deferred tax assets and changes in the valuation allowance in other jurisdictions based on current year operating results.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has assessed, on a jurisdictional basis, the available means of recovering deferred tax assets, including the ability to carry-back net operating losses, the existence of reversing temporary differences, the availability of tax planning strategies and available sources of future taxable income. It has also considered the ability to implement certain strategies that would, if necessary, be implemented to accelerate taxable income and use expiring deferred tax assets. Based upon cumulative profitability in the U.S. and Malaysia, and increases in future taxable income projections, management has determined there is sufficient positive evidence to release a portion of the valuation allowance previously provided against certain U.S. state and foreign deferred tax assets. The Company has concluded future taxable income can be considered a source of income to realize a benefit for deferred tax assets in certain jurisdictions. The Company believes it is able to support the deferred tax assets recognized as of the end of the year based on all of the available evidence. The worldwide net deferred tax liability as of April&#160;1, 2023 includes deferred tax liabilities related to amortizable tax basis in goodwill and other indefinite lived assets, which can only be used as a source of income to benefit other indefinite lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company maintains a valuation allowance against certain U.S. tax credit carryforwards that are not more-likely-than-not realizable as well as a valuation allowance against the net deferred tax assets of certain foreign subsidiaries. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the March 2021 acquisition of Cardiva, the Company acquired federal and state net operating loss carryforwards of $150.9&#160;million and $93.3&#160;million, respectively. The Company also acquired federal and state tax research credit carryforwards of $0.2&#160;million and $0.4&#160;million, respectively. These net operating loss and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shareholders over a three-year period in excess of 50 percent as defined under Section 382 and 383 of the U.S. Internal Revenue Code of 1986, respectively, as well as similar state provisions. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. The Company conducted a Section 382 study covering the period of inception (July 2002) through March 1, 2021. The study concluded that ownership changes occurred during that period which limit the amount of the Company&#8217;s net operating losses and tax credit carryforwards that can be utilized before expiring. The carryforwards disclosed represent the amount of attributes that can be utilized based on the results of the study. The Company does not believe it has had an ownership change through April 1, 2023. Subsequent ownership changes may further affect the limitation in future years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company has U.S. federal net operating loss carryforwards of $64.4&#160;million of which $8.4&#160;million will begin to expire in fiscal 2024 and $56.0&#160;million can be carried forward indefinitely. The Company has U.S. state net operating losses of $75.7&#160;million of which $62.3&#160;million will expire at various times between fiscal 2024 and fiscal 2040 and $13.4&#160;million can be carried forward indefinitely. The Company has federal and state tax credits of $0.6&#160;million and $5.4&#160;million, respectively, which will begin to expire in fiscal 2029 and fiscal 2028, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company has foreign net operating losses of approximately $10.5&#160;million that are available to reduce future income of which $6.9 million will begin to expire in fiscal 2034 and $3.6&#160;million can be carried forward indefinitely. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, substantially all of the unremitted earnings of the Company have been taxed in the U.S. The Company has not provided U.S. deferred income taxes or foreign withholding taxes on unremitted earnings of foreign subsidiaries of approximately $72.0&#160;million as such amounts are considered to be indefinitely reinvested in the business. The accumulated earnings in the foreign subsidiaries are primarily utilized to fund working capital requirements as its subsidiaries continue to expand their operations and to fund future foreign acquisitions. The Company does not believe it is practicable to estimate the amount of income taxes payable on the earnings that are indefinitely reinvested in foreign operations, however a significant portion of the unremitted earnings could be remitted without a future tax cost.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision (benefit) from continuing operations differs from the tax provision (benefit) computed at the U.S.&#160;federal statutory income tax rate due to the following:</span></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.102%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,408)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,799)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,049)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes net of federal benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(924)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low taxed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(828)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(758)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unremitted earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred statutory rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation shortfalls (benefits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,073)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,496)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany sale of intellectual property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,550)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax provision (benefit)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,002</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,556)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company recorded an income tax expense of $26.0&#160;million, representing an effective tax rate of 18.4%. The effective tax rate is lower than the U.S. statutory rate of 21.0%, primarily due to jurisdictional mix of earnings, research credits generated and the change in valuation allowance, partially offset by state taxes, non-deductible executive compensation and disallowed stock compensation expense. The Company has recorded an immaterial tax expense related to unremitted foreign earnings that are not considered permanently reinvested.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unrecognized Tax Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized tax benefits represent uncertain tax positions for which reserves have been established. As of April&#160;1, 2023, the Company had $3.9 million of unrecognized tax benefits, of which $3.2 million would impact the effective tax rate, if recognized. As of April&#160;2, 2022, the Company had $3.9 million of unrecognized tax benefits, of which $3.1 million would impact the effective tax rate, if recognized. At April&#160;3, 2021, the Company had $6.1 million of unrecognized tax benefits, of which $5.3 million would impact the effective tax rate, if recognized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to its gross unrecognized tax benefits for the fiscal years ended April&#160;1, 2023, April&#160;2, 2022 and April&#160;3, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 3,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions of tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements of tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,579)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,941</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,939</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,107</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company anticipates that the liability for unrecognized tax benefits for uncertain tax positions could change by up to $0.2 million in the next twelve months, as a result of closure of various statutes of limitations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s historical practice has been and continues to be to recognize interest and penalties related to federal, state and foreign income tax matters in income tax expense. Approximately $0.2 million and $0.1 million of gross interest and penalties were accrued at April&#160;1, 2023 and April&#160;2, 2022, respectively, and are not included in the amounts above. Additionally, $0.1&#160;million, $0.1&#160;million and $0.9&#160;million of accrued interest and penalties was included in income tax provision (benefit) for the years ended April&#160;1, 2023, April&#160;2, 2022 and April&#160;3, 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business globally and, as a result, files federal, state and foreign income tax returns in multiple jurisdictions. In the normal course of business, it is subject to examination by taxing authorities throughout the world. With a few exceptions, the Company is no longer subject to U.S. federal, state, or local income tax examinations for years before fiscal 2020 and foreign income tax examinations for years before fiscal 2018. To the extent that the Company has tax attribute carry-forwards, the tax years in which the attribute was generated may still be adjusted upon examination by the Internal Revenue Service, state, or foreign tax authorities to the extent utilized in a future period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597103756672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,401&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,375&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic income per share</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.85</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.57</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,401&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,375&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted income per share</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.84</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.55</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated using the Company&#8217;s weighted-average outstanding common shares. Diluted earnings per share is calculated using its weighted-average outstanding common shares including the dilutive effect of stock awards as determined under the treasury stock method and the convertible senior notes as determined under the net share settlement method. From the time of the issuance of the convertible senior notes, the average market price of the Company&#8217;s common shares has been less than the initial conversion price, and consequently no shares have been included in diluted earnings per share for the conversion value of the convertible senior notes. For fiscal 2023, 2022 and 2021, weighted average shares outstanding, assuming dilution, excludes the impact of 0.6 million, 0.9 million and 0.5 million anti-dilutive shares, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company announced that its Board of Directors had approved a new three-year share repurchase program authorizing the repurchase of up to $300.0&#160;million of Haemonetics common stock, based on market conditions, through August 2025. Under the share repurchase program, the Company is authorized to repurchase, from time to time, outstanding shares of common stock in accordance with applicable laws on the open market, including under trading plans established pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, and in privately negotiated transactions. The actual timing, number and value of shares repurchased will be determined by the Company at its discretion and will depend on a number of factors, including market conditions, applicable legal requirements and compliance with the terms of loan covenants. The share repurchase program may be suspended, modified or discontinued at any time, and the Company has no obligation to repurchase any amount of its common stock under the program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2022, the Company completed a $75.0&#160;million repurchase of its common stock pursuant to an accelerated share repurchase agreement (&#8220;ASR&#8221;) entered into with Citibank N.A. in August 2022. The total number of shares repurchased under the ASR was 1.0&#160;million at an average price per share upon final settlement of $75.20.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the total remaining authorization for repurchases of the Company&#8217;s common stock under the share repurchase program was $225.0&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098146544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE</a></td>
<td class="text">REVENUE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenue recognition policy is to recognize revenues from product sales, software and services in accordance with ASC Topic 606,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; this occurs with the transfer of control of the Company&#8217;s goods or services. The Company considers revenue to be earned when all of the following criteria are met: it has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the consideration it expects to receive for transferring goods or providing services, is determinable and it has transferred control of the promised items to the customer. A promise in a contract to transfer a distinct good or service to the customer is identified as a performance obligation. A contract&#8217;s transaction price is allocated to each performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of the Company&#8217;s contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the contract&#8217;s transaction price to each performance obligation based on the estimated standalone selling prices of the good or service in the contract. For goods or services for which observable standalone selling prices are not available, the Company uses an expected cost plus a margin approach to estimate the standalone selling price of each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the Company had $24.0 million of transaction price allocated to remaining performance obligations related to executed contracts with an original duration of one year or more. The Company expects to recognize approximately 77% of this amount as revenue within the next twelve months and the remaining balance thereafter.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables and contract assets, as well as customer advances, customer deposits and deferred revenue (contract liabilities) on the consolidated balance sheets. The difference in timing between billing and revenue recognition primarily occurs in software licensing arrangements, resulting in contract assets and contract liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023 and April&#160;2, 2022, the Company had contract liabilities of $30.2&#160;million and $26.8&#160;million, respectively. During fiscal 2023, the Company recognized $24.3 million of revenue that was included in the above April&#160;2, 2022 contract </span></div>liability balance. Contract liabilities are classified as other current liabilities on the consolidated balance sheet. As of April&#160;1, 2023 and April&#160;2, 2022, the Company&#8217;s contract assets were immaterial.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098314736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text">INVENTORIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value and include the cost of material, labor and manufacturing overhead. Cost is determined with the first-in, first-out method. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,016&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,572&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,187&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">259,379</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">293,027</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Prior year raw materials and finished goods balances have been adjusted to conform with current year presentation.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597104111728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY, PLANT AND EQUIPMENT</a></td>
<td class="text">PROPERTY, PLANT AND EQUIPMENT<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consisted of the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and building improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant equipment and machinery</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and information technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Haemonetics equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(633,330)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(610,665)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">310,885</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">258,482</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $51.2 million, $44.4 million and $43.1 million in fiscal 2023, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, the Company incurred an impairment of property, plant and equipment of $5.2&#160;million in connection with the 2020 Program, refer to Note 3 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details on the 2020 Program, and $2.8&#160;million of accelerated depreciation costs related to disposables manufacturing equipment that was no longer in use. In fiscal 2021, the Company incurred a one-time impairment charge of $20.9&#160;million related to in-process disposables manufacturing equipment that would not be placed in service. These impairment charges were included in cost of goods sold on the consolidated statements of income and impacted the Plasma reporting segment in the respective periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597104111728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill by operating segment for fiscal 2023 and 2022 are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:48.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Plasma</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Blood Center</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hospital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount as of April 3, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,043&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(865)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount as of April 2, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,043&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,166&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404,078&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467,287&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(745)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,056)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying amount as of April 1, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29,043</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,855</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">403,333</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">466,231</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of the Company&#8217;s goodwill impairment test performed in the fourth quarter of fiscal 2023, 2022 and 2021 indicated that the estimated fair value of all reporting units exceeded their respective carrying values. There were no reporting units at risk of impairment as of the fiscal 2023, 2022 and 2021 annual test dates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of intangible assets and the related accumulated amortization as of April&#160;1, 2023 and April&#160;2, 2022 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.784%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of April 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts and related relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">672,720</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">417,422</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">255,298</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-amortizable:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process software development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,473</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.784%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of April 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts and related relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">667,603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">376,552</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">291,051</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-amortizable:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process software development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,210</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Strategic Investments,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding acquisitions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets include the value assigned to license rights and other developed technology, patents, customer contracts and relationships and trade names. The estimated useful lives for all of these intangible assets are approximately 5 to 15&#160;years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate amortization expense for amortized intangible assets for fiscal 2023, 2022 and 2021 was $42.1 million, $56.6 million and $41.2 million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future annual amortization expense on intangible assets is estimated to be as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:83.504%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.563%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,590&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For costs incurred related to the development of software to be sold, leased, or otherwise marketed, the Company applies the provisions of ASC Topic 985-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software - Costs of Software to be Sold, Leased or Marketed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which specifies that costs incurred internally in researching and developing a computer software product should be charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs should be capitalized until the product is available for general release to customers. The costs capitalized for each project are included in intangible assets in the consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized $3.8&#160;million and $3.4&#160;million in software development costs for ongoing initiatives during fiscal 2023 and 2022, respectively. At April&#160;1, 2023 and April&#160;2, 2022, the Company had a total of $82.8&#160;million and $79.0&#160;million of software costs capitalized, of which $3.8&#160;million and $5.0&#160;million are related to in process software development initiatives, respectively, and the remaining balance represents in-service assets that are being amortized over their useful lives. Amortization expense for capitalized software was $8.5&#160;million, $8.4&#160;million and $7.8&#160;million for fiscal 2023, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597104111728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LEASES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee Activity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for office space, land, warehouse and manufacturing space, R&amp;D laboratories, vehicles and certain equipment. Finance leases are not significant. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company&#8217;s leases have remaining lease terms of&#160;1 year&#160;to approximately&#160;30 years, some of which may include options to extend the leases for up to&#160;10 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the appropriate incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, the Company entered into a lease for manufacturing space in Clinton, PA. In fiscal 2023, the Company&#8217;s manufacturing operations in Leetsdale, PA were relocated to the Clinton, PA facility. The lease term associated with the new manufacturing facility is 15 years and 7 months and includes two five year renewal options followed by one four year renewal option. During fiscal 2021, the Company recorded a right-of-use asset of $11.3&#160;million and corresponding liabilities of $15.4&#160;million upon commencement of the lease term in May 2020. In addition, the Company recorded a $4.1&#160;million lease incentive receivable associated with this lease agreement which was received during fiscal 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental balance sheet information related to the Company&#8217;s operating leases:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.806%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMC0xLTEtNzAzMzQ_34cb8f69-e36e-4863-9363-93e365f18a37"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMC0xLTEtNzAzMzQ_4c4b5b40-680d-44df-9a35-0e7bc64d7233"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,749&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMC0xLTEtNzAzMzQ_71a2b58f-3dab-4c09-b137-6558f9c15c80"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMC0xLTEtNzAzMzQ_993d52dc-b21b-4c73-bea1-865c14747532"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current liabilities</span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMC0xLTEtNzAzMzQ_64ce6304-0097-4fab-b514-f225878a9f4b"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMC0xLTEtNzAzMzQ_aece9495-28e3-4cad-8c7d-78640888fb76"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term liabilities</span></span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and discount rate information related to our operating leases:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.806%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 years</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating lease costs were&#160;$10.6 million, $11.0&#160;million and $11.7&#160;million during fiscal 2023, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information related to our operating leases:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:69.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 3, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used for operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,014&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,456&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturities of our operating lease liabilities as of&#160;April&#160;1, 2023:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:83.877%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,007&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,073&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,646&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum operating lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77,630</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,565)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Activity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets on the Company&#8217;s balance sheet classified as Haemonetics equipment primarily consists of medical devices installed at customer sites but owned by Haemonetics. These devices are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as the purchase and consumption of a certain level of disposable products. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where devices are provided under operating lease arrangements, a substantial majority of the entire lease revenue is variable and subject to subsequent non-lease component (disposable products) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Operating lease revenue represents approximately 3 percent of the Company&#8217;s total net sales.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597103756672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND LONG-TERM DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">NOTES&#160;PAYABLE AND LONG-TERM DEBT</a></td>
<td class="text">NOTES&#160;PAYABLE AND LONG-TERM DEBT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes payable and long-term debt consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, net of financing fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,784)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">754,102</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">559,441</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company issued $500.0&#160;million aggregate principal amount of 0% convertible senior notes due 2026 (the &#8220;2026 Notes&#8221;). The 2026 Notes are governed by the terms of the Indenture between the Company and U.S. Bank National Association, as trustee (the &#8220;Indenture&#8221;). The total net proceeds from the sale of the 2026 Notes, after deducting the initial purchasers&#8217; discounts and debt issuance costs, were approximately $486.7&#160;million. The 2026 Notes will mature on March 1, 2026, unless earlier converted, redeemed or repurchased.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their notes at their option at any time prior to the close of business on the business day immediately preceding September 1, 2025 only under the following circumstances:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During any calendar quarter (and only during such calendar quarter) beginning after June 30, 2021, if, the last reported sale price per share of the Company&#8217;s common stock exceeds 130% of the applicable conversion price on each applicable trading day for at least 20 trading days (whether or not consecutive) in the period of the 30 consecutive trading day period ending on, and including, the last trading day of the immediately preceding calendar quarter;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the five business day period after any five consecutive trading day period in which, for each day of that period, the trading price per $1,000 principal amount of the 2026 Notes for such trading day was less than 98% of the product of the last reported sale price of the Company&#8217;s common stock and the applicable conversion rate on such trading day;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company issues to common stockholders any rights, options, or warrants, entitling them, for a period of not more than 60 days, to purchase shares of common stock at a price per share less than the average closing sale price of 10 consecutive trading days, or the Company&#8217;s election to make a distribution to common stockholders exceeding 10% of the previous day&#8217;s closing sale price;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Upon the occurrence of specified corporate events, as set forth in the indenture governing the 2026 Notes; or</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the related redemption date if the Company calls the 2026 Notes for redemption</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after September 1, 2025, until the close of business on the scheduled trading day immediately preceding the maturity date, holders may convert all or a portion of their 2026 Notes, in multiples of $1,000 principal amount, at any time, regardless of the foregoing circumstances. The conversion rate for the 2026 Notes is 5.7033 shares of common stock per $1,000 principal amount of notes (which is equal to an initial conversion price of approximately $175.34 per share of the Company&#8217;s common stock), subject to adjustment as set forth in the Indenture. Upon conversion, the Company will pay cash up to the aggregate principal amount of the notes to be converted and pay or deliver, as the case may be, cash, common stock or a combination of cash and common stock, at the Company&#8217;s election, in respect of the remainder, if any, of the Company&#8217;s conversion obligation in excess of the aggregate principal amount of the notes being converted. If a make-whole adjustment event, as described in the Indenture, occurs and a holder elects to convert its 2026 Notes in connection with such make-whole adjustment event, such holder may be entitled to an increase in the conversion rate as described in the Indenture.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2023, the conditions allowing holders of the 2026 Notes to convert have not been met. The 2026 Notes were therefore not convertible as of April&#160;1, 2023 and were classified as long-term debt on the Company&#8217;s consolidated balance sheets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2026 Notes will be redeemable, in whole or in part, at the Company&#8217;s option at any time, and from time to time, on or after March 5, 2024 and on or before the 40th scheduled trading day immediately before the maturity date, if the last reported sale price per share of the Company&#8217;s common stock exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately before the date the Company sends the related redemption notice at a redemption price equal to 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. Upon the occurrence of certain fundamental changes involving the Company, holders of the 2026 Notes may require the Company to repurchase for cash all or part of their 2026 Notes at a repurchase price equal to 100% of the principal amount of the 2026 Notes to be repurchased, plus</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accrued and unpaid interest.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2021, the Company adopted ASC Update No. 2020-06 using the modified retrospective method, which resulted in a decrease of $61.2&#160;million to additional paid-in capital, a decrease to non-current deferred tax liabilities of $20.0&#160;million, and an increase of $80.3&#160;million to non-current convertible notes, net, on the consolidated balance sheets. Additionally, retained earnings was adjusted to remove amortization expense recognized in prior periods related to the debt discount and the convertible notes no longer have a debt discount that will be amortized, net of taxes. The impact to retained earnings on the consolidated balance sheets as of April 4, 2021 is an increase of $1.0&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, the $500.0&#160;million principal balance was netted down by the $7.9&#160;million of remaining debt issuance costs, resulting in a net convertible note payable of $492.1&#160;million. Interest expense related to the 2026 Notes was $2.7&#160;million for the fiscal year ended April 1, 2023, which is entirely attributable to the amortization of the debt issuance costs. The debt issuance costs are amortized at an effective interest rate of 0.5%. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capped Calls</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the 2026 Notes, the Company entered into capped call transactions with certain counterparties (&#8220;Capped Calls&#8221;). The Capped Calls each have an initial strike price of approximately $175.34 per share, subject to certain adjustments, which corresponds to the initial conversion price of the 2026 Notes. The Capped Calls have initial cap prices of $250.48 per share, subject to certain adjustments. The Capped Calls are expected to partially offset the potential dilution to the Company&#8217;s common stock upon any conversion of the 2026 Notes, with such offset subject to a cap based on the cap price. The Capped Calls cover, subject to anti-dilution adjustments, approximately 2.85&#160;million shares of the Company&#8217;s common stock. For accounting purposes, the Capped Calls are separate transactions, and not part of the 2026 Notes. As these transactions meet certain accounting criteria, the Capped Calls are recorded in stockholders&#8217; equity and are not accounted for as derivatives. The cost of $47.4&#160;million incurred to purchase the Capped Calls was recorded as a reduction to additional paid-in capital in fiscal 2021 and will not be remeasured.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2018, the Company entered into a credit agreement with certain lenders that provided for a $350.0 million term loan and a $350.0 million revolving loan (together with the term loan, as amended from time to time, the &#8220;2018 Credit Facilities&#8221;) that were each scheduled to mature on June 15, 2023 with applicable interest rates during the period established using LIBOR plus 1.13% - 1.75%, depending on the Company's leverage ratio. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 26, 2022, the Company entered into an amended and restated credit agreement with certain lenders to refinance the 2018 Credit Facilities and extend their maturity date through June 2025. The amended and restated credit agreement provides for a $280.0&#160;million&#160;senior unsecured term loan, the proceeds of which have been used to settle the balance of the term loan under the 2018 Credit Facilities, and a $420.0&#160;million&#160;senior unsecured revolving credit facility (together, the &#8220;Revised Credit Facilities&#8221;). Loans under the Revised Credit Facilities bear interest at an annual rate equal to the Adjusted Term SOFR Rate (as specified in the amended and restated credit agreement), which is subject to a floor of 0%, plus an applicable rate ranging from 1.125% to 1.750% based on the Company&#8217;s consolidated net leverage ratio (as specified in the amended and restated credit agreement) at the applicable measurement date. Adjusted Term SOFR Rate loans are also subject to a credit spread adjustment of 0.10% per annum. The revolving credit facility carries an unused fee that ranges from 0.125% to 0.250% annually based on the Company&#8217;s consolidated net leverage ratio at the applicable measurement date. Under the Revised Credit Facilities, the Company is required to maintain certain leverage and interest coverage ratios specified in the amended and restated credit agreement as well as other customary non-financial affirmative and negative covenants. The Revised Credit Facilities mature on June 15, 2025. The principal amount of the term loan under the Revised Credit Facilities is repayable quarterly through the maturity date at a rate of 2.5% for the first year and 5% thereafter, with the unpaid balance due at maturity.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company applied modification accounting for the credit facility refinancing. For the term loan under the Revised Credit Facilities, for fiscal 2023, the Company recognized interest expense of $0.5&#160;million for third party fees incurred and capitalized $0.2&#160;million of lender fees related to the term loan. For fiscal 2023, the Company capitalized $1.1&#160;million of lender fees and third-party costs incurred in the refinancing related to the revolving credit facility under the Revised Credit Facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;1, 2023, $274.7 million was outstanding under the term loan with an effective interest rate of 6.3%. There were no outstanding borrowings under the revolving credit facility at April&#160;1, 2023. The Company also had $21.3 million of uncommitted operating lines of credit to fund its global operations under which there were no outstanding borrowings as of April&#160;1, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Revised Credit Facilities, the Company is required to maintain a consolidated leverage ratio not to exceed 3.5:1.0 and a consolidated interest coverage ratio not to be less than 4.0:1.0 during periods when the Revised Credit Facilities are outstanding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company is required to satisfy these covenants, on a pro forma basis, in connection with any new borrowings (including any letter of credit issuances) on the revolving credit facility as of the time of such borrowings. The Consolidated Interest Coverage Ratio is calculated as the consolidated EBITDA divided by consolidated interest expense while the Consolidated Net Leverage ratio is calculated as consolidated total debt minus liquidity, divided by consolidated EBITDA. Consolidated EBITDA includes EBITDA adjusted by non-recurring and unusual transactions specifically as defined in the Revised Credit Facilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revised Credit Facilities also contain usual and customary non-financial affirmative and negative covenants that include certain restrictions with respect to subsequent indebtedness, liens, loans and investments (including acquisitions), financial reporting obligations, mergers, consolidations, dispositions, dissolutions or liquidation, asset sales, affiliate transactions, change of its business, capital expenditures, share repurchase and other restricted payments. These covenants are subject to exceptions and qualifications set forth in the credit agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure to comply with the financial and operating covenants of the Revised Credit Facilities would prevent the Company from being able to borrow additional funds and would constitute a default, which could result in, among other things, the amounts outstanding including all accrued interest and unpaid fees, becoming immediately due and payable. In addition, the Revised Credit Facilities include customary events of default, in certain cases subject to customary cure periods. As of April&#160;1, 2023, the Company was in compliance with the covenants. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commitment Fee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Revised Credit Facilities, the Company is required to pay, on the last day of each calendar quarter, a commitment fee on the unused portion of the revolving credit facility. The commitment fee is subject to a pricing grid based on the Company&#8217;s consolidated leverage ratio. The commitment fee ranges from 0.125% to 0.250%. The current commitment fee on the undrawn portion of the revolving credit facility is 0.175%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Issuance Costs and Interest </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses associated with the issuance of the term loan were capitalized and are amortized to interest expense over the life of the term loan using the effective interest method. As of April&#160;1, 2023, the $274.7 million term loan balance was netted down by the $1.0 million of remaining debt discount, resulting in a net note payable of $273.7 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $13.0 million, $5.8 million and $9.4 million for fiscal 2023, 2022 and 2021, respectively. Accrued interest associated with the outstanding debt is included as a component of other current liabilities in the accompanying consolidated balance sheets. As of both April&#160;1, 2023 and April&#160;2, 2022, the Company had an insignificant amount of accrued interest associated with the outstanding debt.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate amount of debt maturing during the next five fiscal years are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:88.358%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.442%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal year</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098340672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manufactures, markets and sells its products globally. For the fiscal year ended April&#160;1, 2023, 27.9% of the Company&#8217;s sales were generated outside the U.S.&#160;in local currencies. The Company also incurs certain manufacturing, marketing and selling costs in international markets in local currency.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, earnings and cash flows are exposed to market risk from changes in foreign currency exchange rates relative to the U.S. Dollar, the Company&#8217;s reporting currency. The Company has a program in place that is designed to mitigate the exposure to changes in foreign currency exchange rates. That program includes the use of derivative financial instruments to minimize, for a period of time, the impact on its financial results from changes in foreign exchange rates. The Company utilizes foreign currency forward contracts to hedge the anticipated cash flows from transactions denominated in foreign currencies, primarily Japanese Yen and Euro, and to a lesser extent Swiss Franc and Mexican Peso. This does not eliminate the impact of the volatility of foreign exchange rates. However, because the Company generally enters into forward contracts one year out, rates are fixed for a one-year period, thereby facilitating financial planning and resource allocation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Designated Foreign Currency Hedge Contracts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s designated foreign currency hedge contracts as of April&#160;1, 2023 and April&#160;2, 2022 were cash flow hedges under ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 815&#8221;). The Company records the effective portion of any change in the fair value of designated foreign currency hedge contracts in other comprehensive income until the related third-party transaction occurs. Once the related third-party transaction occurs, the Company reclassifies the effective portion of any related gain or loss on the designated foreign currency hedge contracts to earnings. In the event the hedged forecasted transaction does not occur, or it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. The Company had designated foreign currency hedge contracts outstanding in the contract amount of $51.8 million as of April&#160;1, 2023 and $67.3 million as of April&#160;2, 2022. At April&#160;1, 2023, a gain of $2.8 million, net of tax, will be reclassified to earnings within the next twelve months. Substantially all currency cash flow hedges outstanding as of April&#160;1, 2023 mature within twelve months. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Designated Foreign Currency Contracts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its exposure to changes in foreign currency on a consolidated basis to take advantage of offsetting transactions and balances. It uses foreign currency forward contracts as a part of its strategy to manage exposure related to foreign currency denominated monetary assets and liabilities. These foreign currency forward contracts are entered into for periods consistent with currency transaction exposures, generally one month. They are not designated as cash flow or fair value hedges under ASC 815. These forward contracts are marked-to-market with changes in fair value recorded to earnings. The Company had non-designated foreign currency hedge contracts under ASC 815 outstanding in the contract amount of $44.7 million as of April&#160;1, 2023 and $39.5 million as of April&#160;2, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swaps</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Part of the Company&#8217;s interest rate risk management strategy includes the use of interest rate swaps to mitigate its exposure to changes in variable interest rates. The Company&#8217;s objective in using interest rate swaps is to add stability to interest expense and to manage and reduce the risk inherent in interest rate fluctuations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2018, the Company entered into the 2018 Credit Facilities which provided for a $350.0 million term loan and a $350.0 million revolving credit facility. Under the terms of the 2018 Credit Facilities, interest was established using LIBOR plus the applicable rate ranging from 1.13% to 1.75% based on the Company&#8217;s leverage ratio. In August 2018, the Company entered into two interest rate swap agreements to pay an average fixed rate of 2.80% plus the applicable rate on a total notional value of $241.9 million of debt, or 70% of the notional value of the unsecured term loan. The 2018 interest rate swaps mature on June 15, 2023. As a result of the Company&#8217;s refinancing of the 2018 Credit Facilities in July 2022, as discussed below, the 2018 interest rate swaps were amended in September 2022 to align with the Term Secured Overnight Financing Rate (&#8220;SOFR&#8221;) rate rather than LIBOR (the &#8220;Amended Swaps&#8221;). In order to avoid dedesignation, the Company elected certain practical expedients under ASC 848.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, the Company&#8217;s earnings and cash flows are exposed to interest rate risk from changes to SOFR. The Company concluded that the Amended Swaps were still effective such that hedge accounting was continued on these swaps.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 26, 2022, the Company entered into an amended and restated credit agreement to refinance the 2018 Credit Facilities and extend their maturity date through June 2025. The Revised Credit Facilities include a $280.0&#160;million senior unsecured term loan and a $420.0&#160;million&#160;senior unsecured revolving credit facility. Loans under the Revised Credit Facilities bear interest at an annual rate equal to the 1-month USD Term SOFR plus 0.10% and an applicable rate ranging from 1.125% to 1.750% based on the Company&#8217;s consolidated net leverage ratio. In September 2022, the Company entered into four additional interest rate swaps, which when combined with the Amended Swaps, result in an average blended fixed interest rate of 3.57% plus the applicable rate on 70% of the notional value of the unsecured term loan until mid-June 2023 and 4.12% plus the applicable rate thereafter on 80% of the notional until the maturity date in June 2025. The Company has concluded that each of these four additional interest rate swaps are effective and qualify for hedge accounting treatment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company held the following interest rate swaps as of April&#160;1, 2023:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"/><td style="width:21.634%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.643%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Original Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount as of April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value Assets (Liabilities)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/28/2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/30/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.67%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/28/2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/30/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/23/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/30/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.44%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/23/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/30/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.46%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/23/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.08%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/23/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(585)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509,514&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,126&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For fiscal 2023, the Company recorded a gain of $2.6 million, net of tax, in accumulated other comprehensive loss to recognize the effective portion of the fair value of the swaps that qualify as cash flow hedges. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trade Receivables</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company grants trade credit to its customers on normal credit terms. In an effort to reduce its credit risk, the Company (i) establishes credit limits for all customers, (ii) performs ongoing credit evaluations of customers&#8217; financial condition, (iii) monitors the payment history and aging of customers&#8217; receivables and (iv) monitors open orders against an individual customer&#8217;s outstanding receivable balance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses is maintained for trade accounts receivable based on the expected collectability, the historical collection experience, the length of time an account is outstanding, the financial position of the customer and information provided by credit rating services. Effective March 29, 2020, the Company adopted Update No. 2016-13,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses&#160;(Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which requires consideration of events or circumstances indicating historic collection rates may not be indicative of future collectability. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of the allowance for credit losses:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.016%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 3, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,475</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,226</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,824</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Credit (gain) loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,623&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(991)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Write-offs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,932</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,475</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,226</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Derivative Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of the Company&#8217;s derivative instruments designated as cash flow hedges and those not designated as hedging instruments under ASC 815 in its consolidated statements of income and comprehensive income for the fiscal year ended April 1, 2023.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:31.696%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.055%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Instruments  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain Recognized in Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Consolidated Statements of Income and Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain Excluded from<br/>Effectiveness<br/>Testing</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Consolidated Statements of Income and Comprehensive Income</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues, COGS and SG&amp;A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have fair value hedges or net investment hedges outstanding as of April&#160;1, 2023 or April&#160;2, 2022. As of April&#160;1, 2023, no material deferred taxes were recognized for designated foreign currency hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 815 requires all derivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, by considering the estimated amount it would receive or pay to sell or transfer these instruments at the reporting date and by taking into account current interest rates, currency exchange rates, current interest rate curves, interest rate volatilities, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company may utilize financial models to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in markets that are not active; other observable inputs for the asset or liability; and inputs derived principally from, or corroborated by, observable market data by correlation or other means. As of April&#160;1, 2023, the Company has classified its derivative assets and liabilities within Level 2 of the fair value hierarchy prescribed by ASC 815, as discussed below, because these observable inputs are available for substantially the full term of its derivative instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of the Company&#8217;s derivative instruments as they appear in its consolidated balance sheets as of April&#160;1, 2023 and April&#160;2, 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:47.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.680%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location in<br/>Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,813</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,889</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,894</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Fair Value Measurements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exit price that would be received from the sale of an asset or paid to transfer a liability, using assumptions that market participants would use in pricing an asset or liability. The fair value guidance establishes the following three-level hierarchy used for measuring fair value:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8212; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8212; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8212; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s money market funds carried at fair value are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measured on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and financial liabilities measured at fair value on a recurring basis consist of the following as of April&#160;1, 2023 and April&#160;2, 2022.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.601%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 1, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">132,341</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,813</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">135,154</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,889</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">863</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,752</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97,425</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100,657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,894</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,675</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,569</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency hedge contracts - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of foreign currency hedge contracts was measured using significant other observable inputs and valued by reference to over-the-counter quoted market prices for similar instruments. The Company does not believe that the fair value of these derivative instruments differs significantly from the amount that could be realized upon settlement or maturity, or that the changes in fair value will have a significant effect on its results of operations, financial condition or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate swaps - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of interest rate swaps are measured using the present value of expected future cash flows using market-based observable inputs, including credit risk and interest rate yield curves. The Company does not believe that the fair values of these derivative instruments differ significantly from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a significant effect on its results of operations, financial condition or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent consideration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The fair value of contingent consideration liabilities is based on significant unobservable inputs, including management estimates and assumptions, and is measured based on the probability-weighted present value of the payments expected to be made. Accordingly, the fair value of contingent consideration has been classified as level 3 within the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fair value hierarchy. The recurring level 3 fair value measurements of contingent consideration liabilities include the following significant unobservable inputs:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:21.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technique</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue-based payments</span></td><td colspan="3" style="padding:0 1pt"/><td rowspan="2" style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5%</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of contingent consideration associated with acquisitions was $0.9&#160;million at April&#160;1, 2023 and was included in other current liabilities. A reconciliation of the change in the fair value of contingent consideration is included in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">863</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Fair Value Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the 2026 Notes as of April&#160;1, 2023 was $425.7&#160;million, which was determined based on the quoted price for the 2026 Notes in an inactive market on the last trading day of the reporting period and is considered as level 2 in the fair value hierarchy. In estimating the risk adjusted yield, the Company utilized both an income and market approach. For the income approach, the Company used a convertible bond pricing model, which included several assumptions including volatility and the risk-free rate. For the market approach, the Company performed an evaluation of issuances of debt securities issued by other comparable companies and broader market indices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term loan (which is carried at amortized cost), accounts receivable and accounts payable approximate fair value.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098208352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">RETIREMENT PLANS</a></td>
<td class="text">RETIREMENT PLANS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Savings Plus Plan (the &#8220;401k Plan&#8221;) that allows its U.S.&#160;employees to accumulate savings on a pre-tax basis. In addition, matching contributions are made to the 401k Plan based upon pre-established rates. The Company&#8217;s matching contributions amounted to approximately $6.9 million, $6.3 million and $4.9 million in fiscal 2023, 2022 and 2021, respectively. Upon the Company&#8217;s Board of Directors&#8217; approval, additional discretionary contributions can also be made. No discretionary contributions were made for the 401k Plan in fiscal 2023, 2022, or 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s subsidiaries also have defined contribution plans, to which both the employee and the employer make contributions. The employer contributions to these plans totaled $0.6 million, $0.6 million and $0.7 million in fiscal 2023, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 715, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation&#160;&#8212; Retirement Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, requires an employer to: (a)&#160;recognize in its statement of financial position an asset for a plan&#8217;s over-funded status or a liability for a plan&#8217;s under-funded status; (b)&#160;measure a plan&#8217;s assets and its obligations that determine its funded status as of the end of the employer&#8217;s fiscal year (with limited exceptions); and (c)&#160;recognize changes in the funded status of a defined benefit post retirement plan in the year in which the changes occur. Accordingly, the Company is required to report changes in its funded status in comprehensive loss on its consolidated statement of stockholders&#8217; equity and consolidated statement of comprehensive income.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefits under these plans are generally based on either career average or final average salaries and creditable years of service as defined in the plans. The annual cost for these plans is determined using the projected unit credit actuarial cost method that includes actuarial assumptions and estimates that are subject to change.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s foreign subsidiaries have defined benefit pension plans covering substantially all full time employees at those subsidiaries. Net periodic benefit costs for the plans in the aggregate include the following components:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized prior service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,191</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,698</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,070</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity under those defined benefit plans are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in Benefit Obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,410)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,453)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee and plan participants contribution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,599)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,093)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit obligation, end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(25,465)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30,410)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in Plan Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(593)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(719)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee and plan participants contribution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of plan assets, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,463</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded Status</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,002)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,963)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized net actuarial gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,757)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,099)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net amount recognized</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11,892)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14,298)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Substantially all of the unfunded status is non-current</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of the benefit plans is funded by benefit payments made by the Company through the purchase of reinsurance contracts that do not qualify as plan assets under ASC Topic 715. Accordingly, that plan has no assets included in the information presented above. The total asset value associated with the reinsurance contracts was $7.1 million and $6.8 million at April&#160;1, 2023 and April&#160;2, 2022, respectively. The total liability for this plan, which is included in the table above, was $7.5 million and $9.6 million as of April&#160;1, 2023 and April&#160;2, 2022, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated benefit obligation for all plans was $25.2 million and $28.4 million for fiscal 2023 and 2022, respectively. There were no plans where the plan assets were greater than the accumulated benefit obligation as of April&#160;1, 2023 and April&#160;2, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the change recorded in the Company&#8217;s accumulated other comprehensive loss related to its defined benefit plans, net of tax, are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 28, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of April 3, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(560)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of April 2, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of April 1, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,075</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to amortize $0.4 million from accumulated other comprehensive loss to net periodic benefit cost during fiscal 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average rates used to determine the net periodic benefit costs and projected benefit obligations were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increased salary levels</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.94&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions for expected long-term rate of return on plan assets are based upon actual historical returns, future expectations of returns for each asset class and the effect of periodic target asset allocation rebalancing. The results are adjusted for the payment of reasonable expenses of the plan from plan assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has no other material obligation for post-retirement or post-employment benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment policy for pension plans is to balance risk and return through a diversified portfolio to reduce interest rate and market risk. Maturities are managed so that sufficient liquidity exists to meet immediate and future benefit payment requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, provides guidance for reporting and measuring the plan assets of the Company&#8217;s defined benefit pension plan at fair value as of April&#160;1, 2023. Using the same three-level valuation hierarchy for disclosure of fair value measurements as described in Note&#160;14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, all of the assets of the Company&#8217;s plan are classified within Level&#160;2 of the fair value hierarchy because the plan assets are primarily insurance contracts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected benefit payments for both plans are estimated using the same assumptions used in determining the Company&#8217;s benefit obligation at April&#160;1, 2023. Benefit payments will depend on future employment and compensation levels, average years employed and average life spans, among other factors, and changes in any of these factors could significantly affect these estimated future benefit payments. Estimated future benefit payments are as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2029-2033</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The Company&#8217;s contributions for fiscal 2024 are expected to be consistent with the current year.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098453136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described below, there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. At each reporting period, management evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for all matters. Legal costs are expensed as incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal 2021, the Company received a subpoena from the U.S. Attorney&#8217;s Office for the District of Massachusetts. The subpoena requested certain documents regarding the Company&#8217;s apheresis and autotransfusion devices and disposables, including documents relating to product complaints and adverse event reporting, regulatory clearances and product design changes, among other matters. The Company has fully cooperated with this inquiry. On August 16, 2022, the U.S. Department of Justice (&#8220;DOJ&#8221;) filed a motion on behalf of the United States and 31 states reflecting their decision to not intervene in the underlying </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> action captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Berthelot et al. v. Haemonetics Corp.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 1:20-cv-11062-ADB, pending in the U.S. District Court for the District of Massachusetts, indicating that the DOJ had completed its investigative activity based on then available information. The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case was unsealed by order dated August 18, 2022. During the fourth fiscal quarter of 2023, the Company recorded a loss contingency related to this matter, which did not have a material impact on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of fiscal 2021, a putative class action complaint was filed against the Company in the Circuit Court of Cook County, Illinois by Mary Crumpton, on behalf of herself and similarly situated individuals. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mary Crumpton v. Haemonetics Corporation, Case No. 1:21-cv-1402</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In her complaint, the plaintiff asserts that between June 2017 and August 2018 she donated plasma at a center operated by one of the Company&#8217;s customers, that the center required her to scan her finger print in a scanner that stored her finger print to identify her prior to plasma donation, and that the Company&#8217;s eQue donor management software sent her biometric information to a Company-owned server to be collected and stored in a manner that violated her rights under the Illinois Biometric Information Privacy Act (&#8220;BIPA&#8221;). The plaintiff seeks statutory damages, attorneys&#8217; fees, and injunctive and equitable relief. In March 2021, the Company moved to dismiss the complaint for lack of personal jurisdiction and concurrently filed a motion to dismiss for failure to state a claim and a motion to stay. In March 2022, the court denied the Company&#8217;s motion to dismiss for lack of personal jurisdiction but did not address the merits of the Company&#8217;s other positions. In March 2023, the Company filed a second motion to dismiss the complaint, which is pending before the court. The Company believes it has valid and meritorious defenses to the complaint. During the fourth fiscal quarter of 2023, the Company recorded a loss contingency related to this matter, which did not have a material impact on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098314736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">CAPITAL STOCK</a></td>
<td class="text">CAPITAL STOCK<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 25, 2019 (the &#8220;Effective Date&#8221;), the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan (the &#8220;2019 Equity Plan&#8221;) was approved and became effective. The 2019 Equity Plan permits the award of incentive stock options, non-qualified stock options, stock appreciation rights (&#8220;SARs&#8221;), restricted stock, restricted stock units (including performance-based restricted stock units) and other awards to the Company&#8217;s key employees, non-employee directors and certain consultants and advisors of the Company and its subsidiaries. The 2019 Equity Plan is administered by the Compensation Committee of the Board of Directors (the &#8220;Committee&#8221;), which consists of four independent members of the Company&#8217;s Board of Directors, and </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is the successor to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan, as amended (the &#8220;2005 Equity Plan&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the Effective Date, no further awards were granted under the 2005 Equity Plan; however, each outstanding award under the 2005 Equity Plan will remain outstanding under that plan and continue to be governed under its terms and any applicable award agreement. The maximum number of shares available for award under 2019 Equity Plan is 5,759,433, which consists of 2,700,000 shares of common stock authorized for issuance under the 2019 Equity Plan plus 3,059,433 shares of common stock reserved for issuance under the 2005 Equity Plan that remained available for grant under the 2005 Plan as of the Effective Date. Under the 2019 Equity Plan, any shares that are subject to the award of stock options or SARs will be counted against the authorized share reserve as one share for every one&#160;share issued and any shares that are subject to awards other than stock options, SARs or cash awards will be counted against the authorized share reserve as 2.76&#160;shares for every one&#160;share granted. Shares of common stock subject to outstanding grants under the 2005 Equity Plan as of the Effective Date that terminate, expire, or are otherwise canceled without having been exercised will be added to the share reserve at the applicable 2019 Equity Plan ratios. The total shares available for future grant as of April&#160;1, 2023 were 3,118,602.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation cost related to share-based transactions is recognized in the consolidated financial statements based on fair</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">value. The total amount of share-based compensation expense, which is recorded on a straight line basis, is as follows:</span></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21,903</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20,694</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22,888</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,583</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24,359</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,516</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options are granted to purchase common stock at prices as determined by the Committee, but in no event shall such exercise price be less than the fair market value of the common stock at the time of the grant. Options generally vest in equal installments over a four year period for employees and one year from grant for non-employee directors. Options expire not more than 7 years from the date of the grant. The grant-date fair value of options, adjusted for estimated forfeitures, is recognized as expense on a straight line basis over the requisite service period, which is generally the vesting period. Forfeitures are estimated based on historical experience. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity for the fiscal year ended April&#160;1, 2023 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price<br/>per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Life (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>($000&#8217;s)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at April 2, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.79</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,972)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,150,194</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64.21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.55</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27,481</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested or expected to vest at April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of options exercised was $1.9 million, $1.7 million and $8.2 million during fiscal 2023, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, there was $9.1 million of total unrecognized compensation cost related to non-vested stock options. This cost is expected to be recognized over a weighted average period of 2.6&#160;years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value was estimated using the Black-Scholes option-pricing model based on the closing stock price at the grant date and the weighted average assumptions specific to the underlying options. Expected volatility assumptions are based on the historical volatility of the Company&#8217;s common stock over the expected term of the option. The risk-free interest rate was selected based upon yields of U.S.&#160;Treasury issues with a term equal to the expected life of the option being valued. The expected life of the option was estimated with reference to historical exercise patterns, the contractual term of the option and the vesting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions utilized for option grants during the periods presented are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value per Option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.53</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted Stock Units (&#8220;RSUs&#8221;) generally vest in equal installments over a four year period for employees and one year from grant for non-employee directors. The grant-date fair value of RSUs, adjusted for estimated forfeitures, is recognized as expense on a straight-line basis over the requisite service period, which is generally the vesting period. The fair market value of RSUs is determined based on the market value of the Company&#8217;s shares on the date of grant.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU activity for the fiscal year ended April&#160;1, 2023 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.543%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at April 2, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,536&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,045)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,360)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">381,308</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63.94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of RSUs granted and total fair value of RSUs vested are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value per RSU</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.96&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of RSUs vested</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, there was $15.4 million of total unrecognized compensation cost related to non-vested restricted stock units. This cost is expected to be recognized over a weighted average period of 2.5&#160;years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Share Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant date fair value of Performance Share Units (&#8220;PSUs&#8221;), adjusted for estimated forfeitures, is recognized as expense on a straight line basis from the grant date through the end of the performance period. The value of these PSUs is generally based on relative total shareholder return which equals total shareholder return for the Company as compared with total shareholder return of the PSU comparison group, measured over a three year performance period. The PSUs comparison group consists of the Standard and Poor's (&#8220;S&amp;P&#8221;) MidCap 400 Index. Depending on the Company&#8217;s relative performance during the performance period, a recipient of the award is entitled to receive a number of ordinary shares equal to a percentage, ranging from 0% to 200%, of the award granted. If the Company&#8217;s total shareholder return for the performance period is negative, then any share payout will be capped at 100% of the target award, regardless of the Company&#8217;s performance relative to the its comparison group. As a result, the Company may issue up to 647,974 shares related to outstanding performance-based awards.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of PSU activity for the fiscal year ended April&#160;1, 2023 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.543%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at April 2, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,810)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">323,987</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Includes the adjustment of 62,577 shares for awards granted in fiscal 2020, based on actual relative total shareholder return of 0%</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Monte Carlo model to estimate the probability of satisfying the performance criteria and the resulting fair value of PSU awards with market conditions. The assumptions used in the Monte Carlo model for PSUs granted during each fiscal year were as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peer group stock price volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Correlation of returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of PSUs granted and total fair value of PSUs vested are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:59.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value per PSU</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.96&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of PSUs vested</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2023, there was $14.5 million of total unrecognized compensation cost related to non-vested performance share units. This cost is expected to be recognized over a weighted average period of 1.8&#160;years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an Employee Stock Purchase Plan (the &#8220;Purchase Plan&#8221;) under which a maximum of 3,200,000&#160;shares (subject to adjustment for stock splits and similar changes) of common stock may be purchased by eligible employees. Substantially all of its full-time employees are eligible to participate in the Purchase Plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Purchase Plan provides for two &#8220;purchase periods&#8221; within each of its fiscal years, the first commencing on November 1 of each year and continuing through April 30 of the next calendar year, and the second commencing on May 1 of each year and continuing through October 31 of such year. Shares are purchased through an accumulation of payroll deductions (of not less than 2% or more than 15% of compensation, as defined) for the number of whole shares determined by dividing the balance in the employee&#8217;s account on the last day of the purchase period by the purchase price per share for the stock determined under the Purchase Plan. The purchase price for shares is the lower of 85% of the fair market value of the common stock at the beginning of the purchase period, or 85% of such value at the end of the purchase period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of shares purchased under the Employee Stock Purchase Plan are estimated using the Black-Scholes single option-pricing model with the following weighted average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (months)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend Yield</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of the six-month option inherent in the Purchase Plan was approximately $18.10, $20.77 and $30.77 during fiscal 2023, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098060288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND ENTERPRISE-WIDE INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND ENTERPRISE-WIDE INFORMATION</a></td>
<td class="text">SEGMENT AND ENTERPRISE-WIDE INFORMATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines its reportable segments by first identifying its operating segments, and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. The Company&#8217;s reporting structure aligns with its operating structure of three global business units and the information that is regularly reviewed by the Company&#8217;s chief operating decision maker.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable and operating segments are as follows:</span></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Plasma</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Blood Center</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Hospital</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management measures and evaluates the operating segments based on operating income. Management excludes certain corporate expenses from segment operating income. In addition, certain amounts that management considers to be non-recurring or non-operational are excluded from segment operating income because management evaluates the operating results of the segments excluding such items. These items include integration and transaction costs, amortization of acquired intangible assets, restructuring and restructuring related costs, digital transformation costs related to the upgrade of our enterprise resource planning system, impairments, accelerated device depreciation and related costs, costs related to compliance with the European Union Medical Device Regulation (&#8220;MDR&#8221;) and In Vitro Diagnostic Regulation (&#8220;IVDR&#8221;), unusual or infrequent and material litigation-related charges and gains and losses on dispositions and sale of assets. Although these amounts are excluded from </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">segment operating income, as applicable, they are included in the reconciliations that follow. Management measures and evaluates the Company&#8217;s net revenues and operating income using internally derived standard currency exchange rates that remain constant from year to year; therefore, segment information is presented on this basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected information by reportable segment is presented below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues by business unit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168,060&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,824)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,605)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,168,660</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">993,196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">870,463</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Reflects revenue for service, maintenance and parts.</span></div></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565,103&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449,605&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Corporate expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(355,089)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(281,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256,751)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Effect of exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,414)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,830)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of assets and PCS2 related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,732)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration and transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,604)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and restructuring related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,824)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,661)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digital transformation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,536)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDR and IVDR costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,033)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,130)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,368)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(897)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on divestitures and sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">156,033</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80,750</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89,747</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.</span></div></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:59.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total depreciation and amortization (excluding impairment charges)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93,307</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97,747</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">84,287</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">310,885</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">258,482</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Long-lived assets are comprised of property, plant and equipment.</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected information by operating regions is presented below:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">310,885</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">258,482</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Long-lived assets are comprised of property, plant and equipment.</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,168,660</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">993,196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">870,463</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews revenue based on the reportable segments noted above.&#160;Although these reportable segments are primarily product-based, they differ from the Company&#8217;s product line revenues for Plasma products and services and Blood Center products and services.&#160;Specifically, the Blood Center reportable segment includes plasma products utilized for collection in blood centers primarily for transfusion purposes.&#160;Additionally, product line revenues also include service revenues which are excluded from the reportable segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues by product line are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:61.972%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.716%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.716%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.720%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma products and services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563,734&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414,266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center products and services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital products and services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,168,660</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">993,196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">870,463</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098210784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE LOSS</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE LOSS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll-forward of the components of accumulated other comprehensive loss, net of tax, for the years ended April&#160;1, 2023 and April&#160;2, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:46.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined benefit plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Unrealized Gain (Loss) on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, April 3, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,528)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(560)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,459)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,547)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,391)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive gain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,391)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,805&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, April 2, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,919)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,954)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,016)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive gain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,016)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(867)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,427)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(33,935)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,075</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(521)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30,381)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Presented net of income taxes, the amounts of which are insignificant.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597097396336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Year</a></td>
<td class="text">Fiscal YearHaemonetics&#8217; fiscal year ends on the Saturday closest to the last day of March. Fiscal years 2023 and 2022 included 52 weeks with each quarter having 13 weeks. Fiscal 2021 included 53 weeks with each of the first three quarters having 13 weeks and the fourth quarter having 14 weeks.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">Principles of ConsolidationThe accompanying consolidated financial statements include all accounts including those of its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. In addition, we assess our strategic investments to determine whether they meet the definition of a variable interest entity (&#8220;VIE&#8221;), and if so, whether the Company has controlling financial interest. Controlling financial interest occurs if the Company has both the power to direct activities of the VIE that most significantly impact the VIE&#8217;s economic performance and an obligation to absorb losses of or the right to receive benefits from the VIE that could potentially be significant to the VIE. The Company&#8217;s strategic investments did not meet the controlling financial interest criteria, as such no VIEs were consolidated during fiscal 2023, 2022 or 2021.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results </span></div>could vary from the amounts derived from its estimates and assumptions. The Company considers estimates to be critical if they are required to make assumptions about material matters that are uncertain at the time of estimation or if materially different estimates could have been made or it is reasonably likely that the accounting estimate will change from period to period. The following are areas considered to be critical and require management&#8217;s judgment: revenue recognition, inventory provisions, intangible asset and goodwill valuation, legal and other judgmental accruals and income taxes.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may become involved in various legal proceedings that arise in the ordinary course of business, including, without limitation, patent infringement, product liability and environmental matters. Accruals recorded for various contingencies including legal proceedings, employee related litigation, self-insurance and other claims are based on judgment, the probability of losses and, where applicable, the consideration of opinions of internal and/or external legal counsel and actuarially determined estimates. When a loss is probable and a range of loss is established but a best estimate cannot be made, the Company records the minimum loss contingency amount, which could be zero. These estimates are often initially developed substantially earlier than the ultimate loss is known and the estimates are reevaluated each accounting period, as additional information is available. As information becomes known, an additional loss provision is recorded when either a best estimate can be made or the minimum loss amount is increased. When events result in an expectation of a more favorable outcome than previously expected, the best estimate is changed to a lower amount.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenue recognition policy is to recognize revenues from product sales, software and services in accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Codification (&#8220;ASC&#8221;) Update No. 2014-19, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers (Topic 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; this occurs with the transfer of control of the Company&#8217;s goods or services. The Company considers revenue to be earned when all of the following criteria are met: it has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the consideration the Company expects to receive for transferring goods or providing services, is determinable and it has transferred control of the promised items to the customer. A promise in a contract to transfer a distinct good or service to the customer is identified as a performance obligation. A contract&#8217;s transaction price is allocated to each performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of the Company&#8217;s contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the contract&#8217;s transaction price to each performance obligation based on the estimated standalone selling prices of the good or service in the contract. For goods or services for which observable standalone selling prices are not available, the Company uses an expected cost plus a margin approach to estimate the standalone selling price of each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Revenues</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company&#8217;s performance obligations related to product sales are satisfied at a point in time. Product revenue consists of the sale of its disposable blood component collection and processing sets and the related equipment. The Company&#8217;s performance obligation related to product sales is satisfied upon shipment or delivery to the customer based on the specified terms set forth in the customer contract. Shipping and handling activities performed after a customer obtains control of the good are treated as fulfillment activities and are not considered to be a separate performance obligation. Revenue is recognized over time for maintenance plans provided to customers that provide services beyond the Company&#8217;s standard warranty period. Payment terms between customers related to product sales vary by the type of customer, country of sale, and the products or services offered and could result in an unbilled receivable or deferred revenue balance depending on whether the performance obligation has been satisfied (or partially satisfied). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For product sales to distributors, the Company recognizes revenue for both equipment and disposables upon shipment to distributors, which is when its performance obligations are complete. The Company's standard contracts with its distributors state that title to the equipment passes to the distributors at point of shipment to a distributor&#8217;s location. The distributors are responsible for shipment to the end customer along with any installation, training and acceptance of the equipment by the end customer. Payments from distributors are not contingent upon resale of the product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also places equipment at customer sites. While the Company retains ownership of this equipment, the customer has the right to use it for a period of time provided they meet certain agreed to conditions. The Company recovers the cost of providing the equipment from the sale of its disposables.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Software and Other Revenues</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To a lesser extent, the Company enters into other types of contracts including certain software licensing arrangements to provide software solutions to support its plasma, blood collection and hospital customers. A portion of its software sales are perpetual licenses typically accompanied by significant implementation services related to software customization as well as other professional and technical services. The Company generally recognizes revenue from the sale of perpetual licenses and related customization services over time (the Company is creating or enhancing an asset that the customer controls) using an input method which requires it to make estimates of the extent of progress toward completion of the contract. When the Company provides other services, including in some instances hosting, technical support and maintenance, it recognizes these fees and charges over time (the customer simultaneously receives and consumes benefits), as performance obligations for these services are satisfied during the contract period. Certain of the Company&#8217;s software licensing arrangements are term-based licenses that include a per-collection or a usage-based fee related to the use of the license and the related technical support and hosting services. For these usage-based arrangements, the Company applies the revenue recognition exception resulting in revenue recognition occurring upon the later of actual usage or satisfaction of the related performance obligations. The payment terms for software licensing arrangements vary by customer pursuant to the terms set forth in the customer contract and result in an unbilled receivable or deferred revenue balance depending on whether the performance obligation has been satisfied (or partially satisfied). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Significant Judgments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price, which includes estimates of variable consideration related to rebates, product returns and volume discounts. These reserves, which are based on estimates of the amounts earned or to be claimed on the related sales, are recorded as a reduction of revenue and a current liability. The Company&#8217;s estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#8217;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract. The amount of variable consideration included in the net sales price is limited to the amount that is probable not to result in a significant reversal in the amount of the cumulative revenue recognized in a future period. Revenue recognized in the current period related to performance obligations satisfied in prior periods was not material. If the Company is unable to estimate the expected rebates reasonably, it records a liability for the maximum potential rebate or discount that could be earned. In circumstances where the Company provides upfront rebate payments to customers, it capitalizes the rebate payments and amortizes the resulting asset as a reduction of revenue using a systematic method over the life of the contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Balances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables and contract assets, as well as customer advances, customer deposits and deferred revenue (contract liabilities) on the consolidated balance sheets. The difference in timing between billing and revenue recognition primarily occurs in software licensing arrangements, resulting in contract assets and contract liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Practical Expedients</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected not to disclose the value of transaction price allocated to unsatisfied performance obligations for contracts with an original expected length of one year or less. When applicable, the Company has also elected to use the practical expedient to not adjust the promised amount of consideration for the effects of a significant financing component if it is expected, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service, will be one year or less.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Translation of Foreign Currencies</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Translation of Foreign Currencies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All assets and liabilities of foreign subsidiaries are translated at the rate of exchange at year-end while sales and expenses are translated at an average rate in effect during the year. The net effect of these translation adjustments is shown in the accompanying financial statements as a component of stockholders&#8217; equity. Foreign currency transaction gains and losses, including those resulting from intercompany transactions, are charged directly to earnings and included in other expense, net on the consolidated statements of income. The impact of foreign exchange on long-term intercompany loans, for which repayment has not been scheduled or planned, are recorded in accumulated other comprehensive loss on the consolidated balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">Cash and Cash EquivalentsCash equivalents include various instruments such as money market funds, U.S. government obligations and commercial paper with maturities of three months or less at date of acquisition. Cash and cash equivalents are recorded at cost, which approximates fair market value. As of April&#160;1, 2023, cash and cash equivalents consisted primarily of investments in United States Government Agency and institutional money market funds.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy', window );">Allowance for Credit Losses</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Credit Losses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes a specific allowance for customers when it is probable that they will not be able to meet their financial obligations. Customer accounts are reviewed individually on a regular basis and reserves are established as deemed appropriate. The Company also maintains a general reserve using a percentage that is established based upon the age of its receivables and its collection history. The Company establishes allowances for balances not yet due and past due accounts based on past experience.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value and include the cost of material, labor and manufacturing overhead. Cost is determined with the first-in, first-out method. The Company has based its provisions for excess, expired and obsolete inventory primarily on its estimates of forecasted net sales. Significant changes in the timing or level of demand for the Company&#8217;s products result in recording additional provisions for excess, expired and obsolete inventory. Additionally, uncertain timing of next-generation product approvals, variability in product launch strategies, non-cancelable purchase commitments, product recalls and variation in product utilization all affect the Company&#8217;s estimates related to excess, expired and obsolete inventory.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment is recorded at historical cost. The Company provides for depreciation and amortization by charges to operations using the straight-line method in amounts estimated to recover the cost of the building and improvements, equipment and furniture and fixtures over their estimated useful lives as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:86.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.191%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Classification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30-40 Years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-20 Years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant equipment and machinery</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-15 Years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and information technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-10 Years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Haemonetics equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-7 Years</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the depreciation periods of property, plant and equipment to determine whether events or circumstances warrant revised estimates of useful lives. All property, plant and equipment are also tested for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s installed base of devices includes devices owned by the Company and devices sold to the customer. The asset on its balance sheet classified as Haemonetics equipment consists of medical devices installed at customer sites but owned by Haemonetics. Generally, the customer has the right to use it for a period of time as long as they meet the conditions the Company has established, which among other things, generally include one or more of the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Purchase and consumption of a certain level of disposable products</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Payment of monthly rental fees </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An asset utilization performance metric, such as performing a minimum level of procedures per month per device</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the impairment tests noted below for other intangible assets subject to amortization, the Company reviews Haemonetics equipment and the related useful lives of such equipment at least once a year, or more frequently if certain conditions arise, to determine if any adverse conditions exist that would indicate the carrying value of these assets may not be recoverable. To conduct these reviews, the Company estimates the future amount and timing of demand for disposables used </span></div>with these devices, from which it generates revenues. The Company also considers product life cycle in its evaluation of useful life and recoverability. Changes in expected demand can result in additional depreciation expense, which is classified as cost of goods sold. Any significant unanticipated changes in demand could impact the value of the Company&#8217;s devices and its reported operating results.Leasehold improvements are depreciated over the lesser of their useful lives or the term of the lease. Maintenance and repairs are generally expensed to operations as incurred. When the repair or maintenance costs significantly extend the life of the asset, these costs may be capitalized. When equipment and improvements are sold or otherwise disposed of, the asset cost and accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is included in the consolidated statements of income.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess purchase price over the fair value of the net tangible and other identifiable intangible assets acquired. Goodwill is not amortized and is instead reviewed for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying value. The Company performs its annual impairment test on the first day of the fiscal fourth quarter for each of its reporting units. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC Update No. 2017-04,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">entities perform their goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit&#8217;s fair value. A reporting unit is defined as an operating segment or one level below an operating segment, referred to as a component. The Company determines its reporting units by first identifying its operating segments and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. The Company aggregates components within an operating segment that have similar economic characteristics. The Company&#8217;s reportable segments and reporting units are as follows: Plasma, Blood Center and Hospital.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When allocating goodwill from business combinations to its reporting units, the Company assigns goodwill to the reporting units that it expects to benefit from the respective business combination at the time of acquisition. In addition, for purposes of performing its goodwill impairment tests, assets and liabilities, including corporate assets, which relate to a reporting unit&#8217;s operations and would be considered in determining its fair value, are allocated to the individual reporting units. The Company allocates assets and liabilities not directly related to a specific reporting unit, but from which the reporting unit benefits, based primarily on the respective revenue contribution of each reporting unit. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the income approach, specifically the discounted cash flow method, to derive the fair value of each of its reporting units in preparing its goodwill impairment assessments. This approach calculates fair value by estimating the after-tax cash flows attributable to a reporting unit and then discounting these after-tax cash flows to a present value using a risk-adjusted discount rate. The Company selected this method as being the most meaningful in preparing its goodwill assessments because the use of the income approach typically generates a more precise measurement of fair value than the market approach.&#160;In applying the income approach to its accounting for goodwill, the Company makes assumptions about the amount and timing of future expected cash flows, terminal value growth rates and appropriate discount rates. The amount and timing of future cash flows within the Company&#8217;s discounted cash flow analysis is based on its most recent operational budgets, long range strategic plans and other estimates. The terminal value growth rate is used to calculate the value of cash flows beyond the last projected period in the Company&#8217;s discounted cash flow analysis and reflects the Company&#8217;s best estimates for stable, perpetual growth of its reporting units. The Company uses estimates of market-participant risk adjusted weighted average cost of capital as a basis for determining the discount rates to apply to its reporting units&#8217; future expected cash flows. The Company corroborated the valuations that arose from the discounted cash flow approach by performing both a market multiple valuation and by reconciling the aggregate fair value of its reporting units to its market capitalization at the time of the test.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2023, 2022 and 2021, the Company performed its annual goodwill impairment test. The results of the goodwill impairment test performed indicated that the estimated fair value of all of its reporting units exceeded their respective carrying values. There were no reporting units at risk of impairment as of the fiscal 2023, 2022 and 2021 annual test date. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews intangible assets subject to amortization for impairment at least annually or more frequently if certain conditions arise to determine if any adverse conditions exist that would indicate that the carrying value of an asset or asset group may not be recoverable, or that a change in the remaining useful life is required. Conditions indicating that an impairment exists include, but are not limited to, a change in the competitive landscape, internal decisions to pursue new or different technology strategies, a loss of a significant customer or a significant change in the marketplace including prices paid for its products or the size of the market for its products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When an impairment indicator exists, the Company tests the intangible asset for recoverability. For purposes of the recoverability test, the Company groups its amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset (asset group) exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset (asset group), the Company will write the carrying value down to the fair value in the period identified. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally calculates the fair value of its intangible assets as the present value of estimated future cash flows it expects to generate from the asset using a risk-adjusted discount rate. In determining its estimated future cash flows associated with its intangible assets, the Company uses estimates and assumptions about future revenue contributions, cost structures and remaining useful lives of the asset (asset group).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company determines the estimate of an intangible asset&#8217;s remaining useful life should be reduced based on its expected use of the asset, the remaining carrying amount of the asset is amortized prospectively over the revised estimated useful life. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has in-process research and development (&#8220;IPR&amp;D&#8221;) intangible assets with indefinite lives. IPR&amp;D assets are not amortized. The Company reviews these assets for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of the asset is less than its carrying value. The Company performs its annual impairment test on the first day of the fiscal fourth quarter for its IPR&amp;D assets. The Company makes assumptions about future cash flows, terminal value growth, costs for completion and appropriate discount rates. The Company elected qualitative assessments in fiscal 2023 and 2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy', window );">Accounting for the Costs of Computer Software to be Sold, Leased, or Otherwise Marketed</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for the Costs of Computer Software to be Sold, Leased, or Otherwise Marketed</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 985-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software - Costs of Software to be Sold, Leased or Marketed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, specifies that costs incurred internally in researching and developing a computer software product should be charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs should be capitalized until the product is available for general release to customers, at which point capitalized costs are amortized over their estimated useful life of 5 to 10 years. Technological feasibility is established when it has a detailed design of the software and when research and development activities on the underlying device, if applicable, are completed. The Company capitalizes costs associated with both software that it sells as a separate product and software that is embedded in a device.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the net realizable value of capitalized assets periodically to assess the recoverability of amounts capitalized. There were no impairment charges recorded during fiscal 2023, 2022 and 2021. In the future, the net realizable value may be adversely affected by the loss of a significant customer or a significant change in the market place, which could result in an impairment being recorded.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text">Research and Development ExpensesAll research and development costs are expensed as incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text">Advertising CostsAll advertising costs are expensed as incurred and are included in selling, general and administrative expenses in the consolidated statements of income.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Shipping and Handling Costs</a></td>
<td class="text">Shipping and Handling CostsShipping and handling costs are included in selling, general and administrative expenses.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision is calculated for all jurisdictions in which the Company operates. The income tax provision process involves calculating current taxes due and assessing temporary differences arising from items that are taxable or deductible in different periods for tax and accounting purposes and are recorded as deferred tax assets and liabilities. Deferred tax assets are evaluated for realizability and a valuation allowance is maintained for the portion of the Company&#8217;s deferred tax assets that are not more-likely-than-not realizable. All available evidence, both positive and negative, has been considered to determine whether, based on the weight of that evidence, a valuation allowance is needed against the deferred tax assets. Refer to Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information and discussion of the Company&#8217;s income tax provision and balances.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in all jurisdictions in which it operates. The Company records a liability for uncertain tax positions taken or expected to be taken in income tax returns. The Company&#8217;s financial statements reflect expected future tax consequences of such positions presuming the taxing authorities&#8217; full knowledge of the position and all relevant facts. The Company records a liability for the portion of unrecognized tax benefits claimed that it has determined are not more-likely-than-not realizable. These tax reserves have been established based on management&#8217;s assessment as to the potential exposure attributable to the Company&#8217;s uncertain tax positions as well as interest and penalties attributable to these uncertain tax positions. All tax reserves are analyzed quarterly and adjustments are made as events occur that result in changes in judgment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates at the end of each reporting period whether some or all of the undistributed earnings of its foreign subsidiaries are permanently reinvested. The Company recognizes deferred income tax liabilities to the extent that management asserts that undistributed earnings of its foreign subsidiaries are not permanently reinvested or will not be permanently reinvested in the future. The Company&#8217;s position is based upon several factors including management&#8217;s evaluation of the Haemonetics and its subsidiaries&#8217; financial requirements, the short-term and long-term operational and fiscal objectives of the Company and the tax consequences associated with the repatriation of earnings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt, Policy</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to April 4, 2021, the Company accounted for convertible senior notes as separate liability and equity components, determining the fair value of the respective liability components based on an estimate of the fair value of a similar liability without a conversion option and assigning the residual value to the equity component.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective April 4, 2021, the Company accounted for convertible senior notes as a single liability measured at its amortized cost. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. At issuance, the carrying amount is calculated as the proceeds, net of initial debt issuance costs. The difference between the principal amount and carrying value is amortized to interest expense over the term of the convertible senior notes using the effective interest rate method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A detailed analysis of the terms of the convertible senior notes transactions is required to determine existence of any derivatives that may require separate mark-to-market accounting under applicable accounting guidance.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its derivative financial instruments in accordance with ASC Topic 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 815&#8221;) and ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 820&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for the change in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative as a hedging instrument for accounting purposes and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. In addition, ASC 815 provides that, for derivative instruments that qualify for hedge accounting, changes in the fair value are either (a)&#160;offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings or (b)&#160;recognized in equity until the hedged item is recognized in earnings, depending on whether the derivative is being used to hedge changes in fair value or cash flows. The ineffective portion of a derivative&#8217;s change in fair value is immediately recognized in earnings. The Company does not use derivative financial instruments for trading or speculation purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the underlying hedged transaction affects earnings, the gains or losses on the forward foreign exchange rate contracts designated as hedges are recorded in net revenues, cost of goods sold, operating expenses and other expense, net in the Company&#8217;s consolidated statements of income, depending on the nature of the underlying hedged transactions. The cash flows related to the gains and losses are classified in the consolidated statements of cash flows as part of cash flows from operating activities. For those derivative instruments that are not designated as part of a hedging relationship the Company records the gains or losses in earnings currently. These gains and losses are intended to offset the gains and losses recorded on net monetary assets or liabilities that are denominated in foreign currencies. The Company recorded foreign currency losses of $1.0 million, $1.5 million and $0.7 million in fiscal 2023, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a quarterly basis, the Company assesses whether the cash flow hedges are highly effective in offsetting changes in the cash flow of the hedged item. The Company manages the credit risk of its counterparties by dealing only with institutions that it considers financially sound and considers the risk of non-performance to be remote. Additionally, the Company&#8217;s interest rate risk management strategy includes the use of interest rate swaps to mitigate its exposure to changes in variable interest rates. The Company&#8217;s objective in using interest rate swaps is to add stability to interest expense and to manage and reduce the risk inherent in interest rate fluctuations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s derivative instruments do not subject its earnings or cash flows to material risk, as gains and losses on these derivatives are intended to offset losses and gains on the item being hedged. The Company does not enter into derivative transactions for speculative purposes and it does not have any non-derivative instruments that are designated as hedging instruments pursuant to ASC 815.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expenses the fair value of share-based awards granted to employees, board members and others, net of estimated forfeitures. To calculate the grant-date fair value of its stock options the Company uses the Black-Scholes option-pricing model and for performance share units it uses Monte Carlo simulation models.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Costs Associated with Exit Activities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Costs Associated with Exit Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records employee termination costs in accordance with ASC Topic 712</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Compensation - Nonretirement and Postemployment Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if it pays the benefits as part of an on-going benefit arrangement, which includes benefits provided as part of its established severance policies or that it provides in accordance with international statutory requirements. The Company accrues employee termination costs associated with an on-going benefit arrangement if the obligation is attributable to prior services rendered, the rights to the benefits have vested, the payment is probable and the liability can be reasonably estimated. The Company accounts for employee termination benefits that represent a one-time benefit in accordance with ASC Topic 420</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Exit or Disposal Cost Obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. It records such costs into expense over the employee&#8217;s future service period, if any.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other costs associated with exit activities may include contract termination costs, including costs related to leased facilities to be abandoned or subleased, consultant fees and impairments of long-lived assets. The costs are expensed in accordance with ASC Topic 420 and ASC Topic 360</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Property, Plant and Equipment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and are included primarily in selling, general and administrative costs in its consolidated statement of income. Additionally, costs directly related to the Company&#8217;s active restructuring initiatives, including program management costs, accelerated depreciation and costs to transfer product lines </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">among facilities are included within costs of goods sold and selling, general and administrative costs in its consolidated statement of income. Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information and discussion of its restructuring plans.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Valuation of Acquisitions</a></td>
<td class="text">Valuation of AcquisitionsThe Company allocates the amounts it pays for each acquisition to the assets acquired and liabilities assumed based on their estimated fair values at the dates of acquisition, including acquired identifiable intangible assets. The Company bases the estimated fair value of identifiable intangible assets on detailed valuations that use significant assumptions including forecasted cash flows, revenues attributable to existing technology and existing customer attrition. When estimating the significant assumptions to be used in the valuation, the Company includes a consideration of current industry information, market and economic trends, historical results of the acquired business, and other relevant factors. These significant assumptions are forward-looking and could be affected by future economic and market conditions. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Strategic Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds strategic investments, including preferred stock and a special share, in a privately held entity. The special share allows the Company to acquire the entity in accordance with an agreement between the parties. As these equity instruments do not have readily determinable fair values, they have been measured using the measurement alternative, at cost less impairment. The carrying amount for these instruments would be subsequently adjusted for observable price changes, or prices in orderly transactions for an identical investment or similar investment of the same issuer. In addition, these investments are periodically evaluated for impairment. The investments are classified as other long-term assets on the Company&#8217;s Consolidated Balance Sheets and the Company has not recorded any adjustments to the carrying value of strategic investments in fiscal 2023.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and Significant Customers</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Significant Customers</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents and accounts receivable. In fiscal 2023, 2022 and 2021, the Company&#8217;s ten largest customers accounted for approximately 48%, 45% and 49% of net revenues, respectively. In fiscal 2023, one Plasma customer, CSL Limited (together with its affiliates, &#8220;CSL&#8221;) was greater than 10% of total net revenues and in total accounted for approximately 14% of net revenues. In addition to CSL, two customers also accounted for greater than 10% of the Plasma segment&#8217;s net revenues and one customer also accounted for greater than 10% of the Blood Center segment&#8217;s net revenues, but did not exceed 10% of total net revenues, in fiscal 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain other markets and industries can expose the Company to concentrations of credit risk. For example, in the Plasma business unit, sales are concentrated with several large customers. As a result, accounts receivable extended to any one of these biopharmaceutical customers can be significant at any point in time. Also, a portion of the Company&#8217;s trade accounts receivable outside the U.S. include sales to government-owned or supported healthcare systems in several countries, which are subject to payment delays. Payment is dependent upon the financial stability and creditworthiness of those countries&#8217; national economies. The Company has not incurred significant losses on government receivables. The Company continually evaluates all government receivables for potential collection risks associated with the availability of government funding and reimbursement practices. If the financial condition of customers or the countries&#8217; healthcare systems deteriorate such that their ability to make payments is uncertain, allowances may be required in future periods.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Standards Implemented</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Codification (&#8220;ASC&#8221;) Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326). ASC Update No. 2016-13 is intended to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information, including forecasted information, to develop credit loss estimates. The Company adopted ASC Update No. 2016-13 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company&#8217;s consolidated financial statements. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASC Update No. 2018-15, Intangibles, Goodwill and Other - Internal-Use Software (Subtopic 350-40). The new guidance aligns the accounting implementation costs incurred in a cloud computing arrangement that is a service contract with the accounting for internal-use software licenses. The Company adopted ASC Update No. 2018-15 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Securities and Exchange Commission (&#8220;SEC&#8221;) issued a final rule that amends the financial statement requirements for acquisitions and dispositions of businesses. The amendments primarily relate to disclosures required by Rule 3-05 and Article 11 of Regulation S-X and modifies the tests provided in Rule 1-02(w) of Regulation S-X used to determine whether a subsidiary or an acquired or disposed business is significant and modifies the number of years of audited financial statements required for acquisitions with significance levels greater than specified percentages. The Company early adopted these amendments during the fourth quarter of fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Codification (&#8220;ASC&#8221;) Update No. 2019-12 &#8212; Income Taxes (Topic 740). The new guidance improves consistent application of and simplifies the accounting for income taxes by removing certain exceptions to the general principals in Topic 740. The Company adopted ASC Update No. 2019-12 effective April 4, 2021. The adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASC ASU Update No. 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). The amendments simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company early adopted ASC Update No. 2020-06 effective April 4, 2021 using the modified retrospective method, which resulted in a decrease of $61.2&#160;million to additional paid-in capital, a decrease to non-current deferred tax liabilities of $20.0&#160;million, and an increase of $80.3&#160;million to non-current convertible notes, net, on the consolidated balance sheets. Additionally, retained earnings was adjusted to remove amortization expense recognized in prior periods related to the debt discount and the convertible notes no longer have a debt discount that will be amortized, net of taxes. The impact to retained earnings on the consolidated balance sheets as of April 4, 2021 is an increase of $1.0&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the FASB issued ASC Update No. 2021-05 &#8212; Leases (Topic 842). The new guidance requires a lessor to classify a lease with variable lease payments that do not depend on an index or rate as an operating lease at lease commencement if the lease would have been classified as a sales-type lease or a direct financing lease in accordance with the classification criteria of ASC 842 and the lessor would have otherwise recognized a day-one loss. The Company prospectively adopted ASC Update No. 2021-05 effective in the second quarter of fiscal year 2022. The adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the estimated allowance for doubtful accounts for premium amounts due from policyholders, insureds, and other insurance entities. May include factors that management considered, such as historical loss experience and current economic and competitive conditions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6933075&amp;loc=SL5748726-161290<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred to (1) establish the technological feasibility of a computer software product to be sold, leased, or otherwise marketed; and (2) produce product masters after establishing technological feasibility. This accounting policy also may apply to purchased computer software. This policy also may address the entity's amortization policy for its capitalized computer software costs and how it evaluates such capitalized costs for impairment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098169664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock', window );">Schedule of Property, Plant and Equipment Estimated Useful Lives</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment is recorded at historical cost. The Company provides for depreciation and amortization by charges to operations using the straight-line method in amounts estimated to recover the cost of the building and improvements, equipment and furniture and fixtures over their estimated useful lives as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:86.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.191%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Classification</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30-40 Years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-20 Years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant equipment and machinery</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-15 Years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and information technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-10 Years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Haemonetics equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-7 Years</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Other Accrued Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities represent items payable or expected to settle within the next twelve months. The items included in the fiscal year end balances were:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,809&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">111,628</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">121,207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/></tr></table></div>Other Long-Term LiabilitiesOther long-term liabilities represent items that are not payable or expected to settle within the next twelve months.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Property, Plant and Equipment, Estimated Useful Lives [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597101756976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring and Transformation Costs by Type of Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for restructuring reserves related to the 2020 Program and prior programs for the fiscal years ended April&#160;1, 2023, April&#160;2, 2022 and April&#160;3, 2021, substantially all of which relates to employee severance and other employee costs:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 Program</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior Programs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 28, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred, net of reversals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,062)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,018)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,080)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 3, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred, net of reversals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,317)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,437)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 2, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred, net of reversals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 1, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,810&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the restructuring costs by line item during fiscal 2023, 2022 and 2021 within our accompanying consolidated statements of income and comprehensive income: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs by Segment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the restructuring related costs by line item during fiscal 2023, 2022 and 2021 within our accompanying consolidated statements of income and comprehensive income: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,991&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,892&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,594&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present restructuring and restructuring related costs by reportable segment:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring related costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,906&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,594&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total restructuring and restructuring related costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,549</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,824</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,661</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597103797760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts represent the fair value of the identifiable assets acquired and liabilities assumed for Cardiva:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">534,240</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91,971</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">442,269</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets acquired consist of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk-Adjusted Discount<br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">250,560</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts represent the fair value of the identifiable assets acquired and liabilities assumed for enicor completed during fiscal 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.182%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 1, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,851</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,325</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,526</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets acquired consist of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.063%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk-Adjusted Discount<br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 Years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,090</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:86.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) (Unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916,601&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597100214256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule Domestic and Foreign Income Before Provision for Income Tax</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Domestic and foreign income before provision (benefit) for income tax is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,657&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,219)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,746&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,848&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,387&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">141,403</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63,629</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Income Tax Provision Components</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision (benefit) from continuing operations contains the following components:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,906)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,678)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,436)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(843)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,777&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,842)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,002</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,556)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Net Deferred Tax Asset</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax effected, significant temporary differences comprising the net deferred tax liability are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals, reserves and other deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carry-forward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carry-forward, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized research expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,838)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,077)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets (after valuation allowance)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of goodwill and intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,752)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,004)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unremitted earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,877)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,942)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,477)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,505)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30,954)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24,259)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.102%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,408)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,799)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,049)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes net of federal benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(924)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low taxed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(828)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(758)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unremitted earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred statutory rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation shortfalls (benefits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,073)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,496)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany sale of intellectual property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,550)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax provision (benefit)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,002</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,556)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Summary of Gross Unrecognized Tax Benefits</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to its gross unrecognized tax benefits for the fiscal years ended April&#160;1, 2023, April&#160;2, 2022 and April&#160;3, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 3,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions of tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements of tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,579)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,941</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,939</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,107</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098208352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share Reconciliation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,401&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,375&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic income per share</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.85</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.57</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,401&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,375&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted income per share</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.84</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.55</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098197264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value and include the cost of material, labor and manufacturing overhead. Cost is determined with the first-in, first-out method. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,016&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,572&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,187&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">259,379</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">293,027</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Prior year raw materials and finished goods balances have been adjusted to conform with current year presentation.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098237056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consisted of the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and building improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant equipment and machinery</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and information technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Haemonetics equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(633,330)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(610,665)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">310,885</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">258,482</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597097488112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:48.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Plasma</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Blood Center</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hospital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount as of April 3, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,043&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(865)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount as of April 2, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,043&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,166&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404,078&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467,287&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(745)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,056)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying amount as of April 1, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29,043</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,855</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">403,333</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">466,231</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Amoritized Intangibles</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of intangible assets and the related accumulated amortization as of April&#160;1, 2023 and April&#160;2, 2022 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.784%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of April 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts and related relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">672,720</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">417,422</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">255,298</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-amortizable:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process software development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,473</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.784%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of April 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts and related relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">667,603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">376,552</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">291,051</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-amortizable:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process software development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,210</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Future Amortization Expense</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future annual amortization expense on intangible assets is estimated to be as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:83.504%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.563%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,590&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093046640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AssetsandLiabilitiesLesseeTableTextBlock', window );">Assets and Liabilities Lessee [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental balance sheet information related to the Company&#8217;s operating leases:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.806%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMC0xLTEtNzAzMzQ_34cb8f69-e36e-4863-9363-93e365f18a37"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMC0xLTEtNzAzMzQ_4c4b5b40-680d-44df-9a35-0e7bc64d7233"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,749&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMC0xLTEtNzAzMzQ_71a2b58f-3dab-4c09-b137-6558f9c15c80"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMC0xLTEtNzAzMzQ_993d52dc-b21b-4c73-bea1-865c14747532"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current liabilities</span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMC0xLTEtNzAzMzQ_64ce6304-0097-4fab-b514-f225878a9f4b"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMC0xLTEtNzAzMzQ_aece9495-28e3-4cad-8c7d-78640888fb76"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term liabilities</span></span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_LesseeOperatingLeasesOtherInformationTableTextBlock', window );">Lessee, Operating Leases, Other Information [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and discount rate information related to our operating leases:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.806%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 years</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information related to our operating leases:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:69.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 3, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used for operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,014&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,456&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturities of our operating lease liabilities as of&#160;April&#160;1, 2023:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:83.877%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,007&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,073&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,646&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum operating lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77,630</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,565)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_AssetsandLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets and Liabilities Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_AssetsandLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_LesseeOperatingLeasesOtherInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Leases, Other Information [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_LesseeOperatingLeasesOtherInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098910432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND LONG-TERM DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Notes Payable and Long-Term Debt</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes payable and long-term debt consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, net of financing fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,784)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">754,102</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">559,441</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Notes Payable and Long-Term Debt Maturities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate amount of debt maturing during the next five fiscal years are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:88.358%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.442%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal year</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098945296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock', window );">Schedule of Interest Rate Derivatives</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company held the following interest rate swaps as of April&#160;1, 2023:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"/><td style="width:21.634%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.643%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Original Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount as of April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value Assets (Liabilities)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/28/2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/30/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.67%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/28/2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/30/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/23/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/30/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.44%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/23/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/30/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.46%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/23/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.08%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-month USD Term SOFR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/23/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/15/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(585)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509,514&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,126&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of the allowance for credit losses:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.016%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 3, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,475</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,226</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,824</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Credit (gain) loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,623&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(991)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Write-offs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,932</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,475</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,226</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of the Company&#8217;s derivative instruments designated as cash flow hedges and those not designated as hedging instruments under ASC 815 in its consolidated statements of income and comprehensive income for the fiscal year ended April 1, 2023.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:31.696%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.055%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Instruments  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain Recognized in Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Consolidated Statements of Income and Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain Excluded from<br/>Effectiveness<br/>Testing</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Consolidated Statements of Income and Comprehensive Income</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues, COGS and SG&amp;A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Fair Value of Derivative Instruments as They Appear in Consolidated Balance Sheets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of the Company&#8217;s derivative instruments as they appear in its consolidated balance sheets as of April&#160;1, 2023 and April&#160;2, 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:47.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.680%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location in<br/>Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,813</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,889</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,894</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and financial liabilities measured at fair value on a recurring basis consist of the following as of April&#160;1, 2023 and April&#160;2, 2022.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.601%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 1, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">132,341</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,813</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">135,154</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,889</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">863</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,752</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97,425</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100,657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,894</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,675</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,569</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The recurring level 3 fair value measurements of contingent consideration liabilities include the following significant unobservable inputs:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:21.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technique</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue-based payments</span></td><td colspan="3" style="padding:0 1pt"/><td rowspan="2" style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5%</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>A reconciliation of the change in the fair value of contingent consideration is included in the following table:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">863</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098945296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Components of Net Periodic Benefit Costs of Defined Benefit Pension Plans</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s foreign subsidiaries have defined benefit pension plans covering substantially all full time employees at those subsidiaries. Net periodic benefit costs for the plans in the aggregate include the following components:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized prior service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,191</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,698</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,070</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetFundedStatusTableTextBlock', window );">Schedule of Activity Under Defined Benefit Plans</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity under those defined benefit plans are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in Benefit Obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,410)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,453)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee and plan participants contribution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,599)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,093)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit obligation, end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(25,465)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30,410)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in Plan Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(593)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(719)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee and plan participants contribution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of plan assets, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,463</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,447</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded Status</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,002)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,963)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized net actuarial gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,757)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,099)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net amount recognized</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11,892)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14,298)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Substantially all of the unfunded status is non-current</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the change recorded in the Company&#8217;s accumulated other comprehensive loss related to its defined benefit plans, net of tax, are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 28, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of April 3, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(560)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of April 2, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of April 1, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,075</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of Weighted Average Rates Used to Determine Net Periodic Benefit Costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average rates used to determine the net periodic benefit costs and projected benefit obligations were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increased salary levels</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.94&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Estimated Future Benefit Payments</a></td>
<td class="text">Estimated future benefit payments are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2029-2033</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetFundedStatusTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of net funded status of pension plans and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetFundedStatusTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098973632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation cost related to share-based transactions is recognized in the consolidated financial statements based on fair</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">value. The total amount of share-based compensation expense, which is recorded on a straight line basis, is as follows:</span></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21,903</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20,694</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22,888</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,583</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24,359</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,516</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Summary of Stock Option Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity for the fiscal year ended April&#160;1, 2023 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price<br/>per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Life (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>($000&#8217;s)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at April 2, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.79</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,972)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,150,194</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64.21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.55</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27,481</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested or expected to vest at April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Utilized for Estimating Fair Value of Option Grants</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions utilized for option grants during the periods presented are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value per Option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.53</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of Assumptions Used, Other than Options</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average rates used to determine the net periodic benefit costs and projected benefit obligations were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increased salary levels</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.94&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Summary of Restricted Stock Units Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU activity for the fiscal year ended April&#160;1, 2023 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.543%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at April 2, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,536&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,045)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,360)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">381,308</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63.94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of RSUs granted and total fair value of RSUs vested are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value per RSU</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.96&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of RSUs vested</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock', window );">Schedule of Performance Share Unit awards</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of PSU activity for the fiscal year ended April&#160;1, 2023 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.543%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at April 2, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,810)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at April 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">323,987</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Includes the adjustment of 62,577 shares for awards granted in fiscal 2020, based on actual relative total shareholder return of 0%</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of shares purchased under the Employee Stock Purchase Plan are estimated using the Black-Scholes single option-pricing model with the following weighted average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (months)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend Yield</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Equity Other Than Options, Valuation Assumptions</a></td>
<td class="text">The assumptions used in the Monte Carlo model for PSUs granted during each fiscal year were as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peer group stock price volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Correlation of returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of PSUs granted and total fair value of PSUs vested are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:59.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant-date fair value per PSU</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.96&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of PSUs vested</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Share-based Payment Award, Equity Other Than Options, Valuation Assumptions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding performance-based awards that are fully vested and expected to vest. Includes, but is not limited to, unvested awards for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597097529056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Selected Information by Business Segment</a></td>
<td class="text"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues by business unit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168,060&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,824)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,605)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,168,660</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">993,196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">870,463</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Reflects revenue for service, maintenance and parts.</span></div></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565,103&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449,605&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Corporate expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(355,089)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(281,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256,751)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Effect of exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,414)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,830)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of assets and PCS2 related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,732)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration and transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,604)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and restructuring related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,824)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,661)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digital transformation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,536)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDR and IVDR costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,033)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,130)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,368)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(897)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on divestitures and sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">156,033</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80,750</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89,747</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.</span></div></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:59.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total depreciation and amortization (excluding impairment charges)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93,307</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97,747</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">84,287</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">310,885</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">258,482</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Long-lived assets are comprised of property, plant and equipment.</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected information by operating regions is presented below:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 1,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 2,<br/>2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">310,885</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">258,482</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Long-lived assets are comprised of property, plant and equipment.</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,168,660</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">993,196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">870,463</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Schedule of Revenues by Product Line</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues by product line are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:61.972%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.716%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.716%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.720%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma products and services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563,734&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414,266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center products and services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital products and services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,168,660</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">993,196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">870,463</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098137584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 01, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll-forward of the components of accumulated other comprehensive loss, net of tax, for the years ended April&#160;1, 2023 and April&#160;2, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:46.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined benefit plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Unrealized Gain (Loss) on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, April 3, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,528)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(560)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,459)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,547)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,391)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive gain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,391)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,805&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, April 2, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,919)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,954)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,016)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive gain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,016)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(867)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,427)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, April 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(33,935)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,075</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(521)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30,381)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Presented net of income taxes, the amounts of which are insignificant.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597090509056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
<th class="th"><div>Apr. 04, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems', window );"><strong>Summary of Significant Accounting Pronouncements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration', window );">Optional exemption term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_MaximumTermOfMaturitiesForCashAndCashEquivalents', window );">Cash and cash equivalents maximum maturity period</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareImpairments1', window );">Impairment charges related to the discontinuance of certain capitalized software projects</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="nump">30,209,000<span></span>
</td>
<td class="nump">26,809,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent consideration</a></td>
<td class="nump">863,000<span></span>
</td>
<td class="nump">31,184,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">All other</a></td>
<td class="nump">80,556,000<span></span>
</td>
<td class="nump">63,214,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">111,628,000<span></span>
</td>
<td class="nump">121,207,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense</a></td>
<td class="nump">7,200,000<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency losses</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Gain (Loss) on Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="num">(817,997,000)<span></span>
</td>
<td class="num">(749,424,000)<span></span>
</td>
<td class="num">(731,670,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (587,109,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred Income Tax Liabilities, Net</a></td>
<td class="num">(36,195,000)<span></span>
</td>
<td class="num">(28,727,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="num">(594,706,000)<span></span>
</td>
<td class="num">(572,476,000)<span></span>
</td>
<td class="num">(602,727,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(553,229,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="num">$ (253,168,000)<span></span>
</td>
<td class="num">$ (202,391,000)<span></span>
</td>
<td class="num">$ (157,981,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (78,512,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems', window );"><strong>Summary of Significant Accounting Pronouncements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SoftwareCapitalizationTerm', window );">Software capitalization term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems', window );"><strong>Summary of Significant Accounting Pronouncements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SoftwareCapitalizationTerm', window );">Software capitalization term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems', window );"><strong>Summary of Significant Accounting Pronouncements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems', window );"><strong>Summary of Significant Accounting Pronouncements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems', window );"><strong>Summary of Significant Accounting Pronouncements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems', window );"><strong>Summary of Significant Accounting Pronouncements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Plant equipment and machinery | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems', window );"><strong>Summary of Significant Accounting Pronouncements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Plant equipment and machinery | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems', window );"><strong>Summary of Significant Accounting Pronouncements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_OfficeEquipmentAndInformationTechnologyMember', window );">Office equipment and information technology | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems', window );"><strong>Summary of Significant Accounting Pronouncements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_OfficeEquipmentAndInformationTechnologyMember', window );">Office equipment and information technology | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems', window );"><strong>Summary of Significant Accounting Pronouncements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_HaemoneticsEquipmentMember', window );">Haemonetics equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems', window );"><strong>Summary of Significant Accounting Pronouncements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_HaemoneticsEquipmentMember', window );">Haemonetics equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems', window );"><strong>Summary of Significant Accounting Pronouncements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Net Revenues | Customer Concentration Risk | Ten Largest Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems', window );"><strong>Summary of Significant Accounting Pronouncements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Net Revenues | Customer Concentration Risk | Plasma Customer, CSL Limited (CSL) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems', window );"><strong>Summary of Significant Accounting Pronouncements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred Income Tax Liabilities, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Convertible Notes Payable, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06 | Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06 | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_MaximumTermOfMaturitiesForCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum Term of Maturities for Cash and Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_MaximumTermOfMaturitiesForCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_SoftwareCapitalizationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Software Capitalization Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_SoftwareCapitalizationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_SummaryOfSignificantAccountingPronouncementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of Significant Accounting Pronouncements [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_SummaryOfSignificantAccountingPronouncementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareImpairments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareImpairments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining duration of performance obligation for which optional exemption was applied not to disclose amount of transaction price allocated to and timing of revenue recognition for remaining performance obligation, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_OfficeEquipmentAndInformationTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_OfficeEquipmentAndInformationTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_HaemoneticsEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_HaemoneticsEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hae_TenLargestCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hae_TenLargestCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hae_PlasmaCustomerCSLLimitedCSLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hae_PlasmaCustomerCSLLimitedCSLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597097331504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_RestructuringandRestructuringRelatedCosts', window );">Total restructuring and restructuring related costs</a></td>
<td class="nump">$ 11,549<span></span>
</td>
<td class="nump">$ 28,824<span></span>
</td>
<td class="nump">$ 15,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="nump">67,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring liability</a></td>
<td class="nump">2,150<span></span>
</td>
<td class="nump">2,805<span></span>
</td>
<td class="nump">1,012<span></span>
</td>
<td class="nump">$ 2,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_RestructuringChargesPayableInNextTwelveMonths', window );">Restructuring Charges Payable In Next Twelve Months</a></td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_RestructuringRelatedCosts', window );">Restructuring related costs</a></td>
<td class="nump">10,892<span></span>
</td>
<td class="nump">24,594<span></span>
</td>
<td class="nump">14,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember', window );">2020 Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring liability</a></td>
<td class="nump">1,810<span></span>
</td>
<td class="nump">2,460<span></span>
</td>
<td class="nump">575<span></span>
</td>
<td class="nump">$ 1,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring costs</a></td>
<td class="nump">$ 11,500<span></span>
</td>
<td class="nump">$ 28,700<span></span>
</td>
<td class="nump">$ 15,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | 2020 Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | 2020 Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_RestructuringChargesPayableInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges Payable In Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_RestructuringChargesPayableInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_RestructuringRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Related Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_RestructuringRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_RestructuringandRestructuringRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Restructuring Related Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_RestructuringandRestructuringRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093811840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING (Schedule of Restructuring Reserve by Type of Cost) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">$ 2,805<span></span>
</td>
<td class="nump">$ 1,012<span></span>
</td>
<td class="nump">$ 2,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Cost Incurred</a></td>
<td class="nump">657<span></span>
</td>
<td class="nump">4,230<span></span>
</td>
<td class="nump">1,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(1,312)<span></span>
</td>
<td class="num">(2,437)<span></span>
</td>
<td class="num">(3,080)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">2,150<span></span>
</td>
<td class="nump">2,805<span></span>
</td>
<td class="nump">1,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_RestructuringRelatedCosts', window );">Restructuring related costs</a></td>
<td class="nump">10,892<span></span>
</td>
<td class="nump">24,594<span></span>
</td>
<td class="nump">14,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_RestructuringandRestructuringRelatedCosts', window );">Total restructuring and restructuring related costs</a></td>
<td class="nump">11,549<span></span>
</td>
<td class="nump">28,824<span></span>
</td>
<td class="nump">15,661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember', window );">Plasma products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Cost Incurred</a></td>
<td class="num">(48)<span></span>
</td>
<td class="nump">2,492<span></span>
</td>
<td class="nump">454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_RestructuringRelatedCosts', window );">Restructuring related costs</a></td>
<td class="nump">1,385<span></span>
</td>
<td class="nump">7,906<span></span>
</td>
<td class="nump">1,870<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember', window );">Blood Center products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Cost Incurred</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="nump">201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_RestructuringRelatedCosts', window );">Restructuring related costs</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">556<span></span>
</td>
<td class="nump">1,599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember', window );">Hospital products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Cost Incurred</a></td>
<td class="nump">165<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_RestructuringRelatedCosts', window );">Restructuring related costs</a></td>
<td class="nump">546<span></span>
</td>
<td class="nump">379<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Cost Incurred</a></td>
<td class="nump">540<span></span>
</td>
<td class="nump">1,849<span></span>
</td>
<td class="nump">467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_RestructuringRelatedCosts', window );">Restructuring related costs</a></td>
<td class="nump">8,886<span></span>
</td>
<td class="nump">15,753<span></span>
</td>
<td class="nump">10,734<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember', window );">2020 Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">2,460<span></span>
</td>
<td class="nump">575<span></span>
</td>
<td class="nump">1,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Cost Incurred</a></td>
<td class="nump">576<span></span>
</td>
<td class="nump">4,202<span></span>
</td>
<td class="nump">1,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(1,226)<span></span>
</td>
<td class="num">(2,317)<span></span>
</td>
<td class="num">(2,062)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">1,810<span></span>
</td>
<td class="nump">2,460<span></span>
</td>
<td class="nump">575<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=hae_PriorRestructuringProgramsMember', window );">Prior Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">345<span></span>
</td>
<td class="nump">437<span></span>
</td>
<td class="nump">1,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Cost Incurred</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(86)<span></span>
</td>
<td class="num">(120)<span></span>
</td>
<td class="num">(1,018)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">340<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="nump">437<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Goods Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Cost Incurred</a></td>
<td class="num">(215)<span></span>
</td>
<td class="nump">2,236<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_RestructuringRelatedCosts', window );">Restructuring related costs</a></td>
<td class="nump">7,991<span></span>
</td>
<td class="nump">17,832<span></span>
</td>
<td class="nump">9,318<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Cost Incurred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_RestructuringRelatedCosts', window );">Restructuring related costs</a></td>
<td class="nump">1,050<span></span>
</td>
<td class="nump">714<span></span>
</td>
<td class="nump">1,026<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Cost Incurred</a></td>
<td class="nump">872<span></span>
</td>
<td class="nump">1,889<span></span>
</td>
<td class="nump">912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_RestructuringRelatedCosts', window );">Restructuring related costs</a></td>
<td class="nump">$ 1,851<span></span>
</td>
<td class="nump">$ 6,048<span></span>
</td>
<td class="nump">$ 3,873<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_RestructuringRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Related Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_RestructuringRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_RestructuringandRestructuringRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Restructuring Related Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_RestructuringandRestructuringRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=hae_PriorRestructuringProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=hae_PriorRestructuringProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597092406624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
<th class="th"><div>Jan. 13, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,850<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="nump">$ 434,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Term loan borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 466,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 466,444<span></span>
</td>
<td class="nump">466,231<span></span>
</td>
<td class="nump">467,287<span></span>
</td>
<td class="nump">466,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=hae_HASIntellectualPropertyMember', window );">HAS Intellectual Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AssetAcquisitionMilestonePayment', window );">Asset Acquisition, Milestone Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=hae_EnicorMember', window );">Enicor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AssetAcquisitionMilestonePayment', window );">Asset Acquisition, Milestone Payment</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember', window );">Cardiva Medical, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business Acquisition, Percentage of Voting Interests Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 489,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">465,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">418,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Term loan borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">916,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Business Acquisition, Pro Forma Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed', window );">Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember', window );">Cardiva Medical, Inc. | Selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business Combination, Acquisition Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember', window );">Cardiva Medical, Inc. | Other Nonoperating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business Combination, Acquisition Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember', window );">Enicor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business Combination, Acquisition Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate', window );">Risk-Adjusted Discount Rates used in Purchase Price Allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_HASIntellectualPropertyMember', window );">HAS Intellectual Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired Intangible Assets, Risk-Adjusted Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_AssetAcquisitionMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_AssetAcquisitionMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs which have been expensed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=hae_HASIntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=hae_HASIntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=hae_EnicorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=hae_EnicorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hae_EnicorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hae_HASIntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hae_HASIntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093649936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS - Purchase Price Allocation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 466,231<span></span>
</td>
<td class="nump">$ 467,287<span></span>
</td>
<td class="nump">$ 466,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember', window );">Cardiva Medical, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">534,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts', window );">Accrued payroll and related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 442,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember', window );">Enicor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">685<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,153<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,036<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,526<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Payroll and Related Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hae_EnicorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597091337136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS - Intangible Assets Acquired (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember', window );">Cardiva Medical, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="nump">$ 250,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember', window );">Cardiva Medical, Inc. | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Indefinite lived intangibles acquired</a></td>
<td class="nump">$ 13,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate', window );">Risk-Adjusted Discount Rates used in Purchase Price Allocation</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember', window );">Cardiva Medical, Inc. | Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="nump">$ 213,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Amortization Period</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate', window );">Risk-Adjusted Discount Rates used in Purchase Price Allocation</a></td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember', window );">Cardiva Medical, Inc. | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="nump">$ 18,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Amortization Period</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate', window );">Risk-Adjusted Discount Rates used in Purchase Price Allocation</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember', window );">Cardiva Medical, Inc. | Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="nump">$ 5,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Amortization Period</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate', window );">Risk-Adjusted Discount Rates used in Purchase Price Allocation</a></td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember', window );">Enicor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate', window );">Risk-Adjusted Discount Rates used in Purchase Price Allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember', window );">Enicor | Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate', window );">Risk-Adjusted Discount Rates used in Purchase Price Allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember', window );">Enicor | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate', window );">Risk-Adjusted Discount Rates used in Purchase Price Allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember', window );">Enicor | Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate', window );">Risk-Adjusted Discount Rates used in Purchase Price Allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired Intangible Assets, Risk-Adjusted Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hae_EnicorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098718672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STRATEGIC INVESTMENTS (Details) - 12 months ended Apr. 01, 2023<br> &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>USD ($)</div></th>
<th class="th"><div>EUR (&#8364;)</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Gain (Loss) on Investments | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hae_VivasureMedicalLTDMember', window );">Vivasure Medical LTD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 30,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hae_VivasureMedicalLTDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hae_VivasureMedicalLTDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093503248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 18, 2020</div></th>
<th class="th"><div>Jul. 01, 2020</div></th>
<th class="th"><div>Jun. 29, 2020</div></th>
<th class="th"><div>Oct. 01, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="nump">$ 10,642<span></span>
</td>
<td class="nump">$ 44,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">607<span></span>
</td>
<td class="nump">7,953<span></span>
</td>
<td class="nump">21,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">466,231<span></span>
</td>
<td class="nump">467,287<span></span>
</td>
<td class="nump">466,444<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_FajardoPuertoRicoManufacturingOperationsMember', window );">Fajardo, Puerto Rico Manufacturing Operations | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from Divestiture of Businesses, Net of Cash Divested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments', window );">Disposal Group, Not Discontinued Operations, Incremental Loss On Closing Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell', window );">Disposal Group, Not Discontinued Operations, Expected Cost To Sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Disposal Group, Including Discontinued Operation, Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Disposal Group, Including Discontinued Operation, Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Disposal Group, Including Discontinued Operation, Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_USBloodDonorManagementSoftwareMember', window );">U.S. Blood Donor Management Software | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Disposal Group, Including Discontinued Operation, Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments', window );">Proceeds From Divesture Of Business Net Of Working Capital Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Disposal Group, Including Discontinued Operation, Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (Loss) on Disposition of Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 9,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Disposal Group, Including Discontinued Operation, Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived', window );">Proceeds From Divesture of Business, Contingent Consideration Received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_InlogHoldingsFranceMember', window );">Inlog Holdings France | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures</a></td>
<td class="nump">$ 30,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from Divestiture of Businesses, Net of Cash Divested</a></td>
<td class="nump">24,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</a></td>
<td class="nump">2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Disposal Group, Including Discontinued Operation, Intangible Assets</a></td>
<td class="nump">2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (Loss) on Disposition of Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Disposal Group, Including Discontinued Operation, Other Assets</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Disposal Group, Including Discontinued Operation, Liabilities</a></td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Disposal Group, Including Discontinued Operation, Goodwill</a></td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operations, Expected Cost To Sell</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operations, Incremental Loss On Closing Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Divesture of Business, Contingent Consideration Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Divesture Of Business Net Of Working Capital Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_FajardoPuertoRicoManufacturingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_FajardoPuertoRicoManufacturingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_USBloodDonorManagementSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_USBloodDonorManagementSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_InlogHoldingsFranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_InlogHoldingsFranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597091123920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
<th class="th"><div>Jan. 17, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foregin source income</a></td>
<td class="nump">$ 55,746<span></span>
</td>
<td class="nump">$ 68,848<span></span>
</td>
<td class="nump">$ 67,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">5,135<span></span>
</td>
<td class="num">(254)<span></span>
</td>
<td class="nump">3,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</a></td>
<td class="nump">2,073<span></span>
</td>
<td class="nump">1,496<span></span>
</td>
<td class="nump">$ 1,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Unremitted earnings</a></td>
<td class="nump">1,163<span></span>
</td>
<td class="nump">1,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carry-forward, net</a></td>
<td class="nump">5,072<span></span>
</td>
<td class="nump">$ 6,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed foreign earnings of subsidiaries</a></td>
<td class="nump">$ 72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal statutory income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount', window );">Unremitted earnings</a></td>
<td class="num">$ (91)<span></span>
</td>
<td class="nump">$ 194<span></span>
</td>
<td class="nump">$ 257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (benefit) for income taxes</a></td>
<td class="nump">26,002<span></span>
</td>
<td class="nump">20,254<span></span>
</td>
<td class="num">(6,556)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">3,941<span></span>
</td>
<td class="nump">3,939<span></span>
</td>
<td class="nump">6,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that will impact effective tax rate</a></td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="nump">5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit', window );">Unrecognized tax positions possible change in the next twelve months</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Unrecognized tax benefits increases</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Accrued interest and penalties</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense', window );">Income Tax Examination, Penalties and Interest Included in Income Tax Expense</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</a></td>
<td class="nump">5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry-forwards</a></td>
<td class="nump">64,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carry-forwards subject to expiration</a></td>
<td class="nump">8,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carry-forwards not subject to expiration</a></td>
<td class="nump">56,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority | Cardiva Medical, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Operating Carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tax Credit, Research</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry-forwards</a></td>
<td class="nump">75,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carry-forwards subject to expiration</a></td>
<td class="nump">62,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carry-forwards not subject to expiration</a></td>
<td class="nump">13,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</a></td>
<td class="nump">5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction | Cardiva Medical, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Operating Carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tax Credit, Research</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry-forwards</a></td>
<td class="nump">10,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carry-forwards subject to expiration</a></td>
<td class="nump">6,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carry-forwards not subject to expiration</a></td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_MY', window );">Malaysia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_TaxHolidayTerm', window );">Tax grant or holiday term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Operating Carryforwards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tax Credit, Research</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Unremitted Earnings, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Penalties and Interest Included in Income Tax Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_TaxHolidayTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Holiday Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_TaxHolidayTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123452999&amp;loc=d3e28200-109314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hae_CardivaMedicalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_MY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_MY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597100261072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule Domestic and Foreign Income Before Provision for Income Tax) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="nump">$ 85,657<span></span>
</td>
<td class="num">$ (5,219)<span></span>
</td>
<td class="nump">$ 5,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">55,746<span></span>
</td>
<td class="nump">68,848<span></span>
</td>
<td class="nump">67,387<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision (benefit) for income taxes</a></td>
<td class="nump">$ 141,403<span></span>
</td>
<td class="nump">$ 63,629<span></span>
</td>
<td class="nump">$ 72,913<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597097546560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Income Tax Provision Components) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 6,461<span></span>
</td>
<td class="nump">$ 3,586<span></span>
</td>
<td class="num">$ (289)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">4,824<span></span>
</td>
<td class="nump">1,682<span></span>
</td>
<td class="nump">1,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">8,940<span></span>
</td>
<td class="nump">9,940<span></span>
</td>
<td class="nump">13,319<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">20,225<span></span>
</td>
<td class="nump">15,208<span></span>
</td>
<td class="nump">14,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">14,298<span></span>
</td>
<td class="nump">3,455<span></span>
</td>
<td class="num">(12,906)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(7,678)<span></span>
</td>
<td class="nump">310<span></span>
</td>
<td class="num">(2,436)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(843)<span></span>
</td>
<td class="nump">1,281<span></span>
</td>
<td class="num">(5,500)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="nump">5,777<span></span>
</td>
<td class="nump">5,046<span></span>
</td>
<td class="num">(20,842)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (benefit)</a></td>
<td class="nump">$ 26,002<span></span>
</td>
<td class="nump">$ 20,254<span></span>
</td>
<td class="num">$ (6,556)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093362512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Net Deferred Tax Asset) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DeferredTaxAssetsDepreciation', window );">Depreciation</a></td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">$ 623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DeferredTaxAssetsAmortization', window );">Amortization of intangibles</a></td>
<td class="nump">1,013<span></span>
</td>
<td class="nump">1,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory</a></td>
<td class="nump">7,674<span></span>
</td>
<td class="nump">6,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accruals, reserves and other deferred tax assets</a></td>
<td class="nump">15,680<span></span>
</td>
<td class="nump">13,020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carry-forward</a></td>
<td class="nump">20,996<span></span>
</td>
<td class="nump">30,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock based compensation</a></td>
<td class="nump">4,230<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DeferredTaxAssetsOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">15,851<span></span>
</td>
<td class="nump">15,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carry-forward, net</a></td>
<td class="nump">5,072<span></span>
</td>
<td class="nump">6,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DeferredTaxAssetsResearchExpensesCapitalized', window );">Deferred Tax Assets, Research Expenses Capitalized</a></td>
<td class="nump">19,671<span></span>
</td>
<td class="nump">6,733<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">90,361<span></span>
</td>
<td class="nump">85,323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowance</a></td>
<td class="num">(8,838)<span></span>
</td>
<td class="num">(14,077)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Total deferred tax assets (after valuation allowance)</a></td>
<td class="nump">81,523<span></span>
</td>
<td class="nump">71,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DeferredTaxLiabilitiesDepreciation', window );">Depreciation</a></td>
<td class="num">(37,400)<span></span>
</td>
<td class="num">(15,727)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DeferredTaxLiabilitiesAmortization', window );">Amortization of goodwill and intangibles</a></td>
<td class="num">(57,752)<span></span>
</td>
<td class="num">(63,004)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Unremitted earnings</a></td>
<td class="num">(1,163)<span></span>
</td>
<td class="num">(1,254)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset', window );">Operating lease assets</a></td>
<td class="num">(13,220)<span></span>
</td>
<td class="num">(12,877)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other deferred tax liabilities</a></td>
<td class="num">(2,942)<span></span>
</td>
<td class="num">(2,643)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(112,477)<span></span>
</td>
<td class="num">(95,505)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">$ (30,954)<span></span>
</td>
<td class="num">$ (24,259)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DeferredTaxAssetsAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DeferredTaxAssetsAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DeferredTaxAssetsDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Depreciation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DeferredTaxAssetsDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DeferredTaxAssetsOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DeferredTaxAssetsOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DeferredTaxAssetsResearchExpensesCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Research Expenses Capitalized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DeferredTaxAssetsResearchExpensesCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DeferredTaxLiabilitiesAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DeferredTaxLiabilitiesAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DeferredTaxLiabilitiesDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Depreciation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DeferredTaxLiabilitiesDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Operating Lease, Right of Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597096740512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Effective Income Tax Rate Reconciliation) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Tax at federal statutory rate</a></td>
<td class="nump">$ 29,695<span></span>
</td>
<td class="nump">$ 13,362<span></span>
</td>
<td class="nump">$ 15,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax at federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Impact of foreign operations</a></td>
<td class="num">$ (2,408)<span></span>
</td>
<td class="num">$ (3,799)<span></span>
</td>
<td class="num">$ (7,049)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Impact of foreign operations</a></td>
<td class="num">(1.70%)<span></span>
</td>
<td class="num">(6.00%)<span></span>
</td>
<td class="num">(9.70%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes net of federal benefit</a></td>
<td class="nump">$ 2,939<span></span>
</td>
<td class="nump">$ 1,384<span></span>
</td>
<td class="num">$ (924)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes net of federal benefit</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
<td class="num">(1.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_IncomeTaxReconciliationChangeinUncertainTaxPositions', window );">Change in uncertain tax positions</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="num">$ (777)<span></span>
</td>
<td class="nump">$ 1,172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions', window );">Change in uncertain tax positions</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount', window );">Global intangible low taxed income</a></td>
<td class="num">$ (828)<span></span>
</td>
<td class="nump">$ 3,608<span></span>
</td>
<td class="num">$ (758)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent', window );">Global intangible low taxed income</a></td>
<td class="num">(0.60%)<span></span>
</td>
<td class="nump">5.70%<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount', window );">Unremitted earnings</a></td>
<td class="num">$ (91)<span></span>
</td>
<td class="nump">$ 194<span></span>
</td>
<td class="nump">$ 257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent', window );">Unremitted earnings</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Deferred statutory rate changes</a></td>
<td class="nump">$ 82<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="num">$ (243)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Deferred statutory rate changes</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Non-deductible executive compensation</a></td>
<td class="nump">$ 1,439<span></span>
</td>
<td class="nump">$ 1,080<span></span>
</td>
<td class="nump">$ 2,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Non-deductible executive compensation</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Non-deductible expenses</a></td>
<td class="nump">$ 827<span></span>
</td>
<td class="nump">$ 741<span></span>
</td>
<td class="nump">$ 2,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Non-deductible expenses</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock compensation shortfalls (benefits)</a></td>
<td class="nump">$ 1,883<span></span>
</td>
<td class="nump">$ 2,070<span></span>
</td>
<td class="num">$ (5,504)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock compensation shortfalls (benefits)</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="num">(7.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research credits</a></td>
<td class="num">$ (2,073)<span></span>
</td>
<td class="num">$ (1,496)<span></span>
</td>
<td class="num">$ (1,230)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research credits</a></td>
<td class="num">(1.50%)<span></span>
</td>
<td class="num">(2.40%)<span></span>
</td>
<td class="num">(1.70%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount', window );">Contingent consideration</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,880<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent', window );">Contingent consideration</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty', window );">Intercompany sale of intellectual property</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (7,550)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent', window );">Intercompany sale of intellectual property</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(10.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">$ (5,135)<span></span>
</td>
<td class="nump">$ 254<span></span>
</td>
<td class="num">$ (3,144)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(3.60%)<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="num">(4.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other, net</a></td>
<td class="num">$ (409)<span></span>
</td>
<td class="nump">$ 1,713<span></span>
</td>
<td class="num">$ (1,171)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (benefit)</a></td>
<td class="nump">$ 26,002<span></span>
</td>
<td class="nump">$ 20,254<span></span>
</td>
<td class="num">$ (6,556)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax provision (benefit)</a></td>
<td class="nump">18.40%<span></span>
</td>
<td class="nump">31.80%<span></span>
</td>
<td class="num">(9.00%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Change in Uncertain Tax Positions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Contingent Consideration Liability, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Contingent Consideration Liability, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Global Intangible Low Taxed Income, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Global Intangible Low Taxes Income, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Intercompany Sale of Intellectual Property</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Intercompany Sale of Intellectual Property, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Unremitted Earnings, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Unremitted Earnings, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_IncomeTaxReconciliationChangeinUncertainTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Reconciliation, Change in Uncertain Tax Positions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_IncomeTaxReconciliationChangeinUncertainTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093377008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Summary of Gross Unrecognized Tax Benefits) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning Balance</a></td>
<td class="nump">$ 3,939<span></span>
</td>
<td class="nump">$ 6,107<span></span>
</td>
<td class="nump">$ 4,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions for tax positions of current year</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions of prior years</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions', window );">Reductions of tax positions</a></td>
<td class="num">(290)<span></span>
</td>
<td class="num">(808)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,579<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending Balance</a></td>
<td class="nump">$ 3,941<span></span>
</td>
<td class="nump">$ 3,939<span></span>
</td>
<td class="nump">$ 6,107<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597100613408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Schedule of Earnings Per Share Reconciliation) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic EPS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 115,401<span></span>
</td>
<td class="nump">$ 43,375<span></span>
</td>
<td class="nump">$ 79,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares (in shares)</a></td>
<td class="nump">50,783<span></span>
</td>
<td class="nump">51,047<span></span>
</td>
<td class="nump">50,688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic income per share (in dollars per share)</a></td>
<td class="nump">$ 2.27<span></span>
</td>
<td class="nump">$ 0.85<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted EPS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 115,401<span></span>
</td>
<td class="nump">$ 43,375<span></span>
</td>
<td class="nump">$ 79,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares (in shares)</a></td>
<td class="nump">50,783<span></span>
</td>
<td class="nump">51,047<span></span>
</td>
<td class="nump">50,688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Net effect of common stock equivalents (in shares)</a></td>
<td class="nump">637<span></span>
</td>
<td class="nump">306<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares (in shares)</a></td>
<td class="nump">51,420<span></span>
</td>
<td class="nump">51,353<span></span>
</td>
<td class="nump">51,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted income per share (in dollars per share)</a></td>
<td class="nump">$ 2.24<span></span>
</td>
<td class="nump">$ 0.84<span></span>
</td>
<td class="nump">$ 1.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares (in shares)</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597101748688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Share Repurchase Plan) (Details) - 2022 Share Repurchase Program - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 04, 2022</div></th>
<th class="th"><div>Nov. 04, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Aug. 16, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated Share Repurchases, Settlement (Payment) or Receipt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare', window );">Repurchase price (in dollars per share)</a></td>
<td class="nump">$ 75.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock Repurchase Program, Remaining Authorized Repurchase Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Stock Repurchase Program, Period in Force</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=hae_A2022AcceleratedShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=hae_A2022AcceleratedShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093602848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligation amount</a></td>
<td class="nump">$ 24.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration', window );">Optional exemption term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Performance obligation percent</a></td>
<td class="nump">77.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">$ 30.2<span></span>
</td>
<td class="nump">$ 26.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 24.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining duration of performance obligation for which optional exemption was applied not to disclose amount of transaction price allocated to and timing of revenue recognition for remaining performance obligation, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597104051408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUE Performance Obligations (Details)<br></strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-04-03', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-03</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Timing of satisifaction</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-04-03">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-04-03</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093614320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Schedule of Inventories) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 115,016<span></span>
</td>
<td class="nump">$ 77,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">12,572<span></span>
</td>
<td class="nump">17,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">131,791<span></span>
</td>
<td class="nump">197,994<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 259,379<span></span>
</td>
<td class="nump">$ 293,027<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093338400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 944,215<span></span>
</td>
<td class="nump">$ 869,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(633,330)<span></span>
</td>
<td class="num">(610,665)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">310,885<span></span>
</td>
<td class="nump">258,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">51,200<span></span>
</td>
<td class="nump">44,400<span></span>
</td>
<td class="nump">$ 43,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=hae_AssetImpairmentsMember', window );">Asset Impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
<td class="nump">$ 20,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=hae_AssetImpairmentsMember', window );">Asset Impairments | 2020 Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">5,358<span></span>
</td>
<td class="nump">5,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and building improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">127,634<span></span>
</td>
<td class="nump">104,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Plant equipment and machinery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">194,539<span></span>
</td>
<td class="nump">180,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_OfficeEquipmentAndInformationTechnologyMember', window );">Office equipment and information technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">123,611<span></span>
</td>
<td class="nump">120,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_HaemoneticsEquipmentMember', window );">Haemonetics equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">463,706<span></span>
</td>
<td class="nump">405,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 29,367<span></span>
</td>
<td class="nump">$ 53,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=hae_AssetImpairmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=hae_AssetImpairmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_OfficeEquipmentAndInformationTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_OfficeEquipmentAndInformationTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_HaemoneticsEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_HaemoneticsEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093439632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Aggregate amortization expense</a></td>
<td class="nump">$ 42.1<span></span>
</td>
<td class="nump">$ 56.6<span></span>
</td>
<td class="nump">$ 41.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopSoftware', window );">Software development costs capitalized</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Capitalized costs amortized (placed into service)</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">$ 7.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers', window );">Total costs capitalized related to in process software development initiatives</a></td>
<td class="nump">$ 82.8<span></span>
</td>
<td class="nump">79.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Software Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers', window );">Total costs capitalized related to in process software development initiatives</a></td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unamortized costs incurred for development of computer software, which is to be sold, leased or otherwise marketed, after establishing technological feasibility through to the general release of the software products. Excludes capitalized costs of developing software for internal use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597091330144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS Schedule of Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, carrying amount</a></td>
<td class="nump">$ 467,287<span></span>
</td>
<td class="nump">$ 466,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="num">(1,056)<span></span>
</td>
<td class="num">(1,227)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, carrying amount</a></td>
<td class="nump">466,231<span></span>
</td>
<td class="nump">467,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">672,720<span></span>
</td>
<td class="nump">667,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, accumulated amortization</a></td>
<td class="nump">417,422<span></span>
</td>
<td class="nump">376,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">255,298<span></span>
</td>
<td class="nump">291,051<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Non-amortizable intangibles</a></td>
<td class="nump">20,473<span></span>
</td>
<td class="nump">19,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember', window );">Plasma products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, carrying amount</a></td>
<td class="nump">29,043<span></span>
</td>
<td class="nump">29,043<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, carrying amount</a></td>
<td class="nump">29,043<span></span>
</td>
<td class="nump">29,043<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember', window );">Blood Center products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, carrying amount</a></td>
<td class="nump">34,166<span></span>
</td>
<td class="nump">34,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="num">(311)<span></span>
</td>
<td class="num">(362)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, carrying amount</a></td>
<td class="nump">33,855<span></span>
</td>
<td class="nump">34,166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember', window );">Hospital products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, carrying amount</a></td>
<td class="nump">404,078<span></span>
</td>
<td class="nump">402,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="num">(745)<span></span>
</td>
<td class="num">(865)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, carrying amount</a></td>
<td class="nump">$ 403,333<span></span>
</td>
<td class="nump">$ 404,078<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597094323872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Non-amortizable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Non-amortizable intangibles</a></td>
<td class="nump">$ 20,473<span></span>
</td>
<td class="nump">$ 19,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Amortizable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">672,720<span></span>
</td>
<td class="nump">667,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">417,422<span></span>
</td>
<td class="nump">376,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">255,298<span></span>
</td>
<td class="nump">291,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Fiscal 2024</a></td>
<td class="nump">35,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Fiscal 2025</a></td>
<td class="nump">28,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Fiscal 2026</a></td>
<td class="nump">22,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Fiscal 2027</a></td>
<td class="nump">20,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Fiscal 2028</a></td>
<td class="nump">19,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">42,100<span></span>
</td>
<td class="nump">56,600<span></span>
</td>
<td class="nump">$ 41,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=hae_InProcessSoftwareDevelopmentMember', window );">In-process software development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Non-amortizable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Non-amortizable intangibles</a></td>
<td class="nump">3,841<span></span>
</td>
<td class="nump">2,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Non-amortizable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Non-amortizable intangibles</a></td>
<td class="nump">13,667<span></span>
</td>
<td class="nump">13,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=hae_InProcessPatentsMember', window );">In-process patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Non-amortizable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Non-amortizable intangibles</a></td>
<td class="nump">2,965<span></span>
</td>
<td class="nump">2,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Amortizable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">18,504<span></span>
</td>
<td class="nump">14,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">10,831<span></span>
</td>
<td class="nump">9,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">7,673<span></span>
</td>
<td class="nump">4,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Capitalized software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Amortizable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">78,962<span></span>
</td>
<td class="nump">76,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">60,776<span></span>
</td>
<td class="nump">52,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">18,186<span></span>
</td>
<td class="nump">24,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hae_OtherTechnologyMember', window );">Other developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Amortizable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">362,506<span></span>
</td>
<td class="nump">362,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">153,099<span></span>
</td>
<td class="nump">124,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">209,407<span></span>
</td>
<td class="nump">237,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Customer contracts and related relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Amortizable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">203,240<span></span>
</td>
<td class="nump">204,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">187,774<span></span>
</td>
<td class="nump">185,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">15,466<span></span>
</td>
<td class="nump">19,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Amortizable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">9,508<span></span>
</td>
<td class="nump">9,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">4,942<span></span>
</td>
<td class="nump">4,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 4,566<span></span>
</td>
<td class="nump">$ 4,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=hae_InProcessSoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=hae_InProcessSoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=hae_InProcessPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=hae_InProcessPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hae_OtherTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hae_OtherTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597092437296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
<th class="th"><div>Jan. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, Operating Lease, Renewal Term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">$ 53,413<span></span>
</td>
<td class="nump">$ 52,749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="nump">63,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">7,162<span></span>
</td>
<td class="nump">7,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 55,903<span></span>
</td>
<td class="nump">$ 55,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">4.95%<span></span>
</td>
<td class="nump">4.58%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">$ 10,600<span></span>
</td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="nump">$ 11,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="nump">11,450<span></span>
</td>
<td class="nump">11,014<span></span>
</td>
<td class="nump">10,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</a></td>
<td class="nump">211<span></span>
</td>
<td class="nump">587<span></span>
</td>
<td class="nump">29,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">310,885<span></span>
</td>
<td class="nump">$ 258,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months</a></td>
<td class="nump">9,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Lessee, Operating Lease, Liability, Payments, Due Year Two</a></td>
<td class="nump">9,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Lessee, Operating Lease, Liability, Payments, Due Year Three</a></td>
<td class="nump">8,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Lessee, Operating Lease, Liability, Payments, Due Year Four</a></td>
<td class="nump">9,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due Year Five</a></td>
<td class="nump">7,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due after Year Five</a></td>
<td class="nump">33,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Lessee, Operating Lease, Liability, Payments, Due</a></td>
<td class="nump">77,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</a></td>
<td class="num">$ (14,565)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other long-term assets<span></span>
</td>
<td class="text">Other long-term assets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales', window );">Operating lease revenue as a percentage of net sales (as a percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_ManufacturingSpaceMember', window );">Manufacturing Space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years 6 months 30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, Operating Lease, Renewal Term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_ManufacturingSpaceSecondRenewalTermMember', window );">Manufacturing Space, Second Renewal Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, Operating Lease, Renewal Term</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Revenue, As A Percentage Of Total Net Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_ManufacturingSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_ManufacturingSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_ManufacturingSpaceSecondRenewalTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_ManufacturingSpaceSecondRenewalTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597094077424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND LONG-TERM DEBT (Schedule of Notes Payable and Long-Term Debt) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 26, 2022</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11,784,000)<span></span>
</td>
<td class="num">$ (214,148,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">754,102,000<span></span>
</td>
<td class="nump">559,441,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,276,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=hae_TermLoanNetofFinancingFeesMember', window );">Term loan, net of financing fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273,728,000<span></span>
</td>
<td class="nump">284,052,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=hae_BankLoansandOtherBorrowingMember', window );">Bank loans and other borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">492,131,000<span></span>
</td>
<td class="nump">$ 489,462,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revised Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="nump">$ 280,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne', window );">Debt Instrument, Percent of Principal Amount Due In Year One</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity', window );">Debt Instrument, Percent Of Principal Amount Due After Year One Per Year Until Maturity</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Interest costs capitalized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revised Credit Agreement | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revised Credit Agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DebtInstrumentInterestRateFloor', window );">Debt Instrument, Interest Rate, Floor</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revised Credit Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revised Credit Agreement | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="nump">$ 420,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Interest costs capitalized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revised Credit Agreement | Revolving Credit Facility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Commitment fee</a></td>
<td class="nump">0.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revised Credit Agreement | Revolving Credit Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Commitment fee</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Commitment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.175%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Commitment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Commitment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DebtInstrumentInterestRateFloor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Rate, Floor</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DebtInstrumentInterestRateFloor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Percent Of Principal Amount Due After Year One Per Year Until Maturity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Percent of Principal Amount Due In Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=hae_TermLoanNetofFinancingFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=hae_TermLoanNetofFinancingFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=hae_BankLoansandOtherBorrowingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=hae_BankLoansandOtherBorrowingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hae_RevisedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hae_RevisedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597092554336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND LONG-TERM DEBT (Narrative) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 15, 2018</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="nump">$ 9,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice', window );">Debt Instrument, Convertible, Capped Call Transaction, Initial Strike Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice', window );">Debt Instrument, Convertible, Capped Call Transaction, Initial Cap Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares', window );">Debt Instrument, Convertible, Capped Call Transaction, Anti-Dilution Adjustment, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DebtInstrumentConvertibleCappedCallTransactionAmount', window );">Debt Instrument, Convertible, Capped Call Transaction, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 486,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice', window );">Debt Instrument, Redemption Price, Percentage of Previous Closing Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DebtInstrumentConvertibleComponentConversionPrice', window );">Debt Instrument, Convertible, Conversion Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.7033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt Instrument, Convertible, Conversion Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">492,131,000<span></span>
</td>
<td class="nump">489,462,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible notes | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible notes | Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 274,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=hae_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_ConsolidatedTotalLeverageRatio', window );">Consolidated total leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_ConsolidatedInterestCoverageRatio', window );">Consolidated interest coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Commitment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.175%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Commitment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Commitment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | LIBOR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=hae_TermLoanNetofFinancingFeesMember', window );">Term loan, net of financing fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 273,728,000<span></span>
</td>
<td class="nump">$ 284,052,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_ConsolidatedInterestCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consolidated Interest Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_ConsolidatedInterestCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_ConsolidatedTotalLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consolidated Total Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_ConsolidatedTotalLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DebtInstrumentConvertibleCappedCallTransactionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Capped Call Transaction, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DebtInstrumentConvertibleCappedCallTransactionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Capped Call Transaction, Anti-Dilution Adjustment, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Capped Call Transaction, Initial Cap Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Capped Call Transaction, Initial Strike Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DebtInstrumentConvertibleComponentConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible Component, Conversion Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DebtInstrumentConvertibleComponentConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption Price, Percentage of Previous Closing Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=hae_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=hae_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=hae_TermLoanNetofFinancingFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=hae_TermLoanNetofFinancingFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098965584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTES PAYABLE AND LONG-TERM DEBT (Schedule of Notes Payable and Long-Term Debt Maturities) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 12,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">10,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">752,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2028</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597088410848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 15, 2023</div></th>
<th class="th"><div>Jul. 26, 2022</div></th>
<th class="th">
<div>Jun. 15, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>unit</div>
</th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 02, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 03, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 23, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>USD ($) </div>
<div>swap</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on cash flow hedges, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,269,000<span></span>
</td>
<td class="nump">$ 5,785,000<span></span>
</td>
<td class="num">$ (489,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember', window );">Enicor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | LIBOR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) One-Month USD Term Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) One-Month USD Term Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) One-Month USD Term Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_PercentageOfNetSalesGeneratedOutsideOfUs', window );">Percentage of sales generated outside the US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1', window );">Maturity period for foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 412,126,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 509,514,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_NumberOfInterestRateSwapsEntered', window );">Number Of Interest Rate Swaps Entered | unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DerivativeBlendedFixedInterestRate', window );">Derivative, Blended Fixed Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DerivativePercentageOfNotionalValueOfDebt', window );">Derivative, Percentage Of Notional Value Of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DerivativeBlendedFixedInterestRate', window );">Derivative, Blended Fixed Interest Rate</a></td>
<td class="nump">4.12%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DerivativePercentageOfNotionalValueOfDebt', window );">Derivative, Percentage Of Notional Value Of Debt</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Number of instruments held | swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 241,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Interest Rate Swap | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DerivativePercentofDebtExposed', window );">Debt exposed to interest rate risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet', window );">Designated foreign currency hedge contracts outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,800,000<span></span>
</td>
<td class="nump">67,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Net revenues, COGS and SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on cash flow hedges, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,828,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest Rate Swap | Net revenues, COGS and SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on cash flow hedges, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest Rate Swap | Interest and other expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on cash flow hedges, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,441,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet', window );">Non-designated foreign currency hedge contracts outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,700,000<span></span>
</td>
<td class="nump">39,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on cash flow hedges, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,752,000<span></span>
</td>
<td class="nump">35,569,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">863,000<span></span>
</td>
<td class="nump">33,675,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Contingent Consideration, Acquisition Date Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(504,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Contingent Consideration, Increase (Decrease) in Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,293,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_ContingentConsiderationForeignCurrencyTranslationAdjustment', window );">Contingent Consideration, Foreign Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,889,000<span></span>
</td>
<td class="nump">1,894,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Designated as Hedging Instrument | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">56,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Designated as Hedging Instrument | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,807,000<span></span>
</td>
<td class="nump">1,813,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Not Designated as Hedging Instrument | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,889,000<span></span>
</td>
<td class="nump">1,894,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Level 2 | Designated as Hedging Instrument | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_ContingentConsiderationForeignCurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Foreign Currency Translation Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_ContingentConsiderationForeignCurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DerivativeBlendedFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Blended Fixed Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DerivativeBlendedFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DerivativePercentageOfNotionalValueOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Percentage Of Notional Value Of Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DerivativePercentageOfNotionalValueOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DerivativePercentofDebtExposed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Percent of Debt Exposed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DerivativePercentofDebtExposed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_NumberOfInterestRateSwapsEntered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Interest Rate Swaps Entered</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_NumberOfInterestRateSwapsEntered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_PercentageOfNetSalesGeneratedOutsideOfUs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Net Sales Generated Outside Of The US</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_PercentageOfNetSalesGeneratedOutsideOfUs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average period remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular group held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(b),(c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivatives not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=117331979&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hae_EnicorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=hae_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=hae_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hae_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hae_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093515664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Interest Rate Swaps) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>unit</div>
</th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 23, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap267FixedInterestRateMember', window );">Interest Rate Swap, 2.67% Fixed Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, Fair Value, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap276FixedInterestRateMember', window );">Interest Rate Swap, 2.76% Fixed Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, Fair Value, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap444FixedInterestRateMember', window );">Interest Rate Swap, 4.44% Fixed Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,663<span></span>
</td>
<td class="nump">$ 23,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, Fair Value, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap446FixedInterestRateMember', window );">Interest Rate Swap, 4.46% Fixed Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,663<span></span>
</td>
<td class="nump">23,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.46%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, Fair Value, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap408FixedInterestRateMember', window );">Interest Rate Swap, 4.08% Fixed Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,900<span></span>
</td>
<td class="nump">109,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, Fair Value, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (464)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap415FixedInterestRateMember', window );">Interest Rate Swap, 4.15% Fixed Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,900<span></span>
</td>
<td class="nump">109,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, Fair Value, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (585)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412,126<span></span>
</td>
<td class="nump">$ 509,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, Fair Value, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (696)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_NumberOfInterestRateSwapsEntered', window );">Number Of Interest Rate Swaps Entered | unit</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_NumberOfInterestRateSwapsEntered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Interest Rate Swaps Entered</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_NumberOfInterestRateSwapsEntered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap267FixedInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap267FixedInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap276FixedInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap276FixedInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap444FixedInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap444FixedInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap446FixedInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap446FixedInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap408FixedInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap408FixedInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap415FixedInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hae_InterestRateSwap415FixedInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098916768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Allowance for credit losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning balance</a></td>
<td class="nump">$ 2,475<span></span>
</td>
<td class="nump">$ 2,226<span></span>
</td>
<td class="nump">$ 3,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Credit (gain) loss</a></td>
<td class="nump">2,623<span></span>
</td>
<td class="nump">359<span></span>
</td>
<td class="num">(991)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-offs</a></td>
<td class="num">(166)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="num">(607)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending balance</a></td>
<td class="nump">$ 4,932<span></span>
</td>
<td class="nump">$ 2,475<span></span>
</td>
<td class="nump">$ 2,226<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597092404800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on cash flow hedges, net of tax</a></td>
<td class="nump">$ 4,269<span></span>
</td>
<td class="nump">$ 5,785<span></span>
</td>
<td class="num">$ (489)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Net revenues, COGS and SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on cash flow hedges, net of tax</a></td>
<td class="nump">2,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings</a></td>
<td class="nump">6,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Interest and other expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet', window );">Amount of Gain Excluded from Effectiveness Testing</a></td>
<td class="nump">983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet', window );">Amount of Gain Excluded from Effectiveness Testing</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest Rate Swap | Net revenues, COGS and SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on cash flow hedges, net of tax</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest Rate Swap | Interest and other expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on cash flow hedges, net of tax</a></td>
<td class="nump">1,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings</a></td>
<td class="num">(1,119)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on cash flow hedges, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign Exchange Contract | Interest and other expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet', window );">Amount of Gain Excluded from Effectiveness Testing</a></td>
<td class="nump">$ 923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net gain (loss) relating to components of the gain (loss) on the fair value hedging instrument excluded from the assessment of fair value hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=hae_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=hae_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597087284544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedules of Derivatives) (Details) - Fair Value, Measurements, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">$ 132,341<span></span>
</td>
<td class="nump">$ 97,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets fair value</a></td>
<td class="nump">135,154<span></span>
</td>
<td class="nump">100,657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">2,752<span></span>
</td>
<td class="nump">35,569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">132,341<span></span>
</td>
<td class="nump">97,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets fair value</a></td>
<td class="nump">132,341<span></span>
</td>
<td class="nump">97,425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets fair value</a></td>
<td class="nump">2,813<span></span>
</td>
<td class="nump">3,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">1,889<span></span>
</td>
<td class="nump">1,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">863<span></span>
</td>
<td class="nump">33,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">2,813<span></span>
</td>
<td class="nump">3,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">1,889<span></span>
</td>
<td class="nump">1,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">1,401<span></span>
</td>
<td class="nump">3,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Designated as Hedging Instrument | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">302<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Not Designated as Hedging Instrument | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Assets | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Assets | Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">1,401<span></span>
</td>
<td class="nump">3,133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Assets | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Assets | Not Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">302<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Liabilities | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Liabilities | Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Liabilities | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Liabilities | Not Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Interest Rate Swap | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">1,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">1,807<span></span>
</td>
<td class="nump">1,813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Interest Rate Swap | Designated as Hedging Instrument | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Interest Rate Swap | Other Current Assets | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Interest Rate Swap | Other Current Assets | Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">1,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Interest Rate Swap | Other Current Liabilities | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Interest Rate Swap | Other Current Liabilities | Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Interest Rate Swap | Other Noncurrent Liabilities | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Interest Rate Swap | Other Noncurrent Liabilities | Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">1,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">863<span></span>
</td>
<td class="nump">33,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Contingent Consideration | Revenue-based payments | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">$ 863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative fixed interest rate</a></td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Contingent Consideration | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">$ 863<span></span>
</td>
<td class="nump">$ 33,675<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hae_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hae_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=hae_RevenueBasedPayments2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=hae_RevenueBasedPayments2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597101744624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany', window );">Benefit obligation, plan funded by company</a></td>
<td class="nump">$ 7,500,000<span></span>
</td>
<td class="nump">$ 9,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DefinedBenefitPlanReinsuranceContractsAssetValue', window );">Reinsurance contracts asset value</a></td>
<td class="nump">7,100,000<span></span>
</td>
<td class="nump">6,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">25,200,000<span></span>
</td>
<td class="nump">28,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear', window );">Amount expected to be amortized from accumulated other comprehensive loss in next fiscal year</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember', window );">Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Company contributions</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=hae_SavingsPlusPlanMember', window );">Savings Plus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Company contributions</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">6,300,000<span></span>
</td>
<td class="nump">4,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=hae_A401kPlanMember', window );">401k Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Company contributions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Plan Funded by Company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DefinedBenefitPlanReinsuranceContractsAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Reinsurance Contracts Asset Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DefinedBenefitPlanReinsuranceContractsAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost (credit) included in accumulated other comprehensive (income) loss expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (s)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=hae_SavingsPlusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=hae_SavingsPlusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=hae_A401kPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=hae_A401kPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093813536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS (Schedule of Components of Net Periodic Benefit Costs of Defined Benefit Pension Plans) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 1,453<span></span>
</td>
<td class="nump">$ 1,714<span></span>
</td>
<td class="nump">$ 1,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on benefit obligation</a></td>
<td class="nump">$ 409<span></span>
</td>
<td class="nump">$ 242<span></span>
</td>
<td class="nump">$ 279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag', window );">DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</a></td>
<td class="text">Expected return on plan assets<span></span>
</td>
<td class="text">Expected return on plan assets<span></span>
</td>
<td class="text">Expected return on plan assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">$ (180)<span></span>
</td>
<td class="num">$ (88)<span></span>
</td>
<td class="num">$ (66)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag', window );">DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</a></td>
<td class="text">Actuarial loss<span></span>
</td>
<td class="text">Actuarial loss<span></span>
</td>
<td class="text">Actuarial loss<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Actuarial loss</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 189<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag', window );">DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</a></td>
<td class="text">Amortization of unrecognized prior service cost<span></span>
</td>
<td class="text">Amortization of unrecognized prior service cost<span></span>
</td>
<td class="text">Amortization of unrecognized prior service cost<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of unrecognized prior service cost</a></td>
<td class="num">$ (180)<span></span>
</td>
<td class="num">$ (175)<span></span>
</td>
<td class="num">$ (123)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Plan settlements</a></td>
<td class="num">(330)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Totals</a></td>
<td class="nump">$ 1,191<span></span>
</td>
<td class="nump">$ 1,698<span></span>
</td>
<td class="nump">$ 2,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag', window );">DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</a></td>
<td class="text">Interest cost on benefit obligation<span></span>
</td>
<td class="text">Interest cost on benefit obligation<span></span>
</td>
<td class="text">Interest cost on benefit obligation<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag', window );">DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</a></td>
<td class="text">Plan settlements<span></span>
</td>
<td class="text">Plan settlements<span></span>
</td>
<td class="text">Plan settlements<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093818752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS (Schedule of Activity Under Defined Benefit Plans) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in Benefit Obligation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit Obligation, beginning of year</a></td>
<td class="num">$ (30,410)<span></span>
</td>
<td class="num">$ (31,891)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="num">(1,453)<span></span>
</td>
<td class="num">(1,714)<span></span>
</td>
<td class="num">$ (1,861)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="num">(409)<span></span>
</td>
<td class="num">(242)<span></span>
</td>
<td class="num">(279)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="nump">748<span></span>
</td>
<td class="nump">928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain</a></td>
<td class="nump">3,675<span></span>
</td>
<td class="nump">3,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Employee and plan participants contribution</a></td>
<td class="num">(1,599)<span></span>
</td>
<td class="num">(2,093)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</a></td>
<td class="num">(1,775)<span></span>
</td>
<td class="nump">1,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency changes</a></td>
<td class="nump">2,208<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation, end of year</a></td>
<td class="num">(25,465)<span></span>
</td>
<td class="num">(30,410)<span></span>
</td>
<td class="num">(31,891)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Plan Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, beginning of year</a></td>
<td class="nump">17,447<span></span>
</td>
<td class="nump">16,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined Benefit Plan, Plan Assets, Contributions by Employer</a></td>
<td class="nump">1,436<span></span>
</td>
<td class="nump">1,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Defined Benefit Plan, Plan Assets, Benefits Paid</a></td>
<td class="nump">593<span></span>
</td>
<td class="nump">719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease', window );">Gain (loss) on plan assets</a></td>
<td class="nump">105<span></span>
</td>
<td class="num">(108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</a></td>
<td class="nump">1,670<span></span>
</td>
<td class="nump">2,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Plan settlements</a></td>
<td class="num">(1,647)<span></span>
</td>
<td class="num">(1,356)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency changes</a></td>
<td class="nump">45<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, end of year</a></td>
<td class="nump">18,463<span></span>
</td>
<td class="nump">17,447<span></span>
</td>
<td class="nump">$ 16,142<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded Status*</a></td>
<td class="num">(7,002)<span></span>
</td>
<td class="num">(12,963)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_UnrecognizedNetActuarialLossGain', window );">Unrecognized net actuarial gain</a></td>
<td class="num">(3,757)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_UnrecognizedPriorServiceCost', window );">Unrecognized prior service cost</a></td>
<td class="num">(1,133)<span></span>
</td>
<td class="num">(1,099)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Net amount recognized</a></td>
<td class="num">$ (11,892)<span></span>
</td>
<td class="num">$ (14,298)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_UnrecognizedNetActuarialLossGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Net Actuarial Loss/(Gain)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_UnrecognizedNetActuarialLossGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_UnrecognizedPriorServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Prior Service Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_UnrecognizedPriorServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597101820512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS (Schedule of Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward', window );"><strong>Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Impact of defined benefit plans, net of tax, balance</a></td>
<td class="nump">$ 1,619<span></span>
</td>
<td class="num">$ (560)<span></span>
</td>
<td class="num">$ (209)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial loss</a></td>
<td class="nump">2,695<span></span>
</td>
<td class="nump">2,532<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax', window );">Prior service cost</a></td>
<td class="nump">46<span></span>
</td>
<td class="num">(194)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax', window );">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</a></td>
<td class="num">(285)<span></span>
</td>
<td class="num">(159)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Impact of defined benefit plans, net of tax, balance</a></td>
<td class="nump">$ 4,075<span></span>
</td>
<td class="nump">$ 1,619<span></span>
</td>
<td class="num">$ (560)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597101506112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS (Schedule of Weighted Average Rates Used to Determine Net Periodic Benefit Costs) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.43%<span></span>
</td>
<td class="nump">1.38%<span></span>
</td>
<td class="nump">0.58%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of increased salary levels</a></td>
<td class="nump">1.94%<span></span>
</td>
<td class="nump">1.81%<span></span>
</td>
<td class="nump">1.64%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on assets</a></td>
<td class="nump">0.87%<span></span>
</td>
<td class="nump">0.69%<span></span>
</td>
<td class="nump">0.42%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093548064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RETIREMENT PLANS (Schedule of Estimated Future Benefit Payments) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Expected Benefit Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">Fiscal 2024</a></td>
<td class="nump">$ 1,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">Fiscal 2025</a></td>
<td class="nump">1,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">Fiscal 2026</a></td>
<td class="nump">1,474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">Fiscal 2027</a></td>
<td class="nump">1,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">Fiscal 2028</a></td>
<td class="nump">1,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Fiscal 2029-2033</a></td>
<td class="nump">$ 11,654<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597087105968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK (Narrative) (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($) </div>
<div>period </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 02, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 03, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Maximum number of shares available for grant (in shares)</a></td>
<td class="nump">3,118,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=hae_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Maximum number of shares available for award (in shares)</a></td>
<td class="nump">3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_NumberOfPurchasePeriods', window );">Number of purchase periods (in purchase periods) | period</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue', window );">Percentage of purchase price for shares of common stock at fair market value (as a percent)</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan', window );">Weighted average grant date fair value of the six-month option inherent in the Purchase Plan (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 18.10<span></span>
</td>
<td class="nump">$ 20.77<span></span>
</td>
<td class="nump">$ 30.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=hae_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_PercentageOfSharesPurchasedThroughPayrollDeductions', window );">Percentage of shares purchased through payroll deductions (as a percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=hae_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_PercentageOfSharesPurchasedThroughPayrollDeductions', window );">Percentage of shares purchased through payroll deductions (as a percent)</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="nump">1,150,194<span></span>
</td>
<td class="nump">1,056,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised | $</a></td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="nump">$ 8.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation cost related to non vested awards | $</a></td>
<td class="nump">$ 9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Total unrecognized compensation cost related to non vested stock options, weighted average period of recognition (in years)</a></td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Non-employee director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Equity instruments other than options outstanding (in shares)</a></td>
<td class="nump">381,308<span></span>
</td>
<td class="nump">386,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation cost related to non vested awards | $</a></td>
<td class="nump">$ 15.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Total unrecognized compensation cost related to non vested stock options, weighted average period of recognition (in years)</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares, Vested (in shares)</a></td>
<td class="nump">161,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Granted | $ / shares</a></td>
<td class="nump">$ 59.36<span></span>
</td>
<td class="nump">$ 56.96<span></span>
</td>
<td class="nump">$ 102.19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Non-employee director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Maximum number of shares available for award (in shares)</a></td>
<td class="nump">647,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Equity instruments other than options outstanding (in shares)</a></td>
<td class="nump">323,987<span></span>
</td>
<td class="nump">282,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation cost related to non vested awards | $</a></td>
<td class="nump">$ 14.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Total unrecognized compensation cost related to non vested stock options, weighted average period of recognition (in years)</a></td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares, Vested (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget', window );">Performance shares target, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Granted | $ / shares</a></td>
<td class="nump">$ 84.96<span></span>
</td>
<td class="nump">$ 72.52<span></span>
</td>
<td class="nump">$ 123.92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units (PSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget', window );">Performance shares target, percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units (PSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget', window );">Performance shares target, percentage</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units (PSUs) | Fiscal 2016 Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod', window );">Award performance period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hae_A2019EquityPlanMember', window );">2019 Equity Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Maximum number of shares available for award (in shares)</a></td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hae_A2019EquityPlanMember', window );">2019 Equity Plan [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Maximum number of shares available for award (in shares)</a></td>
<td class="nump">5,759,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hae_IncentiveCompensationPlan2005Member', window );">Incentive Compensation Plan 2005 | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares', window );">Number of options counted against maximum number of award shares for every share option issued (in shares)</a></td>
<td class="nump">2.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hae_IncentiveCompensationPlan2005Member', window );">Incentive Compensation Plan 2005 | Share-based Payment Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Maximum number of shares available for award (in shares)</a></td>
<td class="nump">3,059,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_NumberOfPurchasePeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Purchase Periods</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_NumberOfPurchasePeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Options Counted Against Maximum Number of Award Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Purchase Price for Shares of Common Stock at Fair Market Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_PercentageOfSharesPurchasedThroughPayrollDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Shares Purchased Through Payroll Deductions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_PercentageOfSharesPurchasedThroughPayrollDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Award Performance Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Performance Target</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Grant Date Fair Value of Six-Month Option Inherent in Purchase Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=hae_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=hae_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=hae_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=hae_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=hae_Fiscal2016AwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=hae_Fiscal2016AwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hae_A2019EquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hae_A2019EquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hae_IncentiveCompensationPlan2005Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hae_IncentiveCompensationPlan2005Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597092750384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK (Schedule of Share-Based Compensation) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense recognized</a></td>
<td class="nump">$ 25,583<span></span>
</td>
<td class="nump">$ 24,359<span></span>
</td>
<td class="nump">$ 25,516<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense recognized</a></td>
<td class="nump">21,903<span></span>
</td>
<td class="nump">20,694<span></span>
</td>
<td class="nump">22,888<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense recognized</a></td>
<td class="nump">2,364<span></span>
</td>
<td class="nump">2,537<span></span>
</td>
<td class="nump">1,874<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Goods Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense recognized</a></td>
<td class="nump">$ 1,316<span></span>
</td>
<td class="nump">$ 1,128<span></span>
</td>
<td class="nump">$ 754<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098834064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK (Schedule of Summary of Stock Option Activity) (Details) - Stock Options - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, (in shares), Beginning Balance</a></td>
<td class="nump">1,056,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options Outstanding, (in shares), Granted</a></td>
<td class="nump">276,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options Outstanding, (in shares), Exercised</a></td>
<td class="num">(59,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options Outstanding, (in shares), Forfeited</a></td>
<td class="num">(123,972)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, (in shares), Ending Balance</a></td>
<td class="nump">1,150,194<span></span>
</td>
<td class="nump">1,056,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price (in dollars per share), Beginning Balance</a></td>
<td class="nump">$ 66.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price (in dollars per share), Granted</a></td>
<td class="nump">58.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price (in dollars per share), Exercised</a></td>
<td class="nump">44.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price (in dollars per share), Forfeited</a></td>
<td class="nump">82.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price (in dollars per share), Ending Balance</a></td>
<td class="nump">$ 64.21<span></span>
</td>
<td class="nump">$ 66.87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life, Balance</a></td>
<td class="text">3 years 6 months 18 days<span></span>
</td>
<td class="text">3 years 9 months 14 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Balance</a></td>
<td class="nump">$ 27,481<span></span>
</td>
<td class="nump">$ 12,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options Outstanding, (in shares), Exercisable and End of Period</a></td>
<td class="nump">618,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price (in dollars per share), Exercisable at End of Period</a></td>
<td class="nump">$ 62.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Life, Exercisable at End of Period</a></td>
<td class="text">1 year 11 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Exercisable at End of Period</a></td>
<td class="nump">$ 16,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options Outstanding, (in shares), Vested and Expected to Vest at End of Period</a></td>
<td class="nump">1,054,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price (in dollars per share), Vested or Expected to Vest at End of Period</a></td>
<td class="nump">$ 64.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Life, Vested or Expected to Vest at End of Period</a></td>
<td class="text">3 years 1 month 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Vested and Expected to Vest at End of Period</a></td>
<td class="nump">$ 25,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597091080912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK (Schedule of Assumptions Used to Estimate Fair Value) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=hae_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">44.90%<span></span>
</td>
<td class="nump">55.60%<span></span>
</td>
<td class="nump">49.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend Yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">41.90%<span></span>
</td>
<td class="nump">33.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend Yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value per option (in dollars per share)</a></td>
<td class="nump">$ 24.86<span></span>
</td>
<td class="nump">$ 20.97<span></span>
</td>
<td class="nump">$ 30.53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Granted</a></td>
<td class="nump">59.36<span></span>
</td>
<td class="nump">56.96<span></span>
</td>
<td class="nump">102.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Vested</a></td>
<td class="nump">$ 70.24<span></span>
</td>
<td class="nump">$ 79.60<span></span>
</td>
<td class="nump">$ 66.87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">52.22%<span></span>
</td>
<td class="nump">49.23%<span></span>
</td>
<td class="nump">36.79%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility', window );">Peer group stock price volatility</a></td>
<td class="nump">47.43%<span></span>
</td>
<td class="nump">45.75%<span></span>
</td>
<td class="nump">42.31%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns', window );">Correlation of returns</a></td>
<td class="nump">65.45%<span></span>
</td>
<td class="nump">65.06%<span></span>
</td>
<td class="nump">65.12%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Granted</a></td>
<td class="nump">$ 84.96<span></span>
</td>
<td class="nump">$ 72.52<span></span>
</td>
<td class="nump">$ 123.92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Vested</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 47.43<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Correlation of Returns</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Peer Group Stock Price Volatility</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=hae_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=hae_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597098682768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK (Schedule of Summary of Equity Awards other than Options Activity) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Beginning Balance (in shares)</a></td>
<td class="nump">386,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares, Granted (in shares)</a></td>
<td class="nump">207,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares, Vested (in shares)</a></td>
<td class="num">(161,045)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Shares, Forfeited (in shares)</a></td>
<td class="num">(51,360)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Ending Balance (in shares)</a></td>
<td class="nump">381,308<span></span>
</td>
<td class="nump">386,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Beginning Balance</a></td>
<td class="nump">$ 69.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Granted</a></td>
<td class="nump">59.36<span></span>
</td>
<td class="nump">$ 56.96<span></span>
</td>
<td class="nump">$ 102.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Vested</a></td>
<td class="nump">70.24<span></span>
</td>
<td class="nump">79.60<span></span>
</td>
<td class="nump">66.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Forfeited</a></td>
<td class="nump">65.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Ending Balance</a></td>
<td class="nump">$ 63.94<span></span>
</td>
<td class="nump">$ 69.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Beginning Balance (in shares)</a></td>
<td class="nump">282,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares, Granted (in shares)</a></td>
<td class="nump">88,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares, Vested (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Shares, Forfeited (in shares)</a></td>
<td class="num">(47,810)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Ending Balance (in shares)</a></td>
<td class="nump">323,987<span></span>
</td>
<td class="nump">282,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Beginning Balance</a></td>
<td class="nump">$ 102.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Granted</a></td>
<td class="nump">84.96<span></span>
</td>
<td class="nump">$ 72.52<span></span>
</td>
<td class="nump">123.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Vested</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 47.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Forfeited</a></td>
<td class="nump">89.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value (in dollars per share), Ending Balance</a></td>
<td class="nump">$ 87.35<span></span>
</td>
<td class="nump">$ 102.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597093154192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 01, 2023 </div>
<div>USD ($) </div>
<div>unit</div>
</th>
<th class="th">
<div>Apr. 02, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 03, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of business units | unit</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_NetRevenuesBeforeForeignExchangeImpact', window );">Net revenues by business unit</a></td>
<td class="nump">$ 1,168,060<span></span>
</td>
<td class="nump">$ 968,066<span></span>
</td>
<td class="nump">$ 851,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_EffectofExchangeRateonRevenues', window );">Effect of exchange rates</a></td>
<td class="num">(20,824)<span></span>
</td>
<td class="nump">4,319<span></span>
</td>
<td class="num">(1,605)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">1,168,660<span></span>
</td>
<td class="nump">993,196<span></span>
</td>
<td class="nump">870,463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">156,033<span></span>
</td>
<td class="nump">80,750<span></span>
</td>
<td class="nump">89,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_EffectofExchangeRatesonOperatingIncome', window );">Effect of exchange rates</a></td>
<td class="nump">8,419<span></span>
</td>
<td class="nump">18,993<span></span>
</td>
<td class="nump">12,830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_AmortizationOfAcquiredIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">32,640<span></span>
</td>
<td class="nump">47,414<span></span>
</td>
<td class="nump">32,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_ImpairmentOfAssetsAndRelatedCharges', window );">Impairment of assets and PCS2 related charges</a></td>
<td class="nump">616<span></span>
</td>
<td class="num">(5,732)<span></span>
</td>
<td class="num">(25,696)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_OperatingExpensesTransactionCosts', window );">Integration and transaction costs</a></td>
<td class="num">(411)<span></span>
</td>
<td class="nump">21,604<span></span>
</td>
<td class="nump">18,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_RestructuringandRestructuringRelatedCosts', window );">Restructuring and Restructuring Related Costs</a></td>
<td class="num">(11,549)<span></span>
</td>
<td class="num">(28,824)<span></span>
</td>
<td class="num">(15,661)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_DigitalTransformationCosts', window );">Digital transformation costs</a></td>
<td class="nump">4,536<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_EuropeanMedicalDeviceRegulationCosts', window );">European Medical Device Regulation Costs</a></td>
<td class="nump">9,854<span></span>
</td>
<td class="nump">11,033<span></span>
</td>
<td class="nump">4,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation-related charges</a></td>
<td class="num">(5,230)<span></span>
</td>
<td class="num">(1,368)<span></span>
</td>
<td class="num">(897)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gains on divestitures and sale of assets</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">9,603<span></span>
</td>
<td class="nump">32,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">93,307<span></span>
</td>
<td class="nump">97,747<span></span>
</td>
<td class="nump">84,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">$ 310,885<span></span>
</td>
<td class="nump">258,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments | unit</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 21,424<span></span>
</td>
<td class="nump">20,811<span></span>
</td>
<td class="nump">20,758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hae_PlasmaMember', window );">Plasma products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">563,734<span></span>
</td>
<td class="nump">427,611<span></span>
</td>
<td class="nump">414,266<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hae_BloodCenterMember', window );">Blood Center products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">226,819<span></span>
</td>
<td class="nump">236,158<span></span>
</td>
<td class="nump">239,614<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hae_HospitalMember', window );">Hospital products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">378,107<span></span>
</td>
<td class="nump">329,427<span></span>
</td>
<td class="nump">216,583<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">842,897<span></span>
</td>
<td class="nump">639,322<span></span>
</td>
<td class="nump">522,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">251,812<span></span>
</td>
<td class="nump">200,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">61,295<span></span>
</td>
<td class="nump">75,562<span></span>
</td>
<td class="nump">77,676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">997<span></span>
</td>
<td class="nump">1,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">156,680<span></span>
</td>
<td class="nump">163,520<span></span>
</td>
<td class="nump">159,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">14,587<span></span>
</td>
<td class="nump">11,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Asia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">104,135<span></span>
</td>
<td class="nump">110,802<span></span>
</td>
<td class="nump">105,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">26,263<span></span>
</td>
<td class="nump">28,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hae_OtherCountryorRegionMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">3,653<span></span>
</td>
<td class="nump">3,990<span></span>
</td>
<td class="nump">5,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">17,226<span></span>
</td>
<td class="nump">16,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember', window );">Plasma products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_NetRevenuesBeforeForeignExchangeImpact', window );">Net revenues by business unit</a></td>
<td class="nump">500,489<span></span>
</td>
<td class="nump">351,945<span></span>
</td>
<td class="nump">333,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">41,612<span></span>
</td>
<td class="nump">28,314<span></span>
</td>
<td class="nump">24,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">202,075<span></span>
</td>
<td class="nump">129,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember', window );">Blood Center products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_NetRevenuesBeforeForeignExchangeImpact', window );">Net revenues by business unit</a></td>
<td class="nump">289,365<span></span>
</td>
<td class="nump">294,541<span></span>
</td>
<td class="nump">307,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">13,927<span></span>
</td>
<td class="nump">32,489<span></span>
</td>
<td class="nump">39,672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">68,395<span></span>
</td>
<td class="nump">82,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember', window );">Hospital products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hae_NetRevenuesBeforeForeignExchangeImpact', window );">Net revenues by business unit</a></td>
<td class="nump">378,206<span></span>
</td>
<td class="nump">321,580<span></span>
</td>
<td class="nump">210,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">37,768<span></span>
</td>
<td class="nump">36,944<span></span>
</td>
<td class="nump">20,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">40,415<span></span>
</td>
<td class="nump">46,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">565,103<span></span>
</td>
<td class="nump">449,605<span></span>
</td>
<td class="nump">398,491<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Plasma products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">278,580<span></span>
</td>
<td class="nump">183,131<span></span>
</td>
<td class="nump">172,463<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Blood Center products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">132,107<span></span>
</td>
<td class="nump">136,691<span></span>
</td>
<td class="nump">141,962<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Hospital products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">154,416<span></span>
</td>
<td class="nump">129,783<span></span>
</td>
<td class="nump">84,066<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate, Non-Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other Expenses</a></td>
<td class="nump">$ 355,089<span></span>
</td>
<td class="nump">$ 281,476<span></span>
</td>
<td class="nump">$ 256,751<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_AmortizationOfAcquiredIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Acquired Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_AmortizationOfAcquiredIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DigitalTransformationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Digital transformation costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DigitalTransformationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EffectofExchangeRateonRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effect of Exchange Rate on Revenues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EffectofExchangeRateonRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EffectofExchangeRatesonOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effect of Exchange Rates on Operating Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EffectofExchangeRatesonOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EuropeanMedicalDeviceRegulationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>European Medical Device Regulation Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EuropeanMedicalDeviceRegulationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_ImpairmentOfAssetsAndRelatedCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment Of Assets And Related Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_ImpairmentOfAssetsAndRelatedCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_NetRevenuesBeforeForeignExchangeImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Revenues, Before Foreign Exchange Impact</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_NetRevenuesBeforeForeignExchangeImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_OperatingExpensesTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>OperatingExpensesTransactionCosts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_OperatingExpensesTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_RestructuringandRestructuringRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Restructuring Related Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_RestructuringandRestructuringRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4,6)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hae_PlasmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hae_PlasmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hae_BloodCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hae_BloodCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hae_HospitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hae_HospitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hae_OtherCountryorRegionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hae_OtherCountryorRegionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140597092413584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), Balance</a></td>
<td class="num">$ (25,954)<span></span>
</td>
<td class="num">$ (29,547)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">709<span></span>
</td>
<td class="nump">1,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="num">(5,136)<span></span>
</td>
<td class="nump">2,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(4,427)<span></span>
</td>
<td class="nump">3,593<span></span>
</td>
<td class="nump">$ 15,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), Balance</a></td>
<td class="num">(30,381)<span></span>
</td>
<td class="num">(25,954)<span></span>
</td>
<td class="num">(29,547)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), Balance</a></td>
<td class="num">(27,919)<span></span>
</td>
<td class="num">(21,528)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(6,016)<span></span>
</td>
<td class="num">(6,391)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(6,016)<span></span>
</td>
<td class="num">(6,391)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), Balance</a></td>
<td class="num">(33,935)<span></span>
</td>
<td class="num">(27,919)<span></span>
</td>
<td class="num">(21,528)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), Balance</a></td>
<td class="nump">1,619<span></span>
</td>
<td class="num">(560)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">2,456<span></span>
</td>
<td class="nump">2,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="nump">2,456<span></span>
</td>
<td class="nump">2,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), Balance</a></td>
<td class="nump">4,075<span></span>
</td>
<td class="nump">1,619<span></span>
</td>
<td class="num">(560)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Net Unrealized Gain (Loss) on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), Balance</a></td>
<td class="nump">346<span></span>
</td>
<td class="num">(7,459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">4,269<span></span>
</td>
<td class="nump">5,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="num">(5,136)<span></span>
</td>
<td class="nump">2,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(867)<span></span>
</td>
<td class="nump">7,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), Balance</a></td>
<td class="num">$ (521)<span></span>
</td>
<td class="nump">$ 346<span></span>
</td>
<td class="num">$ (7,459)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>hae-20230401_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:hae="http://www.haemonetics.com/20230401"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="hae-20230401.xsd" xlink:type="simple"/>
    <context id="i09227d97ca0f437ba5950fed30790726_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i82f00f58456d4ce9b4e8c3e6f30b1b13_I20221001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <instant>2022-10-01</instant>
        </period>
    </context>
    <context id="ice2c089f520648328aa2b345444e9e2d_I20230518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <instant>2023-05-18</instant>
        </period>
    </context>
    <context id="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="iff466f709be0458d96d07670e8506c93_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i0ca40b48f3114d14bf1271d7751fa199_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i4c45fa2cfd044c32806ebad955872fa5_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ica07a6a12db04420a640cda640d48dcd_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ifb2d524b6a72478a8ce2435530d7cbc4_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i42ee76458100485abe569121bb8658a3_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i52763a808517454786578412ff4262d9_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i60812e5a52b74920a9ce77100e55369d_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i2752e169c88b4ff2a289838d456aec0d_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i37f5873c934c4f319a70ed61b214fb3f_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="id668923a47bf4311bb983f1280642d51_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i697ca53aa7594d49b0f5f0ea4adc78fc_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="ia8a40e6978d54c79bf15a000c4fe1242_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i6a75725e0d6e42c5b75f249d0fd73f03_I20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-03</instant>
        </period>
    </context>
    <context id="i18bd16d259fa4608b4077e65accd3342_I20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-03</instant>
        </period>
    </context>
    <context id="ib5fe2762223141c79cda70db2a2e1be5_I20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-03</instant>
        </period>
    </context>
    <context id="i3a31987923a94e60800afa0e777b9b45_I20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-03</instant>
        </period>
    </context>
    <context id="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <instant>2021-04-03</instant>
        </period>
    </context>
    <context id="ie5148af9ebc54cf1b637aaff64021039_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i5dfd4364e8c24bc4b8394dd292c16b8c_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ida4469bc869a466b9e701b962dc524a8_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="id2250e1e0cab44768927b6683d1fa68a_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i99c9262cec6b4dda9414dc17ce49c2c4_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i0a826461f49548eeaa6114591f43ea92_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i529b729b5858426a8917c2a33f2e400c_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i642712cd53f84556a5ccf4b37238b593_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i83ac7a16fc574ea38c5d4d9bbfa9d783_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i3f76d034fa45484ea27ccefad26663e6_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ie18371e832794ec985b640a184d0d733_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i54f0ad46abac454891cfccff72983699_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="iafa9b4b7857b47e3ba345fec50c6803f_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i5e354d29beb04828b88b6371c1870695_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ib3cf28e5ca804729899b65c631cd302c_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ib38708d3cbd24fe78b4b34a0adf8f366_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ie7db70ed758f45088a07ed84e94c60aa_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ia734649bb2e94aaaba0ee38844e22e8d_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i4cb751cf6eb5433f9a53896b439e745e_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i9b1bc73a7c434d8e9c1c7ea1d43cb121_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i8d19f87949e24b99a793aca6577b9df5_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i4c33fc42a5f5449fa7494bc0c090d585_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ib49d6de2075749128f193bc5cdce0870_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ibd32c41156c94b0589e00e52da019550_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:OfficeEquipmentAndInformationTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i03fe4b852d714a1aa9e19e12fe06664b_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:OfficeEquipmentAndInformationTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i6edb3ee4a05545b48465b7b748a5455b_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:HaemoneticsEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i40bfcce1095940b7b5d05d79a9a16330_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:HaemoneticsEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i3acb260a76164a64b8af93dcc2faa623_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="iecd0cd60e86c45669800594f2197741d_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ib118e4be0869418993e5e01e0a05c3d3_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hae:TenLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ica5c1f5ccf23408886c2ccf29b825567_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hae:TenLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ic27d4ecc7a734888b526104ed27669d7_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hae:TenLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i04ed8db1084a467599f50150cbd6f746_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hae:PlasmaCustomerCSLLimitedCSLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i916dfcb35225444db2be37fbccd76378_I20210404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-04</instant>
        </period>
    </context>
    <context id="ie55a1738904642cd8ecd0cbc158879ef_I20210404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-04</instant>
        </period>
    </context>
    <context id="i8fbc64b8be934aaba7b7e05bf27bf2df_I20210404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-04</instant>
        </period>
    </context>
    <context id="ic28c109153f44c518dc27cd58f174f92_I20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="ia169b122e4e748a2bbfec2d666095114_I20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="i6982a32b8c784f13bc9963f00302b541_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i5ca6348e2ac24a4195142c309fc7a641_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ifea5055cceb64d2faa7c2c933a01dfc9_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i6a75e1df66c146d8bc21150965eea19b_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="id761fa129e9b4c9b8c14ce258bfb5327_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:PriorRestructuringProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i4177f085a6164014b652e8ba2cbc96bc_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:PriorRestructuringProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i823363dc6c2c4b3ea41d483a51719275_I20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-03</instant>
        </period>
    </context>
    <context id="i0fbf2c91e0d14fe299efc100a438a840_I20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:PriorRestructuringProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-03</instant>
        </period>
    </context>
    <context id="i687b01b80c934827b2cb6b312b9524ad_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:PriorRestructuringProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i8589d7325ec74adabcdb6aef0a20354d_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i002292f589b9486bbc885d8889b15b7b_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:PriorRestructuringProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i407111b2df044b2d85cd23b1b5025a83_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:PriorRestructuringProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i62b2b847dc034a3db085e75ba45fed2e_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i984a455da961408f925ca49751e6ddef_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:PriorRestructuringProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ie757a5b3c6874d30b0632b13796f7765_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i35a58bb523b34502b7e9328f05462202_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i54605da039714724a8b332c1eadca994_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i6e94fc8a563c41dbb911f86eebd74fb4_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i60c21727b1644983b67286f3ff83bf6f_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="if570127cbc674472bddd6c920a6680a6_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="ic03bd40350ab47b59e94e0eb9a16722d_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i44318b6edd204f9bb959e54aa88e533c_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i202912003ea5483c8e977d2876231a84_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="iceda53e10aa943db9898cb8ab8dac15a_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ic069cd0eb4c94953be95e2deb98ea5e5_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ia79a8918d94541fbb215b791d3bc0308_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="ie3ffef01c50b40dcbbc6f463d67d82a6_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i0b364431a43245b7a9f05a60dc7416df_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ie6794b0b382b4fb7886de74ba621481b_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i753483fb84d94062bdc30420838c80cf_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i5c4e22f5dd7d46aab1223c60d287905f_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i4e8e2ad8db6d4f6c859bc3263d7c9235_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i206a029467f0420ab5932b24faf54368_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i2f56f2e6daa64033b788180008d0fb12_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="icf36ce0a0ea1444d88b791a90bbfdf76_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="id6fc9e356f064785861fafa202778d12_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i7405bd2190704f40b0b1839ce85522b7_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="id878234d30d043a1869cefb375fae586_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i5f85a675d779468d9d4dbca1c8a1df77_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="i8ff998f127d34759a4f6f4837bf4c1c2_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i1a4624f506734e78b0c21280a438461f_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="i9823c17774ed4746ae030a36d0b5328b_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i95ab359c02104ffb9f744088a78d1303_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="if6dd8c04e15e409a938cebbc415144b4_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="id5dc66016da24927b10302bc7adc1138_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="idfb28cdda17d4216bac7c9d5cc1183fe_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="idcb82f284dea477ea7ca024b9ae58bae_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="idc62548e17174a3eaf8c1c8435fb16e5_D20210301-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i4651aa24e89d4f19b23ca9c1b848272a_I20210113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:HASIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-13</instant>
        </period>
    </context>
    <context id="id4e2ba32e7d846df811c490e96dfc2db_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">hae:HASIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i86f7e1c8849a4449adccae1f6aa3a753_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">hae:HASIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ied3f33df8d1c44b78b90db973a88aed4_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="ic0252aa2fd7447a48396f27529ad8ce1_D20230401-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="id62c57cefd2b41e5a3798110a7fa7e0a_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i3e1cd971bed141ee9e1ec7750e91d3fd_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="ic6277c2898c846d3b4349c549833daf4_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i616e2c0925064b749fa614ff59dd7499_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="ifd18f7423eb842dca4250857300a60d4_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i203dfbcae1dd44178cef12e0b4685fe4_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="if633c82b96c64c7e994ccb564cfd6ca7_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i5038a81c8b424af199422b8a9d70bc1c_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">hae:VivasureMedicalLTDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ia4acc494c5054244829743f91b7e2da7_D20200629-20200629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:FajardoPuertoRicoManufacturingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-06-29</endDate>
        </period>
    </context>
    <context id="i2752501b70f24fe681ec2c0d0d6e1c32_D20220703-20221001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:FajardoPuertoRicoManufacturingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-03</startDate>
            <endDate>2022-10-01</endDate>
        </period>
    </context>
    <context id="i3207d32bf765482d974e19e8a1ba412c_I20200629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:FajardoPuertoRicoManufacturingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-29</instant>
        </period>
    </context>
    <context id="i44250ce6b1a74481b968a4be5acfd176_D20200701-20200701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:USBloodDonorManagementSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-01</endDate>
        </period>
    </context>
    <context id="id6966c90880e42ea87ed7bdf600844e5_I20200701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:USBloodDonorManagementSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-01</instant>
        </period>
    </context>
    <context id="i0f15ab7ccf5a4506a8affa0b65b6006a_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:USBloodDonorManagementSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ib2b9fa2b5f664127b8fdc362bbb48a1e_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:USBloodDonorManagementSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i415a9f8fdf8b4219856aecb281c27444_D20200918-20200918">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:InlogHoldingsFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-18</startDate>
            <endDate>2020-09-18</endDate>
        </period>
    </context>
    <context id="i1ed16aebc739402e9a2e33283c09034b_I20200918">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:InlogHoldingsFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-18</instant>
        </period>
    </context>
    <context id="if9b6d677fac64743add841031ac4146a_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:InlogHoldingsFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="ifb9a6ef65b5a4fbda10aff17313ea7f0_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ieb2d1cef790a43cc813e187423890c9d_I20210117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-17</instant>
        </period>
    </context>
    <context id="ibec6ab6de3e844179c838dce47275e1a_I20210117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-17</instant>
        </period>
    </context>
    <context id="i66bfdbf0893842978853fb1777820b01_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i4314f040e25a485baf6b4975aeefb581_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i2625054aca6d4672ac4dfe103e5f3018_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="if0c1ae0e5e35463eabd3c1bdbdae5618_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="if001c425b20b415582a047fc50a913ad_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i284b8cd4b4544ab58be9c3a7b5aef631_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hae:A2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i1e9d4875df194dab89de359ddb229826_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hae:A2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i911fdad529ca44e49f9d2e6eb98bf48e_I20220816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hae:A2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-16</instant>
        </period>
    </context>
    <context id="i6fc032744cf14e5b8712fe75bf23387a_D20220816-20221104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hae:A2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-16</startDate>
            <endDate>2022-11-04</endDate>
        </period>
    </context>
    <context id="i474dead76fa741a1b6b0fcf117803177_D20221104-20221104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hae:A2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-04</startDate>
            <endDate>2022-11-04</endDate>
        </period>
    </context>
    <context id="ic8cb16fc7fbd4a119a8e39abd06c3f48_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hae:A2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i46b375b6b4f542949b51fd68eaa34739_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-04-03</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i1ba643cdd69040399b37d76690fc345d_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i72965c4a62614d3290bfa903e33eced7_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i07ed489541e746a8b9deae1198e9c1c1_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i9b12e4fae98b451180b4184af64d8b88_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i004e8ca241ac4e4ca56b1a2a8a573d30_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i42ce0fe93a644396931110078249d049_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i1e34ec5fd8bd4a428a2c86c1f65a1c72_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:OfficeEquipmentAndInformationTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ie45ed624179b44a9aa90e98cbf443cd3_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:OfficeEquipmentAndInformationTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ia49c226af761477286c878a9c01a26a8_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:HaemoneticsEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="idaf174529292432b93ffce203a8852e0_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:HaemoneticsEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i9462d8afba8e42f1bdf6538fdf313e40_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i4b7e9feaba63462fb4d7c25051b882b9_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i3b2e53451fe5414ab6223fd9340d04f2_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">hae:AssetImpairmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i66e23e49fe97425b9d4a7409908fbe9f_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">hae:AssetImpairmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="iee98836794a841af872ac5d2c262b2e1_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">hae:AssetImpairmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i4d967115487d4000bb10ef11e17c5ee3_I20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-03</instant>
        </period>
    </context>
    <context id="i6471edc0acff4583a5b44bae2caf6812_I20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-03</instant>
        </period>
    </context>
    <context id="i3c0b4a3a52234ebca2c87d023a372f0d_I20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-03</instant>
        </period>
    </context>
    <context id="ida4846630e6b4fe9abc8b036a5b0f2ca_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i0134e8414f8c42618080f11b9286ca14_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i5193ad1e9e4b4c359e874dfa2c7b2e29_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i890c831316434ae1b18be3b1ae53a567_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ida09061210f544b39381b92caca71c36_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i728903670b674bc8867059c6c7f26220_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ia69c0d5a250d4229b959398b479ddfa4_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i2604f664a0d54bf69c814bdee8df438e_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ifc6430777b2d43ea89991090017c9b5a_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hae:OtherTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="idd9d2b7da12a4869876ddf3bd5cb0cd3_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i0e460218ba5d4a98bb1ebba94551faa3_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ib1c1d8f7dde943afbae8276595f08b9e_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">hae:InProcessSoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ic30962d93d8542679db996ff09021707_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i25a58336b11a40d2bc0242ec0ddcdf16_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">hae:InProcessPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="idfa652c38c114d559e869e8c58458b18_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="iface21e4b3d043d29b088f04c24bece5_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i23809cd4e75445928f37404062b1dd03_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hae:OtherTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i92a64ff94d044686be5f9c39a18d0fd1_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i108b71d6b3c24623a40275dbf161561d_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i85451529d01a46ff987455865e8cc517_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">hae:InProcessSoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ia9cc62c7a26a4855a7c2bde8ac969d41_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i0d4a14f19c3740fa8ef8bb4e38b7b19e_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">hae:InProcessPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i4373220213f242c8b26e3d18d69d2ca7_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ic4f1d2dfba3142c997fbce5f50dfa603_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ia88c59c423ec44039b63736f7e925910_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i6fb24bdd79a74f0eb39e5b0eecfbdaf6_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ie4cf1b883fd6484c9800097c24c1d893_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:ManufacturingSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i178b7f39a47e48ccbbd4fb779775b3cf_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:ManufacturingSpaceSecondRenewalTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i523638b9b7c54c378edd933028123e1e_I20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:ManufacturingSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-03</instant>
        </period>
    </context>
    <context id="i85fa50a491e746dbbe80adc41c28821c_I20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:ManufacturingSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="i760c632c599245f5913431ba3dca78dd_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:ManufacturingSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i6ef7fed91302418381fe9c7f81fce03e_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">hae:TermLoanNetofFinancingFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i5206cff195784c31b27c9fddad5c6b59_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">hae:TermLoanNetofFinancingFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i925003616419483dae22f32ba1685a31_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i25e28000700d43b485d92326bbc4bfb7_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i903c8d9492d64dafb77bbdf28e97066f_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">hae:BankLoansandOtherBorrowingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i5a29f8010b0f483eb7647596726afd6d_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">hae:BankLoansandOtherBorrowingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ib2c47b417de24ec0a72dcccb7db3cbe4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iab86433186af40dcb319110ff6d19da1_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i11f3eed068e24237b4a649f0058c65a2_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibb6b31fbfdc24cad84abad0853c2b26c_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i81bf02c0713c4e65b37b37c4baf36474_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i8998d1b0b6314a3c9cc6e3cf409ae0e8_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib996e7dc8ee44cd2ad33f983f5f21944_I20180615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-15</instant>
        </period>
    </context>
    <context id="i3967cacf6e894b93b61883e912ba1fe6_I20180615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-15</instant>
        </period>
    </context>
    <context id="ibb54cb0a2108432db260e72c7a6d4079_D20180615-20180615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-15</startDate>
            <endDate>2018-06-15</endDate>
        </period>
    </context>
    <context id="iee47837acab14fbdac774a769db72497_D20180615-20180615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-15</startDate>
            <endDate>2018-06-15</endDate>
        </period>
    </context>
    <context id="i2be5f41c5e2b4e1c8302bd6e01bebdfa_I20220726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-26</instant>
        </period>
    </context>
    <context id="i2a9006835c4148deb219670605797d8d_I20220726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-26</instant>
        </period>
    </context>
    <context id="id657b251abdc4abebff797dc16703707_I20220726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-26</instant>
        </period>
    </context>
    <context id="i1fd10418194d4183846d9bb8e0212b5d_I20220726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-26</instant>
        </period>
    </context>
    <context id="i5fce0a136f5a44868f4e4a7f2e21a61a_D20220726-20220726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-26</startDate>
            <endDate>2022-07-26</endDate>
        </period>
    </context>
    <context id="i29c8a067458945ffa8f7969389dce91f_D20220726-20220726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-26</startDate>
            <endDate>2022-07-26</endDate>
        </period>
    </context>
    <context id="i7a709732686240949bc3efe71990d70e_D20220726-20220726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-26</startDate>
            <endDate>2022-07-26</endDate>
        </period>
    </context>
    <context id="i973bd797eb414599820e9d35565eeede_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i9a1b40a602a74e26bef73bbaf259f41c_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hae:RevisedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="if339c602382f4eaf8286ac7302f32991_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="id0d3e0503f2e47369182add4c536c0b0_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i0373e5b59bde4b20931153fa64e29e2b_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ica4fb645f2a44680b45401f71819ac02_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i8896432b873649499c520736535daf9b_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia304a8f1861445a888815c4e3fe5f060_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i7f25693c211040ecb83adb263cfb9f7f_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">hae:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i0c2e06723032498cae382b252778126a_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i4174f7cffc824248a65ba67bdeea5ccf_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="iaea3475e1f9349fe82f8c3d1a089214d_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i764ec41ce0424c3da439a7f3192b0337_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i203893fd11e847cf96e92a3382d9cf3e_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i40bb49f3669047d78a200b57b5089b10_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ic098477b86064390ab0ce23b1ab8e887_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i1fd6349491de4fe18e35a4e8da7c6adb_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="ide370a9836b84207b26c4ba915b66f5e_D20220726-20220726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">hae:SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-26</startDate>
            <endDate>2022-07-26</endDate>
        </period>
    </context>
    <context id="i97fd6203f93c48a497546a24430f37f5_I20220726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">hae:SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-26</instant>
        </period>
    </context>
    <context id="i5594635815ba48028990d42040a8998c_I20220726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">hae:SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-26</instant>
        </period>
    </context>
    <context id="ic7aae77517ed42c7b472d781ea7f2fd5_D20220901-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7e00c74476ee4f559c6f5da509474dc8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i17c4195f41c04cd69212868e1ecf674f_I20230615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-15</instant>
        </period>
    </context>
    <context id="ibc4d6f8cfb4043299d632162cf4b2dd3_D20230615-20230615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-15</startDate>
            <endDate>2023-06-15</endDate>
        </period>
    </context>
    <context id="i68eff29e4ad24dbbbb27184442823054_I20180928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap267FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-28</instant>
        </period>
    </context>
    <context id="i7000a797e0454253afd12b28826cf4c1_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap267FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i2ebfc574daa0449aa36b42ccd3735fb8_I20180928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap276FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-28</instant>
        </period>
    </context>
    <context id="i2fd5a33d65ce4c719c8ef554f98fd1b3_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap276FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="iee0aef522d1c43b297cb87bd0a1062c5_I20220923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap444FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-23</instant>
        </period>
    </context>
    <context id="icc20bf01217b405abe467d85031aa1d8_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap444FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i929893b4a65b42a99d8cd2ed3e4ad16f_I20220923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap446FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-23</instant>
        </period>
    </context>
    <context id="i95d4787e8ccb4c79bb1a2ae21210589b_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap446FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i0a2bff04bb124b3cb9565ede568309e3_I20220923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap408FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-23</instant>
        </period>
    </context>
    <context id="i5a0016d855bc4eae89b59f2528f0aac5_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap408FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ia88f4a493fba4a00b9f4326a9f0089c9_I20220923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap415FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-23</instant>
        </period>
    </context>
    <context id="i143f09af5d36486a95b6a2443695e880_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:InterestRateSwap415FixedInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i40cd2d153ec649379e2713e53825581e_I20220923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-23</instant>
        </period>
    </context>
    <context id="i38a3ef0a8b5c416391e812e3c975190b_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i0a086617625d4770aa1177f5b215bdfe_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ice83d5f54d3b4d1591f7e898bf73fe94_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i34427df65a3f408681e89de77f0bcba5_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i496992eb4e324c4d93a9779270bd0d95_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="if57d6790a07844cc9da693a20bd4bffe_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i926351f2cdb64cfca4fca48cd71ce175_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ibf952df669d84ad79ebbd6961839ffa5_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i0bd4348fb37642cb9d19c854b0b98777_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i82d640169aec444b861eade7d445b02e_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ib905d6d3d68e4f13963e09cdca04d335_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i6d438a36d1f445b99fa95273454cd16f_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ifc5fe4fd66044c45abd2da237f5b01bf_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="if685fcb31a604071a3aea04895ad5ca2_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ie1ef3242c33f4d14968403e733c74eb4_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i745bbb354f3c49e4acff9d758a7db139_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="if2d5c4548b37436eade14b50d116e37c_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i4d0667d1ab6e437eb9e2cccfe3114e71_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ifc84f5e642914bcd8c36ff54535f264b_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i228a035c89694077beb4571a980c3787_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i6b7cc66dd3cd45aebc86f3ccac3daccb_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ib78abe8a21bb47f6b491e1e88a0c022a_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i21efcb597c134d47a7cdd7695ada55c7_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i40d487570854407eae1cd91197412837_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i0b34b4bf50694564a2bdc0ddefcf34d0_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="id5d605e3bfc94e56bc0743876ebc5034_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ie12da83b81b74a6f8c251cbd3104102c_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i71f5eeccac2e405cbde81dd345b9a918_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="if45b2edcb0a34394bcc87dce4e55afb6_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i7652e23f4d9749d58d9f74cc7d60f8f7_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i943bf7094e994bad85fe8de21c1cb0da_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ifc297a9a523d452588c49f61b90fe397_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ie449786761b5459d81987ca7b30f976f_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ic114d1ef99f7486e882e676e604e60d4_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i192129d9183945dfb1fa96a6e3f72823_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i79baee9eabb44eaea4f2911723087bce_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i4ed4fde198f34c0e96958ff15ac93475_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ide6dff6dae06426caaac4bd1fc9ef699_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ic3dfaa9406244d52a985e71d364da711_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="id872bc48d1694456accfff526b09b5e0_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i7949d38eb6ed4baaa1e5b677d09753c9_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i8bba1f3bac8247d9a7bf0303421a3e7c_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i65e664ee98504b0b8f8186d1d3cedbee_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i6760b9812af24258ad4ca438476747d4_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i5d7138fbdd0d40408d7f37574315a72b_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="icb5872f4ce6d4a36ae9ff072fc3da7c5_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ifa8b08aa795f429987456bca970a1829_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ic93412d801134bd49e320c00ae5f3f41_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i0515c0920ac74a3fa99ec66f590742fa_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="if632bd50d393422b8036fdeb475158dc_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i0efe65c8e6a44ca28515bf3a0446df60_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="if4247054189a43a1a0450606d3475abb_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="iffb2d6495cab432aa90ea55629e7a34e_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:RevenueBasedPayments2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ib4f3c2f8402c490aa5ec976019d2d592_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i9e0e0c2a238340e5af49c732b3425472_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i21aee3c1b74747239031c9b963f5fe6a_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">hae:SavingsPlusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="icb0b69d83b20498cb8aca63402b766a0_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">hae:SavingsPlusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i6925d4ec697647ffa368e97ca8e3c332_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">hae:SavingsPlusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="ifd7616c964054c72a3769144d3c72c21_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">hae:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i3185e1665d8d4e5ab9844e5e3ff0d869_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">hae:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i6a0a0ee071214f54bd0d353709289c03_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">hae:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i460ae7aa48544e75825ca977d4447d2b_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i4050db15299d4a36bbab78482cb7fb2f_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="if4da492c5e554b3890ff74a7a13fd058_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="ied4aca325d3e42f794837acb9bf1c5c7_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hae:A2019EquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i31435e1c79be48e7b4ba1de17ba323da_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hae:A2019EquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i51dd2ace410143febe089bb6d634e842_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hae:IncentiveCompensationPlan2005Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ib1fc79184fba4faa8a07007a4d564998_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hae:IncentiveCompensationPlan2005Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ib3ff55824d064fbd859089a1dce11fcb_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hae:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i98eb603c686a4dcfaabd4aeab4b77a27_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i44a4bfb9e6ff4d9b876946af45bf3409_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i717dd0e3550541a19cb91afee06fa0c1_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i83a9bb7c454d4256b50d1b2a36133ef0_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="ie01f5826ba434059bfbcca75ed1388fb_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hae:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ied103559dd2b43a4b0de550c083ea67f_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="iffbadda382114e1eb91a79d7e988c700_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="if6792b00ca8b4378bcb06b91412550eb_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ibd48961a67cf47bcaa9d15e8932acecb_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i0b0d0e4e19f34194b2cc3d61739b6ec8_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i1366c0d1a26f4ae99257fc0a3af5b117_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">hae:Fiscal2016AwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia22139de2bdb42ccaa1b42693e6081e1_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i1a025b99984c40c8aa80efd44bf08d80_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i13ad711590264a0292e2f60317f18a68_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i07c8760c6cc84cf3b9856e00588d1d24_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i59b37d77f2e14639a7e9f54a0a50c9ef_D20190331-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i55c8b8347e1243739c1e1fac07b7a6c0_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="id1524cac1b104c79b7706146b0a9bdc2_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i78a954ba53b547c2bed2e4234f13c99d_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">hae:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i1aa3abbe789d42b1bb931051619eea7c_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">hae:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ib47a041d2f4a41c580a5732760d4464d_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">hae:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">hae:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="id8876ecaa10546b49f1574bdf9545726_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">hae:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i5b7c9d1af64d4d1ba8bf38b9460a37f9_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">hae:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i4f9b935310f84ea0a50db4a3f1516c09_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i9f4398aaa87e4aeca6c11c93436c50e9_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i4d1e74dd6311434089cd6836e717625c_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i57226d1153c648e282451a752c136567_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i7892776f995348be9cb282d7d7c17651_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i62ca9ec732184b39b11517312a810c90_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i5e5300fbf53a4887a95a3edcae203e9f_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i399cf413d8244296bc74b84fb599fdfd_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i5feb3720fec44a2b9a7ac2e43eebe25a_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="if49e6050da52421980ac8d48fb39b261_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ia94875fad58e496e88688163402cab14_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i1f932dedc3e84a1fbcde03eaf16d4ba2_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i7c9dc15838804a3bb4198e9625eab973_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ieaff6cca2e524da7a844b31893ea255f_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i576a32257e5e4be9bdce60172bdce930_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="icadc8db134484aaa9370b59b63b8a1be_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ie6464f6090754fc397d2bc24da66f3a5_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="if321e27503a64a269742b2fad027648e_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i273ad073c5694d79aed7c48a2228305a_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i8b623f3420d9458a8f791677dd437cb4_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="if43262ae4db34a16abb1b00f16706fe0_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ie84ef4886d9b46769afc2d9cb8935627_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i91c825bc7a7b400ea37266ab846efd90_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ia7897fa4a6b84510a657a7bf9ba065f2_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i94645cd7c7cb469aa8da2ab698ba7ca3_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i0b81c17ea1be415d9752a1ec535c0262_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i9f37dbe4585f4c288f1e4f7cbbe8a03e_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ic7b45150004748bb969ff69c5cac6d6d_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i658880d6f36c48ed97500e003792583f_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i1c3f7ebdb8d149b1991a542469a17c70_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="iebc032eb54984b4da6020c485a1829e9_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="ib37801b66fa64a738f993541669fe76b_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ied904893cdab40ac8e4ecf4261b0392c_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i54c7a18fd41c4b87addd14329d3b8eb3_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i7f6c260335fd4fb6951eb3d58718e908_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i437233f16d55490f81474cc61bd50d53_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ied7abd5a64d44ec8be1482592153b618_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="ib0ea7f7a83854a4fb04976b762a1d6b4_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i44db282af41942a9bc8bf049fea7b13c_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i3065d0c1ee844421ae0cb9af4f53bd46_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i8760c4c6918543eabfca879c50151fc5_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i2ad75f10bcaa44d3870719c7728eee20_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ic2ca668eb57a4e6ea2aa6d35644cb889_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i77e56895100346f8967a4f2f2f7478e9_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ibbcb5690ee9e4cf58369fb43962e39d7_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ie082775b703647d2a596091af2b69615_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="ie54d9c04734f4a3ca440be55cadea86d_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="if8b3574a63ea41058d11dde501f4dd4b_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i57d49f4f72de40b6b6dcbc6a662b5afe_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i831da503c99a4196bacf1bd7aaa8e97c_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="iba74e960f8174b6eb6f8237d8ec75488_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ibadbeb7294884727ba79dd447d78e637_D20200329-20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2021-04-03</endDate>
        </period>
    </context>
    <context id="i1d9aaac5c08240e7ac639d3d9318182d_I20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-03</instant>
        </period>
    </context>
    <context id="i20163d468f534459b8f5e133c39e76bc_I20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-03</instant>
        </period>
    </context>
    <context id="i258a2ee961ae4548a116f4702808d630_I20210403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-03</instant>
        </period>
    </context>
    <context id="if9661b76a961497bbfd87ed0b21aa594_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ibe8f263a99854b0f83abe062df3af1a2_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i8e8bc4e14d294ed18a1106b9bfecc30d_D20210404-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-04</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="ie871fb22a3cf4c40ae275a678c22a4c6_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i212720196aab4e27b97320442307e199_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i3f4e6fa1de00426ba9dc50efcffee0dd_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="ib8ff71c228644456aa078f7b405de97b_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i4888ce624cf2491996b6ac5702a159b1_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="ie331660e8b3c4a1d855c3ea8e8032707_D20220403-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-03</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i93a31928c3f04bbe9786669a94886e63_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i31840d7f9a0f42fb8999b7022a505464_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="ib7b16ebd9bdb4cd58a89613d51ab905e_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="unit">
        <measure>hae:unit</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="swap">
        <measure>hae:swap</measure>
    </unit>
    <unit id="period">
        <measure>hae:period</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl80L2ZyYWc6ZDUwMDlkZDk3ZmM4NGQ4Y2JhMjhjZTkzZWU3NWJkZjEvdGFibGU6YWZmNDM3M2QzY2M4NDQwYzljY2I5ZWJkOWQ1NDg0NDAvdGFibGVyYW5nZTphZmY0MzczZDNjYzg0NDBjOWNjYjllYmQ5ZDU0ODQ0MF8wLTEtMS0xLTcwMzM0_e03e3178-babf-4e38-8521-498ac065c249">0000313143</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl80L2ZyYWc6ZDUwMDlkZDk3ZmM4NGQ4Y2JhMjhjZTkzZWU3NWJkZjEvdGFibGU6YWZmNDM3M2QzY2M4NDQwYzljY2I5ZWJkOWQ1NDg0NDAvdGFibGVyYW5nZTphZmY0MzczZDNjYzg0NDBjOWNjYjllYmQ5ZDU0ODQ0MF8xLTEtMS0xLTcwMzM0_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl80L2ZyYWc6ZDUwMDlkZDk3ZmM4NGQ4Y2JhMjhjZTkzZWU3NWJkZjEvdGFibGU6YWZmNDM3M2QzY2M4NDQwYzljY2I5ZWJkOWQ1NDg0NDAvdGFibGVyYW5nZTphZmY0MzczZDNjYzg0NDBjOWNjYjllYmQ5ZDU0ODQ0MF8yLTEtMS0xLTcwMzM0_1c6a4386-e46f-4a2c-bcd2-32d53fcedf70">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl80L2ZyYWc6ZDUwMDlkZDk3ZmM4NGQ4Y2JhMjhjZTkzZWU3NWJkZjEvdGFibGU6YWZmNDM3M2QzY2M4NDQwYzljY2I5ZWJkOWQ1NDg0NDAvdGFibGVyYW5nZTphZmY0MzczZDNjYzg0NDBjOWNjYjllYmQ5ZDU0ODQ0MF8zLTEtMS0xLTcwMzM0_3b91239e-a37d-44a2-b81b-19a4a07f2aa4">false</dei:AmendmentFlag>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMC0xLTEtNzAzMzQ_34cb8f69-e36e-4863-9363-93e365f18a37">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMC0xLTEtNzAzMzQ_4c4b5b40-680d-44df-9a35-0e7bc64d7233">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMC0xLTEtNzAzMzQ_71a2b58f-3dab-4c09-b137-6558f9c15c80">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMC0xLTEtNzAzMzQ_993d52dc-b21b-4c73-bea1-865c14747532">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMC0xLTEtNzAzMzQ_64ce6304-0097-4fab-b514-f225878a9f4b">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMC0xLTEtNzAzMzQ_aece9495-28e3-4cad-8c7d-78640888fb76">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i760c632c599245f5913431ba3dca78dd_I20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzAvZnJhZzpmMjY0MjFjYmMwYzc0ZWVjOTQyM2FmMDY1MjMzNzQwZi90ZXh0cmVnaW9uOmYyNjQyMWNiYzBjNzRlZWM5NDIzYWYwNjUyMzM3NDBmXzc_79441a6f-c39a-4b83-8324-195651c66585">P15Y6M30D</us-gaap:LesseeOperatingLeaseTermOfContract>
    <dei:DocumentType
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQ4_7530065b-f45f-4b5d-8524-d7148bd8681d">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQz_3ca9654e-a549-46d3-a7a0-6293ac6fbf14">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8yMDI_0ea9c83d-1481-46ed-9f98-94c1855879db">2023-04-01</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8yMDI_bf6577ec-0395-4023-af52-1c15bf5ddf02">--04-01</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQ1_15bd5467-930f-4e00-a1fa-f3dc811f26a9">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQ5_f3eaa656-8257-4d7d-a765-b046ed80087f">001-14041</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTUw_4124ec12-1e57-4f0a-8fcb-61c93b7f43e9">HAEMONETICS CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV8wLTAtMS0xLTcwMzM0_4001148d-1236-4f5d-8def-5d1715eeeeac">MA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV8wLTQtMS0xLTcwMzM0_cf403e96-021d-46ca-8b79-f2b90871b69e">04-2882273</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV8yLTAtMS0xLTcwMzM0_f2076f61-7617-4832-8ab7-7342c4574b72">125 Summer Street,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV8yLTQtMS0xLTcwMzM0_343a6a84-2d1e-4b3b-85f7-74b4e2666297">02110</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV8zLTAtMS0xLTcwMzM0_7037b1d4-fa53-4924-9e0b-5c8f8fdf61a4">Boston,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV8zLTItMS0xLTcwMzM0_f673e35e-a4a9-4f5e-a36a-447aef91c533">MA</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV81LTAtMS0xLTcwMzM0_711a779a-d372-48d3-9231-738391c92757">(781)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZDQxODJjYTlkYjZjNDg3MmJiYjc5YjM1NzNmN2E4OWUvdGFibGVyYW5nZTpkNDE4MmNhOWRiNmM0ODcyYmJiNzliMzU3M2Y3YTg5ZV81LTItMS0xLTcwMzM0_3e1a95ab-ca5b-4aca-80d8-fc2e8830dfbb">848-7100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6NTBjZTA1NzJhOGQ4NDMyZGFhNDljZWZiOWU2OGVlNmIvdGFibGVyYW5nZTo1MGNlMDU3MmE4ZDg0MzJkYWE0OWNlZmI5ZTY4ZWU2Yl8xLTAtMS0xLTcwMzM0_6cb1d059-ce9d-40cd-8972-79171bf9bf95">Common stock, $.01&#160;par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6NTBjZTA1NzJhOGQ4NDMyZGFhNDljZWZiOWU2OGVlNmIvdGFibGVyYW5nZTo1MGNlMDU3MmE4ZDg0MzJkYWE0OWNlZmI5ZTY4ZWU2Yl8xLTItMS0xLTcwMzM0_14f084fe-7e4a-4187-8181-ea3b46ecbeae">HAE</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6NTBjZTA1NzJhOGQ4NDMyZGFhNDljZWZiOWU2OGVlNmIvdGFibGVyYW5nZTo1MGNlMDU3MmE4ZDg0MzJkYWE0OWNlZmI5ZTY4ZWU2Yl8xLTQtMS0xLTcwMzM0_7536fc5d-146a-49c0-8080-19dcba70e45a">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQw_e0b4f638-3bad-41dd-8fc9-5ab325cd19e0">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQ0_1ce69b89-9987-44f9-b2bd-8f522b9add8a">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQ2_8bf983b7-c259-45b7-936a-c65391f781d6">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQ3_f1485a29-210d-46a3-941e-a03b3967c898">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZWNjZGU2ZjU2YmI2NGFhOWI1YzI2M2QwZDQ5NDQ3NTEvdGFibGVyYW5nZTplY2NkZTZmNTZiYjY0YWE5YjVjMjYzZDBkNDk0NDc1MV8wLTAtMS0xLTcwMzM0_07a8c11f-d39e-40df-91bb-55b09559f982">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZWNjZGU2ZjU2YmI2NGFhOWI1YzI2M2QwZDQ5NDQ3NTEvdGFibGVyYW5nZTplY2NkZTZmNTZiYjY0YWE5YjVjMjYzZDBkNDk0NDc1MV8xLTYtMS0xLTcwMzM0_8fb79e3b-f0ae-4f9b-b248-9e14c013ad90">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGFibGU6ZWNjZGU2ZjU2YmI2NGFhOWI1YzI2M2QwZDQ5NDQ3NTEvdGFibGVyYW5nZTplY2NkZTZmNTZiYjY0YWE5YjVjMjYzZDBkNDk0NDc1MV8yLTYtMS0xLTcwMzM0_8a222bc3-059b-4f1c-9b29-f5d8ac413ff6">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTUx_cb92bc9e-bff6-4ef2-8f75-f2081325050d">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQx_17cd12f5-d667-4a98-8f82-4dcac8d4b82a">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i82f00f58456d4ce9b4e8c3e6f30b1b13_I20221001"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zNTQz_5459c92c-d050-453f-ba6a-e9e965ecb5f0"
      unitRef="usd">3725273032</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ice2c089f520648328aa2b345444e9e2d_I20230518"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zNzQ1_3039ff19-1fda-4aac-955b-243bf8e115ae"
      unitRef="shares">50540770</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xL2ZyYWc6ZTVjNGQ2MjUzOWNlNDZmOGFhZjBiYzY0OWQ3Njc5OGQvdGV4dHJlZ2lvbjplNWM0ZDYyNTM5Y2U0NmY4YWFmMGJjNjQ5ZDc2Nzk4ZF8zOTQy_e0bb93ad-05da-4451-949d-f7999f0115bb">Portions of the definitive proxy statement for our Annual Meeting of Shareholders to be held on August&#160;4, 2023 are incorporated by reference in Part&#160;III of this report.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83MC9mcmFnOjliNTE2NTZmNzY5ZjQ1Yjc5MWMzOTExZDM0NGRiNjNjL3RleHRyZWdpb246OWI1MTY1NmY3NjlmNDViNzkxYzM5MTFkMzQ0ZGI2M2NfMzk5MA_c5b7cce4-a63a-4a3e-a63e-a7cd65a839b7">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83MC9mcmFnOjliNTE2NTZmNzY5ZjQ1Yjc5MWMzOTExZDM0NGRiNjNjL3RleHRyZWdpb246OWI1MTY1NmY3NjlmNDViNzkxYzM5MTFkMzQ0ZGI2M2NfMzk5MQ_31ebefa0-7674-4ef0-aed9-37658b17d1a6">Boston, Massachusetts</dei:AuditorLocation>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMy0xLTEtMS03MDMzNA_eaf5e460-8173-4bb9-9f15-c3d2e179a56d"
      unitRef="usd">1168660000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMy0zLTEtMS03MDMzNA_542d5bb6-7c86-418a-b443-1fe17b3a9f19"
      unitRef="usd">993196000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMy01LTEtMS03MDMzNA_7f745772-ee68-4897-be2a-398c8c1eba99"
      unitRef="usd">870463000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNC0xLTEtMS03MDMzNA_8384fb9c-6d7d-4e66-b6c4-b64e9d362a57"
      unitRef="usd">553563000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNC0zLTEtMS03MDMzNA_55375f4e-1867-47d2-a192-b866c6e83e86"
      unitRef="usd">487694000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNC01LTEtMS03MDMzNA_87a862c7-2b2f-45b4-bfb7-9027d575e0bf"
      unitRef="usd">472625000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNS0xLTEtMS03MDMzNA_ac2f5822-d0ae-4bad-9738-cc0f54c55510"
      unitRef="usd">615097000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNS0zLTEtMS03MDMzNA_136444ed-7f1c-4f6e-8c05-b97591e5510f"
      unitRef="usd">505502000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNS01LTEtMS03MDMzNA_c4bbb651-4f66-4846-9191-190b2edb5742"
      unitRef="usd">397838000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNy0xLTEtMS03MDMzNA_114e3c45-1ec2-46b2-942e-3b43af2626a3"
      unitRef="usd">50131000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNy0zLTEtMS03MDMzNA_851918b2-8028-4b57-bea9-15686841e7fc"
      unitRef="usd">46801000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfNy01LTEtMS03MDMzNA_9d76ffc6-9054-4bde-8b01-6d31ceaacf8e"
      unitRef="usd">32857000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfOC0xLTEtMS03MDMzNA_2f974bfb-89d2-41db-b0ad-df6ae0fce807"
      unitRef="usd">376675000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfOC0zLTEtMS03MDMzNA_4025683f-bbda-4ae9-95bc-24735b4df9c2"
      unitRef="usd">340140000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfOC01LTEtMS03MDMzNA_535f421f-eda6-4453-a09d-701cb68ef0cc"
      unitRef="usd">275216000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <hae:AmortizationOfAcquiredIntangibleAssets
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfOS0xLTEtMS03MDMzNA_84419a76-a1ab-4b94-a598-2dd4d8cacdc5"
      unitRef="usd">32640000</hae:AmortizationOfAcquiredIntangibleAssets>
    <hae:AmortizationOfAcquiredIntangibleAssets
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfOS0zLTEtMS03MDMzNA_6f27446e-1610-4463-8038-0dda6516c078"
      unitRef="usd">47414000</hae:AmortizationOfAcquiredIntangibleAssets>
    <hae:AmortizationOfAcquiredIntangibleAssets
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfOS01LTEtMS03MDMzNA_301612dc-98e5-465a-bed6-efaecaaa2ab2"
      unitRef="usd">32830000</hae:AmortizationOfAcquiredIntangibleAssets>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTEtMS0xLTEtNzAzMzQ_7e496ed2-fdb5-4f41-bb31-46cf90491220"
      unitRef="usd">382000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTEtMy0xLTEtNzAzMzQ_371b43c7-4e96-4555-8cbc-f61269da888b"
      unitRef="usd">9603000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTEtNS0xLTEtNzAzMzQ_564b8536-15c9-4530-bc29-05c1b25dac05"
      unitRef="usd">32812000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:OperatingExpenses
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTItMS0xLTEtNzAzMzQ_a9c4caf7-7dbe-49d8-b543-aaedbc9ae652"
      unitRef="usd">459064000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTItMy0xLTEtNzAzMzQ_d7c4e2c7-1e78-4f75-8d8f-0841c4f26006"
      unitRef="usd">424752000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTItNS0xLTEtNzAzMzQ_b076c31f-54bd-4bf4-acb0-059d0ba068c6"
      unitRef="usd">308091000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTMtMS0xLTEtNzAzMzQ_3a7ce93b-54be-4a28-812e-564693fbb81c"
      unitRef="usd">156033000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTMtMy0xLTEtNzAzMzQ_277a71ba-aa53-480e-ae3d-1197a5d61f06"
      unitRef="usd">80750000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTMtNS0xLTEtNzAzMzQ_999fbe18-a285-4d08-9bc1-bb7bc52363ee"
      unitRef="usd">89747000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTQtMS0xLTEtNzAzMzQ_37b7b96d-c749-493e-9ef0-949177f69119"
      unitRef="usd">-14630000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTQtMy0xLTEtNzAzMzQ_57ac7432-eedc-4663-8e8a-88a3255388d1"
      unitRef="usd">-17121000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTQtNS0xLTEtNzAzMzQ_549666c7-ba49-4c35-b093-7619342c900e"
      unitRef="usd">-16834000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTUtMS0xLTEtNzAzMzQ_d256a525-b9bf-4168-836b-f9c3ff0114b3"
      unitRef="usd">141403000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTUtMy0xLTEtNzAzMzQ_526c4679-1817-4d41-87f6-06cf88990c33"
      unitRef="usd">63629000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTUtNS0xLTEtNzAzMzQ_9319090f-d7e0-4e11-a262-40fe22c4443e"
      unitRef="usd">72913000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTYtMS0xLTEtNzAzMzQ_4a8093ca-955d-4d9c-94f5-8ba3b6ff7315"
      unitRef="usd">26002000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTYtMy0xLTEtNzAzMzQ_a08f175e-6a4e-4eff-b0fc-4d3d0292933b"
      unitRef="usd">20254000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTYtNS0xLTEtNzAzMzQ_0a3bf612-a54f-40a6-9ab7-747c4d9cb8cb"
      unitRef="usd">-6556000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTctMS0xLTEtNzAzMzQ_818ae1b9-2843-415a-ab42-e876a1170ca8"
      unitRef="usd">115401000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTctMy0xLTEtNzAzMzQ_3230b122-f2f4-4a59-8f15-e9323a791978"
      unitRef="usd">43375000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTctNS0xLTEtNzAzMzQ_bb658622-d311-413d-a287-33ab1f7460ed"
      unitRef="usd">79469000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTktMS0xLTEtNzAzMzQ_6022b2ca-9f45-4e21-8bb7-1a576edd866f"
      unitRef="usdPerShare">2.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTktMy0xLTEtNzAzMzQ_058bdf63-ab5d-48bf-95ea-bacd7f3e5794"
      unitRef="usdPerShare">0.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMTktNS0xLTEtNzAzMzQ_86e354ac-3703-46e4-918e-27d2a2a1bf9f"
      unitRef="usdPerShare">1.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjAtMS0xLTEtNzAzMzQ_34539a32-7ae7-47db-9087-43204c290eb2"
      unitRef="usdPerShare">2.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjAtMy0xLTEtNzAzMzQ_5c342655-9e49-4d20-b376-fab8db03c8a6"
      unitRef="usdPerShare">0.84</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjAtNS0xLTEtNzAzMzQ_f7314aa2-5e85-41be-8180-1086f63154de"
      unitRef="usdPerShare">1.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjMtMS0xLTEtNzAzMzQ_84dfc82e-9696-47c7-ab93-dc4457d38d2c"
      unitRef="shares">50783000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjMtMy0xLTEtNzAzMzQ_5e3d4a7d-41b1-47a1-a6a2-7e5d087264e8"
      unitRef="shares">51047000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjMtNS0xLTEtNzAzMzQ_18a89bc3-0dec-400c-93da-38d35bc179b2"
      unitRef="shares">50688000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjQtMS0xLTEtNzAzMzQ_87e8a700-fe68-417f-b936-25f0eacdc808"
      unitRef="shares">51420000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjQtMy0xLTEtNzAzMzQ_f7c4d74c-5cde-4d81-989f-ee46d9cd815b"
      unitRef="shares">51353000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83Ni9mcmFnOmIyODc4ZDkxOWNjMTRiZjBhMzFiM2RjNDA0ZDAwZDMzL3RhYmxlOmQyMjNjYjIxNjVlNzQ0YTc5OWMzOTg2ZDY1YjAwYmYwL3RhYmxlcmFuZ2U6ZDIyM2NiMjE2NWU3NDRhNzk5YzM5ODZkNjViMDBiZjBfMjQtNS0xLTEtNzAzMzQ_6d66ddba-e58e-476b-ba90-ff69ed80b108"
      unitRef="shares">51292000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMy0xLTEtMS03MDMzNA_5edd5a89-a154-4d3c-9a9f-d92b3533224f"
      unitRef="usd">115401000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0ca40b48f3114d14bf1271d7751fa199_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMy0xLTEtMS03MDMzNA_fc54bcfb-a261-4c75-a8f1-6e33b32cb391"
      unitRef="usd">115401000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMy0zLTEtMS03MDMzNA_47457ec8-9427-480a-acaf-9836c8b7f318"
      unitRef="usd">43375000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMy01LTEtMS03MDMzNA_05ab8e59-50d9-4d35-86b3-1bf38ddb5427"
      unitRef="usd">79469000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfNi0xLTEtMS03MDMzNA_d06f3dff-48e5-4170-8538-06c3e4111a74"
      unitRef="usd">-2456000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfNi0zLTEtMS03MDMzNA_243ceec2-6ec8-4fc5-9468-69985099e5b4"
      unitRef="usd">-2179000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfNi01LTEtMS03MDMzNA_852ee6a6-089f-4c1c-bb9f-87466ca2198f"
      unitRef="usd">351000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfNy0xLTEtMS03MDMzNA_b7883c4c-d546-4a18-a9b3-319caee191f6"
      unitRef="usd">-6016000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfNy0zLTEtMS03MDMzNA_4103a197-ac01-44af-93f1-f36e37579654"
      unitRef="usd">-6391000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfNy01LTEtMS03MDMzNA_29e14710-f25c-49b8-8fa3-c0e746749a1c"
      unitRef="usd">9572000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfOC0xLTEtMS03MDMzNA_6fffe657-a2f7-4ec6-9c8e-59b46af726b1"
      unitRef="usd">4269000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfOC0zLTEtMS03MDMzNA_b437ef1a-7443-48a7-80d5-e3049e6ad53b"
      unitRef="usd">5785000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfOC01LTEtMS03MDMzNA_6f02d821-a533-4d19-989f-b4e4c827ebbc"
      unitRef="usd">-489000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfOS0xLTEtMS03MDMzNA_c5c95d13-4599-4602-9ca5-a5fad4630009"
      unitRef="usd">5136000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfOS0zLTEtMS03MDMzNA_ee8a75b8-18d5-4413-a84e-facb67ba2393"
      unitRef="usd">-2020000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfOS01LTEtMS03MDMzNA_215be425-92e9-4831-bb0e-ad1bd15231f1"
      unitRef="usd">-6856000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMTAtMS0xLTEtNzAzMzQ_33b763ba-fc4d-48ff-af40-a9d46f2327e6"
      unitRef="usd">-4427000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMTAtMy0xLTEtNzAzMzQ_c807dd30-d533-428f-88f7-f6a85644c21a"
      unitRef="usd">3593000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMTAtNS0xLTEtNzAzMzQ_7852006e-e4a8-4c37-a623-b78aaffc73fc"
      unitRef="usd">15588000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMTEtMS0xLTEtNzAzMzQ_db90342a-b95b-49f2-83eb-7c1592a76b10"
      unitRef="usd">110974000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMTEtMy0xLTEtNzAzMzQ_7a895131-a123-4b44-ac17-800f536aa908"
      unitRef="usd">46968000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl83OS9mcmFnOjBkYzRmZjYwOGYwMjRkY2NiZDg0YzY4OGU2YTY3MWRjL3RhYmxlOmQ5M2E5MGYwMDU4MDRiODU4NmJlNTllMDVhNmI4ZjNiL3RhYmxlcmFuZ2U6ZDkzYTkwZjAwNTgwNGI4NTg2YmU1OWUwNWE2YjhmM2JfMTEtNS0xLTEtNzAzMzQ_9e89da07-8e91-4820-81d4-ecc987dfe405"
      unitRef="usd">95057000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNC0xLTEtMS03MDMzNA_f1768fc8-01b5-4f0e-a078-1a17a05ba007"
      unitRef="usd">284466000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNC0zLTEtMS03MDMzNA_ba6f631b-08c3-4eca-82aa-2176dba13ba4"
      unitRef="usd">259496000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNS0wLTEtMS03MDMzNC90ZXh0cmVnaW9uOjE0MjcxNDhjZmI1MjRmMDQ5ZDg5MTcwNzhjM2RkM2Y3XzQz_9b6ebaa1-ace3-430d-9cbd-d537fdeb2c43"
      unitRef="usd">4932000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNS0wLTEtMS03MDMzNC90ZXh0cmVnaW9uOjE0MjcxNDhjZmI1MjRmMDQ5ZDg5MTcwNzhjM2RkM2Y3XzY3_a3abc4df-3430-474d-bfcc-bbf00f09ccb7"
      unitRef="usd">2475000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNS0xLTEtMS03MDMzNA_f8db3251-6c0f-4a85-a2ef-3dde3a3a1809"
      unitRef="usd">179142000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNS0zLTEtMS03MDMzNA_5ceb633b-fea3-41ff-a02e-04726006e8a6"
      unitRef="usd">159376000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNi0xLTEtMS03MDMzNA_b003f5a6-ba3f-4b3d-b90a-9bb86af8eca3"
      unitRef="usd">259379000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfNi0zLTEtMS03MDMzNA_642ee430-2824-47df-957a-470834736c6c"
      unitRef="usd">293027000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfOC0xLTEtMS03MDMzNA_2e0138b4-e1c1-4f87-81c7-fe02bdbd0204"
      unitRef="usd">46735000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfOC0zLTEtMS03MDMzNA_81e956af-4ce0-42cc-acbb-c55ecc96dbc5"
      unitRef="usd">44132000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfOS0xLTEtMS03MDMzNA_8f25ce81-288c-489f-aa39-c518ae14c4c7"
      unitRef="usd">769722000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfOS0zLTEtMS03MDMzNA_9d40c1d8-cceb-45b4-b1bf-701a18c4e982"
      unitRef="usd">756031000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTAtMS0xLTEtNzAzMzQ_a8fc986e-5b51-4f02-9356-015ee7a733bc"
      unitRef="usd">310885000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTAtMy0xLTEtNzAzMzQ_f85e7b77-39dd-4a37-91db-627ef6de4087"
      unitRef="usd">258482000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTEtMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjo2NTFiODZjOWU3NWE0NjJjYTEzYzI5MDM5YjdlMzdmOF81Ng_45b34273-7549-4f02-bd28-5e131285417e"
      unitRef="usd">417422000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTEtMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjo2NTFiODZjOWU3NWE0NjJjYTEzYzI5MDM5YjdlMzdmOF84MA_aca5e001-461d-4acd-a4b0-8c37d613cef6"
      unitRef="usd">376552000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTEtMS0xLTEtNzAzMzQ_f5170388-dd79-4248-9243-88029905d116"
      unitRef="usd">275771000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTEtMy0xLTEtNzAzMzQ_8a46b839-f7e3-4035-84c5-410163b17db6"
      unitRef="usd">310261000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTItMS0xLTEtNzAzMzQ_5cab51ee-0145-4daf-a606-6829774bdaba"
      unitRef="usd">466231000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTItMy0xLTEtNzAzMzQ_ef337b73-fc59-485b-90dc-937a46ac1c7a"
      unitRef="usd">467287000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTMtMS0xLTEtNzAzMzQ_70d14603-172f-4a6b-bdb3-2d75d0055d95"
      unitRef="usd">5241000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTMtMy0xLTEtNzAzMzQ_2d642095-6bab-4a0a-a0bd-385ba43cff50"
      unitRef="usd">4468000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTQtMS0xLTEtNzAzMzQ_be775653-0111-4c99-b407-0ddc0ce9b2ad"
      unitRef="usd">106975000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTQtMy0xLTEtNzAzMzQ_c723e598-90f2-4c13-a157-3d5c549bdf41"
      unitRef="usd">63205000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTUtMS0xLTEtNzAzMzQ_1eb3f1de-056f-41d9-83b4-04b1dd4636fa"
      unitRef="usd">1934825000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTUtMy0xLTEtNzAzMzQ_1d9e0053-19da-48c7-a0f4-45beb75861a7"
      unitRef="usd">1859734000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTgtMS0xLTEtNzAzMzQ_0f34eede-d560-40b1-a9cd-536f09702704"
      unitRef="usd">11784000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTgtMy0xLTEtNzAzMzQ_45c8e119-f98d-431a-a195-6e49511d6612"
      unitRef="usd">214148000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTktMS0xLTEtNzAzMzQ_df90d110-3afc-44d9-98fa-440988af26a2"
      unitRef="usd">63929000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMTktMy0xLTEtNzAzMzQ_062b5696-6664-4ea6-ad75-2fd09cfefbb8"
      unitRef="usd">58371000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjAtMS0xLTEtNzAzMzQ_2ba7f85b-f3e8-460b-831d-470d4e47f440"
      unitRef="usd">64475000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjAtMy0xLTEtNzAzMzQ_3ab7138d-8be6-43e9-83c5-fe9912d35ee0"
      unitRef="usd">48540000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjEtMS0xLTEtNzAzMzQ_3d8042ae-4fb2-42a9-8fa8-297b12c3e9d0"
      unitRef="usd">111628000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjEtMy0xLTEtNzAzMzQ_72b299a2-cade-4baf-b1bd-7848e8d0cbd6"
      unitRef="usd">121207000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjItMS0xLTEtNzAzMzQ_77e3dcc1-b5ec-4364-a1ff-284b9eff2044"
      unitRef="usd">251816000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjItMy0xLTEtNzAzMzQ_bee3eaf3-d0ff-4aa1-8872-301a62b29813"
      unitRef="usd">442266000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjMtMS0xLTEtNzAzMzQ_767062ab-41a5-47a6-8857-ac79f5917ca9"
      unitRef="usd">754102000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjMtMy0xLTEtNzAzMzQ_e604693c-fbe3-469f-ba1f-a8ad35fe6caa"
      unitRef="usd">559441000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjQtMS0xLTEtNzAzMzQ_2163c873-76b9-4595-851b-cedd45e1180c"
      unitRef="usd">36195000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjQtMy0xLTEtNzAzMzQ_3fca16f2-e8cc-469d-84a7-8e0203f9425f"
      unitRef="usd">28727000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjUtMS0xLTEtNzAzMzQ_ea0c8dd4-d3bd-4d84-8962-132678b360b6"
      unitRef="usd">74715000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjUtMy0xLTEtNzAzMzQ_6ccfb6c7-7cd8-427a-ae63-fcc3c5fb8b8f"
      unitRef="usd">79876000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N18xOA_e2c9579c-ccb4-4dc5-9a26-b55b5280345d"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N18xOA_f0f2d02a-e166-4fbd-8201-94dedf9a94f8"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N180NQ_c8f4f426-11a9-4b85-85c0-0269185ad83a"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N180NQ_f1810447-bb4a-4f7c-ac5e-f70cf69336cc"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N184MQ_dcda904d-429e-4a1e-a6a5-9d13d9c6bb7c"
      unitRef="shares">50448519</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N184MQ_e309f461-5ecc-4d88-a457-1146ed31d8b4"
      unitRef="shares">50448519</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N18xMTI_2bfbf2cc-8bae-457e-9441-2543166122c4"
      unitRef="shares">51124240</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjpkMDc4MjJjZjBhN2U0NzRkOGIyZjZjZDZhMDY2YWQ3N18xMTI_ef5e337a-876b-474b-b373-2efceb85f855"
      unitRef="shares">51124240</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMS0xLTEtNzAzMzQ_a6cd1591-94e8-4c3a-9458-6b9010fb81ca"
      unitRef="usd">504000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjctMy0xLTEtNzAzMzQ_f671d9a4-efae-4363-ad50-83874facc8fc"
      unitRef="usd">511000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjgtMS0xLTEtNzAzMzQ_72227dd2-7ace-4e60-af0b-8e421e8897b8"
      unitRef="usd">594706000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjgtMy0xLTEtNzAzMzQ_3f4d6154-c4d5-4902-a615-a92bbfdec6c1"
      unitRef="usd">572476000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjktMS0xLTEtNzAzMzQ_03fad37d-bdec-488a-9570-55ce3b01b299"
      unitRef="usd">253168000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMjktMy0xLTEtNzAzMzQ_99dee86a-6e96-4c45-a6a6-79c1d62e8367"
      unitRef="usd">202391000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMzAtMS0xLTEtNzAzMzQ_a45de49e-1dbb-448f-8c84-949d122a1eb1"
      unitRef="usd">-30381000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMzAtMy0xLTEtNzAzMzQ_0bdbd894-5ab1-4061-84ce-4a89b2751e2e"
      unitRef="usd">-25954000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMzEtMS0xLTEtNzAzMzQ_99bfd95d-6f59-4c60-a6cd-0cb87b18cf06"
      unitRef="usd">817997000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMzEtMy0xLTEtNzAzMzQ_7e155d31-92be-4825-a993-ed322d5654c2"
      unitRef="usd">749424000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMzItMS0xLTEtNzAzMzQ_52b8574a-e3f1-4c61-952d-555f28f33763"
      unitRef="usd">1934825000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84Mi9mcmFnOjZlZTg3YTI3ODBjZjRiNjhiY2QyNTFmZWQzZTJlNGM1L3RhYmxlOjcxZDhlYzM5NDc0MDRmYjZiMjM3OGQxZWQ2NzhjNDMxL3RhYmxlcmFuZ2U6NzFkOGVjMzk0NzQwNGZiNmIyMzc4ZDFlZDY3OGM0MzFfMzItMy0xLTEtNzAzMzQ_c5cf5aa9-ecfc-44d2-98bb-2b3e5b76115c"
      unitRef="usd">1859734000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ifb2d524b6a72478a8ce2435530d7cbc4_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMi0xLTEtMS03MDMzNA_4c3a9840-b7b3-42c1-9e27-7cc6e39b447a"
      unitRef="shares">50323000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ifb2d524b6a72478a8ce2435530d7cbc4_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMi0zLTEtMS03MDMzNA_9015b582-70cc-4ff4-8e53-2fe000cbc07c"
      unitRef="usd">503000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i42ee76458100485abe569121bb8658a3_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMi01LTEtMS03MDMzNA_31f5af0f-331d-4b42-b0d1-ad1eaa64f36a"
      unitRef="usd">553229000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i52763a808517454786578412ff4262d9_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMi03LTEtMS03MDMzNA_282fdf73-bbd8-4bfc-ad7c-b3189c661491"
      unitRef="usd">78512000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i60812e5a52b74920a9ce77100e55369d_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMi05LTEtMS03MDMzNA_97e60cb8-9afc-4954-ad20-1a58c5163bf1"
      unitRef="usd">-45135000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2752e169c88b4ff2a289838d456aec0d_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMi0xMS0xLTEtNzAzMzQ_26530d0d-0cdd-4f42-a2bb-1790ed08a335"
      unitRef="usd">587109000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i37f5873c934c4f319a70ed61b214fb3f_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMy0xLTEtMS03MDMzNA_b7a486f0-ca38-47fc-9234-ebc3324e4a16"
      unitRef="shares">44000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i37f5873c934c4f319a70ed61b214fb3f_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMy0zLTEtMS03MDMzNA_a502c720-ea4f-461f-9679-d4260cf83717"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="id668923a47bf4311bb983f1280642d51_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMy01LTEtMS03MDMzNA_ad149d85-e83d-4cc3-ab7c-70981258f408"
      unitRef="usd">4012000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMy0xMS0xLTEtNzAzMzQ_ed78348a-cc92-4df8-8721-4e9f05b08a87"
      unitRef="usd">4013000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i37f5873c934c4f319a70ed61b214fb3f_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNC0xLTEtMS03MDMzNA_8a15b319-98e3-4267-b912-d120b1e7c281"
      unitRef="shares">128000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i37f5873c934c4f319a70ed61b214fb3f_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNC0zLTEtMS03MDMzNA_ae81ad41-36ed-4b04-85f1-ab4d3af7cbdc"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id668923a47bf4311bb983f1280642d51_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNC01LTEtMS03MDMzNA_f62d0236-1ac0-4d60-94fc-ef34e89a1c7f"
      unitRef="usd">6218000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNC0xMS0xLTEtNzAzMzQ_3f1bbe16-1b5c-43fe-b15a-a0887a71d8cb"
      unitRef="usd">6219000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i37f5873c934c4f319a70ed61b214fb3f_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNy0xLTEtMS03MDMzNA_2b450eaf-37ff-4f9e-aaf9-4589d32c79ab"
      unitRef="shares">374000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i37f5873c934c4f319a70ed61b214fb3f_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNy0zLTEtMS03MDMzNA_6ffe80ea-a450-443a-8bbc-04ff68421f1b"
      unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="id668923a47bf4311bb983f1280642d51_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNy01LTEtMS03MDMzNA_b0fd11ba-8c1e-4d27-9fbe-25613f88ea21"
      unitRef="usd">-4000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfNy0xMS0xLTEtNzAzMzQ_bca67e8e-0f80-45e8-a33d-05e5b2e21d17"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id668923a47bf4311bb983f1280642d51_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfOC01LTEtMS03MDMzNA_92b1a31c-2025-4235-a22b-8538d2583798"
      unitRef="usd">25516000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfOC0xMS0xLTEtNzAzMzQ_e998ea4f-531f-405b-a332-776e6246749c"
      unitRef="usd">25516000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="id668923a47bf4311bb983f1280642d51_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfOS01LTEtMS03MTMyNg_70a3aee9-8b49-4eb6-b365-b6a9056d4422"
      unitRef="usd">61156000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfOS0xMS0xLTEtNzEzMjY_af30fd8c-ed30-49a8-90e9-3f06eebd6cef"
      unitRef="usd">61156000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <hae:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases
      contextRef="id668923a47bf4311bb983f1280642d51_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTAtNS0xLTEtNzEzMjY_40da6c14-b584-41d3-9cef-cd7f540b5643"
      unitRef="usd">47400000</hae:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases>
    <hae:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTAtMTEtMS0xLTcxMzI2_6f49712f-ec77-429c-97de-61c49e916bf4"
      unitRef="usd">47400000</hae:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases>
    <us-gaap:NetIncomeLoss
      contextRef="i697ca53aa7594d49b0f5f0ea4adc78fc_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfOS03LTEtMS03MDMzNA_b5035786-661d-4c4b-9e43-41d4590ad5e9"
      unitRef="usd">79469000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfOS0xMS0xLTEtNzAzMzQ_b8209525-dd26-40bc-9d44-b85c58d9b1b7"
      unitRef="usd">79469000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia8a40e6978d54c79bf15a000c4fe1242_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTAtOS0xLTEtNzAzMzQ_32c8b6bb-c331-4dfd-9399-834b4da76698"
      unitRef="usd">15588000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTAtMTEtMS0xLTcwMzM0_35503c56-ee54-46db-bb55-036205860a2a"
      unitRef="usd">15588000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i6a75725e0d6e42c5b75f249d0fd73f03_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTEtMS0xLTEtNzAzMzQ_7d59cd15-2b79-4646-bf98-0b8b77c78ca5"
      unitRef="shares">50869000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i6a75725e0d6e42c5b75f249d0fd73f03_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTEtMy0xLTEtNzAzMzQ_4e25a582-68ad-40ed-8dff-99d57b212917"
      unitRef="usd">509000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i18bd16d259fa4608b4077e65accd3342_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTEtNS0xLTEtNzAzMzQ_d209418d-0cee-46c6-99b4-d1ff900301b3"
      unitRef="usd">602727000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib5fe2762223141c79cda70db2a2e1be5_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTEtNy0xLTEtNzAzMzQ_70e620c7-db7f-45ef-990a-5f2b0f9744a1"
      unitRef="usd">157981000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3a31987923a94e60800afa0e777b9b45_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTEtOS0xLTEtNzAzMzQ_010c2788-63ff-4ffd-b4ac-05aadf0c712a"
      unitRef="usd">-29547000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTEtMTEtMS0xLTcwMzM0_da7706e2-ff3b-40fe-a0cb-dbfe2fc9c68c"
      unitRef="usd">731670000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ie5148af9ebc54cf1b637aaff64021039_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTItMS0xLTEtNzAzMzQ_514be53f-ce73-44fc-a6e3-6b0775b23744"
      unitRef="shares">74000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ie5148af9ebc54cf1b637aaff64021039_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTItMy0xLTEtNzAzMzQ_9bf81e04-ada0-46ac-960a-3c5b19a05519"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i5dfd4364e8c24bc4b8394dd292c16b8c_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTItNS0xLTEtNzAzMzQ_f0c3c0aa-cad0-486a-9ac2-9f7b971342bd"
      unitRef="usd">4209000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTItMTEtMS0xLTcwMzM0_645344eb-345f-456e-a694-0c0cf0120434"
      unitRef="usd">4209000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ie5148af9ebc54cf1b637aaff64021039_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTMtMS0xLTEtNzAzMzQ_291fca50-0057-49fc-904a-50a1c7053e29"
      unitRef="shares">66000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie5148af9ebc54cf1b637aaff64021039_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTMtMy0xLTEtNzAzMzQ_3640e6c5-0fee-48c5-b5f2-a88a58d53be6"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5dfd4364e8c24bc4b8394dd292c16b8c_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTMtNS0xLTEtNzAzMzQ_ceb54abe-6215-4c34-9ac1-359a4d156cb6"
      unitRef="usd">2337000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTMtMTEtMS0xLTcwMzM0_6e967825-57ba-4abb-ba01-304d2975b226"
      unitRef="usd">2338000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ie5148af9ebc54cf1b637aaff64021039_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTUtMS0xLTEtNzAzMzQ_2d3105dc-a84a-417a-abef-df86c46f5068"
      unitRef="shares">115000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ie5148af9ebc54cf1b637aaff64021039_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTUtMy0xLTEtNzAzMzQ_afcd073a-73c4-490f-beaa-942d7e74183a"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i5dfd4364e8c24bc4b8394dd292c16b8c_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTUtNS0xLTEtNzAzMzQ_3365a73f-e153-4671-aed0-42b134ca94d6"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTUtMTEtMS0xLTcwMzM0_4ef2e506-42eb-4d44-8105-34a1d7fb3cd2"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5dfd4364e8c24bc4b8394dd292c16b8c_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTYtNS0xLTEtNzAzMzQ_571c3d45-e70a-4aee-9d14-27848e6f7b8e"
      unitRef="usd">24359000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTYtMTEtMS0xLTcwMzM0_e0d14a90-2dbe-43a7-a864-7960f9a6673d"
      unitRef="usd">24359000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity
      contextRef="ida4469bc869a466b9e701b962dc524a8_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtNS0xLTEtNzEzNjI_a772fde3-a869-4a0e-93d9-c78a1ddcad6e"
      unitRef="usd">-61156000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id2250e1e0cab44768927b6683d1fa68a_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtNy0xLTEtNzEzNjI_d021210d-1eb2-4a6a-b32b-a131c5c2ab0a"
      unitRef="usd">1035000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i99c9262cec6b4dda9414dc17ce49c2c4_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtMTEtMS0xLTcxMzYy_1d13659d-7589-4663-82b3-bb03910efee5"
      unitRef="usd">-60121000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i0a826461f49548eeaa6114591f43ea92_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTktNy0xLTEtNzAzMzQ_580b460d-5eec-4e6d-ae6c-62afa48bb758"
      unitRef="usd">43375000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMTktMTEtMS0xLTcwMzM0_971e6a84-0cc2-4617-9ea9-8f7f3053043e"
      unitRef="usd">43375000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i529b729b5858426a8917c2a33f2e400c_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjAtOS0xLTEtNzAzMzQ_e8571828-19f5-43eb-8b58-01d50ed0aa7d"
      unitRef="usd">3593000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjAtMTEtMS0xLTcwMzM0_c2ab2b61-a522-4924-acf8-6b47f0687e53"
      unitRef="usd">3593000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i642712cd53f84556a5ccf4b37238b593_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtMS0xLTEtNzAzMzQ_93a8971c-30ce-456a-8b3d-1321c6e79390"
      unitRef="shares">51124000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i642712cd53f84556a5ccf4b37238b593_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtMy0xLTEtNzAzMzQ_dfe35026-55d8-44de-a61c-df72fbf3fc38"
      unitRef="usd">511000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i83ac7a16fc574ea38c5d4d9bbfa9d783_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtNS0xLTEtNzAzMzQ_1078e112-1438-4e60-9efa-f6b53b6528c6"
      unitRef="usd">572476000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3f76d034fa45484ea27ccefad26663e6_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtNy0xLTEtNzAzMzQ_d53b92e8-3fc1-44a7-8c0a-36a12e2e39ae"
      unitRef="usd">202391000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie18371e832794ec985b640a184d0d733_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtOS0xLTEtNzAzMzQ_a08b3b85-690d-48da-8bad-36b51dab1eaf"
      unitRef="usd">-25954000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjEtMTEtMS0xLTcwMzM0_bcd671aa-64f2-4e4a-8f7f-56576f862df8"
      unitRef="usd">749424000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjItMS0xLTEtNzAzMzQ_9efa9b15-d5f2-4927-aa57-868a60f2a429"
      unitRef="shares">102000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjItMy0xLTEtNzAzMzQ_fa3d43ca-ddb1-4dad-8b82-1c4d91677d96"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i54f0ad46abac454891cfccff72983699_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjItNS0xLTEtNzAzMzQ_19b28db4-3118-4c17-8e25-5c1d34b87f15"
      unitRef="usd">4378000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjItMTEtMS0xLTcwMzM0_8bacc67e-8769-4850-b0e6-da63e22f1071"
      unitRef="usd">4378000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjMtMS0xLTEtNzAzMzQ_ac72ac79-f542-4436-8763-a42d79c71d21"
      unitRef="shares">59000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjMtMy0xLTEtNzAzMzQ_42cfda62-2a1f-4f97-8738-8154cd642460"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i54f0ad46abac454891cfccff72983699_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjMtNS0xLTEtNzAzMzQ_04e8eb62-4fbe-4f39-999e-086b0776cbf1"
      unitRef="usd">2637000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjMtMTEtMS0xLTcwMzM0_bc956dd8-2ed9-4368-96f2-fd769770a315"
      unitRef="usd">2638000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtMS0xLTEtODUyNTU_9a0f40bc-5028-4f09-a5ba-6d741c87f942"
      unitRef="shares">997000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtMy0xLTEtODUyNTU_743e15c0-d269-4ce5-ab45-7e4655f2f076"
      unitRef="usd">10000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i54f0ad46abac454891cfccff72983699_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtNS0xLTEtODUyNTU_0a14e92a-d08a-4a30-99d9-d2246cddf1d6"
      unitRef="usd">10366000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i0ca40b48f3114d14bf1271d7751fa199_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtNy0xLTEtODUyNTU_9d0c3b7e-d1d4-4601-8c2f-b9bc4283c48d"
      unitRef="usd">64624000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtMTEtMS0xLTg1MjU1_088842cf-1c0c-4350-842e-babe7067ce83"
      unitRef="usd">75000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjUtMS0xLTEtNzAzMzQ_70b73518-851c-4f92-b90e-f159aaa68015"
      unitRef="shares">161000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i21208a97bc1c4a3396227541c8675fa8_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjUtMy0xLTEtNzAzMzQ_37be65cc-1a1e-444c-a960-a23d60563841"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i54f0ad46abac454891cfccff72983699_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjUtNS0xLTEtNzAzMzQ_eb7adcca-1d03-4321-924c-106813a18264"
      unitRef="usd">-2000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjUtMTEtMS0xLTcwMzM0_c407c02b-3f51-4a40-a140-12cd29cf1682"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i54f0ad46abac454891cfccff72983699_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjYtNS0xLTEtNzAzMzQ_77917d6e-71e2-4d29-8e29-4699dd902e52"
      unitRef="usd">25583000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjYtMTEtMS0xLTcwMzM0_e3be77ec-9384-4b3e-859c-f4c77d213a6f"
      unitRef="usd">25583000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtNy0xLTEtNzAzMzQ_5edd5a89-a154-4d3c-9a9f-d92b3533224f"
      unitRef="usd">115401000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0ca40b48f3114d14bf1271d7751fa199_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtNy0xLTEtNzAzMzQ_fc54bcfb-a261-4c75-a8f1-6e33b32cb391"
      unitRef="usd">115401000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjgtMTEtMS0xLTcwMzM0_1e8cb236-bf2a-47e7-ad26-1bbf11a130d5"
      unitRef="usd">115401000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iafa9b4b7857b47e3ba345fec50c6803f_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjktOS0xLTEtNzAzMzQ_eb7893ef-a7a0-45c6-83a4-519775770ec0"
      unitRef="usd">-4427000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMjktMTEtMS0xLTcwMzM0_f6acf489-b74d-4b0b-94fc-f78e875c3f40"
      unitRef="usd">-4427000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i5e354d29beb04828b88b6371c1870695_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMzAtMS0xLTEtNzAzMzQ_fc6a6269-67f0-459e-a731-eee4fcfc87fa"
      unitRef="shares">50449000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i5e354d29beb04828b88b6371c1870695_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMzAtMy0xLTEtNzAzMzQ_17a04647-8590-4de7-a5c9-ec8d6c92d496"
      unitRef="usd">504000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib3cf28e5ca804729899b65c631cd302c_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMzAtNS0xLTEtNzAzMzQ_7a9d5107-a567-41ed-83a3-bb45a48e0873"
      unitRef="usd">594706000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib38708d3cbd24fe78b4b34a0adf8f366_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMzAtNy0xLTEtNzAzMzQ_04da522c-07f6-4898-834f-d6d766c43c67"
      unitRef="usd">253168000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie7db70ed758f45088a07ed84e94c60aa_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMzAtOS0xLTEtNzAzMzQ_2a9b2fab-13b7-4e01-96a6-4442aa636a5c"
      unitRef="usd">-30381000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84NS9mcmFnOjJmZWM4NjE4ZGYyZDRjNDQ5N2FkMWJiNGJlZjE2ODkyL3RhYmxlOjJlZGZjMjFmZmQ0NjQxZmZiYjU1ZjE4OGIyMTlhMzM5L3RhYmxlcmFuZ2U6MmVkZmMyMWZmZDQ2NDFmZmJiNTVmMTg4YjIxOWEzMzlfMzAtMTEtMS0xLTcwMzM0_aed79006-f0ef-4eed-bbe3-23f9cfa86c46"
      unitRef="usd">817997000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMy0xLTEtMS03MDMzNA_5edd5a89-a154-4d3c-9a9f-d92b3533224f"
      unitRef="usd">115401000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0ca40b48f3114d14bf1271d7751fa199_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMy0xLTEtMS03MDMzNA_fc54bcfb-a261-4c75-a8f1-6e33b32cb391"
      unitRef="usd">115401000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMy0zLTEtMS03MDMzNA_47457ec8-9427-480a-acaf-9836c8b7f318"
      unitRef="usd">43375000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMy01LTEtMS03MDMzNA_05ab8e59-50d9-4d35-86b3-1bf38ddb5427"
      unitRef="usd">79469000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNi0xLTEtMS03MDMzNA_b56b48f4-2f59-480b-aa6a-4f41a09df6cb"
      unitRef="usd">93307000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNi0zLTEtMS03MDMzNA_52f78b39-c861-4b1b-a37f-998bc6a3def7"
      unitRef="usd">97747000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNi01LTEtMS03MDMzNA_09187305-b482-4580-8db5-2fd5064f0490"
      unitRef="usd">84287000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AssetImpairmentCharges
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNy0xLTEtMS03MDMzNA_7509e6fa-3ad6-4f1a-be5a-2c3dbf179c30"
      unitRef="usd">607000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNy0zLTEtMS03MDMzNA_68d69743-68f6-457a-8717-badb0b1186f6"
      unitRef="usd">7953000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNy01LTEtMS03MDMzNA_836e348c-80d6-4970-9cef-7c9e78832739"
      unitRef="usd">21969000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ShareBasedCompensation
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfOC0xLTEtMS03MDMzNA_ec749ed1-674c-4110-a89c-c72f6e56ab4b"
      unitRef="usd">25583000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfOC0zLTEtMS03MDMzNA_83c72504-28d2-4ec3-a5b0-edaac0a85b2b"
      unitRef="usd">24359000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfOC01LTEtMS03MDMzNA_6ac403ec-84af-4745-9a65-47d1400e5ded"
      unitRef="usd">25516000</us-gaap:ShareBasedCompensation>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfOS0xLTEtMS03MDMzNA_838768d0-c294-4cd5-8d00-b9d795ae4e40"
      unitRef="usd">382000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfOS0zLTEtMS03MDMzNA_c9aed119-e353-43ee-b79d-b4aa07271181"
      unitRef="usd">9603000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfOS01LTEtMS03MDMzNA_07a5a211-96c5-47e8-8f5f-6a958b3461c1"
      unitRef="usd">32812000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTAtMS0xLTEtNzAzMzQ_32d230c4-5afd-49cd-a475-c7f9dcdfd83a"
      unitRef="usd">-504000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTAtMy0xLTEtNzAzMzQ_dcd24994-c989-4e58-8596-18e59856d744"
      unitRef="usd">10461000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTAtNS0xLTEtNzAzMzQ_9cb51749-acfe-4a6f-bdd6-3d6c414dea54"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:DeferredOtherTaxExpenseBenefit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTItMS0xLTEtNzAzMzQ_be721edf-fc48-4091-8109-c71d4a50d77b"
      unitRef="usd">4783000</us-gaap:DeferredOtherTaxExpenseBenefit>
    <us-gaap:DeferredOtherTaxExpenseBenefit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTItMy0xLTEtNzAzMzQ_d87901ae-f292-4823-ab92-9b9336617c5e"
      unitRef="usd">5013000</us-gaap:DeferredOtherTaxExpenseBenefit>
    <us-gaap:DeferredOtherTaxExpenseBenefit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTItNS0xLTEtNzAzMzQ_e4b09c38-abd4-4266-ab69-821a7d1ef2ef"
      unitRef="usd">-19866000</us-gaap:DeferredOtherTaxExpenseBenefit>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTQtMS0xLTEtNzAzMzQ_5dce4074-4c01-4e01-afa6-bda70e7d30c6"
      unitRef="usd">1970000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTQtMy0xLTEtNzAzMzQ_45a285e6-30c6-4a0e-9cd7-126b118c3c25"
      unitRef="usd">3404000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTQtNS0xLTEtNzAzMzQ_e1d42618-1c8f-4509-870f-119accc5ea22"
      unitRef="usd">564000</us-gaap:AmortizationOfFinancingCosts>
    <hae:InventoryLossesProvisionBenefit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTUtMS0xLTEtNzAzMzQ_2fb06603-9edb-47c0-bd75-96333e5bde30"
      unitRef="usd">664000</hae:InventoryLossesProvisionBenefit>
    <hae:InventoryLossesProvisionBenefit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTUtMy0xLTEtNzAzMzQ_4dcedc81-75af-423e-ab8c-beed29e4a897"
      unitRef="usd">-861000</hae:InventoryLossesProvisionBenefit>
    <hae:InventoryLossesProvisionBenefit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTUtNS0xLTEtNzAzMzQ_315b8aea-ef58-4825-a203-2df3ae201d51"
      unitRef="usd">7860000</hae:InventoryLossesProvisionBenefit>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTYtMS0xLTEtNzAzMzQ_186ab4d7-e9b2-4d03-9444-6db52f92a0c8"
      unitRef="usd">6126000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTYtMy0xLTEtNzAzMzQ_b2e3835a-6d4b-40a5-b545-9cef48316857"
      unitRef="usd">5592000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTYtNS0xLTEtNzAzMzQ_25114c25-a969-456a-a63a-a40a3bb89610"
      unitRef="usd">1500000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTgtMS0xLTEtNzAzMzQ_137f2452-2b0f-4776-a1d5-aca23e8f166d"
      unitRef="usd">24421000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTgtMy0xLTEtNzAzMzQ_cd426017-e82f-460f-a84f-c2124a1828e3"
      unitRef="usd">34974000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTgtNS0xLTEtNzAzMzQ_2d1abf7a-f001-48e7-89da-8a4f898c128f"
      unitRef="usd">-44121000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTktMS0xLTEtNzAzMzQ_ed0e3dc6-8898-4abf-b044-b50167f78e74"
      unitRef="usd">-30754000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTktMy0xLTEtNzAzMzQ_2aeb4f71-c446-4b58-bed6-397315938e98"
      unitRef="usd">-24307000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMTktNS0xLTEtNzAzMzQ_3dea24f9-839b-457c-a655-1d777f6660b8"
      unitRef="usd">38909000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjAtMS0xLTEtNzAzMzQ_c06ccbec-3936-4f83-aff6-54e684e12c22"
      unitRef="usd">-1688000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjAtMy0xLTEtNzAzMzQ_033f4f66-6569-4302-8d2f-3c461d358130"
      unitRef="usd">-2870000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjAtNS0xLTEtNzAzMzQ_5004118c-9e1f-41f1-87bc-cc07f079e49c"
      unitRef="usd">3822000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjEtMS0xLTEtNzAzMzQ_61f4f716-68b8-418f-b536-703379cb1c47"
      unitRef="usd">22334000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjEtMy0xLTEtNzAzMzQ_66e17274-d9dc-471c-90ee-a727c5a5defa"
      unitRef="usd">15022000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjEtNS0xLTEtNzAzMzQ_23e62c66-73ec-4097-8554-05bb9389c99a"
      unitRef="usd">4650000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjMtMS0xLTEtNzAzMzQ_4e3c185f-2149-41b4-be12-487a1ec1192b"
      unitRef="usd">39816000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjMtMy0xLTEtNzAzMzQ_c616adb0-3106-4dad-8940-38cea30170d5"
      unitRef="usd">7642000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjMtNS0xLTEtNzAzMzQ_60e6b993-65fc-4255-81f1-a6e2ebec192a"
      unitRef="usd">-56422000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjQtMS0xLTEtNzAzMzQ_60bd63cc-b899-40ae-bd83-418c453d5469"
      unitRef="usd">273058000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjQtMy0xLTEtNzAzMzQ_c99ded54-8bc2-41df-aaa5-269a1d5ecfaf"
      unitRef="usd">172263000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjQtNS0xLTEtNzAzMzQ_1add179e-7f34-4da2-99a2-aa38b0d2dffb"
      unitRef="usd">108805000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjYtMS0xLTEtNzAzMzQ_3f717d49-376c-457c-bead-fc9524e62bf1"
      unitRef="usd">110191000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjYtMy0xLTEtNzAzMzQ_85824cc6-1ade-4b74-969a-0cf7b7f554a5"
      unitRef="usd">96509000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjYtNS0xLTEtNzAzMzQ_3c41d40b-eafb-4dd1-80d4-7f3a0b740c3e"
      unitRef="usd">37040000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjctMS0xLTEtNzAzMzQ_73f4637d-4fdb-4a8e-a939-57e23f6bd7e7"
      unitRef="usd">850000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjctMy0xLTEtNzAzMzQ_94926e71-d036-4f54-96c0-4fdd6a9cbc50"
      unitRef="usd">10642000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjctNS0xLTEtNzAzMzQ_dd54e299-aa73-482b-9c0b-f71d4de922c9"
      unitRef="usd">44587000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjgtMS0xLTEtNzAzMzQ_aed06ebc-166d-4101-9581-52cdd5453a83"
      unitRef="usd">1608000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjgtMy0xLTEtNzAzMzQ_d59da98c-02bd-48c8-8bfa-3e84bf2fe025"
      unitRef="usd">2022000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMjgtNS0xLTEtNzAzMzQ_85e39f53-75d1-4bb6-94c1-d67dc70da9aa"
      unitRef="usd">1815000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzAtMS0xLTEtNzAzMzQ_2cd1cc82-361b-4e29-aa41-9161bce84c15"
      unitRef="usd">2850000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzAtMy0xLTEtNzAzMzQ_7720f3bf-4dfa-4b5d-90e3-dee025b6deab"
      unitRef="usd">2500000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzAtNS0xLTEtNzAzMzQ_17576968-f585-4b5a-a9ad-ec68c2547ccd"
      unitRef="usd">434804000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzEtMS0xLTEtNzAzMzQ_1ef6fe16-fc63-4154-8dee-dd86b236dca5"
      unitRef="usd">33205000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzEtMy0xLTEtNzAzMzQ_ff5fbbe2-942d-4028-9d91-d0392632fcdc"
      unitRef="usd">0</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzEtNS0xLTEtNzAzMzQ_f510c552-3ed3-45ad-9a57-a506e925673b"
      unitRef="usd">0</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzItMS0xLTEtNzAzMzQ_9425ae14-eb9a-45ac-8526-b758a101ce46"
      unitRef="usd">-143788000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzItMy0xLTEtNzAzMzQ_f772abc1-14c1-45e7-a616-5c07d2077766"
      unitRef="usd">-86345000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzItNS0xLTEtNzAzMzQ_3fbdc76b-abca-4332-8d7f-9a0c4ba6f3e7"
      unitRef="usd">-425442000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzQtMS0xLTEtNzAzMzQ_7150ef33-e3c0-4cdc-ae28-e813f15db395"
      unitRef="usd">280000000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzQtMy0xLTEtNzAzMzQ_f967b1b9-ee57-4023-8b43-003d52199212"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzQtNS0xLTEtNzAzMzQ_fb399cdb-8673-4fd7-976c-61ba5567ad7c"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <hae:DecreaseForRedemptionOfLongTermDebt
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzUtMS0xLTEtNzQ4MzU_af38a743-fdc0-43ec-859f-03380f8d9a47"
      unitRef="usd">280000000</hae:DecreaseForRedemptionOfLongTermDebt>
    <hae:DecreaseForRedemptionOfLongTermDebt
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzUtMy0xLTEtNzQ4MzU_8586ce52-2898-4ec6-98ea-59e2874e3355"
      unitRef="usd">0</hae:DecreaseForRedemptionOfLongTermDebt>
    <hae:DecreaseForRedemptionOfLongTermDebt
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzUtNS0xLTEtNzQ4MzU_c38704f0-318e-4b0e-9489-bcef20b67772"
      unitRef="usd">0</hae:DecreaseForRedemptionOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzUtMS0xLTEtNzAzMzQ_77152dab-3cba-477c-ab5f-e5ff033152b5"
      unitRef="usd">9625000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzUtMy0xLTEtNzAzMzQ_aa5d862d-15a9-41fd-b6f9-5d97ac8f40ee"
      unitRef="usd">17500000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzUtNS0xLTEtNzAzMzQ_4e5ed7eb-340a-41dc-91e1-c51620dd1166"
      unitRef="usd">21875000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzctMS0xLTEtNzQ4ODc_75bb71e3-4f86-4d29-a92b-a669f8ec496f"
      unitRef="usd">50000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzctMy0xLTEtNzQ4ODc_9fc07df0-25c2-48c4-9783-7e5db320588d"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzctNS0xLTEtNzQ4ODc_e25697a6-3908-4578-9adb-4035f0d7c2d5"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzgtMS0xLTEtNzQ4ODc_921b37fc-caab-4a9b-9ce3-50faceb13a7d"
      unitRef="usd">50000000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzgtMy0xLTEtNzQ4ODc_5b58406b-5284-4a1b-b2fe-cddc06a56d70"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzgtNS0xLTEtNzQ4ODc_4d90e702-238f-4e1e-aab7-5e777be771e4"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzktMS0xLTEtNzQ4ODc_b0848465-e5cb-473a-8ab2-61bd4e2158d5"
      unitRef="usd">1118000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzktMy0xLTEtNzQ4ODc_ad74c947-e0d5-4a06-b10f-4f9f9ddcfb83"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzktNS0xLTEtNzQ4ODc_783407c9-c29c-4533-9dd4-201f187c3c5f"
      unitRef="usd">13457000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzYtMS0xLTEtNzAzMzQ_6dcebaaf-8f95-46bc-8607-617beb89432d"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzYtMy0xLTEtNzAzMzQ_cb4cccf6-7dfa-4071-8809-d1a11613a02a"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzYtNS0xLTEtNzAzMzQ_9a181e0e-2000-4678-955b-65aeb6251d24"
      unitRef="usd">-60000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzctMS0xLTEtNzAzMzQ_fe22c3c4-8ee8-4941-9be4-47f7e478ee75"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzctMy0xLTEtNzAzMzQ_00b45773-f362-4a4f-bdfb-17c7c1e5fb99"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzctNS0xLTEtNzAzMzQ_b6bd373a-e8e2-4b15-a116-4ed18a402ddf"
      unitRef="usd">500000000</us-gaap:ProceedsFromConvertibleDebt>
    <hae:PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzgtMS0xLTEtNzAzMzQ_290df380-cfc3-4d38-a043-8fdf60808b99"
      unitRef="usd">0</hae:PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes>
    <hae:PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzgtMy0xLTEtNzAzMzQ_151955cf-34dc-4911-b438-f7e854d49dac"
      unitRef="usd">0</hae:PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes>
    <hae:PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfMzgtNS0xLTEtNzAzMzQ_cf074d20-1b51-4240-bc41-d68f34f383ff"
      unitRef="usd">47400000</hae:PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDAtMS0xLTEtNzAzMzQ_55422f53-8db4-4912-acf5-f748d962b715"
      unitRef="usd">21593000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDAtMy0xLTEtNzAzMzQ_d6313c17-61c1-4440-869d-b26576f13448"
      unitRef="usd">4791000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDAtNS0xLTEtNzAzMzQ_192fb5e0-7cb3-4695-a37d-fb329f96eff3"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDEtMS0xLTEtNzAzMzQ_64147c33-4a72-4cfd-be85-fe167e576cc4"
      unitRef="usd">4378000</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
    <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDEtMy0xLTEtNzAzMzQ_48de1baf-438d-472f-b4fb-7b682cb23f29"
      unitRef="usd">4209000</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
    <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDEtNS0xLTEtNzAzMzQ_bf69a225-9ef3-4b4a-ae70-22b04835b064"
      unitRef="usd">4013000</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDItMS0xLTEtNzAzMzQ_b258fe99-0aec-4e87-92d6-e2aa8edbe3e8"
      unitRef="usd">2638000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDItMy0xLTEtNzAzMzQ_d6a8719b-2caf-4f91-bcab-e182633e226a"
      unitRef="usd">2338000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDItNS0xLTEtNzAzMzQ_4199f53a-3d90-4df5-a0c6-ccd7e53f78d1"
      unitRef="usd">6217000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDMtMS0xLTEtNzAzMzQ_8a80041e-5df2-4ebf-9742-5a3ef84c6506"
      unitRef="usd">75000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDMtMy0xLTEtNzAzMzQ_223cfb8d-5e00-4389-8c8e-2ae8acf9edaf"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDMtNS0xLTEtNzAzMzQ_9e632ff4-1456-46a3-9987-5e5173b69acf"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDQtMS0xLTEtNzAzMzQ_3d5a8ea8-a740-4aae-b3dc-20876acd8ae7"
      unitRef="usd">-44000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDQtMy0xLTEtNzAzMzQ_b6d4f8e4-7abc-4dbe-8cfc-598b11738215"
      unitRef="usd">-5000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDQtNS0xLTEtNzAzMzQ_e0b21ac3-f5b7-435f-8cf4-18e8e5681968"
      unitRef="usd">-46000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDUtMS0xLTEtNzAzMzQ_99b6e4f5-f3cb-497d-a331-f5ba14dcfecc"
      unitRef="usd">-100364000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDUtMy0xLTEtNzAzMzQ_b02971a6-5251-465e-9390-edb46af3f74c"
      unitRef="usd">-15749000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDUtNS0xLTEtNzAzMzQ_b5f8a2f8-fb60-4a80-991f-26206b00e1ce"
      unitRef="usd">367452000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDYtMS0xLTEtNzAzMzQ_8f50e090-2911-4fcc-a8a0-90a61517630f"
      unitRef="usd">-3936000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDYtMy0xLTEtNzAzMzQ_ab7894c3-658d-46ea-aee0-d8075038e9e4"
      unitRef="usd">-2978000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDYtNS0xLTEtNzAzMzQ_3ae5bd9a-ecf1-4110-8df4-d0e74603248c"
      unitRef="usd">4179000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDctMS0xLTEtNzAzMzQ_bcf0d325-8be3-4ec1-ad38-18e75e0afe65"
      unitRef="usd">24970000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDctMy0xLTEtNzAzMzQ_c25fd66b-74cc-490d-a4c0-29a1275d4301"
      unitRef="usd">67191000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDctNS0xLTEtNzAzMzQ_7570e834-d52c-435a-9c94-eb57ef1334af"
      unitRef="usd">54994000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDgtMS0xLTEtNzAzMzQ_fbc82fdd-11cd-412a-8dfb-d83d01829fe8"
      unitRef="usd">259496000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDgtMy0xLTEtNzAzMzQ_876182fa-478f-4124-9728-d3169a789c43"
      unitRef="usd">192305000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2752e169c88b4ff2a289838d456aec0d_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDgtNS0xLTEtNzAzMzQ_2de97dfc-b7db-4db0-a67f-0f3e4061a097"
      unitRef="usd">137311000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDktMS0xLTEtNzAzMzQ_45c0e852-a6b2-4b22-a881-d02b8f785bc0"
      unitRef="usd">284466000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDktMy0xLTEtNzAzMzQ_44fef604-67ce-42b9-befd-1d34d3e2619f"
      unitRef="usd">259496000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNDktNS0xLTEtNzAzMzQ_1ce6c73f-4fe3-49c2-8ffe-03dbebe81891"
      unitRef="usd">192305000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTEtMS0xLTEtNzAzMzQ_32008deb-a706-4e3c-aef6-4a5b34b40a28"
      unitRef="usd">13587000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTEtMy0xLTEtNzAzMzQ_314da785-8564-4545-b46e-3d678ffff756"
      unitRef="usd">6187000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTEtNS0xLTEtNzAzMzQ_660fd792-197b-473b-9768-4ea30f7c597e"
      unitRef="usd">7824000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTItMS0xLTEtNzAzMzQ_20ba15cb-ce47-480a-934b-b20dc6fd549c"
      unitRef="usd">17967000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTItMy0xLTEtNzAzMzQ_cac86991-b816-4645-98a2-1b716a6ae11d"
      unitRef="usd">24298000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTItNS0xLTEtNzAzMzQ_ea37fbb8-eeb0-4243-90c1-b170766f1b36"
      unitRef="usd">12487000</us-gaap:IncomeTaxesPaid>
    <hae:TransfersFromInventoryToFixedAssets
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTQtMS0xLTEtNzAzMzQ_21eb4b69-e78d-41e5-8b54-b26c9517f1ec"
      unitRef="usd">81136000</hae:TransfersFromInventoryToFixedAssets>
    <hae:TransfersFromInventoryToFixedAssets
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTQtMy0xLTEtNzAzMzQ_568fc833-7712-4bef-945b-414056a47a94"
      unitRef="usd">51800000</hae:TransfersFromInventoryToFixedAssets>
    <hae:TransfersFromInventoryToFixedAssets
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl84OC9mcmFnOmUzZWJjYzUxOTRiODQyODJhMzU1M2M0ZWY0NTc5YmM3L3RhYmxlOjBhZmM1NjA0ZjEyYzQ3OGQ5ZGVmZjk1ZGE5NzY3YmI4L3RhYmxlcmFuZ2U6MGFmYzU2MDRmMTJjNDc4ZDlkZWZmOTVkYTk3NjdiYjhfNTQtNS0xLTEtNzAzMzQ_9728b389-b102-4fc5-b2ab-11bae8abd0dc"
      unitRef="usd">9287000</hae:TransfersFromInventoryToFixedAssets>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85NC9mcmFnOjdhZTU4NTRiZDkzYTRmNGZiZjE1YmU4NGIxMzA5NDdlL3RleHRyZWdpb246N2FlNTg1NGJkOTNhNGY0ZmJmMTViZTg0YjEzMDk0N2VfMjYwOA_dfc68c53-d03a-4d89-bac5-873ebfaeb99e">DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Haemonetics is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. When used in this report, the terms &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; &#x201c;Haemonetics&#x201d; and the &#x201c;Company&#x201d; mean Haemonetics Corporation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blood is essential to a modern healthcare system. Blood and its components (plasma, red cells and platelets) have many vital and frequently life-saving clinical applications. Plasma is used for patients with major blood loss and is manufactured into biopharmaceuticals to treat a variety of illnesses, including immune diseases and coagulation disorders. Red cells treat trauma patients or patients undergoing surgery with high blood loss, such as open heart surgery or organ transplant. Platelets have many uses in patient care, including supporting cancer patients undergoing chemotherapy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Haemonetics manages its business in three principal reporting segments: Plasma, Blood Center and Hospital. For that purpose, &#x201c;Plasma&#x201d; includes plasma collection devices and disposables, plasma donor management software, and anticoagulant and saline sold to plasma customers. &#x201c;Blood Center&#x201d; includes blood collection and processing devices and disposables for red cells, platelets and whole blood. &#x201c;Hospital&#x201d;, which is comprised of Hemostasis Management, Vascular Closure, Cell Salvage and Transfusion Management products, includes devices and methodologies for measuring coagulation characteristics of blood, vascular closure devices, specialized blood cell processing systems and disposables, surgical blood salvage systems and blood transfusion management software.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements present separately the Company&#x2019;s consolidated financial position, results of operations, cash flows and changes in shareholders&#x2019; equity. The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). All amounts presented, except per share amounts, are stated in thousands of U.S. dollars, unless otherwise indicated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NumberOfReportingUnits
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85NC9mcmFnOjdhZTU4NTRiZDkzYTRmNGZiZjE1YmU4NGIxMzA5NDdlL3RleHRyZWdpb246N2FlNTg1NGJkOTNhNGY0ZmJmMTViZTg0YjEzMDk0N2VfMTY0OTI2NzQ0NDQzNA_287febe9-4bf5-4a4e-8d6a-1fb6ecb2ce5a"
      unitRef="unit">3</us-gaap:NumberOfReportingUnits>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE2NzI_2c6fac7b-4a14-447a-9fb8-df4811eb9e7c">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Haemonetics&#x2019; fiscal year ends on the Saturday closest to the last day of March. Fiscal years 2023 and 2022 included 52 weeks with each quarter having 13 weeks. Fiscal 2021 included 53 weeks with each of the first three quarters having 13 weeks and the fourth quarter having 14 weeks. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements include all accounts including those of its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. In addition, we assess our strategic investments to determine whether they meet the definition of a variable interest entity (&#x201c;VIE&#x201d;), and if so, whether the Company has controlling financial interest. Controlling financial interest occurs if the Company has both the power to direct activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and an obligation to absorb losses of or the right to receive benefits from the VIE that could potentially be significant to the VIE. The Company&#x2019;s strategic investments did not meet the controlling financial interest criteria, as such no VIEs were consolidated during fiscal 2023, 2022 or 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;could vary from the amounts derived from its estimates and assumptions. The Company considers estimates to be critical if they are required to make assumptions about material matters that are uncertain at the time of estimation or if materially different estimates could have been made or it is reasonably likely that the accounting estimate will change from period to period. The following are areas considered to be critical and require management&#x2019;s judgment: revenue recognition, inventory provisions, intangible asset and goodwill valuation, legal and other judgmental accruals and income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may become involved in various legal proceedings that arise in the ordinary course of business, including, without limitation, patent infringement, product liability and environmental matters. Accruals recorded for various contingencies including legal proceedings, employee related litigation, self-insurance and other claims are based on judgment, the probability of losses and, where applicable, the consideration of opinions of internal and/or external legal counsel and actuarially determined estimates. When a loss is probable and a range of loss is established but a best estimate cannot be made, the Company records the minimum loss contingency amount, which could be zero. These estimates are often initially developed substantially earlier than the ultimate loss is known and the estimates are reevaluated each accounting period, as additional information is available. As information becomes known, an additional loss provision is recorded when either a best estimate can be made or the minimum loss amount is increased. When events result in an expectation of a more favorable outcome than previously expected, the best estimate is changed to a lower amount.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenue recognition policy is to recognize revenues from product sales, software and services in accordance with the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Codification (&#x201c;ASC&#x201d;) Update No. 2014-19, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers (Topic 606)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; this occurs with the transfer of control of the Company&#x2019;s goods or services. The Company considers revenue to be earned when all of the following criteria are met: it has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the consideration the Company expects to receive for transferring goods or providing services, is determinable and it has transferred control of the promised items to the customer. A promise in a contract to transfer a distinct good or service to the customer is identified as a performance obligation. A contract&#x2019;s transaction price is allocated to each performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of the Company&#x2019;s contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the contract&#x2019;s transaction price to each performance obligation based on the estimated standalone selling prices of the good or service in the contract. For goods or services for which observable standalone selling prices are not available, the Company uses an expected cost plus a margin approach to estimate the standalone selling price of each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Product Revenues&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company&#x2019;s performance obligations related to product sales are satisfied at a point in time. Product revenue consists of the sale of its disposable blood component collection and processing sets and the related equipment. The Company&#x2019;s performance obligation related to product sales is satisfied upon shipment or delivery to the customer based on the specified terms set forth in the customer contract. Shipping and handling activities performed after a customer obtains control of the good are treated as fulfillment activities and are not considered to be a separate performance obligation. Revenue is recognized over time for maintenance plans provided to customers that provide services beyond the Company&#x2019;s standard warranty period. Payment terms between customers related to product sales vary by the type of customer, country of sale, and the products or services offered and could result in an unbilled receivable or deferred revenue balance depending on whether the performance obligation has been satisfied (or partially satisfied). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For product sales to distributors, the Company recognizes revenue for both equipment and disposables upon shipment to distributors, which is when its performance obligations are complete. The Company's standard contracts with its distributors state that title to the equipment passes to the distributors at point of shipment to a distributor&#x2019;s location. The distributors are responsible for shipment to the end customer along with any installation, training and acceptance of the equipment by the end customer. Payments from distributors are not contingent upon resale of the product.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also places equipment at customer sites. While the Company retains ownership of this equipment, the customer has the right to use it for a period of time provided they meet certain agreed to conditions. The Company recovers the cost of providing the equipment from the sale of its disposables.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Software and Other Revenues&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To a lesser extent, the Company enters into other types of contracts including certain software licensing arrangements to provide software solutions to support its plasma, blood collection and hospital customers. A portion of its software sales are perpetual licenses typically accompanied by significant implementation services related to software customization as well as other professional and technical services. The Company generally recognizes revenue from the sale of perpetual licenses and related customization services over time (the Company is creating or enhancing an asset that the customer controls) using an input method which requires it to make estimates of the extent of progress toward completion of the contract. When the Company provides other services, including in some instances hosting, technical support and maintenance, it recognizes these fees and charges over time (the customer simultaneously receives and consumes benefits), as performance obligations for these services are satisfied during the contract period. Certain of the Company&#x2019;s software licensing arrangements are term-based licenses that include a per-collection or a usage-based fee related to the use of the license and the related technical support and hosting services. For these usage-based arrangements, the Company applies the revenue recognition exception resulting in revenue recognition occurring upon the later of actual usage or satisfaction of the related performance obligations. The payment terms for software licensing arrangements vary by customer pursuant to the terms set forth in the customer contract and result in an unbilled receivable or deferred revenue balance depending on whether the performance obligation has been satisfied (or partially satisfied). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from product sales are recorded at the net sales price, which includes estimates of variable consideration related to rebates, product returns and volume discounts. These reserves, which are based on estimates of the amounts earned or to be claimed on the related sales, are recorded as a reduction of revenue and a current liability. The Company&#x2019;s estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#x2019;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract. The amount of variable consideration included in the net sales price is limited to the amount that is probable not to result in a significant reversal in the amount of the cumulative revenue recognized in a future period. Revenue recognized in the current period related to performance obligations satisfied in prior periods was not material. If the Company is unable to estimate the expected rebates reasonably, it records a liability for the maximum potential rebate or discount that could be earned. In circumstances where the Company provides upfront rebate payments to customers, it capitalizes the rebate payments and amortizes the resulting asset as a reduction of revenue using a systematic method over the life of the contract.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables and contract assets, as well as customer advances, customer deposits and deferred revenue (contract liabilities) on the consolidated balance sheets. The difference in timing between billing and revenue recognition primarily occurs in software licensing arrangements, resulting in contract assets and contract liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Practical Expedients&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected not to disclose the value of transaction price allocated to unsatisfied performance obligations for contracts with an original expected length of one year or less. When applicable, the Company has also elected to use the practical expedient to not adjust the promised amount of consideration for the effects of a significant financing component if it is expected, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service, will be one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Translation of Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All assets and liabilities of foreign subsidiaries are translated at the rate of exchange at year-end while sales and expenses are translated at an average rate in effect during the year. The net effect of these translation adjustments is shown in the accompanying financial statements as a component of stockholders&#x2019; equity. Foreign currency transaction gains and losses, including those resulting from intercompany transactions, are charged directly to earnings and included in other expense, net on the consolidated statements of income. The impact of foreign exchange on long-term intercompany loans, for which repayment has not been scheduled or planned, are recorded in accumulated other comprehensive loss on the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents include various instruments such as money market funds, U.S. government obligations and commercial paper with maturities of three months or less at date of acquisition. Cash and cash equivalents are recorded at cost, which approximates fair market value. As of April&#160;1, 2023, cash and cash equivalents consisted primarily of investments in United States Government Agency and institutional money market funds. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes a specific allowance for customers when it is probable that they will not be able to meet their financial obligations. Customer accounts are reviewed individually on a regular basis and reserves are established as deemed appropriate. The Company also maintains a general reserve using a percentage that is established based upon the age of its receivables and its collection history. The Company establishes allowances for balances not yet due and past due accounts based on past experience.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value and include the cost of material, labor and manufacturing overhead. Cost is determined with the first-in, first-out method. The Company has based its provisions for excess, expired and obsolete inventory primarily on its estimates of forecasted net sales. Significant changes in the timing or level of demand for the Company&#x2019;s products result in recording additional provisions for excess, expired and obsolete inventory. Additionally, uncertain timing of next-generation product approvals, variability in product launch strategies, non-cancelable purchase commitments, product recalls and variation in product utilization all affect the Company&#x2019;s estimates related to excess, expired and obsolete inventory.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is recorded at historical cost. The Company provides for depreciation and amortization by charges to operations using the straight-line method in amounts estimated to recover the cost of the building and improvements, equipment and furniture and fixtures over their estimated useful lives as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30-40 Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-20 Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plant equipment and machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-15 Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment and information technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-10 Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Haemonetics equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-7 Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the depreciation periods of property, plant and equipment to determine whether events or circumstances warrant revised estimates of useful lives. All property, plant and equipment are also tested for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s installed base of devices includes devices owned by the Company and devices sold to the customer. The asset on its balance sheet classified as Haemonetics equipment consists of medical devices installed at customer sites but owned by Haemonetics. Generally, the customer has the right to use it for a period of time as long as they meet the conditions the Company has established, which among other things, generally include one or more of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Purchase and consumption of a certain level of disposable products&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Payment of monthly rental fees &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;An asset utilization performance metric, such as performing a minimum level of procedures per month per device&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consistent with the impairment tests noted below for other intangible assets subject to amortization, the Company reviews Haemonetics equipment and the related useful lives of such equipment at least once a year, or more frequently if certain conditions arise, to determine if any adverse conditions exist that would indicate the carrying value of these assets may not be recoverable. To conduct these reviews, the Company estimates the future amount and timing of demand for disposables used &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;with these devices, from which it generates revenues. The Company also considers product life cycle in its evaluation of useful life and recoverability. Changes in expected demand can result in additional depreciation expense, which is classified as cost of goods sold. Any significant unanticipated changes in demand could impact the value of the Company&#x2019;s devices and its reported operating results.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are depreciated over the lesser of their useful lives or the term of the lease. Maintenance and repairs are generally expensed to operations as incurred. When the repair or maintenance costs significantly extend the life of the asset, these costs may be capitalized. When equipment and improvements are sold or otherwise disposed of, the asset cost and accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is included in the consolidated statements of income. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess purchase price over the fair value of the net tangible and other identifiable intangible assets acquired. Goodwill is not amortized and is instead reviewed for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying value. The Company performs its annual impairment test on the first day of the fiscal fourth quarter for each of its reporting units. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC Update No. 2017-04,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;entities perform their goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit&#x2019;s fair value. A reporting unit is defined as an operating segment or one level below an operating segment, referred to as a component. The Company determines its reporting units by first identifying its operating segments and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. The Company aggregates components within an operating segment that have similar economic characteristics. The Company&#x2019;s reportable segments and reporting units are as follows: Plasma, Blood Center and Hospital.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When allocating goodwill from business combinations to its reporting units, the Company assigns goodwill to the reporting units that it expects to benefit from the respective business combination at the time of acquisition. In addition, for purposes of performing its goodwill impairment tests, assets and liabilities, including corporate assets, which relate to a reporting unit&#x2019;s operations and would be considered in determining its fair value, are allocated to the individual reporting units. The Company allocates assets and liabilities not directly related to a specific reporting unit, but from which the reporting unit benefits, based primarily on the respective revenue contribution of each reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the income approach, specifically the discounted cash flow method, to derive the fair value of each of its reporting units in preparing its goodwill impairment assessments. This approach calculates fair value by estimating the after-tax cash flows attributable to a reporting unit and then discounting these after-tax cash flows to a present value using a risk-adjusted discount rate. The Company selected this method as being the most meaningful in preparing its goodwill assessments because the use of the income approach typically generates a more precise measurement of fair value than the market approach.&#160;In applying the income approach to its accounting for goodwill, the Company makes assumptions about the amount and timing of future expected cash flows, terminal value growth rates and appropriate discount rates. The amount and timing of future cash flows within the Company&#x2019;s discounted cash flow analysis is based on its most recent operational budgets, long range strategic plans and other estimates. The terminal value growth rate is used to calculate the value of cash flows beyond the last projected period in the Company&#x2019;s discounted cash flow analysis and reflects the Company&#x2019;s best estimates for stable, perpetual growth of its reporting units. The Company uses estimates of market-participant risk adjusted weighted average cost of capital as a basis for determining the discount rates to apply to its reporting units&#x2019; future expected cash flows. The Company corroborated the valuations that arose from the discounted cash flow approach by performing both a market multiple valuation and by reconciling the aggregate fair value of its reporting units to its market capitalization at the time of the test.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of fiscal 2023, 2022 and 2021, the Company performed its annual goodwill impairment test. The results of the goodwill impairment test performed indicated that the estimated fair value of all of its reporting units exceeded their respective carrying values. There were no reporting units at risk of impairment as of the fiscal 2023, 2022 and 2021 annual test date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews intangible assets subject to amortization for impairment at least annually or more frequently if certain conditions arise to determine if any adverse conditions exist that would indicate that the carrying value of an asset or asset group may not be recoverable, or that a change in the remaining useful life is required. Conditions indicating that an impairment exists include, but are not limited to, a change in the competitive landscape, internal decisions to pursue new or different technology strategies, a loss of a significant customer or a significant change in the marketplace including prices paid for its products or the size of the market for its products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When an impairment indicator exists, the Company tests the intangible asset for recoverability. For purposes of the recoverability test, the Company groups its amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset (asset group) exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset (asset group), the Company will write the carrying value down to the fair value in the period identified. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally calculates the fair value of its intangible assets as the present value of estimated future cash flows it expects to generate from the asset using a risk-adjusted discount rate. In determining its estimated future cash flows associated with its intangible assets, the Company uses estimates and assumptions about future revenue contributions, cost structures and remaining useful lives of the asset (asset group).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company determines the estimate of an intangible asset&#x2019;s remaining useful life should be reduced based on its expected use of the asset, the remaining carrying amount of the asset is amortized prospectively over the revised estimated useful life. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) intangible assets with indefinite lives. IPR&amp;amp;D assets are not amortized. The Company reviews these assets for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of the asset is less than its carrying value. The Company performs its annual impairment test on the first day of the fiscal fourth quarter for its IPR&amp;amp;D assets. The Company makes assumptions about future cash flows, terminal value growth, costs for completion and appropriate discount rates. The Company elected qualitative assessments in fiscal 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting for the Costs of Computer Software to be Sold, Leased, or Otherwise Marketed&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Topic 985-20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Software - Costs of Software to be Sold, Leased or Marketed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, specifies that costs incurred internally in researching and developing a computer software product should be charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs should be capitalized until the product is available for general release to customers, at which point capitalized costs are amortized over their estimated useful life of 5 to 10 years. Technological feasibility is established when it has a detailed design of the software and when research and development activities on the underlying device, if applicable, are completed. The Company capitalizes costs associated with both software that it sells as a separate product and software that is embedded in a device.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews the net realizable value of capitalized assets periodically to assess the recoverability of amounts capitalized. There were no impairment charges recorded during fiscal 2023, 2022 and 2021. In the future, the net realizable value may be adversely affected by the loss of a significant customer or a significant change in the market place, which could result in an impairment being recorded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Current Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities represent items payable or expected to settle within the next twelve months. The items included in the fiscal year end balances were:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;111,628&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;121,207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Long-Term Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term liabilities represent items that are not payable or expected to settle within the next twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Expenses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All research and development costs are expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All advertising costs are expensed as incurred and are included in selling, general and administrative expenses in the consolidated statements of income. Advertising expenses were $7.2 million, $4.4 million and $2.7 million in fiscal 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shipping and Handling Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling costs are included in selling, general and administrative expenses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision is calculated for all jurisdictions in which the Company operates. The income tax provision process involves calculating current taxes due and assessing temporary differences arising from items that are taxable or deductible in different periods for tax and accounting purposes and are recorded as deferred tax assets and liabilities. Deferred tax assets are evaluated for realizability and a valuation allowance is maintained for the portion of the Company&#x2019;s deferred tax assets that are not more-likely-than-not realizable. All available evidence, both positive and negative, has been considered to determine whether, based on the weight of that evidence, a valuation allowance is needed against the deferred tax assets. Refer to Note 6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information and discussion of the Company&#x2019;s income tax provision and balances.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in all jurisdictions in which it operates. The Company records a liability for uncertain tax positions taken or expected to be taken in income tax returns. The Company&#x2019;s financial statements reflect expected future tax consequences of such positions presuming the taxing authorities&#x2019; full knowledge of the position and all relevant facts. The Company records a liability for the portion of unrecognized tax benefits claimed that it has determined are not more-likely-than-not realizable. These tax reserves have been established based on management&#x2019;s assessment as to the potential exposure attributable to the Company&#x2019;s uncertain tax positions as well as interest and penalties attributable to these uncertain tax positions. All tax reserves are analyzed quarterly and adjustments are made as events occur that result in changes in judgment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates at the end of each reporting period whether some or all of the undistributed earnings of its foreign subsidiaries are permanently reinvested. The Company recognizes deferred income tax liabilities to the extent that management asserts that undistributed earnings of its foreign subsidiaries are not permanently reinvested or will not be permanently reinvested in the future. The Company&#x2019;s position is based upon several factors including management&#x2019;s evaluation of the Haemonetics and its subsidiaries&#x2019; financial requirements, the short-term and long-term operational and fiscal objectives of the Company and the tax consequences associated with the repatriation of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to April 4, 2021, the Company accounted for convertible senior notes as separate liability and equity components, determining the fair value of the respective liability components based on an estimate of the fair value of a similar liability without a conversion option and assigning the residual value to the equity component.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective April 4, 2021, the Company accounted for convertible senior notes as a single liability measured at its amortized cost. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below. At issuance, the carrying amount is calculated as the proceeds, net of initial debt issuance costs. The difference between the principal amount and carrying value is amortized to interest expense over the term of the convertible senior notes using the effective interest rate method.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A detailed analysis of the terms of the convertible senior notes transactions is required to determine existence of any derivatives that may require separate mark-to-market accounting under applicable accounting guidance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its derivative financial instruments in accordance with ASC Topic 815, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC 815&#x201d;) and ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC 820&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for the change in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative as a hedging instrument for accounting purposes and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. In addition, ASC 815 provides that, for derivative instruments that qualify for hedge accounting, changes in the fair value are either (a)&#160;offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings or (b)&#160;recognized in equity until the hedged item is recognized in earnings, depending on whether the derivative is being used to hedge changes in fair value or cash flows. The ineffective portion of a derivative&#x2019;s change in fair value is immediately recognized in earnings. The Company does not use derivative financial instruments for trading or speculation purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the underlying hedged transaction affects earnings, the gains or losses on the forward foreign exchange rate contracts designated as hedges are recorded in net revenues, cost of goods sold, operating expenses and other expense, net in the Company&#x2019;s consolidated statements of income, depending on the nature of the underlying hedged transactions. The cash flows related to the gains and losses are classified in the consolidated statements of cash flows as part of cash flows from operating activities. For those derivative instruments that are not designated as part of a hedging relationship the Company records the gains or losses in earnings currently. These gains and losses are intended to offset the gains and losses recorded on net monetary assets or liabilities that are denominated in foreign currencies. The Company recorded foreign currency losses of $1.0 million, $1.5 million and $0.7 million in fiscal 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a quarterly basis, the Company assesses whether the cash flow hedges are highly effective in offsetting changes in the cash flow of the hedged item. The Company manages the credit risk of its counterparties by dealing only with institutions that it considers financially sound and considers the risk of non-performance to be remote. Additionally, the Company&#x2019;s interest rate risk management strategy includes the use of interest rate swaps to mitigate its exposure to changes in variable interest rates. The Company&#x2019;s objective in using interest rate swaps is to add stability to interest expense and to manage and reduce the risk inherent in interest rate fluctuations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s derivative instruments do not subject its earnings or cash flows to material risk, as gains and losses on these derivatives are intended to offset losses and gains on the item being hedged. The Company does not enter into derivative transactions for speculative purposes and it does not have any non-derivative instruments that are designated as hedging instruments pursuant to ASC 815.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expenses the fair value of share-based awards granted to employees, board members and others, net of estimated forfeitures. To calculate the grant-date fair value of its stock options the Company uses the Black-Scholes option-pricing model and for performance share units it uses Monte Carlo simulation models.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Costs Associated with Exit Activities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records employee termination costs in accordance with ASC Topic 712&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Compensation - Nonretirement and Postemployment Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, if it pays the benefits as part of an on-going benefit arrangement, which includes benefits provided as part of its established severance policies or that it provides in accordance with international statutory requirements. The Company accrues employee termination costs associated with an on-going benefit arrangement if the obligation is attributable to prior services rendered, the rights to the benefits have vested, the payment is probable and the liability can be reasonably estimated. The Company accounts for employee termination benefits that represent a one-time benefit in accordance with ASC Topic 420&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Exit or Disposal Cost Obligation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s. It records such costs into expense over the employee&#x2019;s future service period, if any.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other costs associated with exit activities may include contract termination costs, including costs related to leased facilities to be abandoned or subleased, consultant fees and impairments of long-lived assets. The costs are expensed in accordance with ASC Topic 420 and ASC Topic 360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Property, Plant and Equipment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and are included primarily in selling, general and administrative costs in its consolidated statement of income. Additionally, costs directly related to the Company&#x2019;s active restructuring initiatives, including program management costs, accelerated depreciation and costs to transfer product lines &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;among facilities are included within costs of goods sold and selling, general and administrative costs in its consolidated statement of income. Refer to Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information and discussion of its restructuring plans.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Valuation of Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company allocates the amounts it pays for each acquisition to the assets acquired and liabilities assumed based on their estimated fair values at the dates of acquisition, including acquired identifiable intangible assets. The Company bases the estimated fair value of identifiable intangible assets on detailed valuations that use significant assumptions including forecasted cash flows, revenues attributable to existing technology and existing customer attrition. When estimating the significant assumptions to be used in the valuation, the Company includes a consideration of current industry information, market and economic trends, historical results of the acquired business, and other relevant factors. These significant assumptions are forward-looking and could be affected by future economic and market conditions. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Strategic Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds strategic investments, including preferred stock and a special share, in a privately held entity. The special share allows the Company to acquire the entity in accordance with an agreement between the parties. As these equity instruments do not have readily determinable fair values, they have been measured using the measurement alternative, at cost less impairment. The carrying amount for these instruments would be subsequently adjusted for observable price changes, or prices in orderly transactions for an identical investment or similar investment of the same issuer. In addition, these investments are periodically evaluated for impairment. The investments are classified as other long-term assets on the Company&#x2019;s Consolidated Balance Sheets and the Company has not recorded any adjustments to the carrying value of strategic investments in fiscal 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Significant Customers&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents and accounts receivable. In fiscal 2023, 2022 and 2021, the Company&#x2019;s ten largest customers accounted for approximately 48%, 45% and 49% of net revenues, respectively. In fiscal 2023, one Plasma customer, CSL Limited (together with its affiliates, &#x201c;CSL&#x201d;) was greater than 10% of total net revenues and in total accounted for approximately 14% of net revenues. In addition to CSL, two customers also accounted for greater than 10% of the Plasma segment&#x2019;s net revenues and one customer also accounted for greater than 10% of the Blood Center segment&#x2019;s net revenues, but did not exceed 10% of total net revenues, in fiscal 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain other markets and industries can expose the Company to concentrations of credit risk. For example, in the Plasma business unit, sales are concentrated with several large customers. As a result, accounts receivable extended to any one of these biopharmaceutical customers can be significant at any point in time. Also, a portion of the Company&#x2019;s trade accounts receivable outside the U.S. include sales to government-owned or supported healthcare systems in several countries, which are subject to payment delays. Payment is dependent upon the financial stability and creditworthiness of those countries&#x2019; national economies. The Company has not incurred significant losses on government receivables. The Company continually evaluates all government receivables for potential collection risks associated with the availability of government funding and reimbursement practices. If the financial condition of customers or the countries&#x2019; healthcare systems deteriorate such that their ability to make payments is uncertain, allowances may be required in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Standards Implemented&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Codification (&#x201c;ASC&#x201d;) Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326). ASC Update No. 2016-13 is intended to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information, including forecasted information, to develop credit loss estimates. The Company adopted ASC Update No. 2016-13 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company&#x2019;s consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASC Update No. 2018-15, Intangibles, Goodwill and Other - Internal-Use Software (Subtopic 350-40). The new guidance aligns the accounting implementation costs incurred in a cloud computing arrangement that is a service contract with the accounting for internal-use software licenses. The Company adopted ASC Update No. 2018-15 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, the Securities and Exchange Commission (&#x201c;SEC&#x201d;) issued a final rule that amends the financial statement requirements for acquisitions and dispositions of businesses. The amendments primarily relate to disclosures required by Rule 3-05 and Article 11 of Regulation S-X and modifies the tests provided in Rule 1-02(w) of Regulation S-X used to determine whether a subsidiary or an acquired or disposed business is significant and modifies the number of years of audited financial statements required for acquisitions with significance levels greater than specified percentages. The Company early adopted these amendments during the fourth quarter of fiscal 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Codification (&#x201c;ASC&#x201d;) Update No. 2019-12 &#x2014; Income Taxes (Topic 740). The new guidance improves consistent application of and simplifies the accounting for income taxes by removing certain exceptions to the general principals in Topic 740. The Company adopted ASC Update No. 2019-12 effective April 4, 2021. The adoption did not have a material impact on the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASC ASU Update No. 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40). The amendments simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company early adopted ASC Update No. 2020-06 effective April 4, 2021 using the modified retrospective method, which resulted in a decrease of $61.2&#160;million to additional paid-in capital, a decrease to non-current deferred tax liabilities of $20.0&#160;million, and an increase of $80.3&#160;million to non-current convertible notes, net, on the consolidated balance sheets. Additionally, retained earnings was adjusted to remove amortization expense recognized in prior periods related to the debt discount and the convertible notes no longer have a debt discount that will be amortized, net of taxes. The impact to retained earnings on the consolidated balance sheets as of April 4, 2021 is an increase of $1.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the FASB issued ASC Update No. 2021-05 &#x2014; Leases (Topic 842). The new guidance requires a lessor to classify a lease with variable lease payments that do not depend on an index or rate as an operating lease at lease commencement if the lease would have been classified as a sales-type lease or a direct financing lease in accordance with the classification criteria of ASC 842 and the lessor would have otherwise recognized a day-one loss. The Company prospectively adopted ASC Update No. 2021-05 effective in the second quarter of fiscal year 2022. The adoption did not have a material impact on the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:FiscalPeriod
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3NDk_33a4ed01-44f3-4f51-b4c1-6b2c1903c5b1">Fiscal YearHaemonetics&#x2019; fiscal year ends on the Saturday closest to the last day of March. Fiscal years 2023 and 2022 included 52 weeks with each quarter having 13 weeks. Fiscal 2021 included 53 weeks with each of the first three quarters having 13 weeks and the fourth quarter having 14 weeks.</us-gaap:FiscalPeriod>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjc1_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE2NzM_8406d651-1068-4b71-a7bc-8a3f6f41634d">Principles of ConsolidationThe accompanying consolidated financial statements include all accounts including those of its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. In addition, we assess our strategic investments to determine whether they meet the definition of a variable interest entity (&#x201c;VIE&#x201d;), and if so, whether the Company has controlling financial interest. Controlling financial interest occurs if the Company has both the power to direct activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and an obligation to absorb losses of or the right to receive benefits from the VIE that could potentially be significant to the VIE. The Company&#x2019;s strategic investments did not meet the controlling financial interest criteria, as such no VIEs were consolidated during fiscal 2023, 2022 or 2021.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE2NTM_3fc39ea4-b0e0-4bb1-978a-a2d3e1f70040">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results &lt;/span&gt;&lt;/div&gt;could vary from the amounts derived from its estimates and assumptions. The Company considers estimates to be critical if they are required to make assumptions about material matters that are uncertain at the time of estimation or if materially different estimates could have been made or it is reasonably likely that the accounting estimate will change from period to period. The following are areas considered to be critical and require management&#x2019;s judgment: revenue recognition, inventory provisions, intangible asset and goodwill valuation, legal and other judgmental accruals and income taxes.</us-gaap:UseOfEstimates>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4MDg_64497716-a48a-4849-8ba8-a2ba08f8b518">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may become involved in various legal proceedings that arise in the ordinary course of business, including, without limitation, patent infringement, product liability and environmental matters. Accruals recorded for various contingencies including legal proceedings, employee related litigation, self-insurance and other claims are based on judgment, the probability of losses and, where applicable, the consideration of opinions of internal and/or external legal counsel and actuarially determined estimates. When a loss is probable and a range of loss is established but a best estimate cannot be made, the Company records the minimum loss contingency amount, which could be zero. These estimates are often initially developed substantially earlier than the ultimate loss is known and the estimates are reevaluated each accounting period, as additional information is available. As information becomes known, an additional loss provision is recorded when either a best estimate can be made or the minimum loss amount is increased. When events result in an expectation of a more favorable outcome than previously expected, the best estimate is changed to a lower amount.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4MTg_7cb66d79-3330-46c7-bf19-287ea489ebb1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenue recognition policy is to recognize revenues from product sales, software and services in accordance with the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Codification (&#x201c;ASC&#x201d;) Update No. 2014-19, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers (Topic 606)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; this occurs with the transfer of control of the Company&#x2019;s goods or services. The Company considers revenue to be earned when all of the following criteria are met: it has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the consideration the Company expects to receive for transferring goods or providing services, is determinable and it has transferred control of the promised items to the customer. A promise in a contract to transfer a distinct good or service to the customer is identified as a performance obligation. A contract&#x2019;s transaction price is allocated to each performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of the Company&#x2019;s contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the contract&#x2019;s transaction price to each performance obligation based on the estimated standalone selling prices of the good or service in the contract. For goods or services for which observable standalone selling prices are not available, the Company uses an expected cost plus a margin approach to estimate the standalone selling price of each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Product Revenues&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company&#x2019;s performance obligations related to product sales are satisfied at a point in time. Product revenue consists of the sale of its disposable blood component collection and processing sets and the related equipment. The Company&#x2019;s performance obligation related to product sales is satisfied upon shipment or delivery to the customer based on the specified terms set forth in the customer contract. Shipping and handling activities performed after a customer obtains control of the good are treated as fulfillment activities and are not considered to be a separate performance obligation. Revenue is recognized over time for maintenance plans provided to customers that provide services beyond the Company&#x2019;s standard warranty period. Payment terms between customers related to product sales vary by the type of customer, country of sale, and the products or services offered and could result in an unbilled receivable or deferred revenue balance depending on whether the performance obligation has been satisfied (or partially satisfied). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For product sales to distributors, the Company recognizes revenue for both equipment and disposables upon shipment to distributors, which is when its performance obligations are complete. The Company's standard contracts with its distributors state that title to the equipment passes to the distributors at point of shipment to a distributor&#x2019;s location. The distributors are responsible for shipment to the end customer along with any installation, training and acceptance of the equipment by the end customer. Payments from distributors are not contingent upon resale of the product.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also places equipment at customer sites. While the Company retains ownership of this equipment, the customer has the right to use it for a period of time provided they meet certain agreed to conditions. The Company recovers the cost of providing the equipment from the sale of its disposables.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Software and Other Revenues&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To a lesser extent, the Company enters into other types of contracts including certain software licensing arrangements to provide software solutions to support its plasma, blood collection and hospital customers. A portion of its software sales are perpetual licenses typically accompanied by significant implementation services related to software customization as well as other professional and technical services. The Company generally recognizes revenue from the sale of perpetual licenses and related customization services over time (the Company is creating or enhancing an asset that the customer controls) using an input method which requires it to make estimates of the extent of progress toward completion of the contract. When the Company provides other services, including in some instances hosting, technical support and maintenance, it recognizes these fees and charges over time (the customer simultaneously receives and consumes benefits), as performance obligations for these services are satisfied during the contract period. Certain of the Company&#x2019;s software licensing arrangements are term-based licenses that include a per-collection or a usage-based fee related to the use of the license and the related technical support and hosting services. For these usage-based arrangements, the Company applies the revenue recognition exception resulting in revenue recognition occurring upon the later of actual usage or satisfaction of the related performance obligations. The payment terms for software licensing arrangements vary by customer pursuant to the terms set forth in the customer contract and result in an unbilled receivable or deferred revenue balance depending on whether the performance obligation has been satisfied (or partially satisfied). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from product sales are recorded at the net sales price, which includes estimates of variable consideration related to rebates, product returns and volume discounts. These reserves, which are based on estimates of the amounts earned or to be claimed on the related sales, are recorded as a reduction of revenue and a current liability. The Company&#x2019;s estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company&#x2019;s best estimates of the amount of consideration to which it is entitled based on the terms of the contract. The amount of variable consideration included in the net sales price is limited to the amount that is probable not to result in a significant reversal in the amount of the cumulative revenue recognized in a future period. Revenue recognized in the current period related to performance obligations satisfied in prior periods was not material. If the Company is unable to estimate the expected rebates reasonably, it records a liability for the maximum potential rebate or discount that could be earned. In circumstances where the Company provides upfront rebate payments to customers, it capitalizes the rebate payments and amortizes the resulting asset as a reduction of revenue using a systematic method over the life of the contract.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables and contract assets, as well as customer advances, customer deposits and deferred revenue (contract liabilities) on the consolidated balance sheets. The difference in timing between billing and revenue recognition primarily occurs in software licensing arrangements, resulting in contract assets and contract liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Practical Expedients&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected not to disclose the value of transaction price allocated to unsatisfied performance obligations for contracts with an original expected length of one year or less. When applicable, the Company has also elected to use the practical expedient to not adjust the promised amount of consideration for the effects of a significant financing component if it is expected, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service, will be one year or less.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTAzNTc_66892351-0fde-48b6-8599-e89a8c440d9e">P1Y</us-gaap:RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration>
    <us-gaap:RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTA3NDU_66892351-0fde-48b6-8599-e89a8c440d9e">P1Y</us-gaap:RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE2ODI_a527e76f-b654-451b-9fda-182dba25a99c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Translation of Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All assets and liabilities of foreign subsidiaries are translated at the rate of exchange at year-end while sales and expenses are translated at an average rate in effect during the year. The net effect of these translation adjustments is shown in the accompanying financial statements as a component of stockholders&#x2019; equity. Foreign currency transaction gains and losses, including those resulting from intercompany transactions, are charged directly to earnings and included in other expense, net on the consolidated statements of income. The impact of foreign exchange on long-term intercompany loans, for which repayment has not been scheduled or planned, are recorded in accumulated other comprehensive loss on the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3MzE_535437c9-3ac3-4fcb-93ec-190d7c3218a7">Cash and Cash EquivalentsCash equivalents include various instruments such as money market funds, U.S. government obligations and commercial paper with maturities of three months or less at date of acquisition. Cash and cash equivalents are recorded at cost, which approximates fair market value. As of April&#160;1, 2023, cash and cash equivalents consisted primarily of investments in United States Government Agency and institutional money market funds.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <hae:MaximumTermOfMaturitiesForCashAndCashEquivalents
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTE3MTA_2cce708b-8eb0-481d-9f84-27bfedddae3d">P3M</hae:MaximumTermOfMaturitiesForCashAndCashEquivalents>
    <us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4MTA_d806b00a-e3ce-488a-8cd6-94620141bd90">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes a specific allowance for customers when it is probable that they will not be able to meet their financial obligations. Customer accounts are reviewed individually on a regular basis and reserves are established as deemed appropriate. The Company also maintains a general reserve using a percentage that is established based upon the age of its receivables and its collection history. The Company establishes allowances for balances not yet due and past due accounts based on past experience.&lt;/span&gt;&lt;/div&gt;</us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3MDA_24168525-d39a-462d-8ed9-f42ce0bcc9b5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value and include the cost of material, labor and manufacturing overhead. Cost is determined with the first-in, first-out method. The Company has based its provisions for excess, expired and obsolete inventory primarily on its estimates of forecasted net sales. Significant changes in the timing or level of demand for the Company&#x2019;s products result in recording additional provisions for excess, expired and obsolete inventory. Additionally, uncertain timing of next-generation product approvals, variability in product launch strategies, non-cancelable purchase commitments, product recalls and variation in product utilization all affect the Company&#x2019;s estimates related to excess, expired and obsolete inventory.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4MjA_9bb4545c-8e9d-43b8-8054-9d7860a50c77">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is recorded at historical cost. The Company provides for depreciation and amortization by charges to operations using the straight-line method in amounts estimated to recover the cost of the building and improvements, equipment and furniture and fixtures over their estimated useful lives as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30-40 Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-20 Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plant equipment and machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-15 Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment and information technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-10 Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Haemonetics equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-7 Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the depreciation periods of property, plant and equipment to determine whether events or circumstances warrant revised estimates of useful lives. All property, plant and equipment are also tested for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s installed base of devices includes devices owned by the Company and devices sold to the customer. The asset on its balance sheet classified as Haemonetics equipment consists of medical devices installed at customer sites but owned by Haemonetics. Generally, the customer has the right to use it for a period of time as long as they meet the conditions the Company has established, which among other things, generally include one or more of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Purchase and consumption of a certain level of disposable products&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Payment of monthly rental fees &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;An asset utilization performance metric, such as performing a minimum level of procedures per month per device&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consistent with the impairment tests noted below for other intangible assets subject to amortization, the Company reviews Haemonetics equipment and the related useful lives of such equipment at least once a year, or more frequently if certain conditions arise, to determine if any adverse conditions exist that would indicate the carrying value of these assets may not be recoverable. To conduct these reviews, the Company estimates the future amount and timing of demand for disposables used &lt;/span&gt;&lt;/div&gt;with these devices, from which it generates revenues. The Company also considers product life cycle in its evaluation of useful life and recoverability. Changes in expected demand can result in additional depreciation expense, which is classified as cost of goods sold. Any significant unanticipated changes in demand could impact the value of the Company&#x2019;s devices and its reported operating results.Leasehold improvements are depreciated over the lesser of their useful lives or the term of the lease. Maintenance and repairs are generally expensed to operations as incurred. When the repair or maintenance costs significantly extend the life of the asset, these costs may be capitalized. When equipment and improvements are sold or otherwise disposed of, the asset cost and accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is included in the consolidated statements of income.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <hae:ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3NTE_34f2c7f2-1857-4f97-aef1-d35b6431300f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is recorded at historical cost. The Company provides for depreciation and amortization by charges to operations using the straight-line method in amounts estimated to recover the cost of the building and improvements, equipment and furniture and fixtures over their estimated useful lives as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30-40 Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-20 Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plant equipment and machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-15 Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment and information technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-10 Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Haemonetics equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-7 Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</hae:ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia734649bb2e94aaaba0ee38844e22e8d_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfMS0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOmQ3MTZiNDRjYmEyMjRlYmY4NGNlZmE5YjQ1Mjk4NjhiXzQ_aa8b30fe-3fb6-4af0-972f-fd3a83669e34">P30Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i4cb751cf6eb5433f9a53896b439e745e_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfMS0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOmQ3MTZiNDRjYmEyMjRlYmY4NGNlZmE5YjQ1Mjk4NjhiXzc_88ef2860-b690-48de-b270-ff782c4bde1e">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9b1bc73a7c434d8e9c1c7ea1d43cb121_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfMi0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjQxM2MwOTNkMGUxOTQ1YjE4OTgxNTMxNDM4ZGQxMTBkXzQ_845b8a4c-d6c0-4bdd-afcf-5737294e2423">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8d19f87949e24b99a793aca6577b9df5_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfMi0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjQxM2MwOTNkMGUxOTQ1YjE4OTgxNTMxNDM4ZGQxMTBkXzc_beb65f29-e0f9-4f85-be69-eec2f065bb65">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i4c33fc42a5f5449fa7494bc0c090d585_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfMy0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjZkNTdkMTk5NTAxZDRiMGFiYTEzYTZhOWViNjIyZTYwXzQ_7f713eb4-34df-4dd1-bc65-1739a04c2fbe">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ib49d6de2075749128f193bc5cdce0870_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfMy0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjZkNTdkMTk5NTAxZDRiMGFiYTEzYTZhOWViNjIyZTYwXzc_9ffe3e1f-c701-4fba-b7da-430f920193ee">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ibd32c41156c94b0589e00e52da019550_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfNC0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjg4Y2RkMzVkZDMyNzRkZjg4MDdlNDk5MjMzZmZiMjRhXzQ_06fad584-c0f1-42c1-9ab1-7287ffd69fbe">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i03fe4b852d714a1aa9e19e12fe06664b_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfNC0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjg4Y2RkMzVkZDMyNzRkZjg4MDdlNDk5MjMzZmZiMjRhXzc_8f77ea71-3658-464f-abd9-687f185af2fd">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i6edb3ee4a05545b48465b7b748a5455b_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfNS0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjRlNjA3NmM4Y2QyNjQ1MDk4OWVlN2NjMjNkNTliZmU0XzQ_c2c6a65f-d619-4546-af07-fd3de6245bf1">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i40bfcce1095940b7b5d05d79a9a16330_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOjExYTE2MDNkMDRhNDQwODJiZGFmYWMxYmU1N2FjNGY5L3RhYmxlcmFuZ2U6MTFhMTYwM2QwNGE0NDA4MmJkYWZhYzFiZTU3YWM0ZjlfNS0yLTEtMS03MDMzNC90ZXh0cmVnaW9uOjRlNjA3NmM4Y2QyNjQ1MDk4OWVlN2NjMjNkNTliZmU0Xzc_346e4e92-be95-4965-91fa-fce35c7d904c">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3Mzk_fd846c70-8bd2-46a1-9426-38b977348849">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess purchase price over the fair value of the net tangible and other identifiable intangible assets acquired. Goodwill is not amortized and is instead reviewed for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying value. The Company performs its annual impairment test on the first day of the fiscal fourth quarter for each of its reporting units. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC Update No. 2017-04,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;entities perform their goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit&#x2019;s fair value. A reporting unit is defined as an operating segment or one level below an operating segment, referred to as a component. The Company determines its reporting units by first identifying its operating segments and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. The Company aggregates components within an operating segment that have similar economic characteristics. The Company&#x2019;s reportable segments and reporting units are as follows: Plasma, Blood Center and Hospital.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When allocating goodwill from business combinations to its reporting units, the Company assigns goodwill to the reporting units that it expects to benefit from the respective business combination at the time of acquisition. In addition, for purposes of performing its goodwill impairment tests, assets and liabilities, including corporate assets, which relate to a reporting unit&#x2019;s operations and would be considered in determining its fair value, are allocated to the individual reporting units. The Company allocates assets and liabilities not directly related to a specific reporting unit, but from which the reporting unit benefits, based primarily on the respective revenue contribution of each reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the income approach, specifically the discounted cash flow method, to derive the fair value of each of its reporting units in preparing its goodwill impairment assessments. This approach calculates fair value by estimating the after-tax cash flows attributable to a reporting unit and then discounting these after-tax cash flows to a present value using a risk-adjusted discount rate. The Company selected this method as being the most meaningful in preparing its goodwill assessments because the use of the income approach typically generates a more precise measurement of fair value than the market approach.&#160;In applying the income approach to its accounting for goodwill, the Company makes assumptions about the amount and timing of future expected cash flows, terminal value growth rates and appropriate discount rates. The amount and timing of future cash flows within the Company&#x2019;s discounted cash flow analysis is based on its most recent operational budgets, long range strategic plans and other estimates. The terminal value growth rate is used to calculate the value of cash flows beyond the last projected period in the Company&#x2019;s discounted cash flow analysis and reflects the Company&#x2019;s best estimates for stable, perpetual growth of its reporting units. The Company uses estimates of market-participant risk adjusted weighted average cost of capital as a basis for determining the discount rates to apply to its reporting units&#x2019; future expected cash flows. The Company corroborated the valuations that arose from the discounted cash flow approach by performing both a market multiple valuation and by reconciling the aggregate fair value of its reporting units to its market capitalization at the time of the test.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of fiscal 2023, 2022 and 2021, the Company performed its annual goodwill impairment test. The results of the goodwill impairment test performed indicated that the estimated fair value of all of its reporting units exceeded their respective carrying values. There were no reporting units at risk of impairment as of the fiscal 2023, 2022 and 2021 annual test date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews intangible assets subject to amortization for impairment at least annually or more frequently if certain conditions arise to determine if any adverse conditions exist that would indicate that the carrying value of an asset or asset group may not be recoverable, or that a change in the remaining useful life is required. Conditions indicating that an impairment exists include, but are not limited to, a change in the competitive landscape, internal decisions to pursue new or different technology strategies, a loss of a significant customer or a significant change in the marketplace including prices paid for its products or the size of the market for its products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When an impairment indicator exists, the Company tests the intangible asset for recoverability. For purposes of the recoverability test, the Company groups its amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset (asset group) exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset (asset group), the Company will write the carrying value down to the fair value in the period identified. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally calculates the fair value of its intangible assets as the present value of estimated future cash flows it expects to generate from the asset using a risk-adjusted discount rate. In determining its estimated future cash flows associated with its intangible assets, the Company uses estimates and assumptions about future revenue contributions, cost structures and remaining useful lives of the asset (asset group).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company determines the estimate of an intangible asset&#x2019;s remaining useful life should be reduced based on its expected use of the asset, the remaining carrying amount of the asset is amortized prospectively over the revised estimated useful life. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) intangible assets with indefinite lives. IPR&amp;amp;D assets are not amortized. The Company reviews these assets for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of the asset is less than its carrying value. The Company performs its annual impairment test on the first day of the fiscal fourth quarter for its IPR&amp;amp;D assets. The Company makes assumptions about future cash flows, terminal value growth, costs for completion and appropriate discount rates. The Company elected qualitative assessments in fiscal 2023 and 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4MzQ_627271f4-b965-4c63-b7e0-41b8ff5ecbea">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting for the Costs of Computer Software to be Sold, Leased, or Otherwise Marketed&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Topic 985-20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Software - Costs of Software to be Sold, Leased or Marketed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, specifies that costs incurred internally in researching and developing a computer software product should be charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs should be capitalized until the product is available for general release to customers, at which point capitalized costs are amortized over their estimated useful life of 5 to 10 years. Technological feasibility is established when it has a detailed design of the software and when research and development activities on the underlying device, if applicable, are completed. The Company capitalizes costs associated with both software that it sells as a separate product and software that is embedded in a device.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews the net realizable value of capitalized assets periodically to assess the recoverability of amounts capitalized. There were no impairment charges recorded during fiscal 2023, 2022 and 2021. In the future, the net realizable value may be adversely affected by the loss of a significant customer or a significant change in the market place, which could result in an impairment being recorded.&lt;/span&gt;&lt;/div&gt;</us-gaap:SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy>
    <hae:SoftwareCapitalizationTerm
      contextRef="i3acb260a76164a64b8af93dcc2faa623_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjQwMTc_d0e47447-e6f1-4afb-be2b-4555bba5cb13">P5Y</hae:SoftwareCapitalizationTerm>
    <hae:SoftwareCapitalizationTerm
      contextRef="iecd0cd60e86c45669800594f2197741d_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjQwMjM_30a0d7a3-95ff-4f9e-9bee-38a89ae3746d">P10Y</hae:SoftwareCapitalizationTerm>
    <us-gaap:CapitalizedComputerSoftwareImpairments1
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjQ0OTk_150c3d39-af54-456a-932a-c544ab6fe701"
      unitRef="usd">0</us-gaap:CapitalizedComputerSoftwareImpairments1>
    <us-gaap:CapitalizedComputerSoftwareImpairments1
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjQ0OTk_67b8c789-b38a-49a0-b8a1-d5bf76e0e386"
      unitRef="usd">0</us-gaap:CapitalizedComputerSoftwareImpairments1>
    <us-gaap:CapitalizedComputerSoftwareImpairments1
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjQ0OTk_dd9bcd8a-33b7-4601-a16c-7301c7266c5b"
      unitRef="usd">0</us-gaap:CapitalizedComputerSoftwareImpairments1>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjQ1NDQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3ODE_215e0a59-4298-4879-9d1b-4f2224e9f1c6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Current Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities represent items payable or expected to settle within the next twelve months. The items included in the fiscal year end balances were:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;111,628&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;121,207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Other Long-Term LiabilitiesOther long-term liabilities represent items that are not payable or expected to settle within the next twelve months.</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfMy0xLTEtMS03MDMzNA_383d1582-03da-44c2-82b1-6edb8f5ca27f"
      unitRef="usd">30209000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfMy0zLTEtMS03MDMzNA_0d642e47-fb9e-4222-8466-a81a2f945a6c"
      unitRef="usd">26809000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfNy0xLTEtMS03MDMzNA_b3ff5c99-4ec8-412f-a0fe-9c1e84f03457"
      unitRef="usd">863000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfNy0zLTEtMS03MDMzNA_6776d9c9-6b80-4e80-b71d-80b125c4bbd1"
      unitRef="usd">31184000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfOC0xLTEtMS03MDMzNA_b291fe6c-3e53-4c73-bb2d-a67d39826b74"
      unitRef="usd">80556000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfOC0zLTEtMS03MDMzNA_dba932ab-f7d5-4b42-8018-aab206214a96"
      unitRef="usd">63214000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfOS0xLTEtMS03MDMzNA_ce88a954-18e9-49d8-a289-58388ec3b1f1"
      unitRef="usd">111628000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RhYmxlOmZkNTJjZjNhY2FlYTRkNTU4MmI2MzJjMmQyZTQyZDA5L3RhYmxlcmFuZ2U6ZmQ1MmNmM2FjYWVhNGQ1NTgyYjYzMmMyZDJlNDJkMDlfOS0zLTEtMS03MDMzNA_4ff75efc-31c6-4c58-b67f-d14d6706a574"
      unitRef="usd">121207000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4NDE_427ea4ff-9379-4546-9f71-a118d16613b2">Research and Development ExpensesAll research and development costs are expensed as incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4MjU_407225dd-b77b-46a5-978e-5affd577f592">Advertising CostsAll advertising costs are expensed as incurred and are included in selling, general and administrative expenses in the consolidated statements of income.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjUzOTc_63691334-a4f4-4db3-b769-37c76eb292b7"
      unitRef="usd">7200000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjU0MDE_2c3a7d52-f368-4ffc-8075-7d3c99f2c49c"
      unitRef="usd">4400000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjU0MDg_44070206-c477-4e21-b014-6b1f81698686"
      unitRef="usd">2700000</us-gaap:AdvertisingExpense>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMjU0MjE_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3NjI_76998b31-0989-4425-9821-1428e271df3a">Shipping and Handling CostsShipping and handling costs are included in selling, general and administrative expenses.</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3NDA_aa0f4818-5cf0-4b88-b216-961d3be142c3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision is calculated for all jurisdictions in which the Company operates. The income tax provision process involves calculating current taxes due and assessing temporary differences arising from items that are taxable or deductible in different periods for tax and accounting purposes and are recorded as deferred tax assets and liabilities. Deferred tax assets are evaluated for realizability and a valuation allowance is maintained for the portion of the Company&#x2019;s deferred tax assets that are not more-likely-than-not realizable. All available evidence, both positive and negative, has been considered to determine whether, based on the weight of that evidence, a valuation allowance is needed against the deferred tax assets. Refer to Note 6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information and discussion of the Company&#x2019;s income tax provision and balances.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in all jurisdictions in which it operates. The Company records a liability for uncertain tax positions taken or expected to be taken in income tax returns. The Company&#x2019;s financial statements reflect expected future tax consequences of such positions presuming the taxing authorities&#x2019; full knowledge of the position and all relevant facts. The Company records a liability for the portion of unrecognized tax benefits claimed that it has determined are not more-likely-than-not realizable. These tax reserves have been established based on management&#x2019;s assessment as to the potential exposure attributable to the Company&#x2019;s uncertain tax positions as well as interest and penalties attributable to these uncertain tax positions. All tax reserves are analyzed quarterly and adjustments are made as events occur that result in changes in judgment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates at the end of each reporting period whether some or all of the undistributed earnings of its foreign subsidiaries are permanently reinvested. The Company recognizes deferred income tax liabilities to the extent that management asserts that undistributed earnings of its foreign subsidiaries are not permanently reinvested or will not be permanently reinvested in the future. The Company&#x2019;s position is based upon several factors including management&#x2019;s evaluation of the Haemonetics and its subsidiaries&#x2019; financial requirements, the short-term and long-term operational and fiscal objectives of the Company and the tax consequences associated with the repatriation of earnings.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:DebtPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ4ODExOA_0e05bf70-0308-4959-b92b-59e0d44429c2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to April 4, 2021, the Company accounted for convertible senior notes as separate liability and equity components, determining the fair value of the respective liability components based on an estimate of the fair value of a similar liability without a conversion option and assigning the residual value to the equity component.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective April 4, 2021, the Company accounted for convertible senior notes as a single liability measured at its amortized cost. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below. At issuance, the carrying amount is calculated as the proceeds, net of initial debt issuance costs. The difference between the principal amount and carrying value is amortized to interest expense over the term of the convertible senior notes using the effective interest rate method.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A detailed analysis of the terms of the convertible senior notes transactions is required to determine existence of any derivatives that may require separate mark-to-market accounting under applicable accounting guidance.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE4NDA_b22411a5-7c60-4d5c-938b-d0077bcec887">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its derivative financial instruments in accordance with ASC Topic 815, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC 815&#x201d;) and ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC 820&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for the change in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative as a hedging instrument for accounting purposes and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. In addition, ASC 815 provides that, for derivative instruments that qualify for hedge accounting, changes in the fair value are either (a)&#160;offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings or (b)&#160;recognized in equity until the hedged item is recognized in earnings, depending on whether the derivative is being used to hedge changes in fair value or cash flows. The ineffective portion of a derivative&#x2019;s change in fair value is immediately recognized in earnings. The Company does not use derivative financial instruments for trading or speculation purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the underlying hedged transaction affects earnings, the gains or losses on the forward foreign exchange rate contracts designated as hedges are recorded in net revenues, cost of goods sold, operating expenses and other expense, net in the Company&#x2019;s consolidated statements of income, depending on the nature of the underlying hedged transactions. The cash flows related to the gains and losses are classified in the consolidated statements of cash flows as part of cash flows from operating activities. For those derivative instruments that are not designated as part of a hedging relationship the Company records the gains or losses in earnings currently. These gains and losses are intended to offset the gains and losses recorded on net monetary assets or liabilities that are denominated in foreign currencies. The Company recorded foreign currency losses of $1.0 million, $1.5 million and $0.7 million in fiscal 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a quarterly basis, the Company assesses whether the cash flow hedges are highly effective in offsetting changes in the cash flow of the hedged item. The Company manages the credit risk of its counterparties by dealing only with institutions that it considers financially sound and considers the risk of non-performance to be remote. Additionally, the Company&#x2019;s interest rate risk management strategy includes the use of interest rate swaps to mitigate its exposure to changes in variable interest rates. The Company&#x2019;s objective in using interest rate swaps is to add stability to interest expense and to manage and reduce the risk inherent in interest rate fluctuations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s derivative instruments do not subject its earnings or cash flows to material risk, as gains and losses on these derivatives are intended to offset losses and gains on the item being hedged. The Company does not enter into derivative transactions for speculative purposes and it does not have any non-derivative instruments that are designated as hedging instruments pursuant to ASC 815.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMzEyMDY_f927ebee-def8-400b-8a22-703678913375"
      unitRef="usd">-1000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMzEyMTA_e64ae4f6-1b32-4ea8-a325-26edec703052"
      unitRef="usd">-1500000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMzEyMTc_51971b52-f8dc-4828-8092-b41033b6c513"
      unitRef="usd">-700000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMzEyMzA_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3NTI_ccb15765-a275-49bb-9f87-da1741a563e7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expenses the fair value of share-based awards granted to employees, board members and others, net of estimated forfeitures. To calculate the grant-date fair value of its stock options the Company uses the Black-Scholes option-pricing model and for performance share units it uses Monte Carlo simulation models.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3NDc_0ca7c02f-b4f3-4f76-9947-84ad40afa807">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Costs Associated with Exit Activities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records employee termination costs in accordance with ASC Topic 712&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Compensation - Nonretirement and Postemployment Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, if it pays the benefits as part of an on-going benefit arrangement, which includes benefits provided as part of its established severance policies or that it provides in accordance with international statutory requirements. The Company accrues employee termination costs associated with an on-going benefit arrangement if the obligation is attributable to prior services rendered, the rights to the benefits have vested, the payment is probable and the liability can be reasonably estimated. The Company accounts for employee termination benefits that represent a one-time benefit in accordance with ASC Topic 420&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Exit or Disposal Cost Obligation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s. It records such costs into expense over the employee&#x2019;s future service period, if any.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other costs associated with exit activities may include contract termination costs, including costs related to leased facilities to be abandoned or subleased, consultant fees and impairments of long-lived assets. The costs are expensed in accordance with ASC Topic 420 and ASC Topic 360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Property, Plant and Equipment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and are included primarily in selling, general and administrative costs in its consolidated statement of income. Additionally, costs directly related to the Company&#x2019;s active restructuring initiatives, including program management costs, accelerated depreciation and costs to transfer product lines &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;among facilities are included within costs of goods sold and selling, general and administrative costs in its consolidated statement of income. Refer to Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information and discussion of its restructuring plans.&lt;/span&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE3NzY_f8159a8b-b23e-4c8b-8f03-36fd232f327d">Valuation of AcquisitionsThe Company allocates the amounts it pays for each acquisition to the assets acquired and liabilities assumed based on their estimated fair values at the dates of acquisition, including acquired identifiable intangible assets. The Company bases the estimated fair value of identifiable intangible assets on detailed valuations that use significant assumptions including forecasted cash flows, revenues attributable to existing technology and existing customer attrition. When estimating the significant assumptions to be used in the valuation, the Company includes a consideration of current industry information, market and economic trends, historical results of the acquired business, and other relevant factors. These significant assumptions are forward-looking and could be affected by future economic and market conditions. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ4NTM2NA_51d93681-104a-4af5-b6cd-4280879a8220">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Strategic Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds strategic investments, including preferred stock and a special share, in a privately held entity. The special share allows the Company to acquire the entity in accordance with an agreement between the parties. As these equity instruments do not have readily determinable fair values, they have been measured using the measurement alternative, at cost less impairment. The carrying amount for these instruments would be subsequently adjusted for observable price changes, or prices in orderly transactions for an identical investment or similar investment of the same issuer. In addition, these investments are periodically evaluated for impairment. The investments are classified as other long-term assets on the Company&#x2019;s Consolidated Balance Sheets and the Company has not recorded any adjustments to the carrying value of strategic investments in fiscal 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:GainLossOnInvestments
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ4ODc5Ng_d2e6d671-c348-4763-b6c5-57ec8655a846"
      unitRef="usd">0</us-gaap:GainLossOnInvestments>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE2OTg_311a9075-1d2c-449a-aabb-5bedca98b5b4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Significant Customers&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents and accounts receivable. In fiscal 2023, 2022 and 2021, the Company&#x2019;s ten largest customers accounted for approximately 48%, 45% and 49% of net revenues, respectively. In fiscal 2023, one Plasma customer, CSL Limited (together with its affiliates, &#x201c;CSL&#x201d;) was greater than 10% of total net revenues and in total accounted for approximately 14% of net revenues. In addition to CSL, two customers also accounted for greater than 10% of the Plasma segment&#x2019;s net revenues and one customer also accounted for greater than 10% of the Blood Center segment&#x2019;s net revenues, but did not exceed 10% of total net revenues, in fiscal 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain other markets and industries can expose the Company to concentrations of credit risk. For example, in the Plasma business unit, sales are concentrated with several large customers. As a result, accounts receivable extended to any one of these biopharmaceutical customers can be significant at any point in time. Also, a portion of the Company&#x2019;s trade accounts receivable outside the U.S. include sales to government-owned or supported healthcare systems in several countries, which are subject to payment delays. Payment is dependent upon the financial stability and creditworthiness of those countries&#x2019; national economies. The Company has not incurred significant losses on government receivables. The Company continually evaluates all government receivables for potential collection risks associated with the availability of government funding and reimbursement practices. If the financial condition of customers or the countries&#x2019; healthcare systems deteriorate such that their ability to make payments is uncertain, allowances may be required in future periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib118e4be0869418993e5e01e0a05c3d3_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMzU3MzY_226b0829-0ab0-4cb3-afa4-5a51f286a86a"
      unitRef="number">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ica5c1f5ccf23408886c2ccf29b825567_D20210404-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ4ODgxOA_e14e4aac-2703-44f4-b5a4-d860afef16ae"
      unitRef="number">0.45</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic27d4ecc7a734888b526104ed27669d7_D20200329-20210403"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ4ODgyMg_8dee7c0c-f861-4956-9f7d-94bada969438"
      unitRef="number">0.49</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i04ed8db1084a467599f50150cbd6f746_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMzU5NzE_9d1fb7ec-9263-4f23-a2d6-7f8de11a77a6"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfNDE2NjA_40d28ebe-ddb3-477d-b941-9cb89a875f79">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Standards Implemented&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Codification (&#x201c;ASC&#x201d;) Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326). ASC Update No. 2016-13 is intended to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information, including forecasted information, to develop credit loss estimates. The Company adopted ASC Update No. 2016-13 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company&#x2019;s consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASC Update No. 2018-15, Intangibles, Goodwill and Other - Internal-Use Software (Subtopic 350-40). The new guidance aligns the accounting implementation costs incurred in a cloud computing arrangement that is a service contract with the accounting for internal-use software licenses. The Company adopted ASC Update No. 2018-15 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, the Securities and Exchange Commission (&#x201c;SEC&#x201d;) issued a final rule that amends the financial statement requirements for acquisitions and dispositions of businesses. The amendments primarily relate to disclosures required by Rule 3-05 and Article 11 of Regulation S-X and modifies the tests provided in Rule 1-02(w) of Regulation S-X used to determine whether a subsidiary or an acquired or disposed business is significant and modifies the number of years of audited financial statements required for acquisitions with significance levels greater than specified percentages. The Company early adopted these amendments during the fourth quarter of fiscal 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Codification (&#x201c;ASC&#x201d;) Update No. 2019-12 &#x2014; Income Taxes (Topic 740). The new guidance improves consistent application of and simplifies the accounting for income taxes by removing certain exceptions to the general principals in Topic 740. The Company adopted ASC Update No. 2019-12 effective April 4, 2021. The adoption did not have a material impact on the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASC ASU Update No. 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40). The amendments simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company early adopted ASC Update No. 2020-06 effective April 4, 2021 using the modified retrospective method, which resulted in a decrease of $61.2&#160;million to additional paid-in capital, a decrease to non-current deferred tax liabilities of $20.0&#160;million, and an increase of $80.3&#160;million to non-current convertible notes, net, on the consolidated balance sheets. Additionally, retained earnings was adjusted to remove amortization expense recognized in prior periods related to the debt discount and the convertible notes no longer have a debt discount that will be amortized, net of taxes. The impact to retained earnings on the consolidated balance sheets as of April 4, 2021 is an increase of $1.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the FASB issued ASC Update No. 2021-05 &#x2014; Leases (Topic 842). The new guidance requires a lessor to classify a lease with variable lease payments that do not depend on an index or rate as an operating lease at lease commencement if the lease would have been classified as a sales-type lease or a direct financing lease in accordance with the classification criteria of ASC 842 and the lessor would have otherwise recognized a day-one loss. The Company prospectively adopted ASC Update No. 2021-05 effective in the second quarter of fiscal year 2022. The adoption did not have a material impact on the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i916dfcb35225444db2be37fbccd76378_I20210404"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ5NjY2Nw_a9199d05-d9f0-4e93-81cb-ce1c4851319e"
      unitRef="usd">-61200000</us-gaap:StockholdersEquity>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ie55a1738904642cd8ecd0cbc158879ef_I20210404"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ5NjY5OA_ee48642b-6e9a-4e58-9aec-bb3744e31f5a"
      unitRef="usd">-20000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="ie55a1738904642cd8ecd0cbc158879ef_I20210404"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ5NjcyNw_21402c4e-490a-4471-8298-7a4342cc4218"
      unitRef="usd">80300000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:StockholdersEquity
      contextRef="i8fbc64b8be934aaba7b7e05bf27bf2df_I20210404"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl85Ny9mcmFnOjcyNzU2MjQ1MDJkNDQzNWU5OWNlOTg0MzM0MGRkOGVkL3RleHRyZWdpb246NzI3NTYyNDUwMmQ0NDM1ZTk5Y2U5ODQzMzQwZGQ4ZWRfMTY0OTI2NzQ5Njc1Ng_86a0ef42-9f5e-4a8b-bd3b-790072e6f149"
      unitRef="usd">1000000</us-gaap:StockholdersEquity>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzI5MDE_a7f215c1-f3df-4967-b220-2c37a53f25d2">RESTRUCTURING&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On an ongoing basis, the Company reviews the global economy, the healthcare industry, and the markets in which it competes to identify opportunities for efficiencies, enhance commercial capabilities, align its resources and offer its customers better solutions. In order to realize these opportunities, the Company undertakes restructuring-type activities to transform its business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2019, the Board of Directors of the Company approved the Operational Excellence Program (the &#x201c;2020 Program&#x201d;) and delegated authority to the Company&#x2019;s management to determine the detail of the initiatives that will comprise the program. During fiscal 2022, the Company revised the program to improve product and service quality, reduce cost principally in its manufacturing and supply chain operations and ensure sustainability while helping to offset impacts from a previously announced customer loss, rising inflationary pressures and effects of the COVID-19 pandemic. The Company expects to incur aggregate charges between $95&#160;million and $105&#160;million by the end of fiscal 2025 under the program. The majority of charges will result in cash outlays, including severance and other employee costs, and will be incurred as the specific actions required to execute these initiatives are identified and approved. During fiscal 2023, 2022 and 2021, the Company incurred $11.5 million, $28.7 million and $15.1&#160;million of restructuring and restructuring related costs under this program, respectively. Total cumulative charges under this program are $67.2 million as of April&#160;1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity for restructuring reserves related to the 2020 Program and prior programs for the fiscal years ended April&#160;1, 2023, April&#160;2, 2022 and April&#160;3, 2021, substantially all of which relates to employee severance and other employee costs:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020 Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prior Programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs incurred, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 3, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs incurred, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs incurred, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the restructuring costs by line item during fiscal 2023, 2022 and 2021 within our accompanying consolidated statements of income and comprehensive income: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023, the Company had a restructuring liability of $2.2 million, of which approximately $1.8 million is payable within the next twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the restructuring expenses included in the table above, the Company also incurred costs of $10.9 million, $24.6 million and $14.2 million in fiscal 2023, 2022 and 2021, respectively, that do not constitute restructuring costs under ASC 420, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Exit and Disposal Cost Obligations,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and which the Company instead refers to as restructuring related costs. These costs consist primarily of expenditures directly related to the restructuring actions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the restructuring related costs by line item during fiscal 2023, 2022 and 2021 within our accompanying consolidated statements of income and comprehensive income: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below present restructuring and restructuring related costs by reportable segment:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total restructuring and restructuring related costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,549&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;28,824&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,661&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="ic28c109153f44c518dc27cd58f174f92_I20190731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzEwNjY_ddf02f97-a9ab-43ab-bfe5-91acf38325a6"
      unitRef="usd">95000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="ia169b122e4e748a2bbfec2d666095114_I20190731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzEwNzM_b599e4c9-df74-4259-aa19-679d971acd34"
      unitRef="usd">105000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzEzMjg_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i6982a32b8c784f13bc9963f00302b541_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzEzNjQ_d66bf2b3-357d-41e8-b4f2-3bf291cfd831"
      unitRef="usd">11500000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i5ca6348e2ac24a4195142c309fc7a641_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzEzNjg_d7bead0f-bb5b-418f-b3c0-a7730259993c"
      unitRef="usd">28700000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ifea5055cceb64d2faa7c2c933a01dfc9_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzEzNzU_7f131477-e2df-473f-92b7-666d06403970"
      unitRef="usd">15100000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzE1MDk_269919f4-25b1-4bfa-9fdd-cb0067e00706"
      unitRef="usd">67200000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzI5MTQ_255a1683-6f43-472e-b7ac-543c347e3f6a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity for restructuring reserves related to the 2020 Program and prior programs for the fiscal years ended April&#160;1, 2023, April&#160;2, 2022 and April&#160;3, 2021, substantially all of which relates to employee severance and other employee costs:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020 Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prior Programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs incurred, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 3, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs incurred, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs incurred, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the restructuring costs by line item during fiscal 2023, 2022 and 2021 within our accompanying consolidated statements of income and comprehensive income: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i6a75e1df66c146d8bc21150965eea19b_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEtMS0xLTEtNzAzMzQ_09a79dd4-b033-452b-8b86-8c2ea046a38c"
      unitRef="usd">1136000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="id761fa129e9b4c9b8c14ce258bfb5327_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEtMy0xLTEtNzAzMzQ_091f0533-93d7-4796-9a5e-28304b0c1f57"
      unitRef="usd">1512000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i2752e169c88b4ff2a289838d456aec0d_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEtNS0xLTEtNzAzMzQ_81a172d2-622c-42d9-8f2b-5ee27d385479"
      unitRef="usd">2648000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="ifea5055cceb64d2faa7c2c933a01dfc9_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzItMS0xLTEtNzAzMzQ_f965087a-293b-4a36-b63f-260c2a79c7eb"
      unitRef="usd">1501000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4177f085a6164014b652e8ba2cbc96bc_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzItMy0xLTEtNzAzMzQ_b8cc0941-b6b8-4439-8668-945437334adb"
      unitRef="usd">-57000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzItNS0xLTEtNzAzMzQ_697ad85d-0efa-443a-b4d5-9d38b90fec64"
      unitRef="usd">1444000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="ifea5055cceb64d2faa7c2c933a01dfc9_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzMtMS0xLTEtNzAzMzQ_235c5f40-a8fe-4e75-bdca-e08b2e010d98"
      unitRef="usd">2062000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i4177f085a6164014b652e8ba2cbc96bc_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzMtMy0xLTEtNzAzMzQ_95456e40-5ad6-430b-9ffb-40fe7700655a"
      unitRef="usd">1018000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzMtNS0xLTEtNzAzMzQ_c38b5693-cf42-4896-9925-34c65d484c1d"
      unitRef="usd">3080000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i823363dc6c2c4b3ea41d483a51719275_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzUtMS0xLTEtNzAzMzQ_884e3233-4c40-4c4e-9125-ae3ad2fbb960"
      unitRef="usd">575000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i0fbf2c91e0d14fe299efc100a438a840_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzUtMy0xLTEtNzAzMzQ_78953fed-b783-4ec4-b8b6-e67de9c60812"
      unitRef="usd">437000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzUtNS0xLTEtNzAzMzQ_0502a823-ce15-4805-a889-85d4eae94285"
      unitRef="usd">1012000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i5ca6348e2ac24a4195142c309fc7a641_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzYtMS0xLTEtNzAzMzQ_208984d9-1f48-4744-aec1-eb018bf87242"
      unitRef="usd">4202000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i687b01b80c934827b2cb6b312b9524ad_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzYtMy0xLTEtNzAzMzQ_75724522-3f88-4009-987f-95eed11b026c"
      unitRef="usd">28000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzYtNS0xLTEtNzAzMzQ_e9db3fff-1e35-401e-80cf-35b118280902"
      unitRef="usd">4230000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i5ca6348e2ac24a4195142c309fc7a641_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzctMS0xLTEtNzAzMzQ_84b7de53-ad69-4def-b62e-c1509497da85"
      unitRef="usd">2317000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i687b01b80c934827b2cb6b312b9524ad_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzctMy0xLTEtNzAzMzQ_aadd1b97-3ee4-4a19-a314-c432cb666fbb"
      unitRef="usd">120000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzctNS0xLTEtNzAzMzQ_6f940334-d60f-4d64-afa2-6041d8dd7166"
      unitRef="usd">2437000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i8589d7325ec74adabcdb6aef0a20354d_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzktMS0xLTEtNzAzMzQ_20aa38ec-cc5c-46a7-ab10-7065fb746de6"
      unitRef="usd">2460000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i002292f589b9486bbc885d8889b15b7b_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzktMy0xLTEtNzAzMzQ_e09e337f-fbcb-451a-93ef-63ce36c8bf53"
      unitRef="usd">345000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzktNS0xLTEtNzAzMzQ_7e6acff8-1f72-4385-85f3-c2e4d30c30df"
      unitRef="usd">2805000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i6982a32b8c784f13bc9963f00302b541_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEwLTEtMS0xLTcwMzM0_f681a99b-9d13-4bb5-a00b-d121a0b17130"
      unitRef="usd">576000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i407111b2df044b2d85cd23b1b5025a83_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEwLTMtMS0xLTcwMzM0_97fda0aa-47aa-4838-b0ff-1efd59b8a56c"
      unitRef="usd">81000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEwLTUtMS0xLTcwMzM0_ec6ff2c5-564b-4025-8804-8ff9c8acb50f"
      unitRef="usd">657000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i6982a32b8c784f13bc9963f00302b541_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzExLTEtMS0xLTcwMzM0_26273253-ab58-4e40-a8a9-a7a85be78456"
      unitRef="usd">1226000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i407111b2df044b2d85cd23b1b5025a83_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzExLTMtMS0xLTcwMzM0_a1db4dec-7bff-493c-be40-193ae49fa061"
      unitRef="usd">86000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzExLTUtMS0xLTcwMzM0_d48920b0-29a5-42f5-92b7-e6925b04353b"
      unitRef="usd">1312000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i62b2b847dc034a3db085e75ba45fed2e_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEyLTEtMS0xLTcwMzM0_49d1d244-5998-4f7b-a00c-ef556647450a"
      unitRef="usd">1810000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i984a455da961408f925ca49751e6ddef_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEyLTMtMS0xLTcwMzM0_833c8e75-5c33-42f6-b7a8-7cbf839ed3b7"
      unitRef="usd">340000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo4Mzc5NjA5NzQ2NGM0ZmMyODA4YTE0NTU1MzlhOGRmMS90YWJsZXJhbmdlOjgzNzk2MDk3NDY0YzRmYzI4MDhhMTQ1NTUzOWE4ZGYxXzEyLTUtMS0xLTcwMzM0_48dcd7bc-0048-46a4-ac96-b1e7f38e49d5"
      unitRef="usd">2150000</us-gaap:RestructuringReserve>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzE4NDM_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:RestructuringCharges
      contextRef="ie757a5b3c6874d30b0632b13796f7765_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzEtMS0xLTEtNzAzMzQ_a2805209-d5a5-4045-b7b1-e33d912d8970"
      unitRef="usd">-215000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i35a58bb523b34502b7e9328f05462202_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzEtMy0xLTEtNzAzMzQ_fd25d962-d09b-401c-bc3d-3dfbdf4a4b9d"
      unitRef="usd">2236000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i54605da039714724a8b332c1eadca994_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzEtNS0xLTEtNzAzMzQ_58c83ebc-b2e1-41b0-8090-8dc0e91ab9bb"
      unitRef="usd">390000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6e94fc8a563c41dbb911f86eebd74fb4_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzItMS0xLTEtNzAzMzQ_57f50d2b-d13e-4045-86bf-1406fc2bd6e2"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i60c21727b1644983b67286f3ff83bf6f_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzItMy0xLTEtNzAzMzQ_16d8aec3-457e-44c3-b942-2c7996750c09"
      unitRef="usd">105000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if570127cbc674472bddd6c920a6680a6_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzItNS0xLTEtNzAzMzQ_ab9e5dad-2fd4-4efc-9ec7-e7e8a246c753"
      unitRef="usd">142000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic03bd40350ab47b59e94e0eb9a16722d_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzMtMS0xLTEtNzAzMzQ_9ee21837-48dd-490c-991b-5d753490d476"
      unitRef="usd">872000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i44318b6edd204f9bb959e54aa88e533c_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzMtMy0xLTEtNzAzMzQ_0c0874de-0cde-44dd-b753-414004bdb120"
      unitRef="usd">1889000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i202912003ea5483c8e977d2876231a84_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzMtNS0xLTEtNzAzMzQ_c0c9e9ed-3fcd-4d36-b7f9-28d67b52c694"
      unitRef="usd">912000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzQtMS0xLTEtNzAzMzQ_127d0c3c-4f35-444a-8f28-90deceb9ee0a"
      unitRef="usd">657000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzQtMy0xLTEtNzAzMzQ_576e74cd-0ddf-417b-8f11-ab693746346e"
      unitRef="usd">4230000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZDY3MTQ4N2RmMDc0ODgwODVmMDQ2MmI1Y2M3ZGFjYS90YWJsZXJhbmdlOjRkNjcxNDg3ZGYwNzQ4ODA4NWYwNDYyYjVjYzdkYWNhXzQtNS0xLTEtNzAzMzQ_300138e4-2914-43cb-a22f-6506dd75f9bd"
      unitRef="usd">1444000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserve
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzIwMDA_d784f7fe-e00d-4ce5-a56e-ea34fb8a0cbb"
      unitRef="usd">2200000</us-gaap:RestructuringReserve>
    <hae:RestructuringChargesPayableInNextTwelveMonths
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzIwMjc_e988de08-381e-49db-a676-5485a18288d2"
      unitRef="usd">1800000</hae:RestructuringChargesPayableInNextTwelveMonths>
    <hae:RestructuringRelatedCosts
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzIxODA_35251ed3-9fce-428c-bb52-a50dd480189b"
      unitRef="usd">10900000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzIxODQ_1c839f59-b66d-4d39-aec0-a7a50e724b6d"
      unitRef="usd">24600000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzIxOTE_82f46e83-a24b-4531-9061-5da85fd5806f"
      unitRef="usd">14200000</hae:RestructuringRelatedCosts>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzI5MTY_424e1b58-4069-491a-b9af-850b3c54dd27">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the restructuring related costs by line item during fiscal 2023, 2022 and 2021 within our accompanying consolidated statements of income and comprehensive income: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below present restructuring and restructuring related costs by reportable segment:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total restructuring and restructuring related costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,549&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;28,824&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,661&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90ZXh0cmVnaW9uOmM1Y2EyZWI3MTAwMzQ2Y2JhZTU5Y2RmMTk2NTIzZDgwXzI2OTk_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <hae:RestructuringRelatedCosts
      contextRef="ie757a5b3c6874d30b0632b13796f7765_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzEtMS0xLTEtNzAzMzQ_4f2288e4-7f2d-428b-ba42-2b1dcda08f21"
      unitRef="usd">7991000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i35a58bb523b34502b7e9328f05462202_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzEtMy0xLTEtNzAzMzQ_108bca00-12f3-4f54-b342-9958307a0b3d"
      unitRef="usd">17832000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i54605da039714724a8b332c1eadca994_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzEtNS0xLTEtNzAzMzQ_c1b44bd3-ed4d-46b8-91f0-aedcb296c8f3"
      unitRef="usd">9318000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i6e94fc8a563c41dbb911f86eebd74fb4_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzItMS0xLTEtNzAzMzQ_d12766ce-9c76-457b-83c8-bcf0c734b39c"
      unitRef="usd">1050000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i60c21727b1644983b67286f3ff83bf6f_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzItMy0xLTEtNzAzMzQ_05753f63-a912-4393-b624-baa37837d0f9"
      unitRef="usd">714000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="if570127cbc674472bddd6c920a6680a6_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzItNS0xLTEtNzAzMzQ_b4a31b96-2b39-439e-b567-e30cf1438bef"
      unitRef="usd">1026000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="ic03bd40350ab47b59e94e0eb9a16722d_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzMtMS0xLTEtNzAzMzQ_720ec2e4-9f89-4ec1-8a2f-35834d1243f9"
      unitRef="usd">1851000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i44318b6edd204f9bb959e54aa88e533c_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzMtMy0xLTEtNzAzMzQ_0716cae0-a11e-4c25-8d63-51c4386e7a35"
      unitRef="usd">6048000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i202912003ea5483c8e977d2876231a84_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzMtNS0xLTEtNzAzMzQ_458d5105-4f50-49f6-8be8-f4ea19bde1df"
      unitRef="usd">3873000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzQtMS0xLTEtNzAzMzQ_fa6e71ff-691e-4dce-bdfa-0cc2aec01b5e"
      unitRef="usd">10892000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzQtMy0xLTEtNzAzMzQ_ec8a77d6-a83b-4a69-adc9-e00f804000bd"
      unitRef="usd">24594000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0ZjhjNGJkNjVlNWM0ZGZkYjZmM2U0OWFiM2JjNjQ3MC90YWJsZXJhbmdlOjRmOGM0YmQ2NWU1YzRkZmRiNmYzZTQ5YWIzYmM2NDcwXzQtNS0xLTEtNzAzMzQ_71c0fb45-6641-428e-9223-eaad5c58a256"
      unitRef="usd">14217000</hae:RestructuringRelatedCosts>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:RestructuringCharges
      contextRef="iceda53e10aa943db9898cb8ab8dac15a_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzItMS0xLTEtNzAzMzQ_ccc71b1f-387b-424f-8822-ff0cc8bed29f"
      unitRef="usd">-48000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic069cd0eb4c94953be95e2deb98ea5e5_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzItMy0xLTEtNzAzMzQ_1c15a79d-135f-4d92-ba30-657c7776f73f"
      unitRef="usd">2492000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia79a8918d94541fbb215b791d3bc0308_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzItNS0xLTEtNzAzMzQ_c479dd7a-e1c9-485e-943a-c423d7918abc"
      unitRef="usd">454000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie3ffef01c50b40dcbbc6f463d67d82a6_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzMtMS0xLTEtNzAzMzQ_069f7a3a-fe40-42da-b330-bff2677c65af"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i0b364431a43245b7a9f05a60dc7416df_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzMtMy0xLTEtNzAzMzQ_90a248ad-1d75-4a5d-8c9f-13af379d7b39"
      unitRef="usd">-18000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie6794b0b382b4fb7886de74ba621481b_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzMtNS0xLTEtNzAzMzQ_d5198805-40fa-47af-9d14-22aef0a5c0f6"
      unitRef="usd">201000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i753483fb84d94062bdc30420838c80cf_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzQtMS0xLTEtNzAzMzQ_d60bdf7d-9ce1-4440-9e2b-0ce351efca25"
      unitRef="usd">165000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5c4e22f5dd7d46aab1223c60d287905f_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzQtMy0xLTEtNzAzMzQ_aa0e65a3-946a-4b50-9891-bc5e1689e0cc"
      unitRef="usd">-93000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4e8e2ad8db6d4f6c859bc3263d7c9235_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzQtNS0xLTEtNzAzMzQ_7157b0ab-9b6c-4663-af37-eb90a8909816"
      unitRef="usd">322000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i206a029467f0420ab5932b24faf54368_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzUtMS0xLTEtNzAzMzQ_8daa1b37-2389-4feb-a303-1ff99bead2f6"
      unitRef="usd">540000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2f56f2e6daa64033b788180008d0fb12_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzUtMy0xLTEtNzAzMzQ_547d9434-1bfe-4c32-aea8-7c9fa98fd756"
      unitRef="usd">1849000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icf36ce0a0ea1444d88b791a90bbfdf76_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzUtNS0xLTEtNzAzMzQ_1a9bf8b5-549b-418a-a08f-4026ce0e53ad"
      unitRef="usd">467000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzYtMS0xLTEtNzAzMzQ_17a6d82a-2446-4d4f-b717-a4050482fe8b"
      unitRef="usd">657000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzYtMy0xLTEtNzAzMzQ_5706051f-15d2-4880-ba94-a5b5af7d3899"
      unitRef="usd">4230000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzYtNS0xLTEtNzAzMzQ_61278da0-09d7-4949-8d5c-b3de23e0e548"
      unitRef="usd">1444000</us-gaap:RestructuringCharges>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzktMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <hae:RestructuringRelatedCosts
      contextRef="iceda53e10aa943db9898cb8ab8dac15a_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEwLTEtMS0xLTcwMzM0_861d0bed-001a-48fe-8e6c-b087c255e7fe"
      unitRef="usd">1385000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="ic069cd0eb4c94953be95e2deb98ea5e5_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEwLTMtMS0xLTcwMzM0_f46da577-8d54-4f82-ae74-340d77edbae6"
      unitRef="usd">7906000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="ia79a8918d94541fbb215b791d3bc0308_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEwLTUtMS0xLTcwMzM0_887e830e-4953-4d3d-8d7d-31774b1e59f6"
      unitRef="usd">1870000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="ie3ffef01c50b40dcbbc6f463d67d82a6_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzExLTEtMS0xLTcwMzM0_2a4f8534-6271-48df-a337-65bb8ff9de10"
      unitRef="usd">75000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i0b364431a43245b7a9f05a60dc7416df_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzExLTMtMS0xLTcwMzM0_0a627843-dbdb-41b7-b4e0-99b76e7e079a"
      unitRef="usd">556000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="ie6794b0b382b4fb7886de74ba621481b_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzExLTUtMS0xLTcwMzM0_6e7a9269-bb05-43a3-b55d-86dcc88cbc49"
      unitRef="usd">1599000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i753483fb84d94062bdc30420838c80cf_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEyLTEtMS0xLTcwMzM0_dce08647-9629-4308-9b4c-db266828fb9a"
      unitRef="usd">546000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i5c4e22f5dd7d46aab1223c60d287905f_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEyLTMtMS0xLTcwMzM0_d3638df1-affc-4ee8-9d9c-4fedef6dbac6"
      unitRef="usd">379000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i4e8e2ad8db6d4f6c859bc3263d7c9235_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEyLTUtMS0xLTcwMzM0_23148394-3ea0-44dd-944d-c9b275b9b473"
      unitRef="usd">14000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i206a029467f0420ab5932b24faf54368_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEzLTEtMS0xLTcwMzM0_61c9be52-ef94-4d9f-a23f-787412a925a3"
      unitRef="usd">8886000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i2f56f2e6daa64033b788180008d0fb12_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEzLTMtMS0xLTcwMzM0_f2a1b053-9a53-413d-b11b-40f4df3cc4c8"
      unitRef="usd">15753000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="icf36ce0a0ea1444d88b791a90bbfdf76_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzEzLTUtMS0xLTcwMzM0_8d210529-44a6-46b7-86f8-7162a5a9566c"
      unitRef="usd">10734000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzE0LTEtMS0xLTcwMzM0_186d8233-d8cc-4eb9-919e-2a689b71bf8a"
      unitRef="usd">10892000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzE0LTMtMS0xLTcwMzM0_e7807e98-5e3c-4a6e-b25a-ebfc3bacee50"
      unitRef="usd">24594000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzE0LTUtMS0xLTcwMzM0_dd7d1911-3cf4-4a07-8429-410abb441a6f"
      unitRef="usd">14217000</hae:RestructuringRelatedCosts>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzE2LTEtMS0xLTcwMzM0_362a5a11-7a47-4c7a-b599-d9c41dcbc9fd"
      unitRef="usd">11549000</hae:RestructuringandRestructuringRelatedCosts>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzE2LTMtMS0xLTcwMzM0_b6b78b39-2000-4014-9ec6-b56a3a51cf5f"
      unitRef="usd">28824000</hae:RestructuringandRestructuringRelatedCosts>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDAvZnJhZzpjNWNhMmViNzEwMDM0NmNiYWU1OWNkZjE5NjUyM2Q4MC90YWJsZTo0YzA3MmNhZjY2OTc0ODRmYWI0ODYwZTNjZGFhOGIzNC90YWJsZXJhbmdlOjRjMDcyY2FmNjY5NzQ4NGZhYjQ4NjBlM2NkYWE4YjM0XzE2LTUtMS0xLTcwMzM0_51cd8109-b52f-4330-8ee6-0306b6ff8480"
      unitRef="usd">15661000</hae:RestructuringandRestructuringRelatedCosts>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzk5NTc_8256db22-efbb-431c-82c0-815583ba3426">ACQUISITIONS AND STRATEGIC INVESTMENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cardiva Medical, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 17, 2021, the Company entered into an Agreement and Plan of Merger with Cardiva Medical, Inc. (&#x201c;Cardiva&#x201d;), an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. In connection with this acquisition, which closed on March 1, 2021, the Company acquired 100% of the issued and outstanding shares of capital stock of Cardiva for total consideration of $489.8&#160;million, which consisted of upfront payments in the aggregate of $465.5&#160;million ($418.2&#160;million net of cash acquired) and the fair value of contingent consideration of $24.3&#160;million.  Cardiva achieved the contingent consideration maximum payout of $35.0&#160;million, of which the final payment was made in fiscal 2023. The Company financed the acquisition through a combination of cash, borrowings under its revolving credit facility and an additional $150.0&#160;million term loan under its existing credit facility.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cardiva&#x2019;s portfolio includes two catheter-based vascular access site closure devices. The VASCADE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; vascular closure system is designed for &#x201c;small-bore&#x201d; femoral arterial and venous closure, generally used in interventional cardiology and peripheral vascular procedures. The VASCADE MVP&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; vascular closure system is designed for &#x201c;mid-bore&#x201d; multi-access femoral venous closure, generally used in electrophysiology procedures, and is the only U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) approved closure device for use following cardiac ablation procedures requiring two or more access sites within the same vessel. The addition of the VASCADE portfolio to the Hospital business unit includes products with demonstrated benefits and enhances penetration into the large and growing interventional cardiology and electrophysiology markets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the acquisition of Cardiva as a business combination, and in accordance with FASB ASC Topic 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Topic 805&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following amounts represent the fair value of the identifiable assets acquired and liabilities assumed for Cardiva:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;534,240&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued payroll and related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;91,971&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;442,269&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined the identifiable intangible assets were completed technology, customer relationships, trademarks and in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;). The fair values of intangible assets were based on valuation techniques with estimates and assumptions developed by the Company. Completed technology and IPR&amp;amp;D were valued using the excess earnings method. Customer relationships were valued using the distributor method. Trademarks were valued using the relief from royalty method. The cash flows used in the valuation of the intangible assets were based on estimates used to price the transaction. In developing the discount rates applied to the cash flow projections, the discount rates were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital and then adjusted to reflect the relative risk of the asset.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The excess of the purchase price over the tangible assets, identifiable intangible assets and assumed liabilities was recorded as goodwill. As a result of the acquisition of Cardiva, the Company recognized goodwill of $253.7&#160;million, which is attributable to the revenue and cash flow projections associated with completed technologies and the development of future technology that does not exist in the current IPR&amp;amp;D pipeline. The goodwill is not deductible for tax purposes and relates entirely to the Hospital reportable segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets acquired consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount&lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;250,560&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a long-term deferred tax liability, net, of $26.8&#160;million primarily related to acquired intangible assets which cannot be deducted for tax purposes, partially offset by deferred tax assets primarily related to net operating losses acquired.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition-Related Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of acquisition-related costs incurred associated with the acquisition was $9.6&#160;million for the fiscal year ending April 3, 2021. The Company incurred acquisition costs related to legal and other professional fees in the amount of $6.6&#160;million and an additional $3.0&#160;million of debt financing costs and lender fees which were recognized in selling, general and administrative and as interest expense on the consolidated statements of income, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unaudited Pro Forma Financial Information&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cardiva contributed revenues of $7.7&#160;million to net revenues and losses of $7.6&#160;million to net income for the period post acquisition through April 3, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited estimated pro forma results presented below include the effects of the acquisition of Cardiva as if it was consummated on March 31, 2019. In fiscal 2021, the Company incurred nonrecurring charges attributed to the acquisition of Cardiva, which are presented in the consolidated statements of income for this period. These charges include acquisition-related costs, retention bonuses and severance payments, adjusted for the related tax effects. These nonrecurring charges are reflected as adjustments to the pro forma earnings presented below for fiscal 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, these pro forma amounts have been calculated, net of tax, after adjusting the results of Cardiva to reflect the additional costs associated with fair value adjustments relating to inventories, leases and intangible assets as if the acquisition had occurred on March 31, 2019 and adjusting interest amounts related to long-term debt assumptions. There was no significant impact to the pro forma amounts after applying the Company&#x2019;s accounting policies.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The supplemental pro forma information presented below is for informational purposes only and should be read in conjunction with our historical financial statements. The pro forma results do not include any anticipated synergies or other expected benefits of the acquisition. Accordingly, the unaudited estimated pro forma financial information below is not necessarily indicative of what the actual results of operations of the combined companies would have been had the acquisition of Cardiva occurred as of March 31, 2019, nor are they indicative of future results of operations. The pro forma assumptions and adjustments are reasonable and appropriate under the circumstances and are factually supported based on information currently available.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) (Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;916,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;HAS Intellectual Property&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the Company entered into an agreement to acquire certain intellectual property owned by HemoAssay Science and Technology (Suzhou) Co. Ltd., a China-incorporated company, and its affiliates (collectively, &#x201c;HemoAssay&#x201d;) underlying their HAS viscoelastic diagnostic devices, related assays and disposables. The Company previously entered into exclusive manufacturing and distribution agreements with HemoAssay pursuant to which it has exclusive rights to commercialize HemoAssay&#x2019;s HAS devices in China. In connection with the transaction, the Company has agreed to pay up to $15.0&#160;million to HemoAssay in contingent consideration based on certain developmental and manufacturing based milestones. In fiscal years 2023 and 2022, the Company made milestone payments of $2.9&#160;million and $2.5&#160;million, respectively, which were recorded within intangible assets on the consolidated balance sheets. These products augment the Company&#x2019;s portfolio of hemostasis analyzers within the Hospital business unit.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;enicor GmbH&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2020, the Company acquired all of the outstanding equity of enicor GmbH (&#x201c;enicor&#x201d;), the manufacturer of ClotPro&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a new generation whole blood coagulation testing system that is currently available in select European and Asia Pacific markets, for total consideration of $20.5&#160;million, which consisted of upfront payments of $16.6&#160;million and the fair value of contingent consideration of $3.9&#160;million. The contingent consideration, which could total a maximum of $4.5&#160;million, consists of payments related to the achievement of certain revenue and regulatory milestones. As of April 1, 2023, the Company has made $2.3&#160;million of milestone payments. The acquisition of this viscoelastic diagnostic device augments the Company&#x2019;s portfolio of hemostasis analyzers within the Hospital business unit.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the acquisition of enicor as a business combination, and in accordance with FASB ASC Topic 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Topic 805&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following amounts represent the fair value of the identifiable assets acquired and liabilities assumed for enicor completed during fiscal 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;April 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,851&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,325&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,526&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined the identifiable intangible assets were completed technology, customer relationships and a trademark. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a rate of 20%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The benefits of adding a viscoelastic diagnostic device to the Company&#x2019;s portfolio of hemostasis analyzers within the Hospital business unit contributed to an acquisition price in excess of the fair value of net assets acquired for enicor, which resulted in the establishment of goodwill. In addition, the benefits of lower cost manufacturing and complementary sales channels also contributed to the establishment of goodwill for this acquisition. The goodwill is not deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets acquired consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount&lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademark&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,090&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition-Related Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2021, the Company incurred $0.2&#160;million of acquisition-related costs associated with the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unaudited Pro Forma Financial Information&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;enicor had an immaterial impact to the Company&#x2019;s net revenues and net income for fiscal 2021. The unaudited estimated pro forma impact of the results of the acquisition of enicor as if it was consummated on April 1, 2019 are immaterial. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Strategic Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal year 2023, the Company made investments in Vivasure Medical LTD (&#x201c;Vivasure&#x201d;), totaling &#x20ac;30&#160;million. The investments include both preferred stock and a special share that allows the Company to acquire Vivasure in accordance with an agreement between the parties. The investments are classified as other long-term assets on the consolidated balance sheets and the Company has not recorded any adjustments to the carrying value of our strategic investments in fiscal 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzM0OA_9c982a9b-e51a-4740-894f-1e5123171a21"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i7405bd2190704f40b0b1839ce85522b7_D20210301-20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzQ0Mw_2df1d5c3-45bd-4f70-8c28-5be23d4cb230"
      unitRef="usd">489800000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i7405bd2190704f40b0b1839ce85522b7_D20210301-20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzUwMw_edcd6cb6-5a75-40d0-8a41-3ea7368dd015"
      unitRef="usd">465500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i7405bd2190704f40b0b1839ce85522b7_D20210301-20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzUwNw_35ac4eca-8be4-49f3-8cf5-cefd1d9cef3a"
      unitRef="usd">418200000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzU4Mg_736f836f-b406-4437-8726-19671c5841d5"
      unitRef="usd">24300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzY0Nw_570a1482-0df2-48e7-a4d6-0642eb2db742"
      unitRef="usd">35000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i7405bd2190704f40b0b1839ce85522b7_D20210301-20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzg0MQ_9d845974-be38-44de-a9f3-a9ba23ae5770"
      unitRef="usd">150000000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzk5NjE_fa134f42-ae41-43f4-956a-fc2adbb53847">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following amounts represent the fair value of the identifiable assets acquired and liabilities assumed for Cardiva:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;534,240&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued payroll and related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;91,971&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;442,269&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets acquired consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount&lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;250,560&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following amounts represent the fair value of the identifiable assets acquired and liabilities assumed for enicor completed during fiscal 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;April 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,851&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,325&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,526&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets acquired consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount&lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademark&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,090&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzEtMS0xLTEtNzAzMzQ_0b27fd6f-dff8-40dd-86b6-4a604e125349"
      unitRef="usd">7304000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzItMS0xLTEtNzAzMzQ_c37292cb-42ba-4054-932e-a3b4514b5d72"
      unitRef="usd">18765000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzMtMS0xLTEtNzAzMzQ_819848b9-9807-492b-9237-9d5fe8a8cf52"
      unitRef="usd">850000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzQtMS0xLTEtNzAzMzQ_0bf5ca8a-7b4e-47bd-9c52-49e9e8af0520"
      unitRef="usd">1186000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzUtMS0xLTEtNzAzMzQ_e5ca28be-0d22-4d38-8813-a4df930d9dbe"
      unitRef="usd">250560000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzYtMS0xLTEtNzAzMzQ_645128f2-cba4-4f99-bf2d-cee43091e34b"
      unitRef="usd">253707000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzctMS0xLTEtNzAzMzQ_16da6268-6ba4-439e-bd6a-e2515c67c242"
      unitRef="usd">1868000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzgtMS0xLTEtNzAzMzQ_7dd88dde-ad58-482f-bd36-4963f82fec91"
      unitRef="usd">534240000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzktMS0xLTEtNzAzMzQ_d180f008-6e64-41cd-9a1b-137ff76413d3"
      unitRef="usd">3292000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <hae:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzEwLTEtMS0xLTcwMzM0_5399fcb9-6ae5-44bb-84ef-4771852c6c45"
      unitRef="usd">58211000</hae:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzExLTEtMS0xLTcwMzM0_ac524582-cdd6-4d30-ba1f-23cc49b9d7dc"
      unitRef="usd">1903000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzEyLTEtMS0xLTcwMzM0_bc562094-cad8-43ab-a0b7-8a8239345bce"
      unitRef="usd">26793000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzEzLTEtMS0xLTcwMzM0_e070a6fc-1511-4126-998f-ba0dcd09b7ea"
      unitRef="usd">1772000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzE0LTEtMS0xLTcwMzM0_afaf3d47-485d-408c-8acd-62fdfa3f88dc"
      unitRef="usd">91971000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTpmOWMxNGNlZGM3OTA0ZjkxYTBhNTU5OGY1ZjZjM2Y1Ni90YWJsZXJhbmdlOmY5YzE0Y2VkYzc5MDRmOTFhMGE1NTk4ZjVmNmMzZjU2XzE1LTEtMS0xLTcwMzM0_e118a86a-8713-4608-aee3-56cb513b66dc"
      unitRef="usd">442269000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzMyNjU_86e94fb2-11d9-427b-8f1c-1ba138b49b27"
      unitRef="usd">253700000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="id878234d30d043a1869cefb375fae586_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzEtMS0xLTEtNzAzMzQ_ad1290eb-db7a-4b79-ad20-7e41d0e0b6c4"
      unitRef="usd">213290000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i5f85a675d779468d9d4dbca1c8a1df77_D20210301-20210301"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzEtMi0xLTEtNzAzMzQ_d0790a4b-c4cd-499d-89d3-6985610d3eff">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate
      contextRef="id878234d30d043a1869cefb375fae586_I20210301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzEtMy0xLTEtNzAzMzQ_89360467-427f-4e08-aaf5-f43e7fadad40"
      unitRef="number">0.135</hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i8ff998f127d34759a4f6f4837bf4c1c2_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzItMS0xLTEtNzAzMzQ_7280b746-60ac-4ee1-8277-ca7ea1da41c9"
      unitRef="usd">18166000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i1a4624f506734e78b0c21280a438461f_D20210301-20210301"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzItMi0xLTEtNzAzMzQ_9ba4a62c-6d32-4fba-a05b-16d4a44578a2">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate
      contextRef="i8ff998f127d34759a4f6f4837bf4c1c2_I20210301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzItMy0xLTEtNzAzMzQ_1bdfd129-2aa1-432e-806c-a1f652a5d38b"
      unitRef="number">0.130</hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9823c17774ed4746ae030a36d0b5328b_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzMtMS0xLTEtNzAzMzQ_6454e04e-cf5e-4ab0-b493-99ed08f6db00"
      unitRef="usd">5437000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i95ab359c02104ffb9f744088a78d1303_D20210301-20210301"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzMtMi0xLTEtNzAzMzQ_55a3bc13-ac78-4efe-91b6-8a30fa384fc7">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate
      contextRef="i9823c17774ed4746ae030a36d0b5328b_I20210301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzMtMy0xLTEtNzAzMzQ_fc536274-a183-4d27-8a9a-0a8c3d325fd9"
      unitRef="number">0.135</hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="if6dd8c04e15e409a938cebbc415144b4_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzQtMS0xLTEtNzAzMzQ_a36c3ea2-6eaa-4722-a363-fa74f25752df"
      unitRef="usd">13667000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate
      contextRef="if6dd8c04e15e409a938cebbc415144b4_I20210301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzQtMy0xLTEtNzAzMzQ_0631ebde-8991-4af5-9c61-4730c22dfd0f"
      unitRef="number">0.150</hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphNTJhZjNiYjZmZDU0NWMzYWVmNDlkODZhNTc1OTEyYy90YWJsZXJhbmdlOmE1MmFmM2JiNmZkNTQ1YzNhZWY0OWQ4NmE1NzU5MTJjXzUtMS0xLTEtNzAzMzQ_3453da50-901e-454b-ba8f-c1fc394414a0"
      unitRef="usd">250560000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="id6fc9e356f064785861fafa202778d12_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzM2OTA_ef8904e6-1f73-43da-b847-b8a859ec78c9"
      unitRef="usd">26800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
      contextRef="id5dc66016da24927b10302bc7adc1138_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzM5ODk_ec90e896-2470-453f-8994-8b59ab901604"
      unitRef="usd">9600000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="idfb28cdda17d4216bac7c9d5cc1183fe_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzQxMzU_6d864e8f-8dc9-448a-86ab-ed7da034144e"
      unitRef="usd">6600000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="idcb82f284dea477ea7ca024b9ae58bae_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzQxNTY_8968948b-500b-4dc2-80e9-228d8e84d758"
      unitRef="usd">3000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="idc62548e17174a3eaf8c1c8435fb16e5_D20210301-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzQ0MTY_ac22dcac-761e-4889-b568-da179f8da773"
      unitRef="usd">7700000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="idc62548e17174a3eaf8c1c8435fb16e5_D20210301-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzQ0NDk_c03e2a87-c58a-41d5-aa30-6dd2a8d642dd"
      unitRef="usd">7600000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzk5NTk_e9e235a1-a542-4f76-8f25-72e7be8f2101">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) (Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;916,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="id5dc66016da24927b10302bc7adc1138_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo3MWNiOGY2Nzc1MTk0M2E1OWRjNmYwNGRkNDU5NjBmZC90YWJsZXJhbmdlOjcxY2I4ZjY3NzUxOTQzYTU5ZGM2ZjA0ZGQ0NTk2MGZkXzEtMS0xLTEtNzAzMzQ_317270dc-b733-4ef0-babc-873a098113bb"
      unitRef="usd">916601000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="id5dc66016da24927b10302bc7adc1138_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo3MWNiOGY2Nzc1MTk0M2E1OWRjNmYwNGRkNDU5NjBmZC90YWJsZXJhbmdlOjcxY2I4ZjY3NzUxOTQzYTU5ZGM2ZjA0ZGQ0NTk2MGZkXzItMS0xLTEtNzAzMzQ_f3923cb1-a2eb-4439-af92-b53ead29e62a"
      unitRef="usd">53884000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i4651aa24e89d4f19b23ca9c1b848272a_I20210113"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzY5NDk_df51e019-11ce-4531-ad30-59fc730474a1"
      unitRef="usd">15000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <hae:AssetAcquisitionMilestonePayment
      contextRef="id4e2ba32e7d846df811c490e96dfc2db_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzE2NDkyNjc0NjAzMDc_a57d0267-117b-402b-9bd7-f916a6f50e89"
      unitRef="usd">2900000</hae:AssetAcquisitionMilestonePayment>
    <hae:AssetAcquisitionMilestonePayment
      contextRef="i86f7e1c8849a4449adccae1f6aa3a753_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzcwOTM_97036dcd-8fa7-443f-ab85-82b3c16cccdc"
      unitRef="usd">2500000</hae:AssetAcquisitionMilestonePayment>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ied3f33df8d1c44b78b90db973a88aed4_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzc2MDE_b9af0544-6646-40cf-b5dc-4f6a2124186c"
      unitRef="usd">20500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ied3f33df8d1c44b78b90db973a88aed4_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzc2NDQ_ed881b90-4d3a-4bb5-9308-74a5ffb38f22"
      unitRef="usd">16600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzc2OTc_a24fb686-97d4-4c5c-842f-94be5dc8e3ba"
      unitRef="usd">3900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzc3NjI_9ecdf4c6-5b1f-4414-9a60-dafb1be27296"
      unitRef="usd">4500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <hae:AssetAcquisitionMilestonePayment
      contextRef="ic0252aa2fd7447a48396f27529ad8ce1_D20230401-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzE2NDkyNjc0NTk5MzY_16539082-d6c9-4d58-91cc-d2fac3a91815"
      unitRef="usd">2300000</hae:AssetAcquisitionMilestonePayment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzEtMi0xLTEtNzAzMzQ_5ce910a1-5eb9-4636-9798-29a3d6b8514f"
      unitRef="usd">634000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzItMi0xLTEtNzAzMzQ_4ea38ff3-bcf3-47b8-a0a4-61a623f3a381"
      unitRef="usd">685000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzMtMi0xLTEtNzAzMzQ_772e4fbf-5a78-4f66-9dd4-963757eeb905"
      unitRef="usd">289000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzQtMi0xLTEtNzAzMzQ_b9c24561-03d6-44e9-84c3-f88c82c41845"
      unitRef="usd">14090000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzUtMi0xLTEtNzAzMzQ_9bd76d06-dc46-48d1-ad46-d993620721d6"
      unitRef="usd">8153000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzYtMi0xLTEtNzAzMzQ_71da7f0e-b1b3-45c1-b126-ba9160502c5b"
      unitRef="usd">23851000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzctMi0xLTEtNzAzMzQ_6f1e700f-0dd2-4af4-ae77-d8d170584932"
      unitRef="usd">289000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzgtMi0xLTEtNzAzMzQ_1640bed1-45f6-4b8c-b333-8f857b5aaa63"
      unitRef="usd">3036000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzktMi0xLTEtNzAzMzQ_bc65ceed-7b73-4c5a-a9e0-a92c75c6170b"
      unitRef="usd">3325000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTphMjY1NGU1ZTFhMTI0NzdjOWU4OGUzNGZkNmNjNjUwMy90YWJsZXJhbmdlOmEyNjU0ZTVlMWExMjQ3N2M5ZTg4ZTM0ZmQ2Y2M2NTAzXzEwLTItMS0xLTcwMzM0_89faff4e-d1e3-42fb-91b2-9aafc4315c74"
      unitRef="usd">20526000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate
      contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzg3MjU_62d57413-8241-41ab-b9e2-2dc289ea8d29"
      unitRef="number">0.20</hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="id62c57cefd2b41e5a3798110a7fa7e0a_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzEtMi0xLTEtNzAzMzQ_6a5eb860-0277-4383-88f5-233e38e56ec4"
      unitRef="usd">13441000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i3e1cd971bed141ee9e1ec7750e91d3fd_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzEtNC0xLTEtNzAzMzQ_c5612929-eee9-40ea-862f-681b9f3e61f3">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate
      contextRef="id62c57cefd2b41e5a3798110a7fa7e0a_I20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzEtNi0xLTEtNzAzMzQ_af5793e4-56f7-4d40-ba23-c09439542b5e"
      unitRef="number">0.20</hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic6277c2898c846d3b4349c549833daf4_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzItMi0xLTEtNzAzMzQ_ba2a5f02-a2a2-4fc7-b73c-5151aeb117a0"
      unitRef="usd">347000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i616e2c0925064b749fa614ff59dd7499_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzItNC0xLTEtNzAzMzQ_e835d199-7220-4a79-ae79-45fe03cd43a8">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate
      contextRef="ic6277c2898c846d3b4349c549833daf4_I20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzItNi0xLTEtNzAzMzQ_8b5f913e-8135-4dc1-a08f-0cbe2d94ce44"
      unitRef="number">0.20</hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ifd18f7423eb842dca4250857300a60d4_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzMtMi0xLTEtNzAzMzQ_e00e841e-41a9-4e43-950f-ef9cac6a58d8"
      unitRef="usd">302000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i203dfbcae1dd44178cef12e0b4685fe4_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzMtNC0xLTEtNzAzMzQ_cf03b485-e2e0-495b-96ce-b831c04b3129">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate
      contextRef="ifd18f7423eb842dca4250857300a60d4_I20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzMtNi0xLTEtNzAzMzQ_abed81a6-80de-4d9e-861d-8135bb9ac7a9"
      unitRef="number">0.20</hae:AcquiredIntangibleAssetsRiskAdjustedDiscountRate>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ia79eef6ed827468db16b5f84e3ea9e2b_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90YWJsZTo1NmQ3OWM2NDQ3OWY0MjZkYjllYmU2ZTA4ZDhiMWFmMi90YWJsZXJhbmdlOjU2ZDc5YzY0NDc5ZjQyNmRiOWViZTZlMDhkOGIxYWYyXzQtMi0xLTEtNzAzMzQ_d8451b7e-b963-4a7e-ad05-f1d7d8354f53"
      unitRef="usd">14090000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="if633c82b96c64c7e994ccb564cfd6ca7_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzk2MDk_c24ca3e7-3352-4079-87f5-596b2817a7c8"
      unitRef="usd">200000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:Investments
      contextRef="i5038a81c8b424af199422b8a9d70bc1c_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzIxOTkwMjMyNzMwMTc_d35cc9f9-b9e4-4912-aad0-2be7e5df7252"
      unitRef="eur">30000000</us-gaap:Investments>
    <us-gaap:GainLossOnInvestments
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDMvZnJhZzphMTQ2NmIzNjk0YTI0YjgwYjk3ZTA2MjM2MTM4YTI4Zi90ZXh0cmVnaW9uOmExNDY2YjM2OTRhMjRiODBiOTdlMDYyMzYxMzhhMjhmXzE2NDkyNjc0NTgzNTY_a87539fc-cc4a-43ba-968f-c031344f3d07"
      unitRef="usd">0</us-gaap:GainLossOnInvestments>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzQ4MjA_76af0308-f429-436e-a441-1cf01b6ec249">DIVESTITURES &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fajardo, Puerto Rico Manufacturing Operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 29, 2020, the Company sold its Fajardo, Puerto Rico, manufacturing operations to GVS, S.p.A (&#x201c;GVS&#x201d;), a leading provider of advanced filtration solutions for critical applications for $15.1&#160;million ($7.8&#160;million, net of cash transferred). Under the terms of the agreement, Haemonetics retained all intellectual property rights to its proprietary blood filters currently manufactured at its Fajardo facility and GVS acquired certain assets consisting primarily of property, plant and equipment, inventory and cash and has assumed certain related liabilities. In connection with this transaction, the Company and GVS also entered into a long-term supply and development agreement that, among other things, grants GVS exclusive rights to manufacture and supply the blood filters currently produced at the Fajardo facility for Haemonetics. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of this transaction, Haemonetics recognized a pre-tax impairment charge in its Blood Center business unit of $1.0&#160;million in the first quarter of fiscal 2021 and an incremental loss of $0.4&#160;million based on closing adjustments during the third quarter of fiscal 2021, as the carrying value of the assets and liabilities in the asset transfer exceeded the net of the $15.1&#160;million of cash proceeds and an additional contingent liability of $1.5&#160;million. The disposal group consisted of $3.3&#160;million of inventory, $7.2&#160;million of fixed assets, $3.2&#160;million of other liabilities, and $0.4&#160;million of goodwill allocated based on fair value to the business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Blood Donor Management Software&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 1, 2020, the Company sold certain U.S. blood donor management software solution assets within its Blood Center business unit to the GPI Group (&#x201c;GPI&#x201d;) for an upfront cash payment of $14.0&#160;million ($13.6&#160;million, net of working capital adjustments) and up to $14.0&#160;million in additional consideration contingent on the achievement of commercial milestones over the twelve month period immediately following the closing of the transaction. The disposal group consisted of $1.4&#160;million of accounts receivable, $0.9&#160;million of intangible assets, other liabilities of $1.8&#160;million and $1.4&#160;million of goodwill allocated based on fair value to the business. The Company recognized a gain of $13.2&#160;million associated with the transaction in fiscal 2021. In fiscal years 2023 and 2022, the Company recognized additional gains of $0.4&#160;million and $9.6&#160;million, respectively, for contingent consideration earned.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inlog Holdings France&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 18, 2020, the Company sold its wholly-owned subsidiary Inlog Holdings France SAS to Ab&#xe9;nex Capital (&#x201c;Ab&#xe9;nex&#x201d;), a private equity firm based in France for $30.5&#160;million ($24.5&#160;million, net of cash transferred). Inlog Holdings France SAS, through its subsidiary In Log SAS, develops and sells blood bank and hospital software solutions used predominantly in France and in several other countries outside of the U.S. The disposal group included $2.2&#160;million of intangible assets, $2.2&#160;million of accounts receivable, $0.3&#160;million of other assets, $3.3&#160;million of liabilities and $3.3&#160;million of goodwill allocated based on the fair value of the business which impacted both the Blood Center and Hospital business units. The Company recognized a gain of $20.0&#160;million associated with the transaction in fiscal 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ia4acc494c5054244829743f91b7e2da7_D20200629-20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI2Mg_9d72f1a0-feb6-4c91-b211-b53d9fcf38bd"
      unitRef="usd">15100000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ia4acc494c5054244829743f91b7e2da7_D20200629-20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI2Ng_2d97d32a-d1e9-433a-9e16-0ae5e0abfa2e"
      unitRef="usd">7800000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:AssetImpairmentCharges
      contextRef="ia4acc494c5054244829743f91b7e2da7_D20200629-20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzEwMTY_d8b737b9-79f7-43ea-aa03-4d170c335362"
      unitRef="usd">1000000</us-gaap:AssetImpairmentCharges>
    <hae:DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments
      contextRef="i2752501b70f24fe681ec2c0d0d6e1c32_D20220703-20221001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzEwODI_b60838db-7738-4973-8b85-ca8f06ce3eee"
      unitRef="usd">400000</hae:DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ia4acc494c5054244829743f91b7e2da7_D20200629-20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzEyNTM_4c2f719a-1cbb-481d-8475-2b55526068b9"
      unitRef="usd">15100000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <hae:DisposalGroupNotDiscontinuedOperationsExpectedCostToSell
      contextRef="ia4acc494c5054244829743f91b7e2da7_D20200629-20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzEzMTU_ea024c9b-1200-4c32-be8b-60bdeb518d1e"
      unitRef="usd">1500000</hae:DisposalGroupNotDiscontinuedOperationsExpectedCostToSell>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="i3207d32bf765482d974e19e8a1ba412c_I20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzEzNTE_b5426a08-fd27-4114-adc5-53e691853a35"
      unitRef="usd">3300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="i3207d32bf765482d974e19e8a1ba412c_I20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzEzNjg_080b821c-83eb-4309-87b6-ebc5a74d3869"
      unitRef="usd">7200000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="i3207d32bf765482d974e19e8a1ba412c_I20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzEzODg_088efaa8-04fe-4e5a-8a63-bcb818d764f4"
      unitRef="usd">3200000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="i3207d32bf765482d974e19e8a1ba412c_I20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzE0MTc_99d6ac96-b21a-4c19-994b-7b228f158c05"
      unitRef="usd">400000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i44250ce6b1a74481b968a4be5acfd176_D20200701-20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzE3MDc_415747ed-555e-431d-a280-d52887201c98"
      unitRef="usd">14000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <hae:ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments
      contextRef="id6966c90880e42ea87ed7bdf600844e5_I20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzE3MTE_8897860e-1775-4ab8-aa58-528ee7fb862c"
      unitRef="usd">13600000</hae:ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments>
    <hae:ProceedsFromDivestureOfBusinessContingentConsiderationReceived
      contextRef="i44250ce6b1a74481b968a4be5acfd176_D20200701-20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzE3NjE_f4a823e7-d2cc-4144-a0e7-b2f49db77d48"
      unitRef="usd">14000000</hae:ProceedsFromDivestureOfBusinessContingentConsiderationReceived>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="id6966c90880e42ea87ed7bdf600844e5_I20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzE5NjI_da50245e-5052-4d23-a0cb-757ab946d8b8"
      unitRef="usd">1400000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="id6966c90880e42ea87ed7bdf600844e5_I20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzE5ODk_1c170ca5-6e9c-4581-8a33-0c76acac0c6e"
      unitRef="usd">900000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="id6966c90880e42ea87ed7bdf600844e5_I20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzIwMzU_a4d49894-36a9-478e-af46-33ee87519bb4"
      unitRef="usd">1800000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="id6966c90880e42ea87ed7bdf600844e5_I20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzIwNDI_ce7b3e16-a31b-4f51-9ad8-a9a2f17ee09e"
      unitRef="usd">1400000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i44250ce6b1a74481b968a4be5acfd176_D20200701-20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzIxMzc_c71684fc-70e7-494f-875e-2ade719e2955"
      unitRef="usd">13200000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i0f15ab7ccf5a4506a8affa0b65b6006a_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzIxOTkwMjMyNjQwODQ_da2e189c-0580-49c1-b0ff-d0f9c7004f0a"
      unitRef="usd">400000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ib2b9fa2b5f664127b8fdc362bbb48a1e_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzIyNTQ_ac5cdf58-7ac9-4842-851e-d41ac8551c01"
      unitRef="usd">9600000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i415a9f8fdf8b4219856aecb281c27444_D20200918-20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI0ODQ_dba07136-552e-4e8e-a309-5857fe06c3d0"
      unitRef="usd">30500000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i415a9f8fdf8b4219856aecb281c27444_D20200918-20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI0ODg_025e3bf9-e0da-4c70-a65b-0040b5de8368"
      unitRef="usd">24500000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i1ed16aebc739402e9a2e33283c09034b_I20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI3NTE_bb768554-faea-4403-baea-80e20417968f"
      unitRef="usd">2200000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i1ed16aebc739402e9a2e33283c09034b_I20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI3NzY_14b33d41-daa2-4717-8f82-5e26b9e631ce"
      unitRef="usd">2200000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="i1ed16aebc739402e9a2e33283c09034b_I20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI4MDM_edc6e6ff-b328-4cb3-a1aa-0b34dafdf925"
      unitRef="usd">300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i1ed16aebc739402e9a2e33283c09034b_I20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI4MjM_d0dae1a6-a325-4830-b69c-e0f5ea7a2cec"
      unitRef="usd">3300000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="i1ed16aebc739402e9a2e33283c09034b_I20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzI4NDU_21493e10-0c5d-465e-9d1d-f75a787adc36"
      unitRef="usd">3300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="if9b6d677fac64743add841031ac4146a_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDYvZnJhZzo5NzJmYTgxMWViNjk0MjdjYWUxYmY2MDIwZmVjYWJhOS90ZXh0cmVnaW9uOjk3MmZhODExZWI2OTQyN2NhZTFiZjYwMjBmZWNhYmE5XzMwMDk_76ed7725-3c60-4add-a4db-405cf6e8c3e3"
      unitRef="usd">20000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzg3OTA_b3fca83d-9c44-4cea-ad53-fb7a060db7ef">INCOME TAXES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Domestic and foreign income before provision (benefit) for income tax is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;141,403&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;63,629&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision (benefit) from continuing operations contains the following components:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,906)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,678)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,842)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,002&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts business globally and reports its results of operations in a number of foreign jurisdictions in addition to the United States. The Company&#x2019;s reported tax rate is impacted by the jurisdictional mix of earnings in any given period as the foreign jurisdictions in which it operates have tax rates that differ from the U.S. statutory tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s subsidiary in Malaysia has been granted a full income tax exemption to manufacture whole blood and apheresis devices that could be in effect for up to ten years, provided certain conditions are satisfied. The income tax exemption was in effect beginning June 1, 2016.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax effected, significant temporary differences comprising the net deferred tax liability are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals, reserves and other deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carry-forward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credit carry-forward, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized research expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,077)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets (after valuation allowance)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of goodwill and intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63,004)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unremitted earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(30,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(24,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The increase in the worldwide net deferred tax liability is primarily due to tax depreciation deductions in excess of book depreciation expense during fiscal 2023 and utilization of net operating loss carryforwards, partially offset by research expenditures capitalized for tax purposes and impact of the release of valuation allowance previously maintained against certain U.S. state and foreign deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The valuation allowance decrease of $5.2&#160;million during fiscal 2023 is primarily due to the release of valuation allowance related to certain U.S. state and foreign deferred tax assets and changes in the valuation allowance in other jurisdictions based on current year operating results.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has assessed, on a jurisdictional basis, the available means of recovering deferred tax assets, including the ability to carry-back net operating losses, the existence of reversing temporary differences, the availability of tax planning strategies and available sources of future taxable income. It has also considered the ability to implement certain strategies that would, if necessary, be implemented to accelerate taxable income and use expiring deferred tax assets. Based upon cumulative profitability in the U.S. and Malaysia, and increases in future taxable income projections, management has determined there is sufficient positive evidence to release a portion of the valuation allowance previously provided against certain U.S. state and foreign deferred tax assets. The Company has concluded future taxable income can be considered a source of income to realize a benefit for deferred tax assets in certain jurisdictions. The Company believes it is able to support the deferred tax assets recognized as of the end of the year based on all of the available evidence. The worldwide net deferred tax liability as of April&#160;1, 2023 includes deferred tax liabilities related to amortizable tax basis in goodwill and other indefinite lived assets, which can only be used as a source of income to benefit other indefinite lived assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023, the Company maintains a valuation allowance against certain U.S. tax credit carryforwards that are not more-likely-than-not realizable as well as a valuation allowance against the net deferred tax assets of certain foreign subsidiaries. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the March 2021 acquisition of Cardiva, the Company acquired federal and state net operating loss carryforwards of $150.9&#160;million and $93.3&#160;million, respectively. The Company also acquired federal and state tax research credit carryforwards of $0.2&#160;million and $0.4&#160;million, respectively. These net operating loss and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;shareholders over a three-year period in excess of 50 percent as defined under Section 382 and 383 of the U.S. Internal Revenue Code of 1986, respectively, as well as similar state provisions. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. The Company conducted a Section 382 study covering the period of inception (July 2002) through March 1, 2021. The study concluded that ownership changes occurred during that period which limit the amount of the Company&#x2019;s net operating losses and tax credit carryforwards that can be utilized before expiring. The carryforwards disclosed represent the amount of attributes that can be utilized based on the results of the study. The Company does not believe it has had an ownership change through April 1, 2023. Subsequent ownership changes may further affect the limitation in future years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023, the Company has U.S. federal net operating loss carryforwards of $64.4&#160;million of which $8.4&#160;million will begin to expire in fiscal 2024 and $56.0&#160;million can be carried forward indefinitely. The Company has U.S. state net operating losses of $75.7&#160;million of which $62.3&#160;million will expire at various times between fiscal 2024 and fiscal 2040 and $13.4&#160;million can be carried forward indefinitely. The Company has federal and state tax credits of $0.6&#160;million and $5.4&#160;million, respectively, which will begin to expire in fiscal 2029 and fiscal 2028, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023, the Company has foreign net operating losses of approximately $10.5&#160;million that are available to reduce future income of which $6.9 million will begin to expire in fiscal 2034 and $3.6&#160;million can be carried forward indefinitely. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023, substantially all of the unremitted earnings of the Company have been taxed in the U.S. The Company has not provided U.S. deferred income taxes or foreign withholding taxes on unremitted earnings of foreign subsidiaries of approximately $72.0&#160;million as such amounts are considered to be indefinitely reinvested in the business. The accumulated earnings in the foreign subsidiaries are primarily utilized to fund working capital requirements as its subsidiaries continue to expand their operations and to fund future foreign acquisitions. The Company does not believe it is practicable to estimate the amount of income taxes payable on the earnings that are indefinitely reinvested in foreign operations, however a significant portion of the unremitted earnings could be remitted without a future tax cost.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision (benefit) from continuing operations differs from the tax provision (benefit) computed at the U.S.&#160;federal statutory income tax rate due to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,799)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Global intangible low taxed income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(758)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unremitted earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred statutory rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible executive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation shortfalls (benefits)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,073)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,496)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intercompany sale of intellectual property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(409)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,002&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18.4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company recorded an income tax expense of $26.0&#160;million, representing an effective tax rate of 18.4%. The effective tax rate is lower than the U.S. statutory rate of 21.0%, primarily due to jurisdictional mix of earnings, research credits generated and the change in valuation allowance, partially offset by state taxes, non-deductible executive compensation and disallowed stock compensation expense. The Company has recorded an immaterial tax expense related to unremitted foreign earnings that are not considered permanently reinvested.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Unrecognized Tax Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrecognized tax benefits represent uncertain tax positions for which reserves have been established. As of April&#160;1, 2023, the Company had $3.9 million of unrecognized tax benefits, of which $3.2 million would impact the effective tax rate, if recognized. As of April&#160;2, 2022, the Company had $3.9 million of unrecognized tax benefits, of which $3.1 million would impact the effective tax rate, if recognized. At April&#160;3, 2021, the Company had $6.1 million of unrecognized tax benefits, of which $5.3 million would impact the effective tax rate, if recognized.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to its gross unrecognized tax benefits for the fiscal years ended April&#160;1, 2023, April&#160;2, 2022 and April&#160;3, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 3,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions of tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements of tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,941&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,939&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023, the Company anticipates that the liability for unrecognized tax benefits for uncertain tax positions could change by up to $0.2 million in the next twelve months, as a result of closure of various statutes of limitations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s historical practice has been and continues to be to recognize interest and penalties related to federal, state and foreign income tax matters in income tax expense. Approximately $0.2 million and $0.1 million of gross interest and penalties were accrued at April&#160;1, 2023 and April&#160;2, 2022, respectively, and are not included in the amounts above. Additionally, $0.1&#160;million, $0.1&#160;million and $0.9&#160;million of accrued interest and penalties was included in income tax provision (benefit) for the years ended April&#160;1, 2023, April&#160;2, 2022 and April&#160;3, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts business globally and, as a result, files federal, state and foreign income tax returns in multiple jurisdictions. In the normal course of business, it is subject to examination by taxing authorities throughout the world. With a few exceptions, the Company is no longer subject to U.S. federal, state, or local income tax examinations for years before fiscal 2020 and foreign income tax examinations for years before fiscal 2018. To the extent that the Company has tax attribute carry-forwards, the tax years in which the attribute was generated may still be adjusted upon examination by the Internal Revenue Service, state, or foreign tax authorities to the extent utilized in a future period.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzg4MDc_f6945a9a-aff1-4cb2-ae82-77f03b6efbf5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Domestic and foreign income before provision (benefit) for income tax is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;141,403&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;63,629&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzEtMS0xLTEtNzAzMzQ_49f808ed-2437-47b2-a918-a9ac21ba198e"
      unitRef="usd">85657000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzEtMy0xLTEtNzAzMzQ_166eaf98-d169-459f-bf1a-01b64811fa13"
      unitRef="usd">-5219000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzEtNS0xLTEtNzAzMzQ_369db891-21ac-446c-968e-34aaea8e947f"
      unitRef="usd">5526000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzItMS0xLTEtNzAzMzQ_c69671d7-8434-40f6-8df4-50c7303081e8"
      unitRef="usd">55746000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzItMy0xLTEtNzAzMzQ_0cd78b7c-8944-4538-901a-a7170bb8bd93"
      unitRef="usd">68848000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzItNS0xLTEtNzAzMzQ_530950a3-aeb2-4ce1-b0c8-ffca62b663db"
      unitRef="usd">67387000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzMtMS0xLTEtNzAzMzQ_5961314c-8b6c-441a-8551-dc2963b134ef"
      unitRef="usd">141403000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzMtMy0xLTEtNzAzMzQ_efc2dee6-8994-4df9-8084-d157a54735e3"
      unitRef="usd">63629000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTowNzc0NTkxZmM4MDA0YzAxYWZiOWYwN2E0YTMyMjg5Ny90YWJsZXJhbmdlOjA3NzQ1OTFmYzgwMDRjMDFhZmI5ZjA3YTRhMzIyODk3XzMtNS0xLTEtNzAzMzQ_23289a65-ef41-4d5d-b910-49d72b463f34"
      unitRef="usd">72913000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzg4MTc_c0a22b91-7a90-4b91-bece-a51802f7898b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision (benefit) from continuing operations contains the following components:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,906)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,678)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,842)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,002&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzItMS0xLTEtNzAzMzQ_d5d4677e-6fee-4db1-b424-fbc99c0b7ba5"
      unitRef="usd">6461000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzItMy0xLTEtNzAzMzQ_697ad329-1897-4e67-80c9-e7695eebedbc"
      unitRef="usd">3586000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzItNS0xLTEtNzAzMzQ_d81848d0-e3ca-45d7-9bf3-cfc7ed793c95"
      unitRef="usd">-289000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzMtMS0xLTEtNzAzMzQ_506ed584-680a-4594-ab9e-c062a45dfc8a"
      unitRef="usd">4824000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzMtMy0xLTEtNzAzMzQ_796e40df-5514-4b5a-8e5f-ff0b37bd047a"
      unitRef="usd">1682000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzMtNS0xLTEtNzAzMzQ_fd54f11e-ab93-4d87-b7c9-6de154d8e303"
      unitRef="usd">1256000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzQtMS0xLTEtNzAzMzQ_2760d1b5-4f90-480b-94d8-09735a72d4ec"
      unitRef="usd">8940000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzQtMy0xLTEtNzAzMzQ_918d6518-46b0-4c99-a9b3-173d59226ae6"
      unitRef="usd">9940000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzQtNS0xLTEtNzAzMzQ_a7566126-30ea-48bd-91f6-dff191c47955"
      unitRef="usd">13319000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzUtMS0xLTEtNzAzMzQ_611715ac-4bca-4fb7-9265-24dfac713475"
      unitRef="usd">20225000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzUtMy0xLTEtNzAzMzQ_35193b34-9fb8-4653-96b0-72ff43d9b027"
      unitRef="usd">15208000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzUtNS0xLTEtNzAzMzQ_731e1144-62b5-45bf-b8e3-65f53220c5e2"
      unitRef="usd">14286000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzctMS0xLTEtNzAzMzQ_93dc5671-75df-4215-872b-a60cce36c9f3"
      unitRef="usd">14298000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzctMy0xLTEtNzAzMzQ_c52c2c51-fbb6-4eb7-b507-6bfdd9311514"
      unitRef="usd">3455000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzctNS0xLTEtNzAzMzQ_50bdba77-3654-48b2-bda4-5973d972c26a"
      unitRef="usd">-12906000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzgtMS0xLTEtNzAzMzQ_194254a6-c801-4d04-91ae-821e149e866a"
      unitRef="usd">-7678000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzgtMy0xLTEtNzAzMzQ_adb1c734-fc2f-4f35-8352-b16633c510f9"
      unitRef="usd">310000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzgtNS0xLTEtNzAzMzQ_88893f27-6c5b-4f13-b0c0-72ad0de55e8c"
      unitRef="usd">-2436000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzktMS0xLTEtNzAzMzQ_876f7cb3-8c80-45ec-9b65-597772d902dd"
      unitRef="usd">-843000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzktMy0xLTEtNzAzMzQ_fd2c5813-12b7-4d93-9e31-874b17c66ce2"
      unitRef="usd">1281000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzktNS0xLTEtNzAzMzQ_7f6bce3a-4b5a-4663-8cfc-7310cdc978c2"
      unitRef="usd">-5500000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzEwLTEtMS0xLTcwMzM0_bcf7f4ea-c3f0-4c48-bd37-0e445106e787"
      unitRef="usd">5777000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzEwLTMtMS0xLTcwMzM0_8d6cdb66-bb4f-45b3-907c-3e767c5cabff"
      unitRef="usd">5046000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzEwLTUtMS0xLTcwMzM0_865ebebc-b0f4-4c65-862a-fba639b7cc0b"
      unitRef="usd">-20842000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzExLTEtMS0xLTcwMzM0_6c7f2b50-2b53-4800-aad7-4ba017880093"
      unitRef="usd">26002000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzExLTMtMS0xLTcwMzM0_de9f3179-d92b-42ed-a173-aab1b533daf5"
      unitRef="usd">20254000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3OGNkYzVlMGE4MTQ0MWRiYTRlNzk1YTZhNmQ2YjRjMy90YWJsZXJhbmdlOjc4Y2RjNWUwYTgxNDQxZGJhNGU3OTVhNmE2ZDZiNGMzXzExLTUtMS0xLTcwMzM0_d3f6f1a4-b7f4-47dc-ac14-a62157f9b76b"
      unitRef="usd">-6556000</us-gaap:IncomeTaxExpenseBenefit>
    <hae:TaxHolidayTerm
      contextRef="ifb9a6ef65b5a4fbda10aff17313ea7f0_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzc0NQ_f5e323c6-012d-4388-ac3d-50934fc2191e">P10Y</hae:TaxHolidayTerm>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzg4MDI_4162b950-4879-466a-865f-cc41f0f7466b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax effected, significant temporary differences comprising the net deferred tax liability are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals, reserves and other deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carry-forward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credit carry-forward, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized research expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,077)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets (after valuation allowance)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of goodwill and intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63,004)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unremitted earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(30,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(24,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <hae:DeferredTaxAssetsDepreciation
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzItMS0xLTEtNzAzMzQ_f1e87993-fcee-4d00-aa64-5dc701996de5"
      unitRef="usd">174000</hae:DeferredTaxAssetsDepreciation>
    <hae:DeferredTaxAssetsDepreciation
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzItMy0xLTEtNzAzMzQ_6d7dc193-7750-40d2-9570-771f67b1df03"
      unitRef="usd">623000</hae:DeferredTaxAssetsDepreciation>
    <hae:DeferredTaxAssetsAmortization
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzMtMS0xLTEtNzAzMzQ_2198ac0f-7288-4c29-95b3-674dcc147d9e"
      unitRef="usd">1013000</hae:DeferredTaxAssetsAmortization>
    <hae:DeferredTaxAssetsAmortization
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzMtMy0xLTEtNzAzMzQ_5c6ba3bf-6e96-4622-880a-ca5d75d7a756"
      unitRef="usd">1243000</hae:DeferredTaxAssetsAmortization>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzQtMS0xLTEtNzAzMzQ_14bd85df-1159-43af-b7bb-cddd8b68db42"
      unitRef="usd">7674000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzQtMy0xLTEtNzAzMzQ_eda131b2-ee13-47f5-acc0-7c398a875021"
      unitRef="usd">6841000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzYtMS0xLTEtNzAzMzQ_6412a131-2ec3-4a60-b364-5598c89c430f"
      unitRef="usd">15680000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzYtMy0xLTEtNzAzMzQ_be5bebe1-2b42-4ad8-8e58-c34b21bba75f"
      unitRef="usd">13020000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzctMS0xLTEtNzAzMzQ_ffd63f1c-3db8-4650-8344-e38ec1468601"
      unitRef="usd">20996000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzctMy0xLTEtNzAzMzQ_b4b44f67-62f1-413d-bf77-3c9f4d633e95"
      unitRef="usd">30212000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzgtMS0xLTEtNzAzMzQ_0b034f83-65d7-46d2-bc54-7a222b87b9ee"
      unitRef="usd">4230000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzgtMy0xLTEtNzAzMzQ_7437dafa-2e15-4c7f-bc7c-8de4d6eb74cb"
      unitRef="usd">4422000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <hae:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzktMS0xLTEtNzAzMzQ_2951d4bb-3fa0-4ac1-b611-9ef5f4252149"
      unitRef="usd">15851000</hae:DeferredTaxAssetsOperatingLeaseLiability>
    <hae:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzktMy0xLTEtNzAzMzQ_6800c306-8638-4280-9554-54404e3e76d6"
      unitRef="usd">15777000</hae:DeferredTaxAssetsOperatingLeaseLiability>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzEwLTEtMS0xLTcwMzM0_422d9836-ad35-41b3-8760-e908f49d9633"
      unitRef="usd">5072000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzEwLTMtMS0xLTcwMzM0_6bd1d66b-8e7f-4b33-b319-b1808eadcdca"
      unitRef="usd">6452000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <hae:DeferredTaxAssetsResearchExpensesCapitalized
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzExLTEtMS0xLTcwMzM0_05230e45-321f-4050-9755-8126480f75f5"
      unitRef="usd">19671000</hae:DeferredTaxAssetsResearchExpensesCapitalized>
    <hae:DeferredTaxAssetsResearchExpensesCapitalized
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzExLTMtMS0xLTcwMzM0_fea848cb-db94-47da-9443-47953d346423"
      unitRef="usd">6733000</hae:DeferredTaxAssetsResearchExpensesCapitalized>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzEyLTEtMS0xLTcwMzM0_a5bb4198-507c-4686-a463-7bfc70b4cdbe"
      unitRef="usd">90361000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzEyLTMtMS0xLTcwMzM0_acac8954-e9d1-4b01-827d-060896e83311"
      unitRef="usd">85323000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzEzLTEtMS0xLTcwMzM0_5aecb010-1fab-4601-bdc4-d1e98f98372f"
      unitRef="usd">8838000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzEzLTMtMS0xLTcwMzM0_a217ebbb-8053-44cc-92ed-be66f4829cef"
      unitRef="usd">14077000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE0LTEtMS0xLTcwMzM0_76d6659b-b758-4ea8-b641-84444d674d87"
      unitRef="usd">81523000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE0LTMtMS0xLTcwMzM0_54e9909c-f143-42c4-9d38-1bd82899e7fd"
      unitRef="usd">71246000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <hae:DeferredTaxLiabilitiesDepreciation
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE2LTEtMS0xLTcwMzM0_aaa41495-0f1f-4dff-acbb-1095a0918ce9"
      unitRef="usd">37400000</hae:DeferredTaxLiabilitiesDepreciation>
    <hae:DeferredTaxLiabilitiesDepreciation
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE2LTMtMS0xLTcwMzM0_1c0f32cf-ec68-44d5-ac29-920a47d0af3e"
      unitRef="usd">15727000</hae:DeferredTaxLiabilitiesDepreciation>
    <hae:DeferredTaxLiabilitiesAmortization
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE3LTEtMS0xLTcwMzM0_91f2b2e8-2aa3-44ef-9693-df6e3c28c947"
      unitRef="usd">57752000</hae:DeferredTaxLiabilitiesAmortization>
    <hae:DeferredTaxLiabilitiesAmortization
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE3LTMtMS0xLTcwMzM0_46970053-1bc5-426c-af5c-15e1b1213a44"
      unitRef="usd">63004000</hae:DeferredTaxLiabilitiesAmortization>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE4LTEtMS0xLTcwMzM0_2671667e-5d18-49f7-9c2c-cf28300e18dc"
      unitRef="usd">1163000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE4LTMtMS0xLTcwMzM0_2d98e613-cce5-49cd-92ee-6e274b46b826"
      unitRef="usd">1254000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <hae:DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE5LTEtMS0xLTcwMzM0_ecf610fb-9dae-4997-a92f-d85dd32ddecb"
      unitRef="usd">13220000</hae:DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset>
    <hae:DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzE5LTMtMS0xLTcwMzM0_e0783e1d-5553-494a-9fd2-bd9ddab7ca1e"
      unitRef="usd">12877000</hae:DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzIxLTEtMS0xLTcwMzM0_8e7190b3-1aeb-486c-b7cb-ae79cbae1c38"
      unitRef="usd">2942000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzIxLTMtMS0xLTcwMzM0_95d6b018-c251-4541-997a-258cceb30abe"
      unitRef="usd">2643000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzIyLTEtMS0xLTcwMzM0_d2194295-91a6-4695-a10d-fd34ca4e6356"
      unitRef="usd">112477000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzIyLTMtMS0xLTcwMzM0_c0f500a0-fb54-4184-b49d-2da98391eb84"
      unitRef="usd">95505000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzIzLTEtMS0xLTcwMzM0_9a097d56-55b8-466a-8887-3d8cbf359586"
      unitRef="usd">30954000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo3YzNmNjJjNTY4YmI0MGJjYWU2OGYzYTQxNWNhYWI4Mi90YWJsZXJhbmdlOjdjM2Y2MmM1NjhiYjQwYmNhZTY4ZjNhNDE1Y2FhYjgyXzIzLTMtMS0xLTcwMzM0_67464c16-c8ce-45d9-a5c7-98dada862582"
      unitRef="usd">24259000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzIxOTkwMjMyNzQ3MjU_85224ee3-c958-4fcf-8b10-3914da02d846"
      unitRef="usd">5200000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <hae:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards
      contextRef="ieb2d1cef790a43cc813e187423890c9d_I20210117"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzMyNDY_f9719545-ef88-4845-806e-fe8f11b1c273"
      unitRef="usd">150900000</hae:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards>
    <hae:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards
      contextRef="ibec6ab6de3e844179c838dce47275e1a_I20210117"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzMyNTM_f11c6969-da5d-44da-bb10-360b30319477"
      unitRef="usd">93300000</hae:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards>
    <hae:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch
      contextRef="ieb2d1cef790a43cc813e187423890c9d_I20210117"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzMzNTI_52dd0741-1522-4d43-b4fe-2622b5da7dc1"
      unitRef="usd">200000</hae:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch>
    <hae:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch
      contextRef="ibec6ab6de3e844179c838dce47275e1a_I20210117"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzMzNTk_09ee9e1f-51b9-4b51-bcfd-d5b51ceaf14c"
      unitRef="usd">400000</hae:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i66bfdbf0893842978853fb1777820b01_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQzODI_cdf3a9cb-8c12-4ab6-8f0b-8bc66bb2ff16"
      unitRef="usd">64400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i66bfdbf0893842978853fb1777820b01_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQzOTQ_b2fc15f6-4bac-4814-b5ab-bbe3f3872f5c"
      unitRef="usd">8400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="i66bfdbf0893842978853fb1777820b01_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ0Mzc_f12c0c49-8ff4-4b4a-8b92-2a75e1dbf736"
      unitRef="usd">56000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i4314f040e25a485baf6b4975aeefb581_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ1Mjg_bcb676b5-6cbc-4c69-b15b-5429c87d4faa"
      unitRef="usd">75700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i4314f040e25a485baf6b4975aeefb581_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ1NDA_50d85187-bbca-40c5-a4e2-d8769311a22d"
      unitRef="usd">62300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="i4314f040e25a485baf6b4975aeefb581_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ1ODM_2267f24e-4f35-466a-8944-4b3d78ca7488"
      unitRef="usd">13400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i2625054aca6d4672ac4dfe103e5f3018_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ2NzI_e9c86ab1-2be8-4f67-9334-385ec92b2598"
      unitRef="usd">600000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="if0c1ae0e5e35463eabd3c1bdbdae5618_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ2Nzk_06653023-e6a8-4c13-b5af-93a7c1c428b4"
      unitRef="usd">5400000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:OperatingLossCarryforwards
      contextRef="if001c425b20b415582a047fc50a913ad_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ4NDQ_11598f34-aefa-40be-9fa2-f8170d3bf07e"
      unitRef="usd">10500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="if001c425b20b415582a047fc50a913ad_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ4OTk_9235fbc2-ea3d-4031-8646-81a8b23f0d92"
      unitRef="usd">6900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="if001c425b20b415582a047fc50a913ad_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzQ5NDI_178f7be0-2342-45bd-95fd-f98e9e6a3218"
      unitRef="usd">3600000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzUzODU_8fba698c-4708-4744-893f-fdd75199a250"
      unitRef="usd">72000000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzg4MjM_d268c694-9c87-42c0-8f64-72af70fee07c">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,799)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Global intangible low taxed income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(758)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unremitted earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred statutory rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible executive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation shortfalls (benefits)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,073)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,496)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intercompany sale of intellectual property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(409)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,002&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18.4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEtMS0xLTEtNzAzMzQ_9729ecf7-cabe-4181-86f7-9ebe7176a2f7"
      unitRef="usd">29695000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEtMy0xLTEtNzAzMzQ_cdba3166-69da-4775-9129-47734a3a40ca"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEtNS0xLTEtNzAzMzQ_930606a9-ed6e-4791-b8e0-0bc900066799"
      unitRef="usd">13362000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEtNy0xLTEtNzAzMzQ_92781814-c523-415a-844d-fa7bf112d05f"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEtOS0xLTEtNzAzMzQ_59d9f9db-1193-431e-ac9b-ea89467bf093"
      unitRef="usd">15312000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEtMTEtMS0xLTcwMzM0_c5f9cf2c-127c-4e5e-9e1f-139673c5f58c"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzMtMS0xLTEtNzAzMzQ_97624218-e509-4305-b7f9-e66f71afb493"
      unitRef="usd">-2408000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzMtMy0xLTEtNzAzMzQ_50d96e24-ebc5-4fb9-8c65-1046436ee334"
      unitRef="number">0.017</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzMtNS0xLTEtNzAzMzQ_71d394f4-4e25-46d4-8d88-a9965e5e7eec"
      unitRef="usd">-3799000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzMtNy0xLTEtNzAzMzQ_c6781eaa-4762-494d-b764-82ef74b2bfc4"
      unitRef="number">0.060</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzMtOS0xLTEtNzAzMzQ_3d73872b-1962-4d55-916a-324ae15ea1d5"
      unitRef="usd">-7049000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzMtMTEtMS0xLTcwMzM0_757baf29-986b-4dbb-96e3-3d677d1011fa"
      unitRef="number">0.097</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzQtMS0xLTEtNzAzMzQ_b7272bd3-4b79-44e4-a478-3737bc185d10"
      unitRef="usd">2939000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzQtMy0xLTEtNzAzMzQ_02362605-3dd6-42ec-ac2d-9952a84c5aa1"
      unitRef="number">0.021</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzQtNS0xLTEtNzAzMzQ_4bac72e9-237b-4c47-81f0-d245e9ba711c"
      unitRef="usd">1384000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzQtNy0xLTEtNzAzMzQ_9bc4fa05-ea6b-43ab-a962-39564cae503b"
      unitRef="number">0.022</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzQtOS0xLTEtNzAzMzQ_5ca28a6f-fd0b-4e6a-96e7-c426289193f2"
      unitRef="usd">-924000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzQtMTEtMS0xLTcwMzM0_639bfd64-7fc7-43ef-9c88-38dcd3675679"
      unitRef="number">-0.013</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <hae:IncomeTaxReconciliationChangeinUncertainTaxPositions
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzUtMS0xLTEtNzAzMzQ_e56ff44b-c8ce-4369-9a80-347ccbfc1a8d"
      unitRef="usd">81000</hae:IncomeTaxReconciliationChangeinUncertainTaxPositions>
    <hae:EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzUtMy0xLTEtNzAzMzQ_6342261c-4d01-4abe-a9ce-a53f491b13f6"
      unitRef="number">0.001</hae:EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions>
    <hae:IncomeTaxReconciliationChangeinUncertainTaxPositions
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzUtNS0xLTEtNzAzMzQ_7fdaf997-5364-4d97-977c-21986dcb7a5e"
      unitRef="usd">-777000</hae:IncomeTaxReconciliationChangeinUncertainTaxPositions>
    <hae:EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzUtNy0xLTEtNzAzMzQ_4b3b6cc9-c11b-4c18-910c-aaaa6ebabfbd"
      unitRef="number">-0.012</hae:EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions>
    <hae:IncomeTaxReconciliationChangeinUncertainTaxPositions
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzUtOS0xLTEtNzAzMzQ_6ee95701-1c71-4188-b30b-8602519116ef"
      unitRef="usd">1172000</hae:IncomeTaxReconciliationChangeinUncertainTaxPositions>
    <hae:EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzUtMTEtMS0xLTcwMzM0_d6ec0544-15f4-490c-9e2d-0df141a1ba0b"
      unitRef="number">0.016</hae:EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions>
    <hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzctMS0xLTEtNzAzMzQ_35c98512-aa22-4040-9245-12f4c0922233"
      unitRef="usd">-828000</hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount>
    <hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzctMy0xLTEtNzAzMzQ_af90dbb6-d924-4328-8718-4ba0e56ae9c0"
      unitRef="number">-0.006</hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent>
    <hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzctNS0xLTEtNzAzMzQ_e9af8917-2d0e-4625-8060-09110a347c96"
      unitRef="usd">3608000</hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount>
    <hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzctNy0xLTEtNzAzMzQ_9f1a9289-5e78-42bd-86a4-7ba202cd0a86"
      unitRef="number">0.057</hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent>
    <hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzctOS0xLTEtNzAzMzQ_1484c297-4aaf-424a-8bf1-99b74ca6806f"
      unitRef="usd">-758000</hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount>
    <hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzctMTEtMS0xLTcwMzM0_f5a348bf-0d47-4a12-9006-c01e9ab44c0b"
      unitRef="number">-0.010</hae:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent>
    <hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzgtMS0xLTEtNzAzMzQ_e4f7f32e-631c-4d66-a116-4eec5c379157"
      unitRef="usd">-91000</hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount>
    <hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzgtMy0xLTEtNzAzMzQ_a8528916-adfa-4e73-abfc-ec6246f99376"
      unitRef="number">-0.001</hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent>
    <hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzgtNS0xLTEtNzAzMzQ_c90a0b7f-10e5-4539-b99c-6451437d9742"
      unitRef="usd">194000</hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount>
    <hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzgtNy0xLTEtNzAzMzQ_171028ad-f133-4d9c-ab41-02043c1616d9"
      unitRef="number">0.003</hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent>
    <hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzgtOS0xLTEtNzAzMzQ_1609fc27-7baa-4dcd-b9c6-1471d7c3c9b5"
      unitRef="usd">257000</hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount>
    <hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzgtMTEtMS0xLTcwMzM0_1b25e6b3-f2a8-466c-b0e7-915248347d33"
      unitRef="number">0.004</hae:EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzktMS0xLTEtNzAzMzQ_5436bc77-15e9-443e-87ca-8d95bf89314d"
      unitRef="usd">82000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzktMy0xLTEtNzAzMzQ_5cb3bc7c-c03c-4fca-97c1-d17c3933831d"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzktNS0xLTEtNzAzMzQ_28df5052-df2c-4ec0-ae11-a448a39c5e6b"
      unitRef="usd">40000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzktNy0xLTEtNzAzMzQ_e1575b18-6c50-4970-9794-ade4cd02b4a0"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzktOS0xLTEtNzAzMzQ_7fdf1856-21b5-4b78-98a1-570eb5567053"
      unitRef="usd">-243000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzktMTEtMS0xLTcwMzM0_51649405-ea41-4256-a9cd-0226388eea77"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzExLTEtMS0xLTcwMzM0_a93e7888-1359-465b-b6e2-cb9494dafa5e"
      unitRef="usd">1439000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzExLTMtMS0xLTcwMzM0_4e27939f-fe09-4052-8ce6-81fd2e11373c"
      unitRef="number">0.010</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzExLTUtMS0xLTcwMzM0_f681016d-66ac-487a-8b8b-14b7d7896cda"
      unitRef="usd">1080000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzExLTctMS0xLTcwMzM0_a7c02a95-2ed5-4ef6-a77f-dbd62decde79"
      unitRef="number">0.017</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzExLTktMS0xLTcwMzM0_e2d2406f-c466-4c42-92b8-ba9e6415ea4b"
      unitRef="usd">2238000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzExLTExLTEtMS03MDMzNA_11283491-7042-45d0-a3b6-e1a46aef2c3c"
      unitRef="number">0.031</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEyLTEtMS0xLTcwMzM0_6201c499-d7d5-4cfa-9403-f9df9471fd67"
      unitRef="usd">827000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEyLTMtMS0xLTcwMzM0_76714084-4ff7-4df4-b3c9-4f28e4690994"
      unitRef="number">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEyLTUtMS0xLTcwMzM0_27b07778-2478-4a3f-ae3a-cad599703edf"
      unitRef="usd">741000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEyLTctMS0xLTcwMzM0_21d3bf43-9060-4d76-9291-ba036f7f47b5"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEyLTktMS0xLTcwMzM0_28dedaa6-5a12-4256-847b-bc39f05d19c5"
      unitRef="usd">2038000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEyLTExLTEtMS03MDMzNA_95b8e042-6b81-4244-8417-186c5320fab6"
      unitRef="number">0.028</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEzLTEtMS0xLTcwMzM0_b0d53fac-359b-447e-b3cd-bfb49737eb3b"
      unitRef="usd">1883000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEzLTMtMS0xLTcwMzM0_c3ccd4ee-6e84-4686-8f27-d57c4cc0e585"
      unitRef="number">-0.013</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEzLTUtMS0xLTcwMzM0_71ad1c35-7aa0-45e2-a2eb-04ddaca8db85"
      unitRef="usd">2070000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEzLTctMS0xLTcwMzM0_4a1518e1-34c8-49a6-adf9-c7ae4c459e70"
      unitRef="number">-0.033</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEzLTktMS0xLTcwMzM0_ee73b446-a860-44c9-b69f-ea9ffefbef81"
      unitRef="usd">-5504000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzEzLTExLTEtMS03MDMzNA_0afd5dff-b8c7-44c0-a8a6-df57e0f7be0e"
      unitRef="number">0.075</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE0LTEtMS0xLTcwMzM0_c9ac17a6-1646-4538-bcc0-fa4ad175e16a"
      unitRef="usd">2073000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE0LTMtMS0xLTcwMzM0_23d7c3cd-28d6-47c7-bfdc-1a33b0ed2037"
      unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE0LTUtMS0xLTcwMzM0_17cb7566-acfe-4595-b4e3-ea3304b97983"
      unitRef="usd">1496000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE0LTctMS0xLTcwMzM0_b4fa62ec-ae09-4f38-936f-6a7e14fe945a"
      unitRef="number">0.024</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE0LTktMS0xLTcwMzM0_f48ee20a-4c1b-4672-aa68-b763551b0376"
      unitRef="usd">1230000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE0LTExLTEtMS03MDMzNA_250c3711-9685-475e-961e-339b309913ae"
      unitRef="number">0.017</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE1LTEtMS0xLTcwMzM0_3ca34ad2-9166-4394-a96d-aa5bba739d3c"
      unitRef="usd">0</hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount>
    <hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE1LTMtMS0xLTcwMzM0_6bd26d1b-78ba-447d-8d23-24960d13d56e"
      unitRef="number">0</hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent>
    <hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE1LTUtMS0xLTcwMzM0_da79a305-3cec-41b6-a210-4e3dd315591c"
      unitRef="usd">1880000</hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount>
    <hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE1LTctMS0xLTcwMzM0_6f8a9856-9c82-4fc9-af84-00b215162832"
      unitRef="number">0.030</hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent>
    <hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE1LTktMS0xLTcwMzM0_2cc206e9-1c3f-4673-9b5e-f1a9f7a1cf7f"
      unitRef="usd">0</hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount>
    <hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE1LTExLTEtMS03MDMzNA_1f0ebfef-bd4b-461e-91b9-15af2164b159"
      unitRef="number">0</hae:EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent>
    <hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE2LTEtMS0xLTcwMzM0_06ee9659-e072-46f9-a80d-ade6c5f07d46"
      unitRef="usd">0</hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty>
    <hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE2LTMtMS0xLTcwMzM0_e4c880cb-21d7-4885-bf17-45f6ae3bee43"
      unitRef="number">0</hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent>
    <hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE2LTUtMS0xLTcwMzM0_5ff8a6d2-68cb-4dd3-9c21-969469cec148"
      unitRef="usd">0</hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty>
    <hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE2LTctMS0xLTcwMzM0_ca1e8d3e-b6b0-461d-835a-00bbfcb0cb15"
      unitRef="number">0</hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent>
    <hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE2LTktMS0xLTcwMzM0_32d942f1-c79a-403b-99ed-c474736ef8d3"
      unitRef="usd">7550000</hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty>
    <hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE2LTExLTEtMS03MDMzNA_7e6b32c4-7e50-48f8-bb49-af83e45e572f"
      unitRef="number">0.104</hae:EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE5LTEtMS0xLTcwMzM0_962256e6-bfbc-4289-995c-32aa90b949d7"
      unitRef="usd">-5135000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE5LTMtMS0xLTcwMzM0_694a4b05-2b9b-42c1-93bf-555a2a279e91"
      unitRef="number">-0.036</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE5LTUtMS0xLTcwMzM0_cbcdfb12-6fcd-4936-a7c5-300472df2ca3"
      unitRef="usd">254000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE5LTctMS0xLTcwMzM0_01563903-b5fb-4a1b-94b0-7f16f6fadff0"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE5LTktMS0xLTcwMzM0_bc629995-1bdc-444a-a253-ffa7e2659c51"
      unitRef="usd">-3144000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzE5LTExLTEtMS03MDMzNA_51a1f9c8-9be4-4852-a464-371fb5f2e320"
      unitRef="number">-0.044</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIwLTEtMS0xLTcwMzM0_c045b0f5-702c-433f-8fc0-11ed83385c7c"
      unitRef="usd">-409000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIwLTMtMS0xLTcwMzM0_58566b7e-067f-4ab3-aed1-37dae995b079"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIwLTUtMS0xLTcwMzM0_584cfb40-d4b4-47a7-b5b7-f5dfea966a8f"
      unitRef="usd">1713000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIwLTctMS0xLTcwMzM0_b6fb4bfb-0917-42cc-89c6-40f60c5e6258"
      unitRef="number">0.027</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIwLTktMS0xLTcwMzM0_59eb02b8-e4bb-4a6c-bbc7-62396d14acc6"
      unitRef="usd">-1171000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIwLTExLTEtMS03MDMzNA_993d3453-5e8d-45c3-b72e-a068e1c490c5"
      unitRef="number">-0.016</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIxLTEtMS0xLTcwMzM0_46d6ea48-5105-486d-b036-90cd78ecd5d5"
      unitRef="usd">26002000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIxLTMtMS0xLTcwMzM0_fd88efff-71b9-4bb5-b00f-9774fe1878fd"
      unitRef="number">0.184</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIxLTUtMS0xLTcwMzM0_215b718b-8121-4d4d-8f75-0e99814b30de"
      unitRef="usd">20254000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIxLTctMS0xLTcwMzM0_7fb213f6-2efd-4269-ac7c-f2d95bca7b74"
      unitRef="number">0.318</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIxLTktMS0xLTcwMzM0_7494c4da-b78c-4837-a970-0c13f8a57b00"
      unitRef="usd">-6556000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZTo1YTQ1MGFjZWNhNDc0ZTgwOGE4ZDBhODFkZGJlOTUzZS90YWJsZXJhbmdlOjVhNDUwYWNlY2E0NzRlODA4YThkMGE4MWRkYmU5NTNlXzIxLTExLTEtMS03MDMzNA_2f4cec27-847d-4bd5-9eab-85eba9ce1b6a"
      unitRef="number">-0.090</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzE2NDkyNjc0NzA5NDE_93831c6c-d21d-434d-9320-6f09479dafa7"
      unitRef="usd">26000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzYyNTQ_fd88efff-71b9-4bb5-b00f-9774fe1878fd"
      unitRef="number">0.184</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzYzMjM_cdba3166-69da-4775-9129-47734a3a40ca"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzY4OTY_0257c4d9-d518-48f0-8ad7-d429fc44755f"
      unitRef="usd">3900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzY5Mzg_f83764a0-fa17-4399-a1f6-bd907c061b8e"
      unitRef="usd">3200000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzcwMTk_1421f889-042f-4a85-bcf1-bac33a5ec80f"
      unitRef="usd">3900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzcwNjE_3368c638-9806-41a1-a85f-e1e89b4e81b4"
      unitRef="usd">3100000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzcxMzk_71c55829-022a-47b5-b621-be5f8395b364"
      unitRef="usd">6100000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2XzcxODE_040b16c4-b7b6-4b39-9566-984d17d50b5c"
      unitRef="usd">5300000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzg4MTM_9f08c4e0-af89-468e-b1b3-c7744d3a5f6b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to its gross unrecognized tax benefits for the fiscal years ended April&#160;1, 2023, April&#160;2, 2022 and April&#160;3, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 3,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions of tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements of tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,941&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,939&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzEtMS0xLTEtNzAzMzQ_f825f277-6090-44a0-9def-3c4c4c92d66a"
      unitRef="usd">3939000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzEtMy0xLTEtNzAzMzQ_11d61f7c-c8e2-4b5a-b4b7-3e7247c7474d"
      unitRef="usd">6107000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i2752e169c88b4ff2a289838d456aec0d_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzEtNS0xLTEtNzAzMzQ_e67461b4-00c5-44df-8b2f-9465f093ff40"
      unitRef="usd">4620000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzItMS0xLTEtNzAzMzQ_7e3bbd7a-2200-4a06-9186-f371eb8d79b1"
      unitRef="usd">292000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzItMy0xLTEtNzAzMzQ_81a282d8-bbfe-4e62-b8a8-913f09b27434"
      unitRef="usd">219000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzItNS0xLTEtNzAzMzQ_e33e9020-1879-4889-b81c-31c9fb3eb72a"
      unitRef="usd">335000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzMtMS0xLTEtNzAzMzQ_b2e872e1-61cc-447e-89f3-d2a2cb4073a5"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzMtMy0xLTEtNzAzMzQ_e7e5a533-b5a9-4324-aa6a-860954ca4d97"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzMtNS0xLTEtNzAzMzQ_07396d2e-6f5b-413b-a3ac-4502e27e1a00"
      unitRef="usd">1194000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzQtMS0xLTEtNzAzMzQ_8ab661d0-d147-4837-87bc-55c1278a43bd"
      unitRef="usd">290000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzQtMy0xLTEtNzAzMzQ_751fc3d6-df22-4a48-9089-a4ccf0055ac1"
      unitRef="usd">808000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzQtNS0xLTEtNzAzMzQ_392e0c65-9a35-4235-af73-9bd7d01684c7"
      unitRef="usd">42000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzUtMS0xLTEtNzAzMzQ_a720bbeb-4f0b-4a58-93ab-7ea2d2bc2d67"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzUtMy0xLTEtNzAzMzQ_a2b8af20-7e5e-485c-98a8-1386e2a05665"
      unitRef="usd">1579000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzUtNS0xLTEtNzAzMzQ_fbb20597-30df-431d-8e88-7e84a89ea577"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzctMS0xLTEtNzAzMzQ_ae7596f8-cc2d-4f27-b76f-75dca5b9d6ad"
      unitRef="usd">3941000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzctMy0xLTEtNzAzMzQ_16ffa965-d2f4-4983-9609-60c949a93f12"
      unitRef="usd">3939000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90YWJsZToyM2NkNmJkMDI0YmU0NjMwYjg0NjNhMTZhZjY1YWEzNi90YWJsZXJhbmdlOjIzY2Q2YmQwMjRiZTQ2MzBiODQ2M2ExNmFmNjVhYTM2XzctNS0xLTEtNzAzMzQ_c02034a3-7fb6-4330-8cd9-b8882352fd91"
      unitRef="usd">6107000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzc1MDg_73d7467e-7f06-46df-b9e5-a33049c57da9"
      unitRef="usd">200000</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzc3OTE_456d396e-4276-4340-820c-4e327fb755a7"
      unitRef="usd">200000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzc3OTg_ccec2b11-2b1d-4125-946f-5ebef02f8aaa"
      unitRef="usd">100000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <hae:IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzc5MzE_e22bfd87-7ef4-4a52-a983-618e71d502ac"
      unitRef="usd">100000</hae:IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense>
    <hae:IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzc5MzU_46d8c07b-feb7-4429-9368-f8b98bb10e63"
      unitRef="usd">100000</hae:IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense>
    <hae:IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMDkvZnJhZzoxNjcxMWVhMTZlMWY0MjBkYjYxZGM0NGYyNWRlODk4Ni90ZXh0cmVnaW9uOjE2NzExZWExNmUxZjQyMGRiNjFkYzQ0ZjI1ZGU4OTg2Xzc5NDI_8d10cd5e-30d4-4833-ab2f-e2c8ef109cea"
      unitRef="usd">900000</hae:IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzEyOTM_1fc44953-62c2-4b49-a031-62044582a33e">EARNINGS PER SHARE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic income per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.85&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.57&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.84&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated using the Company&#x2019;s weighted-average outstanding common shares. Diluted earnings per share is calculated using its weighted-average outstanding common shares including the dilutive effect of stock awards as determined under the treasury stock method and the convertible senior notes as determined under the net share settlement method. From the time of the issuance of the convertible senior notes, the average market price of the Company&#x2019;s common shares has been less than the initial conversion price, and consequently no shares have been included in diluted earnings per share for the conversion value of the convertible senior notes. For fiscal 2023, 2022 and 2021, weighted average shares outstanding, assuming dilution, excludes the impact of 0.6 million, 0.9 million and 0.5 million anti-dilutive shares, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, the Company announced that its Board of Directors had approved a new three-year share repurchase program authorizing the repurchase of up to $300.0&#160;million of Haemonetics common stock, based on market conditions, through August 2025. Under the share repurchase program, the Company is authorized to repurchase, from time to time, outstanding shares of common stock in accordance with applicable laws on the open market, including under trading plans established pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, and in privately negotiated transactions. The actual timing, number and value of shares repurchased will be determined by the Company at its discretion and will depend on a number of factors, including market conditions, applicable legal requirements and compliance with the terms of loan covenants. The share repurchase program may be suspended, modified or discontinued at any time, and the Company has no obligation to repurchase any amount of its common stock under the program.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2022, the Company completed a $75.0&#160;million repurchase of its common stock pursuant to an accelerated share repurchase agreement (&#x201c;ASR&#x201d;) entered into with Citibank N.A. in August 2022. The total number of shares repurchased under the ASR was 1.0&#160;million at an average price per share upon final settlement of $75.20.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023, the total remaining authorization for repurchases of the Company&#x2019;s common stock under the share repurchase program was $225.0&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzEzMDk_17e43664-bdf5-4a65-aebf-c5b459906f4a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic income per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.85&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.57&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.84&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:NetIncomeLoss
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzItMS0xLTEtNzAzMzQ_5edd5a89-a154-4d3c-9a9f-d92b3533224f"
      unitRef="usd">115401000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0ca40b48f3114d14bf1271d7751fa199_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzItMS0xLTEtNzAzMzQ_fc54bcfb-a261-4c75-a8f1-6e33b32cb391"
      unitRef="usd">115401000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzItMy0xLTEtNzAzMzQ_47457ec8-9427-480a-acaf-9836c8b7f318"
      unitRef="usd">43375000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzItNS0xLTEtNzAzMzQ_05ab8e59-50d9-4d35-86b3-1bf38ddb5427"
      unitRef="usd">79469000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzMtMS0xLTEtNzAzMzQ_84dfc82e-9696-47c7-ab93-dc4457d38d2c"
      unitRef="shares">50783000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzMtMy0xLTEtNzAzMzQ_5e3d4a7d-41b1-47a1-a6a2-7e5d087264e8"
      unitRef="shares">51047000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzMtNS0xLTEtNzAzMzQ_18a89bc3-0dec-400c-93da-38d35bc179b2"
      unitRef="shares">50688000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzQtMS0xLTEtNzAzMzQ_6022b2ca-9f45-4e21-8bb7-1a576edd866f"
      unitRef="usdPerShare">2.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzQtMy0xLTEtNzAzMzQ_058bdf63-ab5d-48bf-95ea-bacd7f3e5794"
      unitRef="usdPerShare">0.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzQtNS0xLTEtNzAzMzQ_86e354ac-3703-46e4-918e-27d2a2a1bf9f"
      unitRef="usdPerShare">1.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzYtMS0xLTEtNzAzMzQ_5edd5a89-a154-4d3c-9a9f-d92b3533224f"
      unitRef="usd">115401000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0ca40b48f3114d14bf1271d7751fa199_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzYtMS0xLTEtNzAzMzQ_fc54bcfb-a261-4c75-a8f1-6e33b32cb391"
      unitRef="usd">115401000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzYtMy0xLTEtNzAzMzQ_47457ec8-9427-480a-acaf-9836c8b7f318"
      unitRef="usd">43375000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzYtNS0xLTEtNzAzMzQ_05ab8e59-50d9-4d35-86b3-1bf38ddb5427"
      unitRef="usd">79469000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzctMS0xLTEtNzAzMzQ_84dfc82e-9696-47c7-ab93-dc4457d38d2c"
      unitRef="shares">50783000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzctMy0xLTEtNzAzMzQ_5e3d4a7d-41b1-47a1-a6a2-7e5d087264e8"
      unitRef="shares">51047000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzctNS0xLTEtNzAzMzQ_18a89bc3-0dec-400c-93da-38d35bc179b2"
      unitRef="shares">50688000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzgtMS0xLTEtNzAzMzQ_57c8f0d8-9660-4fc3-b4d0-9821079be7ff"
      unitRef="shares">637000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzgtMy0xLTEtNzAzMzQ_95647693-e522-492e-9e9f-d8d69f1d873c"
      unitRef="shares">306000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzgtNS0xLTEtNzAzMzQ_c3edb022-7aa8-4c17-ab59-16dddafacc6f"
      unitRef="shares">604000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzktMS0xLTEtNzAzMzQ_87e8a700-fe68-417f-b936-25f0eacdc808"
      unitRef="shares">51420000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzktMy0xLTEtNzAzMzQ_f7c4d74c-5cde-4d81-989f-ee46d9cd815b"
      unitRef="shares">51353000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzktNS0xLTEtNzAzMzQ_6d66ddba-e58e-476b-ba90-ff69ed80b108"
      unitRef="shares">51292000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzEwLTEtMS0xLTcwMzM0_34539a32-7ae7-47db-9087-43204c290eb2"
      unitRef="usdPerShare">2.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzEwLTMtMS0xLTcwMzM0_5c342655-9e49-4d20-b376-fab8db03c8a6"
      unitRef="usdPerShare">0.84</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90YWJsZTo1ZWE5ODQ2MzJkMDc0NTFiYmU0YzNhOWEwODNiNDgyNC90YWJsZXJhbmdlOjVlYTk4NDYzMmQwNzQ1MWJiZTRjM2E5YTA4M2I0ODI0XzEwLTUtMS0xLTcwMzM0_f7314aa2-5e85-41be-8180-1086f63154de"
      unitRef="usdPerShare">1.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzk0Ng_26db6737-1bc8-490b-bf00-97b94428870e"
      unitRef="shares">600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzk1MA_aba4c874-dfc1-4568-9eb1-77049380e168"
      unitRef="shares">900000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzk1Nw_e71a2dab-4275-465a-b72d-d618c359fa78"
      unitRef="shares">500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockRepurchaseProgramPeriodInForce1
      contextRef="i284b8cd4b4544ab58be9c3a7b5aef631_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzQzOTgwNDY1MTUzMDk_93160487-0cfc-4d8c-8c44-292301acb243">P3Y</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i1e9d4875df194dab89de359ddb229826_I20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzE2NDkyNjc0NDQ0NDc_0b545ebb-f03c-4aa2-9a2a-91a14b0d4707"
      unitRef="usd">300000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="i911fdad529ca44e49f9d2e6eb98bf48e_I20220816"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzE2NDkyNjc0NDQ0NjI_66e0fc50-7d79-432b-8aec-1ae75edce1d6"
      unitRef="usd">75000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i6fc032744cf14e5b8712fe75bf23387a_D20220816-20221104"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzE2NDkyNjc0NDQ0ODU_a0d1c333-19b9-4c24-8763-b2629b1261b1"
      unitRef="shares">1000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare
      contextRef="i474dead76fa741a1b6b0fcf117803177_D20221104-20221104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzE2NDkyNjc0NDQ0Nzc_385f92b0-8ca1-4ab4-9f7e-1a8bbbed3fbf"
      unitRef="usdPerShare">75.20</us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ic8cb16fc7fbd4a119a8e39abd06c3f48_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTIvZnJhZzpjYTk3MmUzNjYwYWE0MmM3YjM3N2RjNjg4ZDNhZTM3ZS90ZXh0cmVnaW9uOmNhOTcyZTM2NjBhYTQyYzdiMzc3ZGM2ODhkM2FlMzdlXzE2NDkyNjc0NDQ0OTg_edbfb78d-2330-40d1-8cff-6f49166423f5"
      unitRef="usd">225000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzI5MjY_2d6af812-9d12-4a53-a1a7-485a8926217c">REVENUE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenue recognition policy is to recognize revenues from product sales, software and services in accordance with ASC Topic 606,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; this occurs with the transfer of control of the Company&#x2019;s goods or services. The Company considers revenue to be earned when all of the following criteria are met: it has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the consideration it expects to receive for transferring goods or providing services, is determinable and it has transferred control of the promised items to the customer. A promise in a contract to transfer a distinct good or service to the customer is identified as a performance obligation. A contract&#x2019;s transaction price is allocated to each performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of the Company&#x2019;s contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the contract&#x2019;s transaction price to each performance obligation based on the estimated standalone selling prices of the good or service in the contract. For goods or services for which observable standalone selling prices are not available, the Company uses an expected cost plus a margin approach to estimate the standalone selling price of each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023, the Company had $24.0 million of transaction price allocated to remaining performance obligations related to executed contracts with an original duration of one year or more. The Company expects to recognize approximately 77% of this amount as revenue within the next twelve months and the remaining balance thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables and contract assets, as well as customer advances, customer deposits and deferred revenue (contract liabilities) on the consolidated balance sheets. The difference in timing between billing and revenue recognition primarily occurs in software licensing arrangements, resulting in contract assets and contract liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023 and April&#160;2, 2022, the Company had contract liabilities of $30.2&#160;million and $26.8&#160;million, respectively. During fiscal 2023, the Company recognized $24.3 million of revenue that was included in the above April&#160;2, 2022 contract &lt;/span&gt;&lt;/div&gt;liability balance. Contract liabilities are classified as other current liabilities on the consolidated balance sheet. As of April&#160;1, 2023 and April&#160;2, 2022, the Company&#x2019;s contract assets were immaterial.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzE2MTE_246e7fbf-db73-431d-8766-f9479c4d8f8f"
      unitRef="usd">24000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzE3NDE_66892351-0fde-48b6-8599-e89a8c440d9e">P1Y</us-gaap:RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzE4MDA_ed112e7e-e20c-4a58-a5a8-012880e9d02b"
      unitRef="number">0.77</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i46b375b6b4f542949b51fd68eaa34739_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzE4NDU_d81de252-36b5-4b41-a272-9cd5250ca4ac">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzE2NDkyNjc0NDUwODY_d68d1a28-6215-4d76-a591-8bc21117b521"
      unitRef="usd">30200000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzE2NDkyNjc0NDUwOTM_e5148fc4-5c18-41de-b678-648f562572c8"
      unitRef="usd">26800000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTUvZnJhZzpjZDgxNTU0M2ExZWM0OTUwODRmNjI1YzI2OWQzMjQ1MS90ZXh0cmVnaW9uOmNkODE1NTQzYTFlYzQ5NTA4NGY2MjVjMjY5ZDMyNDUxXzI3MTg_ee050ec3-e775-464c-af4d-d0b055a678a9"
      unitRef="usd">24300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90ZXh0cmVnaW9uOjI4NGVlY2FiMThhNjRhZjk5NjJlM2I4ZWQwZmQ5N2NhXzIxNg_7c848416-ca6d-42e1-aa80-e61ab189e30b">INVENTORIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value and include the cost of material, labor and manufacturing overhead. Cost is determined with the first-in, first-out method. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;259,379&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;293,027&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; Prior year raw materials and finished goods balances have been adjusted to conform with current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90ZXh0cmVnaW9uOjI4NGVlY2FiMThhNjRhZjk5NjJlM2I4ZWQwZmQ5N2NhXzIyNw_90ff4e64-a40b-4e2f-a8e5-4ef0c2fb1e6a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value and include the cost of material, labor and manufacturing overhead. Cost is determined with the first-in, first-out method. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;259,379&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;293,027&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; Prior year raw materials and finished goods balances have been adjusted to conform with current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzEtMS0xLTEtNzAzMzQ_be87c6b9-a489-4af8-a3ab-386a87056041"
      unitRef="usd">115016000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzEtMy0xLTEtNzAzMzQ_c80d4ff7-df53-475a-bc1e-e91e0afda4a1"
      unitRef="usd">77846000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzItMS0xLTEtNzAzMzQ_47c32c95-fc27-475d-968f-8839a6b87953"
      unitRef="usd">12572000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzItMy0xLTEtNzAzMzQ_1f2e0a08-11bd-4ffc-87fe-dd7eed70a041"
      unitRef="usd">17187000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzMtMS0xLTEtNzAzMzQ_bbc3a90c-10b9-4adc-996e-3282e40f7acc"
      unitRef="usd">131791000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzMtMy0xLTEtNzAzMzQ_7d6b5ffd-2e8d-41e2-a6dc-0dbc6a246e82"
      unitRef="usd">197994000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzQtMS0xLTEtNzAzMzQ_bfbaa99d-f29f-4878-938a-6c2bfb866bfc"
      unitRef="usd">259379000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMTgvZnJhZzoyODRlZWNhYjE4YTY0YWY5OTYyZTNiOGVkMGZkOTdjYS90YWJsZTo0NDM4ZjkyZDNiMGU0M2VmOTVlYTVkZDhhOTliODk4Zi90YWJsZXJhbmdlOjQ0MzhmOTJkM2IwZTQzZWY5NWVhNWRkOGE5OWI4OThmXzQtMy0xLTEtNzAzMzQ_10254462-7c1f-42a2-ac50-e53c02948c77"
      unitRef="usd">293027000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzMwMTk_3d4349bd-0f44-4dc4-958c-e89b3740ea2f">PROPERTY, PLANT AND EQUIPMENT&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plant equipment and machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment and information technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Haemonetics equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(633,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(610,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;310,885&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;258,482&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $51.2 million, $44.4 million and $43.1 million in fiscal 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2022, the Company incurred an impairment of property, plant and equipment of $5.2&#160;million in connection with the 2020 Program, refer to Note 3 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for details on the 2020 Program, and $2.8&#160;million of accelerated depreciation costs related to disposables manufacturing equipment that was no longer in use. In fiscal 2021, the Company incurred a one-time impairment charge of $20.9&#160;million related to in-process disposables manufacturing equipment that would not be placed in service. These impairment charges were included in cost of goods sold on the consolidated statements of income and impacted the Plasma reporting segment in the respective periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzMwMzQ_41bb3662-c0d3-4859-b59d-4c4c98baf8de">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plant equipment and machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment and information technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Haemonetics equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(633,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(610,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;310,885&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;258,482&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1ba643cdd69040399b37d76690fc345d_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzEtMi0xLTEtNzAzMzQ_cad3728e-83d4-4272-8042-9b28cf129763"
      unitRef="usd">5358000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i72965c4a62614d3290bfa903e33eced7_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzEtNC0xLTEtNzAzMzQ_01e3263c-9547-4f37-9ee7-89ac8ee30a26"
      unitRef="usd">5165000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i07ed489541e746a8b9deae1198e9c1c1_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzItMi0xLTEtNzAzMzQ_60d3f655-384c-4756-a3d7-8b83d18e0eb2"
      unitRef="usd">127634000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9b12e4fae98b451180b4184af64d8b88_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzItNC0xLTEtNzAzMzQ_c5246ad8-b272-4084-ae19-0b2a802038fd"
      unitRef="usd">104363000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i004e8ca241ac4e4ca56b1a2a8a573d30_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzMtMi0xLTEtNzAzMzQ_30343c38-5d22-4ff0-a152-8eacff1082c4"
      unitRef="usd">194539000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i42ce0fe93a644396931110078249d049_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzMtNC0xLTEtNzAzMzQ_bdc1da0a-0284-4def-8890-4244bc251ac8"
      unitRef="usd">180140000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1e34ec5fd8bd4a428a2c86c1f65a1c72_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzQtMi0xLTEtNzAzMzQ_345c2962-6e80-47d0-9daf-ff373afd64cf"
      unitRef="usd">123611000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie45ed624179b44a9aa90e98cbf443cd3_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzQtNC0xLTEtNzAzMzQ_1aaa036f-eac4-4a9f-b65c-b91ed7b98bd0"
      unitRef="usd">120119000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia49c226af761477286c878a9c01a26a8_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzUtMi0xLTEtNzAzMzQ_8d042ea4-d194-463b-9887-9091339d1454"
      unitRef="usd">463706000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="idaf174529292432b93ffce203a8852e0_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzUtNC0xLTEtNzAzMzQ_a00ef515-2563-4cc8-ac56-6bcf683f10bb"
      unitRef="usd">405753000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9462d8afba8e42f1bdf6538fdf313e40_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzYtMi0xLTEtNzg3Mzk_cc920700-821d-4bce-8f76-4b54bdf032fb"
      unitRef="usd">29367000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4b7e9feaba63462fb4d7c25051b882b9_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzYtNC0xLTEtNzg3Mzk_17e4b187-ec72-4d1a-abe6-1fdb26b5018b"
      unitRef="usd">53607000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzYtMi0xLTEtNzAzMzQ_470444e2-68e9-4c98-9de6-12dfd2c3457d"
      unitRef="usd">944215000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzYtNC0xLTEtNzAzMzQ_bc225fbd-c7cf-40c2-8f37-de70f1a76ab2"
      unitRef="usd">869147000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzctMi0xLTEtNzAzMzQ_dae30650-f47c-48f4-9030-7e334e254498"
      unitRef="usd">633330000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzctNC0xLTEtNzAzMzQ_a70118db-28f8-4711-a45d-cf0b20ce1aa0"
      unitRef="usd">610665000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzgtMi0xLTEtNzAzMzQ_391f7732-6882-40e9-b9e5-9d68074b014b"
      unitRef="usd">310885000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90YWJsZTpjNDI1MGJlZWVmMDU0ZDljODkxZDVhZDkyOGFjMGEzMS90YWJsZXJhbmdlOmM0MjUwYmVlZWYwNTRkOWM4OTFkNWFkOTI4YWMwYTMxXzgtNC0xLTEtNzAzMzQ_7442ca52-6844-4bcc-805e-d8c56e97e4ae"
      unitRef="usd">258482000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzEyMA_5bd8ef47-c62f-44c4-9c3d-70396c00d767"
      unitRef="usd">51200000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzEyNA_48887638-d37c-4ac9-88f8-e0e059a5a9f5"
      unitRef="usd">44400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzEzMQ_21989799-8d11-4f58-84d6-d305253d1d92"
      unitRef="usd">43100000</us-gaap:Depreciation>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzE0NA_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i3b2e53451fe5414ab6223fd9340d04f2_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzIxOTkwMjMyNjk2NTM_86b4376a-d403-4232-9d39-82339474b553"
      unitRef="usd">5200000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i66e23e49fe97425b9d4a7409908fbe9f_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzIxNQ_83516229-7a57-4a50-a5f5-019cfa96271b"
      unitRef="usd">2800000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="iee98836794a841af872ac5d2c262b2e1_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjEvZnJhZzplMDYwZjlkZGQ5MGE0ZTU5YTIxNWFmODUxNDNmNmYzMS90ZXh0cmVnaW9uOmUwNjBmOWRkZDkwYTRlNTlhMjE1YWY4NTE0M2Y2ZjMxXzEwNzI_0de5a8f9-9159-4286-b8a9-708919120d5c"
      unitRef="usd">20900000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzI1Nzg_aecd76f1-131d-49a6-814d-198928b6ca64">GOODWILL AND INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill by operating segment for fiscal 2023 and 2022 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount as of April 3, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount as of April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying amount as of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29,043&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;403,333&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;466,231&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of the Company&#x2019;s goodwill impairment test performed in the fourth quarter of fiscal 2023, 2022 and 2021 indicated that the estimated fair value of all reporting units exceeded their respective carrying values. There were no reporting units at risk of impairment as of the fiscal 2023, 2022 and 2021 annual test dates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount of intangible assets and the related accumulated amortization as of April&#160;1, 2023 and April&#160;2, 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts and related relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;672,720&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;417,422&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;255,298&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-amortizable:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process software development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,473&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts and related relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;667,603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;376,552&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;291,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-amortizable:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process software development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,210&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions and Strategic Investments,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets include the value assigned to license rights and other developed technology, patents, customer contracts and relationships and trade names. The estimated useful lives for all of these intangible assets are approximately 5 to 15&#160;years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate amortization expense for amortized intangible assets for fiscal 2023, 2022 and 2021 was $42.1 million, $56.6 million and $41.2 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future annual amortization expense on intangible assets is estimated to be as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For costs incurred related to the development of software to be sold, leased, or otherwise marketed, the Company applies the provisions of ASC Topic 985-20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Software - Costs of Software to be Sold, Leased or Marketed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which specifies that costs incurred internally in researching and developing a computer software product should be charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs should be capitalized until the product is available for general release to customers. The costs capitalized for each project are included in intangible assets in the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalized $3.8&#160;million and $3.4&#160;million in software development costs for ongoing initiatives during fiscal 2023 and 2022, respectively. At April&#160;1, 2023 and April&#160;2, 2022, the Company had a total of $82.8&#160;million and $79.0&#160;million of software costs capitalized, of which $3.8&#160;million and $5.0&#160;million are related to in process software development initiatives, respectively, and the remaining balance represents in-service assets that are being amortized over their useful lives. Amortization expense for capitalized software was $8.5&#160;million, $8.4&#160;million and $7.8&#160;million for fiscal 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzI1NTk_23189da2-1fa1-4880-b7c2-60c9c65eb7f4">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount as of April 3, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount as of April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying amount as of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29,043&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;403,333&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;466,231&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i4d967115487d4000bb10ef11e17c5ee3_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEtMS0xLTEtNzAzMzQ_400ea227-4c11-4b83-a2fa-d5dc89607823"
      unitRef="usd">29043000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6471edc0acff4583a5b44bae2caf6812_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEtMy0xLTEtNzAzMzQ_fbe00fa8-a74f-4191-b285-c2e963b89ab6"
      unitRef="usd">34528000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3c0b4a3a52234ebca2c87d023a372f0d_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEtNS0xLTEtNzAzMzQ_ed0a63d8-9463-4564-8117-e004a2b4c31d"
      unitRef="usd">402873000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEtNy0xLTEtNzAzMzQ_37dae78a-c4e5-4a28-8d24-f6cfbb009a5a"
      unitRef="usd">466444000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ic069cd0eb4c94953be95e2deb98ea5e5_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzQtMS0xLTEtNzYxODA_7ff5feda-1fba-4a69-8c9d-1f60891c329b"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i0b364431a43245b7a9f05a60dc7416df_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzQtMy0xLTEtNzYxODA_ba468f48-10ab-44b8-a770-caa950e0a14a"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i5c4e22f5dd7d46aab1223c60d287905f_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzQtNS0xLTEtNzYxODA_59313b10-72ec-40c5-9b23-68eef1f283e2"
      unitRef="usd">2070000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzQtNy0xLTEtNzYxODA_694f942e-6335-444e-bbd1-2ae0f6d7ac99"
      unitRef="usd">2070000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ic069cd0eb4c94953be95e2deb98ea5e5_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzUtMS0xLTEtNzAzMzQ_f1b85c63-3aef-4e4e-8c81-37886585d1cd"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i0b364431a43245b7a9f05a60dc7416df_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzUtMy0xLTEtNzAzMzQ_e95a3c57-cb88-4671-9820-a0be35e9cc46"
      unitRef="usd">-362000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5c4e22f5dd7d46aab1223c60d287905f_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzUtNS0xLTEtNzAzMzQ_cd3e79c1-f10e-45f4-8c72-11a880a222e2"
      unitRef="usd">-865000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzUtNy0xLTEtNzAzMzQ_e4202401-63a1-43f4-a21d-985c886683ab"
      unitRef="usd">-1227000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ida4846630e6b4fe9abc8b036a5b0f2ca_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzYtMS0xLTEtNzAzMzQ_e8bac8c8-539c-4467-82b7-7b917b21fb4d"
      unitRef="usd">29043000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0134e8414f8c42618080f11b9286ca14_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzYtMy0xLTEtNzAzMzQ_734294d3-1e52-4904-8f1a-93fce4bf0cdd"
      unitRef="usd">34166000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5193ad1e9e4b4c359e874dfa2c7b2e29_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzYtNS0xLTEtNzAzMzQ_11f5c239-6fa2-4198-abc7-16a220cfefbd"
      unitRef="usd">404078000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzYtNy0xLTEtNzAzMzQ_648dfedd-dc9b-4e34-9734-b2900ebc8ddd"
      unitRef="usd">467287000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="iceda53e10aa943db9898cb8ab8dac15a_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEwLTEtMS0xLTcwMzM0_ff18c0e0-f218-480b-be50-564ae4aaa9bb"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ie3ffef01c50b40dcbbc6f463d67d82a6_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEwLTMtMS0xLTcwMzM0_24f2bce0-78d8-4ac5-9244-a8d95a71599f"
      unitRef="usd">-311000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i753483fb84d94062bdc30420838c80cf_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEwLTUtMS0xLTcwMzM0_72ed49ea-5715-4f71-84b5-bcfc71beda80"
      unitRef="usd">-745000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzEwLTctMS0xLTcwMzM0_27159bf1-b40b-4136-9add-7bf500cd955e"
      unitRef="usd">-1056000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i890c831316434ae1b18be3b1ae53a567_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzExLTEtMS0xLTcwMzM0_74d776e6-3960-4eec-be57-17d2250b166f"
      unitRef="usd">29043000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ida09061210f544b39381b92caca71c36_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzExLTMtMS0xLTcwMzM0_1876541d-111e-4442-95fa-3316390096fa"
      unitRef="usd">33855000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i728903670b674bc8867059c6c7f26220_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzExLTUtMS0xLTcwMzM0_3a9598cb-449c-4cb0-b327-1c08dfd5cdbf"
      unitRef="usd">403333000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTphZmUyNjc2YmU0NTQ0ZWNjYmEwMWU3MjQyYzhjZmZlOS90YWJsZXJhbmdlOmFmZTI2NzZiZTQ1NDRlY2NiYTAxZTcyNDJjOGNmZmU5XzExLTctMS0xLTcwMzM0_c12fb540-f5eb-48d8-a6f4-1738c3f6b038"
      unitRef="usd">466231000</us-gaap:Goodwill>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzQyMA_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzI1NTI_f5a349bf-ee21-4583-9675-670329e0fe45">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount of intangible assets and the related accumulated amortization as of April&#160;1, 2023 and April&#160;2, 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts and related relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;672,720&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;417,422&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;255,298&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-amortizable:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process software development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,473&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts and related relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;667,603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;376,552&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;291,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-amortizable:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process software development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,210&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia69c0d5a250d4229b959398b479ddfa4_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzQtMS0xLTEtNzAzMzQ_5df1c751-fb34-42f0-b5aa-d776b74710db"
      unitRef="usd">18504000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia69c0d5a250d4229b959398b479ddfa4_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzQtMy0xLTEtNzAzMzQ_552782c4-301f-4eba-beb5-b9b51a40c58e"
      unitRef="usd">10831000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia69c0d5a250d4229b959398b479ddfa4_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzQtNS0xLTEtNzAzMzQ_f38cf39e-6018-4ad2-a531-85f8a96ee9f9"
      unitRef="usd">7673000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2604f664a0d54bf69c814bdee8df438e_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzUtMS0xLTEtNzAzMzQ_af3af2dd-319c-4d02-8e94-af32625e29cb"
      unitRef="usd">78962000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2604f664a0d54bf69c814bdee8df438e_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzUtMy0xLTEtNzAzMzQ_6d6dcdd3-ae7f-4aff-8cf8-68823a8baf1c"
      unitRef="usd">60776000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2604f664a0d54bf69c814bdee8df438e_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzUtNS0xLTEtNzAzMzQ_25341857-4c3c-4c2c-bea1-98c6a4d89999"
      unitRef="usd">18186000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifc6430777b2d43ea89991090017c9b5a_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzYtMS0xLTEtNzAzMzQ_878a27f0-a8b6-49c6-8671-930d7f540c04"
      unitRef="usd">362506000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifc6430777b2d43ea89991090017c9b5a_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzYtMy0xLTEtNzAzMzQ_a735b635-2497-45b6-9557-fc48e89aecc3"
      unitRef="usd">153099000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ifc6430777b2d43ea89991090017c9b5a_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzYtNS0xLTEtNzAzMzQ_e4cedaea-d788-4126-b5f7-8486d1dc1555"
      unitRef="usd">209407000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idd9d2b7da12a4869876ddf3bd5cb0cd3_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzctMS0xLTEtNzAzMzQ_ce6fc6ba-de37-47da-94c0-139c20cf4ac7"
      unitRef="usd">203240000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idd9d2b7da12a4869876ddf3bd5cb0cd3_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzctMy0xLTEtNzAzMzQ_03826f7a-f11b-46b2-80b9-18afbde69c9b"
      unitRef="usd">187774000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idd9d2b7da12a4869876ddf3bd5cb0cd3_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzctNS0xLTEtNzAzMzQ_2ebbb0c2-8b31-4432-9bb1-1987a6931682"
      unitRef="usd">15466000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0e460218ba5d4a98bb1ebba94551faa3_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzgtMS0xLTEtNzAzMzQ_e9961664-a423-43b1-9484-29d5194fe888"
      unitRef="usd">9508000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0e460218ba5d4a98bb1ebba94551faa3_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzgtMy0xLTEtNzAzMzQ_a7e54d0a-04f1-4ef4-88d0-fef3583644d2"
      unitRef="usd">4942000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0e460218ba5d4a98bb1ebba94551faa3_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzgtNS0xLTEtNzAzMzQ_7dd8330d-6c6d-4473-8c81-2adf9b40a858"
      unitRef="usd">4566000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzktMS0xLTEtNzAzMzQ_88fe18db-448d-4e82-b13e-cf6ab47ac693"
      unitRef="usd">672720000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzktMy0xLTEtNzAzMzQ_e53515a8-a021-4b04-b120-bd352a5bd9ed"
      unitRef="usd">417422000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzktNS0xLTEtNzAzMzQ_701b93fc-4ebc-4856-b5b8-2428f149c89c"
      unitRef="usd">255298000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ib1c1d8f7dde943afbae8276595f08b9e_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzExLTEtMS0xLTcwMzM0_26704565-bf8d-4c4e-abf0-35474f3896ef"
      unitRef="usd">3841000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic30962d93d8542679db996ff09021707_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzEyLTEtMS0xLTcwMzM0_4a9b93d9-a33a-41e8-8375-bbfdc00c8a1d"
      unitRef="usd">13667000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i25a58336b11a40d2bc0242ec0ddcdf16_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzEzLTEtMS0xLTcwMzM0_483ac653-5592-4c0e-987e-5ccf3bf9dd5b"
      unitRef="usd">2965000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTowYjk4NmI5OTk1MzQ0ODMwYmJlMDQ2N2NhZDNhOGJlZi90YWJsZXJhbmdlOjBiOTg2Yjk5OTUzNDQ4MzBiYmUwNDY3Y2FkM2E4YmVmXzE0LTEtMS0xLTcwMzM0_9b8cf1ad-e7c2-418d-b3db-b60ccd80fc52"
      unitRef="usd">20473000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idfa652c38c114d559e869e8c58458b18_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzQtMS0xLTEtNzAzMzQ_6d3acf9b-201c-4ff3-a5b6-f49bc5a10c52"
      unitRef="usd">14777000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idfa652c38c114d559e869e8c58458b18_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzQtMy0xLTEtNzAzMzQ_5b96e964-8426-4fd4-aaf5-b57d6412d7f0"
      unitRef="usd">9821000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idfa652c38c114d559e869e8c58458b18_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzQtNS0xLTEtNzAzMzQ_328dbe5a-3b4c-4b39-8fe6-112f3ad8a7af"
      unitRef="usd">4956000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iface21e4b3d043d29b088f04c24bece5_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzUtMS0xLTEtNzAzMzQ_d9ee51ce-7aab-4043-86d6-ba94003fbe38"
      unitRef="usd">76360000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iface21e4b3d043d29b088f04c24bece5_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzUtMy0xLTEtNzAzMzQ_dbcbcee8-a677-4c93-bffe-f9c6ac58a03c"
      unitRef="usd">52249000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iface21e4b3d043d29b088f04c24bece5_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzUtNS0xLTEtNzAzMzQ_a6de78a7-2b4c-482a-9f0f-832d20b0d756"
      unitRef="usd">24111000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i23809cd4e75445928f37404062b1dd03_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzYtMS0xLTEtNzAzMzQ_9046ed3a-615c-43f4-a202-7b64d3a148d7"
      unitRef="usd">362783000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i23809cd4e75445928f37404062b1dd03_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzYtMy0xLTEtNzAzMzQ_1009273b-1d02-44c6-b435-ca560e96d94d"
      unitRef="usd">124799000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i23809cd4e75445928f37404062b1dd03_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzYtNS0xLTEtNzAzMzQ_d99875fd-387d-4436-8bbe-23958c14b037"
      unitRef="usd">237984000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i92a64ff94d044686be5f9c39a18d0fd1_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzctMS0xLTEtNzAzMzQ_7ef0f8b0-f693-4287-819a-4a8f44d75477"
      unitRef="usd">204166000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i92a64ff94d044686be5f9c39a18d0fd1_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzctMy0xLTEtNzAzMzQ_67652c20-799d-41bd-b11c-dcb552fdc29f"
      unitRef="usd">185150000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i92a64ff94d044686be5f9c39a18d0fd1_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzctNS0xLTEtNzAzMzQ_48a6ddee-1120-43ae-b6c6-8dcc934855bc"
      unitRef="usd">19016000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i108b71d6b3c24623a40275dbf161561d_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzgtMS0xLTEtNzAzMzQ_96345e5b-018a-4091-82b5-6d08109fd776"
      unitRef="usd">9517000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i108b71d6b3c24623a40275dbf161561d_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzgtMy0xLTEtNzAzMzQ_aa706bff-826d-4e9c-bcde-037973399e02"
      unitRef="usd">4533000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i108b71d6b3c24623a40275dbf161561d_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzgtNS0xLTEtNzAzMzQ_7489a9e5-068c-45bc-b7cb-365524b1beab"
      unitRef="usd">4984000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzktMS0xLTEtNzAzMzQ_d74e10c8-0b9f-4754-8dde-3a33d1826e2c"
      unitRef="usd">667603000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzktMy0xLTEtNzAzMzQ_99ae96c2-2c7e-4fb2-bbad-e3d673ae3071"
      unitRef="usd">376552000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzktNS0xLTEtNzAzMzQ_d9bcad06-0a38-45ff-bd3b-35495b3225ae"
      unitRef="usd">291051000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i85451529d01a46ff987455865e8cc517_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzExLTEtMS0xLTcwMzM0_8d5f5a59-7447-4e19-934d-f11868213206"
      unitRef="usd">2648000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ia9cc62c7a26a4855a7c2bde8ac969d41_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzEyLTEtMS0xLTc2MjM0_82254bdf-cc77-458f-8080-1510b04f2568"
      unitRef="usd">13667000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i0d4a14f19c3740fa8ef8bb4e38b7b19e_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzEyLTEtMS0xLTcwMzM0_c7ab3782-1bc5-4051-b682-d8408611f6f1"
      unitRef="usd">2895000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTo2YzRiYjEzNGMzYmE0NmFiOTE4ZDViYzZiOTljMjRlNS90YWJsZXJhbmdlOjZjNGJiMTM0YzNiYTQ2YWI5MThkNWJjNmI5OWMyNGU1XzEzLTEtMS0xLTcwMzM0_5a86d845-a52f-41be-af1f-146b043ac464"
      unitRef="usd">19210000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3acb260a76164a64b8af93dcc2faa623_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzkwMA_2f847cf9-c347-4784-81a5-e9e6e598acef">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iecd0cd60e86c45669800594f2197741d_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzkwNg_7ecad5bd-165b-468f-bf62-3ee7da8fed4d">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzEwMDM_26b33add-6599-4135-b602-1f3b2fc63683"
      unitRef="usd">42100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzEwMDc_1b8f275c-e915-455d-a3e2-e7840ef07cf8"
      unitRef="usd">56600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzEwMTQ_d81d014b-d7bc-4d5d-8d48-c4bcb51824b7"
      unitRef="usd">41200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzI1NTM_f8413760-f8f9-4499-bde5-5d31e3e19d93">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future annual amortization expense on intangible assets is estimated to be as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTpkOWQ5YWI0MDJiMmM0NjA0YWU3ZDg2N2Y2NGFmMjQyNi90YWJsZXJhbmdlOmQ5ZDlhYjQwMmIyYzQ2MDRhZTdkODY3ZjY0YWYyNDI2XzEtMi0xLTEtNzAzMzQ_17cddae6-910a-4197-9cfa-2a40d24fa51b"
      unitRef="usd">35590000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTpkOWQ5YWI0MDJiMmM0NjA0YWU3ZDg2N2Y2NGFmMjQyNi90YWJsZXJhbmdlOmQ5ZDlhYjQwMmIyYzQ2MDRhZTdkODY3ZjY0YWYyNDI2XzItMi0xLTEtNzAzMzQ_c07c121b-53c4-4253-ad66-dfde932ea966"
      unitRef="usd">28170000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTpkOWQ5YWI0MDJiMmM0NjA0YWU3ZDg2N2Y2NGFmMjQyNi90YWJsZXJhbmdlOmQ5ZDlhYjQwMmIyYzQ2MDRhZTdkODY3ZjY0YWYyNDI2XzMtMi0xLTEtNzAzMzQ_88f05a20-252f-491f-8643-ddb1c216f765"
      unitRef="usd">22710000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTpkOWQ5YWI0MDJiMmM0NjA0YWU3ZDg2N2Y2NGFmMjQyNi90YWJsZXJhbmdlOmQ5ZDlhYjQwMmIyYzQ2MDRhZTdkODY3ZjY0YWYyNDI2XzQtMi0xLTEtNzAzMzQ_38ed83cb-182d-4a85-9529-f499b054712f"
      unitRef="usd">20795000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90YWJsZTpkOWQ5YWI0MDJiMmM0NjA0YWU3ZDg2N2Y2NGFmMjQyNi90YWJsZXJhbmdlOmQ5ZDlhYjQwMmIyYzQ2MDRhZTdkODY3ZjY0YWYyNDI2XzUtMi0xLTEtNzAzMzQ_935b704b-4881-4238-b41a-53acdb76bb6b"
      unitRef="usd">19089000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzIwMzc_b23e4813-cd19-4b15-9852-c5b2845c5a00"
      unitRef="usd">3800000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzIwNDQ_49f593dd-da16-43e8-885e-605d29420257"
      unitRef="usd">3400000</us-gaap:PaymentsToDevelopSoftware>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzIxMTU_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzIxOTkwMjMyNTgxODU_26c53dfe-635b-438a-b9d9-73f934856d19"
      unitRef="usd">82800000</us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers>
    <us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzIxOTkwMjMyNTgxNzY_12f41500-0848-4f5d-9d93-ac6f6fd4e09f"
      unitRef="usd">79000000</us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers>
    <us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
      contextRef="i4373220213f242c8b26e3d18d69d2ca7_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzIyMzE_175b188c-9ed4-4aa1-9ed7-663e97a075a2"
      unitRef="usd">3800000</us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers>
    <us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
      contextRef="ic4f1d2dfba3142c997fbce5f50dfa603_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzIyMzg_10dd3a4b-13ed-47d0-99d1-a21442c821a7"
      unitRef="usd">5000000</us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzI0NzA_ecff8500-68df-4208-8ab4-5d749b3e57d9"
      unitRef="usd">8500000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzI0NzQ_f53f6eec-ec48-440d-b04d-7d274348da8b"
      unitRef="usd">8400000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzI0ODI_b3c9d287-c220-46c9-9655-2efe4142d442"
      unitRef="usd">7800000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjQvZnJhZzpmMTYzZTJlODRmMzc0ZTg2YjQ1MGI2NDEzYWM5ZjA4NS90ZXh0cmVnaW9uOmYxNjNlMmU4NGYzNzRlODZiNDUwYjY0MTNhYzlmMDg1XzE2NDkyNjc0NDU1MjI_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQwOTA_a63d53bc-3ae0-4787-abab-1744d272e862">LEASES &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessee Activity&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases for office space, land, warehouse and manufacturing space, R&amp;amp;D laboratories, vehicles and certain equipment. Finance leases are not significant. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company&#x2019;s leases have remaining lease terms of&#160;1 year&#160;to approximately&#160;30 years, some of which may include options to extend the leases for up to&#160;10 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the appropriate incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2021, the Company entered into a lease for manufacturing space in Clinton, PA. In fiscal 2023, the Company&#x2019;s manufacturing operations in Leetsdale, PA were relocated to the Clinton, PA facility. The lease term associated with the new manufacturing facility is 15 years and 7 months and includes two five year renewal options followed by one four year renewal option. During fiscal 2021, the Company recorded a right-of-use asset of $11.3&#160;million and corresponding liabilities of $15.4&#160;million upon commencement of the lease term in May 2020. In addition, the Company recorded a $4.1&#160;million lease incentive receivable associated with this lease agreement which was received during fiscal 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental balance sheet information related to the Company&#x2019;s operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMC0xLTEtNzAzMzQ_34cb8f69-e36e-4863-9363-93e365f18a37"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMC0xLTEtNzAzMzQ_4c4b5b40-680d-44df-9a35-0e7bc64d7233"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMC0xLTEtNzAzMzQ_71a2b58f-3dab-4c09-b137-6558f9c15c80"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMC0xLTEtNzAzMzQ_993d52dc-b21b-4c73-bea1-865c14747532"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMC0xLTEtNzAzMzQ_64ce6304-0097-4fab-b514-f225878a9f4b"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMC0xLTEtNzAzMzQ_aece9495-28e3-4cad-8c7d-78640888fb76"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the weighted average remaining lease term and discount rate information related to our operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s operating lease costs were&#160;$10.6 million, $11.0&#160;million and $11.7&#160;million during fiscal 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental cash flow information related to our operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 3, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows used for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the maturities of our operating lease liabilities as of&#160;April&#160;1, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.877%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal Year &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;77,630&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;63,065&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor Activity&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets on the Company&#x2019;s balance sheet classified as Haemonetics equipment primarily consists of medical devices installed at customer sites but owned by Haemonetics. These devices are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as the purchase and consumption of a certain level of disposable products. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where devices are provided under operating lease arrangements, a substantial majority of the entire lease revenue is variable and subject to subsequent non-lease component (disposable products) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Operating lease revenue represents approximately 3 percent of the Company&#x2019;s total net sales.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ia88c59c423ec44039b63736f7e925910_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzYwMA_dc52fc53-cdad-40bc-b99c-bb4885a6db36">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i6fb24bdd79a74f0eb39e5b0eecfbdaf6_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzYyNQ_ebc0de79-ef66-4881-bdef-376e98be4f58">P30Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzcwMA_ee46fd26-9a00-4bc1-96d7-88405cc80883">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ie4cf1b883fd6484c9800097c24c1d893_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQzOTgwNDY1MTYzNDQ_ff7d0f1e-a2bc-4976-85c5-a91ce804e087">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i178b7f39a47e48ccbbd4fb779775b3cf_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQzOTgwNDY1MTYzNDU_e73b6e81-aaed-4b44-9848-f35db46504ac">P4Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i523638b9b7c54c378edd933028123e1e_I20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzE2NDkyNjc0NDY5MzM_87243dca-0bc0-46b2-a113-0787000c16fa"
      unitRef="usd">11300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="i523638b9b7c54c378edd933028123e1e_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzE2NDkyNjc0NDY5NjI_61a52910-486d-4488-958e-4fdeccb570ea"
      unitRef="usd">15400000</us-gaap:OperatingLeaseLiability>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i85fa50a491e746dbbe80adc41c28821c_I20220101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzE2NDkyNjc0NDY5OTA_e241f0d2-54a7-4075-a28e-f36365bf8ece"
      unitRef="usd">4100000</us-gaap:PropertyPlantAndEquipmentNet>
    <hae:AssetsandLiabilitiesLesseeTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQwOTE_2046fd9b-6589-45bb-9b5c-3896ace269df">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental balance sheet information related to the Company&#x2019;s operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMC0xLTEtNzAzMzQ_34cb8f69-e36e-4863-9363-93e365f18a37"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMC0xLTEtNzAzMzQ_4c4b5b40-680d-44df-9a35-0e7bc64d7233"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMC0xLTEtNzAzMzQ_71a2b58f-3dab-4c09-b137-6558f9c15c80"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMC0xLTEtNzAzMzQ_993d52dc-b21b-4c73-bea1-865c14747532"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMC0xLTEtNzAzMzQ_64ce6304-0097-4fab-b514-f225878a9f4b"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMC0xLTEtNzAzMzQ_aece9495-28e3-4cad-8c7d-78640888fb76"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</hae:AssetsandLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMi0xLTEtNzAzMzQ_fe04e14b-3462-4114-ae2e-7f76a692cc41"
      unitRef="usd">53413000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzItMy0xLTEtNzAzMzQ_d90b0b82-3283-4fa7-8087-a81cd9fdc9ac"
      unitRef="usd">52749000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMi0xLTEtNzAzMzQ_35f5d72b-aa33-4e49-b4e5-2bcf08b5b4a3"
      unitRef="usd">7162000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzQtMy0xLTEtNzAzMzQ_cfc0e7d0-3ae1-4668-987f-d48bb610e949"
      unitRef="usd">7196000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMi0xLTEtNzAzMzQ_5b6876e2-1fa2-4075-ba10-41a15668440d"
      unitRef="usd">55903000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTplNWZlZTlhMWQ4YmQ0N2FjODU4NmI0Y2RhYmQxZTVlZC90YWJsZXJhbmdlOmU1ZmVlOWExZDhiZDQ3YWM4NTg2YjRjZGFiZDFlNWVkXzUtMy0xLTEtNzAzMzQ_8db663ce-daa4-4859-957c-79538716b89c"
      unitRef="usd">55704000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <hae:LesseeOperatingLeasesOtherInformationTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQwODc_68753f96-8c5d-445d-ad1f-ebc7f41b9235">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the weighted average remaining lease term and discount rate information related to our operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</hae:LesseeOperatingLeasesOtherInformationTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTphZDA5NjU1MTFkY2M0NWZkYWFhOTNmZDA4MDMyZWJkNC90YWJsZXJhbmdlOmFkMDk2NTUxMWRjYzQ1ZmRhYWE5M2ZkMDgwMzJlYmQ0XzEtMi0xLTEtNzAzMzQ_0d36ef59-67f1-4ee1-bdc7-d174c219ef40">P9Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTphZDA5NjU1MTFkY2M0NWZkYWFhOTNmZDA4MDMyZWJkNC90YWJsZXJhbmdlOmFkMDk2NTUxMWRjYzQ1ZmRhYWE5M2ZkMDgwMzJlYmQ0XzEtMy0xLTEtNzAzMzQ_96d3927c-2f32-42b3-ad83-17bd178465a1">P10Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTphZDA5NjU1MTFkY2M0NWZkYWFhOTNmZDA4MDMyZWJkNC90YWJsZXJhbmdlOmFkMDk2NTUxMWRjYzQ1ZmRhYWE5M2ZkMDgwMzJlYmQ0XzItMi0xLTEtNzAzMzQ_5240586e-09a5-4b1f-9442-1a3c2549e1ef"
      unitRef="number">0.0495</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTphZDA5NjU1MTFkY2M0NWZkYWFhOTNmZDA4MDMyZWJkNC90YWJsZXJhbmdlOmFkMDk2NTUxMWRjYzQ1ZmRhYWE5M2ZkMDgwMzJlYmQ0XzItMy0xLTEtNzAzMzQ_87f938c0-a4dc-4d91-a462-d79263065179"
      unitRef="number">0.0458</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseCost
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzI5MDY_29544f38-aad0-40cd-ab64-e043e406584a"
      unitRef="usd">10600000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzI5MTA_a187c54d-3a2d-4c6b-a3bd-1f80a4af52cd"
      unitRef="usd">11000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzI5MTc_12d9a454-5ba4-4eda-a5c3-f2be77aed72e"
      unitRef="usd">11700000</us-gaap:OperatingLeaseCost>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQwODg_97153239-6ddd-4cfd-8633-c608e2a6a764">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental cash flow information related to our operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 3, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows used for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo4NTdjZTM0YTgwNmI0YjQwYjczYTEzMzBhNGFhNDE4Yy90YWJsZXJhbmdlOjg1N2NlMzRhODA2YjRiNDBiNzNhMTMzMGE0YWE0MThjXzItMi0xLTEtNzAzMzQ_5610ccf9-2597-4002-bd5c-d0e39b9a2688"
      unitRef="usd">11450000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo4NTdjZTM0YTgwNmI0YjQwYjczYTEzMzBhNGFhNDE4Yy90YWJsZXJhbmdlOjg1N2NlMzRhODA2YjRiNDBiNzNhMTMzMGE0YWE0MThjXzItMy0xLTEtNzAzMzQ_2714c710-11f5-4941-96f2-487443ddbf00"
      unitRef="usd">11014000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo4NTdjZTM0YTgwNmI0YjQwYjczYTEzMzBhNGFhNDE4Yy90YWJsZXJhbmdlOjg1N2NlMzRhODA2YjRiNDBiNzNhMTMzMGE0YWE0MThjXzItNC0xLTEtNzAzMzQ_96b125a3-5ede-4bd1-8258-f1f643162972"
      unitRef="usd">10456000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo4NTdjZTM0YTgwNmI0YjQwYjczYTEzMzBhNGFhNDE4Yy90YWJsZXJhbmdlOjg1N2NlMzRhODA2YjRiNDBiNzNhMTMzMGE0YWE0MThjXzMtMi0xLTEtNzAzMzQ_0cf0acc6-f3bf-4101-9d93-c88f7b0f74d2"
      unitRef="usd">211000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo4NTdjZTM0YTgwNmI0YjQwYjczYTEzMzBhNGFhNDE4Yy90YWJsZXJhbmdlOjg1N2NlMzRhODA2YjRiNDBiNzNhMTMzMGE0YWE0MThjXzMtMy0xLTEtNzAzMzQ_50b18828-3f6a-4252-bd8e-8f03bb1489f8"
      unitRef="usd">587000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo4NTdjZTM0YTgwNmI0YjQwYjczYTEzMzBhNGFhNDE4Yy90YWJsZXJhbmdlOjg1N2NlMzRhODA2YjRiNDBiNzNhMTMzMGE0YWE0MThjXzMtNC0xLTEtNzAzMzQ_9071d224-3c8e-4f41-85d9-af3873b0ea46"
      unitRef="usd">29595000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQwODk_fec46fa9-ecc5-4bb2-834a-9ae00b16b10e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the maturities of our operating lease liabilities as of&#160;April&#160;1, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.877%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal Year &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;77,630&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;63,065&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzEtMi0xLTEtNzAzMzQ_d27559c9-fad2-4e9b-bd53-696077b5062e"
      unitRef="usd">9813000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzItMi0xLTEtNzAzMzQ_cf3cb52c-10df-4ce4-9011-44dc8d1d48d0"
      unitRef="usd">9007000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzMtMi0xLTEtNzAzMzQ_5e3d54eb-6d84-4e57-a3a2-3199162b29c2"
      unitRef="usd">8601000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzQtMi0xLTEtNzAzMzQ_dc312afe-3e08-4520-9749-f2b4bc8a401d"
      unitRef="usd">9073000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzUtMi0xLTEtNzAzMzQ_03adfc06-958d-41a2-9fc1-98ed4e6122ef"
      unitRef="usd">7490000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzYtMi0xLTEtNzAzMzQ_41631c00-73cd-448a-bb98-fd591d351521"
      unitRef="usd">33646000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzctMi0xLTEtNzAzMzQ_b6ca3472-dff7-47c6-b488-dcb27d2bf167"
      unitRef="usd">77630000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzgtMi0xLTEtNzAzMzQ_dca8dc70-6969-44d2-bf1d-fea25e43f1f6"
      unitRef="usd">14565000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90YWJsZTo5NWMwNjYxZDhlMDI0MDVkYTc2ZGQwYzhiMjA3MzQzYi90YWJsZXJhbmdlOjk1YzA2NjFkOGUwMjQwNWRhNzZkZDBjOGIyMDczNDNiXzktMi0xLTEtNzAzMzQ_8020f012-a95f-4275-9531-8e60231dad63"
      unitRef="usd">63065000</us-gaap:OperatingLeaseLiability>
    <hae:OperatingLeaseRevenueAsAPercentageOfTotalNetSales
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMjcvZnJhZzpjNThiYjRhYmZlOTA0MzBjODZmMWVkYWM0YmU2ZWYzOC90ZXh0cmVnaW9uOmM1OGJiNGFiZmU5MDQzMGM4NmYxZWRhYzRiZTZlZjM4XzQwNTE_9c998482-78fd-4d9a-b48f-3df06e241565"
      unitRef="number">0.03</hae:OperatingLeaseRevenueAsAPercentageOfTotalNetSales>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzExMzcy_66d2ce48-2b68-40ac-b932-eff627b70f80">NOTES&#160;PAYABLE AND LONG-TERM DEBT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Notes payable and long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan, net of financing fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;754,102&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;559,441&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, the Company issued $500.0&#160;million aggregate principal amount of 0% convertible senior notes due 2026 (the &#x201c;2026 Notes&#x201d;). The 2026 Notes are governed by the terms of the Indenture between the Company and U.S. Bank National Association, as trustee (the &#x201c;Indenture&#x201d;). The total net proceeds from the sale of the 2026 Notes, after deducting the initial purchasers&#x2019; discounts and debt issuance costs, were approximately $486.7&#160;million. The 2026 Notes will mature on March 1, 2026, unless earlier converted, redeemed or repurchased.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders may convert their notes at their option at any time prior to the close of business on the business day immediately preceding September 1, 2025 only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;During any calendar quarter (and only during such calendar quarter) beginning after June 30, 2021, if, the last reported sale price per share of the Company&#x2019;s common stock exceeds 130% of the applicable conversion price on each applicable trading day for at least 20 trading days (whether or not consecutive) in the period of the 30 consecutive trading day period ending on, and including, the last trading day of the immediately preceding calendar quarter;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;During the five business day period after any five consecutive trading day period in which, for each day of that period, the trading price per $1,000 principal amount of the 2026 Notes for such trading day was less than 98% of the product of the last reported sale price of the Company&#x2019;s common stock and the applicable conversion rate on such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Company issues to common stockholders any rights, options, or warrants, entitling them, for a period of not more than 60 days, to purchase shares of common stock at a price per share less than the average closing sale price of 10 consecutive trading days, or the Company&#x2019;s election to make a distribution to common stockholders exceeding 10% of the previous day&#x2019;s closing sale price;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Upon the occurrence of specified corporate events, as set forth in the indenture governing the 2026 Notes; or&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Prior to the related redemption date if the Company calls the 2026 Notes for redemption&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after September 1, 2025, until the close of business on the scheduled trading day immediately preceding the maturity date, holders may convert all or a portion of their 2026 Notes, in multiples of $1,000 principal amount, at any time, regardless of the foregoing circumstances. The conversion rate for the 2026 Notes is 5.7033 shares of common stock per $1,000 principal amount of notes (which is equal to an initial conversion price of approximately $175.34 per share of the Company&#x2019;s common stock), subject to adjustment as set forth in the Indenture. Upon conversion, the Company will pay cash up to the aggregate principal amount of the notes to be converted and pay or deliver, as the case may be, cash, common stock or a combination of cash and common stock, at the Company&#x2019;s election, in respect of the remainder, if any, of the Company&#x2019;s conversion obligation in excess of the aggregate principal amount of the notes being converted. If a make-whole adjustment event, as described in the Indenture, occurs and a holder elects to convert its 2026 Notes in connection with such make-whole adjustment event, such holder may be entitled to an increase in the conversion rate as described in the Indenture.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2023, the conditions allowing holders of the 2026 Notes to convert have not been met. The 2026 Notes were therefore not convertible as of April&#160;1, 2023 and were classified as long-term debt on the Company&#x2019;s consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2026 Notes will be redeemable, in whole or in part, at the Company&#x2019;s option at any time, and from time to time, on or after March 5, 2024 and on or before the 40th scheduled trading day immediately before the maturity date, if the last reported sale price per share of the Company&#x2019;s common stock exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately before the date the Company sends the related redemption notice at a redemption price equal to 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. Upon the occurrence of certain fundamental changes involving the Company, holders of the 2026 Notes may require the Company to repurchase for cash all or part of their 2026 Notes at a repurchase price equal to 100% of the principal amount of the 2026 Notes to be repurchased, plus&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;accrued and unpaid interest.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 4, 2021, the Company adopted ASC Update No. 2020-06 using the modified retrospective method, which resulted in a decrease of $61.2&#160;million to additional paid-in capital, a decrease to non-current deferred tax liabilities of $20.0&#160;million, and an increase of $80.3&#160;million to non-current convertible notes, net, on the consolidated balance sheets. Additionally, retained earnings was adjusted to remove amortization expense recognized in prior periods related to the debt discount and the convertible notes no longer have a debt discount that will be amortized, net of taxes. The impact to retained earnings on the consolidated balance sheets as of April 4, 2021 is an increase of $1.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023, the $500.0&#160;million principal balance was netted down by the $7.9&#160;million of remaining debt issuance costs, resulting in a net convertible note payable of $492.1&#160;million. Interest expense related to the 2026 Notes was $2.7&#160;million for the fiscal year ended April 1, 2023, which is entirely attributable to the amortization of the debt issuance costs. The debt issuance costs are amortized at an effective interest rate of 0.5%. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capped Calls&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the issuance of the 2026 Notes, the Company entered into capped call transactions with certain counterparties (&#x201c;Capped Calls&#x201d;). The Capped Calls each have an initial strike price of approximately $175.34 per share, subject to certain adjustments, which corresponds to the initial conversion price of the 2026 Notes. The Capped Calls have initial cap prices of $250.48 per share, subject to certain adjustments. The Capped Calls are expected to partially offset the potential dilution to the Company&#x2019;s common stock upon any conversion of the 2026 Notes, with such offset subject to a cap based on the cap price. The Capped Calls cover, subject to anti-dilution adjustments, approximately 2.85&#160;million shares of the Company&#x2019;s common stock. For accounting purposes, the Capped Calls are separate transactions, and not part of the 2026 Notes. As these transactions meet certain accounting criteria, the Capped Calls are recorded in stockholders&#x2019; equity and are not accounted for as derivatives. The cost of $47.4&#160;million incurred to purchase the Capped Calls was recorded as a reduction to additional paid-in capital in fiscal 2021 and will not be remeasured.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 15, 2018, the Company entered into a credit agreement with certain lenders that provided for a $350.0 million term loan and a $350.0 million revolving loan (together with the term loan, as amended from time to time, the &#x201c;2018 Credit Facilities&#x201d;) that were each scheduled to mature on June 15, 2023 with applicable interest rates during the period established using LIBOR plus 1.13% - 1.75%, depending on the Company's leverage ratio. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On July 26, 2022, the Company entered into an amended and restated credit agreement with certain lenders to refinance the 2018 Credit Facilities and extend their maturity date through June 2025. The amended and restated credit agreement provides for a $280.0&#160;million&#160;senior unsecured term loan, the proceeds of which have been used to settle the balance of the term loan under the 2018 Credit Facilities, and a $420.0&#160;million&#160;senior unsecured revolving credit facility (together, the &#x201c;Revised Credit Facilities&#x201d;). Loans under the Revised Credit Facilities bear interest at an annual rate equal to the Adjusted Term SOFR Rate (as specified in the amended and restated credit agreement), which is subject to a floor of 0%, plus an applicable rate ranging from 1.125% to 1.750% based on the Company&#x2019;s consolidated net leverage ratio (as specified in the amended and restated credit agreement) at the applicable measurement date. Adjusted Term SOFR Rate loans are also subject to a credit spread adjustment of 0.10% per annum. The revolving credit facility carries an unused fee that ranges from 0.125% to 0.250% annually based on the Company&#x2019;s consolidated net leverage ratio at the applicable measurement date. Under the Revised Credit Facilities, the Company is required to maintain certain leverage and interest coverage ratios specified in the amended and restated credit agreement as well as other customary non-financial affirmative and negative covenants. The Revised Credit Facilities mature on June 15, 2025. The principal amount of the term loan under the Revised Credit Facilities is repayable quarterly through the maturity date at a rate of 2.5% for the first year and 5% thereafter, with the unpaid balance due at maturity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company applied modification accounting for the credit facility refinancing. For the term loan under the Revised Credit Facilities, for fiscal 2023, the Company recognized interest expense of $0.5&#160;million for third party fees incurred and capitalized $0.2&#160;million of lender fees related to the term loan. For fiscal 2023, the Company capitalized $1.1&#160;million of lender fees and third-party costs incurred in the refinancing related to the revolving credit facility under the Revised Credit Facilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At April&#160;1, 2023, $274.7 million was outstanding under the term loan with an effective interest rate of 6.3%. There were no outstanding borrowings under the revolving credit facility at April&#160;1, 2023. The Company also had $21.3 million of uncommitted operating lines of credit to fund its global operations under which there were no outstanding borrowings as of April&#160;1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Revised Credit Facilities, the Company is required to maintain a consolidated leverage ratio not to exceed 3.5:1.0 and a consolidated interest coverage ratio not to be less than 4.0:1.0 during periods when the Revised Credit Facilities are outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company is required to satisfy these covenants, on a pro forma basis, in connection with any new borrowings (including any letter of credit issuances) on the revolving credit facility as of the time of such borrowings. The Consolidated Interest Coverage Ratio is calculated as the consolidated EBITDA divided by consolidated interest expense while the Consolidated Net Leverage ratio is calculated as consolidated total debt minus liquidity, divided by consolidated EBITDA. Consolidated EBITDA includes EBITDA adjusted by non-recurring and unusual transactions specifically as defined in the Revised Credit Facilities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revised Credit Facilities also contain usual and customary non-financial affirmative and negative covenants that include certain restrictions with respect to subsequent indebtedness, liens, loans and investments (including acquisitions), financial reporting obligations, mergers, consolidations, dispositions, dissolutions or liquidation, asset sales, affiliate transactions, change of its business, capital expenditures, share repurchase and other restricted payments. These covenants are subject to exceptions and qualifications set forth in the credit agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any failure to comply with the financial and operating covenants of the Revised Credit Facilities would prevent the Company from being able to borrow additional funds and would constitute a default, which could result in, among other things, the amounts outstanding including all accrued interest and unpaid fees, becoming immediately due and payable. In addition, the Revised Credit Facilities include customary events of default, in certain cases subject to customary cure periods. As of April&#160;1, 2023, the Company was in compliance with the covenants. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commitment Fee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Revised Credit Facilities, the Company is required to pay, on the last day of each calendar quarter, a commitment fee on the unused portion of the revolving credit facility. The commitment fee is subject to a pricing grid based on the Company&#x2019;s consolidated leverage ratio. The commitment fee ranges from 0.125% to 0.250%. The current commitment fee on the undrawn portion of the revolving credit facility is 0.175%.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Issuance Costs and Interest &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenses associated with the issuance of the term loan were capitalized and are amortized to interest expense over the life of the term loan using the effective interest method. As of April&#160;1, 2023, the $274.7 million term loan balance was netted down by the $1.0 million of remaining debt discount, resulting in a net note payable of $273.7 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense was $13.0 million, $5.8 million and $9.4 million for fiscal 2023, 2022 and 2021, respectively. Accrued interest associated with the outstanding debt is included as a component of other current liabilities in the accompanying consolidated balance sheets. As of both April&#160;1, 2023 and April&#160;2, 2022, the Company had an insignificant amount of accrued interest associated with the outstanding debt.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate amount of debt maturing during the next five fiscal years are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal year&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzExMzc3_698452bb-7bb8-4f63-9178-9d5abaaf3c19">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Notes payable and long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan, net of financing fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;754,102&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;559,441&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i6ef7fed91302418381fe9c7f81fce03e_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzEtMS0xLTEtNzAzMzQ_774d8512-6fd8-4d31-abf3-66cabef9a946"
      unitRef="usd">273728000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5206cff195784c31b27c9fddad5c6b59_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzEtMy0xLTEtNzAzMzQ_00c694da-3d75-4fae-b122-9f14208cf306"
      unitRef="usd">284052000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i925003616419483dae22f32ba1685a31_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzItMS0xLTEtNzAzMzQ_67929f7a-96fb-4a55-bfa7-e17e4782b288"
      unitRef="usd">492131000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i25e28000700d43b485d92326bbc4bfb7_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzItMy0xLTEtNzAzMzQ_b8295453-78f7-4795-b833-2b55389b9931"
      unitRef="usd">489462000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i903c8d9492d64dafb77bbdf28e97066f_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzMtMS0xLTEtNzAzMzQ_3e8683a2-52bf-4888-aa17-65f06f5bf216"
      unitRef="usd">27000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5a29f8010b0f483eb7647596726afd6d_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzMtMy0xLTEtNzAzMzQ_6a1380a1-653f-45cf-a183-282e302b4575"
      unitRef="usd">75000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzQtMS0xLTEtNzAzMzQ_98f3c40b-f644-41a0-9b9f-68296aecda60"
      unitRef="usd">11784000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzQtMy0xLTEtNzAzMzQ_59b4a1e3-e766-4317-9ac5-da5febd6585a"
      unitRef="usd">214148000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzUtMS0xLTEtNzAzMzQ_654e6084-ada9-4e7b-bc38-1ed36f723cb0"
      unitRef="usd">754102000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTo1YWRjYTE5ZTU5MGQ0YzQxYmRhMjJmOGM5ZTlkY2MwMy90YWJsZXJhbmdlOjVhZGNhMTllNTkwZDRjNDFiZGEyMmY4YzllOWRjYzAzXzUtMy0xLTEtNzAzMzQ_d9b131ea-e994-41ed-b7d2-75e2c7f22dcf"
      unitRef="usd">559441000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib2c47b417de24ec0a72dcccb7db3cbe4_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2Nw_bcdec7eb-0960-4b06-a584-3abbccb9c3ad"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib2c47b417de24ec0a72dcccb7db3cbe4_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzIwMA_83774249-729b-40e3-8472-f0ac543c9629"
      unitRef="number">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="iab86433186af40dcb319110ff6d19da1_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzU1MQ_d2760821-80fc-410d-8815-1792e9d77597"
      unitRef="usd">486700000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="iab86433186af40dcb319110ff6d19da1_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwMjQ_6dde60fe-c6bd-4353-a37f-3109b1ad5f77"
      unitRef="number">1.30</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
      contextRef="iab86433186af40dcb319110ff6d19da1_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE1MjE_e9a24f7e-d21e-429f-9767-af12706de59c"
      unitRef="number">0.98</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <hae:DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice
      contextRef="iab86433186af40dcb319110ff6d19da1_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzIwMDA_4fc75ce8-9059-4630-b8fd-9e4268d540e7"
      unitRef="number">0.10</hae:DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice>
    <hae:DebtInstrumentConvertibleComponentConversionPrice
      contextRef="iab86433186af40dcb319110ff6d19da1_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzI1NzI_779087ee-64a3-479e-8c96-43fb9e280ee2"
      unitRef="number">5.7033</hae:DebtInstrumentConvertibleComponentConversionPrice>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ib2c47b417de24ec0a72dcccb7db3cbe4_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzI2OTk_58863f5f-f5d4-4535-b964-786c928ec775"
      unitRef="usdPerShare">175.34</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i11f3eed068e24237b4a649f0058c65a2_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzQwMTM_e65eea26-59fd-4796-a54c-5ff45cd8f420"
      unitRef="number">1.30</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ibb6b31fbfdc24cad84abad0853c2b26c_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzQ0MTc_76024192-6795-44cb-9326-ec70f9a4ed4d"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ibb6b31fbfdc24cad84abad0853c2b26c_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzQ3NjA_d782e963-b678-4992-8285-07a41d2271b3"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:StockholdersEquity
      contextRef="i916dfcb35225444db2be37fbccd76378_I20210404"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTg3NTI_a9199d05-d9f0-4e93-81cb-ce1c4851319e"
      unitRef="usd">-61200000</us-gaap:StockholdersEquity>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ie55a1738904642cd8ecd0cbc158879ef_I20210404"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTg3NTY_ee48642b-6e9a-4e58-9aec-bb3744e31f5a"
      unitRef="usd">-20000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="ie55a1738904642cd8ecd0cbc158879ef_I20210404"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTg3NjA_21402c4e-490a-4471-8298-7a4342cc4218"
      unitRef="usd">80300000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:StockholdersEquity
      contextRef="i8fbc64b8be934aaba7b7e05bf27bf2df_I20210404"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTg3NjQ_86a0ef42-9f5e-4a8b-bd3b-790072e6f149"
      unitRef="usd">1000000</us-gaap:StockholdersEquity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib2c47b417de24ec0a72dcccb7db3cbe4_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzU1NDU_1c6c7807-b75e-4a13-811a-bdced1f69832"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i81bf02c0713c4e65b37b37c4baf36474_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzU1ODk_46ce1feb-0ee4-428a-b9cf-af0410cfd745"
      unitRef="usd">7900000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:LongTermDebt
      contextRef="i925003616419483dae22f32ba1685a31_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzU2NzM_6b25b93f-43f6-4675-9073-eb223869d759"
      unitRef="usd">492100000</us-gaap:LongTermDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i81bf02c0713c4e65b37b37c4baf36474_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzU3MjQ_feea3a41-1d27-4684-8101-421961e137d4"
      unitRef="usd">2700000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i925003616419483dae22f32ba1685a31_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzU4Nzg_7b976a9a-538b-4aea-b44d-104b12266d32"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <hae:DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice
      contextRef="i8998d1b0b6314a3c9cc6e3cf409ae0e8_D20210301-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzYxMTU_b7263f13-1f08-4cfb-a0e6-98cec42d5580"
      unitRef="usdPerShare">175.34</hae:DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice>
    <hae:DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice
      contextRef="i8998d1b0b6314a3c9cc6e3cf409ae0e8_D20210301-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzYyNzQ_dcb4f6c5-0962-4643-9845-9ce36c81513f"
      unitRef="usdPerShare">250.48</hae:DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice>
    <hae:DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares
      contextRef="i8998d1b0b6314a3c9cc6e3cf409ae0e8_D20210301-20210331"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzY1OTY_3eb3a0bb-aebb-418d-b160-2e336b3bd51f"
      unitRef="shares">2850000</hae:DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares>
    <hae:DebtInstrumentConvertibleCappedCallTransactionAmount
      contextRef="i8998d1b0b6314a3c9cc6e3cf409ae0e8_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzY5MDI_a27e2598-7c7d-4d5f-b588-e180e1e66356"
      unitRef="usd">47400000</hae:DebtInstrumentConvertibleCappedCallTransactionAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib996e7dc8ee44cd2ad33f983f5f21944_I20180615"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzcxNTM_4c7d2bb8-1257-4f2b-942d-37e9c5cef93f"
      unitRef="usd">350000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i3967cacf6e894b93b61883e912ba1fe6_I20180615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzcxOTA_b5d6b381-79c3-4bb9-a7da-517fd11ad256"
      unitRef="usd">350000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ibb54cb0a2108432db260e72c7a6d4079_D20180615-20180615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc0MTM_4bdb1704-ba99-4f7e-bbdd-ddff0288efa9"
      unitRef="number">0.0113</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iee47837acab14fbdac774a769db72497_D20180615-20180615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc0MTg_c50aac50-9c40-4aa5-b0df-4b002396ac7f"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2be5f41c5e2b4e1c8302bd6e01bebdfa_I20220726"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU3Njg_61e672be-5248-4e56-92d0-7b90dd922cad"
      unitRef="usd">280000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2a9006835c4148deb219670605797d8d_I20220726"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU3ODg_d1b84563-bcaa-40dc-a8c8-2eced74e8415"
      unitRef="usd">420000000</us-gaap:DebtInstrumentFaceAmount>
    <hae:DebtInstrumentInterestRateFloor
      contextRef="id657b251abdc4abebff797dc16703707_I20220726"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4MDc_b3794fb0-a55e-43cb-a747-4cf6da3c19a0"
      unitRef="number">0</hae:DebtInstrumentInterestRateFloor>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id657b251abdc4abebff797dc16703707_I20220726"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4MTM_f7024950-999c-45f1-88be-622ce8f227e1"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1fd10418194d4183846d9bb8e0212b5d_I20220726"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4MjE_eefba645-2e38-4afc-aad9-739160963f85"
      unitRef="number">0.01750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i5fce0a136f5a44868f4e4a7f2e21a61a_D20220726-20220726"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4Mjk_11dbbcd0-c389-4d72-af43-439983c286ff"
      unitRef="number">0.0010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i29c8a067458945ffa8f7969389dce91f_D20220726-20220726"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4MzY_8a7a4e6d-169b-4863-b9e8-b9c1f00ddc06"
      unitRef="number">0.00125</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i7a709732686240949bc3efe71990d70e_D20220726-20220726"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4NDQ_95cd310c-d195-4cbd-8a72-421e17cfd449"
      unitRef="number">0.00250</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <hae:DebtInstrumentPercentOfPrincipalAmountDueInYearOne
      contextRef="i2be5f41c5e2b4e1c8302bd6e01bebdfa_I20220726"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4NTI_35212e9a-b658-44b7-9567-ec518516c0f3"
      unitRef="number">0.025</hae:DebtInstrumentPercentOfPrincipalAmountDueInYearOne>
    <hae:DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity
      contextRef="i2be5f41c5e2b4e1c8302bd6e01bebdfa_I20220726"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU4NTg_ff980c6b-6ecf-4aa1-b5e6-fc891bffc936"
      unitRef="number">0.05</hae:DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity>
    <us-gaap:InterestExpense
      contextRef="i973bd797eb414599820e9d35565eeede_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU5NTE_ee9a9ce6-762f-40bf-b6c1-f0809b946243"
      unitRef="usd">500000</us-gaap:InterestExpense>
    <us-gaap:InterestCostsCapitalized
      contextRef="i973bd797eb414599820e9d35565eeede_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTU5NzA_d308e9ef-02b3-4fd1-9135-37bff69b9759"
      unitRef="usd">200000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i9a1b40a602a74e26bef73bbaf259f41c_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTYwMjk_83253ff2-4b4b-4c62-93eb-43035f94e942"
      unitRef="usd">1100000</us-gaap:InterestCostsCapitalized>
    <us-gaap:LongTermDebt
      contextRef="if339c602382f4eaf8286ac7302f32991_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc0NzI_f7ceb09a-c5c7-450d-aa3e-d9903b67e847"
      unitRef="usd">274700000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="if339c602382f4eaf8286ac7302f32991_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc1NDY_542a4ae7-d5da-45bf-b809-4b272b618847"
      unitRef="number">0.063</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt
      contextRef="id0d3e0503f2e47369182add4c536c0b0_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzE2NDkyNjc0NTYwNTI_91bbd2fb-dffa-4813-ba50-b14248264272"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0373e5b59bde4b20931153fa64e29e2b_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc2NDQ_eb90c6d3-05bd-4c90-b90c-0123fc04a02a"
      unitRef="usd">21300000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LongTermDebt
      contextRef="i0373e5b59bde4b20931153fa64e29e2b_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc3NDE_ece7059a-fb10-4f56-8b30-d3e42725e5bf"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <hae:ConsolidatedTotalLeverageRatio
      contextRef="id0d3e0503f2e47369182add4c536c0b0_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc4ODc_216278f5-534b-4415-b042-ee7b9146b084"
      unitRef="number">3.5</hae:ConsolidatedTotalLeverageRatio>
    <hae:ConsolidatedInterestCoverageRatio
      contextRef="id0d3e0503f2e47369182add4c536c0b0_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzc5NTc_dca514d3-18e5-4a8c-838a-60aaa44e02e0"
      unitRef="number">4.0</hae:ConsolidatedInterestCoverageRatio>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="ica4fb645f2a44680b45401f71819ac02_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwNDcw_326acbfb-c90f-4412-bfe1-cc94993eb9f9"
      unitRef="number">0.00125</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i8896432b873649499c520736535daf9b_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwNDc2_9e321d74-c5a2-4955-b0c7-87b90fce3019"
      unitRef="number">0.00250</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="ia304a8f1861445a888815c4e3fe5f060_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwNTY2_a1df1cc5-5b8b-457d-b2cc-effee0201bde"
      unitRef="number">0.00175</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LongTermDebt
      contextRef="if339c602382f4eaf8286ac7302f32991_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwNzk4_f7ceb09a-c5c7-450d-aa3e-d9903b67e847"
      unitRef="usd">274700000</us-gaap:LongTermDebt>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i7f25693c211040ecb83adb263cfb9f7f_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwODQy_b8a281ae-116e-4319-964b-6b9306e23c59"
      unitRef="usd">1000000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:LongTermDebt
      contextRef="i6ef7fed91302418381fe9c7f81fce03e_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwOTA4_65827cd6-e648-49b7-9410-cd3a48e8f483"
      unitRef="usd">273700000</us-gaap:LongTermDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwOTM1_d1cffaec-6954-4f3a-8ca4-90d7b433b4b1"
      unitRef="usd">13000000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwOTM5_6ce7d6f3-e6d2-4e5b-b4f0-f17bc5f3d37b"
      unitRef="usd">5800000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzEwOTQ2_018ff355-cff2-42d1-b028-ed23b45d0fc7"
      unitRef="usd">9400000</us-gaap:InterestExpenseDebt>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90ZXh0cmVnaW9uOjdiZmQ2YjhmMzc4YzQ1YjM5NzA4MGMwYjg4OWZkMzQyXzExMzU2_6f14117e-3465-4cce-8d09-4935199d0f38">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate amount of debt maturing during the next five fiscal years are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal year&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTpjMDNhZmI3ZmMyMWY0NmVkODQ1NGQ3MThhMmZiZWJkMS90YWJsZXJhbmdlOmMwM2FmYjdmYzIxZjQ2ZWQ4NDU0ZDcxOGEyZmJlYmQxXzEtMS0xLTEtNzAzMzQ_1bc4c6ba-8555-49aa-8245-a862dc86a062"
      unitRef="usd">12276000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTpjMDNhZmI3ZmMyMWY0NmVkODQ1NGQ3MThhMmZiZWJkMS90YWJsZXJhbmdlOmMwM2FmYjdmYzIxZjQ2ZWQ4NDU0ZDcxOGEyZmJlYmQxXzItMS0xLTEtNzAzMzQ_c4d0f67a-bb50-4fb4-9006-eb3dcf41777d"
      unitRef="usd">10500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTpjMDNhZmI3ZmMyMWY0NmVkODQ1NGQ3MThhMmZiZWJkMS90YWJsZXJhbmdlOmMwM2FmYjdmYzIxZjQ2ZWQ4NDU0ZDcxOGEyZmJlYmQxXzMtMS0xLTEtNzAzMzQ_7cbf2e57-cd7d-46f2-8e09-7d298a15e6d4"
      unitRef="usd">752000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTpjMDNhZmI3ZmMyMWY0NmVkODQ1NGQ3MThhMmZiZWJkMS90YWJsZXJhbmdlOmMwM2FmYjdmYzIxZjQ2ZWQ4NDU0ZDcxOGEyZmJlYmQxXzQtMS0xLTEtNzAzMzQ_f3922f80-f434-41de-bff4-3eb6160e8fa2"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzMvZnJhZzo3YmZkNmI4ZjM3OGM0NWIzOTcwODBjMGI4ODlmZDM0Mi90YWJsZTpjMDNhZmI3ZmMyMWY0NmVkODQ1NGQ3MThhMmZiZWJkMS90YWJsZXJhbmdlOmMwM2FmYjdmYzIxZjQ2ZWQ4NDU0ZDcxOGEyZmJlYmQxXzUtMS0xLTEtNzAzMzQ_858083fa-2f4c-498c-9b83-0268a4a7ff86"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:DerivativesAndFairValueTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzEyMzA5_751e8b14-4914-40db-bcdc-68ec0f19ccc2">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manufactures, markets and sells its products globally. For the fiscal year ended April&#160;1, 2023, 27.9% of the Company&#x2019;s sales were generated outside the U.S.&#160;in local currencies. The Company also incurs certain manufacturing, marketing and selling costs in international markets in local currency.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accordingly, earnings and cash flows are exposed to market risk from changes in foreign currency exchange rates relative to the U.S. Dollar, the Company&#x2019;s reporting currency. The Company has a program in place that is designed to mitigate the exposure to changes in foreign currency exchange rates. That program includes the use of derivative financial instruments to minimize, for a period of time, the impact on its financial results from changes in foreign exchange rates. The Company utilizes foreign currency forward contracts to hedge the anticipated cash flows from transactions denominated in foreign currencies, primarily Japanese Yen and Euro, and to a lesser extent Swiss Franc and Mexican Peso. This does not eliminate the impact of the volatility of foreign exchange rates. However, because the Company generally enters into forward contracts one year out, rates are fixed for a one-year period, thereby facilitating financial planning and resource allocation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Designated Foreign Currency Hedge Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s designated foreign currency hedge contracts as of April&#160;1, 2023 and April&#160;2, 2022 were cash flow hedges under ASC 815, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC 815&#x201d;). The Company records the effective portion of any change in the fair value of designated foreign currency hedge contracts in other comprehensive income until the related third-party transaction occurs. Once the related third-party transaction occurs, the Company reclassifies the effective portion of any related gain or loss on the designated foreign currency hedge contracts to earnings. In the event the hedged forecasted transaction does not occur, or it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. The Company had designated foreign currency hedge contracts outstanding in the contract amount of $51.8 million as of April&#160;1, 2023 and $67.3 million as of April&#160;2, 2022. At April&#160;1, 2023, a gain of $2.8 million, net of tax, will be reclassified to earnings within the next twelve months. Substantially all currency cash flow hedges outstanding as of April&#160;1, 2023 mature within twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non-Designated Foreign Currency Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages its exposure to changes in foreign currency on a consolidated basis to take advantage of offsetting transactions and balances. It uses foreign currency forward contracts as a part of its strategy to manage exposure related to foreign currency denominated monetary assets and liabilities. These foreign currency forward contracts are entered into for periods consistent with currency transaction exposures, generally one month. They are not designated as cash flow or fair value hedges under ASC 815. These forward contracts are marked-to-market with changes in fair value recorded to earnings. The Company had non-designated foreign currency hedge contracts under ASC 815 outstanding in the contract amount of $44.7 million as of April&#160;1, 2023 and $39.5 million as of April&#160;2, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Part of the Company&#x2019;s interest rate risk management strategy includes the use of interest rate swaps to mitigate its exposure to changes in variable interest rates. The Company&#x2019;s objective in using interest rate swaps is to add stability to interest expense and to manage and reduce the risk inherent in interest rate fluctuations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 15, 2018, the Company entered into the 2018 Credit Facilities which provided for a $350.0 million term loan and a $350.0 million revolving credit facility. Under the terms of the 2018 Credit Facilities, interest was established using LIBOR plus the applicable rate ranging from 1.13% to 1.75% based on the Company&#x2019;s leverage ratio. In August 2018, the Company entered into two interest rate swap agreements to pay an average fixed rate of 2.80% plus the applicable rate on a total notional value of $241.9 million of debt, or 70% of the notional value of the unsecured term loan. The 2018 interest rate swaps mature on June 15, 2023. As a result of the Company&#x2019;s refinancing of the 2018 Credit Facilities in July 2022, as discussed below, the 2018 interest rate swaps were amended in September 2022 to align with the Term Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;) rate rather than LIBOR (the &#x201c;Amended Swaps&#x201d;). In order to avoid dedesignation, the Company elected certain practical expedients under ASC 848.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result, the Company&#x2019;s earnings and cash flows are exposed to interest rate risk from changes to SOFR. The Company concluded that the Amended Swaps were still effective such that hedge accounting was continued on these swaps.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On July 26, 2022, the Company entered into an amended and restated credit agreement to refinance the 2018 Credit Facilities and extend their maturity date through June 2025. The Revised Credit Facilities include a $280.0&#160;million senior unsecured term loan and a $420.0&#160;million&#160;senior unsecured revolving credit facility. Loans under the Revised Credit Facilities bear interest at an annual rate equal to the 1-month USD Term SOFR plus 0.10% and an applicable rate ranging from 1.125% to 1.750% based on the Company&#x2019;s consolidated net leverage ratio. In September 2022, the Company entered into four additional interest rate swaps, which when combined with the Amended Swaps, result in an average blended fixed interest rate of 3.57% plus the applicable rate on 70% of the notional value of the unsecured term loan until mid-June 2023 and 4.12% plus the applicable rate thereafter on 80% of the notional until the maturity date in June 2025. The Company has concluded that each of these four additional interest rate swaps are effective and qualify for hedge accounting treatment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company held the following interest rate swaps as of April&#160;1, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedged Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Original Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount as of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Designation Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-month USD Term SOFR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/28/2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.67%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-month USD Term SOFR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/28/2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.76%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-month USD Term SOFR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/23/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-month USD Term SOFR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/23/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-month USD Term SOFR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/23/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.08%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-month USD Term SOFR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/23/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For fiscal 2023, the Company recorded a gain of $2.6 million, net of tax, in accumulated other comprehensive loss to recognize the effective portion of the fair value of the swaps that qualify as cash flow hedges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Trade Receivables&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, the Company grants trade credit to its customers on normal credit terms. In an effort to reduce its credit risk, the Company (i) establishes credit limits for all customers, (ii) performs ongoing credit evaluations of customers&#x2019; financial condition, (iii) monitors the payment history and aging of customers&#x2019; receivables and (iv) monitors open orders against an individual customer&#x2019;s outstanding receivable balance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for credit losses is maintained for trade accounts receivable based on the expected collectability, the historical collection experience, the length of time an account is outstanding, the financial position of the customer and information provided by credit rating services. Effective March 29, 2020, the Company adopted Update No. 2016-13,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses&#160;(Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which requires consideration of events or circumstances indicating historic collection rates may not be indicative of future collectability. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a roll forward of the allowance for credit losses:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 3, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,475&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,824&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Credit (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(991)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,932&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,475&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effect of the Company&#x2019;s derivative instruments designated as cash flow hedges and those not designated as hedging instruments under ASC 815 in its consolidated statements of income and comprehensive income for the fiscal year ended April 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.055%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative Instruments  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain Recognized in Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Consolidated Statements of Income and Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain Excluded from&lt;br/&gt;Effectiveness&lt;br/&gt;Testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Consolidated Statements of Income and Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues, COGS and SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not have fair value hedges or net investment hedges outstanding as of April&#160;1, 2023 or April&#160;2, 2022. As of April&#160;1, 2023, no material deferred taxes were recognized for designated foreign currency hedges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 815 requires all derivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, by considering the estimated amount it would receive or pay to sell or transfer these instruments at the reporting date and by taking into account current interest rates, currency exchange rates, current interest rate curves, interest rate volatilities, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company may utilize financial models to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in markets that are not active; other observable inputs for the asset or liability; and inputs derived principally from, or corroborated by, observable market data by correlation or other means. As of April&#160;1, 2023, the Company has classified its derivative assets and liabilities within Level 2 of the fair value hierarchy prescribed by ASC 815, as discussed below, because these observable inputs are available for substantially the full term of its derivative instruments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value of the Company&#x2019;s derivative instruments as they appear in its consolidated balance sheets as of April&#160;1, 2023 and April&#160;2, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location in&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,813&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,894&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the exit price that would be received from the sale of an asset or paid to transfer a liability, using assumptions that market participants would use in pricing an asset or liability. The fair value guidance establishes the following three-level hierarchy used for measuring fair value:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2014; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2014; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2014; Inputs to the valuation methodology are unobservable inputs based on management&#x2019;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s money market funds carried at fair value are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measured on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and financial liabilities measured at fair value on a recurring basis consist of the following as of April&#160;1, 2023 and April&#160;2, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;132,341&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,813&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;135,154&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;863&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,752&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97,425&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100,657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,894&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33,675&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,569&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign currency hedge contracts - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of foreign currency hedge contracts was measured using significant other observable inputs and valued by reference to over-the-counter quoted market prices for similar instruments. The Company does not believe that the fair value of these derivative instruments differs significantly from the amount that could be realized upon settlement or maturity, or that the changes in fair value will have a significant effect on its results of operations, financial condition or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest rate swaps - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of interest rate swaps are measured using the present value of expected future cash flows using market-based observable inputs, including credit risk and interest rate yield curves. The Company does not believe that the fair values of these derivative instruments differ significantly from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a significant effect on its results of operations, financial condition or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent consideration&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The fair value of contingent consideration liabilities is based on significant unobservable inputs, including management estimates and assumptions, and is measured based on the probability-weighted present value of the payments expected to be made. Accordingly, the fair value of contingent consideration has been classified as level 3 within the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;fair value hierarchy. The recurring level 3 fair value measurements of contingent consideration liabilities include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td rowspan="2" style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected fiscal year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of contingent consideration associated with acquisitions was $0.9&#160;million at April&#160;1, 2023 and was included in other current liabilities. A reconciliation of the change in the fair value of contingent consideration is included in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;863&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Fair Value Disclosures&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the 2026 Notes as of April&#160;1, 2023 was $425.7&#160;million, which was determined based on the quoted price for the 2026 Notes in an inactive market on the last trading day of the reporting period and is considered as level 2 in the fair value hierarchy. In estimating the risk adjusted yield, the Company utilized both an income and market approach. For the income approach, the Company used a convertible bond pricing model, which included several assumptions including volatility and the risk-free rate. For the market approach, the Company performed an evaluation of issuances of debt securities issued by other comparable companies and broader market indices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The term loan (which is carried at amortized cost), accounts receivable and accounts payable approximate fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesAndFairValueTextBlock>
    <hae:PercentageOfNetSalesGeneratedOutsideOfUs
      contextRef="i0c2e06723032498cae382b252778126a_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE1Nw_05ffb6de-9cdd-4d63-92d4-ea4e73d65870"
      unitRef="number">0.279</hae:PercentageOfNetSalesGeneratedOutsideOfUs>
    <us-gaap:AverageRemainingMaturityOfForeignCurrencyDerivatives1
      contextRef="i0c2e06723032498cae382b252778126a_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzEyMzE0_46e5f746-32bf-451a-b135-11c90cba9be4">P1Y</us-gaap:AverageRemainingMaturityOfForeignCurrencyDerivatives1>
    <us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet
      contextRef="i4174f7cffc824248a65ba67bdeea5ccf_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzIyOTM_ae338821-aa33-404b-acbd-cbfa7fed6c61"
      unitRef="usd">51800000</us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet
      contextRef="iaea3475e1f9349fe82f8c3d1a089214d_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzIzMDk_34e43af2-8630-4ea8-b906-90ea97d28e32"
      unitRef="usd">67300000</us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i764ec41ce0424c3da439a7f3192b0337_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzIzMzk_893c95f2-9dbd-49ff-9737-e923718a4615"
      unitRef="usd">2800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet
      contextRef="i203893fd11e847cf96e92a3382d9cf3e_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzMyODg_5af9d361-c15a-4226-a048-97184ba12f4e"
      unitRef="usd">44700000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet
      contextRef="i40bb49f3669047d78a200b57b5089b10_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzMzMDQ_88007d4f-1878-41d0-9187-79a22ee710f4"
      unitRef="usd">39500000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib996e7dc8ee44cd2ad33f983f5f21944_I20180615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzM0MjE_3dbc2835-9e6d-41a2-89a8-24297f95328f"
      unitRef="usd">350000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i3967cacf6e894b93b61883e912ba1fe6_I20180615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzM0NDA_610c73e3-0f02-4df1-a61d-db0a84fc32e3"
      unitRef="usd">350000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ibb54cb0a2108432db260e72c7a6d4079_D20180615-20180615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzM1NTM_4a1754a9-e50a-4ad8-8edf-00194a4f7914"
      unitRef="number">0.0113</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iee47837acab14fbdac774a769db72497_D20180615-20180615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzM1NTg_baa77c87-6de0-44b4-a076-9140dadbaec8"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="ic098477b86064390ab0ce23b1ab8e887_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzQwNDQ_1f4c4191-cb6a-4bd8-9379-3ab79b0ab1a0"
      unitRef="swap">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ic098477b86064390ab0ce23b1ab8e887_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzQxMjM_66444f18-64e4-417a-9549-33b714e917f9"
      unitRef="number">0.0280</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic098477b86064390ab0ce23b1ab8e887_I20180831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzQxNTU_1c8f50ab-de53-45d8-97e9-06c8661b61c3"
      unitRef="usd">241900000</us-gaap:DerivativeNotionalAmount>
    <hae:DerivativePercentofDebtExposed
      contextRef="i1fd6349491de4fe18e35a4e8da7c6adb_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzQyMDc_12306153-4b6a-47df-9e71-70760a205718"
      unitRef="number">0.70</hae:DerivativePercentofDebtExposed>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2be5f41c5e2b4e1c8302bd6e01bebdfa_I20220726"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NTk5ODY_61e672be-5248-4e56-92d0-7b90dd922cad"
      unitRef="usd">280000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2a9006835c4148deb219670605797d8d_I20220726"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NTk5OTM_d1b84563-bcaa-40dc-a8c8-2eced74e8415"
      unitRef="usd">420000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ide370a9836b84207b26c4ba915b66f5e_D20220726-20220726"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwNTc_b8c45a98-2ce1-41e8-83e7-f9f6a8db11fe"
      unitRef="number">0.0010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i97fd6203f93c48a497546a24430f37f5_I20220726"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwMDY_3f0bddfc-421f-42f8-bc09-4d7841672330"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5594635815ba48028990d42040a8998c_I20220726"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwMTQ_139639d4-32bf-4678-a885-5d926f9ba3e7"
      unitRef="number">0.01750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <hae:NumberOfInterestRateSwapsEntered
      contextRef="ic7aae77517ed42c7b472d781ea7f2fd5_D20220901-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwMjE_bb7dc13c-df6a-4a07-a461-55f742d4a277"
      unitRef="unit">4</hae:NumberOfInterestRateSwapsEntered>
    <hae:DerivativeBlendedFixedInterestRate
      contextRef="i7e00c74476ee4f559c6f5da509474dc8_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwMjM_303fd90b-6a50-41e9-ab0e-07c97d3f74dc"
      unitRef="number">0.0357</hae:DerivativeBlendedFixedInterestRate>
    <hae:DerivativePercentageOfNotionalValueOfDebt
      contextRef="ic7aae77517ed42c7b472d781ea7f2fd5_D20220901-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwMzA_57bf0edb-3b6a-47b7-b662-6de76ffac7c7"
      unitRef="number">0.70</hae:DerivativePercentageOfNotionalValueOfDebt>
    <hae:DerivativeBlendedFixedInterestRate
      contextRef="i17c4195f41c04cd69212868e1ecf674f_I20230615"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwMzU_3a8455b5-aa71-4918-b745-142920e48ed4"
      unitRef="number">0.0412</hae:DerivativeBlendedFixedInterestRate>
    <hae:DerivativePercentageOfNotionalValueOfDebt
      contextRef="ibc4d6f8cfb4043299d632162cf4b2dd3_D20230615-20230615"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjAwNDI_b259e80d-2de6-4ef8-80c4-60531995439c"
      unitRef="number">0.80</hae:DerivativePercentageOfNotionalValueOfDebt>
    <hae:NumberOfInterestRateSwapsEntered
      contextRef="ic7aae77517ed42c7b472d781ea7f2fd5_D20220901-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjI1MjY_c6a7f93c-6576-482c-a895-e40dd3b0ca50"
      unitRef="unit">4</hae:NumberOfInterestRateSwapsEntered>
    <us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjA4Mjg_d55f9816-8198-4864-bb59-fe04c27f5cc9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company held the following interest rate swaps as of April&#160;1, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedged Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Original Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount as of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Designation Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-month USD Term SOFR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/28/2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.67%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-month USD Term SOFR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/28/2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.76%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-month USD Term SOFR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/23/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-month USD Term SOFR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/23/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/30/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-month USD Term SOFR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/23/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.08%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1-month USD Term SOFR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9/23/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/15/2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i68eff29e4ad24dbbbb27184442823054_I20180928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzItMi0xLTEtNzQ2NDA_ee3d21a4-18dc-443e-a56b-88bfded9300c"
      unitRef="usd">140719000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7000a797e0454253afd12b28826cf4c1_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzItNC0xLTEtNzQ2NDM_86219476-97e8-4b9b-8a39-ba9594c91fb9"
      unitRef="usd">28500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i7000a797e0454253afd12b28826cf4c1_I20230401"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzItMTItMS0xLTc0NjQ1_7d0b8279-03cf-4c5f-99ec-ac50b06e8b51"
      unitRef="number">0.0267</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i7000a797e0454253afd12b28826cf4c1_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzItMTQtMS0xLTc0NjQ3_52d3bc16-f6db-48b7-b03f-e9e22e6e44a4"
      unitRef="usd">132000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2ebfc574daa0449aa36b42ccd3735fb8_I20180928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzMtMi0xLTEtNzQ2NTE_063ccb90-a6ed-43a1-820a-5794e24d13a8"
      unitRef="usd">101219000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2fd5a33d65ce4c719c8ef554f98fd1b3_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzMtNC0xLTEtNzQ2NTE_2515deb1-266f-447c-96be-9428c27e2f12"
      unitRef="usd">20500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i2fd5a33d65ce4c719c8ef554f98fd1b3_I20230401"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzMtMTItMS0xLTc0NjYy_205fc945-9b4c-4bb5-998c-1379657eed74"
      unitRef="number">0.0276</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i2fd5a33d65ce4c719c8ef554f98fd1b3_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzMtMTQtMS0xLTc0NjYy_cd639928-f4e3-43d1-8a4c-631a2d4a70d7"
      unitRef="usd">91000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iee0aef522d1c43b297cb87bd0a1062c5_I20220923"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzQtMi0xLTEtNzQ2NTE_6ff551a6-569e-48ec-a6e3-bbeecdfc8f21"
      unitRef="usd">23888000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icc20bf01217b405abe467d85031aa1d8_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzQtNC0xLTEtNzQ2NTE_4d984ee9-7710-46dd-989c-5f6bc08dc28f"
      unitRef="usd">71663000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="icc20bf01217b405abe467d85031aa1d8_I20230401"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzQtMTItMS0xLTc0NjYy_b0100f1c-66d2-4c7c-9dce-43151bfd7a3d"
      unitRef="number">0.0444</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="icc20bf01217b405abe467d85031aa1d8_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzQtMTQtMS0xLTc0NjYy_28fddab4-cafc-4668-8d89-1f9c01eadac2"
      unitRef="usd">67000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i929893b4a65b42a99d8cd2ed3e4ad16f_I20220923"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzUtMi0xLTEtNzQ2NTE_0394ab36-c538-4b6c-88ce-c5e93edbe543"
      unitRef="usd">23888000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i95d4787e8ccb4c79bb1a2ae21210589b_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzUtNC0xLTEtNzQ2NTE_aebd6f9b-b128-4c2e-be93-29fe58032c2a"
      unitRef="usd">71663000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i95d4787e8ccb4c79bb1a2ae21210589b_I20230401"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzUtMTItMS0xLTc0NjYy_43af0143-1c31-4c27-a501-d235d46adec9"
      unitRef="number">0.0446</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i95d4787e8ccb4c79bb1a2ae21210589b_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzUtMTQtMS0xLTc0NjYy_17493047-7fd0-4abc-abbc-585db352636e"
      unitRef="usd">63000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0a2bff04bb124b3cb9565ede568309e3_I20220923"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzYtMi0xLTEtNzQ2NTE_15ce28fb-da75-429a-92b9-9cfcf7013d40"
      unitRef="usd">109900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5a0016d855bc4eae89b59f2528f0aac5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzYtNC0xLTEtNzQ2NTE_101982e4-5e77-4f33-8d59-6b42897f4ab1"
      unitRef="usd">109900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i5a0016d855bc4eae89b59f2528f0aac5_I20230401"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzYtMTItMS0xLTc0NjYy_ccbc864c-cf95-4b9f-94bf-509cd38d2371"
      unitRef="number">0.0408</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i5a0016d855bc4eae89b59f2528f0aac5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzYtMTQtMS0xLTc0NjYy_7bfb1593-ee13-41bd-80f5-f8f3b522294f"
      unitRef="usd">-464000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia88f4a493fba4a00b9f4326a9f0089c9_I20220923"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzctMi0xLTEtNzQ2NTE_82be1c11-2a86-418e-b9f8-e519c4553b34"
      unitRef="usd">109900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i143f09af5d36486a95b6a2443695e880_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzctNC0xLTEtNzQ2NTE_c7381224-d71d-4e26-b453-bd1c2bf9fdda"
      unitRef="usd">109900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i143f09af5d36486a95b6a2443695e880_I20230401"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzctMTItMS0xLTc0NjYy_214d410d-613f-4f76-9501-cd9cb31985fd"
      unitRef="number">0.0415</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i143f09af5d36486a95b6a2443695e880_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzctMTQtMS0xLTc0NjYy_3aff2e66-f1c0-4d2c-beb0-cc7e7a4d4658"
      unitRef="usd">-585000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i40cd2d153ec649379e2713e53825581e_I20220923"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzgtMi0xLTEtNzQ3MjE_08c9eb1e-2508-445c-a1fd-1603fb7991d1"
      unitRef="usd">509514000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i38a3ef0a8b5c416391e812e3c975190b_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzgtNC0xLTEtNzQ3MjM_0e19cbfd-6d08-4e41-b391-c62c730e75f8"
      unitRef="usd">412126000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i38a3ef0a8b5c416391e812e3c975190b_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2MTA2Y2MxZGU1M2U0MTMwYTU2ZWQxY2FhZjk5MTdjYi90YWJsZXJhbmdlOjYxMDZjYzFkZTUzZTQxMzBhNTZlZDFjYWFmOTkxN2NiXzgtMTQtMS0xLTc0NzI1_18f3d9db-abd1-4a2f-a992-995040a5a3a6"
      unitRef="usd">-696000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i0a086617625d4770aa1177f5b215bdfe_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzQ1Mzc_f8dc7989-e16b-4f27-a7da-ec8464e8d739"
      unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzEyMzE4_d9a5bce6-4b19-4f5e-bd2f-cb9ecfadbb2c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a roll forward of the allowance for credit losses:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 3, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,475&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,824&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Credit (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(991)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,932&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,475&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzItMi0xLTEtNzAzMzQ_42bf1d16-9b9d-4f13-9bc1-e8ed9d46fe35"
      unitRef="usd">2475000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzItNC0xLTEtNzAzMzQ_230804dc-4140-4333-ac27-3efd06e1f008"
      unitRef="usd">2226000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i2752e169c88b4ff2a289838d456aec0d_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzItNi0xLTEtNzAzMzQ_e276a9c1-1f11-4906-b529-3841f13f6f6b"
      unitRef="usd">3824000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzMtMi0xLTEtNzAzMzQ_ddb38c46-1009-49b5-84a7-0dbe9cbbc8cc"
      unitRef="usd">-2623000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzMtNC0xLTEtNzAzMzQ_cee67d4b-c71e-4800-b1f8-fea8c8549cec"
      unitRef="usd">-359000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzMtNi0xLTEtNzAzMzQ_231ade7e-ddf6-4f81-b2b4-273569e1abba"
      unitRef="usd">991000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzQtMi0xLTEtNzAzMzQ_6c3db267-c1b6-462e-a23b-a07481ffb489"
      unitRef="usd">166000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzQtNC0xLTEtNzAzMzQ_f35a531d-d81e-44c2-87dd-85e9a3050018"
      unitRef="usd">110000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzQtNi0xLTEtNzAzMzQ_2afcdd2f-5142-457d-aaee-53ab30f27602"
      unitRef="usd">607000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzUtMi0xLTEtNzAzMzQ_a0758c77-0179-48ad-81ce-daea929ee0f4"
      unitRef="usd">4932000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzUtNC0xLTEtNzAzMzQ_1724a678-2c1d-45fd-becb-6da47e2677c9"
      unitRef="usd">2475000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpjMzdhNjFhMmMzMTU0ZmFhOWVhYWViYmYyZGU5MzAzMC90YWJsZXJhbmdlOmMzN2E2MWEyYzMxNTRmYWE5ZWFhZWJiZjJkZTkzMDMwXzUtNi0xLTEtNzAzMzQ_50287ca8-6588-4408-ae46-de70446d3538"
      unitRef="usd">2226000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzEyMzIw_194d2242-ff8c-48e7-99e6-aee1441317e3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effect of the Company&#x2019;s derivative instruments designated as cash flow hedges and those not designated as hedging instruments under ASC 815 in its consolidated statements of income and comprehensive income for the fiscal year ended April 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.055%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative Instruments  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain Recognized in Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Consolidated Statements of Income and Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain Excluded from&lt;br/&gt;Effectiveness&lt;br/&gt;Testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Consolidated Statements of Income and Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues, COGS and SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i764ec41ce0424c3da439a7f3192b0337_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzItMi0xLTEtNzAzMzQ_6bef7336-5597-4145-9337-605b0d74fb18"
      unitRef="usd">2828000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i764ec41ce0424c3da439a7f3192b0337_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzItNC0xLTEtNzAzMzQ_b2151598-d676-4bef-919a-5ca3704a9ab4"
      unitRef="usd">6255000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
      contextRef="ice83d5f54d3b4d1591f7e898bf73fe94_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzItOC0xLTEtNzAzMzQ_00828cba-56c1-463a-a941-1633e2efe587"
      unitRef="usd">983000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i34427df65a3f408681e89de77f0bcba5_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzMtMi0xLTEtNzAzMzQ_ade24dd6-e5c4-4d2c-b59b-109ada2b3cff"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i34427df65a3f408681e89de77f0bcba5_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzMtNC0xLTEtNzAzMzQ_fe957a24-fcfe-48a7-b889-9a7af5f28c1f"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
      contextRef="i496992eb4e324c4d93a9779270bd0d95_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzMtOC0xLTEtNzAzMzQ_6320ec3b-4f5e-4326-be6a-aae65861cea7"
      unitRef="usd">923000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="if57d6790a07844cc9da693a20bd4bffe_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzQtMi0xLTEtNzAzMzQ_d73a7111-df32-4242-8059-272d7c95be7b"
      unitRef="usd">1441000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="if57d6790a07844cc9da693a20bd4bffe_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzQtNC0xLTEtNzAzMzQ_608e26fe-d178-4d80-8813-1e4ce46efa24"
      unitRef="usd">-1119000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
      contextRef="i926351f2cdb64cfca4fca48cd71ce175_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpkZWFiZTZjNTk5NTA0NzI5YWJiNDA2MzAxNGYxNzllMS90YWJsZXJhbmdlOmRlYWJlNmM1OTk1MDQ3MjlhYmI0MDYzMDE0ZjE3OWUxXzQtOC0xLTEtNzAzMzQ_458ffc84-585d-4616-aa6b-c02c09db7d95"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzEyMzE5_fad79a71-b83d-436f-b29a-8a87911791ac">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value of the Company&#x2019;s derivative instruments as they appear in its consolidated balance sheets as of April&#160;1, 2023 and April&#160;2, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location in&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,813&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,894&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ibf952df669d84ad79ebbd6961839ffa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzItMy0xLTEtNzAzMzQ_0b9cf66c-6dcd-41d7-84f0-073919348511"
      unitRef="usd">1401000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i0bd4348fb37642cb9d19c854b0b98777_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzItNS0xLTEtNzAzMzQ_fe535085-0bc6-4c0e-95aa-f864d2288151"
      unitRef="usd">3133000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i82d640169aec444b861eade7d445b02e_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzMtMy0xLTEtNzAzMzQ_fec1e323-76fc-4f1e-a000-b6f5b6dbf04c"
      unitRef="usd">302000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib905d6d3d68e4f13963e09cdca04d335_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzMtNS0xLTEtNzAzMzQ_674dc0bb-30ad-4ef5-a901-c027bc9538f8"
      unitRef="usd">99000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6d438a36d1f445b99fa95273454cd16f_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzQtMy0xLTEtNzU3Njc_fd1338ef-c9c0-41fc-8a69-bcb53f39bff1"
      unitRef="usd">1110000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ifc5fe4fd66044c45abd2da237f5b01bf_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzQtNS0xLTEtNzU3Njc_73f2683d-24ce-4f6f-98c4-d2d03a69dfd6"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if685fcb31a604071a3aea04895ad5ca2_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzQtMy0xLTEtNzAzMzQ_df149aba-2742-4f2c-b275-1a2046139d15"
      unitRef="usd">2813000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie1ef3242c33f4d14968403e733c74eb4_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzQtNS0xLTEtNzAzMzQ_8ad45843-d8ef-4137-94f3-73fd2a9c53ef"
      unitRef="usd">3232000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i745bbb354f3c49e4acff9d758a7db139_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzYtMy0xLTEtNzAzMzQ_86c1b59f-2d0a-4a7b-a8da-5ca097a73559"
      unitRef="usd">24000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if2d5c4548b37436eade14b50d116e37c_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzYtNS0xLTEtNzAzMzQ_1d315c63-3780-4f46-af62-6027b1712e48"
      unitRef="usd">56000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4d0667d1ab6e437eb9e2cccfe3114e71_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzctMy0xLTEtNzAzMzQ_8d3b9213-a3c2-47fd-926e-544b410ecc92"
      unitRef="usd">58000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ifc84f5e642914bcd8c36ff54535f264b_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzctNS0xLTEtNzAzMzQ_b66a525c-fb40-4d6a-a6ec-9feaa286cdb0"
      unitRef="usd">25000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i228a035c89694077beb4571a980c3787_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzgtMy0xLTEtNzAzMzQ_3aef6364-f414-4c21-8b7f-dff454222f91"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6b7cc66dd3cd45aebc86f3ccac3daccb_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzgtNS0xLTEtNzAzMzQ_1072f530-6ecd-414f-b594-1b21f40af416"
      unitRef="usd">1813000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib78abe8a21bb47f6b491e1e88a0c022a_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzktMy0xLTEtNzAzMzQ_5be4106e-0d87-4feb-82e4-ca39d3190fad"
      unitRef="usd">1807000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i21efcb597c134d47a7cdd7695ada55c7_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzktNS0xLTEtNzAzMzQ_9831dcd1-52b7-4ad5-902d-c90e68409b19"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if685fcb31a604071a3aea04895ad5ca2_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzEwLTMtMS0xLTcwMzM0_23ac12bc-7f02-4b73-b3a7-3f5d33143410"
      unitRef="usd">1889000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie1ef3242c33f4d14968403e733c74eb4_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZToxM2RjMGJkZTg3NjI0NzZlYmQ0ZjMyNmFiNzVkOTVjZi90YWJsZXJhbmdlOjEzZGMwYmRlODc2MjQ3NmViZDRmMzI2YWI3NWQ5NWNmXzEwLTUtMS0xLTcwMzM0_246e950b-8745-48ec-bf60-8a48250aa86f"
      unitRef="usd">1894000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzEyMjkx_83701310-ae0e-4a79-a3ae-84841430e619">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and financial liabilities measured at fair value on a recurring basis consist of the following as of April&#160;1, 2023 and April&#160;2, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;132,341&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,813&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;135,154&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;863&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,752&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97,425&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100,657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,894&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33,675&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,569&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The recurring level 3 fair value measurements of contingent consideration liabilities include the following significant unobservable inputs:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td rowspan="2" style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected fiscal year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;A reconciliation of the change in the fair value of contingent consideration is included in the following table:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;863&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i40d487570854407eae1cd91197412837_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzMtMi0xLTEtNzAzMzQ_b6cfc301-b509-49a7-b3e8-cbec10b9f87e"
      unitRef="usd">132341000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0b34b4bf50694564a2bdc0ddefcf34d0_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzMtNC0xLTEtNzAzMzQ_1dea39ca-4d6f-4cee-b180-f4500a367d2c"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id5d605e3bfc94e56bc0743876ebc5034_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzMtOC0xLTEtNzAzMzQ_2db7d6b4-eca4-481d-8f94-9c93509521a3"
      unitRef="usd">132341000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie12da83b81b74a6f8c251cbd3104102c_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzQtMi0xLTEtNzAzMzQ_5dd1fe02-120f-4058-96d5-c7c7ef85b197"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ibf952df669d84ad79ebbd6961839ffa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzQtNC0xLTEtNzAzMzQ_0b9cf66c-6dcd-41d7-84f0-073919348511"
      unitRef="usd">1401000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i71f5eeccac2e405cbde81dd345b9a918_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzQtOC0xLTEtNzAzMzQ_defe66da-c5ff-4f4f-805f-17759b92d31b"
      unitRef="usd">1401000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if45b2edcb0a34394bcc87dce4e55afb6_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzUtMi0xLTEtNzAzMzQ_69ccaae2-3857-4b3a-8aa5-f14455345047"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i82d640169aec444b861eade7d445b02e_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzUtNC0xLTEtNzAzMzQ_fec1e323-76fc-4f1e-a000-b6f5b6dbf04c"
      unitRef="usd">302000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i7652e23f4d9749d58d9f74cc7d60f8f7_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzUtOC0xLTEtNzAzMzQ_e58d19eb-88ad-4bdc-9dc3-c16017a1e88d"
      unitRef="usd">302000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i943bf7094e994bad85fe8de21c1cb0da_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzctMi0xLTEtNzU3ODE_02ba920b-ab12-45ee-9204-b847d52c1b9b"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6d438a36d1f445b99fa95273454cd16f_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzctNC0xLTEtNzU3ODE_fd1338ef-c9c0-41fc-8a69-bcb53f39bff1"
      unitRef="usd">1110000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ifc297a9a523d452588c49f61b90fe397_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzctOC0xLTEtNzU3ODk_eec9eb0a-a5d8-4f90-94f8-e052b97c0526"
      unitRef="usd">1110000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i40d487570854407eae1cd91197412837_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzctMi0xLTEtNzAzMzQ_1ce70cb0-7db1-408d-b952-32eee985350a"
      unitRef="usd">132341000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0b34b4bf50694564a2bdc0ddefcf34d0_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzctNC0xLTEtNzAzMzQ_f0a02f10-f015-4f1a-9af2-9b96a9ceb04a"
      unitRef="usd">2813000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id5d605e3bfc94e56bc0743876ebc5034_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzctOC0xLTEtNzAzMzQ_6b898060-0f57-4d5e-bc53-f3af8d15d20c"
      unitRef="usd">135154000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie12da83b81b74a6f8c251cbd3104102c_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzktMi0xLTEtNzAzMzQ_c55c0b3f-8cf0-460a-8a1b-3180a4e51fe1"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i745bbb354f3c49e4acff9d758a7db139_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzktNC0xLTEtNzAzMzQ_86c1b59f-2d0a-4a7b-a8da-5ca097a73559"
      unitRef="usd">24000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i71f5eeccac2e405cbde81dd345b9a918_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzktOC0xLTEtNzAzMzQ_de64bd5c-f73f-411f-b6d8-1938e1f89f19"
      unitRef="usd">24000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if45b2edcb0a34394bcc87dce4e55afb6_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEwLTItMS0xLTcwMzM0_a9d0320a-dc5f-4774-9dc7-3e20c452d113"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4d0667d1ab6e437eb9e2cccfe3114e71_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEwLTQtMS0xLTcwMzM0_8d3b9213-a3c2-47fd-926e-544b410ecc92"
      unitRef="usd">58000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7652e23f4d9749d58d9f74cc7d60f8f7_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEwLTgtMS0xLTcwMzM0_9e526ebc-fac6-448c-a50e-1b219a0594c2"
      unitRef="usd">58000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i943bf7094e994bad85fe8de21c1cb0da_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzExLTItMS0xLTcwMzM0_30fbd189-b9dd-4c14-a0b1-27454eea1abe"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib78abe8a21bb47f6b491e1e88a0c022a_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzExLTQtMS0xLTcwMzM0_5be4106e-0d87-4feb-82e4-ca39d3190fad"
      unitRef="usd">1807000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ifc297a9a523d452588c49f61b90fe397_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzExLTgtMS0xLTcwMzM0_31bc7acf-919a-4dfe-830a-5a905650b8f8"
      unitRef="usd">1807000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie449786761b5459d81987ca7b30f976f_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEyLTYtMS0xLTcwMzM0_be2c09e0-439c-455c-9e0b-aa2dd1537b78"
      unitRef="usd">863000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic114d1ef99f7486e882e676e604e60d4_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEyLTgtMS0xLTcwMzM0_0a5a2607-94f1-4814-88bf-86e67b97f353"
      unitRef="usd">863000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i40d487570854407eae1cd91197412837_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEzLTItMS0xLTcwMzM0_0952cbbf-cedc-444f-baea-7040c9633812"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0b34b4bf50694564a2bdc0ddefcf34d0_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEzLTQtMS0xLTcwMzM0_cef76656-7c2a-4f9c-97eb-4379ee165165"
      unitRef="usd">1889000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i192129d9183945dfb1fa96a6e3f72823_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEzLTYtMS0xLTcwMzM0_4e5d401a-3523-46cb-9b8d-5cc900397c78"
      unitRef="usd">863000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id5d605e3bfc94e56bc0743876ebc5034_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzEzLTgtMS0xLTcwMzM0_dd38f37d-8ea9-4f5a-8c38-110c798fe0b1"
      unitRef="usd">2752000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i79baee9eabb44eaea4f2911723087bce_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzE4LTItMS0xLTcwMzM0_b0b60cfe-ea02-4980-a808-d003e293f230"
      unitRef="usd">97425000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i4ed4fde198f34c0e96958ff15ac93475_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzE4LTQtMS0xLTcwMzM0_c00f237e-63dd-41c6-b45e-f9eddb4e0dbf"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ide6dff6dae06426caaac4bd1fc9ef699_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzE4LTgtMS0xLTcwMzM0_447d8e69-098e-4a63-af13-ebe0861440a5"
      unitRef="usd">97425000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic3dfaa9406244d52a985e71d364da711_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzE5LTItMS0xLTcwMzM0_1532b3d0-067a-494f-99cd-5d14920491ee"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id872bc48d1694456accfff526b09b5e0_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzE5LTQtMS0xLTcwMzM0_2698cdc4-0487-4caf-8567-5213ca9c80c4"
      unitRef="usd">3133000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i7949d38eb6ed4baaa1e5b677d09753c9_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzE5LTgtMS0xLTcwMzM0_cde5fa2c-5520-4842-8851-ff73f99ba5e1"
      unitRef="usd">3133000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i8bba1f3bac8247d9a7bf0303421a3e7c_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzIwLTItMS0xLTcwMzM0_6140ce0e-d5a4-4d23-bee2-7c3d6a4e57a4"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i65e664ee98504b0b8f8186d1d3cedbee_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzIwLTQtMS0xLTcwMzM0_5abbf08e-3b89-47de-8208-4f0ff59a66b5"
      unitRef="usd">99000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6760b9812af24258ad4ca438476747d4_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzIwLTgtMS0xLTcwMzM0_8e62c452-377e-4f6b-b0c3-da7678c84ac0"
      unitRef="usd">99000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i79baee9eabb44eaea4f2911723087bce_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzIyLTItMS0xLTcwMzM0_b95ad33f-fde4-4a69-b46f-dffc874521ad"
      unitRef="usd">97425000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4ed4fde198f34c0e96958ff15ac93475_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzIyLTQtMS0xLTcwMzM0_005e30be-f47c-412f-a87f-7d296897403b"
      unitRef="usd">3232000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ide6dff6dae06426caaac4bd1fc9ef699_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzIyLTgtMS0xLTcwMzM0_dd111768-ba39-44ae-87c0-419fab92f404"
      unitRef="usd">100657000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic3dfaa9406244d52a985e71d364da711_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI0LTItMS0xLTcwMzM0_1911e68b-0794-4646-8095-450fba70d19b"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i5d7138fbdd0d40408d7f37574315a72b_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI0LTQtMS0xLTcwMzM0_36df5da5-c3ab-4911-b2cb-fd86c669a1ea"
      unitRef="usd">56000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7949d38eb6ed4baaa1e5b677d09753c9_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI0LTgtMS0xLTcwMzM0_77ca4f66-8efe-4320-aec8-974899c2da13"
      unitRef="usd">56000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i8bba1f3bac8247d9a7bf0303421a3e7c_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI1LTItMS0xLTcwMzM0_62ac0c9f-8093-4c88-9632-2b5c2da5e911"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="icb5872f4ce6d4a36ae9ff072fc3da7c5_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI1LTQtMS0xLTcwMzM0_e09c67bc-4bc5-4092-a163-0cbc5f1a5e95"
      unitRef="usd">25000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6760b9812af24258ad4ca438476747d4_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI1LTgtMS0xLTcwMzM0_55d12866-c57c-47a4-8765-d169da18f86c"
      unitRef="usd">25000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ifa8b08aa795f429987456bca970a1829_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI2LTItMS0xLTcwMzM0_ad73195e-f928-4390-96b1-86c681d534c5"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic93412d801134bd49e320c00ae5f3f41_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI2LTQtMS0xLTcwMzM0_8b946fb2-7b18-48bf-92ef-76a5ee8a4a08"
      unitRef="usd">1813000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i0515c0920ac74a3fa99ec66f590742fa_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI2LTgtMS0xLTcwMzM0_32db77cd-f5d2-41dd-9328-8233293cb801"
      unitRef="usd">1813000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if632bd50d393422b8036fdeb475158dc_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI3LTYtMS0xLTcwMzM0_f4883978-efb1-4848-821f-e62f1a9680da"
      unitRef="usd">33675000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0efe65c8e6a44ca28515bf3a0446df60_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI3LTgtMS0xLTcwMzM0_b41b092a-ea47-44cf-82cc-927132cc8fcc"
      unitRef="usd">33675000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i79baee9eabb44eaea4f2911723087bce_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI4LTItMS0xLTcwMzM0_3e11b4a3-44c4-4f31-8c06-ebdf663c7862"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4ed4fde198f34c0e96958ff15ac93475_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI4LTQtMS0xLTcwMzM0_58892467-5997-449d-b731-f5ede7ce871e"
      unitRef="usd">1894000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if4247054189a43a1a0450606d3475abb_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI4LTYtMS0xLTcwMzM0_57059b65-f360-4fa2-b2b1-a64ec6c205aa"
      unitRef="usd">33675000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ide6dff6dae06426caaac4bd1fc9ef699_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTphZDA0ZGEwMjVjY2I0MTI5OTcxZGY5YWRhNDgwMDM1Ni90YWJsZXJhbmdlOmFkMDRkYTAyNWNjYjQxMjk5NzFkZjlhZGE0ODAwMzU2XzI4LTgtMS0xLTcwMzM0_23298b58-5e41-47e7-8791-0fa6300c6f7d"
      unitRef="usd">35569000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iffb2d6495cab432aa90ea55629e7a34e_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpiYmRjMjdlNGYyZGM0ODIwYjBiMGQ1NGI0Nzk0MDdiNS90YWJsZXJhbmdlOmJiZGMyN2U0ZjJkYzQ4MjBiMGIwZDU0YjQ3OTQwN2I1XzQtMi0xLTEtNzAzMzQ_5f10c737-295d-4e90-b71f-08feca6a92a7"
      unitRef="usd">863000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="iffb2d6495cab432aa90ea55629e7a34e_I20230401"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTpiYmRjMjdlNGYyZGM0ODIwYjBiMGQ1NGI0Nzk0MDdiNS90YWJsZXJhbmdlOmJiZGMyN2U0ZjJkYzQ4MjBiMGIwZDU0YjQ3OTQwN2I1XzQtOC0xLTEtNzAzMzQ_958a0756-9d60-4106-b036-752bcdec37e5"
      unitRef="number">0.085</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic114d1ef99f7486e882e676e604e60d4_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzE2NDkyNjc0NjQzNjI_871c7238-a321-4429-93ec-4aba69a1ed21"
      unitRef="usd">900000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0efe65c8e6a44ca28515bf3a0446df60_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2ODc1MmUwY2U0YzQ0MjVhYTk1NWY5NTlkM2VkZDAxYy90YWJsZXJhbmdlOjY4NzUyZTBjZTRjNDQyNWFhOTU1Zjk1OWQzZWRkMDFjXzEtMi0xLTEtNzAzMzQ_13f1ea5b-77de-4022-905c-d36f4c7ca9a8"
      unitRef="usd">33675000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ib4f3c2f8402c490aa5ec976019d2d592_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2ODc1MmUwY2U0YzQ0MjVhYTk1NWY5NTlkM2VkZDAxYy90YWJsZXJhbmdlOjY4NzUyZTBjZTRjNDQyNWFhOTU1Zjk1OWQzZWRkMDFjXzItMi0xLTEtNzAzMzQ_a2e7ccb7-eee9-4fdd-9b5b-2a2fd4a8b700"
      unitRef="usd">-504000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ib4f3c2f8402c490aa5ec976019d2d592_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2ODc1MmUwY2U0YzQ0MjVhYTk1NWY5NTlkM2VkZDAxYy90YWJsZXJhbmdlOjY4NzUyZTBjZTRjNDQyNWFhOTU1Zjk1OWQzZWRkMDFjXzMtMi0xLTEtNzAzMzQ_bce8cce3-4fbb-4e14-b2c1-a4a04f1311eb"
      unitRef="usd">-32293000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <hae:ContingentConsiderationForeignCurrencyTranslationAdjustment
      contextRef="ib4f3c2f8402c490aa5ec976019d2d592_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2ODc1MmUwY2U0YzQ0MjVhYTk1NWY5NTlkM2VkZDAxYy90YWJsZXJhbmdlOjY4NzUyZTBjZTRjNDQyNWFhOTU1Zjk1OWQzZWRkMDFjXzQtMi0xLTEtNzAzMzQ_0247b397-badf-42cb-9e38-3c38363545cc"
      unitRef="usd">-15000</hae:ContingentConsiderationForeignCurrencyTranslationAdjustment>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic114d1ef99f7486e882e676e604e60d4_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90YWJsZTo2ODc1MmUwY2U0YzQ0MjVhYTk1NWY5NTlkM2VkZDAxYy90YWJsZXJhbmdlOjY4NzUyZTBjZTRjNDQyNWFhOTU1Zjk1OWQzZWRkMDFjXzUtMi0xLTEtNzAzMzQ_6c8cb760-d6fa-4cb8-8727-dc71a3093ad2"
      unitRef="usd">863000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LongTermDebtFairValue
      contextRef="i9e0e0c2a238340e5af49c732b3425472_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzYvZnJhZzo3YTNmMDZjZTkyNjc0YmQwYTM5NzBmNmNjYmRkYjJhNi90ZXh0cmVnaW9uOjdhM2YwNmNlOTI2NzRiZDBhMzk3MGY2Y2NiZGRiMmE2XzExNTY1_a7cebfd3-f029-49b7-9866-240aa4333593"
      unitRef="usd">425700000</us-gaap:LongTermDebtFairValue>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUwNjg_0024e006-cf66-4443-897c-cb4279525062">RETIREMENT PLANS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a Savings Plus Plan (the &#x201c;401k Plan&#x201d;) that allows its U.S.&#160;employees to accumulate savings on a pre-tax basis. In addition, matching contributions are made to the 401k Plan based upon pre-established rates. The Company&#x2019;s matching contributions amounted to approximately $6.9 million, $6.3 million and $4.9 million in fiscal 2023, 2022 and 2021, respectively. Upon the Company&#x2019;s Board of Directors&#x2019; approval, additional discretionary contributions can also be made. No discretionary contributions were made for the 401k Plan in fiscal 2023, 2022, or 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s subsidiaries also have defined contribution plans, to which both the employee and the employer make contributions. The employer contributions to these plans totaled $0.6 million, $0.6 million and $0.7 million in fiscal 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Topic 715, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation&#160;&#x2014; Retirement Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, requires an employer to: (a)&#160;recognize in its statement of financial position an asset for a plan&#x2019;s over-funded status or a liability for a plan&#x2019;s under-funded status; (b)&#160;measure a plan&#x2019;s assets and its obligations that determine its funded status as of the end of the employer&#x2019;s fiscal year (with limited exceptions); and (c)&#160;recognize changes in the funded status of a defined benefit post retirement plan in the year in which the changes occur. Accordingly, the Company is required to report changes in its funded status in comprehensive loss on its consolidated statement of stockholders&#x2019; equity and consolidated statement of comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Benefits under these plans are generally based on either career average or final average salaries and creditable years of service as defined in the plans. The annual cost for these plans is determined using the projected unit credit actuarial cost method that includes actuarial assumptions and estimates that are subject to change.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s foreign subsidiaries have defined benefit pension plans covering substantially all full time employees at those subsidiaries. Net periodic benefit costs for the plans in the aggregate include the following components:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,191&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,698&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,070&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The activity under those defined benefit plans are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in Benefit Obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(409)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee and plan participants contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(25,465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(30,410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in Plan Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Company contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(593)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(719)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee and plan participants contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded Status&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,002)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized net actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,757)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,099)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net amount recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(11,892)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(14,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; Substantially all of the unfunded status is non-current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;One of the benefit plans is funded by benefit payments made by the Company through the purchase of reinsurance contracts that do not qualify as plan assets under ASC Topic 715. Accordingly, that plan has no assets included in the information presented above. The total asset value associated with the reinsurance contracts was $7.1 million and $6.8 million at April&#160;1, 2023 and April&#160;2, 2022, respectively. The total liability for this plan, which is included in the table above, was $7.5 million and $9.6 million as of April&#160;1, 2023 and April&#160;2, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accumulated benefit obligation for all plans was $25.2 million and $28.4 million for fiscal 2023 and 2022, respectively. There were no plans where the plan assets were greater than the accumulated benefit obligation as of April&#160;1, 2023 and April&#160;2, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the change recorded in the Company&#x2019;s accumulated other comprehensive loss related to its defined benefit plans, net of tax, are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of April 3, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,075&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expects to amortize $0.4 million from accumulated other comprehensive loss to net periodic benefit cost during fiscal 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average rates used to determine the net periodic benefit costs and projected benefit obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of increased salary levels&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assumptions for expected long-term rate of return on plan assets are based upon actual historical returns, future expectations of returns for each asset class and the effect of periodic target asset allocation rebalancing. The results are adjusted for the payment of reasonable expenses of the plan from plan assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has no other material obligation for post-retirement or post-employment benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investment policy for pension plans is to balance risk and return through a diversified portfolio to reduce interest rate and market risk. Maturities are managed so that sufficient liquidity exists to meet immediate and future benefit payment requirements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, provides guidance for reporting and measuring the plan assets of the Company&#x2019;s defined benefit pension plan at fair value as of April&#160;1, 2023. Using the same three-level valuation hierarchy for disclosure of fair value measurements as described in Note&#160;14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, all of the assets of the Company&#x2019;s plan are classified within Level&#160;2 of the fair value hierarchy because the plan assets are primarily insurance contracts. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected benefit payments for both plans are estimated using the same assumptions used in determining the Company&#x2019;s benefit obligation at April&#160;1, 2023. Benefit payments will depend on future employment and compensation levels, average years employed and average life spans, among other factors, and changes in any of these factors could significantly affect these estimated future benefit payments. Estimated future benefit payments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2029-2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;The Company&#x2019;s contributions for fiscal 2024 are expected to be consistent with the current year.</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i21aee3c1b74747239031c9b963f5fe6a_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzM2Mw_9b75f6e8-04b2-42fb-aaf1-96bc96ca3951"
      unitRef="usd">6900000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="icb0b69d83b20498cb8aca63402b766a0_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzM2Nw_370506cd-c496-4bed-bdbd-f71ad29669c7"
      unitRef="usd">6300000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i6925d4ec697647ffa368e97ca8e3c332_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzM3NA_89395369-112c-4676-aa6a-0d0da8dafb07"
      unitRef="usd">4900000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzM4Nw_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="ifd7616c964054c72a3769144d3c72c21_D20210404-20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUyMg_4408acaa-0d1e-4f9d-8928-d907238ae48c"
      unitRef="usd">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i3185e1665d8d4e5ab9844e5e3ff0d869_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUyMg_5f4fd392-6302-4276-941c-c939a96f1565"
      unitRef="usd">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i6a0a0ee071214f54bd0d353709289c03_D20200329-20210403"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUyMg_c0c606dd-491a-4c63-9b00-0133f6c5ec40"
      unitRef="usd">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzU5MQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i460ae7aa48544e75825ca977d4447d2b_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzc5NA_7fa642dc-0791-44cd-9dfe-b87141ec4152"
      unitRef="usd">600000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i4050db15299d4a36bbab78482cb7fb2f_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzc5OA_9d09e905-0ac5-47b1-96cb-b24f92814642"
      unitRef="usd">600000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="if4da492c5e554b3890ff74a7a13fd058_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzgwNQ_c19e2074-8dc8-40f7-b508-fdbd4acc68f2"
      unitRef="usd">700000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzgxOA_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUwNzU_3957efa1-1924-4943-b926-cce5d6d62e48">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s foreign subsidiaries have defined benefit pension plans covering substantially all full time employees at those subsidiaries. Net periodic benefit costs for the plans in the aggregate include the following components:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,191&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,698&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,070&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzEtMS0xLTEtNzAzMzQ_2d7205c2-a8cd-424d-b7bd-1801a49556ac"
      unitRef="usd">1453000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzEtMy0xLTEtNzAzMzQ_61fd8fe4-3ee3-42b5-b6ea-8e7f9fca3ccc"
      unitRef="usd">1714000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzEtNS0xLTEtNzAzMzQ_1042feca-da0d-4d01-a7f2-e3323a8dd49d"
      unitRef="usd">1861000</us-gaap:DefinedBenefitPlanServiceCost>
    <hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzItMC0xLTEtNzAzMzQ_187d8f0f-fe1e-4c11-97bd-50e2ebb5ef34">Interest cost on benefit obligation</hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzItMC0xLTEtNzAzMzQ_88e5742b-a426-4d10-948e-e8b8721513af">Interest cost on benefit obligation</hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzItMC0xLTEtNzAzMzQ_ff05df60-541f-416e-9c77-c039000f6b4d">Interest cost on benefit obligation</hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzItMS0xLTEtNzAzMzQ_84395802-6240-4ca7-be44-daf4a41fe802"
      unitRef="usd">409000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzItMy0xLTEtNzAzMzQ_e2cc3178-81ff-484b-8b1e-d7f48a4dcdc4"
      unitRef="usd">242000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzItNS0xLTEtNzAzMzQ_0eccbf80-3346-4a0f-9c01-fa5786345d20"
      unitRef="usd">279000</us-gaap:DefinedBenefitPlanInterestCost>
    <hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzMtMC0xLTEtNzAzMzQ_410a90f4-a4ce-4cb6-840f-d38b2cc33cd8">Expected return on plan assets</hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzMtMC0xLTEtNzAzMzQ_76264dd2-73ed-4769-bbe4-fbf74170ce19">Expected return on plan assets</hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzMtMC0xLTEtNzAzMzQ_d7c4e939-1801-40fb-a48c-aa212c390d19">Expected return on plan assets</hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzMtMS0xLTEtNzAzMzQ_284d29b5-7d8c-4d6a-950a-056da261c7c5"
      unitRef="usd">180000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzMtMy0xLTEtNzAzMzQ_1c44060d-b10e-4a49-be05-bce52f3bf3e3"
      unitRef="usd">88000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzMtNS0xLTEtNzAzMzQ_4ec5f8bf-42b5-4eb5-9fd4-59087dd6eddd"
      unitRef="usd">66000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzQtMC0xLTEtNzAzMzQ_1cfdc20e-be01-4d62-887b-f07df4734030">Actuarial loss</hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzQtMC0xLTEtNzAzMzQ_64d9ddef-da2d-432a-9202-392d7d1894e0">Actuarial loss</hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzQtMC0xLTEtNzAzMzQ_db134473-6bce-4e8a-8dd9-abae9338a85d">Actuarial loss</hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzQtMS0xLTEtNzAzMzQ_c7c2bf9a-9a67-4154-abd8-b05ecbec660b"
      unitRef="usd">-19000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzQtMy0xLTEtNzAzMzQ_eb6fbc6a-0d25-40e6-9158-6e904ce2f98f"
      unitRef="usd">-189000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzQtNS0xLTEtNzAzMzQ_26c2fcf3-0177-48ca-89f1-4394011d20b9"
      unitRef="usd">-119000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzUtMC0xLTEtNzAzMzQ_07e5e158-7276-4e99-bfd0-01f1f673f727">Amortization of unrecognized prior service cost</hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzUtMC0xLTEtNzAzMzQ_327c3c05-bdcb-4d94-bd08-a40f3578f479">Amortization of unrecognized prior service cost</hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzUtMC0xLTEtNzAzMzQ_9f7bc171-91cd-47dc-9402-90f6e61e7579">Amortization of unrecognized prior service cost</hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzUtMS0xLTEtNzAzMzQ_f9963927-ab5b-463b-b23b-d6e8918fadb7"
      unitRef="usd">-180000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzUtMy0xLTEtNzAzMzQ_0f3d93e1-fe9e-4ca5-affc-123f56b4460c"
      unitRef="usd">-175000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzUtNS0xLTEtNzAzMzQ_4f9c56a8-a50f-478f-9cfa-f8be95367021"
      unitRef="usd">-123000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzctMC0xLTEtNzAzMzQ_145800d4-5aae-4f18-ae25-6d007756aaac">Plan settlements</hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzctMC0xLTEtNzAzMzQ_a927d1a0-67b4-4758-b243-b16defbbc948">Plan settlements</hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzctMC0xLTEtNzAzMzQ_d32db4cc-a58c-48fe-9111-d1b313f3e38b">Plan settlements</hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzctMS0xLTEtNzAzMzQ_0feeb835-a57d-457b-a6cf-f1f00cc18232"
      unitRef="usd">330000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzctMy0xLTEtNzAzMzQ_01313c26-1624-4239-afca-d82569667167"
      unitRef="usd">184000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzctNS0xLTEtNzAzMzQ_55a634fc-0acb-4fd3-bfe2-d0640731ce87"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzgtMS0xLTEtNzAzMzQ_f8a49316-a4bc-4125-aedd-b04b13a1ab43"
      unitRef="usd">1191000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzgtMy0xLTEtNzAzMzQ_56279ccd-9c27-433d-85d4-882c6057192b"
      unitRef="usd">1698000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjODgwMzAxMTIxNTk0YjZjOTdlZmFiNzE1YzM0MmNkNi90YWJsZXJhbmdlOmM4ODAzMDExMjE1OTRiNmM5N2VmYWI3MTVjMzQyY2Q2XzgtNS0xLTEtNzAzMzQ_d84c30cd-5d4c-4609-bc5a-069d52fa2b09"
      unitRef="usd">2070000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfNetFundedStatusTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUwNDk_dd0eed20-41a4-42f8-a880-0039fea07886">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The activity under those defined benefit plans are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in Benefit Obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(409)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee and plan participants contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(25,465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(30,410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in Plan Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Company contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(593)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(719)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee and plan participants contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,447&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded Status&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,002)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized net actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,757)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,099)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net amount recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(11,892)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(14,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; Substantially all of the unfunded status is non-current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetFundedStatusTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzItMS0xLTEtNzAzMzQ_0f223973-b1fa-47fb-be93-61617f7937bb"
      unitRef="usd">30410000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzItMy0xLTEtNzAzMzQ_43a74eef-db69-4578-9e5c-c8146636a780"
      unitRef="usd">31891000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzMtMS0xLTEtNzAzMzQ_1f7f2ece-73f5-4d2b-be59-256bcac2c007"
      unitRef="usd">1453000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzMtMy0xLTEtNzAzMzQ_66f12be2-3713-433d-ab00-8b098412466e"
      unitRef="usd">1714000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzQtMS0xLTEtNzAzMzQ_81ff6893-c349-4220-8be2-170d4b1928cd"
      unitRef="usd">409000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzQtMy0xLTEtNzAzMzQ_7ba092f9-bc6b-455a-b911-cefe302b8751"
      unitRef="usd">242000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzUtMS0xLTEtNzAzMzQ_f3bc0489-875f-4748-9453-c1b611a229fc"
      unitRef="usd">748000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzUtMy0xLTEtNzAzMzQ_e909fb32-ce2c-4c24-ad74-283d5d1b09ca"
      unitRef="usd">928000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzYtMS0xLTEtNzAzMzQ_72798c47-8fa3-4806-a7c3-38da8d1e0f47"
      unitRef="usd">3675000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzYtMy0xLTEtNzAzMzQ_afd0f1cf-d2bf-4ac0-92d6-b8cc67b493a0"
      unitRef="usd">3208000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzctMS0xLTEtNzAzMzQ_441cd33a-b6a3-4acf-94f0-dfc1822021c2"
      unitRef="usd">1599000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzctMy0xLTEtNzAzMzQ_489ec027-a0c0-4b94-8417-839dd3bc502a"
      unitRef="usd">2093000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzgtMS0xLTEtNzAzMzQ_e067ae4e-8c84-41b1-821a-1576787090b1"
      unitRef="usd">-1775000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzgtMy0xLTEtNzAzMzQ_dbd8b653-d3b0-4adf-8ff6-0117b11ac5c9"
      unitRef="usd">1367000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzktMS0xLTEtNzAzMzQ_19063d10-a491-4389-a3d7-d3f37127a8f8"
      unitRef="usd">-2208000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzktMy0xLTEtNzAzMzQ_602548c4-d8d9-465a-a1f8-650e5e011657"
      unitRef="usd">-27000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzEwLTEtMS0xLTcwMzM0_66fea61a-2843-4b32-a0d6-5f9a87573c88"
      unitRef="usd">25465000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzEwLTMtMS0xLTcwMzM0_c2672a44-d91d-4e04-b329-3fa549eef5fb"
      unitRef="usd">30410000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzEyLTEtMS0xLTcwMzM0_ad1bbc74-20c3-424d-ac06-22e3311d68de"
      unitRef="usd">17447000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzEyLTMtMS0xLTcwMzM0_c4575a3d-af78-433a-8222-161ee8ca7b85"
      unitRef="usd">16142000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzEzLTEtMS0xLTcwMzM0_8844a983-eff4-4cca-9670-b2795b2221d1"
      unitRef="usd">1436000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzEzLTMtMS0xLTcwMzM0_9385a02e-0278-4f60-adcd-3e0b32e3b1a0"
      unitRef="usd">1432000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE0LTEtMS0xLTcwMzM0_c7d29ce9-d59c-47f5-9f1b-1b63d29c2acc"
      unitRef="usd">593000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE0LTMtMS0xLTcwMzM0_f9b473b1-0f93-487c-93d5-28ef24c0c307"
      unitRef="usd">719000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE1LTEtMS0xLTcwMzM0_9505af20-c31d-4324-99ac-4fdfbe200edb"
      unitRef="usd">105000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE1LTMtMS0xLTcwMzM0_efbb1747-6f6d-4cb5-ac57-6be5742997b4"
      unitRef="usd">-108000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE2LTEtMS0xLTcwMzM0_3b69c352-5a66-45b4-9ef9-753541e9e3d6"
      unitRef="usd">1670000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE2LTMtMS0xLTcwMzM0_3cd7e973-edf3-49a1-b0b9-4b002df0feec"
      unitRef="usd">2077000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE3LTEtMS0xLTcwMzM0_75517b30-eb5e-477b-aa24-5e75e6fdec59"
      unitRef="usd">1647000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE3LTMtMS0xLTcwMzM0_80ad9e40-b045-4663-b390-a8a677d82675"
      unitRef="usd">1356000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE4LTEtMS0xLTcwMzM0_68e51bca-ce9c-47d1-a726-191dfd56fd16"
      unitRef="usd">45000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE4LTMtMS0xLTcwMzM0_9d63be66-ebc4-4c50-be67-d32a51e16695"
      unitRef="usd">-21000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE5LTEtMS0xLTcwMzM0_2b307c25-6761-45a0-99d0-c3ab6bdba875"
      unitRef="usd">18463000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzE5LTMtMS0xLTcwMzM0_b4acac21-7d0d-45c8-9932-c8357431ec58"
      unitRef="usd">17447000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIwLTEtMS0xLTcwMzM0_214727bc-ea7e-4025-807d-fcbf23b5d316"
      unitRef="usd">-7002000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIwLTMtMS0xLTcwMzM0_157ac174-07c9-4084-a30d-8dbce727a6f3"
      unitRef="usd">-12963000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <hae:UnrecognizedNetActuarialLossGain
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIxLTEtMS0xLTcwMzM0_0080e7e2-ff66-4979-b7b5-c43cac9524a5"
      unitRef="usd">-3757000</hae:UnrecognizedNetActuarialLossGain>
    <hae:UnrecognizedNetActuarialLossGain
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIxLTMtMS0xLTcwMzM0_60fba306-2bcf-4bcd-9a1d-3f4cc85ce463"
      unitRef="usd">-236000</hae:UnrecognizedNetActuarialLossGain>
    <hae:UnrecognizedPriorServiceCost
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIyLTEtMS0xLTcwMzM0_a058104c-fdda-4927-b0d4-9efcbb3ce644"
      unitRef="usd">1133000</hae:UnrecognizedPriorServiceCost>
    <hae:UnrecognizedPriorServiceCost
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIyLTMtMS0xLTcwMzM0_5ced7967-7b33-4b53-8e94-fbe5dfea623c"
      unitRef="usd">1099000</hae:UnrecognizedPriorServiceCost>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIzLTEtMS0xLTcwMzM0_7498f493-38fc-4475-bd19-7d3fd4135940"
      unitRef="usd">11892000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTpjNGI5MjliYmU4MDc0NTIyODNmMDc4NDM5YmZhNzNhNy90YWJsZXJhbmdlOmM0YjkyOWJiZTgwNzQ1MjI4M2YwNzg0MzliZmE3M2E3XzIzLTMtMS0xLTcwMzM0_cfe7073c-3ba8-42b1-8b16-9c6947319f36"
      unitRef="usd">14298000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <hae:DefinedBenefitPlanReinsuranceContractsAssetValue
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzI1NDY_6b8f11ad-e086-4013-948e-2b3cf6d54906"
      unitRef="usd">7100000</hae:DefinedBenefitPlanReinsuranceContractsAssetValue>
    <hae:DefinedBenefitPlanReinsuranceContractsAssetValue
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzI1NTM_9aa9f87c-4262-41df-b9d6-8caa669793d9"
      unitRef="usd">6800000</hae:DefinedBenefitPlanReinsuranceContractsAssetValue>
    <hae:DefinedBenefitPlanBenefitObligationPlanFundedbyCompany
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzI2NjE_53ab6c77-1bc3-4080-8444-c08c8ea4491e"
      unitRef="usd">7500000</hae:DefinedBenefitPlanBenefitObligationPlanFundedbyCompany>
    <hae:DefinedBenefitPlanBenefitObligationPlanFundedbyCompany
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzI2Njg_77177251-a9ae-4c84-8fa2-7ff60c954ab7"
      unitRef="usd">9600000</hae:DefinedBenefitPlanBenefitObligationPlanFundedbyCompany>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzI3NTY_60bcecd2-85f1-4e35-a71f-67812f3b168d"
      unitRef="usd">25200000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzI3NjM_3d51cc63-ece8-4086-992f-8371326d1ac3"
      unitRef="usd">28400000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUwNTk_c5fa37b1-553f-42f6-933a-5be83cf3157e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the change recorded in the Company&#x2019;s accumulated other comprehensive loss related to its defined benefit plans, net of tax, are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of April 3, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,075&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i2752e169c88b4ff2a289838d456aec0d_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzAtMS0xLTEtNzAzMzQ_33fd3742-61fd-49d3-8999-ddb4ab184086"
      unitRef="usd">209000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzItMS0xLTEtNzAzMzQ_f81cfc62-b864-4901-9aac-63c77d148227"
      unitRef="usd">221000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzMtMS0xLTEtNzAzMzQ_d8075d8f-0b3e-43b2-b5bd-bf36f663e827"
      unitRef="usd">-130000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzUtMS0xLTEtNzAzMzQ_eef945c7-5506-45dc-9620-853e6d1ce83e"
      unitRef="usd">560000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzYtMS0xLTEtNzAzMzQ_7ab1e34b-7721-4e28-89d6-914aa3374217"
      unitRef="usd">-2532000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzctMS0xLTEtNzAzMzQ_560a17bd-2aa1-499d-9b9d-a17e8988a883"
      unitRef="usd">-194000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzgtMS0xLTEtNzAzMzQ_bf186e88-f38a-4ec6-bb17-88f769f95e08"
      unitRef="usd">-159000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzktMS0xLTEtNzAzMzQ_078dfcb8-3d02-4231-a02f-4e24a55857e2"
      unitRef="usd">-1619000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzEwLTEtMS0xLTcwMzM0_9228ffb8-047b-4a08-bed6-705a9c9828d4"
      unitRef="usd">-2695000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzExLTEtMS0xLTcwMzM0_816837e3-0168-4ac0-9356-798b4617caea"
      unitRef="usd">46000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzEyLTEtMS0xLTcwMzM0_a8f1bc8e-f647-45a4-b08b-0c58bd256e11"
      unitRef="usd">-285000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1YTRlYWI5YmZjOWU0MDUwYmMwOGY4MjgwYWUzNDZmYi90YWJsZXJhbmdlOjVhNGVhYjliZmM5ZTQwNTBiYzA4ZjgyODBhZTM0NmZiXzEzLTEtMS0xLTcwMzM0_0e228b8d-18ab-45ec-8917-82da5ba88f48"
      unitRef="usd">-4075000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationNextFiscalYear
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzMxMTc_c2e4fb5d-0fe7-4348-a837-d9223fc463fe"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanExpectedAmortizationNextFiscalYear>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUwMjY_b59990b8-ecda-441b-91b2-2b7a1e5b16a5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average rates used to determine the net periodic benefit costs and projected benefit obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of increased salary levels&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzEtMS0xLTEtNzAzMzQ_95ce9e0a-0e9a-4c80-be2b-26e32876f12e"
      unitRef="number">0.0243</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzEtMy0xLTEtNzAzMzQ_59064117-8472-4d7b-987a-bb248f777170"
      unitRef="number">0.0138</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzEtNS0xLTEtNzAzMzQ_d52a1ff8-850b-400b-940c-04ca3cf10ada"
      unitRef="number">0.0058</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzItMS0xLTEtNzAzMzQ_9e59e724-8106-4494-ac4e-48e8f680a3e3"
      unitRef="number">0.0194</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzItMy0xLTEtNzAzMzQ_0b9eaeaa-4515-43a2-aaed-a65c1ac08348"
      unitRef="number">0.0181</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzItNS0xLTEtNzAzMzQ_d4fac23a-ceca-4e38-82c7-694b49394b9c"
      unitRef="number">0.0164</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzMtMS0xLTEtNzAzMzQ_c27b15ff-965a-4818-81f6-b3ebd08a56d4"
      unitRef="number">0.0087</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzMtMy0xLTEtNzAzMzQ_a07f5a53-2aa6-42d3-86d3-c61dc1b5dc0e"
      unitRef="number">0.0069</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo1ODQzZGQ5ZjIzYTg0YTdhYmRmNTA1M2IyZGYwNTRlNi90YWJsZXJhbmdlOjU4NDNkZDlmMjNhODRhN2FiZGY1MDUzYjJkZjA1NGU2XzMtNS0xLTEtNzAzMzQ_9c0947a9-134f-474b-b905-6f40593d481c"
      unitRef="number">0.0042</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90ZXh0cmVnaW9uOmU0ZmMwY2E5NGE1ZjRhOTliMGVhYjI5OTNjY2M1MDlkXzUwNTI_83eb8d29-5f79-4c74-a8d4-c70d1a3baad9">Estimated future benefit payments are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2029-2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo4NjU5ZDZlOTYyZDU0N2E5OThmYzFiZjZmNzkyOGRiNS90YWJsZXJhbmdlOjg2NTlkNmU5NjJkNTQ3YTk5OGZjMWJmNmY3OTI4ZGI1XzEtMS0xLTEtNzAzMzQ_ab241b5a-2c2c-477b-99ea-2bfb0aefac07"
      unitRef="usd">1453000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo4NjU5ZDZlOTYyZDU0N2E5OThmYzFiZjZmNzkyOGRiNS90YWJsZXJhbmdlOjg2NTlkNmU5NjJkNTQ3YTk5OGZjMWJmNmY3OTI4ZGI1XzItMS0xLTEtNzAzMzQ_6124ea3d-d0dc-45ed-b7a2-212563a4ff8d"
      unitRef="usd">1352000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo4NjU5ZDZlOTYyZDU0N2E5OThmYzFiZjZmNzkyOGRiNS90YWJsZXJhbmdlOjg2NTlkNmU5NjJkNTQ3YTk5OGZjMWJmNmY3OTI4ZGI1XzMtMS0xLTEtNzAzMzQ_0242b5bc-f5c8-4dbf-b6e1-9af88ea5d47d"
      unitRef="usd">1474000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo4NjU5ZDZlOTYyZDU0N2E5OThmYzFiZjZmNzkyOGRiNS90YWJsZXJhbmdlOjg2NTlkNmU5NjJkNTQ3YTk5OGZjMWJmNmY3OTI4ZGI1XzQtMS0xLTEtNzAzMzQ_e593f2b5-c767-41e6-b1e2-8959f185d56a"
      unitRef="usd">1733000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo4NjU5ZDZlOTYyZDU0N2E5OThmYzFiZjZmNzkyOGRiNS90YWJsZXJhbmdlOjg2NTlkNmU5NjJkNTQ3YTk5OGZjMWJmNmY3OTI4ZGI1XzUtMS0xLTEtNzAzMzQ_34e7f5ae-17ae-4d6e-896a-3266ff970e44"
      unitRef="usd">1809000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xMzkvZnJhZzplNGZjMGNhOTRhNWY0YTk5YjBlYWIyOTkzY2NjNTA5ZC90YWJsZTo4NjU5ZDZlOTYyZDU0N2E5OThmYzFiZjZmNzkyOGRiNS90YWJsZXJhbmdlOjg2NTlkNmU5NjJkNTQ3YTk5OGZjMWJmNmY3OTI4ZGI1XzYtMS0xLTEtNzAzMzQ_d0ec9bc5-02ad-4fc0-8989-50b6dc805581"
      unitRef="usd">11654000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDIvZnJhZzpjZmIwZTZkYjhkNDI0YWE4YmUxMGU5NWVhMmNlNjNlMC90ZXh0cmVnaW9uOmNmYjBlNmRiOGQ0MjRhYThiZTEwZTk1ZWEyY2U2M2UwXzI2MjY_0c591b69-689f-4c3f-b2b2-dfc2da95ac28">COMMITMENTS AND CONTINGENCIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to various legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described below, there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. At each reporting period, management evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for all matters. Legal costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of fiscal 2021, the Company received a subpoena from the U.S. Attorney&#x2019;s Office for the District of Massachusetts. The subpoena requested certain documents regarding the Company&#x2019;s apheresis and autotransfusion devices and disposables, including documents relating to product complaints and adverse event reporting, regulatory clearances and product design changes, among other matters. The Company has fully cooperated with this inquiry. On August 16, 2022, the U.S. Department of Justice (&#x201c;DOJ&#x201d;) filed a motion on behalf of the United States and 31 states reflecting their decision to not intervene in the underlying &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; action captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Berthelot et al. v. Haemonetics Corp.,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 1:20-cv-11062-ADB, pending in the U.S. District Court for the District of Massachusetts, indicating that the DOJ had completed its investigative activity based on then available information. The&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case was unsealed by order dated August 18, 2022. During the fourth fiscal quarter of 2023, the Company recorded a loss contingency related to this matter, which did not have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of fiscal 2021, a putative class action complaint was filed against the Company in the Circuit Court of Cook County, Illinois by Mary Crumpton, on behalf of herself and similarly situated individuals. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mary Crumpton v. Haemonetics Corporation, Case No. 1:21-cv-1402&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In her complaint, the plaintiff asserts that between June 2017 and August 2018 she donated plasma at a center operated by one of the Company&#x2019;s customers, that the center required her to scan her finger print in a scanner that stored her finger print to identify her prior to plasma donation, and that the Company&#x2019;s eQue donor management software sent her biometric information to a Company-owned server to be collected and stored in a manner that violated her rights under the Illinois Biometric Information Privacy Act (&#x201c;BIPA&#x201d;). The plaintiff seeks statutory damages, attorneys&#x2019; fees, and injunctive and equitable relief. In March 2021, the Company moved to dismiss the complaint for lack of personal jurisdiction and concurrently filed a motion to dismiss for failure to state a claim and a motion to stay. In March 2022, the court denied the Company&#x2019;s motion to dismiss for lack of personal jurisdiction but did not address the merits of the Company&#x2019;s other positions. In March 2023, the Company filed a second motion to dismiss the complaint, which is pending before the court. The Company believes it has valid and meritorious defenses to the complaint. During the fourth fiscal quarter of 2023, the Company recorded a loss contingency related to this matter, which did not have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0NjU_e6fd9709-5059-4718-80bb-e6eb08b8041f">CAPITAL STOCK&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 25, 2019 (the &#x201c;Effective Date&#x201d;), the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan (the &#x201c;2019 Equity Plan&#x201d;) was approved and became effective. The 2019 Equity Plan permits the award of incentive stock options, non-qualified stock options, stock appreciation rights (&#x201c;SARs&#x201d;), restricted stock, restricted stock units (including performance-based restricted stock units) and other awards to the Company&#x2019;s key employees, non-employee directors and certain consultants and advisors of the Company and its subsidiaries. The 2019 Equity Plan is administered by the Compensation Committee of the Board of Directors (the &#x201c;Committee&#x201d;), which consists of four independent members of the Company&#x2019;s Board of Directors, and &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;is the successor to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan, as amended (the &#x201c;2005 Equity Plan&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the Effective Date, no further awards were granted under the 2005 Equity Plan; however, each outstanding award under the 2005 Equity Plan will remain outstanding under that plan and continue to be governed under its terms and any applicable award agreement. The maximum number of shares available for award under 2019 Equity Plan is 5,759,433, which consists of 2,700,000 shares of common stock authorized for issuance under the 2019 Equity Plan plus 3,059,433 shares of common stock reserved for issuance under the 2005 Equity Plan that remained available for grant under the 2005 Plan as of the Effective Date. Under the 2019 Equity Plan, any shares that are subject to the award of stock options or SARs will be counted against the authorized share reserve as one share for every one&#160;share issued and any shares that are subject to awards other than stock options, SARs or cash awards will be counted against the authorized share reserve as 2.76&#160;shares for every one&#160;share granted. Shares of common stock subject to outstanding grants under the 2005 Equity Plan as of the Effective Date that terminate, expire, or are otherwise canceled without having been exercised will be added to the share reserve at the applicable 2019 Equity Plan ratios. The total shares available for future grant as of April&#160;1, 2023 were 3,118,602.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation cost related to share-based transactions is recognized in the consolidated financial statements based on fair&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;value. The total amount of share-based compensation expense, which is recorded on a straight line basis, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21,903&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$20,694&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$22,888&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$25,583&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$24,359&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$25,516&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options are granted to purchase common stock at prices as determined by the Committee, but in no event shall such exercise price be less than the fair market value of the common stock at the time of the grant. Options generally vest in equal installments over a four year period for employees and one year from grant for non-employee directors. Options expire not more than 7 years from the date of the grant. The grant-date fair value of options, adjusted for estimated forfeitures, is recognized as expense on a straight line basis over the requisite service period, which is generally the vesting period. Forfeitures are estimated based on historical experience. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of stock option activity for the fiscal year ended April&#160;1, 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;br/&gt;per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;($000&#x2019;s)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited/Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,150,194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64.21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27,481&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested or expected to vest at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,054,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total intrinsic value of options exercised was $1.9 million, $1.7 million and $8.2 million during fiscal 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023, there was $9.1 million of total unrecognized compensation cost related to non-vested stock options. This cost is expected to be recognized over a weighted average period of 2.6&#160;years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value was estimated using the Black-Scholes option-pricing model based on the closing stock price at the grant date and the weighted average assumptions specific to the underlying options. Expected volatility assumptions are based on the historical volatility of the Company&#x2019;s common stock over the expected term of the option. The risk-free interest rate was selected based upon yields of U.S.&#160;Treasury issues with a term equal to the expected life of the option being valued. The expected life of the option was estimated with reference to historical exercise patterns, the contractual term of the option and the vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions utilized for option grants during the periods presented are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value per Option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.53&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted Stock Units (&#x201c;RSUs&#x201d;) generally vest in equal installments over a four year period for employees and one year from grant for non-employee directors. The grant-date fair value of RSUs, adjusted for estimated forfeitures, is recognized as expense on a straight-line basis over the requisite service period, which is generally the vesting period. The fair market value of RSUs is determined based on the market value of the Company&#x2019;s shares on the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of RSU activity for the fiscal year ended April&#160;1, 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;381,308&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;63.94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant-date fair value of RSUs granted and total fair value of RSUs vested are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value per RSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023, there was $15.4 million of total unrecognized compensation cost related to non-vested restricted stock units. This cost is expected to be recognized over a weighted average period of 2.5&#160;years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance Share Units&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The grant date fair value of Performance Share Units (&#x201c;PSUs&#x201d;), adjusted for estimated forfeitures, is recognized as expense on a straight line basis from the grant date through the end of the performance period. The value of these PSUs is generally based on relative total shareholder return which equals total shareholder return for the Company as compared with total shareholder return of the PSU comparison group, measured over a three year performance period. The PSUs comparison group consists of the Standard and Poor's (&#x201c;S&amp;amp;P&#x201d;) MidCap 400 Index. Depending on the Company&#x2019;s relative performance during the performance period, a recipient of the award is entitled to receive a number of ordinary shares equal to a percentage, ranging from 0% to 200%, of the award granted. If the Company&#x2019;s total shareholder return for the performance period is negative, then any share payout will be capped at 100% of the target award, regardless of the Company&#x2019;s performance relative to the its comparison group. As a result, the Company may issue up to 647,974 shares related to outstanding performance-based awards.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of PSU activity for the fiscal year ended April&#160;1, 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;323,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87.35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Includes the adjustment of 62,577 shares for awards granted in fiscal 2020, based on actual relative total shareholder return of 0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the Monte Carlo model to estimate the probability of satisfying the performance criteria and the resulting fair value of PSU awards with market conditions. The assumptions used in the Monte Carlo model for PSUs granted during each fiscal year were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peer group stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Correlation of returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant-date fair value of PSUs granted and total fair value of PSUs vested are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value per PSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of PSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;1, 2023, there was $14.5 million of total unrecognized compensation cost related to non-vested performance share units. This cost is expected to be recognized over a weighted average period of 1.8&#160;years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an Employee Stock Purchase Plan (the &#x201c;Purchase Plan&#x201d;) under which a maximum of 3,200,000&#160;shares (subject to adjustment for stock splits and similar changes) of common stock may be purchased by eligible employees. Substantially all of its full-time employees are eligible to participate in the Purchase Plan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Purchase Plan provides for two &#x201c;purchase periods&#x201d; within each of its fiscal years, the first commencing on November 1 of each year and continuing through April 30 of the next calendar year, and the second commencing on May 1 of each year and continuing through October 31 of such year. Shares are purchased through an accumulation of payroll deductions (of not less than 2% or more than 15% of compensation, as defined) for the number of whole shares determined by dividing the balance in the employee&#x2019;s account on the last day of the purchase period by the purchase price per share for the stock determined under the Purchase Plan. The purchase price for shares is the lower of 85% of the fair market value of the common stock at the beginning of the purchase period, or 85% of such value at the end of the purchase period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of shares purchased under the Employee Stock Purchase Plan are estimated using the Black-Scholes single option-pricing model with the following weighted average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend Yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average grant date fair value of the six-month option inherent in the Purchase Plan was approximately $18.10, $20.77 and $30.77 during fiscal 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ied4aca325d3e42f794837acb9bf1c5c7_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzEyNDY_9f46d160-1412-46d1-8131-6968a2b2747c"
      unitRef="shares">5759433</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i31435e1c79be48e7b4ba1de17ba323da_I20230401"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzEyNjg_a7f3ae31-0a43-4cb3-b19d-0a16762d3a78"
      unitRef="shares">2700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i51dd2ace410143febe089bb6d634e842_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzEzNTA_96d09d82-a09d-49ac-9156-62bbaca3602f"
      unitRef="shares">3059433</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <hae:NumberofOptionsCountedAgainstMaximumNumberofAwardShares
      contextRef="ib1fc79184fba4faa8a07007a4d564998_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzE4MzY_8182fe2c-af24-42c6-85bb-55d5045fd33c"
      unitRef="shares">2.76</hae:NumberofOptionsCountedAgainstMaximumNumberofAwardShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzIxOTY_f7984bab-a0b7-4f3b-9691-d33ee563e032"
      unitRef="shares">3118602</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0NDM_221bbc99-8374-4b42-8d84-d9e067193694">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation cost related to share-based transactions is recognized in the consolidated financial statements based on fair&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;value. The total amount of share-based compensation expense, which is recorded on a straight line basis, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21,903&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$20,694&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$22,888&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$25,583&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$24,359&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$25,516&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic03bd40350ab47b59e94e0eb9a16722d_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzEtMS0xLTEtNzAzMzQ_009e2094-a450-46ec-b4b2-a45ded538420"
      unitRef="usd">21903000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i44318b6edd204f9bb959e54aa88e533c_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzEtMy0xLTEtNzAzMzQ_cc5dae38-f5ef-4287-94ef-67777664e1bc"
      unitRef="usd">20694000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i202912003ea5483c8e977d2876231a84_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzEtNS0xLTEtNzAzMzQ_dbbef7aa-f8f7-4ea8-935f-9ee62014e9a3"
      unitRef="usd">22888000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6e94fc8a563c41dbb911f86eebd74fb4_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzItMS0xLTEtNzAzMzQ_6686b4b5-36a9-4bb8-9253-679e86792a5e"
      unitRef="usd">2364000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i60c21727b1644983b67286f3ff83bf6f_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzItMy0xLTEtNzAzMzQ_9f2b7270-30d9-4e1a-af8c-41e6bacdf4fd"
      unitRef="usd">2537000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if570127cbc674472bddd6c920a6680a6_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzItNS0xLTEtNzAzMzQ_8b9a8b6f-e8b8-45eb-969c-c6eedb1be0ba"
      unitRef="usd">1874000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie757a5b3c6874d30b0632b13796f7765_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzMtMS0xLTEtNzAzMzQ_f5e5373f-ce42-49ad-95f6-08afbd467396"
      unitRef="usd">1316000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i35a58bb523b34502b7e9328f05462202_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzMtMy0xLTEtNzAzMzQ_247b9d76-4a0d-486d-a20f-6b88ad2fd28a"
      unitRef="usd">1128000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i54605da039714724a8b332c1eadca994_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzMtNS0xLTEtNzAzMzQ_bf0f33d6-9222-4f9b-8e51-c976f1d30ce2"
      unitRef="usd">754000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzQtMS0xLTEtNzAzMzQ_fbb2aa40-d729-449c-b11d-846b2c322886"
      unitRef="usd">25583000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzQtMy0xLTEtNzAzMzQ_ff2f6a18-54c1-4fe4-9a6c-9b781c88cd29"
      unitRef="usd">24359000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpjN2ZhYjhlN2Y0MmQ0NDg4OGZiYTg0ZmJhN2VhMDE5MC90YWJsZXJhbmdlOmM3ZmFiOGU3ZjQyZDQ0ODg4ZmJhODRmYmE3ZWEwMTkwXzQtNS0xLTEtNzAzMzQ_409accc2-36cf-4b50-ab7f-1399ebafe2a8"
      unitRef="usd">25516000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib3ff55824d064fbd859089a1dce11fcb_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzQzOTgwNDY1MTk2MjM_ba6830ed-2868-4d86-a371-e348f178dea1">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i98eb603c686a4dcfaabd4aeab4b77a27_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzI3ODM_b3920458-614e-4b42-8915-12c8eeed29aa">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzI4NTQ_82614829-44fb-4e49-8860-ee9e3dcd576d">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0ODU_30eb7f8c-6cce-4a2e-a31b-e661509dcbf7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of stock option activity for the fiscal year ended April&#160;1, 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;br/&gt;per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;($000&#x2019;s)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited/Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,150,194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64.21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27,481&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested or expected to vest at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,054,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i44a4bfb9e6ff4d9b876946af45bf3409_I20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzEtMS0xLTEtNzAzMzQ_4fe8ee2f-c86b-40cf-b27e-a823d2c5a0af"
      unitRef="shares">1056638</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i44a4bfb9e6ff4d9b876946af45bf3409_I20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzEtMy0xLTEtNzAzMzQ_1c2e5fd3-b735-4d36-b110-ae33685d0400"
      unitRef="usdPerShare">66.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzEtNS0xLTEtNzAzMzQ_e169e529-59a5-4f58-8ff7-48949585e600">P3Y9M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i44a4bfb9e6ff4d9b876946af45bf3409_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzEtNy0xLTEtNzAzMzQ_77f57005-9c79-4018-a499-789ebfdbc991"
      unitRef="usd">12423000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzItMS0xLTEtNzAzMzQ_cd7c2a26-ba6c-4f87-994b-3d2ba433892d"
      unitRef="shares">276928</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzItMy0xLTEtNzAzMzQ_ccdce404-1c4d-4936-8bd7-936e0f7d1263"
      unitRef="usdPerShare">58.02</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzMtMS0xLTEtNzAzMzQ_86c60f30-8a7e-45cd-8905-dde9b1d0c454"
      unitRef="shares">59400</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzMtMy0xLTEtNzAzMzQ_478e979e-0266-49da-b876-6d61b1115ee1"
      unitRef="usdPerShare">44.82</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzQtMS0xLTEtNzAzMzQ_ee23c037-e5eb-4bcd-8199-ef2acffe92ed"
      unitRef="shares">123972</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzQtMy0xLTEtNzAzMzQ_7a3329ef-1060-4a40-982a-b8c7a76df72f"
      unitRef="usdPerShare">82.42</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzUtMS0xLTEtNzAzMzQ_9fa39dee-bad7-403b-b02d-c6d7a11a2c1e"
      unitRef="shares">1150194</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzUtMy0xLTEtNzAzMzQ_d9f0c0e7-ec17-4a17-b02c-0e98741ba3b3"
      unitRef="usdPerShare">64.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzUtNS0xLTEtNzAzMzQ_78ca479b-4fea-48d3-88bf-4c7bef2f650f">P3Y6M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzUtNy0xLTEtNzAzMzQ_21b723af-f023-4fab-8bd2-2103c7b9a0b5"
      unitRef="usd">27481000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzctMS0xLTEtNzAzMzQ_06bd6f52-5125-4083-a35d-c2afda206eb7"
      unitRef="shares">618735</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzctMy0xLTEtNzAzMzQ_09f66ed6-f7c0-4b68-a515-1a2931b5413b"
      unitRef="usdPerShare">62.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzctNS0xLTEtNzAzMzQ_339ae186-ece9-4dff-a58e-aeda906be01d">P1Y11M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzctNy0xLTEtNzAzMzQ_f72d7240-6427-4de9-92de-8652af8238c5"
      unitRef="usd">16617000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzktMS0xLTEtNzAzMzQ_add3a4c5-f7db-4214-92aa-25fd280af61f"
      unitRef="shares">1054821</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzktMy0xLTEtNzAzMzQ_f63dca84-8aae-4c68-ace5-8cd557b7ccf1"
      unitRef="usdPerShare">64.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzktNS0xLTEtNzAzMzQ_02490518-2ceb-4289-b8fa-fbceb19e2b97">P3Y1M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo4MmNjZmE3NzY5NWM0YTFiYjI2ODhjMWQ0OGQwNWFhOS90YWJsZXJhbmdlOjgyY2NmYTc3Njk1YzRhMWJiMjY4OGMxZDQ4ZDA1YWE5XzktNy0xLTEtNzAzMzQ_2d452dc3-a377-49ba-8b14-9ecb3192106a"
      unitRef="usd">25311000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzMyNzY_6cfb279e-c2c2-4047-b19f-c69b054efc77"
      unitRef="usd">1900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzMyODA_a9de8188-f697-4cef-ad79-2e9fc1fa3755"
      unitRef="usd">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i83a9bb7c454d4256b50d1b2a36133ef0_D20200329-20210403"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzMyODc_38de8bb6-8d11-4d78-83e8-fe52b80712c9"
      unitRef="usd">8200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzMzMDQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i717dd0e3550541a19cb91afee06fa0c1_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzMzNTQ_90717b51-30f4-4a0d-9e45-30f9a13bf929"
      unitRef="usd">9100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzM1MDc_a135592d-73d6-4984-b266-55764a3af98f">P2Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0OTM_9041bd71-e791-41a6-a7b3-5b2a56638a4d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions utilized for option grants during the periods presented are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value per Option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.53&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzEtMS0xLTEtNzAzMzQ_9a51250a-30c4-4de6-b7e1-648901bc769d"
      unitRef="number">0.450</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzEtMy0xLTEtNzAzMzQ_4936d184-c12e-4316-acb2-9356f12485ef"
      unitRef="number">0.419</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i83a9bb7c454d4256b50d1b2a36133ef0_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzEtNS0xLTEtNzAzMzQ_a69e8fe4-8636-4df2-b2e4-510fe5286efb"
      unitRef="number">0.335</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzItMS0xLTEtNzAzMzQ_a02890da-3c36-455c-8e4e-cb6ca8f384d9">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzItMy0xLTEtNzAzMzQ_aaf38bcb-90bd-4f97-a95f-956c365174ed">P4Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i83a9bb7c454d4256b50d1b2a36133ef0_D20200329-20210403"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzItNS0xLTEtNzAzMzQ_3e21b13c-3525-46a9-b7c1-ce561e432b61">P4Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzMtMS0xLTEtNzAzMzQ_16b96a71-2f4f-448f-8cac-e1d539e53542"
      unitRef="number">0.029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzMtMy0xLTEtNzAzMzQ_502e021e-cde8-4236-b5ed-1c560a1cb32e"
      unitRef="number">0.008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i83a9bb7c454d4256b50d1b2a36133ef0_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzMtNS0xLTEtNzAzMzQ_43ad23fd-bf38-4867-8bd6-a180a2f95b8f"
      unitRef="number">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzQtMS0xLTEtNzAzMzQ_c0f29ced-a0da-4ccd-a81c-54f61425e360"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzQtMy0xLTEtNzAzMzQ_ca624f65-8ba2-40b0-8e48-f541d818d566"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i83a9bb7c454d4256b50d1b2a36133ef0_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzQtNS0xLTEtNzAzMzQ_d2ad2583-da59-4e95-a844-39db1555cc38"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzUtMS0xLTEtNzAzMzQ_95e7148f-984e-4aac-9688-d153a024c116"
      unitRef="usdPerShare">24.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia9c4ce2faaec4764aa31349ee6036b02_D20210404-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzUtMy0xLTEtNzAzMzQ_2bb33b5b-1984-41bd-999e-f882a5f0b081"
      unitRef="usdPerShare">20.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i83a9bb7c454d4256b50d1b2a36133ef0_D20200329-20210403"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1MjNiZmVjNjU4NjY0YzNjOGY2MjA4ZWY3NmVmN2IzMi90YWJsZXJhbmdlOjUyM2JmZWM2NTg2NjRjM2M4ZjYyMDhlZjc2ZWY3YjMyXzUtNS0xLTEtNzAzMzQ_086d6e1f-3553-4aae-ae22-f142dfbd7692"
      unitRef="usdPerShare">30.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie01f5826ba434059bfbcca75ed1388fb_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzQzOTgwNDY1MTk2MjA_98f700b6-e712-4a84-84cc-6154ad530b85">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ied103559dd2b43a4b0de550c083ea67f_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzQzODU_847cc1e3-ca30-4651-9365-b260084625fb">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0NTg_2ff65413-6f5c-46fd-a20b-c7c932241ff8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of RSU activity for the fiscal year ended April&#160;1, 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;381,308&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;63.94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant-date fair value of RSUs granted and total fair value of RSUs vested are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value per RSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iffbadda382114e1eb91a79d7e988c700_I20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzEtMS0xLTEtNzAzMzQ_a934dc00-045b-4cdb-ba3c-55bd6beb0f68"
      unitRef="shares">386536</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iffbadda382114e1eb91a79d7e988c700_I20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzEtMy0xLTEtNzAzMzQ_b13fa9e4-aba8-4362-a78a-19b095802612"
      unitRef="usdPerShare">69.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzItMS0xLTEtNzAzMzQ_fd9f25d0-72e9-4061-95a9-d10af2729be0"
      unitRef="shares">207177</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzItMy0xLTEtNzAzMzQ_2bae6684-3bc9-49bc-8828-a959159498f9"
      unitRef="usdPerShare">59.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzMtMS0xLTEtNzAzMzQ_447ae432-02d8-4191-a21c-e30ec4a46bae"
      unitRef="shares">161045</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzMtMy0xLTEtNzAzMzQ_8c8ee717-e859-40aa-9e35-be4fd11ddb71"
      unitRef="usdPerShare">70.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzQtMS0xLTEtNzAzMzQ_d873a5b5-b20f-424b-a3dc-d7b9299ad9c5"
      unitRef="shares">51360</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzQtMy0xLTEtNzAzMzQ_4e941d8b-d7f0-466b-b8ff-df338226fabb"
      unitRef="usdPerShare">65.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if6792b00ca8b4378bcb06b91412550eb_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzUtMS0xLTEtNzAzMzQ_7a7828cb-24c3-4dfe-a6b4-a340477e89e7"
      unitRef="shares">381308</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if6792b00ca8b4378bcb06b91412550eb_I20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1NWJkNDU2ZTIxMDY0ZTM5YWEzOTFkNDZhM2FjM2E0NC90YWJsZXJhbmdlOjU1YmQ0NTZlMjEwNjRlMzlhYTM5MWQ0NmEzYWMzYTQ0XzUtMy0xLTEtNzAzMzQ_df637b98-1dfc-498b-9730-b29dde14eb75"
      unitRef="usdPerShare">63.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTozMDVkMjZlMzBkYjE0N2I1ODZlZjU0YWE2NjAzYzBkYS90YWJsZXJhbmdlOjMwNWQyNmUzMGRiMTQ3YjU4NmVmNTRhYTY2MDNjMGRhXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTozMDVkMjZlMzBkYjE0N2I1ODZlZjU0YWE2NjAzYzBkYS90YWJsZXJhbmdlOjMwNWQyNmUzMGRiMTQ3YjU4NmVmNTRhYTY2MDNjMGRhXzEtMS0xLTEtNzAzMzQ_03600c63-1785-4a30-887e-ffc5d3cb7bf1"
      unitRef="usdPerShare">59.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibd48961a67cf47bcaa9d15e8932acecb_D20210404-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTozMDVkMjZlMzBkYjE0N2I1ODZlZjU0YWE2NjAzYzBkYS90YWJsZXJhbmdlOjMwNWQyNmUzMGRiMTQ3YjU4NmVmNTRhYTY2MDNjMGRhXzEtMy0xLTEtNzAzMzQ_b26907a0-a83a-4b8e-a508-d88edf9bd662"
      unitRef="usdPerShare">56.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0b0d0e4e19f34194b2cc3d61739b6ec8_D20200329-20210403"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTozMDVkMjZlMzBkYjE0N2I1ODZlZjU0YWE2NjAzYzBkYS90YWJsZXJhbmdlOjMwNWQyNmUzMGRiMTQ3YjU4NmVmNTRhYTY2MDNjMGRhXzEtNS0xLTEtNzAzMzQ_da02f836-e366-4ac6-b630-520d00a7d09e"
      unitRef="usdPerShare">102.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTozMDVkMjZlMzBkYjE0N2I1ODZlZjU0YWE2NjAzYzBkYS90YWJsZXJhbmdlOjMwNWQyNmUzMGRiMTQ3YjU4NmVmNTRhYTY2MDNjMGRhXzItMS0xLTEtNzAzMzQ_add8c16b-4cca-4e0a-8c7b-8bcf55a2605a"
      unitRef="usdPerShare">70.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibd48961a67cf47bcaa9d15e8932acecb_D20210404-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTozMDVkMjZlMzBkYjE0N2I1ODZlZjU0YWE2NjAzYzBkYS90YWJsZXJhbmdlOjMwNWQyNmUzMGRiMTQ3YjU4NmVmNTRhYTY2MDNjMGRhXzItMy0xLTEtNzAzMzQ_6ec28d5a-7f87-4b40-8d8f-2a1ee206fb7f"
      unitRef="usdPerShare">79.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0b0d0e4e19f34194b2cc3d61739b6ec8_D20200329-20210403"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTozMDVkMjZlMzBkYjE0N2I1ODZlZjU0YWE2NjAzYzBkYS90YWJsZXJhbmdlOjMwNWQyNmUzMGRiMTQ3YjU4NmVmNTRhYTY2MDNjMGRhXzItNS0xLTEtNzAzMzQ_395ddf15-965b-492d-898c-af23d2525cfc"
      unitRef="usdPerShare">66.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="if6792b00ca8b4378bcb06b91412550eb_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzQ5NDY_70b4fe13-c108-491b-ad7c-f964f4fd9f23"
      unitRef="usd">15400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzUxMDg_8d267b02-0279-4664-9e2b-f89506fd83b5">P2Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <hae:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod
      contextRef="i1366c0d1a26f4ae99257fc0a3af5b117_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzQzOTgwNDY1MTk2MjE_7d0d9164-fc8e-48c0-bbd2-0c24704f73fe">P3Y</hae:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod>
    <hae:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget
      contextRef="ia22139de2bdb42ccaa1b42693e6081e1_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzU4ODQ_9aeceba8-5174-4ce0-83e8-37434a1eea91"
      unitRef="number">0</hae:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget>
    <hae:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget
      contextRef="i1a025b99984c40c8aa80efd44bf08d80_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzU4OTA_efd12769-43ce-4998-8acd-b245b356a8c2"
      unitRef="number">2</hae:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget>
    <hae:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget
      contextRef="i13ad711590264a0292e2f60317f18a68_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzYwMzg_5a1d7c6e-48bc-43fd-aade-bfc27a7a46f5"
      unitRef="number">1</hae:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i13ad711590264a0292e2f60317f18a68_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzYxODE_4651428c-1e89-48c7-8abd-d2d8bacce99a"
      unitRef="shares">647974</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0NDc_5fff49a2-c3fe-4c3e-8dd2-1b83ffc6d7b7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of PSU activity for the fiscal year ended April&#160;1, 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;323,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87.35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Includes the adjustment of 62,577 shares for awards granted in fiscal 2020, based on actual relative total shareholder return of 0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i07c8760c6cc84cf3b9856e00588d1d24_I20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzEtMS0xLTEtNzAzMzQ_bd71e28d-3e69-451a-b1fa-615399aa6614"
      unitRef="shares">282946</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i07c8760c6cc84cf3b9856e00588d1d24_I20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzEtMy0xLTEtNzAzMzQ_f069f96a-c79e-41a9-a635-99afdfda8ed8"
      unitRef="usdPerShare">102.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzItMS0xLTEtNzAzMzQ_13082a4f-4a03-4b15-a243-bbb6ec778626"
      unitRef="shares">88851</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzItMy0xLTEtNzAzMzQ_6e96eea0-c6be-4098-810a-f7d4e9655fe1"
      unitRef="usdPerShare">84.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzMtMS0xLTEtNzAzMzQ_311ec1e2-0c62-4444-bf8f-7f8169b89f82"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzMtMy0xLTEtNzAzMzQ_7f4af61b-821c-454f-8f6a-fc4ab00960b8"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzQtMS0xLTEtNzAzMzQ_46f07347-d4bf-48c1-936a-4282f987895c"
      unitRef="shares">47810</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzQtMy0xLTEtNzAzMzQ_03b69d2b-abb2-4dd9-bc62-bd0f16f2adbf"
      unitRef="usdPerShare">89.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i13ad711590264a0292e2f60317f18a68_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzUtMS0xLTEtNzAzMzQ_5a46972c-e759-44dc-869c-60afc58c8125"
      unitRef="shares">323987</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i13ad711590264a0292e2f60317f18a68_I20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzUtMy0xLTEtNzAzMzQ_71c9b765-02b1-4bd7-945f-5b6627b74bdc"
      unitRef="usdPerShare">87.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i59b37d77f2e14639a7e9f54a0a50c9ef_D20190331-20200328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTphNTM0ODFiMDNhMzQ0NmJjYWYzYTI0NmNiZGZlZDc2ZS90YWJsZXJhbmdlOmE1MzQ4MWIwM2EzNDQ2YmNhZjNhMjQ2Y2JkZmVkNzZlXzYtMC0xLTEtOTQ2NDUvdGV4dHJlZ2lvbjowMDUxM2IzNmUxODk0MjAxYmRlZWFkNGU0OGVkMjA2MF8xNjQ5MjY3NDQxODI4_34afbec8-a029-4203-a342-5505b291cfe5"
      unitRef="shares">62577</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <hae:ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0NjE_8a964ff9-a8eb-4fb8-8ac1-faf90cf3695b">The assumptions used in the Monte Carlo model for PSUs granted during each fiscal year were as follows: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peer group stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Correlation of returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant-date fair value of PSUs granted and total fair value of PSUs vested are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant-date fair value per PSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of PSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</hae:ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzEtMS0xLTEtNzAzMzQ_81c13f43-2e30-4c06-8e17-e762fab9fd0e"
      unitRef="number">0.5222</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i55c8b8347e1243739c1e1fac07b7a6c0_D20210404-20220402"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzEtMy0xLTEtNzAzMzQ_ef0d2dee-010d-4c7c-b47d-3da041c73741"
      unitRef="number">0.4923</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="id1524cac1b104c79b7706146b0a9bdc2_D20200329-20210403"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzEtNS0xLTEtNzAzMzQ_19fbcf0c-c4b8-4cf1-8600-73e9e248ba51"
      unitRef="number">0.3679</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility
      contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzItMS0xLTEtNzAzMzQ_6c2cbff5-6e16-46bb-a9be-0e18b5b0c215"
      unitRef="number">0.4743</hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility>
    <hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility
      contextRef="i55c8b8347e1243739c1e1fac07b7a6c0_D20210404-20220402"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzItMy0xLTEtNzAzMzQ_11311be8-817d-40bd-9e0b-5665e8a90e33"
      unitRef="number">0.4575</hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility>
    <hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility
      contextRef="id1524cac1b104c79b7706146b0a9bdc2_D20200329-20210403"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzItNS0xLTEtNzAzMzQ_d22e4707-c377-449e-88e7-8c5a5a814052"
      unitRef="number">0.4231</hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility>
    <hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns
      contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzMtMS0xLTEtNzAzMzQ_961cf7d5-41dc-4c8e-b5bc-2ce35f479061"
      unitRef="number">0.6545</hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns>
    <hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns
      contextRef="i55c8b8347e1243739c1e1fac07b7a6c0_D20210404-20220402"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzMtMy0xLTEtNzAzMzQ_9f87a7c8-2c76-4785-a82d-5b30f24df801"
      unitRef="number">0.6506</hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns>
    <hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns
      contextRef="id1524cac1b104c79b7706146b0a9bdc2_D20200329-20210403"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo0M2U1NzJlODlkZjk0ZDY2YTcyMjkwZDRjYzkzYzU1MS90YWJsZXJhbmdlOjQzZTU3MmU4OWRmOTRkNjZhNzIyOTBkNGNjOTNjNTUxXzMtNS0xLTEtNzAzMzQ_6c7c7e3f-650e-4be4-851e-e35d79611131"
      unitRef="number">0.6512</hae:SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1Y2NmMDk5MWUyZTM0NzFlOTA5MmUwYzY2NjQyZGQ0Mi90YWJsZXJhbmdlOjVjY2YwOTkxZTJlMzQ3MWU5MDkyZTBjNjY2NDJkZDQyXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1Y2NmMDk5MWUyZTM0NzFlOTA5MmUwYzY2NjQyZGQ0Mi90YWJsZXJhbmdlOjVjY2YwOTkxZTJlMzQ3MWU5MDkyZTBjNjY2NDJkZDQyXzEtMS0xLTEtNzAzMzQ_c405e0e4-a2ba-49f8-8fbd-f8fda35d6af8"
      unitRef="usdPerShare">84.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i55c8b8347e1243739c1e1fac07b7a6c0_D20210404-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1Y2NmMDk5MWUyZTM0NzFlOTA5MmUwYzY2NjQyZGQ0Mi90YWJsZXJhbmdlOjVjY2YwOTkxZTJlMzQ3MWU5MDkyZTBjNjY2NDJkZDQyXzEtMy0xLTEtNzAzMzQ_d1b58336-d492-44d4-8a1f-f538827aa01f"
      unitRef="usdPerShare">72.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id1524cac1b104c79b7706146b0a9bdc2_D20200329-20210403"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1Y2NmMDk5MWUyZTM0NzFlOTA5MmUwYzY2NjQyZGQ0Mi90YWJsZXJhbmdlOjVjY2YwOTkxZTJlMzQ3MWU5MDkyZTBjNjY2NDJkZDQyXzEtNS0xLTEtNzAzMzQ_00527b11-2ff8-4f56-8e4a-02c0554c9091"
      unitRef="usdPerShare">123.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1Y2NmMDk5MWUyZTM0NzFlOTA5MmUwYzY2NjQyZGQ0Mi90YWJsZXJhbmdlOjVjY2YwOTkxZTJlMzQ3MWU5MDkyZTBjNjY2NDJkZDQyXzItMS0xLTEtNzAzMzQ_b5c06477-8ead-4d52-8401-064143ea1058"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i55c8b8347e1243739c1e1fac07b7a6c0_D20210404-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1Y2NmMDk5MWUyZTM0NzFlOTA5MmUwYzY2NjQyZGQ0Mi90YWJsZXJhbmdlOjVjY2YwOTkxZTJlMzQ3MWU5MDkyZTBjNjY2NDJkZDQyXzItMy0xLTEtNzAzMzQ_70888391-85b6-45b3-8005-fa7498fe9382"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="id1524cac1b104c79b7706146b0a9bdc2_D20200329-20210403"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTo1Y2NmMDk5MWUyZTM0NzFlOTA5MmUwYzY2NjQyZGQ0Mi90YWJsZXJhbmdlOjVjY2YwOTkxZTJlMzQ3MWU5MDkyZTBjNjY2NDJkZDQyXzItNS0xLTEtNzAzMzQ_77cc71a8-3758-4608-8ea9-52738432cb21"
      unitRef="usdPerShare">47.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i13ad711590264a0292e2f60317f18a68_I20230401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzY3Mjg_796e56dc-aa44-4856-91f5-5c605b315aaf"
      unitRef="usd">14500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i32f5dbe4aebb43b2a3fe9336a4ea09e6_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzY4OTE_4ad0ece3-ea93-4b85-9699-887c87a48b8a">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i78a954ba53b547c2bed2e4234f13c99d_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzcwMjc_f71cad6d-6cad-4102-856a-773cbcf75dbc"
      unitRef="shares">3200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <hae:NumberOfPurchasePeriods
      contextRef="i78a954ba53b547c2bed2e4234f13c99d_I20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzcyODE_a09e8bf5-3935-4134-ab5d-94f810dc8b72"
      unitRef="period">2</hae:NumberOfPurchasePeriods>
    <hae:PercentageOfSharesPurchasedThroughPayrollDeductions
      contextRef="i1aa3abbe789d42b1bb931051619eea7c_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzc2MjQ_4c7ca643-4f82-4aee-b095-f3ea7b90f304"
      unitRef="number">0.02</hae:PercentageOfSharesPurchasedThroughPayrollDeductions>
    <hae:PercentageOfSharesPurchasedThroughPayrollDeductions
      contextRef="ib47a041d2f4a41c580a5732760d4464d_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzc2NDA_9eed1733-b4fc-4640-93de-d5482f65676b"
      unitRef="number">0.15</hae:PercentageOfSharesPurchasedThroughPayrollDeductions>
    <hae:PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue
      contextRef="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzc5MzE_72854ec4-5b52-4a0f-9e43-23c392993866"
      unitRef="number">0.85</hae:PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue>
    <hae:PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue
      contextRef="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzgwMjM_72854ec4-5b52-4a0f-9e43-23c392993866"
      unitRef="number">0.85</hae:PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0ODA_186867e7-9d64-4b45-a89a-3b2b381d9b23">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of shares purchased under the Employee Stock Purchase Plan are estimated using the Black-Scholes single option-pricing model with the following weighted average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend Yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzEtMS0xLTEtNzAzMzQ_9edd60e3-3db5-403f-abd2-ff6d0d68ab4a"
      unitRef="number">0.449</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="id8876ecaa10546b49f1574bdf9545726_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzEtMy0xLTEtNzAzMzQ_8e07c44d-91c1-4cad-a976-bb85d35468dc"
      unitRef="number">0.556</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i5b7c9d1af64d4d1ba8bf38b9460a37f9_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzEtNS0xLTEtNzAzMzQ_87ba7108-f6d4-46d4-ad60-54c27a085524"
      unitRef="number">0.498</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzItMS0xLTEtNzAzMzQ_dfebc439-eb60-454b-b5fb-8fd5121c317a">P6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="id8876ecaa10546b49f1574bdf9545726_D20210404-20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzItMy0xLTEtNzAzMzQ_706fde32-79de-4ae0-a9c6-88781b25c987">P6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i5b7c9d1af64d4d1ba8bf38b9460a37f9_D20200329-20210403"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzItNS0xLTEtNzAzMzQ_d3784db3-93a6-481a-ac0f-cfaf61b4e078">P6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzMtMS0xLTEtNzAzMzQ_5fc8fae3-24fb-4fb3-8ebd-967b720b1951"
      unitRef="number">0.029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="id8876ecaa10546b49f1574bdf9545726_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzMtMy0xLTEtNzAzMzQ_ad0c5bbb-f07a-4e09-bd4d-c89b2c2ca4fc"
      unitRef="number">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i5b7c9d1af64d4d1ba8bf38b9460a37f9_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzMtNS0xLTEtNzAzMzQ_28a8fc99-b061-4cbf-9d80-90ffc7b4d966"
      unitRef="number">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzQtMS0xLTEtNzAzMzQ_6c5400a6-52ac-441b-82b3-a4567abdf9e3"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="id8876ecaa10546b49f1574bdf9545726_D20210404-20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzQtMy0xLTEtNzAzMzQ_21a7c27b-64b7-4fe5-bdc8-f114569ebd4f"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i5b7c9d1af64d4d1ba8bf38b9460a37f9_D20200329-20210403"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90YWJsZTpiMzhlNTZhMTk3YzA0ZGQ3ODUwYmM1ZmEwMjg0MTJlNS90YWJsZXJhbmdlOmIzOGU1NmExOTdjMDRkZDc4NTBiYzVmYTAyODQxMmU1XzQtNS0xLTEtNzAzMzQ_0f3616bc-3590-4653-8e76-754b3caeb1c1"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="id8876ecaa10546b49f1574bdf9545726_D20210404-20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzQzOTgwNDY1MTk2MjI_f95cea89-3910-4918-99ad-3aa024cb8741">P6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <hae:WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan
      contextRef="i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzgzODM_99481ae4-2a62-4d55-9c8d-80b17aa120d9"
      unitRef="usdPerShare">18.10</hae:WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan>
    <hae:WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan
      contextRef="id8876ecaa10546b49f1574bdf9545726_D20210404-20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzgzODc_89d5b261-a947-4dd8-8a8b-3dde172efe4f"
      unitRef="usdPerShare">20.77</hae:WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan>
    <hae:WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan
      contextRef="i5b7c9d1af64d4d1ba8bf38b9460a37f9_D20200329-20210403"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzgzOTQ_8dfe25e0-f569-4c8f-a755-bb5d4053ff43"
      unitRef="usdPerShare">30.77</hae:WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDUvZnJhZzowMTI3ZmI5YjNiMWY0Y2EzYmU0ZjUzY2E0MmM5Mzc2MC90ZXh0cmVnaW9uOjAxMjdmYjliM2IxZjRjYTNiZTRmNTNjYTQyYzkzNzYwXzg0MTE_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90ZXh0cmVnaW9uOjFmMmM0MTU1Y2YwMzQ4ZTE5YmJlMzBhM2Y1ODI3NmI1XzI1OTA_7d76547b-c8d0-4e36-89d1-e77b95a07845">SEGMENT AND ENTERPRISE-WIDE INFORMATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines its reportable segments by first identifying its operating segments, and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. The Company&#x2019;s reporting structure aligns with its operating structure of three global business units and the information that is regularly reviewed by the Company&#x2019;s chief operating decision maker.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reportable and operating segments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Plasma&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Blood Center&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Hospital&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management measures and evaluates the operating segments based on operating income. Management excludes certain corporate expenses from segment operating income. In addition, certain amounts that management considers to be non-recurring or non-operational are excluded from segment operating income because management evaluates the operating results of the segments excluding such items. These items include integration and transaction costs, amortization of acquired intangible assets, restructuring and restructuring related costs, digital transformation costs related to the upgrade of our enterprise resource planning system, impairments, accelerated device depreciation and related costs, costs related to compliance with the European Union Medical Device Regulation (&#x201c;MDR&#x201d;) and In Vitro Diagnostic Regulation (&#x201c;IVDR&#x201d;), unusual or infrequent and material litigation-related charges and gains and losses on dispositions and sale of assets. Although these amounts are excluded from &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;segment operating income, as applicable, they are included in the reconciliations that follow. Management measures and evaluates the Company&#x2019;s net revenues and operating income using internally derived standard currency exchange rates that remain constant from year to year; therefore, segment information is presented on this basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected information by reportable segment is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues by business unit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,168,660&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;993,196&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;870,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; Reflects revenue for service, maintenance and parts.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Corporate expenses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(355,089)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(281,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256,751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Effect of exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,830)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of assets and PCS2 related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,732)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration and transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and restructuring related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digital transformation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MDR and IVDR costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains on divestitures and sale of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;156,033&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;80,750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;89,747&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total depreciation and amortization (excluding impairment charges)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93,307&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97,747&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;84,287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;310,885&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;258,482&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; Long-lived assets are comprised of property, plant and equipment.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected information by operating regions is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;310,885&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;258,482&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; Long-lived assets are comprised of property, plant and equipment.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,168,660&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;993,196&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;870,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management reviews revenue based on the reportable segments noted above.&#160;Although these reportable segments are primarily product-based, they differ from the Company&#x2019;s product line revenues for Plasma products and services and Blood Center products and services.&#160;Specifically, the Blood Center reportable segment includes plasma products utilized for collection in blood centers primarily for transfusion purposes.&#160;Additionally, product line revenues also include service revenues which are excluded from the reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenues by product line are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.972%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,168,660&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;993,196&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;870,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90ZXh0cmVnaW9uOjFmMmM0MTU1Y2YwMzQ4ZTE5YmJlMzBhM2Y1ODI3NmI1XzQ0Mg_25b5380f-c61d-442c-8b39-d49b585ae6a2"
      unitRef="unit">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90ZXh0cmVnaW9uOjFmMmM0MTU1Y2YwMzQ4ZTE5YmJlMzBhM2Y1ODI3NmI1XzI1ODY_839b333f-9076-4830-9f47-efff1db85721">&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues by business unit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,168,660&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;993,196&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;870,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; Reflects revenue for service, maintenance and parts.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Corporate expenses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(355,089)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(281,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256,751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Effect of exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,830)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of assets and PCS2 related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,732)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration and transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and restructuring related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digital transformation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MDR and IVDR costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains on divestitures and sale of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;156,033&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;80,750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;89,747&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total depreciation and amortization (excluding impairment charges)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93,307&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97,747&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;84,287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;310,885&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;258,482&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; Long-lived assets are comprised of property, plant and equipment.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected information by operating regions is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 2,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;310,885&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;258,482&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; Long-lived assets are comprised of property, plant and equipment.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,168,660&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;993,196&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;870,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="iceda53e10aa943db9898cb8ab8dac15a_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzItMS0xLTEtNzAzMzQ_aff9a251-b060-4845-b315-c994cfefcaee"
      unitRef="usd">500489000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="ic069cd0eb4c94953be95e2deb98ea5e5_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzItMy0xLTEtNzAzMzQ_1a2bcca6-afab-440c-9a6a-6ed2d23e9ac3"
      unitRef="usd">351945000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="ia79a8918d94541fbb215b791d3bc0308_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzItNS0xLTEtNzAzMzQ_24cf999f-d505-45b4-8677-1c541c985e14"
      unitRef="usd">333334000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="ie3ffef01c50b40dcbbc6f463d67d82a6_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzMtMS0xLTEtNzAzMzQ_fb2ce0b7-cec2-479a-a0f9-d12e9cace11c"
      unitRef="usd">289365000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i0b364431a43245b7a9f05a60dc7416df_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzMtMy0xLTEtNzAzMzQ_ab7aa5ac-c1d8-43a8-b38a-f01f0542a32b"
      unitRef="usd">294541000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="ie6794b0b382b4fb7886de74ba621481b_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzMtNS0xLTEtNzAzMzQ_230052c8-e1a2-4c31-86f4-e71705229fa2"
      unitRef="usd">307370000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i753483fb84d94062bdc30420838c80cf_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzQtMS0xLTEtNzAzMzQ_30ba3f64-c6ec-4b60-8c52-0d43c3d03511"
      unitRef="usd">378206000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i5c4e22f5dd7d46aab1223c60d287905f_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzQtMy0xLTEtNzAzMzQ_8ad32bb2-42ef-4a87-b30a-617cb6a33574"
      unitRef="usd">321580000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i4e8e2ad8db6d4f6c859bc3263d7c9235_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzQtNS0xLTEtNzAzMzQ_259c5f38-f2c8-4a28-be3c-188737515045"
      unitRef="usd">210606000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzUtMS0xLTEtNzAzMzQ_608264c8-6116-4c48-8395-21c11f40fe8b"
      unitRef="usd">1168060000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzUtMy0xLTEtNzAzMzQ_4f9c9329-a4c4-4b38-9f0c-03b432db167f"
      unitRef="usd">968066000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzUtNS0xLTEtNzAzMzQ_e8409a31-c976-405d-b049-5c77bb178c12"
      unitRef="usd">851310000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4f9b935310f84ea0a50db4a3f1516c09_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzYtMS0xLTEtNzAzMzQ_d87ce59d-48ee-4bd6-a936-0b55a937895c"
      unitRef="usd">21424000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9f4398aaa87e4aeca6c11c93436c50e9_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzYtMy0xLTEtNzAzMzQ_f51f9185-a0e1-48e4-b80b-a4e5bcfa5248"
      unitRef="usd">20811000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4d1e74dd6311434089cd6836e717625c_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzYtNS0xLTEtNzAzMzQ_f3146322-7a6a-4b90-842d-8af1ba4d8bdc"
      unitRef="usd">20758000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <hae:EffectofExchangeRateonRevenues
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzctMS0xLTEtNzAzMzQ_fd35ce1b-1efb-405c-a0a1-17ff7e8ee0d9"
      unitRef="usd">-20824000</hae:EffectofExchangeRateonRevenues>
    <hae:EffectofExchangeRateonRevenues
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzctMy0xLTEtNzAzMzQ_a4ca1c08-ea83-4cdd-b31f-6fbad4623060"
      unitRef="usd">4319000</hae:EffectofExchangeRateonRevenues>
    <hae:EffectofExchangeRateonRevenues
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzctNS0xLTEtNzAzMzQ_a92d68c8-8599-40e4-8366-680ffcedbc7c"
      unitRef="usd">-1605000</hae:EffectofExchangeRateonRevenues>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzgtMS0xLTEtNzAzMzQ_159abb41-2b1d-4a38-a27a-1b9d63fcb18a"
      unitRef="usd">1168660000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzgtMy0xLTEtNzAzMzQ_c0b9d488-ae83-4e44-ac81-0ac681a87748"
      unitRef="usd">993196000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZToyM2Y5ZmI2NGY3NjU0MjFlYmRmM2Y3MjZiMjY3ZWFmOS90YWJsZXJhbmdlOjIzZjlmYjY0Zjc2NTQyMWViZGYzZjcyNmIyNjdlYWY5XzgtNS0xLTEtNzAzMzQ_fb33f552-20e7-43c1-b61f-64d3ff2466fc"
      unitRef="usd">870463000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:OperatingIncomeLoss
      contextRef="i57226d1153c648e282451a752c136567_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzItMS0xLTEtNzAzMzQ_b8b91d8b-b664-46f2-8d21-88de9353af2d"
      unitRef="usd">278580000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7892776f995348be9cb282d7d7c17651_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzItMy0xLTEtNzAzMzQ_0b8067e9-8d8d-4103-a41e-ecaba7c37752"
      unitRef="usd">183131000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i62ca9ec732184b39b11517312a810c90_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzItNS0xLTEtNzAzMzQ_14b27694-0e1b-4e04-91cd-bd581eee4a3b"
      unitRef="usd">172463000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5e5300fbf53a4887a95a3edcae203e9f_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzMtMS0xLTEtNzAzMzQ_cde84e17-9ac0-406b-8147-331fa3e71d68"
      unitRef="usd">132107000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i399cf413d8244296bc74b84fb599fdfd_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzMtMy0xLTEtNzAzMzQ_20fb563a-3bd2-4185-8f9e-a5ba796cd893"
      unitRef="usd">136691000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5feb3720fec44a2b9a7ac2e43eebe25a_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzMtNS0xLTEtNzAzMzQ_c85d8422-d6a3-42e9-9c0c-512ef57cbf2b"
      unitRef="usd">141962000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if49e6050da52421980ac8d48fb39b261_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzQtMS0xLTEtNzAzMzQ_70305a9e-38ae-42a1-9310-13d397fa8195"
      unitRef="usd">154416000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia94875fad58e496e88688163402cab14_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzQtMy0xLTEtNzAzMzQ_ef25fca0-cae9-4b62-a82f-04c268ae18f1"
      unitRef="usd">129783000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1f932dedc3e84a1fbcde03eaf16d4ba2_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzQtNS0xLTEtNzAzMzQ_ab431ffd-16e9-4848-a6d5-50b984005e70"
      unitRef="usd">84066000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7c9dc15838804a3bb4198e9625eab973_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzUtMS0xLTEtNzAzMzQ_e89139ee-f697-4490-876d-df7f788d131d"
      unitRef="usd">565103000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieaff6cca2e524da7a844b31893ea255f_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzUtMy0xLTEtNzAzMzQ_600b47f0-1d41-4df6-a182-62bf556a862f"
      unitRef="usd">449605000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i576a32257e5e4be9bdce60172bdce930_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzUtNS0xLTEtNzAzMzQ_f8a89ca8-f299-43ab-a246-d837104a1cd2"
      unitRef="usd">398491000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherExpenses
      contextRef="icadc8db134484aaa9370b59b63b8a1be_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzYtMS0xLTEtNzAzMzQ_a0104c39-b0f3-4765-a7ab-f4f6953ee3a2"
      unitRef="usd">355089000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="ie6464f6090754fc397d2bc24da66f3a5_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzYtMy0xLTEtNzAzMzQ_ee72116e-d242-427a-a484-d9cdc9875bea"
      unitRef="usd">281476000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="if321e27503a64a269742b2fad027648e_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzYtNS0xLTEtNzAzMzQ_d743db83-7fca-4448-848e-2b3bff11ea8b"
      unitRef="usd">256751000</us-gaap:OtherExpenses>
    <hae:EffectofExchangeRatesonOperatingIncome
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzctMS0xLTEtNzAzMzQ_de1ba7dc-b6da-4471-acce-eb80ef45b383"
      unitRef="usd">8419000</hae:EffectofExchangeRatesonOperatingIncome>
    <hae:EffectofExchangeRatesonOperatingIncome
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzctMy0xLTEtNzAzMzQ_678f0a3b-93c1-4b70-a6cc-119e562fd18d"
      unitRef="usd">18993000</hae:EffectofExchangeRatesonOperatingIncome>
    <hae:EffectofExchangeRatesonOperatingIncome
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzctNS0xLTEtNzAzMzQ_d3d9072a-6ae9-44a8-aeb9-5e4abd2a67c8"
      unitRef="usd">12830000</hae:EffectofExchangeRatesonOperatingIncome>
    <hae:AmortizationOfAcquiredIntangibleAssets
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzgtMS0xLTEtNzAzMzQ_1cd7cac7-90a8-499b-b8ca-a2abcdcf043b"
      unitRef="usd">32640000</hae:AmortizationOfAcquiredIntangibleAssets>
    <hae:AmortizationOfAcquiredIntangibleAssets
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzgtMy0xLTEtNzAzMzQ_42165b22-46e4-442b-a134-8ac1e4e5ae5c"
      unitRef="usd">47414000</hae:AmortizationOfAcquiredIntangibleAssets>
    <hae:AmortizationOfAcquiredIntangibleAssets
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzgtNS0xLTEtNzAzMzQ_b5ad6c7d-5dd4-486f-893e-5641bc98b3c1"
      unitRef="usd">32830000</hae:AmortizationOfAcquiredIntangibleAssets>
    <hae:ImpairmentOfAssetsAndRelatedCharges
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzktMS0xLTEtNzAzMzQ_a00f183b-dbeb-4c17-b594-952132930fce"
      unitRef="usd">-616000</hae:ImpairmentOfAssetsAndRelatedCharges>
    <hae:ImpairmentOfAssetsAndRelatedCharges
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzktMy0xLTEtNzAzMzQ_d9047c48-72a7-479d-b0d6-769a7abe89d3"
      unitRef="usd">5732000</hae:ImpairmentOfAssetsAndRelatedCharges>
    <hae:ImpairmentOfAssetsAndRelatedCharges
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzktNS0xLTEtNzAzMzQ_e98f7afb-8785-46ac-8084-40b76eda22c5"
      unitRef="usd">25696000</hae:ImpairmentOfAssetsAndRelatedCharges>
    <hae:OperatingExpensesTransactionCosts
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEwLTEtMS0xLTcwMzM0_fbcb1e45-28bc-468c-a691-12aa9a512551"
      unitRef="usd">-411000</hae:OperatingExpensesTransactionCosts>
    <hae:OperatingExpensesTransactionCosts
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEwLTMtMS0xLTcwMzM0_44a892f5-fce4-49f4-a6cd-11ce4f6bb046"
      unitRef="usd">21604000</hae:OperatingExpensesTransactionCosts>
    <hae:OperatingExpensesTransactionCosts
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEwLTUtMS0xLTcwMzM0_cf9aa0ac-abb3-4450-966a-aefd3cd1466b"
      unitRef="usd">18421000</hae:OperatingExpensesTransactionCosts>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzExLTEtMS0xLTcwMzM0_e39f96ef-883e-453a-9ffb-47c25a45f48b"
      unitRef="usd">11549000</hae:RestructuringandRestructuringRelatedCosts>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzExLTMtMS0xLTcwMzM0_17333a14-905a-46d0-b06a-738969e7ac3e"
      unitRef="usd">28824000</hae:RestructuringandRestructuringRelatedCosts>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzExLTUtMS0xLTcwMzM0_6db5d9d2-5674-4c6b-84eb-2f601d4ded42"
      unitRef="usd">15661000</hae:RestructuringandRestructuringRelatedCosts>
    <hae:DigitalTransformationCosts
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEyLTEtMS0xLTg5ODEx_f17aee80-a657-4919-9b82-e279ba5fb6f5"
      unitRef="usd">4536000</hae:DigitalTransformationCosts>
    <hae:DigitalTransformationCosts
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEyLTMtMS0xLTg5ODEx_30d21d34-4b8f-410e-92ba-c62dff108b61"
      unitRef="usd">0</hae:DigitalTransformationCosts>
    <hae:DigitalTransformationCosts
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEyLTUtMS0xLTg5ODEx_97860d49-1749-4aba-9d3d-77e4794c9841"
      unitRef="usd">0</hae:DigitalTransformationCosts>
    <hae:EuropeanMedicalDeviceRegulationCosts
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEyLTEtMS0xLTcwMzM0_5b27d4ed-0470-48ec-b41b-1e532012a9cd"
      unitRef="usd">9854000</hae:EuropeanMedicalDeviceRegulationCosts>
    <hae:EuropeanMedicalDeviceRegulationCosts
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEyLTMtMS0xLTcwMzM0_9a318ece-a3d0-4a6a-b508-bbe6814fdfdc"
      unitRef="usd">11033000</hae:EuropeanMedicalDeviceRegulationCosts>
    <hae:EuropeanMedicalDeviceRegulationCosts
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEyLTUtMS0xLTcwMzM0_9e5f41d4-42aa-416e-bf69-1c197ad59e2f"
      unitRef="usd">4130000</hae:EuropeanMedicalDeviceRegulationCosts>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEzLTEtMS0xLTcwMzM0_29fb1eeb-9ebb-45e4-8787-f171ca651e08"
      unitRef="usd">5230000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEzLTMtMS0xLTcwMzM0_5770462b-5e27-47b2-badb-037d4086f597"
      unitRef="usd">1368000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzEzLTUtMS0xLTcwMzM0_99cc1b31-144f-4646-a35f-3bb87c83800b"
      unitRef="usd">897000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzE0LTEtMS0xLTcwMzM0_a708ef69-b9b7-43e9-870f-df078861595f"
      unitRef="usd">-382000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzE0LTMtMS0xLTcwMzM0_f9b30e6e-afa7-4ba2-973a-b1c4af23755e"
      unitRef="usd">-9603000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzE0LTUtMS0xLTcwMzM0_1dd90ce4-0a13-4704-8f04-e2e04c05a60c"
      unitRef="usd">-32812000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:OperatingIncomeLoss
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzE1LTEtMS0xLTcwMzM0_e49bce7c-30a0-4b26-a017-80f9445f0eb2"
      unitRef="usd">156033000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzE1LTMtMS0xLTcwMzM0_56c7faa5-c513-40e8-842f-f4bb9cafba32"
      unitRef="usd">80750000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTowYzA5ZDFjZDVmMDY0ZTVlYTg4N2RlNTkwZmQxZmJhMi90YWJsZXJhbmdlOjBjMDlkMWNkNWYwNjRlNWVhODg3ZGU1OTBmZDFmYmEyXzE1LTUtMS0xLTcwMzM0_08c97689-e974-4534-ba94-68ec8d1693d0"
      unitRef="usd">89747000</us-gaap:OperatingIncomeLoss>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:DepreciationAndAmortization
      contextRef="iceda53e10aa943db9898cb8ab8dac15a_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzItMS0xLTEtNzAzMzQ_9f194e72-39e2-4723-a4a3-ae5e6c6ac392"
      unitRef="usd">41612000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic069cd0eb4c94953be95e2deb98ea5e5_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzItMy0xLTEtNzAzMzQ_6efb55dc-a614-450e-b341-68a89830832c"
      unitRef="usd">28314000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ia79a8918d94541fbb215b791d3bc0308_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzItNS0xLTEtNzAzMzQ_11cd9516-6917-4f02-8026-fc7fdc8f8388"
      unitRef="usd">24093000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie3ffef01c50b40dcbbc6f463d67d82a6_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzMtMS0xLTEtNzAzMzQ_0b703f93-fe1e-4ca0-b3fe-03e879e03317"
      unitRef="usd">13927000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i0b364431a43245b7a9f05a60dc7416df_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzMtMy0xLTEtNzAzMzQ_8898945c-6717-4b55-bbc9-120b24de8c18"
      unitRef="usd">32489000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie6794b0b382b4fb7886de74ba621481b_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzMtNS0xLTEtNzAzMzQ_e8af99ff-da91-411c-b519-67439ce6b930"
      unitRef="usd">39672000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i753483fb84d94062bdc30420838c80cf_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzQtMS0xLTEtNzAzMzQ_890aada6-d65f-4f4a-8074-57b85d2657a4"
      unitRef="usd">37768000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i5c4e22f5dd7d46aab1223c60d287905f_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzQtMy0xLTEtNzAzMzQ_4fbc9e99-766d-4617-93f9-b21c65ca2635"
      unitRef="usd">36944000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4e8e2ad8db6d4f6c859bc3263d7c9235_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzQtNS0xLTEtNzAzMzQ_37bd1175-c76b-423e-941d-07aeb9ab0e74"
      unitRef="usd">20522000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzUtMS0xLTEtNzAzMzQ_fa11d9bc-8020-4e62-ac0e-72ca1524ce23"
      unitRef="usd">93307000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzUtMy0xLTEtNzAzMzQ_d8f99966-3e8d-4a0c-9ced-df33487b8103"
      unitRef="usd">97747000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo4MWE5ZjQ5ZTU1NjI0ZDMyYjhmNWEzYmY1M2Y0YWUxOS90YWJsZXJhbmdlOjgxYTlmNDllNTU2MjRkMzJiOGY1YTNiZjUzZjRhZTE5XzUtNS0xLTEtNzAzMzQ_3de582a6-f8a5-4821-a8bf-9d8f90890804"
      unitRef="usd">84287000</us-gaap:DepreciationAndAmortization>
    <us-gaap:NoncurrentAssets
      contextRef="i890c831316434ae1b18be3b1ae53a567_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzItMS0xLTEtNzAzMzQ_0c557ac9-83d1-42ae-96b8-ee38bcd91c42"
      unitRef="usd">202075000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ida4846630e6b4fe9abc8b036a5b0f2ca_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzItMy0xLTEtNzAzMzQ_93940ffc-5742-4347-a61d-70d25f611ba7"
      unitRef="usd">129241000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ida09061210f544b39381b92caca71c36_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzMtMS0xLTEtNzAzMzQ_0eb11922-4f29-46c9-a967-f6fc803dd760"
      unitRef="usd">68395000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i0134e8414f8c42618080f11b9286ca14_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzMtMy0xLTEtNzAzMzQ_30480b97-d682-48b3-b8be-b408a33f3742"
      unitRef="usd">82714000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i728903670b674bc8867059c6c7f26220_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzQtMS0xLTEtNzAzMzQ_a8b08589-3cf7-407a-ac13-3ea6eb1fa027"
      unitRef="usd">40415000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i5193ad1e9e4b4c359e874dfa2c7b2e29_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzQtMy0xLTEtNzAzMzQ_c74cde99-4d46-450e-a763-57edc30f0c7d"
      unitRef="usd">46527000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzUtMS0xLTEtNzAzMzQ_3fb9d4bd-e65c-4b80-bb79-31c4a8ecdd67"
      unitRef="usd">310885000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpkNzM0ZDNhZDNlYjc0NjNiODM0M2YxNmJlY2QwN2U3OC90YWJsZXJhbmdlOmQ3MzRkM2FkM2ViNzQ2M2I4MzQzZjE2YmVjZDA3ZTc4XzUtMy0xLTEtNzAzMzQ_c8562517-0941-485b-aaf8-d16bfe2df516"
      unitRef="usd">258482000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i273ad073c5694d79aed7c48a2228305a_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzItMS0xLTEtNzAzMzQ_836661cb-bcbe-4a96-a95a-bf6c7335dc13"
      unitRef="usd">251812000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i8b623f3420d9458a8f791677dd437cb4_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzItMy0xLTEtNzAzMzQ_d971440f-4672-4677-be7c-01d3fb2199e9"
      unitRef="usd">200927000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="if43262ae4db34a16abb1b00f16706fe0_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzMtMS0xLTEtNzAzMzQ_f9e4579e-88fa-42dd-8810-d10e407f1fd2"
      unitRef="usd">997000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ie84ef4886d9b46769afc2d9cb8935627_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzMtMy0xLTEtNzAzMzQ_6fe36737-1ed3-4f84-80e6-274b7a649211"
      unitRef="usd">1096000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i91c825bc7a7b400ea37266ab846efd90_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzQtMS0xLTEtNzAzMzQ_15ae29cc-2aa1-424b-aa74-d159a3636421"
      unitRef="usd">14587000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ia7897fa4a6b84510a657a7bf9ba065f2_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzQtMy0xLTEtNzAzMzQ_ac479eec-5085-4bbc-8941-f44d33acbf46"
      unitRef="usd">11989000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i94645cd7c7cb469aa8da2ab698ba7ca3_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzUtMS0xLTEtNzAzMzQ_5de83a81-421b-48a4-8973-396c116be6a4"
      unitRef="usd">26263000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i0b81c17ea1be415d9752a1ec535c0262_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzUtMy0xLTEtNzAzMzQ_f75f8d37-2507-4b0c-b1a9-98f7998b7dbd"
      unitRef="usd">28132000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i9f37dbe4585f4c288f1e4f7cbbe8a03e_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzYtMS0xLTEtNzAzMzQ_faa438d2-2f06-4855-bba0-6c2608098140"
      unitRef="usd">17226000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ic7b45150004748bb969ff69c5cac6d6d_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzYtMy0xLTEtNzAzMzQ_1b85ab57-a219-49e6-8947-5e725941676d"
      unitRef="usd">16338000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzctMS0xLTEtNzAzMzQ_c677ad82-56c8-4257-b467-7051800e74ec"
      unitRef="usd">310885000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiNWU0YTZkYzcxODM0N2JmYTkzNWQ5NDkyYzQwZDRkYy90YWJsZXJhbmdlOmI1ZTRhNmRjNzE4MzQ3YmZhOTM1ZDk0OTJjNDBkNGRjXzctMy0xLTEtNzAzMzQ_76eb8520-c54a-4876-a273-388eeeed8723"
      unitRef="usd">258482000</us-gaap:NoncurrentAssets>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i658880d6f36c48ed97500e003792583f_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzEtMS0xLTEtNzAzMzQ_80b83d0b-98b9-4f52-9566-0b7f9c47f421"
      unitRef="usd">842897000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1c3f7ebdb8d149b1991a542469a17c70_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzEtMy0xLTEtNzAzMzQ_684d762e-ef60-4bca-999b-31915c3fb58a"
      unitRef="usd">639322000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iebc032eb54984b4da6020c485a1829e9_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzEtNS0xLTEtNzAzMzQ_24548fdc-6b90-42dd-94db-24543dd5b88c"
      unitRef="usd">522607000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib37801b66fa64a738f993541669fe76b_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzItMS0xLTEtNzAzMzQ_b07d806d-c5ed-483c-8eb4-337cbd3d89a9"
      unitRef="usd">61295000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ied904893cdab40ac8e4ecf4261b0392c_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzItMy0xLTEtNzAzMzQ_623d6f07-d899-4946-b50b-734f3c50ba81"
      unitRef="usd">75562000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i54c7a18fd41c4b87addd14329d3b8eb3_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzItNS0xLTEtNzAzMzQ_95c8f740-3fe1-4cf7-92a6-2f950310cd1e"
      unitRef="usd">77676000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7f6c260335fd4fb6951eb3d58718e908_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzMtMS0xLTEtNzAzMzQ_8b2e011e-15b9-47d6-a60c-dedd7deb20b1"
      unitRef="usd">156680000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i437233f16d55490f81474cc61bd50d53_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzMtMy0xLTEtNzAzMzQ_8a36f604-b6cf-4e82-b782-af1029e15767"
      unitRef="usd">163520000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ied7abd5a64d44ec8be1482592153b618_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzMtNS0xLTEtNzAzMzQ_18dfae70-aec2-4e1a-950d-4017afd84bfe"
      unitRef="usd">159077000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib0ea7f7a83854a4fb04976b762a1d6b4_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzQtMS0xLTEtNzAzMzQ_c96aebd7-1ece-4a47-b6b9-e9da1022f1fd"
      unitRef="usd">104135000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i44db282af41942a9bc8bf049fea7b13c_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzQtMy0xLTEtNzAzMzQ_0dcfb2ff-3dbc-4784-bbc4-72c347b2ee63"
      unitRef="usd">110802000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3065d0c1ee844421ae0cb9af4f53bd46_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzQtNS0xLTEtNzAzMzQ_7e1b9b1d-c2a2-4f26-8380-7152698f685c"
      unitRef="usd">105820000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8760c4c6918543eabfca879c50151fc5_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzUtMS0xLTEtNzAzMzQ_2fd785d3-e699-44a3-9084-c1bb54cb7ef3"
      unitRef="usd">3653000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2ad75f10bcaa44d3870719c7728eee20_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzUtMy0xLTEtNzAzMzQ_6ed90a67-b9be-4f3f-92cd-72dc117dc8c5"
      unitRef="usd">3990000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic2ca668eb57a4e6ea2aa6d35644cb889_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzUtNS0xLTEtNzAzMzQ_9cabe911-1a95-4f1e-8008-0d124ef82275"
      unitRef="usd">5283000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzYtMS0xLTEtNzAzMzQ_dc9bc66b-dbb4-4e5f-bab2-acb1dfc9c8ec"
      unitRef="usd">1168660000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzYtMy0xLTEtNzAzMzQ_238ada8d-2220-48c6-b425-8d0219138030"
      unitRef="usd">993196000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTpiOGJjNjk1NzBhOTc0N2JjOTZlZWIwYTAzNzZmNDVhMS90YWJsZXJhbmdlOmI4YmM2OTU3MGE5NzQ3YmM5NmVlYjBhMDM3NmY0NWExXzYtNS0xLTEtNzAzMzQ_0f8b7b73-5af9-49af-a78d-969f2302eb95"
      unitRef="usd">870463000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90ZXh0cmVnaW9uOjFmMmM0MTU1Y2YwMzQ4ZTE5YmJlMzBhM2Y1ODI3NmI1XzI1Nzg_1fa65f7d-dfff-441c-ac12-fa0012206eb0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenues by product line are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.972%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.720%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,168,660&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;993,196&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;870,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <dei:DocumentFiscalYearFocus
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzAtMS0xLTEtNzAzMzQ_559042ef-5ac5-4d5b-8266-50477f88f380">2023</dei:DocumentFiscalYearFocus>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i77e56895100346f8967a4f2f2f7478e9_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzEtMS0xLTEtNzAzMzQ_4ae0aa75-8618-49a5-b937-d5ed3a5633e7"
      unitRef="usd">563734000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibbcb5690ee9e4cf58369fb43962e39d7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzEtMy0xLTEtNzAzMzQ_1bba2fb8-be1a-42e8-88fa-1c6a796ceda7"
      unitRef="usd">427611000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie082775b703647d2a596091af2b69615_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzEtNS0xLTEtNzAzMzQ_0747a6c4-45db-4cb6-b048-5918868cfe1a"
      unitRef="usd">414266000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie54d9c04734f4a3ca440be55cadea86d_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzItMS0xLTEtNzAzMzQ_08fcc5f8-3a67-47ce-8e94-5685c965b1e2"
      unitRef="usd">226819000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if8b3574a63ea41058d11dde501f4dd4b_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzItMy0xLTEtNzAzMzQ_382c84d0-3e30-4954-abc1-ed19758a1707"
      unitRef="usd">236158000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i57d49f4f72de40b6b6dcbc6a662b5afe_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzItNS0xLTEtNzAzMzQ_5e89630b-bc7c-4220-87e9-d419bd83a310"
      unitRef="usd">239614000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i831da503c99a4196bacf1bd7aaa8e97c_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzMtMS0xLTEtNzAzMzQ_26ce98c7-0acb-48f0-845c-b8de5fbc28b8"
      unitRef="usd">378107000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iba74e960f8174b6eb6f8237d8ec75488_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzMtMy0xLTEtNzAzMzQ_6d097f31-8298-4a1f-8b69-9b10045da37e"
      unitRef="usd">329427000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibadbeb7294884727ba79dd447d78e637_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzMtNS0xLTEtNzAzMzQ_749d324a-e468-4b49-90ff-bee533eca234"
      unitRef="usd">216583000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzQtMS0xLTEtNzAzMzQ_7fa9a88f-5119-4653-99c8-b753dda4f37a"
      unitRef="usd">1168660000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzQtMy0xLTEtNzAzMzQ_e62961c5-d66c-43d0-9964-b4bcd9abebad"
      unitRef="usd">993196000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iff466f709be0458d96d07670e8506c93_D20200329-20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNDgvZnJhZzoxZjJjNDE1NWNmMDM0OGUxOWJiZTMwYTNmNTgyNzZiNS90YWJsZTo5MDA1MDc2Zjk0MWM0Nzg1OWI0MDQyYWZiZGNjNjQzYy90YWJsZXJhbmdlOjkwMDUwNzZmOTQxYzQ3ODU5YjQwNDJhZmJkY2M2NDNjXzQtNS0xLTEtNzAzMzQ_d0e60f58-55cb-48ad-865d-0b9791b7b88b"
      unitRef="usd">870463000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90ZXh0cmVnaW9uOjQ5Mzk5NGMwMDU3YzRiYTY5NzY5NjY3Yzk4YWVlOGQ1XzE4Nw_20c207d2-f486-4bcc-85f1-af707a927965">ACCUMULATED OTHER COMPREHENSIVE LOSS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a roll-forward of the components of accumulated other comprehensive loss, net of tax, for the years ended April&#160;1, 2023 and April&#160;2, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Unrealized Gain (Loss) on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, April 3, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(560)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,459)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive gain&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive gain&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(33,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,075&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(30,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Presented net of income taxes, the amounts of which are insignificant.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90ZXh0cmVnaW9uOjQ5Mzk5NGMwMDU3YzRiYTY5NzY5NjY3Yzk4YWVlOGQ1XzE4NQ_1d540fee-6bd9-4d39-9ade-89324fc38685">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a roll-forward of the components of accumulated other comprehensive loss, net of tax, for the years ended April&#160;1, 2023 and April&#160;2, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Unrealized Gain (Loss) on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, April 3, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(560)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,459)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive gain&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, April 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive gain&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, April 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(33,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,075&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(30,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Presented net of income taxes, the amounts of which are insignificant.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1d9aaac5c08240e7ac639d3d9318182d_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzEtMi0xLTEtNzAzMzQ_dfd29e12-4e73-474e-974f-0935d711829e"
      unitRef="usd">-21528000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i20163d468f534459b8f5e133c39e76bc_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzEtNC0xLTEtNzAzMzQ_41b385fb-a6cb-47cb-a5ff-d18626d68556"
      unitRef="usd">-560000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i258a2ee961ae4548a116f4702808d630_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzEtNi0xLTEtNzAzMzQ_982befb9-dcb6-47ef-b071-ba8ae643a985"
      unitRef="usd">-7459000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i55d8dd9a076e4419bc59c7dbd0ee0cdc_I20210403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzEtOC0xLTEtNzAzMzQ_7c028e5b-f7b3-45f8-9f91-898eb2fa0ba9"
      unitRef="usd">-29547000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if9661b76a961497bbfd87ed0b21aa594_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzItMi0xLTEtNzAzMzQ_2a14fd48-6e04-4f7c-be99-5750a65e158c"
      unitRef="usd">-6391000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibe8f263a99854b0f83abe062df3af1a2_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzItNC0xLTEtNzAzMzQ_73ccf0af-f433-4a9f-b04e-549369e1a602"
      unitRef="usd">2179000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8e8bc4e14d294ed18a1106b9bfecc30d_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzItNi0xLTEtNzAzMzQ_a45c5398-4b02-4825-a468-a2b7be012c2d"
      unitRef="usd">5785000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzItOC0xLTEtNzAzMzQ_b7884643-abfe-4f10-af1e-0cb09ba09057"
      unitRef="usd">1573000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if9661b76a961497bbfd87ed0b21aa594_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzMtMi0xLTEtNzAzMzQ_704dd97b-5686-4dff-b2d2-2aef5dfe362d"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ibe8f263a99854b0f83abe062df3af1a2_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzMtNC0xLTEtNzAzMzQ_703ec232-2d65-4634-95b9-b5527fa6bf96"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8e8bc4e14d294ed18a1106b9bfecc30d_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzMtNi0xLTEtNzAzMzQ_bd16f397-2250-43ad-a896-d43041c69cef"
      unitRef="usd">-2020000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzMtOC0xLTEtNzAzMzQ_82968885-d495-4aa2-9c6a-f8e9b737326c"
      unitRef="usd">-2020000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if9661b76a961497bbfd87ed0b21aa594_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzQtMi0xLTEtNzAzMzQ_d3d6c12e-47d7-4f0e-8b6a-b78b60a9566a"
      unitRef="usd">-6391000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibe8f263a99854b0f83abe062df3af1a2_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzQtNC0xLTEtNzAzMzQ_f684093c-aad7-4cf5-b591-5ae9d3dd1d7d"
      unitRef="usd">2179000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8e8bc4e14d294ed18a1106b9bfecc30d_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzQtNi0xLTEtNzAzMzQ_5d326671-6dfd-4e19-a64c-065740203fbc"
      unitRef="usd">7805000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzQtOC0xLTEtNzAzMzQ_317cf17b-68bd-4829-b568-b1b131afbb96"
      unitRef="usd">3593000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie871fb22a3cf4c40ae275a678c22a4c6_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzUtMi0xLTEtNzAzMzQ_cc7d8c90-f84f-4e99-a0a0-00dae6764841"
      unitRef="usd">-27919000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i212720196aab4e27b97320442307e199_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzUtNC0xLTEtNzAzMzQ_7cbbe36a-e9f4-49cd-9cce-c9a5dc2d8a14"
      unitRef="usd">1619000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3f4e6fa1de00426ba9dc50efcffee0dd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzUtNi0xLTEtNzAzMzQ_762a3cda-9a62-4bc8-bc09-fe18f4bf9ccd"
      unitRef="usd">346000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ica07a6a12db04420a640cda640d48dcd_I20220402"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzUtOC0xLTEtNzAzMzQ_53419278-8ed4-4684-8515-5c7bf1a594de"
      unitRef="usd">-25954000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib8ff71c228644456aa078f7b405de97b_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzYtMi0xLTEtNzAzMzQ_24c2fb64-3011-4e7f-b1ed-d34e35dcf8f1"
      unitRef="usd">-6016000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4888ce624cf2491996b6ac5702a159b1_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzYtNC0xLTEtNzAzMzQ_a13c8bd3-aa1c-4dfd-8365-2e4e3091f244"
      unitRef="usd">2456000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie331660e8b3c4a1d855c3ea8e8032707_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzYtNi0xLTEtNzAzMzQ_94759783-c5ad-4ca6-9f38-939a7f7a56ac"
      unitRef="usd">4269000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzYtOC0xLTEtNzAzMzQ_3b3a2cbe-935f-4e32-a1ee-d9925f7d88b8"
      unitRef="usd">709000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib8ff71c228644456aa078f7b405de97b_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzctMi0xLTEtNzAzMzQ_78591574-3982-450b-a666-0673b39cf595"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4888ce624cf2491996b6ac5702a159b1_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzctNC0xLTEtNzAzMzQ_9f7e6c48-a756-4261-8f29-0030beddf93e"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie331660e8b3c4a1d855c3ea8e8032707_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzctNi0xLTEtNzAzMzQ_84535cc0-2dda-4baf-b8a0-c4213e77429c"
      unitRef="usd">5136000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzctOC0xLTEtNzAzMzQ_4ebf390b-21ae-4295-84b9-8c42ceb624f4"
      unitRef="usd">5136000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib8ff71c228644456aa078f7b405de97b_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzgtMi0xLTEtNzAzMzQ_53652ffb-dac3-4cc0-a0d8-75f6ed5b3aa4"
      unitRef="usd">-6016000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4888ce624cf2491996b6ac5702a159b1_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzgtNC0xLTEtNzAzMzQ_da151c6b-2412-485f-827a-535fedf0eced"
      unitRef="usd">2456000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie331660e8b3c4a1d855c3ea8e8032707_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzgtNi0xLTEtNzAzMzQ_61df5411-d37f-4501-858e-20a120cef5a8"
      unitRef="usd">-867000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzgtOC0xLTEtNzAzMzQ_44f38c40-23b3-4b2b-b2f5-1ab91e3d80c6"
      unitRef="usd">-4427000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i93a31928c3f04bbe9786669a94886e63_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzktMi0xLTEtNzAzMzQ_44983278-a943-4097-bc4d-018a27b6c41f"
      unitRef="usd">-33935000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i31840d7f9a0f42fb8999b7022a505464_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzktNC0xLTEtNzAzMzQ_84cb6e7f-64ef-4bb9-b9c3-df959ec7bff2"
      unitRef="usd">4075000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib7b16ebd9bdb4cd58a89613d51ab905e_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzktNi0xLTEtNzAzMzQ_15fda8b3-f96e-4ad6-a457-13e7a395172c"
      unitRef="usd">-521000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4c45fa2cfd044c32806ebad955872fa5_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xNTEvZnJhZzo0OTM5OTRjMDA1N2M0YmE2OTc2OTY2N2M5OGFlZThkNS90YWJsZTpmYmNmNTdlOTM0YzY0YzUxYWIxZDEwNzA5MjU5ZTUzOS90YWJsZXJhbmdlOmZiY2Y1N2U5MzRjNjRjNTFhYjFkMTA3MDkyNTllNTM5XzktOC0xLTEtNzAzMzQ_d76ac699-81e7-4240-9a77-6a789e1db715"
      unitRef="usd">-30381000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <dei:AuditorFirmId
      contextRef="i09227d97ca0f437ba5950fed30790726_D20220403-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YzlkY2ZlNDU1MzRkNWI5NjAwNWViZTgxNmQ1ZTdiL3NlYzphOWM5ZGNmZTQ1NTM0ZDViOTYwMDVlYmU4MTZkNWU3Yl8xODcvZnJhZzo1OTZjODBkMWJkZmY0YjVhYTFkNDQ0N2NjNDI2YTczZS90YWJsZTo0MTJkYjQ4NjFhNTg0ZDA5OGQwZjc3M2M3YjE3ZmM1MC90YWJsZXJhbmdlOjQxMmRiNDg2MWE1ODRkMDk4ZDBmNzczYzdiMTdmYzUwXzEtMC0xLTEtNzAzMzQvdGV4dHJlZ2lvbjo4NDY5Nzk4YmRmZWE0ZjVkODllZDllMTA1M2RkZDlkY183MA_b73c1d8b-2060-4269-b47b-6314a7e06d44">42</dei:AuditorFirmId>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>102
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" "(@+96G+;G.Z,'   N+P  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;+6:;6_J.!;'OXK%C%9WI+8D#A3F;EN)TG8'S2V@TCNCSFA>F,1 =).8M9T^
M?/L]3@(AE6.2E>F+DJ?S)_YA.^?OG*LWQG^(#:42O<=1(JX[&RFW7[M=X6]H
M3,0%V]($SJP8CXF$7;[NBBVG),B"XJB+'>>R&Y,PZ=Q<9<?F_.:*I3(*$SKG
M2*1Q3/C'+8W8VW7'[>P./(7KC50'NC=76[*F"RJ_;^<<]KI[E2",:2)"EB!.
M5]>=D?OUSANH@.R*/T+Z)@ZVD6K*DK$?:F<27'<<=4<THKY4$@0^7NF81I%2
M@OOX;R':V7^G"CS<WJD_9(V'QBR)H&,6_1D&<G/=&7900%<DC>03>_N-%@WJ
M*SV?12+[C][R:WN]#O)3(5E<!,,=Q&&2?Y+W L1!P-"I"<!% /X4X'HU 5X1
MX'T.Z-<$](J 7D8F;TK&X8Y(<G/%V1OBZFI04QL9S"P:FA\FZG=?2 YG0XB3
M-W>S\??'^^DS&DWO$'Q.GE_09/HP>WH</4]F4W2.OB_NT)>??[GJ2O@Z%=3U
M"^G;7!K72+L8/;)$;@2Z3P(:5 6Z<)_[F\6[F[W%1L71EE\@QSU#V,&>YH;&
MYO!'\H'<86WTG3EZYLO]EV-#8[P]>2_3\^K(,S^% 231* F D SE!YHD^4A6
M(^+OT5)(#N/B'QWZ7+NGUU:3Q5>Q)3Z][L!L("A_I9V;?_WD7CK_UF&S*79G
M2:S"M+=GVC.IETR?/[94A\T<[CKGO^OX&*/:\K$D5N'3W_/I-^,S2I*41.B)
M;AF7.E!F'<E3'=ZQ,:HM*$MB%5"7>U"7S4#-*0^9&I\!@OE5VZ?,2MF<E<T;
MM;.64: M-4MB%6J#/;6!L:WCE',%[2$4/O2N%TJXD9Q9[?S<Z9T[KHZ8,; M
M,4MB%6+#/;%APPF+$\BELHF_?E":M58D$MI1:0QK2\N26(76KWM:OQI;6#PE
M'\*(HFD:+RG743)K.(Y[[O:<GK9?&4/;DK(D5B'E.F5>YS1A]437H4HCH(M-
M2:P=A4>$?AO=/\ZF]\^3\0*-9T_SV5.6&>KPF97:\K.E5@5XD!B[30!.$I]Q
M&)!94G:&%A+F,L0X&K,TD?P#/@,]5;/ZXT@+T!C4&J EM2I 7 +$30 ^DW<T
M"6"."U>AGZ>V]6/WB"0\$/!PB/% ^QPU![>F9TFM2J]T!ZXQ4=[1&P4!J(NS
MW0;Z!M>A6:+O<V9)%_?1 OP]Y="-.3C&,RU%JV[ EEJ58ND'7'-&_YGB6.W!
MZ'UF;XF6H%GNEH$A3_38K)H$6VI5;*5-<,WY_6=L^UEOSMEKF/CZWF?6K)GQ
MK%H&6VI5;*5I<,VY_F=L<^@ND ?_%6[K'Q-F10>[KJ/E9M4TV%*K<BMM@WO$
M-V34."7UF,P"7P9#5[="-3;'M<9T"JO@EE[!-2?XWYAR5?,-2TSI[Q&186]X
M/G =?:>RZA1LJ55IE5[!-2?ZSZ$$F\!6R,5?EK^@!?53#OU,B\RL-&9Q#%D+
M3/W^CS/T\X7CYK>Y!7O[2J*4HBT\4L6&<*W],JNWIGH*6X%+6X'-;@!\:A F
M:[3XB)<LTL$\(@!V0KMR:]4ZV%*K0BJM S8G][N^AN[?_0U)UK36>QT1FKXL
M]+2L^@1;:E5:I4_ C7S"GS2*SG\DD)C!6"4")KD 381(];/<$<T7*K3<K#H$
M6VI5;J5#P(T<PA\L B=*>+XNPG7MOCVB-&5:6%:-@"VU*JS2".!&1F"W0IFO
ML643&:2VJ1Z:6;&NBUGU ;;4JM1*'X ;^8!)(BG/W]"JM5RRPZBE9E:LHV;5
M!MA2JU(K;0!N9 ,6,8DB=)L*."WT/<RL4[N@:XYK3>L4R3\NDW]LSMT/%G4Y
M&H//7#.NS=*.Z'PC'!ZT(]^G( 0R02ZIY6?5%=A2J_(K70$V)_0%O_N8\K6:
MT/X#"G(#3BK>DD0/\O]\CV".:XWM%/8 E_8 -WJ7L-A VF&$99:IAV4UZ[>E
M5JU4*+-^SYRT3\8/3VB4!J%D'(VDI$+F*[D/$5EKRQ/,>G7OC\UAK2L13N$"
MO-(%>(U>(,S3913Z0(H1[0/3K-*ZE,.J,RC4^IF:*B%[O?$&N(\'GN/AJ^ZK
MCD^9]WN-\O["72]R=[U0+EJ@62JABR7*:FJ9V<SCQX7:Y4$K^TZ_YPP&SKZ-
M!8]39/S>0<60.4_?O2T6!V^EX#FW5*_Y5A0R,OW"[!'5N<J$62+46HG<4%4U
M%R9AENQM.7O_0&JPT^PM]0J&/TOYKGSDD=(LAX; ['?;L"@ !X(D0TN*8&8-
M$/RRHW2="IECZ.755P@N1N&G-O!=&^ ,FA->A$PFD_S.0@&7J+3]0OLCVBUB
M.H5;\4JWXC5S*\"< ^=)$M!W]#O5/J".2#GPY[F>V].^,C,'MZ9V"K?BE6[%
M:UC==%A_\@ 'M<GW$;&Z8AUS6&MBIW J7NE4O(9E3@6QHMJIGIE9[N%%2\RJ
M6[&E5B56NA7/[#)&@"O(D=6E/F:!VH31'-<:DU53TCTH,%8^(RO4%LA7-1!Y
MK?'^Z+X8?)250'?+R_-*\D>B;(I $5U!J',Q@!' \^+L?$>R;5:NO&12LCC;
MW% "SQ5U 9Q?,29W.^H+]B7R-_\#4$L#!!0    ( (B ME;:OXNC3 (  +T%
M   8    >&PO=V]R:W-H965T<R]S:&5E=#(N>&ULC91=;]HP%(;_BI5)O:I(
M"!_K*$0*I6A(A2+:;IJF79CD0*S&=F:?E.[?SW8@8U*(>D/\<=[7SS$^9WR0
MZE5G $C>>2[TQ,L0BY'OZR0#3G5'%B#,SDXJ3M%,U=[7A0*:.A'/_3 (ACZG
M3'C1V*VM5326)>9,P%H177).U9\IY/(P\;K>:6'#]AG:!3\:%W0/3X OQ5J9
MF5^[I(R#T$P*HF W\>+N:#JT\2[@&X.#/AL3F\E6RE<[6:03+[! D$."UH&:
MSQO<09Y;(X/Q^^CIU4=:X?GXY#YWN9M<ME3#G<R_LQ2SB7?CD11VM,QQ(P]?
MX9C/P/HE,M?NEQRJV/"+1Y)2H^1'L2'@3%1?^GZ\AW-!>$$0'@6AXZX.<I0S
MBC0:*WD@RD8;-SMPJ3JU@6/"_BE/J,PN,SJ,XI?9XIDL5O/'S3)^7CRNQCX:
M6[OI)T>+:6417K#HAF0I!6::W(L4TO\-?,-30X4GJ&G8ZA@7JD."[C4)@[#7
MXM>KD^PYO]XEOS)E2!:B>L/V,?R,MQJ5>1*_FO*MW/K-;K9,1KJ@"4P\4P<:
MU!MXT=6G[C"X;6'MUZS]-O>*52JRHAR:V-K5]TIH)%>4%[?DARS%GCP\K%NH
M!C75X$-4#S)Q%]A$UNXPE>8MBVNRI%K3)"LU(.H6LF%--OP0V9PI3A:S)K!V
M@W[81.&?E10'M7>-0Y/$W"E6U56OUKTIKDKR7WC5V)94[9G0)(>=D0:=S^:B
M5-4LJ@G*PA7H5J(I=S?,3'\%90/,_DY*/$WL 77'COX"4$L#!!0    ( (B
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MQ8OZ<L-HRD0%T.]7G*O7F^H#[:GT]#]02P,$%     @ B("V5B\K,^#Y P
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MNEQQ!O"- +R_%]"3-S?FV_3V?Q'S_P%02P,$%     @ B("V5B/!<T8@ P
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M>(<R.+L Y]0,[B[ E0)H<"# VP5X4D!P*,#?!?AR2<,# <$N() "_$,!PUW
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M&&@SW>\=OO'J2=WIR\52FO0^A?*1JNXG!-V;IMRTE^H?RZ8IU^W+E>"R$E(
M^?=E*8N[_HWZ@OT/.2[^#U!+ P04    " "(@+96\0O9!?(&   ,$   &
M 'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;+586W/;-A;^*QAUIM/.J)*LI)=Q
M;,_(CE/[(8G'<MJ'G7V R",1#0BP "A%_?7]S@%)TZF3W8?=EU@$SN4[MP]
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M1H,3W#2B],D&D\)9S',1"+,>X,DT*'$>$?%(.Z'VTZ[0TZ[;KK (]YSDFVX
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M;S6F'C6SM(7J8O;SCQ,5\MLS?R3?R'MOXQ-(7G[B.$;Y60#[6^]3_\$.AO\
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M5+<H$ZF=%?^U!0)SM"4D+MYI+<*SZ(AL9,OX.XR$GRLPQ$JX8< "P)R0:+<
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MCEDQ\6JY[%P])W^1/87@G%Z ,3@C!A/RDJ,Y$'\+B&$]^8;-]0AV(CR-"K+
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MC\0+F\A4WB*YSF<AYS8;F$DZ)<1S(:YQ/MCT\F@V*B\+H&NAJS<V3$'4 YT
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M2<S*F,K1$ 020E*2_)1=3AEYDWF,2=DI1F:8$4 GIN7.S]- ^EI0@TBR5'S
MU &;([%2#0JE#MQ983#0-%<SZU C:AP*JYBE%.9B+N; 5*B%(6=MV.-FV*/W
M\FON.6;9M82:)TFH]:XKX^PP?:2RZ+'&F=8?-%[JP)!@X%&QYSLB0[EE1NLS
M0PH;]8!YYU[5<&3#+SP\N<FJTOQRV3/8L25[CT-G0QI[:8$PY0*=Y=@?H-@\
MMHX )_(BB4?SPQZ2C:9/>DAV0-G0\E*;.NP.49C,*B,:XQER7GOJCL\!._2+
MRP_7(DOC",.F#A/7&^U:@PH,P'J_P" >)J:^2W/(CYNC\TI27UO2-([@2?=2
MD^.&XWJF92MUF.6HX=2<:(XUDL%34L6#<[U]VF">=-:RG_U_N+Z/.^__9YW/
MHOF<V#V91<6$J'8.3BR^7>I@?E#@+,GH*IW^7*FCS',0<A2C>4VB8C;9EWL2
M1\6<F3Z+\GE&*ZC]9,;)X/J@N10IV>7C)\>B!26?7MS";*)6Y,PK<?L,K%\.
MXDTMW482069%X,>,[<[R3%S5B*RXAF34Q8X33ZB]XFU._&%<J\G;9)J+D_GD
M5$Q2ZJ$69M'XG:/%($#97&33V8L\>/N"HS]H/3I?D8?TQV&P*&;QL0-H]WD^
MI1EB/G\T/L^F8C*;(ST'IA>@;^S,HUD^H53.)MD/9)8W_%P:<1CV($1#FHZ*
ME,7ET72:B.<^KHP//H3AE6K%G_N(,;K&AV]B^]7]%\7+\"'M<7OX'(F1; 6>
M$K5:XF@\FN4#O)OQ)[YPXTW+G]46QN/]C2_7(#5E:0.>+XWQNQM2L/_.>O$_
M4$L#!!0    ( (B ME8QAZ)0FA$  )HT   9    >&PO=V]R:W-H965T<R]S
M:&5E=#$R+GAM;.U;;7/;.)+^*RBO9RJIHF6]6YZ\5"EV,O'5)N.+/=FZNKH/
M$ E)F*%(#D':T?SZ>[H!D)!$V=FMW;O[<%\2B0(:W8WNI]_HUX]Y^;M9*U6)
M;YLT,V].UE55_'1^;N*UVDC3RPN5X9=E7FYDA:_EZMP4I9();]JDY\-^?WJ^
MD3H[>?N:G]V6;U_G=97J3-V6PM2;C2RW[U2:/[XY&9SX!U_T:EW1@_.WKPNY
M4G>J^K6X+?'MO*&2Z(W*C,XS4:KEFY/YX*=W8UK/"[YJ]6B"SX(D6>3Y[_3E
M)GESTB>&5*KBBBA(_/>@KE2:$B&P\8>C>=(<21O#SY[Z!Y8=LBRD45=Y^C>=
M5.LW)[,3D:BEK-/J2_[X43EY)D0OSE/#_XI'NW9T>2+BVE3YQFT&!QN=V?_E
M-Z>'8,.L?V3#T&T8,M_V(.;R6E;R[>LR?Q0EK08U^L"B\FXPIS.ZE+NJQ*\:
M^ZJW\ZM___7F[N;^YI?/=V+^^5K<W7^9W[__^>9*W'S^^O[N_M/[S_=WK\\K
MG$4[SF-']YVE.SQ"=S 4G_*L6AOQ/DM4LDO@'$PVG X]I^^&3U*<%V5/] >1
M&/:'HR?HC1K)1TQO=(3>N]K@B3'B*M\L=";)2(SXS_G"5"5LY;^Z9+84Q]T4
MR7]^,H6,U9L3.(A1Y8,Z>?OC7P;3_JLG^!TW_(Z?HOYV'O]1:Z,MFS)+!'Z4
ME5KI6-QD#\I4<)7*='']#-WOL@"Q<_R5+!/](,4GE>A8IA$XB'OBETS\F\QJ
M^+887/ ]X;:JM2(-%S+;"C"H2I4(G54Y1!#S5:D4L<WRW*9XE"]!M%RI$GY0
MK8\<].+'O\R&P_XK]RM_&[QZ&1%-G27PFG)[E@*B=+:"LV3U$A=:ER *\@_2
MQ'4J2Q&GN<%#8;:F4AO#SDV\B3N955)<88V,P$&J@7V9ECT<+N(\RQR@,(/5
M6N,V6MU$XG&MXS43!S4L^R1+?!]TZ8/WD4(&_?X/Q!O]J(VI\8@T A U%3Z0
M&&8M85.T*):%KF0J@ WQ[_3 *PELBBJGG\"ET8DJV:AIR>EX=MF; 4#2-&22
MED'XA);4Q;*$QXI";MF22!/$CUSAEE:P-$MG.NE-/!WQXG0\F/6&S?<,480Y
M-.M&N)<L"E%:2EU"_6G-I'!X!<'H]@_9'8Y[(T^UUP@HX[56#\I2.[H?Z*@W
M]88$@0*9W&C2Z[?"XXF5GYF"ZZ=>:/$H#?8GBH1?:@.38[CIB?O@VFA+%CLV
M@KO']S*O5Q ='#68XA42B45>PN?!LQ$U0+$4&EHNU4.>/M -QU"6KJ"E6*>Z
MVK+:8- R29@Z6#D=3/JM( +.M!%ICC4M.?4-%]I!K5$B.<O@XI4115Y6RQR$
M(&N<U@F,JWK,P2JD N4SZPZ-M\@X)K"$I*KQG$0]:#RUVODZO[N:7[\7 +R+
M\:MC;@;SQC:C5QF(D\$Z5S8;F:9GT)!RWBR6:I.7$%J6X$;3!^CC065Y;3S-
M2.#Z<>UINA6U<UY-&(-E3F4Q29VG^<KJLP"I8DU;6@:+,L=E@MR>()^^WOZ#
MPFQTLB/*!BF"/G,:]'(]+PJG+F5>K+?&B="R&K$X.)]L,,^PZ]?>74]\R',+
M'==EO1+S!!F#IGC&ANAA\\/UW$.FD 5HDDOMWBE+ S[P?YJRS5I-REC(16K)
MM<S B,G7:169$+9"1!6:C&&T=(ABY$9!?(/<S&K<F[B'0'\#K8DB7M /'W-C
ML6_A@W>=P<@; P9+21U7]C2(L@$P<)1,Q +J79*'D'94MB8/Q@8\]>KAJ$2G
MX*)7BM>MK+\^8U2']X3\]G>%9%G<U@!_.)*X+4FK<R@SMJ?=[\2!.*^SRAG1
M/JH$" ]TDJWL <@X<\B85)F0<%8''^9W[P34*>[S IG"K#^)1'?F\Z)=(A!*
M2T6$/,CAKBK3QBLZ+-5R0="BH4;\7F_H>47+@?(PBD)QPAV@/JWS5QP*F.""
MK"&TUB8WI!&R+$ZELJHC@G"T3.A6EN E_7XV2<M.I3^)%S=DE7!%K#8O=\,U
MLI[8\Q$K+*=33L5%-.J/.>N"R91$>3"++J83W+(JI(9%?(-A&66-+0>?0(ZZ
M+#G3L3S.)GVL1FU55MM(%$A];!)$CE1P*!I$@]D4AR !6.E NN&D'TVF??$S
M7/T1D0 /1M%%_T+\PN>D>;8ZX\C@U@^BV72&NR6WV5?0J9B,QM%PW&\%121D
M*4?1\')(CTO*1O"TQ-TPBZ5*V:/BW&#]9!8-!P-_>*#L0739'XEKM50E'57)
M;\W/6S&<1A>7HP.6=_=?7 P=WUV7>"HN<<3%0'Q658=@X_$P&DXO=_PLH< &
M2'16O6,[^D#1C\A5R<>*5)&XE8K7&;MWY HS55I=D/NL=0%,!I0 =.#\QOGC
M&8.D(?LQBBV+G@-C40W;:_:@?'/[Y4>Y*5Y=>VAV'A%X#TS^")<V5L.5:*7%
M%V97_U$[Z!4H$#2*6&>3K,3".K[CAC!R&Z:G/?ZP+SQO;YBUQS-_B2!863$%
M]8V%AL09ISL;!0]+0+!3;T>()!2Y]**N*)XX O>M@KLW@;!62X%4=B/*?"M3
M&%NSF;)&2DV7 !G3A%G:UNK-X\HSBF[5R600.0I&>-H+*\B,Y"*!:P:GX$ N
M]C51VNLH"K"<^!#7,$C![#=;:IBH:Z-E2&7QFL--8N^Y)(=3A/^.H-Y8^J5+
MX4N%4BBS&MKC%F$[46F3KS]R2X-P] &9R4JQQX<5B%M(.>IO-=<1.!,,4#ST
MMR$Y")3:_-Y /^G3WH:S$_=#X8.E5272$AL,]VXB>LYQ&P-7N_!/R7T3UO!Y
MY1"T)^845^&BR-.Z E0;@7?K-R*VRO2?(.=IV>IE,NI=[!=;5"=6UJ"9;W<]
MR/]55MMTH_/N290\U@RY?,,=D*2=6[.5!. "9I8U5;ZA U=KA.DDQY8LKVS!
MX-W !ZG6OPM=*.H8V/MJI-1V,Q2)=(MUSYD+,!Z76.0^]-E08:CP!RPC2=W/
MXQ OD>.Q/HQ:$<^]CI#7P+HK6/T=->G"012?<_H@_N8L^&SN+!C/RTK_:5W]
M%L4 TN4OL,VSN;?@:^]DG>!W*H8#BHQ],1B)+? -<6J$@OB'8]"&Q& PG8K!
ML%W=Q^H QR;1>'1Q0*Z] 9PWG5Y *PGRUXS*K\'$TN#0>-HD!/=[EFG-/(BN
M26<LCJAJCZS=3ML> 3DA&-3IM@GXU+3Q-]&!C[:E(#,RC(5RMN%SVL RD.Z@
MIM-<ZN3+)393X-EASI'L9(%[# 47^P!45"UL;(ZO7MBG.OOB=EUQIL*5AK4+
M"!OX]]EN1H-JHF9.]AUO'Q8(3TXO>]-&93Y[=YT#NE"8/K=OYI E15+%:>5N
M.Z$]+Z!M60G$3M7*(:[-)X$02V"G+4B62K7]FD;$TVG 6T<W813T$K \48O*
M]3:XWF,..(56W%[@0^PM<^@)T ]'HY@#3JR:.M8>&!2@#\H!LZVF$$!]FBSR
MS'=T#*J]A$4V%?ZSC2C.>X!Z*@KJBA3YR:^9K"$.5B.5%MRE%Q^L &#@)K,S
M"Q+/%U#4-&((IH!HD9?IGUZT@.V-K/F==6#MS"Z=[B^U[#7W7UA@*2A<=O6'
M.HRA;D3QF45"5RQ8!!>:R"&X%N)REL*$*WQMSK5<JKCJ++!V*T@-==I.%RF<
MAC%5V*D<<>TSN.34I>V![;4N&Z/-\@R&@,]L,VLJG=M UZ8UQ\*IM2=9JD V
M_9WFX/2MC5,X:Q+FY+GPVCGJZF1/E:WJQ2+/:A^VC*)P03F4;X9&;8KC+[GQ
M3>"5T[UGH%LG[#*<&]GTPU*T,CDMM3?>I,[[5T['![<"P&L\.MWR'9F0CJ^C
MU\CA0 &Y&G92+PL4(]^OA0@0< FO=$RUV;2UN\" ]C*\ $\<8.R!9E"RAP+;
M*$G'4/^Q*:0C@(WTU]"1V;'U[MO36L)\8V>/!W;L@,B+U8!/VV%H,38(E8LJ
M+)+X9G&!Y#59+JCEA_PSIJH=^;4D9>S?H*?O](HL?^O5ZIRH:<6Z_@_]7,#B
M8^U;D:;&-C9[ZE$WI'6 ; >08-A$@B6TU2=EW"ED$T>NE-(>0:-<<CFXVV]U
M%HPV\KH4<"ZZ&+*V90.LK2]:+@]Q*LDY/6P<D'I<D"_6A77F+4($)ZW@U(8S
M"@7Q3I_N$,=ZW*4H*9XZ4W\&-EN60XTU>B(6,T45B$TR=$9#)HY4/"*0SL3C
MJN94M?$%EWY0<NZXM*TXQA6Z6JXV6,&MWY&5/@',C0';'MFN#<-3H2E"$%#8
M9]1E^)W\[5]06/>W?F%=T@*4-+ 8=CGZF;K#"%94.MH9 PNKR[C>T&0J]NV$
MDCH5K"?HD:P6:39=IB^70_V[(H,,\4'JE [K[>?O+YK0_M(VXCZ' 9E:/]-H
MVK>/73"@7E8TFXW%Q_D=U1#(1Y2].=]GHX#F!Y3/#R=E,YQL\UX1@XYT4X:&
M?N'IYX^9[:)\5)M\#K/:BCLX,P42TM)]6T>\N*O_A+0O<7I/_+5*>L!?<;6&
MO9Z1./#6TH4I9LZU=QE-ELC:N:AZ$>?, B=#D9\]-$<W+7Z^N 9\@,:DH <J
M<X!\\)I8)%JNLMQ^M".=J(%%2;3L+2?: $7HOLQN!@L,>M"XNW1/BRCOT]J0
MF;9#6&[N6F(V1^#DU.O:-:M:_0&Y3"WM);@ZNH(KF8!V234>AU!H"Q48.3RR
M4K&C"<99$MP)2(C'^CXRU=WIB^P:"IW.#-NV#YBL"_IT.IB$P[D\D,+":_>X
MLO$1;UM! >_2Z%WMV0TX!Y"79W07;:)F:T@:6?)&?!CN,L_#S69O.^SE\J]W
MN5,NX,&D[6*$J7>T7P=PK>E&/(=ANRN_7\B4,RQ^=:7)G)H!CJQ7&]_UWP^7
M[5@(7*^A9$"1H?8*0MWV3U7N#)NZ1T8]&*H&V^+GS>(CO;A@4W+;]N\?F=)+
MV][AB5LPF:>6/3G_<H>F[^O:9^TK"K1[_Y6$JS2OJ()QTT;"@DP]NDK*6N4Z
MASH7*8WWXERNZM1W>6U6X^:1W-J!)CH@UM5HE+>]KPFPI+WDN=%2W,J8TAD_
MMXJ>?)5@V _-XGO>)*!=@_UB].]\(V#4&J?KY!Y9W;)$\=<*(9N7 O@=AI!_
MQSDSV3 <Y(0V9/-[![ZEYATU;-V5BN\D1V@)/7/.=$/C&AV""?LDG&T45N.'
M/NIFI;OI Y<_3X.Y]R7SKW.F?]*8T_G/_T\Y_VE33J?1MF6<V!@25)"'O=,0
M"ILI)_4^IZ.Q&]GM33.GL\DST\SA[+*CL3L81_W+8)0YBP:3T=%9)7QG-AGL
M<1!*3H<<&3B.HOYH^N0T<12-AI,CPT2$A,EP^C\Y2[1I=3M0W)\&/C&GHN2H
M*8;:R9A+DSFE!Z!%#0AW3QV88S]Q:@C)9HPT[/]P,%'[AT9D+2-'!F/_ZW,N
M*V=8F%+7@[7Q#/(ZUOX%F+O3R70%2P V5M/T#M'.A&W7?K(.6V]!P\=16U>V
M;3E<*XQ<F[4/A^T8[:;M+]LH%^H,%D)N2ZH]K :L:W#*"Z0Q$K&/&F?(RE,P
MEYI\7]XG.6D;@SO=@^^88#DG"<<5_]<'4H-1-!X/Q* O_L,E_\>G4:/QQ=["
M9A E1OWA_F]NP.10^OADY?H@J!QI%I_V@Y=%GQS"/#-[^7MZ_RX&4O^%W@_F
M?C>_4+C;N=MWTH,1P%ZC?Z<)^WP+WQWF#"5HUCR9!QWMU0=!FEJ<I0H$ZW6_
M&KYW33R=.DQ(W=NO[2ZX_5?](/GE0/<:MOCK_753X/@?@Q*'[(9.PJ/1=/QJ
MU-_-W'>IVQ;A(L<E%Z4/WO;=9AL#*<?BMN/:-L"0?LF4XTW(=]"D:=CMR!1W
M&CL+53U2:XX;MS23](V-D$,Z- ;"&T1WUYZK.E^T>K[*;2).F/T3"K7C6DJ3
M#^<"L2Q+;N TV$W-6=/<\MY]A6\N=_WEP7GP]R(;>MN>_BJ&3 PP8_]TI'G:
M_.'-W/Z]2;O<_M7.)UFN--*%5"VQM=^[F)S8AHS_4N4%__4)+AB(Q!_7"C96
MT@+\OLSSRG^A YH_1WK[WU!+ P04    " "(@+96:I54-AH'  #H$0  &0
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M98' !#K:EH13*J-E?)VR?+#TH %LV)B.? 38%#WN*:FJ.PCO0I0:)9\3_F%
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MR=*](H,KFIH;.NU)&,.J^J1]\F^V3DWQINK[4.?6H*I_PRE3W;M2"Z5]WVI
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M+W=O<FMS:&5E=',O<VAE970Q-2YX;6R56$UOVS@0_2N$-RBZ@"I+LATG;1+
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M9Y.S]Z/N(-._!-O$"\[<!J1C?*QP/R7' OA>6AOZ%]Y@N/'>_ ]02P,$%
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M\2B;!J [H^LF5C7>7%;*DE7YH;MYU"Z ]DNE[&[B#AC^;99_ 5!+ P04
M" "(@+96=:2*;7H$  #/"0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6RE5EEOXS80_BL#-RAV <76Z2--#.0J-D"2=;/9%D71!UH:6\12I):DXN3?
M=TC)LMLD1HN^B(=FOOGFX)"G&Z6_F1+1PG,EI#D;E-;6)Z.1R4NLF!FJ&B7]
M62E=,4M+O1Z96B,KO%(E1G$8CD<5XW(P/_5["ST_58T57.)"@VFJBNF7"Q1J
M<S:(!MN-![XNK=L8S4]KML8O:+_6"TVK48]2\ JEX4J"QM79X#PZN4B=O!?X
ME>/&[,W!>;)4ZIM;W!1G@] 10H&Y=0B,AB>\1"$<$-'XWF$.>I-.<7^^1?_9
M^TZ^+)G!2R5^XX4MSP;3 12X8HVP#VKS"3M_,H>7*V'\%S:M;$H6\\98577*
MM*ZX;$?VW,5A3V$:OJ,0=PJQY]T:\BROF&7S4ZTVH)TTH;F)=]5K$SDN75*^
M6$U_.>G9^>+A\^+ZX?'W !:WY_>/<'Y_!=>_?+U9W%W?/YZ.+)EP@J.\@[MH
MX>)WX*(8[I2TI8%K66#Q=X 1<>L)QEN"%_%!Q/-:#R&, HC#.#F E_0.)QXO
M><]A306M[0LY+)BTP&0!U]\;7E.E6?CC?&FLIE+Y\RW?6^3T;61W?$Y,S7(\
M&]#Y,*B?<##_\8=H'/YT@'?:\TX/H?_W1/T/.-@%J>Z#A'V0<D5GTE@L0*W
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MW! >2^J*KWD8V*!&QUDT1:OB8N7HK94J#!A%L%T"7.]1@A>>I[$TM$V!A E
MD9_^/).-W'M"*M0?3,7(N5IIZV@;7'OSO(7<52A0A7&R.'RK7X_V+MD*B;=[
M2A@BU$C;WK?];O]:.6\OZ9UX^]2Y([>Y-"!P1:KA<)(-0+?/AW9A5>VO[*6R
M] #PTY)>7*B= /U?*:K8;N$,]&^X^5]02P,$%     @ B("V5BGEEBDN"
MDA0  !D   !X;"]W;W)K<VAE971S+W-H965T,3DN>&ULI5A;;]NX$OXKA#=8
MM !KZRXY30(XZ64#=-N@R=E].#@/C$3;W,JB*U)QLK_^?$/)LI(X+K;[(E$4
MYS[SS4@G&UU_,TLI+;M?E94Y'2VM71]/)B9?RI4P8[V6%=[,=;T2%H_U8F+6
MM12%(UJ5D\#SDLE*J&IT=N+VKNJS$]W84E7RJF:F6:U$_7 N2[TY'?FC[<97
MM5A:VIB<G:S%0EY+^Y_U58VG2<^E4"M9&:4K5LOYZ6CF'Y]'=-X=^$/)C1FL
M&5ERJ_4W>K@L3D<>*21+F5OB('"[DQ>R+(D1U/C>\1SU(HEPN-YR_^!LARVW
MPL@+7?ZI"KL\'64C5LBY:$K[56]^DYT],?'+=6G<E6W:LW$X8GECK%YUQ-!@
MI:KV+NX[/PP(,N\%@J C")S>K2"GY3MAQ=E)K3>LIM/@1@MGJJ.&<JJBH%S;
M&F\5Z.S9QR]?WOUY^>D3FWU^QRX_W\P^?[P\__2>S:ZOW]]<GTPL9-#)2=[Q
M.V_Y!2_P\P/VNZ[LTK#W52&+QPPF4*[7,-AJ>!X<Y#A;UV/F^9P%7A >X!?V
M%H>.7_B2Q5H7&U663%0%NZRLJ!;JMI1L9HRTAKU3)B^U:6K)_CN[-;9&WOQO
MGQ]:*=%^*51+QV8M<GDZ0K$86=_)T=FOO_B)]_: #5%O0W2(^T]$[=_P8S=+
MR?(E'"4-4Q6S]"CJ^D%5"R96NJDLTW.VV#KV]H$!-&IAZ;V1"]2P9< /-H=O
M1>D"Z;R/1< $/"T,WI< "'/,7EV2!-T8G#"OV54IS$JP\Q+<V04XR9K]ILU:
M67"ZT72]>*(+N$$=Y(TJ6>CRQF='+)AR+PJQ"",>!QD6D1?P+*6M*$EX%$7L
MJJEAIX%">4ZL'-/B+Y0AV6#8K[]D@1^\[>\!]U*ONUXT=2VK_($A92I3"@<Z
MVX.OPB1XS5YE28RKSX,@?7U0[8"WSNF4ALI^DD#A"*(RJ)OR($M_)-+W(2R-
M6I%>G!P6V578(T^%/(MCYZF0A^'64T'HNY1 7@/[' M*B0N]6HOJP<E/WYI=
M/BCLJ]IE@97&,N0&=1-9;)-IKIO:+MGW1M047O ;9$KGB2Y??- 4*A<6U'8I
MK*,'4[5R6W,(8G>B;"1Q$1!>R[6N72";2D%9>9]+63AJB;.P82U=9]BEM*,W
M8[(1N;FA2Z6?,8+L6IEO)&=@H.C=<< $454-7CEG%-"[E<46M39F7V6I'4J)
M%J6(E74A*)W=R-=FU73K%>GY=YL-^R),Q(_33)E#)?C1Z=7GSFP@ZS/&AMD>
M$;-.!ZA\S*YPE*KGB/D9C[V(%A[/0JK*E">HP OAZEG]#99&S^V&0"'-^#0)
M6.+Q-$V(U,\2]@56UVB[=Q@GUA1%F2\K7>K% T.)@3M.QB'WIE,H,N611U5"
M7114.1H3P7GKOJWKW!VN,DNU-B *>1!Y$)="; 1F'"G/;FI1( O$"@@XA134
M()]& :XQO74P=,22-.!IX%&9^"F/X%@44QSS8)JQS[IZ(X9>N:S>K&N=2[BV
M-[FSRV42RH]GD3\\1XU$ *&<_L.S?LB3)!T>77<^#^##N%<P\'@$=_]\?+<)
M\U)\(S@MQ6+*,P>Z\%*<O!#>A(>)Q^( _D:P@'"^_Z/PIEG(?!Q-*;QARJ=9
M]$_#VR*IG\7<CQ%F0)W_++Q^2H$%WD5.0A]>P&[B.6"$\G'LPCLE:/5_)KP!
M3Z+L7X<WF^[""VL"WV-?Y1SNL!I*60D;$-'OC3+*N<$Q1^\'@X7*P?-.=MV-
MNQXMBL(=!$-5M4-_.W\O1%TX6!HP&P\'J Z:5)67#;Q)\-0B,5ZH1471U*Q4
M.29Z !=-RZTR^L68\ZV=O!N%]T>YCZY#Q5TH6U3=-8?&R'E30@68W-J*_M"B
M-33: [(TF:SA\GO'H'Q@,9G@Q^P!<0+[V6)!?H&3'V&NO%\[&YV(]H7K=4_Y
M/QF)GG:)#2#Y* K&/N;^L@1CSH[B9)QL']W)H\@?![L#NW96/HS9A\;2'-NU
MF[TZ8OE<,;2#G==@\>W!">U#;P(A>QCS>.H--FE^" #>Z7 SH4W4LS_<3%N$
M2I'1N\VLS6LOFS)\AB'\ILTQ&GUV50XE*=^&18/ ]H77VF!T67!62@QXN(.9
MR[R-@AOP0?I-6MH>3#(4_%(A5V@/:7"GC*L@0L/K"U3=&@4TS>(W4)I=;V6]
M ;EIIZ+KQ_*OG?Q/3CZ)_[T3RCC;+!7JGF*GYJU$C!=/;%4T^Z(ND8>JZL'"
ME>0.+]PC*%?KAD:IW@-0OVARRPSB5A:D#0;=>M&Z;IL,-/&6N_I3%((YU%6W
MJE3V@6$T!J6L*#N <@J?G87+XLY!)&',OE2Y/,"D3:XM.7=%V*O9FCQ0<M Y
M.NUVHMS8<B=428CK]%C("M\=-/2Y*)-M6^#HT* 5,&1+=%+ ^^#Z%VK'E7T'
M8FY"W5,?W3<0DD&7JF@G3U6)*E<0#N.L=(C:BMQFTU#H43C.'M=Q.([Z#?#?
MVS-:Y4EA72TTA5IA%%7".D0KFIJV]GUD/06&F?W12/BX$)8"8R6\26T&>7V4
M!4_53Z=CK]\9EMXSAW-ZW>;[<R_$ RY$/:AO..5@0QVXXK&Y?# MTV\J<M*M
M* 6E*89Z*J3*!?4-?::C/VW#[(J0Q-S*;A[OH%S?R;K[?ACVE'$_%CUK _F^
M"<@!?#:.!_B>#;*@]>O 0X?[Q9,8[_O+,!G\)T))+-S?, 2'OC/:7T;];O_#
M;=;^9]H=;__6 ;L6"EA8RCE(O7$:C]J>OGVP>NW^.MUJB_ISRZ5$:Z[I -[/
M-8:3[H$$]+\AS_X/4$L#!!0    ( (B ME;ZOW[F20D  .X7   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;)58:V_;N!+]*X0W6[2 XUA^)FD2($V[
MV (MMFA[;W%QL1]HB8[9I425I.)D?_V>&5+R(V[:_9+($F<XCS.',[Q86_>7
M7RD5Q'UI*G_96X50GY^<^'RE2ND'ME85OBRM*V7 3W=[XFNG9,%"I3D9#8>S
MDU+JJG=UP>\^N*L+VP2C*_7!"=^4I70/KY2QZ\M>UFM??-2WJT O3JXN:GFK
M/JGPG_J#PZ^33DNA2U5Y;2OAU/*R=YV=OYK0>E[P7ZW6?NM9D"<+:_^B'V^+
MR]Z0#%)&Y8$T2/R[4S?*&%($,[XEG;UN2Q+<?FZU_\:^PY>%].K&FB^Z"*O+
MWFE/%&HI&Q,^VO7O*ODS)7VY-9[_BG5<FV%QWOA@RR0,"TI=Q?_R/L5A2^!T
M^!V!41(8L=UQ([;RM0SRZL+9M7"T&MKH@5UE:1BG*TK*I^#P54,N7+U[<_WI
MS:>+DP!=].8D3W*OHMSH.W+92+RW55AY\:8J5+&KX 1&=):,6DM>C9[4>%V[
M@1AF?3$:CL9/Z!MWGHU9W_A[GBDDRXO_7R]\<$C^GX><C"HFAU5009S[6N;J
ML@?$>^7N5._JV2_9;/CR"0,GG8&3I[0G P]9]0,Y3IEXI[Q72EP3K'5X$)]7
M2MS8LI;5@UA)+U"W3@9=W0H3(X$*%G:YU+D2[%1?&%D5?;&63JULXY7 3V"K
M:I8(5^-(-"W\^$R6]<O7$%A8*+5.*]\7=VJE<P/-))<K%\ !0GUK=(VJ#0/Q
MFZYDA=W2_MA&5#8(KV\K#3,DK4E96NNP@AJA*QVT-"(H5\)8 9B5$68P'EM%
M+;>J@F_&/+ ^IW+K@$&!(@\(PD(:WC:2&MFF[L%A\(\B@!6^,TE[EH8]?T=Y
M*0@L5,G'%'8J>*RQ=XH%HQ@;!^_8(E:C[E7>!&B _TOM<S@ $ ]Y;R.QO,_2
M;79DGMNF"KZU)ZG-\=E6BCZ0('VH;'7\^*,G,Y$=\TARL(V"9[^<CK+Y2]]:
MN9)W"NX24W>H8%\\1UH\* ESK)!U[>R]!N,I1'@\Y ](M[>EHI5K9'T%G#S
MW=PT!5[6Q+">A-5]4,GX+=@U-7W+DBIVC[4=4$ & 3=!"2PU#^R1WZQ@)Q9*
M5:TL!YVV*U0K2FP/.S>1-5HNM*$B6:](,L3$2V\KN8"/+7;#2@86B[L!E<9@
M,\JOR[57Q4Y\16'A'B&0C:(WR676T_H&XM!% TC<2=, NXUT0+Y2?D]9,I^*
M8:5@A*-ZD Z+;Q75$]F,4.8H!]A*&(C.T9G48;^I]#=L0@6<RE*[O"E]H(KP
M@ED,JI*;,%'5;;AV=QN(/W;YHPNB5AT^-9GCH!/H*VBEX\JQRV-F$_!3B 7;
ME>B.L:TU,3 P(6Y4RX>2@=Z5'=5O3O6U77^?V0$\*P\.(,#HLC8ZI^Q676%4
MS/U<Z>&A!NEL6$,6VFSB#B"H@;CV:$_RU6Z]-@%^_\UY5;$Z:J=YPRIW'"UD
M%\0(_N<@X%,_58F.0BZM;A"L@E >5T?&P1'.)"$-L] 6Y5"9E]I061(?RL!)
M*HD\B&>))^T6S+O Z6I+%*&O;*ESH:H[[6P5LWN3("^+KV@RHEA2]CB)7.P+
M2B/(G3R@FM9!E3%:Q$@M<1?XG@?XY*&PEKH@S!+.*NJ^F&X5'E!)K^,)L^'+
M;#?JBG-+Y4V<E%RDC0^<4.3QC:&555]\N!Z(M]M$/-Y1W-'BKIYT7!+'0-D[
M'!V^D$:1.K%6C&%C<QEB_EC?9D,J.":8",L-3"E^-M<LQF<<LSIZU=W-6W'"
M2S;=8LEY>_S1C\0H2-3:PCUP#E.VPVFXAJ<M12Z!)[LF)#T 8!2SQAU:^>,4
M=&4K#X$"!7N498,QVE)CN,,FOMGA@VW.X.73P:1;WF 5'5T 7QX9;H>T.7Q(
MQ7M@CTY33JHL"DVV?]?.H\D@ZW:(BCKT)?!1I1_(BTX'I9"W3D5[8@VOY0:V
MHG@4LICR&'3Z%%A_XC8JD+HV'4GLM":ZBD-5G&_,#K;VL+K?S)V+YV^)1-&V
M(>K^A4#WK(U(W7/Z->)?(Y :$_$^H1\B:\3[#SY[C*UNCUL$TY<C,1WW)]F8
M'D;]^>1,O-M*[E.'1:>3Z0]AW?YX).;];#:*_\]F/Z=H8]RNJNFT?S8<QX?Y
M</)T8BC,:Q[:"#B@6\R@!]LCQG6!A#/O)BH_F#DJM,>9>BHU7W[*@+-!VSEE
MP^[QD>BNB9/!V53\BG_34_P[U!;N69HXF[GN"/O,VC+J<YD/=\J<WLR[-X^*
M8IS<HZ615H@4%$_@J:?[R8K)I5^))1;^NYC_F^K@7]'B3-S0?GQNT5$3SUK_
MJ-<LL4WC.M+:CZ0Y6!F=*UXT/AVBCX:T(Y%E_<ET&!^&V80>AG@S$WQA0MMM
MU:M=T"D>#5/W^8K:-U9,9\Q39AV)4991I9S.Z?FL/P5<?E@O"#]2W=+Y@=#O
M=HF\:B?VYQ@*&23_H_/HN=A.DWBQ%:PT%T*&(G#6/P7SX,<4C\/AG!YGXK0_
M&V;T.*>W<UYP"AZ9G W)%71X2Y2/&(_[L\E,?+:$IV4##Q3=I.BR*1^9W[50
M\WE_AM&'ANQS:BS3>)?:S>?9I#^=35^(#_LM[-,QGXW[P]F4M2)'W>B>"#JU
MQ?MUNGMHY :IQ_A,A>_%[U*A05!!YWXS>2-GF-X<=;?H_=!-!DY$J0KJ?]'Q
MWNF<Z11C@3&D**2K)D3+HZ_#G@V0MJYB$[&U23N.M3JHN6='N19;)0!X52C7
MM=_4J6[-%FE VO3C[:B$[G83/P3(HP'SQUC7]@22^ DSF8QPK!L'R*>+"W*U
M*3?C3#?5&072H5<@R-KZA&I;-)@+!N+3WA[?N:>X2:ZD@?E.N@<*31>V>'5R
M<"3>3+1D<QL3P=5_:&YN5PS$%P+Q3JQA]YTF(HH!WD?;=I#[- ,T"QK]N#,O
MY5?K"&VIRZ*>J,T>"/5.54"P9M=T;)%H2F\67ZF?AX6D"Q C?!VXEA#/#T3W
M1<Q@Y'MDFOKGE)YVPX4*:YKF-WT?;7OPWD/[S?A(7A7'TE!_ZX$("@%0G]-F
MC_J<M)53'9?M77$(2.1;#>A^!0:F#E1 \N?0Y=_)UATL ''+-\U>\(D<KV.[
MM]UE]G6\P]TLCS?A[Z6[I0G?J"5$AX/YM!>;M?9'L#7?Z"YL /KX<85Q5CE:
M@.]+:T/[@S;HKOBO_@%02P,$%     @ B("V5@=")\]F$P  *3P  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&ULK5OK<]NZL?]7,*[3.C,,+5&2[3QG
M'"=I?2<GR20Y]TZGTP\0"4EL*$(%2"ON7W_W 8"@1,D^Y_1+8E)X+/;YVUWP
MU5:;'W:E5"-^KJO:OCY9-<WFQ?FYS5=J+6VJ-ZJ&7Q;:K&4#CV9Y;C=&R8(F
MK:OS;#2Z.%_+LCYY\XK>?3%O7NFVJ<I:?3'"MNNU-/=O5:6WKT_&)_[%UW*Y
M:O#%^9M7&[E4WU3SZ^:+@:?SL$I1KE5M2UT+HQ:O3Z['+]Y.<3P-^-]2;6WT
MM\"3S+7^@0^WQ>N3$1*D*I4WN(*$_^[4C:HJ7 C(^+=;\R1LB1/CO_WJ'^CL
M<):YM.I&5_]7%LWJ]<G5B2C40K95\U5O_Z;<>6:X7JXK2_^*+8^=3$Y$WMI&
MK]UDH&!=UOR__.GX$$VX&AV8D+D)&='-&Q&5[V0CW[PR>BL,CH;5\ \Z*LT&
MXLH:A?*M,?!K"?.:-Y\^?W__37RY_OOUVX_OQ?6G=^+CYT]_??;]_==?Q+OW
M;[^_.F]@%QQ[GKL5W_**V8$5QYGX1=?-RHKW=:&*_@+G0%Z@,?,TOLV.KGB]
M,:D8C1.1C;+)D?4FX<P36F]R8+UW:MZ(=Z7-*VU;H\0_KN>V,: ?_QPZ+:\U
M'5X+;>:%W<A<O3X!H[#*W*F3-W_^T_AB]/((I=- Z?38ZBP=7NVWB>CHLL-$
M/Z0)XI-NE!4;>2_GE1*R+D2EZ^6S1IDUV &P--=@J[91A= +T:R46.@*C+ZL
MER_$V6T-KW1K89Y]*D"D926<2-U31D^9^(X+5EK6B:C!*\%:B[*6=0[KB(4"
M$DY%=CE)+K,K_.MJFHQFF;C1]9TR38FDU43H]'F6C"=C,;UZGDPO,O$9* (+
MUL802186$9<S\5%9"X9FC*H;L=&&?,79>)Q<7DV?BK-L/$W&TZNGXF/_K*<P
M%WX99?#7; 8[3,<]&KZINM3&\0S._HLT^0K/!V=&UMSH]4;6]Z*TM@6&G<Y&
MHW0$!EY5Y*N62Z.6LE$". ,GW\A*R+5N:V+'Z FR.FQE>2L^==$JW.5"G.$N
M?_[359:-7M(+(H5>C%\^3<7WE1O()$JP@Z6&-6N@9GY/-.)IK9?E+1ASW:"Y
MS%6S5:KN'0.UX=?T6RK>ROJ'^"21BT#SM;4Z+^DI$=**QH!'4ZI'7%BX3UNC
M&U@ %6!C=*Y48<7"Z#7M:B4<V]'5G0%V6 #)()^B!5\/VH*_EW79E+#2I@4!
M@/LVQ(/QY4M1@ = EEJBGJ2*T@!-4\!?V\""6P7GE1N@X&<)$4!5]^)T>G61
M7GI)[?%Q"^_!/Q.CM!<[Z_E%(MJZ0G53TE0E4.JDJ(H$XENAU!I-Q\#?GM@B
M%7_350%$PYKW?CR>J_0"E_Y1;SC,-0(%TD#D1.6!Y1I-C$!O1UR;MQ;\ 9"A
M68;AN8 MRC404?)1P3?D\ ",_*8VC5K/@60^R@SFPH 61&?ZEB[RTN3MVC;(
M1ON"A7SQ4KQK#?Z*I.4@O;J01OR[E08%=H;\IP4+'F5;8-KNL*>@>,NRKFD9
M$O3_M+42DU'BS*I<L&E5TC;(0XV<95T!1H!0-S#'KE#3G>XX[74* 6Y K]?
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MT%DXT,BA(O:Y$ GN2K *W,B%AR[()S[API%_-*-XA)B(S)@Z"TO:0\C%44Q
M,GK-_ ZQ<#R*(=N#L)]CB,^V$[&I .')/#>M"RAMO9$E'@Z456&.I!- -@UJ
M0226'8"5'@)_.9@ZA *Q@%19HK?#D WX=TE>\DY7=WY%QY+DB.M!KVC@X*7I
M<Q'.U)4,2/4XE#%80B,>PDF>L6'B?X>QH73Q,&]3!)GL_:;)0&U,%N!C8.KU
MMQO@+RG/)YWBP-&ST85H;4".NF!':51C-(5B5&'PR"M,%=DJ8$< A1P9("U0
M+I8@/KP8IUFHO1'>X8" 92,@^!G&,[DI07A)/!5&UKI^YHN'A5HH^ L<EOPI
MJE+.RPI6<1 TB\I[;#YQ0,,15Z-T$A,1+YWO5C>I-)KX,'#4[5^'PU3WB')1
M'V&8DI1:6,IY.1ISH 7P GD'"AHV_ \#$O5SH\ UP&^Y7M;E?YB+7%YBYV"#
M!3M01V'*E]A"SKMW$/B78AMX0PJG<F<BY?P^5#F:4+=<91A8[0%Y"4K#<'7_
MC _SJ1>+G38BYMZ5TK@3([!V/WZS!N^4<SOS\9LBT^$(2$>AM[6ON)Y>IL_#
M+'+5""3)JPZ5)UFE\6?2:>3)+H-#O1Z)GS[/TG%'_JWW<9UX>R*,P0+0>YIU
M=<^0[C@T=0^LQOB UMIG1Y>] )@S&!!DPPDYE\A<"A!KFW,N T=F20_\0/7K
MH!X,2EPL1D\0O#E75Q9BE,Z>I.(&,B48?4/I\.T^:*5TW.\S4&^.G96B+<BY
M:?06N##FV1@7:RMS!IBTK \*I.'*H(-&-W'F"N(Q5?V:>(]>JHRQS73I(-8Z
M?JA'IX*]+,^3U4%SZ\67:X,ICJ9HK7MU]:$$M,^G =J)[+""W/!4YREGHW1Z
M]7@:!Y9'94"=SITR$X?1_\$&"TQ?*:8!;3414)15* \]B 9;#/141(E2MWW5
MZ)(>MV6<3M.1L9=<!,_D>3!PFEQ39ALO '0_"U3WY-47>)9>S8+)=D6(APZ9
MB@^(7W-24"JPMF:C;5#Y75Y;!1PF;!?I.D<YQ+<1 NFIQ35!/]N?!E$;W9B7
M<T<#Y'5@+*4\0 .&)E-P8(J+>[[;@[BIX4:5=*F86QSF$%S'[-&4=Q(]1BCR
MV(8]YV4Z#8P$9]YRH(_*H'M$H<L,1&&,1=#8AO+D88R!)^B2U#%GA!@!.=7$
MH #A"%):R.]OX-^R$1]D[L$&0"KJBXPIQ1I?'?%2H(<\72X-PN&ZZ?LGK/DC
M$N6Z.R<2CE?B=#*+(USC>[:N4K#SLU$>ZM*8LT8O.0,*;K;IFK[(JS7'DH%<
M,NH<XO'V.>!=IH,.F$J3JXP22AUUZ")F0?9-]$2%^5[@L#Y=BMHQ\!L,+ %$
M% Z0?KQ]^_DK8]]Q.IX\$<_@_\O9$TBVU":D4+%4_H)-!U<+-Q@"4Y8B&O %
M-\6/2;$.[$+>([44Q!\I6X1+W%]7SD"'F$I+JY_@,0N72/12;GAG=+M<,3>Q
M0LSV\SC"0H[J5"N[BG7'M;=;2DW)ZCI5<:T9SL_!3CE:472AFDQK6=S@@)N*
MS^<1F/-'G>)VS<QA%B1>M:?94?(Z77<'7? 2]YW:][3XJ[HKD<R#BIR*CT"?
MC0@\. 5.+4VGM R#9%UC2L>-!Y_=X3+7'O73C8MOGS]\%5]QT!D6>4/7PA72
M'B7*IQ'>ZP6\1:6!271WP>>%=6QG1!Q$@255Z-#JP7:RV1-*1,%Z(!7MQ<NC
MA2_$P7V#^B-'\O6OB%KG?TEY.?T_Q,J*)$?@M+)Z!P3P3GR9+BZ($C[%3M2&
MVJ9UNV9K.JQ9N32&K12TA)1^H10[0,/%!N+I*/!TE&;(4U8-+-+\$>8^AD&_
M/JR\NQ=C?*W#.6S0:@+-P8$Y&K@4Y32>L%*@[/?*'$/05D'$Q:20XA3?Q)/F
MGM)R=Q\)RR&+18EW \L[)J3&*CTWN>]4+0,\/6RQPY'(^<]#=9<AKW5X"V*E
MSP-=![^Z#SY[KX#J*D,N5<H@58K2/0-<IFP/CXO*A-5M*NTF731WA1[O:_%2
M$JSI-TE[+6Q2&Z";BSBY=)<U ^[S6^_JO ];,(;QZF]F#+>[]_H!GK!>L6,G
M4T9,"#GD3CI<FH+ [CW?4PLXD9I*#.YH.9B:Q6D^!V.>M).#AP/Q&0\2VUM^
MW&7YN\MS(08(?<:$<O8<*'56$O%VEZ##3N@1' ='V>P6"$ZSRVE46$#8K-L&
M>ZT$E;I5.]DR2CN:X%^DDR>D9V!;A %KW5LVN@?8[7#X;'*'[!T51M^^ B=^
MFHVC(AZ0T=:85Y54Z-'@SB6I--['Y&XP;P.LQ0(QM=&6E0:S\8-UB/NAM/_P
M@0;:2O]%!RS[\6 G%F". J.Y9R(FZ>P%5LP8.?7F'7#9?H%Y?%EDFHYH&0>_
M?<5QNW*W$ ^[/NKQ=%S"FE?(O(X>UP(Q=G'O$M3@S:GDBO=:M* +\1@X2[YR
ML%L\PD5KM8T%<];U=O#7"@N )M(#7VNR3WTH/J*1(9.G_ @OFF"UH=O-JVC$
M\U#PN_$\_TH\A[.#5\E;-G3?0H]GOG][^_W=M2A*S@'G]P>$Z?TC:&OEFQ31
MN$\ 'C[V%69O[]["? N4"G[K$I -F [("!AQGQPDAFE-^SN[ [  0#'<<RA\
MSSFR&P3QKB56$)8BO!S7)QRDR DW4=%@0<7F\@%=? @(D!.!@Y"1\;X4-WXW
M\F#\YTX<<!.*R91Q.=)?7F@(GUHP H1 >']A#IS!&ST)L%UA1<?!64)<=\H5
MG7IJG8-X+'?3(1GHR.4V+.6^X9X#++A69@EI:!))D'\H2KO1;B%Z@E];)AK"
M(&M!N%=,]359\17@!3!TOQ;%33<T$W2R_JI2$FHNI+@@$<!B\):;PU%OC/K4
MA 0]_Q3=/>DJD+&7X*)8A_71&V[<#0-8"'.P '4&[M/LPE&(FGAW4I85(D6^
MP[:I[CNX%6E%'<>9CB#G*@YKWU:W54%WWE3=Z_=SYL 72WS%GIU,7,+"\,6'
MXX50G UPL^&.#GTDTQ63<03W+N#("6);U MB+V 3\%V);PK0]>PXS$6JAOC<
M-1>[C+?K,B+<28!P8!9-C%K2A$?Y\A >:2 J' '3WIZ"7?)E/F1Q.&B4I^!-
MI%XRW$W$>H$/9D>:2>'ZE'0W:T#X)7>1O )$V<8-X0W*8CY #OBE-1A3&@_?
M?E_P!T:%9B/=JG W<JFPMGLY..&K59X*S$3=5)>;]B_O'8YQO@;;6VJWLH!5
M<YR[-)1P/#:-W2VX#>QT+'-V$T)[=OBTA9';^M''Q:/!/I?8F:)/E&Y]Z^F&
M6UQU%,'?<Z!%L,>?6*CB<,\J0LYTLRC*%7P]O.N=P1GWTYT[AQW!;PV5SD(G
M?@"1<Q?^6+.TGP!TRS[4+(UZL0/-4M]"'FR3[K5&L\M)_%7'7FN4&J#C2=S$
M/YVE5]T7.\#'T^=1DV OM:1OFW 87W1P41=858&B7^\YL@&QQG[0]4"].W(=
M!O0-NG8U)%^Y8!V-+R3X6DB>LXFX2X-'[A"0[.:PXL!MM=[76WTW@CD1=2=M
M"9DTACPLKH12QK[[?L2I764YW(CLEF.82$4&'-O5ZFOUL^%O#Z)VM2O+6??M
MBGTA/D2][)WOU>BRVJD89TEV><%?P,#3*)F-1MS2PN_!,KK)"X^7\$AN)WN)
MCU?1X]!'@>?1YYL$B/ C5<OM8?Z2,[P-W\%>\^>?W7#^B/87:9; ;7!O"Y@Z
M2B]G)_P%@']H](8^!@590A2B/U=*0FJ( ^#WA0;+< ^X0?@Z^,W_ U!+ P04
M    " "(@+96<&4+-:86   (2@  &0   'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6S57.MSVLBR_U>F?)(MNTK&2#P,<9(JXMB[WLJK[&1/W;IU/PS2 +,1
M$M$#V_O7GW[,2",0&.?DR_V0&('4T]W3CU]W#[R^3[/O^4*I0CPLXR1_<[0H
MBM6KL[,\7*BES#OI2B7PR2S-EK* RVQ^EJ\R)2-Z:!F?!=WN\&PI=7+T]C6]
M]R5[^SHMBU@GZDLF\G*YE-GC.Q6G]V^._"/[QJV>+PI\X^SMZY6<JSM5?%M]
MR>#JK*(2Z:5*<ITF(E.S-T<3_]6[/MY/-_REU7WNO!8HR31-O^/%3?3FJ(L,
MJ5B%!5*0\&>M+E4<(R%@XX>A>50MB0^ZKRWU:Y(=9)G*7%VF\;]U5"S>'(V.
M1*1FLHR+V_3^#V7D&2"],(US^E_<\[U#N#DL\R)=FH>!@Z5.^*]\,'IP'AAU
M=SP0F <"XIL7(B[?RT*^?9VE]R+#NX$:OB!1Z6E@3B>X*7=%!I]J>*YX>WWS
M:?+I\F;R0=Q\NOMZ^^WCU:>O=V+RZ;VXGMS<BK\F'[Y=B8]7D[MOMU?TV>NS
M I;%A\]"L\0[7B+8L80?B(]I4BQR<95$*FH2. -^*Z8#R_2[8"_%R2KKB*[O
MB: ;]/;0ZU5*Z!&]W@YZ[U6FUQ+-0]PD>9&58'5%+F02B3]4--?)7$S0>G2A
M52[>ZSR,T[S,E/C?R11N!\OZOS:U\*+]]D71VU[E*QFJ-T?@3KG*UNKH[6__
M\H?=BSTB]2N1^ONH_YI]_<5+B*\+)2[3Y4HFCV##23D#S8$:<P^NLN_*J!Q<
M-LZ%AJM5ED9E""_F<3J5<?S8$>"*H@ R,]@$&8M')3.AT*P$&(6.A3$*^/^\
M,WXITAG=;1;][5^CP#^_R$4N8]C(>P5;.%>)RF0!!"!DY3I2],"WSEU'Z$3$
M*:X2EEFFDA VO].00<9Y"G?!Q[D(559 #'3D K.Q@J$%6='P=9CF(!7<K9-"
M98G$  7K6"UL+@QR3\(PS2)X-G[T! B=P$M65RCSA9A!<(5+D$<]K-(<I"E2
M0TYD.O\N9EFZ%.%")G-%]"&<0\!*JA7@.?Y4H#)RB+<Q.P30J13R/HUCF7FM
M*LW4*LU(T)II5U<+"?SACLXSN40.5C'8/I"2A= Y!-(<V#%\@Y_-@0M:A^1!
M7X,/#N<?UP;"]7)A7,(21+',%=I%5#O]3"<2MA<4KAWW)TX2O=3_* _70_;A
MF30BJX+,Q(K0(%]8",@P:+(U*;!KR SY3LUO,UPKJRQT#,OFVV+"&_<R@UV'
MB(J!A]A<0)!B;<FDT*%>D3T[AD$\P/U)+BD9HKZ3%*2C&[?5J=$GP9_ @G3\
M*/Z4P!6$*/$_*B&;NRJSU*-7L+H4X$P0OT"B A0G[NYUGHMK6"VD6SZJ!QW*
M1'Q1>8IBXFZG(%N2%D+%FKEHJ)*==IVB"<:Z>,1W=JGMC_1>K148Y52%$K?6
M,4[CW! X($: HZ'^@>%M'::)XE ",< S'H#.--,/H!_>>[CGE.YA(Z#-S]04
MMD2&R*4DXZ_W'^P[2:SC@S&D90;V#LR 9^,>@#N1S=,67!OI+NT^_T%;>EEQ
M.(GC7<$LJLELF0M;1BTH."%0:81*XH_?">B=@ -C93Y,)!<EA-E,3.XNQ<@?
M>*).FLU,>8R,!=T+<R-=^1<G30//%(8S]D<UFRG"9H(B"#@2L(@WF8T&\Z2(
M+W4FUC(NC?<>+C002'&SX*TEI-H%0LHUTH5K" ?@,C&M0#$/0]!"9]'I2F9@
M>8[3B#3$2-\1GY-0/>.!1KQ$R6.9YWJFU1/B6^IS3"M@@H YT%+IH>>(#Q9O
M$T8'\ TOND9/Q5=T-U.!'2=I' DJ1R51/&1#%^AJH#G*SU,YC6T4+P"[@IDZ
MM[N"TV>5](\<KI8IJ-\*W":H5<*&-;I""5DP QB3-Y-.]"Q5(00HP)C1CHW9
MV0\=7E\,_,X(<@/D<JPK=KC4B^%YI]=ZEW$S2.K%)FJ11@FP2%"OX8E$<5B4
M#QXK<JI<2XH:^KC78)#,?0(Q613W*@;S6A(([XB[<HI"%IH"(_Q7ZV/+YUV%
MM D*91'F9KMB<Z%/:7*Z+\;5T6T#&$I*E?#^H<D?%8P[E:>QCF@QJ-0TF7XA
MOX.=16L0&,BB!.ELEJN"HG4C)>*F <J$\(UYY:9 H'!0!F9D ]Z/U)%MK D*
M-7]D$(;BU))4,2/=)NTF95"B*J!,!NJY1<:QEE-,-1:(0K8[A#U$A9C^*-7S
MNB:)Y:0TG5/>QDVLZ;A1P#(/H:S.J)@S::>)E4=:!EW?\3=03&U1L*@3PMMR
MBB-3BPB$9J/3(CTUN);Y=:RBIL[II>D6VY$A ?M\3G1H,'MHK.CW.^=/QXK>
MN#/8'RMN: ?S0MPB6KJ[EZM<?#$VUX8*M+T?39%K #9%!+>UA;8AX^:C.2WE
MPO(]GKD&P$@9H4&CJ?N*Q73ZM\E\\&29LR*WEV8_EA&43P7;/SE6=2NP AE=
M63AJ'(Y1%Y2/)E6C G2"D W$MY57M=(LACJS)%Q&"5[\68)Y(\P)NOZHF<@:
MOH0?X"WB$MZ"#'C-8!"3^_U"APO,D6L=52CR16_0[72KK09*2\AWDF'UUL>9
M A"\IJ**R1NL";75-S)&7!YIY-8,VGGQ:G'OP;H4*C+6.1BXT?N'FW>?;P&R
MEFP(<K6* ;/C1K+YP 83NL4ZPN_XO9>H:;]S/GA)/;'(INO-+8X1FTM&ZSHE
M^#$IYR7P\91>[],68Q!RGBE5E6<K"6$'5&?68+1.-X,V(']V7^X6B5)&D1:2
M  O7WQ6Z?!'T_<ZXV@;"F]."X,]YM^HJ;#]'3@2V""$$@X_=7#9_VIHV S=)
M-&U87= #?(")A>O(76Z>*5-QP.[L-0&T^3]+B-L83CR,,9'.PS+'S9MB;]:K
M'VYCDFH"N>1>"]"Z4ZM"+:=@@U0RH(?&&#TI*B.EKRC]G5'%9]BB!!NDXKIB
MEP*9K1;N/E_?VE+!VAQA=D!VB3'/8R1KJPO#"07"NL:X00!)C@'\K%.-\,^&
M> )2#8/#UC!B2].Z66'LUMAWP9 2:3(S)^CW1XTM:>^#'-B;:0G/C48!W((J
M:28MR"\4K2.#=^&CAAYXD_(" 6)=5N1EN. '.*'),,3LA%N P0"3ED[*RH=S
ML^,F#*+%##UC-3O=%;W0<&+*W8)A.YMAY;8HES59M<]:D0KU$U!6!8F=G 1#
M?\3=@BPMYPMV&."-L8.X56N-"FZS?M(<AMA@Y(;87"4:W+K%:VU([@=[[]\3
MHS\ %6M!Q5[VIMA8J&P"MHJ63TKL(Z&\Z@>^-/G&/R7<);[=O3=>!I;"D:[;
M\2$^$>/)DU$\&%1AO/M$'&]@:RQ&6@)[,R+L,9996F:8S[4)GRWAQC/9\QZ*
M=2S;IQI[@U5L:5B]9T.D3MQL &+3/9P5FFM I.QU!N?[T\//1'K335CJZ-2:
M)B.\/JA[SW+42Y(SH(,KCUI6KML434_0R:83N!W7C8BA).B4*1/.?G(?.&Q5
MH00E04O$^AWQS%9 *4"* AU]@Q451]S$26.(AKN07@L\?L6=L CJ,;44GS,-
M%@RL?K)JF3#2WKQN ]KOZSP@WN.B5Y5<=(FNI-W/K\ERFL#["J+KDLM9+#?^
M(GN8<(EV_*&NST[$,;5:TC('I<%EN].^$'Z_ZYW[8W@5C+Q!MRO&9\'HC*+B
M^*S7/:/L.CSS!V<D1- 9@MG"8[U@!TF_ZWL!$ RZ!Y$['[X48W\'K:#GC48C
M<>Y[PV$/2?680!NI?J???RF&Y[^&%' %M^V2<.R-033[MR96D["O!D"L.WHI
MCOO#_JY->"X]'^+F\6 T.!%?"3^^$ -X<N#WX57?#SP_&,*KX^%X>$+S*C.K
MX@[/1B^0R]1&VV?8WO;!Z!:&Y;+D_D%;1Y,:9Y1APW2>Z'_4[@;C=D<5WS&U
M'H8*Z^:-&IZK=O#M3$:8SD*EUQC$<MM7I!D5=BT@(F1<34ZQPE#Y1AMT#LD(
M03P1,HD381&\QU-O[-8#JPF.WN/J#BQU*-E J 6Y0!Z6E^H\>IAO1$#57/!8
MGSAU3W4CSA^*G(LSZH29M3UX )Y8J0P//B K\]3)\0K5QN4BRE@]9A*F,P:
M",P!EB@"2;! 7:09YP&H8 @6+300P&8/9NZY ?-;5#-'X7CGL5X[]/"@!J-?
M^!3M*2<8H6%]J$!+64M75^!.#Z,F;KM@[54[3C#N";ZATJP:P?(4E>IX$ 31
MM*EX>8--ALB;BSAX P$W8W%($/#*U/F\A:P< N;F8].44AE@]-#,X2#=SXN%
MG<T1$N!5D2M'4,_,CZLY39IKURNLDDC#.N%S+_AY5<E/'RLSXZ$/#N\U=0WK
ME/)19I!K@S$EGV[3%F64KE#8;RM*X9\ /T&$'I[Z$!^N*\;<HPBD??_"(L</
MK.[CK^E*AZ(70*!AO)0!4-29,GV]2&72BD8=_QPKV%!G$$90'2$!XTB'+(;5
MLZMEGH4MH=#&WMY45?>OR;EG)96NS5T#NTD)G#2E1CQ",[]JXR*!&5G/<#Q8
MU(JW3F$.U^0\=HC@+>YU<^AK/-I8GU /U)NF[>1@#BK>X+)J,9H]WV/3K\17
M[FJ[9U@VDWL3:#2':7S5HRM?O%/@W306-$Z&B=_KGP_H;T"9 S)ET+=;?8R>
M?,*A/?"&0+XW&(OC\=@_$?\&&*A.L9\MCOTA&,&Q[W?A_V'W_ 09;2[3]\8
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M-0<'Q2)3ZC2FD%F'QS(WF)#S)8VY*K*O>&H\O#"1UJ^T?V.R)0_6JJ8>4($
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M&UE>Q"&FX.PXFT[$J8^:E[U/SKE"W:$/ZZRCPOFOS^UH^^W^VG^R[J;[#_]
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M]]'0%C%8GP@,M"!!$ZV%$%])(;F_*3(Q^!WU,.@,=73PE(?3_(Q8C!_+HI7
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MA3,;G9$%7I!DGI_X;.B."<M@1QCX ,.X CL*X$K@13R"'UX6!'1(XXS=CL=
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M, MD_P=0#Y?1MO=9!-(94B8F*(.0$PY(=_#1$H<D\#AR)XV]&%TR35$K*TC
M2PF:;I"$2"$<XR'2,&W!"7SBSAB P5&?XSH&:_L=3*&7Q* \M#.?@4#19W]H
MSKA?_Y+1?K]83AO]FW$[+.]^SZDT02!&^EGN#.[[UE,$ /],(*\6!'^!!O7>
MJ>G&]$*A;9MVJMTW7W=[&'W%6OE(8U%7P=V"KD&TS-M>;-3QWF6HHSDX:4QO
M5^7"6;2Y:]\87'7?!>9;^IL:+Q9_T\N*)KHNEU^A,;R/G,S<R;1K@-#*MN\V
M[J/*O ')6[+KJOMNT-JU'P116MV_=2\[5_^T_>BU^Q;U2FA/=J;F#:7;7VP.
ME\K!T,3(^!2S?L11$)AM,%*!"I(WA(N!'4 X0\;18 +,XYSZSSHM[]]&[PDT
MMX8@>&C%; _:_M&RV?=)]W3M*SQ&@(G[KX&^1.(-MOT@W]_M_\ZX:K_BKY:W
M_X7<H]/1V%/*,;;Z)VD\8*;]?Z&]J/7<?=,?Z1KSACN=2H%W25J YV.-VNPN
M2$'_)\_E?P%02P,$%     @ B("V5A>V,D+: P  [0@  !D   !X;"]W;W)K
M<VAE971S+W-H965T,C<N>&ULM59M;^,V#/XKA&^XI8!7V[*=EUX2(&VSM4#?
MT+2W#\,^* X3&R=+.4EIVOWZ4;*3:P]M!]QA7ZP7D@_)1R+EX5;I+Z9$M/!8
M"VE&06GM^BB*3%%BS<VA6J,DR5+IFEM:ZE5DUAKYPAO5(F)QW(UJ7LE@//1[
M-WH\5!LK*HDW&LRFKKE^.D:AMJ,@"78;M]6JM&XC&@_7?(4SM/?K&TVK:(^R
MJ&J4IE(2-"Y'P20Y.LZ<OE?X7.'6/)N#RV2NU!>W.%^,@M@%A (+ZQ X#0]X
M@D(X( KC:XL9[%TZP^?S'?KO/G?*9<X-GBCQ9[6PY2CH![# )=\(>ZNV9]CF
MDSN\0@GCO[!M=--> ,7&6%6WQA1!7<EFY(\M#\\,^O$;!JPU8#[NQI&/\I1;
M/AYJM07MM G-37RJWIJ"JZ0[E)G5)*W(SHXG)R?WE_<7D[OI*5S?G4UOX>3Z
M\N9V>C:]FIU_GL+%]6PVC"QY<OI1T:(>-ZCL#=2$P:62MC0PE0M<O 2(*,1]
MG&P7YS%[%W&RUH<0)R&PF*7OX*7[O%./E[Z!-[.J^%(JL4!M?H7IUTUEG^!*
M682_)G-C-=V6OU_+NT'-7D=U%71DUKS 44 E8E _8##^^"'IQI_>B3G;QYR]
MA_[#9_7SJ'!7(BR5H!*NY HJ QPT+7^CKK#E>@%J"994"E6OE41IC=OA1;&I
M-X);) 42:R_76+J:?D 0RI@0)'4>9\X?0W*A/<X3<FT W=T!.OE*0'ORP.5N
MA_D==@2=<TE&:F-(9@Z BI5*45+Q:(VR>()37%+*"YBCI)F%M>#2P!6YO9?4
MQT3U#PG_H/X%G0N*Z "H69RBKAZX:Q@&[I3E HXYF148MMY3[SV!7Z##DC!G
M_0,WS;NQ'WMAE@_\C W"/.L=P/4K^5>2U@@=X;W.D;)':G2%X,94RZK@KF\9
MZ'3#=) <4,));P!YV.OG1$?>2V%2JXWC^IL-9;+4JOY/ZE<^70+]^*'/$O9I
M/[(P9G'[=10U+!)I1(AZ'>ME&B^C[87].">R\D'Z/8/M^7F2>N$@\7PE83<9
MT)AF72_(PT&>_2Q[<=)U\61Y%[*0=2FJ>/!_<-?)PR0E5[OQ1_E[%F^GWZ7+
MT\G"C-'X'8.[FB"BTC0<I+EC, OC7N[O(DO\#4SC,.W3U$5\XYJ2=(FU5=?Z
MIN)#*D57>KSEA83;LBI*X-J%:*BD/*O2'K[6RJ)G3U"->N4?6D.9$ECS&NUW
M]V_YI'G"OJDW/P*77*_((0A<DFE\V,L#T,WCVBRL6OL';:XL/8]^6M+_"&JG
M0/*EHC[>+IR#_1_.^%]02P,$%     @ B("V5O^@=.&R-   P[4  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C@N>&ULU7WKD]M&DN>_@M#.S$D19*N;>OJE
MB%9+\FAC;"G4\NQN7-R'(E$D88$ !X]N<?[ZS6=5%@"R9=EW._?%5I-$H2HK
M*Y^_S/K^MFX^M5OON^SSKJS:'^YMNV[_[<.'[6KK=ZX]J_>^@F_6=;-S'?S9
M;!ZV^\:[G![:E0\7Y^=/'^Y<4=U[\3U]]KYY\7W==V51^?=-UO:[G6L.+WU9
MW_YP[^*>?O"AV&P[_.#AB^_W;N.O???+_GT#?ST,H^3%SE=M45=9X]<_W+N\
M^/;EXAD^0+_X>^%O6_/O#)>RK.M/^,?;_(=[YS@C7_I5AT,X^-^-O_)EB2/!
M//XA@]X+[\0'[;]U]#>T>%C,TK7^JB[_H\B[[0_WGM_+<K]V?=E]J&__ZF5!
M3W"\55VV]-_L5GY[?B];]6U7[^1AF,&NJ/C_[K,0XDL>6,@#"YHWOXAF^<IU
M[L7W37V;-?AK& W_04NEIV%R186[<MTU\&T!SW4OKG_YZ:?+#_^5O7N37;_]
M\>>W;]Y>7?[\,;N\NGKWR\\?W_[\8_;^W=_>7KU]?9W=?U^7Q:KP[8/O'W;P
M:AS@X4I>\Y)?LSCRFHM%]E-===LV>UWE/D\'> AS#A-?Z,1?+DZ.>+EOSK+S
MBUFV.%\\.C'>HT"(1S3>HV/CK59U7W5%M<FN.U?EKLG;[)=][CJ?P9_9U=95
M&Y\5569^^;XIJE6Q+WWVOR^7;=< C_V?*>+PJQ]/OQH/WK?MWJW\#_?@9+6^
MN?'W7OSEWRZ>GG]W8F&/P\(>GQK]Q9NB7;DR^R_OFJFI??'#?W5^5U>^*U;M
M7_[M^>+BV7?9FK\]P+>9KX!><,RZK<^N7=<WN3MDJ[)N?=ME74V?EP[^C9_7
MZ^PGUZRV9]F;.$1+6TG$AG\L@-2KL@=FR9XLLEOO/[5P-+IMYMUJF_VC=TWG
MFVSK;G ?+A[Q+\)X,,"%&>#1: "8 <YH730XO6WCO8[9#@>E&=&/Z[[IQN]^
M+.\^L5=/PEX].4GNP$\M3O"JKEHX<L""(+^F]NZK!_L(JW' QKN]JPZXB%7X
M%LBU+BH'3P(9VPX^ !G<M4K,S)4E/=K'#W& ;@L[C>\IX..V7[9%7K@&A,59
M=@E/M,6F*M;%RE4=/ 34DW?'H8C(C:M:1^*:=L%G2^^KS)<%2#Z:&AR_E5W(
M6?86)'N>%_C'##8B<RUP'*RX!]4#XW5^4ZS@L1M@0UX(\&+N808PI,]NMQYV
MML'M/60[U(*XT2#5BXJ&Q!6Y[ 96XI:EYZDC0\-(17?([N-)6)Q_]_>WK^E?
M%]\]F-%*BG76UC,[/&P KWCK6EQ#U]1EB92+U-;1SW"S3GR?U:M5#WQ:K$<#
M+VM@4/QP7]_B>V&M10,*D+4?+(F9 7\!<X;_NR[;U3"DV:#RD!4PXJK3G\EQ
M;S,/\ZYW0,^];\@@J%8L'!T0:ED6&]H3?*M;MG6SS.#XM_S&FHG0H)+$'\"D
M?$$;7 &Q85O63;U+YP6,4>:PD Z)#6QW@!\GC"12!1XXRSY&0H3I3N]_7N19
M57=QMT]O1K9J"OA7X6!CD;-!=E0UOA.D"?P@/3EYW_ H*H0>S5B6P?)1))V2
M$4^#C'AZ\EC_PN?L==L58)3X=DHPG!QA6M\,AR6*PM=[US@]"4<$ ]( V0%/
M!$G87\ZNS[(?+R_?PS;_HP<&;!-&A7W;N4\^\^%=Q$,M6(9[/ONT_VZ]]L*$
M,(VZ00*['4L+/); 6B(W2CB=1<G<C7_G0']@O;ZA)>'^PJ[ 9(\^(\<>=7U0
M#!-+544P-9W&W_BJEPGXSV U(^<+0\2'\"\X/46=@V!<=3V\ ,@#)F2;G>"-
M9X$WGIWDC2M=*III4XSQ&QZW1PKV"T\?"&V4@3=U><.R& 5CW;=9Z3>PD'U3
MK[Q'=: [V!0MF4RX_KJ!;\#PQW/=,+,M^Q9FT+:SJ$AFQ$'@/F0H]#O'<GWO
M4 C K]9(3MJ-&;XN[U==V,D#D[ZZ*9JZPI_ E("]4*4CK5<-$+M%P0,S02T'
M9U+GOTH6'K7::%VSS._V97WPN)\EG7GDH8W,$[R-];RH@/.":*Q) :Q*5^R
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M14>!CSRI$+562,>P6XT;"(.[&U>42%E@US;YDH^>O!XM##L*S0TVY:9H9:#
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MUCF#A^!G,Q4;J2:RXIQ/=VL-?E2[2F2RC0(92821VM5YS'#_52<%E2/4"(/
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M;<$F[RSZ?B)FE9]NAPZ8YMDH6::3GDBTV?1ME<=QHG'J#NKEN%&J#M%$<,Q
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ME$,A0XV8O6;SPZ.![;5EDJYGVAY)DF?_'R52DCW[G\Z@X&###4C?>\QQ'PF
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MW5<P&O:@%W6B41]F0H#RL1B%G<%@",->)X[Z\*0LL?L9HBCJ#..16\41@5_
ML1+HMIZP JF1W4-MP,_:^C5K3IMO@5G]!+Z)UQ\2=S0'.+6^P(Q4P_,+2KNN
M'^=Z8U7I'\2ULO2\^F5.WS.HG0#=9TK9P\89:+Z0IO\"4$L#!!0    ( (B
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MDL",[W!ZHM*0!6'&1C",@C J\#\.PB(<'8,X21'Z3/,4?Y,X=SA"Q/%-_TF
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M#<Y1.U.6/_7':V!9,#J+7T#^5GXT8AO<^Y)X F=D8A3!>[1['$L2%K#L;$\
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MTOZ.VC'0^5PIN_UP!OI_!.-_ %!+ P04    " "(@+96,P;F564(  !O%
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M+4OZ::&R!G1?2&DN&QM@^ TN_P-02P,$%     @ B("V5D,JH+4M P  @@8
M !D   !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL?57O;],P$/U73@&A30K-
MC[;+.MI*V]C$/@#3-N #XH.;7!J#8P?;:1E_/6<G#9VT]4MCQ_>>WUWN7N=;
MI7^9"M'"GUI(LP@J:YNS*#)YA34S(]6@I)-2Z9I9VNIU9!J-K/"@6D1I')]$
M->,R6,[]NUN]G*O6"B[Q5H-IZYKIQPL4:KL(DF#WXHZO*^M>1,MYP]9XC_9+
M<ZMI%PTL!:]1&JXD:"P7P7ER=C%Q\3[@*\>MV5N#RV2EU"^WN2D60>P$H<#<
M.@9&CPU>HA".B&3\[CF#X4H'W%_OV*]][I3+BAF\5.(;+VRU"$X#*+!DK;!W
M:OL!^WRFCB]7POA?V':QXS2 O#56U3V8%-1<=D_VIZ_#'N T?@&0]H#4Z^XN
M\BK?,\N6<ZVVH%TTL;F%3]6C21R7[J/<6TVGG'!V>?/IZ]6GA\]W-U?W</3
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M +ISO&YC5>-=9J4L>99?NB^/V@70>:F4W6W<!</?SO(?4$L#!!0    ( (B
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M1F/X7@- L*AU]U:_CFPS@@RLP/<PFFB_A&1GLLUFR1+!VQS_/K2$!C/O6H/
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ME:^:GK7]@ !"M'^_U^^$W;7K=_YYN-\90DGO.TGXEZ#DMRUMUS4RM[U&YH]
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M.#ETY-VP<XB=WU&2:"&3$*,X AZA=KO.S(+S9S>K"$DDV[LEB$6T-65:PD<
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M3^13N?&9U9=RE^??ZB\7D]-.KSXCF<IQ52-B]=^C',DTK4GJ/+ZOH)WU,>O
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M1?(8ITU_57>.9+:8J?^K19%4/]E<%DD^L>E+'\)CLR:-VQ0F(]LJC(1Q)$R
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M&:LF4Q=0O[_/U>1L]:4^P%->?&M.^^Q_4$L#!!0    ( (B ME:87%VB\P0
M )<@   9    >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;+6:;6^K-A3'OXK%
MKJ96NBN8 "%=$JD-L'5:JRIMMQ?37KB)FZ +.-<V32OMP\\\E 1":;@Z?=.
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M)>>4+7'%UD_ISB-VK^S&,5-[Z4LP ,'&(U(0B U(.*8D''/:BF-0]\QXY M
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M@<3Z8 ;M)(C;F8O%7C 68VLJBQZ)3EI@?_R2LFI9ELQ$BY,%>M-(,M^'5'E
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M#5E\NZY&J+D I050&D71JFHLC0W+[&RT5^.M7/&4?(S80Q1',FK.LIAK;:U
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M36MI-C@LM?6U"ZW3@])\*"V TBB*5E5FZ=?8>+]&LF09*?V1JY,O49AK;:W
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MX2Z*"9#$NEFVITF Q)*P66QF@V1F6Z#H!T:B;79U\5)T+D5_?"E9,4V1X4;
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M-J>&4$/D-^7^%$'54B1R#S7-*&:4&$^9N1;\J<@5>P/)PMJ*H>LF2%@,"4N
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MM/5. K5+]1%Y:98%=K,LZ9[4^\-[R>R<H;*!TB)06@Q*2Z!HJK[2)0L 7;(
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MPJ"UFAE4R:S8.OR,F7U?**&?9IJGXON_Y_\\W(&GF__O%N!BH?]6Z3:G@*_
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M:T6#W5KAV[G-@&U!.YF@GL&MB@G":,<F@]3JA;C52XM=3@D>G030+,3JYP(
MA;X],@$0\;HR16K-0MS"X6NXP$IE8K.!]88M-F$8Z2)4RQ+BEB6W6B1?&N,,
MJ;60>A5GF4+#2DHKJ)Y?DK:@P-,IM0FV4<0+[9D%H$Z"H*OHDUJ=$/<Z_UW\
M0*6!6P1!&+67M9Z.#L-1X*Z5I!8DQ"U(;I@R*WBR1HE9' P[D!R@1DQ>6N0
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MY #S^TH(_7*3-[#_;F/^'U!+ P04    " "(@+96(W:IGIX#   Y"P  &0
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MIPABQNB2E(<T%RNNZYR7=!U'9V^:=1*U!_[ZT$_CCF?ZZ51^.HU^OA96/V&
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M'DBV+C;>/# I65I\75$RISP/4+\O&).O!_D%ZLU>T_\!4$L#!!0    ( (B
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M-KI*'<_/-O.&9&EVVO?(I&1Q=KD"$@+7 >KY@C'YW- =E"?,PW\!4$L#!!0
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M_:\/)%]6[[;?<REY5GU<,#ICHBR@SL\YEZ\'Y04V/\!P]1]02P,$%     @
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M?>[N]HW,5M6#9>\S*;.D>ODHPH7(RP)J^S++Y/<W90/-TX\G_P=02P,$%
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M^(?V.5 M0C6!:A+58E1+4$VAFD8U0VENSFR?8^:_T,?N[WCV0WO'#*USH)I
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MDOR$[/-5'//7%WD'U1[$\?]02P,$%     @ B("V5K.LU&DI P  '0D  !D
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MQ.[+(#8I@U!9$V4"@]@$#(+;4%8L(9K&W)\-N&+CVSU&<')\,HFW1_FNC %
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ML]8B_)D[<'@$EOR[T*!L;]$O8]('S;.U\G_UDX+'R'OI6NF02 TG,>3;KGJ
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MN;JZ  ^S!)R]>P_>@8R"KVNV%9@NQ*@O5:WE&_MI7=?-KBYTI"Z(P&=&Y5J
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M3H=V-Y)MJO.2.9.2%=7EFN %X25 _;YD3+[<E"]HSNC&_P-02P,$%     @
MB("V5CV644"3 P  -PL  !D   !X;"]W;W)K<VAE971S+W-H965T-SDN>&UL
MQ5;;;N,V$/T50ET4">!$%]NRD]H&;"MM VRRAIUM'XH^,-+8$I8BM21EIW^_
M0TK1^J(80;%H7VR1FG-FS@R'FM%.R"\J!=#D)6=<C9U4Z^+6=56<0D[5M2B
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MI#' ]VLA].O".&AFY<DW4$L#!!0    ( (B ME;3@HNU  ,  (,(   9
M>&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;*U676_:,!3]*U8F39VTD0]"1CN(
MQ->T2FN%H%T?ICV8Y )6DSBS#73_?M=.2 $9U(?R0&SGG.-[KC]N>CLNGN4:
M0)&7/"MDWUDK5=ZXKDS6D%/9XB44^&;)14X5=L7*E:4 FAI2GKF!YT5N3EGA
MQ#TS-A5QCV]4Q@J8"B(W>4[%OR%D?-=W?&<_,&.KM=(#;MPKZ0KFH![+J<">
MVZBD+(=",EX0 <N^,_!OQI'&&\ O!CMYT";:R8+S9]VY3?N.IP."#!*E%2@^
MMC""+--"&,;?6M-IIM3$P_9>_;OQCEX65,*(9T\L5>N^TW5("DNZR=2,[WY
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M2 GPKMQU'<D:4V*>F50%RS1+]8< KA>H^8(Q^=[156OXYZ3_ %!+ P04
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M\Q4!F3 "]1H@_)8 83;[GG !.]O9!Q*9BHE,&(K*N/!+T9=L[PIB<LP452W
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M5Y6:&(DU\<4KA47_U2?6L17=$(64MDG7.\(33VVP(Z0*9+6RX71'Z";;Z9N
M97R(6+XA\W3UM)MXFNVA;5R_A[=^OB>XA,FW*+_%E+]P$Q"2-8?4%)LO"9KO
M^LU/6+S/MK4^QHS%N^QP2_"*T+0!O[^.8_9RDG9PVGL]^1]02P,$%     @
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MVEQ^FSZD^5P&95I+,)UQJ[&/<!AA:OACFU&"8L,;0$NU$X.=$3MGQ*N;"')
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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MD+5M-BP?OF$7?MYG$!/3C$'>VU(P$[G+S;[,6;-E<=[U$!/3C$$^@8'5XC"
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M$)W<OL[*==2RX6'8TTPSS.'*Y.V^+#VY+:P73;9YN=_PY5[)C_\"4$L#!!0
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MDB!I@C6!U@&Y#@1>!P0[$(@=D.Q 8'9 M .!V@'9#@1N!X0[$,@=D.Y 8'=
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MZCV,7\<RW'J^U_C\GZ1ZO-Q;;H^_+K]/HH2K*\[U?<7P]!=02P,$%     @
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M\?"/XY=GVIMV>,[/EK^3W/P"4$L! A0#%     @ B("V5@=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" "(@+96#VE52N\    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " "(@+96F5R<(Q &  "<)P  $P
M    @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( (B ME:<
MMN<[HP<  "XO   8              " @0X(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " "(@+96VK^+HTP"  "]!0  &
M    @('G#P  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @
MB("V5N52+FBZ!0  H18  !@              ("!:1(  'AL+W=O<FMS:&5E
M=',O<VAE970S+GAM;%!+ 0(4 Q0    ( (B ME8O*S/@^0,  $(-   8
M          " @5D8  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M    " "(@+968CN_TU0&  "7&   &               @(&('   >&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ B("V5B/!<T8@ P  Q @
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M965T,3 N>&UL4$L! A0#%     @ B("V5I^!SQJR"   <Q4  !D
M     ("!-VT  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
M" "(@+96,8>B4)H1  ":-   &0              @($@=@  >&PO=V]R:W-H
M965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( (B ME9JE50V&@<  .@1   9
M              " @?&'  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L!
M A0#%     @ B("V5O/>GI$?$@  630  !D              ("!0H\  'AL
M+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " "(@+96S22Z9;,&
M  !U$   &0              @(&8H0  >&PO=V]R:W-H965T<R]S:&5E=#$U
M+GAM;%!+ 0(4 Q0    ( (B ME:+E(U)S04  /T.   9              "
M@8*H  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ B("V
M5ACQ60<? P  >08  !D              ("!AJX  'AL+W=O<FMS:&5E=',O
M<VAE970Q-RYX;6Q02P$"% ,4    " "(@+96=:2*;7H$  #/"0  &0
M        @('<L0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0
M   ( (B ME8IY98I+@@  )(4   9              " @8VV  !X;"]W;W)K
M<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ B("V5OJ_?N9)"0  [A<
M !D              ("!\KX  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q0
M2P$"% ,4    " "(@+96!T(GSV83   I/   &0              @(%RR
M>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( (B ME9P90LU
MIA8   A*   9              " @0_<  !X;"]W;W)K<VAE971S+W-H965T
M,C(N>&UL4$L! A0#%     @ B("V5J31M9AW#   W2   !D
M ("![/(  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "(
M@+96#S;_XMP'  !J$@  &0              @(&:_P  >&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( (B ME9"&_?1E@\  !PN   9
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M970R.2YX;6Q02P$"% ,4    " "(@+965O?/P5$%  "\#0  &0
M    @(%77P$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (
M (B ME:S6_$5OP0  !T,   9              " @=]D 0!X;"]W;W)K<VAE
M971S+W-H965T,S$N>&UL4$L! A0#%     @ B("V5C,&YE5E"   ;Q0  !D
M             ("!U6D! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"
M% ,4    " "(@+96R\F]9B(#   2!P  &0              @(%Q<@$ >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( (B ME9#*J"U+0,
M ((&   9              " @<IU 0!X;"]W;W)K<VAE971S+W-H965T,S0N
M>&UL4$L! A0#%     @ B("V5J."ER(T P  OP8  !D              ("!
M+GD! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " "(@+96
M"4ARMR,%  #Q#   &0              @(&9? $ >&PO=V]R:W-H965T<R]S
M:&5E=#,V+GAM;%!+ 0(4 Q0    ( (B ME96S..:<P0  'D,   9
M      " @?.! 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%
M  @ B("V5D4HY)U8 P  <0<  !D              ("!G88! 'AL+W=O<FMS
M:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " "(@+96/21[,D((  "F&@
M&0              @($LB@$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+
M 0(4 Q0    ( (B ME8SE>(P  <  $T2   9              " @:62 0!X
M;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ B("V5A31#!H>
M"   A18  !D              ("!W)D! 'AL+W=O<FMS:&5E=',O<VAE970T
M,2YX;6Q02P$"% ,4    " "(@+96#M!,L!4'  !9$   &0
M@($QH@$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( (B
MME9<"RII\P,  .8(   9              " @7VI 0!X;"]W;W)K<VAE971S
M+W-H965T-#,N>&UL4$L! A0#%     @ B("V5CIDQ_2K#   G8H  !D
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M=#0X+GAM;%!+ 0(4 Q0    ( (B ME8I# L]H 4  ' J   9
M  " @3#9 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @
MB("V5EEZ\L^A @  &@@  !D              ("!!]\! 'AL+W=O<FMS:&5E
M=',O<VAE970U,"YX;6Q02P$"% ,4    " "(@+96+X7^824)  #)70  &0
M            @('?X0$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4
M Q0    ( (B ME:D$[^1S@D  !M5   9              " @3OK 0!X;"]W
M;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ B("V5M,A*9[\ @
M8@@  !D              ("!0/4! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX
M;6Q02P$"% ,4    " "(@+96O8.R-+<#  #&#0  &0              @(%S
M^ $ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( (B ME9#
MH52QQ@0  &@1   9              " @6'\ 0!X;"]W;W)K<VAE971S+W-H
M965T-34N>&UL4$L! A0#%     @ B("V5MHL^5SX!@  PR$  !D
M     ("!7@$" 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (B ME:OI&BY5 (  %$%   9              "
M@:@7 @!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ B("V
M5M3EH:NE @  [08  !D              ("!,QH" 'AL+W=O<FMS:&5E=',O
M<VAE970V,BYX;6Q02P$"% ,4    " "(@+96N<+BQK8%  #X)0  &0
M        @($/'0( >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0
M   ( (B ME9@'*>M800  &T6   9              " @?PB @!X;"]W;W)K
M<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ B("V5L\,C!,2!0  'AD
M !D              ("!E"<" 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q0
M2P$"% ,4    " "(@+96> ?ZDU@'  "1-@  &0              @('=+ (
M>&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( (B ME:'SJ2,
M,@@  (Q!   9              " @6PT @!X;"]W;W)K<VAE971S+W-H965T
M-C<N>&UL4$L! A0#%     @ B("V5D9\';(="0  "5D  !D
M ("!U3P" 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " "(
M@+96F!IP>=(*  !_=   &0              @($I1@( >&PO=V]R:W-H965T
M<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( (B ME;FL5\E>0(  /P%   9
M          " @3)1 @!X;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#
M%     @ B("V5D[R5#;6%   +$T! !D              ("!XE," 'AL+W=O
M<FMS:&5E=',O<VAE970W,2YX;6Q02P$"% ,4    " "(@+96ZWW"@#T&  "/
M.   &0              @('O: ( >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM
M;%!+ 0(4 Q0    ( (B ME:SK-1I*0,  !T)   9              " @6-O
M @!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @ B("V5C2A
MK,J[!0  +R@  !D              ("!PW(" 'AL+W=O<FMS:&5E=',O<VAE
M970W-"YX;6Q02P$"% ,4    " "(@+96=([VB:L*  "-90  &0
M    @(&U> ( >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    (
M (B ME;(3_Q'2 0  !$5   9              " @9># @!X;"]W;W)K<VAE
M971S+W-H965T-S8N>&UL4$L! A0#%     @ B("V5F;L!;R"!   ,10  !D
M             ("!%H@" 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"
M% ,4    " "(@+96K4+<3L0%  "O&P  &0              @('/C ( >&PO
M=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( (B ME8]EE% DP,
M #<+   9              " @<J2 @!X;"]W;W)K<VAE971S+W-H965T-SDN
M>&UL4$L! A0#%     @ B("V5M."B[4  P  @P@  !D              ("!
ME)8" 'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6Q02P$"% ,4    " "(@+96
M4<@D#'4"  !_!@  &0              @('+F0( >&PO=V]R:W-H965T<R]S
M:&5E=#@Q+GAM;%!+ 0(4 Q0    ( (B ME846F^I=PL  ,AC   9
M      " @7>< @!X;"]W;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%
M  @ B("V5D,"XGW) P  VQ$  !D              ("!):@" 'AL+W=O<FMS
M:&5E=',O<VAE970X,RYX;6Q02P$"% ,4    " "(@+96D+[8=FP%  "6&P
M&0              @($EK ( >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+
M 0(4 Q0    ( (B ME:3W%M0R04  !(>   9              " @<BQ @!X
M;"]W;W)K<VAE971S+W-H965T.#4N>&UL4$L! A0#%     @ B("V5H9KDM-C
M!@  ART  !D              ("!R+<" 'AL+W=O<FMS:&5E=',O<VAE970X
M-BYX;6Q02P$"% ,4    " "(@+96/(FK2M(+  #-60  &0
M@(%BO@( >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4 Q0    ( (B
MME;XRH!QE04  -,B   9              " @6O* @!X;"]W;W)K<VAE971S
M+W-H965T.#@N>&UL4$L! A0#%     @ B("V5EJT4W)M P  CA8   T
M         ( !-] " 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "(@+96EXJ[
M',     3 @  "P              @ '/TP( 7W)E;',O+G)E;'-02P$"% ,4
M    " "(@+96NL<F9H(&  "O.0  #P              @ &XU ( >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ B("V5L,EV4B4 @  WS,  !H
M     ( !9]L" 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ B("V5HV<RZLT @  5C(  !,              ( !,]X" %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&     &  8 !7&@  F. "

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>421</ContextCount>
  <ElementCount>595</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>128</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - DOCUMENT AND ENTITY INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION</Role>
      <ShortName>DOCUMENT AND ENTITY INFORMATION</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - AUDIT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/AUDITINFORMATION</Role>
      <ShortName>AUDIT INFORMATION</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETSPARENTHETICAL</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENT OF STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/DESCRIPTIONOFTHEBUSINESSANDBASISOFPRESENTATION</Role>
      <ShortName>DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - RESTRUCTURING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RESTRUCTURING</Role>
      <ShortName>RESTRUCTURING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - ACQUISITIONS AND STRATEGIC INVESTMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/ACQUISITIONSANDSTRATEGICINVESTMENTS</Role>
      <ShortName>ACQUISITIONS AND STRATEGIC INVESTMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - DIVESTITURE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/DIVESTITURE</Role>
      <ShortName>DIVESTITURE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - REVENUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/REVENUE</Role>
      <ShortName>REVENUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENT</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT</Role>
      <ShortName>NOTES PAYABLE AND LONG-TERM DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - RETIREMENT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RETIREMENTPLANS</Role>
      <ShortName>RETIREMENT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - CAPITAL STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CAPITALSTOCK</Role>
      <ShortName>CAPITAL STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION</Role>
      <ShortName>SEGMENT AND ENTERPRISE-WIDE INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - RESTRUCTURING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RESTRUCTURINGTables</Role>
      <ShortName>RESTRUCTURING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/RESTRUCTURING</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - ACQUISITIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/ACQUISITIONSTables</Role>
      <ShortName>ACQUISITIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/ACQUISITIONSANDSTRATEGICINVESTMENTS</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/INCOMETAXES</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/INVENTORIES</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENT</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/LEASES</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTTables</Role>
      <ShortName>NOTES PAYABLE AND LONG-TERM DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - RETIREMENT PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RETIREMENTPLANSTables</Role>
      <ShortName>RETIREMENT PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/RETIREMENTPLANS</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - CAPITAL STOCK (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CAPITALSTOCKTables</Role>
      <ShortName>CAPITAL STOCK (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/CAPITALSTOCK</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables</Role>
      <ShortName>SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - RESTRUCTURING (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails</Role>
      <ShortName>RESTRUCTURING (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/RESTRUCTURINGTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - RESTRUCTURING (Schedule of Restructuring Reserve by Type of Cost) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails</Role>
      <ShortName>RESTRUCTURING (Schedule of Restructuring Reserve by Type of Cost) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/RESTRUCTURINGTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - ACQUISITIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/ACQUISITIONSDetails</Role>
      <ShortName>ACQUISITIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/ACQUISITIONSTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - ACQUISITIONS - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails</Role>
      <ShortName>ACQUISITIONS - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - ACQUISITIONS - Intangible Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails</Role>
      <ShortName>ACQUISITIONS - Intangible Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - STRATEGIC INVESTMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/STRATEGICINVESTMENTSDetails</Role>
      <ShortName>STRATEGIC INVESTMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - DIVESTITURE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/DIVESTITUREDetails</Role>
      <ShortName>DIVESTITURE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/DIVESTITURE</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - INCOME TAXES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/INCOMETAXESTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - INCOME TAXES (Schedule Domestic and Foreign Income Before Provision for Income Tax) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails</Role>
      <ShortName>INCOME TAXES (Schedule Domestic and Foreign Income Before Provision for Income Tax) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/INCOMETAXESTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - INCOME TAXES (Schedule of Income Tax Provision Components) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Income Tax Provision Components) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/INCOMETAXESTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - INCOME TAXES (Schedule of Net Deferred Tax Asset) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Net Deferred Tax Asset) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/INCOMETAXESTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - INCOME TAXES (Schedule of Effective Income Tax Rate Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>INCOME TAXES (Schedule of Effective Income Tax Rate Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/INCOMETAXESTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - INCOME TAXES (Summary of Gross Unrecognized Tax Benefits) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INCOMETAXESSummaryofGrossUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>INCOME TAXES (Summary of Gross Unrecognized Tax Benefits) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/INCOMETAXESTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - EARNINGS PER SHARE (Schedule of Earnings Per Share Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails</Role>
      <ShortName>EARNINGS PER SHARE (Schedule of Earnings Per Share Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - EARNINGS PER SHARE (Share Repurchase Plan) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails</Role>
      <ShortName>EARNINGS PER SHARE (Share Repurchase Plan) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - REVENUE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/REVENUEDetails</Role>
      <ShortName>REVENUE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/REVENUE</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - REVENUE Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails</Role>
      <ShortName>REVENUE Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - INVENTORIES (Schedule of Inventories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails</Role>
      <ShortName>INVENTORIES (Schedule of Inventories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/INVENTORIESTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - LEASES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/LEASESDetails</Role>
      <ShortName>LEASES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/LEASESTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Schedule of Notes Payable and Long-Term Debt) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails</Role>
      <ShortName>NOTES PAYABLE AND LONG-TERM DEBT (Schedule of Notes Payable and Long-Term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Narrative) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails</Role>
      <ShortName>NOTES PAYABLE AND LONG-TERM DEBT (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Schedule of Notes Payable and Long-Term Debt Maturities) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtMaturitiesDetails</Role>
      <ShortName>NOTES PAYABLE AND LONG-TERM DEBT (Schedule of Notes Payable and Long-Term Debt Maturities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Interest Rate Swaps) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Interest Rate Swaps) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Allowance for credit losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Allowance for credit losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedules of Derivatives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedules of Derivatives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - RETIREMENT PLANS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails</Role>
      <ShortName>RETIREMENT PLANS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/RETIREMENTPLANSTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - RETIREMENT PLANS (Schedule of Components of Net Periodic Benefit Costs of Defined Benefit Pension Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails</Role>
      <ShortName>RETIREMENT PLANS (Schedule of Components of Net Periodic Benefit Costs of Defined Benefit Pension Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/RETIREMENTPLANSTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - RETIREMENT PLANS (Schedule of Activity Under Defined Benefit Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails</Role>
      <ShortName>RETIREMENT PLANS (Schedule of Activity Under Defined Benefit Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/RETIREMENTPLANSTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - RETIREMENT PLANS (Schedule of Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofChangeRecordedinAccumulatedOtherComprehensiveIncomeRelatedtoDefinedBenefitPlansNetofTaxDetails</Role>
      <ShortName>RETIREMENT PLANS (Schedule of Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/RETIREMENTPLANSTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - RETIREMENT PLANS (Schedule of Weighted Average Rates Used to Determine Net Periodic Benefit Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofWeightedAverageRatesUsedtoDetermineNetPeriodicBenefitCostsDetails</Role>
      <ShortName>RETIREMENT PLANS (Schedule of Weighted Average Rates Used to Determine Net Periodic Benefit Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/RETIREMENTPLANSTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - RETIREMENT PLANS (Schedule of Estimated Future Benefit Payments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofEstimatedFutureBenefitPaymentsDetails</Role>
      <ShortName>RETIREMENT PLANS (Schedule of Estimated Future Benefit Payments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/RETIREMENTPLANSTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - CAPITAL STOCK (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails</Role>
      <ShortName>CAPITAL STOCK (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/CAPITALSTOCKTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - CAPITAL STOCK (Schedule of Share-Based Compensation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CAPITALSTOCKScheduleofShareBasedCompensationDetails</Role>
      <ShortName>CAPITAL STOCK (Schedule of Share-Based Compensation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/CAPITALSTOCKTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - CAPITAL STOCK (Schedule of Summary of Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails</Role>
      <ShortName>CAPITAL STOCK (Schedule of Summary of Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/CAPITALSTOCKTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - CAPITAL STOCK (Schedule of Assumptions Used to Estimate Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails</Role>
      <ShortName>CAPITAL STOCK (Schedule of Assumptions Used to Estimate Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/CAPITALSTOCKTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - CAPITAL STOCK (Schedule of Summary of Equity Awards other than Options Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails</Role>
      <ShortName>CAPITAL STOCK (Schedule of Summary of Equity Awards other than Options Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/CAPITALSTOCKTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails</Role>
      <ShortName>SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="hae-20230401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept LondonInterbankOfferedRateLIBORMember in us-gaap/2021 used in 5 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. hae-20230401.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:LesseeOperatingLeaseTermOfContract -  hae-20230401.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="hae-20230401.htm">hae-20230401.htm</File>
    <File>fy2023ex211.htm</File>
    <File>fy2023ex231.htm</File>
    <File>fy2023ex311.htm</File>
    <File>fy2023ex312.htm</File>
    <File>fy2023ex321.htm</File>
    <File>fy2023ex322.htm</File>
    <File>hae-20230401.xsd</File>
    <File>hae-20230401_cal.xml</File>
    <File>hae-20230401_def.xml</File>
    <File>hae-20230401_lab.xml</File>
    <File>hae-20230401_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1543">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="74">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>108
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hae-20230401.htm": {
   "axisCustom": 0,
   "axisStandard": 45,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2021-01-31": 1543,
    "http://xbrl.sec.gov/dei/2021q4": 74
   },
   "contextCount": 421,
   "dts": {
    "calculationLink": {
     "local": [
      "hae-20230401_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "hae-20230401_def.xml"
     ]
    },
    "inline": {
     "local": [
      "hae-20230401.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hae-20230401_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hae-20230401_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hae-20230401.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 917,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 7,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 11
   },
   "keyCustom": 86,
   "keyStandard": 509,
   "memberCustom": 46,
   "memberStandard": 75,
   "nsprefix": "hae",
   "nsuri": "http://www.haemonetics.com/20230401",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - DOCUMENT AND ENTITY INFORMATION",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION",
     "shortName": "DOCUMENT AND ENTITY INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - RESTRUCTURING",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.haemonetics.com/role/RESTRUCTURING",
     "shortName": "RESTRUCTURING",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - ACQUISITIONS AND STRATEGIC INVESTMENTS",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.haemonetics.com/role/ACQUISITIONSANDSTRATEGICINVESTMENTS",
     "shortName": "ACQUISITIONS AND STRATEGIC INVESTMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - DIVESTITURE",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.haemonetics.com/role/DIVESTITURE",
     "shortName": "DIVESTITURE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "ibbac5d507ec34ec4ae240ffc072168b7_D20210404-20220402",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.haemonetics.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - EARNINGS PER SHARE",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.haemonetics.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - REVENUE",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.haemonetics.com/role/REVENUE",
     "shortName": "REVENUE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - INVENTORIES",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.haemonetics.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - PROPERTY, PLANT AND EQUIPMENT",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENT",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - AUDIT INFORMATION",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.haemonetics.com/role/AUDITINFORMATION",
     "shortName": "AUDIT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - LEASES",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.haemonetics.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT",
     "shortName": "NOTES PAYABLE AND LONG-TERM DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - RETIREMENT PLANS",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.haemonetics.com/role/RETIREMENTPLANS",
     "shortName": "RETIREMENT PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - CAPITAL STOCK",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.haemonetics.com/role/CAPITALSTOCK",
     "shortName": "CAPITAL STOCK",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION",
     "shortName": "SEGMENT AND ENTERPRISE-WIDE INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiscalPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "28",
     "role": "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiscalPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hae:ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hae:ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - RESTRUCTURING (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.haemonetics.com/role/RESTRUCTURINGTables",
     "shortName": "RESTRUCTURING (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - ACQUISITIONS (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.haemonetics.com/role/ACQUISITIONSTables",
     "shortName": "ACQUISITIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - INCOME TAXES (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.haemonetics.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - EARNINGS PER SHARE (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.haemonetics.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - INVENTORIES (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.haemonetics.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTTables",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hae:AssetsandLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - LEASES (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.haemonetics.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hae:AssetsandLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTTables",
     "shortName": "NOTES PAYABLE AND LONG-TERM DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - RETIREMENT PLANS (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.haemonetics.com/role/RETIREMENTPLANSTables",
     "shortName": "RETIREMENT PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - CAPITAL STOCK (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.haemonetics.com/role/CAPITALSTOCKTables",
     "shortName": "CAPITAL STOCK (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables",
     "shortName": "SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "lang": "en-US",
      "name": "hae:MaximumTermOfMaturitiesForCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "hae:RestructuringandRestructuringRelatedCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - RESTRUCTURING (Narrative) (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
     "shortName": "RESTRUCTURING (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostCostIncurredToDate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "ica07a6a12db04420a640cda640d48dcd_I20220402",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - RESTRUCTURING (Schedule of Restructuring Reserve by Type of Cost) (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
     "shortName": "RESTRUCTURING (Schedule of Restructuring Reserve by Type of Cost) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - ACQUISITIONS (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.haemonetics.com/role/ACQUISITIONSDetails",
     "shortName": "ACQUISITIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "id4e2ba32e7d846df811c490e96dfc2db_D20220403-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "hae:AssetAcquisitionMilestonePayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - ACQUISITIONS - Purchase Price Allocation (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails",
     "shortName": "ACQUISITIONS - Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "id6fc9e356f064785861fafa202778d12_I20210301",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "id6fc9e356f064785861fafa202778d12_I20210301",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - ACQUISITIONS - Intangible Assets Acquired (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails",
     "shortName": "ACQUISITIONS - Intangible Assets Acquired (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "id6fc9e356f064785861fafa202778d12_I20210301",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InvestmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - STRATEGIC INVESTMENTS (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.haemonetics.com/role/STRATEGICINVESTMENTSDetails",
     "shortName": "STRATEGIC INVESTMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i5038a81c8b424af199422b8a9d70bc1c_I20230401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - DIVESTITURE (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.haemonetics.com/role/DIVESTITUREDetails",
     "shortName": "DIVESTITURE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "ia4acc494c5054244829743f91b7e2da7_D20200629-20200629",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - INCOME TAXES (Narrative) (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
     "shortName": "INCOME TAXES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UndistributedEarningsOfForeignSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - INCOME TAXES (Schedule Domestic and Foreign Income Before Provision for Income Tax) (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.haemonetics.com/role/INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails",
     "shortName": "INCOME TAXES (Schedule Domestic and Foreign Income Before Provision for Income Tax) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - INCOME TAXES (Schedule of Income Tax Provision Components) (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails",
     "shortName": "INCOME TAXES (Schedule of Income Tax Provision Components) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "hae:DeferredTaxAssetsDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - INCOME TAXES (Schedule of Net Deferred Tax Asset) (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails",
     "shortName": "INCOME TAXES (Schedule of Net Deferred Tax Asset) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "hae:DeferredTaxAssetsDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - INCOME TAXES (Schedule of Effective Income Tax Rate Reconciliation) (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails",
     "shortName": "INCOME TAXES (Schedule of Effective Income Tax Rate Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "ica07a6a12db04420a640cda640d48dcd_I20220402",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - INCOME TAXES (Summary of Gross Unrecognized Tax Benefits) (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.haemonetics.com/role/INCOMETAXESSummaryofGrossUnrecognizedTaxBenefitsDetails",
     "shortName": "INCOME TAXES (Summary of Gross Unrecognized Tax Benefits) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - EARNINGS PER SHARE (Schedule of Earnings Per Share Reconciliation) (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails",
     "shortName": "EARNINGS PER SHARE (Schedule of Earnings Per Share Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i1e9d4875df194dab89de359ddb229826_I20220831",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - EARNINGS PER SHARE (Share Repurchase Plan) (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails",
     "shortName": "EARNINGS PER SHARE (Share Repurchase Plan) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i1e9d4875df194dab89de359ddb229826_I20220831",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETSPARENTHETICAL",
     "shortName": "CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - REVENUE (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.haemonetics.com/role/REVENUEDetails",
     "shortName": "REVENUE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i46b375b6b4f542949b51fd68eaa34739_I20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - REVENUE Performance Obligations (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails",
     "shortName": "REVENUE Performance Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i46b375b6b4f542949b51fd68eaa34739_I20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - INVENTORIES (Schedule of Inventories) (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails",
     "shortName": "INVENTORIES (Schedule of Inventories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Narrative (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToDevelopSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "ica07a6a12db04420a640cda640d48dcd_I20220402",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Schedule of Goodwill (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS Schedule of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - LEASES (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.haemonetics.com/role/LEASESDetails",
     "shortName": "LEASES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Schedule of Notes Payable and Long-Term Debt) (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails",
     "shortName": "NOTES PAYABLE AND LONG-TERM DEBT (Schedule of Notes Payable and Long-Term Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i903c8d9492d64dafb77bbdf28e97066f_I20230401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Narrative) (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
     "shortName": "NOTES PAYABLE AND LONG-TERM DEBT (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "ifb2d524b6a72478a8ce2435530d7cbc4_I20200328",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS\u2019 EQUITY",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENT OF STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "ifb2d524b6a72478a8ce2435530d7cbc4_I20200328",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Schedule of Notes Payable and Long-Term Debt Maturities) (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtMaturitiesDetails",
     "shortName": "NOTES PAYABLE AND LONG-TERM DEBT (Schedule of Notes Payable and Long-Term Debt Maturities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "ide370a9836b84207b26c4ba915b66f5e_D20220726-20220726",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i7000a797e0454253afd12b28826cf4c1_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Interest Rate Swaps) (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Interest Rate Swaps) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i7000a797e0454253afd12b28826cf4c1_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "ica07a6a12db04420a640cda640d48dcd_I20220402",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Allowance for credit losses (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Allowance for credit losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i2752e169c88b4ff2a289838d456aec0d_I20200328",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments) (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i764ec41ce0424c3da439a7f3192b0337_D20220403-20230401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "id5d605e3bfc94e56bc0743876ebc5034_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedules of Derivatives) (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedules of Derivatives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "id5d605e3bfc94e56bc0743876ebc5034_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "hae:DefinedBenefitPlanBenefitObligationPlanFundedbyCompany",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - RETIREMENT PLANS (Narrative) (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails",
     "shortName": "RETIREMENT PLANS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "hae:DefinedBenefitPlanBenefitObligationPlanFundedbyCompany",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetFundedStatusTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - RETIREMENT PLANS (Schedule of Components of Net Periodic Benefit Costs of Defined Benefit Pension Plans) (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails",
     "shortName": "RETIREMENT PLANS (Schedule of Components of Net Periodic Benefit Costs of Defined Benefit Pension Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "lang": "en-US",
      "name": "hae:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetFundedStatusTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "ica07a6a12db04420a640cda640d48dcd_I20220402",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - RETIREMENT PLANS (Schedule of Activity Under Defined Benefit Plans) (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails",
     "shortName": "RETIREMENT PLANS (Schedule of Activity Under Defined Benefit Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetFundedStatusTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "ica07a6a12db04420a640cda640d48dcd_I20220402",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - RETIREMENT PLANS (Schedule of Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax) (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofChangeRecordedinAccumulatedOtherComprehensiveIncomeRelatedtoDefinedBenefitPlansNetofTaxDetails",
     "shortName": "RETIREMENT PLANS (Schedule of Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i2752e169c88b4ff2a289838d456aec0d_I20200328",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - RETIREMENT PLANS (Schedule of Weighted Average Rates Used to Determine Net Periodic Benefit Costs) (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofWeightedAverageRatesUsedtoDetermineNetPeriodicBenefitCostsDetails",
     "shortName": "RETIREMENT PLANS (Schedule of Weighted Average Rates Used to Determine Net Periodic Benefit Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - RETIREMENT PLANS (Schedule of Estimated Future Benefit Payments) (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofEstimatedFutureBenefitPaymentsDetails",
     "shortName": "RETIREMENT PLANS (Schedule of Estimated Future Benefit Payments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - CAPITAL STOCK (Narrative) (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
     "shortName": "CAPITAL STOCK (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i4c45fa2cfd044c32806ebad955872fa5_I20230401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - CAPITAL STOCK (Schedule of Share-Based Compensation) (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofShareBasedCompensationDetails",
     "shortName": "CAPITAL STOCK (Schedule of Share-Based Compensation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i44a4bfb9e6ff4d9b876946af45bf3409_I20220402",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - CAPITAL STOCK (Schedule of Summary of Stock Option Activity) (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails",
     "shortName": "CAPITAL STOCK (Schedule of Summary of Stock Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i2f4fe996939d41f19a8a3c550cac4282_D20220403-20230401",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - CAPITAL STOCK (Schedule of Assumptions Used to Estimate Fair Value) (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails",
     "shortName": "CAPITAL STOCK (Schedule of Assumptions Used to Estimate Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i7f8351b1251941fda67c91242b4d2df5_D20220403-20230401",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "iffbadda382114e1eb91a79d7e988c700_I20220402",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - CAPITAL STOCK (Schedule of Summary of Equity Awards other than Options Activity) (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails",
     "shortName": "CAPITAL STOCK (Schedule of Summary of Equity Awards other than Options Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i9e357fb36a4649f7b47041aaa9928468_D20220403-20230401",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "unit",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails",
     "shortName": "SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "unit",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "ica07a6a12db04420a640cda640d48dcd_I20220402",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Details 1)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.haemonetics.com/role/DESCRIPTIONOFTHEBUSINESSANDBASISOFPRESENTATION",
     "shortName": "DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20230401.htm",
      "contextRef": "i09227d97ca0f437ba5950fed30790726_D20220403-20230401",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 128,
   "tag": {
    "country_JP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "JAPAN",
        "verboseLabel": "Japan"
       }
      }
     },
     "localname": "JP",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_MY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MALAYSIA",
        "terseLabel": "Malaysia"
       }
      }
     },
     "localname": "MY",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "verboseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r887",
      "r888",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/AUDITINFORMATION"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r887",
      "r888",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/AUDITINFORMATION"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r887",
      "r888",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/AUDITINFORMATION"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r887",
      "r888",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r890"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r887",
      "r888",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "hae_A2019EquityPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Equity Plan [Member]",
        "label": "2019 Equity Plan [Member]",
        "terseLabel": "2019 Equity Plan [Member]"
       }
      }
     },
     "localname": "A2019EquityPlanMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_A2020ProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Program [Member]",
        "label": "2020 Program [Member]",
        "terseLabel": "2020 Program"
       }
      }
     },
     "localname": "A2020ProgramMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_A2022AcceleratedShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Accelerated Share Repurchase Program",
        "label": "2022 Accelerated Share Repurchase Program [Member]",
        "terseLabel": "2022 Share Repurchase Program"
       }
      }
     },
     "localname": "A2022AcceleratedShareRepurchaseProgramMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_A401kPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "401k Plan [Member]",
        "label": "401k Plan [Member]",
        "terseLabel": "401k Plan"
       }
      }
     },
     "localname": "A401kPlanMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_AcquiredIntangibleAssetsRiskAdjustedDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired Intangible Assets, Risk-Adjusted Discount Rate",
        "label": "Acquired Intangible Assets, Risk-Adjusted Discount Rate",
        "terseLabel": "Risk-Adjusted Discount Rates used in Purchase Price Allocation"
       }
      }
     },
     "localname": "AcquiredIntangibleAssetsRiskAdjustedDiscountRate",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails",
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Convertible Debt, Capped Call Purchases",
        "label": "Adjustments to Additional Paid in Capital, Convertible Debt, Capped Call Purchases",
        "negatedTerseLabel": "Purchase of capped call related to convertible notes"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtCappedCallPurchases",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_AmortizationOfAcquiredIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Acquired Intangible Assets",
        "label": "Amortization Of Acquired Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationOfAcquiredIntangibleAssets",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_AssetAcquisitionMilestonePayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Milestone Payment",
        "label": "Asset Acquisition, Milestone Payment",
        "terseLabel": "Asset Acquisition, Milestone Payment"
       }
      }
     },
     "localname": "AssetAcquisitionMilestonePayment",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_AssetImpairmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairments [Member]",
        "label": "Asset Impairments [Member]",
        "terseLabel": "Asset Impairments"
       }
      }
     },
     "localname": "AssetImpairmentsMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_AssetsandLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and Liabilities Lessee [Table Text Block]",
        "label": "Assets and Liabilities Lessee [Table Text Block]",
        "terseLabel": "Assets and Liabilities Lessee [Table Text Block]"
       }
      }
     },
     "localname": "AssetsandLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hae_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information [Abstract]",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.haemonetics.com/20230401",
     "xbrltype": "stringItemType"
    },
    "hae_BankLoansandOtherBorrowingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bank Loans and Other Borrowing [Member]",
        "label": "Bank Loans and Other Borrowing [Member]",
        "verboseLabel": "Bank loans and other borrowings"
       }
      }
     },
     "localname": "BankLoansandOtherBorrowingMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_BloodCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blood Center [Member]",
        "label": "Blood Center [Member]",
        "terseLabel": "Blood Center products and services"
       }
      }
     },
     "localname": "BloodCenterMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Payroll and Related Costs",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Payroll and Related Costs",
        "terseLabel": "Accrued payroll and related costs"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedPayrollAndRelatedCosts",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Operating Carryforwards",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Operating Carryforwards",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Operating Carryforwards"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetOperatingCarryforwards",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tax Credit, Research",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tax Credit, Research",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tax Credit, Research"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTaxCreditResearch",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_CardivaMedicalIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardiva Medical, Inc.",
        "label": "Cardiva Medical, Inc. [Member]",
        "terseLabel": "Cardiva Medical, Inc."
       }
      }
     },
     "localname": "CardivaMedicalIncMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails",
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails",
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails",
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax [Roll Forward]",
        "label": "Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax [Roll Forward]",
        "terseLabel": "Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "ComponentsOfChangeRecordedInAccumulatedOtherComprehensiveIncomeRelatedToDefinedBenefitPlansNetOfTaxRollForward",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofChangeRecordedinAccumulatedOtherComprehensiveIncomeRelatedtoDefinedBenefitPlansNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hae_ConsolidatedInterestCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated Interest Coverage Ratio",
        "label": "Consolidated Interest Coverage Ratio",
        "terseLabel": "Consolidated interest coverage ratio"
       }
      }
     },
     "localname": "ConsolidatedInterestCoverageRatio",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "hae_ConsolidatedTotalLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated Total Leverage Ratio",
        "label": "Consolidated Total Leverage Ratio",
        "terseLabel": "Consolidated total leverage ratio"
       }
      }
     },
     "localname": "ConsolidatedTotalLeverageRatio",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "hae_ContingentConsiderationForeignCurrencyTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Foreign Currency Translation Adjustment",
        "label": "Contingent Consideration, Foreign Currency Translation Adjustment",
        "terseLabel": "Contingent Consideration, Foreign Currency Translation Adjustment"
       }
      }
     },
     "localname": "ContingentConsiderationForeignCurrencyTranslationAdjustment",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_DebtInstrumentConvertibleCappedCallTransactionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Capped Call Transaction, Amount",
        "label": "Debt Instrument, Convertible, Capped Call Transaction, Amount",
        "terseLabel": "Debt Instrument, Convertible, Capped Call Transaction, Amount"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCappedCallTransactionAmount",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Capped Call Transaction, Anti-Dilution Adjustment, Shares",
        "label": "Debt Instrument, Convertible, Capped Call Transaction, Anti-Dilution Adjustment, Shares",
        "terseLabel": "Debt Instrument, Convertible, Capped Call Transaction, Anti-Dilution Adjustment, Shares"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCappedCallTransactionAntiDilutionAdjustmentShares",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hae_DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Capped Call Transaction, Initial Cap Price",
        "label": "Debt Instrument, Convertible, Capped Call Transaction, Initial Cap Price",
        "terseLabel": "Debt Instrument, Convertible, Capped Call Transaction, Initial Cap Price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCappedCallTransactionInitialCapPrice",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hae_DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Capped Call Transaction, Initial Strike Price",
        "label": "Debt Instrument, Convertible, Capped Call Transaction, Initial Strike Price",
        "terseLabel": "Debt Instrument, Convertible, Capped Call Transaction, Initial Strike Price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCappedCallTransactionInitialStrikePrice",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hae_DebtInstrumentConvertibleComponentConversionPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible Component, Conversion Price",
        "label": "Debt Instrument, Convertible Component, Conversion Price",
        "terseLabel": "Debt Instrument, Convertible, Conversion Price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleComponentConversionPrice",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "hae_DebtInstrumentInterestRateFloor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Interest Rate, Floor",
        "label": "Debt Instrument, Interest Rate, Floor",
        "terseLabel": "Debt Instrument, Interest Rate, Floor"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateFloor",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Percent Of Principal Amount Due After Year One Per Year Until Maturity",
        "label": "Debt Instrument, Percent Of Principal Amount Due After Year One Per Year Until Maturity",
        "terseLabel": "Debt Instrument, Percent Of Principal Amount Due After Year One Per Year Until Maturity"
       }
      }
     },
     "localname": "DebtInstrumentPercentOfPrincipalAmountDueAfterYearOnePerYearUntilMaturity",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_DebtInstrumentPercentOfPrincipalAmountDueInYearOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Percent of Principal Amount Due In Year One",
        "label": "Debt Instrument, Percent of Principal Amount Due In Year One",
        "terseLabel": "Debt Instrument, Percent of Principal Amount Due In Year One"
       }
      }
     },
     "localname": "DebtInstrumentPercentOfPrincipalAmountDueInYearOne",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redemption Price, Percentage of Previous Closing Price",
        "label": "Debt Instrument, Redemption Price, Percentage of Previous Closing Price",
        "terseLabel": "Debt Instrument, Redemption Price, Percentage of Previous Closing Price"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentageOfPreviousClosingPrice",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_DecreaseForRedemptionOfLongTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease For Redemption Of Long-Term Debt",
        "label": "Decrease For Redemption Of Long-Term Debt",
        "negatedTerseLabel": "Term loan redemption"
       }
      }
     },
     "localname": "DecreaseForRedemptionOfLongTermDebt",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DeferredTaxAssetsAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Amortization",
        "label": "Deferred Tax Assets, Amortization",
        "terseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "DeferredTaxAssetsAmortization",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DeferredTaxAssetsDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Depreciation",
        "label": "Deferred Tax Assets, Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "DeferredTaxAssetsDepreciation",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DeferredTaxAssetsOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Lease, Liability",
        "label": "Deferred Tax Assets, Operating Lease, Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiability",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DeferredTaxAssetsResearchExpensesCapitalized": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Research Expenses Capitalized",
        "label": "Deferred Tax Assets, Research Expenses Capitalized",
        "terseLabel": "Deferred Tax Assets, Research Expenses Capitalized"
       }
      }
     },
     "localname": "DeferredTaxAssetsResearchExpensesCapitalized",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DeferredTaxLiabilitiesAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Amortization",
        "label": "Deferred Tax Liabilities, Amortization",
        "negatedTerseLabel": "Amortization of goodwill and intangibles"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAmortization",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DeferredTaxLiabilitiesDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Depreciation",
        "label": "Deferred Tax Liabilities, Depreciation",
        "negatedTerseLabel": "Depreciation"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDepreciation",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Operating Lease, Right of Use Asset",
        "label": "Deferred Tax Liabilities, Operating Lease, Right of Use Asset",
        "negatedTerseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DefinedBenefitPlanBenefitObligationPlanFundedbyCompany": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, Plan Funded by Company",
        "label": "Defined Benefit Plan, Benefit Obligation, Plan Funded by Company",
        "terseLabel": "Benefit obligation, plan funded by company"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationPlanFundedbyCompany",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "label": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "terseLabel": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "label": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "terseLabel": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfPriorServiceCostCreditStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "label": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "terseLabel": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "label": "DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "terseLabel": "DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hae_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "label": "DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
        "terseLabel": "DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleListNotDisclosedFlag",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hae_DefinedBenefitPlanReinsuranceContractsAssetValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Reinsurance Contracts Asset Value",
        "label": "Defined Benefit Plan, Reinsurance Contracts Asset Value",
        "terseLabel": "Reinsurance contracts asset value"
       }
      }
     },
     "localname": "DefinedBenefitPlanReinsuranceContractsAssetValue",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DerivativeBlendedFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Blended Fixed Interest Rate",
        "label": "Derivative, Blended Fixed Interest Rate",
        "terseLabel": "Derivative, Blended Fixed Interest Rate"
       }
      }
     },
     "localname": "DerivativeBlendedFixedInterestRate",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_DerivativePercentageOfNotionalValueOfDebt": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Percentage Of Notional Value Of Debt",
        "label": "Derivative, Percentage Of Notional Value Of Debt",
        "terseLabel": "Derivative, Percentage Of Notional Value Of Debt"
       }
      }
     },
     "localname": "DerivativePercentageOfNotionalValueOfDebt",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_DerivativePercentofDebtExposed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Percent of Debt Exposed",
        "label": "Derivative, Percent of Debt Exposed",
        "terseLabel": "Debt exposed to interest rate risk"
       }
      }
     },
     "localname": "DerivativePercentofDebtExposed",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_DigitalTransformationCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Digital transformation costs",
        "label": "Digital transformation costs",
        "terseLabel": "Digital transformation costs"
       }
      }
     },
     "localname": "DigitalTransformationCosts",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operations, Expected Cost To Sell",
        "label": "Disposal Group, Not Discontinued Operations, Expected Cost To Sell",
        "terseLabel": "Disposal Group, Not Discontinued Operations, Expected Cost To Sell"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationsExpectedCostToSell",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operations, Incremental Loss On Closing Adjustments",
        "label": "Disposal Group, Not Discontinued Operations, Incremental Loss On Closing Adjustments",
        "terseLabel": "Disposal Group, Not Discontinued Operations, Incremental Loss On Closing Adjustments"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Document and Entity Information [Abstract]",
        "label": "Document And Entity Information [Abstract]",
        "terseLabel": "Document And Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.haemonetics.com/20230401",
     "xbrltype": "stringItemType"
    },
    "hae_EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Change in Uncertain Tax Positions",
        "label": "Effective Income Tax Rate Reconciliation, Change in Uncertain Tax Positions",
        "terseLabel": "Change in uncertain tax positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeinUncertainTaxPositions",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 15.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Contingent Consideration Liability, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Contingent Consideration Liability, Amount",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityAmount",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 15.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Contingent Consideration Liability, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Contingent Consideration Liability, Percent",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationContingentConsiderationLiabilityPercent",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Global Intangible Low Taxed Income, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Global Intangible Low Taxed Income, Amount",
        "terseLabel": "Global intangible low taxed income"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeAmount",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Global Intangible Low Taxes Income, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Global Intangible Low Taxes Income, Percent",
        "terseLabel": "Global intangible low taxed income"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomePercent",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Intercompany Sale of Intellectual Property",
        "label": "Effective Income Tax Rate Reconciliation, Intercompany Sale of Intellectual Property",
        "negatedTerseLabel": "Intercompany sale of intellectual property"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualProperty",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Intercompany Sale of Intellectual Property, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Intercompany Sale of Intellectual Property, Percent",
        "negatedTerseLabel": "Intercompany sale of intellectual property"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIntercompanySaleOfIntellectualPropertyPercent",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Unremitted Earnings, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Unremitted Earnings, Amount",
        "terseLabel": "Unremitted earnings"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationUnremittedEarningsAmount",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Unremitted Earnings, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Unremitted Earnings, Percent",
        "terseLabel": "Unremitted earnings"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationUnremittedEarningsPercent",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_EffectofExchangeRateonRevenues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of Exchange Rate on Revenues",
        "label": "Effect of Exchange Rate on Revenues",
        "terseLabel": "Effect of exchange rates"
       }
      }
     },
     "localname": "EffectofExchangeRateonRevenues",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_EffectofExchangeRatesonOperatingIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of Exchange Rates on Operating Income",
        "label": "Effect of Exchange Rates on Operating Income",
        "terseLabel": "Effect of exchange rates"
       }
      }
     },
     "localname": "EffectofExchangeRatesonOperatingIncome",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Member]",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_EmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees [Member]",
        "label": "Employees [Member]",
        "terseLabel": "Employees"
       }
      }
     },
     "localname": "EmployeesMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_EnicorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Enicor",
        "label": "Enicor [Member]",
        "terseLabel": "Enicor"
       }
      }
     },
     "localname": "EnicorMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails",
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails",
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_EuropeanMedicalDeviceRegulationCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "European Medical Device Regulation Costs",
        "label": "European Medical Device Regulation Costs",
        "terseLabel": "European Medical Device Regulation Costs"
       }
      }
     },
     "localname": "EuropeanMedicalDeviceRegulationCosts",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_FajardoPuertoRicoManufacturingOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fajardo, Puerto Rico Manufacturing Operations",
        "label": "Fajardo, Puerto Rico Manufacturing Operations [Member]",
        "terseLabel": "Fajardo, Puerto Rico Manufacturing Operations"
       }
      }
     },
     "localname": "FajardoPuertoRicoManufacturingOperationsMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_Fiscal2016AwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal 2016 Awards [Member]",
        "label": "Fiscal 2016 Awards [Member]",
        "terseLabel": "Fiscal 2016 Awards [Member]"
       }
      }
     },
     "localname": "Fiscal2016AwardsMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_HASIntellectualPropertyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HAS Intellectual Property",
        "label": "HAS Intellectual Property [Member]",
        "terseLabel": "HAS Intellectual Property"
       }
      }
     },
     "localname": "HASIntellectualPropertyMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_HaemoneticsEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Haemonetics Equipment [Member]",
        "label": "Haemonetics Equipment [Member]",
        "terseLabel": "Haemonetics equipment",
        "verboseLabel": "Haemonetics equipment"
       }
      }
     },
     "localname": "HaemoneticsEquipmentMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_HospitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hospital [Member]",
        "label": "Hospital [Member]",
        "terseLabel": "Hospital products and services"
       }
      }
     },
     "localname": "HospitalMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_ImpairmentOfAssetsAndRelatedCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment Of Assets And Related Charges",
        "label": "Impairment Of Assets And Related Charges",
        "negatedTerseLabel": "Impairment of assets and PCS2 related charges"
       }
      }
     },
     "localname": "ImpairmentOfAssetsAndRelatedCharges",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_InProcessPatentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In Process Patents [Member]",
        "label": "In Process Patents [Member]",
        "terseLabel": "In-process patents"
       }
      }
     },
     "localname": "InProcessPatentsMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_InProcessSoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In Process Software Development [Member]",
        "label": "In Process Software Development [Member]",
        "terseLabel": "In-process software development"
       }
      }
     },
     "localname": "InProcessSoftwareDevelopmentMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_IncentiveCompensationPlan2005Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incentive Compensation Plan 2005 [Member]",
        "label": "Incentive Compensation Plan 2005 [Member]",
        "terseLabel": "Incentive Compensation Plan 2005"
       }
      }
     },
     "localname": "IncentiveCompensationPlan2005Member",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Penalties and Interest Included in Income Tax Expense",
        "label": "Income Tax Examination, Penalties and Interest Included in Income Tax Expense",
        "terseLabel": "Income Tax Examination, Penalties and Interest Included in Income Tax Expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesandInterestIncludedinIncomeTaxExpense",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_IncomeTaxReconciliationChangeinUncertainTaxPositions": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Reconciliation, Change in Uncertain Tax Positions",
        "label": "Income Tax Reconciliation, Change in Uncertain Tax Positions",
        "terseLabel": "Change in uncertain tax positions"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeinUncertainTaxPositions",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_IncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Line Items]",
        "label": "Income Taxes [Line Items]",
        "terseLabel": "Income Taxes [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesLineItems",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hae_InlogHoldingsFranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inlog Holdings France",
        "label": "Inlog Holdings France [Member]",
        "terseLabel": "Inlog Holdings France"
       }
      }
     },
     "localname": "InlogHoldingsFranceMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_InterestRateSwap267FixedInterestRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, 2.67% Fixed Interest Rate",
        "label": "Interest Rate Swap, 2.67% Fixed Interest Rate [Member]",
        "terseLabel": "Interest Rate Swap, 2.67% Fixed Interest Rate"
       }
      }
     },
     "localname": "InterestRateSwap267FixedInterestRateMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_InterestRateSwap276FixedInterestRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, 2.76% Fixed Interest Rate",
        "label": "Interest Rate Swap, 2.76% Fixed Interest Rate [Member]",
        "terseLabel": "Interest Rate Swap, 2.76% Fixed Interest Rate"
       }
      }
     },
     "localname": "InterestRateSwap276FixedInterestRateMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_InterestRateSwap408FixedInterestRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, 4.08% Fixed Interest Rate",
        "label": "Interest Rate Swap, 4.08% Fixed Interest Rate [Member]",
        "terseLabel": "Interest Rate Swap, 4.08% Fixed Interest Rate"
       }
      }
     },
     "localname": "InterestRateSwap408FixedInterestRateMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_InterestRateSwap415FixedInterestRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, 4.15% Fixed Interest Rate",
        "label": "Interest Rate Swap, 4.15% Fixed Interest Rate [Member]",
        "terseLabel": "Interest Rate Swap, 4.15% Fixed Interest Rate"
       }
      }
     },
     "localname": "InterestRateSwap415FixedInterestRateMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_InterestRateSwap444FixedInterestRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, 4.44% Fixed Interest Rate",
        "label": "Interest Rate Swap, 4.44% Fixed Interest Rate [Member]",
        "terseLabel": "Interest Rate Swap, 4.44% Fixed Interest Rate"
       }
      }
     },
     "localname": "InterestRateSwap444FixedInterestRateMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_InterestRateSwap446FixedInterestRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, 4.46% Fixed Interest Rate",
        "label": "Interest Rate Swap, 4.46% Fixed Interest Rate [Member]",
        "terseLabel": "Interest Rate Swap, 4.46% Fixed Interest Rate"
       }
      }
     },
     "localname": "InterestRateSwap446FixedInterestRateMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_InventoryLossesProvisionBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Losses, Provision (Benefit)",
        "label": "Inventory Losses, Provision (Benefit)",
        "terseLabel": "Provision (benefit) for losses on inventory"
       }
      }
     },
     "localname": "InventoryLossesProvisionBenefit",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_LesseeOperatingLeasesOtherInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Leases, Other Information [Table Text Block]",
        "label": "Lessee, Operating Leases, Other Information [Table Text Block]",
        "terseLabel": "Lessee, Operating Leases, Other Information [Table Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeasesOtherInformationTableTextBlock",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hae_ManufacturingSpaceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing Space",
        "label": "Manufacturing Space [Member]",
        "terseLabel": "Manufacturing Space"
       }
      }
     },
     "localname": "ManufacturingSpaceMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_ManufacturingSpaceSecondRenewalTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing Space, Second Renewal Term",
        "label": "Manufacturing Space, Second Renewal Term [Member]",
        "terseLabel": "Manufacturing Space, Second Renewal Term"
       }
      }
     },
     "localname": "ManufacturingSpaceSecondRenewalTermMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_MaximumTermOfMaturitiesForCashAndCashEquivalents": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Term of Maturities for Cash and Cash Equivalents",
        "label": "Maximum Term of Maturities for Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents maximum maturity period"
       }
      }
     },
     "localname": "MaximumTermOfMaturitiesForCashAndCashEquivalents",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hae_NetRevenuesBeforeForeignExchangeImpact": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Revenues, Before Foreign Exchange Impact",
        "label": "Net Revenues, Before Foreign Exchange Impact",
        "terseLabel": "Net revenues by business unit"
       }
      }
     },
     "localname": "NetRevenuesBeforeForeignExchangeImpact",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Revenues Cost Of Goods Sold And Selling General And Administrative Expense",
        "label": "Net Revenues Cost Of Goods Sold And Selling General And Administrative Expense [Member]",
        "terseLabel": "Net revenues, COGS and SG&amp;A"
       }
      }
     },
     "localname": "NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_NumberOfInterestRateSwapsEntered": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Interest Rate Swaps Entered",
        "label": "Number Of Interest Rate Swaps Entered",
        "terseLabel": "Number Of Interest Rate Swaps Entered"
       }
      }
     },
     "localname": "NumberOfInterestRateSwapsEntered",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hae_NumberOfPurchasePeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Purchase Periods",
        "label": "Number of Purchase Periods",
        "terseLabel": "Number of purchase periods (in purchase periods)"
       }
      }
     },
     "localname": "NumberOfPurchasePeriods",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hae_NumberofOptionsCountedAgainstMaximumNumberofAwardShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Options Counted Against Maximum Number of Award Shares",
        "label": "Number of Options Counted Against Maximum Number of Award Shares",
        "terseLabel": "Number of options counted against maximum number of award shares for every share option issued (in shares)"
       }
      }
     },
     "localname": "NumberofOptionsCountedAgainstMaximumNumberofAwardShares",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hae_OfficeEquipmentAndInformationTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office Equipment and Information Technology [Member]",
        "label": "Office Equipment and Information Technology [Member]",
        "terseLabel": "Office equipment and information technology",
        "verboseLabel": "Office equipment and information technology"
       }
      }
     },
     "localname": "OfficeEquipmentAndInformationTechnologyMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_OperatingExpensesTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OperatingExpensesTransactionCosts",
        "label": "OperatingExpensesTransactionCosts",
        "terseLabel": "Integration and transaction costs"
       }
      }
     },
     "localname": "OperatingExpensesTransactionCosts",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_OperatingLeaseRevenueAsAPercentageOfTotalNetSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Revenue, As A Percentage Of Total Net Sales",
        "label": "Operating Lease, Revenue, As A Percentage Of Total Net Sales",
        "terseLabel": "Operating lease revenue as a percentage of net sales (as a percent)"
       }
      }
     },
     "localname": "OperatingLeaseRevenueAsAPercentageOfTotalNetSales",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_OtherCountryorRegionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Country or Region [Member]",
        "label": "Other Country or Region [Member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherCountryorRegionMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_OtherIncomeExpenseNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Income (Expense), Net [Member]",
        "label": "Other Income (Expense), Net [Member]",
        "terseLabel": "Interest and other expense, net"
       }
      }
     },
     "localname": "OtherIncomeExpenseNetMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_OtherTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Technology [Member]",
        "label": "Other Technology [Member]",
        "terseLabel": "Other developed technology"
       }
      }
     },
     "localname": "OtherTechnologyMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Purchase of Capped Call Related To Convertible Notes",
        "label": "Payments For Purchase of Capped Call Related To Convertible Notes",
        "negatedTerseLabel": "Purchase of capped call related to convertible notes"
       }
      }
     },
     "localname": "PaymentsForPurchaseOfCappedCallRelatedToConvertibleNotes",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_PercentageOfNetSalesGeneratedOutsideOfUs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Net Sales Generated Outside Of The US",
        "label": "Percentage Of Net Sales Generated Outside Of The US",
        "terseLabel": "Percentage of sales generated outside the US"
       }
      }
     },
     "localname": "PercentageOfNetSalesGeneratedOutsideOfUs",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Purchase Price for Shares of Common Stock at Fair Market Value",
        "label": "Percentage of Purchase Price for Shares of Common Stock at Fair Market Value",
        "terseLabel": "Percentage of purchase price for shares of common stock at fair market value (as a percent)"
       }
      }
     },
     "localname": "PercentageOfPurchasePriceForSharesOfCommonStockAtFairMarketValue",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_PercentageOfSharesPurchasedThroughPayrollDeductions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Shares Purchased Through Payroll Deductions",
        "label": "Percentage of Shares Purchased Through Payroll Deductions",
        "terseLabel": "Percentage of shares purchased through payroll deductions (as a percent)"
       }
      }
     },
     "localname": "PercentageOfSharesPurchasedThroughPayrollDeductions",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_PlasmaCustomerCSLLimitedCSLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Plasma Customer, CSL Limited (CSL)",
        "label": "Plasma Customer, CSL Limited (CSL) [Member]",
        "terseLabel": "Plasma Customer, CSL Limited (CSL) [Member]"
       }
      }
     },
     "localname": "PlasmaCustomerCSLLimitedCSLMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_PlasmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plasma [Member]",
        "label": "Plasma [Member]",
        "terseLabel": "Plasma products and services"
       }
      }
     },
     "localname": "PlasmaMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_PriorRestructuringProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prior Restructuring Programs",
        "label": "Prior Restructuring Programs [Member]",
        "terseLabel": "Prior Programs"
       }
      }
     },
     "localname": "PriorRestructuringProgramsMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_ProceedsFromDivestureOfBusinessContingentConsiderationReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Divesture of Business, Contingent Consideration Received",
        "label": "Proceeds From Divesture of Business, Contingent Consideration Received",
        "terseLabel": "Proceeds From Divesture of Business, Contingent Consideration Received"
       }
      }
     },
     "localname": "ProceedsFromDivestureOfBusinessContingentConsiderationReceived",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Divesture Of Business Net Of Working Capital Adjustments",
        "label": "Proceeds From Divesture Of Business Net Of Working Capital Adjustments",
        "terseLabel": "Proceeds From Divesture Of Business Net Of Working Capital Adjustments"
       }
      }
     },
     "localname": "ProceedsFromDivestureOfBusinessNetOfWorkingCapitalAdjustments",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_RestructuringChargesPayableInNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Charges Payable In Next Twelve Months",
        "label": "Restructuring Charges Payable In Next Twelve Months",
        "terseLabel": "Restructuring Charges Payable In Next Twelve Months"
       }
      }
     },
     "localname": "RestructuringChargesPayableInNextTwelveMonths",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_RestructuringRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Related Costs",
        "label": "Restructuring Related Costs",
        "terseLabel": "Restructuring related costs"
       }
      }
     },
     "localname": "RestructuringRelatedCosts",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_RestructuringandRestructuringRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Restructuring Related Costs",
        "label": "Restructuring and Restructuring Related Costs",
        "negatedTerseLabel": "Restructuring and Restructuring Related Costs",
        "terseLabel": "Total restructuring and restructuring related costs"
       }
      }
     },
     "localname": "RestructuringandRestructuringRelatedCosts",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_RevenueBasedPayments2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Based Payments 2",
        "label": "Revenue Based Payments 2 [Member]",
        "terseLabel": "Revenue-based payments"
       }
      }
     },
     "localname": "RevenueBasedPayments2Member",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_RevisedCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revised Credit Agreement",
        "label": "Revised Credit Agreement [Member]",
        "terseLabel": "Revised Credit Agreement"
       }
      }
     },
     "localname": "RevisedCreditAgreementMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_SavingsPlusPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Savings Plus Plan [Member]",
        "label": "Savings Plus Plan [Member]",
        "terseLabel": "Savings Plus Plan"
       }
      }
     },
     "localname": "SavingsPlusPlanMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Property, Plant and Equipment, Estimated Useful Lives [Table Text Block]",
        "label": "Schedule of Property, Plant and Equipment, Estimated Useful Lives [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment Estimated Useful Lives"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hae_ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Share-based Payment Award, Equity Other Than Options, Valuation Assumptions",
        "label": "Schedule of Share-based Payment Award, Equity Other Than Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Equity Other Than Options, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEquityOtherThanOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hae_SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Overnight Financing Rate (SOFR) One-Month USD Term Rate",
        "label": "Secured Overnight Financing Rate (SOFR) One-Month USD Term Rate [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR) One-Month USD Term Rate"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSOFROneMonthUSDTermRateMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Award Performance Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Performance Period",
        "terseLabel": "Award performance period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardAwardPerformancePeriod",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Correlation of Returns",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Correlation of Returns",
        "terseLabel": "Correlation of returns"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsCorrelationofReturns",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Peer Group Stock Price Volatility",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Peer Group Stock Price Volatility",
        "terseLabel": "Peer group stock price volatility"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsPeerGroupStockPriceVolatility",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Target",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Target",
        "terseLabel": "Performance shares target, percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardPerformanceTarget",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_SoftwareCapitalizationTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Software Capitalization Term",
        "label": "Software Capitalization Term",
        "terseLabel": "Software capitalization term"
       }
      }
     },
     "localname": "SoftwareCapitalizationTerm",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hae_SummaryOfSignificantAccountingPronouncementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of Significant Accounting Pronouncements [Line Items]",
        "label": "Summary of Significant Accounting Pronouncements [Line Items]",
        "terseLabel": "Summary of Significant Accounting Pronouncements [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPronouncementsLineItems",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hae_SummaryOfSignificantAccountingPronouncementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of Significant Accounting Pronouncements [Table]",
        "label": "Summary of Significant Accounting Pronouncements [Table]",
        "terseLabel": "Summary of Significant Accounting Pronouncements [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPronouncementsTable",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hae_TaxHolidayTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Holiday Term",
        "label": "Tax Holiday Term",
        "terseLabel": "Tax grant or holiday term"
       }
      }
     },
     "localname": "TaxHolidayTerm",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hae_TenLargestCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ten Largest Customers [Member]",
        "label": "Ten Largest Customers [Member]",
        "terseLabel": "Ten Largest Customers"
       }
      }
     },
     "localname": "TenLargestCustomersMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan [Member]",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_TermLoanNetofFinancingFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan, Net of Financing Fees [Member]",
        "label": "Term Loan, Net of Financing Fees [Member]",
        "terseLabel": "Term loan, net of financing fees"
       }
      }
     },
     "localname": "TermLoanNetofFinancingFeesMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_TransfersFromInventoryToFixedAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfers from inventory to fixed assets.",
        "label": "Transfers from Inventory to Fixed Assets",
        "terseLabel": "Transfers from inventory to fixed assets for placement of Haemonetics equipment"
       }
      }
     },
     "localname": "TransfersFromInventoryToFixedAssets",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_USBloodDonorManagementSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Blood Donor Management Software",
        "label": "U.S. Blood Donor Management Software [Member]",
        "terseLabel": "U.S. Blood Donor Management Software"
       }
      }
     },
     "localname": "USBloodDonorManagementSoftwareMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_UnrecognizedNetActuarialLossGain": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Net Actuarial Loss/(Gain)",
        "label": "Unrecognized Net Actuarial Loss / (Gain)",
        "terseLabel": "Unrecognized net actuarial gain"
       }
      }
     },
     "localname": "UnrecognizedNetActuarialLossGain",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_UnrecognizedPriorServiceCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Prior Service Cost",
        "label": "Unrecognized Prior Service Cost",
        "negatedTerseLabel": "Unrecognized prior service cost"
       }
      }
     },
     "localname": "UnrecognizedPriorServiceCost",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_VivasureMedicalLTDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vivasure Medical LTD",
        "label": "Vivasure Medical LTD [Member]",
        "terseLabel": "Vivasure Medical LTD"
       }
      }
     },
     "localname": "VivasureMedicalLTDMember",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/STRATEGICINVESTMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Grant Date Fair Value of Six-Month Option Inherent in Purchase Plan",
        "label": "Weighted Average Grant Date Fair Value of Six-Month Option Inherent in Purchase Plan",
        "terseLabel": "Weighted average grant date fair value of the six-month option inherent in the Purchase Plan (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageGrantDateFairValueOfSixMonthOptionInherentInPurchasePlan",
     "nsuri": "http://www.haemonetics.com/20230401",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "srt_AsiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia [Member]",
        "terseLabel": "Asia"
       }
      }
     },
     "localname": "AsiaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r401",
      "r721",
      "r722",
      "r725",
      "r726",
      "r789",
      "r844",
      "r920",
      "r923",
      "r924"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r401",
      "r721",
      "r722",
      "r725",
      "r726",
      "r789",
      "r844",
      "r920",
      "r923",
      "r924"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r401",
      "r442",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r460",
      "r464",
      "r520",
      "r521",
      "r522",
      "r523",
      "r525",
      "r526",
      "r528",
      "r530",
      "r531",
      "r921",
      "r922"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r401",
      "r442",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r460",
      "r464",
      "r520",
      "r521",
      "r522",
      "r523",
      "r525",
      "r526",
      "r528",
      "r530",
      "r531",
      "r921",
      "r922"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r362",
      "r405",
      "r412",
      "r418",
      "r483",
      "r668",
      "r669",
      "r670",
      "r702",
      "r703",
      "r733",
      "r736",
      "r738",
      "r739",
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r362",
      "r405",
      "r412",
      "r418",
      "r483",
      "r668",
      "r669",
      "r670",
      "r702",
      "r703",
      "r733",
      "r736",
      "r738",
      "r739",
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r362",
      "r405",
      "r412",
      "r418",
      "r483",
      "r668",
      "r669",
      "r670",
      "r702",
      "r703",
      "r733",
      "r736",
      "r738",
      "r739",
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Non-employee director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EnergyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Energy [Axis]",
        "terseLabel": "Energy [Axis]"
       }
      }
     },
     "localname": "EnergyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EnergyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Energy [Domain]",
        "terseLabel": "Energy [Domain]"
       }
      }
     },
     "localname": "EnergyDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/STRATEGICINVESTMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r470",
      "r867",
      "r927",
      "r1029"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r658",
      "r795",
      "r814",
      "r845",
      "r846",
      "r864",
      "r874",
      "r882",
      "r925",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails",
      "http://www.haemonetics.com/role/LEASESDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r658",
      "r795",
      "r814",
      "r845",
      "r846",
      "r864",
      "r874",
      "r882",
      "r925",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails",
      "http://www.haemonetics.com/role/LEASESDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r470",
      "r867",
      "r927",
      "r1029"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r466",
      "r797",
      "r865",
      "r880",
      "r927",
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r466",
      "r797",
      "r865",
      "r880",
      "r927",
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r621",
      "r658",
      "r794",
      "r795",
      "r814",
      "r845",
      "r846",
      "r864",
      "r874",
      "r882",
      "r925",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails",
      "http://www.haemonetics.com/role/LEASESDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r621",
      "r658",
      "r794",
      "r795",
      "r814",
      "r845",
      "r846",
      "r864",
      "r874",
      "r882",
      "r925",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails",
      "http://www.haemonetics.com/role/LEASESDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/STRATEGICINVESTMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r467",
      "r468",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r866",
      "r881",
      "r927"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r467",
      "r468",
      "r828",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r866",
      "r881",
      "r927"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r976",
      "r1014",
      "r1015",
      "r1017"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [Member]",
        "terseLabel": "Subsidiaries"
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r913",
      "r1016"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.",
        "label": "Accelerated Share Repurchases, Final Price Paid Per Share",
        "terseLabel": "Repurchase price (in dollars per share)"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accelerated Share Repurchases [Line Items]",
        "terseLabel": "Accelerated Share Repurchases [Line Items]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt": {
     "auth_ref": [
      "r186"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.",
        "label": "Accelerated Share Repurchases, Settlement (Payment) or Receipt",
        "terseLabel": "Accelerated Share Repurchases, Settlement (Payment) or Receipt"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesSettlementPaymentOrReceipt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTable": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.",
        "label": "Accelerated Share Repurchases [Table]",
        "terseLabel": "Accelerated Share Repurchases [Table]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "auth_ref": [
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "terseLabel": "Accounting Standards Update 2020-06"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r51",
      "r879"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r915"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r368",
      "r472",
      "r473",
      "r852"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, less allowance for credit losses of $4,932 at April 1, 2023 and $2,475 at April 2, 2022"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r71",
      "r77",
      "r283",
      "r894",
      "r895",
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Defined benefit plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r49",
      "r154"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r69",
      "r77",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Net Unrealized Gain (Loss) on Derivatives"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r72",
      "r77",
      "r971"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedPeriodEndLabel": "Impact of defined benefit plans, net of tax, balance",
        "negatedPeriodStartLabel": "Impact of defined benefit plans, net of tax, balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofChangeRecordedinAccumulatedOtherComprehensiveIncomeRelatedtoDefinedBenefitPlansNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r369",
      "r809",
      "r822",
      "r826"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Accumulated other comprehensive income (loss), Balance",
        "periodStartLabel": "Accumulated other comprehensive income (loss), Balance",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1",
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r381",
      "r382",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r74",
      "r77",
      "r283",
      "r817",
      "r818",
      "r851",
      "r894",
      "r895",
      "r896",
      "r905",
      "r906",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income/(Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r68",
      "r77",
      "r283",
      "r382",
      "r383",
      "r765",
      "r766",
      "r767",
      "r768",
      "r770",
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign currency"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted-Average Amortization Period"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r668",
      "r669",
      "r670",
      "r905",
      "r906",
      "r907",
      "r1006"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r406",
      "r407",
      "r408",
      "r409",
      "r418",
      "r475",
      "r476",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r519",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r700",
      "r701",
      "r702",
      "r703",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r788",
      "r799",
      "r800",
      "r801",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Non-cash items:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Equity component of convertible notes, net of issuance costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r200",
      "r202",
      "r238",
      "r239"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r673"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising expense"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r438",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "All Other"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r202",
      "r232",
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense recognized"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r474",
      "r486",
      "r487",
      "r490"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r370",
      "r474",
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETSPARENTHETICAL"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r489"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write-offs"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r90",
      "r107",
      "r320",
      "r555"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "negatedTerseLabel": "Debt discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r83",
      "r555",
      "r774",
      "r901"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of deferred financing costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r107",
      "r137",
      "r145"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets",
        "verboseLabel": "Aggregate amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Anti-dilutive shares (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r1002"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r1002"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r107",
      "r150"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment of assets"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r327",
      "r342",
      "r396",
      "r450",
      "r456",
      "r462",
      "r479",
      "r520",
      "r521",
      "r523",
      "r524",
      "r525",
      "r527",
      "r529",
      "r531",
      "r532",
      "r721",
      "r725",
      "r750",
      "r879",
      "r921",
      "r922",
      "r1018"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r18",
      "r19",
      "r65",
      "r396",
      "r479",
      "r520",
      "r521",
      "r523",
      "r524",
      "r525",
      "r527",
      "r529",
      "r531",
      "r532",
      "r721",
      "r725",
      "r750",
      "r879",
      "r921",
      "r922",
      "r1018"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average period remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Average Remaining Maturity of Foreign Currency Derivatives",
        "terseLabel": "Maturity period for foreign currency contracts"
       }
      }
     },
     "localname": "AverageRemainingMaturityOfForeignCurrencyDerivatives1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r203",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r293",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and building improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingImprovementsMember": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Addition, improvement, or renovation to a facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building Improvements [Member]",
        "terseLabel": "Building improvements"
       }
      }
     },
     "localname": "BuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r872",
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails",
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails",
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r265",
      "r266",
      "r872",
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails",
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails",
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails",
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails",
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r1000",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business Acquisition, Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r716",
      "r717"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Business Acquisition, Pro Forma Net Income (Loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r716",
      "r717"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Business Acquisition, Pro Forma Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Business Combination, Acquisition Related Costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r274",
      "r275",
      "r278"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business Combination, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r720",
      "r900"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r273",
      "r276",
      "r719"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Business Combination, Contingent Consideration, Liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r273",
      "r277"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions and Strategic Investments"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSANDSTRATEGICINVESTMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails",
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Indefinite lived intangibles acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r267",
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r267",
      "r268"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r267",
      "r268"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed": {
     "auth_ref": [
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs which have been expensed.",
        "label": "Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed",
        "terseLabel": "Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Valuation of Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "auth_ref": [
      "r355",
      "r358"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for amortization of capitalized computer software costs.",
        "label": "Capitalized Computer Software, Amortization",
        "terseLabel": "Capitalized costs amortized (placed into service)"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareImpairments1": {
     "auth_ref": [
      "r356",
      "r358"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss from capitalized computer software costs.",
        "label": "Capitalized Computer Software, Impairments",
        "terseLabel": "Impairment charges related to the discontinuance of certain capitalized software projects"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareImpairments1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers": {
     "auth_ref": [
      "r28",
      "r326",
      "r341",
      "r354"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unamortized costs incurred for development of computer software, which is to be sold, leased or otherwise marketed, after establishing technological feasibility through to the general release of the software products. Excludes capitalized costs of developing software for internal use.",
        "label": "Capitalized Software Development Costs for Software Sold to Customers",
        "terseLabel": "Total costs capitalized related to in process software development initiatives"
       }
      }
     },
     "localname": "CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r16",
      "r46",
      "r109"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r25",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r103",
      "r109",
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and Cash Equivalents at End of Year",
        "periodStartLabel": "Cash and Cash Equivalents at Beginning of Year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r103",
      "r318"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net Change in Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r170",
      "r172",
      "r517",
      "r518",
      "r830"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r173",
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r905",
      "r906",
      "r1006"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETSPARENTHETICAL"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETSPARENTHETICAL"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETSPARENTHETICAL"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r35",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETSPARENTHETICAL"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r35",
      "r879"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01\u00a0par value; Authorized\u00a0\u2014 150,000,000\u00a0shares; Issued and outstanding\u00a0\u2014 50,448,519\u00a0shares at April 1, 2023 and 51,124,240\u00a0shares at April 2, 2022"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r188",
      "r189",
      "r199",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "RETIREMENT PLANS"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r79",
      "r377",
      "r379",
      "r386",
      "r805",
      "r811"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r875",
      "r916",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Capitalized software"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r115",
      "r116",
      "r316",
      "r317",
      "r470",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r115",
      "r116",
      "r316",
      "r317",
      "r470",
      "r827",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk by Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r115",
      "r116",
      "r316",
      "r317",
      "r470",
      "r829",
      "r1030"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk by Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r338",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk and Significant Customers"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r115",
      "r116",
      "r316",
      "r317",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r115",
      "r116",
      "r316",
      "r317",
      "r470",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r282",
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r576",
      "r577",
      "r598"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r576",
      "r577",
      "r598"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r599"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r176",
      "r533",
      "r534",
      "r545",
      "r546",
      "r547",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible notes"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleLongTermNotesPayable": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.",
        "label": "Convertible Notes Payable, Noncurrent",
        "terseLabel": "Convertible Notes Payable, Noncurrent"
       }
      }
     },
     "localname": "ConvertibleLongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r125",
      "r455",
      "r456",
      "r457",
      "r458",
      "r464",
      "r912"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate, Non-Segment [Member]"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r86",
      "r797"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Goods Sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofShareBasedCompensationDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r929"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Shipping and Handling Costs"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r165",
      "r166",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Costs Associated with Exit Activities"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r259",
      "r904",
      "r997"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r904",
      "r997"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r259",
      "r697",
      "r707",
      "r904"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r259",
      "r904",
      "r997"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r114",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerContractsMember": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's established relationships with its customers through contracts.",
        "label": "Customer Contracts [Member]",
        "terseLabel": "Customer contracts and related relationships"
       }
      }
     },
     "localname": "CustomerContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r179",
      "r394",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r549",
      "r556",
      "r557",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "NOTES\u00a0PAYABLE AND LONG-TERM DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r29",
      "r30",
      "r31",
      "r328",
      "r330",
      "r340",
      "r401",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r539",
      "r545",
      "r546",
      "r547",
      "r548",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r775",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r178",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Debt Instrument, Convertible, Conversion Price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r321",
      "r323",
      "r533",
      "r775",
      "r860",
      "r861"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r56",
      "r321",
      "r561",
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r56",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r57",
      "r401",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r539",
      "r545",
      "r546",
      "r547",
      "r548",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r775",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Debt Instrument, Redemption Price, Percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of principal amount of debt redeemed.",
        "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed",
        "terseLabel": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r57",
      "r181",
      "r182",
      "r183",
      "r184",
      "r320",
      "r321",
      "r323",
      "r336",
      "r401",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r539",
      "r545",
      "r546",
      "r547",
      "r548",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558",
      "r775",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtPolicyTextBlock": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.",
        "label": "Debt, Policy [Policy Text Block]",
        "terseLabel": "Debt, Policy"
       }
      }
     },
     "localname": "DebtPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r259",
      "r904",
      "r998"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r259",
      "r904",
      "r998"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r679",
      "r680"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax asset"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r259",
      "r698",
      "r706",
      "r707",
      "r904"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r32",
      "r33",
      "r329",
      "r339",
      "r691"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r679",
      "r680"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "negatedTerseLabel": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOtherTaxExpenseBenefit": {
     "auth_ref": [
      "r255",
      "r258",
      "r904"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods.",
        "label": "Deferred Other Tax Expense (Benefit)",
        "terseLabel": "Deferred tax benefit"
       }
      }
     },
     "localname": "DeferredOtherTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r259",
      "r904",
      "r998"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r692"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r254",
      "r996"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r995"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Total deferred tax assets (after valuation allowance)"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r254",
      "r996"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carry-forward"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Operating loss carry-forwards not subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Operating loss carry-forwards subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r253",
      "r254",
      "r996"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credit carry-forward, net"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r254",
      "r996"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "auth_ref": [
      "r254",
      "r996"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "terseLabel": "Accruals, reserves and other deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r693"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r244",
      "r995"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r254",
      "r996"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Other deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "auth_ref": [
      "r996"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "negatedTerseLabel": "Unremitted earnings",
        "terseLabel": "Unremitted earnings"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofNetDeferredTaxAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r629"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r611"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "verboseLabel": "Actuarial gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r604",
      "r635",
      "r649",
      "r870",
      "r871"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r604",
      "r636",
      "r650",
      "r870",
      "r871"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "terseLabel": "Amortization of unrecognized prior service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofWeightedAverageRatesUsedtoDetermineNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r642",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Expected long-term rate of return on assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofWeightedAverageRatesUsedtoDetermineNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of increased salary levels"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofWeightedAverageRatesUsedtoDetermineNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r606"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "negatedPeriodEndLabel": "Benefit obligation, end of year",
        "negatedPeriodStartLabel": "Benefit Obligation, beginning of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r613",
      "r654"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Benefits Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r610"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "negatedTerseLabel": "Employee and plan participants contribution"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in Benefit Obligation:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in Plan Assets:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r616",
      "r623",
      "r652",
      "r868",
      "r869",
      "r870",
      "r871"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Contributions by Employer"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Expected Future Benefit Payment [Abstract]",
        "terseLabel": "Expected Benefit Payments"
       }
      }
     },
     "localname": "DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear": {
     "auth_ref": [
      "r359"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost (credit) included in accumulated other comprehensive (income) loss expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.",
        "label": "Defined Benefit Plan, Expected Amortization, Next Fiscal Year",
        "terseLabel": "Amount expected to be amortized from accumulated other comprehensive loss in next fiscal year"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedAmortizationNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r630"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "Fiscal 2029-2033"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r630"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r630"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "Fiscal 2028"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r630"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "Fiscal 2027"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r630"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "Fiscal 2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r630"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r604",
      "r634",
      "r648",
      "r870",
      "r871"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r614",
      "r622",
      "r623",
      "r624",
      "r868",
      "r869",
      "r870"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Fair value of plan assets, end of year",
        "periodStartLabel": "Fair value of plan assets, beginning of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Period Increase (Decrease)",
        "terseLabel": "Gain (loss) on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Foreign currency changes"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r603",
      "r620",
      "r870"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded Status*"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r604",
      "r609",
      "r633",
      "r647",
      "r870",
      "r871"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "negatedTerseLabel": "Interest cost",
        "terseLabel": "Interest cost on benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails",
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r631",
      "r645",
      "r870",
      "r871"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Totals"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": {
     "auth_ref": [
      "r643",
      "r644",
      "r870"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation",
        "negatedTotalLabel": "Net amount recognized"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r618",
      "r991"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Benefits Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r615"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency changes"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r605",
      "r637",
      "r651"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedTerseLabel": "Plan settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r607",
      "r632",
      "r646",
      "r870",
      "r871"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "negatedTerseLabel": "Service cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails",
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofNetPeriodicBenefitCostsofDefinedBenefitPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "auth_ref": [
      "r608"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r619"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedTerseLabel": "Plan settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofActivityUnderDefinedBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r194",
      "r195",
      "r196",
      "r197",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Company contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r107",
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r107",
      "r152"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r66",
      "r296",
      "r324",
      "r371",
      "r853"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative Assets"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r66",
      "r296",
      "r324",
      "r371",
      "r853"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Derivative Liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r749"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Derivative, Fair Value, Net"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Derivative fixed interest rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r294",
      "r297",
      "r301",
      "r303",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r291",
      "r294",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r291",
      "r294",
      "r301",
      "r303",
      "r307",
      "r309",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r300",
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r1003",
      "r1004"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r287",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular group held by the entity.",
        "label": "Derivative, Number of Instruments Held",
        "terseLabel": "Number of instruments held"
       }
      }
     },
     "localname": "DerivativeNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r286",
      "r288",
      "r289",
      "r291",
      "r292",
      "r299",
      "r301",
      "r304",
      "r306",
      "r309",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesAndFairValueTextBlock": {
     "auth_ref": [
      "r310",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.",
        "label": "Derivatives and Fair Value [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "DerivativesAndFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r286",
      "r288",
      "r291",
      "r292",
      "r305",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "CAPITAL STOCK"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCK"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r151",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r158"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r158"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r158"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Intangible Assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r158"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Inventory"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r158"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r158"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r158"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r501",
      "r901",
      "r918"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "negatedTerseLabel": "Gains on divestitures and sale of assets",
        "terseLabel": "Gains on divestitures and sale of assets"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r14",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "DIVESTITURE"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITURE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r872",
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r387",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r419",
      "r421",
      "r423",
      "r424",
      "r425",
      "r429",
      "r739",
      "r740",
      "r806",
      "r812",
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income per share - basic (in dollars per share)",
        "verboseLabel": "Basic income per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic EPS"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r387",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r421",
      "r423",
      "r424",
      "r425",
      "r429",
      "r739",
      "r740",
      "r806",
      "r812",
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income per share - diluted (in dollars per share)",
        "verboseLabel": "Diluted income per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "verboseLabel": "Diluted EPS"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r426",
      "r427",
      "r428",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r763"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rates on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r682"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Income tax provision (benefit)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r398",
      "r682",
      "r709"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. federal statutory income tax rate",
        "verboseLabel": "Tax at federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r993",
      "r999"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r709",
      "r993"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "terseLabel": "Deferred statutory rate changes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r993",
      "r999"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "negatedTerseLabel": "Impact of foreign operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r993",
      "r999"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "terseLabel": "Non-deductible executive compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r993",
      "r999"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent",
        "terseLabel": "Non-deductible expenses"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r993",
      "r999"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent",
        "negatedTerseLabel": "Stock compensation shortfalls (benefits)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r993",
      "r999"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r993",
      "r999"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r993",
      "r999"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedTerseLabel": "Research credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued payroll and related costs"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r233"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation cost related to non vested awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Total unrecognized compensation cost related to non vested stock options, weighted average period of recognition (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r992"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP": {
     "auth_ref": [
      "r240"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the amount of cash contributions during the period made by the entity to the Employee Stock Ownership Plan (ESOP).",
        "label": "Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP",
        "terseLabel": "Proceeds from employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPCashContributionsToESOP",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of employee stock ownership plan.",
        "label": "Employee Stock Ownership Plan (ESOP) Name [Axis]",
        "terseLabel": "Employee Stock Ownership Plan (ESOP) Name [Axis]"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entities identify multiple employee stock ownership plans by unique name.",
        "label": "Employee Stock Ownership Plan (ESOP), Plan [Domain]",
        "terseLabel": "Employee Stock Ownership Plan (ESOP), Plan [Domain]"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r180",
      "r362",
      "r381",
      "r382",
      "r383",
      "r402",
      "r403",
      "r404",
      "r407",
      "r415",
      "r417",
      "r432",
      "r483",
      "r575",
      "r668",
      "r669",
      "r670",
      "r702",
      "r703",
      "r738",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r770",
      "r817",
      "r818",
      "r819",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1",
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r312",
      "r741",
      "r742",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r547",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r742",
      "r791",
      "r792",
      "r793",
      "r860",
      "r861",
      "r868",
      "r869",
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r741",
      "r742",
      "r743",
      "r744",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r547",
      "r623",
      "r628",
      "r742",
      "r791",
      "r868",
      "r869",
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r547",
      "r623",
      "r628",
      "r742",
      "r792",
      "r860",
      "r861",
      "r868",
      "r869",
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r547",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r742",
      "r793",
      "r860",
      "r861",
      "r868",
      "r869",
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r745"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Contingent Consideration, Acquisition Date Fair Value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r314"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "terseLabel": "Contingent Consideration, Increase (Decrease) in Fair Value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r547",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r791",
      "r792",
      "r793",
      "r860",
      "r861",
      "r868",
      "r869",
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r746",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Weighted average useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r498"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Intangible assets, accumulated amortization",
        "verboseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETSPARENTHETICAL",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r146"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r146"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Fiscal 2028"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r146"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Fiscal 2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r146"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Fiscal 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r146"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r495",
      "r497",
      "r498",
      "r500",
      "r798",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r144",
      "r802"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-Lived Intangible Assets, Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r138",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r144",
      "r798"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]",
        "terseLabel": "Amortizable:"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Year"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet": {
     "auth_ref": [
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivatives designated as cash flow hedging instruments.",
        "label": "Foreign Currency Cash Flow Hedge Derivative at Fair Value, Net",
        "terseLabel": "Designated foreign currency hedge contracts outstanding"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivatives not designated as hedging instruments.",
        "label": "Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net",
        "terseLabel": "Non-designated foreign currency hedge contracts outstanding"
       }
      }
     },
     "localname": "ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r759",
      "r760",
      "r761",
      "r762"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedTerseLabel": "Foreign currency losses"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Translation of Foreign Currencies"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r853",
      "r868",
      "r877"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet": {
     "auth_ref": [
      "r308",
      "r727"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net gain (loss) relating to components of the gain (loss) on the fair value hedging instrument excluded from the assessment of fair value hedge effectiveness. Recognized in earnings.",
        "label": "Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net",
        "terseLabel": "Amount of Gain Excluded from Effectiveness Testing"
       }
      }
     },
     "localname": "GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r901"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Assets",
        "negatedTerseLabel": "Gains on divestitures and sale of assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r89",
      "r129",
      "r893"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "terseLabel": "Gain (Loss) on Investments"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/STRATEGICINVESTMENTSDetails",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r724",
      "r901"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "terseLabel": "Gain (Loss) on Disposition of Business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r171"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Litigation-related charges"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r130",
      "r131",
      "r803",
      "r879"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      },
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, carrying amount",
        "periodStartLabel": "Goodwill, carrying amount",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails",
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails",
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.haemonetics.com/role/DIVESTITUREDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r134",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r132"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r133",
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Purchase accounting adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r85",
      "r396",
      "r450",
      "r455",
      "r461",
      "r464",
      "r479",
      "r520",
      "r521",
      "r523",
      "r524",
      "r525",
      "r527",
      "r529",
      "r531",
      "r532",
      "r750",
      "r858",
      "r921"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r291",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the impaired assets to be held and used by the entity.",
        "label": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]",
        "terseLabel": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]"
       }
      }
     },
     "localname": "ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the categories used to group impaired long-lived assets held and used by the type of asset.",
        "label": "Impaired Long-Lived Assets Held and Used by Type [Axis]",
        "terseLabel": "Impaired Long-Lived Assets Held and Used by Type [Axis]"
       }
      }
     },
     "localname": "ImpairedLongLivedAssetsHeldAndUsedByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r397",
      "r708"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r81",
      "r325",
      "r332",
      "r349",
      "r450",
      "r455",
      "r461",
      "r464",
      "r807",
      "r858"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.haemonetics.com/role/INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before provision (benefit) for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.haemonetics.com/role/INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r397",
      "r708"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign",
        "verboseLabel": "Foregin source income"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
      "http://www.haemonetics.com/role/INCOMETAXESScheduleDomesticandForeignIncomeBeforeProvisionforIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r872",
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r10",
      "r11",
      "r12",
      "r13",
      "r159",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r502",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofShareBasedCompensationDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofShareBasedCompensationDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r248",
      "r250",
      "r251",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r398",
      "r683",
      "r689",
      "r696",
      "r704",
      "r710",
      "r712",
      "r713",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r994"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r399",
      "r416",
      "r417",
      "r448",
      "r681",
      "r705",
      "r711",
      "r813"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision (benefit) for income taxes",
        "totalLabel": "Income tax provision (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails",
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofIncomeTaxProvisionComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r380",
      "r677",
      "r678",
      "r689",
      "r690",
      "r695",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r993"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "negatedLabel": "Valuation allowance",
        "verboseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r676",
      "r682"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Deferred statutory rate changes"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r993"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Impact of foreign operations"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r682"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Tax at federal statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r993"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "terseLabel": "Non-deductible executive compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r993"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "terseLabel": "Non-deductible expenses"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r993"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount",
        "terseLabel": "Stock compensation shortfalls (benefits)"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r993"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r993"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income taxes net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r993"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "negatedTerseLabel": "Research credits",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
      "http://www.haemonetics.com/role/INCOMETAXESScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r104",
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Change in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Change in accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Change in inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Change in other assets and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedLabel": "Change in prepaid income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r496",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Non-amortizable intangibles"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]",
        "terseLabel": "Non-amortizable:"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r140",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r136",
      "r142"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, less accumulated amortization of $417,422 at April 1, 2023 and $376,552 at April 2, 2022"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r319"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "terseLabel": "Interest costs capitalized"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r322",
      "r334",
      "r384",
      "r444",
      "r773"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r90",
      "r553",
      "r562",
      "r862",
      "r863"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r389",
      "r391",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r17",
      "r63",
      "r879"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r24",
      "r64",
      "r431",
      "r491",
      "r492",
      "r493",
      "r796",
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r478",
      "r1027"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Strategic Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r347"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/STRATEGICINVESTMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r741"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r1012"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost [Table Text Block]"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r1013"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r786"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r786"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due after Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r786"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r786"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r786"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Four"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r786"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Three"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r786"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Two"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r786"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r1011"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lessee, Operating Lease, Renewal Term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r1011"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r40",
      "r331",
      "r345",
      "r879",
      "r903",
      "r914",
      "r1008"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r55",
      "r396",
      "r479",
      "r520",
      "r521",
      "r523",
      "r524",
      "r525",
      "r527",
      "r529",
      "r531",
      "r532",
      "r722",
      "r725",
      "r726",
      "r750",
      "r879",
      "r921",
      "r1018",
      "r1019"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Liabilities fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r158",
      "r366",
      "r367"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Liabilities"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Commitment fee"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r31",
      "r330",
      "r343",
      "r546",
      "r560",
      "r860",
      "r861"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Debt outstanding"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "negatedTerseLabel": "Less current portion",
        "terseLabel": "Notes payable and current maturities of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Fair value of notes"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r174",
      "r401",
      "r551"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r174",
      "r401",
      "r551"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2028"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r174",
      "r401",
      "r551"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r174",
      "r401",
      "r551"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r174",
      "r401",
      "r551"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long term debt",
        "verboseLabel": "Long-term debt, net of current maturities"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r57",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Plant equipment and machinery",
        "verboseLabel": "Plant equipment and machinery"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MediumTermNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instruments with maturities ranging from five to ten years.",
        "label": "Medium-term Notes [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "MediumTermNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r390"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows from Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r390"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows from Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r103",
      "r105",
      "r108"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash Flows from Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r82",
      "r108",
      "r333",
      "r348",
      "r367",
      "r375",
      "r378",
      "r383",
      "r396",
      "r406",
      "r410",
      "r411",
      "r412",
      "r413",
      "r416",
      "r417",
      "r422",
      "r450",
      "r455",
      "r461",
      "r464",
      "r479",
      "r520",
      "r521",
      "r523",
      "r524",
      "r525",
      "r527",
      "r529",
      "r531",
      "r532",
      "r740",
      "r750",
      "r858",
      "r921"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r468"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Total long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r911"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of business units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r450",
      "r455",
      "r461",
      "r464",
      "r858"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r781",
      "r878"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r777"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r777"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r777"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r779",
      "r782"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r776"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r785",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r784",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carry-forwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments [Member]"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r15",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DESCRIPTIONOFTHEBUSINESSANDBASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r54"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "All other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r73",
      "r75",
      "r638"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax",
        "terseLabel": "Prior service cost"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofChangeRecordedinAccumulatedOtherComprehensiveIncomeRelatedtoDefinedBenefitPlansNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r70",
      "r75",
      "r638"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "negatedTerseLabel": "Actuarial loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofChangeRecordedinAccumulatedOtherComprehensiveIncomeRelatedtoDefinedBenefitPlansNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r77",
      "r80",
      "r382",
      "r764",
      "r766",
      "r770",
      "r894"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r372",
      "r373"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Unrealized gain (loss) on cash flow hedges, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r373",
      "r374"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Reclassifications into earnings of cash flow hedge (gains) losses, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax": {
     "auth_ref": [
      "r75",
      "r78",
      "r193"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSScheduleofComponentsofChangeRecordedinAccumulatedOtherComprehensiveIncomeRelatedtoDefinedBenefitPlansNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r80",
      "r180",
      "r376",
      "r379",
      "r385",
      "r764",
      "r769",
      "r770",
      "r804",
      "r810",
      "r894",
      "r895"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive (loss) income",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1",
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r72",
      "r75"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Impact of defined benefit plans, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r293",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other Current Assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherExpenses": {
     "auth_ref": [
      "r88",
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense classified as other.",
        "label": "Other Expenses",
        "terseLabel": "Other Expenses"
       }
      }
     },
     "localname": "OtherExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r20",
      "r21",
      "r54",
      "r879"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]",
        "terseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Interest and other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other non-cash operating activities"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Contingent consideration payments"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Share repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r506",
      "r899"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r94",
      "r718"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to Acquire Businesses, Gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails",
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherInvestments": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investments classified as other.",
        "label": "Payments to Acquire Other Investments",
        "negatedTerseLabel": "Payments to Acquire Other Investments"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToDevelopSoftware": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments to Develop Software",
        "terseLabel": "Software development costs capitalized"
       }
      }
     },
     "localname": "PaymentsToDevelopSoftware",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Share Units (PSUs)"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r203",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PositionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by position taken for a security.",
        "label": "Position [Axis]",
        "terseLabel": "Position [Axis]"
       }
      }
     },
     "localname": "PositionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PositionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates position taken for a security.",
        "label": "Position [Domain]",
        "terseLabel": "Position [Domain]"
       }
      }
     },
     "localname": "PositionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy": {
     "auth_ref": [
      "r127",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the estimated allowance for doubtful accounts for premium amounts due from policyholders, insureds, and other insurance entities. May include factors that management considered, such as historical loss experience and current economic and competitive conditions.",
        "label": "Premiums Receivable, Allowance for Doubtful Accounts, Estimation Methodology, Policy [Policy Text Block]",
        "terseLabel": "Allowance for Credit Losses"
       }
      }
     },
     "localname": "PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r18",
      "r44",
      "r45"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of convertible notes"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from divestitures"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Proceeds from Divestiture of Businesses, Net of Cash Divested"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.",
        "label": "Proceeds from Issuance of Secured Debt",
        "terseLabel": "Term loan borrowings"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails",
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Proceeds from revolving facility"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r897",
      "r898"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Net decrease in short-term loans"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of property, plant and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r97",
      "r235"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r49",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails",
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r161",
      "r832",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY, PLANT AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r48",
      "r153"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r26",
      "r27",
      "r155",
      "r346",
      "r808",
      "r879"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.haemonetics.com/role/LEASESDetails",
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r47",
      "r155",
      "r832",
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r26",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r26",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails",
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r388",
      "r488"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "negatedTerseLabel": "Credit (gain) loss"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r77",
      "r80",
      "r382",
      "r764",
      "r768",
      "r770",
      "r894"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r122",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of Revenues by Product Line"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESSummaryofGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repayment of term loan borrowings"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-term Lines of Credit",
        "negatedTerseLabel": "Payments on revolving facility"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r243",
      "r357",
      "r1026"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofShareBasedCompensationDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r504",
      "r506",
      "r509",
      "r515",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "RESTRUCTURING"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURING"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r505",
      "r508",
      "r512",
      "r514"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Restructuring and Related Cost, Cost Incurred to Date"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r505",
      "r508",
      "r512",
      "r514"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r505",
      "r508",
      "r512",
      "r514"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "terseLabel": "Restructuring costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r107",
      "r510",
      "r512",
      "r919"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Cost Incurred"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]",
        "verboseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r506",
      "r511"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Restructuring liability"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r37",
      "r185",
      "r344",
      "r671",
      "r821",
      "r826",
      "r879"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r362",
      "r402",
      "r403",
      "r404",
      "r407",
      "r415",
      "r417",
      "r483",
      "r668",
      "r669",
      "r670",
      "r702",
      "r703",
      "r738",
      "r817",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanNameAxis": {
     "auth_ref": [
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r874",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Axis]",
        "terseLabel": "Retirement Plan Name [Axis]"
       }
      }
     },
     "localname": "RetirementPlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanNameDomain": {
     "auth_ref": [
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r874",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Domain]",
        "terseLabel": "Retirement Plan Name [Domain]"
       }
      }
     },
     "localname": "RetirementPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r441",
      "r442",
      "r454",
      "r459",
      "r460",
      "r466",
      "r467",
      "r470",
      "r596",
      "r597",
      "r797"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Net revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r470",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Net Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r602",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r586",
      "r587",
      "r600",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]"
       }
      }
     },
     "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information when using transition method for cumulative effect in initial period of application for revenue from contract with customer.",
        "label": "Revenue, Initial Application Period Cumulative Effect Transition [Table]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Table]"
       }
      }
     },
     "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r584"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Performance obligation amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Timing of satisifaction"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining duration of performance obligation for which optional exemption was applied not to disclose amount of transaction price allocated to and timing of revenue recognition for remaining performance obligation, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Optional Exemption, Remaining Duration",
        "terseLabel": "Optional exemption term"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEDetails",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r926"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Performance obligation percent"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r783",
      "r878"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r77",
      "r1009",
      "r1010"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Components of Change Recorded in Accumulated Other Comprehensive Income Related to Defined Benefit Plans, Net of Tax"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Used, Other than Options",
        "verboseLabel": "Schedule of Weighted Average Rates Used to Determine Net Periodic Benefit Costs"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKTables",
      "http://www.haemonetics.com/role/RETIREMENTPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r265",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails",
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails",
      "http://www.haemonetics.com/role/ACQUISITIONSPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r265",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Income Tax Provision Components"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Notes Payable and Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Net Deferred Tax Asset"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r294",
      "r301",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Derivative Instruments as They Appear in Consolidated Balance Sheets"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r908"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r202",
      "r231",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Stock-Based Compensation Cost"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Estimated Future Benefit Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r741",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r138",
      "r143",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r138",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Amoritized Intangibles"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r134",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r134",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule Domestic and Foreign Income Before Provision for Income Tax"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r147",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails",
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments.",
        "label": "Schedule of Interest Rate Derivatives [Table Text Block]",
        "terseLabel": "Schedule of Interest Rate Derivatives"
       }
      }
     },
     "localname": "ScheduleOfInterestRateDerivativesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r24",
      "r41",
      "r42",
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Schedule of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/STRATEGICINVESTMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule of Investments [Table]",
        "terseLabel": "Schedule of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/STRATEGICINVESTMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Notes Payable and Long-Term Debt Maturities"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Components of Net Periodic Benefit Costs of Defined Benefit Pension Plans"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetFundedStatusTableTextBlock": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of net funded status of pension plans and/or other employee benefit plans.",
        "label": "Schedule of Net Funded Status [Table Text Block]",
        "terseLabel": "Schedule of Activity Under Defined Benefit Plans"
       }
      }
     },
     "localname": "ScheduleOfNetFundedStatusTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RETIREMENTPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r49",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r505",
      "r506",
      "r507",
      "r508",
      "r512",
      "r513",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r163",
      "r164",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs by Segment"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r162",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring and Transformation Costs by Type of Cost"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r84",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Selected Information by Business Segment"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r120",
      "r121",
      "r123",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding performance-based awards that are fully vested and expected to vest. Includes, but is not limited to, unvested awards for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]",
        "terseLabel": "Schedule of Performance Share Unit awards"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r203",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofShareBasedCompensationDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Summary of Restricted Stock Units Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r209",
      "r220",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Summary of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Utilized for Estimating Fair Value of Option Grants"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r1005"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r438",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r470",
      "r508",
      "r514",
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r438",
      "r439",
      "r440",
      "r450",
      "r453",
      "r458",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r469",
      "r470",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT AND ENTERPRISE-WIDE INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofShareBasedCompensationDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r865"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service [Member]"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Shares, Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted Average Grant Date Fair Value (in dollars per share), Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Shares, Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted Average Grant Date Fair Value (in dollars per share), Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Shares, Ending Balance (in shares)",
        "periodStartLabel": "Shares, Beginning Balance (in shares)",
        "terseLabel": "Equity instruments other than options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted Average Grant Date Fair Value (in dollars per share), Ending Balance",
        "periodStartLabel": "Weighted Average Grant Date Fair Value (in dollars per share), Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Shares, Vested (in shares)",
        "terseLabel": "Shares, Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted Average Grant Date Fair Value (in dollars per share), Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend Yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected stock price volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofShareBasedCompensationDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Maximum number of shares available for award (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Maximum number of shares available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options Outstanding, (in shares), Exercisable and End of Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r222"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Options Outstanding, (in shares), Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options Outstanding, (in shares), Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Fair value per option (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r211",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options Outstanding, (in shares), Ending Balance",
        "periodStartLabel": "Options Outstanding, (in shares), Beginning Balance",
        "terseLabel": "Options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Exercise Price (in dollars per share), Ending Balance",
        "periodStartLabel": "Weighted Average Exercise Price (in dollars per share), Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r225"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Exercisable at End of Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price (in dollars per share), Exercisable at End of Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Vested and Expected to Vest at End of Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Options Outstanding, (in shares), Vested and Expected to Vest at End of Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price (in dollars per share), Vested or Expected to Vest at End of Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r201",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofEquityAwardsotherthanOptionsActivityDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price (in dollars per share), Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price (in dollars per share), Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Weighted Average Exercise Price (in dollars per share), Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r203",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Award expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r227",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails",
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofAssumptionsUsedtoEstimateFairValueDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Life, Balance"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Life, Exercisable at End of Period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Life, Vested or Expected to Vest at End of Period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance, shares (in shares)",
        "periodStartLabel": "Balance, shares (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r113",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit",
        "terseLabel": "Unrecognized tax positions possible change in the next twelve months"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Software Development"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs incurred to (1) establish the technological feasibility of a computer software product to be sold, leased, or otherwise marketed; and (2) produce product masters after establishing technological feasibility. This accounting policy also may apply to purchased computer software. This policy also may address the entity's amortization policy for its capitalized computer software costs and how it evaluates such capitalized costs for impairment.",
        "label": "Software to be Sold, Leased, or Otherwise Marketed, Policy [Policy Text Block]",
        "terseLabel": "Accounting for the Costs of Computer Software to be Sold, Leased, or Otherwise Marketed"
       }
      }
     },
     "localname": "SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r365",
      "r438",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r470",
      "r494",
      "r503",
      "r508",
      "r514",
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r59",
      "r180",
      "r362",
      "r381",
      "r382",
      "r383",
      "r402",
      "r403",
      "r404",
      "r407",
      "r415",
      "r417",
      "r432",
      "r483",
      "r575",
      "r668",
      "r669",
      "r670",
      "r702",
      "r703",
      "r738",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r770",
      "r817",
      "r818",
      "r819",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails1",
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r432",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Share-based Payment Arrangement"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r34",
      "r35",
      "r180",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "verboseLabel": "Employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r34",
      "r35",
      "r180",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net of cancellations (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r34",
      "r35",
      "r180",
      "r185",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options Outstanding, (in shares), Exercised",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKScheduleofSummaryofStockOptionActivityDetails",
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r34",
      "r35",
      "r180",
      "r185"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r180",
      "r185"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net of cancellations"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r59",
      "r180",
      "r185"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Stock Repurchase Program, Period in Force",
        "terseLabel": "Stock Repurchase Program, Period in Force"
       }
      }
     },
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock Repurchase Program, Remaining Authorized Repurchase Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r34",
      "r35",
      "r180",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Shares repurchased (in shares)",
        "terseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.haemonetics.com/role/EARNINGSPERSHAREShareRepurchasePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r34",
      "r35",
      "r180",
      "r185"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r35",
      "r38",
      "r39",
      "r128",
      "r879",
      "r903",
      "r914",
      "r1008"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "negatedTerseLabel": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance, value",
        "periodStartLabel": "Balance, value",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r187",
      "r395",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE LOSS"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r771",
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r771",
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r771",
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r246",
      "r250",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Summary of Gross Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Disclosures of Cash Flow Information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "auth_ref": [
      "r2",
      "r156"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.",
        "label": "Tangible Asset Impairment Charges",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "TangibleAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/GOODWILLANDINTANGIBLEASSETSIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONSIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r406",
      "r407",
      "r408",
      "r409",
      "r418",
      "r475",
      "r476",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r519",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r700",
      "r701",
      "r702",
      "r703",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r788",
      "r799",
      "r800",
      "r801",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r337",
      "r352",
      "r674",
      "r714"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed foreign earnings of subsidiaries"
       }
      }
     },
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r675",
      "r684"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
      "http://www.haemonetics.com/role/INCOMETAXESSummaryofGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions",
        "negatedLabel": "Reductions of tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESSummaryofGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r687"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "terseLabel": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESSummaryofGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r686"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Unrecognized tax benefits increases",
        "verboseLabel": "Additions for tax positions of current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails",
      "http://www.haemonetics.com/role/INCOMETAXESSummaryofGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r685"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESSummaryofGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r688"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that will impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r433",
      "r434",
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r694"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r1007"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Valuation Technique, Discounted Cash Flow"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofInterestRateSwapsDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTScheduleofNotesPayableandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CAPITALSTOCKNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r908"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Net effect of common stock equivalents (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r420",
      "r425"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted average shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r419",
      "r425"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic weighted average shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.haemonetics.com/role/EARNINGSPERSHAREScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1000": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1001": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1002": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1003": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1004": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1005": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1006": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1007": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1008": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1009": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1010": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1011": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1012": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1013": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1014": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1015": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1016": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1017": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1018": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1019": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1020": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1021": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1022": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1023": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1024": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1025": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1026": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1027": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1028": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1029": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1030": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466103&loc=SL6014347-161799",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=d3e5291-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.7)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6933075&loc=SL5748726-161290",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(s)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123452999&loc=d3e28200-109314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4,6)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r883": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r884": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r885": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r886": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r887": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r888": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r889": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r891": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r892": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r993": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r995": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r996": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r997": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r998": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r999": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>109
<FILENAME>0000313143-23-000014-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000313143-23-000014-xbrl.zip
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MUTD*4T.R( Z&'@_PY3+&CUE]B,!-FH!"<BZH6[@I-@>#O_;I2CB\< &I<V:
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MS3PRILDG[6!&5WQ0N=2J5??3B6!"#MI>]3>T,TZ&"\JV@]<+6A %-V0#MZ+
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M_Y1_<8EY[;>Y9';7W>-_ %!+ P04    " "(@+96R>Y]9'(%  !9%P  #P
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MJ)-_^[/@=IM.!<12B-(R6'&S="9-A"A("N]8+I6SY"5AF13,\%CC$:WRZO"
M(SO[\* 71<%P*K.<B+5["X=/ 8=?2)5!&#1^@D0JISE'G)("PT.'PB17/*TR
MMUX>^$1#PE,<VV)!MQ<*KR TF@@*)Y?QDH@%0QA9QK6V*/#?SJ1XK<"2*8:
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M^WI,>]N\U6_9=';M[_&?4$L#!!0    ( (B ME;D< *C([<$ %D;,0 0
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M]841HV\*B7$EP)@R93<&S.9]^\ 4/61QQ$Y#6*M*JMZ9-]@X43Q%<1Q3C\-
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M-4'?K+E=Y'IY8&Z$826F7H"S^.P*M))RCE42%(K.0K9ENQCV\L#<",VFX#5
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M316<C84X,=; "F7V3:XJF)]!!KOLYS\4,"[9-9>A"D%*0HG)]';R?>*OT$[
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M[_5__,-S[\\N(&K>O("5$I4?6FFU3\U3S4"%JLG!LRLN\D[ +DO 'KV8;Z.
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M$D&A4J!W7B-H#JU-*C0Y%9;A9Z5LJ0!=[ S1&G,SI$*KHNY6\\!&,&+(K=E
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M%V()IMKBR$?KO30S@GG)(6 S@+E)8YL&.%'C8S53 =6&,5,*4JW/N6U!A/-
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MMMI7H5#]1E>@NMK""$1I!_CGM7C.*4J?FC9!G4G 9D."4IMZ*2&Y.*+H8'2
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MA?\*PN>>&3LNJ<-=I'M>1Z@EV:US+-EMR>UK?^D @8($"P0X "B9_O5O;K4
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MBK",,O-F!8=083=P%Z(E_0NRG-Z58'=*[S*&5\-KO12^,$-3YB(NR A._33
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M"\\V*P/=\_O< Y$$%QE\EA_>Q_I'[K"?T,:Z<&?F][F9EQ-XT>\);+!?;*.
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M.6'YOD*^T[V>?W&/VR6RL^5$ 6);&(#-:$$II#@&[GFO-P,N"!LT?%8?97#
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M_]&9GL'=X)_ 20=_0P\\ 4,<+66M2/2@V(?!;9OXESP6>':9Q["NI"#\!'1
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M F7/*L]=.K(S\RV2IG*8'VK#Q>\VU)\W>W0%(2TO^.^B-ML(8@[CD$+BZDN
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MV50H<6K16I)S;M\*CS51N<S9#A7V6NR<#C]Q/9K;G0>Q"@5]@( T38=4CB'
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M'6<9&-*D&^F\H7^A$"0Q+'9H2$@+[ZF3$ $C1UH+43" &/5A<1  5OCX0F&
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MT*2R;OE0%,_,9D2!&[$KM%R8BZZE12V</-V5<3__7V _BQ\[3'B5W,(HF71
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M#$?%]9[6W6&X4!..HW!?D6#G]E"J)%EWO2#ESW/?W2O"]?03LJ!,IB#]SZ*
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M7!073^>-Y1I2A?P"F81T/6:RR&2*I<=5 I1YMB[IT*/RZ8?5'I\/*Q$'=2:
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ME9PT\2+ A$+#9?5WK7<AKC;)F #J4O@Y^']#)$3K7=M!X+,[P9[6QZ6JMRC
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M(<K<R*?H\22;8 1=D5#7WL)@KBFS#] %P6<.:Z34IB<JM(?WB&(/]$Q,?FL
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M@#.]DLAHR"+!>]EJE8W>@P 0?<)A_5)&?!9F/D<?,9,/=M:P&>#\@X*R,\U
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MZV*,(^&EY<?.C->!M@W"G6=6F#@J2SHGF%"&[/O+*DSDP8.]?W(]-[;7%R7
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MH6*H!+S>+F!_OO-H R'81.[G\KQ-HF#%:C0UH1T!N #2]8H-K"]#FJH4Q$!
MAGDV(A#+[64I+/_A>\B'0YZ&7/F49Y<Y&RFO_]__]$U3?PMOULL/Z2/C[2^
M4%Z^N!@#?O 8(!)8^-]I4B2X*&UDYF2PF_I7;)2!^/]![T=2IE_BH9-T J2<
M@%0$6!1\@C0&$B !FD%I$L-'2G"C# #.(!7@", $@*F0:P$MC-#C:4$+J\HP
MNX:GFK#Y;9AED?*>!C^K#?C%.:$.?E],*NJ_'&8![+^8CL?P=F R^!S/4?^L
M8$-8%S\#Q'SCS?;W#Z+1%5^6I"OIR\;@[3@3D'Y#G)=<\;?72309R NL^2MQ
MM[[1ZY^PH,C01%SYDX4AV<^OD1(/6=8L+)K_.\C+W8S9)> ?4/)-8S%L]@T;
M7K.;XM6O,V<:)6FYN.WW$(3SIU]YQCA^R!G]>QQ1*$; &)E@QC>@4/$<GX(M
ML;9L11GD//[[J_])F!_Z41ASVW$L.W("W]5UAP>\;[B1P[W@/]ZK=Q>HTR!3
MOX<7 O$4?_N5O5N&QF>0S MICT15QRP%BAG!WOZW4/XL:+,G6:K]?G#P23D&
MSI[FC>R"%E\Q]4&4*=[::7F(.$E!*(+45$;R."CL%%3-2>3"W;'X"#T1 OHC
M%*CB_L&_IRG)-;A]X/DQ"KQ+GM(U?H/?\_&$!#?=*G^F"?YU/@%E@)24@Q$<
M+635??)G[[RGX![KRP0V,\K@=Z @B;N_W%A#O.-2^&6I?*@@<+_AE8H/P O+
MS_&.H1I6> (44B#%I!C M]$EW"4DJ%%K"E$_C:>@O'*X'8KI< (:Y<6  RG<
M D*E "UL"._B<$VD10+<@5< W@Z$ WATDJGTDC2;*,"]TZ"8)!,0M/A6E>Z4
MG(_AZL,;IUI?[@#K5\3-OP0/%=AZR%9P,$!Y.,USN+-O%+##KB<#>/,MNU?K
M8R <A<;8U+X"/@'56F!1K#PI53A #&EB@(\D ^T?87T);PL7=@*?@()'-<0@
M1#BHKAQ5=]G[!/6XR2"YC4YA&R$#6@8U'_XY3&!S2C(I?U[@8RF\/)X.)>Z%
M"I'S2Y8+-81@+ "**HE 53$ICR/4*Q)1&,,5>CF>N3P<8*' *R]:\P)7DNCO
MK^X6D*[Q:NOR[^S#^9]_7)PKIQ^5TT\?S@XNCDY/SMLE[Y9O' VJLU*; S7P
M=XYZZ7APLV1_9%K7*A -JH9]#MFXX&_*?[PM3?,DI;?1C]Z"+G<)RH+4FU!3
MF/-6T$TIOJZ5B)XN% D9<Y!OEE_WZ*LY'XKXSK9ZAM]?^;7>,U9^=]NRAMYS
M?.=!R][^G6.M?NDN;_8I'(?W!D"_YV[[_'NZ5T\WMTD!._'D';'2NY,EO85G
MESB^A27Y/)[?_KWJGZ13\@LH-]N.1[<B[-Q_H+O\]1'JC=D4%HV*A8:)RZ(Z
MXCZ>9.,W&",HLF$2*;CQV\+O[:,?]&QMY+3W"&+M#\C,YP+9DV3=[@<:SDHS
M]'>R'3LB7@MZ[TM[-P%C,EQH+]XJZ-UZ>SRGR_>>H%WAW:@"?AO=D],S[[&K
M);YVQ(%F]OJ+MB'&(83_]G6C@[1P>VY?TVNUGKD7!0,S'M!U<SM7<O@\D^];
MLM3:Y]]Z1LGMPV9L4^W[#RPON#<06EY[T!'S?A"S:_FJ93ZP@>2N$/.VJQH>
MQRSM(YH'-(YZ!HK9!B0>5F-Z7W)]@:2%D6/#?-M15T==G>#:,FFUS\9LA=VZ
M@[5D-$(OE1FA^]=:Y7:>-QW5<W=_@LN^H\FQU+[7E2CM9XG2[1%&K^???Q);
MJTN1NJ9&FZ>--68U=K3QHFA#[_4[VFBK7MT*77T'8TPGMW1!O*>5*I-;+2#O
M*)MBJFRY[<YMOS$ M5MF&*KA]E77U1_E[M@ G'8CCM5QS(OG&-^W5,-W7SB_
M;#M4MH-J*);X[U.WKW:')':00%Z;/7=/)LUWM+'Q48J]=5W3^TT@[3,ZG\^0
MU9\NZK3YLL[%]-IE2']X>NW3) 7/)RHO)]06EV'WE'/.GQ@VM. Z0[NH^O]>
MG1=ZLC7 DN3I-G7-NC\$S(7X:MU]1S0E0&P?42T!0N2C;.ST039V:E=I]NHV
M8;)#!!PO:QPOYTN;0ZC*AVD.SZG*/QGN%\&03:BK#\M%@ZN#(F$]1:R<15-L
M>X6KB58[LD_"&+[ZGHQ@Q>&-XNL*M:O($^S*0[*17GR=Y4/\%WQR.2".&05)
M6G4?PIX!49)S@+YHZ!-G><AEJY^(8X<C9$,0TK!R,)UDN< :D'(Z*7:B&=6%
MZ'" E1VP:SQT*7!$+P\)SFP9%D'(Y/Q2-'4JE&(ZPB94/[#I!A]FUV]VN?;>
M,WO>4Y2S&SW7\'>D1!HW:]Y[0\_MK[]3Y_?WJ_3XL>#8NUJ[KL;V(2"[3XUM
M%V=[5"W72TZ2A7OS@=,+7F*2;)=_O4ZUT?H3R5XP:75YS7=!D:S+%Y;/[/36
MK=;;[\RG+BMN[OKNK1O#WF_ZZ#3ANZ H?'6/48%WD$T,ZZ&JR)[R21>9G1^3
MTMO./+^V$DBGCMX%18QIO#!MM+]?8\H[;7334M3HS)5.'5T+BJ<8*'YAVJC>
M*:.=,GHK?719@ITNN@X4+[+)XUH]/'%E3/OHCE)-'J:K;+7\HZT\^J2J<$>=
M'75N^P9I2:[J&IFI<J1ASAM3OL(LQ?1+D2,XS#!Q2>8:)[-30"G8AF.TOO!4
M)'A2HN3[02(^G;)4)'16(YKBA5Q12H/%[,(;F1XM9DG.#3NE^5+E=,AP.F0Y
MO%[FF5ZQX;2:& 8[H3W@9E2ES# O)]7B7"W!,8>8EI@W)E8-6<BCZKU5EO>
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M1+GZO5@>LOY[+["/XOQJRC7\J&Y]&N7 ERFV=KO*AM,1+^^T<-W&B]M!U:&
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M\(G9+8K78.0=]@)")46R4"@KCE\F,D.L/DX!Y!R*S(IXBED&^#OZ1A@#/>6
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M"?9M<DW-(JV4/_&2O#4IV,'@LF^U6;<)UIT0['V[Y]Y+L&\3DJ([W4K!OI1
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M08\ ^+]G*8L2(# !8?CDF']';XCRB1>9\#4=,W0[X4-G\*[+1 9>9L^#YY
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MQV+:PA#E#/*P:-J(C4PQ/8S2*T%'&]05UR)6(]PUJC( B%"OET;'L!G7P?6
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M9+Z&OZ':LYDB.K!I9')ZY8^/I"W2O!QE678JHHAC#  V)?,HBWASP""L<HQ
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MO8S_.1M,!M/X*HX_#'R<:1,OHQ^].VD^I5$L:I"_+<WA8#$KSC!'+:>^R%H
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M,!E,XZLX_C#P<:8PO(Q^].ZD^91&=Z@QWO:4AM<+IK50U/.  J(B)<0;(YA
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M#9-140BDZ14DBN7@20%YD-9XYT69 $1J)NFC!G;[UD,%]FJ!/6\VA" P,F/
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M2"I!9!D'1I12,C.#EGV.]W%,5&)X7,2PO*[KE1@>AA@6:NZ3"UY)!YD=LLK
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M8;W4C*8*ZZ7#>JXTPCOTWB<)JAG=210%K8F!0"VEDG)+F*VP7E-8=Z/U]!T
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M (D]>54_//[TXB(*(X"JR-R0"QR9(4#5#Y5P_<R3"1CH?LJ39>2"OP9QK((
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M>2*YRT*0?H$'UZ\ B_P5I>GIVG2G18%="X;BKC\%E5I34EKLSM+[6V1?+L-
M,-^/8@$RSXO23'F>B@+) 7^C:,>U'IQKG1S<QK4NV9O@]?OC3_]^__;P&,[Q
M^OU;^-OQH028O8^.WQU_>CMY6QZ_>WV%LL^+"PY:#7.%5P#7"H3O9CSWW21(
MDZ*0<?8-LL\+"\7R%- F\1GW.<^4#_\?%,J+XYCE.RSZL;!(7*1%DBB>^&X8
M1ZG+8E:X/)>9&P,2^6G$BZ"0(/MVEE[+A?_)%1:WP&9ZTU]V%M[?(N5B)7-0
MQACWHHA%.4M9'.5)GK"4P^_1CC\]/'^Z+=[R[O48X!&>3(Z!3_UY<T)G>,]
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M;_YH&[[S07)_L\SV3*?B.5IS?7&]D>2"V\]NA"CF_</1'6H[YMAC] 'C.6O
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ME8\&,L9QG9-J6JNY*94BIO8*CJ7/2W_ZS51U/F2(?>24R+JQ^[#FSVVI:3\
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M(\9Q4"H&9Z/<>*TV#98UXM6(][(1;V7L6#7B/2+B?9CQ\;2*FN&(LLU"/+
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M?F,I^KVSQ,^[K+S+]O]IM@[>'M/FE2?[1Y_Q/MTE!_^\/VN>'W]MOH6Q[GR
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MP# 2)GG%,%?<DN_2*TS5-$P$O#POJG:L[& ZVK))TG\$.U-];*N"NNN*57X
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M:PHDK8A.2XPP50IQIAG2.@E$&8M,1R&C!^N0L'7.5WQ._>-SE>]QCX>L:26
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M(U@ )2 Q[<+:)A$;LYIW##W5?UMV,JC'WGYZ;[NGY><Q5'0QBR[J)\<4E/'
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M3HT3G@GXT;EKO]U4$?RHX,MMX^W G\;0;\;]- RR@V#>ZG9CKYO+9QO6-9H
MJ[%;D/XA//KW9MM_>W,R^83O;>\><R(IG%&>L*=,SE"W2$N1D/><))P4_,6M
MU2+8MA>9_SO]> ?Z/J^BF65Y(;IC6"^L]T8" ZO5J_5 P ,4@K99*M:QE?5!
M4  N0#O/ C[KV*W8N\[[+O2"YH :K@K] 52#U&XVVY?==U-XI[#4;F1T81W"
MNIOVHAO?#7_X+32Z%Z#JOFNTBK<OOO3; &T&@CUK V.688$_Y<<W<FX#E[)N
M$-D?/'GP\4;QT9BU6WZFZ(9BLS_&&V3F9[^Z+2$;DIA'W?;7GXEG>EEZOQ>Z
M(WMB*9(D]) [BAN^:_3@8?X^R4Z[8$2=MOMPT]"=\)$\;+6E8'SA]?[26;@%
MO-T$I;T0:%D</&"!]VACO()[0:_W@KZYWL3;H\!N"WG_[AX$\;2N]H_JAGW?
MZLAG><DY57@5+D^UH<324\5%)_I&H= ^I0?'L@66YI35NY2AH2<7+7#/1;+4
MIX Y]XQJ+*.SP0BA%4U6'._^.G,K>_,FC(=12GHUP9ZCG_7S^MF_SNJ'1_SH
M?!?O??S7V=%?7^C^QZ.?1X>??M3_JI\>_;7+]QKCP9YPMD>/Z-[Y'JF?G3:.
MSCY='IW73[_"?;Z>U4_KVSODB'XX/3H[N?K/S]V)GA:)1+ W#$,)<"QWO<O9
M69(C$;S"Q!@98IX9JB;#^"O?-:M"G5>*.MYB9:4E-#B '8J!GK$/^=_ =?"A
M0)U?Y!95J#-WU!EKNB&#"IX ZBB5/1XX4&2$PO K25(Y$A)F:YN23G;26?DQ
MQ:NBKVV=M^%E?I8.R':J-5H]VSIIN&;LOK$>7XO6=T9/XFUDOKP,+.U-*$.4
M&&T]3DA1K1'WU  L.8:DXL%[PE4P,?<"PN3)P%3U EI>+GX6_:'BXF?CXC'E
M0GCI+',)R6@DXI)2I#6VR%L1%/R?54(6';VF-.I;'!>_,7?0;NM[;.4$JS<V
M=> %E8GQ$N=K*+K>^PJ'YH=#GR8'"G 7=!Y41H@PB#.;D%/.(1]"T$[JX#@M
M!PJ\0N=*Q<;STB8J-GYA-AY3)V*PA!%'48R$(:Z20-;G;N.>@;6@E<"4Y&QX
MS9_<(/3EO!7#[ AXV?AKSG^I*]^:>\7[3A\X?3VGX\?.=[ASSJ1N]TYCYW9J
M3!E!K7PN+ZXFP0_#OPW*CSX/CFJK%8;G5V'O_+#W:$*%DIS0C+Z(1@_8:R5&
MCN7HE##::^,YPPE,.;$N]9/'NE0>F>7E\6?3H2H>?WD>'].O7!0NN@@\#O80
M\'C02$>AD6?<4>*<52+S.%O'=)EX_(WY:^IQ6$:7<WB;[6ZWYFVG<X6 -2YM
M9Z)[<V7_/;M^LC\\CC_@--[GPQB<1058<P2LR2GT*07)$O&(!:<1EP(CS3A'
MD>GH"9=:PE'FYA?&S*MW9^7864+&?C:EI&+L%V+L<4V$.\Z35$C21! G+""7
M\JAJ;Q('GF?1B+5-AM<IF>Q4MK2NGM?F.3GHM?VWFK/=7'_</L]*^]2DXLIZ
M6H"'Y/W(@8 %->C7TCTXM9WX>SZRT0O>M[MOI)7+RR#:Y$QK[##C23,D1>ZX
M* -%S@N.E*64.JV<B7%MDZ_#Z2^1:56Y3U9%4ZD 8-D 8$RE49RI8)-%-!*!
MN%<) $!YI$,$C28ZQ;W+ ,#IDS6:RK?R6$[>O_&K1&"1ZV+HQB-3;=^$]?4L
MJ;8WEE<^B&&+@BK /D>,FARK2XT@@3N'6+(8<>L)<I(09&(2B5-!"3=%D$>+
M98JP5_Z4)=-2*HY>&$>/E_=HC#W#$FG)-.* S0APF2/!.>8QCS@*LN#H^4UV
MJQPI#V;-W,/% Z\T>K=#.>NY/4OE35F$-^5]<1R5R_>9D&K*#$HP?(+13"(;
M&!A(Q#&DE<0H&JP3-\%(QHHY;&J9#*3*0[)DND?%U MEZK'Q!-(%$J1T2$>5
M$'>,(<>(08YHK*.%\_0VI^QRL4Q,_<:\'N_M1=$^ZV<,10ZL[?C36BR]B)7?
MXV7]'I\'^S]PXG9'SJ:"JCE"U>1T+"S@L"(7B%$"4(4%F$I*"*0)E5SCI$2>
MI$+,NE25\^,5L_6S.#\JMGXQMA[30%*TFFOO4'"F&*%AD>$\EP\9P0+CDM/<
MX&1=L5?8XF2IU8Z/G9R[.N<*FZ>-15IIX'HV=TAQ4!5,S1&FKB:T#RN<X\1H
M)/+L^9RZBBR7#"F7O,*.^^#BVJ;!ZTP^6?MX**NLD&_D#;/_LSE.*O9_!O8?
MTU*LMUX;P5$T@2#N,$&:JH"PQ-K(J!DC9&U3BW7V]$YL+\7^;\R+\D<>]?7=
M-@>3(FSNFF];/KXQ!\I#QA4^F\;R[^$Q; U/H<*O.>+7SPGU1=CH ;0P(LDZ
M4%\ OUSP' 42C4Y&,SA/P*]US?03!A56;I,E9N9GTS\J9GYN9AY71BA1T3F'
M-!8, 3)[9/)@:1>E3%Q3XV.N ^;K>$K2R$*X^2VX2P[;/=N<YBZI_:T8&3=-
M]Y@]WZ2RI1:BF(S,VJK'*N-^GCB&)Y22G-PFA7'(*:$1CU8C)SE85AS^%W(K
M6:U *2'K8G6,JLJG\BI\*A4./"<.C.DS@D=CL/$HD1SXH6"7F, T(BYHJHV)
M*H6U397[T#ZY3<"*.5>66N.Y-;YJI!3G<3.L[FO)+?(>;RSO^5>3J%YY1N1+
MNLG&,A)&9,_M42J5$)J;$**3 3YK.>%&()QR>E%("5D/-C;!1EALB/;1K&TR
MM0[T\@2CNDIM7F)&GG-J4<7(+\+(8]HD\3@Q &,4O02KDH?<A3C/)X'SY"I@
MFU@L2ZKH4[QC53KSO.8EG;3;X;+1;!9M?9\Z/.EM^/*?3^.HAJ\\$U"Q"8W#
MD$0=C1I1:[,;/R9DI&$H)!F9I]H;KM8VA5I74XHOJJ#<JV#DY],X*D9^/D8>
MTSBX- KG4!QQ7B!.I4<V"8^(B,012ICE?&U3LG6,)^>7K'(\;E4TCB^M3CQO
M]'HQU*+MM& %;VU*P(*S?D9PZ4LK-+J]3L/UX3@^M#OPEJV=P:%4.#5'G.(3
M"@>5BDBI(A*!@&5DDD+&4X]\HIIA' E(G#SNC<C)<%OEX7@5O/T, ;.*MQ?"
MVV,Z2.[-$"5A".@8=!#C0\X)BDA&JKCCTFE:CG(43U%!*J?'O#K7/:&2ZFU8
M1L_GXKC=Z.IS?K]V^M*-1>2_@JDYPI284$&B3Y+@Y) )-@),&86LH0GE\8^!
MT0 ;[8H1)G3*")/*Y_$J./OY?!X59[\@9X\I(!$KS2()2(B<E&RX12;E+MK!
MA&"=\I;DL M=URN2E%P-?ERTRC0YX?&I_7[?AI'WO Z<XE@J,)T?F.Y.]KK1
M41&#'4/$1H>XEAX!@CIDHS+>V4@\TVN;=-WPIT2&*D_-$C/Q\WIJ*B9^!B8>
MTXB,"-)AHI&G@B N.$%@[UA$A082=@S;W#*"KDN^).[6MY"S/*5*:TY#!%Y;
M&<8B-8[=EF^?Q]N05:'5'-%JLL%-H 2T"2.0(58B+N$G2W! *3#N+8^2B>Q
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M,)C@S @(AO_K-S)VENCX'G:[\=W>/LKBFKP]H*V##"G9HX3!NVRVAQH)T=%
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M+IYDH[1=2I$BM>,F"X4_V 6S /JIMWL5"=V?A/#>3W^<"/78<P/0DCC0$;>
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M"2@9#XFH%!+10B)*G,CS>#4RVA(DX"B=$'"B@JUM4K[XB1H5(Z],%4FE(RS
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M. ?8T3GBS+U!3IJ$HC4@+Y*+29.U3;$N\.3 CVH$\ H"P%+'@BI=8ZXNS?$
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M?P:N894J!&TZSJW$GJ=)DC^M-8[V"*<D:6T0YC1G'M(".9\(<M8S9D7T&B\
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MKVOV9WE\]HNW!F'<SI#?!6O$E6#^812_/;7=T*O8'G S$%/ R/S"K/K%?7T
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M#%EB<X&+7#H)2!11?HC&A9&]GA&0R03&F%'12,NE$C8DGVMU1JQ"D-*L5"(
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MS#-2YAEY5)Z1A1D1-T=NW!^),389SL9FWNK%IO\U<R*;9KX%YM;%AF8G>Q_
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MF'I-C7W8J:37X+1]\8,^3SL+4YX)6NYQF#CV\Z0 B%G,NR7Q/MVL*W^!CCQ
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M<=9=B\(YIUUFC0[(S@XKU3='/OHYY %Z8E:ILTH\F#N)LX7K]N=NA:7O#TZ
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M=47K,L9&@6&J:F:/IFM>LI5AT<L-[S??;5:DDEM=#C(E57G9ON!XK> 3E^X
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M=6+@FJ*;^](,(BB][_;^W"]-\/T__Z\]/OE]L]9]:SEQ^WC6J%D02?# ' \
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M;ZJJ!$BTK)DUVP-;R>"QTD%#XN2YT,])I]?,%[SIQE:)"L/Z/D-'W-A=P^I
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M ELB4&N\8#'EHW7*9@]C:LA]X4[G&R/__[K,P[U;^/]*3_^Q:_ O\HPQ2F9
MJZ$SR&F/+R4DO5[0IX[Q?X9.AX>.\7^&2S)Y,C96-:&NH?[:ZPTOTL::"^<<
M$Z 7>FXBMSXE$Y305@4'5OF2'"PC9>*L5NH74NH_S_A1M/3$"9,0#=@B;I5#
M5H>RX30VRBHFA%E[2_D*16O4&%1CT+5.7AJ$YX)KQQ1G,L=V$NX$#H3(R)1?
MDL>AQJ"[8M"T8X$$1H27##&E,>*)2V23I$CFB#&B"(U<K[T5<H4PZ&49[RO3
MJ?<Y+,MR%>4Z[.2VS>D"EE(%8IV,G*GH3*3>^Q09(3PJ4FN63XKJ?E:S#,P9
M2ABRS%/$50K(4!F1X-QQ@J/WA@*JZQ6*+JF9=NFQ8CIW&Y2<&E#!?-">R90$
M%TPD*KFK5;$G9MII5<Q):045'B7'014+N3^DC!Z9%*VE8"P&A\$<%"O$M*_,
M7[FLX/UGN J/ZJ*LLZ]&($ZIMI@)KXTT'"OEHN-"$6LT]F"QJ>5K7G70[Q+
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M08(ZX&<;!#*8 C$;''.,O''$U"F8*Q,66<_VX?*!AFU4Y@33U@E#2UN@59&
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MM<MAR6A'9M-6J?78FY0=#0QQKP'H)*.(.I&A3D10_>NTU5? TMX)K6CB/LK
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MWQ_=OO_RX!O&E_&&<=)MO_UTM/.V#>;L^T,PA3&8Q&+_Z(_N_M_;I[M[7WX
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M5ON ..4!.>4"(AH3RXT0TF;JKC4N+MOP\]84YKJ\*?=+:]4 W_,!/@>3(8+
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M'53C;^0*ZMY9%76WD^"I8*CYX\=@>HZME 2+VA_D%_/%#VWO(.;MNY7-F5J
MJCCY$-Q\U V%>P:DSMO>$&3$UH9C_<&SJ5R^2V;QN2\Z@(D,3-S@\0B>/2U
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M*(^6!11P\)G#.""G+$7@5PC)+$])AXQ 3-PXM:'ITW%-:))-]ODJ0E,^I&O
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MU!/_"SZ5E^>W/'T4_[ZY^Z_R&_G]'R %W;+2Q_T:Z7H R(>VFR;@_Q%\2_C
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M6:!>6&Q33L?&0JY)=ELIV5=)T7C(?.V[Q8R5@];_OK-UO,+ZK116CJK,)EX
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M7[8":5Q\_3PKD):7LUW-RE9$A8 C@XU4<&*)\<X0FV+$,EGL24E'NP_CNJE
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M38B::(V2- #R/B9D@S*(1I,\20#](A](K2^>1DU$J 5;])6D2#-K'/BT7/#
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MJ!&G$$<[$0,B7DALB7>,QI4UO+H@S.,%=UXC[BST)D;!G7G@SF0 Q9D-E*6
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M4$X1SXRT%F 8!>.#-UH)%^W*&M6D#L9=#/AU&G!BE$2J!&96<DNE49PZFFS
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M/0%S:6?&8CL8Q).'!1AO8\ECKA'&U1[93NNC_MBZZ([UJC<*8,T/L&;H:_D
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M@X52(9;2EE$A-EPG(:")4"%C%C."+9V1!EU23'G5;">?47-C],J$BR231#(
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MC>=[S_?/@>]]29JGQO?S#AT=&19EE(>4NF,:J4/.J ZC5"0"I4G*>>I+TCQ
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MFY_WM_]J!9WW[[<W6[M56N1F9_=39[>YWPH^=/YJ[=J$UK7(81V'G^A^Y3@
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MPV$Y"&SW)R0$_!R]X)I"1:P1_#'LG@>8V3\1=U*D>H6Z5T3P<IQ'4HN3(-Y
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M6FF+!"Z!^Y5U]9F1>61[9"]']M:S1[;#C=6!I[3CPMA.MJ8W[AAI#Q_^EST
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M#P\5UO.9N?_]=LU---TMZ9%<F.\[P:ZQ?HI1P:C]\41.Q']CN8>2CPM15<K
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MB ,>US!H:9/:J4Y-SM\>8#0.$B-5DD(P:X\#ORTW*TT RD:N @S=#ECV>_Z
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M1$>I4H;LG$ :.86&CL&!^<24#C9&0YYG\WA>9=L5;CZX=->483WE/?V2QCC
MT4U "XW2,YQ2XK0%(J@%83-N* 8ARL HCC)1*F\;<95X]2BN%=7Z_TV*U9-L
M-;8=I.DUPB='=:9" S4:G3A:QNF3 1$8RUXI8KAI0JX;,+J\_>DB"Q$%2!$#
MS@M1X&TA@4R*:L8IRNYE;W_/NSVLS\?;JZTK+*ALU2'0A<+X-0U3<3&8(<EF
MH4 +IA%,<3%LU,"4ET%I:= ':4C).X Z9>'7YM-FT]_0PZ/<^Z#13]')*Q!)
M!/!:.C18"$<31K"L_'-X>*N/[2A-$D[1EYUA?)>^IL'HO,0I+W=)17&),4=
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MTZ.R8*H1YBA-77^8XIX;#_O#TPG:>!=G%[/-^UW*_="?]C*UE%D1P3CT:85
M.]]+$R!:PH)SQ##:QI!Z&EN7+*G*A*DLF)I>V"6.I8YS9;(*/01T$)DAQ680
MQ6ET:/19Y2D)-(HV%>Y6!-HETZNV[FDHLGJ\FMU#O?(IK>*9E)152R1:A>5Z
MH&$>?<K$&3?11=Y&Y]R L;$AYB;ELG[YIXCQJQO@ATYVIKMN//Z!BWIN*$BC
MC#".@60>+6"'T^TXT4!9RA%7-2,IMK'.EH'7)9-M?8[<L=:J2Z9ZF.LHA83
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M^4-*\ZE%D=+2FJH_/+WJ3369 [L"DR9[WZ=CA\L9>3S^L8^K<%(",>6.Q&B
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M-9X@FH!A6D,B:-@SZ1/S;1RQ&N@[E0O=(;I6E?I6^?I@1D]F3FK#*62:-8B
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MSR;_)??LQ>OEBW>3]+<__2]02P,$%     @ B("V5J?X"#'CM   4PL( !0
M  !H864M,C R,S T,#%?9&5F+GAM;.R]6W=;.9(F^CZ_(D_VZT$E[I=>4SU+
M*3NS-,>WL915TT]< 2!@L8HBW23E3/>O/P%2M&6*E'C9H"2F5W<I=:'W_A#Q
M 8@ XO(__]<?5X,?/N%XTA\-__JC^ O_\0<<IE'N#S_\]<??+GYA_L?_]1__
MXW_\S_^'L?_[\_M7/[P8I>LK'$Y_.!TC3#'_\'M_>OG#/S)._O5#&8^N?OC'
M:/RO_B=@[#]F_^AT]/'SN/_A<OJ#Y%(M_W7\[]EC2-QI9F-43'L!##1/+.H2
M!(IDI+/_[X=_+SPE49QDRA;.M(V<!="*!>0Y@A$Q\3![Z* __->_UR\1)O@#
M#6XXF?WXUQ\OI]./__[33[___OM?_HCCP5]&XP\_2<[53XM/_WCS\3_N?/YW
M-?NT""'\-/OKEX].^JL^2(\5/_W?UZ_.TR5> >L/)U,8IJ\OH-?GZ9=_>!N-
M^6G^1_KHI/_OD]F_?S5*,)VIY\$A_+#V$_4GMO@8J[]B@J0I_O+')/_X'__C
MAQ_FDH-Q&H\&^![+#S??_O;^["[2_G#Z4^Y?_73SF9]@,"#$LR=,/W_$O_XX
MZ5]]'.#B=Y=C+&O1+X9<09D*Y]_JTW[:&],E 1FGZXB,?HO#2O .,:YZ^OZ8
MOSR+92QP/9AVB/CNLSO%.[J"?I<"OO/H#M#.'L2N\"KBN$NHWSSW%LX%R&6$
M]9&7@%>C(4[[:?*7-+KZ:8;P].V;\[>OSEZ<7+Q\<7Y!7U^_?'/Q]I?SB[>G
M_]_?WKYZ\?+]^<O_\]O9Q7]N@![J-)>*:SZ;Y/^V^;-OC8"HTA_VZ^KSBGZ\
M>4&%VFPL^,<4AQGSCS_T\U]_["<$ST/4&7C44<B8G>3.@2W"HN"ZM_EKZJ@6
MXQJ,TC=O'=0U=O2%% .(.)C]MG<]81\ /O;.I[3=U9V/!(%G].VD)[4S7DK!
M5/".:45??-' @LLQ>Q]=-'"74I,%10M,XHQ4-Z\@<DGQ$PZFD\5OJ@(%X^)F
MG?ZW]5CF.MM]=&?#1/OY!%_@_+]GP_/I*/WK<C3(9!N\_*_K_O3S^]%@\,MH
M_#N,<Z]PD*""95J&P#2:S**4GB%WM/=%\$'$)D/?$NBW<OG*YI/Q0D(WB\..
MJT<U>3KER71T.,7,R4'C^_&'T9@>]]<?^;X\.K^$,4[.)I-KS#W0)9<B%<-@
M"!!ZP8+GGIGBDC-.)XZ\S?RXA>+P#&BJLE%'\KZK>[&W[N^,LN>\"L*YS+A-
MQ/R(A0']0[+NP5LC:#JDT&B%7,9RY#S83_9WV2 [8<.<F"^NQ^1.OL-Q?Y3G
MA'U)]LKH,^+L0^^NQ^F2Y/-N ,-)+SD7C':1.5<T+98V,6\$?1$D!9V$=*[-
MSK(CX#\!KQIK\2[Y5"/R_1T&U[@6=<^#]-))FB(9,M/9)1:$=<P$;PLOB6<E
M#DF]^^'^*8G7H0;OTDXW7?-F?WS[L:IH\O(/'*?^A/9L'SA-$^Z8FPE*\<(B
MEY:%D!08AP'+03EW#]8_)>&ZTMU=MIF6B]QJP)ATM@H]$T4(ICU]YVU AEKI
MJ%SA6NN#+W#?N=:QYNY2S79"M??X\6:M73%#>MD5&474#(U.9&Z"8E$0S(#9
MIA@! !LN9/=B^Q.0J3O=W&6/:\F>&>=[:*4C*):!460N)O):8I:<>?)4R'&5
M469_</+,H/UYN;.]9NY2QS>UJ-[C9#KNIRGFV<=.JCC>X/1M(=$4[$^O*_<U
M.&&,C$P["TQK@41["$RZF'0!P8MI2*U]H/\)J'<PS=ZE9FAI?FV$/VB#7B;-
ME):*G!5MR'P,@LG@P 8G/;G)![?&OA/SH'I=<0R[]QG\2?[G]61:KR F%Z.3
MG&>Z@<$[Z.>SX2E\[$]A,)MF-10@GXZN/N)P,HLP>(\DR4E_BN<X_M1/.!_Y
M>TRC#W,-S_<$ZZ+*O' FM7%5NH[%2%ZVE#%E[A0Y0:8)<5N/[+B)_:1XL8+X
M>U] ;#+ N4CKX$9#^N#;<CH:?L+QM!\'I(0X[3G-DT6MB7[UY%)'S\#7@"1C
MM2'SF=O8QH_I OUW G>JWQ4DW?E>Y!)PHP$LX:7??J3)"(/!XJ!STB.(429%
MDG/DQ)'GGYC/PK,,TF93BK;</1 ,TAV:XZ3<(VEK!>'VO@LA^X0D-KK"5Z/)
MI&>+XL&@8,D40E-R9B$E6J.=$S$IKU2CP(UO8!PG:?:7^ K][WTI\79ZB>.Z
M(([QLD;4?<*OX&:VZP7\T?/.!JXL9R5B8CJHR*)2R! Q%AFD4-HVH<4FZ(Z;
M+9WK9P6)]K]KN!UG8GF)!32I,Y1"8()D8!(RI6S(TF>PN5%4Q]JXGDZB55*Q
M.A6C&;B,3%M!0DYUI49K7+)!D:0?)5IECVC%"Z"MJ2>%=")81:2)D>FHD2QS
M+YE1.8#W%D&T.IR_C:/#B7PKXKQY#-X>PEP59O7#/'[XW]-@1'[67W^<CJ_Q
MZR]'PRG^,7TYF+WPKS].\$/]IC,^+-G'DY,_^A.RB=$8+(Z%H@W3J9[O)N&8
M-:$(I903N"(VNDMZK(+5(5ONR06XAST[J'L=<_86>X-XO25,+V9;XT:@>DO9
M"9UR8B6L+DV =3D6]S!A?_6-6LG^8,3@ B-"5@P*<*9]#BQFKIE0+DN#&8Q2
MSYT0WR2Q/#X?MA%Y QX0G*O1W/)]/3.8>T98*(%,O:0+V;G5J_60.$.7/7AM
MO)*I"0?N0#F\3]"!BD9=RK=!]/Z:0XX;<"&2K61-82EZ\D'(8F(176$JFR2E
M,3:X-@O O;".@0C=R;W!*O >IS0^S"]A/.P//TQN4$D!&*P1K)YAD!,HR"PB
M7Y=97TK)H %YF^2.U7B.@08=2+I!(/])2M=7UX.:[+WNJ.(&J.!*:ZL#2Z4"
M561N W>)$4P=K T^Y#9NQ,80CX$E;?3181#^9#SMG<XA$J*7I6":SF\,WY:3
M/)J%-LX,IHQ&B&2!>>7KR;@G@RD"^5C>(V#&['C>A"_TPEM<H9^6>;(IHF?L
M<381>H>KR2;X;B;')@BW\4 [H<=CN*%M=+H%8?902(>&R!9(O<*80"$+D?PP
M+<D%"]+(6E=$>QFX#;!11O:3I\P:1_6I,&8;/1R8*5]O=1?F52TADXUG19)1
M36Z[9\$$SYQ"J1*MM4IO=#;>S2ZTA.YP!DLK[6ZS/^VCFK7N\/_\:4EVK^C'
M/6ITG/_V^O7)^_]\^\OYV:]OSGXY.SUY<W%R>OKVMS<79V]^???VU=GIV<OS
M%]66'TR^1;=1G8[MGM]-K8X]QK1<KT-RT$8:!4"V9U)0\U:"EU98E[(PO>U>
MM7NLS?GUU16,/[\MY_T/PW[I)QA.R70>70^G-:9S/!K2MVEF=4V^7A-Y*X.<
M94EC0EH7BV;!BL*,YTKY;)2(RP=<JT)K=GKY_H[Z)QS6&-4Z2>=QJV4TOJJ5
MI][&0?_#+)1OGED$@Y=_X-7'>6S?S<=?7(]GG^B!3^208*!99VG6R9I$J3$Q
M*[PNQ4 $U29$I*,!'&[-/ S/[AX3'%[/'1XV5J&]AC_Z5]=7%SB^>EM>P_1Z
M3!K"R2^C\2E,+D^&N?ZGNLZ?8% %UXNN'G^JPA0*VFC F.K*2B:CXI9\W$([
MQ ;S<MOW'BN5FNN@P3DDC9]<ZNGGFN@])7@5VL<JB]\F6*X'K_H%>^"\,2D9
M)F(A6:A2&"3M230V.BYU=&:C$X6MEZX-P!TKEUKII\/#AYE 1F7Z.XSQYFR]
M_]^S1;"ROR=2B2AY8-DKPW1.F0!E9,81K0'!JSMIT2LW_;5O.%;5=RC7!D5
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M*:F\D#'J6!Z=Z8]?$/P(>;T7$UKT*_\:T7\.M_.">TH7D,478E"JTRLE%J4
M9I,H3D=I4F[346H=HN_\>S@K8P\=MF@0OJU;=C,GM+"0<_:U?X0F*[M$!E+0
M\FX4_:FX N71#TUOX?U.S*[<\AWTWZ*_]^V&XV6+,?2,1D?6>&+&%Y)5+9T2
M)0B&.D2?G*?OVT0N[8KX.W774?<@'&C1T7L+K(MC#=$+1:GD=*UBYFI(@JU1
MM2*P$E4M&!.5M&UZU.Z"]CMI.UAO=]-]EWV[-SC\.)W!_E!C9TA&_7R#?>X'
MUO@LD5&!Y@Q%R20KX"P&E#37E//%2G1IDR"4_5!\I^,.QUI=:G8%*?>^6FHO
MXGEZ'(]@<B9Y"D[VC@[T)40EF 2I,:.QJEF^\D$&>*@LV*<^)9XRKQX[/_=P
MLIGW@)9")2,B*4TXIC$)%G,B(24GLT+@X4[SJ><RY1XS!_A),OO@LV]KAC4(
M&]\*\*V$NDU@-RUFMR/PQRIH]_2X=)\[T)@(3XC'P7")F5SN0CQCFI,;[NOM
MD,-D%!<B%-?&IGI2_'VP)M[1TG<;_7><F/T+_!/&>?3N&L?3T?M^&KV&X76!
M1,X/(?^*=M'")@<7@HLLV5"+L[A$KG=)3,?B0PG6R+!)'\SMWGIX?_4@BAP=
M1 L=-Q+Z[?SGP6B47XR&HS&!A ^SR7@^*M/?H6:HS_ 5[F20A(]K&9GVQ;$@
MHV(F*3!6.NG=)J<<F[SK^+G1N<0[7D'.AH/1A[^-!E4(DU_&=5&^ >4Y3XF;
MNG8JHFE*B87L.#-02@C*2^";T&#M"XY?]]W(MD&9\V\$,2L:VB_]- ^$F>VB
M)J,3PC+K:ZB+UZ86V*,?0XS.2Z70'2!8^2ZP[[[F>E^S2YT>EG(++V #@(=S
M!U=!?!S'KU/%;DZ:/;32VC=;"51D&:53GG'@BFFM,XO66P99EAAHD=;A %>*
MAZ/- _[6X[)F&V6T9LO\!UILR\^?:[S2VAS015DF&TQ"\AZS"Y;V9@$L%D66
MC2PED7%#]M@!-K\M43^R,;4_">ZC6$L-'JRPUMF;T[>O7UZ<_-^7YV]@7 %_
MPMTK;-WWM&Y*;6V,=ZGF5LH(6CA42182/8+1WNC$LXLE!95Z]SUX'S^FFF@7
M\ ?>NCFSRGN [)C4H=:_-YJ!M9I)1*L0$!U?GLJK79B[S]['YZ(GD5?0S_#Y
M L=7O80%DZ#9H:PLM!3/"LNA8BX%;9TBK/ 0'>X^]7 +0B?2O^TV[2&>)M6^
MZ]!JN&L-+9C'$5Q_<ZSS,Y;1&&^)X!?ZL?]AV/,*BN:Z,!LE"0 59P!.LY)M
MK"4L3*O"8KMC?J:T.;"RFC1%N4'T'FEC2_U!?X;W]!*&'PCN"YH$XS%F^L \
M:/7O,+B>6W.#P>CWZH[V""+/G/8Y$Q)-%)X# U>CJYR24@D7%;8Q7/;'?A2T
M.YCR&KCG-Q-D^*'.G5/:EC_3-/D=QGG2<UG+@+3J)DRS?&7/0G&9.1&ES#$
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MF\2AG<>SE$/$K>+<1R^EMAIC\MX)4V(PQ6']O]XV+]JSCUZ5!<XLU+/A]'8
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MJ.QMF]*ZSA"?-GW:>J2RPBABF8XOAJDD>O.V\^\ L>'TA_G?<#Q0+'#J0.&
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M$J9Q,":",+F+*,"^.)XV;WKWQ!H:[;PGNC-X_-TU<LHP9*:NG&OCPBEIQA>
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M<W5]WB'RK_V\?#?U:F+5%FG83:<0*!;"&?@//[N:#&<_SS/& S#\,GIY-9G
M*/[\99PI&]#,=' RD[(OC FD%*6_5";E?>4*?&HEOKX3W*?+I/Z\U""Z6H+V
MTD^_OKD8__5W2%_@%\ZSV1L_G/S#7UP!OB<#Y:A-RE,,,8N44;2,!",L"8)'
M[0*+D-I<)MX%[=,G5G,?-;B.O)'RO[9 IN_'LU<PQ;\JT^W9M(P'7YL[?[ T
M)$Z3!B85@=(>J80AQ$6))F51 F!$8GB;3+#!8$Z.E;U[N(%@ROTMNC<^PHT8
M<-:E=7!IJR*])J7G:[FC8DATC&8J3:2-"J,V(7KZ]*EBZP:7!-YMTYXO9R9=
M9($PDW"2=:7SBN:)\$R9TDQEQ=J(Y&Z#\NESI9E/&A35=6[<)EA*.0A)7)(%
M)]7$.:5)3*XH %F<[OIHR'M<C?1:SC&5?-&DO&(Q[O=7Q4+G^<X2^7>X2 -E
M:0(6,>VDLAPN"D]"XIR4!L+>!E#>+LNMU=['V #M%%A2T_H5#\^N>Q<LP-UL
M5HSG'?Y>__A6I+\')NKLK74DT[*C&_ KSWDH*I"91N9<",N:B^O[0CSTE*?K
MXLH67/7MWEV:?Z%[,_SQJSELF98&41FKE$\WLO.&%Z&XH'!6\EEJ@U^";?S2
MKX!ZNERH;?%5,NS=\^/.3#0N1O47-S%Q*?:(RN.T8VP@$K(C0>'Z%%S4R@+0
M&%OE'^L1G1(-]K#UF@VYO3=[[S7UQ+4&N F"X!)D,2,R)2%.G AI,92%TH>F
M32'=H9NE5DX@=K7I&@=7J)J\G8 6>Q^E;>^O$?LPSW &R0FI(F/$!EN.:S4G
MCII<^NH%JT!2XYO/_P\B?/K$:.*+-:39>S]U<=7@Y?@R#$?S7L\OQ_/C^.N6
M5N6H:N*OC3\I A_SZ'4N]7&>SZ]F<7P)T_GX_C[\\G7@,7P5(1BBF*9$>H51
MCP!#BH"TR. ,=!,"V_F&3IUQ/'T"'M"O:VBZ]P[JXH49PO3VA2K=R"_&TZL)
M#'+P6AEJB,P>+24EKK(Z%VELIEG(^"O;YN#H85Q/GT85[;Z&%GMOJMYB^@-\
M 51(_%_#V=<_1^,PA<GWLA/S=O3M"ID-<3PJ.WQSSN-W5Y,)O@SSO9O;V?AO
M:.)WX^GT[2A>7*42P[_VDW+D.AT$SIA221*PY6X^5Q&C-R^(2YY%SWCFJ4VD
MW-L0GSY9CY,-:WB_]V9PY9%^@MGLNJW;=""\T,E@V.J*E*BTD(GGWA" D%S(
MW@O>IKJCW9A^,[N2O]=0>:^NVALBDJ43X'D/U0M_O^'N(-L@-*;41*:R]#@;
MB2O=,-"X4>*OG#3+D>;:.[^[0WBZM.K3]FLXL_>MC_/95YA@9/MM E]+K7NI
M#2@!:YFM[U6Q+*;P%Y!Q7/@V7/CI=)B'\7I$>0:3S_['@&M/<[:)")LSD1 5
M"<F7QD<F)%T*C!L5@%0>R--EY#%X=@U3]]Z&O[M!=#N)#[* #$4B7@C%,&P.
MBGBM$Z':)!-CLAH:=;1:!^?ILV9_*Z_Q?85=][NGQ'?/ S[-2MW2G4;-'A2C
M!K%E'A.1+&(H:8TDS!H?1 [1ZE;'L%TQ/GV6-/+'FB+'G??JR\+\Z[#X#L"_
M_+?IZ_D/$B;= ("3%V$I4"*-DL1%Q@E0FZF3(E&^O'V[+O)Y[#E/U^'5K;C&
MQ7O=;O\UT!<7\ULPJR>&(85$E<:8JAPA2*\P+%<12,3O'1>@_4H:]O !_*8G
M/6TW5[;D&D?OU=QPI4;@^DK(S<'@[;% F ULQ$G%! RIF<-_8O3$\4@)$UPD
ME@QHZ-+WL/,#3\7M->VZQOL52G\72*]OYN?@8M XV:A RRW:' L>0Q"8-U13
M&6DK\<Q[0"KZWU]<'.)@;7M[KKOF\F]E6&GVO\N.-J3__'>,#N#7#S%'AA^S
MU]=[)?_Y[U/XLIKX[[%[]^+GG?V<-Q/XUU7)N:_[2;GLK3"","B5@TED$AR@
MC;*6^., B;:)"#N .YS2Q1Z^W[2C5LD'+:Y0K=GTNP6XZ!#7 6)3J8L.( ^C
M?%'=P1VV9&MXYT!$RH%A0LR+@F"T1 HE<$Y.BFB;0W*8 3'9Z.K=H0CTB#C&
M,?!G&Z?TQ)OI[9'"0CF2.LA.*IQU$Y36PY8$GBQ^JW!U5]$ASMZ(LXRN_RBW
MNEL[T&8OGS2X5G[GU;G]\N]#F.!#OOY\!]_A8O[VJ&2T3SAX+UDY>9(8FH-+
M)%B?BHXII8UZYW3#=V)13BU/M+C3NX[3JWAOWIXN8'L/>3;"/7CP4\WO72:B
MJD[K:T7;")IFIS5CG)C235 R8XF/M!3T^FPC8\GD3KWWGB+#ND='QT&P;7S5
MDEC751AS"_!%6Q<C5? ,""0_K[# U9@BOD1=ILQ#:0O2ED:KH(XC,*KDSDW$
MV=,7#2*C&Z&"A7;!0K _<XI# H.C546]U^%K8D$0ZJ)(EEE\5=K$T.OQG$+D
M4\'2#80@5E$M4H(.N)H&-9N0'29^J>&]1PFQA^D;K" ;\04E '-"2I(HK51-
MH,2ZC#-8<#HS9Y2!-E)S_5+BD8"C3T9L8_$FZO</*-LL]+M5=L;BTLBX9T0*
M6X3CB@4$3\EI(9)J=7'S47#]QQ9U/+ERTE37#0W"B??C4;I%>0.)ZZS+341B
MC"OR[A$C)Y$RX=GY*)07RK5)6M: .1$F[&OF)G/$&E6LVYK(GS=F^ C7I;O3
MK\-OU_E85!0<4!(" )%@'/$4 RS!J)4R,9]6J@QJGSYO@_<4 M$>/-5 K6H-
MK,5.3@=@?42JJ] .U9JGO7_7!RZ5G-,NEET#T/ H0@J"> 6E[XCAN& R3R!;
M;FW2-C42O.N9-8]V\#DBTFSCDW9*L:]_Q*_E]G&YES+Q<1%A):\%#M:3Q(M"
M,E.:6.LY,2F8"(Y1G'[;;)X]!.M@@<V^[ENOM5G!]@VBV[OW/>Z<;0:=,*U3
MQ&3TFU3>%?6L1*P223J0$!O-(&OAG H1]K=U@YEAN79[T0LB<*$M=^BCP#$:
MLP9IR372$I12-+H8VP2QZ_&<"@4J6+O!V?"ZE?+C</K/^7K(K0N0#"4@.2;=
M$KWF<LY$6P,.\[W$F@N9K:(ZU:1E)ZLW$4)=8%LL5Z4GS<T+T 5;X[ZAF]$=
M3X*RFR\WDJ22(YKNDZS!&#/X6!8UE8-$C#AE!N<5H<$(822WE+>)+?LGR0[Y
M2'N.;&/_WA,/Y616'H,="D6R,:I$? B*B)P9,U#NC;2YHWMDB4<]#VZ5>VQC
M_@:YQX9@B.4D8Q2T+**E3;I4F(HS1:+PF5++I+%MM+6/)?1LQH8*!J_<@GB#
M0,8B-Y8Y1"DI8;E$VCJS:]D4%C!A2I@?Q;!<O+J%_,C)N+>N(1OD%]?R$O,+
MX&71>S>.=PZ7G16A2$8DR7D1$  2%$>D2=,(TF7/V]R)> #4*607M6S>0#%_
M [1%J4@'<$VSBP?A'2:]J.;,;B39PQ--=J@> AD2\[Q4+5)&,891U!.G\)61
MC#+!.20OVVQ5'H FCR08AV')-@ZH'#V\A]E'^ ZC*YB^'$]GY_EOXW&:?AI?
MI+-1^@07^-]\N6X)>8$_.$N7Z 7,O.8S[.L?W]"LL.BA+6TL:C5$*^LP$M9%
MO2@DPB@-C@?MDNVB!%$-4/]1244GCP_MH8JY2AG$7"_KVCXWF'!8B^*D1&UV
MR1";RWOE="G#Q\6:"Q.TUM13M2PUL(XX#SSB5*A0RXH-5I@B;36[D;8JL?A\
MQC22X8292D=/BJ.CRI. \3@!B!"8=MG8-O7BZ]"<0D2ZMY4K=N?9A&EQQ-,!
M5=,8=#VNPP2?^_OM$2+L8?0>)H,;=$YEGV+2)"6+*31UFEA/+7'99BV!9^_:
M2/;V285' LR^F+"-K1LPX ](PZO+HG7X?CR#Z<T:9444H@Q,@#<(JC212 J7
M+)HUYQ%B;$2 M7#ZCPIJ^&I<V] -=J4Q7AU??"]-*>^WK+P&9W2F $83)'?9
MGPNT1#^<Y* RKHDA,M>F+N)!6"?!AGJ&;S GW&TY.9_V@O&!.\E(9+3(,Z>$
M+,V9")5HMDSIN"(068<(RTA.(33<R[H-&OO=Q;-(>SH@:AH2KF(Z3#BXGZ\>
M</P>AF[\PM\@\RQIGIE &\TGMT1)2"'B5RSH#!Z$:%/*T)?K'PG_6GM^&_NV
M"?S3>#0_(PU^],_SG(N&;<'W[NV+\X^W1VF1)NLB,:E<FL>1$R?0:]GG[*.G
M5*IFLN*/P^L_$-C7CZL9064G5-X,_%1DH""=?X?):/CEZ^S-<.1'L52*ED/U
M\S<?ST?PQW@T^_KGIU<ELBT_OD%=ZGPMG5]?]/1&)E4)2P)HQ:(QEIOEPH9U
M>X6[(WBR[.C1\!4GENED-I@W>YM/EH(+ ,H4H5%P(DTJG2LQU-* "73VU#C:
MJ6L??NJ=20._6YXP[CWV*4>'N]MOU8D[-QJX!7'#I2XPMHD#N[NS_CO\>-"W
MAPN6G;B'_5J\DXN3!\%IXBD0ZB/"X4:4VUZ9*"^AI*M9B4['Q\?AQ@T!7'TO
M;F.VRM[[ RUU>75Y \3QG,"P6&Y.F=(D+A";0!-GE$V:T1Q=I_*A3OZ[]^C^
M%M.]C#^N8;F*,=0<B/]Q#XA2DHE(LE&E- &_"E9G'!U0L%X+U4W<M)L+[S[Z
M";IP9\LU2)@6[6_/XK^NAM/A;:U)2 KS08Y!EK>XUBM%B<U1E!9!B7JJC6O4
M>6D#H*<< ]6T]1H*[+U;O@Y7^7("M_LY'1 VW3A[%.)A]M&J>+0#2_;W1D]3
MQWV@*7-%8VF![9@ETGG\BFE%DN FAZR35VT.6@Y$ET?VW@[#EFV<4+FV[_5H
M&,>3Q0V%4A.?LL9AV7)1A4KBHS7$!YFT Y>=ZM*'].YG]K\74MG<XPJV:G!\
M^NDJ3.=*[+/7W_&?VS(!9378P(!$@_](SB.Q$BSQR@OGHC)"M=D\WP#H%(*"
M&K9>\]KN/;NOP;70SNF K&DPL!':88* *AY\G!5[6+_!XK\98'#&&\4<<4YC
M8AI=)-X'2ACFJ-Y&RS13IT"+1Q;[?EFQC=';LV%Q-=5"Y*& ,J5]AXJ*V& P
MN)D?$@B(D;>IOET+I_]@H9*['B;!#K9N$#'\ZGD^?3.>O(>_SF(<7\VO,WZ8
MC$?X9;P6,I^_ \P;:R(NE<9#*3]7B5AK*0&,G5BD+#G?YG;P5C!/(;IHYY<U
ML\C>=TS+&W*>S]+XVYU[KUU -0TWUJ$Z3*31T)OC1IYHL-BLQ::XI,DDA[->
M0&Q96EQ6E26""AJDM,[P-N+?_;'CD8#CP.38Q@$-2/%KL)]F?I3\)$W__);\
M#-!ME.H;D"%3L*7(A)G$,/AR#..NHM"2,+-VB3NCVM1_=X+7?X2ROR>7UYOJ
M;M@8K/R?_U@RTSO\=OZ+^<^+&3Y"_K?R_W]^?'MKLK_^^NM_??5P.1[!;!BG
M_RN.+_]C;K(W;]^?O7_Y]NS=V_>?/G_\\X_7[S]_.GO_ZLW9VX__.'OWY^L_
M7I]]^O/CZ_G//\6OD*XN8+S:-OT5S/SP8GH?_G1X^>UB^0QS>7>K,H#_^&6+
M^S:Z07&/2 >Q"OR8S5N1__N_#=-__OM06)63S51J(225P6:G70K,>!%5\GE0
M&4LMP:QWM_V:I0<C'$V$^QAP4BUE44%% B8$+W+0VK:6V;L%4T\0;-$M_.RR
MO-H#X%%)Q2W14ALBA?;$:899K(HQ@"Z;E6WFT$V(CJ-#^S:^WRS^M8>M&V1U
MOW"]&?Z =/=-&D@>H\NQU V+(G8&G'@3&%$9 &WA0V"M%?)70)T2$_:S>%.%
MP-N^8>?Y#G-A-L !)\9"((8J4>[WE]X1/I.@(S7"9QE5&QV@Q[&=%#5JV+^B
M1-1<).*J6.-\=;5]/?]!&H!7VGA.RS6R2*07FECF$245.8.DU*Z<':U5YWCD
M.4_7S]6MN.KAO=NR+6]-!0[:!)"$&HI34L8LH>Q=$L-%=!I*F-^JN](](!6]
M[B\N#O%.;V_/=5/\OY5AI=G_CA?C*6!,/9M<P:\?CI%$/V:O+^;; )B4P)?R
MQ3Y%@*]',/ERW>(],,P/G0I$L53F'D".>J8( //,*.,$=-K3[50!^.NYQ[))
MNY7GQGM;L'(][C6*Q>%$!QS5J^/O(NB_/'Y7+ZPX<@\3MG1IPJ=:;R)AU@"1
M1FOB D_$1N,A<P&Y6\YV)*Y\H$2^MB>WL5P?5];!BZAUQ#F*25M40!T.*BNB
M#*X^.G/@NDWV?:Q7UG>9>*M8MX'&ZIJ;=ET0/<\KZUOYZO&+R[L8NI\KZ\:Z
M1+/+!"A@@$EM((XY1FS@WH"/,>E.EPZ/UO7;7EFO[/EM[-MT7V5-2P&EE.4@
MT3M6EL9"D1(?&">I-'</GH:86W=>.-[&+?M,_=6LWC3+7B,NW@7;[\8M._IR
MFZ8<NSBBZ?2Q!B-&IR9G%TGDB2-&!L25;UW1D$?8GBI^(B39IW%+,XYL8__*
M=R^6MQ"Y-BM'"HNZ'@."XH)*6$B:R)"!^"+6%D!KHVS9..YR,Z/[$X^L7\-6
M7AHW-W%EL9,5E$9O0IE,\DI@)"2UQ8Q92(%Y+I.$9TDE"X:'W$5!N_L33Y4(
M=4S<>$:04FY$*9RS&DF*G$6Z"F:)L]*4-B8YJ2R#5EU4;KH_\42)4,G$E<_J
M5E%NI"L@2),I)=IPARBM(MZ80(R.S%B3&%)])R(\LQFADHDK)AMK45*[":5W
M#$2FF&X'4Q2?(N;'2602T  T6!XP7MJ%"!N?>*I$J&/B52+(JD1@:A-*I[GD
MT6-P'!S&RD%JXD3"5<RC":QC@?LNY_C=GWBJ1*ACXE4B[-TW=F.'.6\8!T4D
M]TA/+G/I]% N'!GO)%@;>1M%D"?1TF\76E0T^"H-]N[P]6%\1Z( QV.AU)WX
M7"0*F"UAJ\!O8\ $)@B3^7(7OSK.OXOB%/8==[9JQ1E_&<MB0ZL#FJ8[B_?Q
M'&8O<7?_;'#T'L9ML%NXA"I0)XT("H/-%(C$F8H$S8O>._?."A^SD4_6U8_L
M"+;R]#8V;294RD01"L$($A_FKYN%6LX%B8X++V@T'8OTGZ90Z:[%6+O9KV((
MMBPQUP7&J0J5;N6"#1*7N]BOH5"I2$S1D#+A*>2B&*B)#]R2'*QQG)GH8R=I
MC.-P8R>ATAI>W,9L&[UW'-<%7^<,<3;.ZXZCIJ]@.OPRPB0@^>E+/_WZYF+\
MU]\A?8&I'Z7/7\?3<CWH[A^57PY'7^Y]1+^W#_L:SR$O,Q[$9TMW(Y5VU'DE
M>*1>,L6=PA CA> QG%!"B1WO1O8UM/H5,M._X>3S;CR=OKLMQ#<N@&*>DPS!
M$)ERP/ M!D(E2,V4P+FF]6'W0_CV#=WGO3=?CB^_3>!KF8++TTHCSO*0>^Y9
M//D%Y/$$)[5XX:?381[>=!+.,YA\]C\&K"C#Q"QQ/E9S69%,/%= LA?,8R@,
M/K=13*@\D$-N!%7CXW).<4AG-[U(NL9BOT!#>H/&/HOQZO+JHLPIYR_?OAW-
MQC<=9^>3%7[&A_&D#*[<>+,B2&UY),%C5""]Q-#  887QMIHM0T4VDA,M1K1
M2;+Y*-S?8#=E,80"N[RL&'#@P%[_B!=7Z68PTRE,IV6\Y_GVVN;\Q;T=3I$3
M+6/17.80C2-9X3\R\40\#910 593J2Q FS+?FJ,X2?H>S,T-KA@\:*X7/V]"
MN(]P,5\_IE^'WU[\W-!+_,7/345UU[LP(ELK#02BHL?4CU)<?0" 4)^2E1"B
MY*UO@[<>8__W3@\S1Q^.&(>^Y;HPS\WX%^G.8M\X4T^9Y9A+\[)O[(0E-@N%
M(PLZ<:VBE&TXOA[/X3=@CXL\X^I.;!!%K**Z.4GH@JOI@=PF9(<YFJOAO4<)
ML8?I^Z0&=S0:CPE<<+YTC5$"WP)IB B)@^<V<=7FX*Y?2CQRA-<G([:Q>)-K
M'HM]MK/5?;9%TW63 E44(5)<^:4)FEA:6B0*EQR:1#AHH[S= 5S_B4$=3ZY$
M277=T&"OY?UXE&Y1WD#*WBHC+2Z:(>&B"9(2KW,D$*Q,*BLO1!O!Y35@3H0)
M^YJYIYND#T=A-QV@*<W&&J*SRCA=.LQ((6625,H4% W:]7?']'&\OV/<!V/<
M'DC08%MB#:S;5O*/ ^LC"%Z%=CR776O[=WU,5,DY[<+D-0"]]B*ES'#QY8)(
M[24)60=BHI$I)F= M1$HZYDU.]Q^/1AIMO%) [+</3Y#@(M;.)DF"RD2863I
MR*$P7DLB$>9D=F DT"R:$&4MG(/%2/NZ:US;U@T"Y WE]H;9X((LG5RS(9+1
M0)Q&D"PY[8'+'&6;J>)8[C>TH4 %:_<MNN*C4M1+G.Q$$<"W21(7,('+G)DD
MF!8VM);Q/D;1E2<7]N[DT+[U7+I@^ZWGLJ,OM]'JV,41?>NYL&1I4OAR4,XM
MD1GA>8V0C30&# 7+1&N]W:>@Y]*,(]O8OP$WWHPG,/PR>OTC?BWET0N B_O#
M@E+AN2&!6XS6!0;J3A2U$2U5E-1R&]H4]#T(Z\CN:6[EP7$K\S>):M>NN?/W
M002@-F"8[0PN^I(")]8J08)WH"1H?"/:E!8] .IW//-@/%/+G0VNC6Z =O."
M=0'7-)YY$-YA IIJSNQ&DCT\T6#1>AAD4E)*+C1)VN%\; PG(=$B>  R4T=]
M]FT6K0/0Y)&0YC LV<8!E06IWL/L(WR'T15,7XZGL_/\M_$X33^-+]+9*'V"
M"_QOOOP-1C#Q%_B#LW2)7L!9=C[?OO[Q#<VZN"&FHC8A.$&REV6C,H725)F1
M' /W A)C>5F>8&USD5J ^@]Z*CIY?&@/51; F]^EN*DAO\:$PUJ<U>>@)?+@
M6I)/JB0P9\B6<".9BUD4#8\.Q'G@$:="A5I6/.H+FM.[5^%ZODRY_MF'N_C8
MP19+EQ0C2]D =S92I(-Q3N-;;Z7&_%MY&OA.EQ37P]@SCUZ4Z)>Z_=D4IZYW
M0Q^&%VA<F/X!?GHU@70^^@CQ:C+!*0[_X/UX-%E\^\)/AW>JKGW,\?J 3)<J
M$M"&.(=YH%2A%&0S07V;[>*JP]B[ >\<PRVD5\-I*<]&!&=A.D^3!U+B+ %%
MQTHGM(Y'.X4BM)$SU<$I+;AK4[/X*+3^Y^C#,7"E8V]5OS79V,#W_J:O]2K*
M@8&29OOY!9I(I/".>,TD,5%IS1RCN9%"_L.X^J=494>N)!'5O-!_;\JY:08^
M1Q%<5"2IR,OM&(TYE,-7)4F=@G,.Q$&Z4\[1G1I?JGND0='91@L,E,-(6":,
MBG,HE_0$)2XD230-AG&/V4NC>MF-D$Z-'W5LW^"P]LXZ_-#8650*1^T(10X3
M&8TD5JB2546;0N:"K2ADUV%(-WS/.:)IX,'^EZS%('X.1 :;G0[$8E9%I!3S
MXAM!!((53,; =?-&VP\B[)]K+3R\W?JUFWL:T.AA4PP2E([!SA+-%,7WR$'1
ME X8IB5PP23O=9NRQH=QG21E*KJBZ<7_U<[RV8:DI8F%PZ4IA9+$Q:)@')B/
M(D4F&V7F#X!ZSBM8+5\UH%$-(UV?CALOK2J"?C2I@'$>$\0SCF^>-!;?"!>"
M:",I76T(?:D_' \Q#^/]8]& N!W]BY\W8RV?^F8"_[J"4;QN.NP @&%>1""C
M864.N(!H&\MZ(HT/+@O9Y@YN!W"'*KDY$&LV<;>2]UK4]RT@K@-X<W[7!6+3
M^IH.( ]395/=P9L(5-D[!R*2XM1%<!A#!)C'HQ[CT9+".*%!003OVTCG'8Q
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M?BORK7D-=SX0O;5$_ KIZF)Q@ON03::;C')]EST')HN^'_$TB7*BP#$[%[C
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M:[LEWTO=;8V0(C(91&9,:@T!F$G4)Q6I58;J-=UMVR]^\!ZW,G&64RPMBLI
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MP/S02 L:<8&2=[;^URU9I(_5HC4#&W25&N 'I<B/]HP0 ]BL&B ZXXYJ?!@
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M[?I.VFF^'7@J!B;CM[-0RP_6"H!& ]"H #8Z# N[/H\/#/]()&]_&HR6@#-
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M8R?@T/<<=?24N*Y@)NO2X:&FMCI]W F9[1<QNP=4O:_?#E0#<\ :I6ZX7!-
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M$=];XP,6Z:1D,\\Y>N-^DD;Q7L=3T=8G4);S0W;/%XLYCGQ'.$X,N<=44_:
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M]'R&I>BD3>O>K"@N<9Z_BBQ7Q9J+SUEYOR)_Y[1\R*Z^OZ1U<_"Y+PB5QFP
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M1'(OBBV-].MS8?W&$OW:QK%SHKB?X;+S,E]B$*:>*B[6TVC, I5=Q[]6EMV
MTHSZ--\T3=/?(?AD(KO+?Y7F>DTB]PJ[[UQR/\K-G5+N%=(+F>5^GS^,SC]N
M-_?Z*0]O)=M_TX^HM[>QJ5E)B8 XIDPOVTD(B8@QQ#0)F69GF89.&2^7Q2R-
M:HV6T*@)C)XWP&@Z\,C@"JYV+#H>K8DY<1A0SK36C8-7DKHB:E;*Z3;W.8'T
M7#VR\/\7:93.UWGI.W[:;H043WQOF@[4C7$Z^EL)K)2DG,*4F'8 2OMW3/
MQHK$G,0H"T*G4T8O6BV-;*KZVNW.9*#XOMWM%5VO"_"*U6T??AG8+F#4 -K1
MU.S#,C&KO=-O+2\[W+::#)2'HZ<&FA3FEHG'/F6]-<&K?AT3-"/P,0+3M"@8
MI=G+-"[P >;5=@9>'CZ,W,N#'RUQV]0P.FEQOD(D9*&*8HBS)(2(I-K[0ZF"
M$3,-)P5.4.1T5-,M;FET_*'=JV5;'F;*YKO>R.O?[!"D[>C5'WX3\V9U]-O6
MM"'05[6RUR<Q9\JS0\4KE_6(G)6D[,Q_SCZ6=PU?0GZK'=%#G>,5CD+.@XQ"
M@6D $9,)I%C%,*0\D4G"1)@XL<E%*4LCD;)6=UD\V"0D;[9[UVY/E[&T7S6.
M0FCF1>.QL+G?%>-5#+PO&,\ES;Y>O&KLI>7B]8O=#VQ?T\V_/FZI]DXVHJ27
MU]O=;ON'YI8F\B,0+&(T@UD@M3M!<: ]XXC"C" 9(\%#%<>K'W+'MC;'M7WB
M7-[SMM#I7G>C,5@;E5LN!6NT=JA'U8MT_^FL3_0F9HD2MH\'V"K?XJ!N?PR(
M.WSV1[(^89SI.'8LG$YGL;;X=)S#]CYBMC-86V/:YZ_6]PP]>V7[#YMBOWNJ
MZM (^5 VMKK;Y5S>2?W*Z/?IOJSTD.LUYB-=5QL.YDKY(,5*4A6E6"E(8\8A
MBCB%F 49Y"H*):&Q)*G3QMQ8A9;FOQE[P-$@4S:_,0F4-ID^DXU55<V9VJZF
M'7!CF>LI[<B!M3V=G6^X)C^5G7RD!IS"^H'7\^GK2*5F/G7U ^'Y::NGYPX\
M5GEXU"ZW%,8)_YC_D*(J)OYWN1:W&_%K4?_BDW[AZX/"")N\K""&F*82HBPE
MD(2A)FZ<21DDJ58K<SI"<=5@:=3<& #*961I0EW$'Q@C2N_&F'%3-S4QE@P\
MNW4?+<OSDBG'8&*^G09^]P./H1#Z/=QPUF+>@XRA()T=6@Q^D*_80M/IN72D
M[[::O.4^KZK!MJ\X5F$LJEI\C 1<,:R@9)$)+%09)(0QJ&D3XP0SEL9.L2M>
MM%H:G5Z*:FLO$4\M>W99R[AA=17]#+2MTSOS\$WN^<XT<AZB$$<@/7$(XA#-
M7CC^< 28_<&'8QX^C.Q?/Q5:AZ)XLWU@^::J#71(DY"I"-(D83 2(8*((Y/I
M(P2,9<I"FB">)DX;%5W"ED;-C:Z@K>S@0BB=,-LQJ"_PIMXY'HJ;,]'9 .*5
MOSH%SDI+-J8_9QNK>]Q(Q/3Z_@?],W]X>JAW\9- :7\OX#"-I8 ("PIQ&NF?
MXC1C*$E52*QR \^>O#1ZJ)6S8X%SG+H_^5'63_Q]UWIY/+.X:FW7QZMO:GVX
M^E_//]KSI\[RA5XUIOD<KU\P<+5V\ <^JW:DVI>JXI\)6"O*6+8R(+))9#C,
M/3Q35*I,P93)&*+,%+//$@XQ"N(4!R%) Z=.=N/46=I7WA-*.M@=&#EHEDNN
MV89B8LKQ, KNJR@OX/E=/HU3:=YUDQ?XSA9,?IXZC&C?/3RNMS^E+#,&/O^Q
MT?3S/7\L4\:^?KXS_VT.#2+%I:(<!G&H/1]$$"1QF$!%%<M(&(6Q=*)46\%+
M(\]&[ZJ,.SAH7FZ"@%=&^5^J(HD#3PBL1\2.+Z? >6)F] FQ,T6ZXN65#*V%
MSTI[KI \)SCG^]VHC)O#U-W/U7_<K6*J5)8$"60BS+3?ITD*DUCJ_\D$Q3R0
M3 J[N,#C0Y<7_?<?])%:]G1O8=--%\/LG9@(_N/V[O9ZVS?K3_O<MH[*]/7%
MU3=;_Z/\7,L/M?6H63[!<]6;C^O"7\;V!;OE?/<DQ<><LGR=[_-Z+_;8+R].
M5!A206$B$P6U"R @2\(($J[""(F(8>H4=V\O>FE>0+LW6'4T4EL 6B8,[0?6
M.PYV,_\TZ$Z]*FH!>P'2^F )3-/'T!FPB5J$]8I_H29AMK!<;Q-F_82!]2)-
M;QV3L&XZJJ^"+ H1S3#4L[[4=,42[0AHZ#.1Q8IBI6(6.M6';#]]:8Q4*E<7
M2S#Z.:XZ3I&S(YC!>$S,(?90N!=UO&2RWR*.)Q+F+=IXR;BS(HT7+QKVN7Z2
M^S>T^'ZWV_[(A12O?YJPGP^;]_F&;KCIQ&PRYDN6..[LIFDBA#!',8GV\$,1
M0IHD(8R$_K*Q2+"23H>W[BHL[<,WZH/WZ^T?!3!#"@ZJ@Z/N_\N-# :,BQUC
M3(OVQ+2BE0<EV(WZ@/T$KXP%(-_\<A'W239QAX/HE:@&J#$KFPV'Z3GEC7C2
MP*QG6112?FX2JC^:AH*-R_3S'W3_M-/_?;8F0#Q,L5 1#)#9GY6AA%AE'*I,
MR(2%<9A&3D'= W18&C-6)MR @Q&@M.+FL*#X>0,:2UP6%M[&S(XT)QZ)B5ES
MJD%P3]\>#J/?Y.X!>LR;^CT<J+/$\!&/&KB;==9U=14BA=(@#B"/$()(128Q
MT0R-=B.I_E4B3<SV=D_7EKM69R*<B.\@:+IO[IN1 8J6GO_O_X.C,/O_@2SU
M==R8.H<4*T0RJMWN.,,4HC@AD"0$02H4BX,4!9BF*SWJ^59\W=/=?@Y@GXN;
M#M[75/_39 '^Z"PP80LFH2&-8I%!\U^H@=5+&ARFD.%49#Q&B*2L!O/=1LP'
M92/LWP;(B B9*LEAG!*F@0PC2"4/H.(TH5($!*LA#8D&8CE_!Z*+C<5O]_M=
MSI[VY<2ZWX([NI,=9>)LL;;<@A[U&DZ]U>P!+O<]YJN(^-U+/A<S[Y[Q53//
M]H:O7SFP=7+5-23_;RF^;M7^#SV ;^4/N=Z6[0_+:)KWVUWSIZ]:\K=MTZ"U
M6(488:GG2B@9"?0RBH60(97!S.PNA90D0G&G!LMCM%G:@JKR*[A1&O"C88<^
MS/I[R3?@<;?E)E2^J(T"XFBP_KM>*%-3"-.U4?.H8;6CJ]D&:V)F:]D!&FU!
MRQ)0FE*6C3_\V5AC!O!@C\?VT#Y@]=M$>I1&\[::]@'>64-J+P]UXV<A\]4;
M3>^W.TG?;(5<89:FVBF3,#(1.PCS%%*2(AA%A*0QCU6JL W5/G_PTECS3>E7
M:.6 T<Z.]<[ ZB:P,1!,S45VUEN3RC53.T)Z]"TE-?R.S(^P^K'D@[.'S?)I
M7S.A^4JO_GUPW?6=V7AY*ZO_?MC<\C)ZJ+BC/XV?>[L1Y^?R*R*#1!"10)[%
M'"*N$HA%S* D4L02\2Q"3JGNP]18W,?\W03H&S>'UMJ#QTK],DV:UB$K=7E?
M1Q]GX$C9.3?3XS\QDS0&@%>-";^8<6BL '>M<7")QAI2&7T$DKY+H0]19>[:
MYR/@NE#L?,S3W(N1'JJKO_N3/M0IIG=R0]?FN?I=:XI[Z^O63T**?-.ZHZK)
M+2.<L2P2YC NA4@%%+(8!5"$*(D4$6E,K8(6_*BS-$IM-41HV61JK-56E5_T
MH89Z8YCY]D]N+8VSK]WI85R[B7?^T9J>@/]-!\J^#.N\ S93H=9Y!LZIG*L_
MG#L*OGH0,EM)6'^ M(O&>GRJMTHLIDO)_<;L/7P0^MW/55Y.VV7YK[J-O"D!
MUIJ]]=_T9R+>/.W,9GQUY=U./M)<U%HV%6:JOZV01(Q+%L. D@2B+,00AU1!
M*8* *8Y0HN*1)5ZFMV)I\W2MZV%MTRH]SBN; "T5'UU$9H8WQ&[-M/AQGWC&
MOU3VY@8<(0!M#)J:C0T*Y?O1SMVH@;@!-13U#7H>JM^L&HY6P;';[A?*1W6=
M^09TZK(],UCRTO6 YALLBT)#,RHSM.9ED=]OS-'<;?%W*>[+YCQ-H>*Z9D^$
MTDS0+(-4<0)1R#+(9$2A2CE)E"0R8E:[\ XRES:Q'576$QBHE6X5 '>M/]D/
MNMWLXQG*B>>*/A0]UE8: )#GDH_]<F<NZ&@-Q'FY1OM;A['0W[9;\4>^7M^6
MRPW]RN0'ECR6/CDDDD14$PZ+$&290! %,8$X"A,H<)I@B>,@D$['#D[2E\9,
MC?+-^KQ6O_&TC@8,KMGD-CAVO#49Y!,SF%>TG<EL$&I>:<U-@UD);A XSZEN
MV$,&M"_SZ"I^DOM#^/P;NMO]5-N=R< L5EQR3!E.H/ZO=MP(22".I8*)1%1$
M5'".K1)^9M-X:>0ZT>+6I D>DUU.$'!H+#;+*]1_?K&X%^/?<\/CW^B=<.A8
MM[1W8ZZV=\MY1]PZZ,TY7EUM^&;18[Y>?G/">M(0<%;!P]9^3;7*]]O=%_FH
MO\#OM*C*7#YL-V7H_TIQRA+.$<PXP7K!EV00"^V?4J1")$*<J(@T63MV2[Y^
MH5:L<IK ,[$S4A;X!+N#NHZ'*!8XVZW=/&$WSVS=*%M&LA_5-;6C*H6K"I+^
MUFCVZ'A=F%F(G74U9@_#\R68PYT#"6=G^M#O?YJJDGM-=2:EJ QJ_[60ZFG]
M,5=R)4.4IJ%>+ZD@U8PCLPRR!,<0A9(Q1#4?8:?380N92UO[-"K?@$>C=.F5
MR$;M&_!4*@[66G-''K* WY*(_((Z-1,=\+P[X/GNB&>E,_C8A:<[&=DCY)>-
M+.3.2T?V0)SQD<.MO@H2'!L1Q20@TN0K1TRS3Q1A2#CF$)%8,L&3+$R$4SG-
MJZ*61C]?KY8F<*Q4U8&N'<WXP6QB=G'(5)YD:[H?I(F3EU]FT[G?[/YD9D\5
MH=[FQ>.VH.N_[;9/CY^V>[-?O=4+O,V3%/7";;OY&\TW'[=%\7G37+X*:*3B
MB >0,U.QE\844DP5C*A*TTA114(^H"3"0'4&++OFJ)M@%"V 7BT(DY:\S_=E
M"T,SA6N=R]7$D+BVH4-&2((3IB)(A1XM%/$08L(E5(B)E',>QX%3U=(IQVK.
MH]!%#9)E ,?TT$\=U%&K!$H3;H V K2M  <S;H Q!+PRIOQBQJFYU6OWFC%P
M^FY;,TB7N?O5C 'L0J.:48\;6,_#V+K95T__DA?_>K.3(M^;GU91A!3F(H:<
MA E$*=+3&T<$9DAP(K-(IJ&3!]TA:VE\>*)JN>-5J@J,KB4M?LWO-[G*N5F.
M]A=U<(;>C@$] 3HQRYUB:92[:<.I%_7;=<Y_@M_J_TY2G] "*K\U,#KDS5OA
MHM_PL_H5%K<,8YLKM0H_:8%5T.Y*(H*44C'$BFF7.A(,XDQPR#BF6:12PH53
MH=5>B4MCGJY*GD>MW9BF'W8[OO$*YL2L,Q)'9X*QQL8KS?1+G95LK$%X3CGV
M-PYL72'^MYZDF\.13_*/.JU=2[S;;3?Z1RZKQG^F04.6X8C3D,,D8WJ1F&18
MTU&DO9\P,T6@HS!!3F7PG:0OC9!:RI<G@5I]<-0?G!HPK#N&T^#84=5DD$],
M6RUDO^ZUHVFB!,"OCX+N)VBW,00CO^TXG#28MUW'$'#.VGD,>LC0="2V/^86
MO->OU^V#D;7*4L4201,89EFH72J4:6\JC& 0)*;;!Q%!YL1FUP0MC;B,9H"6
MJID5G-!JN^8:74'4<G_* TY3;T!I%5M)1#>@Q*Q2TV<B43<0GK.'K@B;.66H
MV^3S/*&>ZP?N[E3.T_.J Z_E1JI\OPIX&C$B0JB0.;_@S,2%11RB6$5AD- D
M$\2E=GNW."=^F*V.^Z %50^NEKLWWM":>@.G3B@_KU8"7M7:_N)QI\8*%K^;
M-=TBY]VOL3+_;,O&[JZ7S;:I"X?=T9\:$),GU.[!OA*9PG$<(2BH670%L8 T
MC15,&)-Q2$5&[-R46;5>FL_35.9[K+0MMZJ;^M%E9>F728CH'OENNESL>$[,
MNA,E0C1OR%WK#:D1J I7+_$->9FT&6]ORK]WZLSP-^;%$FBL1FZF))IN7?XM
M$VFLX)TJF<9.^- ]%*7U%+7;9,)6/\G]7=FO)^?U;XV<%26*9DPBO7*2&*)(
M,4@4$C!@42A33%/.G+I>V0I>Y!K*-2K(%F3;;1;_T$V^[5*J#&KMRJCV*D6Q
MT?OP)Z,Y>%4=P'I<9+F"YGF+QE+XS%LV;I"<;^$XWC_P)(MK7^*I9+RRE)6F
MU,>=_*Y7>_D/6:W_3(#0,VW,G[>;IOS5G59C)_>:8HU78E0M3(JBT@O'%<YD
M%H<\@I0$ 42$II E*H)1$L:!7H=I@HN;F-8[UQYT$RMO]8F?1L ^-V&ZC_[#
M@_Y#O1-=??ZL_L9-DE!Q S:R_.N>_GD#6-6[S?$<;>)7 XF8B2!.(,DR/>F%
M60@)(P@F.-'Z4*;_-SE]-:P[ZBWUQ9B^2]^__VMA>2"[@!&>[0BWL;2NLWEB
M*WA56?L+,/;>@,O. %5[?:,VS.-Q[SPCX/> >&*=YSU2GF< S@ZA9Q+KOKE\
MJ]?<_S(/JPLW\C")HE#IN24-$4184,@"3F!&DC1(8Q1@1&VW@)\]>VD;M4:[
M\E.WWVY[CE;_MND(#";FR(/Y_74K>W&PWQP<@<=,6W@.N#AMKEVQO&,+[/D=
MLVU475&UO9UT[9*10<E?Y7T9C%._5R110N((01()I=U=/3M1'@G(XTQ*$HJ8
M<*=FI5?D+(V9CH&SC9Z.WV@?KG;^H@>T)N:P(4 -#RN^#,,TP<3/9+U,"/%E
M@Z\&#E^Y?$19 >,G:2^HZNIQG&Z"+-*NB)(PC<+,!,T@2 -%(>:,(T%P0-+(
MN:[ 95E+HX:RC!)DM*A.@\JZT[>[G>G9YU[)NPMC.XKPA-S$--$#V@2<88&+
M_XH"5^3-7U*@V_"+-05Z;G%?V)R&\[W9;G[(W=[4PS62MIO#[\P2ZVZ7<].N
M-\BRF# H<$+UTL<TL9-!!.-8($236 AEQ2J#I"^-9\["4ELV-/\PRH-2>_N5
M@_NP]*^Q)@5[\G.HZSB#@_[S(FZ_FIL4^9G6>]Y'P&E5.!C!CG6C^S-G6UD.
M-K>]]AS^D&&NZ$=9%%*>YL=]D[L'4]9O4]5B"@-$8A0IF%(:FAJ?VB,5J8 1
M%2P4/,APXK10[1>YM FCTO@&G"5]&K6K@I65XFXNJ@7V=IZJ7T0GGA7&@^GL
ML=KCX]5QM1 [J_]J#\-S-];ASF$T]$5JRLOY7HK28_YUD^^++U]_;=;$&"5,
MX!2&*C:5/D4$F:(,LI0A(H.,"<Y<&*A3VM+(YZAL51 7E.J"5UKAXGK(S@"4
M[;C&&W83TTPG;!.LBJUP\4HOW1)G918KXY^3BMU- ]V:?&,J$Y=Q;>\I+[/]
M?]T\%5*\H?J%T?\R58OS,G?VO91W<F=*DM![O4"0&4F#0$"*N3DI3$PSJU#"
ME. X$91%F=U*>;0F2^.AHYI 2<<8D>'#8>D S0'RU'Z1MJ%5"JHQXP94AH#&
MDAO0&@EM##A:X]%C&@NH7T=JL#;S^E=C03MSNT8_<'"<NMQIJ8=\OU:8_(HF
MF/(LCF!(A7;&8KU*)R1C4 :)4!FB+!:',+UO3B'J5V5:?:7/2H_.EN$K:L5-
M"!U8'Y5VCEJ_#KD="8Y&<+;H] HOD^C;4O'&E*DL/+:+ML'#=^#Y=8%S!YOW
MFGXAP+S_GF%\TN3GE(DW16[V/ VU?=C+AV*5B$0R$L4PX]R49 L"R$*3G8L8
MC7F:L)0Z+>ZZA"W-ISJDU+64!;^5GD"IKV-(1"?.=B3B"[V)260X<(.[SG<A
M,DES^(L"7Z2'>Y?IUUJM=]XS,&S"''4?.\_<[;;W._I0E52+F RT\P&CU)QO
MAC*#U-!)RE$:QG$:*H:<HB:NBEH:A52]IUK]DVI=!Y5*ZT#8CC[\X#8Q>0R%
MS#U2HA<-OX$2U\7-&R?1:_99F$3_'<,HXS_I^JD\8_TF^?=-_ON3+.M>/VU,
M1B\MOK]?;_^HMS^5XBR*N4:5\,2L:P*(41Q#A0D/1*S)13GY(?:BET8I!\W!
M0?4;<%0>&.V!4=^-7!S&PHYLID%X8O*Q!G>"/6IWP+SRDX/X6?G*'9;G_#7@
M"</XK%J<?=W3?1G==^B7I&(:22)3R)40$&&,(4FT.Y1@%B']ETP&@0MY79&S
M-*:J2X8=]+1IH.2$JQT1>4!K8M89 I0SO?3 X)5+KLF:E3AZ#'[.$GV7NP>"
M?E8JY_+0]^YV(SYLU';W<.2B[7I[_[.>5>,T210B,<Q0&)HJC DDH90PC#%G
MF!,5H\0V"-1)\M)HHU+^V#.SK#F4'_4'^X,!]K&(KF.A*)%<0,%B[6VJQ(Q%
MD,$X4 2%<9+&(ES]D#NV?='1:&OP?_5X=!/]I!A/3/TUN.].P&VI#HZZ#\B6
M=$/9/OIV,K1GBKSUBKI3U.T@Y#HB;MV>-UNT[2 SVY&VPQ[@-D<+F:_>;?;Y
M_N<7>9^;Z7ZS_Z3?FA7#8<93D<)8T0PBD<50._ 8<DJ""!$I9&(U%5\3L+09
MM](1')4$1DL[FKD*8C=G^X!F8FIV1,6:!OI,O^")%Y+_Y7[[XZ_ZUM()_QV9
M'V'U8\D%5Q\ZRR??9U+S9?=>Y^YDO]ENBNTZ-STR-$7HKT46^S=;[1G1>_G%
ML,4*\YB'5"F8QN8(,^ ($H(2J#]K1J),A I;%Y;HE;:T3[NML';:*HT!KU4&
M99LO>W^B'^Q^3\TKA!-3P EZC;*@T19\\8V>O0?F%<69O*Y1:#IY6=;H='A6
M_<^8S9NR-J?M0=G?-"YLQ$=9U[J"?76E?HK,?Y@[BY7$DB,L&8Q2*2$BF8*,
MQ@$,TH2K+*881T[QOG,HO;0IH&X[5(#=0<=A@2N3CK3=7N[2QF_B^6>BHMY-
M3X_JAO*!C?'^(W/F&*I)(GPF5?Q%(H7F&(IK$4>SR/95^+O^\3-;Y_>ERF4B
M7<Z>S,_%ZY_FFCNZV^<\?]1+F)4269HBI& 2FRYKB' ]3>D5!PD#+ *%,B;2
M0]2U2[.UD8I94=FST.PY]AL>'M?;GU*6#&4JG8+'H\X%X"V;QE87=QU)NVEH
MGH%YR7KDS;^.!MV $Y, ^UG5JFM9-66)\H$ 3UR[W%6K%RYJ/A#$_FKG0Q\\
M(M3TM2FJU"[>TZJKI"4>KZGK+MW^07?B\V.IT/OM3LE\_Z2_HP^;JMCS?\G\
M_KOFO]MJA?3N3[GCN0EV,W5)2$*2D(0<9CC-(*()ASA@ C*&,T%$A!6/G0-8
M9S1@:4N21E=0*PL:;:L")^!5O@%BNU[370$>Y0X4!HM?;D!MMA0# F?G?%_L
M9I$EOP433SKMNFAMX]O%T<HIYF(!-0.!*5%1@G!X*PP,0+\X%1 WH.<E\QQ(
M_ +CZ#\\>4XCY@]Z?H$ANAA*_1)ZC EH/.]QRA!.!),93#.20J04@Q2G >14
M(9S%" LLW0,:QS6-G6':NMMM?^1E':Y7=9^&7X#:[C3IE/%[>_JG:V+I-8 S
M(AF/(FX:8"*(I$:984IA&L4BHDCQ+ I=6DS]FW3E_7  $CR>8^T'6KNY>?F-
M>>=IR#MG)]Y%M.!U[+WKM^GN]066>;PIQO+^R7!_\X=J?BC^*>GNFQX*N4HX
M#V+)*<0Q5A#A5$*"F(1ZA1(J%-(X384+,0]59&G,_3XO.%T#_>*E8W>4+$=B
MZ$:2?WQ?9/^H,0-4=AS_6EER XPIH+1ERETC-S0GWBRR5.:%]XC<(.O?&G)\
MWN#&>.49Y_%0X)/<U\<%*Y)@R12-( L1-Y'UF?%60QAJ#Y;B6'&>.>4.=@E;
M&O%=./R] 6MSI$C7Z^T?IJ%8Z<+RJJ[1>EL4>A6]5>!_H!L21X#JY?;C+E^#
M\,:P9UQNV?^/Z 9ER?%O4?FWR+DSV?4ALV-/7P,Q,4,>QN!+:PRJ'E^W)X-0
M%Y>J6H/5=GAM =:+EN_^7=<%SMU\J]?T"YVS^N\9QE:_:D>1:S(4IIYP'7S/
MI):#50 SI%?3*#-5-&..(&5$TB#E$19..8(79"R-FPXJ J.C&WM<@M".-$8"
M,S%7G&(R099QA_E>/_Y+<F;]YCL,??ZI=UTZKD:;7AA6T0H?-C\T;VQW/U<D
MDDG( @(316*(TBC6BS6J8)QF/),\E@@KQR7:%5%+^]X/B@TKOG8!2^M%E@>$
MIE]&'0NO-8%9_8@-KKMV'8Q)JJY=$/<B-=>NFWVMXEK''9,V\?YF7(X5"<,X
MC$D" Y&E$-$@@201#&828Y1%2:"HT\FSB_"E\4=?;]UZ1_25,> 7\%MI@V.E
M :>QL5ZD3(+X](L6CV!/U:_X!+67:#Y<*;#$3L(GT QL"WSZC*'9E9I!FT!/
M7IYW?GJJLNP5Q01'&11!JKDM2AG$&@\8X8RQ-$R2D%@E9O5*6AJ1U9F%9J8_
M51=4^KIF7EX#N)N@O,(V,1L-1FQ 5F8/&B/3,Z\]?>8\S1XCSQ,V^V[P==#U
MYKL)A?BP>4_SG2G<)#\K\^LZYGN[7K_?[DP\Q HG21JG(8-4KZ8@(BJ"+&!8
M4WDH4)B(((Q=UU$#55D:O51ZEZ%0)D"WTO=_C3WWLAZ8H2=?4\#](F=?1_R-
M*:"TQ6RIMT8#_&8, K5%'OVF\;!.? AFK<X+'X.YPM9_$.;\1'=_ZVV=R%L=
M=U?A8>_U[XH50HQ)H20, X0@XI)"FC(.>1R0C+ H8RFQ];6N2ED:$3:*@OKX
MOU(5E+K:^UC70>WWK[Q -36)#4')R:_J16&P3W7]R;/Y4[W&M7VI_HL'[BF5
M)-*<GJ:<B)0G(4Q0D$!$J?[8L910!0D+91@'&#&7Z,&3ISM]Y+/U^>!U2BLM
M577<]#D!SW)79R@D4V_;U#O'_D^/+QGL=\?E1,*\6RJ7C#O;,[EXD:]U3W&[
MJ;9B[K;%?B?W^:Z,!V]?4>[&?)-_[E]KW?_U\= [@B:1B'F8PBP2J9[;409I
MQHEIQ1BP5(A 2*?X%I_*+<XEN."Q%V502[7)>6K@L\M*&X$Q$I16CF@&XO4%
M&+KBFF=87V --O&(>EB5C8=^XG7:" 5?>.4V'MK^M9P'&?XZ@C>%$GXV495O
MG^2*L%"@5&&89-H11)(&D$8D@S+FE#-$>8"<(L%M!2^-\*\VM#XH?],$)6NW
M21LPODOXQ?&PX^@I4)Z8?VT WF\!DQKF_'KBKI>VX5U03=X\_*+P%V\AW@6)
M32/QSOLG2M^_E@-IRL'N?W[8:,HM5]%%2<'?OM/-:7:D*7A6K:U7C'$4HI3
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MD"*-0\1,F^9N,G_?ZR]OE1AJC^,$9G' ((JR"-(T"Z$(<98F,J(RM=K3&*K
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M L_4OH4K,M9DT6O]!6(H)/_+_?;'7_6])2?\CLR/L/JQ)(+K3YWEH^\UJOG
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MM(A)'"?<J86.Y;A3<S^: ]RMW*9Q:2?Y=A+4PKOZ(G8VL/4ZO",;W+^P C5
M.0M'K#P[#W9CC^PF. %RZ!"XW3Z,L^JB:%67:C)+"H5R)%(8(:FIR?@"C#$!
M8XIS*J6*D\SIJ.;EXZ?&0(UT-IDV-MC94<IP1 (SAST8SM1P7&>O#+ WQ*@?
M^G'U]K_G$U<-[:W51O%]6<Y+_GPO?Z[?:)'^-9-,T*B(,TCC*-6^!6>0"%Q
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MN'@C)Z"UH&Z,&]B\=M0\':,%YO!.4=#3] ;L= 5]9;L#G4[=VH?N*0Q:C6]
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M)9?'DWP_+Q=/3?:NR>>MZGW6_M^-()^7Z_^2ZUW+J5F>2J67T @2D2&(\YQ
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MFU[0^J&F/O"&SDU?U:]RWL2X?B\?[Y=-19CV8)Q&120C3"!C"=/+,<D@P9&
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M>D# &HGZU3F?N!ADFV)2QO4[>;ZJ1N-.M%,PWL&D/ FAADW@]RLJI.EXUT7
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M&GEI+N?G%ZW8K]7L['4[F+:]>GI>6Y$.I8IO9]5Q;OH8V+O-974IX+3)L"-
M>Y1-.\88_5:$#]LBTT]28M!L5=I(W\4ST:'[R]?[70I;:WDJKCG/] ]DN8\:
M*:[9/[=947ZN4]SJDUJ^H!0%<2(2F"!=7,YG F(28)B0,"4D"$-$C8K+323O
MW-:-1EW0TE>9ACN-P5[EMEVI^&:O=2OR2G^^5[S,\6PB(KC=@C/V]\9L#9K1
MMV'D96D.7P3K96JBZ7&Z<HTM\Z2+V403<+B^336LO;-RMWKN0JSU&;,6:<6R
M94:JH>K6C7JG5F2\;B>VRV"L;/E%S /)"/(@YSY2VQ_?AR30718)3V2,4H]B
MX_@@=V+-;0';2PU86VQS5Y7#*;OL;7R?B1AY[=@I!5K-8LL@F+>*78'6;+W1
MK9VC7:GW+O-G[FI\GWF<R-4XZ7Q:^1G=P][A9W0XV&1^1O< M?V,(SS=OI_
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MC<P<_0"SIHS+6#AEC([A)B6,RVH?\H7!'3U-C>J M3E?;55[:>J??1!27?-
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M*8\HAH$?A+4MZ/$4DA3%J1]XB'*KKIM6H\^-.#X**11W<U H[M[JCA4@UR>
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M'D,9)5Q$B'B<6SE9>TDQ-YJJE-"^MEH-4.IQM;-D7J]V/>VO@-(&$*T.T/H
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M@DR-5$TK@)V00/[4V^HZ!$!K900>4.1G\!Q9VGTC(!_:).Q4 (T.ID<H,%J
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M&4-,40RIDI3GE$5YA%R6'H>QI[::!(A^=9D).ZX/A&_HT^)+8UR;E=X?.0^
MT2O?NHP_*H4. .8Y*PZYQ:45?$YT%F\+,!0$"Q+C'$J6%A!A12$N\@(JCE-$
M4H)2PH85]#D[]M2(KI^@_$3XNBI#*WZ]DQV8V>TR+Y:GY&'0#GV&[A'H"XH"
M64,6J$;0^?%?J&20-3#'*PC9WV*H+;?13Y2AS"9E2EN'[WZVZ56_EJ7XL5@N
MYYRS-*GM-VSZD3.$(2NB'"J6IC*519(*1R/N_*!3([6=S(#60L_ 4NIM/>WM
M ?N]RLT[^:\H+F8H20#=@*O[]6()XADPC<#J]_-?TR*?95GOKTG]U\35!K28
M05OCS^^\!*:_WI1<M5-B3C=?;64&G=#'SS '6';V&'DVZ2P&'MF6LX=BWXAS
MN'9HH[B>#ZXQ&O4H-TI;CO.(L4A)12".!(<(%<QD%2&H:!9GDJ8%YH5+!=D3
M8SD1V0@E8Y^Z)IO@9-=^<,>!M2,:3W %YI>G2+4[R\89V#"-IG@ML=X];IJ6
MMG4%QDT)/E'?'>+.PN6Y.]SQ\4;N#'=6\?VN<.<O&=QXLB[3\??%YMN;AVJC
M[[SNBH<]SA.6%)PF$D:9S#2C1 FDF*=0,"5)QJ-4_^/8=O+X:%,SCCIAP7)7
M3,VYQ^0)<&U9Q1-DP7FE1>N'%A1TDL[ 5E:OO27/0^*[L^2)$<?N*WE>^0-=
M)2TN&L8@]=G@ 8(R2TI'4DUM??WY6M)*OI7-O]MR59AF2<2I@IDBIO1]$4,B
M%8522)QD$<NY=*K6<[E(4^.BY@"6/UF[7RWK$[S&V/D/-V;R,&EV]#7N5 3F
MN$/'X$<MJ"#%R?S!Z94?/8@U*HGZ@_$YTWJ\\U#?ES#1/(N-_* '%\^WI'O[
MT>W[+#A+.=&L&Q-F#C73W.2L,5/&GPH:H:C(G$AXJ"!3HUYSPMGYP+3TCD0[
M>#ILG5OA00[N\.I4@$NC ]CS@!UT?@6AUTOA].P;&RC,R/ZRRR#;]Z%=>+_A
MI:OKGJ*/N]X:2"5QH02!,1::!S-2F(IG.4P%YR+'*)=N[4P.C#$ULC,BSIKN
MN(Y)?8< M..P"V$)3$]]1, ?[;]!&I*<P,%[*>KGXXQ>BOJ(HH=*41_[ZN!L
M$;E>&V)I RYZI?)-]"@O<H;TIA-2(BA$*>$01S&&&56<%[%(LMPI=?_,>-,C
M@$9<L-$[F.59W\TPB+GFU;A ,"H*52=40Q8)O>=GFE%%AD54H&'9(Q<C/7[^
MR!;P7I!73_#3\;6#X+=E96_/;7"&O@#!(=DE-KCXSB\Y.>;8&28V !S(,;&Z
M[ (GI-ZIF8XF<K5YTO[$)"'.1:9PEB4%S)3 FM:U5<=0D<"4(\9C*6.<.+4A
M.3?@U'B]<5WM!.Z_(0-<AZ>@=G ,>@)P%+??8>S 'XVXOGU\%LCX]^"=&G1\
M_YP%! >];S;7#6.9UP^5J0%17?%_/"RJA8F(JG]<2]F6+^*<QTFL"!2I2"&*
M8F-'8LTU62IB+@F-L5,MOK,C3HUG.H%!3^(9Z&0>6"+J/.YVG.,5S<"D<RF0
MSK1C#8Y7WCD_ZJC$8PW"<^:QO_ RZGE3WK'%J@[&-)D"MZO%_VB;2FBR6Z@%
MW;K)VK'%TU9P^F\/=U)\6IMFVIM'D^B[T=]XI[][7]<K(01EA"42YB1*C)4D
M(8DC"O-,,I9$1'#N%.\QBM13H\!.T!FX-Z+68;&R$W88\86==3?RG,Q<CD7
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MUIN5<&B'W\=TLC?5Z4%/^AFHY0>U L!HL.O8Y76?,PP^WUL@1RG&WAT- ^G
MQFG@C=R-O3H,Y:ODWU;ELKQ];%=BE<:((&4JT6?&ULLSO;W2<Z)BP1.<8"&Q
M5<&AHR-,C<R:N"DAO\ME>6]"BK?RVELUAZ$\;_)=#%!@_FFPV0DXP. [#(V]
MO7<Q1".9>^Y0.5E[)V$X8>P=OFXT6^^DV'U3[_07![:BM?!/O_FF)U%_X=V*
M<A-+WWQGGB&IN% (YDF$(,HCKDT^E$#)LD+O?S&+$[=NM8-%F1I=;N/8*_U&
M/>@']A&8Y0KP6GK'*-T+9LC.^!L']] N,>L2NXTJ0%OCK3+;K\Z,;<B]>L O
MQ]9OE]?AXHS;"/9BV/9ZQ5Y^QTOC(=[K+?K?Z/*AB\YX$I7QFZ35@Z:,&Q/1
M\;!>MYW&J^<!$C1-I40IC 11$,FL@#2-3/^X(J98J\BP6SM:G])-C8;[I_1F
M9Z!G6F\%V_@N$ZRU^[ ?X-4I:PI?&E1 #8MIETG!5GU0ZS\TOL+'HV!'[B\V
MP8'Y_LG<;B=IUI_=@W.J9_'9'(X4E^$1_D"!&CXD?*'(#8_@'@_E\#G(8+?L
MMH?&D>HTW=Z1RP0QS&%D<E80XQQ2$<?0],C32P7&*'4J]VX]\M36@'.]CQK9
M_[TI^N3LC+6<#6LGK'^,0SM?35^AP_5% ^33.2/DV[]J.?K8?E4W4 [X4QUO
M,+@OSY,R6=>KZ]5W_:"4:\V?\ZQ@6<83!BF6*429I)#)+((I)81C7F D9%=*
MP(ZS3HYG]0X]K2$0F*EV^]+%3DSG?CLG$+9CH<M1&ZO85",?>-5):@HH@FL+
M[(:TRSF/B>\&.2=&'+LESGGE#S3!L;@H:-N;[4:)IS)'DF%(4&**/^$"$H$H
M)%E*] ",%LKI:-IQ_*E91.<ZL;!'\$7>NF>XN4Z+Z_[5.]B!"<JNXTWH;:<3
M:B_1 .>EMXY.  ULA.-I^Z<-L[MR]66C[[37@WV>$:2R@F!8%"R&2&BJ8S1G
M,,$RX:S(4DICMP+OQP>;&J4ULH+*"#L#Y4[0.NBF#K1QW=R=Q-J.NGPA&)BG
M6O"^-. UDLY 3U:OC2+.(N*[4\3Q <=N%7%6]0.](LY?,Y1*JLV-,I4WC1^K
M[1%>?2F78DY1S&*]&X,<8]-2*XT@0YI(%*<BSZB,D')R'1T?:GHT4M4EOV^-
MK*#2$KIRQE%0;1G#!U3!^:)!J1:SMFLZ0<&74Y -8(MS:'CFBJ/#C<P4Y]3>
MYXFS5[A'OK5'X?16&S<?Y>8+7<KJ5[EJXNX,$2V$_LOOU5Q&.,ZX5# G&8>(
MQ0DD,4GU]BJ7A.)"1L(JU\AET*DQQTYN\V941FQPV\E=&R1:<+#Y)L'O7^S#
MPJRGX#2[A (V,,_T,+U1=3>&6FJP%1NT<IL_?PT%K7T07@B(1XK+\PFU4\2>
M*V8G@OBL;S5:7)^K<OU0/^=KAYF!1W:M5R92IBD6TC4Q2 B/$2("8D'K]#8!
MJ4H4Y%&:R)PGB:1.%=2M1YX:U1]WZ^QDM^EH<.%\V!F405!^,;^9&\#.]J8S
M6%[-3_O11[5&G4%Y;IRZWV#@J8#9)E]7U8,4;^NQFMX\S<:Y%F)A@OKJKUW]
MH&M1]_!Y7ZZ57&CA9#5'R)05IJ;XD-[](E5@R#*A=[\TE20J,LHC)P_:Q1)-
MC?J,+E0_-<;&76_E[]QNJZ9?%C??6"YKBZ4:[G^[?#HMSQ?&G*3 S%D+"1IE
M0*,-:-39^?5V*C4>/U KM>UVUE/,XVF$+XS]GD]<+-6X)Q:^0-P[P_!VXV'$
M_6E=<BE%]5ZK_';Q70]8W_9&==7N]+N<YR(M(DE@@;-84S-6D,A4P5QF@B$<
M<<2LBBLXC#DU\NU$!N;1 &(GM&.,B W<=M3I&<30[H0G^/7D-;2WD]@?ZSG
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M;KP]$<TA2E@!:8:Y-IDD3B3+A<S3^:;<T*4=N062T\G4VDH;[CW^:L;HIU(
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MY(LM6&B$J4[:$R+PVJJG79RE-60UZQ;5I/H7CE%=>F@!J"[C8)#K1.,01#4
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M6 N$ AO6UC)N06KQ?)POVT]_Y+*':M8&>')W\X/<'I?1.<(UDBQWTV?!(!T
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M ,LKM6MS9HQ3P4F1+[S!ILZ5$\A%E1 +PE,JA#2JC-592U:S^?/Z052?#EH
MJ.4ZM3D7E-AHI" ( E:-N"&PO6/0N]0II6"YC;C,\<QJ>IK-@-</H1JDW@+L
M;%!D-F>,8,:YY ;YE!EC+B*;*[>!+6ZD--J$,@[UQB0VFP$O8*2*Z*9!T$W&
MT][AC"7@H)-2]-/9W,*S=!!&=Y6JLD,9HB"Y8S+23 ,_7(-#Z:RK.O[;&&)0
MFUWP@1<NX S^M8RQ32EJR?GQ]G%;$=&W'$KS):A9=-ZRF/O9*L0I1">&BCS$
MFW!-#9;&;M3RJA8P-1G,E<' .P"VA4):#K&GR=</VW_$P06A4:(JS_BE&AEA
M-%(L4N9A93*^4>:R'LNU1%U[8;<-,MYCV7914PN\M,<-X 0\SBY\.>E1KH2F
M  EF-(B*Z3SGA%MD('0).E]*$64:^;VDI26U+34F-;<3<PN LCS_N3M\>71P
M,1H,CD?C/^TX]!*VU#(C8:T9@W@4 3E*<YM=!4&+L]J0,G6E[R2T)=G/+7'Q
MHBE_.26U (//BREX"BE1AJ(1P$#4!!F--1))>244]SB624*\NY"E&'J*JGO9
M@FTK^ZUQ<U=MM;!"QM-2U\*49H8H%1#.4RFXBPE9^$7DN-52$%B A3J);'F+
MIU@<N%<D[::'=N%IMB".[L?]X?7,-YPME(<>AK/"U?NQOP&IYDD\DYY7R@BN
M'%(J<3#PTN>IJ_ ' =EQ#UZ&*K,S;DEPLT[8WI%96*.M:./U"J-55?6K?/:T
MI9HJ"LLRV(!XR,TU<M-]"&]DPLGCP I>HGTON<WF;%L VQJUV0;?;]W:K'YX
M5@7DD\[W./;]"7@IVF!8E%A![)T%RW!"#E.)C/',"A5-+-1CX/VT-EL0W0*P
MUJ7']B*U6HZK&8R>!\FB1B01@KB&K[0T$47.N&,J8<Y+56"^D]1F"ZQ;@-.:
MM-@6F%[$N_F>L&(U]H)*U!''413<@UN>I^.0:A) D-XY:VTL:$#7TM;L.,6]
M [$^/;T?>6:&O&&\SN?%5WL!X*R;6Y14 0<26<%RRU(($%W()8 0% K%J:.A
M3)_B-TEK=CYC6^#W?BVU#'VO^2$7<3(=]SV\L/K8099BU0T)))IB?WJ?5QVW
MB@B1NR(I:1'G),*"LP;E6S@\68*3*(C.74AO=DYD"W;Q0EINRZ[^BMNR$;^&
MBZBIYXAQRB LY *<;4,0-<I*HZCVI,Q5T5TI;WA\90M074;)+0#UTR'[Y&KT
M2H%MM:1=WJ%R,5L<3BK57T00_*0_C9=Q_*WOXTQ0%]&/KH?54^9M8Y5C 2>,
M*!<J*T,AYZ1"E#H?L&(0;I:9Y5N:LX;G=NYS4;0*)!]DT2Q5EIZEP]'P6QQ/
M<Y.7/*JBISCV,G(.T,V9;>YT'IOKD1.2"P@VL'2%VG360/UFX/\ISM3VKNP&
M 7YCXT;\+K$'W[V#=6\'@X<T^*0''#F:;_4X%7,Y(D3/.A"-@J4RB)2XQ,M]
M?9;OE-='S69P_= ';0VIKCU1)WAB3_UU>S(Q;$0DR(ND\S2I@(SWL*,H1?(E
M#\8*U4@](V,SW/T4)V7;B[\%&_I&K9JUD@8SB5%RT>?>] XYQB**,;I$#26,
MEVG+4ELS;?)3''/5KJQVU TL%H%)G%RR',!@4@+J#456^(@8DR90':P,A8JG
MWEV ]W.<2&TK_!TKICK#4*K^SB?)?1(<695;14H""\#G33Q*H;PT#%9!F^KO
MR,]SHK2](FJ%TYX:2%V>'1\>7/YV?'+VQ^5S/K9O'/7LF44;1KU.??V-H@[M
MY.9X,/IS\M@'R%-#!+.P2VD-ID8E@FQDN1&BB-RZH((J=<[Q.E4U..+YF>?C
MT;<^R._3CZ^3W.'V## *BAM>'_AI_]NLX?QC/R3C@DF:(\&215RH7)\:!$J"
M1ND,=2&6,5;OI[4EEQIV1=,*][VDTEK@XS\/4)QQF":K@=HL*QP2$,_SW2,1
M&.&1NT*]V;>(#TN!J;3.UT:([U% "]#S++62\]=#WQ_$9RQ=C=XK32&C<(E+
M1, '0)PQ 9Z&=RBQB#$(E-A2 P(*<-/L+8L]8[EQ.+1K2>2!M<!L=<NN/GD$
MRHVP =";(!KC#J(Q0Z)$"E3E"4LQBD+-2PISUJS9;QZ[KR^FYH'4@H5U%.'-
MOC\#Q/#Y! A,#=76&F1EQ/EJ@4260'#)',W!:20IE#DU7$-4:^#< O2\F!Q?
MCRI;@,IJ,DGW]L[VQUG8AS=V?!TG/4$"U2DQ)*,"Z5C'D>8I(I5T,,X:EPK-
M[UA-3[->2*NQ6(,"6P##*E7[:;G.I.<YQ40SCA2CN5*6Y#LL"<()S!VC,7K)
M"]W\7$E/LQ<[6PW#&A38B@.;H_[D;C2Q@\_CT?W=Z6@*_P;A@L#N8YC+;C3\
M;/O#+.*SX</'>Q)''0WFR!,#@:\T.,M.(*&##@0KX3=KD_;^'7P[@IN][-EJ
M*.\# BTPN9_N)_UAG$Q@O;K^L&+JL&+S.F\CH^$$9#V>(V)LX;N5NF!_@2^[
M0_!Y[N<E4:M^Y6'^Z _22UPS96 G$H2 6/+X%B<56(3@':<!$ZO*Q'M[8K#9
MFZBM7DEMA%@+5M[1_+55R<.5_=[YGC?,^"D.8^KGJD*.E:,:$4*!F^0HLLEC
MA)W&+((_IV29"P7KZ6KV)FNK<5ZC0EL S\5P]G$PT_#Z<#293GK!TD@<S_US
M.<VC5!5R0>8((TCLG+,L%.J)OH:J9N^VMAJ:M2FSX?KE[O ;"'@T_I%%&">5
M^"; T\,:8X(+DUE)U3 OPQARN3[1,>DH]UIKN=S<;%5A\ANO:?86:RN!5K=R
M6F  *S.^0DX/9_./Q_6]X(BMKNX:D9-]/@:D@U/(FT2HML0[6Z:EWL8D-GMS
MM96(+:OF%N#W96G<(Y?SZP*/\DN!.9$\051I!O+#&H'53\ >!MJ#,$RF(@#>
MG,;6Y'[;<:Q62+FMA.V!]SD$G(#<8_];U5-88)-$L+#"8>'E!6]@43J,(,1C
M3"NNK2]3KK\)=6UK;EH/,MX$X(YJVO6R42'P/3@UL'![5H.CJ#AX+)AE!P9B
M.>M30, +5X%9;4*9#M]KR6I;!]0]P6U;Q;049^?C>&?[X<I^!WZHDLD0Q9'5
M.2P#OP-IRPQ*6*1$G,(:EYE5MYZNMG4TW1/2ME9-2Z'VW..=RPY\F9X1(GA-
M/(@-!\2)PL@ZDAT2"R$:PYH4BF,VI[%MW4GW!,%:5-92.#[X#>?V1W8:<B6-
M]^-[>-\\M=^O.J](R@-1B'CA$<>$(,=(0"(P"C( /X+O*T+9A-ZV]27=LPM8
MFRI;$(]L7GS<<YYQ98U&TL$&P95(R"8CD9'2$Q$,UJS,C9_-:6QV"]__I802
MJML>E"-8>B5!F7WBR2N"5%SHD)A VHF(N.<$:2,""CQHJ[@DW.WU&M8:6ELR
MVV]/U[#J4EH+;"78_8<&)?Z?]_UQ!%YAL4U_Y,[I4]@.\K79NRJ9R@1Q"7.!
MHHL4<9K/ ; Q2$1'J%;1AE0FEMZ<QE9>X*H-+:.]J*X5/B>PXF,,DV,0\E&_
MDE_NYW>6'BI38 ,@W%OG243>YN0^I1YI3D3.(S@?>(0?E6EEMP%QK;Q]50R(
M-2NK#69Q@:5+.P!>7E]<&@<IC/8@*T<0CQ)\<6XEBMH03K".X L5Q^$;1+;2
MB=P''NM47AMPN6SSGY98U6LGBWG^D]"#4)!P)D&&U>FGE0K"-@J; (1Q"I9C
M;I^^GPU[#97-IH>:WK+K4E\;H5EEP&:2K'[0TQX# U8ARS-# FMDB?4H<<Z<
M]US"RML/'I=):S;YTS0(=U)4JSH.;BC&GL)>@1?L8&DY#=X(Q\A@DU#"&OSA
MP#B/92SCYC0V6[6[9T@64EU[TSZ/]9PK\V>1*<$B6/L\<E1JADPB"5$5 O7.
M.%*H"]'[:6W)U.H]I7WJ4EH;-NL%%SGWV0.^P$V^C![BME"U2,8Q4E9U"U4X
M=YVE'#D!JYNQX!26RGM<YO;/FZ2U,LE3&S;6Q#*[*ZKA6O"'8Z?CT?@BAGA[
M-RMN/QD-K\$-N*W8T4Q8+ )%ACC81@@V2%M8P50[Z86G.M'E2S2KZL$W>%4K
M<S1UXZB$V-OC\EW$N[DSN\2.(B12AQE*U$-8+YA'6K.0K](33"-SPI8)-5ZC
MJ)4)F%)&JQ:UM"X/_<#)28[8P>4 >OK3'B?4>$D5.* X+YS<KT%Y@5+*J2-*
MH[=E.L"\25HK,RO[V"=W5U0+/+15:VB)(:V]L!#Z0/AC$8^YA)(EC$+"@>)H
MHBYTW?1-TEJ93MFGL=M>4>W96\\?N<JF^\'WG-T_E,&J? 415I!,.0A7R%F(
MR47PT2O-G$YEJEW7$-7*A$DQ<U>3<EH$MP4#OKBD+F]&X^FC V&EU$H9ACA0
M@KB1%FEI!8B0RQ0"5R:6/VM[E;QFKS,WN./6H[ 6[+J+3"T/C1*),PBG,5AP
M'\!YE1CIH QRD3 ,4A3.E_?TMAG\5>Q><X.(VT4Y#6=!'FPWA.,/0YYR O-A
M\--%'%26=;3 XNEHFFLHP%7 7@A82PP6%(T&6:X)"DX$Y5A,#"^?6JQ*C6S[
M_F9O).\Q7[(7!;5HYYVQ"]R^U;!GA;![6C&II4I(:@)"C@QXIH(C+*U*(EGE
M8IG^:3N1W? (W6:\Q3UHN#VH[MS>#48_8JQ&P)S].80'W_3O<@%0Y_+L/$L_
MRV+<=_=9 ).K4?YVSU ?I;8@6P&;!P]:(4-I0+" >9!8NA3+G+UM16[#,V_W
MC.+R&FV9 SICM,K63SK?X]CW0;Z]2)F5#&.$!0&&A,[I4X918D%S;155MI#!
M?8NTAJ?0-NB-[JZI-D#OR>V!>.[)\1G=WHYF,[IZDJC@<)+ 1SYK5#0A*R((
MC5=W;!.QI0Z%WZ2MX9FR#>5_:M)5Z\Y:%OBKJM-6^26>>>YRJPJ<'"POC2,R
M(%/$/ 6W)'+C>/E<T :$-CQUMD&S6+<66V D-Y=F3WGOB+<4^8@A&N01G(X$
M;G1@SAO"K8#MH>$ZKH;'U.X9FH5TUX(JPTY*T4_/4N>[KWKP7H!1/AM6+C'\
MEV\[?+.#6'7Z 3GV_31G,B8W!\/P_!L+G^QQD0)AC*!<1 0+4\+"Y XCP0FF
ME'AF;)D6_@68:?8HO%B=8M-J;X$]WHG9\VI,Z\NF"'YP'\ >+(IU)NH>[&P\
M\"00E;D3@LG%=MRE/"0&)!.%5[A,?F"_?#9[@%]LO;08+"W81':S&]([&QB$
MN!Z4D >&: 1[-2@'_F V&0HB:=_*:+9HH)U ?Y<J=QR1#1(83UN 7F*<A94*
MP7+55"?%"%\)AQQ$RPQPQT.A5AOET5NLWJ"EZ'V/*FL=\+[#$*W[N[M!)4H[
M>!!E=YA&X]N9,A^$RDV^*1\YDH9;$*K*L;+32#!MN-84QT)-?S<DL-EJA&)X
M+*&>%KC.W2$\"Y;1N>V'W)@.,RY4R!6Q.H+G'XP%Z6"'6"+<,V<,L65&!RX1
MTO!(]Q+*?M&&;7O)MP(XN8-VU5PS<]##3B2-P5\PQAKP%XQ'+AB"0@Q,6..]
M+%0"L$1(PTVH]@*<[27?<-73U=@.)_#6V4VVA[D35Z/C_O<8JEF8DUPH'6)D
M! EB(ZP#Z9&&6 E)&2-$3-R^G,6WJL!I@U<U?'&U(%1*R+HVZ/S;KR_D?0+?
MJ'Y4_23_UD5,O^2_OUYTGST?.+L=#>.T[R=_A64P>\-1Y_+PHGM^U3T[/3N^
M^JWSZ>ME][1S>7EP>O3IX+)[>79\?M&Y[)Q>'>2//&=HTK\%-;P!J'>^X-<G
M7I:YG+_G!9)JYRM^G\8AF("_[#A-97QMA_,)1+E::#3HAX?)R><+O#U.)[*#
M1Q=L862")51' !:31H [+A@R@7$4:0B":"HC+31II0[R=YY(LPL1>7[E8#2Y
M'\<K4.FG03[556#QJ9("6<T\B%,1Y+BW*$JN!,Y7.%F9-$O=G#3KY>T?VR^&
MV#2)C!8;],NO7[X<7/S][/BR^_FT>]P]/  ;=WAX]O7TJGOZ^?SLI'O8[5QN
M8<@W?'!=!GP;/FHRW*?QSWE;Y_[P^GP\&L*7?@[=89A-Z9P\MGZN/M,'@($(
M%[JY6 Q:=QA)@?/\9^H VD(CP@E53G/)8IE*GQJ(WSD=T[\>]E/?YUYQ3Z^!
M!>K[<?*TX((6L,2Q1:ZZUN>41=;Z@# +)'<]#K;07:3-Z&NZ3<9^,?@B9U._
M#EML-,$5O+KX>G@%'S[]O(5M?/[[=9G -5359.FJ+/"]G]Z/<_E&S@I75S-6
MU8U$X710'IFH'.(48F;+1$1!,ARH3]*+,AV_-B9Q]POC;[QHE=/@J*$V*C4;
MB\(-$\C@&%'23"?,)(=5UXQ86N<REL':R]ODA;788BMV</B?7[N7W1S0YC@7
MC,?!5><S^$FGOX,E^0+![C9^WR9/K<OBO9N#FNS@BGGM3W!,+KCH.$=2>H,X
M#A)I!O&*H8HDC 7GH8R?LHZJ7:W=BF>O6AD _6@2!HXUA0A-^GPL"%*P"3O'
M>"2E>H1O1E^S%JTVU"P;L0+*:;'9.NKFQ=T%-Z>S37YQX;=K2QZ^1E%-YB8K
ML[I(>!_#?#1+ALXPP _N1A,[^#P>W=\MY$DP5XJ%B%0U1MJ!@VVP!$?>TMQ<
MUH7(R]R<?R>ANQJEYT]]+ U;3<6J%<$U)X9A@Q3.7=@DE\A*1E'"G%)FN,&\
MC+G:E?)F#5E)/"[;MKWJN,56KWMZ>/:E<W7P7ULEXQ9_NRZK]RI%-5F]Q\/7
M)ZT^C3-W5@NI"+("@QLN$VR4)!<=!>6B-88K429=MH:HVH[Y5Z$X"BRB%WE0
M0@J(!VN0T]PCB;VSA')KRLT[?96JQL<XUX*/5P_]=]5#BZU)Y^#BM'OZ^?*\
M<W'YV\%6CM2+1]1E5];35I-QZ=CQ$+:17&5^>6,7D*.\],3P[!\[^,/G*1!*
M2B1U%(0( WM&F<35:Q3M?%=IZ;E/6&:!*&-#0#'QW,,'QSRHEP.!5EAL,2>D
MC$UYE:1F#4HMF'AQ9Z@6\;?8E%QT?N^<?MW&@CS\9GWY[Q64U);Y_A;!UYRW
MPJI@\4=_>G-X/YG"9C%^A J6Q(6@$XI$$\"+3<@RZ\#SC5AS3J(LM*8V)'#W
MK/?:URRXW9X&[[A&J9H;H7,!<(#50Y/,/K^,N-"DUTTI;#J[73^>7N:V"^BJ
MQ98H9WU/K\XNMJM76/SM^D*D5RBJ+42:UQJN<($YQH$DPP Y#)0:K40N17"!
M170\&4F$+I/;6$/4[B'2BT<O!OH>!RL\\L)9Q+DQ2$=/ <6.$IQH8*S,V=HZ
MJIH.D>K!Q\L0J28]M-B:G%^<001R]??SDUQ)='K4^<^OW?-\I+2%;7G]6759
MF@VIK<GNO#K?\2GE%Z/U03MDE*GN_^1&.)H#SK","G:4J O-GGN+M!K:YJQ^
MP:JUP(S$PF&?+YG@W(Y7(]C.+<(>D*P@JG"%C/![J&S61M6+I17M<<IHJ\66
MZ_/9V=$?W1.P!$?=; P^=S^== XN+SM;G>>O>UI=UFMCBFNR7Y]'H_!G?S
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M"^=(.R^02IA;'RA/A:+>]]'9[+#@IM%:4*<M0.SQ:!S[U\/#>WCW$/C(@Z6
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M1YR/)UQB58<D<_R$!,]E00+V!R>E0H1I$KUF1I+2Z91W$]WL=EL>M&6UV"K
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M<U$2CVF%;);.[\?^!CZ1>UQNX$P23;A4SB/E&2@Q!8:TI!890:E,6#/F2E\
MK)VIC5:5^G]D534!E(8;U+PIAG_>PVY='0=?W=CAYI&7),)CC$$&P8.UD!RT
MI#5&0G,IE:3&J^5RJ55=;$K1MQ'N]4^$^]8HN\7G6Y>=S[D",_?]/KWJ7)Q?
M="\[?W2/.MW3X[.++P=YXO?6QUZ;/[NNT[ MN:GID.PR7F=<7<2[W.)O>/T(
M7A.4,M8'1"+@EBLED$F2()4T9@D+IWFA.LI7**K/Y;B(W^+P/DZ.8<%W0(SC
MH1T<WD^FHUN ;J[!'@VOJVZ(LZKL3S\^Q]'UV-[=]+T='(RC?;&1Y-.)X#DB
M)+?MSD,'C"88&:9#,BIY$TO'R77SU.S15BVH?-V5:!0 +?"^G\^C>Y1'%L=<
M\I.KT2'L'Z-!/^2=;H%38H-4(B(38T0\8(PTSU.XHS/11>6M*3-":GN:FSVE
M*@+E/2FPQ3[ P>'AUR]?3PZN.D=G5[]U+@[/OIQ?='[KG%YV?^^<G%UN?X%D
MTR?7M?]OQ4E=NW^.FFY& U@"DYE7>3J:/M5>&?!;#0:(!@SHY"1I9)70R(L8
M DF*:&S+[&MKZ:KQ^,;[^]O[RIE_1RFM<-ZHP!FBAF'$:9[,*!Q!%C-EF%=!
M%&_5OA7A#>_I]6%MS7%.<86VV"9>?OWRY>#B[V?'E]W/I]WC[F$>CG1X>/;U
M]*I[^OG\[*1[V.U<'L6I[0^VBHW>]?S:XJ/MN:K)2I[&/^<M+&#_/A^/AO"E
MCP^W10]O<EIWTATN?J8/NS,(="$70&"KC=DYI E"[T@,LIP11*WC#$N+B2C3
M^*X&XG=*7#V,H[WL7P_["1SHX?0U>JI5V;,I,J:90][Q7"@N%=)!RCS#VUB,
ME9)V^6;SRHS4>U_<K'7<-\:>Y9N*ZJ@%\<Y!^&^([BKZCT?C=:+^WI_TC,>8
M!&)AZP&6N X$:6DHLA'XE,%:Y<J<V[V+S&;@N@>X+#</*J:[%@#S"CX'3DL8
M5>G:+_'6Q7'/2A&I=OEJE@,>!*7Y6((APKS@V E%59D0>Q4US5K%@LH?U:R)
M%J#I23B74SL,=APF7^]R^ _ZQEC.F?+>X)1@"5*?".().#,18Q2$9Y'*P+E4
M9<S;)N0UB[?=4;"Z]5F-*FD!S@Y'L.R&T_'L+*P_^<>G'Y_BT-_ KO"/:B$*
MED]4<>Y&0DUNCF*0X28AZYUSPFGO69D ^2W*FDD%[G_3K%5#K43< S='HUO;
M'_9(<H3RQ) FN6TQMP&"=Q60IAB"^!2<D:4ZH*RGK.EV'W7BX$V0[:"4%H!L
M(8D.K%4AU1_]Z<W#P=#<5A.(JZ(5 @FL-4@,"V1-GDP9?9"<B^12F>A@(_+:
M!K==$/'BS*-N];0 <RL6:/9!JK5)%"518)^KS2WBGH%78$U$S-$DX2>P092Y
M@+J&J&8NO+1B ]U*+VV$6&9DOAZ99P$;XE "WS:?049D*9:(&:PQ8<Q:628K
MN8:HMIFP+17_%J"VU$(; #6WN"]8FIM@9HF25(!P. M@@I/*[/ \Y"%R2@3W
MJLRIX1N$M0Q8VP)@&5@U:J,%X )#?A?'TQ^YA'>:B][_>=^_F]7,/ZY#*7E0
MAD3@(8_LTIXCDY,]QA#+HI+ 5AD7; /BFKE2M_\-LFX]M1EZ"RO5)*5MSL]0
M'3#B!F"B!4@0<TXA9I+@UY;);&Q 7+/VK79 ; JX+;73 L!]N@>)PMJ<6VJ5
MRQQ",H@$GV-Q"=03,-R>RJ0L8YZ;,HG9YW2T%$;;JGE4F\Q;A)CN[=UX]&UF
MR^><4*%#;BF!:(@@%.9AQR<N#^[2Q.4FEBZ5R8"]3E.SA9?[0M*.NF@!JKY8
M$.4PCG\L2FG.2IZ/*[4"IY&XB+@ _6N;%XB5#'Y E'!EC-(:HIKMNE$:5W5I
MH^$;:V<)7-#XR  PLSC7._J;X6@PNO[Q8(=5),1IC!31/A_=6F0EYX@EDFOH
M#8YVDVMH[WIIL]TO2L&HK.P;!M5O3P6"+Y:&QP[K)!'GR8+-)1AI0RA2P2JA
M(,[E+R;\K4+0ZV]HMHE$2;C4)-4&L3$93WL7N41N=JAE@A%."X1CY& E->R\
MBE'DL7#@[GGEV$9[%CQU8;^"?RWO5<]>VPP^]A?Y;R_C-@!CCF>1O'"Y@T^2
M I:("APY&Q70;ASC-C=>VZBV:G-H-!E4[:"R9:5O(;^&U?ZE/^S?WM\^%/'
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M!]X5(TWDB>TWN/,I3KHZ2&4/3+HZ1'YCS[JY,:,I)K2F4/274RW*Q9C <ZL
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M4F&RS8O 7N1U#<C307('E$-KK ,8/EH[HT2)2?H$VI+U*E;K%XMRX'D(4N?
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M)FELBFI7$Z])X)%KX$[5X52ZMM '!,:X5"+HR'B;UY)AZ!]IV-,Y779+C7:
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MUZ3W8>CA;QBW?+\E8 :2:A>#[I\OYJOU\F)33[)Y0?I(BKH\FPNBRTB92,9
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MOF3ENOGPB>4Z&!\*B&CJR&VM 9WP( 6:NA^K%-EFR-*^%([["M<<<4T4U0$
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MZO&,' 9<PWFC.VB]G88XO9A>_IQ8HQ43!L&4S$&Y(""(0"FQ2HEE[^HXKB.
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MLY;?XV(ZSZL]T0=D%,50K$W0!171UCG+")3/<V,+?7F4(0Z;9.OI'?/A">W
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MJQ+8<!)MA\F3J>>/Y*K3 NAUPW F[40H%FRI"S!;!D$F ]+9'(S4W)?[2<<
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MJCH/Y=:82SYAA9OHZZ3MH *HK&KKOB@@A*9_,&1L=;;M(VXOU :'H?!X'NL
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M-NH:>ERF<0.E87R^!9#V<$ '4+IN7J)51J:\7IOK.8=<HD:5P+A D5[T H)
M5:G8K4O)&11MV@X>DZ@_&.WC\8V]8P>:OS,8_;:S7Q?9.')DS$&0DE3@6)]J
MF B(S)62T6C7YGGHDV*-&W8? 5"'.:(75%$<D![5QS-OI$?@.@50M"H@!,5
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M"-D%$$(B_E-T0#0)/-$8D]L=)OVD4<!/>& 0\'>[QN#9(PSLS0QZQW0CE]J
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M10  #P              @ $     9GDR,#(S97@R,3$N:'1M4$L! A0#%
M  @ B("V5DT)>]O3 P  PA$   \              ( !6 4  &9Y,C R,V5X
M,C,Q+FAT;5!+ 0(4 Q0    ( (B ME9EHS/)"P@  -8J   /
M  "  5@)  !F>3(P,C-E>#,Q,2YH=&U02P$"% ,4    " "(@+96;C,*=Q$(
M  #F*0  #P              @ &0$0  9GDR,#(S97@S,3(N:'1M4$L! A0#
M%     @ B("V5I=&[,)?!0  21<   \              ( !SAD  &9Y,C R
M,V5X,S(Q+FAT;5!+ 0(4 Q0    ( (B ME;)[GUD<@4  %D7   /
M      "  5H?  !F>3(P,C-E>#,R,BYH=&U02P$"% ,4    " "(@+96Y' "
MHR.W! !9&S$ $               @ 'Y)   :&%E+3(P,C,P-# Q+FAT;5!+
M 0(4 Q0    ( (B ME8I51Y;XAL  )@V 0 0              "  4K<! !H
M864M,C R,S T,#$N>'-D4$L! A0#%     @ B("V5F9VP*EH+@  N]\! !0
M             ( !6O@$ &AA92TR,#(S,#0P,5]C86PN>&UL4$L! A0#%
M  @ B("V5J?X"#'CM   4PL( !0              ( !]"8% &AA92TR,#(S
M,#0P,5]D968N>&UL4$L! A0#%     @ B("V5A0\-6[,M@$ 38X2 !0
M         ( !"=P% &AA92TR,#(S,#0P,5]L86(N>&UL4$L! A0#%     @
MB("V5A??76+!% $ ;J , !0              ( !!Y,' &AA92TR,#(S,#0P
?,5]P<F4N>&UL4$L%!@     ,  P \@(  /JG"     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
